user_id,prompt id,pmid_id,selection,annotation,outcome,comparator,intervention,invalid prompt,prompt reason
edin,82,2875419,Significantly increased,"Weight gain was higher for glargine (difference: 0.77 kg, P < 0.001).", Weight Gain , detemir , glargine ,0,
edin,17,2366143,No significant difference,"No significant differences in the interval to delivery, birth weight, and neonatal outcomes were observed between the 2 groups.", cervical Bishop's score , placebo , antibiotic therapy ,0,
edin,75,3281242,Significantly increased,"Continuous abstinence was higher for varenicline than for placebo subjects at the end of treatment (Weeks 9?12: 53.1% vs. 19.3%; odds ratio [OR] 5.9; 95% CI, 3.7?9.4; p < .0001) and through 24 weeks follow-up (Weeks 9?24: 34.7% vs. 12.7%; OR 4.4; 95% CI, 2.6?7.5; p < .0001).", continuous abstienence at 24 week follow up , placebo , varenicline ,0,
edin,64,1764008,No significant difference,Differences in the duration of the active-first and the second stages of labor were not statistically significant., duration of labor stages , epidural analgesia , Meperidine analgesia ,0,
edin,79,2875419,No significant difference,"The proportions of patients achieving A1C <7% were also similar (44.1 and 47.8%, respectively, P = 0.254), but significantly fewer glargine- than detemir-treated patients reached A1C <6.5% (16.5 and 22.7%, respectively, P = 0.017).",  number of patients with A1C <7%  ,  glargine  ,  detemir  ,0,
edin,13,2366143,No significant difference,"No significant differences in the interval to delivery, birth weight, and neonatal outcomes were observed between the 2 groups.", neonatal outcomes , antibiotic therapy and tocolysis , tocolysis ,0,
edin,88,2944158,No significant difference,"IV therapy duration did not differ between groups (P = 0.22),", therapy duration , staff inclination replacement , routine replacement ,0,
edin,42,2674549,Significantly increased,"The proportion of patients who achieved an ACR20 response at week 14 was 33.1% in the placebo plus methotrexate group, 44.4% (p?=?0.059) in the golimumab 100 mg plus placebo group, 55.1% (p?=?0.001) in the golimumab 50 mg plus methotrexate group and 56.2% (p<0.001) in the golimumab 100 mg plus methotrexate group. At week 24, median improvements from baseline in HAQ-DI scores were 0.13, 0.13 (p?=?0.240), 0.38 (p<0.001) and 0.50 (p<0.001), respectively.", HAQ-DI score , placebo and methotrexate , 50mg of Golimumab and methotrexate ,0,
edin,51,524504,Significantly decreased,"With misoprostol, more women delivered within 12 hours (57.5% vs. 32.5%, p < 0.01) and 24 hours (98.7% vs. 91.4%, p < 0.05), spontaneous rupture of the membranes occurred more frequently (38.8% vs. 20.5%, p < 0.05), there was less need for oxytocin augmentation (65.8% vs. 81.5%, p < 0.05) and fewer additional doses were required (7.5% vs. 22%, p < 0.05).", administration of oxytocin augmentation , dinoprostone , misoprostol ,0,
edin,43,2674549,Significantly increased,"The proportion of patients who achieved an ACR20 response at week 14 was 33.1% in the placebo plus methotrexate group, 44.4% (p?=?0.059) in the golimumab 100 mg plus placebo group, 55.1% (p?=?0.001) in the golimumab 50 mg plus methotrexate group and 56.2% (p<0.001) in the golimumab 100 mg plus methotrexate group. At week 24, median improvements from baseline in HAQ-DI scores were 0.13, 0.13 (p?=?0.240), 0.38 (p<0.001) and 0.50 (p<0.001), respectively.", HAQ-DI score , placebo and methotrexate , 100mg of Golimumab and methotrexate ,0,
edin,48,524504,Significantly increased,"With misoprostol, more women delivered within 12 hours (57.5% vs. 32.5%, p < 0.01) and 24 hours (98.7% vs. 91.4%, p < 0.05),", number of women who deliver within 12 hours , dinoprostone , misoprostol ,0,
edin,77,3281242,Cannot tell based on the abstract,, time to make first quit attempt , placebo , varenicline ,0,
edin,77,3281242,Significantly increased,"Varenicline-treated subjects made their first quit attempt significantly earlier than placebo-treated subjects (p = .0074), with a median of 17 versus 24 days, respectively (Figure 2).", time to make first quit attempt , placebo , varenicline ,0,
edin,53,524504,No significant difference,"Although not statistically significant, a lower Caesarean section (CS) rate was observed with misoprostol (7.5% vs. 13.3%, p > 0.05) but with the disadvantage of higher abnormal fetal heart rate (FHR) tracings (22.5% vs. 12%, p > 0.05).", abnormal fetal heart rate , misoprostol , dinoprostone ,0,
edin,60,524504,No significant difference,Hyperbilirubinemia 2	9 (11.3%)	5 (6.0%)	NS,  Hyperbilirubinemia  ,  misoprostol  ,  dinoprostone  ,0,
edin,70,1764008,No significant difference,There was no significant difference in the incidence of nausea and vomiting between the two groups (epidural 6% vs. meperidine 4%).,  nausea and vomiting  ,  epidural analgesia  ,  Meperidine analgesia  ,0,
edin,40,2674549,No significant difference,"The proportion of patients who achieved an ACR20 response at week 14 was 33.1% in the placebo plus methotrexate group, 44.4% (p?=?0.059) in the golimumab 100 mg plus placebo group,", ACR20  , Golimumab 100 mg and placebo , placebo and methotrexate ,0,
edin,62,1764008,No significant difference,"There was no statistical difference in rates of vacuum-assisted delivery rate. Cesarean deliveries, as a consequence of fetal bradycardia or dystocia, did not differ significantly between the groups.", rates of vacuum-assisted delivery rate , epidural analgesia , Meperidine analgesia ,0,
edin,95,2944158,Significantly increased,"For individual IVD dwell times, the clinically indicated group devices had a median dwell time of 85 hours (quartiles 51 and 121 hours), and those replaced routinely had a median dwell time of 71 hours (quartiles 48 and 90 hours) (P < 0.001).,The maximum IVD dwell time was 1,023 hours (43 days) in the clinical replacement group, and this cannula was still working well on removal for completion of therapy.",  IVD dwell times  ,  routine replacement  ,  staff inclination replacement  ,0,
edin,39,2674549,Significantly increased,The addition of golimumab to methotrexate in patients with active RA despite methotrexate therapy significantly reduced the signs and symptoms of RA and improved physical function., physical function , methotrexate , golimumab and methotrexate ,0,
edin,55,524504,Cannot tell based on the abstract,,  Uterine Hyperstimulation  ,  dinoprostone  ,  misoprostol  ,0,
edin,55,524504,No significant difference,Uterine Hyperstimulation	2 (2.5%)	1 (1.2%)	NS,  Uterine Hyperstimulation  ,  dinoprostone  ,  misoprostol  ,0,
edin,3,3298351,Cannot tell based on the abstract,, venous ulcer healing , no treatment , compression therapy ,0,
edin,3,3298351,Significantly increased,The changes of ulceration area were statistically significant regardless of the type of compression therapy., venous ulcer healing , no treatment , compression therapy ,0,
edin,15,2366143,No significant difference,"Clinical characteristics including gestational age at enrollment, frequency of contractions, cervical Bishop's score, and white blood cell count on admission were similar in the 2 groups.", gestational age , placebo , antibiotic therapy ,0,
edin,26,3233526,Cannot tell based on the abstract,,  side effects  ,  no treatment  ,  daily single iron tablets  ,0,
edin,26,3233526,No significant difference,No side effects were reported throughout the duration of the study.,  side effects  ,  no treatment  ,  daily single iron tablets  ,0,
edin,30,3233526,Cannot tell based on the abstract,,  hemoglobin levels at week 28  ,  no treatment  ,  twice weekly single iron tablet  ,0,
edin,30,3233526,No significant difference,No significant difference was found between the treatment groups for hemoglobin levels at 28 weeks.,  hemoglobin levels at week 28  ,  no treatment  ,  twice weekly single iron tablet  ,0,
edin,46,2674549,Cannot tell based on the abstract,, serious adverse events , 50mg of Golimumab and methotrexate , 100mg of Golimumab and methotrexate ,0,
edin,46,2674549,No significant difference,"The proportion of patients who achieved an ACR20 response at week 14 was 33.1% in the placebo plus methotrexate group, 44.4% (p?=?0.059) in the golimumab 100 mg plus placebo group, 55.1% (p?=?0.001) in the golimumab 50 mg plus methotrexate group and 56.2% (p<0.001) in the golimumab 100 mg plus methotrexate group.,During the placebo-controlled portion of the study (to week 16), serious adverse events occurred in 2.3%, 3.8%, 5.6% and 9.0% of patients and serious infections occurred in 0.8%, 0.8%, 2.2% and 5.6%, respectively.", serious adverse events , 50mg of Golimumab and methotrexate , 100mg of Golimumab and methotrexate ,0,
edin,93,2944158,No significant difference,"There was no statistically significant difference in group outcomes for any phlebitis (P = 0.34), infiltration (P = 0.57), occlusion (P = 0.75), or accidental removal (P = 0.43).",  infiltration  ,  staff inclination replacement  ,  routine replacement  ,0,
edin,81,2875419,No significant difference,Hypoglycemia risk was similar., Hypoglycemia , glargine , detemir ,0,
edin,34,3233526,Significantly increased,"There was a significant increase in ferritin in Group C (P = 0.03) at 28 weeks.,Group A consuming two iron supplementation tablets once weekly (100 mg iron per week, n = 70), Group B consuming one tablet twice weekly (100 mg iron per week, n = 70) and Group C, consuming one tablet daily (50 mg iron per day, n = 70).", ferritin levels at week 28 , twice weekly single iron tablet , daily single iron tablets ,0,
edin,27,3233526,Cannot tell based on the abstract,,  side effects  ,  no treatment  ,  twice weekly single iron tablet  ,0,
edin,27,3233526,No significant difference,No side effects were reported throughout the duration of the study.,  side effects  ,  no treatment  ,  twice weekly single iron tablet  ,0,
edin,90,2944158,Significantly increased,"This review included six trials (n = 3,455) and reported no clinically important or statistically significant difference in catheter-related bloodstream infection or phlebitis between IVDs that were routinely resited (at 48-96 hours) or resited on clinical indication, yet there were significantly lower costs in the group resited on clinical indication",  cost per patient  ,  staff inclination replacement  ,  routine replacement  ,0,
edin,18,2366143,No significant difference,"Clinical characteristics including gestational age at enrollment, frequency of contractions, cervical Bishop's score, and white blood cell count on admission were similar in the 2 groups.", white blood cell count , placebo , antibiotic therapy ,0,
edin,23,3233526,No significant difference,No significant difference was observed with respect to pregnancy or birth outcome across the groups., birth outcome , daily single iron tablets , weekly supplements of two iron tablets ,0,
edin,16,2366143,No significant difference,"Clinical characteristics including gestational age at enrollment, frequency of contractions, cervical Bishop's score, and white blood cell count on admission were similar in the 2 groups.",  frequency of contractions  ,  placebo  ,  antibiotic therapy  ,0,
edin,56,524504,Cannot tell based on the abstract,,  Meconium stained AF  ,  misoprostol  ,  dinoprostone  ,0,
edin,56,524504,No significant difference,Meconium stained AF	15 (18.8%)	7 (9.6%)	NS,  Meconium stained AF  ,  misoprostol  ,  dinoprostone  ,0,
edin,54,524504,Significantly increased,"However, uterine tachysystole (p < 0.05)) and meconium stained amniotic fluid (p > 0.05) occurred more often in the misoprostol group as did abnormal heart rate tracing (22.5% vs.12%, p > 0.05) (Table 1).",  uterine tachysystole  ,  dinoprostone  ,  misoprostol  ,0,
edin,67,1764008,No significant difference,Active phase of first Stage of labor (h)	2.49 ± 1.40	2.40 ± 1.55	NS,  pain levels during first stage labor  ,  Meperidine analgesia  ,  epidural analgesia  ,0,
edin,37,3233526,No significant difference,"There was a significant difference in mean hemoglobin and ferritin levels in Group B at 38 weeks (P = 0.018 and P = 0.035, respectively) but this difference was not clinically significant (hemoglobin >12 g/dL, ferritin >19 ?g/L).", ferritin levels at week 38 , twice weekly single iron tablet , daily single iron tablets ,0,
edin,85,2944158,No significant difference,"IVD complication rates were 68 per 1,000 IVD days (clinically indicated) and 66 per 1,000 IVD days (routine replacement) (P = 0.86; HR 1.03; 95% CI, 0.74-1.43).", IVD comlication rates , staff inclination replacement , routine replacement ,0,
edin,76,3281242,Cannot tell based on the abstract,,  frequency of quit events by day 35  ,  placebo  ,  varenicline  ,0,
edin,76,3281242,No significant difference,"By the end of the quit window (Day 35), 391 (80.5%) varenicline subjects and 121 (73.3%) placebo subjects reported making a quit attempt (p = .062).",  frequency of quit events by day 35  ,  placebo  ,  varenicline  ,0,
edin,41,2674549,No significant difference,"At week 24, median improvements from baseline in HAQ-DI scores were 0.13, 0.13 (p?=?0.240), 0.38 (p<0.001) and 0.50 (p<0.001), respectively.", Median HAQ-DI score , Golimumab 100 mg and placebo , placebo and methotrexate ,0,
edin,89,2944158,Significantly increased,"The overall number of IVDs per patient was significantly less (P = 0.004) for those replaced on clinical indication (mean 1.5, SD 0.8, median 1, quartiles 1 and 2) than for those routinely replaced (mean 1.8, SD 1.1, median 1, quartiles 1 and 2)",  frequency of replacements  ,  staff inclination replacement  ,  routine replacement  ,0,
edin,49,524504,Significantly increased,"With misoprostol, more women delivered within 12 hours (57.5% vs. 32.5%, p < 0.01) and 24 hours (98.7% vs. 91.4%, p < 0.05),", number of women who deliver within 24 hours , dinoprostone , misoprostol ,0,
edin,58,524504,No significant difference,"More neonates in the misoprostol group had first minute Apgar scores lower than 7 (12.6% vs. 6.1%, p > 0.05), or needed neonatal resuscitation (11.4% vs. 9.9%, p > 0.05) but none of the babies had birth asphyxia,Neonatal resuscitation	9 (11.3%)	9 (10.8%)	NS",  Neonatal resuscitation  ,  misoprostol  ,  dinoprostone  ,0,
edin,96,2858204,Significantly increased,"In the intention-to-treat analysis, complete healing of the index ulcer was achieved in 37 patients at 1-year of follow-up in 25/48 (52%) in the HBOT group and 12/42 (29%) in the placebo group (P = 0.03).,n the per-protocol analysis, complete healing of the index ulcer occurred in 23/38 (61%) in the HBOT group and 10/37 (27%) in the placebo group (P = 0.009)",  frequency of healed index ucler after 1 year  ,  placebo  ,  HBOT   ,0,
edin,80,2875419,Significantly increased,"Improvements in A1C were ?1.46 ± 1.09% for glargine and ?1.54 ± 1.11% for detemir (P = 0.149), with similar proportions of patients achieving A1C <7% (P = 0.254) but more detemir-treated patients reaching A1C <6.5% (P = 0.017).", number of patients with A1C <6.5% , glargine , detemir ,0,
edin,91,2944158,No significant difference,"Resite on clinical indication would allow one in two patients to have a single cannula per course of IV treatment, as opposed to one in five patients managed with routine resite; overall complication rates appear similar.", IVD complications per person , staff inclination replacement , routine replacement ,0,
edin,44,2674549,Cannot tell based on the abstract,, serious adverse events , placebo and methotrexate , 100mg of Golimumab and methotrexate ,0,
edin,44,2674549,No significant difference,"During the placebo-controlled portion of the study (to week 16), serious adverse events occurred in 2.3%, 3.8%, 5.6% and 9.0% of patients", serious adverse events , placebo and methotrexate , 100mg of Golimumab and methotrexate ,0,
edin,22,3233526,No significant difference,No significant difference was observed with respect to pregnancy or birth outcome across the groups., birth outcome , weekly supplements of two iron tablets , twice weekly single iron tablet ,0,
edin,92,2944158,No significant difference,There were no local infections or IVD-related bloodstream infections in either group., phlebitis , staff inclination replacement , routine replacement ,0,
edin,65,1764008,No significant difference,"Oxytocin augmentation After initiation of Analgesia	197(100)	192(96)	NS,Administration of epidural analgesia with 1% lidocaine do not prolong the active-first or second stages of labor significantly, and do not increase the incidence of oxytocin augmentation",  oxytocin augmentation  ,  epidural analgesia  ,  Meperidine analgesia  ,0,
edin,4,3298351,No significant difference,"In all patients, independently of the type of compression therapy, a few significant statistical changes of ulceration area in time were observed (Student?s t test for matched pairs, p < 0.05). The largest loss of ulceration area in each of the successive measurements was observed in patients treated with the four-layer system ? on average 0.63 cm2/per week. The smallest loss of ulceration area was observed in patients using compression stockings ? on average 0.44 cm2/per week. However, the observed differences were not statistically significant (Kruskal-Wallis test H = 4.45, p > 0.05).", venous ulcer healing , two-layer bandage , four-layer bandage ,0,
edin,74,3281242,Significantly increased,"Continuous abstinence was higher for varenicline than for placebo subjects at the end of treatment (Weeks 9?12: 53.1% vs. 19.3%; odds ratio [OR] 5.9; 95% CI, 3.7?9.4; p < .0001)", continuous abstienence at week 12 , placebo , varenicline ,0,
edin,97,2858204,No significant difference,"Hypoglycemia (symptoms and blood-glucose <3.0 mmol/l) within 6 h after treatment occurred in two and four patients in the HBOT and placebo groups, respectively (n.s.).",  hypoglycemia occuring after treatment  ,  placebo  ,  HBOT   ,0,
edin,86,2944158,No significant difference,"Time to first complication per patient did not differ between groups (KM with log rank, P = 0.53).", time until first complication , staff inclination replacement , routine replacement ,0,
edin,71,1764008,No significant difference,"The higher intensity of the motor block of lidocaine was not associated with any harm in terms of obstetric outcome, duration of the second stage of labor, obstetric intervention or neonatal outcome.",  obstetric outcome  ,  epidural analgesia  ,  Meperidine analgesia  ,0,
edin,20,3233526,No significant difference,No significant difference was observed with respect to pregnancy or birth outcome across the groups., pregnancy , daily single iron tablets , weekly supplements of two iron tablets ,0,
edin,83,2875419,Significantly decreased,"Insulin doses, however, were significantly lower for glargine: 43.5 ± 29.0 versus 76.5 ± 50.5 units/day (P < 0.001),Moreover, trial data suggest that, although insulin doses are indeed higher in patients using detemir twice- versus once-daily, once-daily detemir doses are still higher than once-daily NPH and glargine doses (3,10,11). At present there is no clear explanation for the increased dose requirements for detemir",  frequency of insulin doses  ,  detemir  ,  glargine  ,0,
edin,2,3298351,No significant difference,"In all patients, independently of the type of compression therapy, a few significant statistical changes of ulceration area in time were observed (Student?s t test for matched pairs, p < 0.05). The largest loss of ulceration area in each of the successive measurements was observed in patients treated with the four-layer system ? on average 0.63 cm2/per week. The smallest loss of ulceration area was observed in patients using compression stockings ? on average 0.44 cm2/per week. However, the observed differences were not statistically significant (Kruskal-Wallis test H = 4.45, p > 0.05).", venous ulcer healing , compression stocking , four-layer bandage ,0,
edin,66,1764008,Cannot tell based on the abstract,,  preanalgesic visual analog pain  ,  epidural analgesia  ,  Meperidine analgesia  ,0,
edin,66,1764008,No significant difference,"The preanalgesic visual analog pain scale scores were similar between the two study groups (epidural, 9 ± 1.2 vs. intravenous meperidine, 9 ± 1.3; P = 0.09).",  preanalgesic visual analog pain  ,  epidural analgesia  ,  Meperidine analgesia  ,0,
edin,29,3233526,Cannot tell based on the abstract,,  hemoglobin levels at week 28  ,  no treatment  ,  daily single iron tablets  ,0,
edin,29,3233526,No significant difference,No significant difference was found between the treatment groups for hemoglobin levels at 28 weeks.,  hemoglobin levels at week 28  ,  no treatment  ,  daily single iron tablets  ,0,
edin,45,2674549,Cannot tell based on the abstract,, serious adverse events , Golimumab 100 mg and placebo , 100mg of Golimumab and methotrexate ,0,
edin,45,2674549,No significant difference,"During the placebo-controlled portion of the study (to week 16), serious adverse events occurred in 2.3%, 3.8%, 5.6% and 9.0% of patients and serious infections occurred in 0.8%, 0.8%, 2.2% and 5.6%, respectively.


Conclusion:", serious adverse events , Golimumab 100 mg and placebo , 100mg of Golimumab and methotrexate ,0,
edin,73,1764008,No significant difference,"As shown in table 4, infant outcome showed no evidence that the type of analgesia had any adverse effects on neonatal Apgar scores.",  neonatal outcome  ,  epidural analgesia  ,  Meperidine analgesia  ,0,
edin,10,3298351,Cannot tell based on the abstract,,  higher percentage of healed area  ,  Compression stocking  ,  layer compression  ,0,
edin,10,3298351,No significant difference,"Table I
Comparable characteristics of patients treated with Maxis compression stockings and ProGuide two-layer and Profore four-layer compression systems,Ulceration area [cm2] (x ± SD)	4.7 ±4.18	5.3 ±3.93	6.0 ±3.98	p > 0.05,In the group of patients who used Maxis compression stockings complete healing was achieved in 8 (53.3%) ulcerations, in the groups of patients treated with layer compression systems, complete healing was achieved in 10 (62.5%) ulcerations treated with the two-layer compression system and 9 (60%) ulcerations treated with the four-layer compression system. The differences were statistically significant (p > 0.05).",  higher percentage of healed area  ,  Compression stocking  ,  layer compression  ,0,
edin,31,3233526,No significant difference,"There was a significant difference in mean hemoglobin and ferritin levels in Group B at 38 weeks (P = 0.018 and P = 0.035, respectively) but this difference was not clinically significant (hemoglobin >12 g/dL, ferritin >19 ?g/L).", hemoglobin levels at week 38 , twice weekly single iron tablet , weekly supplements of two iron tablets ,0,
edin,9,3298351,Significantly increased,"However, greater dynamics of healing was observed in patients treated with the four-layer Profore system ? the average loss of area during the whole 12-week observation period was 0.63 cm2/per week.",  faster healing dynamics  ,  Compression stocking  ,  layer compression  ,0,
edin,63,1764008,No significant difference,"There was no statistical difference in rates of vacuum-assisted delivery rate. Cesarean deliveries, as a consequence of fetal bradycardia or dystocia, did not differ significantly between the groups.", c-section , epidural analgesia , Meperidine analgesia ,0,
edin,38,2674549,Significantly decreased,The addition of golimumab to methotrexate in patients with active RA despite methotrexate therapy significantly reduced the signs and symptoms of RA and improved physical function., symptoms of RA , methotrexate , golimumab and methotrexate ,0,
edin,84,2875419,Cannot tell based on the abstract,,  drop-out rate  ,  glargine  ,  detemir  ,0,
edin,84,2875419,Significantly decreased,"Detemir-treated patients had less weight gain and more often achieved A1C <6.5%, but the drop-out rate and daily insulin doses were lower in the glargine group.",  drop-out rate  ,  glargine  ,  detemir  ,0,
edin,94,2944158,No significant difference,"Occlusion, n (%)	5 (3%)	4 (2%)	RR 0.77 (0.21, 2.80), p = 0.75,There was no statistically significant difference in group outcomes for any phlebitis (P = 0.34), infiltration (P = 0.57), occlusion (P = 0.75), or accidental removal (P = 0.43).",  occlusion  ,  staff inclination replacement  ,  routine replacement  ,0,
edin,87,2944158,No significant difference,There were no local infections or IVD-related bloodstream infections in either group., infections , staff inclination replacement , routine replacement ,0,
edin,7,3298351,No significant difference,"Initial CEAP score (x ± SD)	11.9 ±1.12	11.2 ±1.3	12.6 ±1.4	p > 0.05,The statistical analysis showed homogeneity of study groups in terms of age, sex, initial ulceration area and the initial value of CEAP; C-6 score.",  CEAP scores  ,  compression stocking  ,  two-layer bandage  ,0,
edin,5,3298351,No significant difference,"The statistical analysis showed homogeneity of study groups in terms of age, sex, initial ulceration area and the initial value of CEAP; C-6 score.,Initial CEAP score (x ± SD)	11.9 ±1.12	11.2 ±1.3	12.6 ±1.4	p > 0.05",  CEAP scores  ,  two-layer bandage  ,  four-layer bandage  ,0,
edin,33,3233526,Significantly increased,"There was a significant increase in ferritin in Group C (P = 0.03) at 28 weeks.,Group A consuming two iron supplementation tablets once weekly (100 mg iron per week, n = 70), Group B consuming one tablet twice weekly (100 mg iron per week, n = 70) and Group C, consuming one tablet daily (50 mg iron per day, n = 70).", ferritin levels at week 28 , weekly supplements of two iron tablets , daily single iron tablets ,0,
edin,28,3233526,Cannot tell based on the abstract,,  hemoglobin levels at week 28  ,  no treatment  ,  weekly supplements of two iron tablets  ,0,
edin,28,3233526,No significant difference,No significant difference was found between the treatment groups for hemoglobin levels at 28 weeks.,  hemoglobin levels at week 28  ,  no treatment  ,  weekly supplements of two iron tablets  ,0,
edin,19,3233526,No significant difference,No significant difference was observed with respect to pregnancy or birth outcome across the groups., pregnancy , weekly supplements of two iron tablets , twice weekly single iron tablet ,0,
edin,12,2366143,No significant difference,"No significant differences in the interval to delivery, birth weight, and neonatal outcomes were observed between the 2 groups.", birth weight , antibiotic therapy and tocolysis , tocolysis ,0,
edin,24,3233526,No significant difference,No significant difference was observed with respect to pregnancy or birth outcome across the groups., birth outcome , twice weekly single iron tablet , daily single iron tablets ,0,
edin,35,3233526,No significant difference,"There was a significant difference in mean hemoglobin and ferritin levels in Group B at 38 weeks (P = 0.018 and P = 0.035, respectively) but this difference was not clinically significant (hemoglobin >12 g/dL, ferritin >19 ?g/L).", ferritin levels at week 38 , twice weekly single iron tablet , weekly supplements of two iron tablets ,0,
edin,11,2366143,No significant difference,"No significant differences in the interval to delivery, birth weight, and neonatal outcomes were observed between the 2 groups.", interval to delivery , antibiotic therapy and tocolysis , tocolysis ,0,
edin,72,1764008,No significant difference,"Women in both groups were similar in both obstetric and demographic characteristics,The higher intensity of the motor block of lidocaine was not associated with any harm in terms of obstetric outcome, duration of the second stage of labor, obstetric intervention or neonatal outcome.",  obstetric intervention  ,  epidural analgesia  ,  Meperidine analgesia  ,0,
edin,36,3233526,No significant difference,"Group B, on the other hand, achieved significantly lower ferritin levels compared with Group A and Group C at 38 weeks,,Group A consuming two iron supplementation tablets once weekly (100 mg iron per week, n = 70), Group B consuming one tablet twice weekly (100 mg iron per week, n = 70) and Group C, consuming one tablet daily (50 mg iron per day, n = 70).",  ferritin levels at week 38  ,  daily single iron tablets  ,  weekly supplements of two iron tablets  ,0,
edin,59,524504,No significant difference,The mean cord pH and the base deficit were comparable in the two groups.,  Core blood pH  ,  misoprostol  ,  dinoprostone  ,0,
edin,57,524504,Cannot tell based on the abstract,,  perinatal death  ,  misoprostol  ,  dinoprostone  ,0,
edin,57,524504,No significant difference,Perinatal death	0	1(1.2%)	NS,  perinatal death  ,  misoprostol  ,  dinoprostone  ,0,
edin,61,524504,No significant difference,Birth trauma 3	0	2 (2.5%)	NS,  Birth trauma  ,  misoprostol  ,  dinoprostone  ,0,
edin,98,2858204,Significantly increased,"After two weeks of treatment, the reduction in ulcer area was doubled in the HBOT group (P = 0.037).",  downsizing of ucler area 2 weeks after treatment  ,  placebo  ,  HBOT   ,0,
edin,32,3233526,No significant difference,"There was a significant difference in mean hemoglobin and ferritin levels in Group B at 38 weeks (P = 0.018 and P = 0.035, respectively) but this difference was not clinically significant (hemoglobin >12 g/dL, ferritin >19 ?g/L).", hemoglobin levels at week 38 , twice weekly single iron tablet , daily single iron tablets ,0,
edin,69,1764008,Significantly increased,Women who received epidural analgesia had a significantly higher incidence of hypotension compared with women who received intravenous meperidine (30% vs. 0; P < 0.0001).,  hypotension  ,  Meperidine analgesia  ,  epidural analgesia  ,0,
edin,14,2366143,Significantly decreased,Women in the antibiotic group had a significantly lower incidence of postpartum infections compared with women in the placebo group., infection , placebo , antibiotic therapy ,0,
edin,21,3233526,No significant difference,No significant difference was observed with respect to pregnancy or birth outcome across the groups., pregnancy , twice weekly single iron tablet , daily single iron tablets ,0,
edin,8,3298351,Cannot tell based on the abstract,,  venous ulcer healing  ,  Profore compression  ,  ProGuide system  ,0,
edin,8,3298351,No significant difference,"greater dynamics of healing was observed in patients treated with the four-layer Profore system ? the average loss of area during the whole 12-week observation period was 0.63 cm2/per week. The value of the same parameter in patients treated with the two-layer ProGuide compression system was 0.55 cm2/per week and of those treated with compression stockings 0.44 cm2/per week. Although the changes of ulceration area in each analysed group were statistically significant (p < 0.001), inter-group differences were not found (H = 4.45, p > 0.05).",  venous ulcer healing  ,  Profore compression  ,  ProGuide system  ,0,
edin,52,524504,No significant difference,"Although not statistically significant, a lower Caesarean section (CS) rate was observed with misoprostol (7.5% vs. 13.3%, p > 0.05)", Caesarean section rate , misoprostol , dinoprostone ,0,
edin,78,2875419,No significant difference,"Improvements in A1C were ?1.46 ± 1.09% for glargine and ?1.54 ± 1.11% for detemir (P = 0.149), with similar proportions of patients achieving A1C <7% (P = 0.254) but more detemir-treated patients reaching A1C <6.5% (P = 0.017).", improved A1C , glargine , detemir ,0,
edin,50,524504,Significantly increased,"With misoprostol, more women delivered within 12 hours (57.5% vs. 32.5%, p < 0.01) and 24 hours (98.7% vs. 91.4%, p < 0.05), spontaneous rupture of the membranes occurred more frequently (38.8% vs. 20.5%, p < 0.05), there was less need for oxytocin augmentation (65.8% vs. 81.5%, p < 0.05)", spontaneous rupture of membranes , dinoprostone , misoprostol ,0,
edin,68,1764008,Cannot tell based on the abstract,,  pain levels during second stage labor  ,  Meperidine analgesia  ,  epidural analgesia  ,0,
edin,68,1764008,Significantly decreased,"Women who received epidural analgesia reported lower pain scores during the first stage (epidural, 3 ± 3 vs. meperidine, 6 ± 4; P < 0.0001) and second stage (epidural, 4 ± 3 vs. meperidine, 8 ± 2; P < 0.0001) of labor.",  pain levels during second stage labor  ,  Meperidine analgesia  ,  epidural analgesia  ,0,
edin,6,3298351,No significant difference,Initial CEAP score (x ± SD)	11.9 ±1.12	11.2 ±1.3	12.6 ±1.4	p > 0.05,  CEAP scores  ,  compression stocking  ,  four-layer bandage  ,0,
edin,25,3233526,Cannot tell based on the abstract,,  side effects  ,  no treatment  ,  weekly supplements of two iron tablets  ,0,
edin,25,3233526,No significant difference,No side effects were reported throughout the duration of the study.,  side effects  ,  no treatment  ,  weekly supplements of two iron tablets  ,0,
edin,47,524504,Significantly decreased,"The induction-delivery interval was significantly lower in the misoprostol group than in the dinoprostone group (11.9 h vs. 15.5 h, p < 0.001).", induction-delivery interval , dinoprostone , misoprostol ,0,
edin,191,2517154,Cannot tell based on the abstract,,  Dysmenorrhea scores  ,  Placebo  ,  Infliximab  ,0,
edin,191,2517154,Significantly increased,"Over the whole observation period, the infliximab group had a slightly higher intake of pain killers (P < 0.01), and higher dysmenorrhea scores (P < 0.001 for physician assessment, for patient VAS scales and for patient diary).",  Dysmenorrhea scores  ,  Placebo  ,  Infliximab  ,0,
edin,159,2708184,Cannot tell based on the abstract,,  6-minute walk test  ,  Body-weight supported treadmill training combined with Lokomat (Pre-test)  ,  Body-weight supported treadmill training combined with Lokomat (Post-test)  ,0,
edin,159,2708184,No significant difference,"<td colspan=""8""><hr></td>,<td colspan=""8""><hr></td>,<td colspan=""8""><hr></td>,<td colspan=""8""><hr></td>",  6-minute walk test  ,  Body-weight supported treadmill training combined with Lokomat (Pre-test)  ,  Body-weight supported treadmill training combined with Lokomat (Post-test)  ,0,
edin,128,2871176,Cannot tell based on the abstract,, ADA postprandial plasma glucose goals less than 10.0 mmol/l , Placebo plus glimepiride , Liraglutide (1.8 mg) plus glimepiride ,0,
edin,128,2871176,Invalid Prompt,, ADA postprandial plasma glucose goals less than 10.0 mmol/l , Placebo plus glimepiride , Liraglutide (1.8 mg) plus glimepiride ,1, I don't have required information in abstract and I can't open the rest of article. I keep getting 404 page not found error 
edin,114,2871176,Cannot tell based on the abstract,,  Patients reaching HbA1c goals less than 7.0%   ,  Liraglutide (1.2 mg) plus glimepiride  ,  Liraglutide (1.8 mg) plus glimepiride  ,0,
edin,114,2871176,Significantly increased,"At week 26, 42% and 21% of subjects treated with liraglutide 1.8 mg reached an HbA1c < 7.0% and ? 6.5%, respectively, compared with 8% and 4% for placebo (Fig. 4). The estimated proportion of subjects treated with either liraglutide 1.2 or 1.8 mg reaching ADA/EASD and IDF/AACE HbA1c targets was substantially greater compared with either placebo (P < 0.0001) or rosiglitazone (Fig. 4; P ? 0.0003), with more patients reaching < 7.0% with liraglutide 1.8 mg compared with 1.2 mg (P = 0.018).",  Patients reaching HbA1c goals less than 7.0%   ,  Liraglutide (1.2 mg) plus glimepiride  ,  Liraglutide (1.8 mg) plus glimepiride  ,0,
edin,211,2206488,Cannot tell based on the abstract,, C-reactive protein (mg/l) , identical amounts of gelatin infusion , dextran-70 infusion was administered at a dose of 7.5 ml/kg before the initiation of cardiopulmonary bypass and at a dose of 12.5 ml/kg after the cessation of cardiopulmonary bypass ,0,
edin,211,2206488,No significant difference,"There was no significant difference in IL 6, IL-6r and C-reactive protein values between groups.,Forty patients undergoing coronary bypass surgery (n = 32) or aortic valve replacement (n = 8) were enrolled in this prospective, randomized, double-blind study. Two groups were formed. In group A (n = 20), dextran-70 infusion was administered at a dose of 7.5 ml/kg before the initiation of cardiopulmonary bypass and at a dose of 12.5 ml/kg after the cessation of cardiopulmonary bypass. Group B served as a control with identical amounts of gelatin infusion (n = 20).", C-reactive protein (mg/l) , identical amounts of gelatin infusion , dextran-70 infusion was administered at a dose of 7.5 ml/kg before the initiation of cardiopulmonary bypass and at a dose of 12.5 ml/kg after the cessation of cardiopulmonary bypass ,0,
edin,179,2864284,Cannot tell based on the abstract,,  Pruritus  ,  Chloroquine  ,  Dihydroartemisinin-piperaquine  ,0,
edin,179,2864284,Significantly decreased,<td></td><td></td><td></td><td></td>,  Pruritus  ,  Chloroquine  ,  Dihydroartemisinin-piperaquine  ,0,
edin,132,2871176,Cannot tell based on the abstract,,  Proinsulin : insulin ratio  ,  Placebo plus glimepiride   ,  Liraglutide (1.2 mg) plus glimepiride   ,0,
edin,132,2871176,Significantly decreased,Reductions in the proinsulin : insulin ratio were greater with both liraglutide 1.2 and 1.8 mg compared with either rosiglitazone or placebo (Table 2; P ? 0.02).,  Proinsulin : insulin ratio  ,  Placebo plus glimepiride   ,  Liraglutide (1.2 mg) plus glimepiride   ,0,
edin,134,2871176,Cannot tell based on the abstract,,  Proinsulin : insulin ratio  ,  Placebo plus glimepiride   ,  Liraglutide (1.8 mg) plus glimepiride   ,0,
edin,134,2871176,Significantly decreased,Reductions in the proinsulin : insulin ratio were greater with both liraglutide 1.2 and 1.8 mg compared with either rosiglitazone or placebo (Table 2; P ? 0.02).,  Proinsulin : insulin ratio  ,  Placebo plus glimepiride   ,  Liraglutide (1.8 mg) plus glimepiride   ,0,
edin,103,2871176,Significantly decreased,"Decreases in postprandial plasma glucose from baseline were greater with liraglutide 1.2 or 1.8 mg [?2.5 to ?2.7 mmol/l (baseline 12.9 mmol/l for both)] compared with placebo (?0.4 mmol/l, P < 0.0001, baseline 12.7 mmol/l) or rosiglitazone (?1.8 mmol/l, P < 0.05, baseline 13.0 mmol/l).", Postprandial plasma glucose , Placebo plus glimepiride , Liraglutide (1.2 mg) plus glimepiride ,0,
edin,143,2871176,Cannot tell based on the abstract,,  Reductions in systolic blood pressure  ,  Rosiglitazone plus glimepiride   ,  Liraglutide (1.2 mg) plus glimepiride   ,0,
edin,143,2871176,No significant difference,"Although decreases in systolic blood pressure occurred with either liraglutide 1.2 or 1.8 mg (2.6?2.8 mmHg), they were not significantly different from placebo or rosiglitazone (0.9?2.3 mmHg).",  Reductions in systolic blood pressure  ,  Rosiglitazone plus glimepiride   ,  Liraglutide (1.2 mg) plus glimepiride   ,0,
edin,188,2517154,Cannot tell based on the abstract,,  Tissue examination by routine pathology  ,  Placebo  ,  Infliximab  ,0,
edin,188,2517154,No significant difference,"During surgery, no obvious differences were observed in the extend of the disease, the macroscopic aspect of endometriosis (vascularization and sclerosis), the duration of surgery and bleeding estimates. Routine pathology (FC) also showed no obvious differences between the two groups.",  Tissue examination by routine pathology  ,  Placebo  ,  Infliximab  ,0,
edin,163,2708184,Cannot tell based on the abstract,,  Berg Balance Scale score  ,  Body-weight supported treadmill training combined with Lokomat (Pre-test)  ,  Body-weight supported treadmill training combined with Lokomat (Post-test)  ,0,
edin,163,2708184,No significant difference,"<td colspan=""8""><hr></td>",  Berg Balance Scale score  ,  Body-weight supported treadmill training combined with Lokomat (Pre-test)  ,  Body-weight supported treadmill training combined with Lokomat (Post-test)  ,0,
edin,189,2517154,Cannot tell based on the abstract,,  Pain estimates after surgery  ,  Placebo  ,  Infliximab  ,0,
edin,189,2517154,No significant difference,"After surgery, all pain estimates decreased to less than 10% of the baseline in both groups (Figs 1 and 2), and no differences were found between the placebo and the infliximab group (two-way analysis of variance).",  Pain estimates after surgery  ,  Placebo  ,  Infliximab  ,0,
edin,176,2864284,Cannot tell based on the abstract,,  Headache  ,  Chloroquine  ,  Dihydroartemisinin-piperaquine  ,0,
edin,176,2864284,Significantly decreased,<td></td><td></td><td></td><td></td>,  Headache  ,  Chloroquine  ,  Dihydroartemisinin-piperaquine  ,0,
edin,178,2864284,Cannot tell based on the abstract,,  Parasitaemias associated with gametocytaemia  ,  Chloroquine  ,  Dihydroartemisinin-piperaquine  ,0,
edin,178,2864284,No significant difference,<td></td><td></td><td></td><td></td>,  Parasitaemias associated with gametocytaemia  ,  Chloroquine  ,  Dihydroartemisinin-piperaquine  ,0,
edin,147,2871176,Cannot tell based on the abstract,,  Pulse variations  ,  Placebo plus glimepiride  ,  Liraglutide (all doses) plus glimepiride  ,0,
edin,147,2871176,Significantly increased,Changes in pulse for all doses of liraglutide were significant vs. placebo (P ? 0.002).,  Pulse variations  ,  Placebo plus glimepiride  ,  Liraglutide (all doses) plus glimepiride  ,0,
edin,197,3187863,Significantly increased,"The women randomised to the MU had acupuncture in 55.1% of the cases, a significantly higher rate compared with those randomised to the NU (37.9%; RR 1.45, 95% CI 1.25?1.69) and SU (37.9%; RR 1.45, 95% CI 1.22?1.73) (Table 2).",  Pain relief: Acupuncture  ,  Normal unit & Special unit  ,  Midwife-led unit  ,0,
edin,192,1852268,No significant difference,"In this study, ertapenem was as effective as piperacillin?tazobactam for the treatment of acute pelvic infection, was generally well tolerated, and had an overall safety profile similar to that of piperacillin?tazobactam.,The most common single pathogen was Escherichia coli . At the primary efficacy endpoint 2?4 weeks post therapy, 93.9% of patients who received ertapenem and 91.5% of those who received piperacillin?tazobactam were cured (95% confidence interval for the difference, adjusting for strata, ?4% to 8.8%), indicating that cure rates for both treatment groups were equivalent.", obstetric/postpartum infection or gynecologic/postoperative infection ," Intravenous piperacillin?tazobactam, 3.375 g every 6 hours "," Inravenous ertapenem, 1 g once a day ",0,
edin,204,4106715,Cannot tell based on the abstract,,  Prolonged abstinence from smoking rates to 12 months  ,  placebo  ,  high Ab group  ,0,
edin,204,4106715,Significantly increased,"Subjects with high Ab were also significantly more likely to be abstinent for 12 months compared to placebo (18.0% vs. 6.0%, p=0.014; OR of 3.84; 95% CI, 1.32?11.20).",  Prolonged abstinence from smoking rates to 12 months  ,  placebo  ,  high Ab group  ,0,
edin,164,2708184,Cannot tell based on the abstract,,  Berg Balance Scale score  ,  Manually-assisted body-weight supported treadmill training (pre-test)  ,  Manually-assisted body-weight supported treadmill training (post-test)  ,0,
edin,164,2708184,Significantly increased,"<td colspan=""8""><hr></td>,<td colspan=""8""><hr></td>",  Berg Balance Scale score  ,  Manually-assisted body-weight supported treadmill training (pre-test)  ,  Manually-assisted body-weight supported treadmill training (post-test)  ,0,
edin,121,2871176,Cannot tell based on the abstract,, ADA fasting plasma glucose goals between 5.0 mmol/l and less than 7.2 mmol/l , Rosiglitazone plus glimepiride , Liraglutide (1.2 mg) plus glimepiride ,0,
edin,121,2871176,Invalid Prompt,, ADA fasting plasma glucose goals between 5.0 mmol/l and less than 7.2 mmol/l , Rosiglitazone plus glimepiride , Liraglutide (1.2 mg) plus glimepiride ,1, I get 404 not found error when I want to see the whole article 
edin,160,2708184,Cannot tell based on the abstract,,  Late Life Function and Disability Instrument  ,  Body-weight supported treadmill training combined with Lokomat (Pre-test)  ,  Body-weight supported treadmill training combined with Lokomat (Post-test)  ,0,
edin,160,2708184,No significant difference,"<td colspan=""8""><hr></td>,<td colspan=""8""><hr></td>",  Late Life Function and Disability Instrument  ,  Body-weight supported treadmill training combined with Lokomat (Pre-test)  ,  Body-weight supported treadmill training combined with Lokomat (Post-test)  ,0,
edin,201,2688140,No significant difference,"The duration of use of paralysing or sedative agents, mechanical ventilation, stay in the intensive care unit and mortality at 28 days did not differ significantly between the decremental PEEP titration and control groups."," The durations of mechanical ventilation, ICU stay and use of paralysing or sedative agents of patients with ARDS ", table-based PEEP (control) group , Decremental PEEP titration group ,0,
edin,130,2871176,Cannot tell based on the abstract,,  Weight gain  ,  Liraglutide plus glimepiride  ,  Rosiglitazone plus glimepiride  ,0,
edin,130,2871176,Significantly decreased,"Although weight effects were modest, liraglutide produced more favourable weight effects compared with rosiglitazone, which produced substantial weight gain.",  Weight gain  ,  Liraglutide plus glimepiride  ,  Rosiglitazone plus glimepiride  ,0,
edin,135,2871176,Cannot tell based on the abstract,,  HOMA-B  ,  Rosiglitazone plus glimepiride   ,  Liraglutide (1.2 mg) plus glimepiride   ,0,
edin,135,2871176,Significantly increased,"HOMA-B increased with liraglutide (1.8 or 1.2 mg) compared with rosiglitazone (P < 0.05), while this increase was only different to placebo with liraglutide 1.2 mg (P = 0.01) and not liraglutide 1.8 mg (P = 0.051).",  HOMA-B  ,  Rosiglitazone plus glimepiride   ,  Liraglutide (1.2 mg) plus glimepiride   ,0,
edin,208,2206488,Significantly decreased,"In group A, lower peak (median) plasma levels of procalcitonin (0.2 versus 1.4, p < 0.001), IL 8 (5.6 versus 94.8, p < 0.001), IL 10 (47.2 versus 209.7, p = 0.001), endothelial leukocyte adhesion molecule-1 (88.5 versus 130.6, p = 0.033), intercellular adhesion molecule-1 (806.7 versus 1,375.7, P = 0.001) and troponin-I (0.22 versus 0.66, p = 0.018) were found.,n group A (n = 20), dextran-70 infusion was administered at a dose of 7.5 ml/kg before the initiation of cardiopulmonary bypass and at a dose of 12.5 ml/kg after the cessation of cardiopulmonary bypass. Group B served as a control with identical amounts of gelatin infusion (n = 20)."," Procalcitonin, IL 8, IL 10, endothelial leukocyte adhesion molecule-1, intercellular adhesion molecule-1, troponin-I ", identical amounts of gelatin infusion , dextran-70 infusion was administered at a dose of 7.5 ml/kg before the initiation of cardiopulmonary bypass and at a dose of 12.5 ml/kg after the cessation of cardiopulmonary bypass ,0,
edin,169,2864284,Cannot tell based on the abstract,,  Parasite clearance at day 2  ,  Chloroquine  ,  Dihydroartemisinin-piperaquine  ,0,
edin,169,2864284,Significantly increased,<td></td><td></td><td></td><td></td>,  Parasite clearance at day 2  ,  Chloroquine  ,  Dihydroartemisinin-piperaquine  ,0,
edin,137,2871176,Cannot tell based on the abstract,,  HOMA-B  ,  Placebo plus glimepiride   ,  Liraglutide (1.2 mg) plus glimepiride   ,0,
edin,137,2871176,Significantly increased,"HOMA-B increased with liraglutide (1.8 or 1.2 mg) compared with rosiglitazone (P < 0.05), while this increase was only different to placebo with liraglutide 1.2 mg (P = 0.01) and not liraglutide 1.8 mg (P = 0.051).",  HOMA-B  ,  Placebo plus glimepiride   ,  Liraglutide (1.2 mg) plus glimepiride   ,0,
edin,209,2206488,Cannot tell based on the abstract,, Cardiac index  , identical amounts of gelatin infusion , dextran-70 infusion was administered at a dose of 7.5 ml/kg before the initiation of cardiopulmonary bypass and at a dose of 12.5 ml/kg after the cessation of cardiopulmonary bypass ,0,
edin,209,2206488,Significantly increased,"Higher figures of the cardiac index (p = 0.010) along with reduced systemic vascular resistance (p = 0.005) were noted in group A.,n group A (n = 20), dextran-70 infusion was administered at a dose of 7.5 ml/kg before the initiation of cardiopulmonary bypass and at a dose of 12.5 ml/kg after the cessation of cardiopulmonary bypass. Group B served as a control with identical amounts of gelatin infusion (n = 20).", Cardiac index  , identical amounts of gelatin infusion , dextran-70 infusion was administered at a dose of 7.5 ml/kg before the initiation of cardiopulmonary bypass and at a dose of 12.5 ml/kg after the cessation of cardiopulmonary bypass ,0,
edin,120,2871176,Cannot tell based on the abstract,, ADA fasting plasma glucose goals between 5.0 mmol/l and less than 7.2 mmol/l , Placebo plus glimepiride , Liraglutide (1.8 mg) plus glimepiride ,0,
edin,120,2871176,Invalid Prompt,, ADA fasting plasma glucose goals between 5.0 mmol/l and less than 7.2 mmol/l , Placebo plus glimepiride , Liraglutide (1.8 mg) plus glimepiride ,1, I got 404 Not Found error
edin,100,2871176,Cannot tell based on the abstract,,  HbA1c level at 26 weeks  ,  Rosiglitazone plus glimepiride  ,  Liraglutide (1.2 mg) plus glimepiride  ,0,
edin,100,2871176,Significantly decreased,"After 26 weeks, HbA1c decreased by 1.1% from baseline (primary endpoint) with either liraglutide 1.2 or 1.8 mg, respectively, compared with either placebo (+0.2%) or rosiglitazone (?0.4%) (Fig. 3d).",  HbA1c level at 26 weeks  ,  Rosiglitazone plus glimepiride  ,  Liraglutide (1.2 mg) plus glimepiride  ,0,
edin,154,2871176,Cannot tell based on the abstract,, Changes in calcitonin at week 26 , Placebo plus glimepiride , Liraglutide (all doses) plus glimepiride ,0,
edin,154,2871176,No significant difference,No significant differences in calcitonin were found between the three groups treated with liraglutide when compared with either placebo or rosiglitazone at the end of the trial at week 26., Changes in calcitonin at week 26 , Placebo plus glimepiride , Liraglutide (all doses) plus glimepiride ,0,
edin,205,4106715,Cannot tell based on the abstract,, Prolonged abstinence from smoking rates to 12 months , placebo , low Ab group ,0,
edin,205,4106715,No significant difference,"Subjects with high Ab were also significantly more likely to be abstinent for 12 months compared to placebo (18.0% vs. 6.0%, p=0.014; OR of 3.84; 95% CI, 1.32?11.20). The low Ab group did not differ significantly from placebo (7.1% vs. 6.0%, p=0.67).", Prolonged abstinence from smoking rates to 12 months , placebo , low Ab group ,0,
edin,156,2708184,Cannot tell based on the abstract,, Paretic step length ratio , Manually-assisted body-weight supported treadmill training , Body-weight supported treadmill training combined with Lokomat ,0,
edin,156,2708184,No significant difference,"<td colspan=""8""><hr></td>", Paretic step length ratio , Manually-assisted body-weight supported treadmill training , Body-weight supported treadmill training combined with Lokomat ,0,
edin,198,3187863,No significant difference,"There were no significant differences in postpartum haemorrhage, sphincter injuries or in neonatal outcomes.", Postpartum haemorrhage , Normal unit & Special unit , Midwife-led unit ,0,
edin,112,2871176,Cannot tell based on the abstract,, Patients reaching HbA1c goals less than 7.0% and equal or less than 6.5% , Rosiglitazone plus glimepiride , Liraglutide (1.2 mg) plus glimepiride ,0,
edin,112,2871176,Significantly increased,"At week 26, 42% and 21% of subjects treated with liraglutide 1.8 mg reached an HbA1c < 7.0% and ? 6.5%, respectively, compared with 8% and 4% for placebo (Fig. 4). The estimated proportion of subjects treated with either liraglutide 1.2 or 1.8 mg reaching ADA/EASD and IDF/AACE HbA1c targets was substantially greater compared with either placebo (P < 0.0001) or rosiglitazone (Fig. 4; P ? 0.0003), with more patients reaching < 7.0% with liraglutide 1.8 mg compared with 1.2 mg (P = 0.018).", Patients reaching HbA1c goals less than 7.0% and equal or less than 6.5% , Rosiglitazone plus glimepiride , Liraglutide (1.2 mg) plus glimepiride ,0,
edin,212,2206488,No significant difference,"There was no significant difference in IL 6, IL-6r and C-reactive protein values between groups.", IL-6 (pg/ml) , identical amounts of gelatin infusion , dextran-70 infusion was administered at a dose of 7.5 ml/kg before the initiation of cardiopulmonary bypass and at a dose of 12.5 ml/kg after the cessation of cardiopulmonary bypass ,0,
edin,177,2864284,No significant difference,<td></td><td></td><td></td><td></td>, Cure rate at day 28 , Chloroquine , Dihydroartemisinin-piperaquine ,0,
edin,155,2708184,Cannot tell based on the abstract,, Self-selected overground walk velocity , Manually-assisted body-weight supported treadmill training , Body-weight supported treadmill training combined with Lokomat ,0,
edin,155,2708184,No significant difference,"<td colspan=""8""><hr></td>", Self-selected overground walk velocity , Manually-assisted body-weight supported treadmill training , Body-weight supported treadmill training combined with Lokomat ,0,
edin,184,2517154,Cannot tell based on the abstract,, Extend of the disease as visualized during surgery , Placebo , Infliximab ,0,
edin,184,2517154,No significant difference,"During surgery, no obvious differences were observed in the extend of the disease, the macroscopic aspect of endometriosis (vascularization and sclerosis), the duration of surgery and bleeding estimates.", Extend of the disease as visualized during surgery , Placebo , Infliximab ,0,
edin,117,2871176,Cannot tell based on the abstract,, Fasting plasma glucose at week 26 , Rosiglitazone plus glimepiride , Liraglutide (1.8 mg) plus glimepiride ,0,
edin,117,2871176,Significantly decreased,"Fasting plasma glucose decreased by week 2, with a 1.6 mmol/l decrease from baseline at week 26 with liraglutide 1.2 mg (baseline 9.8 mmol/l) or 1.8 mg (baseline 9.7 mmol/l) compared with a 0.9 mmol/l increase (placebo, P < 0.0001, baseline 9.5 mmol/l) or 1.0 mmol/l decrease (rosiglitazone, P < 0.006, baseline 9.9 mmol/l).", Fasting plasma glucose at week 26 , Rosiglitazone plus glimepiride , Liraglutide (1.8 mg) plus glimepiride ,0,
edin,119,2871176,Cannot tell based on the abstract,, ADA fasting plasma glucose goals between 5.0 mmol/l and less than 7.2 mmol/l , Placebo plus glimepiride , Liraglutide (1.2 mg) plus glimepiride ,0,
edin,119,2871176,Significantly increased,The percentage of subjects achieving FPG values between 5.0 mmol/l and ? 7.2 mmol/l (ADA target) after 26 weeks was higher with liraglutide: 0.6 mg (19%; P = 0.002); 1.2 mg (37%; P < 0.001); and 1.8 mg (38%;P < 0.001) compared with placebo (7%)., ADA fasting plasma glucose goals between 5.0 mmol/l and less than 7.2 mmol/l , Placebo plus glimepiride , Liraglutide (1.2 mg) plus glimepiride ,0,
edin,166,3001156,Cannot tell based on the abstract,, Care-seeking from the Kumudini Hospital for ill newborns  , Comparison arm  , Promotion by CHWs of maternal and newborn-care interventions  ,0,
edin,166,3001156,Significantly increased,"Increases were observed in self-referral of sick newborns for care, compliance after referral by the CHWs, and care-seeking from qualified providers and from the Kumudini Hospital, and decreases were observed in care-seeking from unqualified providers in the intervention arm.", Care-seeking from the Kumudini Hospital for ill newborns  , Comparison arm  , Promotion by CHWs of maternal and newborn-care interventions  ,0,
edin,123,2871176,Significantly decreased,"Decreases in postprandial plasma glucose from baseline were greater with liraglutide 1.2 or 1.8 mg [?2.5 to ?2.7 mmol/l (baseline 12.9 mmol/l for both)] compared with placebo (?0.4 mmol/l, P < 0.0001, baseline 12.7 mmol/l) or rosiglitazone (?1.8 mmol/l, P < 0.05, baseline 13.0 mmol/l).", Postprandial plasma glucose , Placebo plus glimepiride , Liraglutide (1.8 mg) plus glimepiride ,0,
edin,199,3187863,No significant difference,"Neonatal outcomes were evaluated by Apgar score <7 at 5 minutes, metabolic acidosis and transfer to NICU within 2 hours of birth. An Apgar score <7 at 5 minutes was observed in 1.0, 1.4 and 0.4% of cases in the MU, NU and SU, respectively."," Neonatal outcomes were evaluated by Apgar score <7 at 5 minutes, metabolic acidosis and transfer to NICU within 2 hours of birth ", Normal unit & Special unit , Midwife-led unit ,0,
edin,207,4106715,Significantly increased,"3?AmNic-rEPA recipients with the highest serum anti-nicotine antibody response (top 30% by AUC) were significantly more likely to attain 8 weeks continuous abstinence from weeks 19 through 26 than the placebo recipients (24.6% vs. 12.0%, p=0.024, OR=2.69, 95% CI, 1.14?6.37).", attain 8 weeks continuous abstinence from weeks 19 through 26 , placebo group , recipients with the highest serum anti-nicotine antibody response (top 30% by AUC) ,0,
edin,99,2871176,Cannot tell based on the abstract,, HbA1c level at 26 weeks , Placebo plus glimepiride , Liraglutide (1.2 mg) plus glimepiride ,0,
edin,99,2871176,Significantly decreased,"After 26 weeks, HbA1c decreased by 1.1% from baseline (primary endpoint) with either liraglutide 1.2 or 1.8 mg, respectively, compared with either placebo (+0.2%) or rosiglitazone (?0.4%) (Fig. 3d).", HbA1c level at 26 weeks , Placebo plus glimepiride , Liraglutide (1.2 mg) plus glimepiride ,0,
edin,206,4106715,Significantly increased,"Statistically significant differences were observed in reduction of daily cigarette consumption and cotinine between non-abstainers (weeks 19?52) with high Ab levels and non-abstainers in the placebo group (p=0.0015 and 0.019, respectively; see Figures 4A and 4C.", Reduction of daily cigarette consumption and cotinine , non-abstainers in the placebo group , non-abstainers (weeks 19?52) with high Ab levels ,0,
edin,172,2864284,Cannot tell based on the abstract,, Serious adverse events , Chloroquine , Dihydroartemisinin-piperaquine ,0,
edin,172,2864284,No significant difference,<td></td><td></td><td></td><td></td>, Serious adverse events , Chloroquine , Dihydroartemisinin-piperaquine ,0,
edin,107,2871176,Cannot tell based on the abstract,, HbA1c level at 26 weeks , Rosiglitazone plus glimepiride , Liraglutide (1.8 mg) plus glimepiride ,0,
edin,107,2871176,Significantly decreased,"After 26 weeks, HbA1c decreased by 1.1% from baseline (primary endpoint) with either liraglutide 1.2 or 1.8 mg, respectively, compared with either placebo (+0.2%) or rosiglitazone (?0.4%) (Fig. 3d).", HbA1c level at 26 weeks , Rosiglitazone plus glimepiride , Liraglutide (1.8 mg) plus glimepiride ,0,
edin,195,3187863,Significantly decreased,"Of all women allocated to the MU, 26.2% were given oxytocin infusion for augmentation of labour, which was significantly lower than 36.7% in the NU (RR 0.73, 95% CI 0.59?0.89) and 38.0% in the SU (RR 0.69, 95% CI 0.56?0.86) (Table 2).", Oxytocin infusion for augmentation of labour , Normal unit & Special unit , Midwife-led unit ,0,
edin,182,2517154,Cannot tell based on the abstract,, Nodules diameters , Placebo , Infliximab ,0,
edin,182,2517154,No significant difference,No effect of treatment was found upon the mean diameters of the nodules as measured by TVU., Nodules diameters , Placebo , Infliximab ,0,
edin,202,4106715,Cannot tell based on the abstract,, Prolonged abstinence from smoking rates to 6 months , placebo , high Ab group ,0,
edin,202,4106715,Significantly increased,"Prolonged abstinence rates to 6 months were significantly higher in the high Ab group vs. placebo (19.7% vs. 6.0%, p=0.0060, OR=4.41, 95% CI, 1.53?12.71) with no significant differences between the placebo and low Ab groups (7.9% vs. 6.0%, p=0.60).", Prolonged abstinence from smoking rates to 6 months , placebo , high Ab group ,0,
edin,168,2864284,Cannot tell based on the abstract,, Parasite clearance at day 1 , Chloroquine , Dihydroartemisinin-piperaquine ,0,
edin,168,2864284,Significantly increased,<td></td><td></td><td></td><td></td>, Parasite clearance at day 1 , Chloroquine , Dihydroartemisinin-piperaquine ,0,
edin,190,2517154,Cannot tell based on the abstract,, Pain killers intake , Placebo , Infliximab ,0,
edin,190,2517154,Significantly increased,"The strong and significant placebo effect and the absence of an infliximab effect were consistently found for all pain estimations in this study, i.e. the five scorings by the clinician and the calculated total scores (i.e. dysmenorrhea, deep dyspareunia, chronic pain, pelvic tenderness, the sum of the 3 BB pain scores and the total BB score) and the pain recorded in the dairy by the patients (i.e. the 3 BB scores, the visual analog scales, the pain killer intake and both calculated total scores, i.e. with or without taking pain killer intake into account).", Pain killers intake , Placebo , Infliximab ,0,
edin,194,3187863,Significantly decreased,"In the MU dystocia was recorded in 29.1% of the cases, which is a significantly lower rate than 36.9% in the NU (RR 0.79, 95% CI 0.65?0.96) and 40.4% in the SU (RR 0.72, 95% CI 0.59?0.89) (Table 2).", Labour dystocia , Normal unit & Special unit , Midwife-led unit ,0,
edin,186,2517154,Cannot tell based on the abstract,, Surgery duration , Placebo , Infliximab ,0,
edin,186,2517154,No significant difference,"During surgery, no obvious differences were observed in the extend of the disease, the macroscopic aspect of endometriosis (vascularization and sclerosis), the duration of surgery and bleeding estimates.", Surgery duration , Placebo , Infliximab ,0,
edin,136,2871176,Cannot tell based on the abstract,, HOMA-B , Rosiglitazone plus glimepiride  , Liraglutide (1.8 mg) plus glimepiride  ,0,
edin,136,2871176,Significantly increased,"HOMA-B increased with liraglutide (1.8 or 1.2 mg) compared with rosiglitazone (P < 0.05), while this increase was only different to placebo with liraglutide 1.2 mg (P = 0.01) and not liraglutide 1.8 mg (P = 0.051).", HOMA-B , Rosiglitazone plus glimepiride  , Liraglutide (1.8 mg) plus glimepiride  ,0,
edin,116,2871176,Cannot tell based on the abstract,, Fasting plasma glucose at week 26 , Placebo plus glimepiride , Liraglutide (0.6 mg) plus glimepiride ,0,
edin,116,2871176,Significantly decreased,"By week 2, subjects treated with liraglutide had rapid and larger decreases in FPG vs. comparator treatment. At week 26, all doses of liraglutide decreased FPG more than did placebo (Fig. 5; P < 0.0001), while only liraglutide 1.2 or 1.8 mg produced greater reductions than rosiglitazone. FPG treatment differences to placebo were 1.7 mmol/l for liraglutide 0.6 mg and 2.6 mmol/l for both liraglutide 1.2 and 1.8 mg.", Fasting plasma glucose at week 26 , Placebo plus glimepiride , Liraglutide (0.6 mg) plus glimepiride ,0,
edin,173,2864284,Cannot tell based on the abstract,, Baseline white blood cell count , Chloroquine , Dihydroartemisinin-piperaquine ,0,
edin,173,2864284,Significantly increased,<td></td><td></td><td></td><td></td>, Baseline white blood cell count , Chloroquine , Dihydroartemisinin-piperaquine ,0,
edin,167,3001156,Cannot tell based on the abstract,, Care-seeking from unqualified providers (such as village doctors) for ill newborns   , Comparison arm  , Promotion by CHWs of maternal and newborn-care interventions  ,0,
edin,167,3001156,No significant difference,"At the time of the baseline household survey in January 2003, there was no significant difference between the intervention arm and the comparison arm of the study in the proportion of sick newborns who were taken outside the home for care from any qualified provider (including Kumudini Hospital), to the Kumudini Hospital specifically, or to an unqualified provider, most commonly an unlicensed ?village doctor?.", Care-seeking from unqualified providers (such as village doctors) for ill newborns   , Comparison arm  , Promotion by CHWs of maternal and newborn-care interventions  ,0,
edin,139,2871176,Cannot tell based on the abstract,, HOMA-IR , Placebo plus glimepiride , Liraglutide (all doses) plus glimepiride ,0,
edin,139,2871176,No significant difference,"There were no significant differences between treatments for HOMA-IR.

Table 2", HOMA-IR , Placebo plus glimepiride , Liraglutide (all doses) plus glimepiride ,0,
edin,213,2206488,No significant difference,"There was no significant difference in IL 6, IL-6r and C-reactive protein values between groups.", IL-6r (ng/ml) , identical amounts of gelatin infusion , dextran-70 infusion was administered at a dose of 7.5 ml/kg before the initiation of cardiopulmonary bypass and at a dose of 12.5 ml/kg after the cessation of cardiopulmonary bypass ,0,
edin,110,2871176,Cannot tell based on the abstract,, Patients reaching HbA1c goals less than 7.0% and equal or less than 6.5% , Placebo plus glimepiride , Liraglutide (1.2 mg) plus glimepiride ,0,
edin,110,2871176,Significantly increased,"The percentage of subjects reaching ADA [2] and International Diabetes Federation (IDF)/American Association of Clinical Endocrinologists (AACE) [11,12] treatment HbA1c goals with liraglutide was dose dependent (Fig. 4). At week 26, 42% and 21% of subjects treated with liraglutide 1.8 mg reached an HbA1c < 7.0% and ? 6.5%, respectively, compared with 8% and 4% for placebo (Fig. 4). The estimated proportion of subjects treated with either liraglutide 1.2 or 1.8 mg reaching ADA/EASD and IDF/AACE HbA1c targets was substantially greater compared with either placebo (P < 0.0001) or rosiglitazone (Fig. 4; P ? 0.0003), with more patients reaching < 7.0% with liraglutide 1.8 mg compared with 1.2 mg (P = 0.018).", Patients reaching HbA1c goals less than 7.0% and equal or less than 6.5% , Placebo plus glimepiride , Liraglutide (1.2 mg) plus glimepiride ,0,
edin,144,2871176,Cannot tell based on the abstract,, Reductions in systolic blood pressure , Rosiglitazone plus glimepiride  , Liraglutide (1.8 mg) plus glimepiride  ,0,
edin,144,2871176,No significant difference,"Although decreases in systolic blood pressure occurred with either liraglutide 1.2 or 1.8 mg (2.6?2.8 mmHg), they were not significantly different from placebo or rosiglitazone (0.9?2.3 mmHg).", Reductions in systolic blood pressure , Rosiglitazone plus glimepiride  , Liraglutide (1.8 mg) plus glimepiride  ,0,
edin,165,3001156,Cannot tell based on the abstract,, Care-seeking from qualified providers for ill newborns   , Comparison arm  , Promotion by CHWs of maternal and newborn-care interventions  ,0,
edin,165,3001156,No significant difference,Figure 2 demonstrates that there was a highly significant (p<0.00001) increase in the proportion of families that sought care from qualified providers for sick newborns in the intervention arm (Fig. 2 and Rows 5 and 7 of Table 2) and a non-significant increase in the comparison arm (Rows 5 and 8)., Care-seeking from qualified providers for ill newborns   , Comparison arm  , Promotion by CHWs of maternal and newborn-care interventions  ,0,
edin,109,2871176,Cannot tell based on the abstract,, HbA1c level at 26 weeks , Placebo plus glimepiride , Rosiglitazone plus glimepiride ,0,
edin,109,2871176,Significantly decreased,"Rosiglitazone also was superior to placebo (P < 0.0001).,he greatest decreases occurred with liraglutide 1.2 and 1.8 mg (Fig. 3a?c). After 26 weeks, HbA1c decreased by 1.1% from baseline (primary endpoint) with either liraglutide 1.2 or 1.8 mg, respectively, compared with either placebo (+0.2%) or rosiglitazone (?0.4%) (Fig. 3d). Estimated treatment differences and 95% CIs to placebo were: liraglutide 1.8 mg: ?1.4% (1.6, ?1.1); liraglutide 1.2 mg: ?1.3% (1.5, ?1.1); liraglutide 0.6 mg: ?0.8% (?1.1, ?0.6); rosiglitazone: ?0.7% (?0.9, ?0.4). All liraglutide doses were superior to placebo (P < 0.0001), while the two higher liraglutide doses were superior to rosiglitazone (P < 0.0001). Liraglutide 0.6 mg was non-inferior to rosiglitazone.", HbA1c level at 26 weeks , Placebo plus glimepiride , Rosiglitazone plus glimepiride ,0,
edin,106,2871176,Cannot tell based on the abstract,, HbA1c level at 26 weeks , Placebo plus glimepiride , Liraglutide (0.6 mg) plus glimepiride ,0,
edin,106,2871176,Significantly decreased,"Estimated treatment differences and 95% CIs to placebo were: liraglutide 1.8 mg: ?1.4% (1.6, ?1.1); liraglutide 1.2 mg: ?1.3% (1.5, ?1.1); liraglutide 0.6 mg: ?0.8% (?1.1, ?0.6); rosiglitazone: ?0.7% (?0.9, ?0.4). All liraglutide doses were superior to placebo (P < 0.0001), while the two higher liraglutide doses were superior to rosiglitazone (P < 0.0001).", HbA1c level at 26 weeks , Placebo plus glimepiride , Liraglutide (0.6 mg) plus glimepiride ,0,
edin,149,2871176,Cannot tell based on the abstract,, Pulse variations , Rosiglitazone plus glimepiride , Liraglutide (1.8 mg) plus glimepiride ,0,
edin,149,2871176,Significantly increased,Changes in pulse for all doses of liraglutide were significant vs. placebo (P ? 0.002). This also was true with either liraglutide 1.8 or 1.2 mg compared with rosiglitazone (P < 0.01)., Pulse variations , Rosiglitazone plus glimepiride , Liraglutide (1.8 mg) plus glimepiride ,0,
edin,104,2871176,Significantly decreased,"Decreases in postprandial plasma glucose from baseline were greater with liraglutide 1.2 or 1.8 mg [?2.5 to ?2.7 mmol/l (baseline 12.9 mmol/l for both)] compared with placebo (?0.4 mmol/l, P < 0.0001, baseline 12.7 mmol/l) or rosiglitazone (?1.8 mmol/l, P < 0.05, baseline 13.0 mmol/l).", Postprandial plasma glucose , Rosiglitazone plus glimepiride , Liraglutide (1.2 mg) plus glimepiride ,0,
edin,180,2864284,Cannot tell based on the abstract,, Haemoglobin concentration , Chloroquine , Dihydroartemisinin-piperaquine ,0,
edin,180,2864284,No significant difference,<td></td><td></td><td></td><td></td>, Haemoglobin concentration , Chloroquine , Dihydroartemisinin-piperaquine ,0,
edin,111,2871176,Cannot tell based on the abstract,, Patients reaching HbA1c goals less than 7.0% and equal or less than 6.5% , Placebo plus glimepiride , Liraglutide (1.8 mg) plus glimepiride ,0,
edin,111,2871176,Significantly increased,"The estimated proportion of subjects treated with either liraglutide 1.2 or 1.8 mg reaching ADA/EASD and IDF/AACE HbA1c targets was substantially greater compared with either placebo (P < 0.0001) or rosiglitazone (Fig. 4; P ? 0.0003), with more patients reaching < 7.0% with liraglutide 1.8 mg compared with 1.2 mg (P = 0.018).

FIGURE 4", Patients reaching HbA1c goals less than 7.0% and equal or less than 6.5% , Placebo plus glimepiride , Liraglutide (1.8 mg) plus glimepiride ,0,
edin,187,2517154,Cannot tell based on the abstract,, Bleeding during surgery , Placebo , Infliximab ,0,
edin,187,2517154,No significant difference,"During surgery, no obvious differences were observed in the extend of the disease, the macroscopic aspect of endometriosis (vascularization and sclerosis), the duration of surgery and bleeding estimates.", Bleeding during surgery , Placebo , Infliximab ,0,
edin,157,2708184,Cannot tell based on the abstract,, Locomotor-training effects , Slow treadmill speed , Fast treadmill speed ,0,
edin,157,2708184,No significant difference,"<td colspan=""8""><hr></td>", Locomotor-training effects , Slow treadmill speed , Fast treadmill speed ,0,
edin,122,2871176,Cannot tell based on the abstract,, ADA fasting plasma glucose goals between 5.0 mmol/l and less than 7.2 mmol/l , Rosiglitazone plus glimepiride , Liraglutide (1.8 mg) plus glimepiride ,0,
edin,122,2871176,Significantly increased,"The percentage of subjects achieving FPG values between 5.0 mmol/l and ? 7.2 mmol/l (ADA target) after 26 weeks was higher with liraglutide: 0.6 mg (19%; P = 0.002); 1.2 mg (37%; P < 0.001); and 1.8 mg (38%;P < 0.001) compared with placebo (7%).,The liraglutide 1.2 and 1.8 mg treatment groups also had more subjects achieving the same FPG target at end of treatment compared with rosiglitazone (26%) (P = 0.007 and P = 0.01, respectively).", ADA fasting plasma glucose goals between 5.0 mmol/l and less than 7.2 mmol/l , Rosiglitazone plus glimepiride , Liraglutide (1.8 mg) plus glimepiride ,0,
edin,126,2871176,Cannot tell based on the abstract,, ADA postprandial plasma glucose goals less than 10.0 mmol/l , Placebo plus glimepiride , Liraglutide (0.6 mg) plus glimepiride ,0,
edin,126,2871176,Significantly increased,"The percentage of subjects with one, two or three PPG measurements < 10.0 mmol/l (ADA target) were greater for all doses of liraglutide compared with placebo (P < 0.05) but not rosiglitazone.", ADA postprandial plasma glucose goals less than 10.0 mmol/l , Placebo plus glimepiride , Liraglutide (0.6 mg) plus glimepiride ,0,
edin,158,2708184,Cannot tell based on the abstract,, Self-selected overground walk velocity , Body-weight supported treadmill training combined with Lokomat (Pre-test) , Body-weight supported treadmill training combined with Lokomat (Post-test) ,0,
edin,158,2708184,Significantly increased,"<td colspan=""8""><hr></td>,<td colspan=""8""><hr></td>,<td colspan=""8""><hr></td>", Self-selected overground walk velocity , Body-weight supported treadmill training combined with Lokomat (Pre-test) , Body-weight supported treadmill training combined with Lokomat (Post-test) ,0,
edin,125,2871176,Significantly decreased,"Decreases in postprandial plasma glucose from baseline were greater with liraglutide 1.2 or 1.8 mg [?2.5 to ?2.7 mmol/l (baseline 12.9 mmol/l for both)] compared with placebo (?0.4 mmol/l, P < 0.0001, baseline 12.7 mmol/l) or rosiglitazone (?1.8 mmol/l, P < 0.05, baseline 13.0 mmol/l).", Postprandial plasma glucose , Rosiglitazone plus glimepiride , Liraglutide (1.8 mg) plus glimepiride ,0,
edin,183,2517154,Cannot tell based on the abstract,, Endometrial thickness , Placebo , Infliximab ,0,
edin,183,2517154,No significant difference,"Endometrial thickness was not affected by treatment, being at baseline and at the end of the treatment period for the infliximab group 5.2 (range 1.3?18) and 7.8 (1.9?11) mm and for the placebo group 7.7 (1.8?23) and 8.2 (3?15) mm, respectively.", Endometrial thickness , Placebo , Infliximab ,0,
edin,175,2864284,Cannot tell based on the abstract,, Fever resolution by day 2 , Chloroquine , Dihydroartemisinin-piperaquine ,0,
edin,175,2864284,No significant difference,<td></td><td></td><td></td><td></td>, Fever resolution by day 2 , Chloroquine , Dihydroartemisinin-piperaquine ,0,
edin,133,2871176,Cannot tell based on the abstract,, Proinsulin : insulin ratio , Rosiglitazone plus glimepiride  , Liraglutide (1.8 mg) plus glimepiride  ,0,
edin,133,2871176,Significantly decreased,Reductions in the proinsulin : insulin ratio were greater with both liraglutide 1.2 and 1.8 mg compared with either rosiglitazone or placebo (Table 2; P ? 0.02)., Proinsulin : insulin ratio , Rosiglitazone plus glimepiride  , Liraglutide (1.8 mg) plus glimepiride  ,0,
edin,171,2864284,Significantly increased,<td></td><td></td><td></td><td></td>, Superiority of treatment given by survival curves , Chloroquine , Dihydroartemisinin-piperaquine ,0,
edin,146,2871176,Cannot tell based on the abstract,, Decreases in diastolic blood pressure , Rosiglitazone plus glimepiride , Liraglutide (all doses) plus glimepiride ,0,
edin,146,2871176,No significant difference,"Reductions in diastolic blood pressure also occurred with all treatments (0.7?1.4 mmHg), with no significant differences between treatments.", Decreases in diastolic blood pressure , Rosiglitazone plus glimepiride , Liraglutide (all doses) plus glimepiride ,0,
edin,127,2871176,Cannot tell based on the abstract,, ADA postprandial plasma glucose goals less than 10.0 mmol/l , Placebo plus glimepiride , Liraglutide (1.2 mg) plus glimepiride ,0,
edin,127,2871176,Significantly increased,"he percentage of subjects with one, two or three PPG measurements < 10.0 mmol/l (ADA target) were greater for all doses of liraglutide compared with placebo (P < 0.05) but not rosiglitazone.", ADA postprandial plasma glucose goals less than 10.0 mmol/l , Placebo plus glimepiride , Liraglutide (1.2 mg) plus glimepiride ,0,
edin,174,2864284,Cannot tell based on the abstract,, Fever resolution by day 1 , Chloroquine , Dihydroartemisinin-piperaquine ,0,
edin,174,2864284,Significantly increased,<td></td><td></td><td></td><td></td>, Fever resolution by day 1 , Chloroquine , Dihydroartemisinin-piperaquine ,0,
edin,118,2871176,Cannot tell based on the abstract,, ADA fasting plasma glucose goals between 5.0 mmol/l and less than 7.2 mmol/l , Placebo plus glimepiride , Liraglutide (0.6 mg) plus glimepiride ,0,
edin,118,2871176,Significantly increased,The percentage of subjects achieving FPG values between 5.0 mmol/l and ? 7.2 mmol/l (ADA target) after 26 weeks was higher with liraglutide: 0.6 mg (19%; P = 0.002); 1.2 mg (37%; P < 0.001); and 1.8 mg (38%;P < 0.001) compared with placebo (7%)., ADA fasting plasma glucose goals between 5.0 mmol/l and less than 7.2 mmol/l , Placebo plus glimepiride , Liraglutide (0.6 mg) plus glimepiride ,0,
edin,185,2517154,Cannot tell based on the abstract,, Macroscopic aspect of the tissue , Placebo , Infliximab ,0,
edin,185,2517154,No significant difference,"During surgery, no obvious differences were observed in the extend of the disease, the macroscopic aspect of endometriosis (vascularization and sclerosis), the duration of surgery and bleeding estimates.", Macroscopic aspect of the tissue , Placebo , Infliximab ,0,
edin,142,2871176,Cannot tell based on the abstract,, Reductions in systolic blood pressure , Placebo plus glimepiride  , Liraglutide (1.8 mg) plus glimepiride  ,0,
edin,142,2871176,No significant difference,"Although decreases in systolic blood pressure occurred with either liraglutide 1.2 or 1.8 mg (2.6?2.8 mmHg), they were not significantly different from placebo or rosiglitazone (0.9?2.3 mmHg).", Reductions in systolic blood pressure , Placebo plus glimepiride  , Liraglutide (1.8 mg) plus glimepiride  ,0,
edin,162,2708184,Cannot tell based on the abstract,, Physical performance battery scores , Body-weight supported treadmill training combined with Lokomat (Pre-test) , Body-weight supported treadmill training combined with Lokomat (Post-test) ,0,
edin,162,2708184,Significantly increased,"<td colspan=""8""><hr></td>,<td colspan=""8""><hr></td>,<td colspan=""8""><hr></td>", Physical performance battery scores , Body-weight supported treadmill training combined with Lokomat (Pre-test) , Body-weight supported treadmill training combined with Lokomat (Post-test) ,0,
edin,129,2871176,Cannot tell based on the abstract,, ADA postprandial plasma glucose goals less than 10.0 mmol/l , Rosiglitazone plus glimepiride , Liraglutide (all doses) plus glimepiride ,0,
edin,129,2871176,No significant difference,"The percentage of subjects with one, two or three PPG measurements < 10.0 mmol/l (ADA target) were greater for all doses of liraglutide compared with placebo (P < 0.05) but not rosiglitazone.", ADA postprandial plasma glucose goals less than 10.0 mmol/l , Rosiglitazone plus glimepiride , Liraglutide (all doses) plus glimepiride ,0,
edin,131,2871176,Cannot tell based on the abstract,, Proinsulin : insulin ratio , Rosiglitazone plus glimepiride  , Liraglutide (1.2 mg) plus glimepiride  ,0,
edin,131,2871176,Significantly decreased,Reductions in the proinsulin : insulin ratio were greater with both liraglutide 1.2 and 1.8 mg compared with either rosiglitazone or placebo (Table 2; P ? 0.02)., Proinsulin : insulin ratio , Rosiglitazone plus glimepiride  , Liraglutide (1.2 mg) plus glimepiride  ,0,
edin,140,2871176,Cannot tell based on the abstract,, HOMA-IR , Rosiglitazone plus glimepiride , Liraglutide (all doses) plus glimepiride ,0,
edin,140,2871176,No significant difference,There were no significant differences between treatments for HOMA-IR., HOMA-IR , Rosiglitazone plus glimepiride , Liraglutide (all doses) plus glimepiride ,0,
edin,203,4106715,Cannot tell based on the abstract,, Prolonged abstinence from smoking rates to 6 months , placebo , low Ab group ,0,
edin,203,4106715,No significant difference,"Prolonged abstinence rates to 6 months were significantly higher in the high Ab group vs. placebo (19.7% vs. 6.0%, p=0.0060, OR=4.41, 95% CI, 1.53?12.71) with no significant differences between the placebo and low Ab groups (7.9% vs. 6.0%, p=0.60).", Prolonged abstinence from smoking rates to 6 months , placebo , low Ab group ,0,
edin,170,2864284,Cannot tell based on the abstract,, Recurrent infections at day 56 , Chloroquine , Dihydroartemisinin-piperaquine ,0,
edin,170,2864284,Significantly decreased,<td></td><td></td><td></td><td></td>, Recurrent infections at day 56 , Chloroquine , Dihydroartemisinin-piperaquine ,0,
edin,150,2871176,Cannot tell based on the abstract,, Incidence of minor hypoglycaemia , Rosiglitazone plus glimepiride , Liraglutide (1.2 mg) plus glimepiride ,0,
edin,150,2871176,No significant difference,"Main adverse events for all treatments were minor hypoglycaemia (< 10%), nausea (< 11%), vomiting (< 5%) and diarrhoea (< 8%).", Incidence of minor hypoglycaemia , Rosiglitazone plus glimepiride , Liraglutide (1.2 mg) plus glimepiride ,0,
edin,124,2871176,Cannot tell based on the abstract,, Postprandial plasma glucose , Placebo plus glimepiride , Liraglutide (0.6 mg) plus glimepiride ,0,
edin,124,2871176,Significantly decreased,reatment differences for PPG were greater with all doses of liraglutide compared with placebo (1.5?2.4 mmol/l; P < 0.0001) and greater with liraglutide 1.2 mg (0.64 mmol/l; P = 0.043) and 1.8 mg (0.87 mmol/l;P = 0.0022) compared with rosiglitazone., Postprandial plasma glucose , Placebo plus glimepiride , Liraglutide (0.6 mg) plus glimepiride ,0,
edin,113,2871176,Cannot tell based on the abstract,, Patients reaching HbA1c goals less than 7.0% and equal or less than 6.5% , Rosiglitazone plus glimepiride , Liraglutide (1.8 mg) plus glimepiride ,0,
edin,113,2871176,Significantly increased,"he estimated proportion of subjects treated with either liraglutide 1.2 or 1.8 mg reaching ADA/EASD and IDF/AACE HbA1c targets was substantially greater compared with either placebo (P < 0.0001) or rosiglitazone (Fig. 4; P ? 0.0003), with more patients reaching < 7.0% with liraglutide 1.8 mg compared with 1.2 mg (P = 0.018).", Patients reaching HbA1c goals less than 7.0% and equal or less than 6.5% , Rosiglitazone plus glimepiride , Liraglutide (1.8 mg) plus glimepiride ,0,
edin,145,2871176,Cannot tell based on the abstract,, Decreases in diastolic blood pressure , Placebo plus glimepiride , Liraglutide (all doses) plus glimepiride ,0,
edin,145,2871176,No significant difference,"Reductions in diastolic blood pressure also occurred with all treatments (0.7?1.4 mmHg), with no significant differences between treatments.", Decreases in diastolic blood pressure , Placebo plus glimepiride , Liraglutide (all doses) plus glimepiride ,0,
edin,161,2708184,Cannot tell based on the abstract,, Improvement in lower extremity Fugl-Meyer score  , Body-weight supported treadmill training combined with Lokomat (Pre-test) , Body-weight supported treadmill training combined with Lokomat (Post-test) ,0,
edin,161,2708184,Significantly increased,"<td colspan=""8""><hr></td>,<td colspan=""8""><hr></td>,<td colspan=""8""><hr></td>", Improvement in lower extremity Fugl-Meyer score  , Body-weight supported treadmill training combined with Lokomat (Pre-test) , Body-weight supported treadmill training combined with Lokomat (Post-test) ,0,
edin,102,2871176,Cannot tell based on the abstract,, Fasting plasma glucose at week 26 , Rosiglitazone plus glimepiride , Liraglutide (1.2 mg) plus glimepiride ,0,
edin,102,2871176,Significantly decreased,"Fasting plasma glucose decreased by week 2, with a 1.6 mmol/l decrease from baseline at week 26 with liraglutide 1.2 mg (baseline 9.8 mmol/l) or 1.8 mg (baseline 9.7 mmol/l) compared with a 0.9 mmol/l increase (placebo, P < 0.0001, baseline 9.5 mmol/l) or 1.0 mmol/l decrease (rosiglitazone, P < 0.006, baseline 9.9 mmol/l).", Fasting plasma glucose at week 26 , Rosiglitazone plus glimepiride , Liraglutide (1.2 mg) plus glimepiride ,0,
edin,101,2871176,Cannot tell based on the abstract,, Fasting plasma glucose at week 26 , Placebo plus glimepiride , Liraglutide (1.2 mg) plus glimepiride ,0,
edin,101,2871176,Significantly decreased,"Fasting plasma glucose decreased by week 2, with a 1.6 mmol/l decrease from baseline at week 26 with liraglutide 1.2 mg (baseline 9.8 mmol/l) or 1.8 mg (baseline 9.7 mmol/l) compared with a 0.9 mmol/l increase (placebo, P < 0.0001, baseline 9.5 mmol/l) or 1.0 mmol/l decrease (rosiglitazone, P < 0.006, baseline 9.9 mmol/l).", Fasting plasma glucose at week 26 , Placebo plus glimepiride , Liraglutide (1.2 mg) plus glimepiride ,0,
edin,108,2871176,Cannot tell based on the abstract,, HbA1c level at 26 weeks , Rosiglitazone plus glimepiride , Liraglutide (0.6 mg) plus glimepiride ,0,
edin,108,2871176,No significant difference,"All liraglutide doses were superior to placebo (P < 0.0001), while the two higher liraglutide doses were superior to rosiglitazone (P < 0.0001). Liraglutide 0.6 mg was non-inferior to rosiglitazone.", HbA1c level at 26 weeks , Rosiglitazone plus glimepiride , Liraglutide (0.6 mg) plus glimepiride ,0,
edin,181,2517154,Cannot tell based on the abstract,, Severity of pain , Placebo , Infliximab ,0,
edin,181,2517154,No significant difference,"Pain severity decreased during the treatment by 30% in both the placebo (P < 0.001) and infliximab groups (P < 0.001). However, no effect of infliximab was observed for any of the outcome measures.", Severity of pain , Placebo , Infliximab ,0,
edin,141,2871176,Cannot tell based on the abstract,, Reductions in systolic blood pressure , Placebo plus glimepiride  , Liraglutide (1.2 mg) plus glimepiride  ,0,
edin,141,2871176,No significant difference,"Although decreases in systolic blood pressure occurred with either liraglutide 1.2 or 1.8 mg (2.6?2.8 mmHg), they were not significantly different from placebo or rosiglitazone (0.9?2.3 mmHg).", Reductions in systolic blood pressure , Placebo plus glimepiride  , Liraglutide (1.2 mg) plus glimepiride  ,0,
edin,153,2871176,Cannot tell based on the abstract,, Changes in calcitonin at week 26 , Rosiglitazone plus glimepiride , Liraglutide (all doses) plus glimepiride ,0,
edin,153,2871176,No significant difference,No significant differences in calcitonin were found between the three groups treated with liraglutide when compared with either placebo or rosiglitazone at the end of the trial at week 26., Changes in calcitonin at week 26 , Rosiglitazone plus glimepiride , Liraglutide (all doses) plus glimepiride ,0,
edin,210,2206488,Cannot tell based on the abstract,, systemic vascular resistance , identical amounts of gelatin infusion , dextran-70 infusion was administered at a dose of 7.5 ml/kg before the initiation of cardiopulmonary bypass and at a dose of 12.5 ml/kg after the cessation of cardiopulmonary bypass ,0,
edin,210,2206488,Significantly decreased,"Higher figures of the cardiac index (p = 0.010) along with reduced systemic vascular resistance (p = 0.005) were noted in group A.,In group A (n = 20), dextran-70 infusion was administered at a dose of 7.5 ml/kg before the initiation of cardiopulmonary bypass and at a dose of 12.5 ml/kg after the cessation of cardiopulmonary bypass.", systemic vascular resistance , identical amounts of gelatin infusion , dextran-70 infusion was administered at a dose of 7.5 ml/kg before the initiation of cardiopulmonary bypass and at a dose of 12.5 ml/kg after the cessation of cardiopulmonary bypass ,0,
edin,196,3187863,Significantly decreased,"Of all women randomised to the MU, 15.8% had an epidural, which is a significantly lower rate than 23.3% in the NU (RR 1.47, 95% CI 1.11?1.96) and 24.8% in the SU (RR 1.57, 95% CI 1.16?2.13).", Pain relief: Epidural anesthesia , Normal unit & Special unit , Midwife-led unit ,0,
edin,115,2871176,Cannot tell based on the abstract,, Fasting plasma glucose at week 26 , Placebo plus glimepiride , Liraglutide (1.8 mg) plus glimepiride ,0,
edin,115,2871176,Significantly decreased,"Fasting plasma glucose decreased by week 2, with a 1.6 mmol/l decrease from baseline at week 26 with liraglutide 1.2 mg (baseline 9.8 mmol/l) or 1.8 mg (baseline 9.7 mmol/l) compared with a 0.9 mmol/l increase (placebo, P < 0.0001, baseline 9.5 mmol/l) or 1.0 mmol/l decrease (rosiglitazone, P < 0.006, baseline 9.9 mmol/l).", Fasting plasma glucose at week 26 , Placebo plus glimepiride , Liraglutide (1.8 mg) plus glimepiride ,0,
edin,193,3187863,No significant difference,There was no significant difference between the three groups concerning the number of episiotomies or the incidence of sphincter injuries (Table 2)., Perineal outcome: the number of episiotomies or the incidence of sphincter injuries , Normal unit & Special unit , Special unit ,0,
edin,200,2688140,Cannot tell based on the abstract,, The survival rate / overall mortality of patients with ARDS , table-based PEEP (control) group , Decremental PEEP titration group ,0,
edin,200,2688140,No significant difference,"The overall mortality at 28 days was 37%. Mortality at 28 days was 33% in the control group and 40% in the decremental PEEP titration group (Table 2). Using Cox regression for 28-day mortality, the survival rate in the decremental PEEP titration group was not different (p = 0.725; hazard ratio = 1.168; 95% confidence interval = 0.493 to 2.768).", The survival rate / overall mortality of patients with ARDS , table-based PEEP (control) group , Decremental PEEP titration group ,0,
edin,138,2871176,Cannot tell based on the abstract,, HOMA-B , Placebo plus glimepiride  , Liraglutide (1.8 mg) plus glimepiride  ,0,
edin,138,2871176,No significant difference,"HOMA-B increased with liraglutide (1.8 or 1.2 mg) compared with rosiglitazone (P < 0.05), while this increase was only different to placebo with liraglutide 1.2 mg (P = 0.01) and not liraglutide 1.8 mg (P = 0.051).", HOMA-B , Placebo plus glimepiride  , Liraglutide (1.8 mg) plus glimepiride  ,0,
edin,148,2871176,Cannot tell based on the abstract,, Pulse variations , Rosiglitazone plus glimepiride , Liraglutide (1.2 mg) plus glimepiride ,0,
edin,148,2871176,Significantly increased,Changes in pulse for all doses of liraglutide were significant vs. placebo (P ? 0.002), Pulse variations , Rosiglitazone plus glimepiride , Liraglutide (1.2 mg) plus glimepiride ,0,
edin,152,2871176,Cannot tell based on the abstract,, Incidence of minor hypoglycaemia , Placebo plus glimepiride , Liraglutide (1.2 mg) plus glimepiride ,0,
edin,152,2871176,Significantly increased,"Incidence was higher with liraglutide 1.2 mg (P = 0.0024) and 1.8 mg (P = 0.0065) compared with rosiglitazone and liraglutide 1.2 mg compared with placebo (P = 0.048), occurring in the setting of lower mean HbA1c values.", Incidence of minor hypoglycaemia , Placebo plus glimepiride , Liraglutide (1.2 mg) plus glimepiride ,0,
edin,151,2871176,Cannot tell based on the abstract,, Incidence of minor hypoglycaemia , Rosiglitazone plus glimepiride , Liraglutide (1.8 mg) plus glimepiride ,0,
edin,151,2871176,Significantly increased,"Incidence was higher with liraglutide 1.2 mg (P = 0.0024) and 1.8 mg (P = 0.0065) compared with rosiglitazone and liraglutide 1.2 mg compared with placebo (P = 0.048), occurring in the setting of lower mean HbA1c values.", Incidence of minor hypoglycaemia , Rosiglitazone plus glimepiride , Liraglutide (1.8 mg) plus glimepiride ,0,
edin,105,2871176,Cannot tell based on the abstract,, HbA1c level at 26 weeks , Placebo plus glimepiride , Liraglutide (1.8 mg) plus glimepiride ,0,
edin,105,2871176,Significantly decreased,"After 26 weeks, HbA1c decreased by 1.1% from baseline (primary endpoint) with either liraglutide 1.2 or 1.8 mg, respectively, compared with either placebo (+0.2%) or rosiglitazone (?0.4%) (Fig. 3d).", HbA1c level at 26 weeks , Placebo plus glimepiride , Liraglutide (1.8 mg) plus glimepiride ,0,
edin,400,2690844,Cannot tell based on the abstract,, Complications after surgery , Midline incision , Transverse incision ,0,
edin,400,2690844,No significant difference,Postoperative complications (Table 4) were seen in 16 out of 75 patients (21%) from the midline incision group and in 15% from the transverse incision group (11 patients) (P = 0.30), Complications after surgery , Midline incision , Transverse incision ,0,
edin,442,2600646,Cannot tell based on the abstract,, Gametocyte dynamics , dihydroartemisinin-piperaquine (AP) , arthemeter-lumefantrine (AL)  ,0,
edin,442,2600646,Significantly decreased,"<td colspan=""8""><hr></td>,<td colspan=""8""><hr></td>,<td colspan=""8""><hr></td>", Gametocyte dynamics , dihydroartemisinin-piperaquine (AP) , arthemeter-lumefantrine (AL)  ,0,
edin,376,3580134,Significantly increased,"Compared with formoterol, mean improvements were significantly greater with budesonide/formoterol 320/9 ?g (p ? 0.038) for all COPD symptom variables except sputum score and percentage of awakening-free nights, and with budesonide/formoterol 160/9 ?g (p ? 0.047) for all COPD symptom variables except BCSS, dyspnoea and sputum score (table IV). Table III", Awakening-free nights percentage improvement , Formoterol DPI 9 ?g , Budesonide/formoterol pMDI 160/9 ?g ,0,
edin,472,2847809,Cannot tell based on the abstract,, Complications and mortality , Placebo , Clopidogrel ,0,
edin,472,2847809,No significant difference,"<td align=""left"" colspan=""1"" rowspan=""1"">Death events</td><td align=""center"" colspan=""1"" rowspan=""1"">4 (4.3)</td><td align=""center"" colspan=""1"" rowspan=""1"">2 (2.1)</td><td align=""center"" colspan=""1"" rowspan=""1"">2 (2.1)</td><td align=""center"" colspan=""1"" rowspan=""1"">0.47</td>", Complications and mortality , Placebo , Clopidogrel ,0,
edin,344,3580134,Significantly increased,Time to first COPD exacerbation was significantly prolonged with both budesonide/formoterol dosages compared with placebo (p ? 0.004) and with budesonide/formoterol 320/9 ?g compared with formoterol (p = 0.026) [figure 6]., Time to first COPD exacerbation , Placebo , Budesonide/formoterol pMDI 160/9 ?g ,0,
edin,474,2847809,Significantly decreased,The primary AVF failures at two months were 21.6% in placebo group and 5.2% in clopidogrel group (P = 0.03)., The primary arteriovenous fistula failures at two months , Placebo , Clopidogrel ,0,
edin,315,3580134,Significantly increased,"Although improvements in 1-hour post-dose FEV1 were significantly greater for both budesonide/formoterol dosages compared with placebo (primary comparison; p < 0.001), budesonide/formoterol 320/9 ?g also resulted in significantly greater improvements compared with formoterol (p = 0.023) [figure 3b].", 1-hour post-dose FEV1 improvements , Placebo , Budesonide/formoterol pMDI 320/9 ?g ,0,
edin,279,2375236,Significantly decreased,"Provision of the question prompt sheet prolonged consultations and increased patient anxiety; however, when oncologists specifically addressed the prompt sheet, anxiety levels were significantly reduced, consultation duration was decreased and recall was significantly improved.", Information recall , Patients who didn't receive a question prompt sheet , Patients who received a question prompt sheet ,0,
edin,480,2447617,Significantly increased,"<td align=""left"">6 months</td><td></td><td></td>", The analysis using the dichotomization of GOS scores at 6 months post injury , placebo , progesterone ,0,
edin,324,3580134,Significantly increased,Mean FEV1 at 12 hours and baseline-adjusted average 12-hour FEV1 were significantly improved with both budesonide/formoterol dosages compared with placebo on the day of randomization and at end of treatment (p ? 0.002) [table II]., Mean FEV1 at 12 hours at end of treatment , Placebo , Budesonide/formoterol pMDI 320/9 ?g ,0,
edin,406,2690844,Cannot tell based on the abstract,, Scar width , Midline incision , Transverse incision ,0,
edin,406,2690844,Significantly decreased,The mean width of the scar after the healing of the midline incisions was found to be 8.3 ± 1.4 mm. The mean width of the scar after the healing of the transverse incisions was measured to be 3.3 ± 1.2 mm. This observed difference is significant (P < 0.0001)., Scar width , Midline incision , Transverse incision ,0,
edin,481,2899760,Significantly increased,"Fusion rate in the SR group was 92%, and in the TM group 69% (P < 0.05).", Fusion rate , anterior cervical decompression and fusion (ACDF) with Trabecular Metal? (TM) , raditional Smith?Robinson (SR) procedure with autograft  ,0,
edin,224,1475568,Cannot tell based on the abstract,, Minnesota living with heart failure (MLHF) questionnaire baseline scores , Standard information about self-care , Follow-up and thorough education on self-care ,0,
edin,224,1475568,Significantly decreased,"The control group did have statistically significantly higher baseline MLHF scores representing worse symptoms at baseline.,Patients enrolled in the control group received a general heart failure education pamphlet written at approximately the 7th grade level, and continued with usual care from their primary physician.", Minnesota living with heart failure (MLHF) questionnaire baseline scores , Standard information about self-care , Follow-up and thorough education on self-care ,0,
edin,374,3580134,Significantly increased,"Significantly greater improvements in COPD symptom variables were observed for both budesonide/formoterol dosages versus placebo for all variables (BCSS, dyspnoea score, cough score, sputum score, sleep score, percentage of awakening-free nights and total daily rescue medication use) [p ? 0.003].,Compared with formoterol, mean improvements were significantly greater with budesonide/formoterol 320/9 ?g (p ? 0.038) for all COPD symptom variables except sputum score and percentage of awakening-free nights, and with budesonide/formoterol 160/9 ?g (p ? 0.047) for all COPD symptom variables except BCSS, dyspnoea and sputum score (table IV). Table III", Sleep score improvement , Formoterol DPI 9 ?g , Budesonide/formoterol pMDI 160/9 ?g ,0,
edin,319,3580134,Significantly increased,Morning and evening PEF improved significantly for all active treatments compared with placebo (p ? 0.012), Peak expiratory flow in the morning and evening  , Placebo , Budesonide/formoterol pMDI 320/9 ?g ,0,
edin,440,2600646,Cannot tell based on the abstract,, mean Hb , dihydroartemisinin-piperaquine (AP) , arthemeter-lumefantrine (AL)  ,0,
edin,440,2600646,No significant difference,"<td colspan=""8""><hr></td>", mean Hb , dihydroartemisinin-piperaquine (AP) , arthemeter-lumefantrine (AL)  ,0,
edin,268,2691927,Significantly decreased,Differences regarding postoperative dosage of opiates and the visual analog scale (VAS) for pain scoring system were in favor of the laparoscopic procedure., Need for opiates , Conventional open approach , Laparoscopic surgery ,0,
edin,286,1871574,Significantly increased,"<td></td><td colspan=""5""><hr></td>", Quit attempt of 1 week or longer reported at 3 months , Usual care , Smoking cessation advice and NRT offered ,0,
edin,309,2817867,Significantly increased,Sixty percent of patients suffered local recurrences after RFA compared to 7% after hepatic resection., Local recurrence rate through the study , Hepatic resection , Radiofrequency ablation ,0,
edin,241,3090298,Cannot tell based on the abstract,, Higher-order aberrations during the study , Thin-flap laser in situ keratomileusis (LASIK) , Photo-refractive keratectomy (PRK) ,0,
edin,241,3090298,No significant difference,"Total root-mean square (RMS) HOAs, coma, trefoil, and spherical aberrations are compared in Figure 2. There were no significant differences between groups in any HOAs throughout the study (P ? 0.101), with all P values at 6 months ?0.63.", Higher-order aberrations during the study , Thin-flap laser in situ keratomileusis (LASIK) , Photo-refractive keratectomy (PRK) ,0,
edin,216,1475568,Cannot tell based on the abstract,, Heart failure-related quality of life at the end of treatment , Standard information about self-care , Follow-up and thorough education on self-care ,0,
edin,216,1475568,No significant difference,"In unadjusted analysis, the control group, on average, improved 5 points on the MLHF and the intervention group improved by 1 point. The difference was not statistically significant (3.5 points, 95% CI 11, -4, p = 0.36). After adjusting for baseline differences between the groups, the difference was 2 points (95% CI 9, -5, p = 0.59) suggesting no effect on heart failure-related quality of life.", Heart failure-related quality of life at the end of treatment , Standard information about self-care , Follow-up and thorough education on self-care ,0,
edin,307,2817867,Cannot tell based on the abstract,, Overall survival rate at 5 years , Hepatic resection , Radiofrequency ablation ,0,
edin,307,2817867,Significantly decreased,"The 5-year overall survival after resection alone was 43% (95% CI = 26 to 58%), while the 5-year survival after RFA alone was 23% (95% CI = 11 to 39%), as shown in Figure 1. This difference was statistically significant (P = .02).", Overall survival rate at 5 years , Hepatic resection , Radiofrequency ablation ,0,
edin,432,3187863,Cannot tell based on the abstract,, Pain relief: Acupuncture , Normal unit &amp; Special unit , Midwife-led unit ,0,
edin,432,3187863,Significantly increased,"There were statistically significant differences in augmentation (midwife-led unit versus normal unit RR 0.73, 95% CI 0.59?0.89; midwife-led unit versus special unit RR 0.69, 95% CI 0.56?0.86), in epidural analgesia (midwife-led unit versus normal unit RR 0.68, 95% CI 0.52?0.90; midwife-led unit versus special unit RR 0.64, 95% CI 0.47?0.86) and in acupuncture (midwife-led unit versus normal unit RR 1.45, 95% CI 1.25?1.69; midwife-led unit versus special unit RR 1.45, 95% CI 1.22?1.73).", Pain relief: Acupuncture , Normal unit &amp; Special unit , Midwife-led unit ,0,
edin,302,2817867,Cannot tell based on the abstract,, Blood loss during surgery , Hepatic resection , Radiofrequency ablation ,0,
edin,302,2817867,Significantly decreased,Operative blood loss (median 1400?mL (range 100 to 9000) versus 150?mL (range 50 to 2300); P < .0005) and transfusion requirements (44% of patients versus 5%; P < .0005) were higher for resection than for RFA., Blood loss during surgery , Hepatic resection , Radiofrequency ablation ,0,
edin,326,3580134,Significantly increased,Mean FEV1 at 12 hours and baseline-adjusted average 12-hour FEV1 were significantly improved with both budesonide/formoterol dosages compared with placebo on the day of randomization and at end of treatment (p ? 0.002) [table II]., Baseline-adjusted average 12-hour FEV1 at end of treatment , Placebo , Budesonide/formoterol pMDI 160/9 ?g ,0,
edin,443,1468428,No significant difference,"We found no significant differences in puerperal or neonatal infection rates (Puerperal infection: 41/190 [22%] with enema v 26/182 [14%] without enema; RR 0.66 CI 95%: 0.43 to 1.03; neonatal infection 38/191 [20%] with enema v 40/179 [22%] without enema; RR 1.12, 95% CI 95% 0.76 to 1.66),", Puerperal and neonatal infection rates  , no enema , 1 litre saline enema ,0,
edin,341,3580134,Significantly increased,"Improvements from baseline to the average over the randomized treatment period in 1-hour post-dose IC were significantly greater with both budesonide/formoterol dosages compared with placebo (p < 0.001) and formoterol (p ? 0.018) [figure 5b].,Both dosages of budesonide/formoterol resulted in a 350 mL (?25%) improvement from baseline to the average over the randomized treatment period in 1-hour post-dose IC, and formoterol resulted in a 210 mL (17%) improvement in 1-hour post-dose IC. Fig. 5", 1-hour post-dose inspiratory capacity mean improvements from baseline to the average over the randomized treatment period , Formoterol DPI 9 ?g , Budesonide/formoterol pMDI 320/9 ?g ,0,
edin,403,2690844,Cannot tell based on the abstract,, Infection of the surgical site , Midline incision , Transverse incision ,0,
edin,403,2690844,No significant difference,"Surgical site infections were diagnosed in 7 and 3 patients, respectively (P = 0.33).Table 4", Infection of the surgical site , Midline incision , Transverse incision ,0,
edin,347,3580134,Significantly decreased,"In addition, significant reductions in the overall number of exacerbations per patient-treatment year were observed with budesonide/formoterol 320/9 ?g and 160/9 ?g versus placebo (37% and 41%, respectively; p < 0.001) and formoterol (25% and 29%, respectively; p ? 0.004) [see figure S2 in the supplementary material].", Amount of exacerbations per patient-treatment year , Placebo , Budesonide/formoterol pMDI 160/9 ?g ,0,
edin,231,3090298,Cannot tell based on the abstract,, Uncorrected distance visual acuity at 1 month , Thin-flap laser in situ keratomileusis (LASIK) , Photo-refractive keratectomy (PRK) ,0,
edin,231,3090298,Significantly decreased,"Statistically significant differences were found between PRK and thin-flap LASIK in UDVA at 1 month postoperatively, with thin-flap LASIK eyes showing more improvement in UDVA.", Uncorrected distance visual acuity at 1 month , Thin-flap laser in situ keratomileusis (LASIK) , Photo-refractive keratectomy (PRK) ,0,
edin,389,2690844,Cannot tell based on the abstract,, Smaller incision  , Midline incision , Transverse incision ,0,
edin,389,2690844,Significantly increased,"The length of the incisions was 140 ± 24 mm and 164 ± 28 mm for the transverse and the midline incisions, respectively. The difference in scar length was found to be significant (P < 0.0001).", Smaller incision  , Midline incision , Transverse incision ,0,
edin,482,2899760,No significant difference,There was no statistically significant difference in clinical outcomes between fusion techniques or between patients who appeared radiologically fused or non-fused., clinical outcomes , anterior cervical decompression and fusion (ACDF) with Trabecular Metal? (TM) , raditional Smith?Robinson (SR) procedure with autograft  ,0,
edin,367,3580134,Significantly increased,"Significantly greater improvements in COPD symptom variables were observed for both budesonide/formoterol dosages versus placebo for all variables (BCSS, dyspnoea score, cough score, sputum score, sleep score, percentage of awakening-free nights and total daily rescue medication use) [p ? 0.003].", Overall use of daily rescue medication improvement , Placebo , Budesonide/formoterol pMDI 320/9 ?g ,0,
edin,402,2690844,Cannot tell based on the abstract,, Urinary retention , Midline incision , Transverse incision ,0,
edin,402,2690844,No significant difference,"Briefly, one patient in each group developed cardiac complications; 8 and 6 patients developed urinary retention after the midline and transverse incisions, respectively (P = 0.59).", Urinary retention , Midline incision , Transverse incision ,0,
edin,283,2361806,No significant difference,"For ILF and ELF, respectively, median progression-free survival was 4.5 vs 2.3 months, time to treatment failure was 3.6 vs 2.2 months (P=0.4542), and overall survival was 10.8 vs 8.3 months (P=0.2818).", Overall survival , Etoposide with 5-fluorouracil plus leucovorin (ELF) , Irinotecan with high-dose 5-fluorouracil plus leucovorin (ILF) ,0,
edin,397,2690844,Cannot tell based on the abstract,, Procedure performed directly by the staff surgeon , Midline incision , Transverse incision ,0,
edin,397,2690844,No significant difference,Staff surgeons performed 17% (13/75 patients) of all procedures performed through a midline incision. The remainder of the procedures through a midline incision was carried out under staff surgeon supervision. Staff surgeons performed 14% of all procedures in the transverse incisions study group (10/74 patients) and supervised the remainder. No statistically significant difference was found between the two randomised groups (P = 0.65)., Procedure performed directly by the staff surgeon , Midline incision , Transverse incision ,0,
edin,233,3090298,Cannot tell based on the abstract,, Corrected distance visual acuity at 6 months , Thin-flap laser in situ keratomileusis (LASIK) , Photo-refractive keratectomy (PRK) ,0,
edin,233,3090298,No significant difference,Visual acuities were not statistically different between the groups at 3 or 6 months., Corrected distance visual acuity at 6 months , Thin-flap laser in situ keratomileusis (LASIK) , Photo-refractive keratectomy (PRK) ,0,
edin,254,1831737,Cannot tell based on the abstract,, Patients infected with T. vaginalis , Baseline communities that received standard Government services , Baseline communities that received additional education and preventive measures ,0,
edin,254,1831737,No significant difference,"T. vaginalis infection, secondary school education, and spatial mobility were more common in the control communities, whilst history of genital discharge and uptake of STI treatment and VCT services offered in the survey were low overall but more frequent in the intervention communities (Table 1). However, the differences in each case were small and were unlikely to be clinically meaningful.", Patients infected with T. vaginalis , Baseline communities that received standard Government services , Baseline communities that received additional education and preventive measures ,0,
edin,282,2361806,No significant difference,"For ILF and ELF, respectively, median progression-free survival was 4.5 vs 2.3 months, time to treatment failure was 3.6 vs 2.2 months (P=0.4542), and overall survival was 10.8 vs 8.3 months (P=0.2818).", Time to treatment failure , Etoposide with 5-fluorouracil plus leucovorin (ELF) , Irinotecan with high-dose 5-fluorouracil plus leucovorin (ILF) ,0,
edin,447,2607225,Cannot tell based on the abstract,, cognitive functioning , standard care ," individual support, group rehabilitation and a combination of the two (Group rehabilitation) ",0,
edin,447,2607225,Significantly increased,"Individual support patients had a higher level of cognitive functioning (mean=87.4, s.d.=14.2) as compared with non-IS patients (mean=84.0, s.d.=16.4) (F=4.6, d.f.=1/321, P=0.046) from 3 to 24 months.", cognitive functioning , standard care ," individual support, group rehabilitation and a combination of the two (Group rehabilitation) ",0,
edin,385,2721929,Significantly increased,"Mean urgency score decreased by 44.8%, 62.2% and 60.2% in the BT, To, and Co groups, respectively, and the improvement was significantly greater in the To and Co groups than in the BT group (p<0.05 for each).", Urgency score improvement , Bladder training only (BT) , Bladder training plus tolterodine (Co) ,0,
edin,467,3387601,Significantly increased,"There was a negative correlation between CSF protein and duration of mechanical ventilation in the PE group (p = 0.037), but not in the IVIG group (p = 0.132).", negative correlation between CSF protein and duration of mechanical ventilation , intravenous immunoglobulin (IVIG) , plasma exchange (PE)  ,0,
edin,305,2817867,Cannot tell based on the abstract,, Hospital stay , Hepatic resection , Radiofrequency ablation ,0,
edin,305,2817867,No significant difference,"Rates of ICU admission (6.5% of patients overall), and length of stay (median of 7 days for all patients; range 1 to 48) were not significantly different between patients having hepatic resection and RFA.", Hospital stay , Hepatic resection , Radiofrequency ablation ,0,
edin,273,2691927,Cannot tell based on the abstract,, Time to nasogastric decompression , Conventional open approach , Laparoscopic surgery ,0,
edin,273,2691927,No significant difference,"Nasogastric decompression could be stopped after 2?3 days in both groups (Table 4).Table 4,<td align=""left"">Median duration of nasogastric decompression (days) + IQR</td><td align=""char"" char=""("">2.0 (3.0)</td><td align=""char"" char=""("">3.0 (1.3)</td><td align=""char"" char=""."">0.334</td>", Time to nasogastric decompression , Conventional open approach , Laparoscopic surgery ,0,
edin,456,3446002,Cannot tell based on the abstract,, side effects , control group , single dose of 50 mg/kg clofibrate ,0,
edin,456,3446002,No significant difference,On serial daily examination during phototherapy and up to 2 days after that no problems or side effects were observed., side effects , control group , single dose of 50 mg/kg clofibrate ,0,
edin,269,2691927,Cannot tell based on the abstract,, Hospital permanence , Conventional open approach , Laparoscopic surgery ,0,
edin,269,2691927,No significant difference,"Time to discharge was similar for the two groups, with a median difference of 1.5 days (Table 4),<td align=""left"">Median hospital stay (days) + IQR</td><td align=""char"" char=""("">6.5 (9.3)</td><td align=""char"" char=""("">8.0 (7.3)</td><td align=""char"" char=""."">0.235</td>", Hospital permanence , Conventional open approach , Laparoscopic surgery ,0,
edin,463,1876597,No significant difference,Both drugs were well tolerated; serious adverse events were uncommon and unrelated to study drugs., Adverse Events , artemether-lumefantrine , dihydroartemisinin-piperaquine  ,0,
edin,238,3090298,Cannot tell based on the abstract,, Contrast sensitivity at 3 months seen at 3 cpd , Pre-surgery baseline , Photo-refractive keratectomy (PRK) ,0,
edin,238,3090298,No significant difference,"At 6 months contrast sensitivity in the PRK group was still significantly decreased from baseline at 3 cpd (P = 0.013), although it did not reach a statistically significant difference at 3 months (P = 0.101).", Contrast sensitivity at 3 months seen at 3 cpd , Pre-surgery baseline , Photo-refractive keratectomy (PRK) ,0,
edin,265,2691927,Significantly decreased,"The VAS score on postoperative days 1, 3, and 7 was significant lower (P < 0.05) in the laparoscopic group.", Visual analog scale pain score at day 3 , Conventional open approach , Laparoscopic surgery ,0,
edin,395,2690844,Cannot tell based on the abstract,, Average patient's weight , Midline incision , Transverse incision ,0,
edin,395,2690844,No significant difference,"Furthermore, no differences were found in the body mass and average length between the two groups (Table 1).", Average patient's weight , Midline incision , Transverse incision ,0,
edin,264,2691927,Significantly decreased,"he VAS score on postoperative days 1, 3, and 7 was significant lower (P < 0.05) in the laparoscopic group.", Visual analog scale pain score at day 1 , Conventional open approach , Laparoscopic surgery ,0,
edin,278,2375236,Significantly decreased,"Provision of the question prompt sheet prolonged consultations and increased patient anxiety; however, when oncologists specifically addressed the prompt sheet, anxiety levels were significantly reduced, consultation duration was decreased and recall was significantly improved.", Anxiety , Patients who didn't receive a question prompt sheet , Patients who received a question prompt sheet ,0,
edin,370,3580134,Significantly increased,"Significantly greater improvements in COPD symptom variables were observed for both budesonide/formoterol dosages versus placebo for all variables (BCSS, dyspnoea score, cough score, sputum score, sleep score, percentage of awakening-free nights and total daily rescue medication use) [p ? 0.003].", Cough score improvement , Formoterol DPI 9 ?g , Budesonide/formoterol pMDI 320/9 ?g ,0,
edin,479,2447617,Significantly increased,"<td align=""left"">6 months</td><td></td><td></td>", The analysis using the dichotomization of GOS scores at 3 months post injury , placebo , progesterone ,0,
edin,261,1831737,Cannot tell based on the abstract,, Programme meeting attendance , Baseline communities that received standard Government services , Baseline communities that received additional education and preventive measures ,0,
edin,261,1831737,Significantly increased,"In the general population sample interviewed in the follow-up survey, 1,779 (35%) and 647 (13%) of 5,098 respondents reported attending an HIV/AIDS meeting and a programme meeting, respectively (Table 5). More respondents in the intervention communities than in the control communities attended an HIV/AIDS meeting (41% versus 28%, prevalence rate ratio 1.44 [95% CI 1.33?1.56], p < 0.001) and a programme meeting (20% versus 5%, 4.27 [95% CI 3.52?5.17], p < 0.001),", Programme meeting attendance , Baseline communities that received standard Government services , Baseline communities that received additional education and preventive measures ,0,
edin,387,2721929,Cannot tell based on the abstract,, Urgency score improvement , Tolterodine only (To) , Bladder training plus tolterodine (Co) ,0,
edin,387,2721929,No significant difference,"No difference was observed between the To and Co groups.,When we compared these changes among the three groups, we found that patients in the Co group showed greater improvements in frequency and urgency scores than did patients in the BT group (p<0.05 each), and that urgency scores in the To and Co groups showed significantly greater improvement than in the BT group (p=0.017 and p=0.021, respectively).", Urgency score improvement , Tolterodine only (To) , Bladder training plus tolterodine (Co) ,0,
edin,276,2375236,Cannot tell based on the abstract,, Prognosis information given , Patients who didn't receive a question prompt sheet , Patients who received a question prompt sheet ,0,
edin,276,2375236,Significantly increased,Patients provided with a question prompt sheet asked more questions about prognosis compared with controls and oncologists gave significantly more prognostic information to these patients., Prognosis information given , Patients who didn't receive a question prompt sheet , Patients who received a question prompt sheet ,0,
edin,237,3090298,Cannot tell based on the abstract,, Contrast sensitivity at 1 month seen at 3 cpd , Pre-surgery baseline , Photo-refractive keratectomy (PRK) ,0,
edin,237,3090298,Significantly decreased,"The thin-flap LASIK group showed no change in contrast sensitivity postoperatively (P > 0.131), while patients in the PRK group had a slight decrease in contrast sensitivity at 1 month seen at 3 and 12 cpd (P = 0.004) and (P = 0.025), respectively", Contrast sensitivity at 1 month seen at 3 cpd , Pre-surgery baseline , Photo-refractive keratectomy (PRK) ,0,
edin,298,1871574,Cannot tell based on the abstract,, Smoking cessation at 6 months , Usual care , Smoking cessation advice and NRT offered ,0,
edin,298,1871574,Significantly increased,"<td></td><td colspan=""5""><hr></td>", Smoking cessation at 6 months , Usual care , Smoking cessation advice and NRT offered ,0,
edin,428,3187863,Cannot tell based on the abstract,, Perineal outcome: the number of episiotomies or the incidence of sphincter injuries , Normal unit &amp; Special unit , Special unit ,0,
edin,428,3187863,No significant difference,There was no significant difference between the three groups concerning the number of episiotomies or the incidence of sphincter injuries (Table 2)., Perineal outcome: the number of episiotomies or the incidence of sphincter injuries , Normal unit &amp; Special unit , Special unit ,0,
edin,292,1871574,Cannot tell based on the abstract,, Baseline cotinine level , Usual care , Smoking cessation advice and NRT offered ,0,
edin,292,1871574,No significant difference,"<td></td><td colspan=""5""><hr></td>,<td></td><td colspan=""5""><hr></td>", Baseline cotinine level , Usual care , Smoking cessation advice and NRT offered ,0,
edin,423,1187893,Significantly increased,"<td colspan=""7""><hr></td>", Knee injury and Osteoarthritis Outcome Score quality of life subscale at 6 months , No exercise , Exercise ,0,
edin,323,3580134,Significantly increased,Mean FEV1 at 12 hours and baseline-adjusted average 12-hour FEV1 were significantly improved with both budesonide/formoterol dosages compared with placebo on the day of randomization and at end of treatment (p ? 0.002) [table II]., Mean FEV1 at 12 hours on the day of randomization , Placebo , Budesonide/formoterol pMDI 160/9 ?g ,0,
edin,295,1871574,Cannot tell based on the abstract,, Smoking reduction at 3 months , Usual care , Smoking cessation advice and NRT offered ,0,
edin,295,1871574,Significantly increased,"<td></td><td colspan=""5""><hr></td>", Smoking reduction at 3 months , Usual care , Smoking cessation advice and NRT offered ,0,
edin,316,3580134,Significantly increased,"lthough improvements in 1-hour post-dose FEV1 were significantly greater for both budesonide/formoterol dosages compared with placebo (primary comparison; p < 0.001), budesonide/formoterol 320/9 ?g also resulted in significantly greater improvements compared with formoterol (p = 0.023) [figure 3b].", 1-hour post-dose FEV1 improvements , Placebo , Budesonide/formoterol pMDI 160/9 ?g ,0,
edin,217,1475568,Cannot tell based on the abstract,, Baseline hypertension , Standard information about self-care , Follow-up and thorough education on self-care ,0,
edin,217,1475568,No significant difference,"At baseline, most characteristics were similar between the two groups (Table 1). However, the control group had more participants with hypertension, fewer with diabetes, and fewer men.,Regardless of these differences, none were statistically significant.", Baseline hypertension , Standard information about self-care , Follow-up and thorough education on self-care ,0,
edin,258,1831737,Cannot tell based on the abstract,, Intake of STI treatment , Baseline communities that received standard Government services , Baseline communities that received additional education and preventive measures ,0,
edin,258,1831737,No significant difference,"T. vaginalis infection, secondary school education, and spatial mobility were more common in the control communities, whilst history of genital discharge and uptake of STI treatment and VCT services offered in the survey were low overall but more frequent in the intervention communities (Table 1). However, the differences in each case were small and were unlikely to be clinically meaningful.", Intake of STI treatment , Baseline communities that received standard Government services , Baseline communities that received additional education and preventive measures ,0,
edin,448,2607225,Cannot tell based on the abstract,, Appetite loss , standard care ," individual support, group rehabilitation and a combination of the two (Group rehabilitation) ",0,
edin,448,2607225,Significantly decreased,"Appetite loss decreased from 3 to 6 months (mean=5.1?3.7, s.d.=14.2?11.1), worsened at 12 months (mean=5.8, s.d.=16.0) and decreased again at 24 months (mean=4.1, s.d.=12.7) in GR patients, whereas it improved from 3 to 6 and 12 months (mean=8.1, 4.0, 2.4; s.d.=17.7, 12.6, 10.8) and worsened at 24 months (mean=2.8, s.d.=10.7) in non-GR patients (F=4.1, d.f.=3/963, P=0.007).", Appetite loss , standard care ," individual support, group rehabilitation and a combination of the two (Group rehabilitation) ",0,
edin,441,2600646,Cannot tell based on the abstract,, Adverse events , dihydroartemisinin-piperaquine (AP) , arthemeter-lumefantrine (AL)  ,0,
edin,441,2600646,No significant difference,"<td colspan=""8""><hr></td>", Adverse events , dihydroartemisinin-piperaquine (AP) , arthemeter-lumefantrine (AL)  ,0,
edin,377,3580134,Significantly decreased,The geometric mean values of 24-hour urinary cortisol at 6 months and end of treatment were lower in both budesonide/formoterol dosage groups compared with formoterol and placebo (see table SV in the supplementary material). Significant differences in 24-hour urinary cortisol were observed between the budesonide/formoterol 320/9 ?g and placebo groups (p = 0.035) at month 6 and between the budesonide/formoterol 320/9 ?g and formoterol groups (p = 0.044) at end of treatment., 24-hour urinary cortisol at 6 months , Placebo , Budesonide/formoterol pMDI 320/9 ?g ,0,
edin,218,1475568,Cannot tell based on the abstract,, Baseline diabetes , Standard information about self-care , Follow-up and thorough education on self-care ,0,
edin,218,1475568,No significant difference,"At baseline, most characteristics were similar between the two groups (Table 1). However, the control group had more participants with hypertension, fewer with diabetes, and fewer men. Of heart failure related characteristics, the control group had more participants with systolic dysfunction, and taking ?-blockers. The intervention group had more participants taking ACE inhibitors or ARBs, and digoxin. Regardless of these differences, none were statistically significant.", Baseline diabetes , Standard information about self-care , Follow-up and thorough education on self-care ,0,
edin,255,1831737,Cannot tell based on the abstract,, Secondary school education , Baseline communities that received standard Government services , Baseline communities that received additional education and preventive measures ,0,
edin,255,1831737,No significant difference,"T. vaginalis infection, secondary school education, and spatial mobility were more common in the control communities, whilst history of genital discharge and uptake of STI treatment and VCT services offered in the survey were low overall but more frequent in the intervention communities (Table 1). However, the differences in each case were small and were unlikely to be clinically meaningful.", Secondary school education , Baseline communities that received standard Government services , Baseline communities that received additional education and preventive measures ,0,
edin,393,2690844,Significantly decreased,"More patients having undergone a midline incision, reported pain on day one, two and three postoperatively than patients from the transverse group.", Pain on day three after surgery , Midline incision , Transverse incision ,0,
edin,289,1871574,Cannot tell based on the abstract,, Baseline smoking habits , Usual care , Smoking cessation advice and NRT offered ,0,
edin,289,1871574,No significant difference,"<td></td><td colspan=""5""><hr></td>", Baseline smoking habits , Usual care , Smoking cessation advice and NRT offered ,0,
edin,473,2847809,Significantly increased,First hemodialysis from newly created AVF in clopidogrel group was significantly more successful than placebo group (P = 0.008)., First hemodialysis success , Placebo , Clopidogrel ,0,
edin,228,1475568,Cannot tell based on the abstract,, Baseline life-quality score , Standard information about self-care , Follow-up and thorough education on self-care ,0,
edin,228,1475568,No significant difference,"Among these patients, there was no difference in quality of life score in unadjusted and adjusted analyses (difference = -1.6; 95% CI -15, 12); p = 0.81).", Baseline life-quality score , Standard information about self-care , Follow-up and thorough education on self-care ,0,
edin,275,2375236,Significantly increased,Patients provided with a question prompt sheet asked more questions about prognosis compared with controls and oncologists gave significantly more prognostic information to these patients., Prognosis enquiry , Patients who didn't receive a question prompt sheet , Patients who received a question prompt sheet ,0,
edin,401,2690844,Cannot tell based on the abstract,, Cardiac complications , Midline incision , Transverse incision ,0,
edin,401,2690844,No significant difference,"Briefly, one patient in each group developed cardiac complications; 8 and 6 patients developed urinary retention after the midline and transverse incisions, respectively (P = 0.59).", Cardiac complications , Midline incision , Transverse incision ,0,
edin,310,3580134,Significantly increased,Time to discontinuation was significantly (p ? 0.004) prolonged in both budesonide/formoterol groups versus placebo., Time to discontinuation , Placebo , Budesonide/formoterol pMDI 320/9 ?g ,0,
edin,355,3580134,Significantly increased,"Significantly greater improvements in COPD symptom variables were observed for both budesonide/formoterol dosages versus placebo for all variables (BCSS, dyspnoea score, cough score, sputum score, sleep score, percentage of awakening-free nights and total daily rescue medication use) [p ? 0.003].", Breathlessness Cough and Sputum Scale improvement , Placebo , Budesonide/formoterol pMDI 160/9 ?g ,0,
edin,287,1871574,Cannot tell based on the abstract,, Gender , Usual care , Smoking cessation advice and NRT offered ,0,
edin,287,1871574,No significant difference,"<td></td><td colspan=""5""><hr></td>", Gender , Usual care , Smoking cessation advice and NRT offered ,0,
edin,427,1187893,Cannot tell based on the abstract,, Functional performance improvement , No exercise , Exercise ,0,
edin,427,1187893,No significant difference,"<td colspan=""7""><hr></td>", Functional performance improvement , No exercise , Exercise ,0,
edin,290,1871574,Cannot tell based on the abstract,, Baseline nicotine dependence variables , Usual care , Smoking cessation advice and NRT offered ,0,
edin,290,1871574,No significant difference,"<td></td><td colspan=""5""><hr></td>", Baseline nicotine dependence variables , Usual care , Smoking cessation advice and NRT offered ,0,
edin,391,2690844,Significantly decreased,"More patients having undergone a midline incision, reported pain on day one, two and three postoperatively than patients from the transverse group.", Pain on day one after surgery , Midline incision , Transverse incision ,0,
edin,384,2721929,Significantly increased,"Mean urgency score decreased by 44.8%, 62.2% and 60.2% in the BT, To, and Co groups, respectively, and the improvement was significantly greater in the To and Co groups than in the BT group (p<0.05 for each).", Urgency score improvement , Bladder training only (BT) , Tolterodine only (To) ,0,
edin,259,1831737,No significant difference,No evidence was found for reduced incidence of self-reported STI symptoms or high-risk sexual behaviour in the intervention communities., Self-reported STI symptoms , Baseline communities that received standard Government services , Baseline communities that received additional education and preventive measures ,0,
edin,407,2690844,Cannot tell based on the abstract,, Better cosmetic appearance of the incision as subjectively assessed by patients , Midline incision , Transverse incision ,0,
edin,407,2690844,Significantly increased,Transverse incisions were found to be significantly shorter than midline incisions and associated with more pleasing appearance., Better cosmetic appearance of the incision as subjectively assessed by patients , Midline incision , Transverse incision ,0,
edin,226,1475568,Cannot tell based on the abstract,, Knowledge about heart failure , Standard information about self-care , Follow-up and thorough education on self-care ,0,
edin,226,1475568,Significantly increased,"Heart failure related knowledge improved more in the intervention group than in the control group. Mean difference in score improvement was 12 percentage points (95% CI 6, 18; p < 0.001).", Knowledge about heart failure , Standard information about self-care , Follow-up and thorough education on self-care ,0,
edin,368,3580134,Significantly increased,"Significantly greater improvements in COPD symptom variables were observed for both budesonide/formoterol dosages versus placebo for all variables (BCSS, dyspnoea score, cough score, sputum score, sleep score, percentage of awakening-free nights and total daily rescue medication use) [p ? 0.003].", Dyspnoea score improvement , Formoterol DPI 9 ?g , Budesonide/formoterol pMDI 320/9 ?g ,0,
edin,611,5577662,Cannot tell based on the abstract,, percentage changes in area ," dose of 0.25 mg, 0.40 mg, or 0.60 mg (1:1:1 ratio) and then allocated placebo (4:1 ratio) ", receive a dose of 0.25 mg (1:1:1 ratio) and then allocated to active treatment (CCH) ,0,
edin,611,5577662,Significantly decreased,"<td colspan=""5"">Week 8</td>", percentage changes in area ," dose of 0.25 mg, 0.40 mg, or 0.60 mg (1:1:1 ratio) and then allocated placebo (4:1 ratio) ", receive a dose of 0.25 mg (1:1:1 ratio) and then allocated to active treatment (CCH) ,0,
edin,571,5602855,No significant difference,The EQ-5D-3L summary index is shown in Fig.Â 2. No significant change could be observed in the anxiety/depression dimension of the EQ-5D-3L system either in those with good (pÂ =Â 0.26) or inadequate (pÂ =Â 0.71) motivation/capability during the three years of follow-up., Quality of life , inadequate motivation/capability , good motivation/capability ,0,
edin,578,4577567,Significantly decreased,"Kinematic parameters measured before and after the 3-week training in RWM showed increased stride length (4.54%; p<0.0001) and contact time (4.58%; p<0.001); inversely, a decreased stride frequency (4.44%; p<0.0001) and internal work (7.09%; p<0.05) were found.,In RWF the effect of the training showed a decrease in stride length (1.18%; p<0.0001) and contact time (<1%; p<0.0001) with respect to baseline conditions and an increased stride frequency and internal work of 1.19% (p<0.0001).", internal work , free stride frequency , stride frequency manipulation ,0,
edin,495,2253708,No significant difference,"<th colspan=""1"" rowspan=""1""></th><th colspan=""1"" rowspan=""1""></th><th align=""left"" colspan=""3"" rowspan=""1""><hr></th><th align=""left"" colspan=""3"" rowspan=""1""><hr></th><th align=""left"" colspan=""3"" rowspan=""1""><hr></th>", 7-day point prevalence abstinence , Practitioner-delivered brief advice , Tailored letters ,0,
edin,619,4139977,No significant difference,Improvement in bowel habit was observed in 33.3% of the probiotic and 36.5% of the placebo group (P = 0.910)., Improvement in bowel habit ," similar placebo, twice daily after a meal for 14 consecutive days "," receive a probiotic compound containing seven bacteria species including Lactobacillus strains, Bifidobacterium strains and Streptococcus thermophiles ",0,
edin,608,5577662,Significantly increased,"<td colspan=""5"">Week 8</td>,<td colspan=""5"">Week 8</td>", percentage changes in area ," dose of 0.25 mg, 0.40 mg, or 0.60 mg (1:1:1 ratio) and then allocated placebo (4:1 ratio) "," receive a dose of 0.40 mg, or 0.60 mg (1:1:1 ratio) and then allocated to active treatment (CCH) ",0,
edin,595,4819709,Significantly increased,"UGFS was superior to EVLA in terms of return to fullâ??time work (hazard ratio 1Â·43, 95 per cent c.i. 1Â·11 to 1Â·85),", Full return to normal work/employment , surgery , Ultrasoundâ??guided foam sclerotherapy ,0,
edin,593,4819709,No significant difference,The two behaviours for which there was no evidence of a difference in the time to recover between the trial arms were â??having a bath or showerâ?? and â??wearing clothes that show the legsâ??., Wearing clothes that show the legs , surgery , Ultrasoundâ??guided foam sclerotherapy ,0,
edin,551,125315,No significant difference,"<td></td><td colspan=""3""><hr></td><td colspan=""3""><hr></td><td colspan=""3""><hr></td>", The median stay in hospital , received only standard therapy for sepsis , received standard therapy for sepsis and physiological-dose steroid therapy for 10 days; ,0,
edin,617,5062234,Significantly decreased,"The visual analog scale scores at rest and on coughing were significantly higher in the local infiltration group in the immediate postoperative period (P = 0.034 and P = 0.007, respectively).", The visual analog scale scores at rest and on coughing , local anesthetic infiltration of the port site. , Transversus abdominis plane block with 0.375% ropivacaine  ,0,
edin,544,2666722,Cannot tell based on the abstract,, the risk of SARS infection , health care workers without IgG against Severe acute respiratory syndrome , health care workers with IgG against Severe acute respiratory syndrome ,0,
edin,544,2666722,Invalid Prompt,, the risk of SARS infection , health care workers without IgG against Severe acute respiratory syndrome , health care workers with IgG against Severe acute respiratory syndrome ,1, I was not able to find any connection in text between health care workers with IgG against Severe acute respiratory syndrome and the risk of SARS infection. 
edin,556,4785315,Significantly decreased,"The prespecified comparison for women with two or more social risk factors showed a statistically significant reduction in mean EPDS (MD â??0.79 (95% CI â??1.56 to â??0.02) p=0.05), although no significant differences were seen in the mean EPDS (mean difference (MD) â??0.59 (95% CI â??1.24 to 0.06)) for all the women recruited.", Postnatal depression (Edinburgh Postnatal Depression Scale17 EPDS) , standard maternity care ," additional lay support (in this instance Pregnancy Outreach Workers, POWs) ",0,
edin,519,1261533,Significantly decreased,"The mean (SD) decrease in haematocrit value at day seven from baseline was greater in the group receiving MAS3 than in the ALN group: 9.3% (SD,11.5%; 95% CI, 7.7% to 10.9%) compared with 6.7% (SD, 11.4%; 95% CI, 5.1 to 8.3%) respectively (P = 0.023).", Decrease in haematocrit level at day 7 , Mefloquine-artesunate , Artemether-lumefantrine ,0,
edin,620,4139977,No significant difference,"With regard to QOL, an improvement was observed in the probiotic (P = 0.008), but not in the placebo group (P = 0.175); though, there was no significant difference between the two groups in this regard (P = 0.372), Table 2.", quality-of-life  ," similar placebo, twice daily after a meal for 14 consecutive days "," receive a probiotic compound containing seven bacteria species including Lactobacillus strains, Bifidobacterium strains and Streptococcus thermophiles ",0,
edin,583,4819709,Significantly increased,"<td align=""left"" colspan=""1"" rowspan=""2"" style=""padding-left:10%"" valign=""top"">Bending the legs without discomfort</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""top"">50</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""top"">3Â·0</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""top"">4Â·6</td><td align=""center"" colspan=""1"" rowspan=""2"" valign=""top"">1Â·38 (1Â·14, 1Â·67)</td>,Participants randomized to UGFS recalled being able to carry out 13 of the 15 behaviours significantly more quickly than those randomized to surgery (Table â?? 2 ).", Bending the legs without discomfort , surgery , Ultrasoundâ??guided foam sclerotherapy ,0,
edin,599,4819709,Significantly decreased,"Return to â??walking short distances without discomfortâ??, â??walking long distancesâ??, â??looking after childrenâ?? and â??full return to normal work/employmentâ?? took longer for the EVLA group than the UGFS group."," walking short distances without discomfort, walking long distances, looking after children, full return to normal work/employment ", Ultrasoundâ??guided foam sclerotherapy , Endovenous laser ablation ,0,
edin,582,3800940,Cannot tell based on the abstract,," Indralupta is a unique, idiopathic, non-cictricial, non-inflammatory alopecia, presents as discoid areas of hair loss. ", Godugdha sodhit Langali moola with honey for external application , Gomutra sodhit Langali moola with honey for external application ,0,
edin,582,3800940,Invalid Prompt,," Indralupta is a unique, idiopathic, non-cictricial, non-inflammatory alopecia, presents as discoid areas of hair loss. ", Godugdha sodhit Langali moola with honey for external application , Gomutra sodhit Langali moola with honey for external application ,1, Required info can't be found in abstract and there are no other sections for this article. 
edin,560,2888205,Significantly decreased,"<th></th><th colspan=""6""><hr></th>", pain , fibromyalgia (FM) education control (FME) group - received information and support ," lifestyle physical activity (LPA) - 30 minutes of self-selected moderate-intensity LPA, five to seven days per week ",0,
edin,485,2806484,No significant difference,"184 (24%) patients having home and 145 (27%) facility care either had virological failure, were lost to follow-up, or withdrew from the trial (adjusted rate ratio [RR] 0Â·88, 95% CI 0Â·70â??1Â·10).", Virological failure , Facility-based HIV-care strategy , Home-based HIV-care strategy ,0,
edin,500,2956883,No significant difference,"Gel efficacy against HIV-1 transmission did not differ between centres (p=0Â·19 for interaction), or between consistent (HR 0Â·97, 95% CI 0Â·87â??1Â·35, p=0Â·87) and inconsistent (1Â·17, 0Â·42â??1Â·72, p=0Â·42) gel users (p=0Â·47 for interaction).", Gel efficacy in consistent gel users , Placebo gel , 0Â·5% PRO2000 gel ,0,
edin,561,2888205,No significant difference,"<th></th><th colspan=""6""><hr></th>", six-minute walk test , fibromyalgia (FM) education control (FME) group - received information and support ," lifestyle physical activity (LPA) - 30 minutes of self-selected moderate-intensity LPA, five to seven days per week ",0,
edin,534,3198285,Significantly decreased,The LGI group achieved a modestly lower GI than the HF group (mean Â± SEM 47 Â± 1 vs. 53 Â± 1; P < 0.001)., lowâ??glycemic index , high-fiber moderate-GI diet (HF) (target glycemic index GI ~60) , lowâ??glycemic index diet (target glycemic index [GI] ~50) ,0,
edin,502,2956883,No significant difference,No deaths or serious adverse events were regarded as related to study gels., Adverse events , Placebo gel , PRO2000 gels ,0,
edin,589,4819709,No significant difference,The two behaviours for which there was no evidence of a difference in the time to recover between the trial arms were â??having a bath or showerâ?? and â??wearing clothes that show the legsâ??., Having a bath or shower , surgery , Ultrasoundâ??guided foam sclerotherapy ,0,
edin,601,2891743,Significantly increased,"<td colspan=""4""><hr></td>", transurethral resection (TUR) syndrome , glucose 5% solution , glycine 1.5% solution as irrigating fluid ,0,
edin,510,1964758,Significantly increased,"<td colspan=""4""><hr></td>", 8-year survivorship in patients with osteoarthritis , BioModularÂ® shoulder prosthesis , Initial Nottingham TSR design prosthesis ,0,
edin,615,5062234,No significant difference,The 24 h morphine requirement (mean Â± standard deviation) was 34.57 Â± 14.64 mg in TAP group and 32.76 Â± 14.34 mg in local infiltration group (P = 0.688)., The 24 h morphine requirement , local anesthetic infiltration of the port site. , Transversus abdominis plane block with 0.375% ropivacaine  ,0,
edin,602,2891743,Significantly increased,"<td colspan=""4""><hr></td>", transurethral resection (TUR) syndrome , normal saline 0.9% solution , glycine 1.5% solution as irrigating fluid ,0,
edin,512,2829413,Significantly decreased,"After 6 weeks of treatment, greater reductions in total cholesterol (- 35.94 Â± 11.38 vs. - 30.07 Â± 10.46%, p < 0.001), LDL-C (48.04 Â± 14.45 vs. 39.52 Â± 14.42%, p < 0.001), non-high-density lipoprotein cholesterol (- 42.93 Â± 13.15 vs. - 35.52 Â± 11.76%, p < 0.001), and apolipoprotein-B (- 38.7 Â± 18.85 vs. - 32.57 Â± 17.56%, p = 0.002) levels were observed in the rosuvastatin group as compared to the atorvastatin group.", Levels of LDL cholesterol after 6 weeks of treatment , Atorvastatin , Rosuvastatin ,0,
edin,610,5577662,Significantly increased,"<td colspan=""5"">Week 8</td>", global assessment of improvement ," dose of 0.25 mg, 0.40 mg, or 0.60 mg (1:1:1 ratio) and then allocated placebo (4:1 ratio) "," receive a dose of 0.40 mg, or 0.60 mg (1:1:1 ratio) and then allocated to active treatment (CCH) ",0,
edin,572,5602855,No significant difference,No statistically significant changes were observed either in the number of visits to the municipal primary healthcare centre (pÂ =Â 0.39) or to special healthcare outpatient clinics (pÂ =Â 0.072) during the follow-up., Health care burden , inadequate motivation/capability , good motivation/capability ,0,
edin,522,1261533,Significantly increased,"Of 452 patients, 119 (26.3%) had P. vivax parasitaemia detected during follow up. There were significantly fewer cases of vivax malaria in the MAS3 group (29 of 227) than in the ALN group (90 of 225) (P < 0.001).", P. vivax parasitaemia diagnosed during follow up , Mefloquine-artesunate , Artemether-lumefantrine ,0,
edin,531,2364680,No significant difference,Fifteen of 380 women (3.9%) developed a wound problem; six had scalpel and nine had electrosurgical subcutaneous incisions (P = 0.4)., wound problem , opening subcutaneous tissues with scalpel , opening subcutaneous tissues with electrocautery ,0,
edin,491,2363351,No significant difference,"Three-year overall survival was 58% and 74% accordingly (n.s., median not yet reached).", Overall survival at 3 years , Cisplatin and Cyclophosphamide ," Cisplatin and Cyclophosphamide, plus subcutaneous IFN-Î³  ",0,
edin,536,3198285,No significant difference,"Table 4
Pregnancy outcomes by diet group,<td align=""left"" colspan=""1"" rowspan=""1"" scope=""row"">Emergency caesarean (%)</td><td align=""center"" colspan=""1"" rowspan=""1"">44</td><td align=""center"" colspan=""1"" rowspan=""1"">20.5</td><td align=""center"" colspan=""1"" rowspan=""1"">44</td><td align=""center"" colspan=""1"" rowspan=""1"">11.6</td><td align=""center"" colspan=""1"" rowspan=""1"">0.263</td>"," Birth weight (kg), Birth weight centile, Small for gestational age, Macrosomia, Infant head circumference, Infant length (cm), Ponderal index (kg/m3), Maternal weight gain (kg), Insulin treatment, Emergency caesarean ", high-fiber moderate-GI diet (HF) (target glycemic index GI ~60) , lowâ??glycemic index diet (target glycemic index [GI] ~50) ,0,
edin,501,2956883,No significant difference,"Gel efficacy against HIV-1 transmission did not differ between centres (p=0Â·19 for interaction), or between consistent (HR 0Â·97, 95% CI 0Â·87â??1Â·35, p=0Â·87) and inconsistent (1Â·17, 0Â·42â??1Â·72, p=0Â·42) gel users (p=0Â·47 for interaction).", Gel efficacy in inconsistent gel users , Placebo gel , 0Â·5% PRO2000 gel ,0,
edin,498,2364533,No significant difference,"When the results were examined without regard to study site, erythromycin had little impact on reducing low birth weight (8% vs. 11%, P = 0.4) or preterm delivery (13% vs. 15%, P = 0.7).", Preterm delivery , Placebo , Erythromycin ,0,
edin,487,2806484,Significantly decreased,"Table 6 shows mean yearly health services cost per patient calculated during 4 years, (including capital and recurrent expenses, and those of the starting phase and subsequent years). A large proportion of the costs were for drugs and staff salaries. The main cause of excess expenditure for the facility-based group was the increased number of contacts with health staffâ??especially with nurses and medical officers. These costs outweighed those of transport for field officers in the home-based group. Patient costs (transport of patient and companion, lunches, child care, and time lost from work) were much higher for the facility-based than for the home-based group (table 6).", Costs for the health service , Facility-based HIV-care strategy , Home-based HIV-care strategy ,0,
edin,609,5577662,Significantly increased,Mean change in nodular consistency and hardness were significantly improved with CCH versus placebo at Weeks 4 and 8 (PÂ â?¤Â 0.0139 for all)., Mean change in nodular consistency and hardness ," dose of 0.25 mg, 0.40 mg, or 0.60 mg (1:1:1 ratio) and then allocated placebo (4:1 ratio) "," receive a dose of 0.25 mg, 0.40 mg, or 0.60 mg (1:1:1 ratio) and then allocated to active treatment (CCH) ",0,
edin,591,4819709,No significant difference,"<td align=""left"" colspan=""1"" rowspan=""2"" style=""padding-left:10%"" valign=""top"">Doing housework</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""top"">50</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""top"">2Â·1</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""top"">4Â·5</td><td align=""center"" colspan=""1"" rowspan=""2"" valign=""top"">2Â·10 (1Â·72, 2Â·56)</td>,Table 2
Behavioural recovery: ultrasoundâ??guided foam sclerotherapy versus surgery", Doing housework , surgery , Ultrasoundâ??guided foam sclerotherapy ,0,
edin,539,2722000,Significantly decreased,"The actuarial rebleeding rate in the prophylactic group was significantly lower than that in the ondemand group (33.9% vs. 62.1%, p=0.004).", rebleeding , received antibiotics only when infection was suspected or established , received antibiotics treatment after randomization with intravenous cefotaxime 2 gram q 8 hr for 7 days ,0,
edin,543,2650992,No significant difference,"Overall, the fibrin glue and control groups were similar in terms of drainage duration, overall drain output, and incidence of seroma.", The mean drainage duration , control group , fibrin glue group (glue sprayed onto the axillary dissection site) ,0,
edin,573,5602855,Cannot tell based on the abstract,, Self-detected pulse irregularity and outcome events , inadequate motivation/capability , good motivation/capability ,0,
edin,573,5602855,No significant difference,"At the four monthsâ?? follow-up, 112 (80.6%) subjects with good motivation/capability and 26 (39.4%) with inadequate motivation/capability continued self-assessment of pulse daily.,Irregular pulse findings were not significantly associated with the composite outcome variable (pÂ =Â 0.06), stroke/TIA (pÂ =Â 0.48), pacemaker implantation (pÂ =Â 0.10) or death (pÂ =Â 1.00).,No statistically significant changes were observed either in the number of visits to the municipal primary healthcare centre (pÂ =Â 0.39) or to special healthcare outpatient clinics (pÂ =Â 0.072) during the follow-up.", Self-detected pulse irregularity and outcome events , inadequate motivation/capability , good motivation/capability ,0,
edin,533,3221331,Cannot tell based on the abstract,, did not attempt to quit smoking at all , set a quit date and received a general health video message sent to their phone every 2 weeks. ," an automated package of video and text messages over 6 months that was tailored to self-selected quit date, role model, and timing of messages. Extra messages were available on demand to beat cravings and address lapses. ",0,
edin,533,3221331,No significant difference,"In the intervention group 7/73 respondents (9.6%) and in the control group 4/81 (4.9%) (P = .3) stated they did not attempt to quit at all, but the majority of respondents in both groups made multiple quit attempts.", did not attempt to quit smoking at all , set a quit date and received a general health video message sent to their phone every 2 weeks. ," an automated package of video and text messages over 6 months that was tailored to self-selected quit date, role model, and timing of messages. Extra messages were available on demand to beat cravings and address lapses. ",0,
edin,314,3580134,Significantly increased,Improvements in pre-dose FEV1 were significantly greater for budesonide/formoterol 320/9 Î¼g compared with formoterol (primary comparison; p = 0.008) and for both budesonide/formoterol dosages compared with placebo (p < 0.001) [figure 3a]., Pre-dose FEV1 improvement , Placebo , Budesonide/formoterol pMDI 320/9 Î¼g ,0,
edin,604,5062194,No significant difference,There were no between-group differences regarding the neonatal outcome., neonatal outcome ," equal volume of normal saline, 30 min before spinal anesthesia ", intravenous dose of 0.035 mg/kg of midazolam ,0,
edin,741,3446002,Cannot tell based on the abstract,, Total serum bilirubin level , control group , single dose of 50 mg/kg clofibrate ,0,
edin,741,3446002,Significantly decreased,The results show that TSB was significantly decreased after 24 and 48 hours in clofibrate group (P<0.001), Total serum bilirubin level , control group , single dose of 50 mg/kg clofibrate ,0,
edin,922,3015551,No significant difference,"Outpatient recovery was the same, unless pelvic pain required overnight observation (ligation, 4 patients; coagulation, 2 patients).", Outpatient recovery , undergo a tubal resection after bipolar coagulation with Kleppinger forceps , undergo a tubal resection after Pomeroy ligation ,0,
edin,966,5372931,Cannot tell based on the abstract,, 14 (poly)phenol metabolites , nothing , cranberry juices ,0,
edin,966,5372931,Significantly increased,"The linear dose response for each plasma metabolite was assessed and of the 60 identified metabolites, 14 (poly)phenol metabolites displayed a linear dose-response curve (r2 â¥ 0.89) in plasma (Figure 1) with slopes significantly different from zero (p < 0.05): caffeic acid 4-O-Ã-d-glucuronide and quercetin-3-O-Ã-d-glucuronide displayed r2 > 0.98, while ferulic acid 4-O-Ã-d-glucuronide, 2,5-dihydroxybenzoic acid, 2,4-dihydroxybenzoic acid, ferulic acid, caffeic acid 3-O-Ã-d-glucuronide, sinapic acid, ferulic acid 4-O-sulfate, 3-hydroxybenzoic acid and syringic acid exhibited r2 > 0.90.,The time to reach Cmax (Tmax) varied depending on the metabolite and depending on the amount of (poly)phenols in the juice (Supplementary Figure S1). The level of TP in cranberry juice seemed to impact the Tmax of individual metabolites, for example the Tmax for 3-(4-hydroxyphenyl) propionic acid varied between 7.2 h (409 mg TP juice) and 13.8 h (787 mg TP juice).", 14 (poly)phenol metabolites , nothing , cranberry juices ,0,
edin,869,5332972,Significantly increased,"The findings of the Fugl-Meyer assessment, Stroke Impairment Assessment Set, Timed Up & Go test, and 10-m walk test significantly improved after the intervention.", TUG: Timed âUp &amp; Goâ? test; , before repetitive facilitative exercises  and orthotic treatment. , after 4 weeks of repetitive facilitative exercises  and orthotic treatment. ,0,
edin,881,5539984,Cannot tell based on the abstract,, Primary outcome effect , standard mental health care , The Network for Mental Health (NWpG-IC) ,0,
edin,881,5539984,No significant difference,"Mixed-models for EPAS total score (see Table 3) indicated a significant effect of time (bÂ =Â 0.07, pÂ <Â 0.001), but no significant group by time interaction effect (bÂ =Â 0.02; pÂ =Â 0.258). This means with regard to the parameterisation of the mixed effects model that there was a significant change of overall empowerment in the control group, but NWpG-IC treatment had no additional effect on improvement of overall empowerment during the 18Â month study period.", Primary outcome effect , standard mental health care , The Network for Mental Health (NWpG-IC) ,0,
edin,635,4106715,Cannot tell based on the abstract,, Reduction of daily cigarette consumption and cotinine , non-abstainers in the placebo group , non-abstainers (weeks 19â52) with high Ab levels ,0,
edin,635,4106715,Significantly increased,"Statistically significant differences were observed in reduction of daily cigarette consumption and cotinine between non-abstainers (weeks 19â52) with high Ab levels and non-abstainers in the placebo group (p=0.0015 and 0.019, respectively; see Figures 4A and 4C.", Reduction of daily cigarette consumption and cotinine , non-abstainers in the placebo group , non-abstainers (weeks 19â52) with high Ab levels ,0,
edin,829,4819709,Cannot tell based on the abstract,, Walking long distances (&gt;?20 min) , surgery , Ultrasound?guided foam sclerotherapy ,0,
edin,829,4819709,Significantly increased,"<td align=""left"" colspan=""1"" rowspan=""2"" style=""padding-left:10%"" valign=""top"">Walking long distances (&gt;â20 min)</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""top"">50</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""top"">4Â·5</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""top"">8Â·0</td><td align=""center"" colspan=""1"" rowspan=""2"" valign=""top"">1Â·76 (1Â·45, 2Â·14)</td>,Table 2
Behavioural recovery: ultrasoundâ?guided foam sclerotherapy versus surgery,Participants randomized to UGFS recalled being able to carry out 13 of the 15 behaviours significantly more quickly than those randomized to surgery (Table â 2 ),The two behaviours for which there was no evidence of a difference in the time to recover between the trial arms were âhaving a bath or showerâ and âwearing clothes that show the legsâ", Walking long distances (&gt;?20 min) , surgery , Ultrasound?guided foam sclerotherapy ,0,
edin,676,3387601,Cannot tell based on the abstract,, side effects , intravenous immunoglobulin (IVIG) , plasma exchange (PE)  ,0,
edin,676,3387601,No significant difference,There was no significant side effect attributable to any of the treatment modalities in any of the studied patients., side effects , intravenous immunoglobulin (IVIG) , plasma exchange (PE)  ,0,
edin,699,3187863,Cannot tell based on the abstract,, Labour dystocia , Normal unit &amp; Special unit , Midwife-led unit ,0,
edin,699,3187863,Significantly decreased,"In the MU dystocia was recorded in 29.1% of the cases, which is a significantly lower rate than 36.9% in the NU (RR 0.79, 95% CI 0.65â0.96) and 40.4% in the SU (RR 0.72, 95% CI 0.59â0.89) (Table 2).", Labour dystocia , Normal unit &amp; Special unit , Midwife-led unit ,0,
edin,948,4693888,Cannot tell based on the abstract,, CKMB AUC and Troponin-T AUC , Custodiol , Custodiol-N ,0,
edin,948,4693888,No significant difference,"CKMB AUC (878 Â± 549 vs. 778 Â± 439 h*U/l, non-inferiority p < 0.001) and Troponin-T AUC (12990 Â± 8347 vs. 13498 Â± 6513 h*pg/ml, non-inferiority p < 0.001) was similar in both groups.", CKMB AUC and Troponin-T AUC , Custodiol , Custodiol-N ,0,
edin,688,2447617,Significantly increased,"<td align=""left"">6 months</td><td></td><td></td>", The analysis using the dichotomization of GOS scores at 6 months post injury , placebo , progesterone ,0,
edin,919,3616124,Cannot tell based on the abstract,, preeclampsia risk , Haptoglobinâs (Hp) 2-2 phenotypes ," Haptoglobinâs (Hp)  1-1, 2-1,  ",0,
edin,919,3616124,No significant difference,"Hp phenotype was not significantly associated with the risk of the primary outcome, preeclampsia, severe preeclampsia, or early onset preeclampsia in white/other, Hispanic or black women (Table 2).", preeclampsia risk , Haptoglobinâs (Hp) 2-2 phenotypes ," Haptoglobinâs (Hp)  1-1, 2-1,  ",0,
edin,778,2722000,Cannot tell based on the abstract,, The incidence of bacterial infection , received antibiotics only when infection was suspected or established , received antibiotics treatment after randomization with intravenous cefotaxime 2 gram q 8 hr for 7 days ,0,
edin,778,2722000,Significantly decreased,"The incidence of bacterial infection was significantly lower in patient receiving antibiotic prophylaxis (2/62, 3.2% vs. 9/58, 15.5%, p=0.026).", The incidence of bacterial infection , received antibiotics only when infection was suspected or established , received antibiotics treatment after randomization with intravenous cefotaxime 2 gram q 8 hr for 7 days ,0,
edin,833,4819709,Significantly increased,"UGFS was superior to EVLA in terms of return to fullâ?time work (hazard ratio 1Â·43, 95 per cent c.i. 1Â·11 to 1Â·85), looking after children (1Â·45, 1Â·04 to 2Â·02) and walks of short (1Â·48, 1Â·19 to 1Â·84) and longer (1Â·32, 1Â·05 to 1Â·66) duration.", Looking after children , surgery , Ultrasound?guided foam sclerotherapy ,0,
edin,943,5551012,Significantly decreased,"However, antibiotic use less than 24Â h to delivery was associated with a decrease in mean APGAR score.", mean Apgar , no antibiotics , antibiotics in less than 24 h to parturition ,0,
edin,812,5602855,No significant difference,Quality of life and number of outpatient clinic visits remained unchanged during follow-up., Quality of life , inadequate motivation/capability , good motivation/capability ,0,
edin,897,1198254,Significantly increased,ME-3 was well tolerated and a significant increase in total faecal lactobacilli yet no predominance of ME-3 was detected in all study groups., total fecal counts of lactobacilli , goat milk , L. fermentum ME-3 fermented goat milk ,0,
edin,871,5209819,Cannot tell based on the abstract,, Pre-treatment testing performed within the ADDO ," Before trainings covered signs and symptoms of uncomplicated and severe malaria, stocking, use, and disposal of RDTs, and appropriate case management based on RDT results. "," After trainings covered signs and symptoms of uncomplicated and severe malaria, stocking, use, and disposal of RDTs, and appropriate case management based on RDT results. ",0,
edin,871,5209819,No significant difference,Pre-treatment testing performed within the ADDO increased from 0 to 65% of suspected malaria patients who visited a shop (95% CI 60.8â69.6%) with no difference between intervention districts., Pre-treatment testing performed within the ADDO ," Before trainings covered signs and symptoms of uncomplicated and severe malaria, stocking, use, and disposal of RDTs, and appropriate case management based on RDT results. "," After trainings covered signs and symptoms of uncomplicated and severe malaria, stocking, use, and disposal of RDTs, and appropriate case management based on RDT results. ",0,
edin,825,4819709,Cannot tell based on the abstract,, Lifting heavy objects without discomfort , surgery , Ultrasound?guided foam sclerotherapy ,0,
edin,825,4819709,Significantly increased,"<td align=""left"" colspan=""1"" rowspan=""2"" style=""padding-left:10%"" valign=""top"">Lifting heavy objects without discomfort</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""top"">50</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""top"">4Â·8</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""top"">9Â·8</td><td align=""center"" colspan=""1"" rowspan=""2"" valign=""top"">1Â·97 (1Â·59, 2Â·44)</td>,Table 2
Behavioural recovery: ultrasoundâ?guided foam sclerotherapy versus surgery,Participants randomized to UGFS recalled being able to carry out 13 of the 15 behaviours significantly more quickly than those randomized to surgery (Table â 2 ). The two behaviours for which there was no evidence of a difference in the time to recover between the trial arms were âhaving a bath or showerâ and âwearing clothes that show the legsâ.", Lifting heavy objects without discomfort , surgery , Ultrasound?guided foam sclerotherapy ,0,
edin,647,1201146,Cannot tell based on the abstract,, Dry skin at the application site , vehicle control solution (carrier with no diclofenac) , topical diclofenac solution (PennsaidÂ®) ,0,
edin,647,1201146,Significantly increased,"<td colspan=""3""><hr></td>", Dry skin at the application site , vehicle control solution (carrier with no diclofenac) , topical diclofenac solution (PennsaidÂ®) ,0,
edin,814,5602855,Cannot tell based on the abstract,, Self-detected pulse irregularity and outcome events , inadequate motivation/capability , good motivation/capability ,0,
edin,814,5602855,Invalid Prompt,, Self-detected pulse irregularity and outcome events , inadequate motivation/capability , good motivation/capability ,1," There is Self-detected pulse irregularity and outcome events section of the article. However, motivation/capability is not mentioned in it or I was not able to find it. "
edin,941,3039191,Cannot tell based on the abstract,, the result of frequency doubling technique (FDT) perimetry. , clear IOL was used as a control. ," IOLs were selected randomly among two types of yellow IOLs (Acrysof SN60WF IOL, Hoya YA60BBR IOL) ",0,
edin,941,3039191,No significant difference,"The results of FDT perimetry testing are shown in Figs. 1, 2, and 3. There were no statistically significant differences for MD and PSD between the clear IOL and Hoya YA60BBR IOL groups (MD: clear IOL, -5.09 Â± 4.72 Db; Hoya YA60BBR IOL, -3.68 Â± 3.83 dB; p = 0.21 / PSD: clear IOL, 4.26 Â± 2.45 dB; Hoya YA60BBR IOL, 3.81 Â± 1.99; p = 0.27, Mann-Whitney U-test).", the result of frequency doubling technique (FDT) perimetry. , clear IOL was used as a control. ," IOLs were selected randomly among two types of yellow IOLs (Acrysof SN60WF IOL, Hoya YA60BBR IOL) ",0,
edin,937,4918678,Significantly increased,"<th colspan=""2"" rowspan=""1""><hr></th><th colspan=""2"" rowspan=""1""><hr></th><th colspan=""2"" rowspan=""1""><hr></th>", Reading , nothing , soundfield amplification devices in the classroom ,0,
edin,793,2830179,Significantly decreased,"<th></th><th colspan=""2""><hr></th><th colspan=""2""><hr></th><th colspan=""2""><hr></th><th colspan=""1""><hr></th>", pain during movement , received no treatment , attended individual sessions with an experienced clinician once a week for 10 weeks and performed daily home exercises with adherence monitored by a self-report diary ,0,
edin,880,4088715,Cannot tell based on the abstract,," tidal volume (TV), end-tidal carbon dioxide (EtCO2) and Rapid Shallow Breathing Index (RSBI) ", standard group , CPAP + standard of care (nCPAP group) ,0,
edin,880,4088715,Significantly increased,"Subjects in the nCPAP group had a greater improvement for various parameters compared with the standard group including TV (0.8 l, 0.3 l), EtCO2 (30 mmHg, 38 mmHg) and RSBI (39, 150), respectively."," tidal volume (TV), end-tidal carbon dioxide (EtCO2) and Rapid Shallow Breathing Index (RSBI) ", standard group , CPAP + standard of care (nCPAP group) ,0,
edin,846,5062194,Significantly increased,"Mothers premedicated with midazolam showed a lower level of preoperative anxiety and a higher degree of postoperative satisfaction than the control group.,Preeclamptic parturients premedicated with midazolam (0.035 mg/kg) before spinal anesthesia have lower anxiety and higher postoperative satisfaction levels, with no adverse effects on the newborns.", postoperative satisfaction ," equal volume of normal saline, 30 min before spinal anesthesia ", intravenous dose of 0.035 mg/kg of midazolam ,0,
edin,907,5816054,Cannot tell based on the abstract,, The duration of nebulization , 0.9% saline , furosemide ,0,
edin,907,5816054,No significant difference,"The duration of nebulization was not significantly different across treatments: 0.9% saline, 35.7 Â± 1.0 min; 40 mg furosemide, 36.4 Â± 1.2 min; and 120 mg furosemide, 39.2 Â± 1.1 min (p = 0.075).", The duration of nebulization , 0.9% saline , furosemide ,0,
edin,956,3330821,Cannot tell based on the abstract,, The overall satisfaction score , Employee Assistance Program , trained psychotherapists in addition to the pre-existing Employee Assistance Program (EAP) ,0,
edin,956,3330821,Significantly increased,The overall satisfaction score for the services was 3.57 (3.31 to 3.81) for the EAP alone group and 4.42 (4.17 to 4.67) for the tCBT +EAP group (p<0.001)., The overall satisfaction score , Employee Assistance Program , trained psychotherapists in addition to the pre-existing Employee Assistance Program (EAP) ,0,
edin,884,5514258,Significantly increased,"Patients in the high-risk group had greater survival (hazard ratio [HR], 0.76; P = .002; 95% confidence interval [CI], 0.64-0.91) if they received adjuvant radiation therapy.", survival , major salivary gland cancer in high risk group without adjuvant radiation therapy , major salivary gland cancer in high risk group plus adjuvant radiation therapy ,0,
edin,677,2430614,Significantly decreased,"In a per-protocol analysis, the parasitological and clinical failure rate at day 28 post treatment (PCF28) was lower in the AS+AQ group compared to the AL or AS+CD groups (corrected for re-infections: 6.6% vs 13.8% and 13.8% respectively, pâ=â0.08; uncorrected: 14.6% vs 27.6% and 28.1% respectively, pâ=â0.005).", the parasitological and clinical failure rate at day 28 post treatment , artemether-lumefantrine (AL) and  and Artesunate+chlorproguanil-dapsone (AS+CD) , Artesunate+amodiaquine (AS+AQ) ,0,
edin,673,3387601,No significant difference,"hose in the PE group had a tendency for a shorter Pediatric Intensive Care Unit (PICU) stay (p = 0.094).,In children with GBS requiring MV, PE is superior to IVIG regarding the duration of MV but not PICU stay or the short term neurological outcome.", Pediatric Intensive Care Unit (PICU) stay , intravenous immunoglobulin (IVIG) , plasma exchange (PE)  ,0,
edin,942,5551012,No significant difference,"Intrapartum antibiotic exposure did not significantly affect the birthweight, incidence of congenital birth defect and mean Apgar scores."," birthweight, incidence of congenital birth defect and mean Apgar scores ", no antibiotics , antibiotics ,0,
edin,638,2206488,Cannot tell based on the abstract,, Cardiac index  , identical amounts of gelatin infusion , dextran-70 infusion was administered at a dose of 7.5 ml/kg before the initiation of cardiopulmonary bypass and at a dose of 12.5 ml/kg after the cessation of cardiopulmonary bypass ,0,
edin,638,2206488,Significantly increased,"Higher figures of the cardiac index (p = 0.010) along with reduced systemic vascular resistance (p = 0.005) were noted in group A.,In group A (n = 20), dextran-70 infusion was administered at a dose of 7.5 ml/kg before the initiation of cardiopulmonary bypass and at a dose of 12.5 ml/kg after the cessation of cardiopulmonary bypass.", Cardiac index  , identical amounts of gelatin infusion , dextran-70 infusion was administered at a dose of 7.5 ml/kg before the initiation of cardiopulmonary bypass and at a dose of 12.5 ml/kg after the cessation of cardiopulmonary bypass ,0,
edin,868,5332972,Cannot tell based on the abstract,, FMA-LE: the Fugl-Meyer Assessment of the lower extremity; SIAS: Stroke Impairment Assessment Set; , before repetitive facilitative exercises  and orthotic treatment. , after 4 weeks of repetitive facilitative exercises  and orthotic treatment. ,0,
edin,868,5332972,Significantly increased,"**Significant difference p<0.01. SD: standard deviation; FMA-LE: the Fugl-Meyer Assessment of the lower extremity; SIAS: Stroke Impairment Assessment Set; TUG: Timed âUp & Goâ? test; 10MWT: 10-m walk test; CGS: comfortable gait speed; FGS: fast gait speed,The findings of the Fugl-Meyer assessment, Stroke Impairment Assessment Set, Timed Up & Go test, and 10-m walk test significantly improved after the intervention.", FMA-LE: the Fugl-Meyer Assessment of the lower extremity; SIAS: Stroke Impairment Assessment Set; , before repetitive facilitative exercises  and orthotic treatment. , after 4 weeks of repetitive facilitative exercises  and orthotic treatment. ,0,
edin,650,2600646,Cannot tell based on the abstract,, Gametocyte dynamics , dihydroartemisinin-piperaquine (AP) , arthemeter-lumefantrine (AL)  ,0,
edin,650,2600646,No significant difference,"<td colspan=""8""><hr></td>,<td colspan=""8""><hr></td>", Gametocyte dynamics , dihydroartemisinin-piperaquine (AP) , arthemeter-lumefantrine (AL)  ,0,
edin,824,4819709,Cannot tell based on the abstract,, Bending the legs without discomfort , surgery , Ultrasound?guided foam sclerotherapy ,0,
edin,824,4819709,Significantly increased,"<td align=""left"" colspan=""1"" rowspan=""2"" style=""padding-left:10%"" valign=""top"">Bending the legs without discomfort</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""top"">50</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""top"">3Â·0</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""top"">4Â·6</td><td align=""center"" colspan=""1"" rowspan=""2"" valign=""top"">1Â·38 (1Â·14, 1Â·67)</td>,Participants randomized to UGFS recalled being able to carry out 13 of the 15 behaviours significantly more quickly than those randomized to surgery (Table â 2 ). The two behaviours for which there was no evidence of a difference in the time to recover between the trial arms were âhaving a bath or showerâ and âwearing clothes that show the legsâ.", Bending the legs without discomfort , surgery , Ultrasound?guided foam sclerotherapy ,0,
edin,859,4139977,No significant difference,"After treatment, there was a decrease in abdominal pain and distension severity in both probiotic and the placebo groups (P<0.001), but there was no difference between the two groups in this regard (P>0.05).", decrease in abdominal pain and distension severity ," similar placebo, twice daily after a meal for 14 consecutive days "," receive a probiotic compound containing seven bacteria species including Lactobacillus strains, Bifidobacterium strains and Streptococcus thermophiles ",0,
edin,683,2447617,Significantly increased,The modified Functional Independence Measure scores in the progesterone group were higher than those in the placebo group at both 3-month and 6-month follow-up (P < 0.05 and P < 0.01)., The modified Functional Independence Measure scores , placebo , progesterone ,0,
edin,770,2361948,Cannot tell based on the abstract,, 6- and 12-month survival probabilities , palliative radiotherapy schedules for inoperable symptomatic non-small-cell lung cancer 16?Gy/2 fr/day 1 and 8 (arm B) , palliative radiotherapy schedules for inoperable symptomatic non-small-cell lung cancer 20?Gy/5 fractions (fr)/5 days (arm A) ,0,
edin,770,2361948,Significantly decreased,"In all, 6- and 12-month survival probabilities were 57% (95% CI: 42â72%) and 27% (95% CI: 14â40%) for patients receiving 16âGy/2 fr, and 30% (95% CI: 18â42%) and 11% (95% CI: 3â20%) for patients receiving 20âGy/5 fr, respectively. This difference remained significant after correction for disease extent (P=0.022) and performance status (P=0.007).", 6- and 12-month survival probabilities , palliative radiotherapy schedules for inoperable symptomatic non-small-cell lung cancer 16?Gy/2 fr/day 1 and 8 (arm B) , palliative radiotherapy schedules for inoperable symptomatic non-small-cell lung cancer 20?Gy/5 fractions (fr)/5 days (arm A) ,0,
edin,959,2656477,Significantly increased,<td></td><td></td><td></td><td></td><td></td><td></td>, self-efficacy related to social pressure and restraint in overweight and obese endometrial cancer survivors. , usual care , lifestyle intervention (LI) consisting of exercise and nutritional counseling with cognitive-behavior modification ,0,
edin,717,2206488,No significant difference,"There was no significant difference in IL 6, IL-6r and C-reactive protein values between groups.", IL-6 (pg/ml) , identical amounts of gelatin infusion , dextran-70 infusion was administered at a dose of 7.5 ml/kg before the initiation of cardiopulmonary bypass and at a dose of 12.5 ml/kg after the cessation of cardiopulmonary bypass ,0,
edin,811,5256321,Cannot tell based on the abstract,," he Berg Balance Scale (BBS), Timed Up and Go Test (TUG), Functional Reach Test (FRT), the Korean version of the Fall Efficacy Scale-International (KFES-I)  "," Biodex Balance System (Biodex Medical Systems, Shirley, NY, USA) ", Spine Balance 3D (CyberMedic) ,0,
edin,811,5256321,Significantly increased,"Table 3 shows that the experimental group showed significant improvements in all testsâBBS (p=0.001), TUG (p=0.001), forward FRT (p=0.001), affected lateral FRT (p=0.001), and unaffected lateral FRT (p=0.002)âwhen the values before and after training were compared in each group"," he Berg Balance Scale (BBS), Timed Up and Go Test (TUG), Functional Reach Test (FRT), the Korean version of the Fall Efficacy Scale-International (KFES-I)  "," Biodex Balance System (Biodex Medical Systems, Shirley, NY, USA) ", Spine Balance 3D (CyberMedic) ,0,
edin,935,4264479,No significant difference,All participants developed blood-stage infection confirmed by quantitative polymerase chain reaction (qPCR)., blood-stage infection , minimally exposed volunteers for both antigens , definitely exposed volunteers for both antigens  ,0,
edin,730,1468428,Invalid Prompt,, You must have prompts generated from different sections. , 2 , 1 ,1, There is no question formed and no provided answers. 
edin,885,5514258,No significant difference,"In contrast, patients in the intermediate- (HR, 1.01; P = .904; 95% CI, 0.85-1.20) and low-risk groups (HR, 0.85; PÂ =Â .427; 95% CI, 0.57-1.26) did not experience a survival benefit with adjuvant radiation therapy.", survival , major salivary gland cancer in low/intermediate risk group without adjuvant radiation therapy , major salivary gland cancer in low/intermediate risk group plus adjuvant radiation therapy ,0,
edin,939,4918678,Cannot tell based on the abstract,, Silent reading , nothing , soundfield amplification devices in the classroom ,0,
edin,939,4918678,No significant difference,"<td align=""left"" colspan=""1"" rowspan=""1"">âEG</td><td align=""center"" colspan=""1"" rowspan=""1"">131.8</td><td align=""center"" colspan=""1"" rowspan=""1"">59.9</td><td align=""center"" colspan=""1"" rowspan=""1"">112.9</td><td align=""center"" colspan=""1"" rowspan=""1"">52.8</td><td align=""center"" colspan=""1"" rowspan=""1"">1.31 (9)</td><td align=""center"" colspan=""1"" rowspan=""1"">.221</td>,<th colspan=""2"" rowspan=""1""><hr></th><th colspan=""2"" rowspan=""1""><hr></th><th colspan=""2"" rowspan=""1""><hr></th>", Silent reading , nothing , soundfield amplification devices in the classroom ,0,
edin,658,2720945,Cannot tell based on the abstract,, Side effects , placebo , cineole ,0,
edin,658,2720945,No significant difference,"All patients receiving the study medication (including those with FEV1/VC > 0.7) were included in the safety examination. During treatment side effects were seen in 22 patients whereas in 17 cases adverse events were not related to the study medication. In the placebo group 11 adverse events were estimated not being related to the study medication whereas 2 cases were interpreted as being related to the study medication (heartburn). During treatment with cineole 9 cases of adverse events were reported whereas 6 adverse events were reported not being related to the study medication. In 3 patients (nausea, diarrhoea, heartburn) the adverse events were estimated being related to the study medication. The difference between the two treatment groups was neither clinically relevant nor statistically significant.", Side effects , placebo , cineole ,0,
edin,938,4918678,Cannot tell based on the abstract,, Arithmetic , nothing , soundfield amplification devices in the classroom ,0,
edin,938,4918678,No significant difference,"<th colspan=""2"" rowspan=""1""><hr></th><th colspan=""2"" rowspan=""1""><hr></th><th colspan=""2"" rowspan=""1""><hr></th>,<th colspan=""2"" rowspan=""1""><hr></th><th colspan=""2"" rowspan=""1""><hr></th><th colspan=""2"" rowspan=""1""><hr></th>", Arithmetic , nothing , soundfield amplification devices in the classroom ,0,
edin,680,2847809,Cannot tell based on the abstract,, Complications and mortality , Placebo , Clopidogrel ,0,
edin,680,2847809,No significant difference,"<td align=""left"" colspan=""1"" rowspan=""1"">Death events</td><td align=""center"" colspan=""1"" rowspan=""1"">4 (4.3)</td><td align=""center"" colspan=""1"" rowspan=""1"">2 (2.1)</td><td align=""center"" colspan=""1"" rowspan=""1"">2 (2.1)</td><td align=""center"" colspan=""1"" rowspan=""1"">0.47</td>", Complications and mortality , Placebo , Clopidogrel ,0,
edin,809,5256321,Cannot tell based on the abstract,, The 10mWT (10-m walking test ) ," Biodex Balance System (Biodex Medical Systems, Shirley, NY, USA) ", Spine Balance 3D (CyberMedic) ,0,
edin,809,5256321,Significantly increased,"The 10mWT improved significantly (p=0.001) in the experimental group (using the Spine Balance 3D system) but not in the control group, and core muscle strength, which we checked using Spine Balance 3D system evaluation program, improved more in the experimental group as well.", The 10mWT (10-m walking test ) ," Biodex Balance System (Biodex Medical Systems, Shirley, NY, USA) ", Spine Balance 3D (CyberMedic) ,0,
edin,783,2650992,Significantly decreased,"However, subgroup analysis showed that fibrin glue use resulted in a shorter drainage duration (3.5 vs. 4.7 days; p=0.0006) and overall drain output (196 vs. 278 mL; p=0.0255) in patients undergoing level II or III axillary dissection.", overall drain output , control group , fibrin glue group (glue sprayed onto the axillary dissection site) ,0,
edin,675,3387601,Significantly increased,"There was a negative correlation between CSF protein and duration of mechanical ventilation in the PE group (p = 0.037), but not in the IVIG group (p = 0.132).", negative correlation between CSF protein and duration of mechanical ventilation , intravenous immunoglobulin (IVIG) , plasma exchange (PE)  ,0,
edin,712,4106715,Significantly increased,"3âAmNic-rEPA recipients with the highest serum anti-nicotine antibody response (top 30% by AUC) were significantly more likely to attain 8 weeks continuous abstinence from weeks 19 through 26 than the placebo recipients (24.6% vs. 12.0%, p=0.024, OR=2.69, 95% CI, 1.14â6.37).", attain 8 weeks continuous abstinence from weeks 19 through 26 , placebo group , recipients with the highest serum anti-nicotine antibody response (top 30% by AUC) ,0,
edin,622,3187863,Cannot tell based on the abstract,, Perineal outcome: the number of episiotomies or the incidence of sphincter injuries , Normal unit &amp; Special unit , Special unit ,0,
edin,622,3187863,No significant difference,here was no significant difference between the three groups concerning the number of episiotomies or the incidence of sphincter injuries (Table 2)., Perineal outcome: the number of episiotomies or the incidence of sphincter injuries , Normal unit &amp; Special unit , Special unit ,0,
edin,911,2774638,Cannot tell based on the abstract,, obtained calcium from dairy  , black women , white women ,0,
edin,911,2774638,Significantly increased,"White women obtained more calcium (630 [423] mg) from dairy than did black women (424 [373] mg, P < .004).", obtained calcium from dairy  , black women , white women ,0,
edin,777,3198285,Cannot tell based on the abstract,," Birth weight (kg), Birth weight centile, Small for gestational age, Macrosomia, Infant head circumference, Infant length (cm), Ponderal index (kg/m3), Maternal weight gain (kg), Insulin treatment, Emergency caesarean ", high-fiber moderate-GI diet (HF) (target glycemic index GI ~60) , lowâglycemic index diet (target glycemic index [GI] ~50) ,0,
edin,777,3198285,No significant difference,"<td align=""left"" colspan=""1"" rowspan=""1"" scope=""row"">Emergency caesarean (%)</td><td align=""center"" colspan=""1"" rowspan=""1"">44</td><td align=""center"" colspan=""1"" rowspan=""1"">20.5</td><td align=""center"" colspan=""1"" rowspan=""1"">44</td><td align=""center"" colspan=""1"" rowspan=""1"">11.6</td><td align=""center"" colspan=""1"" rowspan=""1"">0.263</td>"," Birth weight (kg), Birth weight centile, Small for gestational age, Macrosomia, Infant head circumference, Infant length (cm), Ponderal index (kg/m3), Maternal weight gain (kg), Insulin treatment, Emergency caesarean ", high-fiber moderate-GI diet (HF) (target glycemic index GI ~60) , lowâglycemic index diet (target glycemic index [GI] ~50) ,0,
edin,691,2899760,Cannot tell based on the abstract,, Radiological fusion , anterior cervical decompression and fusion (ACDF) with Trabecular Metalâ¢ (TM) , raditional SmithâRobinson (SR) procedure with autograft  ,0,
edin,691,2899760,Significantly increased,"he fusion rate shown by the radiological analysis is presented in TableÂ 4. All patients in group III (clearly non-fused) showed at least 4Â° of mobility (the limit for the group set by the classification was 3.0Â°). There was no statistically significant difference in the fusion rate between smokers (92%) and non-smokers (74%) (PÂ =Â 0.2). Smokers operated on with TM showed an 87% fusion rate. Kappa analysis showed 0.63 and 0.66 for the intra-observer correlation, and 0.58 for inter-observer correlation.TableÂ 4,Radiological fusion

Fusion group	TM	SR
No.	Percentage	No.	Percentage
I (clearly fused)	18	46	35	89
IIA (probably fused)	9	23	1	3
IIB (probably non-fused)	5	13	0	0
III (clearly non-fused)	7	18	3	8
Fusion rate (IÂ +Â IIA)		69		92,his study of uninstrumented single-level ACDF showed a lower fusion rate with Trabecular Metal than with the SmithâRobinson technique with autograft after single-level anterior cervical fusion without plating.", Radiological fusion , anterior cervical decompression and fusion (ACDF) with Trabecular Metalâ¢ (TM) , raditional SmithâRobinson (SR) procedure with autograft  ,0,
edin,909,2774638,Significantly increased,"The CFFFQ estimated greater total daily calcium intake than did the 24-hour recall (mean [SD], 1,021 [624] mg/d vs 800 [433] mg/d, P < .001).", Estimation of total daily calcium intake , 24-hour recall , calcium-focused food frequency questionnaire (CFFFQ) ,0,
edin,887,5801479,Significantly decreased,"Results of RT-PCR indicated that after the 12-week intervention, compared to the placebo, vitamin D supplementation downregulated gene expression of interleukin (IL)-1Î² (P = 0.02), tumor necrosis factor alpha (TNF-Î±) (P = 0.02) and interferon gamma (IFN-Î³) (P = 0.03) in PBMCs of diabetic HD patients."," gene expression of interleukin (IL), tumor necrosis factor alpha (TNF-?), interferon gamma (IFN-?)  ", placebo (n = 30) every 2 weeks for 12 weeks ," vitamin D supplements at a dosage of 50,000 IU (n = 30) every 2 weeks for 12 weeks ",0,
edin,781,2722000,Cannot tell based on the abstract,, Total mortality and 30-day mortality , received antibiotics only when infection was suspected or established , received antibiotics treatment after randomization with intravenous cefotaxime 2 gram q 8 hr for 7 days ,0,
edin,781,2722000,No significant difference,Total mortality and 30-day mortality were not different between the two groups (Table 7)., Total mortality and 30-day mortality , received antibiotics only when infection was suspected or established , received antibiotics treatment after randomization with intravenous cefotaxime 2 gram q 8 hr for 7 days ,0,
edin,672,3387601,Significantly increased,"There was a negative correlation between CSF protein and duration of mechanical ventilation in the PE group (p = 0.037), but not in the IVIG group (p = 0.132).", Period of mechanical ventilation  , intravenous immunoglobulin (IVIG) , plasma exchange (PE)  ,0,
edin,703,3187863,No significant difference,"here were no significant differences in postpartum haemorrhage, sphincter injuries or in neonatal outcomes.", Postpartum haemorrhage , Normal unit &amp; Special unit , Midwife-led unit ,0,
edin,719,1201146,Significantly increased,"<td colspan=""3""><hr></td>"," Pain, physical function, PGA, stiffness  ", vehicle control solution (carrier with no diclofenac) , topical diclofenac solution (PennsaidÂ®) ,0,
edin,841,4819709,Cannot tell based on the abstract,," Bending the legs without discomfort, Lifting heavy objects without discomfort, Moving from standing to sitting without discomfort, Standing still for a long time (&gt;?15 min) without discomfort, Walking short distances (&lt;?20 min) without discomfort, Walking long distances (&gt;?20 min), Driving a car, Doing housework, Looking after children, Partial return to normal work/employment, Full return to normal work/employment, Going out socially, Sporting activity or exercise,  ", surgery , Endovenous laser ablation ,0,
edin,841,4819709,Significantly increased,"Participants randomized to EVLA recalled being able to carry out 13 of the 15 behaviours significantly more quickly than those randomized to surgery (Table â 3). Return to âhaving a bath or showerâ was quicker after surgery than after EVLA. There was no difference in time to return to the participation behaviour of âwearing clothes that show the legsâ.,<td align=""left"" colspan=""1"" id=""bjs10081-ent-0450"" rowspan=""1"" valign=""top"">Participation items</td><td align=""center"" colspan=""1"" id=""bjs10081-ent-0451"" rowspan=""1"" valign=""top""></td><td align=""center"" colspan=""1"" id=""bjs10081-ent-0452"" rowspan=""1"" valign=""top""></td><td align=""center"" colspan=""1"" id=""bjs10081-ent-0453"" rowspan=""1"" valign=""top""></td><td align=""center"" colspan=""1"" id=""bjs10081-ent-0454"" rowspan=""1"" valign=""top""></td>"," Bending the legs without discomfort, Lifting heavy objects without discomfort, Moving from standing to sitting without discomfort, Standing still for a long time (&gt;?15 min) without discomfort, Walking short distances (&lt;?20 min) without discomfort, Walking long distances (&gt;?20 min), Driving a car, Doing housework, Looking after children, Partial return to normal work/employment, Full return to normal work/employment, Going out socially, Sporting activity or exercise,  ", surgery , Endovenous laser ablation ,0,
edin,726,2600646,Cannot tell based on the abstract,, Gametocyte dynamics , dihydroartemisinin-piperaquine (AP) , arthemeter-lumefantrine (AL)  ,0,
edin,726,2600646,No significant difference,"<td colspan=""8""><hr></td>,<td colspan=""8""><hr></td>", Gametocyte dynamics , dihydroartemisinin-piperaquine (AP) , arthemeter-lumefantrine (AL)  ,0,
edin,784,2650992,Significantly decreased,"However, subgroup analysis showed that fibrin glue use resulted in a shorter drainage duration (3.5 vs. 4.7 days; p=0.0006) and overall drain output (196 vs. 278 mL; p=0.0255) in patients undergoing level II or III axillary dissection.", The mean drainage duration , control group , fibrin glue group (glue sprayed onto the axillary dissection site) ,0,
edin,877,2974815,No significant difference,There was no difference in the percentage of patients with controlled blood pressure in the âphone callsâ? group and âno phone callsâ? group or in the âtraditionalâ? and âcurrentâ? groups., The percentage of patients with controlled blood pressure (&lt;140/90 mmHg) , âno phone callsâ? group , phone callsâ? group ,0,
edin,646,1201146,Cannot tell based on the abstract,, good or very good PGA response and OMERACT-OARSI responder , vehicle control solution (carrier with no diclofenac) , topical diclofenac solution (PennsaidÂ®) ,0,
edin,646,1201146,Significantly increased,"<td colspan=""3""><hr></td>", good or very good PGA response and OMERACT-OARSI responder , vehicle control solution (carrier with no diclofenac) , topical diclofenac solution (PennsaidÂ®) ,0,
edin,740,3446002,Cannot tell based on the abstract,, side effects , control group , single dose of 50 mg/kg clofibrate ,0,
edin,740,3446002,No significant difference,On serial daily examination during phototherapy and up to 2 days after that no problems or side effects were observed., side effects , control group , single dose of 50 mg/kg clofibrate ,0,
edin,727,1468428,No significant difference,"We found no significant differences in puerperal or neonatal infection rates (Puerperal infection: 41/190 [22%] with enema v 26/182 [14%] without enema; RR 0.66 CI 95%: 0.43 to 1.03; neonatal infection 38/191 [20%] with enema v 40/179 [22%] without enema; RR 1.12, 95% CI 95% 0.76 to 1.66), and median labour time was similar between groups (515 min. with enema v 585 min. without enema; P = 0.24).", Puerperal and neonatal infection rates  , no enema , 1 litre saline enema ,0,
edin,906,4320624,Cannot tell based on the abstract,," Change from baseline in normalized FEV1 AUC0â6, FEV1 AUC0â12, and FEV1 AUC0â2 ", placebo , Abediterol ,0,
edin,906,4320624,Significantly increased,"Change from baseline in normalized FEV1 AUC0â6, FEV1 AUC0â12, and FEV1 AUC0â24 was significantly higher for all doses of abediterol versus placebo (pâ<â0.0001 for all, TableÂ 2), with dose-related effects observed."," Change from baseline in normalized FEV1 AUC0â6, FEV1 AUC0â12, and FEV1 AUC0â2 ", placebo , Abediterol ,0,
edin,918,3616124,No significant difference,"<td align=""left"" colspan=""1"" rowspan=""1"">Hispanic</td><td align=""left"" colspan=""1"" rowspan=""1""></td><td align=""left"" colspan=""1"" rowspan=""1""></td><td align=""left"" colspan=""1"" rowspan=""1""></td>", preeclampsia risk  in Hispanic Hp 2-2 women. , placebo from 9-16 weeks gestation until delivery. , daily doses of 400 IU of vitamin E and 1000 mg of vitamin C from 9-16 weeks gestation until delivery. ,0,
edin,864,4078386,No significant difference,"We didnât find any significant differences in the mean of HCV-RNA numbers between statin and placebo groups in 12th week of treatment, in the end of treatment and 6 months after treatment (P > 0.05).", mean of HCV-RNA numbers 6 months after treatment  , placebo , 20 mg atorvastatin nightly for 3 months ,0,
edin,720,1201146,Cannot tell based on the abstract,, Pain on walking , vehicle control solution (carrier with no diclofenac) , topical diclofenac solution (PennsaidÂ®) ,0,
edin,720,1201146,Significantly decreased,"<td colspan=""3""><hr></td>", Pain on walking , vehicle control solution (carrier with no diclofenac) , topical diclofenac solution (PennsaidÂ®) ,0,
edin,823,3800940,Cannot tell based on the abstract,," Indralupta is a unique, idiopathic, non-cictricial, non-inflammatory alopecia, presents as discoid areas of hair loss. ", Godugdha sodhit Langali moola with honey for external application , Gomutra sodhit Langali moola with honey for external application ,0,
edin,823,3800940,Invalid Prompt,," Indralupta is a unique, idiopathic, non-cictricial, non-inflammatory alopecia, presents as discoid areas of hair loss. ", Godugdha sodhit Langali moola with honey for external application , Gomutra sodhit Langali moola with honey for external application ,1, There is no question in this prompt. It contains only a statement 
edin,696,2858204,Cannot tell based on the abstract,," In the per-protocol analysis, complete healing of the index ulcer ", placebo , hyperbaric oxygen therapy ,0,
edin,696,2858204,Significantly increased,"In the per-protocol analysis, complete healing of the index ulcer occurred in 23/38 (61%) in the HBOT group and 10/37 (27%) in the placebo group (P = 0.009) (Fig. 2)."," In the per-protocol analysis, complete healing of the index ulcer ", placebo , hyperbaric oxygen therapy ,0,
edin,632,4106715,Cannot tell based on the abstract,, Prolonged abstinence from smoking rates to 6 months , placebo , low Ab group ,0,
edin,632,4106715,No significant difference,"Prolonged abstinence rates to 6 months were significantly higher in the high Ab group vs. placebo (19.7% vs. 6.0%, p=0.0060, OR=4.41, 95% CI, 1.53â12.71) with no significant differences between the placebo and low Ab groups (7.9% vs. 6.0%, p=0.60).", Prolonged abstinence from smoking rates to 6 months , placebo , low Ab group ,0,
edin,873,5729252,Cannot tell based on the abstract,, hospital-free survival of patients with pulmonary hypertension (PH) secondary to idiopathic pulmonary fibrosis (IPF) , no treatment , bosentan ,0,
edin,873,5729252,Significantly increased,"At the time of survival time analysis, hospital-free survival was 358.87âÂ±â68.65Â days (meanâÂ±âSE) (median, 331Â days) in the untreated group, which was significantly different from that in the drug-treated group (603.44âÂ±â50.074Â days) as assessed by proportional hazard analysis (hazard ratio of the drug-treated group to the untreated group, 0.19, Pâ=â0.017; log-rank test, Pâ=â0.019; and Wilcoxon test, Pâ=â0.014).", hospital-free survival of patients with pulmonary hypertension (PH) secondary to idiopathic pulmonary fibrosis (IPF) , no treatment , bosentan ,0,
edin,928,4192987,Cannot tell based on the abstract,, Median 17-hydroxy progesterone and testosterone levels , 10-15 mg/m2 total dose of hydrocortisone. Two-fifths of the total dose of hydrocortisone was administered in the morning and one-fifth of the total dose was replaced by equivalent dose of prednisolone suspension which was administered at 10.00 pm. , 10-15 mg/m2 total dose of hydrocortisone. Two-fifths of the total dose of hydrocortisone was administered in the morning and one-fifth of the total dose was administered at 06.00-07.00 pm ,0,
edin,928,4192987,No significant difference,The difference in median was not statistically significant for serum 17-hydroxyprogesterone and testosterone levels [Tables 2 and 3]., Median 17-hydroxy progesterone and testosterone levels , 10-15 mg/m2 total dose of hydrocortisone. Two-fifths of the total dose of hydrocortisone was administered in the morning and one-fifth of the total dose was replaced by equivalent dose of prednisolone suspension which was administered at 10.00 pm. , 10-15 mg/m2 total dose of hydrocortisone. Two-fifths of the total dose of hydrocortisone was administered in the morning and one-fifth of the total dose was administered at 06.00-07.00 pm ,0,
edin,639,2206488,Cannot tell based on the abstract,, systemic vascular resistance , identical amounts of gelatin infusion , dextran-70 infusion was administered at a dose of 7.5 ml/kg before the initiation of cardiopulmonary bypass and at a dose of 12.5 ml/kg after the cessation of cardiopulmonary bypass ,0,
edin,639,2206488,Significantly decreased,"Higher figures of the cardiac index (p = 0.010) along with reduced systemic vascular resistance (p = 0.005) were noted in group A.,In group A (n = 20), dextran-70 infusion was administered at a dose of 7.5 ml/kg before the initiation of cardiopulmonary bypass and at a dose of 12.5 ml/kg after the cessation of cardiopulmonary bypass.", systemic vascular resistance , identical amounts of gelatin infusion , dextran-70 infusion was administered at a dose of 7.5 ml/kg before the initiation of cardiopulmonary bypass and at a dose of 12.5 ml/kg after the cessation of cardiopulmonary bypass ,0,
edin,645,1201146,Cannot tell based on the abstract,, 50% reduction in pain , vehicle control solution (carrier with no diclofenac) , topical diclofenac solution (PennsaidÂ®) ,0,
edin,645,1201146,Significantly increased,"<td colspan=""3""><hr></td>", 50% reduction in pain , vehicle control solution (carrier with no diclofenac) , topical diclofenac solution (PennsaidÂ®) ,0,
edin,747,1876597,No significant difference,Both drugs were well tolerated; serious adverse events were uncommon and unrelated to study drugs., Adverse Events , artemether-lumefantrine , dihydroartemisinin-piperaquine  ,0,
edin,890,5519461,No significant difference,"The eradication rates of the EAC and RAC regimens were 79.8% (95% confidential interval: 71.7-89.0%) and 74.7% (66.0-83.4%), respectively, in a per protocol (PP) analysis (p=0.488). The eradication rates of the EAC and RAC regimens were not significantly different between patients with the homo EM genotype (p=0.999) or hetero IM or PM genotypes (p=0.286).", H. pylori eradication ," amoxicillin (750 mg), clarithromycin (200 mg), and rabeprazole (10 mg) (RAC group), twice a day for one week. "," amoxicillin (750 mg), clarithromycin (200 mg), and either esomeprazole (20 mg) (EAC group), twice a day for one week. ",0,
edin,736,2720945,Cannot tell based on the abstract,," Mean of sum of number, duration and severity of exacerbations during 6 months of treatment ", placebo , cineole ,0,
edin,736,2720945,Significantly increased,"<td align=""left""><bold>Summarized parameter</bold><break><bold>(directional test)</bold></break></td><td></td><td></td><td align=""center"">0.0120</td>,As primary outcome measure the sum of exacerbations for frequency, duration and severity at all 6 following visits as composite endpoint (equally weighted) were calculated according to the Wei-Lachin Test procedure for multiple criteria and showed a statistically significant difference for the primary outcome measure between both treatment groups (p = 0.0120) Table 3."," Mean of sum of number, duration and severity of exacerbations during 6 months of treatment ", placebo , cineole ,0,
edin,865,5680306,Significantly increased,Serum 25(OH)D concentrations increased with vitamin D supplementation compared to placebo (pâ<â0.001)., Serum 25(OH)D concentrations ," the placebo group receiving an equivalent number of identical placebo capsules, which were continued daily for a period of 16 weeks "," vitamin D group receiving an initial bolus dose of 100,000 IU (in 2 capsules) followed by 4,000 IU (in 4 capsules) of cholecalciferol daily ",0,
edin,732,2607225,Cannot tell based on the abstract,, Appetite loss , standard care ," individual support, group rehabilitation and a combination of the two (Group rehabilitation) ",0,
edin,732,2607225,Significantly decreased,"Global quality of life, emotional functioning, cognitive functioning, pain, insomnia, appetite loss, anxiety, depression, intrusion and avoidance improved from baseline to 3 months. Financial difficulties worsened from baseline to 3 months. Global quality of life, physical functioning, role functioning, emotional functioning, social functioning, fatigue, nausea/vomiting, appetite loss, diarrhoea, financial difficulties, and depression improved from 3 to 24 months.,Appetite loss decreased from 3 to 6 months (mean=5.1â3.7, s.d.=14.2â11.1), worsened at 12 months (mean=5.8, s.d.=16.0) and decreased again at 24 months (mean=4.1, s.d.=12.7) in GR patients, whereas it improved from 3 to 6 and 12 months (mean=8.1, 4.0, 2.4; s.d.=17.7, 12.6, 10.8) and worsened at 24 months (mean=2.8, s.d.=10.7) in non-GR patients (F=4.1, d.f.=3/963, P=0.007).", Appetite loss , standard care ," individual support, group rehabilitation and a combination of the two (Group rehabilitation) ",0,
edin,967,5372931,Cannot tell based on the abstract,," flavonols, valerolactones, benzoic acids, cinnamic acids, phenylacetic acids, benzaldehydes  ", nothing , cranberry juices ,0,
edin,967,5372931,Significantly increased,"Linear regression analysis was performed between the TP level in the intervention and the AUC of each class of compounds. The AUC for flavonols produced the highest r2 (0.97, p < 0.001), followed by the valerolactones (r2 = 0.89, p < 0.005), benzoic acids (r2 = 0.85, p < 0.01), cinnamic acids (r2 = 0.72, p < 0.05), phenylacetic acids (r2 = 0.71, p < 0.05), benzaldehydes (r2 = 0.65, p < 0.05); hippuric acids, pyrogallols, and catechols did not show a linear dose response."," flavonols, valerolactones, benzoic acids, cinnamic acids, phenylacetic acids, benzaldehydes  ", nothing , cranberry juices ,0,
edin,792,125315,Cannot tell based on the abstract,, The median stay in hospital , received only standard therapy for sepsis , received standard therapy for sepsis and physiological-dose steroid therapy for 10 days; ,0,
edin,792,125315,No significant difference,"<td></td><td colspan=""3""><hr></td><td colspan=""3""><hr></td><td colspan=""3""><hr></td>,<td></td><td colspan=""3""><hr></td><td colspan=""3""><hr></td><td colspan=""3""><hr></td>", The median stay in hospital , received only standard therapy for sepsis , received standard therapy for sepsis and physiological-dose steroid therapy for 10 days; ,0,
edin,934,4264479,Cannot tell based on the abstract,, blood-stage infection , nothing ," aseptic, cryopreserved P. falciparum sporozoites (PfSPZ Challenge) ",0,
edin,934,4264479,No significant difference,"ll volunteers were diagnosed with malaria [see Table S5 for criteria for treatment and Table S6 for time to diagnosis (TTD) and parasitemia at diagnosis] with the exception of one volunteer in Group 2 (Volunteer 110), who was asymptomatic and blood film negative at all time-points, despite blood-stage infection confirmed by qPCR", blood-stage infection , nothing ," aseptic, cryopreserved P. falciparum sporozoites (PfSPZ Challenge) ",0,
edin,961,2656477,Cannot tell based on the abstract,, depression , no weight lost , lost weight ,0,
edin,961,2656477,No significant difference,"<td></td><td></td><td></td><td></td><td></td><td></td>,<td></td><td></td><td></td><td></td><td></td><td></td>", depression , no weight lost , lost weight ,0,
edin,660,2720945,Cannot tell based on the abstract,," Mean of sum of number, duration and severity of exacerbations during 6 months of treatment ", placebo , cineole ,0,
edin,660,2720945,Significantly decreased,"Table 3
Mean of sum of number, duration and severity of exacerbations during 6 months of treatment with cineole or placebo*,<td align=""left""><bold>Summarized parameter</bold><break><bold>(directional test)</bold></break></td><td></td><td></td><td align=""center"">0.0120</td>"," Mean of sum of number, duration and severity of exacerbations during 6 months of treatment ", placebo , cineole ,0,
edin,891,5519461,No significant difference,The eradication rates of the EAC and RAC regimens were not significantly different between patients with the homo EM genotype (p=0.999) or hetero IM or PM genotypes (p=0.286)., Eradication of H. pylori with homo EM genotype and those with hetero IM or PM genotype. ," amoxicillin (750 mg), clarithromycin (200 mg), and rabeprazole (10 mg) (RAC group), twice a day for one week. "," amoxicillin (750 mg), clarithromycin (200 mg), and either esomeprazole (20 mg) (EAC group), twice a day for one week. ",0,
edin,629,2688140,Cannot tell based on the abstract,, The survival rate / overall mortality of patients with ARDS , table-based PEEP (control) group , Decremental PEEP titration group ,0,
edin,629,2688140,Cannot tell based on the abstract,, The survival rate / overall mortality of patients with ARDS , table-based PEEP (control) group , Decremental PEEP titration group ,0,
edin,629,2688140,No significant difference,"Using Cox regression for 28-day mortality, the survival rate in the decremental PEEP titration group was not different (p = 0.725; hazard ratio = 1.168; 95% confidence interval = 0.493 to 2.768).,<td align=""left"">âMortality at 60 days</td><td align=""center"">15 (55.6)</td><td align=""center"">14 (46.7)</td><td align=""center"">0.599</td>,Table 2
Clinical outcomes according to treatment group", The survival rate / overall mortality of patients with ARDS , table-based PEEP (control) group , Decremental PEEP titration group ,0,
edin,679,2430614,Cannot tell based on the abstract,, parasitological or clinical failure rates by day 14 or day 28 in G6PD deficient children , artemether-lumefantrine (AL) , Artesunate+amodiaquine (AS+AQ) ,0,
edin,679,2430614,No significant difference,There was no statistically significant differences in the parasitological or clinical failure rates by day 14 or day 28 between the AS+AQ and AL groups (Table 6)., parasitological or clinical failure rates by day 14 or day 28 in G6PD deficient children , artemether-lumefantrine (AL) , Artesunate+amodiaquine (AS+AQ) ,0,
edin,883,5539984,Cannot tell based on the abstract,, reduction of total needs and the increase of met needs , standard mental health care , The Network for Mental Health (NWpG-IC) ,0,
edin,883,5539984,No significant difference,"However, as indicated by the non-significant group by time interaction, there was no difference between groups regarding the reduction of total needs (bÂ =Â 0.09; pÂ =Â 0.217) or the increase of met needs (bÂ =Â 0.01; pÂ =Â 0.621).", reduction of total needs and the increase of met needs , standard mental health care , The Network for Mental Health (NWpG-IC) ,0,
edin,882,5539984,Cannot tell based on the abstract,, prevalence of psychiatric inpatient admission , standard mental health care , The Network for Mental Health (NWpG-IC) ,0,
edin,882,5539984,No significant difference,"<td>number of psychiatric inpatient admissions [+ 1]</td><td>1.131</td><td>1.045</td><td>-</td><td>1.225</td>,The results of the mixed effects logistic regression model (not presented) did neither show differences of the prevalence of psychiatric inpatient admission between groups during the six months before baseline assessment (OR 0.99; pÂ =Â 0.985), nor a change over time (OR 0.62; pÂ =Â 0.086) in either groups or a difference between the groups (OR 0.97; pÂ =Â 0.878) during the study period.", prevalence of psychiatric inpatient admission , standard mental health care , The Network for Mental Health (NWpG-IC) ,0,
edin,900,1198254,Significantly increased,"Faecal recovery of ME-3 was documented by molecular methods only in fermented milk group, however the significant improvement of blood TAA (Total Antioxidative Activity) and TAS (Total Antioxidative Status) indices was seen both in case of fermented goat milk and capsules"", yet glutathione re-ox ratio values decreased only in case of fermented by ME-3 goat milk.", Total Antioxidative Activity , goat milk , L. fermentum ME-3 fermented goat milk ,0,
edin,923,5295802,Cannot tell based on the abstract,, cytokine levels at baseline , placebo , levocarnitine ,0,
edin,923,5295802,No significant difference,"here was no statistically significant difference in cytokine levels between symptom groups (severe vs. non-severe fatigue and severe vs. non-severe depression) at baseline based on the Wilcoxon rank sum test (p>0.05 for all cytokines, data not shown).", cytokine levels at baseline , placebo , levocarnitine ,0,
edin,636,4106715,Significantly increased,"3âAmNic-rEPA recipients with the highest serum anti-nicotine antibody response (top 30% by AUC) were significantly more likely to attain 8 weeks continuous abstinence from weeks 19 through 26 than the placebo recipients (24.6% vs. 12.0%, p=0.024, OR=2.69, 95% CI, 1.14â6.37).", attain 8 weeks continuous abstinence from weeks 19 through 26 , placebo group , recipients with the highest serum anti-nicotine antibody response (top 30% by AUC) ,0,
edin,694,2858204,Significantly increased,"n the intention-to-treat analysis, complete healing of the index ulcer was achieved in 37 patients at 1-year of follow-up: 25/48 (52%) in the HBOT group and 12/42 (29%) in the placebo group (P = 0.03).", complete healing of the index ulcer at 1-year of follow-up , placebo , hyperbaric oxygen therapy ,0,
edin,925,5295802,Cannot tell based on the abstract,," all ten cytokines/growth factors -  IL-1, IL-1?, IL-6, IL-8, IL-1Ra, interferon-? (IFN-?), tumor necrosis factor-? (TNF-?), EGF, TGF-?, and vascular endothelial growth factor (VEGF) ", before intervention , after intervention ,0,
edin,925,5295802,No significant difference,"There was no statistically significant difference in cytokine levels between symptom groups (severe vs. non-severe fatigue and severe vs. non-severe depression) at baseline based on the Wilcoxon rank sum test (p>0.05 for all cytokines, data not shown)."," all ten cytokines/growth factors -  IL-1, IL-1?, IL-6, IL-8, IL-1Ra, interferon-? (IFN-?), tumor necrosis factor-? (TNF-?), EGF, TGF-?, and vascular endothelial growth factor (VEGF) ", before intervention , after intervention ,0,
edin,763,2447617,Cannot tell based on the abstract,, The analysis using the dichotomization of GOS scores at 3 months post injury , placebo , progesterone ,0,
edin,763,2447617,Significantly increased,The analysis using the dichotomization of GOS scores at 3 months post injury revealed a favorable outcome in 47% of the patients receiving progesterone and in 31% of the placebo group (P = 0.034)., The analysis using the dichotomization of GOS scores at 3 months post injury , placebo , progesterone ,0,
edin,794,2830179,Cannot tell based on the abstract,, Pain on rest (0-10) , received no treatment , attended individual sessions with an experienced clinician once a week for 10 weeks and performed daily home exercises with adherence monitored by a self-report diary ,0,
edin,794,2830179,Significantly decreased,"<th></th><th colspan=""2""><hr></th><th colspan=""2""><hr></th><th colspan=""2""><hr></th><th colspan=""1""><hr></th>,<td align=""left"">Pain on rest (0-10)</td><td align=""center"">3.0 (2.7)</td><td align=""center"">1.4 (1.8)</td><td align=""center"">1.1 (2.2)</td><td align=""center"">2.0 (2.6)</td><td align=""center"">-1.9 (2.3)</td><td align=""center"">0.6 (1.0)</td><td align=""center"">-2.0 (-3.8 to -0.2)</td>,<th></th><th colspan=""2""><hr></th><th colspan=""2""><hr></th><th colspan=""2""><hr></th><th colspan=""1""><hr></th>", Pain on rest (0-10) , received no treatment , attended individual sessions with an experienced clinician once a week for 10 weeks and performed daily home exercises with adherence monitored by a self-report diary ,0,
edin,813,5602855,Cannot tell based on the abstract,, Health care burden , inadequate motivation/capability , good motivation/capability ,0,
edin,813,5602855,No significant difference,No statistically significant changes were observed either in the number of visits to the municipal primary healthcare centre (pÂ =Â 0.39) or to special healthcare outpatient clinics (pÂ =Â 0.072) during the follow-up., Health care burden , inadequate motivation/capability , good motivation/capability ,0,
edin,936,4918678,Cannot tell based on the abstract,, Writing , nothing , soundfield amplification devices in the classroom ,0,
edin,936,4918678,No significant difference,"<th colspan=""2"" rowspan=""1""><hr></th><th colspan=""2"" rowspan=""1""><hr></th><th colspan=""2"" rowspan=""1""><hr></th>,<th colspan=""2"" rowspan=""1""><hr></th><th colspan=""2"" rowspan=""1""><hr></th><th colspan=""2"" rowspan=""1""><hr></th>", Writing , nothing , soundfield amplification devices in the classroom ,0,
edin,896,4140547,Cannot tell based on the abstract,, Mean calculated GFR at 1 year. , tacrolimus groups , belatacept groups ,0,
edin,896,4140547,Significantly increased,"<th colspan=""1"" rowspan=""1""></th><th align=""left"" colspan=""5"" rowspan=""1""><hr></th>,<th colspan=""1"" rowspan=""1""></th><th align=""left"" colspan=""5"" rowspan=""1""><hr></th>", Mean calculated GFR at 1 year. , tacrolimus groups , belatacept groups ,0,
edin,644,1201146,Cannot tell based on the abstract,, Pain on walking , vehicle control solution (carrier with no diclofenac) , topical diclofenac solution (PennsaidÂ®) ,0,
edin,644,1201146,Significantly increased,"<td colspan=""3""><hr></td>", Pain on walking , vehicle control solution (carrier with no diclofenac) , topical diclofenac solution (PennsaidÂ®) ,0,
edin,684,2447617,Significantly decreased,The mortality rate of the progesterone group was significantly lower than that of the placebo group at 6-month follow-up (P < 0.05)., The mortality rate , placebo , progesterone ,0,
edin,764,2447617,Significantly increased,"<td align=""left"">6 months</td><td></td><td></td>", The analysis using the dichotomization of GOS scores at 6 months post injury , placebo , progesterone ,0,
edin,716,2206488,No significant difference,"There was no significant difference in IL 6, IL-6r and C-reactive protein values between groups.", C-reactive protein (mg/l) , identical amounts of gelatin infusion , dextran-70 infusion was administered at a dose of 7.5 ml/kg before the initiation of cardiopulmonary bypass and at a dose of 12.5 ml/kg after the cessation of cardiopulmonary bypass ,0,
edin,742,1913177,Cannot tell based on the abstract,, Postoperative Mortality , prosthetic repair with e-PTFE patch (PR) , components separation technique (CST) ,0,
edin,742,1913177,No significant difference,"Major wound complications were found in 10 of the 19 patients in the CST group: wound infection (n = 3), skin necrosis (n = 2), hematoma (n = 1). Four patients developed seroma; these were not associated with the aforementioned complications.,Major wound complications were found in 13 of the 18 patients in the e-PTFE group: wound infection (n = 2), skin necrosis (n = 3), hematoma (n = 1).", Postoperative Mortality , prosthetic repair with e-PTFE patch (PR) , components separation technique (CST) ,0,
edin,892,5618071,Cannot tell based on the abstract,," ADI-R (algorithm for current condition), the Autism Behavioral Checklist (ABC), and the Autism Treatment Evaluation Checklist (ATEC)  after 1 month ", before Non-Invasive Brain Stimulation (NIBS) , after Non-Invasive Brain Stimulation (NIBS) ,0,
edin,892,5618071,Significantly decreased,"As a global result (G1 + G2), a significant decrease in the total score was observed in ADI-R, ABC, and ATEC scales one month after the intervention (Wilcoxon matched pair test; ABC, Z = 3.823, p = 0.000131; ADI-R, 3.337, p = 0.000846; ATEC, Z = 3.723, p = 0.000196)."," ADI-R (algorithm for current condition), the Autism Behavioral Checklist (ABC), and the Autism Treatment Evaluation Checklist (ATEC)  after 1 month ", before Non-Invasive Brain Stimulation (NIBS) , after Non-Invasive Brain Stimulation (NIBS) ,0,
edin,665,3446002,Cannot tell based on the abstract,, Total serum bilirubin level , control group , single dose of 50 mg/kg clofibrate ,0,
edin,665,3446002,Significantly decreased,"Clofibrate group (group I) was given a single dose of 50 mg/kg clofibrate before starting phototherapy. I,<td align=""left"" colspan=""1"" rowspan=""1"" style=""background-color: #aae1ff"">
<bold>TSB<xref ref-type=""table-fn"" rid=""TF0002"">*</xref> (mg/dl)</bold>
</td><td align=""center"" colspan=""1"" rowspan=""1"" style=""background-color: #aae1ff"">17.24 (1.48)</td><td align=""center"" colspan=""1"" rowspan=""1"" style=""background-color: #aae1ff"">17.42 (1.44)</td>,TSB: total serum bilirubin,<td align=""center"" colspan=""1"" rowspan=""1"" style=""background-color: #aae1ff"">
<bold>Control (II)</bold>
</td><td align=""center"" colspan=""1"" rowspan=""1"" style=""background-color: #aae1ff"">30</td><td align=""center"" colspan=""1"" rowspan=""1"" style=""background-color: #aae1ff"">12.6 (1.44)</td>", Total serum bilirubin level , control group , single dose of 50 mg/kg clofibrate ,0,
edin,640,2206488,No significant difference,"There was no significant difference in IL 6, IL-6r and C-reactive protein values between groups.", C-reactive protein (mg/l) , identical amounts of gelatin infusion , dextran-70 infusion was administered at a dose of 7.5 ml/kg before the initiation of cardiopulmonary bypass and at a dose of 12.5 ml/kg after the cessation of cardiopulmonary bypass ,0,
edin,843,2891743,Significantly increased,"<td colspan=""4""><hr></td>,<td colspan=""4""><hr></td>", transurethral resection (TUR) syndrome , normal saline 0.9% solution , glycine 1.5% solution as irrigating fluid ,0,
edin,1180,5002324,Significantly increased,"After training, participants in the balance-based exergaming group showed significant improvements in LOS performance, and in the eyes-closed condition of the OLS test.", the limits of stability (LOS) performance and one-leg stance (OLS) tests , a balance training group for an 8-week balance training period. , a balance-based exergaming group for an 8-week balance training period. ,0,
edin,1115,3423952,Cannot tell based on the abstract,," chondroitin sulfate-846 (CS) in synovial fluid (SF) and adjusted-PGE2,  ", no exercise , exercise ,0,
edin,1115,3423952,Significantly increased,"Main effects for PGE2 concentrations in synovial fluid were not detected (P > 0.05); however, after adjusting the data by subtracting the PRE value from each POST value, and evaluating changes relative to pre-exercise values, effects of exercise (P = 0.03) and joint (P = 0.04) were detected (Figure 2(b)).,Similar to synovial fluid CS concentrations, there were greater relative increases (P = 0.04) in PGE2 concentrations in hock joints when compared to carpus joints (Figure 2(b))."," chondroitin sulfate-846 (CS) in synovial fluid (SF) and adjusted-PGE2,  ", no exercise , exercise ,0,
edin,1061,3787573,No significant difference,"For the comparison between the groups, no statistically significant difference was found between the NMES + Ex and the Ex groups in NRS (P = 0.52), TUG test (P = 0.12), and aspects of WOMAC: pain (P = 0.26), function (P = 0.23), and stiffness (P = 0.63).", Western Ontario and McMaster Universities Osteoarthritis Index for stiffness , Exercise alone , NMES plus exercise ,0,
edin,1004,3442969,Cannot tell based on the abstract,, Disease control rates , CAPOX , FUFOX ,0,
edin,1004,3442969,No significant difference,"Disease control rates (DCR) were 77%, 81% and 88%, respectively, which was not statistically significant (Table3, pâ=â0.29).", Disease control rates , CAPOX , FUFOX ,0,
edin,1168,5354011,Cannot tell based on the abstract,, willingness?to?pay. , before treatment , after treatment  ,0,
edin,1168,5354011,Significantly increased,"The average maximum WTP for treatment for menorrhagia was approximately Â£27 (US$41) per month (see Table 2). The average combined MMAS score for treatment doubled from approximately 43 at preâtreatment to 85 following treatment, generating a statistically significant improvement in health status as measured by this instrument (P = 0.000).", willingness?to?pay. , before treatment , after treatment  ,0,
edin,1080,4565804,Significantly decreased,"Dogs in the Placebo group received significantly more morphine doses than the Gabapentin group (P=0.021), despite no significant differences in pain scores.", morphine doses , Placebo , gabapentin (10 mg/kg) ,0,
edin,987,2920262,Cannot tell based on the abstract,Singers also had a significant fall in HAD anxiety score; -1.1(2.7) vs. +0.8(1.7) p = 0.03., Improvement in HAD anxiety score , Usual care , Singing classes ,0,
edin,987,2920262,Significantly increased,Singers also had a significant fall in HAD anxiety score; -1.1(2.7) vs. +0.8(1.7) p = 0.03., Improvement in HAD anxiety score , Usual care , Singing classes ,0,
edin,1130,5225252,Significantly increased,"Gag-specific IFN-Î³ enzyme-linked immunospotâdetermined response rates and geometric mean responses were higher (96% and 248 spot-forming units, respectively) in groups primed with SeV-Gag and boosted with Ad35-GRIN (SLA and SHA) than those after a single dose of Ad35-GRIN (56% and 54 spot-forming units, respectively) or SeV-Gag (55% and 59 spot-forming units, respectively); responses persisted for â¥8 months after completion of the prime-boost regimen.", Gag-specific IFN-? enzyme-linked immunospotâdetermined response rates and geometric mean responses , a single dose of Ad35-GRIN or SeV-Gag , groups primed with SeV-Gag and boosted with Ad35-GRIN (SLA and SHA) ,0,
edin,1015,5101425,No significant difference,No significant difference was noted between the groups regarding the rate of bleeding after surgery (359.3 Â± 266.2 in group D vs. 406.3 Â± 341.6 in group P (control group); P = 0.208)., Bleeding rate after surgery , Placebo , Desmopressin ,0,
edin,1104,4109867,No significant difference,"Dietary SW supplementation had no effect on saturated fatty acids (SFA), unsaturated fatty acids, poly unsaturated fatty acid (PUFA) or mono unsaturated fatty acid content in muscles."," saturated fatty acids (SFA), unsaturated fatty acids, poly unsaturated fatty acid (PUFA) or mono unsaturated fatty acid content in muscles ", basal diet , 2% seamustard ,0,
edin,1042,5746685,No significant difference,"There were no significant between-group differences in the primary outcome of change in BMI (basic â0.5 (1.9) kg/m2, enhanced â0.5 (1.6) kg/m2, p = 0.93).", Change in body mass index , Basic weight loss maintenance program , Enhanced weight loss maintenance program ,0,
edin,1082,5610854,Cannot tell based on the abstract,, intraocular pressure (IOP) , primary trabeculectomy group 2 , laser peripheral iridotomy (LPI) group 1 ,0,
edin,1082,5610854,Significantly decreased,"7 of the 38 eyes (44.7%, CI: 28.9%â60.5%) in group 1 required a mean of 1.8 IOP-lowering medications while seven of the 111 eyes (6.3%, CI: 1.8%â10.8%) in group 2 required a mean of 1.1 medications (Pearson's chi-square valueâ=â30.940, p < 0.001).", intraocular pressure (IOP) , primary trabeculectomy group 2 , laser peripheral iridotomy (LPI) group 1 ,0,
edin,1020,3159986,Cannot tell based on the abstract,, Lung function parameters , Baseline characteristics , Respiratory muscle endurance training ,0,
edin,1020,3159986,No significant difference,"Baseline lung function was normal for all patients with VC being 95.5 Â± 3.7%, FEV1 90.5 Â± 3.6%, PEF 86.9 Â± 4.5%, MVV 93.8 Â± 6.6%, and maximal inspiratory pressure (PImax) 75.1 Â± 5.4% predicted. RMET induced mild but not significant increases in VC (P1: 95.9 Â± 3.5%, P4: 99.2 Â± 4.1%, P = 0.39), FEV1 (P1: 93.1 Â± 2.7%, P4: 96.3 Â± 3.8%, P = 0.28), PEF (P1: 90.0 Â± 4.8%, P4: 95.7 Â± 5.4%, P = 0.07), MVV (P1: 95.6 Â± 6.0%, P4: 101.0 Â± 6.5%, P = 0.24), and PImax (P1: 79.2 Â± 5.4%, P4: 78.0 Â± 6.4%, P = 0.42).", Lung function parameters , Baseline characteristics , Respiratory muscle endurance training ,0,
edin,1128,5936036,No significant difference,There was no significant difference among the drop-out rates in the three groups., drop-out rates , the SCBT with medication group or regular medication group , simplified cognitive behavioral therapy (SCBT) on generalized anxiety disorder (GAD) ,0,
edin,976,3798949,Cannot tell based on the abstract,, Extra clinic visits and CT scans assessments , Commercial sponsored trials ," Academic, non-commercial sponsored trials ",0,
edin,976,3798949,Significantly decreased,"The contribution of extra clinic visits and investigations, in particular CT scans used for response assessment, was significantly higher for commercial compared with non-commercial trials.", Extra clinic visits and CT scans assessments , Commercial sponsored trials ," Academic, non-commercial sponsored trials ",0,
edin,1024,4895766,Cannot tell based on the abstract,, Control of infection , Betadine ointment , Katupila Kalka with Tila Taila ,0,
edin,1024,4895766,Significantly increased,"In Group A, diabetic wounds treated with Katupila paste got healed within 28 days with minimal scar formation without any complications, whereas in Group B, wound was healed completely only in two patients within 28 days.,The surrounded skin color became normal skin color within 7 days in maximum patients (76%) of Group A, whereas only 32% patients showed normal peri-wound skin color in Group B.", Control of infection , Betadine ointment , Katupila Kalka with Tila Taila ,0,
edin,1099,4109867,Cannot tell based on the abstract,, IgG concentrations , basal diet , 2% seamustard ,0,
edin,1099,4109867,Significantly increased,The SW supplementation significantly increased (p<0.05) IgG concentrations while IgM concentrations remained unaffected (Table 4)., IgG concentrations , basal diet , 2% seamustard ,0,
edin,1210,4306068,No significant difference,"The mean timing to analgesic administration for the displayed and non-displayed groups were 81.3âÂ±â41.2 (95% C.I 65.9, 96.7) and 88.7âÂ±â45.4 (95% C.I 69.0, 108.3), respectively (pâ>â0.05).", The mean timing to analgesic administration , not displayed in the control. , pain score display group ,0,
edin,1122,5489138,Cannot tell based on the abstract,"he 3-part composite measure was associated with more CDP events (41.4% and 63.9% of patients at 12 and 24 months, respectively) than the 2-part measure (EDSS/T25FW [38.5% and 59.5%, respectively]) and any single measure.", confirmed disability progression , 9-hole peg test [9HPT] ," timed 25-foot walk [T25FW], ",0,
edin,1122,5489138,Significantly increased,"3M CDP = 3-month confirmed disability progression;,The 3-part composite measure was associated with more CDP events (41.4% and 63.9% of patients at 12 and 24 months, respectively) than the 2-part measure (EDSS/T25FW [38.5% and 59.5%, respectively]) and any single measure.", confirmed disability progression , 9-hole peg test [9HPT] ," timed 25-foot walk [T25FW], ",0,
edin,1132,5225252,Cannot tell based on the abstract,, The GMTs ," SLA, SHA, SHSH, and placebo groups, ", ASH group ,0,
edin,1132,5225252,Significantly increased,"The GMTs were significantly higher (P < .0001, by the Kruskal-Wallis test) in the ASH group after the SeV boost than in the other groups (53, 53, 245, 50, and 59 in the SLA, SHA, ASH, SHSH, and placebo groups, respectively; Figure 4).", The GMTs ," SLA, SHA, SHSH, and placebo groups, ", ASH group ,0,
edin,1165,4223523,Cannot tell based on the abstract,, awake time , placebo , olanzapine ,0,
edin,1165,4223523,Significantly decreased,"As well as an increase in TST, olanzapine treated participants experienced significantly fewer awakenings (TableÂ  2) and less overall time awake compared to treatment with placebo (2-way repeated measures ANOVA; main effect of treatment, number of awakenings, F[1,23]â=â10.0, pâ=â0.004; awake time, F[1,23]â=â4.8, pâ=â0.037).", awake time , placebo , olanzapine ,0,
edin,1141,3895597,No significant difference,"The incidence of adverse events was similar in the 2 groups, and no severe adverse events involving either drug were observed.", The incidence of adverse events , octylonium 20 mg , tiropramide 100 ,0,
edin,1106,5064802,No significant difference,"Postoperative troponin T was 11 arbitrary units [5, 31; area-under-the-curve (interquartile range)] for controls, and no statistically significant changes were observed after helium preconditioning [He-pre: 11 (6, 18)], helium postconditioning [He-post: 11 (8, 15)], helium pre- and postconditioning [He-PP: 14 (6, 20)] and after sevoflurane preconditioning [APC: 12 (8, 24), pÂ =Â 0.13].", Postoperative troponin T , no helium , Helium preconditioning (3 Ã 5 min of 70 % helium and 30 % oxygen) was applied before aortic cross clamping; postconditioning (15 min of helium) was applied before release of the aortic cross clamp. ,0,
edin,1177,3752932,Cannot tell based on the abstract,," mean volume voided/micturition, mean level of urgency, mean number of urgency episodesand mean number of urgency incontinence episodes/24 h ", placebo , mirabegron (50 and 100 mg) ,0,
edin,1177,3752932,Significantly increased,"<th colspan=""1"" rowspan=""1""></th><th align=""left"" colspan=""2"" rowspan=""1""><hr></th><th align=""left"" colspan=""2"" rowspan=""1""><hr></th><th align=""left"" colspan=""2"" rowspan=""1""><hr></th><th align=""left"" colspan=""2"" rowspan=""1""><hr></th><th align=""left"" colspan=""2"" rowspan=""1""><hr></th>"," mean volume voided/micturition, mean level of urgency, mean number of urgency episodesand mean number of urgency incontinence episodes/24 h ", placebo , mirabegron (50 and 100 mg) ,0,
edin,1074,1562433,Significantly increased,"<td colspan=""4""><hr></td>", vastus medialis obliquus (VMO) EMG activity  , hip abduction at 0Â° and 30Â° , knee extension at 90Â° of flexion ,0,
edin,1107,5064802,No significant difference,"No effect was observed of helium preconditioning, postconditioning or the combination thereof on activation of p38 MAPK, ERK 1/2 or levels of HSP27 and PKC-Îµ in the human heart."," activation of p38 MAPK, ERK 1/2 or levels of HSP27 and PKC-? in the human heart ", no helium , Helium preconditioning (3 Ã 5 min of 70 % helium and 30 % oxygen) was applied before aortic cross clamping; postconditioning (15 min of helium) was applied before release of the aortic cross clamp. ,0,
edin,1079,4667210,Significantly increased,"Although there was no significant difference in the appearance time of the MSG symptom complex between subjects orally administered G101 and those administered the placebo, its disappearance in < 3 h was observed in 69.9% of subjects in the G101 treatment group and in 38.0% of subjects in the placebo group (P = 0.0841).", disappearance in &amp;lt; 3 h  of the MSG symptom complex , maltodextrin (placebo) , Capsules (300 mg) containing Lactobacillus brevis G101 (1Ã1010 CFU/individual) ,0,
edin,1113,3423952,Significantly increased,"Exercise resulted in increased (P < 0.05) antioxidant defenses including erythrocyte SOD, total glutathione, glutathione peroxidase, gene transcripts for interferon-gamma, interleukin-10, and interleukin-1Î² in blood, and decreased plasma nitric oxide."," erythrocyte SOD, total glutathione, glutathione peroxidase, gene transcripts for interferon-gamma, interleukin-10, and interleukin-1? in blood ", no exercise , exercise ,0,
edin,1013,5018157,No significant difference,"The one-minute Apgar score was significantly lower for the preeclamptic parturients (8.4 Â± 0.7 versus 7.2 Â± 1.5) (P = 0.001), but there was no significant difference in the five-minute Apgar scores between the two groups.", Five-minute Apgar score , Low-dose bupivacaine spinal anesthesia in healthy parturients , Low-dose bupivacaine spinal anesthesia in pre-eclamptic parturients ,0,
edin,1086,4395717,Significantly decreased,"After the intervention, the error angle was significantly smaller in flexion and right left side-bending, and pain was significantly reduced in the upper thoracic manipulation group.", repositioning error in flexion and right and left side-bending and reduction in pain , cervical stability training (CST) , upper thoracic manipulation (UTM) ,0,
edin,979,5619630,Cannot tell based on the abstract,, Improvement in Presumptive Stressful Life Events Scale , Medication only , Medication plus exercise ,0,
edin,979,5619630,No significant difference,there was no significant difference between the groupsâ PSLES scores at any follow-up point., Improvement in Presumptive Stressful Life Events Scale , Medication only , Medication plus exercise ,0,
edin,1159,3296686,Cannot tell based on the abstract,, serum ALT and AST values , baseline , Pioglitazone (30 mg/day for 14 days) ,0,
edin,1159,3296686,Significantly decreased,Pioglitazone treatment decreased at day-14 serum ALT levels (mean changeâ=â7.5 IU/ml; 95% CI: 2.1 to 12.9; Pâ=â0.012) and to a smaller degree serum AST levels (mean changeâ=â2.6 IU/ml; 95% CI: â0.6 to 5.8; Pâ=â0.096) ( Table 5 )., serum ALT and AST values , baseline , Pioglitazone (30 mg/day for 14 days) ,0,
edin,981,5490116,Cannot tell based on the abstract,, Glucometric random blood sugar at 24 hours , Ropivacaine 0.2% with injection dexamethasone 8 mg (Group C) ," Ropivacaine 0.2%, and intravenous injection dexamethasone 8 mg (Group B) ",0,
edin,981,5490116,Significantly increased,Glucometric random blood sugar (GRBS) was significantly (P < 0.005) higher in Group B compared to Groups A and C at 24 h as shown in Table 2., Glucometric random blood sugar at 24 hours , Ropivacaine 0.2% with injection dexamethasone 8 mg (Group C) ," Ropivacaine 0.2%, and intravenous injection dexamethasone 8 mg (Group B) ",0,
edin,1198,3743641,Cannot tell based on the abstract,, sexual function and total scores , placebo ," BZA/CE combines bazedoxifene (BZA), a selective estrogen receptor modulator, with conjugated estrogens (CE), ",0,
edin,1198,3743641,Significantly increased,"Additionally, in SMART-3 (subjects with vulvovaginal atrophy), the Menopause-Specific Quality of Life questionnaire results at week 12 showed significant improvements in sexual function and total scores with both BZA/CE doses versus placebo or BZA 20 mg (P < 0.001).", sexual function and total scores , placebo ," BZA/CE combines bazedoxifene (BZA), a selective estrogen receptor modulator, with conjugated estrogens (CE), ",0,
edin,1054,2223531,No significant difference,"he median AUC(inf) (area under the concentration vs time curve from zero to infinity) of etoposide was 77.7 mg l(-1) h after etoposide phosphate (95% CI 61.3-100.5) and 62.0 mg l(-1) h after oral etoposide (95% CI 52.2-76.9).,In conclusion, oral etoposide phosphate does not offer a clinically relevant benefit over oral etoposide.", Median AUC(inf) , Oral etoposide , Oral etoposide phosphate ,0,
edin,1001,3878029,No significant difference,The intervention had no effect on smoking status (p =â.73) or on the number of cigarettes smoked per day (p =â.56)., Cigarettes smoked per day , Relaxation , Hypnotherapy ,0,
edin,999,3074545,Significantly increased,"<td align=""left"">SF36</td><td></td><td></td><td></td><td></td><td></td><td></td>,<td></td><td></td><td></td><td></td><td></td><td></td><td></td>", Improvements in physical and mental wellbeing , Non-mentored group , Non-professional mentor support ,0,
edin,1158,3296686,Cannot tell based on the abstract,, day-14 fasting serum glucose  and  the 2-hr glucose (Glucose-120 min) after an OGTT  , baseline , Pioglitazone (30 mg/day for 14 days) ,0,
edin,1158,3296686,Significantly decreased,Pioglitazone treatment decreased by day-14 fasting serum glucose (Glucose-0) (mean changeâ=â8.2 mg/dL; Pâ=â0.024) as well as the 2-hr glucose (Glucose-120 min) after an OGTT (mean changeâ=â18.8 mg/dL; Pâ=â0.001) ( Table 4 )., day-14 fasting serum glucose  and  the 2-hr glucose (Glucose-120 min) after an OGTT  , baseline , Pioglitazone (30 mg/day for 14 days) ,0,
edin,1191,3743641,Cannot tell based on the abstract,, mean daily number of moderate to severe hot flushes at week 12 , placebo ," BZA/CE combines bazedoxifene (BZA), a selective estrogen receptor modulator, with conjugated estrogens (CE), ",0,
edin,1191,3743641,Significantly decreased,"At week 12, BZA 20 mg/CE 0.45 mg and BZA 20 mg/CE 0.625 mg were associated with a decrease (P < 0.001) in the adjusted mean daily number of moderate to severe hot flushes, reaching a 74% and a 80% reduction, respectively, representing a clinically meaningful reduction of approximately 7â8 hot flushes per day, compared with a 51% reduction (representing a reduction of approximately five hot flushes per day) in the placebo group (Figure 1).18", mean daily number of moderate to severe hot flushes at week 12 , placebo ," BZA/CE combines bazedoxifene (BZA), a selective estrogen receptor modulator, with conjugated estrogens (CE), ",0,
edin,1075,1562433,No significant difference,"<td colspan=""4""><hr></td>", vastus lateralis longus (VLL) EMG activity , hip abduction at 0Â° and 30Â° , knee extension at 90Â° of flexion ,0,
edin,1038,4588874,Cannot tell based on the abstract,, Serious adverse events , Conventional tobacco cigarette , E-cigarettes  ,0,
edin,1038,4588874,No significant difference,There were no serious adverse events reported and no subjects were discontinued due to AEs., Serious adverse events , Conventional tobacco cigarette , E-cigarettes  ,0,
edin,1126,3611646,Cannot tell based on the abstract,, high density lipoprotein (HDL) , administered Sarkaradi Granules (SG). ," administered with the Granules of Guduchyadi Medhya Rasayana (GMR), which contains Guduchi (Tinospora cordifolia Wild.), Apamarga (Achyranthes aspera Linn.), Vidanga (Embelia ribes Burm. f.), Shankhapushpi (Convolvulus pluricaulis Chois.), Vaca (Acorus calamus Linn.), Haritaki (Terminalia chebula Zetz.), Kushtha (Saussurea lappa C.B. Clarke), Shatavari (Asparagus racemosus Wild.), Cowâs ghee and sugar. ",0,
edin,1126,3611646,Significantly increased,"With regard to the biochemical parameters, Group A showed highly significant decrease (P`0.01) in serum cholesterol, serum triglyceride, low density lipoprotein (LDL), and very low density lipoprotein (VLDL) levels, while high density lipoprotein (HDL) increased highly significantly (P`0.01) and a significant decrease (P`0.05) was found in blood urea (13.80%) as well as serum AChE (3.67%) within normal limits [Table 6].,Group A (Trial Group)
Patients of this group were administered with the Granules of Guduchyadi Medhya Rasayana (GMR), which contains Guduchi (Tinospora cordifolia Wild.), Apamarga (Achyranthes aspera Linn.), Vidanga (Embelia ribes Burm. f.), Shankhapushpi (Convolvulus pluricaulis Chois.), Vaca (Acorus calamus Linn.), Haritaki (Terminalia chebula Zetz.), Kushtha (Saussurea lappa C.B. Clarke), Shatavari (Asparagus racemosus Wild.), Cowâs ghee and sugar.", high density lipoprotein (HDL) , administered Sarkaradi Granules (SG). ," administered with the Granules of Guduchyadi Medhya Rasayana (GMR), which contains Guduchi (Tinospora cordifolia Wild.), Apamarga (Achyranthes aspera Linn.), Vidanga (Embelia ribes Burm. f.), Shankhapushpi (Convolvulus pluricaulis Chois.), Vaca (Acorus calamus Linn.), Haritaki (Terminalia chebula Zetz.), Kushtha (Saussurea lappa C.B. Clarke), Shatavari (Asparagus racemosus Wild.), Cowâs ghee and sugar. ",0,
edin,1057,3787573,No significant difference,"ollowing the interventions, a statistically significant improvement in both groups was observed in all outcomes assessed. For the comparison between the groups, no statistically significant difference was found between the NMES + Ex and the Ex groups in NRS (P = 0.52), TUG test (P = 0.12), and aspects of WOMAC: pain (P = 0.26), function (P = 0.23), and stiffness (P = 0.63).", Numerical Rating Scale , Exercise alone , NMES plus exercise ,0,
edin,1142,3895597,Cannot tell based on the abstract,, the degree of symptom reduction in abdominal pain using symptom diaries from week 1  , octylonium 20 mg , tiropramide 100 ,0,
edin,1142,3895597,Significantly increased,"Furthermore, the degree of symptom reduction in abdominal pain using symptom diaries was higher in the tiropramide group than in the octylonium group from week 1 (P = 0.033).", the degree of symptom reduction in abdominal pain using symptom diaries from week 1  , octylonium 20 mg , tiropramide 100 ,0,
edin,1100,4109867,Cannot tell based on the abstract,, IgM concentrations , basal diet , 2% seamustard ,0,
edin,1100,4109867,No significant difference,The SW supplementation significantly increased (p<0.05) IgG concentrations while IgM concentrations remained unaffected (Table 4)., IgM concentrations , basal diet , 2% seamustard ,0,
edin,1145,5851630,Significantly increased,"However, in the ET+TA treatment, ABP values were greater after exercise, except for Fp1.", absolute beta power (ABP) after exercise , PlaceboâPL , Taurine combined with Ethanol (TA+ET) ,0,
edin,1192,3743641,Cannot tell based on the abstract,, mean proportion of superficial cells , placebo ," BZA/CE combines bazedoxifene (BZA), a selective estrogen receptor modulator, with conjugated estrogens (CE), ",0,
edin,1192,3743641,Significantly increased,BZA 20 mg/CE 0.45 or 0.625 mg showed a significantly greater increase from baseline in the mean proportion of superficial cells compared with placebo (P < 0.001)., mean proportion of superficial cells , placebo ," BZA/CE combines bazedoxifene (BZA), a selective estrogen receptor modulator, with conjugated estrogens (CE), ",0,
edin,1208,4526336,Significantly increased,"Compared to those with normal cognitive function, MCI participants generated a greater proportion of words out of the total number of words during the timed conversation sessions (p=0.01).", proportion of words out of the total number of words , healthy , mild cognitive impairment (MCI) ,0,
edin,1174,4821313,Significantly increased,There was a significant increase in serum creatinine and a decrease in eGFR 48 hr post-intervention in group 1 (short regimen) with no statically difference regarding those parameters group 2 (long regimen)., serum creatinine , sodium bicarbonate solution using the long regimen (initial intravenous bolus of 3 mL/kg/h of 166 mEq/L sodium bicarbonate for 6 hr). , sodium bicarbonate solution using the short regimen (intravenous bolus 3 mL/kg/h of 166 mEq/L sodium bicarbonate for 1 hour immediately before radiocontrast) ,0,
edin,1084,5610854,Cannot tell based on the abstract,, The absolute risk for ?2 lost lines of vision , primary trabeculectomy group 2 , laser peripheral iridotomy (LPI) group 1 ,0,
edin,1084,5610854,No significant difference,The absolute risk for â¥2 lost lines of vision in the trabeculectomy group was 18% (20 of 111) compared to 16% (6 of 38) in the LPI group., The absolute risk for ?2 lost lines of vision , primary trabeculectomy group 2 , laser peripheral iridotomy (LPI) group 1 ,0,
edin,1156,3296686,Significantly increased,"Although Prednisone did increase serum HCV RNA at day-4 (nâ=â10; change from baselineâ=ââ42,786 IU/ml; 95% CI â85,500 to â15,700; Pâ=â0.049), the log10 HCV RNA titers were statistically not different from baseline day-0.", HCV RNA at day-14 , baseline , Pioglitazone (30 mg/day for 14 days) ,0,
edin,1062,5100099,No significant difference,"There were no statistically significant differences on blood pH levels between the two modes of ventilation (7.32âÂ±â0.02 vs. 7.32âÂ±â0.04, Pâ=â0.34).", Blood pH levels , Conventional Ventilation , Neurally Adjusted Ventilatory Assist ,0,
edin,1028,4486943,Cannot tell based on the abstract,, Tobacco abstinence , Standard quitline treatment , Technology Enhanced Quitline-10 and Technology Enhanced Quitline-20 ,0,
edin,1028,4486943,No significant difference,"TableÂ 3
Estimates of abstinence at 6 and 12âmonths, N=1785,<td colspan=""1"" rowspan=""1"">âStandard</td><td colspan=""1"" rowspan=""1"">368</td><td colspan=""1"" rowspan=""1"">66.0 (61.2 to 70.9)</td><td colspan=""1"" rowspan=""1"">368</td><td colspan=""1"" rowspan=""1"">60.6 (55.6 to 65.6)</td><td colspan=""1"" rowspan=""1"">363</td><td colspan=""1"" rowspan=""1"">65.3 (60.4 to 70.2)</td><td colspan=""1"" rowspan=""1"">362</td><td colspan=""1"" rowspan=""1"">61.6 (56.6 to 66.6)</td>,<td colspan=""1"" rowspan=""1"">âStandard plus TEQ-10</td><td colspan=""1"" rowspan=""1"">368</td><td colspan=""1"" rowspan=""1"">69.6 (64.9 to 74.3)</td><td colspan=""1"" rowspan=""1"">368</td><td colspan=""1"" rowspan=""1"">65.2 (60.4 to 70.1)</td><td colspan=""1"" rowspan=""1"">370</td><td colspan=""1"" rowspan=""1"">67.0 (62.2 to 71.8)</td><td colspan=""1"" rowspan=""1"">371</td><td colspan=""1"" rowspan=""1"">63.1 (58.2 to 68.0)</td>,<td colspan=""1"" rowspan=""1"">âDifference compared to standard</td><td colspan=""1"" rowspan=""1""></td><td colspan=""1"" rowspan=""1"">1.3 (â5.6 to 8.2)<break>p=0.7121</break></td><td colspan=""1"" rowspan=""1""></td><td colspan=""1"" rowspan=""1"">0.5 (â6.6 to 7.6)<break>p=0.8947</break></td><td colspan=""1"" rowspan=""1""></td><td colspan=""1"" rowspan=""1"">â2.7 (â10.0 to 4.6)<break>p=0.4655</break></td><td colspan=""1"" rowspan=""1""></td><td colspan=""1"" rowspan=""1"">â5.0 (â12.5 to 2.4)<break>p=0.1871</break></td>", Tobacco abstinence , Standard quitline treatment , Technology Enhanced Quitline-10 and Technology Enhanced Quitline-20 ,0,
edin,1111,4940009,No significant difference,"Overall, the incidence of POM in Group K was significantly less, when compared with Group N (P<0.05), but both groups were comparable based on the grade 2 of POM.", grade 2 of POM ," Group N, the same volume (5 mL) of normal saline was injected "," Group K, 0.5 mg/kg of ketamine was injected intravenously, ",0,
edin,1199,3743641,Cannot tell based on the abstract,, lumbar spine bone mineral density (BMD) , placebo ," BZA/CE combines bazedoxifene (BZA), a selective estrogen receptor modulator, with conjugated estrogens (CE), ",0,
edin,1199,3743641,Significantly increased,"In addition, in SMART-1, a statistically significant increase in lumbar spine BMD from baseline to month 24 was observed for both the BZA 20 mg/CE 0.45 mg and BZA 20 mg/CE 0.625 mg treatment groups compared with a decrease in lumbar spine BMD in the placebo group (P < 0.001).", lumbar spine bone mineral density (BMD) , placebo ," BZA/CE combines bazedoxifene (BZA), a selective estrogen receptor modulator, with conjugated estrogens (CE), ",0,
edin,1203,4280954,Cannot tell based on the abstract,, serum glucose ," received a high-fat diet (40% energy as fat), deficient in ?-linolenic acid (ALA)  "," high-fat diet enriched with ground flaxseed 15 g/100 g of food, rich in ALA; or enriched with vitamin E, 40 mg ?-tocopherol/100 g of food ",0,
edin,1203,4280954,Significantly decreased,The addition of flaxseed or/and vitamin E to the high-fat diet led to significant reductions of serum glucose levels compared with those in the DM group (Table II)., serum glucose ," received a high-fat diet (40% energy as fat), deficient in ?-linolenic acid (ALA)  "," high-fat diet enriched with ground flaxseed 15 g/100 g of food, rich in ALA; or enriched with vitamin E, 40 mg ?-tocopherol/100 g of food ",0,
edin,1193,3743641,Cannot tell based on the abstract,, reduction from baseline in the mean proportion of parabasal cells , placebo ," BZA/CE combines bazedoxifene (BZA), a selective estrogen receptor modulator, with conjugated estrogens (CE), ",0,
edin,1193,3743641,Significantly decreased,Both BZA/CE groups also showed a significantly greater reduction from baseline in the mean proportion of parabasal cells (P < 0.001) and a significantly greater increase from baseline in the mean proportion of intermediate cells (P < 0.05) compared with placebo at weeks 4 and 12., reduction from baseline in the mean proportion of parabasal cells , placebo ," BZA/CE combines bazedoxifene (BZA), a selective estrogen receptor modulator, with conjugated estrogens (CE), ",0,
edin,1129,5936036,Cannot tell based on the abstract,," quality of treatment, the duration and the number of session, or whether their expectations for treatment had been met. ", the SCBT with medication group  , simplified cognitive behavioral therapy (SCBT) on generalized anxiety disorder (GAD) ,0,
edin,1129,5936036,No significant difference,"As stated in Table 1, participants in the SCBT group and SCBT with medication group were not significantly different in satisfaction factors, such as the quality of treatment, the duration and the number of session, or whether their expectations for treatment had been met."," quality of treatment, the duration and the number of session, or whether their expectations for treatment had been met. ", the SCBT with medication group  , simplified cognitive behavioral therapy (SCBT) on generalized anxiety disorder (GAD) ,0,
edin,1025,4486943,Cannot tell based on the abstract,, Programme engagement , Standard quitline treatment , Technology Enhanced Quitline-10 and Technology Enhanced Quitline-20 ,0,
edin,1025,4486943,Significantly increased,"Programme engagement was measured as the number of counselling calls completed by participants:1 planned programme counselling calls,2 participant-initiated inbound calls, or3 IVR-transferred counselling calls (table 2). Overall, the average number of total calls completed was 3.9 (SD=1.7; range 2â19). There was a statistical difference between groups; the TEQ-10 and TEQ-20 groups completed slightly more calls than the standard study group due to the additional IVR-transferred counselling calls they received after a positive screen (p<0.001).", Programme engagement , Standard quitline treatment , Technology Enhanced Quitline-10 and Technology Enhanced Quitline-20 ,0,
edin,1017,5101425,Cannot tell based on the abstract,, Hb levels , Placebo , Desmopressin ,0,
edin,1017,5101425,No significant difference,"A paired T-test revealed that the Hb levels decreased significantly in each group after surgery (P = 0.0001), but the difference was not statistically significant between the groups (0.134).", Hb levels , Placebo , Desmopressin ,0,
edin,1144,4893237,Cannot tell based on the abstract,, mortality in old people with femoral neck fracture. , no comorbidities , pulmonary emboli or cancer or cardiac failure or cardiovascular disease or dementia or dependence in P-ADL ,0,
edin,1144,4893237,Significantly increased,"In this study 13 participants died within 30Â days of sustaining the index hip fracture. T,The participants who died during hospitalization due to a cardiovascular event all had a history of cardiovascular disease. The three participants who died after discharge but within 30Â days of the index hip fracture did so due to a cerebrovascular event, a myocardial infarction and a pulmonary emboli, respectively.", mortality in old people with femoral neck fracture. , no comorbidities , pulmonary emboli or cancer or cardiac failure or cardiovascular disease or dementia or dependence in P-ADL ,0,
edin,1201,3743641,Cannot tell based on the abstract,," risk for serious adverse events, such as venous thromboembolism, cardiovascular events, endometrial cancer, or breast cancer, ", placebo ," BZA/CE combines bazedoxifene (BZA), a selective estrogen receptor modulator, with conjugated estrogens (CE), ",0,
edin,1201,3743641,No significant difference,"No apparent increased risk for serious adverse events, such as venous thromboembolism, cardiovascular events, endometrial cancer, or breast cancer, was observed with either dose strength of BZA/CE."," risk for serious adverse events, such as venous thromboembolism, cardiovascular events, endometrial cancer, or breast cancer, ", placebo ," BZA/CE combines bazedoxifene (BZA), a selective estrogen receptor modulator, with conjugated estrogens (CE), ",0,
edin,1114,3423952,Significantly decreased,"Exercise resulted in increased (P < 0.05) antioxidant defenses including erythrocyte SOD, total glutathione, glutathione peroxidase, gene transcripts for interferon-gamma, interleukin-10, and interleukin-1Î² in blood, and decreased plasma nitric oxide.", plasma nitric oxide , no exercise , exercise ,0,
edin,1022,4895766,Cannot tell based on the abstract,, Healing of diabetic wounds , Betadine ointment , Katupila Kalka with Tila Taila ,0,
edin,1022,4895766,Significantly increased,The strength and positive finding of this study is Katupila Kalka had the potential to cure the diabetic wounds early than Betadine ointment., Healing of diabetic wounds , Betadine ointment , Katupila Kalka with Tila Taila ,0,
edin,1136,4627811,Cannot tell based on the abstract,, Quality of life , continuous training (CT) 12-weeks inpatients NYHA II-III , high-intensity interval training (HIT) for 12-weeks in patients NYHA II-III ,0,
edin,1136,4627811,No significant difference,There was no significant change in the SF-36 total score (Table 5)., Quality of life , continuous training (CT) 12-weeks inpatients NYHA II-III , high-intensity interval training (HIT) for 12-weeks in patients NYHA II-III ,0,
edin,1189,5122238,Cannot tell based on the abstract,," Mean central temperature, Mean peripheral temperature, Mean blood pressure, Mean heart rate ", received normal saline , received 1 mg/kg and 2 mg/kg hydrocortisone ,0,
edin,1189,5122238,No significant difference,Mean central temperature from 0 to 60 min recovery in the three groups (P = 0.64)," Mean central temperature, Mean peripheral temperature, Mean blood pressure, Mean heart rate ", received normal saline , received 1 mg/kg and 2 mg/kg hydrocortisone ,0,
edin,1064,5100099,Significantly increased,"With regard to hemodynamics, systolic arterial pressures were higher using NAVA: +8.4Â % (95Â % CI: +3.3 to +13.6Â %, Pâ=â0.03).", Systolic arterial pressure , Conventional Ventilation , Neurally Adjusted Ventilatory Assist ,0,
edin,1041,5746685,No significant difference,"There was no significant weight rebound from the start of weight loss maintenance to 12 months for either group (mean: basic 1.3%, enhanced 1.5%) and limited change in secondary outcomes for either program.", Weight rebound after 12 months , Basic weight loss maintenance program , Enhanced weight loss maintenance program ,0,
edin,1173,4821313,Cannot tell based on the abstract,, the pH of urine , sodium bicarbonate solution using the long regimen (initial intravenous bolus of 3 mL/kg/h of 166 mEq/L sodium bicarbonate for 6 hr). , sodium bicarbonate solution using the short regimen (intravenous bolus 3 mL/kg/h of 166 mEq/L sodium bicarbonate for 1 hour immediately before radiocontrast) ,0,
edin,1173,4821313,No significant difference,"Regarding the pH of urine, we found that it was (5.95 Â± 0.26) in group 1 and (5.97 Â± 0.24) in group 2, showing no statistical difference and highlighting the fact that both regimen had almost the same alkalinizing efficacy with no proven extra benefit for patients with pH values greater than 6.", the pH of urine , sodium bicarbonate solution using the long regimen (initial intravenous bolus of 3 mL/kg/h of 166 mEq/L sodium bicarbonate for 6 hr). , sodium bicarbonate solution using the short regimen (intravenous bolus 3 mL/kg/h of 166 mEq/L sodium bicarbonate for 1 hour immediately before radiocontrast) ,0,
edin,971,3491047,No significant difference,"No statistical significance (p> 0.05) was observed for long-term adherence (6 to 12 months), and total adherence between the three groups.", Total adherence to the program , Self-directed control (C) , Walking and Behavioural intervention (WB) ,0,
edin,968,5372931,Cannot tell based on the abstract,, 12 (poly)phenol metabolites , nothing , cranberry juices ,0,
edin,968,5372931,Significantly increased,"A positive, linear dose response for total excretion over 24 h of each urinary metabolite was assessed and of the 60 identified metabolites, 12 (poly)phenol metabolites displayed a positive linear dose-response curve (r2 â¥ 0.66) in urine with slopes significantly different from zero (p < 0.05); they were: 2,3-dihydrobenzoic acid (r2 = 0.79), 2,4-dihydrobenzoic acid (r2 = 0.77), dihydrocaffeic-3-O-sulfate (r2 = 0.66), ferulic-O-4-sulfate (r2 = 0.89), o-courmaric acid (r2 = 0.72), quercetin-3-O-Ã-d-glucuronide (r2 = 0.89), 2,5-dihydroxybenzoic acid (r2 = 0.80), chlorogenic acid (r2 = 0.72), p-coumaric acid (r2 = 0.90), sinapic acid (r2 = 0.85), benzoic acid (r2 = 0.99), isoferulic acid (r2 = 0.74).", 12 (poly)phenol metabolites , nothing , cranberry juices ,0,
edin,1157,3296686,Significantly decreased,"Pioglitazone was effective in decreasing serum HCV RNA at day-14 (nâ=â10; difference of meansâ=â205,618 IU/ml; 95% CI 26,600 to 384,600; P<0.001).", HCV RNA at day-14 , baseline , Prednisone (40 mg/day for 4 days) ,0,
edin,1101,4109867,Significantly decreased,Dietary SW significantly reduced meat cholesterol concentration (p<0.05)., Meat cholesterol concentration , basal diet , 2% seamustard ,0,
edin,969,3491047,Significantly increased,Short-term program adherence was greater in WB compared to C (p<0.012) after 3 months., Short-term adherence to the program at 3 months , Self-directed control (C) , Walking and Behavioural intervention (WB) ,0,
edin,1046,4748685,Significantly decreased,"The statistical evaluation of primary measures revealed significant decreases of systolic blood pressure (mean of the differences = â9 mmHg; p = 0.03; 95 % CI = [â17.29, â0.71]), LDL (pseudo-median of the differences = â7.9 mg/dl; p = 0.04; 95 % CI = [â18.5, â0.5]) and triglyceride values (pseudo-median of the differences = â12.5 mg/dl; p = 0.04; 95 % CI = [â26, â0.5]) in the intervention group, while no such changes could be observed in the control group.", Triglyceride levels , Standard care , CAPSYS system ,0,
edin,1089,4082484,Significantly increased,"On the other hand, the consumption of the curry meal increased FMD from 5.2âÂ±â2.5% to 6.6âÂ±â2.0% (Pâ=â0.001), and the postprandial FMD after the curry meal was higher than that after the control meal (Pâ=â0.002).", postprandial FMD , spice-free control meal , single serving of curry meal ,0,
edin,1009,5003313,Cannot tell based on the abstract,, Symptom severity after 4 weeks  , No exercises , Stretching exercises ,0,
edin,1009,5003313,No significant difference,Also the results of t-test show that the changes in the severity of RLS symptoms before intervention and after 4 weeks were not statistically meaningful between intervention and control groups., Symptom severity after 4 weeks  , No exercises , Stretching exercises ,0,
edin,980,5619630,Cannot tell based on the abstract,, Relapse rates , Medication only , Medication plus exercise ,0,
edin,980,5619630,No significant difference,"Relapse rates were also recorded via subjective reports and as a measured increase of >50% from baseline HRSD scores (Neumeister et al, 1997). In total, nine patients relapsed, two from the medication-plus-exercise group (both in week 18) and seven from the medication-only group (one relapse in week 6, two in week 12 and four in week 24). This difference in relapse rates did not reach significance (Fisherâs exact test: one-tailed, P = 0.07; two-tailed, P = 0.14).", Relapse rates , Medication only , Medication plus exercise ,0,
edin,1195,3743641,Cannot tell based on the abstract,, vaginal pH , placebo ," BZA/CE combines bazedoxifene (BZA), a selective estrogen receptor modulator, with conjugated estrogens (CE), ",0,
edin,1195,3743641,Significantly decreased,"Additionally, treatment with BZA 20 mg/CE 0.625 mg resulted in a significantly greater decrease from baseline in vaginal pH (P < 0.001) and a greater improvement in the womenâs most bothersome vulvovaginal atrophy symptoms (P < 0.05) compared with placebo (Figure 4).19", vaginal pH , placebo ," BZA/CE combines bazedoxifene (BZA), a selective estrogen receptor modulator, with conjugated estrogens (CE), ",0,
edin,1202,4280954,Cannot tell based on the abstract,," DM + E group received a high-fat diet enriched with vitamin E, 40 mg ?-tocopherol/100 g of food "," high-fat diet enriched with ground flaxseed 15 g/100 g of food, rich in ALA; "," ceived a high-fat diet (40% energy as fat), deficient in ?-linolenic acid (ALA) ",0,
edin,1202,4280954,Significantly increased,"Serum and liver TBARS, as indices of lipid peroxidation, were significantly increased in the DM group compared with those in the control group, while the addition of flaxseed or a combination of flaxseed and Î±-tocopherol to the high-fat diet of the hamsters with DM significantly decreased these two markers compared with those in the unsupplemented DM group."," DM + E group received a high-fat diet enriched with vitamin E, 40 mg ?-tocopherol/100 g of food "," high-fat diet enriched with ground flaxseed 15 g/100 g of food, rich in ALA; "," ceived a high-fat diet (40% energy as fat), deficient in ?-linolenic acid (ALA) ",0,
edin,993,3074545,Cannot tell based on the abstract,, Depression mean scores , Non-mentored group , Non-professional mentor support ,0,
edin,993,3074545,No significant difference,"Observed reduction in depression mean scores from 15.0 to 8.9 in the intervention arm compared favourably with non-mentored women (12.9 to 9.9), but the adjusted difference (AdjDiff) of -1.90, 95% CI -4.12 to 0.32, did not reach conventional statistical significance.", Depression mean scores , Non-mentored group , Non-professional mentor support ,0,
edin,1250,5225191,Cannot tell based on the abstract,, GASE-AD (antidepressant-specific side effects) , placebo pill , amitriptyline ,0,
edin,1250,5225191,Significantly increased,"After evocation, participants who underwent the conditioning procedure with amitriptyline reported significantly more antidepressant-specific side effects than those who never received amitriptyline, even though both groups received a placebo.", GASE-AD (antidepressant-specific side effects) , placebo pill , amitriptyline ,0,
edin,1321,5494586,Significantly decreased,"P300 latency tended to decrease following each of the three breakfasts, but B3 was the only breakfast capable to elicit a statistically significant reduction in P300 latency with respect to A (p < 0.01), suggesting ameliorated cognitive performance. Such amelioration was correlated with the 2-hour final inhibition of plasma ghrelin concentration (r = 0.61, p = 0.01).,In a randomized crossover design, 12 healthy individuals (6M/6F; BMI 22.2âÂ±â0.4âkg/m2; 27âÂ±â1.3 years, meanâÂ±âSEM) underwent 50âg OGTT (A) and 3 breakfasts (B1: milk and cereals; B2: milk, apple, and chocolate cream-filled sponge cake; B3: milk, apple, bread, and hazelnut chocolate cream) to assess plasma glucose-, insulin-, and ghrelin excursions.", the 2-hour plasma ghrelin , 50?g OGTT  (A) ," 3 breakfasts (B1: milk and cereals; B2: milk, apple, and chocolate cream-filled sponge cake; B3: milk, apple, bread, and hazelnut chocolate cream) ",0,
edin,1306,5789132,Cannot tell based on the abstract,, The mean pain score using FRS scale ,  receive the injection with conventional syringe , receive the injection with diabetic needle ,0,
edin,1306,5789132,Significantly decreased,"The mean pain score using FRS scale for 26 gauge conventional syringe was found to be 3.25, whereas mean pain score for 30 gauge insulin syringe was found to be 1.35 (Table 1). The mean difference found was statistically significant (p = 0.05).", The mean pain score using FRS scale ,  receive the injection with conventional syringe , receive the injection with diabetic needle ,0,
edin,1293,3636800,No significant difference,"Although there were no significant differences in participantsâ quantitative feedback for the two delivery modalities, most participants reported preferring the native smartphone application (67%; n=16) and found it easier to use (71%; n=16). 33% of participants reported that they would be willing to complete mobile phone assessment for 5 weeks or longer.", the total quantitative feedback score , completing 6 days of assessment (four sets of questions per day) with the SMS text-only implementation , completing 6 days of assessment (four sets of questions per day) with a native smartphone application ,0,
edin,586,4819709,Cannot tell based on the abstract,, Standing still for a long time (&gt;â15 min ) without discomfort , surgery , Ultrasoundâguided foam sclerotherapy ,0,
edin,586,4819709,Significantly increased,"<td align=""center"" colspan=""1"" rowspan=""1"" valign=""top"">90</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""top"">15Â·8</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""top"">28Â·7</td>,Participants randomized to UGFS recalled being able to carry out 13 of the 15 behaviours significantly more quickly than those randomized to surgery (Table â 2 ). The two behaviours for which there was no evidence of a difference in the time to recover between the trial arms were âhaving a bath or showerâ and âwearing clothes that show the legsâ.", Standing still for a long time (&gt;â15 min ) without discomfort , surgery , Ultrasoundâguided foam sclerotherapy ,0,
edin,1223,3917123,Cannot tell based on the abstract,, Fatigue score in the sensory dimension , Placebo , Acupressure ,0,
edin,1223,3917123,Significantly decreased,"ost-hoc Duncan test showed that mean reduction of total fatigue score and mean reduction of fatigue scores in sensory and cognitive dimensions in the study group were more than in the placebo group, and they were more in the placebo group compared to the control group (P < 0.05).", Fatigue score in the sensory dimension , Placebo , Acupressure ,0,
edin,1213,5397544,Cannot tell based on the abstract,, Maximum amplitude values , Low-molecular-weight heparin only before the surgery , Low-molecular-weight heparin before and after the surgery ,0,
edin,1213,5397544,No significant difference,There were no significant changes in Î±-angle and maximum amplitude values during or after laparoscopic fundoplication in both groups (Tables IV and V)., Maximum amplitude values , Low-molecular-weight heparin only before the surgery , Low-molecular-weight heparin before and after the surgery ,0,
edin,1343,5320660,Cannot tell based on the abstract,, Mean overall satiety score , muffins enriched with 0 g HAM-RS2 (control) , muffins enriched with 30 g HAM-RS2 ,0,
edin,1343,5320660,No significant difference,Mean overall satiety score did not differ within or between groups (Pâ=â0.230)., Mean overall satiety score , muffins enriched with 0 g HAM-RS2 (control) , muffins enriched with 30 g HAM-RS2 ,0,
edin,1279,5928476,Significantly decreased,SureFil SDR and EverX Posterior bulk-fill composite resinsâ bond strengths were significantly higher than ProRoot MTA and Biodentine calcium silicate cements., bulk-fill composite resinsâ bond strengths , ProRoot MTA or Biodentine calcium silicate cements , SureFil SDR or EverX Posterior bulk-fill composite resinsâ bond ,0,
edin,724,2600646,Cannot tell based on the abstract,, mean Hb , dihydroartemisinin-piperaquine (AP) , arthemeter-lumefantrine (AL)  ,0,
edin,724,2600646,No significant difference,Final mean Hb levels were 7.15 mmol/l Â± 1.07 for the DP treatment group and 6.79 mmol/l Â± 1.24 for the AL group. A possible influence of anaemia on gametocyte carriage at enrollment was not observed in the present study (p > 0.05)., mean Hb , dihydroartemisinin-piperaquine (AP) , arthemeter-lumefantrine (AL)  ,0,
edin,1238,5228611,Cannot tell based on the abstract,, quantitative proteinuria (urine protein-to-creatinine ratio) and tubular proteinuria (retinol binding protein-to-creatinine ratio and beta 2 microglobulin-to-creatinine ratio) , stay on their baseline regimen , elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide (E/C/F/TAF) 150/150/200/10 mg plus DRV 800 mg (Janssen) once daily ,0,
edin,1238,5228611,Significantly decreased,Participants in the E/C/F/TAF plus DRV group had statistically significant declines in both measures of quantitative proteinuria (urine protein-to-creatinine ratio) and tubular proteinuria (retinol binding protein-to-creatinine ratio and beta 2 microglobulin-to-creatinine ratio) at week 48 vs. increases in the baseline regimen group (Fig. 4)., quantitative proteinuria (urine protein-to-creatinine ratio) and tubular proteinuria (retinol binding protein-to-creatinine ratio and beta 2 microglobulin-to-creatinine ratio) , stay on their baseline regimen , elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide (E/C/F/TAF) 150/150/200/10 mg plus DRV 800 mg (Janssen) once daily ,0,
edin,1219,5741263,Significantly increased,"In contrast to the reported positive effects of training on writing size, the current results showed increases in stroke duration and normalized jerk after amplitude training, which were absent in the placebo group.", Stroke duration , Placebo , Amplitude training ,0,
edin,637,2206488,Significantly decreased,"In group A, lower peak (median) plasma levels of procalcitonin (0.2 versus 1.4, p < 0.001), IL 8 (5.6 versus 94.8, p < 0.001), IL 10 (47.2 versus 209.7, p = 0.001), endothelial leukocyte adhesion molecule-1 (88.5 versus 130.6, p = 0.033), intercellular adhesion molecule-1 (806.7 versus 1,375.7, P = 0.001) and troponin-I (0.22 versus 0.66, p = 0.018) were found."," Procalcitonin, IL 8, IL 10, endothelial leukocyte adhesion molecule-1, intercellular adhesion molecule-1, troponin-I ", identical amounts of gelatin infusion , dextran-70 infusion was administered at a dose of 7.5 ml/kg before the initiation of cardiopulmonary bypass and at a dose of 12.5 ml/kg after the cessation of cardiopulmonary bypass ,0,
edin,1243,3466198,Significantly decreased,The median vaginal and cervical pH was significantly lower 2 hours after application of Acidform and was associated with an increase in the bactericidal activity of CVL against E. coli., The median vaginal and cervical pH , hydroxyethylcellulose (HEC) placebo gel twice daily for 14 consecutive days , Acidform twice daily for 14 consecutive days ,0,
edin,1278,3585965,Cannot tell based on the abstract,, the rate of absorption of methotrexate , GLPG0259  , GLPG0259 and methotrexate ,0,
edin,1278,3585965,No significant difference,"When methotrexate was co-administered with GLPG0259 50 mg, the rate of absorption of methotrexate was slightly but not statistically significantly decreased, with a point estimate for Cmax of 89.63% (figure 3, table IV).", the rate of absorption of methotrexate , GLPG0259  , GLPG0259 and methotrexate ,0,
edin,1264,3933059,Significantly decreased,Comparison of pre- vs. post-trial values revealed a significant reduction in both SBP (7%; P = 0.013) and DBP (6%; P < 0.010).," Systolic blood pressure (SBP), diastolic blood pressure (DBP) ", baseline , Pomegranate juice (PJ) ,0,
edin,1304,5451423,Cannot tell based on the abstract,," Cmax, Tmax, t1/2, elimination rate constant, AUC0-t and AUC0-inf ", empagliflozin after administration to Egyptian volunteers , empagliflozin after administration to Japanese and Chinese subjects ,0,
edin,1304,5451423,No significant difference,"<td>AUC<sub>0-inf</sub> (nMol.h/L), MeanâÂ±âS.D. (% C.V.)</td><td>4103âÂ±â427 (10.41)</td>,No clinically meaningful interactions were observed when EG was co-administered with other commonly used medicinal products and no dose adjustment was recommended"," Cmax, Tmax, t1/2, elimination rate constant, AUC0-t and AUC0-inf ", empagliflozin after administration to Egyptian volunteers , empagliflozin after administration to Japanese and Chinese subjects ,0,
edin,1285,4132637,No significant difference,"Regardless of revascularization or not, ticagrelor consistently reduced the primary outcome (HR 0.86 vs. 0.85, interaction P = 0.93), and all-cause death (HR 0.75 vs. 0.73, interaction P = 0.89) with no significant increase in overall major bleeding.", All-cause death , clopidogrel , ticagrelor ,0,
edin,1269,3655855,Cannot tell based on the abstract,," central pulse wave velocity, augmentation index, aortic systolic blood pressure, BMI, waist, total cholesterol, serum glucose, IL-8, and IL-10,CRP  ", safflower oil placebo for 4 weeks , 1.7 g of Long chain omega-3 fatty acids from fish oils (O3) per day for 4 weeks ,0,
edin,1269,3655855,No significant difference,"<td align=""left"">CRP (nmol/L)</td><td align=""center"">20.7</td><td align=""left"">21.8</td><td align=""center"">17.3</td><td align=""left"">18.7</td><td align=""left"">+0.12</td><td align=""left"">0.34</td><td align=""left"">0.53</td>,The effects of supplementation on components of the metabolic syndrome, plasma lipids, vascular measures, and cytokines are shown in TableÂ 3. The daily treatment dose of 1.7Â g of O3 for four weeks had no effect on any of these measures compared to the safflower placebo. Not shown are BMI, waist, total cholesterol, serum glucose, IL-8, and IL-10, all of which also showed no effect."," central pulse wave velocity, augmentation index, aortic systolic blood pressure, BMI, waist, total cholesterol, serum glucose, IL-8, and IL-10,CRP  ", safflower oil placebo for 4 weeks , 1.7 g of Long chain omega-3 fatty acids from fish oils (O3) per day for 4 weeks ,0,
edin,1267,4709985,Cannot tell based on the abstract,, would have liked more information on acupuncture , other educations , tertiary education ,0,
edin,1267,4709985,Significantly increased,"The role of educational status was examined in response these questions and we found women with tertiary education would have liked more information on acupuncture (pâ<â0.009), no other associations were found.", would have liked more information on acupuncture , other educations , tertiary education ,0,
edin,702,3187863,Cannot tell based on the abstract,, Pain relief: Acupuncture , Normal unit &amp; Special unit , Midwife-led unit ,0,
edin,702,3187863,Significantly increased,"The women randomised to the MU had acupuncture in 55.1% of the cases, a significantly higher rate compared with those randomised to the NU (37.9%; RR 1.45, 95% CI 1.25â1.69) and SU (37.9%; RR 1.45, 95% CI 1.22â1.73) (Table 2).", Pain relief: Acupuncture , Normal unit &amp; Special unit , Midwife-led unit ,0,
edin,1342,5320660,Significantly decreased,"Within the HAM-RS2 group, the area under the curve (AUC) glucose (Pâ=â0.028), AUC leptin (Pâ=â0.022), and postprandial 120-min leptin (Pâ=â0.028) decreased independent of changes in body composition or overall energy intake at the end of 6Â weeks."," glucose, AUC leptin, and postprandial 120-min leptin ", muffins enriched with 0 g HAM-RS2 (control) , muffins enriched with 30 g HAM-RS2 ,0,
edin,1301,3924124,Cannot tell based on the abstract,, CD4/8 , received only general health guidance. ," 2-hour program comprising comprehensive health education and hot spa bathing, offered once every 2 weeks, in addition to individualized programs once a week, for 24 weeks ",0,
edin,1301,3924124,Significantly increased,"Significant (P < 0.05) interaction was observed for the secondary outcome measure CD4/8, which was used to represent participants' immunological function.,Significant (P < 0.05) effects were observed in CD4+ and CD4/8, which were maintained in the high adherence group, but tended to decrease in the low adherence and control groups", CD4/8 , received only general health guidance. ," 2-hour program comprising comprehensive health education and hot spa bathing, offered once every 2 weeks, in addition to individualized programs once a week, for 24 weeks ",0,
edin,1310,3258678,Significantly decreased,These adjusted models showed a trend toward a treatment effect for ADAS-cog (P = 0.098) and indicated significantly less HV loss for tramiprosate 100 mg (P = 0.035) and 150 mg (P = 0.009) compared to placebo., hippocampus volume (HV) change , 78-week treatment with placebo , 78-week treatment with tramiprosate 150 mg BID ,0,
edin,1331,4716419,No significant difference,"Composites of unfavourable outcomes (death, doubling of serum creatinine, non-remission and intolerance to treatment) were 46.9% and 37% in CYC and EC-MPS (risk difference=9.84; p=0.44)."," Composites of unfavourable outcomes (death, doubling of serum creatinine, non-remission and intolerance to treatment) ",  intravenous cyclophosphamide (CYC) 0.5â1?g/m2 monthly , enteric-coated mycophenolate sodium (EC-MPS) 1440?mg/day for first 6?months ,0,
edin,820,5294349,Cannot tell based on the abstract,, datasets of 3D coordinates , 2â4 stereo radiograph pair examinations , CT scan ,0,
edin,820,5294349,Invalid Prompt,, datasets of 3D coordinates , 2â4 stereo radiograph pair examinations , CT scan ,1," No datasets of 3D coordinates or anything similar was mentioned in results, discussion or conclusion section of the article. "
edin,768,3108665,Cannot tell based on the abstract,, Postoperative complications , No medication was given to the control group , somatostatin ,0,
edin,768,3108665,Significantly decreased,"Finally, with the help of logistic regression we concluded that the patients who did not receive somatostatin (control group) had a 6.2 times higher probability of developing complications than the treatment group.", Postoperative complications , No medication was given to the control group , somatostatin ,0,
edin,1292,5551214,Cannot tell based on the abstract,," Childhood Autism Rating Scale, Second Edition (CARS2) ", control group , horse riding intervention ,0,
edin,1292,5551214,Significantly decreased,"There was a significant interaction effect between pre- to post-test change in CARS2 scores and intervention condition (F(1, 22) = 7.219, p = 0.013, r = 0.5).,Whilst the control group had the same mean CARS2 scores at pre-test and post-test (42.61), the intervention groupâs mean score was significantly lower at post-test (40.05) than at pre-test (40.95) (Figure 1)."," Childhood Autism Rating Scale, Second Edition (CARS2) ", control group , horse riding intervention ,0,
edin,1322,5494586,Significantly decreased,"P300 latency tended to decrease following each of the three breakfasts, but B3 was the only breakfast capable to elicit a statistically significant reduction in P300 latency with respect to A (p < 0.01), suggesting ameliorated cognitive performance.", P300 latency incremental values , 50?g OGTT  (A) ," B3: milk, apple, bread, and hazelnut chocolate cream ",0,
edin,1322,5494586,Significantly decreased,"P300 latency tended to decrease following each of the three breakfasts, but B3 was the only breakfast capable to elicit a statistically significant reduction in P300 latency with respect to A (p < 0.01),", P300 latency incremental values , 50?g OGTT  (A) ," B3: milk, apple, bread, and hazelnut chocolate cream ",0,
edin,1255,4864053,Cannot tell based on the abstract,, mean decrease in [11C]Ro15?4513 BP , placebo (starch) ," MSD, 100 mg l?dopa plus 25 mg carbidopa ",0,
edin,1255,4864053,Significantly decreased,"For a composite gray matter region, a oneâsample tâtest showed that lâdopa was associated with an 11% mean decrease in [11C]Ro15â4513 BP (tÂ =Â â2.29, 9 degrees of freedom, PÂ =Â 0.048).", mean decrease in [11C]Ro15?4513 BP , placebo (starch) ," MSD, 100 mg l?dopa plus 25 mg carbidopa ",0,
edin,1298,5951568,Cannot tell based on the abstract,, Overall pain scores , control , provided with written information about the electrodiagnostic testing ,0,
edin,1298,5951568,No significant difference,Overall pain scores between the intervention (20.91Â±2.33mm) and non-intervention group (25.30Â±2.44mm) in the NCS cohort did not differ significantly (p = 0.15)., Overall pain scores , control , provided with written information about the electrodiagnostic testing ,0,
edin,1271,4401879,No significant difference,"Serumlevels of fasting blood sugar, insulin and homeostatic model assessment of insulin resistance slightly decreased in zinc group, but these changes were not statistically significant."," fasting blood sugar, insulin and homeostatic model assessment of insulin resistance ", placebo for eight consecutive weeks , 30mg/day zinc gluconate for eight consecutive weeks ,0,
edin,734,2720945,Cannot tell based on the abstract,, Side effects , placebo , cineole ,0,
edin,734,2720945,No significant difference,"All patients receiving the study medication (including those with FEV1/VC > 0.7) were included in the safety examination. During treatment side effects were seen in 22 patients whereas in 17 cases adverse events were not related to the study medication. In the placebo group 11 adverse events were estimated not being related to the study medication whereas 2 cases were interpreted as being related to the study medication (heartburn). During treatment with cineole 9 cases of adverse events were reported whereas 6 adverse events were reported not being related to the study medication. In 3 patients (nausea, diarrhoea, heartburn) the adverse events were estimated being related to the study medication. The difference between the two treatment groups was neither clinically relevant nor statistically significant.", Side effects , placebo , cineole ,0,
edin,1226,4996255,Significantly increased,"Across the two Phase IIIa active comparator studies, patients consistently stated a preference for the Elliptaâ¢ DPI over HandiHalerÂ® regarding the number of steps to use (59% vs 17%), time taken to use (62% vs 14%), and ease of use (63% vs 15%) regardless of which inhaler contained active drug."," the number of steps to use, time taken to use and ease of use ", HandiHalerÂ® , Elliptaâ¢ DPI ,0,
edin,1240,5228611,Cannot tell based on the abstract,, HIV-1 RNA &amp;lt;50 copies per mililiter at week 24; , stay on their baseline regimen , elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide (E/C/F/TAF) 150/150/200/10 mg plus DRV 800 mg (Janssen) once daily ,0,
edin,1240,5228611,No significant difference,E/C/F/TAF plus DRV was noninferior to baseline regimens for the primary outcome (HIV-1 RNA <50 copies per mililiter at week 24; FDA-snapshot algorithm) using the full analysis set (96.6% vs. 91.3%; difference 5.3%; 95.001% CI: â3.4% to 17.4%) (Fig. 3)., HIV-1 RNA &amp;lt;50 copies per mililiter at week 24; , stay on their baseline regimen , elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide (E/C/F/TAF) 150/150/200/10 mg plus DRV 800 mg (Janssen) once daily ,0,
edin,1265,3933059,No significant difference,"However, changes in FMD (20%) as well as circulating levels of CRP, ICAM-1, VCAM-1, E-selectin, and IL-6 did not reach statistical significance (P = 0.172).", flow-mediated dilation (FMD) , baseline , Pomegranate juice (PJ) ,0,
edin,1312,3258678,Significantly increased,These adjusted models showed a trend toward a treatment effect for ADAS-cog (P = 0.098) and indicated significantly less HV loss for tramiprosate 100 mg (P = 0.035) and 150 mg (P = 0.009) compared to placebo., Alzheimer Disease Assessment Scale â cognitive subscale (ADAS-cog) , 78-week treatment with placebo , 78-week treatment with tramiprosate 100 mg or tramiprosate 150 mg BID ,0,
edin,1281,4132637,Cannot tell based on the abstract,, The incidence of the primary composite endpoint , clopidogrel , ticagrelor ,0,
edin,1281,4132637,Significantly decreased,"The incidence of the primary composite endpoint was reduced with ticagrelor vs. clopidogrel (10.0 vs. 12.3%; HR 0.83; 95% CI = 0.74â0.93; P = 0.0013) (see Supplementary material online, Figure S1A).", The incidence of the primary composite endpoint , clopidogrel , ticagrelor ,0,
edin,1319,5494586,Cannot tell based on the abstract,, glucose incremental peaks , 50?g OGTT  (A) ," 3 breakfasts (B1: milk and cereals; B2: milk, apple, and chocolate cream-filled sponge cake; B3: milk, apple, bread, and hazelnut chocolate cream) ",0,
edin,1319,5494586,Significantly decreased,"As for the comparison among the incremental peak values of glycemia (Figure 1(a), 1(b), and 1(c)), the repeated measures ANOVA with Greenhouse-Geisser correction resulted significant (p < 0.001) and the Tukey-Kramer post hoc test revealed that B1 (36.2âÂ±â3.8âmg/dL), B2 (19.6âÂ±â2.9âmg/dL), and B3 (27.3âÂ±â4.0âmg/dL) had significantly smaller glucose incremental peaks than A (55.9âÂ±â6.1âmg/dL) with p values associated to such post hoc comparisons that were p = 0.04, p < 0.001, and p = 0.002, respectively.", glucose incremental peaks , 50?g OGTT  (A) ," 3 breakfasts (B1: milk and cereals; B2: milk, apple, and chocolate cream-filled sponge cake; B3: milk, apple, bread, and hazelnut chocolate cream) ",0,
edin,1291,5551214,Cannot tell based on the abstract,, the Aberrant Behaviour Checklist-Community Edition (ABC-C) , control group , horse riding intervention ,0,
edin,1291,5551214,No significant difference,"No significant Spearmanâs correlations were found between change and baseline scores on the CARS2, nor between change and baseline scores on the Hyperactivity subscale of the ABC-C.,The mixed ANOVA for the Irritability subscale of the ABC-C found no significant main or interaction effects (Table 2).", the Aberrant Behaviour Checklist-Community Edition (ABC-C) , control group , horse riding intervention ,0,
edin,710,4106715,Cannot tell based on the abstract,, Prolonged abstinence from smoking rates to 12 months , placebo , low Ab group ,0,
edin,710,4106715,No significant difference,"Subjects with high Ab were also significantly more likely to be abstinent for 12 months compared to placebo (18.0% vs. 6.0%, p=0.014; OR of 3.84; 95% CI, 1.32â11.20). The low Ab group did not differ significantly from placebo (7.1% vs. 6.0%, p=0.67).", Prolonged abstinence from smoking rates to 12 months , placebo , low Ab group ,0,
edin,1253,3172326,Significantly increased,The interval time for the first analgesic request was 23.1 Â± 6.7 minutes for the case group and 18.1 Â± 7.3 minutes for the control (P = 0.02)., The interval time for the first analgesic request , 0.5 mg/kg of normal saline was injected , received 0.5 mg/kg of ketamine IV 10 minutes before the surgical incision ,0,
edin,548,2666722,Cannot tell based on the abstract,, the risk of SARS infection , health care workers without IgG against Severe acute respiratory syndrome , health care workers with IgG against Severe acute respiratory syndrome ,0,
edin,548,2666722,Invalid Prompt,, the risk of SARS infection , health care workers without IgG against Severe acute respiratory syndrome , health care workers with IgG against Severe acute respiratory syndrome ,1," Health care workers with IgG are only mentioned in methods section where groups are explained. In the results section IgG is not mentioned, there only higher risk of infection for workers working on the frontline"
edin,1340,4012222,Cannot tell based on the abstract,, Global performance status and STS , baseline , lower limb neuromuscular electrical stimulation (NMES) applied daily to both quadriceps muscles for six weeks. ,0,
edin,1340,4012222,No significant difference,"Global performance status and STS appeared somewhat better, but these changes did not achieve statistical significance (Fisherâs exact test p =â0.15 comparing categories of PS; mean reduction in STSâ=ââ1.2s, Pâ=â0.3).", Global performance status and STS , baseline , lower limb neuromuscular electrical stimulation (NMES) applied daily to both quadriceps muscles for six weeks. ,0,
edin,1320,5494586,Cannot tell based on the abstract,,  insulin excursions  , 50?g OGTT  (A) ," 3 breakfasts (B1: milk and cereals; B2: milk, apple, and chocolate cream-filled sponge cake; B3: milk, apple, bread, and hazelnut chocolate cream) ",0,
edin,1320,5494586,Significantly decreased,"All three commercial breakfasts showed somewhat smaller insulin excursions with respect to the one elicited by glucose administration (Figure 2(a), 2(b), and 2(c)).",  insulin excursions  , 50?g OGTT  (A) ," 3 breakfasts (B1: milk and cereals; B2: milk, apple, and chocolate cream-filled sponge cake; B3: milk, apple, bread, and hazelnut chocolate cream) ",0,
edin,1280,5928476,No significant difference,"SureFil SDR and EverX Posterior bulk-fill composite resinsâ bond strengths were significantly higher than ProRoot MTA and Biodentine calcium silicate cements. However, no statistically significant differences were observed between bulk-fill composite resins values and calcium silicate cement values.", bulk-fill composite resin values and calcium silicate cement values , ProRoot MTA or Biodentine calcium silicate cements , SureFil SDR or EverX Posterior bulk-fill composite resinsâ bond ,0,
edin,1245,3466198,Significantly decreased,"While there was no increase in inflammatory cytokines or chemokines, CVL concentrations of lactoferrin and interleukin-1 receptor antagonist (IL-1ra), an anti-inflammatory protein, were significantly lower following Acidform compared to HEC placebo gel application."," CVL concentrations of lactoferrin and interleukin-1 receptor antagonist (IL-1ra), an anti-inflammatory protein, ", hydroxyethylcellulose (HEC) placebo gel twice daily for 14 consecutive days , Acidform twice daily for 14 consecutive days ,0,
edin,1335,5673730,Significantly decreased,Significant numbers of babies were delivered after 38 weeks of pregnancy in Group-B (P=0.021)., numbers of babies were delivered after 38 weeks of pregnancy , insulin 0.8-0.9 mg/kg/day in two divided doses subcutaneously (Group-B) , oral metformin 500 mg TDS (Group-A) ,0,
edin,1325,5236513,Significantly increased,"At the end of supplementation period, stool consistency in the Active group of the ITT population was significantly improved and classified as ânormalâ compared to Placebo (respectively 3.13 Â± 1.197 a.u. vs 2.58 Â± 1.020 a.u., P = 0.0003).", stool consistency , placebo , Saccharomyces cerevisiae (S. cerevisiae) CNCM I-3856 ,0,
edin,1237,5228611,Cannot tell based on the abstract,, eGFR , stay on their baseline regimen , elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide (E/C/F/TAF) 150/150/200/10 mg plus DRV 800 mg (Janssen) once daily ,0,
edin,1237,5228611,No significant difference,There were no differences between the 2 groups in median changes from baseline in eGFR (week 48: +7.4 mL/min vs. +3.9 mL/min; P = 0.18)., eGFR , stay on their baseline regimen , elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide (E/C/F/TAF) 150/150/200/10 mg plus DRV 800 mg (Janssen) once daily ,0,
edin,1344,5320660,Cannot tell based on the abstract,, The mean score for the question âhow full do you feel?â , muffins enriched with 0 g HAM-RS2 (control) , muffins enriched with 30 g HAM-RS2 ,0,
edin,1344,5320660,No significant difference,The mean score for the question âhow full do you feel?â in the HAM-RS2 group increased from baseline to the end of the study and approached significance (Pâ=â0.058) (data not shown)., The mean score for the question âhow full do you feel?â , muffins enriched with 0 g HAM-RS2 (control) , muffins enriched with 30 g HAM-RS2 ,0,
edin,1252,3172326,Significantly decreased,"For all of the evaluated times, the VAS score was significantly lower in the ketamine group compared to the control.", visual analogue scale (VAS). , 0.5 mg/kg of normal saline was injected , received 0.5 mg/kg of ketamine IV 10 minutes before the surgical incision ,0,
edin,1287,4132637,Significantly increased,"Major bleeding rate was similar between treatment groups (13.4 vs. 12.6%; HR 1.07; 95% CI = 0.95â1.19), but ticagrelor was associated with an increase in non-CABG major bleeding (4.8 vs. 3.8%; HR 1.28; 95% CI = 1.05â1.56).", non-CABG-related major bleeding , clopidogrel , ticagrelor ,0,
edin,1233,5506592,Significantly decreased,"In 2012, after the intervention, the proportion of households who purchased anti-mosquito products in the last month was significantly lower in intervention clusters (47.8%; 2503/5293) than in control clusters (53.3%; 2707/5079) (differenceÂ âÂ 0.05, 95% CIca â0.100 to â0.010).", the proportion of households who purchased anti-mosquito products in the last month , baseline , education and mobilisation activities ,0,
edin,654,1468428,Invalid Prompt,, You must have prompts generated from different sections. , 2 , 1 ,1, There is no question 
edin,1333,3917204,Cannot tell based on the abstract,, Clinical improvement in multi-rooted teeth  , received scaling and root planing with hand instruments , received treatment with rotary instruments ,0,
edin,1333,3917204,No significant difference,Clinical improvement was noticed in both moderately deep pocket sites and deep pocket areas. But comparison of groups showed them to be statistically nonsignificant [Tables 4 and 5]., Clinical improvement in multi-rooted teeth  , received scaling and root planing with hand instruments , received treatment with rotary instruments ,0,
edin,791,125315,Cannot tell based on the abstract,, The 28-day mortality , received only standard therapy for sepsis , received standard therapy for sepsis and physiological-dose steroid therapy for 10 days; ,0,
edin,791,125315,No significant difference,There were eight deaths (40%) in the steroid therapy group and 12 (60%) deaths in the standard therapy group (P = 0.343)., The 28-day mortality , received only standard therapy for sepsis , received standard therapy for sepsis and physiological-dose steroid therapy for 10 days; ,0,
edin,1303,5451423,Cannot tell based on the abstract,," Cmax, Tmax, t1/2, elimination rate constant, AUC0-t and AUC0-inf ", empagliflozin after administration to Egyptian volunteers , empagliflozin after administration to German subjects ,0,
edin,1303,5451423,No significant difference,"<td>AUC<sub>0-inf</sub> (nMol.h/L), MeanâÂ±âS.D. (% C.V.)</td><td>4103âÂ±â427 (10.41)</td>,The calculated pharmacokinetic parameters were closely related to previous studies conducted in white German subjects using 25âmg EG. The insignificant difference in ANOVA statistical results (TableÂ 2) of the pharmacokinetic evaluation in Egyptians and white German subjects13, 15, 20, 38 suggests that no dose adjustment should be considered with administration of 25âmg EG to Egyptian population.Table 2"," Cmax, Tmax, t1/2, elimination rate constant, AUC0-t and AUC0-inf ", empagliflozin after administration to Egyptian volunteers , empagliflozin after administration to German subjects ,0,
edin,1225,3917123,Cannot tell based on the abstract,, Fatigue score in the sensory dimension , Placebo , Routine unit care ,0,
edin,1225,3917123,Significantly increased,"Post-hoc Duncan test showed that mean reduction of total fatigue score and mean reduction of fatigue scores in sensory and cognitive dimensions in the study group were more than in the placebo group, and they were more in the placebo group compared to the control group (P < 0.05).", Fatigue score in the sensory dimension , Placebo , Routine unit care ,0,
edin,1364,4365564,Cannot tell based on the abstract,, Complications related to approach method , ALIF with BAK cages , CharitÃÂ© artificial disc ,0,
edin,1364,4365564,No significant difference,"The rate of approach-related complications in all 304 patients was 9.9% (30/304) and was similar between the 2 groups, with 9.8% (20/205) in the investigational group and 10.1% (10/99) in the control group (Table 2).,<td align=""left"" colspan=""1"" rowspan=""1"">Retrograde ejaculation, no. (%)<xref ref-type=""table-fn"" rid=""TF0002"">a</xref></td><td align=""center"" colspan=""1"" rowspan=""1"">3 (3.3)</td><td align=""center"" colspan=""1"" rowspan=""1"">3 (5.5)</td><td align=""center"" colspan=""1"" rowspan=""1"">.515</td>", Complications related to approach method , ALIF with BAK cages , CharitÃÂ© artificial disc ,0,
edin,1471,4367028,Cannot tell based on the abstract,, PACU stay , Trendelenburg (TBG) tilt &amp;lt;30ÃÂ° , Trendelenburg (TBG) tilt &amp;gt;30ÃÂ° ,0,
edin,1471,4367028,Significantly increased,Again PACU stay was longer (P < 0.05) in TBG >30Â° group compared to TBG <30Â° group [Table 6]., PACU stay , Trendelenburg (TBG) tilt &amp;lt;30ÃÂ° , Trendelenburg (TBG) tilt &amp;gt;30ÃÂ° ,0,
edin,1420,2361654,Cannot tell based on the abstract,, colposcopy referrals (sensitivity?) , cytological screening , primary hrHPV screening ,0,
edin,1420,2361654,Significantly increased,"Compared with the conventional arm, clearly more colposcopy referrals were made in the hrHPV screening arm (RR 1.51, CI 95% 1.03â2.22).", colposcopy referrals (sensitivity?) , cytological screening , primary hrHPV screening ,0,
edin,1498,3846239,Significantly decreased,The analgesic requirement was significantly lower in the B+D group compared with the B group., The analgesic requirement , bupivacaine  , bupivacaine plus dexamethasone  ,0,
edin,1515,2361520,Cannot tell based on the abstract,, time to disease progression or survival , receive delayed treatment , receive immediate treatment ,0,
edin,1515,2361520,No significant difference,The time to disease progression from randomisation to after chemotherapy was similar in the immediate- and delayed-treatment groups for both studies (Table 3), time to disease progression or survival , receive delayed treatment , receive immediate treatment ,0,
edin,1428,5553001,Cannot tell based on the abstract,, PTSD-Checklist-Civilian version (PCL-C) difference  , wait-list control condition ," Internet-based guided self-help program, including weekly support from a therapist via encrypted email ",0,
edin,1428,5553001,No significant difference,"Table 1
Baseline characteristics of parents.,<td colspan=""1"" rowspan=""1""><break></break></td><td colspan=""1"" rowspan=""1"">PCL-C<sup>j</sup></td><td colspan=""1"" rowspan=""1"">49.1 (10.3)</td><td colspan=""1"" rowspan=""1"">51.5 (9.4)</td><td colspan=""1"" rowspan=""1"">46.6 (10.7)</td><td colspan=""1"" rowspan=""1"">.06</td>", PTSD-Checklist-Civilian version (PCL-C) difference  , wait-list control condition ," Internet-based guided self-help program, including weekly support from a therapist via encrypted email ",0,
edin,1378,3628658,No significant difference,There was not statistical significance on union time and Harris values in the two position groups., Harris hip values and union time of fractures , Supine position , Lateral decubitus position ,0,
edin,1369,5311860,Cannot tell based on the abstract,," All responses, excluding Ã¢â¬Ëwatchful waitingÃ¢â¬â¢ ", Pre-existing syndromic surveillance infrastructure and processes , Standardized aberrant event detection algorithm and response protocol ,0,
edin,1369,5311860,No significant difference,"However, when the term for âwatchful waitingâ is excluded from public health response, the results were not significant (TableÂ 5).Table 5"," All responses, excluding Ã¢â¬Ëwatchful waitingÃ¢â¬â¢ ", Pre-existing syndromic surveillance infrastructure and processes , Standardized aberrant event detection algorithm and response protocol ,0,
edin,1380,4659198,Significantly decreased,"On the third day, the massage group showed significantly higher defecation frequency (pâ=â0.045) and significantly lower bilirubin levels (pâ=â0.03) compared with the control group.", Bilirubin levels after 3 days , Phototherapy only , Phototherapy plus massage ,0,
edin,1459,4600230,Cannot tell based on the abstract,, a pre-established pass/fail level of 50.0% in OSAUS score , clinical training only , simulation-based training followed by clinical training ,0,
edin,1459,4600230,Significantly increased,"A significantly higher number of participants from the intervention group passed a pre-established pass/fail level of 50.0% in OSAUS score compared with the control group (85.7% vs 8.3%, respectively; P < 0.001).", a pre-established pass/fail level of 50.0% in OSAUS score , clinical training only , simulation-based training followed by clinical training ,0,
edin,1507,5850185,Significantly increased,he subjects in the bilateral TENS+TOT group showed greater improvement in paretic ankle dorsiflexion strength (Î²=1.32; P=0.032) and in the completion time for the Timed Up and Go test (Î²=â1.54; P=0.004) than those in the unilateral TENS+TOT group., the TUG completion time at A1 and A2 , baseline , bilareal Transcutaneous electrical nerve stimulation (TENS) and taskÃ¢â¬?oriented training (TOT) ,0,
edin,1372,5285426,Significantly increased,Composite male urological and sexual function score changes from baseline were better in the robotic cohort (pÂ <Â 0.001)., Male sexual function scores , Laparoscopic surgery , Robotic surgery ,0,
edin,1412,5578640,Significantly increased,The ESAS QoL-score improved in the Vitamin D group the first month; -1.4; 95% CI -2.6 - (-0.21)., The ESAS QoL-score after 1 month , untreated (control) , vitamin D 4000 IE/day ,0,
edin,1482,4881089,Cannot tell based on the abstract,, prevalence rates of reported musculoskeletal symptoms , baseline ,  ergonomic intervention ,0,
edin,1482,4881089,No significant difference,McNemar test showed no significant difference in the prevalence rates of musculoskeletal symptoms in all regions before and after intervention., prevalence rates of reported musculoskeletal symptoms , baseline ,  ergonomic intervention ,0,
edin,1525,4092926,No significant difference,"There was no influence of the treatments on any of the mean values of the evaluated measures (p>0.05): 21.78 kg (body weight at slaughter), 8.65 kg (hot carcass weight), 8.59 kg (cold carcass weight), 40.27% (hot carcass yield), 39.20% (cold carcass yield), 7.73 cm2(rib eye area), 46.74 cm (carcass outer length), 45.68 cm (carcass internal length), 36.92 cm (leg length), 26.04 cm (leg perimeter), 48.66 cm (hind perimeter), 58.62 cm (thoracic perimeter), 0.20 (carcass compactness index), 68.48% (total muscle of the leg), 2.79% (total leg fat), 55.19% (subcutaneous leg fat), 28.82% (total bone), 81.66 g (femur weight), 14.88 cm (femur length), 0.38 (leg muscularity index), 2.53 (muscle:bone ratio) and 33.42 (muscle:fat ratio).", goats body weight at slaughter , soybean meal , sunflower cake ,0,
edin,1511,4134501,Cannot tell based on the abstract,, Partial responses , pertuzumab 840Ã¢â¬â°mg q3w for six cycles (Arm B) , pertuzumab 840Ã¢â¬â°mg for cycle 1 and 420Ã¢â¬â°mg q3w for cycles 2Ã¢â¬â6 (Arm A) ,0,
edin,1511,4134501,No significant difference,"At the end of cycle 3, 10 (67%) and 7 (58%) patients in Arms A and B, respectively, had achieved a partial response, whereas an additional 4 patients in each arm (27% and 33%, respectively) had stable disease.", Partial responses , pertuzumab 840Ã¢â¬â°mg q3w for six cycles (Arm B) , pertuzumab 840Ã¢â¬â°mg for cycle 1 and 420Ã¢â¬â°mg q3w for cycles 2Ã¢â¬â6 (Arm A) ,0,
edin,1497,4274342,Cannot tell based on the abstract,, pelvic organ prolapse , placebo , ospemifene 60 mg/day ,0,
edin,1497,4274342,No significant difference,"There were rare cases of pelvic organ prolapse in both the ospemifene and placebo groups. Two women had bladder prolapse (one ospemifene participant and one placebo participant), and one ospemifene participant had a report of cystocele.", pelvic organ prolapse , placebo , ospemifene 60 mg/day ,0,
edin,1512,2361520,No significant difference,"Median survival was not significantly better with immediate treatment (median 13.0 vs 11.0 months; hazard ratio, 1.15; 95% confidence interval (CI) 0.79â1.72; P=0.49).", Median survival , receive delayed treatment , receive immediate treatment ,0,
edin,1261,5414544,Significantly increased,"he rate of HBsAg positivity was significantly higher in Zimbabwe than Uganda (12.2 vs. 7.7%, adjusted odds ratioâ=â1.54, Pâ<â0.001) despite a similar prevalence of antibody to HBV core antigen (56.3 vs. 52.4%) in the two settings.", The rate of HBsAg positivity , Uganda , Zimbabwe ,0,
edin,1501,2627861,Cannot tell based on the abstract,, maternal blood lead concentrations , ingest placebo ," ingest 1,200 mg dietary calcium ",0,
edin,1501,2627861,Significantly decreased,"In the intent-to-treat analysis (n = 557), calcium supplementation was associated with an overall average reduction of 11% in maternal blood lead concentrations relative to placebo (p = 0.004) (Table 2).", maternal blood lead concentrations , ingest placebo ," ingest 1,200 mg dietary calcium ",0,
edin,1493,5021748,No significant difference,"he initial bolus heparin dosages required to produce an ACT 15Â min after the initial bolus that was identical to the control (333Â Â±Â 32Â s) were 120 U/kg (318Â Â±Â 29Â s) and 130 U/kg (339Â Â±Â 43Â s) for dabigatran, 130 U/kg (314Â Â±Â 31Â s) for rivaroxaban and 130 U/kg (317Â Â±Â 39Â s) for apixaban.,The NOAC groups required significantly larger doses of total heparin than the warfarin group.,The results of the comparison with warfarin (the control) indicated that dosages of 120 or 130 U/kg for dabigatran, and 130 U/kg for rivaroxaban and apixaban, were adequate initial heparin dosages.", heparin dosages required to produce an ACT 15 min after the initial bolus  that was identical to the control (110U/kg) , control (warfarin) , rivaroxaban or apixaban or dabigatran   ,0,
edin,1473,4222592,Significantly decreased,"ompared to the C test meal, the AA test meal increased satisfaction by 23% (P=0.05) and decreased the desire to eat by 28% (P=0.04) for the AUC(0-5h).", desire to eat  for the AUC(0-5h) , consumed a standardized breakfast  [Control (C)avocado-free] , consumed a standardized breakfast with Avocado Added (AA) ,0,
edin,1461,4600230,Cannot tell based on the abstract,, knowledge of equipment  , clinical training only , simulation-based training followed by clinical training ,0,
edin,1461,4600230,No significant difference,"There were statistically significant differences between the scores of the two groups (Figure 3) on image optimization (P < 0.001), systematic examination (P = 0.001), interpretation of images (P < 0.001), documentation of examination (P < 0.001), and medical decision-making (P = 0.005) but no difference was observed for knowledge of equipment (P = 0.095).", knowledge of equipment  , clinical training only , simulation-based training followed by clinical training ,0,
edin,1453,3406743,Cannot tell based on the abstract,, engaging in moderate physical activity , baseline , usual care (UCG) ,0,
edin,1453,3406743,No significant difference,"The EIG was approximately twice as likely to report engaging in moderate physical activity at follow-up as at baseline; 71% of women in this group reported moderate physical activity at baseline, and 84% at follow-up.,The UCG did not change between baseline and follow-up; 75% of women in this group reported moderate physical activity at baseline, and 77% at follow-up.", engaging in moderate physical activity , baseline , usual care (UCG) ,0,
edin,1495,4274342,Cannot tell based on the abstract,, vaginal bleeding , placebo , ospemifene 60 mg/day ,0,
edin,1495,4274342,No significant difference,"aginal bleeding or spotting was reported in 10 of 851 women (1.2%) with an intact uterus in the ospemifene 60 mg/day group (incidence rate, 2.17 per 100 patient-years) and in 5 of 543 women (0.9%) in the placebo group (incidence rate, 2.72 per 100 patient-years; P = 0.7; Table 3).", vaginal bleeding , placebo , ospemifene 60 mg/day ,0,
edin,1499,3846239,Significantly decreased,"At 1, 2, 4, 6, and 12 h post surgery, VAS pain values were significantly lower in the B+D group than in the B group."," At 1, 2, 4, 6, and 12 h post surgery, VAS pain scores ", bupivacaine  , bupivacaine plus dexamethasone  ,0,
edin,1444,5610684,Cannot tell based on the abstract,," tension, anxiety, well-being ", quietly read , use their own Facebook profile ,0,
edin,1444,5610684,No significant difference,"There were no significant condition differences for tension F(1, 91) = 1.56, p = 0.21, 95% CI [â0.29, 1.25], Î·2 = 0.02; anxiety F(1, 88) = 0.004, p = 0.95, 95% CI [â1.01, 0.95], Î·2 = 0.00; or well-being F(1, 91) = 0.33, p = 0.57, 95% CI [â0.49, 0.90], Î·2 = 0.004."," tension, anxiety, well-being ", quietly read , use their own Facebook profile ,0,
edin,1416,5456350,Cannot tell based on the abstract,, wanted to receive a DEKA Arm , completers of in-laboratory (Part A) only , completers of in-laboratory (Part A) and home trial (Part B) ,0,
edin,1416,5456350,No significant difference,"There were no significant differences in responses to survey items (pertaining to desire to receive a DEKA Arm, self-rated skill in use, perception of weight, ratings of socket comfort, or preferences for DEKA Arm over personal prosthesis) administered at the end of Part A and the end of Part B (Table 2).", wanted to receive a DEKA Arm , completers of in-laboratory (Part A) only , completers of in-laboratory (Part A) and home trial (Part B) ,0,
edin,1435,5336430,Significantly increased,"At 8Â weeks after the end of treatment, CCC was significantly higher with 5-FU 0.5%/salicylic acid 10% than with vehicle [49.5% vs. 18.2%, respectively; odds ratio (OR) 3.9 (95% CI) 1.7, 8.7; PÂ =Â 0.0006].", The percentage of patients with complete clinical clearance (CCC) 8 weeks after the end of treatment (primary endpoint) , vehicle , 5-fluorouracil (5-FU) 0.5%/salicylic acid 10% ,0,
edin,1523,4107254,Significantly increased,"Centers admitting â¥ 200 patients/year (70.7% vs. 45%; p = 0.039), and those with stroke units (95 vs. 20; p = 0.031) were more willing to join a randomized trial evaluating any of the methods.", willing to join a randomized trial evaluating any of the methods used in VTE prophylaxis in stroke patients , centers without stroke unit , centers with stroke unit ,0,
edin,1430,5566825,Cannot tell based on the abstract,, total duration of illnesses , cup of milk only twice a day while continuing with their normal/routine diet. , receive orally daily either CyavanaprÃ?Ãâºa (CP) (approx. 6 g) followed by a cup of milk (100 Ã¢â¬â 200 ml) ,0,
edin,1430,5566825,Significantly decreased,"Evaluation of total duration of illnesses related to infection and allergy showed that of the total duration of 3983 days of illness, there were 1369 (34.37%) illness days in CP group whereas it was 2614 (65.62%) days in the control group. This difference was observed statistically significant (P < 0.01) and the proportionate difference was about 2 times (1.91) [Figure 3].", total duration of illnesses , cup of milk only twice a day while continuing with their normal/routine diet. , receive orally daily either CyavanaprÃ?Ãâºa (CP) (approx. 6 g) followed by a cup of milk (100 Ã¢â¬â 200 ml) ,0,
edin,1503,5854362,Cannot tell based on the abstract,, anxiety and depressive symptoms  , placebo training ,  Cognitive Bias Modification for Interpretations (CBM-I) training ,0,
edin,1503,5854362,No significant difference,"Our first and primary hypothesis, that CBM-I would result in reduced anxiety and depressive symptoms compared to Placebo, was not confirmed, as no significant Condition x Time interactions were observed for SCARED and CDI scores.", anxiety and depressive symptoms  , placebo training ,  Cognitive Bias Modification for Interpretations (CBM-I) training ,0,
edin,1522,4107254,Cannot tell based on the abstract,, Dextrans administration , centers without stroke unit , centers with stroke unit ,0,
edin,1522,4107254,No significant difference,"Dextrans were less frequently used in centers with a stroke unit (6.6% vs. 13%, p = 0.05).", Dextrans administration , centers without stroke unit , centers with stroke unit ,0,
edin,1494,4274342,Cannot tell based on the abstract,, The mean (SD) increase in endometrial thickness based on TVUS , placebo , ospemifene 60 mg/day ,0,
edin,1494,4274342,Significantly increased,"The mean (SD) increase in endometrial thickness based on TVUS was 0.51 (1.5) versus 0.06 (1.2) mm at 12 weeks, 0.56 (1.6) versus 0.05 (1.3) mm at 6 months, and 0.81 (1.5) versus 0.07 (1.2) mm at 12 months for participants in the ospemifene and placebo groups, respectively. The differences between participants receiving ospemifene and participants receiving placebo were statistically significant (P â¤ 0.001, Welchâs test) at all three evaluations.", The mean (SD) increase in endometrial thickness based on TVUS , placebo , ospemifene 60 mg/day ,0,
edin,1510,4134501,No significant difference,The safety profiles were similar between arms and treatment was well tolerated., The safety profiles , pertuzumab 840Ã¢â¬â°mg q3w for six cycles (Arm B) , pertuzumab 840Ã¢â¬â°mg for cycle 1 and 420Ã¢â¬â°mg q3w for cycles 2Ã¢â¬â6 (Arm A) ,0,
edin,1393,4599543,Significantly decreased,"Postoperative bleeding was significantly (P=0.042) less in the treatment arm (median, 300Â mL; interquartile range, 200 to 400Â mL) than in the control arm (median, 355Â mL; interquartile range, 250 to 600Â mL).", postoperative bleeding , received saline solution (placebo) , received fibrinogen concentrate ,0,
edin,1466,2837815,No significant difference,The Merle dâAubigne Postel score was the maximum of 18 points for all patients in both groups., The Merle dÃ¢â¬â¢Aubigne Postel score , Palacos R acrylic bone cements (without antibiotics) , SmartSet HV acrylic bone cements (without antibiotics) ,0,
edin,1374,3628658,Significantly decreased,"The hospital stay, operating time, intraoperative blood loss, length of incision, X-ray fluoroscopy time, and out-of-bed activity time in the lateral decubitus position group were significantly lower than those in the supine position group.", Hospital stay , Supine position , Lateral decubitus position ,0,
edin,1359,3842830,Significantly decreased,"The change in daily OFF time was significantly reduced in the istradefylline 20 mg/day (â0.99 hours, Pâ=â.003) and istradefylline 40 mg/day (â0.96 hours, Pâ=â.003) groups compared with the placebo group (â0.23 hours).", Daily OFF time , Placebo , Istradefylline 20 mg or 40 mg ,0,
edin,1452,3406743,Cannot tell based on the abstract,, engaging in moderate physical activity , baseline ," enhanced intervention (EIG) - The enhanced intervention was delivered by CHWs as 3 individually tailored, one-on-one counseling sessions. The sessions occurred approximately 1 month, 2 months, and 6 months after screening. Each session averaged 50 minutes. Participants received transportation tokens and grocery store vouchers as incentives for attendance. ",0,
edin,1452,3406743,Significantly increased,"The EIG was approximately twice as likely to report engaging in moderate physical activity at follow-up as at baseline; 71% of women in this group reported moderate physical activity at baseline, and 84% at follow-up.", engaging in moderate physical activity , baseline ," enhanced intervention (EIG) - The enhanced intervention was delivered by CHWs as 3 individually tailored, one-on-one counseling sessions. The sessions occurred approximately 1 month, 2 months, and 6 months after screening. Each session averaged 50 minutes. Participants received transportation tokens and grocery store vouchers as incentives for attendance. ",0,
edin,1375,3628658,Significantly decreased,"The hospital stay, operating time, intraoperative blood loss, length of incision, X-ray fluoroscopy time, and out-of-bed activity time in the lateral decubitus position group were significantly lower than those in the supine position group.", Loss of blood during surgery , Supine position , Lateral decubitus position ,0,
edin,1496,4274342,Cannot tell based on the abstract,, endometrial cancer , placebo , ospemifene 60 mg/day ,0,
edin,1496,4274342,No significant difference,There were no cases of endometrial cancer observed with exposure of up to 52 weeks in the ospemifene clinical trials., endometrial cancer , placebo , ospemifene 60 mg/day ,0,
edin,1441,5336430,Cannot tell based on the abstract,, DLQI total score 8 weeks after the end of treatment , vehicle , 5-fluorouracil (5-FU) 0.5%/salicylic acid 10% ,0,
edin,1441,5336430,No significant difference,"<td align=""left"" colspan=""4"">DLQI total score</td>", DLQI total score 8 weeks after the end of treatment , vehicle , 5-fluorouracil (5-FU) 0.5%/salicylic acid 10% ,0,
edin,1467,4367028,Cannot tell based on the abstract,, SBP and DBP , Trendelenburg (TBG) tilt &amp;lt;30ÃÂ° , Trendelenburg (TBG) tilt &amp;gt;30ÃÂ°  ,0,
edin,1467,4367028,No significant difference,"Baseline hemodynamic parameters like SBP, DBP, mean arterial pressure (MAP), pulse rate and also hemoglobin were found to be comparable [Table 3] among two groups.,Head down tilt was associated with a rising trend in SBP and DBP which was higher in TBG >30Â° than TBG <30Â° group however the results were not statistically significant [Table 4].", SBP and DBP , Trendelenburg (TBG) tilt &amp;lt;30ÃÂ° , Trendelenburg (TBG) tilt &amp;gt;30ÃÂ°  ,0,
edin,1401,5766333,Cannot tell based on the abstract,, the minimum pulse rate , PF alone (PF group) , combination of propofol (PF) and dexmedetomidine (DEX) (Combination group) ,0,
edin,1401,5766333,Significantly decreased,"On the other hand, the minimum pulse rate was significantly lower in the Combination group than in the PF group (47 [34âââ61] bpm vs. 59 [36âââ72] bpm, P â<â0.001, median [range]),", the minimum pulse rate , PF alone (PF group) , combination of propofol (PF) and dexmedetomidine (DEX) (Combination group) ,0,
edin,1460,4600230,Cannot tell based on the abstract,," image optimization, systematic examination, interpretation of images, documentation of examination, and medical decision-making ", clinical training only , simulation-based training followed by clinical training ,0,
edin,1460,4600230,Significantly increased,"There were statistically significant differences between the scores of the two groups (Figure 3) on image optimization (P < 0.001), systematic examination (P = 0.001), interpretation of images (P < 0.001), documentation of examination (P < 0.001), and medical decision-making (P = 0.005) but no difference was observed for knowledge of equipment (P = 0.095)."," image optimization, systematic examination, interpretation of images, documentation of examination, and medical decision-making ", clinical training only , simulation-based training followed by clinical training ,0,
edin,1394,5724392,Cannot tell based on the abstract,"Final model-based TCD velocities (mean Â± standard error) on Standard versus Alternative Arm were 143 Â± 1.6 and 138 Â± 1.6 cm/sec, respectively, with difference (95% CI) = 4.54 (0.10, 8.98), non-inferiority p=8.82 Ã 10â16 and post-hoc superiority p=0.023.", transcranial Doppler (TCD) flow velocities , transfusions , hydroxyurea ,0,
edin,1394,5724392,Significantly increased,"The final model-based TCD velocities (mean Â± standard error) on the Standard Arm versus Alternative Arm were 143 Â± 1.6 and 138 Â± 1.6 cm/sec, respectively, with difference (95% CI) = 4.54 (0.10, 8.98), non-inferiority p=8.82 Ã 10â16 and a post-hoc superiority p=0.023.", transcranial Doppler (TCD) flow velocities , transfusions , hydroxyurea ,0,
edin,1456,3406743,Significantly increased,A culturally tailored adaptation of the WISEWOMAN program that used community health workers significantly improved both self-reported readiness to engage in physical activity and vigorous physical activity among low-income Latinas., readiness to engage in vigorous physical activity , baseline , enhanced intervention (EIG) ,0,
edin,1419,5456350,Cannot tell based on the abstract,, rated the DEKA function and the external battery life , completers of in-laboratory (Part A) only , completers of in-laboratory (Part A) and home trial (Part B) ,0,
edin,1419,5456350,No significant difference,"<td align=""left"" colspan=""1"" rowspan=""1"">&nbsp;&nbsp;&nbsp;&nbsp;DEKA arm function</td><td align=""center"" colspan=""1"" rowspan=""1"">31</td><td align=""center"" colspan=""1"" rowspan=""1"">5.3 (1.4)</td><td align=""center"" colspan=""1"" rowspan=""1"">17</td><td align=""center"" colspan=""1"" rowspan=""1"">5.8 (1.0)</td><td align=""center"" colspan=""1"" rowspan=""1"">14</td><td align=""center"" colspan=""1"" rowspan=""1"">4.7 (1.6)</td><td align=""center"" colspan=""1"" rowspan=""1""><bold>0.0468</bold></td>,<td align=""left"" colspan=""1"" rowspan=""1"">&nbsp;&nbsp;&nbsp;&nbsp;External Battery Life</td><td align=""center"" colspan=""1"" rowspan=""1"">32</td><td align=""center"" colspan=""1"" rowspan=""1"">5.7 (1.1)</td><td align=""center"" colspan=""1"" rowspan=""1"">18</td><td align=""center"" colspan=""1"" rowspan=""1"">5.8 (0.8)</td><td align=""center"" colspan=""1"" rowspan=""1"">14</td><td align=""center"" colspan=""1"" rowspan=""1"">5.5 (1.5)</td><td align=""center"" colspan=""1"" rowspan=""1"">0.9928</td>", rated the DEKA function and the external battery life , completers of in-laboratory (Part A) only , completers of in-laboratory (Part A) and home trial (Part B) ,0,
edin,1470,4367028,Cannot tell based on the abstract,, Nitroglycerine and fentanyl use , Trendelenburg (TBG) tilt &amp;lt;30ÃÂ° , Trendelenburg (TBG) tilt &amp;gt;30ÃÂ° ,0,
edin,1470,4367028,Significantly increased,Nitroglycerine and fentanyl use in TBG >30Â° group was higher and statistically significant (P < 0.05) when compared with TBG <30Â° [Table 6]., Nitroglycerine and fentanyl use , Trendelenburg (TBG) tilt &amp;lt;30ÃÂ° , Trendelenburg (TBG) tilt &amp;gt;30ÃÂ° ,0,
edin,1370,5285426,No significant difference,"In females, there was no difference between the two groups in any of the components of urological or sexual function.", Urological function scores in females , Laparoscopic surgery , Robotic surgery ,0,
edin,1478,4673066,Cannot tell based on the abstract,, performance on the diagnostic performance test , traditional , schema-based lecture ,0,
edin,1478,4673066,Significantly increased,"Schema-based instruction was associated with increased performance on the diagnostic performance test (64â%âÂ±â22 vs 44â%âÂ±â25, pâ<â0.001).", performance on the diagnostic performance test , traditional , schema-based lecture ,0,
edin,1383,4659198,Cannot tell based on the abstract,, Baseline medical characteristics , Phototherapy only , Phototherapy plus massage ,0,
edin,1383,4659198,No significant difference,"TableÂ 1 shows the medical characteristics of participating neonates. We observed no significant differences between the two groups in terms of type of feeding, gestational age at birth, body weight at birth, body weight on the date of admission, phototherapy duration, or physical weight loss.Table 1", Baseline medical characteristics , Phototherapy only , Phototherapy plus massage ,0,
edin,1485,4881089,Cannot tell based on the abstract,, any of the scales of the Thai version of the COPSOQ questionnaire , baseline , control ,0,
edin,1485,4881089,No significant difference,Table 5 also shows that there was no significant difference in any of the scales of the Thai version of the COPSOQ questionnaire before and after intervention in the control group., any of the scales of the Thai version of the COPSOQ questionnaire , baseline , control ,0,
edin,1526,4092926,Cannot tell based on the abstract,," Weights, carcass yields, rib eye area of goats ", soybean meal , sunflower cake ,0,
edin,1526,4092926,No significant difference,Weights and carcass yields as well as rib eye area showed no differences (p>0.05) with the substitution of soybean meal by sunflower cake.," Weights, carcass yields, rib eye area of goats ", soybean meal , sunflower cake ,0,
edin,1434,5566825,Cannot tell based on the abstract,, CGI-I scale improvement , cup of milk only twice a day while continuing with their normal/routine diet. , receive orally daily either CyavanaprÃ?Ãâºa (CP) (approx. 6 g) followed by a cup of milk (100 Ã¢â¬â 200 ml) ,0,
edin,1434,5566825,Significantly increased,Assessment of participants on CGI-I scale showed that a higher percentage of participants (66.12%) showed improvement on this scale in CP Group as compared to control group (51.43%) [Table 7]., CGI-I scale improvement , cup of milk only twice a day while continuing with their normal/routine diet. , receive orally daily either CyavanaprÃ?Ãâºa (CP) (approx. 6 g) followed by a cup of milk (100 Ã¢â¬â 200 ml) ,0,
edin,1492,5021748,Cannot tell based on the abstract,, protamine usage for haemostasis , control (warfarin) , rivaroxaban or apixaban or dabigatran   ,0,
edin,1492,5021748,No significant difference,"No significant differences in protamine usage for haemostasis were found among the control and three NOAC groups (control, 13Â Â±Â 20; dabigatran, 26Â Â±Â 23; rivaroxaban, 25Â Â±Â 25; apixaban, 28Â Â±Â 28Â mg).", protamine usage for haemostasis , control (warfarin) , rivaroxaban or apixaban or dabigatran   ,0,
edin,1377,3628658,Significantly decreased,"he hospital stay, operating time, intraoperative blood loss, length of incision, X-ray fluoroscopy time, and out-of-bed activity time in the lateral decubitus position group were significantly lower than those in the supine position group.", Surgery time , Supine position , Lateral decubitus position ,0,
edin,1440,5336430,Cannot tell based on the abstract,, the TSQM convenience and side effect domain scores , vehicle , 5-fluorouracil (5-FU) 0.5%/salicylic acid 10% ,0,
edin,1440,5336430,No significant difference,"No statistically significant differences were observed between the study arms for the TSQM convenience (70.7 and 71.2, respectively) and side effect (92.4 and 96.4, respectively) domain scores.", the TSQM convenience and side effect domain scores , vehicle , 5-fluorouracil (5-FU) 0.5%/salicylic acid 10% ,0,
edin,1365,4365564,Significantly increased,There was a higher rate of superficial wound infection in the investigational group but no deep wound infections in either group., Rate of superficial wound infection , ALIF with BAK cages , CharitÃÂ© artificial disc ,0,
edin,1355,3179725,Significantly increased,"<td align=""left""><bold>After four treatments</bold></td><td></td><td></td><td></td>", Dyspnea improvement , Sham chest wall oscillation treatment , Active chest wall oscillation treatment ,0,
edin,1637,5420386,Significantly increased,"<td colspan=""5"">5D-ASC scale</td>"," ratings of blissful state, insightfulness, and changed meaning of percepts ", 100&amp;amp;nbsp;ÃÂ¼g dose of LSD , oral administration of 200 ÃÂ¼g LSD ,0,
edin,1623,3719224,Significantly increased,"Despite the similarity of two groups of intervention (n = 53) and control (n = 59) at baseline, there were significant differences between the two groups in mean scores of the variables, knowledge (4.62 Â± 1.38 vs. 3.53 Â± 1.61), perceived susceptibility (14.05 Â± 1.51 vs. 12.37 Â± 2.11), and perceived benefits (28.41 Â± 2.14 vs. 27.51 Â± 3.05), at follow-up time after 3 months (P < 0.05)."," the variables, knowledge ", received just routine education , received educational intervention plus routine education ,0,
edin,1551,4396724,Cannot tell based on the abstract,, Maximal heart rate at the end of the test , Traditional moderate-intensity continuous training , High-intensity interval training ,0,
edin,1551,4396724,No significant difference,"Maximal heart rate achieved at the end of the graded exercise test, body mass, and waist circumference did not change significantly from baseline to one-month follow-up in either HIIT or MICT (P's > 0.05).", Maximal heart rate at the end of the test , Traditional moderate-intensity continuous training , High-intensity interval training ,0,
edin,1632,5420386,No significant difference,"On the MEQ, 200Â Î¼g LSD induced mystical experiences that were comparable to those in patients who underwent LSD-assisted psychotherapy but were fewer than those reported for psilocybin in healthy subjects or patients.", Mystical Experience Questionnaire (MEQ) scores , placebo , oral administration of 100 and 200&amp;nbsp;ÃÂ¼g LSD ,0,
edin,1536,5941723,No significant difference,"There were no significant differences in number of sensations elicited, MASS index, range of spreading, and intensity of needle pain for 5âmm penetration versus 1âmm skin press and 10âmm penetration versus 2âmm skin press.", Needle pain intensity , Placebo , Acupuncture ,0,
edin,1531,5343624,Cannot tell based on the abstract,, Formation of new bone ,"  Synthetic bone substitute material (NanoBoneÃÂ®, NB)  "," Xenogeneic bone substitute material (Bio-OssÃÂ®, BO)  ",0,
edin,1531,5343624,No significant difference,"The radiologic analysis of the BO graft revealed volumetric reduction in all patients.,The volume reduction of the BO graft was not significant.,The radiologic analysis of the NB graft revealed volumetric reduction in all patients.,The volume reduction of the NB graft was not significant.", Formation of new bone ,"  Synthetic bone substitute material (NanoBoneÃÂ®, NB)  "," Xenogeneic bone substitute material (Bio-OssÃÂ®, BO)  ",0,
edin,1588,3810136,Cannot tell based on the abstract,, Free IGF-1 concentrations at day 4 and day 6 ," T-HS/SE, T-HS/EAA ", T-HS/Ctr ,0,
edin,1588,3810136,Significantly decreased,"In addition, lower free IGF-1 levels were measured in the T-HS/Ctr group than PF group at day 4 and it reached statistical difference by day 6 (p<0.01), indicating that the depressed IGF-1 expression was sustained 6 days following T-HS after eliminating the interference of reduced food intake.", Free IGF-1 concentrations at day 4 and day 6 ," T-HS/SE, T-HS/EAA ", T-HS/Ctr ,0,
edin,1667,5017045,Cannot tell based on the abstract,, number of operated patients , standard consultation , video-assisted remote consultations ,0,
edin,1667,5017045,No significant difference,There were no significant differences in the number of operated patients between the two groups (pâ=â0.432)., number of operated patients , standard consultation , video-assisted remote consultations ,0,
edin,1563,3094237,Cannot tell based on the abstract,, Adverse side effects , Placebo , L-lysine ,0,
edin,1563,3094237,No significant difference,"urthermore, the L-lysine treatment was not found to induce any adverse side effects including extrapyramidal effects.", Adverse side effects , Placebo , L-lysine ,0,
edin,1600,5434251,Cannot tell based on the abstract,, PTQ (perseverative thinking) scores , Patients not receiving text message assistance during follow-up , Patients receiving text messageÃ¢â¬âbased feedback ,0,
edin,1600,5434251,No significant difference,"<td colspan=""2"" rowspan=""1"">PTQ<sup>g</sup> (perseverative thinking), mean (SD)</td><td colspan=""1"" rowspan=""1"">38.50 (10.97)</td><td colspan=""1"" rowspan=""1"">45.32 (9.95)</td><td colspan=""1"" rowspan=""1"">t<sub>35</sub>=â1.98; <italic>P</italic>=.06</td>", PTQ (perseverative thinking) scores , Patients not receiving text message assistance during follow-up , Patients receiving text messageÃ¢â¬âbased feedback ,0,
edin,1561,5916905,No significant difference,"After BM-intervention, fat mass increased (+1.0âÂ±â1.8âkg; pâ<â0.05) and postprandial insulin sensitivity tended to decrease (ÎMatsudaISI: â0.89âÂ±â2.3; pâ=â0.06).,Daylong glycaemia, insulin secretion, changes in basal insulin sensitivity, and triglycerides did not differ between WM- and BM-interventions (all pâ>â0.05).",  Insulin sensitivity after meals , Orange juice intake with each meal (WM)  , Orange juice intake in-between meals (BM) ,0,
edin,1591,2714198,No significant difference,No difference in survival time was observed across the different groups., Survival time , Control groups , Suture groups ,0,
edin,1609,4086013,No significant difference,"We did not observe any differences between the ISM1 control group and GM501 study group with regard to fertilization, pregnancy, implantation rates, ongoing pregnancy, and babies born.", Pregnancy , Standard sequential culture medium ISM1 , New universal medium (GM501) ,0,
edin,1574,5791393,Cannot tell based on the abstract,, Hospital stay after surgery , Without catheter (group I) , With catheter (group II) ,0,
edin,1574,5791393,No significant difference,"There was also no significant difference in the post-operative hospital stay between the groups, both in total and separately in women and in men.", Hospital stay after surgery , Without catheter (group I) , With catheter (group II) ,0,
edin,1564,3094237,Significantly decreased,"<td align=""left""><underline>PANSS</underline></td><td></td><td></td><td></td><td></td><td></td>", Symptom severity by PANSS measure , Placebo , L-lysine ,0,
edin,1583,5642191,Cannot tell based on the abstract,, Baseline characteristics , Lunch meals with meat (meat group) or lunch meals with n-3 LCPUFAs supplements (supplements group) , Lunch meals with fatty fish (fish group) ,0,
edin,1583,5642191,No significant difference,No differences in baseline characteristics were found between the three intervention groups (Table 1)., Baseline characteristics , Lunch meals with meat (meat group) or lunch meals with n-3 LCPUFAs supplements (supplements group) , Lunch meals with fatty fish (fish group) ,0,
edin,1575,5791393,No significant difference,"Catheterisation does not influence: the number of additional doses of ketoprofen and pethidine administered during the 1st day after the operation, the duration of hospitalization, the occurrence of fever, significant bacteriuria, the postoperative acute urinary retention and the post-void residual urine volume.", Fever , Without catheter (group I) , With catheter (group II) ,0,
edin,1666,5017045,Cannot tell based on the abstract,, The mean consultation duration in the subgroup patients who required casting , standard consultation (UNN) , video-assisted remote consultations  ,0,
edin,1666,5017045,Significantly increased,"In the subgroup analyses restricted to patients who required casting, we observed a significantly longer mean consultation time in the RMC group (29.0Â min) compared to the UNN group (22.6Â min, pâ=â0.0063).", The mean consultation duration in the subgroup patients who required casting , standard consultation (UNN) , video-assisted remote consultations  ,0,
edin,1672,2941605,Cannot tell based on the abstract,, Skin reaction , Vinorelbine 6mg/m2 , Cisplatin 40mg/m2 ,0,
edin,1672,2941605,Significantly increased,Skin reaction was also lower in the Vinorelbine arm when compared with the other arm., Skin reaction , Vinorelbine 6mg/m2 , Cisplatin 40mg/m2 ,0,
edin,1630,3640164,Cannot tell based on the abstract,," The duration of the procedure, time from anesthesia induction until start of surgery, and surgery time ", spinal anesthesia with 2.5 ml of 0.5% bupivacaine   , popliteal sciatic nerve block (PSNB) with 30 ml of 0.75% ropivacaine mixed with 10 ml of normal saline solution using a nerve stimulator ,0,
edin,1630,3640164,Significantly increased,"The duration of the procedure, time from anesthesia induction until start of surgery, and surgery time were shorter in the spinal anesthesia group than in the PSNB group (P < 0.01)."," The duration of the procedure, time from anesthesia induction until start of surgery, and surgery time ", spinal anesthesia with 2.5 ml of 0.5% bupivacaine   , popliteal sciatic nerve block (PSNB) with 30 ml of 0.75% ropivacaine mixed with 10 ml of normal saline solution using a nerve stimulator ,0,
edin,1604,4335741,Significantly decreased,"Further, laryngoscopy, jaw relaxation, and limb movement scores were similar in the R and A groups and there were no significant differences, but vocal cords were significantly more patent in group R than those in group A (P = 0. 028).", Vocal cords patency , Remifentanil , Alfentanil ,0,
edin,1675,4737200,Cannot tell based on the abstract,, second peak in EKAM during late stance , control condition , lateral wedge insoles ,0,
edin,1675,4737200,Significantly decreased,"For the second peak in EKAM during late stance, both of the lateral wedge insoles significantly reduced the magnitude of this peak in comparison to the control condition.", second peak in EKAM during late stance , control condition , lateral wedge insoles ,0,
edin,1675,4737200,Significantly decreased,"For the second peak in EKAM during late stance, both of the lateral wedge insoles significantly reduced the magnitude of this peak in comparison to the control condition.", second peak in EKAM during late stance , control condition , lateral wedge insoles ,0,
edin,1607,4335741,Cannot tell based on the abstract,, Scores for ease of laryngoscopy , Remifentanil , Alfentanil ,0,
edin,1607,4335741,No significant difference,"As shown in Table 3, the scores for ease of laryngoscopy (A), jaw relaxation (C), and limb movement (D) did not differ significantly between the two groups (Mann-Whitney test), but vocal cord patency (B) in group A was significantly higher than that in remifentanil group (P = 0. 028).", Scores for ease of laryngoscopy , Remifentanil , Alfentanil ,0,
edin,1611,4086013,No significant difference,"We did not observe any differences between the ISM1 control group and GM501 study group with regard to fertilization, pregnancy, implantation rates, ongoing pregnancy, and babies born.", Live birth rate , Standard sequential culture medium ISM1 , New universal medium (GM501) ,0,
edin,1550,4396724,Cannot tell based on the abstract,, Changes in fitness measures , Traditional moderate-intensity continuous training , High-intensity interval training ,0,
edin,1550,4396724,No significant difference,"There were no main effects for group or group by time interactions for these fitness parameter variables, indicating that there were no differences in the degree of change experienced between HIIT and MICT over time.", Changes in fitness measures , Traditional moderate-intensity continuous training , High-intensity interval training ,0,
edin,1658,2291328,Cannot tell based on the abstract,, hospitalization hospitalization for worsening CHF in CIBIS-III , 20 mg/day for enalapril , 10 mg/day for bisoprolol ,0,
edin,1658,2291328,No significant difference,"There was a non-significant increase in the number of patients having a hospitalization for worsening CHF in the bisoprolol-first group compared with the enalapril-first group (63 vs 51 patients, respectively, HR = 1.25 [0.87â1.81], p = 0.23).", hospitalization hospitalization for worsening CHF in CIBIS-III , 20 mg/day for enalapril , 10 mg/day for bisoprolol ,0,
edin,1597,2911596,Cannot tell based on the abstract,, HR values , Isoflurane-fentanyl anesthesia , Sevoflurane-fentanyl anesthesia ,0,
edin,1597,2911596,Significantly increased,"However, HR values were significantly different in SEVO and ISOF groups 70.6 Â± 13.0 versus 64.9 Â± 11.8, (P < .01), respectively (Figure 2).", HR values , Isoflurane-fentanyl anesthesia , Sevoflurane-fentanyl anesthesia ,0,
edin,1608,4086013,No significant difference,"We did not observe any differences between the ISM1 control group and GM501 study group with regard to fertilization, pregnancy, implantation rates, ongoing pregnancy, and babies born.", Fertilization , Standard sequential culture medium ISM1 , New universal medium (GM501) ,0,
edin,621,1852268,Cannot tell based on the abstract,, obstetric/postpartum infection or gynecologic/postoperative infection ," Intravenous piperacillinâtazobactam, 3.375 g every 6 hours "," Inravenous ertapenem, 1 g once a day ",0,
edin,621,1852268,No significant difference,"At the primary efficacy endpoint 2â4 weeks post therapy, 93.9% of patients who received ertapenem and 91.5% of those who received piperacillinâtazobactam were cured (95% confidence interval for the difference, adjusting for strata, â4% to 8.8%), indicating that cure rates for both treatment groups were equivalent.", obstetric/postpartum infection or gynecologic/postoperative infection ," Intravenous piperacillinâtazobactam, 3.375 g every 6 hours "," Inravenous ertapenem, 1 g once a day ",0,
edin,1676,4737200,Cannot tell based on the abstract,, mobility , control condition , barefoot conditions ,0,
edin,1676,4737200,No significant difference,There was no difference in the mobility or barefoot conditions in comparison to the control condition., mobility , control condition , barefoot conditions ,0,
edin,1655,2291328,Cannot tell based on the abstract,, heart rate reduction and blood pressure reduction in CIBIS-II study  , placebo , Bisoprolol ,0,
edin,1655,2291328,Significantly increased,Bisoprolol produced a significant reduction in heart rate associated with a non-significant increase in peak oxygen consumption., heart rate reduction and blood pressure reduction in CIBIS-II study  , placebo , Bisoprolol ,0,
edin,1601,5434251,Cannot tell based on the abstract,, SCS-D (self-compassion) scores , Patients not receiving text message assistance during follow-up , Patients receiving text messageÃ¢â¬âbased feedback ,0,
edin,1601,5434251,No significant difference,"The effects of the post-hoc assessment of mindfulness home practice (number and duration of exercises practiced) and the four selected outcome questionnaires (PHQ-9, PTQ, FFA, and SCS-D) yielded near zero to small, nonsignificant effect sizes (see Table 2).", SCS-D (self-compassion) scores , Patients not receiving text message assistance during follow-up , Patients receiving text messageÃ¢â¬âbased feedback ,0,
edin,1571,4924222,No significant difference,"After adjustment for baseline measurements there was no time by treatment effect for central systolic or diastolic BP, AIx or cfPWV.", Augmentation index (AIx) , Usual diet ," Increased intake of fruits, vegetables and dairy ",0,
edin,1663,3489577,Significantly decreased,"Total-, LDL-cholesterol and waist circumference decreased significantly in the oat group compared to the control.", total cholesterol and LDL-C  , 100 grams of wheat flour-based noodles , 100 grams of instant oat cereal ,0,
edin,1647,5498096,Cannot tell based on the abstract,, pain intensity and disability index , baseline , stabilization in prone and supine group (SIPS) ,0,
edin,1647,5498096,No significant difference,"There was no significant difference when the pretreatment (F=0.57, P>0.05), 4th week (F=0.779, P>0.468) and 8 week (F=0.000, P>1.000) pain intensity and disability index were compared across the groups.", pain intensity and disability index , baseline , stabilization in prone and supine group (SIPS) ,0,
edin,1578,5074260,Cannot tell based on the abstract,, Change in levels of glycated haemoglobin after 26 weeks , Liraglutide and metformin plus placebo , Liraglutide and metformin plus insulin degludec (IDeg) ,0,
edin,1578,5074260,Significantly decreased,"At 26âweeks, 77.6% of patients receiving IDeg and 35.5% of those receiving placebo had achieved an HbA1c level <7.0% (<53âmmol/mol); the likelihood of achieving HbA1c <7.0% was significantly higher for participants in the IDeg addâon group [odds ratio 7.79 (95% CI 4.57; 13.27); pâ<â0.0001].", Change in levels of glycated haemoglobin after 26 weeks , Liraglutide and metformin plus placebo , Liraglutide and metformin plus insulin degludec (IDeg) ,0,
edin,1598,5434251,Cannot tell based on the abstract,, Number of practiced exercises  , Patients not receiving text message assistance during follow-up , Patients receiving text messageÃ¢â¬âbased feedback ,0,
edin,1598,5434251,No significant difference,"<td colspan=""1"" rowspan=""1"">Number of exercises practiced</td><td colspan=""1"" rowspan=""1"">7.88 (4.92)</td><td colspan=""1"" rowspan=""1"">10.06 (6.80)</td><td colspan=""1"" rowspan=""1"">62.67 (61.64)</td><td colspan=""1"" rowspan=""1"">48.71 (44.28)</td><td colspan=""1"" rowspan=""1""><italic>t</italic><sub>30</sub>=â0.72</td><td colspan=""1"" rowspan=""1"">.48</td><td colspan=""1"" rowspan=""1"">0.25 (â0.45 to 0.96)</td>,The effects of the post-hoc assessment of mindfulness home practice (number and duration of exercises practiced) and the four selected outcome questionnaires (PHQ-9, PTQ, FFA, and SCS-D) yielded near zero to small, nonsignificant effect sizes (see Table 2).", Number of practiced exercises  , Patients not receiving text message assistance during follow-up , Patients receiving text messageÃ¢â¬âbased feedback ,0,
edin,1679,4737200,Cannot tell based on the abstract,, knee adduction angular impulse (KAAI) , control condition , supported wedge ,0,
edin,1679,4737200,Significantly decreased,"For the knee adduction angular impulse (KAAI), the barefoot condition and the two lateral wedge conditions were significantly different in comparison to the control condition (barefoot â4.3%, pâ=â0.023; typical wedge â7.95%, pâ<â0.001; supported wedge â5.5%, pâ<â0.001).", knee adduction angular impulse (KAAI) , control condition , supported wedge ,0,
edin,1580,5074260,Cannot tell based on the abstract,, Overall confirmed hypoglycaemia , Liraglutide and metformin plus placebo , Liraglutide and metformin plus insulin degludec (IDeg) ,0,
edin,1580,5074260,Significantly increased,"The number of patients experiencing confirmed hypoglycaemia during randomized treatment was higher with IDeg (17.3%) than with placebo (4.7%; Table S3, Supporting Information).", Overall confirmed hypoglycaemia , Liraglutide and metformin plus placebo , Liraglutide and metformin plus insulin degludec (IDeg) ,0,
edin,1674,4737200,Cannot tell based on the abstract,, early stance peak EKAM , control shoe , barefoot walking ,0,
edin,1674,4737200,Significantly decreased,"When we examined the effects of the conditions on measures of medial loading (Tables 1 and 2, Fig. 3), we found that barefoot walking had the greatest effect on early stance peak EKAM, lowering it by â7.6% (pâ<â0.001 vs. control shoe).", early stance peak EKAM , control shoe , barefoot walking ,0,
edin,1665,5017045,Cannot tell based on the abstract,, The mean consultation duration , standard consultation (UNN) , video-assisted remote consultations ,0,
edin,1665,5017045,No significant difference,The mean consultation duration was not significantly different between the groups (pâ=â0.60)., The mean consultation duration , standard consultation (UNN) , video-assisted remote consultations ,0,
edin,1631,3640164,Cannot tell based on the abstract,, he anesthesia-related side effects , spinal anesthesia with 2.5 ml of 0.5% bupivacaine   , popliteal sciatic nerve block (PSNB) with 30 ml of 0.75% ropivacaine mixed with 10 ml of normal saline solution using a nerve stimulator ,0,
edin,1631,3640164,No significant difference,"The anesthesia-related side effects in the spinal anesthesia group were hypotension, bradycardia, shivering, vomiting, postoperative headache, and urinary retension, occurring in 15%, 10%, 5%, 5%, 10%, and 20% of patients, respectively. There was no incidence of side effects in the PSNB group, but it was not statistically significant.", he anesthesia-related side effects , spinal anesthesia with 2.5 ml of 0.5% bupivacaine   , popliteal sciatic nerve block (PSNB) with 30 ml of 0.75% ropivacaine mixed with 10 ml of normal saline solution using a nerve stimulator ,0,
edin,1554,1488892,Significantly increased,"Compared to the control group, significant increases in CD4 cell count were observed for both IL-2 dose groups: 104.2/mm3 (p = 0.008) and 128.4 cells/mm3 (p = 0.002) for the 4.5 and 7.5 MIU dose groups, respectively.", Increase in CD4 T lymphocyte count  , No treatment , IL-2 injection at 4.5 MIU dose ,0,
edin,1648,5498096,Cannot tell based on the abstract,, pain intensity and functional disability , stabilization in supine (SIS) or prone and supine (SIPS) position group , stabilization in prone (SIP) ,0,
edin,1648,5498096,No significant difference,"There was no significant difference when the pretreatment (F=0.57, P>0.05), 4th week (F=0.779, P>0.468) and 8 week (F=0.000, P>1.000) pain intensity and disability index were compared across the groups.", pain intensity and functional disability , stabilization in supine (SIS) or prone and supine (SIPS) position group , stabilization in prone (SIP) ,0,
edin,1656,2291328,Cannot tell based on the abstract,," heart rate, hospital admission, sudden cardiac death, hospital admission for worsening heart failure in CIBIS-II study  ", placebo , Bisoprolol ,0,
edin,1656,2291328,Significantly decreased,"Bisoprolol significantly reduced cardiovascular mortality (HR: 0.71 [0.56â0.9]), sudden cardiac death (HR: 0.56 [0.39â0.80]), hospital admission (HR: 0.80 [0.71â0.91]), and hospital admission for worsening heart failure (HR: 0.64 [0.53â0.79]) compared with placebo."," heart rate, hospital admission, sudden cardiac death, hospital admission for worsening heart failure in CIBIS-II study  ", placebo , Bisoprolol ,0,
edin,1584,5642191,Cannot tell based on the abstract,, SDQ change scores , Lunch meals with meat (meat group) or lunch meals with n-3 LCPUFAs supplements (supplements group) , Lunch meals with fatty fish (fish group) ,0,
edin,1584,5642191,No significant difference,"There were no differences in any of the SDQ change scores from pre to post between the fish and meat or fish and supplement group, neither before nor after adjusting for the participantsâ baseline scores or baseline and compliance scores (Table 2).Table 2.", SDQ change scores , Lunch meals with meat (meat group) or lunch meals with n-3 LCPUFAs supplements (supplements group) , Lunch meals with fatty fish (fish group) ,0,
edin,1555,1488892,Significantly increased,"Compared to the control group, significant increases in CD4 cell count were observed for both IL-2 dose groups: 104.2/mm3 (p = 0.008) and 128.4 cells/mm3 (p = 0.002) for the 4.5 and 7.5 MIU dose groups, respectively.", Increase in CD4 T lymphocyte count  , No treatment , IL-2 injection at 7.5 MIU dose ,0,
edin,1636,5420386,Cannot tell based on the abstract,, all of the scales , placebo , oral administration of 100 and 200&amp;amp;amp;amp;amp;nbsp;ÃÂ¼g LSD ,0,
edin,1636,5420386,Significantly increased,"<td colspan=""5"">MEQ30</td>", all of the scales , placebo , oral administration of 100 and 200&amp;amp;amp;amp;amp;nbsp;ÃÂ¼g LSD ,0,
edin,1537,5941723,Cannot tell based on the abstract,, Severe adverse events , Placebo , Acupuncture ,0,
edin,1537,5941723,No significant difference,There were no critical adverse events., Severe adverse events , Placebo , Acupuncture ,0,
edin,1616,3430047,Cannot tell based on the abstract,, PHS criteria and bupivacaine consumption , subpleural intermittent analgesia (SIA) (0.1cc/kg/6h of 0.5% bupivacaine) , subpleural patient-controlled analgesia (SPCA) (0.02 cc/kg/h of 0.5% bupivacaine) ,0,
edin,1616,3430047,Significantly decreased,"Supplemental opioid demand, PHS criteria and bupivacaine consumption were statistically significant, as, rate of IV opioid consumption, PHS criteria and bupivacaine consumption in SPCA group was significantly lower than in SIA group. (Table 2).", PHS criteria and bupivacaine consumption , subpleural intermittent analgesia (SIA) (0.1cc/kg/6h of 0.5% bupivacaine) , subpleural patient-controlled analgesia (SPCA) (0.02 cc/kg/h of 0.5% bupivacaine) ,0,
edin,1649,2856148,Cannot tell based on the abstract,, acute exacerbation of COPD , Pressure support ventilation (PSV) , Noninvasive ventilation (NIV) ,0,
edin,1649,2856148,No significant difference,"No significant difference between the two groups in duration of MV (6.20 Â± 5.20 days vs. 7.47 Â± 6.38 days, P > 0.05), duration of weaning (35.17 Â± 16.98 and 47.05 Â± 20.98 hours, P > 0.05) or duration of ICU stay (8.47 Â± 4.79 and 10.80 Â± 5.28 days, P > 0.05) in Gp I and Gp II, respectively.", acute exacerbation of COPD , Pressure support ventilation (PSV) , Noninvasive ventilation (NIV) ,0,
edin,1596,2911596,Cannot tell based on the abstract,," HR, MAC and SE values after fentanyl boluses ", Isoflurane-fentanyl anesthesia , Sevoflurane-fentanyl anesthesia ,0,
edin,1596,2911596,No significant difference,"MAC and SE values were similar in SEVO and ISOF groups before fentanyl boluses [0.74 Â± 0.12 versus 0.77 Â± 0.17, (P = .32) and 43.5 Â± 8.1 versus 45.2 Â± 8.3, (P = .47), resp.]."," HR, MAC and SE values after fentanyl boluses ", Isoflurane-fentanyl anesthesia , Sevoflurane-fentanyl anesthesia ,0,
edin,1573,5791393,Cannot tell based on the abstract,, Pain intensity , Without catheter (group I) , With catheter (group II) ,0,
edin,1573,5791393,Significantly increased,It was confirmed that the catheterised patients had sensed more intensive pain than the non-catheterised subjects., Pain intensity , Without catheter (group I) , With catheter (group II) ,0,
edin,1721,5742644,No significant difference,"Finally, there were no adaptive coding effects in any brain regions.", Brain regions with adaptive coding  , Placebo , Haloperidol ,0,
edin,1845,5599918,Cannot tell based on the abstract,, Total dose of remifentanil , Dexmedetomidine plus fentanyl-based IV-PCA (dIV-PCA group) and Conventional thoracic epidural patient-controlled analgesia (E-PCA group) , Fentanyl-based IV-PCA only (IV-PCA group) ,0,
edin,1845,5599918,Significantly increased,"Apart from the total administered dose of remifentanil and ephedrine, there were no significant differences among the 3 groups. The total administered dose of remifentanil was higher in the IV-PCA group than in the E-PCA and dIV-PCA groups (Bonferroni corrected P = 0.017 and P < 0.001, respectively).", Total dose of remifentanil , Dexmedetomidine plus fentanyl-based IV-PCA (dIV-PCA group) and Conventional thoracic epidural patient-controlled analgesia (E-PCA group) , Fentanyl-based IV-PCA only (IV-PCA group) ,0,
edin,1688,5362210,Cannot tell based on the abstract,, Risk of severe brain injury or death , Blinded collection of NIRS values combined with treatment as usual , Cerebral NIRS monitoring in combination with an evidence based intervention guideline ,0,
edin,1688,5362210,Significantly decreased,"Correlation analyses of the following variables showed a significant correlation (p<0.05) between gestational age, birth weight, clinical chorioamnionitis, surfactant, mechanical ventilation, use of vasopressors, blood transfusions, and the burden of cerebral hypoxia within the 4th quartile on one hand and the composite outcome of severe brain injury or death on the other.,As described in the methods, centre, gestational age below 26 weeks, and intervention were forced-entry variables in the model. The following variables remained statistically significant: intervention (OR (95% CI) 0.29 (0.12â0.69; p = 0.003,)), gestational age below 26 weeks (3.33 (1.38â8.06; p = 0.007)), use of vasopressors (3.26 (1.26â8.44; p = 0.014)), and blood transfusion (2.97 (1.22â7.23; p = 0.016)).", Risk of severe brain injury or death , Blinded collection of NIRS values combined with treatment as usual , Cerebral NIRS monitoring in combination with an evidence based intervention guideline ,0,
edin,1797,4900317,No significant difference,"During the postoperative 48 h, there was marked reduction in morphine requirements in Group B compared to Group C, (8.6 Â± 0.94 mg vs. 18.83 Â± 3.4 mg respectively, P = 0.2), lower postoperative pain scores, shorter extubation time (117 Â± 10 min vs. 195 Â± 19 min, respectively, P = 0.03), better respiratory parameters (PaO2/FiO2, PaCO2 and pH), with no incidence of wound infection, no differences in ICU or hospital stay duration.", Wound infection incidence , Presternal catheter with continuous saline infusion (Group C) , Presternal catheter with continuous infusion of 5 mL/h bupivacaine 0.25% (Group B) ,0,
edin,1716,5742644,No significant difference,"Finally, there were no adaptive coding effects in any brain regions.", Brain regions with adaptive coding  , Placebo , Haloperidol ,0,
edin,1694,3600348,Significantly increased,Five (83%) of the patients who failed the SBT in ATC group were reintubated. This represented a higher negative predictive value for ATC of 83% than for PSV which was 56%, Causes of reintubation , Pressure support ventilation , Automatic tube compensation ,0,
edin,1844,5599918,Significantly decreased,"Patients in the dIV-PCA and E-PCA groups needed significantly fewer additional analgesic rescues between 6 and 24 hours after surgery, and had a significantly lower number of bolus attempts and bolus deliveries during the first 24 hours after surgery than those in the IV-PCA group."," Need for additional analgesic rescues, number of bolus attempts, and bolus deliveries ", Fentanyl-based IV-PCA only (IV-PCA group) , Dexmedetomidine plus fentanyl-based IV-PCA (dIV-PCA group) and Conventional thoracic epidural patient-controlled analgesia (E-PCA group) ,0,
edin,1745,5742644,Cannot tell based on the abstract,, Habituation from phase I to phase III , Placebo , Haloperidol ,0,
edin,1745,5742644,No significant difference,"Under haloperidol, however, there was no significant habituation from phase I to phase III.", Habituation from phase I to phase III , Placebo , Haloperidol ,0,
edin,1809,3154934,Cannot tell based on the abstract,, Baseline characteristics , Placebo  , Vitamin A supplementation (VAS) ,0,
edin,1809,3154934,No significant difference,"There were no baseline differences between the children who had received neonatal VAS or placebo, continued to live in the study area and were met at follow-up (Table 1).", Baseline characteristics , Placebo  , Vitamin A supplementation (VAS) ,0,
edin,1753,5742644,Cannot tell based on the abstract,, Subjective well-being , Placebo , Haloperidol ,0,
edin,1753,5742644,No significant difference,"The 2 Ã 3 ANOVA on subjective well-being (mean rating across seven side effects) with drug (placebo/haloperidol) and time (before drug intake, after 2.5 h, at the end) revealed neither a main effect of drug nor an interaction between time and drug (all pâs > 0.531).", Subjective well-being , Placebo , Haloperidol ,0,
edin,1766,4526979,Cannot tell based on the abstract,, Treatment categories change scores , Nonusers , Website users ,0,
edin,1766,4526979,No significant difference,"Summary change scores for treatment categories were also obtained. Between the intervention group and nonusers, there were minimal differences that did not reach statistical significance in core treatments (change scores 10.3% vs 4.7%, P=.17), adjunct treatments (change scores 3.1% vs 1.2%, P=.54), pharmacological treatments (change scores â1.7% vs â2.4%, P=.35), and nonpharmacological treatments (change scores 9.5% vs 4.0%, P=.29).", Treatment categories change scores , Nonusers , Website users ,0,
edin,1709,5742644,Cannot tell based on the abstract,, Stimulation outcomes , Placebo , Haloperidol ,0,
edin,1709,5742644,No significant difference,Separate post hoc t-tests for each context revealed no difference between both stimulation outcomes (all pâs > 0.093)., Stimulation outcomes , Placebo , Haloperidol ,0,
edin,1722,5742644,Cannot tell based on the abstract,, Discrimination between stimulation intensities , Placebo , Haloperidol ,0,
edin,1722,5742644,No significant difference,"The mean proportion of hits for each condition is displayed in Table 3. A 2 Ã 3 Ã 2 way ANOVA on the mean hit rate revealed no main effect of stimulation magnitude, drug treatment and there was no interaction between any factors (all pâs > 0.081).", Discrimination between stimulation intensities , Placebo , Haloperidol ,0,
edin,1697,4045368,Cannot tell based on the abstract,, Severity of the tibial plateau fractures , Nonlocking plate fixation , Locking plate fixation ,0,
edin,1697,4045368,No significant difference,No significant differences were found between the two groups in the severity of the tibial plateau fractures according to the Schatzker (P = 0.556) or AO (P = 0.257) classifications systems (Figures 2 and 3)., Severity of the tibial plateau fractures , Nonlocking plate fixation , Locking plate fixation ,0,
edin,1689,5362210,Significantly increased,"Significantly more infants with a cerebral burden of hypoxia within the 4th quartile versus infants within quartile 1â3 were diagnosed with severe intracranial haemorrhage (11/39 versus 11/117, p = 0.003), had low burst rate on EEG (12/28 versus 21/103, p = 0.015), or died (14/41 versus 18/123, p = 0.006), whereas none of these events were significantly associated with cerebral hyperoxia.", Burden of hypoxia within the 4th quartile versus quartile 1Ã¢â¬â3 , Blinded collection of NIRS values combined with treatment as usual , Cerebral NIRS monitoring in combination with an evidence based intervention guideline ,0,
edin,1821,5003869,Cannot tell based on the abstract,," Therapy discontinuation in patients starting with RAS-inhibitors, statins and bisphosphonates. ", Usual care , Pharmacist telephone counseling ,0,
edin,1821,5003869,No significant difference,"For patients starting with RAS-inhibitors 22.6% of the patients in the intervention arm discontinued therapy compared to 27.9% of patients with usual care which is significantly lower (HR 0.77, 95% CI 0.69, 0.91). The result of the PP-analysis is comparable but not statistically significant. For statins and bisphosphonate users, discontinuation rates were not significantly different (HR 0.87, 95% CI 0.73, 1.10, respectively 0.73, 95% CI 0.56, 1.02)."," Therapy discontinuation in patients starting with RAS-inhibitors, statins and bisphosphonates. ", Usual care , Pharmacist telephone counseling ,0,
edin,1707,5556332,Cannot tell based on the abstract,, Satisfaction with pain control as reported by surgeons , No PAN administered before the surgery ," Combination of pregabalin, acetaminophen, and naproxen (PAN) before the surgery ",0,
edin,1707,5556332,Significantly increased,Surgeons reported more satisfaction with pain control in the medication group in 24 and 48 hours after surgery (P = 0.001) (Table 2)., Satisfaction with pain control as reported by surgeons , No PAN administered before the surgery ," Combination of pregabalin, acetaminophen, and naproxen (PAN) before the surgery ",0,
edin,1704,5556332,Significantly decreased,"Patients in the PAN group had significantly lower UPAT scores at 0, 2, 4, 6, 12, 24 and 48 hours after the surgery than those in the control group (P = 0.008, 0.021, 0.008, 0.047, 0.004, 0.001, and 0.001).", UPAT scores , No PAN administered before the surgery ," Combination of pregabalin, acetaminophen, and naproxen (PAN) before the surgery ",0,
edin,1817,5003869,Cannot tell based on the abstract,, Mean adherence rates , Usual care , Pharmacist telephone counseling ,0,
edin,1817,5003869,No significant difference,In the overall ITT analysis we found a mean adherence rate (MPRm) of 74.7% (SD 37.5) for intervention patients and 74.5% (SD 37.9) for control patients (see Table 2)., Mean adherence rates , Usual care , Pharmacist telephone counseling ,0,
edin,1759,4199180,Cannot tell based on the abstract,, Rate of morbidity and complications , Pentoxifylline alone (Group 1) , Pentoxifylline plus prednisolone (Group 2) ,0,
edin,1759,4199180,No significant difference,The morbidity/complication profiles among the two groups were comparable [Table 2]., Rate of morbidity and complications , Pentoxifylline alone (Group 1) , Pentoxifylline plus prednisolone (Group 2) ,0,
edin,1720,5742644,Cannot tell based on the abstract,, Habituation from phase I to phase III , Placebo , Haloperidol ,0,
edin,1720,5742644,No significant difference,"Under haloperidol, however, there was no significant habituation from phase I to phase III.", Habituation from phase I to phase III , Placebo , Haloperidol ,0,
edin,1727,5742644,Cannot tell based on the abstract,, Discrimination between stimulation intensities , Placebo , Haloperidol ,0,
edin,1727,5742644,Cannot tell based on the abstract,, Discrimination between stimulation intensities , Placebo , Haloperidol ,0,
edin,1727,5742644,No significant difference,"The mean proportion of hits for each condition is displayed in Table 3. A 2 Ã 3 Ã 2 way ANOVA on the mean hit rate revealed no main effect of stimulation magnitude, drug treatment and there was no interaction between any factors (all pâs > 0.081).", Discrimination between stimulation intensities , Placebo , Haloperidol ,0,
edin,1729,5742644,Cannot tell based on the abstract,, Stimulation outcomes , Placebo , Haloperidol ,0,
edin,1729,5742644,No significant difference,Separate post hoc t-tests for each context revealed no difference between both stimulation outcomes (all pâs > 0.093)., Stimulation outcomes , Placebo , Haloperidol ,0,
edin,1802,4900317,No significant difference,"During the postoperative 48 h, there was marked reduction in morphine requirements in Group B compared to Group C, (8.6 Â± 0.94 mg vs. 18.83 Â± 3.4 mg respectively, P = 0.2), lower postoperative pain scores, shorter extubation time (117 Â± 10 min vs. 195 Â± 19 min, respectively, P = 0.03), better respiratory parameters (PaO2/FiO2, PaCO2 and pH), with no incidence of wound infection, no differences in ICU or hospital stay duration.", Wound infection incidence , Presternal catheter with continuous saline infusion (Group C) , Presternal catheter with continuous infusion of 5 mL/h bupivacaine 0.25% (Group B) ,0,
edin,1836,5599918,Cannot tell based on the abstract,, Total dose of ephedrine , Conventional thoracic epidural patient-controlled analgesia (E-PCA group) , Fentanyl-based IV-PCA only (IV-PCA group) ,0,
edin,1836,5599918,Significantly decreased,"In addition, the patients in the E-PCA group required more ephedrine than those in the IV-PCA group (8.4 Â± 9.1 vs. 4.0 Â± 4.8 Î¼g; Bonferroni corrected P = 0.013).", Total dose of ephedrine , Conventional thoracic epidural patient-controlled analgesia (E-PCA group) , Fentanyl-based IV-PCA only (IV-PCA group) ,0,
edin,1696,4045368,Cannot tell based on the abstract,, Follow-up duration , Nonlocking plate fixation , Locking plate fixation ,0,
edin,1696,4045368,No significant difference,"No difference was observed in the duration of follow-up between the locking plate and nonlocking plate groups (10.61 Â± 3.05 months versus 12.95 Â± 2.63 months, P = 0.158).", Follow-up duration , Nonlocking plate fixation , Locking plate fixation ,0,
edin,1765,4526979,No significant difference,"With the exception of health service navigation, mean effect sizes from all other heiQ domains showed a positive trend for My Joint Pain users compared to the nonusers, although the differences between groups did not reach statistical significance.", Domains examined for the heiQ , Nonusers , Website users ,0,
edin,1728,5742644,Cannot tell based on the abstract,, Subjective well-being , Placebo , Haloperidol ,0,
edin,1728,5742644,No significant difference,"The 2 Ã 3 ANOVA on subjective well-being (mean rating across seven side effects) with drug (placebo/haloperidol) and time (before drug intake, after 2.5 h, at the end) revealed neither a main effect of drug nor an interaction between time and drug (all pâs > 0.531)", Subjective well-being , Placebo , Haloperidol ,0,
edin,1841,5599918,Cannot tell based on the abstract,, Total dose of ephedrine , Conventional thoracic epidural patient-controlled analgesia (E-PCA group) , Fentanyl-based IV-PCA only (IV-PCA group) ,0,
edin,1841,5599918,Significantly decreased,"In addition, the patients in the E-PCA group required more ephedrine than those in the IV-PCA group (8.4 Â± 9.1 vs. 4.0 Â± 4.8 Î¼g; Bonferroni corrected P = 0.013).", Total dose of ephedrine , Conventional thoracic epidural patient-controlled analgesia (E-PCA group) , Fentanyl-based IV-PCA only (IV-PCA group) ,0,
edin,1782,5697397,Significantly increased,Native whey ingestion induced a greater phosphorylation of p70S6K than milk 180Â min after exercise (Pâ=â0.03)., Phosphorylation of p70S6K 3 hours after exercise , Milk protein  , Native whey protein ,0,
edin,1813,5003869,Cannot tell based on the abstract,"Comparing patients with counseling to patients with usual care (per protocol analysis), adherence was statistically significant higher for patients starting with RAS-inhibitors, statins and bisphosphonates."," Adherence in patients starting with RAS-inhibitors, statins and bisphosphonates. ", Usual care , Pharmacist telephone counseling ,0,
edin,1813,5003869,No significant difference,"The mean adherence rate in patients in the intervention arm starting with RAS-inhibitors was 84.1% (SD 31.6) compared to 78.5% (SD 36.6) in the usual care arm which is a significant improvement with a adherence difference based on mixed-effect models of 5.16% (95% CI 1.17, 10.03) (See,In statin users, patients in the intervention arm had a mean adherence rate of 80.5% (32.4) compared to 75.1% (36.8) in the usual care arm, which is a non-significant adherence difference of 4.08% (95% CI â0.81, 6.62).,n patients starting with bisphosphonates, the mean adherence rate in intervention arm (75.2%) was not different from the usual care arm (73.3%) neither was the proportion of adherent patients (70.2% respectively 67.1%)."," Adherence in patients starting with RAS-inhibitors, statins and bisphosphonates. ", Usual care , Pharmacist telephone counseling ,0,
edin,1780,4137650,Significantly decreased,The rise in HR (P = 0.08481) and rate pressure product (P = 0.0666) at the time of intubation were minimal and was statistically significant up to 15 min in Group D., Mean rate pressure product up to 15 min after intubation , Dexmedetomidine (Group D) , Placebo (Group C) and esmolol (Group E) ,0,
edin,1718,5742644,Cannot tell based on the abstract,, Subjective well-being , Placebo , Haloperidol ,0,
edin,1718,5742644,No significant difference,"The 2 Ã 3 ANOVA on subjective well-being (mean rating across seven side effects) with drug (placebo/haloperidol) and time (before drug intake, after 2.5 h, at the end) revealed neither a main effect of drug nor an interaction between time and drug (all pâs > 0.531).", Subjective well-being , Placebo , Haloperidol ,0,
edin,1705,5556332,Significantly decreased,The mean dose of postoperative morphine consumption in the PAN group was 37% less than the control group (P = 0.001)., Consumption of morphine after the surgery , No PAN administered before the surgery ," Combination of pregabalin, acetaminophen, and naproxen (PAN) before the surgery ",0,
edin,1755,5742644,Cannot tell based on the abstract,, Habituation from phase I to phase III , Placebo , Haloperidol ,0,
edin,1755,5742644,No significant difference,"Under haloperidol, however, there was no significant habituation from phase I to phase III.", Habituation from phase I to phase III , Placebo , Haloperidol ,0,
edin,1756,5742644,No significant difference,"Finally, there were no adaptive coding effects in any brain regions.", Brain regions with adaptive coding  , Placebo , Haloperidol ,0,
edin,1711,5742644,No significant difference,"Finally, there were no adaptive coding effects in any brain regions.", Brain regions with adaptive coding  , Placebo , Haloperidol ,0,
edin,1837,5599918,Significantly decreased,"The postoperative pain intensity was significantly lower in the dIV-PCA and E-PCA groups than in the IV-PCA group, but comparable between the dIV-PCA group and the E-PCA group.", Pain intensity after surgery , Fentanyl-based IV-PCA only (IV-PCA group) , Dexmedetomidine plus fentanyl-based IV-PCA (dIV-PCA group) and conventional thoracic epidural patient-controlled analgesia (E-PCA group) ,0,
edin,1834,5599918,Significantly decreased,"Patients in the dIV-PCA and E-PCA groups needed significantly fewer additional analgesic rescues between 6 and 24 hours after surgery, and had a significantly lower number of bolus attempts and bolus deliveries during the first 24 hours after surgery than those in the IV-PCA group."," Need for additional analgesic rescues, number of bolus attempts, and bolus deliveries ", Fentanyl-based IV-PCA only (IV-PCA group) , Dexmedetomidine plus fentanyl-based IV-PCA (dIV-PCA group) and Conventional thoracic epidural patient-controlled analgesia (E-PCA group) ,0,
edin,1786,4878364,Significantly increased,"When compared to the control group, the exercise group experienced significant improvements in gait speed (F(4.078) = 8.265, p = 0.007),", Gait speed , No exercise , Exercise program ,0,
edin,1778,4137650,Significantly increased,The mean arterial pressure was significantly increased in patients receiving placebo (P < 0.0001) and esmolol (P < 0.0001) after laryngoscopy and intubation compared with baseline value and Group D (P = 0.6294). T, Mean systolic arterial pressure after intubation , Dexmedetomidine (Group D) , Placebo (Group C) and esmolol (Group E) ,0,
edin,1792,3798206,Significantly increased,"In the pooled analysis of individual patient data comparing dabigatran with warfarin (SPAF and venous thromboembolism treatment indications), myocardial infarction occurrence favored warfarin (odds ratio [OR] 1.30, 95% confidence interval [CI] 0.96â1.76 for dabigatran 110 mg twice daily and OR 1.42, 95% CI 1.07â1.88 for dabigatran 150 mg twice daily).", Rates of myocardial infarction  , Warfarin , Dabigatran ,0,
edin,1814,5003869,Cannot tell based on the abstract,, Adherence in patients starting with antidepressants , Usual care , Pharmacist telephone counseling ,0,
edin,1814,5003869,No significant difference,"For antidepressants we found no significant difference in adherence rate between patients in the intervention arm (62.7% SD 41.7) and patients with usual care (66.8%, 40.9).", Adherence in patients starting with antidepressants , Usual care , Pharmacist telephone counseling ,0,
edin,1808,111193,Cannot tell based on the abstract,, Hospital stay , No preoperative hemodilution (non-ANH) , Preoperative acute normovolaemic hemodilution (ANH) ,0,
edin,1808,111193,No significant difference,Fifty percent in the ANH group received homologous blood transfusion during the hospital stay (771 mL pr. patient transfused) vs. 42 % in non-ANH group (800 mL pr. patient transfused) (ns)., Hospital stay , No preoperative hemodilution (non-ANH) , Preoperative acute normovolaemic hemodilution (ANH) ,0,
edin,1763,4526979,No significant difference,"Following 12 months of exposure to the website, there were significant improvements for users compared to nonusers in self-management (absolute change score 15% vs 2%, P=.001) and weight reduction (absolute change scores 3% vs â6%, P=.03) measured on the OAQI."," Self-management as measured on the OAQI, after 12 months ", Nonusers , Website users ,0,
edin,1822,3388481,Significantly increased,In the control group (n = 122) 27.3% (n = 33) had a statistically significant lower successful ECV procedure than NLP (P = 0.05) and hypnosis and NLP (P = 0.03)., Success of external cephalic version (ECV) procedure , Standard medical care alone , Hypnosis and Neurolinguistic Programming (NLP) ,0,
edin,1826,4733710,Cannot tell based on the abstract,, Hemoglobin at day 1 after surgery , Control group , Peri-operative Transfusion Trigger Score of Emergency [POTTS-E] group ,0,
edin,1826,4733710,No significant difference,"Peri-operative Transfusion Trigger Score of Emergency group and control group were compared in age, gender, body mass index, ASA score, and operation area; Heart rate, mean arterial pressure, SpO2, body temperature, and shock index when entering into the operation room; there was no statistical difference between the two groups for Hb values and APACHE II scores after entering into the operation room,Table 4
The two groups of patients are compared in vital signs and Hb (mean Â± SD)", Hemoglobin at day 1 after surgery , Control group , Peri-operative Transfusion Trigger Score of Emergency [POTTS-E] group ,0,
edin,1831,2967098,No significant difference,Comparison of the improvement rate in both study groups revealed no significant difference., Improvement rate , Low dose (5 mg/day) haloperidol , High dose (20 mg/day) haloperidol ,0,
edin,1767,4780150,No significant difference,"fter intervention, total body stores (TBS) and liver retinol concentrations did not differ between intervention and control groups;", Total body stores of vitamin A , Sachets of Ã¢â¬ÅSprinklesÃ¢â¬ï¿½ without vitamin A , Sachets of Ã¢â¬ÅSprinklesÃ¢â¬ï¿½ with vitamin A ,0,
edin,1768,4780150,No significant difference,"After intervention, total body stores (TBS) and liver retinol concentrations did not differ between intervention and control groups;", Vitamin A concentrations in the liver , Sachets of Ã¢â¬ÅSprinklesÃ¢â¬ï¿½ without vitamin A , Sachets of Ã¢â¬ÅSprinklesÃ¢â¬ï¿½ with vitamin A ,0,
edin,1757,5742644,Cannot tell based on the abstract,, Discrimination between stimulation intensities , Placebo , Haloperidol ,0,
edin,1757,5742644,No significant difference,"The mean proportion of hits for each condition is displayed in Table 3. A 2 Ã 3 Ã 2 way ANOVA on the mean hit rate revealed no main effect of stimulation magnitude, drug treatment and there was no interaction between any factors (all pâs > 0.081).", Discrimination between stimulation intensities , Placebo , Haloperidol ,0,
edin,1805,111193,Cannot tell based on the abstract,, Surgery duration , No preoperative hemodilution (non-ANH) , Preoperative acute normovolaemic hemodilution (ANH) ,0,
edin,1805,111193,No significant difference,Time used for anaesthesia (from patient enters the operating theatre to entering the recovery room) and duration of surgery was identical between groups., Surgery duration , No preoperative hemodilution (non-ANH) , Preoperative acute normovolaemic hemodilution (ANH) ,0,
edin,1779,4137650,Cannot tell based on the abstract,, Mean diastolic arterial pressure after intubation , Dexmedetomidine (Group D) , Placebo (Group C) and esmolol (Group E) ,0,
edin,1779,4137650,Significantly increased,The DAP levels in Group D were significantly lower than Groups C and E at all times after intubation., Mean diastolic arterial pressure after intubation , Dexmedetomidine (Group D) , Placebo (Group C) and esmolol (Group E) ,0,
edin,1853,5145296,Cannot tell based on the abstract,, chronic cough ," PPIs, lifestyle changes, and placebo "," PPIs, lifestyle changes, and daily zinc capsules ",0,
edin,1853,5145296,Significantly decreased,"Based on the results obtained byFisherâs exact test, the statistical difference between the drug and placebo groups in terms of presentationsâ frequencies was statistically significant in 6 items: Throat cleansing (p=0.05), chronic cough (p=0.04), postnasal drip (p=0.03), foreign body sensation (p=0.003), heart burn (p=0.003), and otitis media (p=0.003).,<td colspan=""1"" rowspan=""1"">Chronic cough</td><td colspan=""1"" rowspan=""1"">50 (71.4)</td><td colspan=""1"" rowspan=""1"">12 (17.1)</td><td colspan=""1"" rowspan=""1"">0.001</td><td colspan=""1"" rowspan=""1"">44 (62.9)</td><td colspan=""1"" rowspan=""1"">26 (37.1)</td><td colspan=""1"" rowspan=""1"">0.001</td>", chronic cough ," PPIs, lifestyle changes, and placebo "," PPIs, lifestyle changes, and daily zinc capsules ",0,
edin,2071,3835146,Cannot tell based on the abstract,, C3 levels , placebo ," atacicept (single dose: 3, 9 or 18 mg/kg; or multiple dose: 2 Ãâ 9 mg/kg) ",0,
edin,2071,3835146,No significant difference,"C3 levels remained within the normal range throughout the study for most patients. At baseline, only three of 24 patients had C3 values below the normal range (0.9â1.8 g/L): one patient in the 9 mg/kg group, one patient in the 18 mg kg group and one patient in the 2 Ã 9 mg/kg group. All three of these patients showed transient increases in C3 to normal levels during treatment.", C3 levels , placebo ," atacicept (single dose: 3, 9 or 18 mg/kg; or multiple dose: 2 Ãâ 9 mg/kg) ",0,
edin,1971,4404560,Cannot tell based on the abstract,, the falls rate in the women only , routine activity , exercise  ,0,
edin,1971,4404560,No significant difference,There was no significant difference in the falls rate reduction in the women only analysis compared to the overall group., the falls rate in the women only , routine activity , exercise  ,0,
edin,2060,5404215,Cannot tell based on the abstract,, flow-mediated dilation (FMD) score at 240 min postconsumption , baseline , 3 ounces (85 g) ground peanuts ,0,
edin,2060,5404215,No significant difference,There were no significant differences in FMD between baseline and 240 min postconsumption of the peanut shake (Figure 2)., flow-mediated dilation (FMD) score at 240 min postconsumption , baseline , 3 ounces (85 g) ground peanuts ,0,
edin,2054,3793419,Cannot tell based on the abstract,, burning sensation ," Group 2-Patients were administered 0.5 ml intralesional injection Hyaluronidase 1,500 IU and 0.5 ml intralesional injection Hydrocortisone acetate 25 mg/ml in each buccal mucosa once a week "," tablet colchicine orally, 0.5 mg twice daily and 0.5 ml intralesional injection Hyaluronidase 1,500 IU into each buccal mucosa once a week ",0,
edin,2054,3793419,No significant difference,Almost all the patients in both the groups were relieved from burning sensation after treatment., burning sensation ," Group 2-Patients were administered 0.5 ml intralesional injection Hyaluronidase 1,500 IU and 0.5 ml intralesional injection Hydrocortisone acetate 25 mg/ml in each buccal mucosa once a week "," tablet colchicine orally, 0.5 mg twice daily and 0.5 ml intralesional injection Hyaluronidase 1,500 IU into each buccal mucosa once a week ",0,
edin,1900,5045666,Significantly increased,"The mean serum levels of both HDL-C and vitamin D showed a significant rise following the treatment in the study group (P = 0.007 and P < 0.001, respectively), whereas both variables decreased slightly in the control group (P = 0.27).", Mean serum levels of vitamin D , Placebo , Vitamin D supplement ,0,
edin,1925,4374260,Significantly decreased,Postmicturition dribble annoyed 12.8% of those who received 50 mg tramadol and 33.6% of those who received 100 mg tramadol (P < 0.001)., Postmicturition dribble , placebo  , 50 mg of tramadol and 100 mg of tramadol ,0,
edin,1973,5376493,Significantly increased,"Non-technical skills concerning situation awareness (p<.01, r=0.5) and teamwork (p<.01, r=0.45) improved from simulation I to II in the NTS group.", Non-technical skills concerning situation awareness and teamwork , medical seminar , non-technical skills seminar ,0,
edin,1913,5630555,No significant difference,"Although the titers of GADAb were not significantly different between the S and P groups during the study, the change ratio of the GADAb titers from baseline was significantly inversely correlated with the change ratio of the âC-peptide values from baseline in the S group (pÂ =Â 0.003); in particular, when the GADAb titers decreased from baseline, the âC-peptide values frequently increased.", The titers of GADAb , pioglitazone , sitagliptin ,0,
edin,1891,3687261,Cannot tell based on the abstract,, incremental areas under the curve ," placebo and sucralose, or sitagliptin and sucralose "," placebo and d-xylose, or sitagliptin and d-xylose ",0,
edin,1891,3687261,Invalid Prompt,, incremental areas under the curve ," placebo and sucralose, or sitagliptin and sucralose "," placebo and d-xylose, or sitagliptin and d-xylose ",1, incremental areas under the curve is mentioned in the methods section of the article. I was not able to find any data in results or conclusion section
edin,2093,5452066,Cannot tell based on the abstract,, Median OS , topotecan , PM01183 ,0,
edin,2093,5452066,No significant difference,"Median OS was 9.7âmonths (95% CI, 7.7â19.3âmonths) with PM01183, and 8.5âmonths (95% CI, 3.3â15.6âmonths) with topotecan (Pâ=â0.2871).", Median OS , topotecan , PM01183 ,0,
edin,2081,4628236,Cannot tell based on the abstract,, the slope of EDPVR , placebo orally for 8 weeks , the sGC activator cinaciguat (10 mg/kg/day) orally for 8 weeks ,0,
edin,2081,4628236,Significantly decreased,"In comparison with Co group the slope of EDPVR tended to increase (PÂ =Â 0.063) in diabetic animals, which was significantly reduced by cinaciguat (Fig.Â 6b).", the slope of EDPVR , placebo orally for 8 weeks , the sGC activator cinaciguat (10 mg/kg/day) orally for 8 weeks ,0,
edin,2039,4882968,No significant difference,"Before intervention, mean severity of mania in the experimental group (23.50 Â± 7.02) and control group (23.70 Â± 8.09) was not significant (P â¤ 0.89).", mean severity of mania , placebo , omega-3 supplement ,0,
edin,1999,5012042,No significant difference,"Circumferential and radial strains derived from FG acquisitions were slightly reduced compared to NF acquisitions (â16âÂ±â2Â % vs â17âÂ±â2Â %, pâ<â0.001; 40âÂ±â10Â % vs 44âÂ±â11Â %, pâ=â0.005, respectively).", Circumferential and radial strains , underwent a respiratory navigator-gated 2D spiral cine displacement encoding with stimulated echoes (DENSE) CMR acquisition first with no feedback (NF)  , underwent a respiratory navigator-gated 2D spiral cine displacement encoding with stimulated echoes (DENSE) CMR acquisition first with the feedback game (FG) ,0,
edin,1901,5045666,Cannot tell based on the abstract,, Baseline levels of high-density lipoprotein cholesterol (HDL-C) and vitamin D , Placebo , Vitamin D supplement ,0,
edin,1901,5045666,No significant difference,"There was no statistically significant difference in the mean serum levels of HDL-C and vitamin D between the two groups after the intervention (P = 0.11 and P = 0.20, respectively).", Baseline levels of high-density lipoprotein cholesterol (HDL-C) and vitamin D , Placebo , Vitamin D supplement ,0,
edin,2079,4628236,Cannot tell based on the abstract,, Expression of MMP-9 and MMP-2 , placebo orally for 8 weeks , the sGC activator cinaciguat (10 mg/kg/day) orally for 8 weeks ,0,
edin,2079,4628236,No significant difference,"DM was associated with dysregulation of the MMP system indicated by markedly increased MMP-9/TIMP-1 and reduced MMP-2/TIMP-2 gene expression ratios (Fig.Â 4a).,Expression of MMP-9 showed a twofold increase in DM, while MMP-2 remained unchanged (Fig.Â 4c).,Cinaciguat did not significantly alter these parameters (Fig.Â 4c).", Expression of MMP-9 and MMP-2 , placebo orally for 8 weeks , the sGC activator cinaciguat (10 mg/kg/day) orally for 8 weeks ,0,
edin,2059,3655565,Cannot tell based on the abstract,," heart rate, respiratory rate, mean arterial pressure, peripheral oxygen saturation [SpO2], tidal volumes [V T], minute ventilation [V E], dynamic lung compliance [Cdyn], and rapid shallow breathing index the ratio of the frequency of breathing (f) divided by the tidal volume (V T) ", standard care  , two-day adjunctive acupressure with standard care  ,0,
edin,2059,3655565,No significant difference,"As Table 2 shows, there were no statistically significant differences between the three treatment arms on the outcome variables of interest at baseline.,To the best of our knowledge, this trial was the first to investigate the potential benefits of adjunctive acupressure on weaning indices in a group of stable, mechanically ventilated coma patients."," heart rate, respiratory rate, mean arterial pressure, peripheral oxygen saturation [SpO2], tidal volumes [V T], minute ventilation [V E], dynamic lung compliance [Cdyn], and rapid shallow breathing index the ratio of the frequency of breathing (f) divided by the tidal volume (V T) ", standard care  , two-day adjunctive acupressure with standard care  ,0,
edin,2026,3178704,Cannot tell based on the abstract,," body weight, BMI, body fat, muscle mass and VFA ", baseline , diet with resistance training (RT) ,0,
edin,2026,3178704,Significantly increased,"The RT group had increases in body weight, BMI, body fat, muscle mass and VFA as measured by CT following the 12-week program."," body weight, BMI, body fat, muscle mass and VFA ", baseline , diet with resistance training (RT) ,0,
edin,1857,4223282,Cannot tell based on the abstract,, men discussing and using condoms within stable relationships , no intervention , SASA! community mobilization intervention program ,0,
edin,1857,4223282,Significantly increased,"Positive impacts include increased discussion about, and use of, condoms within regular partnerships in the past year with men in intervention communities twice as likely to report condom use with their partner at last intercourse than men in control communities (aRR 2.03, 95% CI 1.22â3.39).", men discussing and using condoms within stable relationships , no intervention , SASA! community mobilization intervention program ,0,
edin,1944,4481831,Cannot tell based on the abstract,, durations of the gait phases , baseline , after Ice application ,0,
edin,1944,4481831,Cannot tell based on the abstract,, durations of the gait phases , baseline , after Ice application ,0,
edin,1944,4481831,No significant difference,Ice application did not affect the durations of the gait phases (Table 2)., durations of the gait phases , baseline , after Ice application ,0,
edin,1889,3687261,Significantly decreased,"Both peak blood glucose and the amplitude of glycemic excursion were lower after PX and SC than PC (P < 0.01 for each) and were lowest after SX (P < 0.05 for each), while overall blood glucose was lower after SX than PC (P < 0.05).", peak blood glucose , placebo and sucralose , sitagliptin and d-xylose ,0,
edin,1876,3259296,Significantly decreased,"In study 1, the 5 g xylose-containing solutions exhibited significantly lower area under the glucose curve (AUCg) and area under the insulin curve (AUCi) values for 0-15 min (P < 0.0001, P < 0.0001), 0-30 min (P < 0.0001, P < 0.0001), 0-45 min (P < 0.0001, P < 0.0001), 0-60 min (P < 0.0001, P < 0.0001), 0-90 min (P < 0.0001, P < 0.0001) and 0-120 min (P = 0.0071, P = 0.0016). In study 2, the test meal exhibited significantly lower AUCg and AUCi values for 0-15 min (P < 0.0001, P < 0.0001), 0-30 min (P < 0.0001, P < 0.0001), 0-45 min (P < 0.0001, P = 0.0005), 0-60 min (P = 0.0002, P = 0.0025), and 0-90 min (P = 0.0396, P = 0.0246)."," AUCg and AUCi values for 0-15 min, 0-30 min, 0-45 min, 0-60 min, and 0-90 min in study 2 ", sucrose-containing meal , xylose-containing test meal ,0,
edin,1881,5291156,Cannot tell based on the abstract,, pain evaluated by VAS in the presence of sedation , lidocaine spray and viscous solution , lidocaine spray ,0,
edin,1881,5291156,No significant difference,"There were almost no differences in pain evaluated by VAS (2.27âÂ±â2.88 vs. 2.33âÂ±â2.63, Pâ=â0.85), pharyngeal observation time (72.0âÂ±â34.7 vs. 67.0âÂ±â27.8 seconds, Pâ=â0.15), and the number of gag reflexes (2.12âÂ±â2.58 vs. 1.68âÂ±â2.27, Pâ=â0.10) in the two groups.,Subgroup analysis for presence of sedation (223 cases) revealed almost no differences between the 2 groups in the number of pharyngeal observation sites (8.48âÂ±â2.16 vs. 8.79âÂ±â1.85, Pâ=â0.25), pain evaluated by VAS (1.08âÂ±â2.06 vs. 1.33âÂ±â2.16, Pâ=â0.79), pharyngeal observation time (73.3âÂ±â36.6 vs. 68.3âÂ±â30.9 seconds, Pâ=â0.14), and number of gag reflexes (2.02âÂ±â2.44 vs. 1.86âÂ±â2.45, Pâ=â0.63) (Tableâ4).", pain evaluated by VAS in the presence of sedation , lidocaine spray and viscous solution , lidocaine spray ,0,
edin,1916,3276929,Significantly decreased,Morning stiffness decreased more (P<0.001) in yoga (post 1=68.6% and post 2=98.1%) than control group (post 1=38.6% and post 2=71.6%)., Morning stiffness in participants with OA knees , control , yoga ,0,
edin,1855,5145296,Cannot tell based on the abstract,, foreign body sensation ," PPIs, lifestyle changes, and placebo "," PPIs, lifestyle changes, and daily zinc capsules ",0,
edin,1855,5145296,Significantly increased,"Based on the results obtained byFisherâs exact test, the statistical difference between the drug and placebo groups in terms of presentationsâ frequencies was statistically significant in 6 items: Throat cleansing (p=0.05), chronic cough (p=0.04), postnasal drip (p=0.03), foreign body sensation (p=0.003), heart burn (p=0.003), and otitis media (p=0.003).", foreign body sensation ," PPIs, lifestyle changes, and placebo "," PPIs, lifestyle changes, and daily zinc capsules ",0,
edin,1940,5340016,Significantly decreased,"However, weekly PE has a higher response rate and superior down-staging effects.", down-staging effect , weekly paclitaxelÃ¢â¬âepirubicin (PE) regimen , receive 4Ã¢â¬â6 cycles of neoadjuvant chemotherapy with tri-weekly 5-fluorouracilÃ¢â¬âepirubicinÃ¢â¬âcyclophosphamide (FEC) regimen ,0,
edin,2072,3921228,Significantly increased,Significant pre-post scan decreases in anxiety ratings and increases in happiness ratings were evident in the experimental versus control group., happiness  , rtfMRI-nf from the horizontal segment of the intraparietal sulcus (HIPS , rtfMRI-nf from left amygdala (LA) ,0,
edin,1992,3232004,Cannot tell based on the abstract,, The response rate , placebo , sertraline ,0,
edin,1992,3232004,No significant difference,"The response rate was slightly higher for sertraline than for placebo, but this difference was not statistically significant (25/43 (58%) vs 18/46 (39%) responders, Ï2(1)=1.39, P=0.24).", The response rate , placebo , sertraline ,0,
edin,1976,5376493,Cannot tell based on the abstract,," Ã¢â¬Ëcommand roles and responsibilitiesÃ¢â¬â¢, Ã¢â¬Ëspeaking upÃ¢â¬â¢, Ã¢â¬ËdebriefingÃ¢â¬â¢, Ã¢â¬Ëfeedback and critiqueÃ¢â¬â¢, Ã¢â¬Ërealistic appraisal of stressÃ¢â¬â¢, and Ã¢â¬Ëdenial of stressÃ¢â¬â¢ ", medical seminar , non-technical skills seminar ,0,
edin,1976,5376493,No significant difference,"Data for âcommand roles and responsibilitiesâ, âspeaking upâ, âdebriefingâ, âfeedback and critiqueâ, ârealistic appraisal of stressâ, and âdenial of stressâ showed no significant effects between or within groups over time (.06"," Ã¢â¬Ëcommand roles and responsibilitiesÃ¢â¬â¢, Ã¢â¬Ëspeaking upÃ¢â¬â¢, Ã¢â¬ËdebriefingÃ¢â¬â¢, Ã¢â¬Ëfeedback and critiqueÃ¢â¬â¢, Ã¢â¬Ërealistic appraisal of stressÃ¢â¬â¢, and Ã¢â¬Ëdenial of stressÃ¢â¬â¢ ", medical seminar , non-technical skills seminar ,0,
edin,1886,4188762,Cannot tell based on the abstract,, heart rate ," normal saline, lidocaine, or ketamine ", remifentanil ,0,
edin,1886,4188762,No significant difference,There were no significant differences in mean blood pressure and heart rate before injection of pretreatment drugs among the groups (Figs. 1 and 2)., heart rate ," normal saline, lidocaine, or ketamine ", remifentanil ,0,
edin,2095,5360580,No significant difference,"In an intention-to-treat analysis including both mild AD (20Â â¤Â MMSE-JÂ â¤Â 23) and MCI (24Â â¤Â MMSE-JÂ â¤Â 27), no significant difference was shown between the treatment and placebo groups in the primary and secondary outcomes, with no severe adverse events in either group.", occurrence of adverse events , placebo , 1 mg/day of Pls purified from scallop ,0,
edin,1996,5808396,No significant difference,"Participants receiving CPT experienced moderate reductions in felt stigma relative to those in individual support (Cohenâs Dâ=â0.44, pâ=âvalueâ=â0.02) following the end of treatment, though this difference was no longer significant six-months later (Cohenâs Dâ=â0.45, pâ=âvalueâ=â0.12).", felt stigma after 6 months of treatment , baseline , Cognitive Processing Therapy or individual support ,0,
edin,1965,4723180,Cannot tell based on the abstract,, passive drag ," Head-up (HU): the swimmer looked directly forward, and his ears were above the forearms and fully extended over the head. "," Head-middle (HM): the swimmer looked downward at 90 degrees to the swimming direction, in a neutral position. The swimmerÃ¢â¬â¢s ears were covered by the forearms, which were fully extended over the head or Head-down (HD): the swimmer looked backwards, and his ears were below the forearms, which were fully extended over the head. ",0,
edin,1965,4723180,Significantly decreased,"Regarding the swimmerâs head position, passive drag was found to be significantly lower in the LA condition (with the arms in front of the head) for the HD and HM than the HU at all speeds (Figure 2).", passive drag ," Head-up (HU): the swimmer looked directly forward, and his ears were above the forearms and fully extended over the head. "," Head-middle (HM): the swimmer looked downward at 90 degrees to the swimming direction, in a neutral position. The swimmerÃ¢â¬â¢s ears were covered by the forearms, which were fully extended over the head or Head-down (HD): the swimmer looked backwards, and his ears were below the forearms, which were fully extended over the head. ",0,
edin,1951,3085176,Significantly increased,"In the group receiving 100 mg hesperidin in addition to the 50 mg p-synephrine plus 600 mg naringin, the RMR increased by 183 kcal, an increase that was statistically significant with respect to the placebo control (p<0.02).", Resting metabolic rates (RMR) , placebo , 1000 mg hesperidin with 50 mg p-synephrine plus 600 mg naringin ,0,
edin,1932,4175246,Cannot tell based on the abstract,, anterior reach , baeeline , control group ,0,
edin,1932,4175246,Significantly increased,"After the intervention, anterior reach was significantly higher (p<0.05) in the control group.", anterior reach , baeeline , control group ,0,
edin,1959,4048120,Significantly increased,"At the moment of prosthetic loading, keratinized mucosa width and probing depth were higher in immediate implants than delayed implants, with statistically significant differences.", Keratinized mucosa width , implants were placed in healed sites , received implants immediately after extraction ,0,
edin,2094,5360580,Significantly increased,Patients with mild AD showed a significantly greater decrease in plasma PlsPE in the placebo group than in the treatment group., Plasma PlsPE , placebo , 1 mg/day of Pls purified from scallop ,0,
edin,2003,4845428,Significantly decreased,The levels of decompression determined by MRI + (PM or DTI) in the experimental group were significantly less than that determined by MRI + NE in the control group (pâ=â0.000)., levels of decompression  ,  MRI + NE , MRI + (PM or DTI) ,0,
edin,2032,4747995,No significant difference,"Productsâ systemic exposures were comparable, with 90Â % CIs around ratios for AUCinf (0.96; 90Â % CI 0.88â1.04) and Cmax (1.04; 90Â % CI 0.98â1.11) within standard bioequivalence bounds (90Â % CI 0.80â1.25).", Cmax , ch14.18-NCI , ch14.18-UTC ,0,
edin,2105,4760045,Significantly decreased,Postoperative VAS value at 18 h were significantly lower in group RD (P < 0.05)., VAS score , 30 ml 0.5% ropivacaine + 75 ÃÂ¼g clonidine (RC) , 30 ml 0.5% ropivacaine + 100 ÃÂ¼g of dexmedetomidine (RD) ,0,
edin,1945,4481831,Cannot tell based on the abstract,, peak value immediately after contact of the foot with the ground (PVF1) , baseline , after Ice application ,0,
edin,1945,4481831,Significantly increased,"The application of ice to the sole and calf increased PVF1 immediately following application (Table 3).,<td colspan=""1"" rowspan=""1""> PVF1 â Calf (BW)</td><td colspan=""1"" rowspan=""1""> 1.020Â±0.045</td><td colspan=""1"" rowspan=""1""> 1.030Â±0.045*</td><td colspan=""1"" rowspan=""1""> 1.017Â±0.039<sup>#</sup>
</td>", peak value immediately after contact of the foot with the ground (PVF1) , baseline , after Ice application ,0,
edin,1918,3276929,Significantly decreased,Diastolic blood pressure reduced (P<0.001) better in yoga group (post 1=â7.6% and post 2=â16.4%) than the control group (post 1=â2.1% and post 2=â5.0%)., Diastolic blood pressure , control , yoga ,0,
edin,1923,4374260,Significantly decreased,"On multivariate logistic regression analysis, baseline IELT was the only predictor of successful treatment of PE with both tramadol 50 mg (odds ratio [OR]: 1.05, 95% confidence interval [CI]: 1.03-1.07, P < 0.001) and tramadol 100 mg (OR: 1.07, 95% CI: 1.04-1.11, P < 0.001).,PE was successfully treated in only 2.4% of patients with placebo, in contrast to 53.6% and 85.6% with 50 and 100 mg tramadol, respectively (P < 0.001 for all comparisons).", premature ejaculation (PE). , placebo  , 50 mg of tramadol and 100 mg of tramadol ,0,
edin,2045,4121500,Cannot tell based on the abstract,," oral dryness, tachycardia, excessive bradycardia and use of atropine and ephedrine ", group H - 1.0 ÃÂµg/kg , Group L - loading dose of 0.5 ÃÂµg/kg for 10 minutes ,0,
edin,2045,4121500,No significant difference,"Incidence of oral dryness, tachycardia, excessive bradycardia and use of atropine and ephedrine did not show any significant differences."," oral dryness, tachycardia, excessive bradycardia and use of atropine and ephedrine ", group H - 1.0 ÃÂµg/kg , Group L - loading dose of 0.5 ÃÂµg/kg for 10 minutes ,0,
edin,2034,3101755,Significantly decreased,Total epidural dose of fentanyl and bupivacaine required in Group A was significantly lower in comparison with Group B in 24 hours., Total epidural dose of fentanyl and bupivacaine , control , magnesium sulfate injection 30 mg/kg i.v. bolus was followed by infusion of magnesium sulfate at 10 mg/kg/hr and continued up to 24 hours ,0,
edin,1887,2742700,No significant difference,"Of the 24 subjects who completed the study, only 20% achieved the target blood pressure of <130/80 and there was no statistical difference in mean systolic and diastolic blood pressures among the three groups (p > 0.05).", mean systolic and diastolic blood pressure , usual care , nurse educator-conducted class and home blood pressure monitorization ,0,
edin,1897,5389230,Cannot tell based on the abstract,, Extubation times , Intranasal saline 0.9% (Group C) , Intranasal dexmedetomidine (Group D) ,0,
edin,1897,5389230,No significant difference,"There was no statistically significant difference between the two groups regarding extubation, emergence, and discharge times with a P > 0.05 [Table 4].", Extubation times , Intranasal saline 0.9% (Group C) , Intranasal dexmedetomidine (Group D) ,0,
edin,2098,3190091,Cannot tell based on the abstract,, seeing HIV prevention posters displayed on the walls , control , study-specific prevention activities ,0,
edin,2098,3190091,No significant difference,"As expected, high proportions of patrons at both intervention and control beer halls reported seeing HIV prevention posters displayed on the walls (74.2 vs. 65.5%, respectively, PÂ =Â 0.005), as these were placed in both intervention and control beer halls.", seeing HIV prevention posters displayed on the walls , control , study-specific prevention activities ,0,
edin,2044,4121500,Cannot tell based on the abstract,," bradycardia, hypoxemia, hypotension and hypertension ", group H - 1.0 ÃÂµg/kg , Group L - loading dose of 0.5 ÃÂµg/kg for 10 minutes ,0,
edin,2044,4121500,No significant difference,"There were no significant differences between two groups in the incidence of bradycardia, hypoxemia, hypotension and hypertension (Table 3)."," bradycardia, hypoxemia, hypotension and hypertension ", group H - 1.0 ÃÂµg/kg , Group L - loading dose of 0.5 ÃÂµg/kg for 10 minutes ,0,
edin,1214,3743198,No significant difference,"The admission rate decreased by 8.3% in the intervention group (adjusted odds ratio 0.31, 95% confidence interval 0.13-0.70, p=0.005).", Admission rate , No standardized guidelines or educational programs , Educational program and ED protocol for syncope evaluation ,0,
edin,1880,5291156,Cannot tell based on the abstract,, percentage of images of suitable quality at the right pyriform sinus , lidocaine spray and viscous solution , lidocaine spray ,0,
edin,1880,5291156,Significantly decreased,"The percentage of suitable quality images at the right pyriform sinus was significantly lower in the spray group compared to the combination group (82.8â% vs. 91.2â%, Pâ=â0.02).", percentage of images of suitable quality at the right pyriform sinus , lidocaine spray and viscous solution , lidocaine spray ,0,
edin,2001,5012042,No significant difference,"Using the FG improved average navigator efficiency from 33âÂ±â15 to 58âÂ±â13Â % (pâ<â0.001) and improved SNR by 5Â % (pâ=â0.01) compared to acquisitions with NF.,There was no difference in navigator efficiency (pâ=â0.90) or SNR (pâ=â0.77) between untrained and trained participants for FG acquisitions.", navigator efficiency and signal-to-noise ratio (SNR) , no off-scanner training , xtensive off-scanner training with the FG using a MRI simulator ,0,
edin,2104,4760045,Cannot tell based on the abstract,, suffered from bradycardia , 30 ml 0.5% ropivacaine + 75 ÃÂ¼g clonidine (RC) , 30 ml 0.5% ropivacaine + 100 ÃÂ¼g of dexmedetomidine (RD) ,0,
edin,2104,4760045,Significantly increased,"Again group RD suffered from bradycardia, which was statistically higher (P < 0.05) than group RC.", suffered from bradycardia , 30 ml 0.5% ropivacaine + 75 ÃÂ¼g clonidine (RC) , 30 ml 0.5% ropivacaine + 100 ÃÂ¼g of dexmedetomidine (RD) ,0,
edin,1898,5389230,No significant difference,"Extubation, emergence, and discharge times were comparable in both groups, and none of the subjects reported any adverse effects.", Discharge times , Intranasal saline 0.9% (Group C) , Intranasal dexmedetomidine (Group D) ,0,
edin,2036,5609057,Cannot tell based on the abstract,, Mean score of general symptoms , placebo , extract of three Cretan herbs ,0,
edin,2036,5609057,Significantly decreased,"Mean score of general symptoms was 19.1 (SE: 0.9) in day one, dropping to 8.6 (SE: 0.6) and 3.1 (SE: 0.4) in days 4 and 7 respectively, illustrating a decrease by 55.0% in day 4 and by 83.8% in day 7 (pÂ <Â 0.001 for all paired differences).", Mean score of general symptoms , placebo , extract of three Cretan herbs ,0,
edin,1905,3000449,Cannot tell based on the abstract,, Patient being held responsible for the weight-related symptoms , Interaction with a non-obese patient in a digital environment , Interaction with an obese patient in a digital environment ,0,
edin,1905,3000449,Significantly increased,"That is, the obese patient was held significantly more responsible for causing her shortness of breath, F(1,73)=26.37, p<.0001, and her knee pain, F(1,73)=36.11, p<.0001, but there was no difference in student ratings of the obese and non-obese patients' responsibility for causing the eczema.", Patient being held responsible for the weight-related symptoms , Interaction with a non-obese patient in a digital environment , Interaction with an obese patient in a digital environment ,0,
edin,1875,3259296,Significantly decreased,"In study 1, the 5 g xylose-containing solutions exhibited significantly lower area under the glucose curve (AUCg) and area under the insulin curve (AUCi) values for 0-15 min (P < 0.0001, P < 0.0001), 0-30 min (P < 0.0001, P < 0.0001), 0-45 min (P < 0.0001, P < 0.0001), 0-60 min (P < 0.0001, P < 0.0001), 0-90 min (P < 0.0001, P < 0.0001) and 0-120 min (P = 0.0071, P = 0.0016).", glucose concentration at 120 minutes in study 1 , sucrose solution , xylose-containing solution ,0,
edin,2000,5012042,No significant difference,There were no differences in longitudinal strain (pâ=â0.38)., longitudinal strain , underwent a respiratory navigator-gated 2D spiral cine displacement encoding with stimulated echoes (DENSE) CMR acquisition first with no feedback (NF)  , underwent a respiratory navigator-gated 2D spiral cine displacement encoding with stimulated echoes (DENSE) CMR acquisition first with the feedback game (FG) ,0,
edin,2037,4477402,Significantly decreased,Length of ICU stay was significantly higher in late extubation group (4.2 Â± 1.2 days) than the UFE group (1.72 Â± 1.5 days) (P = 0.02)., Length of ICU , Late extubation  , Ultra fast-track extubation (UFE) ,0,
edin,2073,3921228,Cannot tell based on the abstract,, POMS depression , rtfMRI-nf from the horizontal segment of the intraparietal sulcus (HIPS , rtfMRI-nf from left amygdala (LA) ,0,
edin,2073,3921228,No significant difference,"<td align=""left"" colspan=""1"" rowspan=""1"">POMS</td><td align=""left"" colspan=""1"" rowspan=""1""></td><td align=""left"" colspan=""1"" rowspan=""1""></td>,The increase in happiness was significantly greater in the experimental compared to control group (t(19)â=â2.33, pâ=â0.01), while the change in POMS depression between groups failed to reach significance (t(19)â=â1.33, pâ=â0.10).", POMS depression , rtfMRI-nf from the horizontal segment of the intraparietal sulcus (HIPS , rtfMRI-nf from left amygdala (LA) ,0,
edin,2074,3921228,Cannot tell based on the abstract,Significant pre-post scan decreases in anxiety ratings and increases in happiness ratings were evident in the experimental versus control group., state anxiety , rtfMRI-nf from the horizontal segment of the intraparietal sulcus (HIPS , rtfMRI-nf from left amygdala (LA) ,0,
edin,2074,3921228,Significantly decreased,"Significant decreases were also found within the experimental group for ratings of POMS anger (t(13)â=â2.42, pâ=â0.015), trait anxiety (STAI-Trait subscale; t(13)â=â2.62, pâ=â0.01), state anxiety (STAI-Trait subscale; t(13)â=â2.34, pâ=â0.02), and VAS ratings of restlessness (t(13)â=â2.23, pâ=â0.02), anxiety (t(13)â=â4.37, p<0.001), and irritability (t(13)â=â2.14, pâ=â0.025), and the difference between the groups on state anxiety was significant t(19)â=â2.58, pâ=â0.03).", state anxiety , rtfMRI-nf from the horizontal segment of the intraparietal sulcus (HIPS , rtfMRI-nf from left amygdala (LA) ,0,
edin,1878,3259296,Significantly decreased,"In study 1, the 5 g xylose-containing solutions exhibited significantly lower area under the glucose curve (AUCg) and area under the insulin curve (AUCi) values for 0-15 min (P < 0.0001, P < 0.0001), 0-30 min (P < 0.0001, P < 0.0001), 0-45 min (P < 0.0001, P < 0.0001), 0-60 min (P < 0.0001, P < 0.0001), 0-90 min (P < 0.0001, P < 0.0001) and 0-120 min (P = 0.0071, P = 0.0016)."," AUCg and AUCi values for 0-15 min, 0-30 min, 0-45 min, 0-60 min, 0-90 min, and 0-120 min in study 1 ", sucrose solution , 5 g xylose-containing solution ,0,
edin,2035,3101755,Cannot tell based on the abstract,," pruritus, nausea, vomiting during first 24 h ", control , magnesium sulfate injection 30 mg/kg i.v. bolus was followed by infusion of magnesium sulfate at 10 mg/kg/hr and continued up to 24 hours ,0,
edin,2035,3101755,Significantly decreased,Pruritus was significantly less in Group A compared with Group B. The incidence of nausea and vomiting was also significantly less in Group A in comparison with the control.," pruritus, nausea, vomiting during first 24 h ", control , magnesium sulfate injection 30 mg/kg i.v. bolus was followed by infusion of magnesium sulfate at 10 mg/kg/hr and continued up to 24 hours ,0,
edin,2021,5614293,Significantly increased,"The mean score of final visual acuity was 0.293Â±0.11 in the IVT group, 0.25Â±0.10 in the IVB group and 0.48Â±0.15 in the IVB+IVT group. The differences between groups considering final visual acuity was significant (p<0.001).", The mean score of final visual acuity , intravitreal triamcinolone acetonide (IVT) or intravitreal bevacizumab (IVB) , combination of IVT and IVB ,0,
edin,1894,5389230,Cannot tell based on the abstract,, Emergence agitation  , Intranasal saline 0.9% (Group C) , Intranasal dexmedetomidine (Group D) ,0,
edin,1894,5389230,Significantly decreased,The median four-point agitation scales and the median scores of FLACC pain scales of Group D were significantly lower than those of Group C at the all six time points with P < 0.05., Emergence agitation  , Intranasal saline 0.9% (Group C) , Intranasal dexmedetomidine (Group D) ,0,
edin,2091,5452066,Cannot tell based on the abstract,, median PFS (Progression-free survival) , topotecan , PM01183 ,0,
edin,2091,5452066,Significantly increased,"Median PFS was 4.0âmonths (95% CI, 2.7â5.6âmonths) (Figure 2A). Median OS was 10.6âmonths (95% CI, 9.5â18.1âmonths). Table 2,In the second randomized stage, median PFS was significantly longer with PM01183: 3.9âmonths (95% CI, 2.5â5.7âmonths) versus 2.0âmonths (95% CI, 1.4â2.8âmonths) with topotecan (Pâ=â0.0067).", median PFS (Progression-free survival) , topotecan , PM01183 ,0,
edin,2057,4045752,No significant difference,The anti-HBs level in the therapeutic paracetamol group (4958 mIU/mL) was not different (pâ=â0.34) from the level in the control group., The anti-HBs level  , The control group received no paracetamol. , paracetamol for 6 hours after (therapeutic use)  vaccination ,0,
edin,1870,3657931,No significant difference,No significant difference in the induction dose of propofol was observed when assessed clinically (loss of verbal response) or by BIS monitoring., mean dose of propofol required for induction , propofol induction guided by clinical signs , propofol induction guided by BIS ,0,
edin,2086,4342682,Significantly increased,"A logistic regression analysis indicated that the odds of participants choosing the best treatment were 2.25 times higher in the unconscious-thought condition compared to the immediate-decision condition (b=.81, Wald=4.32, P=.04, 95% CI 1.048-4.836), and 2.39 times greater compared to the conscious-thought condition (b=.87, Wald=4.87, P=.027, 95% CI 1.103-5.186).", choosing the best treatment , conscious-thought condition , unconscious-thought condition ,0,
edin,2068,5659064,Cannot tell based on the abstract,, Inspiratory muscle strength , PLACEBO ," oral nutritional supplementation, enriched with leucine, vitamin D, and omegaÃ¢â¬ï¿½3 fatty acids (NUTRITION) ",0,
edin,2068,5659064,Significantly increased,Inspiratory muscle strength improved significantly only in NUTRITION (Figure 4)., Inspiratory muscle strength , PLACEBO ," oral nutritional supplementation, enriched with leucine, vitamin D, and omegaÃ¢â¬ï¿½3 fatty acids (NUTRITION) ",0,
edin,1938,5340016,Significantly decreased,"The overall clinical response rate was significantly higher in the PE arm than in the FEC arm (76.06% vs. 59.95%, PÂ =Â 0.001).", The clinical response rates , weekly paclitaxelÃ¢â¬âepirubicin (PE) regimen , receive 4Ã¢â¬â6 cycles of neoadjuvant chemotherapy with tri-weekly 5-fluorouracilÃ¢â¬âepirubicinÃ¢â¬âcyclophosphamide (FEC) regimen ,0,
edin,2024,3178704,Cannot tell based on the abstract,," weight, BMI, body fat, waist circumference, and visceral fat area (VFA) ", baseline , the diet only (DO) ,0,
edin,2024,3178704,Significantly increased,"Significant increases in weight, BMI, body fat, waist circumference, and visceral fat area (VFA) as measured by CT were observed in the DO group while their glucose area under the curve (AUC) decreased from the baseline value."," weight, BMI, body fat, waist circumference, and visceral fat area (VFA) ", baseline , the diet only (DO) ,0,
edin,1977,5376493,Cannot tell based on the abstract,, Ã¢â¬ËTeamworkÃ¢â¬â¢ over time , medical seminar , non-technical skills seminar ,0,
edin,1977,5376493,Significantly decreased,"Teamworkâ decreased significantly over time in the NTS group (t(42) = 2.26, p = .03, r = 0.33), but not in the control group (t(33) = 1.15, p=.26, r=0.20).", Ã¢â¬ËTeamworkÃ¢â¬â¢ over time , medical seminar , non-technical skills seminar ,0,
edin,2089,4471244,Cannot tell based on the abstract,, Mortality , placebo , thiamine ,0,
edin,2089,4471244,No significant difference,"Mortality in the thiamine and placebo groups was 13% and 46%, respectively (P = 0.10).", Mortality , placebo , thiamine ,0,
edin,1943,5340016,Significantly increased,"Consistently, the post-chemotherapy pathologic T and N stages were significantly lower in the PE arm than in the FEC arm (PÂ <Â 0.001).", the post-chemotherapy pathologic T and N stages , weekly paclitaxelÃ¢â¬âepirubicin (PE) regimen , receive 4Ã¢â¬â6 cycles of neoadjuvant chemotherapy with tri-weekly 5-fluorouracilÃ¢â¬âepirubicinÃ¢â¬âcyclophosphamide (FEC) regimen ,0,
edin,1309,3258678,Cannot tell based on the abstract,, Clinical Dementia Rating â Sum of Boxes (CDR-SB) , 78-week treatment with placebo , 78-week treatment with tramiprosate 100 mg or tramiprosate 150 mg BID ,0,
edin,1309,3258678,No significant difference,"Neither the planned G Ã V interaction (P = 0.573) nor the planned contrast for the primary CDR-SB outcome at Week 78 (100 mg vs. Placebo: P = 0.405; 150 mg vs. Placebo: P = 0.837) revealed a statistically significant treatment effect.,No statistical difference relative to placebo was observed for any of the secondary CDR-SB outcomes.", Clinical Dementia Rating â Sum of Boxes (CDR-SB) , 78-week treatment with placebo , 78-week treatment with tramiprosate 100 mg or tramiprosate 150 mg BID ,0,
edin,1988,5193306,No significant difference,"All the participants in this study improved their IBS symptoms (pain, bloating, constipation and diarrhoea) and physical functioning at the end of the treatment from baseline, but this was not significantly different across the treatment arms."," irritable bowel syndrome (IBS) symptoms (pain, bloating, constipation and diarrhoea) ", standard Ã¢â¬Ëgut-directedÃ¢â¬â¢ hypnotherapy , Ã¢â¬ËindividualisedÃ¢â¬â¢ (holistic) hypnotherapy ,0,
edin,1937,4094699,Significantly increased,"By comparing the physical fitness indices, it was found that the increase of the results of sit-and-reach test in the intervention group had statistical significance (P = 0.001).", the results of sit-and-reach test , control , Baduanjin exercise ,0,
edin,2031,4747995,No significant difference,"Productsâ systemic exposures were comparable, with 90Â % CIs around ratios for AUCinf (0.96; 90Â % CI 0.88â1.04) and Cmax (1.04; 90Â % CI 0.98â1.11) within standard bioequivalence bounds (90Â % CI 0.80â1.25).", AUCinf , ch14.18-NCI , ch14.18-UTC ,0,
edin,1982,4227976,Significantly increased,A significant difference between the two groups regarding sexual satisfaction after the intervention (p=0.003) compared to the beginning of the study (p=0.356)., mean score of sexual satisfaction , control , Sildenafil citrate and Elaeagnus angustifolia flower extract ,0,
edin,1967,4723180,Cannot tell based on the abstract,, passive drag ," Head-up (HU): the swimmer looked directly forward, and his ears were above the forearms and fully extended over the head. "," Head-middle (HM): the swimmer looked downward at 90 degrees to the swimming direction, in a neutral position. The swimmerÃ¢â¬â¢s ears were covered by the forearms, which were fully extended over the head or Head-down (HD): the swimmer looked backwards, and his ears were below the forearms, which were fully extended over the head. ",0,
edin,1967,4723180,Significantly decreased,"Regarding the swimmerâs head position, passive drag was found to be significantly lower in the LA condition (with the arms in front of the head) for the HD and HM than the HU at all speeds (Figure 2).", passive drag ," Head-up (HU): the swimmer looked directly forward, and his ears were above the forearms and fully extended over the head. "," Head-middle (HM): the swimmer looked downward at 90 degrees to the swimming direction, in a neutral position. The swimmerÃ¢â¬â¢s ears were covered by the forearms, which were fully extended over the head or Head-down (HD): the swimmer looked backwards, and his ears were below the forearms, which were fully extended over the head. ",0,
edin,2038,4477402,No significant difference,"In survival analysis there was no significant difference between ultra-fast and late extubation groups (Log-rank test, P = 0.9).", The length of survival , Late extubation  , Ultra fast-track extubation (UFE) ,0,
edin,1893,3687261,Significantly decreased,"Both peak blood glucose and the amplitude of glycemic excursion were lower after PX and SC than PC (P < 0.01 for each) and were lowest after SX (P < 0.05 for each), while overall blood glucose was lower after SX than PC (P < 0.05).", amplitude of glycemic excursion , placebo and sucralose , sitagliptin and d-xylose ,0,
edin,2076,4628236,Cannot tell based on the abstract,, expression of PDE-5 , placebo orally for 8 weeks , the sGC activator cinaciguat (10 mg/kg/day) orally for 8 weeks ,0,
edin,2076,4628236,Significantly decreased,"Application of cinaciguat in diabetic animals significantly reduced the expression of PDE-5, markedly increased PKG activity (as indicated by elevated p-VASP/VASP ratio) (Fig.Â 3a), while the expression of PKG did not differ between the two diabetic groups (Fig.Â 3a).Fig.Â 3", expression of PDE-5 , placebo orally for 8 weeks , the sGC activator cinaciguat (10 mg/kg/day) orally for 8 weeks ,0,
edin,1964,3293139,Significantly decreased,"Responses to the COS-LC collected before the incidence round were statistically significantly different on the scales âanxietyâ, âbehaviourâ, âdejectionâ, âself-blameâ, âfocus on airway symptomsâ and âintrovertâ, with the control group reporting higher negative psychosocial consequences.", negative psychosocial consequences , control group , screen group ,0,
edin,1931,4175246,Cannot tell based on the abstract,," anterior, non-paretic and paretic reach ", baseline ,"  task-oriented training program with WBV, which was performed for 15 minutes, five times per week, for four weeks ",0,
edin,1931,4175246,Significantly increased,"After intervention, anterior, non-paretic and paretic reach were significantly higher in the experimental group (p<0.05)."," anterior, non-paretic and paretic reach ", baseline ,"  task-oriented training program with WBV, which was performed for 15 minutes, five times per week, for four weeks ",0,
edin,1924,4374260,Significantly increased,"Weak scanty ejaculation was the main complaint in 7.2% versus 21.6% of those using 50 and 100 mg tramadol, respectively (P = 0.002).", Weak scanty ejaculation , placebo , 50 mg of tramadol and 100 mg of tramadol ,0,
edin,1960,4048120,No significant difference,"Peri-implant health showed no statistically significant differences for any of the studied parameters (crevicular fluid volume, plaque index, gingival retraction, keratinized mucosa, probing depth, modified gingival index and presence of mucositis) at the twelve-month follow-up.", Modified gingival index , implants were placed in healed sites , received implants immediately after extraction ,0,
edin,2019,4235088,Significantly decreased,"PHES significantly improved after medication in all the three groups (Gp-LPr: â3.8 Â± 3.9 to â1.6 Â± 3.0; Gp-L: â4.8 Â± 4.1 to â1.6 Â± 2.9; and Gp-Pr: â4.9 Â± 3.7 to â2.1 Â± 2.5, P < 0.001). After 8 weeks follow-up, improvement was maintained in Gp-LPr and Gp-Pr, but there was deterioration in those who did not receive probiotics (Gp-L: PHES score reversed to â4.8 Â± 4.2).", psychometric hepatic encephalopathy score (PHES) after 8 weeks , baseline , receive lactulose (30Ã¢â¬â60 mL/day) + probiotic (200 million colony forming units of seven bacteria species/day) (Gp-LPr)  or probiotic alone (Gp-Pr) ,0,
edin,2033,3101755,Significantly increased,A significant increase in the mean and maximum duration of analgesia in Group A in comparison with Group B (P<0.05) was observed., the mean and maximum duration of analgesia , control , magnesium sulfate injection 30 mg/kg i.v. bolus was followed by infusion of magnesium sulfate at 10 mg/kg/hr and continued up to 24 hours ,0,
edin,2119,5437665,Significantly decreased,"In addition, the physical activity level was significantly decreased in patients from simvastatin group when compared to those from red yeast rice group.", Level of physical activity , Red yeast rice , Simvastatin ,0,
edin,2207,4064763,Cannot tell based on the abstract,, Mean drug dose , 10 units of Oxytip (Caspian Tamin Company Iran) in 500 cc serum , 10 units of Syntocinon (Novartis Pharma Canada) in 500 cc Ringer lactate ,0,
edin,2207,4064763,Significantly increased,"Mean drug dose was 28.98 drops in group A, and 24.29 drops in group B, and the difference between the two groups was statistically significant (p= 0.042).", Mean drug dose , 10 units of Oxytip (Caspian Tamin Company Iran) in 500 cc serum , 10 units of Syntocinon (Novartis Pharma Canada) in 500 cc Ringer lactate ,0,
edin,2282,5589093,Cannot tell based on the abstract,, cardiorespiratory complications , pancreaticoduodenectomy , pancreaticoduodenectomy with a cardiac output goal directed therapy (GDT) ,0,
edin,2282,5589093,No significant difference,"A difference between the proportions of cardiorespiratory complications in the usual care group (54%) compared to GDT (27%) was noticed, which did not achieve statistical significance (p = 0.066).", cardiorespiratory complications , pancreaticoduodenectomy , pancreaticoduodenectomy with a cardiac output goal directed therapy (GDT) ,0,
edin,2199,5320759,No significant difference,"The intubation success rates at the first, second, and third attempts as well as the average intubation times were similar between the two groups (P > 0.05),"," The intubation success rates at the first, second, and third attempt ",  midline approach technique group (R group) , transillumination-assisted technique group (T group)  ,0,
edin,2252,3467590,Significantly increased,"For A1c control, medication intensification increased in both groups (intervention, pre 26.4% vs post 32.6%, p=0.022; control, pre 24.8% vs post 31.1%, p=0.033) (intervention, adjusted OR (AOR) 1.37; 95% CI 1.06 to 1.76; control, AOR 1.41 (95% CI 1.06 to 1.89)); however, we observed no incremental benefit solely due to the intervention (group-by-time interaction, p=0.948).", medication intensification , baseline ," web-based continuing medical education (CME), performance feedback and quality improvement tools in experimental group and control group ",0,
edin,2305,3747462,Cannot tell based on the abstract,," RBCs count, PCV %, and Hb concentration ", control , Vaccinated group ,0,
edin,2305,3747462,Significantly increased,"Compared to normal control group (1) before challenge, red blood cell count (RBC), packed cell volume (PCV) %, and haemoglobin (Hb) concentration showed significant increase in glycyrrhizin-treated group (2) from the 1st till the 3rd week. G"," RBCs count, PCV %, and Hb concentration ", control , Vaccinated group ,0,
edin,2300,5509597,Significantly increased,he experimental group showed significant improvements in the variations of muscle activity and proprioception compared to the control group., muscle activity and proprioception , neurodevelopmental treatment , motor imagery training  ,0,
edin,2223,3804449,Significantly increased,"All caregiver outcome variables improved in the intervention group more than in the control. Home safety was significant at P â¤ 0.001, caregiver strain at P â¤ 0.001, and caregiver self-efficacy at P = 0.002.", caregiver self-efficacy , customary care ," Home Safety Toolkit (HST), including a new booklet based on health literacy principles, and sample safety items ",0,
edin,2212,5308129,Significantly increased,"In comparison with lactulose alone, PEG-lactulose could improve HESA score in 24 hours more effectively (p =0.04).", Hepatic Encephalopathy Scoring Algorithm (HESA) score ," 20-30 grams of lactulose orally or by a nasogastric tube, or 200 grams of lactulose enema by a rectal tube "," PEGÃ¢â¬âlactulose group received the 20-30 grams of lactulose of oral or rectal lactulose, plus 280 grams of PEG in 4 liters of water orally as a single dose in 30-120 minutes  ",0,
edin,2281,5589093,Cannot tell based on the abstract,, electrolyte derangements , pancreaticoduodenectomy , pancreaticoduodenectomy with a cardiac output goal directed therapy (GDT) ,0,
edin,2281,5589093,Significantly decreased,Patients in the usual care group were significantly more likely to develop electrolyte derangements: GDT (27%) vs. usual care (62%) (p = 0.012)., electrolyte derangements , pancreaticoduodenectomy , pancreaticoduodenectomy with a cardiac output goal directed therapy (GDT) ,0,
edin,2271,5589093,Cannot tell based on the abstract,, intraoperative ephedrine , pancreaticoduodenectomy , pancreaticoduodenectomy with a cardiac output goal directed therapy (GDT) ,0,
edin,2271,5589093,No significant difference,Eleven patients (42%) received intraoperative ephedrine in the GDT group vs. 7 patients (27%) in the usual care (p = 0.125)., intraoperative ephedrine , pancreaticoduodenectomy , pancreaticoduodenectomy with a cardiac output goal directed therapy (GDT) ,0,
edin,2162,5174811,Significantly decreased,"In ACCORD, aclidinium reduced night-time cough frequency (â0.36 vs 0.1 for placebo; p<0.001) and severity (â0.24 vs â0.1 for placebo; p<0.05), and frequency of night-time sputum production (â0.37 vs 0.05 for placebo; p<0.001).", Night-time cough frequency and severity , Placebo (ACCORD) , Aclidinium (ACCORD) ,0,
edin,2143,5867479,Significantly decreased,The concentrations of serum S100B and NGF in dexmedetomidine group was lower than those in control group (P<0.01)., Levels of NGF , Normal saline (control group) , Dexmedetomidine ,0,
edin,2217,3556334,Significantly decreased,"After 12âweeks, the vitamin D supplemented arm demonstrated significantly greater mean weight gain (kg)â+â3.75, (3.16 â 4.34) versusâ+â2.61 (95% CI 1.99 â 3.23) p 0.009 and lesser residual disease by chest radiograph; number of zones involved 1.35 v/s 1.82 p 0.004 (95% CI 0.15, 0.79) and 50% or greater reduction in cavity size 106 (89.8%) v/s 111 (94.8%), p 0.035.", number of zones involved , placebo for 2 doses ," 600,000Ã¢â¬â°IU of Intramuscular vitamin D3 ",0,
edin,2157,5174811,Significantly decreased,"ACCORD, aclidinium reduced night-time cough frequency (â0.36 vs 0.1 for placebo; p<0.001) and severity (â0.24 vs â0.1 for placebo; p<0.05), and frequency of night-time sputum production (â0.37 vs 0.05 for placebo; p<0.001).", Night-time cough frequency and severity , Placebo (ACCORD) , Aclidinium (ACCORD) ,0,
edin,2133,4860224,No significant difference,"Most were Hispanic (68%), single (61%), primiparous (39%), and without high school diploma (44%). 35 (21%) neonates in the intervention group and 41 (27%) in the control group were brought at least once for a NUC to the ED (p = 0.12).", Nonurgent ED visit , Routine anticipatory guidance program , Intensified anticipatory guidance program ,0,
edin,2175,5174811,Significantly decreased,"Data for 1792 patients were evaluated. E-RS cough/sputum domain scores were significantly reduced with aclidinium 400âÂµg versus placebo in ATTAIN (â0.7 vs â0.3, respectively; p<0.01) and the active-comparator study (â0.6 vs â0.2, respectively; p<0.01).", E-RS cough/sputum domain scores , Placebo (active-comparator study) , Aclidinium (active-comparator study) ,0,
edin,2299,5509597,No significant difference,"Only the experimental group showed significant improvements in proprioception.,The experimental group showed significant improvements in the variations of muscle activity and proprioception compared to the control group.", improvement in proprioception , baseline , control group ,0,
edin,2187,4509558,No significant difference,"At the end point, 22 patients (78.6Â %) in SG group and 23 patients (85.2Â %) in RYGB group achieved complete remission of diabetes mellitus with HbA1câ<â6.0Â % (Pâ=â0.525)", Glycated hemoglobin A1c (HbA1c) , Roux-en-Y gastric bypass (RYGB) procedure , laparoscopic sleeve gastrectomy (SG) ,0,
edin,2176,5174811,Significantly decreased,"n the active-comparator study, significantly greater improvements were observed with aclidinium versus placebo for severity of morning cough (â0.19 vs â0.02; p<0.01) and phlegm (â0.19 vs â0.02; p<0.05).", Morning cough severity and phlegm , Placebo (active-comparator study) , Aclidinium (active-comparator study) ,0,
edin,2274,5589093,Cannot tell based on the abstract,, volumes of crystalloid or colloid fluids on both postoperative Day 1 and Day 2 , pancreaticoduodenectomy , pancreaticoduodenectomy with a cardiac output goal directed therapy (GDT) ,0,
edin,2274,5589093,No significant difference,"<td align=""left"" colspan=""5"" rowspan=""1""><bold>Day 2</bold></td>", volumes of crystalloid or colloid fluids on both postoperative Day 1 and Day 2 , pancreaticoduodenectomy , pancreaticoduodenectomy with a cardiac output goal directed therapy (GDT) ,0,
edin,2231,4056626,Cannot tell based on the abstract,, cough reflex , propofol and remifentanil , 100 ÃÂ³/kg/min of racemic ketamine for 10&amp;nbsp;minutes  ,0,
edin,2231,4056626,Significantly decreased,"Following ketamine administration (T2), ICP did not modify (11.7âÂ±â7.3 vs. 11.0âÂ±â6.4Â mmHg; Pâ=â0.28); after ETS (T3) cough reflex was significantly reduced in comparison with controls (cough score 4 (IQR 3 to 4) vs. 2 (IQR1 to 2); P <0.0001) (FigureÂ 6).", cough reflex , propofol and remifentanil , 100 ÃÂ³/kg/min of racemic ketamine for 10&amp;nbsp;minutes  ,0,
edin,2286,5337766,Significantly increased,A significantly higher number of large-sized follicles was observed in group D than in group B (P=0.036)., number of large-sized follicles , groups B(hFSH) and C (rFSH) , group D Human Follicle Stimulating Hormone/ Recombinant human follicle stimulating hormone (hFSH/rFSH) ,0,
edin,2130,5787910,Cannot tell based on the abstract,, Frequency of side effects , Low-dose isotretinoin  , Conventional isotretinoin dose ,0,
edin,2130,5787910,Significantly increased,"As shown in Table 1, considering the significance level of 5%, a significant difference can be seen in the frequency of side effects dry mouth, dry nose, repeated rhinorrhea, and hair thinning and loss in both groups (P < 0.05), so that the frequency of side effects in the group receiving a higher dose of the drug (the second group) was more than the group receiving the low dose of the drug (the first group).", Frequency of side effects , Low-dose isotretinoin  , Conventional isotretinoin dose ,0,
edin,2269,5589093,Cannot tell based on the abstract,, intraoperative metaraminol , pancreaticoduodenectomy , pancreaticoduodenectomy with a cardiac output goal directed therapy (GDT) ,0,
edin,2269,5589093,Significantly decreased,Three patients (12%) in the GDT group received intraoperative metaraminol vs. 23 patients (88%) in the usual care group (p<0.0001)., intraoperative metaraminol , pancreaticoduodenectomy , pancreaticoduodenectomy with a cardiac output goal directed therapy (GDT) ,0,
edin,2147,5029935,No significant difference,"Higher LTOT duration analyzed as a continuous variable was not associated with any change in mortality rate (hazard ratio [HR] 1.00; (95% confidence interval [CI], 0.98 to 1.02) per 1 h/day increase above 15 h/day.,Mortality was similar between the groups for all-cause, respiratory and cardiovascular mortality.", Mortality rates , Long-term oxygen therapy 24 h/day , Long-term oxygen therapy 15 h/day ,0,
edin,2129,5787910,Cannot tell based on the abstract,, Patients' satisfaction score , Low-dose isotretinoin  , Conventional isotretinoin dose ,0,
edin,2129,5787910,Significantly decreased,"Considering the significance level of 5%, a significant difference can be observed between patients' satisfaction in the two treatment groups (P < 0.05), so the average of patients' satisfaction score in the first group (mean = 4.78, SD = 0.4) was significantly higher than the second group (mean = 4.43, SD = 0.6) (P = 0.02), which shows that the satisfaction of patients treated with lower doses of medication (Group I) was higher than patients treated with higher doses of the drug (Group II).", Patients' satisfaction score , Low-dose isotretinoin  , Conventional isotretinoin dose ,0,
edin,2296,5337626,Cannot tell based on the abstract,, the proportions of R0 resections ," control group (chemotherapy alone) received three pre-operative and three post-operative cycles of epirubicin, cisplatin, and capecitabine chemotherapy: 50 mg/m2 epirubicin and 60 mg/m2 cisplatin on day 1 and 1250 mg/m2 oral capecitabine on days 1Ã¢â¬â21. "," 7ÃÂ·5 mg/kg intravenous bevacizumab on day 1 of every cycle of chemotherapy and for six further doses once every 21 days following chemotherapy and three pre-operative and three post-operative cycles of epirubicin, cisplatin, and capecitabine chemotherapy: 50 mg/m2 epirubicin and 60 mg/m2 cisplatin on day 1 and 1250 mg/m2 oral capecitabine on days 1Ã¢â¬â21. ",0,
edin,2296,5337626,No significant difference,"When the comparison was repeated including only patients who underwent a resection (R0 vs R1), the proportions of R0 resections were again similar between the groups (321 [75%] of 429 patients in the chemotherapy alone group vs 305 [75%] of 405 in the chemotherapy plus bevacizumab group).", the proportions of R0 resections ," control group (chemotherapy alone) received three pre-operative and three post-operative cycles of epirubicin, cisplatin, and capecitabine chemotherapy: 50 mg/m2 epirubicin and 60 mg/m2 cisplatin on day 1 and 1250 mg/m2 oral capecitabine on days 1Ã¢â¬â21. "," 7ÃÂ·5 mg/kg intravenous bevacizumab on day 1 of every cycle of chemotherapy and for six further doses once every 21 days following chemotherapy and three pre-operative and three post-operative cycles of epirubicin, cisplatin, and capecitabine chemotherapy: 50 mg/m2 epirubicin and 60 mg/m2 cisplatin on day 1 and 1250 mg/m2 oral capecitabine on days 1Ã¢â¬â21. ",0,
edin,2246,5372977,Significantly increased,Six days of BR ingestion effectively improves high-intensity intermittent type exercise performance in trained soccer players., High-intensity intermittent running performance as assessed by the Yo-Yo IR1 , nitrate-depleted beetroot juice (PLA) for six subsequent days , ingested nitrate-rich (140 mL; ~800 mg nitrate/day; BR) for six subsequent days ,0,
edin,2244,5372977,Significantly increased,"Six days of BR ingestion increased plasma and salivary nitrate and nitrite concentrations in comparison to PLA (p < 0.001), and enhanced Yo-Yo IR1 test performance by 3.4 Â± 1.3% (from 1574 Â± 47 to 1623 Â± 48 m; p = 0.027).", plasma and salivary nitrate and nitrite concentrations , nitrate-depleted beetroot juice (PLA) for six subsequent days , ingested nitrate-rich (140 mL; ~800 mg nitrate/day; BR) for six subsequent days ,0,
edin,2256,3467590,Cannot tell based on the abstract,, haemogloblin A1c (%) among patients with worse glucose control - &amp;gt;9% , baseline ," web-based continuing medical education (CME), performance feedback and quality improvement tools in experimental group and control group ",0,
edin,2256,3467590,Significantly increased,"In the unadjusted analysis and among patients with worse glucose control (A1c >9%), intensification of medications to control A1c increased in both trial arms between baseline and follow-up (intervention, pre 34.8% vs post 62.5%, p=0.002; control, pre 35.7% vs post 61.4%, p=0.008; figure 3 top panel).", haemogloblin A1c (%) among patients with worse glucose control - &amp;gt;9% , baseline ," web-based continuing medical education (CME), performance feedback and quality improvement tools in experimental group and control group ",0,
edin,2289,5695666,Cannot tell based on the abstract,, weight  after 1 year , baseline , moderate-to-vigorous intensity physical activity (MVPA) ,0,
edin,2289,5695666,Significantly decreased,"Year 1 PA was significantly associated with 1-year weight change (r=0.23, p<0.0001), and this relationship was further strengthened after controlling for baseline PA and demographic factors (r=0.34, p<0.0001).", weight  after 1 year , baseline , moderate-to-vigorous intensity physical activity (MVPA) ,0,
edin,2292,1971065,Significantly increased,"At trial end, the proportions of participants in remission (SIGH-SAD less than 9) were significantly greater (Fisher's exact test), and SIGH-SAD scores, as percent individual score at randomization, were significantly lower (t-test), with active treatment than with control, both in an intent-to-treat analysis and an observed cases analysis.", amount of remission of Seasonal Affective Disorder (SAD) , control treatment , efficient light-emitting diodes (LEDs) ,0,
edin,2221,3804449,Cannot tell based on the abstract,, home environmental safety , customary care ," Home Safety Toolkit (HST), including a new booklet based on health literacy principles, and sample safety items ",0,
edin,2221,3804449,Significantly increased,"After controlling for the effects of caregiver age, and baseline measures of caregiver self-efficacy, baseline caregiver strain, and baseline home safety, caregivers who receive the Home Safety Toolkit will have improved home environmental safety higher postintervention self-efficacy, and lower postintervention caregiver strain than the control group which receives standard patient education.,Caregivers in the intervention group had significantly improved home environmental safety (P â¤ 0.000) higher caregiver self-efficacy (P â¤ 0.002), and lower caregiver strain (P â¤ 0.000) than caregivers in the control group.", home environmental safety , customary care ," Home Safety Toolkit (HST), including a new booklet based on health literacy principles, and sample safety items ",0,
edin,2227,4477338,Cannot tell based on the abstract,, percent suppression of Endogenous Glucose Production (EGP) , placebo ,  3.9 g/day EPA+DHA ,0,
edin,2227,4477338,Significantly increased,"Hepatic insulin sensitivity, determined from the suppression of endogenous glucose production by insulin, exhibited a small but significant improvement with EPA+DHA compared with placebo.", percent suppression of Endogenous Glucose Production (EGP) , placebo ,  3.9 g/day EPA+DHA ,0,
edin,2153,5174811,Significantly decreased,"In ACCORD, aclidinium reduced night-time cough frequency (â0.36 vs 0.1 for placebo; p<0.001) and severity (â0.24 vs â0.1 for placebo; p<0.05), and frequency of night-time sputum production (â0.37 vs 0.05 for placebo; p<0.001).", Frequency of sputum production at night-time , Placebo (ACCORD) , Aclidinium (ACCORD) ,0,
edin,2173,5174811,Significantly decreased,"In ACCORD, aclidinium reduced night-time cough frequency (â0.36 vs 0.1 for placebo; p<0.001) and severity (â0.24 vs â0.1 for placebo; p<0.05), and frequency of night-time sputum production (â0.37 vs 0.05 for placebo; p<0.001).", Frequency of sputum production at night-time , Placebo (ACCORD) , Aclidinium (ACCORD) ,0,
edin,2290,5695666,Cannot tell based on the abstract,, weight  after 1 year , moderate-to-vigorous intensity physical activity (MVPA) &amp;lt;50 min/week  , moderate-to-vigorous intensity physical activity (MVPA) 50 - 150 min/week  ,0,
edin,2290,5695666,Significantly decreased,"Year 1 PA was significantly associated with 1-year weight change (r=0.23, p<0.0001), and this relationship was further strengthened after controlling for baseline PA and demographic factors (r=0.34, p<0.0001).,The PA groups were as follows: <50 min/week (n=188), 50 to <150 min/week (n=167), 150 to <250 min/week (n=83), and â¥250 min/week (n=115). Participants engaging in 150 to <250 or â¥250 min/week of MVPA had significantly greater WL at 1-year compared to those engaging in <50 or 50 to <150 min/week. Similar findings were observed when the change in PA from baseline to 1-year was examined â participants with greater improvements in PA also had better WL at Year 1 (adjusted r=0.34, p<0.001).", weight  after 1 year , moderate-to-vigorous intensity physical activity (MVPA) &amp;lt;50 min/week  , moderate-to-vigorous intensity physical activity (MVPA) 50 - 150 min/week  ,0,
edin,2206,4064763,No significant difference,"After intervention, variables including: induction duration, duration of the 1st and the 2nd stages of labor, delivery method; and labor outcomes such as: hyper-stimulation of uterine, postpartum bleeding, 5-minute Apgar score, and infant's birth weight; and neonatal outcomes (admission to NICU, oxygen and intubation), in the two groups, were found to be the same (P < 0.05)."," induction duration, duration of the 1st and the 2nd stages of labor, delivery method; and labor outcomes such as: hyper-stimulation of uterine, postpartum bleeding, 5-minute Apgar score, and infant's birth weight; and neonatal outcomes (admission to NICU, oxygen and intubation) ", 10 units of Oxytip (Caspian Tamin Company Iran) in 500 cc serum , 10 units of Syntocinon (Novartis Pharma Canada) in 500 cc Ringer lactate ,0,
edin,2169,5174811,Significantly decreased,"E-RS cough/sputum domain scores were significantly reduced with aclidinium 400âÂµg versus placebo in ATTAIN (â0.7 vs â0.3, respectively; p<0.01) and the active-comparator study (â0.6 vs â0.2, respectively; p<0.01).", E-RS cough/sputum domain scores , Placebo (ATTAIN) , Aclidinium 400Ã¢â¬â¦ÃÂµg (ATTAIN) ,0,
edin,2302,4025600,Cannot tell based on the abstract,," HbA1c, Total cholesterol, LDL cholesterol, HDL cholesterol, Triglycerides  ", low-carbohydrate diet (LCD) , traditional low-fat diet (LFD) ,0,
edin,2302,4025600,No significant difference,"<td colspan=""1"" rowspan=""1"">â
<italic>P</italic> within group</td><td colspan=""1"" rowspan=""1"">NS</td><td colspan=""1"" rowspan=""1"">NS</td><td colspan=""1"" rowspan=""1""></td>"," HbA1c, Total cholesterol, LDL cholesterol, HDL cholesterol, Triglycerides  ", low-carbohydrate diet (LCD) , traditional low-fat diet (LFD) ,0,
edin,2266,5589093,Significantly decreased,Intraoperative fluid balance was 1005mL (475:1873) in the GDT group vs. 3300mL (2474:3874) in the usual care group (p<0.0001)., intraoperative fluid balance , pancreaticoduodenectomy , pancreaticoduodenectomy with a cardiac output goal directed therapy (GDT) ,0,
edin,2214,5308129,Cannot tell based on the abstract,, blood level of ammonia ," 20-30 grams of lactulose orally or by a nasogastric tube, or 200 grams of lactulose enema by a rectal tube "," PEGÃ¢â¬âlactulose group received the 20-30 grams of lactulose of oral or rectal lactulose, plus 280 grams of PEG in 4 liters of water orally as a single dose in 30-120 minutes ",0,
edin,2214,5308129,No significant difference,"In addition, baseline lab data including blood level of ammonia was similar between PEG-lactulose group and lactulose group (tables 2 and 3).,<td colspan=""1"" rowspan=""1"">Length of hospital stay, mean (SE), day</td><td colspan=""1"" rowspan=""1"">7.8 (0.4)</td><td colspan=""1"" rowspan=""1"">8.9 (0.7)</td><td colspan=""1"" rowspan=""1"">6.8 (0.5)</td><td colspan=""1"" rowspan=""1"">*0.03</td>,There was no significant change in the blood level of ammonia after 24 hours between the treatment groups (p =0.858, table 3).", blood level of ammonia ," 20-30 grams of lactulose orally or by a nasogastric tube, or 200 grams of lactulose enema by a rectal tube "," PEGÃ¢â¬âlactulose group received the 20-30 grams of lactulose of oral or rectal lactulose, plus 280 grams of PEG in 4 liters of water orally as a single dose in 30-120 minutes ",0,
edin,2248,3373832,Cannot tell based on the abstract,, PRTEE , Waitlist , dextrose prolotherapy ,0,
edin,2248,3373832,Significantly increased,"Prolotherapy participants (n=10) reported improved PRTEE composite scores compared to Waitlist (n=12) at 4 and 16 weeks (p<0.05), and improved pain and function PRTEE subscale scores (p<0.05) at 4 and 16 weeks, respectively.", PRTEE , Waitlist , dextrose prolotherapy ,0,
edin,2215,4313493,Significantly decreased,IOP lowering with bimatoprost (8.9 Â± 1.598 mm Hg) was significantly (P < 0.0001) higher than brimonidine (6.55 Â± 1.26 mm Hg)., IOP (intraocular pressure) , group B brimonidine 0.2% eye drops twice daily for a period of 4 weeks , group A bimatoprost 0.03% eye drops once daily for a period of 4 weeks ,0,
edin,2291,1971065,Significantly increased,"At trial end, the proportions of participants in remission (SIGH-SAD less than 9) were significantly greater (Fisher's exact test),", amount of remission of Seasonal Affective Disorder (SAD) , control treatment , efficient light-emitting diodes (LEDs) ,0,
edin,2184,3118076,No significant difference,"The success rate in group I was found to be 80%, which was lower than the success rate in group II which was found to be 90%. On comparison, there is no statistically significant difference in success rate between the two study groups.", Rate of success , Delayed loading implants (group II) , Immediate loading implants (group I) ,0,
edin,2285,5337766,Significantly increased,The serum estradiol level was significantly higher in group D than in groups B and C (P=0.005)., The serum estradiol level , groups B ( hFSH) and C(rFSH) , group D Human Follicle Stimulating Hormone/  Recombinant human follicle stimulating hormone (hFSH/rFSH) ,0,
edin,2158,5174811,Significantly decreased,"In ACCORD, aclidinium reduced night-time cough frequency (â0.36 vs 0.1 for placebo; p<0.001) and severity (â0.24 vs â0.1 for placebo; p<0.05), and frequency of night-time sputum production (â0.37 vs 0.05 for placebo; p<0.001).", Frequency of sputum production at night-time , Placebo (ACCORD) , Aclidinium (ACCORD) ,0,
edin,2197,5320759,No significant difference,The overall success rate of intubation was not significantly different between the two groups (P > 0.05)., success rate of intubation ,  midline approach technique group (R group) , transillumination-assisted technique group (T group)  ,0,
edin,2194,3735552,Significantly decreased,"Mean duration of antibiotic exposure was reduced from 6.3 to 4.5 days under PCT guidance (â1.8 days; 95% CI â3.1, â0.5; Pâ=â0.039) for all LRTI and from 9.1 to 5.7 days for pneumonia (â3.4 days 95% CI â4.9, â1.7; P<0.001).", The mean duration of antibiotic exposure in the subgroup of community-acquired pneumonia (CAP) patients , standard care clinical guidelines , PCT guidance algorithm established for adult LRTI in the subgroup of community-acquired pneumonia (CAP) patients ,0,
edin,2254,3467590,No significant difference,"A wide-reach, low-intensity, web-based interactive multicomponent intervention had no significant incremental effect on medication intensification for control of glucose, blood pressure or lipids for patients with diabetes of physicians practising in the rural Southeastern USA.", intensification of medications to control BP , baseline ," web-based continuing medical education (CME), performance feedback and quality improvement tools in experimental group and control group ",0,
edin,2114,5437665,Significantly increased,"At the end of study, the fatigue score was significantly increased in patients treated with simvastatin, whereas no significant change was observed in patients receiving red yeast rice.", Fatigue score at week 4 , Red yeast rice , Simvastatin ,0,
edin,2307,3747462,Cannot tell based on the abstract,, activities of AST and ALT , control , Vaccinated group ,0,
edin,2307,3747462,Significantly increased,"Before challenge, compared to normal control group (1), activities of AST and ALT showed significant increases in vaccinated groups (3) at the 1st and 2nd weeks.", activities of AST and ALT , control , Vaccinated group ,0,
edin,2142,5867479,Significantly decreased,The concentrations of serum S100B and NGF in dexmedetomidine group was lower than those in control group (P<0.01)., Levels of S100B , Normal saline (control group) , Dexmedetomidine ,0,
edin,2188,4509558,No significant difference,"Change in HbA1c, FBG and C peptide were comparable in the two groups."," HbA1c, FBG and C peptid ", Roux-en-Y gastric bypass (RYGB) procedure , laparoscopic sleeve gastrectomy (SG) ,0,
edin,2170,5174811,Significantly decreased,"E-RS cough/sputum domain scores were significantly reduced with aclidinium 400âÂµg versus placebo in ATTAIN (â0.7 vs â0.3, respectively; p<0.01) and the active-comparator study (â0.6 vs â0.2, respectively; p<0.01).", E-RS cough/sputum domain scores , Placebo (active-comparator study) , Aclidinium (active-comparator study) ,0,
edin,2279,5589093,Cannot tell based on the abstract,, delayed gastric emptying , pancreaticoduodenectomy , pancreaticoduodenectomy with a cardiac output goal directed therapy (GDT) ,0,
edin,2279,5589093,No significant difference,Three patients (12%) in the GDT group developed delayed gastric emptying vs. 6 patients (23%) in the usual care group (p = 0.213)., delayed gastric emptying , pancreaticoduodenectomy , pancreaticoduodenectomy with a cardiac output goal directed therapy (GDT) ,0,
edin,2306,3747462,Cannot tell based on the abstract,, Serum Creatinine and Uric Acid , control , Vaccinated group ,0,
edin,2306,3747462,Significantly increased,"Before challenge, compared to normal control group (1), vaccinated group (3) showed significant increase in uric acid and creatinine at the 1st week and at the 1st and 2nd weeks, respectively.", Serum Creatinine and Uric Acid , control , Vaccinated group ,0,
edin,2262,4379665,Significantly increased,The following post hoc Tukey's test confirmed that Group 2 (SAF) exhibited significantly least (P < 0.01) debris extrusion between the three groups tested., debris extrusion ," Group 2: Self-adjusting file (SAF; ReDent-Nova, RaÃ¢â¬â¢anana, Israel) (1.5 mm) Group 3: ProTaper NEXT X1 and X2 (PTN; Dentsply Tulsa Dental, Tulsa, OK) (25/06) "," Group 1: WaveOne (primary) single reciprocating file (WO; Dentsply Maillefer, Ballaigues, Switzerland) (25/08),  ",0,
edin,2249,3373832,Cannot tell based on the abstract,, pain and function PRTEE subscale scores at 4 and 16 weeks , Waitlist , dextrose prolotherapy ,0,
edin,2249,3373832,Significantly increased,"Prolotherapy participants (n=10) reported improved PRTEE composite scores compared to Waitlist (n=12) at 4 and 16 weeks (p<0.05),", pain and function PRTEE subscale scores at 4 and 16 weeks , Waitlist , dextrose prolotherapy ,0,
edin,2202,5372065,Cannot tell based on the abstract,, weight loss , baseline ," Phase I (months 1Ã¢â¬â6), an individually tailored intervention promoting a Mediterranean-style dietary and Phase II (months 7Ã¢â¬â12), option of a 16-week weight loss intervention, Phase III (months 13Ã¢â¬â24), weight loss maintenance intervention  ",0,
edin,2202,5372065,Significantly decreased,"<td colspan=""1"" rowspan=""1"">Weight, kg</td><td colspan=""1"" rowspan=""1"">248</td><td colspan=""1"" rowspan=""1"">â0.7 (â1.2 to â0.3)**</td><td colspan=""1"" rowspan=""1"">250</td><td colspan=""1"" rowspan=""1"">â1.7 (â2.5 to â1.0)***</td><td colspan=""1"" rowspan=""1"">247</td><td colspan=""1"" rowspan=""1"">â1.6 (â2.5 to â0.8)***</td>,*p<0.05; **p<0.01; ***p<0.001.,Participants with diabetes had significant, sustained, and progressive weight loss compared with baseline at 6, 12, and 24âmonths (mean â1.2âkg, â1.5âkg, and â3.7âkg, respectively) across all intervention groups.,At 24-month follow-up (data not shown), it was â5.2âkg (95% CI â9.6 to â0.8, p=0.2) for the group weight loss program (n=18); â2.2âkg (95% CI â4.6 to 0.1, p=0.06) for the combination weight loss program (n=25); and â3.8âkg (95% CI â5.9 to â1.8, p<0.001) for the maintenance of lifestyle intervention program (n=50).", weight loss , baseline ," Phase I (months 1Ã¢â¬â6), an individually tailored intervention promoting a Mediterranean-style dietary and Phase II (months 7Ã¢â¬â12), option of a 16-week weight loss intervention, Phase III (months 13Ã¢â¬â24), weight loss maintenance intervention  ",0,
edin,2228,3329148,Significantly increased,The H. pylori eradication rate of group A was slightly higher than group B (P < 0.05) and both of them were obviously higher than group C (P < 0.05)., H. pylori eradication rate ," Group B received 20Ã¢â¬â°mg of Esomeprazole, 1000Ã¢â¬â°mg of Amoxicillin for the first 5 days, followed by 20Ã¢â¬â°mg of Esomeprazole, 500Ã¢â¬â°mg of Clarithromycin, and 1000Ã¢â¬â°mg of Amoxicillin for the remaining 5 days. "," group A received 20Ã¢â¬â°mg of Esomeprazole, 500Ã¢â¬â°mg of Clarithromycin for the first 5 days, followed by 20Ã¢â¬â°mg of Esomeprazole, 500Ã¢â¬â°mg of Clarithromycin, and 1000Ã¢â¬â°mg of Amoxicillin for the remaining 5 days. ",0,
edin,2272,5589093,Cannot tell based on the abstract,, dopamine and/or dobutamine , pancreaticoduodenectomy , pancreaticoduodenectomy with a cardiac output goal directed therapy (GDT) ,0,
edin,2272,5589093,Significantly increased,"Similarly, the use of dopamine and/or dobutamine was significantly higher in the GDT group compared to the usual care group: 12 patients (46%) vs. 1 patient (4%) (p = 0.007). Use of intraoperative beta-blockers was similar between groups.", dopamine and/or dobutamine , pancreaticoduodenectomy , pancreaticoduodenectomy with a cardiac output goal directed therapy (GDT) ,0,
edin,2222,3804449,Significantly increased,"All caregiver outcome variables improved in the intervention group more than in the control. Home safety was significant at P â¤ 0.001, caregiver strain at P â¤ 0.001, and caregiver self-efficacy at P = 0.002.", caregiver strain  , customary care ," Home Safety Toolkit (HST), including a new booklet based on health literacy principles, and sample safety items ",0,
edin,2238,3210325,Cannot tell based on the abstract,, Depression ratings , received an Attention bias modification procedure designed to induce a bias in attention toward negative material , received an Attention bias modification procedure designed to induce a bias in attention toward positive pictures ,0,
edin,2238,3210325,Significantly decreased,"Depression ratings also increased more following negative ABM [t(56) = â7.1, p < .001, Cohen's d = .95] than positive ABM [t(58) = â3.6, p < .001, Cohen's d = .47].", Depression ratings , received an Attention bias modification procedure designed to induce a bias in attention toward negative material , received an Attention bias modification procedure designed to induce a bias in attention toward positive pictures ,0,
edin,2198,5320759,Significantly increased,"The incidences of dry throat, sore throat, and hoarseness were higher in the T group (all P < 0.05)."," the frequencies of dry throat, sore throat and hoarseness ",  midline approach technique group (R group) , transillumination-assisted technique group (T group)  ,0,
edin,2127,5787910,No significant difference,The average severity of acne in the two treatment groups did not differ significantly within any of the study periods., Mean acne severity , Low-dose isotretinoin  , Conventional isotretinoin dose ,0,
edin,2203,5372065,Cannot tell based on the abstract,," Systolic BP, mmÃ¢â¬â¦Hg ", baseline ," Phase I (months 1Ã¢â¬â6), an individually tailored intervention promoting a Mediterranean-style dietary and Phase II (months 7Ã¢â¬â12), option of a 16-week weight loss intervention, Phase III (months 13Ã¢â¬â24), weight loss maintenance intervention  ",0,
edin,2203,5372065,Significantly decreased,"<td colspan=""1"" rowspan=""1"">Systolic BP, mmâHg</td><td colspan=""1"" rowspan=""1"">249</td><td colspan=""1"" rowspan=""1"">â6.4 (â8.7 to â4.1)***</td><td colspan=""1"" rowspan=""1"">251</td><td colspan=""1"" rowspan=""1"">â6.2 (â9.0 to â3.3)***</td><td colspan=""1"" rowspan=""1"">250</td><td colspan=""1"" rowspan=""1"">â7.3 (â9.9 to â4.6)***</td>,Among all participants, there was a statistically significant reduction in systolic BP of about 6 to 7âmmHg across all follow-up time points."," Systolic BP, mmÃ¢â¬â¦Hg ", baseline ," Phase I (months 1Ã¢â¬â6), an individually tailored intervention promoting a Mediterranean-style dietary and Phase II (months 7Ã¢â¬â12), option of a 16-week weight loss intervention, Phase III (months 13Ã¢â¬â24), weight loss maintenance intervention  ",0,
edin,2179,5174811,Significantly decreased,"E-RS cough/sputum domain scores were significantly reduced with aclidinium 400âÂµg versus placebo in ATTAIN (â0.7 vs â0.3, respectively; p<0.01) and the active-comparator study (â0.6 vs â0.2, respectively; p<0.01).", E-RS cough/sputum domain scores , Placebo (ATTAIN) , Aclidinium 400Ã¢â¬â¦ÃÂµg (ATTAIN) ,0,
edin,2200,5320759,Significantly increased,"he intubation success rates at the first, second, and third attempts as well as the average intubation times were similar between the two groups (P > 0.05), but in patients receiving successful intubation at the second attempt, the intubation time was longer in the T group (P = 0.0006).", The intubation time at the second attempt ,  midline approach technique group (R group) , transillumination-assisted technique group (T group)  ,0,
edin,2295,5337626,Cannot tell based on the abstract,, patients achieving pathological tumour responses ," control group (chemotherapy alone) received three pre-operative and three post-operative cycles of epirubicin, cisplatin, and capecitabine chemotherapy: 50 mg/m2 epirubicin and 60 mg/m2 cisplatin on day 1 and 1250 mg/m2 oral capecitabine on days 1Ã¢â¬â21. "," 7ÃÂ·5 mg/kg intravenous bevacizumab on day 1 of every cycle of chemotherapy and for six further doses once every 21 days following chemotherapy and three pre-operative and three post-operative cycles of epirubicin, cisplatin, and capecitabine chemotherapy: 50 mg/m2 epirubicin and 60 mg/m2 cisplatin on day 1 and 1250 mg/m2 oral capecitabine on days 1Ã¢â¬â21. ",0,
edin,2295,5337626,No significant difference,The proportion of patients achieving pathological tumour responses were also similar between the groups (147 [33%] of 452 patients in the chemotherapy alone group vs 135 [30%] of 443 in the chemotherapy plus bevacizumab group; p=0Â·51)., patients achieving pathological tumour responses ," control group (chemotherapy alone) received three pre-operative and three post-operative cycles of epirubicin, cisplatin, and capecitabine chemotherapy: 50 mg/m2 epirubicin and 60 mg/m2 cisplatin on day 1 and 1250 mg/m2 oral capecitabine on days 1Ã¢â¬â21. "," 7ÃÂ·5 mg/kg intravenous bevacizumab on day 1 of every cycle of chemotherapy and for six further doses once every 21 days following chemotherapy and three pre-operative and three post-operative cycles of epirubicin, cisplatin, and capecitabine chemotherapy: 50 mg/m2 epirubicin and 60 mg/m2 cisplatin on day 1 and 1250 mg/m2 oral capecitabine on days 1Ã¢â¬â21. ",0,
edin,2284,5337766,Significantly increased,The duration of stimulation was significantly longer in group C than in groups A and D (P=0.030)., The duration of stimulation , groups A (hMG) and D (hFSH/rFSH) , group C Human Follicle Stimulating Hormone (hFSH) ,0,
edin,2250,3373832,Cannot tell based on the abstract,, pain and function PRTEE subscale scores at 4 and 16 weeks , baseline , dextrose prolotherapy ,0,
edin,2250,3373832,Significantly increased,"Prolotherapy participants (n=10) reported improved PRTEE composite scores compared to Waitlist (n=12) at 4 and 16 weeks (p<0.05), and improved pain and function PRTEE subscale scores (p<0.05) at 4 and 16 weeks, respectively.", pain and function PRTEE subscale scores at 4 and 16 weeks , baseline , dextrose prolotherapy ,0,
edin,2165,5174811,Significantly decreased,"E-RS cough/sputum domain scores were significantly reduced with aclidinium 400âÂµg versus placebo in ATTAIN (â0.7 vs â0.3, respectively; p<0.01) and the active-comparator study (â0.6 vs â0.2, respectively; p<0.01).", E-RS cough/sputum domain scores , Placebo (active-comparator study) , Aclidinium (active-comparator study) ,0,
edin,2230,3329148,No significant difference,There was no significant difference in total score descending of symptoms between each group (P > 0.05)., total score descending of symptoms ," Group C received 20Ã¢â¬â°mg of Esomeprazole, 500Ã¢â¬â°mg of Clarithromycin, and 1000Ã¢â¬â°mg of Amoxicillin for standard 10-day therapy. "," group A received 20Ã¢â¬â°mg of Esomeprazole, 500Ã¢â¬â°mg of Clarithromycin for the first 5 days, followed by 20Ã¢â¬â°mg of Esomeprazole, 500Ã¢â¬â°mg of Clarithromycin, and 1000Ã¢â¬â°mg of Amoxicillin for the remaining 5 days and Group B received 20Ã¢â¬â°mg of Esomeprazole, 1000Ã¢â¬â°mg of Amoxicillin for the first 5 days, followed by 20Ã¢â¬â°mg of Esomeprazole, 500Ã¢â¬â°mg of Clarithromycin, and 1000Ã¢â¬â°mg of Amoxicillin for the remaining 5 days. ",0,
edin,2118,5437665,Significantly increased,"At the end of study, the fatigue score was significantly increased in patients treated with simvastatin, whereas no significant change was observed in patients receiving red yeast rice.", Fatigue score at week 4 , Red yeast rice , Simvastatin ,0,
edin,2196,5320759,No significant difference,"Among the cases of successful intubation, the intubation time was not significantly different between the two groups (P > 0.05).", intubation time ,  midline approach technique group (R group) , transillumination-assisted technique group (T group)  ,0,
edin,2178,5174811,Significantly decreased,"In ACCORD, aclidinium reduced night-time cough frequency (â0.36 vs 0.1 for placebo; p<0.001) and severity (â0.24 vs â0.1 for placebo; p<0.05), and frequency of night-time sputum production (â0.37 vs 0.05 for placebo; p<0.001).", Frequency of sputum production at night-time , Placebo (ACCORD) , Aclidinium (ACCORD) ,0,
edin,2229,3329148,Significantly increased,The H. pylori eradication rate of group A was slightly higher than group B (P < 0.05) and both of them were obviously higher than group C (P < 0.05)., H. pylori eradication rate ," Group C received 20Ã¢â¬â°mg of Esomeprazole, 500Ã¢â¬â°mg of Clarithromycin, and 1000Ã¢â¬â°mg of Amoxicillin for standard 10-day therapy. "," group A received 20Ã¢â¬â°mg of Esomeprazole, 500Ã¢â¬â°mg of Clarithromycin for the first 5 days, followed by 20Ã¢â¬â°mg of Esomeprazole, 500Ã¢â¬â°mg of Clarithromycin, and 1000Ã¢â¬â°mg of Amoxicillin for the remaining 5 days and Group B received 20Ã¢â¬â°mg of Esomeprazole, 1000Ã¢â¬â°mg of Amoxicillin for the first 5 days, followed by 20Ã¢â¬â°mg of Esomeprazole, 500Ã¢â¬â°mg of Clarithromycin, and 1000Ã¢â¬â°mg of Amoxicillin for the remaining 5 days. ",0,
edin,2258,5223669,Significantly increased,"With all available data (n=233), applying the cLDA model yielded an LDL improvement of 8.9âmg/dL (95% CI â16.7 to â1.0; p=0.03) for GMC compared with usual care.", LDL measured by cLDA , usual care , Group Medical Clinics (GMC) ,0,
edin,2123,2815285,Cannot tell based on the abstract,, Blood volume in the retroperitoneal hematoma , Hypertonic saline plus dextran (group III) , Lactated Ringer (group II)  ,0,
edin,2123,2815285,Significantly increased,"Significantly higher VRPH was observed in LR-treated animals when compared to the HSD group, indicating more pronounced rebleeding (p<0.05 NT vs. LR and HSD; p<0.05 LR vs. HSD) (panel C).", Blood volume in the retroperitoneal hematoma , Hypertonic saline plus dextran (group III) , Lactated Ringer (group II)  ,0,
edin,2121,5437665,Cannot tell based on the abstract,," Concentrations of ALT, AST, Cr, or CPK ", Red yeast rice , Simvastatin ,0,
edin,2121,5437665,No significant difference,"No significant increases of in the concentrations of ALT, AST, Cr, or CPK from baseline were observed in either arm (Fig. 4)."," Concentrations of ALT, AST, Cr, or CPK ", Red yeast rice , Simvastatin ,0,
edin,2273,5589093,Cannot tell based on the abstract,, intraoperative beta-blockers , pancreaticoduodenectomy , pancreaticoduodenectomy with a cardiac output goal directed therapy (GDT) ,0,
edin,2273,5589093,No significant difference,Use of intraoperative beta-blockers was similar between groups., intraoperative beta-blockers , pancreaticoduodenectomy , pancreaticoduodenectomy with a cardiac output goal directed therapy (GDT) ,0,
edin,2141,5387905,Cannot tell based on the abstract,, Mean pain scores 2 hours after the procedure ,  Ibuprofen group , Diclofenac potassium group and paracetamol group ,0,
edin,2141,5387905,No significant difference,"For both paracetamol and diclofenac potassium groups at 2 hours postoperatively, there were no significant decreases in mean pain scores compared with the ibuprofen group (p-values from one-way ANOVA: 1.000, 0.06, Table 1).", Mean pain scores 2 hours after the procedure ,  Ibuprofen group , Diclofenac potassium group and paracetamol group ,0,
edin,2259,5223669,No significant difference,"The less efficient, LDA analysis yielded an LDL improvement of 7.2âmg/dL (95% CI â17.2 to 2.8; p=0.15) for GMC compared with usual care.", LDL measured by LDA  , usual care , Group Medical Clinics (GMC) ,0,
edin,2226,4477338,Cannot tell based on the abstract,," Total cholesterol, HDL and LDL ", placebo ,  3.9 g/day EPA+DHA ,0,
edin,2226,4477338,No significant difference,"Total cholesterol, HDL and LDL, did not change in either group."," Total cholesterol, HDL and LDL ", placebo ,  3.9 g/day EPA+DHA ,0,
edin,2255,3467590,No significant difference,"A wide-reach, low-intensity, web-based interactive multicomponent intervention had no significant incremental effect on medication intensification for control of glucose, blood pressure or lipids for patients with diabetes of physicians practising in the rural Southeastern USA.", intensification of medications to control LDL , baseline ," web-based continuing medical education (CME), performance feedback and quality improvement tools in experimental group and control group ",0,
edin,2182,5174811,Significantly decreased,"In ACCORD, aclidinium reduced night-time cough frequency (â0.36 vs 0.1 for placebo; p<0.001) and severity (â0.24 vs â0.1 for placebo; p<0.05), and frequency of night-time sputum production (â0.37 vs 0.05 for placebo; p<0.001).", Night-time cough frequency and severity , Placebo (ACCORD) , Aclidinium (ACCORD) ,0,
edin,2154,5174811,Significantly decreased,"E-RS cough/sputum domain scores were significantly reduced with aclidinium 400âÂµg versus placebo in ATTAIN (â0.7 vs â0.3, respectively; p<0.01) and the active-comparator study (â0.6 vs â0.2, respectively; p<0.01).", E-RS cough/sputum domain scores , Placebo (ATTAIN) , Aclidinium 400Ã¢â¬â¦ÃÂµg (ATTAIN) ,0,
edin,2120,5437665,Cannot tell based on the abstract,, Effects in reduction of lipids levels , Red yeast rice , Simvastatin ,0,
edin,2120,5437665,No significant difference,"The administration of both simvastatin (20Â mg daily) or red yeast rice (1200Â mg daily) resulted in significant reductions in TC (â19.6% vs. -18.5% of baseline level for simvastatin and red yeast rice groups respectively, PÂ <Â .001 vs. baseline for both) and LDL-C (â30.9% vs.-33.4% of baseline level for simvastatin and red yeast rice groups respectively, PÂ <Â .001 vs. baseline for both) after 4Â weeks of treatment (Fig. 3a-b) that were not significantly different between the two groups (PÂ =Â 0.84 for the comparison of the percentage drop in the TC level and PÂ =Â 0.64 for the comparison of the percentage drop in the LDL-C level; Fig. 3c). The improvements in TG and HDL-C concentrations were not significant in either treatment group (Fig. 3a-b).Fig. 3,Comparison of lipid levels at week 4 and baseline in the simvastatin and red yeast rice groups (meanÂ Â±Â SD). No significant changes in TG or HDL levels were observed in either arm;", Effects in reduction of lipids levels , Red yeast rice , Simvastatin ,0,
edin,2280,5589093,Cannot tell based on the abstract,, blood transfusion , pancreaticoduodenectomy , pancreaticoduodenectomy with a cardiac output goal directed therapy (GDT) ,0,
edin,2280,5589093,Significantly decreased,Patients in the usual care group were significantly more likely to receive blood transfusion: GDT (nil) vs. usual care (35%) (p = 0.0005)., blood transfusion , pancreaticoduodenectomy , pancreaticoduodenectomy with a cardiac output goal directed therapy (GDT) ,0,
edin,2167,5174811,Significantly decreased,"In ACCORD, aclidinium reduced night-time cough frequency (â0.36 vs 0.1 for placebo; p<0.001) and severity (â0.24 vs â0.1 for placebo; p<0.05), and frequency of night-time sputum production (â0.37 vs 0.05 for placebo; p<0.001).", Night-time cough frequency and severity , Placebo (ACCORD) , Aclidinium (ACCORD) ,0,
edin,2277,5589093,Cannot tell based on the abstract,, most severe complications , pancreaticoduodenectomy , pancreaticoduodenectomy with a cardiac output goal directed therapy (GDT) ,0,
edin,2277,5589093,No significant difference,Assessment of most severe complications demonstrated no significant differences between the GDT group and usual care group (p = 0.414)., most severe complications , pancreaticoduodenectomy , pancreaticoduodenectomy with a cardiac output goal directed therapy (GDT) ,0,
edin,2136,5444773,Cannot tell based on the abstract,,  Surfactant protein B expression , Pressure-controlled ventilation (PCV) , Pressure support ventilation (PSV) ,0,
edin,2136,5444773,Significantly increased,"In the presence of IAH, PSV improved oxygenation; decreased alveolar collapse, interstitial edema, and diffuse alveolar damage; and increased expression of surfactant protein B as compared to PCV.",  Surfactant protein B expression , Pressure-controlled ventilation (PCV) , Pressure support ventilation (PSV) ,0,
edin,2309,3065646,Cannot tell based on the abstract,," Glasgow outcome scale (GOS), Barthel index (BI), modified Rankin Scale (mRS) ", conventional craniotomy (CC) , minimally invasive stereotactic puncture and thrombolysis therapy (MISPTT) with a HV &amp;lt;50 mL ,0,
edin,2309,3065646,Significantly increased,"<td align=""left"" colspan=""4"">mRS</td>"," Glasgow outcome scale (GOS), Barthel index (BI), modified Rankin Scale (mRS) ", conventional craniotomy (CC) , minimally invasive stereotactic puncture and thrombolysis therapy (MISPTT) with a HV &amp;lt;50 mL ,0,
edin,2117,5437665,Cannot tell based on the abstract,," Concentrations of ALT, AST, Cr, or CPK ", Red yeast rice , Simvastatin ,0,
edin,2117,5437665,No significant difference,"No significant increases of in the concentrations of ALT, AST, Cr, or CPK from baseline were observed in either arm (Fig. 4)."," Concentrations of ALT, AST, Cr, or CPK ", Red yeast rice , Simvastatin ,0,
edin,2310,3065646,Cannot tell based on the abstract,, case fatality 1 year after stroke , conventional craniotomy (CC) , minimally invasive stereotactic puncture and thrombolysis therapy (MISPTT) ,0,
edin,2310,3065646,No significant difference,"There were no sharp differences in case fatality between the MISPTT group and the CC group 1Â year after stroke (17.2 and 25.9%, respectively, PÂ =Â 0.243);", case fatality 1 year after stroke , conventional craniotomy (CC) , minimally invasive stereotactic puncture and thrombolysis therapy (MISPTT) ,0,
edin,2245,5372977,Significantly decreased,Mean HR was lower in the BR (172 Â± 2) vs. PLA trial (175 Â± 2; p = 0.014)., Mean HR , nitrate-depleted beetroot juice (PLA) for six subsequent days , ingested nitrate-rich (140 mL; ~800 mg nitrate/day; BR) for six subsequent days ,0,
edin,2418,3771300,Significantly decreased,"The index lesion cure rate after 6 months follow-up was 13 of 15 (87%) for WR 279,396 and 9 of 15 (60%) for Paromomycin Alone (P = 0.099).", index lesion cure rate after 6 months follow-up ," WR 279,396 (15% paromomycin + 0.5% gentamicin) ", Paromomycin Alone (15% paromomycin) for 20 days ,0,
edin,2428,3614647,Significantly decreased,"Maca-GO significantly reduced both frequency and severity of individual menopausal symptoms (hot flushes and night sweating in particular) resulting in significant (P<0.001) alleviation of KMI (from 22 to 10), thus, offering an attractive non-hormonal addition to the choices available to early-postmenopausal women in the form of a natural plant alternative to Hormone Replacement Therapy (HRT) â hence, reducing dependence on hormone therapy programs.", severity of individual menopausal symptoms (hot flushes and night sweating in particular) , Placebo , Pre-Gelatinized Organic Maca (Maca-GO) treatment ,0,
edin,2465,5482825,No significant difference,"Change in total cholesterol (pâ=â0.3), low-density lipoprotein (pâ=â0.7), high-densityÂ lipoprotein (pâ=â0.2), and triglycerides (pâ=â0.4) also did not differ and there was no difference in inflammatory markers: interleukin-6 (pâ=â0.6), monocyte chemoattractant protein-1 (pâ=â0.9), tumour necrosis factor Î± (pâ=â0.2), C-reactive protein (pâ=â0.6) and nuclear factor kappa beta (pâ=â0.2).", C-reactive protein , high AGE diet , Low advanced glycation end products (AGEs) diet ,0,
edin,2385,2662857,Significantly increased,"After 40 sessions, mean physician CGI scores significantly improved in the treatment group compared to controls in overall functioning (p = 0.0008), receptive language (p < 0.0001), social interaction (p = 0.0473), and eye contact (p = 0.0102); 9/30 children (30%) in the treatment group were rated as ""very much improved"" or ""much improved"" compared to 2/26 (8%) of controls (p = 0.0471); 24/30 (80%) in the treatment group improved compared to 10/26 (38%) of controls (p = 0.0024).", mean physician Clinical Global Impression (CGI) scale - eye contact , control group , 40 hourly treatments of either hyperbaric treatment ,0,
edin,2472,4365008,No significant difference,"Similarly, the antioxidant enzymes GPx and SOD activity were unchanged by treatments.", glutathione peroxidase (GPx) and superoxide dismutase (SOD) levels , 10 mg rosuvastatin over 4 months , 10 mg rosuvastatin over 4 months with zinc (30 mg/d) and selenium (150 ÃÂ¼g/d) supplementation. ,0,
edin,2443,2001223,Significantly increased,"Furthermore, when analyzed by Ki67 immunohistochemistry, letrozole was significantly more effective than tamoxifen in reducing tumor proliferation (PÂ =Â 0.0009).", reducing tumor proliferation , tamoxifen , aromatase inhibitors (AIs) - letrozole ,0,
edin,2497,3661884,Significantly increased,Both groups showed significant increases in flexibility but in different joints (SSGpre vs. SSGpost; PIGpre vs. PIGpost)., flexibility of joints , baseline , the static stretching (SSG) or passive interval (PIG) ,0,
edin,2349,5331772,No significant difference,"In spite of this, analysis of variance showed no significant differences in three groups regarding the three indices such as intercellular adhesion molecule-1 (ICAM-1) (P = 0.093), MCP-1(P = 0.075), and serum interleukin-10 (IL-10) (P = 0.164).", Intercellular adhesion molecule-1 (ICAM-1) , Ginger alone , High-intensity interval training (HIIT) plus either ginger or placebo ,0,
edin,2506,5738810,No significant difference,"The three other parameters evaluated by veterinary subjective assessment (lameness, pain at palpation and joint mobility) did not show statistical differences."," lameness, pain at palpation and joint mobility at T0 and T3 ", an experimental diet (control) ," an experimental diet supplemented with Curcuminoids extract, hydrolyzed COllagen and green Tea extract (CCOT) ",0,
edin,2505,5738810,Significantly decreased,"After 3Â months of feeding, there was a significant reduction of pain at manipulation in the CCOT group, but not in the control group.", Pain at manipulation , an experimental diet (control) ," an experimental diet supplemented with Curcuminoids extract, hydrolyzed COllagen and green Tea extract (CCOT) ",0,
edin,2523,4759876,Cannot tell based on the abstract,, The total blood loss after Total knee arthroplasty (TKA) , intraarticular indwelling closed suction drainage method , subcutaneous indwelling closed suction drainage method  ,0,
edin,2523,4759876,Significantly decreased,The total blood loss after TKA was significantly different between two groups (P = 0.04). The total blood loss (visible drained blood + hidden loss) was less in subcutaneous drainage group., The total blood loss after Total knee arthroplasty (TKA) , intraarticular indwelling closed suction drainage method , subcutaneous indwelling closed suction drainage method  ,0,
edin,2451,4574984,Cannot tell based on the abstract,, numbers overall complications ," control group, which received standard care "," intervention group, i.e. patient empowerment through information booklet and diary keeping  ",0,
edin,2451,4574984,No significant difference,Overall complications occurred in 74% of the patients. There was no difference between intervention and control group (p = 0.79)., numbers overall complications ," control group, which received standard care "," intervention group, i.e. patient empowerment through information booklet and diary keeping  ",0,
edin,2445,2639700,Cannot tell based on the abstract,, mean weekly steps during the first month ," groups with exercise energy expenditure of 4 , 8 , or 12 kcal/kg/week (KKW) ", non-exercise control group ,0,
edin,2445,2639700,Significantly increased,"There were no significant differences in mean weekly steps during the first month among any of the exercise intervention groups, but the non-exercise control group (6098 (2065)) had significantly (P<0.05 for each) more steps compared to all of the exercise groups.", mean weekly steps during the first month ," groups with exercise energy expenditure of 4 , 8 , or 12 kcal/kg/week (KKW) ", non-exercise control group ,0,
edin,2386,2662857,Significantly increased,"Mean parental CGI scores significantly improved in the treatment group compared to controls in overall functioning (p = 0.0336), receptive language (p = 0.0168), and eye contact (p = 0.0322).", Mean parental CGI scores - overall functioning  , control group , 40 hourly treatments of either hyperbaric treatment ,0,
edin,2496,3661884,No significant difference,"Both groups showed significant increases in strength (SSGpre vs. SSGpost; PIGpre vs. PIGpost) in the same exercises for leg extension (LE) and Low Row (LR). Specifically, in the SSG group, the parameters for LE were (p = 0.0015 and ES = 2.28 - Large), and the parameters for LR were (p = 0.002 and ES = 1.95 - Large). Moreover, in the PIG group, the parameters for LE were (p = 0.009 and ES = 1.95 - Large), and the parameters for LR were (p = 0.0001 and ES = 2.88 - Large). No differences were found between the groups (SSGpost vs. PIGpost).", strength in the exercises for leg extension (LE) and Low Row (LR) , passive interval (PIG) , the static stretching (SSG)  ,0,
edin,2414,4842481,Cannot tell based on the abstract,, compliance coefficient (CC) , control group , WBV training ,0,
edin,2414,4842481,No significant difference,"Similarly, there was no significant interaction effect (p = 0.237) or main effect for compliance coefficient (CC) (Table 2) between the WBV and control groups (p = 0.496).", compliance coefficient (CC) , control group , WBV training ,0,
edin,2332,4602159,Cannot tell based on the abstract,," apnea, laryngospasm, bronchospasm, vomiting ", intravenous lidocaine , topical lidocaine ,0,
edin,2332,4602159,No significant difference,"Other variables including apnea, laryngospasm, bronchospasm, desaturation, and vomiting were not statistically different."," apnea, laryngospasm, bronchospasm, vomiting ", intravenous lidocaine , topical lidocaine ,0,
edin,2501,4266420,Cannot tell based on the abstract,The subjective fatigue of the MBT group was lower than that of the CON (P<0.05) or trail running shoe groups (P<0.05) on day 3., The subjective fatigue on day 3. , control , trail running shoes  ,0,
edin,2501,4266420,No significant difference,No difference between the CON and TR groups was found (P=0.64; Figure 2)., The subjective fatigue on day 3. , control , trail running shoes  ,0,
edin,2340,4749757,Significantly increased,"132 patients were randomised at 24 sites in six countries. PR-fampridine therapy resulted in greater median improvements from baseline in MSWS-12 score, TUG speed and BBS total score versus placebo over 24 weeks.", Improvement in Berg Balance Scale (BBS) Score  during 24 weeks , Placebo , Prolonged-release fampridine ,0,
edin,2467,5622764,Cannot tell based on the abstract,, coefficient of variation , placebo (Plac) , StomacolÃÂ® tablets (1.53 g of ÃÂ²-glucan) ,0,
edin,2467,5622764,Significantly increased,"Indeed, whereas glucose variability tended to increase between the first and last two CGM days on Plac (coefficient of variation from 34.3 Â± 1.9 to 39.1 Â± 3.0%; p < 0.05), it remained unchanged on Î²-glucan (from 38.2 Â± 3.2 to 38.9 Â± 2.1%; p = ns (non-significant)), suggesting a time dependent positive effect in maintaining a stable glucose level.", coefficient of variation , placebo (Plac) , StomacolÃÂ® tablets (1.53 g of ÃÂ²-glucan) ,0,
edin,2508,5738810,Cannot tell based on the abstract,, Coll2Ã¢â¬â1 and Coll2Ã¢â¬â1 NO2 serum concentrations , an experimental diet (control) ," an experimental diet supplemented with Curcuminoids extract, hydrolyzed COllagen and green Tea extract (CCOT) ",0,
edin,2508,5738810,No significant difference,Coll2â1 and Coll2â1 NO2 serum concentrations were not significantly different between control and CCOT groups at T0 and T3., Coll2Ã¢â¬â1 and Coll2Ã¢â¬â1 NO2 serum concentrations , an experimental diet (control) ," an experimental diet supplemented with Curcuminoids extract, hydrolyzed COllagen and green Tea extract (CCOT) ",0,
edin,2406,2806387,Significantly increased,The intensity of the unpleasant sensation was rated significantly higher after injection of saline from prefilled syringes compared to saline from polyethylene (p = 0.001)., The intensity of an unpleasant sensation , saline 9 mg/ml for injection in polyethylene package , saline 9 mg/ml syringes ,0,
edin,2390,2662857,Significantly increased,"On the ABC, significant improvements were observed in the treatment group in total score, irritability, stereotypy, hyperactivity, and speech (p < 0.03 for each), but not in the control group.", Aberrant Behavior Checklist (ABC) total score - irritability , control group , 40 hourly treatments of either hyperbaric treatment ,0,
edin,2502,5738810,Cannot tell based on the abstract,, change in dogsÃ¢â¬â¢ body weight , an experimental diet (control) ," an experimental diet supplemented with Curcuminoids extract, hydrolyzed COllagen and green Tea extract (CCOT) ",0,
edin,2502,5738810,No significant difference,There was no significant change in dogsâ body weight nor evidence of side effects over the duration of the study., change in dogsÃ¢â¬â¢ body weight , an experimental diet (control) ," an experimental diet supplemented with Curcuminoids extract, hydrolyzed COllagen and green Tea extract (CCOT) ",0,
edin,2367,4763632,Significantly increased,New dot/globule formation was observed more frequently in the covered and uncovered nevi of PUVA group., Formation of new dot-globule  , Narrowband ultraviolet B (NB-UVB) , Psoralen-ultraviolet A (PUVA) ,0,
edin,2339,4749757,Significantly increased,"PR-fampridine therapy resulted in greater median improvements from baseline in MSWS-12 score, TUG speed and BBS total score versus placebo over 24 weeks.", Improvement in Timed Up and Go (TUG) speed  during 24 weeks , Placebo , Prolonged-release fampridine ,0,
edin,2417,4662683,Significantly increased,"Onset time of swallowing therapy after stroke was effective on swallowing recovery on the main outcome variables. So that in first group patients, recovery was rather than other groups P < 0.050.", recovery ,  (3) late group (1-month after stroke) with swallowing therapy  ,  (2) medium group (2 weeks after stroke) with swallowing therapy  ,0,
edin,2357,5331772,Cannot tell based on the abstract,, VO2max , Ginger alone , High-intensity interval training (HIIT) plus either ginger or placebo ,0,
edin,2357,5331772,Significantly increased,"The KruskalâWallis test showed VO2max changes (pre- to post-test) were significantly different between groups (P < 0.001).,Tukey's post hoc test revealed increased VO2max in both âexercise + gingerâ (P < 0.000) and âexercise + placeboâ (P < 0.000) groups, in comparison to âgingerâ group.", VO2max , Ginger alone , High-intensity interval training (HIIT) plus either ginger or placebo ,0,
edin,2351,5331772,Cannot tell based on the abstract,, Baseline characteristics , Ginger alone , High-intensity interval training (HIIT) plus either ginger or placebo ,0,
edin,2351,5331772,No significant difference,There was no significant difference between three groups regarding the baseline characteristics [Tables 1 and 2]., Baseline characteristics , Ginger alone , High-intensity interval training (HIIT) plus either ginger or placebo ,0,
edin,2355,5331772,No significant difference,"In spite of this, analysis of variance showed no significant differences in three groups regarding the three indices such as intercellular adhesion molecule-1 (ICAM-1) (P = 0.093), MCP-1(P = 0.075), and serum interleukin-10 (IL-10) (P = 0.164).", Serum interleukin-10 (IL-10) , Ginger alone , High-intensity interval training (HIIT) plus either ginger or placebo ,0,
edin,2425,3614647,Significantly increased,"Maca-GO significantly stimulated production of E2 (P<0.001) with a simultaneous suppression (P<0.05) of blood FSH, increase (P<0.05) in HDL.", estradiol (E2) level  in group APMM , Placebo , Pre-Gelatinized Organic Maca (Maca-GO) treatment ,0,
edin,2318,3668955,Cannot tell based on the abstract,, Relief of plantar pain , sham trigger point dry needling , real trigger point dry needling ,0,
edin,2318,3668955,No significant difference,"At the primary end-point, significant effects favored real dry needling over sham dry needling for pain (adjusted mean difference: VAS first-step pain -14.4 mm, 95% CI -23.5 to -5.2, p=0.002; FHSQ foot pain 10.0 points, 95% CI 1.0 to 19.1, p=0.029), although the between-group difference was lower than the minimal important difference.", Relief of plantar pain , sham trigger point dry needling , real trigger point dry needling ,0,
edin,2398,3210361,Significantly decreased,"Critically, ketamine also impaired accuracy on the perceptual timing task while having no effect on performance of the colour perception task.", accuracy in the timing task , placebo , ketamine (100&amp;nbsp;ng/ml blood plasma level) ,0,
edin,2478,5742427,Significantly decreased,"The experimental group and control group showed a significant difference in perceived stress (F = 60.11, p < .001),,The results revealed that aromatherapy alleviated stress and improved sleep quality in intensive care unit patients after 2 days of the experimental treatment.", perceived stress , sleep without receiving the lavender aroma oil , deep breathing with essential oils ,0,
edin,2391,2662857,Significantly increased,"On the ABC, significant improvements were observed in the treatment group in total score, irritability, stereotypy, hyperactivity, and speech (p < 0.03 for each), but not in the control group."," Aberrant Behavior Checklist (ABC) total score - irritability, stereotypy, hyperactivity, and speech ", baseline and control group , 40 hourly treatments of either hyperbaric treatment ,0,
edin,2348,5331772,Significantly decreased,Paired t-test revealed a significant decrease in the density of type 1 monocytes chemo tactic protein (MCP-1) in HIIT + ginger (P = 0.026) and HIIT + placebo (P = 0.001) groups., Density of type 1 monocytes chemo tactic protein (MCP-1) , Ginger alone , High-intensity interval training (HIIT) plus either ginger or placebo ,0,
edin,2354,5331772,No significant difference,"In spite of this, analysis of variance showed no significant differences in three groups regarding the three indices such as intercellular adhesion molecule-1 (ICAM-1) (P = 0.093), MCP-1(P = 0.075), and serum interleukin-10 (IL-10) (P = 0.164).", Intercellular adhesion molecule-1 (ICAM-1) , Ginger alone , High-intensity interval training (HIIT) plus either ginger or placebo ,0,
edin,2356,5331772,Cannot tell based on the abstract,, Baseline characteristics , Ginger alone , High-intensity interval training (HIIT) plus either ginger or placebo ,0,
edin,2356,5331772,No significant difference,There was no significant difference between three groups regarding the baseline characteristics [Tables 1 and 2]., Baseline characteristics , Ginger alone , High-intensity interval training (HIIT) plus either ginger or placebo ,0,
edin,2315,5031764,Significantly increased,Statistical analyses showed a significant decrease in the levels of impulsivity and aggressiveness in the experimental group compared with the control group., decrease in the levels of impulsivity and aggressiveness in experimental group , decrease in the levels of impulsivity and aggressiveness in control grup , mindfulness training psycho-educative program ,0,
edin,2453,4574984,Cannot tell based on the abstract,, overall mortality ," control group, which received standard care "," intervention group, i.e. patient empowerment through information booklet and diary keeping  ",0,
edin,2453,4574984,No significant difference,The overall mortality did not differ significantly between the two groups (Log-Rank-test p = 0.197) (Fig 7)., overall mortality ," control group, which received standard care "," intervention group, i.e. patient empowerment through information booklet and diary keeping  ",0,
edin,2462,5482825,No significant difference,"Change in total cholesterol (pâ=â0.3), low-density lipoprotein (pâ=â0.7), high-densityÂ lipoprotein (pâ=â0.2), and triglycerides (pâ=â0.4) also did not differ and there was no difference in inflammatory markers: interleukin-6 (pâ=â0.6), monocyte chemoattractant protein-1 (pâ=â0.9), tumour necrosis factor Î± (pâ=â0.2), C-reactive protein (pâ=â0.6) and nuclear factor kappa beta (pâ=â0.2).", interleukin-6 , high AGE diet , Low advanced glycation end products (AGEs) diet ,0,
edin,2323,5300822,Cannot tell based on the abstract,, reduce muscle damage. , post-exercise  vibration stimulation  , pre-exercise vibration stimulation ,0,
edin,2323,5300822,Significantly increased,Pre-induced muscle damage vibration stimulation is more effective than post-induced muscle damage vibration stimulation for preventing muscle damage., reduce muscle damage. , post-exercise  vibration stimulation  , pre-exercise vibration stimulation ,0,
edin,2456,5482825,No significant difference,"Low AGE diets did not change systolic (pâ=â0.2) and diastolic blood pressure (pâ=â0.3), mean arterial pressure (pâ=â0.8) and pulse pressure (pâ=â0.2) compared to high AGE diets.", mean arterial pressure , high AGE diet , Low advanced glycation end products (AGEs) diet ,0,
edin,2392,2662857,Significantly increased,"On the ATEC, sensory/cognitive awareness significantly improved (p = 0.0367) in the treatment group compared to the control group.",  Autism Treatment Evaluation Checklist (ATEC) - sensory/cognitive awareness , control group , 40 hourly treatments of either hyperbaric treatment ,0,
edin,2482,5742427,Significantly decreased,"The experimental group and control group showed a significant difference in perceived stress (F = 60.11, p < .001), objective stress index (F = 25.65, p < .001), systolic blood pressure (F = 9.09, p < .001), diastolic blood pressure (F = 2.47, p = .046), heart rate (F = 5.71, p < .001), and sleep quality (F = 109.46, p < .001).",  heart rate , sleep without receiving the lavender aroma oil , deep breathing with essential oils ,0,
edin,2402,3210361,Cannot tell based on the abstract,,  benefit of temporally valid cues at the short interval , placebo , ketamine (100ng/ml blood plasma level) ,0,
edin,2402,3210361,Significantly increased,"Specifically, the benefit of temporally valid cues was significant at the short (t(10)â=ââ4.71, pâ=â0.001) but not long (t(10)â=ââ0.48, ns) interval (TableÂ 1): when a target does not appear after the short interval as expected it must, by process of elimination, appear at the longer one.",  benefit of temporally valid cues at the short interval , placebo , ketamine (100ng/ml blood plasma level) ,0,
edin,2434,5054611,Cannot tell based on the abstract,, The mean peak inspiratory pressure and plateau pressure , The Laryngeal Tube Suction Disposable (LTS-D)  , the Supreme Laryngeal Mask Airway (SLMA) ,0,
edin,2434,5054611,Significantly decreased,The mean peak inspiratory pressure and plateau pressure in patients with SLMA was significantly lower than in patients with LTS-D (pâ=â0.006) and (pâ=â0.008)., The mean peak inspiratory pressure and plateau pressure , The Laryngeal Tube Suction Disposable (LTS-D)  , the Supreme Laryngeal Mask Airway (SLMA) ,0,
edin,2288,4392900,Significantly decreased,"After 108 weeks, subjects with prediabetes and/or MetS in the placebo, 7.5/46, and 15/92 groups experienced mean percent weight loss of 2.5, 10.9, and 12.1%, respectively (ITT-MI; P < 0.0001 vs. placebo), associated with reductions of 70.5 and 78.7% in the annualized incidence rate of type 2 diabetes for those receiving 7.5/46 and 15/92, respectively (ITT, P < 0.05), versus placebo.", incidence rate of type 2 diabetes , placebo , intent-to-treat population using multiple imputation (ITT-MI)  of subjects with prediabetes and/or MetS ,0,
edin,2338,4749757,Significantly increased,"A higher proportion of patients receiving PR-fampridine versus placebo experienced significant improvements at MSWS-12 improvement thresholds â©¾7 (p = 0.0275), â©¾8 (p = 0.0153) and â©¾9 points (p = 0.0088) and TUG speed thresholds â©¾10% (p = 0.0021) and â©¾15% (p = 0.0262).", Improvement in the 12-item MS Walking Scale (MSWS-12) Score during 24 weeks , Placebo , Prolonged-release fampridine ,0,
edin,2423,3445058,No significant difference,"<th colspan=""1"" rowspan=""1""></th><th colspan=""1"" rowspan=""1""></th><th colspan=""1"" rowspan=""1""></th><th align=""center"" colspan=""3"" rowspan=""1"">% MVIC<hr></th><th colspan=""1"" rowspan=""1""></th><th colspan=""1"" rowspan=""1""></th>"," The supraspinatus, infraspinatus, and anterior deltoid muscle electromyographic (EMG) activity ", upright active forward exercises , gravity-minimized exercises  ,0,
edin,2328,4538249,Cannot tell based on the abstract,, Increase of glycaemic control. , A 1-year follow-up of the RxING study , RxING study first six month ,0,
edin,2328,4538249,Significantly increased,"In the RxING study, HbA1c was reduced from 9.1% (SD 1) at baseline to 7.3% (SD 0.9) at 26âweeks, a change of 1.8% (95% CI 1.4 to 2, p<0.001). Twelve months after completing the study, HbA1c increased from 7.3% (SD 0.9) at study end to 8.1% (SD 1.3), a change of 0.8% (95% CI â1.1 to â0.5, p<0.001; figure 2).", Increase of glycaemic control. , A 1-year follow-up of the RxING study , RxING study first six month ,0,
edin,2394,5040779,Cannot tell based on the abstract,," success rate of intubation on the first, second, and third attempts ", Macintosh blade , McGRATH MAC and C-MAC ,0,
edin,2394,5040779,Significantly increased,"The success rate of intubation on the first, second, and third attempts increased significantly with the McGRATH MAC and C-MAC compared to the Macintosh blade in the normal airway (P < 0.001 on the first attempt, P < 0.001 on the second attempt, and P = 0.012 on the third attempt)."," success rate of intubation on the first, second, and third attempts ", Macintosh blade , McGRATH MAC and C-MAC ,0,
edin,2359,4794540,Cannot tell based on the abstract,, General health , Prescribed medication without yogic intervention , Yogic intervention and medication ,0,
edin,2359,4794540,Significantly increased,"Significant improvement in domains of anxiety (P<0.01), depression (P<0.02), positive well-being (P<0.01), general health (P<0.04) and vitality (P<0.02) in intervention group was noted after six months of yogic intervention when compared to control group (Table 3).", General health , Prescribed medication without yogic intervention , Yogic intervention and medication ,0,
edin,2364,4763632,Cannot tell based on the abstract,Overall demoscopic changes were observed in 34/37 (91.8%) of the uncovered nevi compared to 16/37 (43.2%) of the covered nevi (P value 0.0001)., Demoscopic changes , Narrowband ultraviolet B (NB-UVB) , Psoralen-ultraviolet A (PUVA) ,0,
edin,2364,4763632,Significantly increased,"The prevalence of overall dermoscopic changes was significantly higher in the PUVA-exposed nevi (100% for PUVA, 88.8% for NB-UVB, P value 0.041).", Demoscopic changes , Narrowband ultraviolet B (NB-UVB) , Psoralen-ultraviolet A (PUVA) ,0,
edin,2415,4662683,Significantly increased,"Onset time of swallowing therapy after stroke was effective on swallowing recovery on the main outcome variables. So that in first group patients, recovery was rather than other groups P < 0.050.", recovery ,  (2) medium group (2 weeks after stroke); and (3) late group (1-month after stroke) with swallowing therapy  , early initiation group (3 days after stroke) with swallowing therapy  ,0,
edin,2316,5031764,Significantly decreased,Statistical analyses showed a significant decrease in the levels of impulsivity and aggressiveness in the experimental group compared with the control group., impulsivity and aggressiveness dimensions for experiemental group , impulsivity and aggressiveness dimensions for control group , Wilcoxon test ,0,
edin,2452,4574984,Significantly decreased,Patients in the intervention group reported significantly less postoperative pain (p = 0.03) than the control group., level of postoperative pain ," control group, which received standard care "," intervention group, i.e. patient empowerment through information booklet and diary keeping  ",0,
edin,2510,4516063,Significantly increased,"Comparing the shear bond strength values, All Bond 2 (Group III) demonstrated fairly higher bond strength values at different levels of dentin. Generally comparing All Bond 2 with the other two experimental groups revealed highly significant statistical results.", bond strength values ," Group I, II and Group III (positive control) ", All Bond 2 (Group III) ,0,
edin,2341,4749757,Cannot tell based on the abstract,, Adverse Events , Placebo , Prolonged-release fampridine ,0,
edin,2341,4749757,No significant difference,The proportion of patients with any AE was similar in placebo-treated patients (49 (77%)) versus patients receiving PR-fampridine (51 (75%))., Adverse Events , Placebo , Prolonged-release fampridine ,0,
edin,2397,5040779,Significantly increased,"The McGRATH MAC and C-MAC significantly increased the success rate of intubation, improved the Cormack-Lehane grade, and decreased the difficulty score compared to the Macintosh blade in both airway settings.", The Cormack-Lehane grade , Macintosh blade , McGRATH MAC and C-MAC ,0,
edin,2469,5622764,Significantly increased,"There was an increase in basic measures of glycaemic control (maximal glucose value 341 Â± 15 vs. 378 Â± 13 mg/dL for Plac and Î²-glucan, p = 0.004), and average daily risk range (62 Â± 5 vs. 79 Â± 4 mg/dL for Plac and Î²-glucan, p = 0.003) favouring Plac over Î²-glucan, but no increase in the M-value (the weighted average of the glucose values) or other more complex measures.", average daily risk range , placebo (Plac) , StomacolÃÂ® tablets (1.53 g of ÃÂ²-glucan) ,0,
edin,2314,4051747,Cannot tell based on the abstract,,"  prenatal knowledge, attitudes,behaviors and beliefs related to text4baby ","  prenatal knowledge, attitudes,behaviors beliefs in usual care ", Text4baby mHealth program ,0,
edin,2314,4051747,Significantly increased,"There were significant improvements in several outcome attitudes, beliefs, and behaviors from BL to FL.","  prenatal knowledge, attitudes,behaviors and beliefs related to text4baby ","  prenatal knowledge, attitudes,behaviors beliefs in usual care ", Text4baby mHealth program ,0,
edin,2416,4662683,Significantly decreased,"Furthermore, the frequency of pneumonia in the early group was less than other groups and in the early group no patients experienced pneumonia P = 0.002.", number of patients experienced pneumonia ,  (2) medium group (2 weeks after stroke); and (3) late group (1-month after stroke) with swallowing therapy  , early initiation group (3 days after stroke) with swallowing therapy  ,0,
edin,2524,4759876,Cannot tell based on the abstract,, The mean visible blood drainage during the first 24 h and between 24 and 48 h after TKA , intraarticular indwelling closed suction drainage method , subcutaneous indwelling closed suction drainage method  ,0,
edin,2524,4759876,Significantly decreased,"The mean visible blood drainage in subcutaneous drainage group was significantly less than intraarticular drainage group, both during the first 24 h and between 24 and 48 h (P < 0.001).", The mean visible blood drainage during the first 24 h and between 24 and 48 h after TKA , intraarticular indwelling closed suction drainage method , subcutaneous indwelling closed suction drainage method  ,0,
edin,2442,2001223,Significantly increased,"Significantly more letrozole-treated patients underwent breast-conserving surgery (45 vs. 35%, respectively; PÂ =Â 0.022).", numbers of breast-conserving surgery , tamoxifen , aromatase inhibitors (AIs) - letrozole ,0,
edin,2514,5038569,Significantly decreased,"he mean Â± standard deviation CMT decreased from 604Â±199 Î¼m at baseline to 319Â±115 Î¼m (P=0.001) at 1 month and to 351Â±205 Î¼m (P=0.026) at 4 months.,The mean BCVA did not improve significantly from baseline (1.00 LogMAR) to the 1-month (0.74 LogMAR; P=0.2) and 4-month (0.71 LogMAR; P=0.13) visits.", central macular thickness (CMT) at 1 month and at 4 months , baseline , intravitreal injections of ziv-aflibercept (1.25 mg/0.05 mL) ,0,
edin,2504,5738810,Cannot tell based on the abstract,, PVF change with time , an experimental diet (control) ," an experimental diet supplemented with Curcuminoids extract, hydrolyzed COllagen and green Tea extract (CCOT) ",0,
edin,2504,5738810,No significant difference,The PVF change (Î T3-T0) was not different between groups (pâ=â0.319) (Fig.Â 2).Fig. 2, PVF change with time , an experimental diet (control) ," an experimental diet supplemented with Curcuminoids extract, hydrolyzed COllagen and green Tea extract (CCOT) ",0,
edin,2363,4763632,Significantly increased,Overall demoscopic changes were observed in 34/37 (91.8%) of the uncovered nevi compared to 16/37 (43.2%) of the covered nevi (P value 0.0001)., Demoscopic changes , All covered nevi , All uncovered nevi ,0,
edin,2458,5482825,No significant difference,"Change in total cholesterol (pâ=â0.3), low-density lipoprotein (pâ=â0.7), high-densityÂ lipoprotein (pâ=â0.2), and triglycerides (pâ=â0.4) also did not differ and there was no difference in inflammatory markers: interleukin-6 (pâ=â0.6), monocyte chemoattractant protein-1 (pâ=â0.9), tumour necrosis factor Î± (pâ=â0.2), C-reactive protein (pâ=â0.6) and nuclear factor kappa beta (pâ=â0.2).", total cholesterol , high AGE diet , Low advanced glycation end products (AGEs) diet ,0,
edin,2329,4538249,Cannot tell based on the abstract,, reduced cardiovascular risk. , base line , RxING study first six month ,0,
edin,2329,4538249,Significantly decreased,"Patientsâ risk of cardiovascular events in the next 10âyears was reduced from 31% (SD 17.3) at baseline to 26.7% (SD 14.5) at study end, an absolute reduction of 4.3% (a 14% relative reduction) (95% CI 0.6 to 9.5, p=0.026).", reduced cardiovascular risk. , base line , RxING study first six month ,0,
edin,2424,3614647,Significantly decreased,"Maca-GO significantly stimulated production of E2 (P<0.001) with a simultaneous suppression (P<0.05) of blood FSH, increase (P<0.05) in HDL.", Follicle Stimulating Hormone (FSH) level in group APMM , Placebo , Pre-Gelatinized Organic Maca (Maca-GO) treatment ,0,
edin,2380,4652407,No significant difference,"No significant differences (pâ>0.05) in insulin, cholesterol measurements (total cholesterol, LDL-C, HDL-C, triglycerides and cholesterol ratios) and atherogenic index between or within groups were observed.", Atherogenic index , Any other food , Commercially produced Scoparia dulcis porridge (SDC) ,0,
edin,2431,5054611,Cannot tell based on the abstract,,  successfull insertion , the Supreme Laryngeal Mask Airway (SLMA) , The Laryngeal Tube Suction Disposable (LTS-D) ,0,
edin,2431,5054611,No significant difference,Gastric tube insertion was successful in all patients in both groups.,  successfull insertion , the Supreme Laryngeal Mask Airway (SLMA) , The Laryngeal Tube Suction Disposable (LTS-D) ,0,
edin,2610,3549413,Cannot tell based on the abstract,, bone mineral density (BMD) At the 6-month time point , baseline , placebo ,0,
edin,2610,3549413,No significant difference,"At the 6-month time point, subjects supplemented with the GBB (nÂ =Â 30) maintained femoral neck BMD, whereas in the placebo group (nÂ =Â 28), BMD significantly decreased (pÂ =Â 0.007, Fig.Â 2a),,The difference in femoral neck BMD between groups remained statistically significant in the intention to treat (ITT) analysis (pÂ =Â 0.05); however, when baseline BMD was factored into the analysis, statistical significance was no longer quite achieved (pÂ =Â 0.058).", bone mineral density (BMD) At the 6-month time point , baseline , placebo ,0,
edin,2632,5767990,Cannot tell based on the abstract,, The mean GI after 3 months , Group B: SRP with placebo gel , Group A: scaling and root planing (SRP) with A. aspera gel ,0,
edin,2632,5767990,Significantly decreased,"The mean GIs in the test and control groups at baseline were 2.60 and 2.57, respectively, and after 3 months were 1.35 and 2.32, respectively, which showed statistically significant results (P < 0.001).,The clinical parameter difference in both the test and control groups from baseline to 3 months showed that the mean GIs in the test and control groups were 1.25 and 0.25, respectively, the mean PDs in the test and control groups were 2.24 and 0.34, respectively, and the mean CALs in the test and control groups were 0.73 and 0.20, respectively, which showed statistically significant results (P < 0.001)", The mean GI after 3 months , Group B: SRP with placebo gel , Group A: scaling and root planing (SRP) with A. aspera gel ,0,
edin,2570,4280425,Significantly decreased,"Total morbidity was 27.5% in the case of patients with conventional surgery, vs. 10.9% with laparoscopic intervention (p < 0.05).", Total morbidity , conventional surgery , laparoscopy within the group with ASA 4Ã¢â¬â5 ,0,
edin,2601,3620559,No significant difference,"Stratifying outcomes by anti-MÃ¼llerian hormone (AMH), as indicator of ovarian reserve, and by body mass index (BMI) the oocyte yields, still, did not differ (AMH, r (17)â=ââ0.20, pâ=â0.44; BMI, r (17) =0.02, pâ=â0.96).",  oocyte yield among women with normal ovarian reserve , 17 G/ 35 mm (standard) needle , 20 G/ 35 mm (thin) needle ,0,
edin,2571,4280425,Cannot tell based on the abstract,, Complications , conventional surgery , laparoscopy within the group with ASA 4Ã¢â¬â5 ,0,
edin,2571,4280425,Significantly decreased,"We found a statistically significant difference in the number of complications in favour of laparoscopy, 10.9% vs. 27.5% for conventional operations.", Complications , conventional surgery , laparoscopy within the group with ASA 4Ã¢â¬â5 ,0,
edin,2625,5446666,No significant difference,"There were also no significant differences between the intervention and control groups at 4 weeks on any of the subscales of the MHC-SF (psychological: P=.95, social: P=.42, emotional: P=.95).", Subscales of Mental Health Continuum-Short Form (MHC-SF) , control group , Web-based self-guided app recommendation service (Ã¢â¬ÅThe ToolboxÃ¢â¬ï¿½) ,0,
edin,2537,5057302,Cannot tell based on the abstract,, Improvement in symptom score , Placebo , Sublingual immunotherapy (SLIT) 10 000 AUN/ml ,0,
edin,2537,5057302,Significantly decreased,"Regarding the primary endpoint, in all treatment groups, a decrease in symptom scores after 5 months of treatment compared to the baseline measurement at screening was observed (32.6% in the placebo group up to 58.4% in the 40 000 AUN/ml group; Table 2).", Improvement in symptom score , Placebo , Sublingual immunotherapy (SLIT) 10 000 AUN/ml ,0,
edin,2563,4814821,Significantly decreased,Telemonitoring was also associated with a reduced number of all-cause re-admissions (0.23âvs. 0.68/patient; pâ=â0.002) and emergency room visits (0.36âvs. 0.91/patient; pâ=â0.006)., ER visits for all causes , usual group , telemonitoring group ,0,
edin,2592,4590407,Cannot tell based on the abstract,, The EG had increased in the soft tissue (primarily FFM) , baseline , 10 mg Zn/day ,0,
edin,2592,4590407,Significantly increased,The EG had increased in the soft tissue (primarily FFM) body composition after oral zinc supplementation compared with before supplementation (p<0.0001)., The EG had increased in the soft tissue (primarily FFM) , baseline , 10 mg Zn/day ,0,
edin,2631,5767990,Cannot tell based on the abstract,, probing depth (PD) , Group B: SRP with placebo gel , Group A: scaling and root planing (SRP) with A. aspera gel ,0,
edin,2631,5767990,Significantly decreased,"The mean PDs in the test and control groups at baseline were 5.16 and 4.44, respectively, and after 3 months were 2.92 and 4.10, respectively, which showed statistically significant results (P < 0.001).", probing depth (PD) , Group B: SRP with placebo gel , Group A: scaling and root planing (SRP) with A. aspera gel ,0,
edin,2566,3961219,Cannot tell based on the abstract,, The mean normalized AUC values for the first phase , baseline , Bowman-Birk inhibitor concentrate (BBIC) ,0,
edin,2566,3961219,Significantly increased,"The mean normalized AUC values for subjects treated with placebo or BBIC at doses of 800, 1,200, 1,600 or 2,000 CI units were 1.00Â±0.13, 1.08Â±0.31, 1.60Â±0.27, 2.53Â±0.27 and 2.03Â±0.34, respectively (Fig. 4). The difference among the treatment groups was statistically significant (P=0.006 by one-way ANOVA).,For the first phase I trial, the normalized AUC for the serum BBI level was moderately correlated with the BBIC dose, with a correlation coefficient of 0.65 and a slope value of 0.0007 (Fig. 3).", The mean normalized AUC values for the first phase , baseline , Bowman-Birk inhibitor concentrate (BBIC) ,0,
edin,2591,4590407,Significantly increased,The body mass index-for-age increased after oral zinc supplementation in the EG (p=0.005)., The body mass index-for-age , sorbitol 10% , 10 mg Zn/day ,0,
edin,2623,2409647,Cannot tell based on the abstract,, the bone marker urinary CTx over the 96-week study period , placebo , oral ibandronate 50Ã¢â¬â°mg ,0,
edin,2623,2409647,Significantly decreased,"Patients receiving oral ibandronate 50âmg showed a significant decrease from baseline in the bone marker urinary CTx over the 96-week study period compared with placebo (median change â77.3% and +11.0%, P<0.001) (Figure 2Figure 2", the bone marker urinary CTx over the 96-week study period , placebo , oral ibandronate 50Ã¢â¬â°mg ,0,
edin,2572,4884360,No significant difference,"The CARs for weeks 5â52 were 10.0Â %, 12.4Â %, and 15.3Â % in the NRT, NRT+, and VR groups, respectively; no group differences were observed.", carbon monoxide-confirmed continuous abstinence rates (CAR) , varenicline (VR) ," standard nicotine patch (NRT), extended use of combined formulations of nicotine replacement therapy (NRT+) ",0,
edin,2597,3620559,No significant difference,The standard diameter needle was used to collect a total of 215 oocytes from 355 aspirated follicles (60.6%) compared to 203 oocytes from 352 aspirated follicles (57.7%) with the thinner needle (pâ=â0.23)., The number of oocytes per the number of aspirated follicles , 17 G/ 35 mm (standard) needle , 20 G/ 35 mm (thin) needle ,0,
edin,2552,4714728,Significantly increased,Results indicated that patients in Group B showed higher mean scores (90.3Â±5.4) than Group A (80.4Â±11.5) in terms of ConstantâMurley score (P=0.001)., mean scores of ConstantÃ¢â¬âMurley score , Group A was treated using a hook plate , Group B with autogenous semitendinosus graft and endobutton technique ,0,
edin,2624,5446666,No significant difference,Results demonstrated no significant effect of âThe Toolboxâ intervention on participant well-being at 4 weeks compared with the control group (P=.66)., well-being at 4 weeks , control group , Web-based self-guided app recommendation service (Ã¢â¬ÅThe ToolboxÃ¢â¬ï¿½) ,0,
edin,1993,5808396,Significantly decreased,"Participants receiving CPT experienced moderate reductions in felt stigma relative to those in individual support (Cohenâs Dâ=â0.44, pâ=âvalueâ=â0.02) following the end of treatment,", felt stigma after treatment , individual support , Cognitive Processing Therapy ,0,
edin,2575,3400348,Significantly increased,"Treatment with telmisartan-HCTZ induced significantly greater reductions in BP (â31.1/â18.3âmmâHg) than valsartan-HCTZ (â28.4/â16.3âmmâHg; SBP P = 0.0265, diastolic BP P = 0.0041).",  mean reduction in BP for both systolic blood pressure (SBP) and diastolic blood pressure (DBP)  , valsartan 160Ã¢â¬â°mg combined with hydrochlorothiazide (HCTZ) 25Ã¢â¬â°mg , telmisartan 80Ã¢â¬â°mg combined with hydrochlorothiazide (HCTZ) 25Ã¢â¬â°mg ,0,
edin,2596,3263888,No significant difference,Lifestyle intervention resulted in higher IS (P = 0.02) and lower unadjusted AIGR0â30 (P = 0.08) during the 4-year follow-up., AIGR0Ã¢â¬â30 during the 4-year follow-up , control  , lifestyle intervention  ,0,
edin,2615,2887326,Significantly increased,The prominent efficacy rate was 19% (7 of 37) in the Hochu-ekki-to group and 5% (2 of 40) in the placebo group (P = 0.06)., The prominent efficacy rate , placebo , Hochu-ekki-to ,0,
edin,2626,5446666,Significantly increased,"Repeat engagement with the study platform resulted in a significant difference in mood, energy, rest, and sleep trajectories between intervention and control groups as measured by EMAs (P<.01)."," mood, energy, rest, and sleep ", control group , Web-based self-guided app recommendation service (Ã¢â¬ÅThe ToolboxÃ¢â¬ï¿½) ,0,
edin,2621,2409647,Cannot tell based on the abstract,, the mean number of measurement periods with events per patient , placebo , oral ibandronate 50Ã¢â¬â°mg ,0,
edin,2621,2409647,Significantly decreased,"Supportive analyses of new bone events demonstrated that the mean number of events and the mean number of measurement periods with events per patient were significantly reduced in the ibandronate group compared with placebo (P=0.008 and 0.015, respectively, Table 3 Table 3", the mean number of measurement periods with events per patient , placebo , oral ibandronate 50Ã¢â¬â°mg ,0,
edin,2636,3580611,Significantly increased,"The 30-day rate of stroke or death was 14.7% in the PTAS group (nonfatal stroke, 12.5%; fatal stroke, 2.2%) and 5.8% in the medical-management group (nonfatal stroke, 5.3%; non-stroke-related death, 0.4%) (P = 0.002).", The 30-day rate of stroke or death , medical-management group , percutaneous transluminal angioplasty and stenting (PTAS) ,0,
edin,2541,3376507,Significantly decreased,"Intention-to-treat analysis showed that both intervention groups reduced their BMI compared with the controls (basic: â0.72, SD 1.1 kg/m2, enhanced: â1.0, SD 1.4, control: 0.15, SD 0.82; P < .001)", Body mass index , Wait-list control group , Standard version or enhanced version of commercial Web-based weight-loss program ,0,
edin,2577,3400348,Cannot tell based on the abstract,, DBP change among non-Black patients , valsartan 160Ã¢â¬â°mg combined with hydrochlorothiazide (HCTZ) 25Ã¢â¬â°mg , telmisartan 80Ã¢â¬â°mg combined with hydrochlorothiazide (HCTZ) 25Ã¢â¬â°mg ,0,
edin,2577,3400348,Significantly increased,"Among non-Black patients, T80/H25 resulted in significantly greater DBP reductions from baseline (adjusted mean DBP change â18.3âmmâHg) than V160/H25 (adjusted mean DBP change â16.5âmmâHg; P = 0.0229).", DBP change among non-Black patients , valsartan 160Ã¢â¬â°mg combined with hydrochlorothiazide (HCTZ) 25Ã¢â¬â°mg , telmisartan 80Ã¢â¬â°mg combined with hydrochlorothiazide (HCTZ) 25Ã¢â¬â°mg ,0,
edin,2585,4191553,Cannot tell based on the abstract,," Bone mineral density after 3 months at the lumbar spine, total hip, and femoral neck, and 6 months at the distal one third radius ", placebo , denosumab 60 mg sc every 6 months ,0,
edin,2585,4191553,Significantly increased,"The difference between the two groups was significant as early as 3 months at the lumbar spine, total hip, and femoral neck (P < .0001) and 6 months at the distal one third radius (P < .0001).,Mean BMD percentage change from baseline at 24 months was 9.1% and 0.1% at the lumbar spine in the denosumab and placebo groups, 4.6% and â1.1% at the total hip, 4.0% and â1.1% at the femoral neck, and 0.5% and â1.8% at distal one third radius, respectively (Figure 3, AâD),The difference between the denosumab and alendronate groups was significant as early as 3 months at the lumbar spine and total hip (P < .05), at 12 and 24 months at the femoral neck (P < .05), and from 18 months at the distal one third radius (P < .05)."," Bone mineral density after 3 months at the lumbar spine, total hip, and femoral neck, and 6 months at the distal one third radius ", placebo , denosumab 60 mg sc every 6 months ,0,
edin,2567,3961219,Cannot tell based on the abstract,, The mean normalized AUC values for the first and second clinical trials , placebo , Bowman-Birk inhibitor concentrate (BBIC) ,0,
edin,2567,3961219,Cannot tell based on the abstract,, The mean normalized AUC values for the first and second clinical trials , placebo , Bowman-Birk inhibitor concentrate (BBIC) ,0,
edin,2567,3961219,Significantly increased,"The mean normalized AUC value for BBIC-treated subjects (all doses combined) was 1.808 and 1.325 for the first and second clinical trials, respectively, and the difference was statistically significant (P=0.031)", The mean normalized AUC values for the first and second clinical trials , placebo , Bowman-Birk inhibitor concentrate (BBIC) ,0,
edin,2616,2887326,Significantly decreased,The aggravated rate was significantly (P < 0.05) lower in the Hochu-ekki-to group (3%; 1 of 37) than in the placebo group (18%; 7 of 39).," the aggravated rate, defined as ratio of patients whose TEA had increased more than 50% at 24 weeks from the beginning of the study ", placebo , Hochu-ekki-to ,0,
edin,2620,2409647,Cannot tell based on the abstract,, the number of skeletal fractures , placebo , oral ibandronate 50Ã¢â¬â°mg ,0,
edin,2620,2409647,No significant difference,There was no significant difference in the number of skeletal fractures with ibandronate compared with placebo (P=0.195)., the number of skeletal fractures , placebo , oral ibandronate 50Ã¢â¬â°mg ,0,
edin,2619,2409647,Cannot tell based on the abstract,, bone events requiring surgery , placebo , oral ibandronate 50Ã¢â¬â°mg ,0,
edin,2619,2409647,No significant difference,"<td align=""left"" charoff=""50"" valign=""top"">Need for surgery</td><td align=""center"" char=""."" charoff=""50"" valign=""top"">0.44</td><td align=""center"" char=""."" charoff=""50"" valign=""top"">0.40, <italic>P</italic>=0.098<sup>*</sup></td>", bone events requiring surgery , placebo , oral ibandronate 50Ã¢â¬â°mg ,0,
edin,2531,3881871,Significantly increased,A statistically significant increase in a* and b* chromatic parameters of the MTA Fillapex Group was measured., Chromatic alterations , ZnOE-based sealer (Roth-811) , MTA Fillapex sealer ,0,
edin,2612,3549413,Cannot tell based on the abstract,, Endometrial Thickness , baseline , calcium only or the geniVidaÃ¢âÂ¢ bone blend (GBB) ,0,
edin,2612,3549413,No significant difference,At no time point did endometrial thickness (ET) differ between the groups., Endometrial Thickness , baseline , calcium only or the geniVidaÃ¢âÂ¢ bone blend (GBB) ,0,
edin,2643,5831281,Cannot tell based on the abstract,, the mean intensity of pruritus , placebo , 1 week with clemastine and levocetirizine ,0,
edin,2643,5831281,No significant difference,"Regarding the studied subgroups, the mean intensity of pruritus according to the VAS before treatment was 5.6 Â±2.7 points in the clemastine group, 4.7 Â±3.2 points in the levocetirizine group and 3.6 Â±1.9 points in the placebo group (p = 0.07).", the mean intensity of pruritus , placebo , 1 week with clemastine and levocetirizine ,0,
edin,2550,2801838,Significantly increased,"At week 12, the human milk group had a sixfold higher geometric mean serum lutein (69.3Â mcg/l; 95% CI 40.3â119) than the unfortified formula group (11.3Â mcg/l; 95% CI 8.1â15.8).", Mean lutein concentration at week 12 , Unfortified formula group , Breastfed infants ,0,
edin,2578,5615289,Cannot tell based on the abstract,, The onset of tolerable and intolerable mucositis  , povidone-iodine , honey mitigates ,0,
edin,2578,5615289,Significantly decreased,The onset of tolerable and intolerable mucositis was delayed in the patients using honey and was significant for week 2 (p < 0.0001) and 3 (p < 0.003)., The onset of tolerable and intolerable mucositis  , povidone-iodine , honey mitigates ,0,
edin,2603,5446455,Significantly decreased,"When the groups were compared at the end of the study, a significant decrease was observed in VAS, PDI and HIT values in the individuals in the BAT and aerobic exercise groups."," Visual Analog Scale (VAS), Pain Disability Index (PDI) and Headache Impact Tests (HIT) ", baseline , control ,0,
edin,2581,5615289,Cannot tell based on the abstract,, The incidence of intolerable mucositis (only grade 3) at the end of week 7  , povidone-iodine , honey mitigates ,0,
edin,2581,5615289,No significant difference,"The incidence of intolerable mucositis (only grade 3) were seen earlier and at the end of week 3 in controls (16% (4/24), p = 0.03) and reached a peak in both the groups at the end of week 7 (12/24 in controls vs. 8/25 in honey (p = 0.2)).", The incidence of intolerable mucositis (only grade 3) at the end of week 7  , povidone-iodine , honey mitigates ,0,
edin,2589,3850342,Significantly increased,"We observed a significantly higher percentage of excellent embryos in ISM1 (42.7%) compared to G-1TM v5 (39%, p<0.05).", percentage of excellent embryos ," routine lab culture medium (G-1TM v5; Vitrolife, ", culture in ISM1 (MediCult) ,0,
edin,2576,3400348,Cannot tell based on the abstract,, reduction in BP for systolic blood pressure (SBP) and diastolic blood pressure (DBP)  , valsartan 160Ã¢â¬â°mg combined with hydrochlorothiazide (HCTZ) 25Ã¢â¬â°mg , telmisartan 80Ã¢â¬â°mg combined with hydrochlorothiazide (HCTZ) 25Ã¢â¬â°mg ,0,
edin,2576,3400348,Significantly increased,T80/H25 resulted in significantly greater BP reductions from baseline (adjusted mean SBP/DBP change â31.6/â18.0âmmâHg) than V160/H25 (adjusted mean SBP/DBP change â28.0/â15.8âmmâHg; P = 0.0063 for difference in SBP and P = 0.0041 for DBP)., reduction in BP for systolic blood pressure (SBP) and diastolic blood pressure (DBP)  , valsartan 160Ã¢â¬â°mg combined with hydrochlorothiazide (HCTZ) 25Ã¢â¬â°mg , telmisartan 80Ã¢â¬â°mg combined with hydrochlorothiazide (HCTZ) 25Ã¢â¬â°mg ,0,
edin,2629,5556716,Significantly decreased,"Likewise, among the Plane II fracture patients, those who underwent ultrasound-guided reduction were less dissatisfied than those who underwent blind reduction (p=0.043).", level of patients dissatisfaction , control group (blind reduction) Plane II fracture , ultrasound-guided reduction Plane II fracture ,0,
edin,2544,3376507,Significantly increased,"Intention-to-treat analysis showed that both intervention groups reduced their BMI compared with the controls (basic: â0.72, SD 1.1 kg/m2, enhanced: â1.0, SD 1.4, control: 0.15, SD 0.82; P < .001) and lost significant weight (basic: â2.1, SD 3.3 kg, enhanced: â3.0, SD 4.1, control: 0.4, SD 2.3; P < .001) with changes in waist circumference (basic: â2.0, SD 3.5 cm, enhanced: â3.2, SD 4.7, control: 0.5, SD 3.0; P < .001) and waist-to-height ratio (basic: â0.01, SD 0.02, enhanced: â0.02, SD 0.03, control: 0.0, SD 0.02; P < .001), but no differences were observed between the basic and enhanced groups.", Improvement in waist-to-height ratio , Wait-list control group , Standard version or enhanced version of commercial Web-based weight-loss program ,0,
edin,2640,5101645,Significantly increased,The sedation scores were higher in the BD group than in the other two groups at all time points (P < 0.001)., The sedation scores , the bupivacaine-fentanyl group (Group BF) received 0.25% bupivacaine (1 mL/kg) plus 2 ÃÂµg/kg fentanyl and the bupivacaine group (Group B) received 0.25% bupivacaine (1 ml/kg) , the bupivacaine-dexmedetomidine group (Group BD) received 0.25% bupivacaine (1 mL/kg) plus 2 ÃÂµg/kg dexmedetomidine ,0,
edin,2540,5057302,Cannot tell based on the abstract,," Safety laboratory parameters, ECG, and physical exam. ", Placebo , Sublingual immunotherapy (SLIT)  ,0,
edin,2540,5057302,No significant difference,"No clinically significant changes were observed in safety laboratory (haematology and blood chemistry) parameters, urinalysis, vital signs, physical examination and ECG."," Safety laboratory parameters, ECG, and physical exam. ", Placebo , Sublingual immunotherapy (SLIT)  ,0,
edin,2586,4191553,Cannot tell based on the abstract,," Bone mineral density after 3 months at the lumbar spine, total hip, and femoral neck, at 12 and 24 months at the femoral neck, and from 18 months at the distal one third radius ", oral alendronate 35 mg weekly , denosumab 60 mg sc every 6 months ,0,
edin,2586,4191553,Significantly increased,"As the referential comparison, the difference between the alendronate and placebo groups was significant as early as 3 months at the lumbar spine, total hip, and femoral neck (P < .01) and 6 months at the distal one third radius (P < .01). The difference between the denosumab and alendronate groups was significant as early as 3 months at the lumbar spine and total hip (P < .05), at 12 and 24 months at the femoral neck (P < .05), and from 18 months at the distal one third radius (P < .05)."," Bone mineral density after 3 months at the lumbar spine, total hip, and femoral neck, at 12 and 24 months at the femoral neck, and from 18 months at the distal one third radius ", oral alendronate 35 mg weekly , denosumab 60 mg sc every 6 months ,0,
edin,2639,5021260,Cannot tell based on the abstract,, The median coverage , low vaccine coverage rings , high coverage rings ,0,
edin,2639,5021260,Significantly increased,"The median coverage in the high coverage rings (coverage â¥ 30%) was 41% (interquartile range 34%â44%), compared to 0% (interquartile range 0%â6%) in the low vaccine coverage rings (coverage â¤ 12%).", The median coverage , low vaccine coverage rings , high coverage rings ,0,
edin,2609,5446455,Cannot tell based on the abstract,, VT: Vitality , baseline , aerobic exercise  ,0,
edin,2609,5446455,Significantly increased,"<td align=""center"" colspan=""1"" rowspan=""1""><bold>AE Group</bold></td><td align=""center"" colspan=""1"" rowspan=""1"">42.56Â±6.13</td><td align=""center"" colspan=""1"" rowspan=""1"">0.334</td><td align=""center"" colspan=""1"" rowspan=""1"">0.718</td><td align=""center"" colspan=""1"" rowspan=""1"">51.30Â±8.13</td><td align=""center"" colspan=""1"" rowspan=""1"">4.08</td><td align=""center"" colspan=""1"" rowspan=""1"">0.02</td>", VT: Vitality , baseline , aerobic exercise  ,0,
edin,2554,4714728,Significantly increased,"Group B patients scored higher in terms of pain (P=0.002), activities (P=0.02), range of motion (P<0.001), and strength (P=0.004).", activities , Group A was treated using a hook plate , Group B with autogenous semitendinosus graft and endobutton technique ,0,
edin,2647,4639339,Significantly increased,The use of Midazolam as a benzodiazepine with known sedative and muscle relaxant effects can increase the success rate of enema reduction in intussusception., reduction in intussusception , placebo ," Midazolam at the concentration of 1.0 mg/kg (up to 3 mg) was infused, and then barium reduction was performed under fluoroscopy guideline ",0,
edin,2569,4280425,Significantly decreased,"The results favour laparoscopy within the group with ASA 1â3 in terms of several parameters, namely: duration of hospitalization â 7.7 days in the case of laparoscopic intervention, vs. 10.6 days for conventional surgery (p < 0.05);", duration of hospitalization , conventional surgery , laparoscopy within the group with ASA 1Ã¢â¬â3 ,0,
edin,2642,5101645,Cannot tell based on the abstract,, the mean pain scores , the bupivacaine-fentanyl group (Group BF) received 0.25% bupivacaine (1 mL/kg) plus 2 ÃÂµg/kg fentanyl and the bupivacaine group (Group B) received 0.25% bupivacaine (1 ml/kg)  ,  the bupivacaine-dexmedetomidine group (Group BD) received 0.25% bupivacaine (1 mL/kg) plus 2 ÃÂµg/kg dexmedetomidine ,0,
edin,2642,5101645,No significant difference,There was no significant difference in the mean postoperative pain scores between different time points in each group., the mean pain scores , the bupivacaine-fentanyl group (Group BF) received 0.25% bupivacaine (1 mL/kg) plus 2 ÃÂµg/kg fentanyl and the bupivacaine group (Group B) received 0.25% bupivacaine (1 ml/kg)  ,  the bupivacaine-dexmedetomidine group (Group BD) received 0.25% bupivacaine (1 mL/kg) plus 2 ÃÂµg/kg dexmedetomidine ,0,
edin,2580,5615289,Cannot tell based on the abstract,,  the incidence of grade 2 mucositis at week 2 , povidone-iodine , honey mitigates ,0,
edin,2580,5615289,Significantly decreased,"With continuation of the treatment, the incidence of grade 2 mucositis appeared only in the controls (32% (8/25) vs. 0% (0/25)) and was significant (p = 0.002) at week 2.",  the incidence of grade 2 mucositis at week 2 , povidone-iodine , honey mitigates ,0,
edin,2602,5446455,Significantly decreased,"When the groups were compared at the end of the study, a significant decrease was observed in VAS, PDI and HIT values in the individuals in the BAT and aerobic exercise groups."," Visual Analog Scale (VAS), Pain Disability Index (PDI) and Headache Impact Tests (HIT) ", baseline , Body Awareness Therapy (BAT) and aerobic exercise  ,0,
edin,2565,3961219,Cannot tell based on the abstract,, The mean normalized area under the curve (AUC) values for the second phase , placebo , Bowman-Birk inhibitor concentrate (BBIC) ,0,
edin,2565,3961219,No significant difference,"For the second phase I trial, the normalized AUC for the serum BBI level was only weakly correlated with the BBIC dose, with a correlation coefficient of 0.36 and a slope value of 0.0003 (Fig. 3).,The mean normalized AUC values for the subjects treated with placebo or BBIC at doses of 800, 1,200, 1,600 or 2,000 CI units were 1.00Â±0.24, 0.91Â±0.39, 1.51Â±0.29, 1.39Â±0.12 and 1.49Â±0.33, respectively (Fig. 4), and the difference was not statistically significant (P=0.446 by one-way ANOVA).", The mean normalized area under the curve (AUC) values for the second phase , placebo , Bowman-Birk inhibitor concentrate (BBIC) ,0,
edin,2590,3850342,Significantly increased,Babies born after culture in ISM1 had both higher birth weight (3.03 kg) and length (48.8 cm) compared to G-1TM v5 babies that had a birth weight of 2.66 kg and a length of 46.0 cm (p<0.001 for both).,"  the length, weight babies born  "," routine lab culture medium (G-1TM v5; Vitrolife, ", culture in ISM1 (MediCult) ,0,
edin,2558,4204994,Significantly decreased,Low-dose Epoetin beta decreased PMI on days 4 and 11 to 46.0 (12.8)% (p<0.00001) and 46.1 (10.4)% (p<0.00001)., percentages of migrated isoforms (PMI) on days 4 and 11 , placebo on all days ," low-dose Epoetin beta (5000 IU on days 1, 3, 5, 7, 9, 11 and 13) ",0,
edin,2561,4814821,Cannot tell based on the abstract,, time to first COPD-related emergency room (ER) visit , usual group , telemonitoring group ,0,
edin,2561,4814821,Significantly increased,"In addition, telemonitoring intervention was associated with increased time to first COPD-related ER visit (Fig. 3), with an HR of 0.50 (95% CIâ=â0.24â1.04) over the six months of follow-up.", time to first COPD-related emergency room (ER) visit , usual group , telemonitoring group ,0,
edin,2559,4204994,Significantly decreased,"In both rhEPO groups, PMI on day 25 was still decreased (high-dose Epoetin beta: 72.9 (19.4)% (pâ=â0.029); low-dose Epoetin beta: 73.1 (17.8)% (pâ=â0.039)).", percentages of migrated isoforms (PMI) on day 25 , placebo on all days ," high-dose Epoetin beta (30.000 IU on days 1, 2 and 3 and placebo on days 5, 7, 9, 11 and 13) and low-dose Epoetin beta (5000 IU on days 1, 3, 5, 7, 9, 11 and 13),  ",0,
edin,2583,4191553,Significantly increased,"Denosumab significantly reduced the risk of new or worsening vertebral fracture by 65.7%, with incidences of 3.6% in denosumab and 10.3% in placebo at 24 months (hazard ratio 0.343; 95% confidence interval 0.194â0.606, P = .0001).", the reduction in risk of 24-month incidence of new or worsening vertebral fracture , placebo , denosumab 60 mg sc every 6 months  ,0,
edin,2582,5615289,Cannot tell based on the abstract,, weight loss , povidone-iodine , honey mitigates ,0,
edin,2582,5615289,Significantly decreased,"Additionally, it was observed that when compared to the povidone-iodine (4.86 Â± 1.73) group, the weight loss was less in the honey cohorts (2.77 Â± 0.85) and was statistically significant (p < 0.001).", weight loss , povidone-iodine , honey mitigates ,0,
edin,2608,5446455,Cannot tell based on the abstract,, VT: Vitality , control , aerobic exercise  ,0,
edin,2608,5446455,Significantly increased,"<td align=""center"" colspan=""1"" rowspan=""1""><bold>AE Group</bold></td><td align=""center"" colspan=""1"" rowspan=""1"">42.56Â±6.13</td><td align=""center"" colspan=""1"" rowspan=""1"">0.334</td><td align=""center"" colspan=""1"" rowspan=""1"">0.718</td><td align=""center"" colspan=""1"" rowspan=""1"">51.30Â±8.13</td><td align=""center"" colspan=""1"" rowspan=""1"">4.08</td><td align=""center"" colspan=""1"" rowspan=""1"">0.02</td>", VT: Vitality , control , aerobic exercise  ,0,
edin,2535,4593658,No significant difference,"The serum Cr increased and GFR decreased significantly during the intervention in three groups (P < 0.010). However, the amounts of these changes were equal between groups (P > 0.050).", Glomerular filtration rate , Only normal saline (Group C) , N-acetylcysteine plus normal saline (Group A) and Ascorbic acid plus normal saline (Group B) ,0,
edin,2634,4802087,Cannot tell based on the abstract,, Forced Expiratory Volume in the first second (FEV1) , placebo ," 100,000 IU of oral vitamin D per month, for 6 months ",0,
edin,2634,4802087,Significantly increased,"Also, after the study, in the study group, FEV1 was increased and the number of COPD exacerbations was decreased significantly (Table 4).,<td align=""left"" colspan=""1"" rowspan=""3"">COPD exacerbation (MÂ±SD)</td><td align=""left"" colspan=""1"" rowspan=""1"">Before</td><td align=""left"" colspan=""1"" rowspan=""1"">18.02Â±3.3</td><td align=""left"" colspan=""1"" rowspan=""1"">18.7Â±3.8</td><td align=""left"" colspan=""1"" rowspan=""1"">0.38</td>", Forced Expiratory Volume in the first second (FEV1) , placebo ," 100,000 IU of oral vitamin D per month, for 6 months ",0,
edin,2698,3919744,Cannot tell based on the abstract,, COP path length in the AP plane , Exercises with whole-body vibration (Groups II and III) and exercises without the application of concurrent vibration (Group IV) , Exercises with whole-body vibration (Group I) ,0,
edin,2698,3919744,Significantly increased,Group I was the only group where the COP path length in the AP plane was significantly increased after the last session of the 4-week whole-body vibration training (pâ=â0.046) (fig. 4, COP path length in the AP plane , Exercises with whole-body vibration (Groups II and III) and exercises without the application of concurrent vibration (Group IV) , Exercises with whole-body vibration (Group I) ,0,
edin,2784,5579675,Significantly decreased,"VAS scores for hunger, prospective eating, and desire to eat were all reduced (p < 0.05).","  Hunger, Prospective eating, desire to eat (Pre, immediately before, after, and 30 min post exercise). ", placebo (PLC) , 2 g of YM ,0,
edin,2658,3219777,Cannot tell based on the abstract,, Observer's Assessment of Alertness/Sedation scores after incision , Midazolam plus remifentanil , Midazolam plus remifentanil plus ketamine ,0,
edin,2658,3219777,Significantly decreased,"In the Control group, the VNRS value at 1 min after incision significantly increased and OAA/S values at 3, 5, and 30 min after incision significantly decreased compared to baseline values, while there were no significant changes in the ketamine group.", Observer's Assessment of Alertness/Sedation scores after incision , Midazolam plus remifentanil , Midazolam plus remifentanil plus ketamine ,0,
edin,2673,5385703,No significant difference,"Despite a continuous reduction in VASI score in both groups, according to both physician (P = 0.13) and patient (P = 0.374) assessment oral simvastatin was not statistically more effective than conventional treatment of vitiligo.", Vitiligo Area Scoring Index score , Topical betamethasone valerate cream (Group A) , Betamethasone valerate cream plus oral simvastatin (Group B) ,0,
edin,2655,3137994,No significant difference,There is no significant difference in the mortality rate between the âsurgicalâ and non-âsurgicalâ groups of Iranian patients with SAH., Mortality rate , Medical treatment , Surgical treatment ,0,
edin,2707,3599990,No significant difference,"Mean differences between self-reported and measured weight (pâ=â0.4004), height (pâ=â0.5342) and body mass index (BMI) (pâ=â0.4409) were not statistically different between the informed and uninformed group", Differences between self-reported and measured body mass index , Uninformed group , Informed group ,0,
edin,2778,4972969,Cannot tell based on the abstract,," Within the No-IMID subgroup - the proportion of emergency and priority patients admitted, detained or referred ", Control , on-site support (OSS) ,0,
edin,2778,4972969,Significantly increased,"Within the No-IMID subgroup, the incremental effect of OSS was statistically significant for only two indicators; increases in the proportion of emergency and priority patients admitted, detained or referred (Indicator 2, aRRRâ=â2.12, 99 % CIâ=â1.05-4.28, pâ=â0.006),"," Within the No-IMID subgroup - the proportion of emergency and priority patients admitted, detained or referred ", Control , on-site support (OSS) ,0,
edin,2765,4715405,Cannot tell based on the abstract,"In intervention group, mean level of blood glucose, 2 hours after lunch at 28 weeks of pregnancy was significantly lower than the control group (P<0.05).", MeanÃÂ±SD level of blood glucose before sleeping at 28 weeks of pregnancy , three times of telephone call was established to record blood sugar levels , telephone intervention was performed for 10 weeks ,0,
edin,2765,4715405,No significant difference,MeanÂ±SD level of blood glucose before sleeping at 28 weeks of pregnancy was 124.7Â±13.9 mg/dl in control and 113.2Â±15.8 mg/dl in intervention group (p=0.1)., MeanÃÂ±SD level of blood glucose before sleeping at 28 weeks of pregnancy , three times of telephone call was established to record blood sugar levels , telephone intervention was performed for 10 weeks ,0,
edin,2701,3919744,No significant difference,Most changes in the values of the center of pressure (COP) path lengths in the sagittal and frontal plane were statistically insignificant., Sagittal and frontal planes COP path length values , Exercises without the application of concurrent vibration (Group IV) ," Exercises with whole-body vibration (Group I, II and III) ",0,
edin,2660,3219777,Cannot tell based on the abstract,, Satisfaction scale of physicians and patients , Midazolam plus remifentanil , Midazolam plus remifentanil plus ketamine ,0,
edin,2660,3219777,No significant difference,The satisfaction scale (1 to 4) of the surgeons and the patients were high in both groups (4 vs. 4)., Satisfaction scale of physicians and patients , Midazolam plus remifentanil , Midazolam plus remifentanil plus ketamine ,0,
edin,2680,4517027,Significantly increased,"Breakfast was also beneficial for appetite control before lunch irrespective of size (all p < 0.05, d > 0.43).", Appetite control , No breakfast before exercise , Pre-exercise breakfast ,0,
edin,2762,3688436,No significant difference,"Over the course of 4 weeks, we failed to find that donepezil produced any significant difference in the YMRS (6.71 units difference, t = â1.44, P = 0.16) or the BPRS scale (1.29 units difference, t = â0.33, P = 0.75) as compared to placebo.", YMRS and the BPRS scale over the course of 4 weeks , placebo in addition to lithium , donepezil in addition to lithium ,0,
edin,2732,3348688,Significantly increased,"The bending stiffness anterior-posterior (treatment group 17.48 Nm vs. control group 8.3 Nm), medial-lateral (treatment group 18,9 Nm vs. control group 7.92 Nm) and the torsional stiffness (treatment group 41.17N/Â° vs. control group 16.41N/Â°) are significantly higher in the treatment group than in the control group."," The bending stiffness anterior-posterior, medial-lateral and the torsional stiffness  ", no injection (B) , triple injection of 1 mL rhBMP-2/NaCl (4 mg rhBMP-2/ml) (A)  ,0,
edin,2720,5856914,Significantly increased,"The CANDEN spine inflammation score had high responsiveness, similar to the SPARCC MRI spine index (Guyattâs responsiveness index 1.88 and 1.67, respectively), and discriminated between adalimumab and placebo treatment already at 6 weeksâ follow-up (P=0.03).", The CANDEN spine inflammation score , placebo , adalimumab ,0,
edin,2712,3452084,Significantly increased,"<td align=""left"" colspan=""4"">TOTPAR</td>", Time course of total pain relief (TOTPAR) ,  placebo (PLA) ," paracetamol 1,000mgÃ¢â¬âcaffeine 130mg (PCF)  and naproxen sodium 550 mg (NAP) ",0,
edin,2699,3919744,Cannot tell based on the abstract,, Vibration frequency , Exercises with whole-body vibration (Groups II and III)  , Exercises with whole-body vibration (Group I) ,0,
edin,2699,3919744,No significant difference,"The Mann Whitney U test did not show a significant influence of vibration frequency and amplitude on the path length of the COP and rambling and trembling paths (p>0.05) between the pre-test measurements and those made directly after the first session of whole-body vibration, immediately after the last set of exercises of the 4-week whole-body vibration training and one week after.", Vibration frequency , Exercises with whole-body vibration (Groups II and III)  , Exercises with whole-body vibration (Group I) ,0,
edin,2693,1796543,Cannot tell based on the abstract,, Changes in TLR5 and TLR10 , Placebo , Imiquimod 5% cream ,0,
edin,2693,1796543,No significant difference,There was no change in the expression levels of TLR5 and TLR10 upon treatment with imiquimod., Changes in TLR5 and TLR10 , Placebo , Imiquimod 5% cream ,0,
edin,2787,2430617,Cannot tell based on the abstract,, adverse events , placebo ," 30 ÃÂµg YIC, 60 ÃÂµg of YIC ",0,
edin,2787,2430617,No significant difference,"The occurrence of serious adverse events calculated according to the intent-to-treat principle was 5.1% (4/79), 3.6% (3/83), and 5.0% (4/80) in the placebo, 30 Âµg YIC and 60 Âµg YIC groups respectively (p>0.05).", adverse events , placebo ," 30 ÃÂµg YIC, 60 ÃÂµg of YIC ",0,
edin,2683,5529957,No significant difference,"Cardiac index improved in inoperable patients by a least-squares mean difference of +0.6âL/min/m2 (95% CI 0.4 to 0.7; p<0.0001), while in persistent/recurrent patients the change was +0.2âL/min/m2 (95% CI â0.1 to 0.5; p=0.17).", Improvement of cardiac index in persistent/recurrent patients , Placebo group , Riociguat group ,0,
edin,2745,3604854,No significant difference,The mean preoperative refraction in LDMMC eyes was â3.08 (SD 1.65) sphere and 0.92 (SD 0.88) cylinder. These values for SDMMC eyes were â3.25 (SD 1.80) sphere and 0.81 (SD 0.84) cylinder., The mean preoperative refraction and cylinder , standard dose MMC (SDMMC , low dose intraoperative MMC (LDMMC) ,0,
edin,2665,2806530,Significantly decreased,Results showed significant reductions in TCI after alcohol administration in female participants exclusively., Transcallosal inhibition in women , Placebo , Alcohol ,0,
edin,2713,3843300,Significantly decreased,"The serum level of blood urea nitrogen (BUN) and creatinine (Cr) in the control group increased significantly (P < 0.05), and administration of NAC (150 mg/kg) decreased the serum levels of Cr and BUN.", serum level of blood urea nitrogen (BUN) and creatinine (Cr) , control , sham-operated group ,0,
edin,2740,2212351,Significantly decreased,"Similarly, fasting blood glucose (FBG) levels decreased significantly between 1 and 12 months in group M (p<0.05), and decreased significantly during the entire 12 month period in group D (p<0.01).", fasting blood glucose (FBG) , no intervention , diabetic meal delivery for 12 months (group M) ,0,
edin,2756,4053826,No significant difference,"There was no difference with respect to pain scores on movement, nor with respect to patient satisfaction.", pain score on movement , the 0.9% saline continuous infusion (the control group) , the ropivacaine continuous infusion (the Ropi group) ,0,
edin,2747,3604854,No significant difference,Mean postoperative cylinder 3 and 6 month after PRK was 0.435 (SD 0.218) and 0.423 (SD 0.255)., Mean postoperative cylinder 3 and 6 month after PRK , standard dose MMC (SDMMC , low dose intraoperative MMC (LDMMC) ,0,
edin,2744,2212351,Cannot tell based on the abstract,, serum lipids , conventional dietary education (group C) , individual dietary counseling for 12 months (group D) or diabetic meal delivery for 12 months (group M) ,0,
edin,2744,2212351,No significant difference,"There were no significant changes in serum lipids levels in the three intervention groups, although serum TG levels were tended to decrease in groups M and D.", serum lipids , conventional dietary education (group C) , individual dietary counseling for 12 months (group D) or diabetic meal delivery for 12 months (group M) ,0,
edin,2722,4362117,Cannot tell based on the abstract,, percentage of Prevotella intermedia (Pi) and Porphyromonas gingivalis (Pg) , control group (CG) received only scaling and root planing (SRP) , One month after systemic doxycycline during the reevaluation visit 45 days after the completion of scaling and root planing (SRP) ,0,
edin,2722,4362117,Significantly decreased,"One month after the administration of doxycycline, both Pg, and Pi showed significant reduction in the percentage of site for TG compared with CG (p<0.01 and p=0.04).", percentage of Prevotella intermedia (Pi) and Porphyromonas gingivalis (Pg) , control group (CG) received only scaling and root planing (SRP) , One month after systemic doxycycline during the reevaluation visit 45 days after the completion of scaling and root planing (SRP) ,0,
edin,2811,5491994,Cannot tell based on the abstract,, rating the quality of the physicianÃ¢â¬â¢s explanation , control group ," explanation of patients anatomy, disease state, and treatment options using the education model as an aid ",0,
edin,2811,5491994,Significantly increased,"Patient responses in the 3D model group increased significantly when rating the quality of the physicianâs explanation, their own understanding of their anatomy, their own understanding of their disease state, and their understanding of the proposed surgical treatment.", rating the quality of the physicianÃ¢â¬â¢s explanation , control group ," explanation of patients anatomy, disease state, and treatment options using the education model as an aid ",0,
edin,2766,4715405,Significantly increased,Mean differences in levels of fasting blood glucose between 28 weeks and 32 and between 28 and 36 weeks of pregnancy were significantly higher in the intervention than the control group (P<0.05)., MeanÃÂ±SD of differences in levels of fasting blood glucose between 28 and 32 weeks and between 28 and 36 weeks of pregnancy , three times of telephone call was established to record blood sugar levels , telephone intervention was performed for 10 weeks ,0,
edin,2798,3329100,Significantly increased,"Findings of the study revealed a significant effect of the interval training program on VO2max, SBP, and DBP and WBC count at P<0.05 and VO2max is negatively related to the WBC count (r=â0.339) at P<0.01."," volume of O2 maximum (VO2max), systolic blood pressure (SBP) , white blood cell (WBC) and diastolic blood pressure (DBP) ", the age-matched controls hypertensive  group , 8-week interval training (60-79% HR max reserve) program of between 45 minutes to 60 minutes ,0,
edin,2678,4517027,Cannot tell based on the abstract,, Alertness after exercise , No breakfast before exercise , Pre-exercise breakfast ,0,
edin,2678,4517027,Significantly increased,Energy intake at breakfast prior to exercise was also significantly related to post-exercise alertness (r (43) = 0.315; p = 0.037) and overall mood (r (43) = 0.372; p = 0.013)., Alertness after exercise , No breakfast before exercise , Pre-exercise breakfast ,0,
edin,2771,5735486,Cannot tell based on the abstract,, MAP and HR , Group C receiving identical-looking placebo , Group F receiving preoperative flupirtine ,0,
edin,2771,5735486,No significant difference,MAP and HR between two groups were found to be quite comparable among two groups (P > 0.05) [Figures 1 and 2]., MAP and HR , Group C receiving identical-looking placebo , Group F receiving preoperative flupirtine ,0,
edin,2813,4247720,Significantly increased,"The rate of memory retention, computed by dividing Logical Memory delayed recall by immediate recall, showed a significant interaction (pâ<â.05) in analysis of covariance.,Simple main effects showed that the rate of memory retention of the intervention group improved after the program completion (pâ<â.05).", rate of retention , control group , cognitive intervention through a training program for picture book reading for In the participants with mild cognitive impairment (MCI) ,0,
edin,2661,5777197,Significantly increased,Hazard of death in the first four months was greatest in subjects receiving continuous high-dose lenalidomide; hazards of death thereafter were similar., Risk of death in the first four months , Sequential azacitidine and lenalidomide group and azacitidine only group , High-dose continuous lenalidomide group ,0,
edin,2788,4884260,No significant difference,Regarding the difference between groups for analgesic requirement there were two major points - on one hand it was statistically significant p < 0.05 whereas on the other hand time to first analgesic administration was not statistically significant p = 0.40., analgesic requirement , Local Infiltration Group received 0.2 ml/kg 0.25% bupivacaine , Caudal Group received 1 ml/kg of 0.25% bupivacaine ,0,
edin,2689,5529957,Significantly decreased,"Mean pulmonary artery pressure decreased in inoperable and persistent/recurrent patients(â4.7âmmâHg (95% CI â6.9 to â2.6; p<0.0001 and â4.8âmmâHg (â8.2 to â1.5; p=0.0055), respectively).", Mean pulmonary artery pressure , Placebo group , Riociguat group ,0,
edin,2799,4918317,Cannot tell based on the abstract,, The survival times , placebo , Long-chain omega-3 polyunsaturated fatty acids (PUFAs) ,0,
edin,2799,4918317,Significantly increased,"The survival times were significantly different between the treatment groups, with a more rapid conversion time for the placebo group compared with the omega-3 PUFA group (log-rank test: Ï2=9.84, P=0.002) (Fig. 2)", The survival times , placebo , Long-chain omega-3 polyunsaturated fatty acids (PUFAs) ,0,
edin,2797,5079604,Significantly increased,Subjects who remained in remission had a higher DI (P = 0.02) and incremental AUCi (P < 0.001) than those with hyperglycemia relapse without significant changes in Si., Disposition index (DI) and incremental area under the curve for insulin (AUCi)  , patients with hyperglycemia relapse without significant changes in insulin sensitivity (Si) , subjects who remained in remission ,0,
edin,2723,5268424,Cannot tell based on the abstract,, score on the general dimension scale of negative affects (referred to as NA from here onward) , control , view a video featuring individuals that live in extreme poverty ,0,
edin,2723,5268424,Significantly increased,"These tables show that the Poverty treatment yields a higher score on the general dimension scale of negative affects (referred to as NA from here onward), compared to the Neutral treatment (p<0.01).", score on the general dimension scale of negative affects (referred to as NA from here onward) , control , view a video featuring individuals that live in extreme poverty ,0,
edin,2780,5579675,Significantly increased,Combining YM intake with prolonged exercise at targeted âfat-lossââ intensities augments FAO and improves measures of satiety and mood state., fatty acid oxidation (FAO) , placebo (PLC) , 2 g of YM ,0,
edin,2666,2806530,Cannot tell based on the abstract,, Transcallosal inhibition in men , Placebo , Alcohol ,0,
edin,2666,2806530,No significant difference,"Post hoc analyses demonstrated that alcohol significantly reduced TCI in females (F(1, 11)â=â12.52; pâ=â0.005; Î·p2â=â0.53) but not in males (F(1, 9)â=â0.10; pâ=â0.76; Fig.Â 1). Fig.Â 1", Transcallosal inhibition in men , Placebo , Alcohol ,0,
edin,2700,3919744,Cannot tell based on the abstract,, Amplitude parameters , Exercises with whole-body vibration (Groups II and III)  , Exercises with whole-body vibration (Group I) ,0,
edin,2700,3919744,No significant difference,"The Mann Whitney U test did not show a significant influence of vibration frequency and amplitude on the path length of the COP and rambling and trembling paths (p>0.05) between the pre-test measurements and those made directly after the first session of whole-body vibration, immediately after the last set of exercises of the 4-week whole-body vibration training and one week after.", Amplitude parameters , Exercises with whole-body vibration (Groups II and III)  , Exercises with whole-body vibration (Group I) ,0,
edin,2742,2212351,Significantly decreased,"Similarly, fasting blood glucose (FBG) levels decreased significantly between 1 and 12 months in group M (p<0.05), and decreased significantly during the entire 12 month period in group D (p<0.01).", fasting blood glucose (FBG) levels , no intervention , individual dietary counseling for 12 months (group D) ,0,
edin,2696,3019750,No significant difference,No significant differences were found between G1 and G2 for enamel hardness and wear., Enamel wear , Saliva in situ (G1) , Saliva with fluoride (G2) ,0,
edin,2697,3919744,No significant difference,Most changes in the values of the center of pressure (COP) path lengths in the sagittal and frontal plane were statistically insignificant., Sagittal and frontal planes COP path length values , Exercises without the application of concurrent vibration (Group IV) ," Exercises with whole-body vibration (Group I, II and III) ",0,
edin,2748,3604854,Cannot tell based on the abstract,, haze formation rate , standard dose MMC (SDMMC , low dose intraoperative MMC (LDMMC) ,0,
edin,2748,3604854,No significant difference,Comparison of haze formation rate in these two groups by Mann-Whitney test demonstrated no significant difference in results (P = 0.104 3rd month and P = 0.156 6th month after operation), haze formation rate , standard dose MMC (SDMMC , low dose intraoperative MMC (LDMMC) ,0,
edin,2777,4972969,Cannot tell based on the abstract,, proportion of patients with a negative malaria test result prescribed an antimalarial  in integrated management of infectious diseases (IMID)- mid-level practitioners (MLP) group , Control , on-site support (OSS) ,0,
edin,2777,4972969,Significantly increased,"Within the IMID-MLP, the incremental effect of OSS was statistically significant for three indicators; increases in estimated proportion of malaria cases who received an appropriate antimalarial (Indicator 5, aRRRâ=â1.26, 99 % CIâ=â1.02-1.56, pâ=â0.005) and estimated proportion of patients with acid-fast bacilli (AFB) smear negative results who received empiric treatment for acute respiratory infection (indicator 11, aRRRâ=â2.04, 99 % CIâ=â1.06-3.94, pâ=â0.005) and decrease in proportion of patients with a negative malaria test result prescribed an antimalarial (Indicator 6, aRRRâ=â0.49, 99 % CIâ=â0.26-0.92, pâ=â0.004).", proportion of patients with a negative malaria test result prescribed an antimalarial  in integrated management of infectious diseases (IMID)- mid-level practitioners (MLP) group , Control , on-site support (OSS) ,0,
edin,2721,4362117,Cannot tell based on the abstract,, decline in the percentage of sites harboring Tannerella forsythia (Tf) , control group (CG) received only scaling and root planing (SRP) , One month after administeration systemic doxycycline after the completion of scaling and root planing (SRP) ,0,
edin,2721,4362117,Significantly increased,"In the first month after administering doxycycline, a significantly higher decline in the percentage of sites harboring Tf was observed for TG compared with CG (p=0.02).", decline in the percentage of sites harboring Tannerella forsythia (Tf) , control group (CG) received only scaling and root planing (SRP) , One month after administeration systemic doxycycline after the completion of scaling and root planing (SRP) ,0,
edin,2755,4053826,Significantly decreased,Pain scores at rest were lower for the ropivacaine group and reached significance after 8 and 16 hours (P<0.01)., pain scores at rest at 8 hours and at 16 hours  , the 0.9% saline continuous infusion (the control group) , the ropivacaine continuous infusion (the Ropi group) ,0,
edin,2664,2806530,Cannot tell based on the abstract,, Blood alcohol concentration , Placebo , Alcohol ,0,
edin,2664,2806530,Cannot tell based on the abstract,, Blood alcohol concentration , Placebo , Alcohol ,0,
edin,2664,2806530,No significant difference,"BAC values did not differ between males (mean Â± SD, 0.69âÂ±â0.04) and females (mean Â± SD, 0.603âÂ±â0.05; pâ=â0.17).", Blood alcohol concentration , Placebo , Alcohol ,0,
edin,2761,3688436,Significantly increased,"There was a difference of 0.57 units (t = 2.09, P = 0.04) in the speech item and a difference of 0.29 units in the sexual interest item (t = 2.11, P = 0.04) in the donepezil group as compared to the placebo group.", speech item and the sexual interest item , placebo in addition to lithium , donepezil in addition to lithium ,0,
edin,2657,3219777,Significantly decreased,"The VNRS values at 1, 3, and 5 min after incision and OAA/S scores at 5 min after remifentanil infusion, and 1, 3, and 5 min after incision were lower in the Ketamine group than in the Control group.", Verbal numerical rating scales after incision , Midazolam plus remifentanil , Midazolam plus remifentanil plus ketamine ,0,
edin,2760,3688436,No significant difference,"The total YMRS difference on the first day approached the conventional significance level (1.97 units, t = 1.84, P = 0.07).", Young Mania Rating Scale (YMRS) on the first day , placebo in addition to lithium , donepezil in addition to lithium ,0,
edin,2843,5422432,Cannot tell based on the abstract,, nominal gains at post-intervention , control , Active experiencing (AE) ,0,
edin,2843,5422432,Significantly increased,"Task switching also showed nominal gains at post-intervention (mean = 0.14, p = 0.04, Î±â = 0.01) and follow-up (mean = 0.16, p = 0.04, Î±â = 0.01), whereas category fluency only improved at follow-up (0.21, p = 0.005, Î±â = 0.01; BS 95% CI: 0.09/0.36).", nominal gains at post-intervention , control , Active experiencing (AE) ,0,
edin,2870,4112748,Cannot tell based on the abstract,, The frequency of rescue medication , baseline , frovatriptan and rizatriptan ,0,
edin,2870,4112748,No significant difference,"The frequency of rescue medication was lower in patients during frovatriptan treatment (seven of 20) compared to rizatriptan treatment (13 of 20), this difference just failing to reach statistical significance (P=0.058).", The frequency of rescue medication , baseline , frovatriptan and rizatriptan ,0,
edin,2903,4155124,Significantly decreased,"The ND significantly decreased cathepsin S levels (from 20.1 (+/-4.0 SD) to 19.7Â Î¼g/L (+/-4.3 SD)) compared with control group (from 18.2 (+/-2.9 SD) to 19.1Â Î¼g/L (+/-3.8 SD)). This difference remained after adjusting for sex and change in insulin sensitivity (Pâ=â0.03), and near significant after adjusting for baseline cathepsin S levels (Pâ=â0.06), but not for change in weight or LDL-C.", insulin sensitivity , baseline , healthy Nordic diet (ND) ,0,
edin,2864,5126155,Cannot tell based on the abstract,, The stability of pacing during follow-up ," pacemaker Talos DR (Biotronik, Berlin, Germany) "," pacemaker Qinming8631 DR (Qinming Medical, Baoji, China) ",0,
edin,2864,5126155,No significant difference,"The stability of pacing during follow-up was very high (99.0% in trial and 98.1% in control groups), and the difference was not significant (P = 0.621).", The stability of pacing during follow-up ," pacemaker Talos DR (Biotronik, Berlin, Germany) "," pacemaker Qinming8631 DR (Qinming Medical, Baoji, China) ",0,
edin,2825,3831918,Cannot tell based on the abstract,," pulse wave velocit (PWV), elastic modulus (Ep),  forward expansion wave that decelerates flow and reduces pressure (W2), negative area (NA), and (RC) reflection coefficient  ", pneumatic cuff was applied to the calf and inflated to 0 mmHg , pneumatic cuff was applied to the calf and inflated to 70 mmHg ,0,
edin,2825,3831918,Significantly increased,"There were significant differences in PWV, Ep, W2, NA, and RC across conditions (Table 3 and Fig. 1, P < 0.05)."," pulse wave velocit (PWV), elastic modulus (Ep),  forward expansion wave that decelerates flow and reduces pressure (W2), negative area (NA), and (RC) reflection coefficient  ", pneumatic cuff was applied to the calf and inflated to 0 mmHg , pneumatic cuff was applied to the calf and inflated to 70 mmHg ,0,
edin,2845,5422432,Cannot tell based on the abstract,, category fluency at follow-up , control , Active experiencing (AE) ,0,
edin,2845,5422432,Significantly increased,"Task switching also showed nominal gains at post-intervention (mean = 0.14, p = 0.04, Î±â = 0.01) and follow-up (mean = 0.16, p = 0.04, Î±â = 0.01), whereas category fluency only improved at follow-up (0.21, p = 0.005, Î±â = 0.01; BS 95% CI: 0.09/0.36).", category fluency at follow-up , control , Active experiencing (AE) ,0,
edin,2850,5586978,Significantly increased,"Compared to group B, group A, which had less time on postoperative mechanical ventilation, had a higher VAS score.", The visual analog scale (VAS) scores , baseline , The mini-open anterior approach focal cleaning combined with posterior internal fixation in period I - group A ,0,
edin,2857,4631853,Cannot tell based on the abstract,, pain level , propofol (1.5Ã¢â¬â°mg/kg) combination in Group II  ," propofol (1.5Ã¢â¬â°mg/kg) in Group Ãâ¢, remifentanil (0.05Ã¢â¬â°ÃÂ¼g/kg), fentanyl (1Ã¢â¬â°ÃÂ¼g/kg) + propofol (1.5Ã¢â¬â°mg/kg) combination in Group III ",0,
edin,2857,4631853,Significantly increased,"Also there was statistically significant difference between the groups during the follow-up (monitorization) period in terms of pain levels (p < 0.05). The patients in Group I suffered from the pain most, whereas the patients in Group II had the least pain (Table 3).", pain level , propofol (1.5Ã¢â¬â°mg/kg) combination in Group II  ," propofol (1.5Ã¢â¬â°mg/kg) in Group Ãâ¢, remifentanil (0.05Ã¢â¬â°ÃÂ¼g/kg), fentanyl (1Ã¢â¬â°ÃÂ¼g/kg) + propofol (1.5Ã¢â¬â°mg/kg) combination in Group III ",0,
edin,2841,5422432,Cannot tell based on the abstract,, Story recall improved at post-intervention , control , Active experiencing (AE) ,0,
edin,2841,5422432,Significantly decreased,"Story recall improved at post-intervention (mean = 0.32, p < 0.001, Î±â = 0.01; BS 95% CI: 0.21/0.42), as did thematic recall (mean = 0.18, p = 0.03, Î±â = 0.01; BS 95% CI: 0.04/0.32), although the effect did not survive correction for multiple comparisons.", Story recall improved at post-intervention , control , Active experiencing (AE) ,0,
edin,2840,5722109,Cannot tell based on the abstract,, success rate of inferior alveolar nerve block (IANB) in posterior mandible teeth with symptomatic irreversible pulpitis. , epinephrine 1:200000 and 0.4 mL normal saline (A-saline group) , 3.2 mL 4% articaine with epinephrine 1:200000 and 0.4 mL 50 mg/mL ketamine hydrochloride (A-ketamine group) ,0,
edin,2840,5722109,No significant difference,The success rate of IANB was 55.0% for A-ketamine and 42.9% for A-saline group. There was no statistically significant difference in success rates between the two groups (P=0.437)., success rate of inferior alveolar nerve block (IANB) in posterior mandible teeth with symptomatic irreversible pulpitis. , epinephrine 1:200000 and 0.4 mL normal saline (A-saline group) , 3.2 mL 4% articaine with epinephrine 1:200000 and 0.4 mL 50 mg/mL ketamine hydrochloride (A-ketamine group) ,0,
edin,2922,5771895,Cannot tell based on the abstract,, average severity scores of hot flashes and night sweats , placebo ," transdermal 17ÃÂ²-estradiol (t-E2; 50Ã¢â¬Å ÃÂ¼g/d) plus cyclic progesterone (Prometrium, 200Ã¢â¬Å mg)  or  oral conjugated equine estrogens (o-CEE; 0.45Ã¢â¬Å mg/d)   ",0,
edin,2922,5771895,Significantly decreased,"As reported previously for the entire KEEPS cohort,27 the average severity scores of hot flashes and night sweats were significantly reduced by both HT formulations when compared with PBO (Pâ<â0.001 for both), with no difference between the o-CEE and t-E2 groups (Pâ=â0.343 and Pâ=â0.919, respectively; Table 2).", average severity scores of hot flashes and night sweats , placebo ," transdermal 17ÃÂ²-estradiol (t-E2; 50Ã¢â¬Å ÃÂ¼g/d) plus cyclic progesterone (Prometrium, 200Ã¢â¬Å mg)  or  oral conjugated equine estrogens (o-CEE; 0.45Ã¢â¬Å mg/d)   ",0,
edin,2828,5297995,Cannot tell based on the abstract,, coronal growth of approximal gingival margin on the neighboring teeth , stock , zirconia implant abutments ,0,
edin,2828,5297995,Significantly increased,"Clinical examination revealed a significant (Tâ=â24; pâ<â.05) coronal growth of approximal gingival margin (0.32 mm; 95% CI [0,06 mm; 0,58mm]; SD 0.88 mm) on the neighboring teeth after 12 months.", coronal growth of approximal gingival margin on the neighboring teeth , stock , zirconia implant abutments ,0,
edin,2837,4888158,Cannot tell based on the abstract,, residual antimicrobial activity of CHX at one week and at three and six weeks ,  Resilon/RealSeal SE samples , gutta-percha/AH26  ,0,
edin,2837,4888158,Significantly increased,"The results showed that residual antimicrobial activity of CHX was significantly higher in gutta-percha/AH26 samples than in Resilon/RealSeal SE samples (P=0.02 at one week and P=0.003 at three and six weeks, respectively).", residual antimicrobial activity of CHX at one week and at three and six weeks ,  Resilon/RealSeal SE samples , gutta-percha/AH26  ,0,
edin,2844,5422432,Cannot tell based on the abstract,, nominal gains at follow-up , control , Active experiencing (AE) ,0,
edin,2844,5422432,Significantly increased,"Task switching also showed nominal gains at post-intervention (mean = 0.14, p = 0.04, Î±â = 0.01) and follow-up (mean = 0.16, p = 0.04, Î±â = 0.01), whereas category fluency only improved at follow-up (0.21, p = 0.005, Î±â = 0.01; BS 95% CI: 0.09/0.36).", nominal gains at follow-up , control , Active experiencing (AE) ,0,
edin,2895,3267052,Significantly decreased,The % BOP (5 months) and cumulative plaque scores (8 months) were lowered more in the FV group (p < 0.05)., cumulative plaque scores , placebo , fruit/vegetable (FV) ,0,
edin,2923,5771895,Cannot tell based on the abstract,, average severity scores of hot flashes and night sweats , oral conjugated equine estrogens (o-CEE; 0.45Ã¢â¬Å mg/d)   ," transdermal 17ÃÂ²-estradiol (t-E2; 50Ã¢â¬Å ÃÂ¼g/d) plus cyclic progesterone (Prometrium, 200Ã¢â¬Å mg)   ",0,
edin,2923,5771895,Significantly decreased,"As reported previously for the entire KEEPS cohort,27 the average severity scores of hot flashes and night sweats were significantly reduced by both HT formulations when compared with PBO (Pâ<â0.001 for both), with no difference between the o-CEE and t-E2 groups (Pâ=â0.343 and Pâ=â0.919, respectively; Table 2).", average severity scores of hot flashes and night sweats , oral conjugated equine estrogens (o-CEE; 0.45Ã¢â¬Å mg/d)   ," transdermal 17ÃÂ²-estradiol (t-E2; 50Ã¢â¬Å ÃÂ¼g/d) plus cyclic progesterone (Prometrium, 200Ã¢â¬Å mg)   ",0,
edin,2919,5771895,Cannot tell based on the abstract,, the number of women with improved sleep quality ,  oral conjugated equine estrogens (o-CEE; 0.45Ã¢â¬Å mg/d)  or placebo (PBO) ," transdermal 17ÃÂ²-estradiol (t-E2; 50Ã¢â¬Å ÃÂ¼g/d) plus cyclic progesterone (Prometrium, 200Ã¢â¬Å mg)  ",0,
edin,2919,5771895,Significantly increased,"When compared with PBO, the reduction in the percentage of women with poor sleep quality (ie, the number of women with improved sleep quality) was significantly greater in the t-E2 group (Pâ=â0.003) and modestly but not significantly greater in the o-CEE group (Pâ=â0.07).", the number of women with improved sleep quality ,  oral conjugated equine estrogens (o-CEE; 0.45Ã¢â¬Å mg/d)  or placebo (PBO) ," transdermal 17ÃÂ²-estradiol (t-E2; 50Ã¢â¬Å ÃÂ¼g/d) plus cyclic progesterone (Prometrium, 200Ã¢â¬Å mg)  ",0,
edin,2831,5297995,Cannot tell based on the abstract,, coronal growth of approximal gingival margin on the neighboring teeth , After the intake (T 0) and implant placement , followÃ¢â¬ï¿½up appointments were planned at two weeks (T 1) and 12 months (T 12) after delivery of the restoration ,0,
edin,2831,5297995,Significantly increased,"Clinical examination revealed a significant (Tâ=â24; pâ<â.05) coronal growth of approximal gingival margin (0.32 mm; 95% CI [0,06 mm; 0,58mm]; SD 0.88 mm) on the neighboring teeth after 12 months.", coronal growth of approximal gingival margin on the neighboring teeth , After the intake (T 0) and implant placement , followÃ¢â¬ï¿½up appointments were planned at two weeks (T 1) and 12 months (T 12) after delivery of the restoration ,0,
edin,2894,3267052,Significantly decreased,"Gingival crevicular fluid volumes diminished more in supplement groups than placebo (FVB; p < 0.05) at 2 months, but not at later times.", Gingival crevicular fluid (GCF) volumes , placebo , fruit/vegetable (FV) and FVB ,0,
edin,2829,5297995,Cannot tell based on the abstract,," embarrassment and problems with taste, speech, gum color, tooth color and the visibility of the implant ", After the intake (T 0) and implant placement , followÃ¢â¬ï¿½up appointments were planned at two weeks (T 1) and 12 months (T 12) after delivery of the restoration ,0,
edin,2829,5297995,Significantly decreased,"Patients experienced significantly less embarrassment and problems with taste, speech, gum color, tooth color and the visibility of the implant at T 1 (pâ<â.01) and T 12 (pâ<â.05) than they had expected at T 0."," embarrassment and problems with taste, speech, gum color, tooth color and the visibility of the implant ", After the intake (T 0) and implant placement , followÃ¢â¬ï¿½up appointments were planned at two weeks (T 1) and 12 months (T 12) after delivery of the restoration ,0,
edin,2877,5106877,Significantly increased,"There is no difference between serums Vit D level in case and control group at the beginning of the study, however at the end of the study serum Vit D level was significantly higher in the case group.", serums Vit D level , placebo , Vit D as 50 000 IU/week ,0,
edin,2822,3831918,Cannot tell based on the abstract,," retrograde shear rate, diastolic antegrade shear rate, and consequently mean shear rate ", baseline ," pneumatic cuff was applied to the calf and inflated to 0, 35, and 70 mmHg ",0,
edin,2822,3831918,Significantly decreased,"There were significant differences in retrograde shear rate, diastolic antegrade shear rate, and consequently mean shear rate across conditions (Table 3 and Fig. 1, P < 0.05).,<td align=""left"" colspan=""1"" rowspan=""1"">Mean shear rate, sec<sup>â1</sup></td><td align=""center"" colspan=""1"" rowspan=""1"">102 Â± 9</td><td align=""center"" colspan=""1"" rowspan=""1"">69 Â± 7<xref ref-type=""table-fn"" rid=""tf3-1"">1</xref></td><td align=""center"" colspan=""1"" rowspan=""1"">37 Â± 8<xref ref-type=""table-fn"" rid=""tf3-1"">1</xref>,<xref ref-type=""table-fn"" rid=""tf3-2"">2</xref></td><td align=""center"" colspan=""1"" rowspan=""1"">0.001</td>"," retrograde shear rate, diastolic antegrade shear rate, and consequently mean shear rate ", baseline ," pneumatic cuff was applied to the calf and inflated to 0, 35, and 70 mmHg ",0,
edin,2830,5297995,Cannot tell based on the abstract,, bone apposition , stock , zirconia implant abutments ,0,
edin,2830,5297995,No significant difference,"The difference in bone apposition between the 2 groups (stock: 0.06 mm, 95% CI [â0.05 mm; 0.16 mm], standard deviation 0.23mm versus CAD/CAM customized: 0.11 mm, 95% CI [0.02 mm; 0.20 mm]; standard deviation 0.20 mm) was not statistically significant.", bone apposition , stock , zirconia implant abutments ,0,
edin,2921,5771895,Cannot tell based on the abstract,, sleep disturbances ,  oral conjugated equine estrogens (o-CEE; 0.45Ã¢â¬Å mg/d)   ," transdermal 17ÃÂ²-estradiol (t-E2; 50Ã¢â¬Å ÃÂ¼g/d) plus cyclic progesterone (Prometrium, 200Ã¢â¬Å mg)  ",0,
edin,2921,5771895,Significantly increased,"Among the three domains, only sleep disturbances showed a statistically significant difference between the two HT formulations (Pâ=â0.029), with t-E2 improving more during follow-up than o-CEE (Table 2).", sleep disturbances ,  oral conjugated equine estrogens (o-CEE; 0.45Ã¢â¬Å mg/d)   ," transdermal 17ÃÂ²-estradiol (t-E2; 50Ã¢â¬Å ÃÂ¼g/d) plus cyclic progesterone (Prometrium, 200Ã¢â¬Å mg)  ",0,
edin,2852,5586978,Cannot tell based on the abstract,,  the VAS scores after surgery , conventional anterior extraperitoneal approach focal cleaning combined with posterior internal fixation in period I - group B , The mini-open anterior approach focal cleaning combined with posterior internal fixation in period I - group A ,0,
edin,2852,5586978,Significantly decreased,"After surgery, the VAS scores in group A were better than that in group B (P<0.05), while the Cobb angle and ESR of the two groups showed no difference.",  the VAS scores after surgery , conventional anterior extraperitoneal approach focal cleaning combined with posterior internal fixation in period I - group B , The mini-open anterior approach focal cleaning combined with posterior internal fixation in period I - group A ,0,
edin,2859,5870330,Significantly increased,"Furthermore, the fracture resistance of G4 and G5 was significantly higher than G3 and G6 (P < 0.05),", fracture resistance , G3 was prepared with an occlusal extension that extended one-third of buccolingual width and 2 mm in depth , G4 was prepared with the occlusal extension of 1mm in depth and width. G5: The occlusal extension was 1mm in depth and 2 mm in width ,0,
edin,2892,3267052,Significantly decreased,The % BOP (5 months) and cumulative plaque scores (8 months) were lowered more in the FV group (p < 0.05)., bleeding on probing (% BOP) and cumulative plaque scores  ," fruit/vegetable/berry (FVB), placebo ", fruit/vegetable (FV) ,0,
edin,2890,3267052,Significantly increased,"Clinical outcomes improved in all groups at 2 months, with additional improvement in PPD versus placebo for FV (p < 0.03).", mean probing pocket depth (PPD) , placebo ,"  fruit/vegetable (FV), fruit/vegetable/berry (FVB) ",0,
edin,2913,5459456,Cannot tell based on the abstract,," inflexion-extension and lateral bending for the C2-C6, C2-C4, C4-C5, and C5-C6 segments ", control , ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC ,0,
edin,2913,5459456,No significant difference,"There were no significant differences among the control, ACVC, and ACVC-HA groups inflexion-extension and lateral bending for the C2-C6, C2-C4, C4-C5, and C5-C6 segments."," inflexion-extension and lateral bending for the C2-C6, C2-C4, C4-C5, and C5-C6 segments ", control , ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC ,0,
edin,2915,5459456,Cannot tell based on the abstract,, new bone formation around the screws and bone-implant contact (BIC) in both sections , ACVC , ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating ,0,
edin,2915,5459456,Significantly increased,"In the sections located at the self-drilling fixation screw level (Fig 8E and 8G), we found significantly more new bone formation around the screws for the ACVC-HA group (Fig 8G) than for the ACVC group (Fig 8E).,These findings indicate that, compared with the ACVC group, the ACVC-HA group had a significantly higher bone-implant contact (BIC) in both sections respectively located at the vertebral body component and screw level (Fig 8I), which is an appropriate index for measuring bone ingrowth into the implant.", new bone formation around the screws and bone-implant contact (BIC) in both sections , ACVC , ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating ,0,
edin,2918,4021263,Cannot tell based on the abstract,, M. tuberculosis or nontuberculous mycobacteria detection , self-expectoration (ES) , sputum induction with 7% saline nebulization in clinic (SI)  ,0,
edin,2918,4021263,No significant difference,"Among the 51 confirmed APTB cases, M. tuberculosis or nontuberculous mycobacteria was identified in one or more samples from 27 (52.9%) patients, 14 (58.3%) from the SI group and 13 (48.1%) from the ES group (p=0.46).", M. tuberculosis or nontuberculous mycobacteria detection , self-expectoration (ES) , sputum induction with 7% saline nebulization in clinic (SI)  ,0,
edin,2842,5422432,Cannot tell based on the abstract,, thematic recall , control , Active experiencing (AE) ,0,
edin,2842,5422432,Significantly increased,"Story recall improved at post-intervention (mean = 0.32, p < 0.001, Î±â = 0.01; BS 95% CI: 0.21/0.42), as did thematic recall (mean = 0.18, p = 0.03, Î±â = 0.01; BS 95% CI: 0.04/0.32), although the effect did not survive correction for multiple comparisons.", thematic recall , control , Active experiencing (AE) ,0,
edin,2881,5129820,No significant difference,"There were no statistically significant differences in time to worsening or improvement rates of TOI, FOSI and FACT-O scores in the overall, BRCAm and germline BRCAm populations.", The Functional Assessment of Cancer Therapy/National Comprehensive Cancer Network Ovarian Symptom Index (FOSI) , placebo , olaparib 400Ã¢â¬â°mg b.i.d. (capsules) ,0,
edin,2866,4112748,No significant difference,"Although the time to maximum concentration was similar for both drugs (2.7 versus 2.3 hours), the terminal half-life for frovatriptan was longer than rizatriptan (29.3 versus 3.2 hours, P<0.0001).", the time to maximum concentration , rizatriptan , frovatriptan ,0,
edin,2874,4776123,Cannot tell based on the abstract,, global LCF of CereN , control before scanning , conrtol after scanning ,0,
edin,2874,4776123,Cannot tell based on the abstract,, global LCF of CereN , control before scanning , conrtol after scanning ,0,
edin,2874,4776123,Significantly increased,"After the Fisher r-to-z translation, a repeated measure ANOVA revealed that both groups improved their LCFs in CereN as indicated by a significant main effect of time (F = 6.903, p = 0.015).,Paired-sample t-tests revealed that the global LCF of CereN (T = 2.30, p = 0.03) was significantly increased after the training scan compared with the before-training scan in the control group but not in the training group.", global LCF of CereN , control before scanning , conrtol after scanning ,0,
edin,2909,4069273,Cannot tell based on the abstract,, Exercise , received a routine program ," attended a 20 minute lifestyle and oral health education program, individual lifestyle counseling using motivational interviewing (MI), application of self regulation manual, and individual oral hygiene instruction ",0,
edin,2909,4069273,Significantly increased,"Exercise had a statistically significant difference between the intervention and the control groups (pâ<â0.001).,After 3Â month follow up, the percentage of participants who exercised more than 5 times/week in the intervention group (29.2%) was more than the control group (9.2%).", Exercise , received a routine program ," attended a 20 minute lifestyle and oral health education program, individual lifestyle counseling using motivational interviewing (MI), application of self regulation manual, and individual oral hygiene instruction ",0,
edin,2920,5771895,Cannot tell based on the abstract,," domain scores pertaining to sleep efficiency, sleep duration, or daytime dysfunction ",  oral conjugated equine estrogens (o-CEE; 0.45Ã¢â¬Å mg/d)  ," transdermal 17ÃÂ²-estradiol (t-E2; 50Ã¢â¬Å ÃÂ¼g/d) plus cyclic progesterone (Prometrium, 200Ã¢â¬Å mg)  ",0,
edin,2920,5771895,No significant difference,"There were no significant differences between groups for the changes in domain scores pertaining to sleep efficiency (Pâ=â0.45), sleep duration (Pâ=â0.38), or daytime dysfunction (Pâ=â0.26) across follow-up."," domain scores pertaining to sleep efficiency, sleep duration, or daytime dysfunction ",  oral conjugated equine estrogens (o-CEE; 0.45Ã¢â¬Å mg/d)  ," transdermal 17ÃÂ²-estradiol (t-E2; 50Ã¢â¬Å ÃÂ¼g/d) plus cyclic progesterone (Prometrium, 200Ã¢â¬Å mg)  ",0,
edin,2863,5126155,Cannot tell based on the abstract,, The effective sensitivity rate ," pacemaker Talos DR (Biotronik, Berlin, Germany) "," pacemaker Qinming8631 DR (Qinming Medical, Baoji, China) ",0,
edin,2863,5126155,No significant difference,"The effective sensitivity rate immediately after the procedure was 94.8% and 93.6% in the trial and control groups, respectively, with no significant difference (P = 0.716).", The effective sensitivity rate ," pacemaker Talos DR (Biotronik, Berlin, Germany) "," pacemaker Qinming8631 DR (Qinming Medical, Baoji, China) ",0,
edin,2885,4249579,Significantly increased,"Dihydroartemisinin-piperaquine coadministration significantly increased plasma primaquine levels; geometric mean ratios (90% confidence interval [CI]) of primaquine combined versus primaquine alone for maximum concentration (Cmax), area under the concentration-time curve from 0 h to the end of the study (AUC0âlast), and area under the concentration-time curve from 0 h to infinity (AUC0ââ) were 148% (117 to 187%), 129% (103 to 163%), and 128% (102 to 161%), respectively.", maximum observed plasma concentration after oral administration (Cmax) and predicted area under the plasma concentration time curve after the last dose from zero time to infinity (AUC0Ã¢â¬âlast)values , primaquine phosphate , primaquine phosphate and dihydroartemisinin-piperaquine ,0,
edin,2823,3831918,Significantly increased,Cuff inflation resulted in stepwise increases in retrograde shear rate (P < 0.05 for main effect)., retrograde shear , pneumatic cuff was applied to the calf and inflated to 0 mmHg , pneumatic cuff was applied to the calf and inflated to 70 mmHg ,0,
edin,2821,4450208,Significantly increased,"Regarding the effect of the program on both genders, the change was very similar, but the boys increased assertive social interaction strategies, attention, and emotional clarity significantly more than the girls."," assertive social interaction strategies, attention, and emotional clarity ",  a program of emotional intelligence (EI) 20 one-hour sessions - girls ,  a program of emotional intelligence (EI) 20 one-hour sessions - boys ,0,
edin,2856,4631853,Cannot tell based on the abstract,, total propofol doses , fentanyl (1Ã¢â¬â°ÃÂ¼g/kg) + propofol (1.5Ã¢â¬â°mg/kg) combination in Group III ," propofol (1.5Ã¢â¬â°mg/kg) in Group Ãâ¢, remifentanil (0.05Ã¢â¬â°ÃÂ¼g/kg) + propofol (1.5Ã¢â¬â°mg/kg) combination in Group II ",0,
edin,2856,4631853,Significantly decreased,"In terms of total propofol doses administered during the follow-up (monitorization), the difference between Group I and Group II and between Group I and Group III and Groups II and III was statistically significant (p < 0.001) (p < 0.003).,The comparison of the groups in terms of the total dose of propofol revealed that it was 375âmg in Group I, 150âmg in Group II, and 245âmg in Group III (Figure 1).", total propofol doses , fentanyl (1Ã¢â¬â°ÃÂ¼g/kg) + propofol (1.5Ã¢â¬â°mg/kg) combination in Group III ," propofol (1.5Ã¢â¬â°mg/kg) in Group Ãâ¢, remifentanil (0.05Ã¢â¬â°ÃÂ¼g/kg) + propofol (1.5Ã¢â¬â°mg/kg) combination in Group II ",0,
edin,2908,4069273,Significantly decreased,"Participants in the intervention group had significantly lower glycosylated hemoglobin (HbA1c), fasting plasma glucose (FPG), plaque index score, gingival index score, pocket depth, clinical attachment level (CAL), and percentage of bleeding on probing (BOP) when compared to the control group."," pocket depth, clinical attachment level (CAL), and percentage of bleeding on probing (BOP) ", received a routine program ," attended a 20 minute lifestyle and oral health education program, individual lifestyle counseling using motivational interviewing (MI), application of self regulation manual, and individual oral hygiene instruction ",0,
edin,2818,4450208,Cannot tell based on the abstract,, the effects of the program 1 year after completing the intervention , control ,  a program of emotional intelligence (EI) 20 one-hour sessions ,0,
edin,2818,4450208,Significantly increased,"Subsequently, in order to assess the maintenance of the effects of the program 1 year after completing the intervention, the pretest-follow-up change was analyzed.,The results of the descriptive analysis (mean and SD) and pretest-follow-up ANCOVAs (with the pretest scores as covariates, see Table 4) confirmed statistically significant differences in the pretest-follow-up change between the experimental and control groups.,In particular, we noted a significant increase in the mean scores of the experimental group (Me) compared with the control group (Mc) in EI due to the significant improvement in all three factors, emotional attention (Me = 2.43, Mc = -1.26), emotional clarity (Me = 2.86, Mc = 0.02), and emotional repair (Me = 3.24, Mc = 0.05).", the effects of the program 1 year after completing the intervention , control ,  a program of emotional intelligence (EI) 20 one-hour sessions ,0,
edin,2872,4776123,Cannot tell based on the abstract,,   improving of level laterality cofactor (LCF) in cerebellum network included bilateral cerebellum hemispheres (CereN) , baseline , right- and left- frontoparietal networks (FPNs) and control ,0,
edin,2872,4776123,Significantly increased,"After the Fisher r-to-z translation, a repeated measure ANOVA revealed that both groups improved their LCFs in CereN as indicated by a significant main effect of time (F = 6.903, p = 0.015).",   improving of level laterality cofactor (LCF) in cerebellum network included bilateral cerebellum hemispheres (CereN) , baseline , right- and left- frontoparietal networks (FPNs) and control ,0,
edin,2873,4776123,Cannot tell based on the abstract,,   improving of level laterality cofactor (LCF)  , baseline , right lateral  frontoparietal networks (rFPN) left lateral  frontoparietal networks (lFPN) ,0,
edin,2873,4776123,Significantly increased,"In addition, a significant training main effect on the LCF in rFPN (F = 5.897, p = 0.021) and lFPN (F = 7.641, p = 0.01), as well as interactions of LCF of lFPN (F = 8.908, p = 0.006), were observed.",   improving of level laterality cofactor (LCF)  , baseline , right lateral  frontoparietal networks (rFPN) left lateral  frontoparietal networks (lFPN) ,0,
edin,2848,5422432,Cannot tell based on the abstract,, story recall at post-intervention , baseline , Active Control ,0,
edin,2848,5422432,Significantly increased,"Story recall improved at post-intervention (mean = 0.32, p < 0.001, Î±â = 0.01; BS 95% CI: 0.21/0.42), as did thematic recall (mean = 0.18, p = 0.03, Î±â = 0.01; BS 95% CI: 0.04/0.32), although the effect did not survive correction for multiple comparisons.", story recall at post-intervention , baseline , Active Control ,0,
edin,2906,4069273,Significantly decreased,"articipants in the intervention group had significantly lower glycosylated hemoglobin (HbA1c), fasting plasma glucose (FPG), plaque index score, gingival index score, pocket depth, clinical attachment level (CAL), and percentage of bleeding on probing (BOP) when compared to the control group.", the plaque index score and gingival index score , received a routine program ," attended a 20 minute lifestyle and oral health education program, individual lifestyle counseling using motivational interviewing (MI), application of self regulation manual, and individual oral hygiene instruction ",0,
edin,2910,4069273,Cannot tell based on the abstract,, The percentage of participants who modified diet , received a routine program ," attended a 20 minute lifestyle and oral health education program, individual lifestyle counseling using motivational interviewing (MI), application of self regulation manual, and individual oral hygiene instruction ",0,
edin,2910,4069273,Significantly increased,he percentage of participants in the intervention group (93.8%) who modified diet was higher than the control group (70.8%) with a statistically significant difference (pâ=â0.001)., The percentage of participants who modified diet , received a routine program ," attended a 20 minute lifestyle and oral health education program, individual lifestyle counseling using motivational interviewing (MI), application of self regulation manual, and individual oral hygiene instruction ",0,
edin,2889,4249579,Cannot tell based on the abstract,, t1/2 , primaquine phosphate , primaquine phosphate and dihydroartemisinin-piperaquine ,0,
edin,2889,4249579,Significantly decreased,"Combined administration with dihydroartemisinin-piperaquine resulted in significantly lower primaquine CL/F (P = 0.0229) and V/F (P = 0.0013) values than administration alone, leading to significantly higher Cmax (P = 0.0019) and AUC0âlast (P = 0.0200) values. This also resulted in a shorter primaquine t1/2 (P = 0.0005) than with administration alone. Geometric mean ratios (90% CI) of primaquine administered with and without dihydroartemisinin-piperaquine for Cmax, AUC0âlast, and AUC0ââ were 148% (117 to 187%), 129% (103 to 163%), and 128% (102 to 161%), respectively (Fig. 2).", t1/2 , primaquine phosphate , primaquine phosphate and dihydroartemisinin-piperaquine ,0,
edin,2897,4729786,Cannot tell based on the abstract,," mood scales, stress scales ", positive training (vice versa) ," negative training (pull negative, push positive pictures) ",0,
edin,2897,4729786,No significant difference,The analyses revealed neither an immediate training effect on the mood scales nor on the stress scales (pÂ >Â .398).," mood scales, stress scales ", positive training (vice versa) ," negative training (pull negative, push positive pictures) ",0,
edin,2916,4021263,Significantly increased,"Among the APTB, more adequate specimens were collected from SI (41/65, 63.1%) than ES (34/80, 42.5%) (p=0.01).", APTB adequate specimens collection  , self-expectoration (ES) , sputum induction with 7% saline nebulization in clinic (SI)  ,0,
edin,2862,5126155,No significant difference,"Effective pacing rates of trial and control groups were comparable both in the full analysis set and the per protocol set (81.4% vs. 79.5%, P = 0.712 and 95.4% vs. 89.5%, P = 0.143, respectively).", The effective pacing rate immediately after the procedure ," pacemaker Talos DR (Biotronik, Berlin, Germany) "," pacemaker Qinming8631 DR (Qinming Medical, Baoji, China) ",0,
edin,2820,4450208,Significantly decreased,"In the follow-up phase, the positive effects of the intervention were generally maintained and, moreover, the use of aggressive strategies as an interpersonal conflict-resolution technique was significantly reduced.", the use of aggressive strategies as an interpersonal conflict-resolution technique , control ,  a program of emotional intelligence (EI) 20 one-hour sessions ,0,
edin,2836,4888158,Cannot tell based on the abstract,"The antimicrobial activity of CHX gradually decreased in a time-dependent manner but it maintained over 95% of its antimicrobial activity after six weeks. Moreover, Resilon/RealSeal SE significantly decreased the antimicrobial activity of CHX in comparison with gutta-percha/AH26 (P<0.05).", The antimicrobial activity , baseline , 2% CHX ,0,
edin,2836,4888158,Significantly increased,"The results showed that residual antimicrobial activity of CHX was significantly higher in gutta-percha/AH26 samples than in Resilon/RealSeal SE samples (P=0.02 at one week and P=0.003 at three and six weeks, respectively).", The antimicrobial activity , baseline , 2% CHX ,0,
edin,3064,5377263,Significantly increased,"Compared with patients in the control group, the levels of Th1 and Th1/Th2 in the observation group significantly increased, yet their Th2 decreased. The levels of IL-2 and TNF-Î± were also observed to be significantly elevated, yet IL-10 decreased.", IL-2 and TNF-ÃÂ± , injected with placebo saline solution in the articular cavity ," HBD-3 (standard, 10 ÃÂµg:50 ÃÂµg:1 mg, Art no., CSB-P12186-3; Beijing Biodee Biotechnology Co., Ltd., Beijing, China) of 10 ml once a day, for 7 days. ",0,
edin,2935,5601935,No significant difference,"Number of follicles in ovaries, total number of oocytes or M2 oocytes and quality of fetuses has no significant differences between two groups (p>0.05).", Quality of fetuses , Human menopausal gonadotropin (HMG) plus r-FSH , Recombinant- follicle stimulating hormone (r-FSH) plus recombinant-luteinizing hormone (rLH) ,0,
edin,2949,5600923,Significantly decreased,"The rate of local recurrence was 44.9 and 68.7% in AG and CG, respectively (P < 0.01).", Rate of local recurrence , Placebo (CG group) , Alginate oligosaccharide (AOS; AG group) ,0,
edin,2940,2744923,Cannot tell based on the abstract,, Effectiveness at day 42 , Sulphadoxine-pyrimethamine (SP)  , Chlorproguanil-dapsone (CPD) ,0,
edin,2940,2744923,No significant difference,"<td align=""center"" colspan=""6""><bold>CPD</bold></td>", Effectiveness at day 42 , Sulphadoxine-pyrimethamine (SP)  , Chlorproguanil-dapsone (CPD) ,0,
edin,2999,3220859,Cannot tell based on the abstract,, glucose infusion rate (GIR) ," glargine, NPH insuline ",  detemir ,0,
edin,2999,3220859,Significantly decreased,"Bivariate correlations of BMI and GIR split by treatment showed an inverse correlation that was significant only with detemir (r = â0.68, P = 0.003), but not with glargine (r = â0.41, P = 0.11) and NPH (r = â0.37, P = 0.15) (Supplementary Fig. 1),On the basis of BMI status, with all three basal insulins, GIR was lower in people with BMI >29 kg/m2 compared with people with BMI <29 kg/m2 (Fig. 1), but statistical significance was achieved with detemir treatment only (598 Â± 604 and 1,564 Â± 649 mg/kg, respectively; P = 0.03) and not with NPH (1,058 Â± 859 and 1,282 Â± 532 mg/kg) and glargine (1,408 Â± 563 and 1,668 Â± 807 mg/kg) (both P > 0.2).", glucose infusion rate (GIR) ," glargine, NPH insuline ",  detemir ,0,
edin,3067,5377263,Cannot tell based on the abstract,, implant infection , injected with placebo saline solution in the articular cavity ," HBD-3 (standard, 10 ÃÂµg:50 ÃÂµg:1 mg, Art no., CSB-P12186-3; Beijing Biodee Biotechnology Co., Ltd., Beijing, China) of 10 ml once a day, for 7 days. ",0,
edin,3067,5377263,No significant difference,"There were 3 cases of implant infection in control group (9.4%), 1 case in observation group (3.1%), there was no statistical significance (P=0.306, unilateral) by Fisher's exact probability method.", implant infection , injected with placebo saline solution in the articular cavity ," HBD-3 (standard, 10 ÃÂµg:50 ÃÂµg:1 mg, Art no., CSB-P12186-3; Beijing Biodee Biotechnology Co., Ltd., Beijing, China) of 10 ml once a day, for 7 days. ",0,
edin,3035,3506580,Cannot tell based on the abstract,, mean pain intensity , baseline , Transcranial direct current stimulation (tDCS) ,0,
edin,3035,3506580,No significant difference,"There was no significant difference of the perceived mean pain intensity before and after tDCS stimulation for the factors time (PREPOST: F(1,13)â=â0.85; pâ=â0.374) and stimulation modality (STIM: F(2,26)â=â0.93; pâ=â0.379) and no interaction between STIM*PREPOST (F(2,26)â=â1.18; pâ=â0.323).", mean pain intensity , baseline , Transcranial direct current stimulation (tDCS) ,0,
edin,3072,5870915,Cannot tell based on the abstract,, The daily body weight gain from SD 1 to SD 29 , untreated , 45 mg toltrazuril + 200 mg gleptoferron (ForcerisÃÂ®) or with 20 mg toltrazuril/kg body weight as an oral suspension (BaycoxÃÂ® 5%) ,0,
edin,3072,5870915,Significantly increased,The daily body weight gain from SD 1 to SD 29 was significantly higher in the ForcerisÂ® and BaycoxÂ® groups compared to the Control group without statistical difference between the treatment groups (Fig. 5, The daily body weight gain from SD 1 to SD 29 , untreated , 45 mg toltrazuril + 200 mg gleptoferron (ForcerisÃÂ®) or with 20 mg toltrazuril/kg body weight as an oral suspension (BaycoxÃÂ® 5%) ,0,
edin,3084,5148913,Cannot tell based on the abstract,, abnormalities in haematology or blood chemistry parameters , BDP 100 ÃÂ¼g (four puffs twice a day) , BDP/FF 200/6 ÃÂ¼g pMDI extrafine (two puffs twice a day) ,0,
edin,3084,5148913,No significant difference,No clinically significant abnormalities in haematology or blood chemistry parameters were reported during the study., abnormalities in haematology or blood chemistry parameters , BDP 100 ÃÂ¼g (four puffs twice a day) , BDP/FF 200/6 ÃÂ¼g pMDI extrafine (two puffs twice a day) ,0,
edin,3032,5864139,No significant difference,"Cases of pancreatic cancer were numerically fewer with sitagliptin (9 [0.1%]) versus placebo (14 [0.2%]) (hazard ratio 0.66 [95% CI 0.28â1.51], P = 0.32; 0.042 vs. 0.066 events/100 patient-years).", Cases of pancreatic cancer , placebo ," sitagliptin, 23 (0.3%) ",0,
edin,2925,4286912,Cannot tell based on the abstract,, Antigens of co-administered vaccines , PHiD-CV Commercial lot (Com group) , PHiD-CV Phase III Clinical (Clin group) ,0,
edin,2925,4286912,No significant difference,"Co-administered vaccine antigens
One month post-primary and post-booster vaccination, all children were seroprotected against diphtheria, tetanus and poliovirus types 1, 2 and 3, and all infants were seropositive for antibodies against the three pertussis antigens and polyribosylribitol phosphate from Hib. All infants except one were seroprotected against hepatitis B surface antigen (HBs) at one month post-primary vaccination. Three children had anti-HBs antibody concentrations which were initially measured between 10 and 100 mIU/mL. Out of these 3 children, upon retesting using Immuliteâ¢, one was found to be seroprotected while the other 2 had anti-HBs antibody concentrations <10 mIU/mL. This was further followed up by investigators and one child was subsequently re-vaccinated. Efforts to reach the other child for re-vaccination were unsuccessful. Three months after the second dose of the HRV vaccine, â¥81.9% of infants were seropositive for anti-HRV antibodies (data not shown).", Antigens of co-administered vaccines , PHiD-CV Commercial lot (Com group) , PHiD-CV Phase III Clinical (Clin group) ,0,
edin,3074,3650212,Cannot tell based on the abstract,, The tipping , a combination of the FA with high-pull headgear worn at night , using the FA alone ,0,
edin,3074,3650212,Significantly increased,"The tipping was only significant in group 1, and it was significantly larger in this group than in group 2 (p < 0.001).", The tipping , a combination of the FA with high-pull headgear worn at night , using the FA alone ,0,
edin,3001,4730432,Significantly increased,"A statistically significant increase in the intention to obtain clinical trial information at the three and six month time points was observed in the intervention group, but not the control group.", intention to seek information about clinical trials , baseline , church-based educational intervention ,0,
edin,3051,3177395,Cannot tell based on the abstract,, dental plaque on smooth and approximal tooth surfaces after 14 days , baseline , received herbal extract dentifrices or used a conventional dentifrice ,0,
edin,3051,3177395,Significantly decreased,"After 14 days, significant reduction of dental plaque on smooth and approximal tooth surfaces compared to baseline was observed in all groups (P <60; 0.001).", dental plaque on smooth and approximal tooth surfaces after 14 days , baseline , received herbal extract dentifrices or used a conventional dentifrice ,0,
edin,2992,3671204,Significantly increased,"After six weeks, pain scores increased from 5.3 to 6.6 (p=0.04).", pain scores after six weeks , baseline ,  physical activity (PA) program for patients with knee and/or hip osteoarthritis (OA) ,0,
edin,3063,5377263,Significantly increased,"Compared with patients in the control group, the levels of Th1 and Th1/Th2 in the observation group significantly increased, yet their Th2 decreased.", Th1 and Th1/Th2 , injected with placebo saline solution in the articular cavity ," HBD-3 (standard, 10 ÃÂµg:50 ÃÂµg:1 mg, Art no., CSB-P12186-3; Beijing Biodee Biotechnology Co., Ltd., Beijing, China) of 10 ml once a day, for 7 days. ",0,
edin,3044,3321528,Cannot tell based on the abstract,, handgrip strength , non-dominant hand , dominant hand ,0,
edin,3044,3321528,No significant difference,"A significant difference was found in handgrip strength between patients diagnosed with ICU-AW in comparison to those without an ICU-AW diagnosis (6.6 Â± 4.4 versus 23.4 Â± 8.9âkg, P < 0.01), even when the comparison was adjusted for gender and age (P < 0.01). This was also the case when handgrip performance was expressed in relative values (29.0 Â± 22.4% predicted versus 66.0 Â± 22.2% predicted, P < 0.01).

In concern to between-sides comparison, patients tended to perform better with the dominant rather than the non-dominant hand (16.2 Â± 11.1 versus 14.2 Â± 9.9âkg, resp., P = 0.09).", handgrip strength , non-dominant hand , dominant hand ,0,
edin,3076,3650212,Cannot tell based on the abstract,, Treatment time , a combination of the FA with high-pull headgear worn at night , using the FA alone ,0,
edin,3076,3650212,Significantly increased,Treatment time was significantly greater in group 1 than in group 2 (7.44 Â± 1.30 months versus 6.27 Â± 1.11 months; p < 0.001)., Treatment time , a combination of the FA with high-pull headgear worn at night , using the FA alone ,0,
edin,3013,3636767,Cannot tell based on the abstract,," patients, who achieve the BP target of systolic/diastolic BP &amp;lt; 140/90 mmHg ", telmisartan 80 mg  , telmisartan 80 mg + hydrochlorothiazide 25 mg (T80/H25) ,0,
edin,3013,3636767,Significantly increased,"Across the entire study population, at week 7, single-pill T80/H25 combination therapy significantly reduced the adjusted mean Â± standard error seated trough cuff systolic/diastolic BP from baseline (â37.0 Â± 0.62/â18.6 Â± 0.38 mmHg) as compared with T80 monotherapy (â28.5 Â± 0.88/â15.4 Â± 0.55 mmHg [adjusted mean difference â8.5/â3.2 mmHg; 95% CI â10.6, â6.4/â4.5, â1.9; P < 0.0001]) and allowed more patients to achieve the BP target of systolic/diastolic BP < 140/90 mmHg (55.5% versus 34.7%; OR, 2.39; 95% CI 1.76, 3.26; P < 0.0001).9"," patients, who achieve the BP target of systolic/diastolic BP &amp;lt; 140/90 mmHg ", telmisartan 80 mg  , telmisartan 80 mg + hydrochlorothiazide 25 mg (T80/H25) ,0,
edin,2968,4152682,Significantly decreased,"Pulse rate (95.9 Â± 11.2 bpm vs. 102.9 Â± 8.8 bpm, P = 0.001) systolic and diastolic BP were significantly higher in Group N.", Pulse rate and blood pressure after surgery , Normal saline followed by general anesthesia (Group N) , Transversus abdominis plane block with 0.25% bupivacaine (Group B) ,0,
edin,2998,4586379,Cannot tell based on the abstract,," The elasticity of the major vessels, i.e., the movement of vessel wall between the systole and diastole, as well as blood velocity within these vessels ", control , Hydroxychloroquine (HCQ) ,0,
edin,2998,4586379,Significantly increased,"The elasticity of the major vessels, i.e., the movement of vessel wall between the systole and diastole, as well as blood velocity within these vessels were significantly better in CKD mice treated with HCQ. *P < 0.05 compared with CKD placebo mice."," The elasticity of the major vessels, i.e., the movement of vessel wall between the systole and diastole, as well as blood velocity within these vessels ", control , Hydroxychloroquine (HCQ) ,0,
edin,2987,2836298,No significant difference,"Continued abstinence at 12 months confirmed through CO was 7.4% in the III, 5.4% in the IGI, and 1% in the MI. No significant differences were noted between III and MI on the one hand, and between IGI and MI on the other [RR 7.04 (0.9-7.2) and RR 5.1 (0.6-41.9), respectively].,No differences were noted between IGI and III [RR 0.7 (0.2-2.2)].", Continued abstinence at 1 year , Intensive individual intervention (III) , Intensive group intervention (IGI) ,0,
edin,2982,4323894,No significant difference,"here were 63.2% of patients in cooling group attained good GOS at 6 months compared to only 15.4% in noncooling group (P = 0.007). Interestingly, the analysis at 6 months post-trauma disclosed mild-cooling-treated patients did better than no cooling (70% vs. 15.4% attained good GOS, P = 0.013) and apparently, the deep-cooling-treated patients failed to be better than either no cooling (P = 0.074) or mild cooling group (P = 0.650).", Improvement in Glasgow outcome score at 6 months post-trauma , Mild-cooling , Deep-cooling ,0,
edin,3052,3177395,Cannot tell based on the abstract,, mean values of plaque indices after 14 days , used a conventional dentifrice , received herbal extract dentifrices  ,0,
edin,3052,3177395,Significantly decreased,"However, in the conventional group, mean values of plaque indices were significantly higher than in the herbal groups.", mean values of plaque indices after 14 days , used a conventional dentifrice , received herbal extract dentifrices  ,0,
edin,2927,4286912,Cannot tell based on the abstract,, Reactogenicity and safety profiles , PHiD-CV Commercial lot (Com group) , PHiD-CV Phase III Clinical (Clin group) ,0,
edin,2927,4286912,Invalid Prompt,, Reactogenicity and safety profiles , PHiD-CV Commercial lot (Com group) , PHiD-CV Phase III Clinical (Clin group) ,1, Reactogenicity and safety profiles are mentioned in the methods and materials section of the article but there is no significant information in results or conclusion section. Results section contains only a list of complications. 
edin,2983,4323894,No significant difference,"There were 63.2% of patients in cooling group attained good GOS at 6 months compared to only 15.4% in noncooling group (P = 0.007).,Interestingly, the analysis at 6 months post-trauma disclosed mild-cooling-treated patients did better than no cooling (70% vs. 15.4% attained good GOS, P = 0.013) and apparently, the deep-cooling-treated patients failed to be better than either no cooling (P = 0.074) or mild cooling group (P = 0.650).", Improvement in Glasgow outcome score at 6 months post-trauma , No cooling , Deep-cooling ,0,
edin,2946,4993942,Cannot tell based on the abstract,, Complications , Panretinal photocoagulation (PRP) with red laser , Panretinal photocoagulation (PRP) with green laser ,0,
edin,2946,4993942,No significant difference,No complication occurred in both groups during laser and in follow-up period., Complications , Panretinal photocoagulation (PRP) with red laser , Panretinal photocoagulation (PRP) with green laser ,0,
edin,3024,4240932,Cannot tell based on the abstract,"he significant change value on the before-after BICAMS points were considered to be 8, 13, and 7 points for the symbol digit modality test (SDMT), the California verbal learning test (CVLT), and the brief visual-spatial memory test revised (BVMT-R), respectively.", Brief International Cognitive Assessment for MS (BICAMS) test , placebo ," B. papyrifera (capsule 300 mg, twice a day) ",0,
edin,3024,4240932,Significantly increased,"BICAMS battery changes were considered as significant if SDMT changed 8 points, CVLT, 13 points, and BVMT-R, 7 points.,We observed that 12 patients (31.6%) from the treatment group and 8 patients (21.1%) from the placebo group had a significant change value in SDMT test.

CVLT test also showed a significant change in 17 and 12 patients (44.7% and 31.6%) in the treatment and placebo groups, respectively.

BVMT-R was improved significantly in 13 patients (34.2%) who took BP compared to the placebo group which had no improvement at all.,Although the number of patients who improved after receiving the drug in the treatment group was more than the placebo group in CVLT and SDMT, such a difference was not statistically significant (P = 0.2000 for SDMT, P = 0.1700 for CVLT); regarding BVMT-R, our findings were statistically significant (P < 0.001).", Brief International Cognitive Assessment for MS (BICAMS) test , placebo ," B. papyrifera (capsule 300 mg, twice a day) ",0,
edin,3048,5735476,Significantly increased,"Time for rescue analgesia in Group D5-377.46 Â± 60.05, in Group D10-401.60 Â± 61.11, and in Group D15-517.96 Â± 97.30, which is statistically highly significant (P < 0.000).", Time for rescue analgesia ," Group BD5 (n = 30): intrathecal bupivacaine 12.5 mg (2.5 ml) + dexmedetomidine 5 ÃÂ¼g (0.5ml) , Group BD10 (n = 30): intrathecal bupivacaine 12.5 mg (2.5 ml) + dexmedetomidine 10 ÃÂ¼g (0.5 ml) ", Group BD15 (n = 30): intrathecal bupivacaine 12.5 mg (2.5 ml) + dexmedetomidine 15 ÃÂ¼g (0.5 ml) ,0,
edin,2939,2744923,Cannot tell based on the abstract,, Effectiveness at day 28 , Sulphadoxine-pyrimethamine (SP)  , Chlorproguanil-dapsone (CPD) ,0,
edin,2939,2744923,Significantly increased,"<td align=""center"" colspan=""6""><bold>AL</bold></td>", Effectiveness at day 28 , Sulphadoxine-pyrimethamine (SP)  , Chlorproguanil-dapsone (CPD) ,0,
edin,3020,3152513,Cannot tell based on the abstract,, MADRS remission rates in patients with baseline MADRS total scores Ã¢â°Â¥20 ," placebo, or oral olanzapine 5-20 mg once daily for 3 weeks ", flexible-dose sublingual asenapine (10 mg twice daily on day 1; 5 or 10 mg twice daily thereafter) ,0,
edin,3020,3152513,Significantly increased,"In patients with baseline MADRS total scores â¥20, MADRS remission rates (defined as MADRS total score â¤12) with asenapine were significantly greater than placebo on days 7 (57% vs 17%; P = 0.004) and 21 (70% vs 33%; P = 0.012); remission rate with asenapine on day 7 was significantly greater than olanzapine (57% vs 25%; P = 0.006) and showed a trend towards statistical significance on day 21 (70% vs 48%; P = 0.066).", MADRS remission rates in patients with baseline MADRS total scores Ã¢â°Â¥20 ," placebo, or oral olanzapine 5-20 mg once daily for 3 weeks ", flexible-dose sublingual asenapine (10 mg twice daily on day 1; 5 or 10 mg twice daily thereafter) ,0,
edin,3027,5156617,Significantly decreased,"A total of 19 subjects (31 eyes) completed the trial after five subjects (eight eyes) dropped out. In the patients who completed the study by wearing lenses for 4 weeks, the myopic refractive error decreased significantly by 2.60 Â± 2.21 D (p < 0.001), from -3.65 Â± 1.62 to -1.05 Â± 1.64 D. The astigmatic refractive error were also significantly decreased by 0.63 Â± 0.98 D (p = 0.001), from 2.07 Â± 0.83 to 1.44 Â± 0.99 D.", The mean astigmatic refractive error , baseline , astigmatism of 1.25 to 4.0 D ,0,
edin,3002,4730432,No significant difference,"A statistically significant increase in the intention to obtain clinical trial information at the three and six month time points was observed in the intervention group, but not the control group.", intention to seek information about clinical trials , baseline , control ,0,
edin,3087,4530661,Significantly decreased,"Although soy milk did not have any effect on BP, probiotic soymilk significantly decreased systolic (14.7 Â± 0.48 vs. 13.05 Â± 0.16, P = 0.001) and diastolic BP (10 Â± 0.7 vs. 9.1 Â± 1, P = 0.031).", systolic and diastolic BP , consumed 200 ml/day of soy milk for 8 weeks , consumed 200 ml/day of probiotic soy milk containing Lactobacillus planetarium A7  for 8 weeks ,0,
edin,2967,4152682,Significantly decreased,"Pulse rate (95.9 Â± 11.2 bpm vs. 102.9 Â± 8.8 bpm, P = 0.001) systolic and diastolic BP were significantly higher in Group N.", Pulse rate during surgery , Normal saline followed by general anesthesia (Group N) , Transversus abdominis plane block with 0.25% bupivacaine (Group B) ,0,
edin,3050,5735476,Cannot tell based on the abstract,, mean arterial pressure (MAP) falls , baseline ," Group BD15 (n = 30): intrathecal bupivacaine 12.5 mg (2.5 ml) + dexmedetomidine 15 ÃÂ¼g (0.5 ml), Group BD5 (n = 30): intrathecal bupivacaine 12.5 mg (2.5 ml) + dexmedetomidine 5 ÃÂ¼g (0.5ml) , Group BD10 (n = 30): intrathecal bupivacaine 12.5 mg (2.5 ml) + dexmedetomidine 10 ÃÂ¼g (0.5 ml) ",0,
edin,3050,5735476,Significantly increased,"MAP falls significantly at 30th, 45th, and 60th min from basal rate within the groups, we have noticed hypotension in 4 (13.3%) patients in Group D5, 6 (20.0%) patients in Group D10, 13 (43.3%) patients in Group D15, which is statistically significant (P = 0.020) [Table 3].", mean arterial pressure (MAP) falls , baseline ," Group BD15 (n = 30): intrathecal bupivacaine 12.5 mg (2.5 ml) + dexmedetomidine 15 ÃÂ¼g (0.5 ml), Group BD5 (n = 30): intrathecal bupivacaine 12.5 mg (2.5 ml) + dexmedetomidine 5 ÃÂ¼g (0.5ml) , Group BD10 (n = 30): intrathecal bupivacaine 12.5 mg (2.5 ml) + dexmedetomidine 10 ÃÂ¼g (0.5 ml) ",0,
edin,3071,5870915,Cannot tell based on the abstract,, the number of days with diarrhoea and the number of piglets that had diarrhoea , untreated , 45 mg toltrazuril + 200 mg gleptoferron (ForcerisÃÂ®) or with 20 mg toltrazuril/kg body weight as an oral suspension (BaycoxÃÂ® 5%) ,0,
edin,3071,5870915,Significantly decreased,"The area under the curve for the FS, the number of days with diarrhoea and the number of piglets that had diarrhoea were significantly reduced in the ForcerisÂ® and BaycoxÂ® groups compared to the Control group without statistical difference between the treatment groups (Table 2).Fig. 3", the number of days with diarrhoea and the number of piglets that had diarrhoea , untreated , 45 mg toltrazuril + 200 mg gleptoferron (ForcerisÃÂ®) or with 20 mg toltrazuril/kg body weight as an oral suspension (BaycoxÃÂ® 5%) ,0,
edin,2958,3597059,Cannot tell based on the abstract,, Baseline characteristics , Control (C group) , Crystalloid (RS group) and colloid (HES group) ,0,
edin,2958,3597059,No significant difference,Baseline hemodynamic variables were comparable among the groups (P > 0.05)., Baseline characteristics , Control (C group) , Crystalloid (RS group) and colloid (HES group) ,0,
edin,3016,4630743,Significantly decreased,Only 3.61% patients complained of intolerable pain during dilatation in the study group while in control group 48.74% complained of intolerable pain and required anesthesia., Pain on cervical dilatation , 400 mg of metronidazole tablets (as a placebo) , 400 ÃÂ¼g of misoprostol ,0,
edin,2948,5600923,Significantly decreased,"After 2-year therapy, the mean tumor volume was 214.6 Â± 145.7 c.c. in AG and 467.2 Â± 225.3 c.c in CG (P < 0.01).", Tumor volume after 2 years of therapy , Placebo (CG group) , Alginate oligosaccharide (AOS; AG group) ,0,
edin,2964,4770250,No significant difference,"DRCFI was well tolerated with a similar incidence of systemic adverse events to the placebo group, but fewer pulmonary adverse events.", Systemic adverse events , Placebo , Dual release ciprofloxacin for inhalation (DRCFI) ,0,
edin,3012,5043523,No significant difference,"There were no significant differences between the three groups in terms of changes in folate intakes from baseline to month 6. Similarly, there were no changes in reported intake of food groups high in folate.", folate intakes , control or not at risk , knowledge of MTHFR 677CÃ¢â¬â°Ã¢â âÃ¢â¬â°T genotype ,0,
edin,3031,4483405,No significant difference,"Both groups exhibited significant decreases in pain post-intervention. Moreover, the range of motion of internal and external rotation increased significantly post-intervention in both groups. However, there was no significant difference between groups with respect to pain improvement or range of motion.", pain or  range of motion (ROM) improvement , Kaltenborn mobilization , Maitland mobilization ,0,
edin,3070,5870915,Cannot tell based on the abstract,, the number of piglets that excreted countable oocyst numbers , untreated , 45 mg toltrazuril + 200 mg gleptoferron (ForcerisÃÂ®) or with 20 mg toltrazuril/kg body weight as an oral suspension (BaycoxÃÂ® 5%) ,0,
edin,3070,5870915,No significant difference,"The area under the curve for OpG, the number of days with McMaster countable excretion and the number of piglets that excreted countable oocyst numbers were significantly reduced in the ForcerisÂ® and BaycoxÂ® groups compared to the Control group without statistical difference between the treatment groups (Table 2).", the number of piglets that excreted countable oocyst numbers , untreated , 45 mg toltrazuril + 200 mg gleptoferron (ForcerisÃÂ®) or with 20 mg toltrazuril/kg body weight as an oral suspension (BaycoxÃÂ® 5%) ,0,
edin,2926,4286912,No significant difference,No serious adverse events considered causally related to vaccination were reported throughout the study., Serious adverse events , PHiD-CV Commercial lot (Com group) , PHiD-CV Phase III Clinical (Clin group) ,0,
edin,3036,3506580,Cannot tell based on the abstract,, heat pain thresholds (HPT) , baseline , Transcranial direct current stimulation (tDCS) ,0,
edin,3036,3506580,No significant difference,"There were no significant differences of HPT before and after tDCS (PREPOST: F(1,9)â=â0.82; pâ=â0.389) and between treatment modalities (STIM: F(2,18)â=â1.27; pâ=â0.306).", heat pain thresholds (HPT) , baseline , Transcranial direct current stimulation (tDCS) ,0,
edin,2943,4993942,Significantly increased,"The mean subfoveal choroidal, central retinal, and peripapillary nerve fiber layer (RNFL) thickness increased significantly in each eye 6 weeks after PRP (P values in red laser group: <0.01, 0.03, and <0.01, resp., and in green laser group <0.01, <0.01, and <0.01).", Subfoveal choroidal thickness , Panretinal photocoagulation (PRP) with red laser , Panretinal photocoagulation (PRP) with green laser ,0,
edin,3062,4726501,No significant difference,"<td align=""left"" colspan=""1"" rowspan=""1"">Intention-to-treat analysis</td><td align=""center"" colspan=""1"" rowspan=""1""></td><td align=""right"" colspan=""1"" rowspan=""1""></td><td align=""center"" colspan=""1"" rowspan=""1""></td><td align=""left"" colspan=""1"" rowspan=""1""></td>", the incidence of positive urine dipstick albumin , no aspirin ," receive aspirin (81 mg or 100 mg daily, ",0,
edin,3054,3177395,Cannot tell based on the abstract,, Mean values of the SBI after 42 days , used a conventional dentifrice , received herbal extract dentifrices  ,0,
edin,3054,3177395,Significantly decreased,"The most anti inflammatory effect had been achieved in herbal test groups, where mean values of GI and SBI indices were significantly lower than those of the conventional group (P <60; 0.001).", Mean values of the SBI after 42 days , used a conventional dentifrice , received herbal extract dentifrices  ,0,
edin,2995,5980459,Significantly increased,Abomasal outflow fluid pH was higher in steers treated with famotidine for up to 4 hours after a single dose but the effect decreased with subsequent doses., pH of abomasal outflow fluid for 4 hours , saline control , famotidine administered at 0.4 mg/kg ,0,
edin,2945,4993942,No significant difference,"There was no difference between red and green laser considering subfoveal choroidal, central retinal, and peripapillary nerve fiber layer (RNFL) thickness increase after PRP (P values: 0.184, 0.404, and 0.726, resp.).", Peripapillary nerve fiber layer thickness , Panretinal photocoagulation (PRP) with red laser , Panretinal photocoagulation (PRP) with green laser ,0,
edin,2974,5452353,Significantly increased,"Plasma NO3 â were 10.3Â Î¼mol greater with POMx vs. PLAC (95% CI, 0.8, 19.7,F 1,7â=â7.83, pâ<â0.04).", Levels of NO3 Ã¢Ëâ in plasma , Placebo (PLAC) , Pomegranate extract (POMx) ,0,
edin,3081,5148913,Significantly increased,"The primary endpoint [change from baseline over the entire treatment period in average pre-dose morning peak expiratory flow (PEF)] demonstrated the superiority of BDP/FF over BDP monotherapy, with an adjusted mean difference of 19Â L/min, which is above the minimal important clinical difference reported for this parameter. O", adjusted mean change of PEF , BDP 100 ÃÂ¼g (four puffs twice a day) , BDP/FF 200/6 ÃÂ¼g pMDI extrafine (two puffs twice a day) ,0,
edin,3005,4347450,Cannot tell based on the abstract,, Judge 2's performance quality ratings between time 2 and 3 , waitlist condition , cognitive behavioral (CB) group-delivered intervention ,0,
edin,3005,4347450,No significant difference,"For Judge 2's performance quality ratings, both the interaction between group and time [F(2, 120) = 0.36, p > 0.05] and main effect for group were not significant [F(1, 60) = 1.36, p > 0.05].", Judge 2's performance quality ratings between time 2 and 3 , waitlist condition , cognitive behavioral (CB) group-delivered intervention ,0,
edin,2860,5870330,Significantly increased,"G1 showed the highest fracture resistance value (1737.1 N) while G3 had the lowest mean value (522.9 N). Furthermore, the fracture resistance of G4 and G5 was significantly higher than G3 and G6 (P < 0.05), where in both groups, the preparation of the occlusal extension mostly remained in the enamel layer.", fracture resistance , G6: The occlusal extension was 2 mm in depth and 1 mm in width. , G4 was prepared with the occlusal extension of 1mm in depth and width. G5: The occlusal extension was 1mm in depth and 2 mm in width ,0,
edin,3028,5156617,Cannot tell based on the abstract,"The mean uncorrected and corrected visual acuities before wearing the lenses were 2.14 Â± 0.80 logarithm of the logMAR (logMAR) and 0.05 Â± 0.13 logMAR, respectively, which changed to 0.12 Â± 0.30 logarithm of the logMAR (p < 0.001) and 0.01 Â± 0.04 logMAR (p = 0.156) after 4 weeks.", The mean uncorrected and corrected visual acuities , baseline , myopia of -0.75 to -6.0 diopters (D) and astigmatism of 1.25 to 4.0 D ,0,
edin,3028,5156617,No significant difference,"The mean uncorrected and corrected visual acuities at the screening visit were 2.14 Â± 0.80 and 0.05 Â± 0.13 logMAR, respectively. The equivalent values after wearing the toric orthokeratology lenses for 4 weeks were 0.12 Â± 0.30 and 0.01 Â± 0.04 logarithm of the minimal angle of resolution (logMAR), respectively. The difference in uncorrected visual acuity was -2.03 Â± 0.91 logMAR, which was statistically significant (p < 0.001). The difference in corrected visual acuity was -0.04 Â± 0.14 logMAR, which was not statistically significant (p = 0.156) (Table 3).", The mean uncorrected and corrected visual acuities , baseline , myopia of -0.75 to -6.0 diopters (D) and astigmatism of 1.25 to 4.0 D ,0,
edin,3165,3652505,Cannot tell based on the abstract,The number sized framing effect was also tested to be significant (P < 0.01)., number size framing effect ," Eye surgery may lead to two potential sequelas: one is a minor decline of visual acuity and the other is keratitis. Imagine you will take this kind of surgery and two doctorsâ medical records revealed that: Doctor A: Of 200 patients, 197 didnât suffer from keratitis but 9 were found visual acuity declined. Doctor B: Of 200 patients, 190 didnât suffer from keratitis but 2 were found visual acuity declined. Which doctor you will choose? "," Eye surgery may lead to two potential sequelas: one is a minor decline of visual acuity and the other is keratitis. Imagine you will take this kind of surgery and two doctorsâ medical records revealed that: Doctor A: Of 200 patients, 191 were not found postoperative visual acuity declined but 3 suffered from keratitis; Doctor B: Of 200 patients, 198 were not found postoperative visual acuity declined but 10 suffered from keratitis. Which doctor you will choose? ",0,
edin,3165,3652505,Significantly decreased,"Table 5 described the effect of number size framing. The results revealed that the number size framing effect was significant in medical situation (t = -7.5, P < 0.001).

Table 1,<td colspan=""1"" rowspan=""1"">Framing 2: Eye surgery may lead to two potential sequelas: one is a minor decline of visual acuity and the other is keratitis. Imagine you will take this kind of surgery and two doctorsâ medical records revealed that: Doctor A: Of 200 patients, 197 didnât suffer from keratitis but 9 were found visual acuity declined. Doctor B: Of 200 patients, 190 didnât suffer from keratitis but 2 were found visual acuity declined. Which doctor you will choose? </td><td colspan=""1"" rowspan=""1"">4.14 Â± 1.39</td>", number size framing effect ," Eye surgery may lead to two potential sequelas: one is a minor decline of visual acuity and the other is keratitis. Imagine you will take this kind of surgery and two doctorsâ medical records revealed that: Doctor A: Of 200 patients, 197 didnât suffer from keratitis but 9 were found visual acuity declined. Doctor B: Of 200 patients, 190 didnât suffer from keratitis but 2 were found visual acuity declined. Which doctor you will choose? "," Eye surgery may lead to two potential sequelas: one is a minor decline of visual acuity and the other is keratitis. Imagine you will take this kind of surgery and two doctorsâ medical records revealed that: Doctor A: Of 200 patients, 191 were not found postoperative visual acuity declined but 3 suffered from keratitis; Doctor B: Of 200 patients, 198 were not found postoperative visual acuity declined but 10 suffered from keratitis. Which doctor you will choose? ",0,
edin,3181,4563303,Cannot tell based on the abstract,, Timed Up and Go (TUG) (sec)â¡ , visual disuse group (VDG) , visual feedback group (VFG) ,0,
edin,3181,4563303,Significantly decreased,"Changes in TUG and BBS between pre-test and post-test were statistically significant in both groups and there was an interaction between the groups and time.,<td align=""left"" colspan=""1"" rowspan=""1"">TUG (sec)<sup>â¡</sup></td><td align=""center"" colspan=""1"" rowspan=""1"">15.62Â±4.89</td><td align=""center"" colspan=""1"" rowspan=""1"">9.93Â±3.93<sup>â </sup></td><td align=""center"" colspan=""1"" rowspan=""1"">21.84Â±12.61</td><td align=""center"" colspan=""1"" rowspan=""1"">19.33Â±12.07<sup>â </sup></td>", Timed Up and Go (TUG) (sec)â¡ , visual disuse group (VDG) , visual feedback group (VFG) ,0,
edin,3153,5094682,No significant difference,"The mean changes in eGFR were 0 Â± 14 and â7 Â± 16 mL/min/1.73 m2 (p = 0.09, between groups) for the acarbose and pioglitazone groups, respectively.", glomerular filtration rate (eGFR) , pioglitazone , acarbose ,0,
edin,3157,5094682,Significantly increased,"Significant body weight gain was observed in the pioglitazone group as compared with the acarbose group (1.3 Â± 2.8 vs. â0.6 Â± 1.5 kg, p = 0.002).


Conclusion", body weight , acarbose ,  pioglitazone ,0,
edin,3201,4787139,Cannot tell based on the abstract,, heart rate (HR) , baseline ," MDZ:FEN, DEX 0.25 Î¼g/kg (DEX half) ",0,
edin,3201,4787139,Significantly decreased,"HR values in âDEX fullâ group were significantly lower than in MDZ:FEN and âDEX halfâ group at 10 min (P = 0.001). MDZ: FEN group patients had lower HR than DEX full and DEX half group patients in the post-operative period (150, 180, 210 min) [Figure 1]. Two cases in the âDex fullâ group required injection atropine for treatment of HR less than 50/min.", heart rate (HR) , baseline ," MDZ:FEN, DEX 0.25 Î¼g/kg (DEX half) ",0,
edin,3126,5200917,Cannot tell based on the abstract,, reaction time in simple speeded response task  , placebo , tolcapone ,0,
edin,3126,5200917,No significant difference,"Moreover, in a simple speeded response task, no difference was seen in reaction time for either visual or auditory responding on tolcapone compared to placebo (all T(14)Â â¤Â 1.1, pÂ â¥Â 0.3),", reaction time in simple speeded response task  , placebo , tolcapone ,0,
edin,3141,3845560,Cannot tell based on the abstract,, Distant metastasis , flat intermittent constant rate infusion (Arm B) of DDP and 5-FU followed by radical radiotherapy , 2 cycles of sinusoidal chronomodulated infusion (Arm A) ,0,
edin,3141,3845560,No significant difference,Distant metastasis represented the major failure pattern and occurred in 27 (21.8%) patients: 16 (25.4%) in Arm A and 11 (18.0%) in Arm B (P = 0.597) (Table 4)., Distant metastasis , flat intermittent constant rate infusion (Arm B) of DDP and 5-FU followed by radical radiotherapy , 2 cycles of sinusoidal chronomodulated infusion (Arm A) ,0,
edin,3208,2784386,Significantly increased,"In non-ICU subjects, treatment success was significantly higher for micafungin versus liposomal amphotericin B (85% (n = 108/127) versus 72.1% (n = 98/136); P = 0.0113).", treatment success in non-ICU subjects , liposomal amphotericin B (3 mg/kg/day) , micafungin (100 mg/day for subjects &amp;gt; 40 kg; 2 mg/kg/day for subjects â¤ 40 kg) ,0,
edin,3170,3536709,Cannot tell based on the abstract,, difference in the weight ,  normally diet (ND) , low-protein vegetarian diet (LPVD) ,0,
edin,3170,3536709,No significant difference,In spite of lower energy intake during LPVD there was no difference in the weight of the subjects compared to ND (75.6 Â± 7.9 kg vs. 76.2 Â± 7.6 kg)., difference in the weight ,  normally diet (ND) , low-protein vegetarian diet (LPVD) ,0,
edin,3160,5842771,No significant difference,"After 12 weeks of treatment, the average MMSE scores, ADL scores, and CDR scores in the two groups were significantly improved. But, compared to the control group, the experimental group had a significantly higher average MMSE score (p<0.00001), lower average ADL score (p=0.00002), and lower average CDR score (p=0.030).", Clinical Dementia Rating Scale (CDR) score , memantine 5â20 mg/d ," Î²-asarone 10 mg/d, tenuigenin 10 mg/d, and memantine 5â20 mg/d ",0,
edin,3174,3503942,Significantly decreased,"The changes in visual analog scale were estimated to be 6.86Â±0.90 before first therapy, 2.86Â±0.90 after first therapy, and 1.86Â±0.69 after third therapy in case of ESWT group, whereas the figures were estimated to be 7.20Â±1.30 before first therapy, 4.60Â±0.55 after first therapy, and 2.80Â±0.84 after third therapy in case of TPI+TENS group, and the changes between the groups were significantly different (p=0.010).", The changes in visual analog scale ,  trigger point injections (TPI)+transcutaneous electrical nerve stimulation (TENS) , extracorporeal shock wave therapy (ESWT) ,0,
edin,3162,3652505,Cannot tell based on the abstract,Doctorsâ advices were respectively described in a baneful or beneficial frame and the former one resulted in a better compliance (P < 0.05)., better compliance ," question:  Doctors tells you that although you particularly like to eat bacon, if you continue to eat, your body cholesterol content will significantly rise, and thus the possibility of suffering from cardiovascular disease would be greatly increased. Would you continue to eat bacon? "," question:  Doctor tells you that although you particularly like to eat bacon, if you stop eating, your body cholesterol content would be significantly reduced, and thus the possibility of suffering from cardiovascular disease would be greatly reduced. Would you continue to eat bacon? ",0,
edin,3162,3652505,Significantly increased,"As shown in Table 2 that if the doctorâ advise was respectively described in the benefit of compliance and the aftermath of violation, the former one lead to a better compliance (t = 2.14, P = 0.035).,<td colspan=""1"" rowspan=""1"">Negative: Doctors tells you that although you particularly like to eat bacon, if you continue to eat, your body cholesterol content will significantly rise, and thus the possibility of suffering from cardiovascular disease would be greatly increased. Would you continue to eat bacon? </td><td colspan=""1"" rowspan=""1"">2.10 Â± 0.89</td>", better compliance ," question:  Doctors tells you that although you particularly like to eat bacon, if you continue to eat, your body cholesterol content will significantly rise, and thus the possibility of suffering from cardiovascular disease would be greatly increased. Would you continue to eat bacon? "," question:  Doctor tells you that although you particularly like to eat bacon, if you stop eating, your body cholesterol content would be significantly reduced, and thus the possibility of suffering from cardiovascular disease would be greatly reduced. Would you continue to eat bacon? ",0,
edin,3132,4078065,Cannot tell based on the abstract,, ApoA-I and HDL-mediated cholesterol effluxes , placebo , 3.2 g/day citrulline ,0,
edin,3132,4078065,Significantly increased,"Citrulline enhanced both apoA-I- and HDL-mediated cholesterol efflux from THP-1 macrophages by 96.1Â Â±Â 26.1% (p<0.05) and 14.4Â Â±Â 2.5% (p<0.05), respectively, compared to control (Fig.Â 3A and B).", ApoA-I and HDL-mediated cholesterol effluxes , placebo , 3.2 g/day citrulline ,0,
edin,3171,3536709,No significant difference,"Diet caused no significant difference in venous blood pH, strong ion difference (SID), total concentration of weak acids (Atot), partial pressure of CO2 (pCO2) or HCO3- at rest or during cycling between LPVD and ND.", strong ion difference (SID) ,  normally diet (ND) , low-protein vegetarian diet (LPVD) ,0,
edin,3119,4188585,No significant difference,No differences in SPID between treatments were observed at 2 and 3 months after patch application., The maximum difference in summed pain intensity differences (SPID) , placebo , capsaicin ,0,
edin,3204,4787139,Significantly increased,"DEX fullâ group had a higher incidence of bradycardia, hypotension, level 4 sedation (Ramsay Sedation Scale) and lower surgeon satisfaction."," bradycardia, hypotension and level 4 sedation ", baseline , DEX full ,0,
edin,3175,3503942,No significant difference,The changes in McGill pain questionnaire (p=0.816) and pain rating scale (p=0.644) between the groups were not significantly different., The changes in McGill pain questionnaire ,  trigger point injections (TPI)+transcutaneous electrical nerve stimulation (TENS) , extracorporeal shock wave therapy (ESWT) ,0,
edin,3146,4435250,Significantly increased,"omen in the MHC/WHC arm were more likely to report increases in relationship equity, relative to those in the CHC arm, and had a higher odds of reporting no victimization during the previous 3 months (MHC/WHC vs WHC: odds ratio =3.05, 95% CI: 1.55, 6.0, P=0.001; CHC vs MHC/WHC: odds ratio =0.38, 95% CI: 0.20, 0.74, P=0.004).", relationship equity , Couples Health CoOp [CHC] ,  females in group Menâs Health CoOp/Womenâs Health CoOp [MHC/WHC] ,0,
edin,3095,5091897,Cannot tell based on the abstract,, household smoking bans follow up 3 and 6 months  , Control Group , Intervention group ,0,
edin,3095,5091897,Significantly increased,"<td align=""center"" colspan=""9"" rowspan=""1""><bold>Primary outcome</bold></td>", household smoking bans follow up 3 and 6 months  , Control Group , Intervention group ,0,
edin,3191,4836241,Significantly decreased,"The posttherapeutic serum follicle-stimulating hormone (FSH), luteinizing hormone (LH) and estradiol (E2) level and endometrial thickness decreased significantly in all the three groups (P < 0.05)."," follicle-stimulating hormone (FSH), luteinizing hormone (LH) "," Kuntai, Control "," Tibolone,  ",0,
edin,3199,4568196,No significant difference,"Despite the significant effect of HDEL on increasing TAC in 3 weeks [P = 0.050 (4%)], the level of TAC remained the same in 6 weeks.",  total antioxidant capacity (TAC) , baseline ,  hypocaloric diet enriched with legumes (HDEL) ,0,
edin,3166,3536709,Cannot tell based on the abstract,, Energy intake ,  normally diet (ND) , low-protein vegetarian diet (LPVD) ,0,
edin,3166,3536709,Significantly decreased,"Energy intake was significantly lower during LPVD compared to ND (2400 Â± 338 kcal vs. 2793 Â± 554 kcal, p=0.033).", Energy intake ,  normally diet (ND) , low-protein vegetarian diet (LPVD) ,0,
edin,3097,5306984,Significantly increased,We conclude that arm training using the AA robotic device is safe and able to reduce motor deficits more effectively than matched conventional arm training in subacute phase of stroke., subacute stroke patients , conventional arm training (control group) , ArmAssist (AA group) ,0,
edin,3107,3994428,Significantly decreased,"Six-month mortality was 6.5% in the ICP group and 9.1% in the control group (Pâ<â0.05),", Mortality , control group , ICP monitoring ,0,
edin,3135,5156970,Significantly increased,"The onset of relief occurred significantly sooner, and duration of relief was significantly longer in azithromycin group. Movement, abdominal pain, bloating, and gas were significantly better in azithromycin group.", relief of overall symptoms , baseline , azithromycin ,0,
edin,3113,5516192,Cannot tell based on the abstract,, The incision length , traditional cold instruments (scalpel and scissors) , electrosurgical device ,0,
edin,3113,5516192,No significant difference,"The incision length was not significantly different; cold 15.7 (5.2) cm, electroincision 15.6 (4.2) cm, 95% CI â1.6â1.8, Pâ=â.91.", The incision length , traditional cold instruments (scalpel and scissors) , electrosurgical device ,0,
edin,3127,5200917,Cannot tell based on the abstract,, blood pressure , placebo , tolcapone ,0,
edin,3127,5200917,No significant difference,"Finally, no differential changes in blood pressure were seen on tolcapone versus placebo (T(15)Â =Â 1.31, pÂ =Â 0.21),", blood pressure , placebo , tolcapone ,0,
edin,3098,5306984,Significantly increased,We conclude that arm training using the AA robotic device is safe and able to reduce motor deficits more effectively than matched conventional arm training in subacute phase of stroke., subacute stroke patients , conventional arm training (control group) , ArmAssist AA group ,0,
edin,3123,3775615,Cannot tell based on the abstract,,  HBeAg levels , adefovir (ADV) (10 mg/day) , lamivudine (LAM) (100 mg/day ,0,
edin,3123,3775615,No significant difference,"As described in Figure 2, HBeAg levels in the LAM + ADV group were 1.81Â±1.01, 1.52Â±0.86, 1.26Â±0.93, and 0.71Â±0.93 at weeks 12, 24, 52, and 104 of treatment, respectively.,In the ETV group, the levels of HBeAg were 1.66Â±0.99, 1.43Â±0.92, 1.12Â±0.91, and 0.69Â±0.83 at weeks 12, 24, 52, and 104, respectively. There were no statistically significant differences between these 2 groups (P=0.668, 0.729, 0.614, and 0.955 at weeks 12, 24, 52, and 104, respectively).",  HBeAg levels , adefovir (ADV) (10 mg/day) , lamivudine (LAM) (100 mg/day ,0,
edin,3180,4563303,Cannot tell based on the abstract,, Right (cm)â¡ , visual disuse group (VDG) , visual feedback group (VFG) ,0,
edin,3180,4563303,Significantly increased,"<td align=""left"" colspan=""1"" rowspan=""1"">Right (cm)<sup>â¡</sup></td><td align=""center"" colspan=""1"" rowspan=""1"">3.40Â±1.58</td><td align=""center"" colspan=""1"" rowspan=""1"">4.11Â±2.35<sup>â </sup></td><td align=""center"" colspan=""1"" rowspan=""1"">1.95Â±0.92</td><td align=""center"" colspan=""1"" rowspan=""1"">3.16Â±1.15<sup>â </sup></td>", Right (cm)â¡ , visual disuse group (VDG) , visual feedback group (VFG) ,0,
edin,3103,4450164,Cannot tell based on the abstract,, ureteropelvic junction obstruction , stentless cases , internal drainage group ,0,
edin,3103,4450164,No significant difference,"Intraoperative assessments showed ureteropelvic junction segmental atresia in 45 cases and aberrant vessels in 25 patients.,One patient had distal ureter obstruction because of distal ureter stone, that was treated by Trans-ureteral lithotripsy (TULP) and stent support.", ureteropelvic junction obstruction , stentless cases , internal drainage group ,0,
edin,3195,3661337,No significant difference,The SPTT group showed fewer subjects having any fall (19.23% vs. 33.33% Standard PT; pâ<â0.227) and fewer having an injurious fall (7.69% vs. 18.18%; pâ<â0.243).,  fewer having an injurious fall , baseline , surface perturbation treadmill training (SPTT) ,0,
edin,3125,4815378,Significantly increased,Mean weight changes of neonates 7 weeks after the intervention compared to those in the beginning of the intervention were significantly more in palady group compared to the cup group (cup = 146.7 and palady = 198.8; P < 0.001)., Mean weight changes of neonates 7 weeks , cup ,  palady ,0,
edin,3190,4836241,Significantly increased,"After therapy, serum E2 level in Tibolone group was obviously higher than the other two groups (P < 0.05),", estradiol (E2) leve ," Kuntai, Control "," Tibolone,  ",0,
edin,3158,5842771,Significantly increased,"But, compared to the control group, the experimental group had a significantly higher average MMSE score (p<0.00001),", The Mini Mental State Examination (MMSE) , memantine 5â20 mg/d ," Î²-asarone 10 mg/d, tenuigenin 10 mg/d, and memantine 5â20 mg/d ",0,
edin,3194,3661337,Cannot tell based on the abstract,, falls , baseline , surface perturbation treadmill training (SPTT) ,0,
edin,3194,3661337,No significant difference,"Over a period of 3Â months, 5 of 26 (19.2%) subjects in the SPTT group and 11 of 33 (33.3%) subjects in the Standard PT group had fallen at least once (Chi2â=â1.46; pâ<â0.23); 2 of 26 (7.7%) in the SPTT group and 6 of 33 (18.2%) in the Standard PT group had an injurious fall (Chi2â=â1.37; pâ<â0.25) (see FigureÂ 2).", falls , baseline , surface perturbation treadmill training (SPTT) ,0,
edin,3187,4836241,Significantly increased,"At the 4th week after GnRH-a therapy, KMI and hot flash/sweating score results were as follows: Control group > Kuntai group > Tibolone group (P < 0.05);", KMI and hot flash/sweating score ," Kuntai, Tibolone ",  Control ,0,
edin,3169,3536709,Cannot tell based on the abstract,,  the amount of fat ,  normally diet (ND) , low-protein vegetarian diet (LPVD) ,0,
edin,3169,3536709,Significantly decreased,"As well, the amount of fat differed between LPVD and ND (24.7 Â± 2.3% vs. 28.1 Â± 3.1%, p=0.015).",  the amount of fat ,  normally diet (ND) , low-protein vegetarian diet (LPVD) ,0,
edin,3142,5014878,Significantly increased,Mean antibody reactivity against the associated HPV type rose from 1125 median fluorescence intensity (MFI) pre-vaccination to 4690 MFI post-vaccination (pÂ <Â 0.001)., Mean antibody reactivity against the associated HPV , baseline , quadrivalent HPV vaccine (GardasilÂ®) ,0,
edin,3148,4083640,Significantly decreased,"On postoperative day 5, the self-reported pain intensity was significantly lower in the NBP group than in the CT group (visual analog scale score, 1.50 vs. 3.29; p = 0.04).", postoperative pain on day 5 , conventional thoracotomy (CT) , neurovascular bundle preservation (NBP) ,0,
edin,3227,3089991,Cannot tell based on the abstract,, Face and scalp sensations , Sham rTMS , Prefrontal rTMS ,0,
edin,3227,3089991,No significant difference,"Only 40% of participants guessed correctly (p =â0.27), suggesting that the sham condition was reasonably matched to real TMS with respect to face and scalp sensations.", Face and scalp sensations , Sham rTMS , Prefrontal rTMS ,0,
edin,3273,5682159,Cannot tell based on the abstract,, Overall satisfaction of the patients , Vycross 20 mg/ml HA (VYC-20) , Cohesive Polydensified Matrix 26 mg/ml HA (CPM-26) ,0,
edin,3273,5682159,No significant difference,"Overall, the majority of subjects were satisfied with both treatments throughout the study with a trend in favor of CPM-26.", Overall satisfaction of the patients , Vycross 20 mg/ml HA (VYC-20) , Cohesive Polydensified Matrix 26 mg/ml HA (CPM-26) ,0,
edin,3275,5682159,Cannot tell based on the abstract,, Improvement according to the patients at the M12 and M18 visits , Vycross 20 mg/ml HA (VYC-20) , Cohesive Polydensified Matrix 26 mg/ml HA (CPM-26) ,0,
edin,3275,5682159,Significantly increased,"At both the M12 and M18 visits, more CPM-26-treated subjects considered themselves much improved or very much improved compared with VYC-20-treated subjects", Improvement according to the patients at the M12 and M18 visits , Vycross 20 mg/ml HA (VYC-20) , Cohesive Polydensified Matrix 26 mg/ml HA (CPM-26) ,0,
edin,3218,3994324,No significant difference,"No significant difference in mean adherence over the monitoring period was identified with 77.2% (CI, 73.0, 81.4) for the control group and 74.8% (CI, 69.7, 79.9) for the intervention group (pâ=â0.47).", Adherence , Standard clinical care , Novel glaucoma education and motivational support package using behaviour change counselling ,0,
edin,3251,5457851,Cannot tell based on the abstract,, Time of onset of anesthesia ," 2% lidocaine with 1:200,000 epinephrine  "," 2% lidocaine with 1:80,000 epinephrine  ",0,
edin,3251,5457851,No significant difference,"The meanâÂ±âSD time of onset was 4.9âÂ±â4.1âminutes in the L80 group and 5.2âÂ±â4.1âminutes in the L200 group, with no significant difference between the groups (Pâ=â.447)", Time of onset of anesthesia ," 2% lidocaine with 1:200,000 epinephrine  "," 2% lidocaine with 1:80,000 epinephrine  ",0,
edin,3287,4610927,Significantly decreased,The value difference of the Touch-Test sensory evaluation was significantly higher negative in group RH than in the other two groups., Value of the Touch-Test sensory evaluation after surgery , Remifentanil 0.3 + ketamine 0.5 (group KRH) or remifentanil 0.05 (Group RL)  , Remifentanil 0.3 (group RH) ,0,
edin,3266,3712888,Significantly decreased,"Considering a 6-month treatment period, the recurrence rate in the vitamin C group (16.2%) was significantly lower (P = 0.024) than in the placebo group (32.4%).", Recurrence of bacterial vaginosis after 6 months , Placebo , Vaginal vitamin C ,0,
edin,3294,3504074,Significantly increased,"In total, 239 patients were enrolled in each arm. PASI 75 was significantly higher at week 24 for the combination therapy group compared with the monotherapy group (77Â·3% vs. 60Â·3%; P < 0Â·0001). Other PASI improvement scores at week 12 [PASI 75, 70Â·2% vs. 54Â·3% (P = 0Â·01); PASI 50, 92Â·4% vs. 83Â·8% (P = 0Â·01); and PASI 90, 34Â·0% vs. 23Â·1% (P = 0Â·03)] showed similar results as did week 24 PASI 50 (91Â·6% vs. 84Â·6%; P = 0Â·01) and PASI 90 (53Â·8% vs. 34Â·2%; P = 0Â·01).",  Improvement in Psoriasis Area and Severity Index â¥50% and â¥90% after 24 weeks , Eetanercept alone , Etanercept plus methotrexate ,0,
edin,3317,5219826,Significantly increased,"EDOF was significantly better than AOMF for HCVA at 40Â cm (0.42Â Â±Â 0.18 vs. 0.48Â Â±Â 0.22, pÂ =Â 0.024), stereopsis (98Â Â±Â 88 vs. 141Â Â±Â 114, pÂ <Â 0.001), clarity-of-vision at intermediate (8.5Â Â±Â 1.6 vs. 7.7Â Â±Â 1.9, pÂ =Â 0.006) and near (7.3Â Â±Â 2.5 vs. 6.2Â Â±Â 2.5, pÂ =Â 0.005), lack-of-ghosting (pÂ =Â 0.012), overall vision satisfaction (7.5Â Â±Â 1.7 vs. 6.4Â Â±Â 2.2, pÂ <Â 0.001) and ocular comfort (9.0Â Â±Â 1.0 vs. 8.3Â Â±Â 1.7, pÂ =Â 0.002).", Intermediate and near clarity-of-vision , Center-near lens (AOMF) , Extended depth-of-focus (EDOF) ,0,
edin,3229,3346674,Significantly increased,"Although improvement in the severity of DD was observed in both treatment groups (P < 0.001), patients receiving Calendula ointment had significantly fewer rash sites compared to Aloe group (P = 0.001).", Improvement of rash sites , Calendula ointment , Aloe cream ,0,
edin,3276,4276527,Significantly decreased,"Compared to premenopausal, healthy lean postmenopausal women had increased postprandial glucose and insulin and trend for higher TG, but similar dietary FA oxidation and storage.,Short-term E2 reduced postprandial TG and insulin, but had no effect on oxidation or storage of dietary FA. E2 increased the proportion of small adipocytes in femoral (but not abdominal) SAT.", Postprandial triglycerides , Placebo , Short-term estradiol (E2) ,0,
edin,3267,3712888,Cannot tell based on the abstract,, Baseline characteristics  , Placebo , Vaginal vitamin C ,0,
edin,3267,3712888,Significantly decreased,"The pH-lowering effect of vitamin C was detected after a prophylaxis period of 3 months, with a reduction of 3.8% compared with the baseline value and becoming statistically significant compared with placebo (Fig. 3) after four cycles of treatments (P = 0.032, Mann-Whitney test).", Baseline characteristics  , Placebo , Vaginal vitamin C ,0,
edin,3283,4610927,No significant difference,There was no significant difference among the three groups related to demographic and anesthetic parameters except the end-tidal concentration of desflurane., Demographic and anesthetic parameters , Remifentanil 0.3 + ketamine 0.5 (group KRH) , Remifentanil 0.05 (Group RL) or remifentanil 0.3 (group RH) ,0,
edin,3248,5851532,Significantly increased,"Compared to the provider-collected cervical hrHPV DNA sample (gold standard), the self-collected vaginal hrHPV DNA test demonstrated a sensitivity of 71.4% (95% CI: 0.52, 0.91; p = 0.0495) and specificity of 98.2% (95% CI: 0.96, 1.00; p<0.0001).", Sensitivity and specificity , Provider-collected cervical swabs , Self-collected vaginal specimens ,0,
edin,3250,5457851,Cannot tell based on the abstract,, Self-reported pain intensity ," 2% lidocaine with 1:200,000 epinephrine  "," 2% lidocaine with 1:80,000 epinephrine  ",0,
edin,3250,5457851,No significant difference,"Although the participants in the L200 group reported having experienced more intense pain than those in the L80 group (Pâ=â.055), the upper limit of the 1-sided confidence interval was 12.9âmm, which is lower than the noninferiority tolerance of 15âmm (Table 2).", Self-reported pain intensity ," 2% lidocaine with 1:200,000 epinephrine  "," 2% lidocaine with 1:80,000 epinephrine  ",0,
edin,3302,4450462,Significantly increased,"After 20 weeks, body weight change with the intervention was â6.4âkg (95% confidence interval (CI) â9.4 to â3.4, P<0.001) in an effect size analysis.", Reduction in body weight after 20 weeks , Only vitamin B12 supplement , Prescribed diet plus vitamin B12 supplement ,0,
edin,3308,3662597,No significant difference,"There was no groupâÃâtime interaction for HR, BP, blood glucose, lipids, NOx, hs-CRP, cortisol concentrations or body fat.", Lipid parameters , Placebo group , Multi-ingredient performance supplement (MIPS) group ,0,
edin,3252,5457851,Cannot tell based on the abstract,, Time of anesthesia action ," 2% lidocaine with 1:200,000 epinephrine  "," 2% lidocaine with 1:80,000 epinephrine  ",0,
edin,3252,5457851,No significant difference,"he meanâÂ±âSD duration of action of anesthesia was 183.5âÂ±â5.0âminutes in the L80 group and 182.2âÂ±â5.4âminutes in the L200 group, with no significant difference between the groups (Pâ=â.758)", Time of anesthesia action ," 2% lidocaine with 1:200,000 epinephrine  "," 2% lidocaine with 1:80,000 epinephrine  ",0,
edin,3293,3504074,Significantly increased,"In total, 239 patients were enrolled in each arm. PASI 75 was significantly higher at week 24 for the combination therapy group compared with the monotherapy group (77Â·3% vs. 60Â·3%; P < 0Â·0001).",  Improvement in Psoriasis Area and Severity Index â¥75% after 24 weeks , Eetanercept alone , Etanercept plus methotrexate ,0,
edin,3268,3712888,Cannot tell based on the abstract,, Signs and symptoms of bacterial vaginosis , Placebo , Vaginal vitamin C ,0,
edin,3268,3712888,No significant difference,"he two groups were homogeneous for age, height and weight distribution. BV signs and symptoms (itching, burning, dysuria, odour, erythema, oedema and fissures) were fairly similar across treatment groups, as summarised in Table 1.,BV signs and symptoms did not show any statistically significant differences through the treatment study period (from baseline to the follow-up visit), or in comparison of the treatment groups at the evaluated time points.", Signs and symptoms of bacterial vaginosis , Placebo , Vaginal vitamin C ,0,
edin,3217,4495314,Cannot tell based on the abstract,, Proportion of emotionally distressed parents at 6 months ," Standard care (Control group, CG) "," Extended postpartum care (Intervention group, IG) ",0,
edin,3217,4495314,No significant difference,Midwives identified 20% of mothers and 9% of fathers as highly distressed at 6âmonths postpartum. There was no difference between groups regarding the proportion of emotionally distressed mothers and fathers., Proportion of emotionally distressed parents at 6 months ," Standard care (Control group, CG) "," Extended postpartum care (Intervention group, IG) ",0,
edin,3213,4495314,Cannot tell based on the abstract,, Baseline age and level of education of the mothers ," Standard care (Control group, CG) "," Extended postpartum care (Intervention group, IG) ",0,
edin,3213,4495314,Significantly decreased,"There was a small but significant difference in socio-demographic characteristics between IG and CG mothers [F(3,313)â=â3.562, pâ=â0.015; Wilksâ Îâ=â0.967; Î·p2=0.033], such that CG mothers were significantly older [F(1,315)â=â7.227, pâ=â0.008; Î·p2=0.022] and had a higher level of education [F(1,315)â=â4.348, pâ=â0.038; Î·p2=0.014].", Baseline age and level of education of the mothers ," Standard care (Control group, CG) "," Extended postpartum care (Intervention group, IG) ",0,
edin,3220,3994324,Significantly increased,"Participants in the intervention group were more satisfied with information about glaucoma medication with a mean score of 14.47/17 (CI, 13.85, 15.0) compared with control group which was 8.51 (CI, 7.72, 9.30).", Satisfaction with information given about travoprost , Standard clinical care , Novel glaucoma education and motivational support package using behaviour change counselling ,0,
edin,3264,4464926,No significant difference,"No statistically significant differences were observed for pain (p<0.06), trismus (p<0.71) and swelling (p<0.05) between the test and the control group.", Trismus , Partial closure of the wound , Hermetical closure of the wound ,0,
edin,3280,4276527,Cannot tell based on the abstract,, Serum leptin , Placebo , Short-term estradiol (E2) ,0,
edin,3280,4276527,Significantly increased,"Compared with placebo, 2 weeks of E2 increased serum leptin (Table 1), reduced postprandial TG and insulin responses (Figures 2B and 3D; p<0.05),", Serum leptin , Placebo , Short-term estradiol (E2) ,0,
edin,3234,5720557,Significantly decreased,The use of nonâcoplanar beams was more common with Perspecta plans (82% vs. 27%). The mean target dose differed by less than 2% between rival plans., Use of nonÃ¢â¬ï¿½coplanar beams , Perspecta plans , Pinnacle plan ,0,
edin,3219,3994324,No significant difference,"Similarly, there was no significant difference in percentage intraocular pressure reduction; 27.6% (CI, 23.5, 31.7) for the control group and 25.3% (CI, 21.06, 29.54) for the intervention group (pâ=â0.45).", Decrease in intraocular pressure , Standard clinical care , Novel glaucoma education and motivational support package using behaviour change counselling ,0,
edin,3254,5457851,Cannot tell based on the abstract,, Overall satisfaction score of the participants and operators ," 2% lidocaine with 1:200,000 epinephrine  "," 2% lidocaine with 1:80,000 epinephrine  ",0,
edin,3254,5457851,No significant difference,"The meanâÂ±âSD overall satisfaction score of the operators was 3.9âÂ±â0.9 in the L80 group and 3.8âÂ±â1.0 in the L200 group, with no significant difference between the groups (Pâ=â.548) (Table 3). The meanâÂ±âSD overall satisfaction score of the participants was 3.6âÂ±â0.1 in the L80 group and 3.7âÂ±â0.1 in the L200 group, with no significant difference between the groups (Pâ=â.693) (Table 3). T", Overall satisfaction score of the participants and operators ," 2% lidocaine with 1:200,000 epinephrine  "," 2% lidocaine with 1:80,000 epinephrine  ",0,
edin,3221,3994324,Cannot tell based on the abstract,, Baseline intraocular pressure , Standard clinical care , Novel glaucoma education and motivational support package using behaviour change counselling ,0,
edin,3221,3994324,No significant difference,"The mean IOP at baseline for subsequently treated right and/or left eyes was 23.7Â mmHg (95% CI, 22.6, 24.8) for the control group and 22.4Â mmHg (95% CI, 21.3, 23.5) for the intervention group which was not statistically different (pâ=â0.096, 1.3, CI â0.2, 2.9).,There was no significant difference in percentage reduction in IOP from baseline to visit-3 between the two groups with control group being 27.6% (SD, 19.2) and intervention group being 25.3% (SD 19.7) (2.3 mean difference, CI â3.6, 8.2, pâ=â0.448).", Baseline intraocular pressure , Standard clinical care , Novel glaucoma education and motivational support package using behaviour change counselling ,0,
edin,3246,2972614,Cannot tell based on the abstract,, Adverse effects , Placebo laser therapy (Group II) , Laser therapy (Group I) ,0,
edin,3246,2972614,No significant difference,. All patients were able to complete the therapy program without any adverse effects., Adverse effects , Placebo laser therapy (Group II) , Laser therapy (Group I) ,0,
edin,3310,3662597,No significant difference,"There was no groupâÃâtime interaction for HR, BP, blood glucose, lipids, NOx, hs-CRP, cortisol concentrations or body", Body fat , Placebo group , Multi-ingredient performance supplement (MIPS) group ,0,
edin,3309,3662597,No significant difference,"There was no groupâÃâtime interaction for HR, BP, blood glucose, lipids, NOx, hs-CRP, cortisol concentrations or body fat."," Levels of nitrate/nitrite (NOx), cortisol, and high sensitivity C-reactive protein (hs-CRP) ", Placebo group , Multi-ingredient performance supplement (MIPS) group ,0,
edin,3285,4610927,Significantly increased,"Additional analgesic consumption, numerical rating scale scores at 6 and 24 h, and cumulative fentanyl dose were significantly higher in group RH than in the other two groups.", Cumulative fentanyl dose , Remifentanil 0.3 + ketamine 0.5 (group KRH) or remifentanil 0.05 (Group RL)  , Remifentanil 0.3 (group RH) ,0,
edin,3318,5219826,Significantly increased,"EDOF was significantly better than AOMF for HCVA at 40Â cm (0.42Â Â±Â 0.18 vs. 0.48Â Â±Â 0.22, pÂ =Â 0.024), stereopsis (98Â Â±Â 88 vs. 141Â Â±Â 114, pÂ <Â 0.001), clarity-of-vision at intermediate (8.5Â Â±Â 1.6 vs. 7.7Â Â±Â 1.9, pÂ =Â 0.006) and near (7.3Â Â±Â 2.5 vs. 6.2Â Â±Â 2.5, pÂ =Â 0.005), lack-of-ghosting (pÂ =Â 0.012), overall vision satisfaction (7.5Â Â±Â 1.7 vs. 6.4Â Â±Â 2.2, pÂ <Â 0.001) and ocular comfort (9.0Â Â±Â 1.0 vs. 8.3Â Â±Â 1.7, pÂ =Â 0.002).", Stereopsis and lack-of-ghosting , Center-near lens (AOMF) , Extended depth-of-focus (EDOF) ,0,
edin,3241,3958613,Significantly decreased,"The rate of high on-treatment platelet reactivity (PRU >235) was significant lower in the 5 mg prasugrel group than that in the 75 mg clopidogrel group (15.0% vs. 56.5%, p=0.010).", P2Y12 reaction unit (PRU) values higher than 235 , Clopidogrel 75 mg , Prasugrel 5 mg  ,0,
edin,3296,3504074,Significantly increased,Significantly more patients receiving combination therapy than monotherapy had static Physicianâs Global Assessment of clear/almost clear at week 12 (65Â·5% vs. 47Â·0%; P = 0Â·01) and week 24 (71Â·8% vs. 54Â·3%; P = 0Â·01)., Physicianâs Global Assessment of clear/almost clear , Eetanercept alone , Etanercept plus methotrexate ,0,
edin,3331,5410668,Cannot tell based on the abstract,," carbon, calcium, nitrogen, phosphorus and strontium ", control , G2- brushing with SensodyneÂ®Rapid Relief; ,0,
edin,3331,5410668,Significantly increased,"Evaluation regarding the chemical elements present in the specimen from Group 2 shows a statistically significant difference (p <0.05) in the experimental faces when comparing to the positive control faces for carbon, calcium, nitrogen, phosphorus and strontium.,These data are corroborated taking into account the formulation of Sensodyne Rapid ReliefÂ® dentifrice (8% strontium acetate, calcium carbonate, sodium fluoride; 1,040 ppm fluoride), and the clear deposition of obliterating particles in the dentinal tubules of the experimental regions."," carbon, calcium, nitrogen, phosphorus and strontium ", control , G2- brushing with SensodyneÂ®Rapid Relief; ,0,
edin,3396,5623480,Cannot tell based on the abstract,," Primary outcome: the proportion of patients who did not have 70% resolution of ST-segment elevation and did not meet the criteria for Thrombolysis In Myocardial Infarction (TIMI) flow 3 at initial angiography. Secondary outcome: the composite of death, MI, stent thrombosis, stroke or urgent revascularisation and major or minor bleeding at 30 days. ", Prehospital administration of ticagrelor , in-hospital administration of ticagrelor ,0,
edin,3396,5623480,No significant difference,"No significant interactions between randomised treatment and gender in terms of these outcomes were found in the unadjusted or adjusted model (test for interaction in the multivariable models; p=0.94 for all-cause mortality, p=0.55 for absence of TIMI flow grade 3 in the IRA at initial angiography, p=0.71 for absence of â¥70%âresolution of pre-PCI ST-segment elevation, and p=0.31 for TIMI major bleeding at 30 days) (see online supplementary tables 1â3)."," Primary outcome: the proportion of patients who did not have 70% resolution of ST-segment elevation and did not meet the criteria for Thrombolysis In Myocardial Infarction (TIMI) flow 3 at initial angiography. Secondary outcome: the composite of death, MI, stent thrombosis, stroke or urgent revascularisation and major or minor bleeding at 30 days. ", Prehospital administration of ticagrelor , in-hospital administration of ticagrelor ,0,
edin,3458,4842387,Significantly increased,"dvanced group had more cases of severe SML (severity â©¾ 3) (44/47) and severe SAD (43/47) than the placebo group (39/51 and 37/51, < 0.05, < 0.05, resp.) before the treatment. BrainPower Advanced intervention, however, improved a greater proportion of the severe SML (29.5%)(13/44) (P < 0.01) and SAD (34.9%)(15/43)(P < 0.01) than placebo (5.1% (2/39) and 13.5% (5/37), resp.).", subjective attention/concentration deficits (SAD) , placebo , BrainPower Advanced capsules ,0,
edin,3445,3517846,Cannot tell based on the abstract,,  glycemic index (GI)  , baseline , Group 2 ,0,
edin,3445,3517846,Significantly decreased,"There was a significant decrease in the GI of the diet throughout the intervention period only in Group 2 (51.29 Â± 7.28 to 47.18 Â± 6.93, P = 0.001).",  glycemic index (GI)  , baseline , Group 2 ,0,
edin,3345,4297469,No significant difference,"Resource use with HM ON was clearly different: less FU visits (3.79 Â± 1.67 vs. 5.53 Â± 2.32; P < 0.001) despite a small increase of unscheduled visits (0.95 Â± 1.50 vs. 0.62 Â± 1.25; P < 0.005), more non-office-based contacts (1.95 Â± 3.29 vs. 1.01 Â± 2.64; P < 0.001), more Internet sessions (11.02 Â± 15.28 vs. 0.06 Â± 0.31; P < 0.001) and more in-clinic discussions (1.84 Â± 4.20 vs. 1.28 Â± 2.92; P < 0.03), but with numerically fewer hospitalizations (0.67 Â± 1.18 vs. 0.85 Â± 1.43, P = 0.23) and shorter length-of-stay (6.31 Â± 15.5 vs. 8.26 Â± 18.6; P = 0.27), although not significant.,From a payer perspective, FU-related costs were similar while the total cost per patient (including other physician visits, examinations, and hospitalizations) was numerically (but not significantly) lower."," hospitalizations,  shorter length-of-stay ", regular in-office FU (HM OFF) , Home Monitoring facilitated FU (HM ON) ,0,
edin,3327,4832354,Significantly increased,"PâDA users perceived themselves to be significantly more 1) informed about the treatment choice (Pâ=â.008), 2) aware of options (Pâ=â.009), 3) knowledgeable about treatment benefits (Pâ=â.020), and 4) knowledgeable about treatment risks/side effects (Pâ=â.001) in comparison with controls."," informed about the treatment choice,  aware of options,  knowledgeable about treatment benefits, and knowledgeable about treatment risks/side effects  ", control , Patient decision aids (PÃ¢â¬ï¿½DAs) ,0,
edin,3363,5167461,Cannot tell based on the abstract,, forced expiratory volume in one second (FEV1) , twice-daily SFC 50 Î¼g/500 Î¼g , IND/GLY 110 Î¼g/50 Î¼g ,0,
edin,3363,5167461,Significantly increased,"Pre-dose trough FEV1 improved significantly with IND/GLY versus SFC in the overall population (treatment difference, 0.10 L; P<0.0001)", forced expiratory volume in one second (FEV1) , twice-daily SFC 50 Î¼g/500 Î¼g , IND/GLY 110 Î¼g/50 Î¼g ,0,
edin,3450,4685630,Significantly increased,"Service costs were significantly higher for PACTâ+âTAU (mean difference Â£4,489, pâ<â0.001), but the difference in societal costs was smaller and non-significant (mean difference Â£1,385, pâ=â0.788) due to lower informal care rates for PACTâ+âTAU.", Service costs , societal costs , Pre-School Autism Communication Trial (PACT)+  treatment as usual (TAU) ,0,
edin,3346,4297469,No significant difference,"For the whole study population, the total FU cost for providers was not different for HM ON vs. OFF [mean (95% CI): â¬204 (169â238) vs. â¬213 (182â243); range for difference (â¬â36 to 54), NS].",  total FU cost for providers , regular in-office FU (HM OFF) , Home Monitoring facilitated FU (HM ON) ,0,
edin,3338,4893393,Significantly decreased,"ntravenous lidocaine was superior regarding the reduction of the intensity of pain, the allodynia, and the hyperalgesia compared to placebo.", intensity of pain , placebo , lidocaine (5âmgs/kg) ,0,
edin,3358,3215167,Cannot tell based on the abstract,," pH, HCO3-, &amp;amp; BE ", placebo (plain flour) ," 750 mL of water with either 9 g of EG (manufacturer recommendations), 0.1 gÂ·kg-1 of NaHCO3 ",0,
edin,3358,3215167,Significantly increased,"There were significant interactions (p < 0.01) and main effects for condition (p < 0.001) and time (p < 0.001) for all acid-base variables (pH, HCO3-, & BE)."," pH, HCO3-, &amp;amp; BE ", placebo (plain flour) ," 750 mL of water with either 9 g of EG (manufacturer recommendations), 0.1 gÂ·kg-1 of NaHCO3 ",0,
edin,3359,3215167,Cannot tell based on the abstract,, incidence and severity of GI discomfort , placebo (plain flour) ," 750 mL of water with either 9 g of EG (manufacturer recommendations), 0.1 gÂ·kg-1 of NaHCO3 ",0,
edin,3359,3215167,No significant difference,A large degree of intra-subject variability was evident in both the incidence and severity of GI discomfort (Figure 2). There were no significant interactions (p > 0.98) or main effects for condition (p > 0.80) or time (p > 0.57) for either incidence or severity., incidence and severity of GI discomfort , placebo (plain flour) ," 750 mL of water with either 9 g of EG (manufacturer recommendations), 0.1 gÂ·kg-1 of NaHCO3 ",0,
edin,3444,3517846,Cannot tell based on the abstract,, gaining weight , gestational diabetes mellitus (GDM) , type 2 DM ,0,
edin,3444,3517846,Significantly increased,Women with type 2 DM gained more weight during pregnancy (7.5 Â± 7.41âkg) when compared to women with GDM (4.35 Â± 6.59âkg) (P = 0.023);, gaining weight , gestational diabetes mellitus (GDM) , type 2 DM ,0,
edin,3343,4297469,Significantly increased,"Resource use with HM ON was clearly different: less FU visits (3.79 Â± 1.67 vs. 5.53 Â± 2.32; P < 0.001) despite a small increase of unscheduled visits (0.95 Â± 1.50 vs. 0.62 Â± 1.25; P < 0.005), more non-office-based contacts (1.95 Â± 3.29 vs. 1.01 Â± 2.64; P < 0.001), more Internet sessions (11.02 Â± 15.28 vs. 0.06 Â± 0.31; P < 0.001) and more in-clinic discussions (1.84 Â± 4.20 vs. 1.28 Â± 2.92; P < 0.03),", Internet sessions , regular in-office FU (HM OFF) , Home Monitoring facilitated FU (HM ON) ,0,
edin,3324,5295657,No significant difference,"The mean LDL/HDL ratio decreased during the study (P < 0.001); however, there was not any significant difference between the two groups (P > 0.05).", The mean LDL/HDL ratio , 40 mg/day of lovastatin , 40 mg/day of Lovastatin plus 2 g/day powder of Kelussia odoratissima ,0,
edin,3443,3517846,Cannot tell based on the abstract,, The proportion of women who started using insulin during the intervention , Group 2: low GI foods , Group 1: all types of CHO ,0,
edin,3443,3517846,No significant difference,"The proportion of women who started using insulin during the intervention was similar between study groups in both types of DM (P â¥ 0.40), without differences in insulin doses (Group 1: 42.7 Â± 26.4âu/d and Group 2: 35.5 Â± 21.5âu/d) (P = 0.18).", The proportion of women who started using insulin during the intervention , Group 2: low GI foods , Group 1: all types of CHO ,0,
edin,3381,3564767,Cannot tell based on the abstract,, Smoking status , nothing (waiting list group)   , two sessions of 1.5âhours each of the Pick-Klop game or two sessions of 1.5âhours each of psychoeducation ,0,
edin,3381,3564767,Significantly decreased,"Compared with the participants in the waiting-list group, those in the Pick-Klop group were less likely to be smokers (pâ=â0.04, ORâ=â0.32, and CIâ=â[0.11; 0.96]).", Smoking status , nothing (waiting list group)   , two sessions of 1.5âhours each of the Pick-Klop game or two sessions of 1.5âhours each of psychoeducation ,0,
edin,3453,3702153,Cannot tell based on the abstract,, Chi-square test - frequency distribution of the redness , control , position was changed every 2-3 hours and the bed sore was washed with water and cotton-wool and fish oil with thickness of 2-3 mm was applied on the place of sore ,0,
edin,3453,3702153,Significantly increased,"Chi-square test showed that the frequency distribution of the redness changes, 96 hours after intervention, has significant difference for both groups (p < 0.001).,At the end of the 5th day (120 hours after intervention), 29 people from the treating group and 15 people from the placebo group had recovered (46.7% vs. 50%). Chi-square showed here too that the frequency distribution of the redness changes of the ulcer is different in the two groups, 5 days after 5 days (p < 0.001).

By 144 hours (6th days), all the patients recovered in treating group and 23 patients recovered in placebo group (76.7%). Chi-square test indicated that the frequency distribution of the redness changes has significant difference in this stage, too (p < 0.001).", Chi-square test - frequency distribution of the redness , control , position was changed every 2-3 hours and the bed sore was washed with water and cotton-wool and fish oil with thickness of 2-3 mm was applied on the place of sore ,0,
edin,3374,4768887,Cannot tell based on the abstract,, overall sensitivity and an accuracy in the detection of the metastasis , computed tomography (CT) , Fluorodeoxyglucose-positron emission tomography (PET)/computed tomography (CT) ,0,
edin,3374,4768887,Significantly increased,"On a station-based analysis, PET/CT displayed an overall sensitivity of 86.5% and an accuracy of 92.2% in the detection of the metastasis. CT showed a lower sensitivity of 67.3% (P=0.006) and an accuracy of 87.2% (P=0.024).", overall sensitivity and an accuracy in the detection of the metastasis , computed tomography (CT) , Fluorodeoxyglucose-positron emission tomography (PET)/computed tomography (CT) ,0,
edin,3352,4389977,Cannot tell based on the abstract,, Self-Assessment Questionnaire score at Visit 2 , placebo , oral marine protein supplement (MPS) ,0,
edin,3352,4389977,Significantly increased,"Subjects treated with MPS obtained significantly higher total scores on the Self-Assessment Questionnaire at Visit 2 (f (1,58) = 8.27, P = 0.006; MPS: 61.20 Â± 7; placebo: 55.57 Â± 8)", Self-Assessment Questionnaire score at Visit 2 , placebo , oral marine protein supplement (MPS) ,0,
edin,3417,4067355,Cannot tell based on the abstract,"Compared to imputed placebo, all NOACs reduced the risk of stroke (ORs between 0.24 and 0.42, all p<0.001) and all-cause mortality (ORs between 0.55 and 0.59, all p<0.05).",  risk of stroke ,  rivaroxaban , edoxaban  ,0,
edin,3417,4067355,Significantly increased,"There were no significant differences between the higher dose of edoxaban (60 mg) and any other NOAC in the efficacy outcomes, apart from a slightly higher risk of stroke with edoxaban than rivaroxaban (pâ=â0.032).",  risk of stroke ,  rivaroxaban , edoxaban  ,0,
edin,3326,5149084,Significantly decreased,"Laser group showed the statistically highest mean percentage (%) of reduction in pain scores and ulcer size than the other groups. T,All treatment modalities reduced pain and ulcer size than placebo group.", mean ulcer size , control , Group I -  herbal combination of Acacia nilotica and Licorice (A and L) ,0,
edin,3384,4310883,Cannot tell based on the abstract,, disposition of patients from the OR to the intensive care unit , preâalvimopan , alvimopan ,0,
edin,3384,4310883,Significantly increased,"There was increased disposition of patients from the OR to the intensive care unit in the alvimopan group (44% vs. 66%, p = 0.048).", disposition of patients from the OR to the intensive care unit , preâalvimopan , alvimopan ,0,
edin,3415,4067355,Cannot tell based on the abstract,," the risk of stroke/systemic embolism , stroke, hemorrhagic stroke and systemic embolism ",  warfarin , non vitamin K antagonist oral anticoagulant (NOAC) ,0,
edin,3415,4067355,Significantly decreased,"NOACs as a whole reduced the risk of stroke/systemic embolism (by 21%; p<0.001), stroke (by 20%; p<0.001), hemorrhagic stroke (by 50%; p<0.001) and systemic embolism (by 40%; pâ=â0.006)."," the risk of stroke/systemic embolism , stroke, hemorrhagic stroke and systemic embolism ",  warfarin , non vitamin K antagonist oral anticoagulant (NOAC) ,0,
edin,3291,3427491,No significant difference,"No statistically significant differences were observed in overall survival (15.6 and 17.2Â months; pÂ =Â 0.475); progression-free survival (7.7 and 8.7Â months; pÂ =Â 0.292), and response duration (6.4 and 7.6Â months; pÂ =Â 0.372) for TOMOX and FOLFOX4, respectively.", Response duration , FOLFOX4 , TOMOX ,0,
edin,3341,4297469,Significantly increased,"Resource use with HM ON was clearly different: less FU visits (3.79 Â± 1.67 vs. 5.53 Â± 2.32; P < 0.001) despite a small increase of unscheduled visits (0.95 Â± 1.50 vs. 0.62 Â± 1.25; P < 0.005),", unscheduled visits , regular in-office FU (HM OFF) , Home Monitoring facilitated FU (HM ON) ,0,
edin,3385,4310883,Cannot tell based on the abstract,, use of robotic technique , preâalvimopan , alvimopan ,0,
edin,3385,4310883,Significantly increased,"Additionally, use of robotic technique increased markedly in the alvimopan group (8% vs. 25%, p = 0.030).", use of robotic technique , preâalvimopan , alvimopan ,0,
edin,3360,2788265,No significant difference,"Median progression-free survival was estimated with 4.0, 5.6, and 6.0 months (P=0.21).", Progression-free survival ," gemcitabine (300âmgâmâ2), and cisplatin (30âmgâmâ2) on days 1, 8, 22, and 29 (RT-GC arm), or the same concurrent treatment followed by sequential full-dose gemcitabine (1000âmgâmâ2) and cisplatin (50âmgâmâ2) every 2 weeks (RT-GC+GC arm) "," 5-fluorouracil (350âmgâmâ2 per day on each day of radiotherapy, RT-5-FU arm) ",0,
edin,3432,4234827,Cannot tell based on the abstract,, number of procedures performed , early tracheotomy  , late tracheotomy ,0,
edin,3432,4234827,Significantly increased,"The tracheotomy was performed in 99 patients in the early group (98%; 95% CI 93%, 99.8%) whereas it was performed in 76 patients in the patients randomized to the late group (73.1%; 95% CI 63%, 81%) (P <0.001).", number of procedures performed , early tracheotomy  , late tracheotomy ,0,
edin,3405,4544133,Significantly decreased,"CRP levels significantly decreased from beginning to the end of 4 weeks in both atorvastatin and rosuvastatin groups (from 35.48 to 23.07 mg/l and from 35.88 to 19.91 mg/l respectively, both P < 0.001). However, there was significant difference between the levels of CRP in patients of the rosuvastatin group as compared to the atorvastatin group (19.91 Â± 6.32 vs 23.07 Â± 7.47, P < 0.05). I", CRP levels , baseline ," atorvastatin 40 mg daily,  rosuvastatin 20 mg daily for 4 weeks ",0,
edin,3372,4768887,No significant difference,"Compared to the CT group, the right-sided approach was more frequently used (42.6% versus 25.5%, P=0.065) in the PET/CT group", use of right-sided approach  , computed tomography (CT) , Fluorodeoxyglucose-positron emission tomography (PET)/computed tomography (CT) ,0,
edin,3434,4234827,Significantly decreased,"Mortality at day 90 was similar in both groups (25.7% versus 29.9%), but duration of sedation was shorter in the early tracheotomy group median 11Â days (range 2 to 92) days compared to 14Â days (range 0 to 79) in the late group (P <0.02).", The duration of sedation , late tracheotomy ,  early tracheotomy  ,0,
edin,3337,4069535,Cannot tell based on the abstract,, Pulse pressure variation (PPV) and stroke volume variation (SVV) ,  fluid resuscitation and norepinephrine infusion (SD0) , Dexmedetomidine ,0,
edin,3337,4069535,No significant difference,Dexmedetomidine infusion did not affect PPV and SVV., Pulse pressure variation (PPV) and stroke volume variation (SVV) ,  fluid resuscitation and norepinephrine infusion (SD0) , Dexmedetomidine ,0,
edin,3431,4183082,Cannot tell based on the abstract,, Muscle ache and fasciculation , Cisatracurium group , Succinylcholine group ,0,
edin,3431,4183082,Significantly increased,Muscle ache and fasciculation was experienced in 85% of the patients in Succinylcholine group and 27.5% of the Cisatracurium group (P = 0.002)., Muscle ache and fasciculation , Cisatracurium group , Succinylcholine group ,0,
edin,3439,3704267,Significantly increased,. Continuous abstinence rates from months 24 to 36 (45.8% vs 4.0%) and months 24 to 48 (44.3% vs 5.1%) were also higher in participants receiving behavioral intervention than in those control group., The rates of continuous abstinence at the 48 month follow-up , control group , behavioral intervention ,0,
edin,3323,5295657,No significant difference,The mean of FBS did not change between and within groups (P > 0.05)., fasting blood sugar (FBS) , 40 mg/day of lovastatin , 40 mg/day of Lovastatin plus 2 g/day powder of Kelussia odoratissima ,0,
edin,3425,4183082,Significantly increased,Number of patients who developed sore throat was significantly higher in the Succinylcholine group (75%) compared to Cisatracurium group (27.5%) at the time of entrance to the recovery room (P = 0.001). These numbers decreased at 2 hours postâoperation (42% versus 17.5%) but the difference was still statistically significant (P < 0.05)., sore throat 2 hours postâoperation , Cisatracurium group , Succinylcholine group ,0,
edin,3430,4183082,Cannot tell based on the abstract,, developed fasciculation , Cisatracurium group , Succinylcholine group ,0,
edin,3430,4183082,Significantly increased,"97.5% of the patients who had received Succinylcholine developed fasciculation, while none of the patients in the Cisatraciruim arm showed similar problem (P < 0.001).", developed fasciculation , Cisatracurium group , Succinylcholine group ,0,
edin,3354,5919699,Significantly increased,"Intention-to-treat analysis indicated that moderate physical activity level increased significantly by 269.4 Â± 260.6 minutes per week in the exercise group (mean between-group difference, 254.6 minutes; 95% confidence interval, 172.7â434.7; p < 0.001).", moderate physical activity , usual care , 6-week home-based exercise program ,0,
edin,3371,5374834,Cannot tell based on the abstract,, the level of sedation ,  hyoscine group ,  ketamine group ,0,
edin,3371,5374834,Significantly decreased,"Moreover, there was a significant difference between the two groups regarding the level of sedation where it was lower in ketamine group compared to hyoscine group (P < 0.001), which was assessed by modified observer's assessment of alertness/sedation score [Figure 4].", the level of sedation ,  hyoscine group ,  ketamine group ,0,
edin,3420,5768344,Cannot tell based on the abstract,, Dose reductions , adjuvant dose-dense doxorubicin-cyclophosphamide (ddAC)  , docetaxel-doxorubicin-cyclophosphamide (TAC) ,0,
edin,3420,5768344,Significantly increased,"Dose reductions of more than 10% occurred more frequently for TAC (39 out of 1817 cycles, 2.1%) than for ddAC (13 out of 1914 cycles, 0.7%, P < 0.001).


Adverse events (AEs)", Dose reductions , adjuvant dose-dense doxorubicin-cyclophosphamide (ddAC)  , docetaxel-doxorubicin-cyclophosphamide (TAC) ,0,
edin,3321,5295657,Significantly increased,The HDL-C rate was higher in intervention group compared to control group (P < 0.05)., HDL-C rate , 40 mg/day of lovastatin , 40 mg/day of Lovastatin plus 2 g/day powder of Kelussia odoratissima ,0,
edin,3342,4297469,Significantly increased,"Resource use with HM ON was clearly different: less FU visits (3.79 Â± 1.67 vs. 5.53 Â± 2.32; P < 0.001) despite a small increase of unscheduled visits (0.95 Â± 1.50 vs. 0.62 Â± 1.25; P < 0.005), more non-office-based contacts (1.95 Â± 3.29 vs. 1.01 Â± 2.64; P < 0.001),", non-office-based contacts , regular in-office FU (HM OFF) , Home Monitoring facilitated FU (HM ON) ,0,
edin,3369,5374834,Significantly increased,"There was a significant difference between the two groups in the severity of CRBD measured by visual analog scale score only 30 min after drug administration where it was higher in ketamine group (44.50 Â± 7.70) compared to hyoscine group (36.00 Â± 8.55) (P < 0.001),", severity of postoperative catheter-related bladder discomfort (CRBD) , hyoscine group , ketamine group ,0,
edin,3399,4320136,No significant difference,"Total amount of iron absorbed from raw and cooked bananas was similar (0.77Â±0.33 mg vs. 0.86Â±0.41 mg, respectively).", Total amount of absorbed iron  ,  500 g/day of cooked banana for 4 days ,  480 g/day of raw banana for 6 days ,0,
edin,3412,4067355,Significantly decreased,"Compared to imputed placebo, all NOACs reduced the risk of stroke (ORs between 0.24 and 0.42, all p<0.001) and all-cause mortality (ORs between 0.55 and 0.59, all p<0.05)."," the risk of stroke, all-cause mortality ", placebo , non vitamin K antagonist oral anticoagulant (NOAC) ,0,
edin,3410,4302388,No significant difference,"After adjustment, whole-blood Se concentration was higher in women consuming Brazil nuts (P=Â 0Â·040) and in those consuming more than two seafood portions per week (P=Â 0Â·054).", whole-blood Se concentration , baseline ," Brazil nuts, consuming more than two seafood portions per week ",0,
edin,3325,5149084,Significantly decreased,A and L group showed a lower mean % of reduction in pain scores than laser and Amlexanox groups with a 22.2+10.5 and 43.4+15.8 mean % reduction in pain scores at day 2 and day 5 respectively., mean pain scores , Group I -  herbal combination of Acacia nilotica and Licorice (A and L) ," Group II  - 2 mg Amlexanox paste respectively, group III received diode laser ",0,
edin,3448,4685630,No significant difference,"Clinically meaningful symptom improvement was evident for 53Â % of PACTâ+âTAU versus 41Â % of TAU (odds ratio 1.91, pâ=â0.074).", Clinically meaningful symptom , treatment as usual (TAU) , Pre-School Autism Communication Trial (PACT)+  treatment as usual (TAU) ,0,
edin,3376,4768887,Significantly increased,"Although the overall survival between the two groups was similar, the PET/CT group had a longer disease-free survival (DFS) than the CT group (27.1 months versus 18.9 months; P=0.019), especially in the subgroup of node-positive patients (22.5 months versus 13.5 months; P=0.02).", Disease-free survival (DFS) , computed tomography (CT) , Fluorodeoxyglucose-positron emission tomography (PET)/computed tomography (CT) ,0,
edin,3357,3215167,Significantly increased,Interactions indicated significant elevation in blood alkalosis for only the NaHCO3 condition when compared to both placebo and EG from 15 to 120 minutes., NaHCO3 condition , placebo (plain flour) ," 750 mL of water with either 9 g of EG (manufacturer recommendations), 0.1 gÂ·kg-1 of NaHCO3 ",0,
edin,3383,4310883,Significantly decreased,"Costs were significantly lower in the alvimopan group than the control groups (2012 USD 32,443 vs. 40,604 p <0.001).", Costs , control , alvimopan ,0,
edin,3394,3206382,Significantly decreased,"Gastrointestinal adverse events occurred in 26.9% and 50.9% of IPC and ferrous sulfate patients, respectively (P = 0.012)", gastrointestinal adverse event , baseline ," Iron polymaltose complex (IPC), ferrous sulfate twice daily, (both 5âmg iron/kg/day) ",0,
edin,3389,3206382,Significantly increased,"Mean increases in Hb to months 1 and 4 with IPC were 1.2 Â± 0.9âg/dL and 2.3 Â± 1.3âg/dL, respectively, (both P = 0.001 versus baseline)", improvement in Hb by month 1 , baseline ," Iron polymaltose complex (IPC), ferrous sulfate twice daily, (both 5âmg iron/kg/day) ",0,
edin,3451,3702153,Cannot tell based on the abstract,, precise Fischer tests 48 hours after treatment  -  reduction of redness , control , position was changed every 2-3 hours and the bed sore was washed with water and cotton-wool and fish oil with thickness of 2-3 mm was applied on the place of sore ,0,
edin,3451,3702153,Significantly increased,"According to precise Fischer tests, the difference between the two group was totally significant (p < 0.001) 48 hours after treatment intervention, 23 people (76.7%) of the treating group who had received fish oil had reduction in redness, although none of the patients in placebo group showed such recovery.", precise Fischer tests 48 hours after treatment  -  reduction of redness , control , position was changed every 2-3 hours and the bed sore was washed with water and cotton-wool and fish oil with thickness of 2-3 mm was applied on the place of sore ,0,
edin,3344,4297469,Significantly increased,"Resource use with HM ON was clearly different: less FU visits (3.79 Â± 1.67 vs. 5.53 Â± 2.32; P < 0.001) despite a small increase of unscheduled visits (0.95 Â± 1.50 vs. 0.62 Â± 1.25; P < 0.005), more non-office-based contacts (1.95 Â± 3.29 vs. 1.01 Â± 2.64; P < 0.001), more Internet sessions (11.02 Â± 15.28 vs. 0.06 Â± 0.31; P < 0.001) and more in-clinic discussions (1.84 Â± 4.20 vs. 1.28 Â± 2.92; P < 0.03),", in-clinic discussions , regular in-office FU (HM OFF) , Home Monitoring facilitated FU (HM ON) ,0,
edin,3355,5919699,Significantly increased,"Physical fitness measured by using the step test (-3.9 vs. 2.6, p = 0.012) and push-up test (3.0 vs. -1.2, p = 0.012) also improved significantly in the exercise group compared to the control group.", the step test and  push-up test , usual care , 6-week home-based exercise program ,0,
edin,3353,4389977,Significantly increased,MPS use also resulted in significantly less hair shedding (P = 0.002) and higher total Self-Assessment (P = 0.006) and Quality of Life Questionnaires scores (P = 0.035)., total scores on the Quality of Life Questionnaire , placebo , oral marine protein supplement (MPS) ,0,
edin,3446,3517846,Cannot tell based on the abstract,, clinical outcomes , 2 DM , GDM ,0,
edin,3446,3517846,No significant difference,No differences were found in these clinical outcomes between women with GDM and type 2 DM within each study group (P > 0.05)., clinical outcomes , 2 DM , GDM ,0,
edin,3340,4297469,Cannot tell based on the abstract,, clinically relevant finding/action (âactionable visitsâ) , regular in-office FU (HM OFF) , Home Monitoring facilitated FU (HM ON) ,0,
edin,3340,4297469,Significantly increased,"In the HM ON group, 32.0% of in-office FU visits (193/603) resulted in a clinically relevant finding/action (âactionable visitsâ) compared with 26.8% (213/795) in the HM OFF group (P < 0.05).", clinically relevant finding/action (âactionable visitsâ) , regular in-office FU (HM OFF) , Home Monitoring facilitated FU (HM ON) ,0,
edin,3411,4302388,Significantly decreased,"On excluding non-compliers with Se treatment, Se supplementation also significantly reduced the OR for PE/PIH (OR 0Â·30, 95Â % CI 0Â·09, 1Â·00, P=Â 0Â·049).", developing pre-eclampsia and pregnancy-induced hypertension (PE/PIH) , non-consumers ," Brazil nuts, consuming more than two seafood portions per week ",0,
edin,3460,4842387,Cannot tell based on the abstract,, combined total scores of the memory function , placebo , BrainPower Advanced capsules ,0,
edin,3460,4842387,Significantly increased,Ridit scoring test showed that the improvement in the combined total scores of the memory function subtests was significantly better after the BrainPower Advanced intervention (mean = 0.56 Â± 0.287) than after the placebo intervention (0.445 Â± 0.276) (P < 0.05) (Table 6(c))., combined total scores of the memory function , placebo , BrainPower Advanced capsules ,0,
edin,3350,4389977,Significantly decreased,MPS use also resulted in significantly less hair shedding (P = 0.002) and higher total Self-Assessment (P = 0.006) and Quality of Life Questionnaires scores (P = 0.035)., hair shedding counts following hair washing , placebo , oral marine protein supplement (MPS) ,0,
edin,3393,3206382,Cannot tell based on the abstract,, serum ferritin level by month 4 , baseline ," Iron polymaltose complex (IPC), ferrous sulfate twice daily, (both 5âmg iron/kg/day) ",0,
edin,3393,3206382,Significantly decreased,"The increase in serum ferritin level from baseline to month 4 was almost twofold lower in the IPC group versus ferrous sulfate (22.7 Â± 26.1âÎ¼g/mL versus 42.5 Â± 62.0âÎ¼g/mL, P = 0.001).", serum ferritin level by month 4 , baseline ," Iron polymaltose complex (IPC), ferrous sulfate twice daily, (both 5âmg iron/kg/day) ",0,
edin,3370,5374834,Cannot tell based on the abstract,, rise in heart rate (HR) , ketamine group ,  hyoscine group ,0,
edin,3370,5374834,Significantly increased,There was a statistically significant rise in HR in hyoscine group patients compared to ketamine group over time (P < 0.001, rise in heart rate (HR) , ketamine group ,  hyoscine group ,0,
edin,3397,4320136,Cannot tell based on the abstract,, Ferritin concentration , 480 g/day of raw banana for 6 days ,  500 g/day of cooked banana for 4 days ,0,
edin,3397,4320136,Significantly increased,Ferritin concentration was significantly higher in the group that received the cooked banana compared to the group that received the raw banana with added iron (p<0.05)., Ferritin concentration , 480 g/day of raw banana for 6 days ,  500 g/day of cooked banana for 4 days ,0,
edin,3392,3206382,Cannot tell based on the abstract,,  transferrin saturation (TSAT) , baseline ," Iron polymaltose complex (IPC), ferrous sulfate twice daily, (both 5âmg iron/kg/day) ",0,
edin,3392,3206382,No significant difference,"In terms of iron status parameters, TSAT improved from approximately 5% in each group at baseline to >20% at month 4 (IPC 5.1 Â± 3.3% to 20.2 Â± 15.5%, P = 0.001; ferrous sulfate 5.4 Â± 3.5% to 22.4 Â± 13.2%, P = 0.001) with no significant difference between the groups.",  transferrin saturation (TSAT) , baseline ," Iron polymaltose complex (IPC), ferrous sulfate twice daily, (both 5âmg iron/kg/day) ",0,
edin,3459,4842387,Cannot tell based on the abstract,," audio/visual memory, abstract thinking, memory retrieval, and combined total function test scores ", placebo , BrainPower Advanced capsules  ,0,
edin,3459,4842387,Significantly increased,"Both the BrainPower Advanced and the placebo groups produced significant improvements (129%â150%) (P < 0.01, each) of the subtests and combined total scores in the older adults, with the BrainPower Advanced group producing better improvements (1.50-, 1.35-, 1.43-, and 1.29-fold relative to the baseline values of audio/visual memory, abstract thinking, memory retrieval, and combined total function test scores) than the placebo group (1.35-, 1.27-, 1.13-, and 1.27-fold, resp.) (Tables 6(a) and 6(b))."," audio/visual memory, abstract thinking, memory retrieval, and combined total function test scores ", placebo , BrainPower Advanced capsules  ,0,
edin,3398,4320136,Significantly increased,Percent iron absorption was significantly higher in raw bananas (49.3Â±21.3%) compared with cooked banana (33.9Â±16.2%) (p=0.035)., Percent iron absorption ,  500 g/day of cooked banana for 4 days ,  480 g/day of raw banana for 6 days ,0,
edin,3322,5295657,No significant difference,"The mean LDL/HDL ratio decreased during the study (P < 0.001); however, there was not any significant difference between the two groups (P > 0.05).", The mean LDL/HDL ratio , baseline ," 40 mg/day of Lovastatin plus 2 g/day powder of Kelussia odoratissima, 40 mg/day of lovastatin ",0,
edin,3348,4389977,Significantly increased,MPS-treated subjects achieved a significant increase in the number of terminal hairs within the target area (P < 0.0001) which was significantly greater than placebo (P < 0.0001)., mean number of terminal hairs , placebo , oral marine protein supplement (MPS) ,0,
edin,3549,522822,Cannot tell based on the abstract,," serum total cholesterol, LDL, HDL and triglycerides ", baseline , 12.7 g of psyllium hydrophilic mucilloid ,0,
edin,3549,522822,No significant difference,"Values for total, LDL, HDL cholesterol and triglycerides at baseline, eight and sixteen weeks for various subgroupings are tabulated in tables 1, 2, 3 and 4, respectively. Data for changes from baseline for total, LDL and HDL cholesterol and triglycerides are listed in table 5.,<td align=""left"">TRIGLYCERIDES</td><td align=""left"">0.094</td><td align=""left"">p = 0.22</td><td align=""left"">0.082</td><td align=""left"">p = 0.22</td>"," serum total cholesterol, LDL, HDL and triglycerides ", baseline , 12.7 g of psyllium hydrophilic mucilloid ,0,
edin,3567,4284021,Significantly decreased,"<td align=""left"" colspan=""1"" rowspan=""1"">LDL-C</td><td colspan=""1"" rowspan=""1""></td><td colspan=""1"" rowspan=""1""></td><td colspan=""1"" rowspan=""1""></td>", Apolipoprotein B-100 (apo B) , placebo , evacetrapib (10â600âmg) ,0,
edin,3561,2755038,Cannot tell based on the abstract,, risks of 70% restenosis , angioplasty alone , endovascular arm ,0,
edin,3561,2755038,Significantly decreased,"Of the patients who were assigned to endovascular treatment, the risks of 70% or more restenosis (adjusted HR 0Â·43, 0Â·19â0Â·97; p=0Â·04) and 50% or more restenosis (0Â·37, 0Â·21â0Â·62; p=0Â·0003) were significantly lower in those patients treated with a stent than in those treated by angioplasty alone (table 4, figure 2).", risks of 70% restenosis , angioplasty alone , endovascular arm ,0,
edin,3539,3434899,Cannot tell based on the abstract,, effectiveness according to chi-square test , prednisolon 0.3 mg/kg for 6 weeks ,  NBUVB -  9 J/cm2 for 6 weeks ,0,
edin,3539,3434899,Significantly increased,"According to chi-square test, NBUVB was significantly more effective than systemic steroid in treatment of generalized lichen planus (p = 0.008) (Table 2).", effectiveness according to chi-square test , prednisolon 0.3 mg/kg for 6 weeks ,  NBUVB -  9 J/cm2 for 6 weeks ,0,
edin,3574,4263705,No significant difference,"No statistically significant intervention effects were observed at the center level; the intervention increased the facility-level workplace social capital, and its horizontal and vertical dimensions by 1.0 (pâ=â0.24), 0.4 (pâ=â0.46) and 0.8 (pâ=â0.16), respectively."," scores of WSC total scale, horizontal and vertical dimensions ", control group - remaining participants , control group - those who lost to follow-up ,0,
edin,3552,4298817,Significantly increased,"Changes observed in the NIH-CPSI of group ML at six weeks were greater than those at baseline (group L, -3.2 vs. group ML, -7.2; p<0.05).,Significant improvements were seen in the NIH-CPSI voiding (group L, -0.5 vs. group ML, -1.7; p<0.05) and quality of life domains (group L, -1.0 vs. group ML, -1.8; p<0.05).", National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI) ," levofloxacin (500 mg/d) (group L, 40 patients) for 6 weeks ", levofloxacin (500 mg/d) and mirodenafil (50 mg/d) (group ML) for six weeks ,0,
edin,3516,4263705,Invalid Prompt,, a , c , b ,1, There is no information.
edin,3525,2464595,No significant difference,Major and minor complications were similar in the two groups., overall complications , received only inguino-femoral lymph node dissection , received intraoperative application of a fibrin sealant following inguino-femoral lymph node dissection ,0,
edin,3594,4757976,Cannot tell based on the abstract,, PBMC ,  linseed oil (LO) , echium oil (EO)  ,0,
edin,3594,4757976,Significantly increased,"DHA did not accumulate with EO or LO and instead decreased in plasma, RBC, and PBMC; however, the decrease in plasma was lower with EO vs. LO (Pâ=â0.008),Overall, final EPA and DPA in plasma, RBC and PBMC were in similar order: FOâ>âEOâ>âLOâ>âOO (Pââ¤â0.001; not for DPA in RBC; TableÂ 4).", PBMC ,  linseed oil (LO) , echium oil (EO)  ,0,
edin,3496,3410988,Cannot tell based on the abstract,," Baseline characteristics regarding the patient's age, gender, or educational level of the parents ", Placebo , Memantine ,0,
edin,3496,3410988,No significant difference,"There were no differences expected between the placebo and memantine groups on age or gender, given the matched-pair design. In each group, 62% of the participants were female. The mean age of the participants in the placebo group (22 years and 7 months, range 18â31) did not differ from the mean age of the participants in the memantine group (23 years and 3 months; range 18â30; t(36)=â0.552, P=0.59). Parent's years of education was used to index the socioeconomic status. There were no significant differences between the placebo and memantine groups on the years of education of the mothers or fathers (mother: t(36)=1.43, P=0.16; father: t(36)=â0.43, P=0.67)."," Baseline characteristics regarding the patient's age, gender, or educational level of the parents ", Placebo , Memantine ,0,
edin,3476,4569275,Cannot tell based on the abstract,, Reported use of condom or increase in number of sexual partners , Placebo group , Vaccine group ,0,
edin,3476,4569275,No significant difference,"Most participants reported no change in frequency of sex (75.4%), number of sexual partners (79.7%) or condom use (78.8%) between the year before and year after their last Phambili visit (table 5)", Reported use of condom or increase in number of sexual partners , Placebo group , Vaccine group ,0,
edin,3543,3963555,Cannot tell based on the abstract,," wheezing and coughing frequency, triggers and severity ", control , fraction of exhaled nitric oxide (FeNO group) ,0,
edin,3543,3963555,No significant difference,"There was also no difference in wheezing and coughing frequency, triggers and severity between groups as evaluated by the specific domains of the standardised questionnaire."," wheezing and coughing frequency, triggers and severity ", control , fraction of exhaled nitric oxide (FeNO group) ,0,
edin,3507,3441250,Significantly increased,"At 2 hours the proportion of patients experiencing nausea (38.2â% vs 17.9%, Pâ=â0.03) and the mean nausea score were increased in the colloid compared to crystalloid group respectively (1.49âÂ±â0.3 vs 0.68âÂ±â0.2, Pâ=â0.028).", Nausea at 2 hours , Intravenous crystalloid , Intravenous colloid ,0,
edin,3562,4284021,Significantly increased,"<td align=""left"" colspan=""1"" rowspan=""1"">LDL-C</td><td colspan=""1"" rowspan=""1""></td><td colspan=""1"" rowspan=""1""></td><td colspan=""1"" rowspan=""1""></td>",  high-density lipoprotein-cholesterol (HDL-C) , placebo , evacetrapib (10â600âmg) ,0,
edin,3490,3936610,Cannot tell based on the abstract,, Change of MAP , Group C (control) , Group D (dexmedetomidine) ,0,
edin,3490,3936610,No significant difference,"There was no significant change of MAP in either group among patients, who did not require administration of ephedrine (Fig. 1).", Change of MAP , Group C (control) , Group D (dexmedetomidine) ,0,
edin,3508,3441250,No significant difference,The incidence of vomiting and anti-emetic usage was low and did not differ between the groups., Incidence of vomiting , Intravenous crystalloid , Intravenous colloid ,0,
edin,3584,4731690,No significant difference,"There was no significant difference in HAS shrinkage with alteplase in proximal (vs distal) or more (vs less) extensive HAS (p = 0.516 and p = 0.580, respectively).", HAS shrinkage and alteplase effect , distal extensive HAS , proximal extensive HAS ,0,
edin,3510,3441250,No significant difference,The incidence of vomiting and anti-emetic usage was low and did not differ between the groups., Use of anti-emetic drugs , Intravenous crystalloid , Intravenous colloid ,0,
edin,3514,3661239,Significantly increased,"Improvement in post-test performance of group A was significantly greater than of group B, demonstrating the effectiveness of POPS.", Post-test scores , group B , group A ,0,
edin,3467,3914427,Cannot tell based on the abstract,, Satisfaction with sexual relationship , Placebo , Physta plus Polygonum minus ,0,
edin,3467,3914427,Significantly decreased,Sexual relationship satisfaction was significantly lower in the active group compared to the placebo group at baseline and at 12 weeks (P < 0.0001)., Satisfaction with sexual relationship , Placebo , Physta plus Polygonum minus ,0,
edin,3548,4255428,Significantly increased,"The program identified alcohol use in pregnancy among 21% of users, a higher rate than the 13% (pâ<â.01) found via screening by clinic staff.", alcohol use in pregnancy , screening with the help of clinical staff , screening method with Screening and Brief Intervention (SBI) program ,0,
edin,3602,4489004,Cannot tell based on the abstract,, cost , abatacept , TNFi ,0,
edin,3602,4489004,No significant difference,"The uncorrected difference in cost was significant between the abatacept and rituximab groups (mean differenceâ=ââ¬5,586, 95% CIâ=ââ¬3,681 to â¬7,491, P <0.001) and between the TNFi and rituximab groups (mean differenceâ=ââ¬3,758, 95% CIâ=ââ¬1,661 to â¬5,856, Pâ=â0.001), but not between the TNFi and abatacept groups (mean differenceâ=ââ¬1,828, 95% CIâ=âââ¬294 to â¬3,950, Pâ=â0.090).Figure 4", cost , abatacept , TNFi ,0,
edin,3509,3441250,No significant difference,"Sore throat, dizziness, headache and general well being were not different between the groups."," Sore throat, dizziness, cephalea, and general well being ", Intravenous crystalloid , Intravenous colloid ,0,
edin,3480,4223943,Cannot tell based on the abstract,, Delivery by C-section , No intervention (control group) , Training-based strategies (experimental group) ,0,
edin,3480,4223943,No significant difference,"Based on the results, only 23.4% of women said they would choose cesarean delivery next time, as there was no significant difference between intervention and control groups [Table 7].", Delivery by C-section , No intervention (control group) , Training-based strategies (experimental group) ,0,
edin,3597,2998470,Significantly increased,"There were significant differences in BII at the End-of-Study Visit between subjects reporting improvement versus subjects reporting no improvement (Studies 1 and 2, P < .0001)",  Benign Prostatic Hyperplasia Impact Index (BII) , subjects reporting no improvement , subjects reporting improvement ,0,
edin,3538,3434899,Cannot tell based on the abstract,, duration of the disease , prednisolon 0.3 mg/kg for 6 weeks ,  NBUVB -  9 J/cm2 for 6 weeks ,0,
edin,3538,3434899,No significant difference,"In addition, before initiation of the treatment, ANOVA did not show significant differences regarding duration of the disease between the two groups (p = 0.910).", duration of the disease , prednisolon 0.3 mg/kg for 6 weeks ,  NBUVB -  9 J/cm2 for 6 weeks ,0,
edin,3497,3410988,Cannot tell based on the abstract,, Overall adverse events , Placebo , Memantine ,0,
edin,3497,3410988,No significant difference,There were no laboratory adverse events and no serious adverse events., Overall adverse events , Placebo , Memantine ,0,
edin,3556,2755038,Cannot tell based on the abstract,, history of peripheral vascular disease , angioplasty alone , endovascular arm ,0,
edin,3556,2755038,Significantly decreased,"In the endovascular arm, patients who were treated with stenting were less likely to have a history of peripheral vascular disease than were patients treated with angioplasty alone (4 of 50 [8%] vs 38 of 145 [26%]; p=0Â·005).", history of peripheral vascular disease , angioplasty alone , endovascular arm ,0,
edin,3473,4569275,Cannot tell based on the abstract,, Estimated infection hazard ratios for women , Placebo group , Vaccine group ,0,
edin,3473,4569275,No significant difference,"<td align=""left"" colspan=""1"" rowspan=""1"">Women</td><td align=""center"" colspan=""1"" rowspan=""1"">1.42 (0.85, 2.35)</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">0.18</td><td align=""center"" colspan=""1"" rowspan=""1"">1.12 (0.73, 1.72)</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">0.62</td>", Estimated infection hazard ratios for women , Placebo group , Vaccine group ,0,
edin,3484,5498715,Significantly decreased,"Four months after the intervention, an increase in the mean scores of total PA (p<0.001, ES=4.77), physical fitness tests including flexibility (p<0.001, ES=1.59), muscular endurance (p<0.001, ES=2.0), cardiorespiratory endurance (p<0.001, ES=0.51), and a decrease in mean scores of agility test (p<0.001, ES= â 0.51) and sedentary behavior (p<0.01, ES=â 0.74) was observed in the intervention group compared to the control group", Sedentary behavior and agility test , Standard education session , Motivational interviewing through self-determination theory sessions ,0,
edin,3563,4284021,Significantly decreased,"<td align=""left"" colspan=""1"" rowspan=""1"">LDL-C</td><td colspan=""1"" rowspan=""1""></td><td colspan=""1"" rowspan=""1""></td><td colspan=""1"" rowspan=""1""></td>",  low-density lipoprotein cholesterol (LDL-C) , placebo , evacetrapib (10â600âmg) ,0,
edin,3477,5593355,Significantly increased,"Patients randomised to adaptive servo ventilation who crossed over to the control group were at higher risk of cardiovascular death than controls, while control patients with crossover to adaptive servo ventilation showed a trend towards lower risk of cardiovascular death than patients randomised to adaptive servo ventilation.", Risk of cardiovascular death , Control group , ASV group ,0,
edin,3586,3712961,No significant difference,"The average proportions with HIV RNA <50 copies/mL during the intervention phase were 0.51 in DAART and 0.40 in SAT (difference 0.11, 95% CI: â0.020 to 0.24).", HIV RNA &amp;lt;50 copies/mL , self-administered therapy (SAT) , directly administered antiretroviral therapy (DAART) ,0,
edin,3471,3914427,Significantly increased,"Significant improvements were noted in scores for the Sexual Intercourse Attempt diary, Erection Hardness Scale, Sexual Health Inventory of Men, and Aging Male Symptom scale (P < 0.05 for all)", Improvement in Aging Male Symptom scale , Placebo , Physta plus Polygonum minus ,0,
edin,3504,5684963,Cannot tell based on the abstract,, Mean amplitude of glycemic excursion , Low glycemic index intervention , High glycemic index intervention ,0,
edin,3504,5684963,Significantly increased,"However, the HGI treatment produced a significantly greater MAGE than the LGI treatment over the 48Â h period (pÂ =Â 0.03).,MAGE: Mean Amplitude of Glycemic Excursion.", Mean amplitude of glycemic excursion , Low glycemic index intervention , High glycemic index intervention ,0,
edin,3601,4489004,Significantly increased,"However, our analysis revealed that rituximab therapy is significantly more cost-effective than both abatacept and TNFi over a willingness-to-pay range of 0 to 80,000 euros.", cost , rituximab , TNFi ,0,
edin,3577,3782468,Cannot tell based on the abstract,,  blurred vision severity ," bright white light (10,000 lux), dim red light (&amp;amp;amp;lt; 500 lux) pre-treatment  ","  bright white light (10,000 lux), dim red light (&amp;amp;amp;lt; 500 lux) post-treatment ",0,
edin,3577,3782468,Significantly increased,"Across both groups, the average post-treatment eye strain severity (M = .4, SD = 1.0) was greater than pre-treatment severity (M = .1, SD = .5); likewise, average post-treatment blurred vision severity (M = .2, SD = .5) was greater than the pre-treatment mean (M = .1, SD = .4).",  blurred vision severity ," bright white light (10,000 lux), dim red light (&amp;amp;amp;lt; 500 lux) pre-treatment  ","  bright white light (10,000 lux), dim red light (&amp;amp;amp;lt; 500 lux) post-treatment ",0,
edin,3462,3441250,Cannot tell based on the abstract,, Frequency of nausea , colloid , crystalloid ,0,
edin,3462,3441250,Significantly decreased,"At 2 hours the proportion of the patients experiencing nausea (38.2 vs 17.9%, Pâ=â0.03) (Figure 2, Panel A) and the mean nausea score (1.49âÂ±â0.3 vs 0.68âÂ±â0.2, Pâ=â0.028) (Figure 2, Panel B) and were increased in the colloid group compared to crystalloid respectively.", Frequency of nausea , colloid , crystalloid ,0,
edin,3505,2710065,No significant difference,No statistically significant difference was observed between these groups based on the microbiological and clinical parameters., Microbiological and clinical parameters , No prophylaxis , Single-dose intravenous antibiotic prophylaxis ,0,
edin,3571,5176312,Significantly increased,Participants in the WSTP group improved their total and Advanced-level WST scores by 7.1% and 30.1% relative to baseline (p < 0.001) and retained their scores at one year follow-up.," the Advanced-level subtotal Wheelchair Skills Test (WST) - baseline,  post-training ", Educational Control (EC) , Wheelchair Skills Training Program (WSTP) ,0,
edin,3593,4757976,No significant difference,"Following EO, final DHA was not greater compared to LO.", DHA ,  linseed oil (LO) , echium oil (EO)  ,0,
edin,3499,3410988,Cannot tell based on the abstract,, DAS-II Recall of Digits score , Placebo , Memantine ,0,
edin,3499,3410988,No significant difference,"As can be seen in Figure 2b, various outcome measures had Cohen's d values approaching a moderate effect size (>0.30), and the CVLT-II Free Recall Total Score as well as the DAS-II Recall of Digits score had Cohen's d values of >0.5.,Finally, a contrast effect bordering statistical significance was found for the DAS-II Recall of Digits score (F(1,â34)=2.83, P=0.051).", DAS-II Recall of Digits score , Placebo , Memantine ,0,
edin,3472,4569275,Cannot tell based on the abstract,, Estimated infection hazard ratios for men , Placebo group , Vaccine group ,0,
edin,3472,4569275,Significantly increased,"<td align=""left"" colspan=""1"" rowspan=""1"">Men</td><td align=""center"" colspan=""1"" rowspan=""1"">2.46 (1.22, 4.93)</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">0.01</td><td align=""center"" colspan=""1"" rowspan=""1"">2.75 (1.49, 5.06)</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">0.001</td>,The effect on HIV-1 acquisition by vaccination status was more pronounced in men [HR = 2.75, 95% CI: (1.49, 5.06)], and less for women [HR = 1.12, 95% CI: (0.73, 1.72)], Fig 2", Estimated infection hazard ratios for men , Placebo group , Vaccine group ,0,
edin,3526,2464595,No significant difference,"Thirty patients were then randomized; the median time to drain removal in the control group (n = 14) was 30 days (range, 13â74) compared to 29 days (range, 11â45) in the fibrin sealant group (n = 16; P = 0.6).", the time to drain removal , received only inguino-femoral lymph node dissection , received intraoperative application of a fibrin sealant following inguino-femoral lymph node dissection ,0,
edin,3498,3410988,Cannot tell based on the abstract,, CVLT-II Free Recall Total Score , Placebo , Memantine ,0,
edin,3498,3410988,Significantly increased,"Additionally, significant contrast effect was found for one secondary measure of memory functioning, the CVLT-II Free Recall Total score (F(1,â32)=3.02, *P=0.046),Pre/post difference scores on the CVLT-II Free Recall Total Score were 5.84 (90% CI=3.47â8.21) for the memantine group and 2.53 (90% CI=0.33â4.72) for the placebo group, showing that the memantine group scored disproportionately better than the placebo group at 16 weeks.", CVLT-II Free Recall Total Score , Placebo , Memantine ,0,
edin,3529,4425923,Significantly decreased,"Among oncologists and pulmonologists, 78% (95% CI: 72-85) would offer the treatment to the non-smoker and 66% (95% CI: 58-74) to the smoker (Chi-2â=â5.4, dfâ=â1, pâ=â0.019).", receiving the treatment for cancer among oncologists and pulmonologists  , non-smoking , smoking ,0,
edin,3530,5976501,Significantly increased,"Next, we found that the intake of 5-ALA was significantly associated with improved coping ability (p = 0.004) and improved self-perception of effort spent (p = 0.002).", self-perception of effort spent  , baseline , 5-aminolevulinic acid (5-ALA) ,0,
edin,3779,2655271,Cannot tell based on the abstract,, Expression of EGFR and Raf in CL187 cells , 60Co Î³ ray , 125I seeds ,0,
edin,3779,2655271,Significantly increased,"<td align=""left""><sup>125</sup>I irradiation + Anti-EGFR mAb</td><td align=""left"">2.27 Â± 0.13<sup>c</sup></td><td align=""left"">13.74 Â± 1.82<sup>f</sup></td>,Under low dose rate irradiation, expression of EGFR (74.27 Â± 5.63%) and Raf (53.84 Â± 2.31%) was significantly higher than in the control group (Fig. 5 and Table 3).", Expression of EGFR and Raf in CL187 cells , 60Co Î³ ray , 125I seeds ,0,
edin,3759,3395326,No significant difference,"Gender, BMI, ASA score, total and hidden blood losses, calculated blood loss, preop PLT, PT, PTT, and INR were similar between groups.", average total blood loss , control , epoetin-Î± ,0,
edin,3645,4467206,Cannot tell based on the abstract,," SF-36 mental component summary (MCS),  sense of coherence (SOC) ", salutogenic dialogue (IT) , therapeutic acupuncture (TA) ,0,
edin,3645,4467206,No significant difference,Pairwise comparisons between treatment groups showed that CT had significantly worse MCS and SOC values than did IT and TA (all pâ=â.001). No differences were found between IT and TA on any variable.," SF-36 mental component summary (MCS),  sense of coherence (SOC) ", salutogenic dialogue (IT) , therapeutic acupuncture (TA) ,0,
edin,3765,5117579,Significantly decreased,The incidence of hypotension was significantly lower in Group A (16.1%) than in Group B (48.4%) during infusion of dexmedetomidine (pâ=â0.01)., The incidence of hypotension , Group B received same dose of dexmedetomidine by intravenous administration before 5&amp;nbsp;min of intrathecal bupivacaine injection ," Group A, 1&amp;nbsp;Î¼g/kg of dexmedetomidine was intravenously 10&amp;nbsp;min, followed by the maintenance infusion of dexmedetomidine 0.2&amp;nbsp;Î¼g/kg/hr after 5&amp;nbsp;min of intrathecal bupivacaine injection ",0,
edin,3612,4128673,Cannot tell based on the abstract,, biopsy-proven acute rejection (BPAR) , lower dose 2.25 mg/kg (lowATG) , standard dose ATG (total dose 3.75 mg/kg)(sATG) ,0,
edin,3612,4128673,No significant difference,The two arms showed no significant difference at the primary endpoint of biopsy-proven acute rejection (BPAR)., biopsy-proven acute rejection (BPAR) , lower dose 2.25 mg/kg (lowATG) , standard dose ATG (total dose 3.75 mg/kg)(sATG) ,0,
edin,3661,2956327,Significantly increased,"While there was no significant difference between website use categories in the amount of Phase I change in body weight (P = .45) or income (P = .78), minimal website users (n = 75) were significantly more likely to have attended fewer Phase I sessions (P = .001) and had a higher initial body mass index (BMI) (P < .001).", initial body mass index (BMI) ," weight loss program  in the consistent , and some user group ", weight loss program - minimal user group ,0,
edin,3676,4251531,No significant difference,The sum CTC-NCI toxicity score increased nonsignificantly in the BP-C1 group but significantly in the placebo group (P=0.05). The difference in increase between groups did not meet the level of significance (P=0.12)., The sum CTC-NCI toxicity score , placebo ,  intramuscular injections of 0.035 mg/kg of body weight BP-C1 ,0,
edin,3630,2194675,Significantly increased,"Consumption of PS-FO resulted in higher Î²-carotene (P = 0.0139) and retinol (P = 0.0425) levels than PS-SO and PS-OO, respectively.", plasma Î²-carotene concentrations , PS-sunflower oil (SO)  , plant sterol (PS)  from fish oil (FO) ,0,
edin,3683,3780629,Significantly decreased,"Significant reductions were also observed following the combined intervention on secondary measures associated with depression: disability, anxiety, and repetitive negative thinking (Cohenâs d = 1.51â2.23). T"," disability, anxiety, and repetitive negative thinking ", baseline , CBM-I (cognitive-bias modification (CBM) + Internet-based cognitive behavioral therapy (iCBT) ,0,
edin,3746,3546023,Cannot tell based on the abstract,, The percentage of NK cells , 200âmg/day palmvitee nonsmokers , 200âmg/day palmvitee smokers  ,0,
edin,3746,3546023,Significantly decreased,"The percentage of NK cells were lower in smokers compared to nonsmokers (pâ<â0.0001) at baseline (S1: pâ<â0.05, S2: pâ<â0.005, S3: pâ<â0.01) and after palmvitee supplementation (Tableâ 8 and Tableâ 9).", The percentage of NK cells , 200âmg/day palmvitee nonsmokers , 200âmg/day palmvitee smokers  ,0,
edin,3754,3529678,Cannot tell based on the abstract,, General Health , baseline , telephone-delivered multiple health behaviour change intervention ,0,
edin,3754,3529678,Significantly increased,"From baseline to 6 weeks there was an improvement in physical (3.3) and mental HRQoL scores (4.4). We also observed improvements in physical functioning (2.2), bodily pain (5.8), general health (3.7), vitality (4.8); and role-physical (3.1), social functioning (4.3), role-emotional (3.7) and mental health (4.8; Table 4).", General Health , baseline , telephone-delivered multiple health behaviour change intervention ,0,
edin,3621,2211287,Significantly increased,Changes in MR (kcal/min and kcal/min/kg ffm) from baseline were significantly higher in normal weight subjects (n = 11) across all times following consumption of the HPHF meal versus the HPLF meal., Changes in metabolic rate (MR) (kcal/min and kcal/min/kg ffm) ," normal weight group -  high protein, low fat meal "," normal weight group -  high protein, high fat meal ",0,
edin,3615,4128673,Cannot tell based on the abstract,,  the serum creatinine at 12 months post-transplant , lower dose 2.25 mg/kg (lowATG) , standard dose ATG (total dose 3.75 mg/kg)(sATG) ,0,
edin,3615,4128673,No significant difference,"At 12 months post-transplant, the serum creatinine in the lowATG was 1.4Â±0.44 mg/dl compared with 1.33Â±0.0.36 in the sATG group (pâ=â0.56).",  the serum creatinine at 12 months post-transplant , lower dose 2.25 mg/kg (lowATG) , standard dose ATG (total dose 3.75 mg/kg)(sATG) ,0,
edin,3642,3664086,No significant difference,No significant difference was identified in quality of life score and side effects (Pâ>â0.05)., quality of life score and side effects ," neoadjuvant DE combined with rh-endostatin (7.5&amp;amp;amp;amp;nbsp;mg/m2, d1-d14, every 3&amp;amp;amp;amp;nbsp;weeks) "," neoadjuvant DE (docetaxel: 75&amp;amp;amp;amp;nbsp;mg/m2, d1, epirubicin: 75&amp;amp;amp;amp;nbsp;mg/m2, d1, every 3&amp;amp;amp;amp;nbsp;weeks) ",0,
edin,3633,2194675,No significant difference,"In contrast, plasminogen activator inhibitor 1 (PAI-1) concentrations were lower (P = 0.0282) in the PS-FO-fed than the PS-SO, but not the PS-OO (P = 0.7487) groups.", plasminogen activator inhibitor 1 (PAI-1) concentrations , PS-olive oil (OO) , plant sterol (PS)  from fish oil (FO) ,0,
edin,3751,3529678,Significantly decreased,"From baseline to six weeks, improvements were observed for minutes moderate-vigorous physical activity (150.7 minutes), processed meat intake (â1.2 serves/week), vegetable intake (1 serve/day), alcohol intake (â0.4 standard drinks/day), body mass index (â1.4 kg/m2), and waist circumference (â5.1 cm).,Further, compared with baseline, participants were more likely to meet Australian recommendations post-intervention for: moderate-vigorous physical activity (27.3 vs 59.1%); fruit intake (68.2 vs 81.8%); vegetable intake (4.6 vs 18.2%); alcohol consumption (59.1 vs 72.7%); body mass index (31.8 vs 45.5%) and waist circumference (18.2 vs 27.3%)."," Waist circumference, cm ", baseline , telephone-delivered multiple health behaviour change intervention ,0,
edin,3715,3781545,Significantly decreased,"Liraglutide-treated subjects also had a significant improvement in SSPG concentration (â3.2 vs. 0.2 mmol/L; P < 0.001) and significantly (P â¤ 0.04) greater lowering of systolic blood pressure (â8.1 vs. â2.6 mmHg), fasting glucose (â0.5 vs. 0 mmol/L), and triglyceride (â0.4 vs. â0.1 mmol/L) concentration."," systolic blood pressure, fasting glucose , and triglyceride ", placebo , liraglutide 1.8 mg ,0,
edin,3662,2956327,Cannot tell based on the abstract,, initial weight loss regained ," weight loss program  in the some, and minimal user group ", weight loss program -in the consistent user group ,0,
edin,3662,2956327,Significantly decreased,"Mean weight change in Phase II, both absolute weight and proportion of initial weight loss regained, was significantly lower (less weight regained) in the consistent website-use category (P = .003 [Figure 2] and P = .001 [Figure 3])", initial weight loss regained ," weight loss program  in the some, and minimal user group ", weight loss program -in the consistent user group ,0,
edin,3755,3529678,Cannot tell based on the abstract,, Vitality , baseline , telephone-delivered multiple health behaviour change intervention ,0,
edin,3755,3529678,Significantly increased,"We also observed improvements in physical functioning (2.2), bodily pain (5.8), general health (3.7), vitality (4.8); and role-physical (3.1), social functioning (4.3), role-emotional (3.7) and mental health (4.8; Table 4).", Vitality , baseline , telephone-delivered multiple health behaviour change intervention ,0,
edin,3770,5732563,Cannot tell based on the abstract,, analgesic spread (spinal level/minute) ," catheter, given in 5 mL increments spaced 2 minutes apart ", 10 mL loading dose (0.125% bupivacaine with fentanyl 2 Âµg/mL) through either the epidural needle ,0,
edin,3770,5732563,No significant difference,"The estimated difference in analgesic spread (spinal level/minute), as defined by loss of sharpness of pinprick, was 0.63 (95% CI: â0.12 to 0.19) and did not significantly differ between groups (p=0.166; Figure 2 and Table 2).", analgesic spread (spinal level/minute) ," catheter, given in 5 mL increments spaced 2 minutes apart ", 10 mL loading dose (0.125% bupivacaine with fentanyl 2 Âµg/mL) through either the epidural needle ,0,
edin,3741,3546023,Significantly increased,Urine cotinine levels and serum Î±1-antitrypsin were significantly higher in smokers compared to nonsmokers., Urine cotinine levels  , 200âmg/day palmvitee  nonsmokers , 200âmg/day palmvitee smokers  ,0,
edin,3748,3529678,Significantly decreased,"From baseline to six weeks, improvements were observed for minutes moderate-vigorous physical activity (150.7 minutes), processed meat intake (â1.2 serves/week), vegetable intake (1 serve/day), alcohol intake (â0.4 standard drinks/day), body mass index (â1.4 kg/m2), and waist circumference (â5.1 cm)."," Processed meat, serves/week ", baseline , telephone-delivered multiple health behaviour change intervention ,0,
edin,3619,2211287,No significant difference,"However, when metabolic rate was expressed per kg fat free mass (ffm), no significant difference was found in postprandial energy expenditure between the overweight and normal groups.",  change in energy expenditure ," normal weight group following consumption of the high protein, low fat meal "," normal weight group following consumption of the high protein, high fat meal ",0,
edin,3625,3290117,No significant difference,"There were no initial differences between groups in regards to tumor size, C-peptide, BMI, and Kiâ67.,C-peptide (ng/mL) was equivalent between the two groups (4.55 NC + BC versus 4.74 NC, P = 0.85).", C-peptide (ng/mL) , Neoadjuvant chemotherapy (NC) alone , NC with supervised bootcamp (NC + BC) ,0,
edin,3611,4831612,Significantly decreased,"Between each two groups, there were differences in preparation time (P < 0.05), with Reciproc being the fastest.", preparation time ," K-file, Mtwo ", Reciproc ,0,
edin,3632,2194675,Significantly decreased,"In contrast, plasminogen activator inhibitor 1 (PAI-1) concentrations were lower (P = 0.0282) in the PS-FO-fed than the PS-SO, but not the PS-OO (P = 0.7487) groups.", plasminogen activator inhibitor 1 (PAI-1) concentrations , PS-sunflower oil (SO)  , plant sterol (PS)  from fish oil (FO) ,0,
edin,3771,5732563,No significant difference,The time to VRS â¤3 and level of sensory block 20 minutes after dosing were also similar between groups., The time to VRS â¤3 and level of sensory block 20 minutes after dosing ," catheter, given in 5 mL increments spaced 2 minutes apart ", 10 mL loading dose (0.125% bupivacaine with fentanyl 2 Âµg/mL) through either the epidural needle ,0,
edin,3713,3781545,Cannot tell based on the abstract,, gastrointestinal side effect , placebo , liraglutide 1.8 mg ,0,
edin,3713,3781545,Significantly increased,The majority of individuals (79%) treated with liraglutide experienced at least one gastrointestinal side effect compared with 46% treated with placebo (P = 0.02)., gastrointestinal side effect , placebo , liraglutide 1.8 mg ,0,
edin,3722,4776542,Cannot tell based on the abstract,, postoperative nausea and vomiting (PONV) , saline 0.90% in group S ," midazolam 0.75 mg/kg in group M, ondansetron 4 mg in group O ",0,
edin,3722,4776542,Significantly decreased,"Subsequently, the difference was not significant between group M and group O. However, PONV in both of them were significantly less as compared to group S [Table 3].", postoperative nausea and vomiting (PONV) , saline 0.90% in group S ," midazolam 0.75 mg/kg in group M, ondansetron 4 mg in group O ",0,
edin,3723,4776542,Cannot tell based on the abstract,, The overall patient satisfaction ," midazolam 0.75 mg/kg in group M, ondansetron 4 mg in group O, and saline 0.90% in group S ", midazolam 0.75 mg/kg and ondansetron 4 mg in group MO ,0,
edin,3723,4776542,Significantly increased,"The overall patient satisfaction was significantly higher in the group MO compared the other groups [P < 0.001, Table 2].", The overall patient satisfaction ," midazolam 0.75 mg/kg in group M, ondansetron 4 mg in group O, and saline 0.90% in group S ", midazolam 0.75 mg/kg and ondansetron 4 mg in group MO ,0,
edin,3614,4128673,Cannot tell based on the abstract,, Delayed graft function , lower dose 2.25 mg/kg (lowATG) , standard dose ATG (total dose 3.75 mg/kg)(sATG) ,0,
edin,3614,4128673,No significant difference,Delayed graft function occurred in 40% of patients in the lowATG group compared with 14.3% in the sATG group (pâ=â0.05)., Delayed graft function , lower dose 2.25 mg/kg (lowATG) , standard dose ATG (total dose 3.75 mg/kg)(sATG) ,0,
edin,3635,4558976,Cannot tell based on the abstract,, AAA extinction learning , placebo , tiapride ,0,
edin,3635,4558976,No significant difference,"When considering only extinction learning in a novel context (ABA condition), the TIA group was significantly impaired compared to PLAC [t(38) = 1.989 p = 0.027; TIA 24.00% Â± 3.81; PLAC 15.00% Â± 2.43], while there was no significant difference in AAA extinction learning between groups [t(38) = 0.673 p = 0.252; TIA 18.25% Â± 2.93; PLAC 16.00% Â± 1.59âall t-tests one-tailed].", AAA extinction learning , placebo , tiapride ,0,
edin,3669,4185107,No significant difference,"There were no statistically significant differences in the overall rate of early postoperative complications between the study and control group: 25.6 and 34.1Â % respectively; pÂ =Â 0.245,", overall rate of early postoperative complications , control , gentamicin collagen implant (GCI) ,0,
edin,3733,3382694,Cannot tell based on the abstract,, skin-to-stone distance (SSD) ,  failure group ," Extracorporeal Shock Wave Lithotripsy (ESWL) group B, stone size10 mm -  success  group ",0,
edin,3733,3382694,Significantly increased,"The mean SSD in the success and failure groups, respectively, was 102.4Â±12.88 mm vs. 110.8Â±5.66 mm in group A (p=0.043) and 97.8Â±12.97 mm vs. 107.9Â±13.02 mm in group B (p=0.013) (Table 3)", skin-to-stone distance (SSD) ,  failure group ," Extracorporeal Shock Wave Lithotripsy (ESWL) group B, stone size10 mm -  success  group ",0,
edin,3668,5753687,Cannot tell based on the abstract,, CD endoscopic index of severity (CDEIS) after Colonoscopy  , control ," umbilical cord mesenchymal stem cells (UC-MSCs) 1Ã106 UC-MSCs/kg, with one infusion per week ",0,
edin,3668,5753687,Significantly increased,"Colonoscopy showed that the CDEIS in the UC-MSC group was 9.2Â±1.5 and 3.4Â±1.2 before treatment and at the 12-month follow-up, respectively (Fig. 3).", CD endoscopic index of severity (CDEIS) after Colonoscopy  , control ," umbilical cord mesenchymal stem cells (UC-MSCs) 1Ã106 UC-MSCs/kg, with one infusion per week ",0,
edin,3608,4831612,Significantly increased,"Considering cleanliness, at coronal third Reciproc was better than K-file (P < 0.001), but not more effective than Mtwo (P = 0.080).", cleaning efficacy in the coronal third ,  K-file , Reciproc ,0,
edin,3620,2211287,No significant difference,Changes in MR (kcal/min and kcal/min/kg ffm) from the baseline rate did not significantly differ in the underweight (n = 3) or in the overweight subjects (n = 5) following consumption of either meal at any time., Changes in metabolic rate (MR) (kcal/min and kcal/min/kg ffm) , overweight , underweight ,0,
edin,3675,4251531,No significant difference,"The sum CTC-NCI toxicity score increased nonsignificantly in the BP-C1 group but significantly in the placebo group (P=0.05). The difference in increase between groups did not meet the level of significance (P=0.12). The sum toxicity score was reduced in the patients receiving 64 days of BP-C1 from 9.2 at screening to 8.9 at Day 48, but it increased again to 10.1 by Day 64 and 10.6 during the 28-day follow-up.", The sum CTC-NCI toxicity score , baseline , placebo ,0,
edin,3624,3290117,No significant difference,Mean Ki-67 for NC + BC was 7% versus 29% with NC (P = 0.14)., Mean Ki-67 , Neoadjuvant chemotherapy (NC) alone , NC with supervised bootcamp (NC + BC) ,0,
edin,3766,5117579,No significant difference,The incidence of bradycardia and desaturation did not significantly differ between the two groups., The incidence of bradycardia and desaturation , Group B received same dose of dexmedetomidine by intravenous administration before 5min of intrathecal bupivacaine injection ," Group A, 1Î¼g/kg of dexmedetomidine was intravenously 10min, followed by the maintenance infusion of dexmedetomidine 0.2Î¼g/kg/hr after 5min of intrathecal bupivacaine injection ",0,
edin,3658,3532974,Cannot tell based on the abstract,, changes in medication usage  , baseline , âFlorenceâ- interactive mobile phone texting service ,0,
edin,3658,3532974,Significantly increased,"Significantly more changes, 0.31 vs 0.08 (p<0.05; CI for difference 0.16 to 0.32) were made to the medications of intervention patients, compared with control patients over the 3-month programme, respectively.", changes in medication usage  , baseline , âFlorenceâ- interactive mobile phone texting service ,0,
edin,3724,4776542,Cannot tell based on the abstract,,  visual analog scale (VAS) of nausea ," midazolam 0.75 mg/kg in group M, ondansetron 4 mg in group O, and saline 0.90% in group S ", midazolam 0.75 mg/kg and ondansetron 4 mg in group MO ,0,
edin,3724,4776542,Significantly decreased,VAS of nausea in group MO was significantly less than other groups (P < 0.001).,  visual analog scale (VAS) of nausea ," midazolam 0.75 mg/kg in group M, ondansetron 4 mg in group O, and saline 0.90% in group S ", midazolam 0.75 mg/kg and ondansetron 4 mg in group MO ,0,
edin,3610,4831612,No significant difference,"Regarding shaping ability, no differences were found between Reciproc and Mtwo (P = 1.00).", shaping ability , K-file  ," Reciproc, Mtwo ",0,
edin,3777,2655271,Cannot tell based on the abstract,, Apoptosis rates of CL187 cancer cells , 60Co Î³ ray , 125I seeds ,0,
edin,3777,2655271,Significantly increased,"he apoptotic rates were detected by flow cytometry. In 2 Gy (D), 5 Gy (E), and 10 Gy (F) groups, the CL187 cells had higher apoptosis rates when compared with control groups (C).", Apoptosis rates of CL187 cancer cells , 60Co Î³ ray , 125I seeds ,0,
edin,3761,3395326,Cannot tell based on the abstract,, mean hemoglobin level at admission at the discharge , control , epoetin-Î± ,0,
edin,3761,3395326,Significantly increased,"At admission, the mean hemoglobin level was higher in the epoetin-Î± group (13.8âg/dL versus 12.2âg/dL) (P = 0.001); the discharge hemoglobin level was higher in the epoetin-Î± group (10.6âg/dL versus 9.69âg/dL) (P < 0.001).", mean hemoglobin level at admission at the discharge , control , epoetin-Î± ,0,
edin,3616,4128673,No significant difference,"No statistically significant differences were found in graft survival, patient survival or infections between the two groups, though there was a non-significant increase in leukopenia (43%v s. 30%), CMV (8% vs. 0) and BK (4% vs. 0) infections in sATG group vs. lowATG.", leukopenia , lower dose 2.25 mg/kg (lowATG) , standard dose ATG (total dose 3.75 mg/kg)(sATG) ,0,
edin,3760,3395326,Cannot tell based on the abstract,, mean hemoglobin level at admission , control , epoetin-Î± ,0,
edin,3760,3395326,Significantly increased,"At admission, the mean hemoglobin level was higher in the epoetin-Î± group (13.8âg/dL versus 12.2âg/dL) (P = 0.001);", mean hemoglobin level at admission , control , epoetin-Î± ,0,
edin,3742,3546023,Significantly increased,Urine cotinine levels and serum Î±1-antitrypsin were significantly higher in smokers compared to nonsmokers.,  serum Î±1-antitrypsin , 200âmg/day palmvitee  nonsmokers , 200âmg/day palmvitee smokers  ,0,
edin,3684,3780629,Cannot tell based on the abstract,," The Beck Depression Inventoryâ2nd edition (BDI-II), nine-item Depression Scale of the Patient Health Questionnaire (PHQ-9), and The 10-item Kessler Psychological Distress Scale (K10) ", baseline , CBM-I  ,0,
edin,3684,3780629,Significantly decreased,"Following CBM-I, the reductions in BDI-II, PHQ-9, and K10 scores in the intervention group were all significant and corresponded to medium-large effects."," The Beck Depression Inventoryâ2nd edition (BDI-II), nine-item Depression Scale of the Patient Health Questionnaire (PHQ-9), and The 10-item Kessler Psychological Distress Scale (K10) ", baseline , CBM-I  ,0,
edin,3739,4115605,Cannot tell based on the abstract,, adverse events , placebo , droxidopa dose optimization (100â600 mg 3 times daily) ,0,
edin,3739,4115605,No significant difference,"During double-blind treatment, 15 droxidopa (18.5% of 81) and 12 placebo (14.8% of 81) recipients reported AEs (see table e-3), most frequently headache (in 7.4% of droxidopa and no placebo recipients), dizziness (in 3.7% vs 1.2%), fatigue (2.5% vs 2.5%), syncope (2.5% vs 1.2%), and falls (0.0% vs 3.7%)", adverse events , placebo , droxidopa dose optimization (100â600 mg 3 times daily) ,0,
edin,3686,4871571,Cannot tell based on the abstract,, The concentration of CN54rgp140 antibodies , baseline , two CN54rgp140/GLA-AF immunizations ,0,
edin,3686,4871571,Significantly increased,The concentration of CN54rgp140 antibodies increased significantly from a median of 0.861 (range 0.197â4.449 Î¼g/ml) after the HIV-DNA and HIV-MVA vaccinations to a median of 9.866 (range 0.134â129.6 Î¼g/ml) after the first dose of CN54rgp140/GLA-AF (p<0.001) and then increased further to a median of 17.75 Î¼g/ml (range 0.277 to 219.8 Î¼g/ml) after the second Env protein immunization (p<0.001)., The concentration of CN54rgp140 antibodies , baseline , two CN54rgp140/GLA-AF immunizations ,0,
edin,3734,3382694,Cannot tell based on the abstract,, skin-to-stone distance (SSD) ,  failure group ," Extracorporeal Shock Wave Lithotripsy (ESWL) in group A, stone size â¤10 mm - success group ",0,
edin,3734,3382694,Significantly increased,"The mean SSD in the success and failure groups, respectively, was 102.4Â±12.88 mm vs. 110.8Â±5.66 mm in group A (p=0.043) and 97.8Â±12.97 mm vs. 107.9Â±13.02 mm in group B (p=0.013) (Table 3). All the secondary signs showed statistically significant differences in terms of outcome of ESWL (Table 3).", skin-to-stone distance (SSD) ,  failure group ," Extracorporeal Shock Wave Lithotripsy (ESWL) in group A, stone size â¤10 mm - success group ",0,
edin,3721,4776542,No significant difference,"The incidence of PONV was significantly smaller in group MO than group M and group O, while there was no significant difference between group M and group O during the first 24 h postoperatively.", postoperative nausea and vomiting (PONV) , midazolam 0.75 mg/kg in group M , ondansetron 4 mg in group O ,0,
edin,3763,3395326,Cannot tell based on the abstract,, patients required blood transfusion , control , epoetin-Î± ,0,
edin,3763,3395326,Significantly decreased,"In the epoetin-Î± group, 0% of the patients (0 of 28) required blood transfusion. This was significantly lower than the control group where 53% of the patients (28 of 53) received at least one unit of blood transfusion (P = 0.0001).", patients required blood transfusion , control , epoetin-Î± ,0,
edin,3690,3511949,Significantly decreased,"After the intra-articular injection, there was statistically significant decrease in visual analog scale (VAS) scores in Groups M and T, when compared to Group C. The decrease of VAS scores seen at the first 2 weeks continued steadily up to the end of 12th week.",  visual analog scale (VAS) scores at the end of 12th week , Group C received saline plus bupivacaine intra-articularly ," Group M - morphine plus bupivacaine intra-articularly, Group T - triamcinolone plus bupivacaine intra-articularly  ",0,
edin,3679,4251531,Significantly decreased,âBreast cancer-related pain and discomfortâ and âBreast cancer treatment problem last weekâ were significantly reduced (P=0.02) in the BP-C1 group but increased slightly in the placebo group; between-group differences were significant in favor of BP-C1 (P=0.05)., Ã¢â¬ÅBreast cancer-related pain and discomfortÃ¢â¬ï¿½ and Ã¢â¬ÅBreast cancer treatment problem last weekÃ¢â¬ï¿½ , placebo ,  intramuscular injections of 0.035 mg/kg of body weight BP-C1 ,0,
edin,3613,4128673,Cannot tell based on the abstract,, Patient survival at 1 year , lower dose 2.25 mg/kg (lowATG) , standard dose ATG (total dose 3.75 mg/kg)(sATG) ,0,
edin,3613,4128673,No significant difference,Patient survival at 1 year in the lowATG group was 85% compared with 100% in the sATG (pâ=â0.11), Patient survival at 1 year , lower dose 2.25 mg/kg (lowATG) , standard dose ATG (total dose 3.75 mg/kg)(sATG) ,0,
edin,3704,5972262,Cannot tell based on the abstract,," bispectral index (BIS)  at sputum suction (T5), extubation (T6) and 1 min (T7), 5 min (T8), ", 100 ml 0.9% saline (group C) , creatine phosphate sodium (1.0 g/100 ml 0.9% saline; group P) ,0,
edin,3704,5972262,Significantly increased,"Compared with group C, the BIS values at T5, T6, T7, and T8 in group P were significantly higher (Pâ<â0.001 for all comparisons; one-way ANOVA)."," bispectral index (BIS)  at sputum suction (T5), extubation (T6) and 1 min (T7), 5 min (T8), ", 100 ml 0.9% saline (group C) , creatine phosphate sodium (1.0 g/100 ml 0.9% saline; group P) ,0,
edin,3767,5117579,Cannot tell based on the abstract,, The mean HR and  mean blood pressure (MBP) , Group B received same dose of dexmedetomidine by intravenous administration before 5min of intrathecal bupivacaine injection ," Group A, 1Î¼g/kg of dexmedetomidine was intravenously 10min, followed by the maintenance infusion of dexmedetomidine 0.2Î¼g/kg/hr after 5min of intrathecal bupivacaine injection ",0,
edin,3767,5117579,No significant difference,"he MBP and HR in the PACU were did not statistically differ between the two groups.,The mean HR (Group A vs. Group B, 57.88âÂ±â6.16 vs. 59.49âÂ±â8.13, pâ=â0.133) and MBP (Group A vs. Group B, 80.07âÂ±â12.48 vs. 77.49âÂ±â9.36, pâ=â0.121) were not significantly different.", The mean HR and  mean blood pressure (MBP) , Group B received same dose of dexmedetomidine by intravenous administration before 5min of intrathecal bupivacaine injection ," Group A, 1Î¼g/kg of dexmedetomidine was intravenously 10min, followed by the maintenance infusion of dexmedetomidine 0.2Î¼g/kg/hr after 5min of intrathecal bupivacaine injection ",0,
edin,3719,4776542,Cannot tell based on the abstract,,  postanesthesia care unit (PACU) time ," midazolam 0.75 mg/kg in group M, ondansetron 4 mg in group O, midazolam 0.75 mg/kg and ondansetron 4 mg in group MO ",  saline 0.90% in group S ,0,
edin,3719,4776542,No significant difference,PACU time was not significantly different between the four groups [Table 2].,  postanesthesia care unit (PACU) time ," midazolam 0.75 mg/kg in group M, ondansetron 4 mg in group O, midazolam 0.75 mg/kg and ondansetron 4 mg in group MO ",  saline 0.90% in group S ,0,
edin,3699,4839526,Significantly increased,"Duloxetine was not significantly different from placebo on the DSST or UPSA, but was superior to placebo on the PDQ, CGI-I, and MADRS.", The patient-reported perceived deficits questionnaire (PDQ) , placebo , duloxetine 60âmg ,0,
edin,3736,4115605,Significantly increased,"Improvement in symptom-impact subscore favored droxidopa by 1.06 units (p = 0.003), with maximum change for âstanding a long time.â", Improvement in symptom-impact subscore , placebo , droxidopa dose optimization (100â600 mg 3 times daily) ,0,
edin,3689,3511949,Cannot tell based on the abstract,,  visual analog scale (VAS) scores at every visit over 12 weeks , Group T - triamcinolone plus bupivacaine intra-articularly  ," Group M - morphine plus bupivacaine intra-articularly,  ",0,
edin,3689,3511949,No significant difference,"The morphine and steroid groups had significantly decreased VAS scores at every visit over 12 weeks. The morphine and steroid groups were compared with each other, and their scores were similar (P > 0.05). Variance analysis of repeated measurements revealed decreased VAS scores of both morphine and steroid groups than the control group and this decrease continued until the end of 12th week [P < 0.001,,Figure 1
VAS scores versus time in the groups. *Significance of Group M versus Group T, P > 0.05. â ",  visual analog scale (VAS) scores at every visit over 12 weeks , Group T - triamcinolone plus bupivacaine intra-articularly  ," Group M - morphine plus bupivacaine intra-articularly,  ",0,
edin,3756,3529678,Cannot tell based on the abstract,, Physical HRQoL , baseline , telephone-delivered multiple health behaviour change intervention ,0,
edin,3756,3529678,Significantly increased,"<td align=""left"" valign=""bottom"">Physical HRQoL<hr></td><td align=""char"" char=""("" valign=""bottom"">48.6 (1.6)<hr></td><td align=""char"" char=""("" valign=""bottom"">51.9 (6.6)<hr></td><td align=""char"" char=""("" valign=""bottom"">3.3 (03 6.3)<hr></td><td align=""char"" char=""."" valign=""bottom"">0.03<hr></td>,From baseline to 6 weeks there was an improvement in physical (3.3) and mental HRQoL scores (4.4).", Physical HRQoL , baseline , telephone-delivered multiple health behaviour change intervention ,0,
edin,3674,4251531,No significant difference,The sum CTC-NCI toxicity score increased nonsignificantly in the BP-C1 group but significantly in the placebo group (P=0.05)., The sum CTC-NCI toxicity score , baseline ,  intramuscular injections of 0.035 mg/kg of body weight BP-C1 ,0,
edin,3627,2194675,No significant difference,"There were no differences between PS-containing diet effects on total cholesterol, LDL-cholesterol, or high-density lipoprotein (HDL)-cholesterol levels."," total cholesterol, LDL-cholesterol, or high-density lipoprotein (HDL)-cholesterol levels ", PS-sunflower oil (SO) and PS-olive oil (OO) , plant sterol (PS)  from fish oil (FO) ,0,
edin,3769,5732563,No significant difference,"he estimated difference in the rate of pain relief (VRS/minute) was 0.04 (95% CI: â0.01 to 0.11; p=0.109),", rate of pain relief (VRS/minute) ," catheter, given in 5 mL increments spaced 2 minutes apart ", 10 mL loading dose (0.125% bupivacaine with fentanyl 2 Âµg/mL) through either the epidural needle ,0,
edin,3623,3290117,No significant difference,Final tumor size was 2.59 cm in the NC + BC group versus 3.16 cm for NC (P = 0.76), Final tumor size , Neoadjuvant chemotherapy (NC) alone , NC with supervised bootcamp (NC + BC) ,0,
edin,3647,3716527,Cannot tell based on the abstract,," helping to diagnosed and communication, specific medical and mental health problems ", attention-comparison group (where only daily activities were monitored) ," intervention group (where mood, stress and daily activities were monitored with program mobiletype) ",0,
edin,3647,3716527,Significantly increased,"Finally, GPs indicated that the mobiletype program helped in their diagnosis (pâ=â.002, dâ=â0.69) and communication (pâ=â.031, dâ=â0.47), as well as their patientâs specific medical (pâ=â.023, dâ=â0.52) and mental health problems (pâ=â.011, dâ=â0.56), significantly more than when using the attention comparison."," helping to diagnosed and communication, specific medical and mental health problems ", attention-comparison group (where only daily activities were monitored) ," intervention group (where mood, stress and daily activities were monitored with program mobiletype) ",0,
edin,3709,3781545,Significantly decreased,Liraglutide-treated subjects also had a significant improvement in SSPG concentration (â3.2 vs. 0.2 mmol/L; P < 0.001), steady-state plasma glucose (SSPG) concentration , placebo , liraglutide 1.8 mg ,0,
edin,3609,4831612,No significant difference,"Regarding shaping ability, no differences were found between Reciproc and Mtwo (P = 1.00).", shaping ability , Mtwo , Reciproc ,0,
edin,3737,4115605,Significantly increased,"Mean standing systolic blood pressure (BP) increased by 11.2 vs 3.9 mm Hg (p < 0.001), and mean supine systolic BP by 7.6 vs 0.8 mm Hg (p < 0.001)."," Mean standing systolic blood pressure (BP), mean supine systolic BP ", placebo , droxidopa dose optimization (100â600 mg 3 times daily) ,0,
edin,3671,4185107,No significant difference,The total rate of SSI and organ space SSI were 22.2 and 15.8Â % without differences between the study and control group., The total rate of SSI and organ space surgical site infections (SSI) , control , gentamicin collagen implant (GCI) ,0,
edin,3643,4467206,Significantly increased,"<td valign=""middle"">SOC</td><td valign=""middle""></td><td valign=""middle""></td><td valign=""middle""></td><td valign=""middle""></td><td valign=""middle""></td><td valign=""middle""></td><td valign=""middle""></td><td valign=""middle""></td><td valign=""middle""></td><td valign=""middle""></td><td valign=""middle""></td><td valign=""middle""></td><td valign=""middle""></td>"," SF-36 mental component summary (MCS),  sense of coherence (SOC) ",  conventional treatment (CT) ," therapeutic acupuncture (TA) , salutogenic dialogue (IT) ",0,
edin,3743,3546023,Significantly increased,Natural killer cells were decreased; CD4+ cells and B cells were increased in smokers compared to nonsmokers but were unaffected with vitamin E supplementation except in the percentage of B cells which were increased in nonsmokers supplemented palmvitee compared to placebo., The percentage of B cells , baseline , 200âmg/day palmvitee nonsmokers  ,0,
edin,3753,3529678,Cannot tell based on the abstract,, Bodily Pain , baseline , telephone-delivered multiple health behaviour change intervention ,0,
edin,3753,3529678,Significantly decreased,"We also observed improvements in physical functioning (2.2), bodily pain (5.8), general health (3.7), vitality (4.8); and role-physical (3.1), social functioning (4.3), role-emotional (3.7) and mental health (4.8; Table 4).,<td align=""left"" valign=""bottom"">Bodily Pain<hr></td><td align=""char"" char=""("" valign=""bottom"">45.0 (11.4)<hr></td><td align=""char"" char=""("" valign=""bottom"">50.7 (9.7)<hr></td><td align=""char"" char=""("" valign=""bottom"">5.8 (1.4 10.1)<hr></td><td align=""char"" char=""."" valign=""bottom"">0.01<hr></td>", Bodily Pain , baseline , telephone-delivered multiple health behaviour change intervention ,0,
edin,3660,2956327,Significantly increased,"While there was no significant difference between website use categories in the amount of Phase I change in body weight (P = .45) or income (P = .78), minimal website users (n = 75) were significantly more likely to have attended fewer Phase I sessions (P = .001)", attending Phase I sessions ," weight loss program  in the consistent , and some user group ", weight loss program - minimal user group ,0,
edin,3717,4772687,Cannot tell based on the abstract,, mean modified psoriasis area and severity index (mPASI) score , Cal/BD ointment at week 1 and week 4 , Cal/BD aerosol foam at week 1 and week 4 ,0,
edin,3717,4772687,Significantly decreased,"mPASI further demonstrated statistically significant improvement in disease status for patients using Cal/BD aerosol foam versus those using ointment.,There was a significant difference in adjusted mean mPASI score between Cal/BD aerosol foam and Cal/BD ointment at week 1 (mean difference â0.7; 95% CI â1.1, â0.3; pâ=â0.001) and week 4 (mean difference â0.6; 95% CI â1.1, â0.2; pâ=â0.005; Figure 4).", mean modified psoriasis area and severity index (mPASI) score , Cal/BD ointment at week 1 and week 4 , Cal/BD aerosol foam at week 1 and week 4 ,0,
edin,3772,5732563,Cannot tell based on the abstract,, maternal mean arterial blood pressure or maternal heart rate ," catheter, given in 5 mL increments spaced 2 minutes apart ", 10 mL loading dose (0.125% bupivacaine with fentanyl 2 Âµg/mL) through either the epidural needle ,0,
edin,3772,5732563,No significant difference,"No significant difference was observed in the estimated slope differences of maternal mean arterial blood pressure (0.25, p=0.188; Figure 3) or maternal heart rate (0.03, p=0.807; Figure 4).", maternal mean arterial blood pressure or maternal heart rate ," catheter, given in 5 mL increments spaced 2 minutes apart ", 10 mL loading dose (0.125% bupivacaine with fentanyl 2 Âµg/mL) through either the epidural needle ,0,
edin,3648,3716527,Cannot tell based on the abstract,, post-test in the GP Confidence scale , attention-comparison group (where only daily activities were monitored) ," intervention group (where mood, stress and daily activities were monitored with program mobiletype) ",0,
edin,3648,3716527,No significant difference,"The difference between groups at post-test in the GP Confidence scale (Cronbachâs alpha [Î±]â=â0.93) were tested by regression analysis, adjusting for pre-test GP Confidence scale score. After adjusting for baseline values, the difference between intervention and comparison groupâs doctors confidence was not significant (Î²â=â1.05, pâ=â.131).", post-test in the GP Confidence scale , attention-comparison group (where only daily activities were monitored) ," intervention group (where mood, stress and daily activities were monitored with program mobiletype) ",0,
edin,3698,4839526,Significantly increased,"Vortioxetine was statistically superior to placebo on the DSST (P<0.05), PDQ (P<0.01), CGI-I (P<0.001), MADRS (P<0.05), and UPSA (P<0.001).",  CGI-I score , placebo , vortioxetine (10â20âmg) ,0,
edin,3708,3781545,Significantly decreased,Liraglutide-treated subjects also had a significant improvement in SSPG concentration (â3.2 vs. 0.2 mmol/L; P < 0.001), steady-state plasma glucose (SSPG) concentration , baseline , liraglutide 1.8 mg ,0,
edin,3678,4251531,Cannot tell based on the abstract,, Ã¢â¬ÅBreast cancer-related pain and discomfortÃ¢â¬ï¿½ and Ã¢â¬ÅBreast cancer treatment problem last weekÃ¢â¬ï¿½ , baseline , placebo ,0,
edin,3678,4251531,No significant difference,"âBreast cancer-related pain and discomfort last weekâ was significantly reduced (P=0.02) in the BP-C1 group and slightly increased in the placebo group during the initial 32 days of treatment (Table 4).,Comparison of the groups detected a significant difference in change of âBreast cancer-related painâ in favor of BP-C1 (P=0.05). A similar pattern was detected for âBreast cancer treatment problems last week.â This variable was significantly reduced in the BP-C1 group (P=0.02) and slightly increased in the placebo group.", Ã¢â¬ÅBreast cancer-related pain and discomfortÃ¢â¬ï¿½ and Ã¢â¬ÅBreast cancer treatment problem last weekÃ¢â¬ï¿½ , baseline , placebo ,0,
edin,3641,3664086,No significant difference,Five patients in the rh-endostatin plus chemotherapy arm achieved pathologic complete response compared with 2 in the chemotherapy arm (Pâ=â0.428)., achieving pathologic complete response ," neoadjuvant DE combined with rh-endostatin (7.5&amp;amp;amp;nbsp;mg/m2, d1-d14, every 3&amp;amp;amp;nbsp;weeks) "," neoadjuvant DE (docetaxel: 75&amp;amp;amp;nbsp;mg/m2, d1, epirubicin: 75&amp;amp;amp;nbsp;mg/m2, d1, every 3&amp;amp;amp;nbsp;weeks) ",0,
edin,3701,4839526,Cannot tell based on the abstract,, Trail Making Test B Total Time , placebo , duloxetine 60âmg ,0,
edin,3701,4839526,No significant difference,"Trail Making Test B Total Time (Î â9.67, 95% CI: â15.38, â3.96; P<0.001; ANCOVA, OC) was significantly improved with vortioxetine compared with placebo. None of the other secondary end points of cognitive function improved significantly with vortioxetine. No significant benefit was found with duloxetine compared with placebo on any of the secondary measures of cognitive function.", Trail Making Test B Total Time , placebo , duloxetine 60âmg ,0,
edin,3744,3546023,Cannot tell based on the abstract,Natural killer cells were decreased; CD4+ cells and B cells were increased in smokers compared to nonsmokers but were unaffected with vitamin E supplementation except in the percentage of B cells which were increased in nonsmokers supplemented palmvitee compared to placebo, The percentage of B cells , baseline , 200âmg/day palmvitee smokers  ,0,
edin,3744,3546023,No significant difference,"The percentage of B cells in smokers was higher compared to nonsmokers (pâ<â0.0001) and also in S1 (pâ<â0.005), S2 (pâ<â0.0005) and S3 groups (pâ<â0.005) (Tableâ 2). After palmvitee supplementation, B cells percentage was significantly increased in nonsmokers at 24âweeks (pâ<â0.05) but not in the smokers (Tableâ 6).", The percentage of B cells , baseline , 200âmg/day palmvitee smokers  ,0,
edin,3670,4185107,No significant difference,The reoperation rate was similar in both groups: 12.8 versus 9.4Â %; pÂ =Â 0.628; RR 1.359; (95Â % CI 0.575â3.212)., The reoperation rate , control , gentamicin collagen implant (GCI) ,0,
edin,3749,3529678,Cannot tell based on the abstract,," Vegetables, serves/day ", baseline , telephone-delivered multiple health behaviour change intervention ,0,
edin,3749,3529678,Significantly increased,"Further, from baseline to 6 weeks, participants were more likely to meet the Australian recommendations for moderate-vigorous physical activity (27.3 to 59.1%), red meat (86.4 to 90.9%), fruit (68.2 to 81.8%),vegetables (4.6 to 18.2%), alcohol (59.1 to 72.7%), BMI (31.8 to 45.5%) and waist circumference (18.2 to 27.3%; Table 3).,<td align=""left"" valign=""bottom"">âVegetables, serves/day<hr></td><td align=""char"" char=""("" valign=""bottom"">2.5 (1.3)<hr></td><td align=""char"" char=""("" valign=""bottom"">3.5 (1.1)<hr></td><td align=""char"" char=""("" valign=""bottom"">1.0 (0.4 1.6)<hr></td><td align=""char"" char=""."" valign=""bottom"">&lt;0.01<hr></td>"," Vegetables, serves/day ", baseline , telephone-delivered multiple health behaviour change intervention ,0,
edin,3688,4871571,No significant difference,The vaccine was safe and well tolerated except for one episode of asymptomatic hypoglycaemia that was classified as severe adverse event., adverse events , baseline , two CN54rgp140/GLA-AF immunizations ,0,
edin,3738,4115605,Cannot tell based on the abstract,, systolic BP while supine , placebo , droxidopa dose optimization (100â600 mg 3 times daily) ,0,
edin,3738,4115605,Significantly increased,"From randomization to end of study, systolic BP while supine increased by 7.6 (19.2) mm Hg in droxidopa recipients vs 0.8 (14.5) in placebo recipients, a difference of 6.8 mm Hg (95% CI 1.53â12.07; p < 0.001), to mean (SD) values of 133.7 (23.3) and 125.9 (22.2) mm Hg, respectively.", systolic BP while supine , placebo , droxidopa dose optimization (100â600 mg 3 times daily) ,0,
edin,3720,4776542,Significantly decreased,"The incidence of PONV was significantly smaller in group MO than group M and group O,", postoperative nausea and vomiting (PONV) ," midazolam 0.75 mg/kg in group M, ondansetron 4 mg in group O,  and saline 0.90% in group S ", midazolam 0.75 mg/kg and ondansetron 4 mg in group MO ,0,
edin,3960,4440033,Cannot tell based on the abstract,, Serum 25-OHD after 12 weeks , Calcium  , Vitamin D + Calcium ,0,
edin,3960,4440033,No significant difference,"<td align=""center"" colspan=""1"" rowspan=""1"">Vitamin D + C</td><td align=""center"" colspan=""1"" rowspan=""1"">15.80 (9.37)</td><td align=""center"" colspan=""1"" rowspan=""1"">22.90 (13.85)</td><td align=""center"" colspan=""1"" rowspan=""1"">25.10 (35.57)</td><td align=""center"" colspan=""1"" rowspan=""1"">0.001</td>", Serum 25-OHD after 12 weeks , Calcium  , Vitamin D + Calcium ,0,
edin,3856,4141382,Cannot tell based on the abstract,, Dipyrone needed , Caudal Sufentanil  , Caudal Sufentanil + neostigmine  ,0,
edin,3856,4141382,No significant difference,"The number of postoperative doses of dipyrone in 24 h, administered at the discretion of a trained nurse, was similar among the patients in Group IVSu, Group CSu, and Group CSuAdr (P > 0.05) [Table 3].", Dipyrone needed , Caudal Sufentanil  , Caudal Sufentanil + neostigmine  ,0,
edin,3979,4260664,Cannot tell based on the abstract,, Baseline characteristics , Treatment-as-usual , Internet-based cognitive behavior therapy ,0,
edin,3979,4260664,No significant difference,A comparison of baseline scores revealed no significant difference between treatment groups and the randomization as expected produced a similar distribution across conditions (see Table 1)., Baseline characteristics , Treatment-as-usual , Internet-based cognitive behavior therapy ,0,
edin,3981,3376478,Cannot tell based on the abstract,, Association of parental beliefs with change in parental monitoring , Control group , Parental monitoring ,0,
edin,3981,3376478,No significant difference,"Although there were several differences in demographic predictors of intercepts, compared to the intervention group model, the model for parent-reported open communication within the control group indicated nearly identical patterns of associations between parenting beliefs and open communication intercepts and slopes", Association of parental beliefs with change in parental monitoring , Control group , Parental monitoring ,0,
edin,3865,4280721,Cannot tell based on the abstract,, severity of pain in primary dysmenorrhea , mefenamic acid , extracts of vitagnus or fennelin ,0,
edin,3865,4280721,No significant difference,"In this study, pain intensity was evaluated within a cycle (zero cycle) before treatment with oral drops, mefenamic acid, and placebo drops, and the mean pain intensity of the four groups was not significantly different at the end of the cycle;", severity of pain in primary dysmenorrhea , mefenamic acid , extracts of vitagnus or fennelin ,0,
edin,4000,5504600,No significant difference,Mean maximum pain intensity during exercise in the first 24Â h after surgery was 3.8âÂ±â1.9 (tapentadol) and 3.8âÂ±â2.1 (oxycodone/naloxone). Statistically tapentadol was non-inferior but not superior to oxycodone/naloxone, Pain intensity during exercise in the first 24h of post operatory , extended-release oxycodone/naloxone , perioperative oral extended-release tapentadol ,0,
edin,3802,3890270,Cannot tell based on the abstract,, Reported calorie intake , Baseline (No exercise) , Aerobic interval training  ,0,
edin,3802,3890270,No significant difference,"Although there was no significant change in body mass and only a small non-significant fall in self-reported calorie intake, waist circumference fell by 3â4 cm and total body fat fell by an amount equivalent to a 1.0 kg loss in fat mass.", Reported calorie intake , Baseline (No exercise) , Aerobic interval training  ,0,
edin,3884,5564101,No significant difference,"However, the extent of pulpal anesthesia, surgical duration, and duration of soft tissue anesthesia were not significantly different.", the duration of anesthesia ," 2% lidocaine along with 1:100,000 epinephrine "," 4% lidocaine along with 1:100,000 epinephrine ",0,
edin,3973,5307611,Cannot tell based on the abstract,, Mean scores of the constructs of the Protection Motivation Theory at baseline , Control group , Theory-based educational intervention ,0,
edin,3973,5307611,Significantly increased,"Before the intervention, no significant difference in mean (SD) scores of the constructs of the Protection Motivation Theory was found between the two groups (p>0.05). However, there was a significant difference between mean (SD) scores of all the variables in the two groups after the intervention (p<0.05) (Table 2).,<td colspan=""1"" rowspan=""1"">
</td><td colspan=""1"" rowspan=""1"">
P-value
</td><td colspan=""1"" rowspan=""1"">0.754 </td><td colspan=""1"" rowspan=""1"">&lt;0.001 </td>", Mean scores of the constructs of the Protection Motivation Theory at baseline , Control group , Theory-based educational intervention ,0,
edin,3872,4683729,Cannot tell based on the abstract,, effectiveness of preventive interventions on Latinos with mental disorders , no prevention , universal prevention ,0,
edin,3872,4683729,Invalid Prompt,, effectiveness of preventive interventions on Latinos with mental disorders , no prevention , universal prevention ,1," This article doesn't include the results section, and there is not enough information in the abstract. "
edin,3815,5153686,Cannot tell based on the abstract,, Opioid usage , Ropivacaine (0.5%) 20ml , Ropivacaine (0.33%) 30ml ,0,
edin,3815,5153686,Significantly decreased,"Total postoperative opioid use in group A was slightly higher. Group B used 26Â mg less morphine than group A (â26.1, â75.9 to 23.8), while group C used 23Â mg less than group A (â22.7, â74.72 to 29.34).", Opioid usage , Ropivacaine (0.5%) 20ml , Ropivacaine (0.33%) 30ml ,0,
edin,3878,4357072,Significantly decreased,"Subjects in both the groups showed significant improvement in symptom scores; however, the overall treatment response was higher in the pimecrolimus group compared with the triamcinolone acetonide group.", improvement in symptom scores , triamcinolone acetonide oral paste 0.1% , topical pimecrolimus cream 1% ,0,
edin,3936,4960789,Cannot tell based on the abstract,, Peripheral intravenous catheter failure rates per 1000 hours , Flush frequency every 6 hours , Flush frequency every 24 hours ,0,
edin,3936,4960789,No significant difference,"The overall PIVC failure rate was 46Â % or 6.13/1000 device hours, with occlusion and phlebitis the most common reasons for PIVC failure.,The incidence rate of PIVC failure in patients assigned to 24Â hour flushing was 5.1 per 1000Â hours compared with 7.3 per 1000Â hours in those assigned to 6Â hour flushing (pâ=â0.054, log-rank, TableÂ 2 and Fig.Â 2).", Peripheral intravenous catheter failure rates per 1000 hours , Flush frequency every 6 hours , Flush frequency every 24 hours ,0,
edin,3889,5797014,Significantly increased,"<td align=""left"" colspan=""1"" rowspan=""1"" valign=""middle""><bold>CA72-4</bold></td><td align=""left"" colspan=""1"" rowspan=""1"" valign=""middle""></td><td align=""left"" colspan=""1"" rowspan=""1"" valign=""middle""></td><td align=""left"" colspan=""1"" rowspan=""1"" valign=""middle""></td><td align=""left"" colspan=""1"" rowspan=""1"" valign=""middle""></td><td align=""left"" colspan=""1"" rowspan=""1"" valign=""middle""></td>", cancer specific survival ," CEA, CA19-9 and CA72-4 alone ", three-tumor marker classifier ,0,
edin,3860,3383212,Cannot tell based on the abstract,, Adverse reactions , Generic desogestrel  , Brand-name desogestrel  ,0,
edin,3860,3383212,No significant difference,"No serious adverse events occurred during the trial.,A total of 59 side-effects, in 29 women, were observed (including the analytic alterations) and these occurred. Events were recorded in 28 of the subjects with the test formulation and 31 with the reference formulation.", Adverse reactions , Generic desogestrel  , Brand-name desogestrel  ,0,
edin,3935,4960789,No significant difference,"PIVC failure rates per 1000Â hours were not significantly different for the volume intervention (4.84 [3Â mL] versus 7.44 [10Â mL], pâ=â0.06, log-rank). PIVC failure rates per 1000Â hours were also not significantly different for the frequency intervention (5.06 [24Â hour] versus 7.34 [6Â hour], pâ=â0.05, log-rank).", Peripheral intravenous catheter failure rates per 1000 hours , 0.9&amp;nbsp;% sodium chloride 3&amp;nbsp;mL flush , 0.9&amp;nbsp;% sodium chloride 10&amp;nbsp;mL flush ,0,
edin,3920,4697245,Cannot tell based on the abstract,, Changes in diastolic blood pressure 1 minute after induction of anaesthesia , Placebo , Alfentanil ,0,
edin,3920,4697245,Significantly increased,The mean diastolic blood pressure showed significant statistical differences between the two groups only 1 min after induction of anaesthesia (P = 0.04) and 1 min after endotracheal intubation (P = 0.00) [Figure 2]., Changes in diastolic blood pressure 1 minute after induction of anaesthesia , Placebo , Alfentanil ,0,
edin,3991,5486467,Significantly increased,The change in serum phosphorus level was significantly greater in each PA21 group than in the placebo group (analysis of covariance: PÂ <Â 0.001 for all groups)., Time course of mean serum phosphorus levels , placebo , PA21 ,0,
edin,3921,4697245,Significantly decreased,"Changes in diastolic blood pressure were significantly less in alfentanil group, 1 min after induction of anaesthesia and 1 min after endotracheal intubation.", Changes in diastolic blood pressure 1 minute after endotracheal extubation , Placebo , Alfentanil ,0,
edin,3997,5504600,No significant difference,"Vomiting on day 1 occurred in 11%, constipation in 35% of the tapentadol patients and in 16% and 30% of the oxycodone/naloxone patients (pâ=â0.60 and 0.33), respectively.", Incidence of constipation , extended-release oxycodone/naloxone , perioperative oral extended-release tapentadol ,0,
edin,3842,3160381,Cannot tell based on the abstract,, Vital capacity (after 12 months) , Placebo , Pirfenidone (high-dose)  ,0,
edin,3842,3160381,No significant difference,"In the placebo group, a â¥ 5% decline in VC at month 3 was still present at month 12 at highly rate (positive predictive value; 86.1% (31/36)) and no decline at month 3 was stable at month 12 at a rate of about 50% (negative predictive value; 50.8% (34/67)). On the other hand, in the treated (high- and low-dose pirfenidone) groups, decline at month 3 was still highly present (positive predictive value; 87.1% (27/31), nearly equal to one in the placebo group), and no decline at month 3 was also still stable at month 12 in relatively highly rate (negative predictive value; 71.7% (91/127) (Table 1 ). To put it briefly, the positive predictive values for pirfenidone and placebo groups were 87.1% and 86.1% respectively, and the difference was not significant.", Vital capacity (after 12 months) , Placebo , Pirfenidone (high-dose)  ,0,
edin,3990,5486467,Cannot tell based on the abstract,, Cumulative achievement rates of target serum phosphorus levels , placebo , PA21 ,0,
edin,3990,5486467,Significantly increased,"The cumulative achievement rates for target serum phosphorus level (â¤6Â mg/dL) at each time-point are shown in Fig.Â 4. The cumulative achievement rates were significantly higher in all the PA21 groups than in the placebo group (all PÂ <Â 0.001, Fisherâs exact test).Fig.Â 4", Cumulative achievement rates of target serum phosphorus levels , placebo , PA21 ,0,
edin,3862,3383212,Cannot tell based on the abstract,, T max , Generic desogestrel  , Brand-name desogestrel  ,0,
edin,3862,3383212,Invalid Prompt,, T max , Generic desogestrel  , Brand-name desogestrel  ,1, I wasn't able to find T max anywhere in the article
edin,3995,3972946,Significantly decreased,Total analgesic requirements on postoperative 1st and 24th hours in Group P were lower than in Group C., Total analgesic requirements on postoperative 1st and 24th hours , Conventional Postoperative Epidural Analgesia (Group C) , Preemptive Thoracic Epidural Analgesia (Group P) ,0,
edin,3785,3432828,Cannot tell based on the abstract,, Equol concentrations , Isoflavone diet (GI) , Isoflavone + Fructooligosaccharides diet (GIF) ,0,
edin,3785,3432828,Significantly increased,"Concentrations of equol, a metabolite of daidzein, were significantly higher in rats fed the GIF diet than in those fed GI diet (Fig.Â 2C; p<0.05).", Equol concentrations , Isoflavone diet (GI) , Isoflavone + Fructooligosaccharides diet (GIF) ,0,
edin,3853,4141382,Cannot tell based on the abstract,, Anesthetics during surgery , Caudal Sufentanil + Adrenaline , Caudal Sufentanil + neostigmine ,0,
edin,3853,4141382,Significantly decreased,"The isoflurane consumption (ml/kg/h) was similar among the patients from Group IVSu, Group CSuNeo, and Group CSuNeoAdr (P > 0.05). Their intraoperative anesthetic consumption was lesser when compared to patients who received caudal sufentanil alone or in combination with adrenaline (Group CSu = Group CSuAdr) (P < 0.02) [Table 3].", Anesthetics during surgery , Caudal Sufentanil + Adrenaline , Caudal Sufentanil + neostigmine ,0,
edin,3986,3738485,Significantly increased,"Within each group, HIV viral load significantly reduced at the end of the study (P < 0.001 and P = 0.04 for spirulina and soya beans groups respectively). Between the groups, the viral load was similar at baseline but significantly reduced in the spirulina group at the end of the study (P = 0.02).", Decrease in HIV viral load , Soya Beans , Spirulina Platensis ,0,
edin,3940,5560591,Significantly decreased,"Similarly, total morphine requirement was significantly lower in the EA group with the value of 21.38 (SD = 14.38) mg compared to the control group with the value of 33.94 (SD = 20.24) mg within 24 hours postoperatively.", Total need of morphine  , Control group , 2 Hertz EA stimulation ,0,
edin,3855,4141382,Cannot tell based on the abstract,, Time needed for rescue analgesics  , Caudal Sufentanil  , Caudal Sufentanil + neostigmine + Adrenaline ,0,
edin,3855,4141382,Significantly increased,"he time to first administration of rescue analgesics for patients who received caudal sufentanil plus neostigmine (Group CSuNeo and Group CSuNeoAdr) was similar, but higher when compared to the other groups (10-11 h, P < 0.05) [Table 3].", Time needed for rescue analgesics  , Caudal Sufentanil  , Caudal Sufentanil + neostigmine + Adrenaline ,0,
edin,3919,3914313,No significant difference,No severe adverse effects were reported., Severe adverse effects , Placebo , Shensong Yangxin ,0,
edin,3822,3952602,Cannot tell based on the abstract,, Viral load &amp;lt;200 copies/mL , Abacavir , Nevirapine ,0,
edin,3822,3952602,No significant difference,"The viral load in the majority of participants with suppression was <200 copies/mL in both arms (91% and 95% of those <1000 copies/mL in the ABC and NVP arms, respectively).", Viral load &amp;lt;200 copies/mL , Abacavir , Nevirapine ,0,
edin,3905,3694465,Significantly decreased,"None in the intervention group placed their hands in the abdominal region, compared to 5/18 in the control group (pâ=â0.045).", Placement of hands in the abdominal region , General instructions , Specific instructions ,0,
edin,3945,5593668,Cannot tell based on the abstract,, Peritoneal recurrence related to PECAM1 expression , Surgery alone , Adjuvant S-1 therapy after sugery ,0,
edin,3945,5593668,No significant difference,PECAM1 showed a significant correlation to peritoneal recurrence in both surgery alone (FDR P = 0.005) and S-1 treated patients (FDR P = 0.031)., Peritoneal recurrence related to PECAM1 expression , Surgery alone , Adjuvant S-1 therapy after sugery ,0,
edin,3845,3160381,Cannot tell based on the abstract,, Vital capacity (after 3 months) , Placebo , Pirfenidone (low-dose)  ,0,
edin,3845,3160381,No significant difference,"n the placebo group, a â¥ 5% decline in VC at month 3 was still present at month 12 at highly rate (positive predictive value; 86.1% (31/36)) and no decline at month 3 was stable at month 12 at a rate of about 50% (negative predictive value; 50.8% (34/67)). On the other hand, in the treated (high- and low-dose pirfenidone) groups, decline at month 3 was still highly present (positive predictive value; 87.1% (27/31), nearly equal to one in the placebo group), and no decline at month 3 was also still stable at month 12 in relatively highly rate (negative predictive value; 71.7% (91/127) (Table 1 ). To put it briefly, the positive predictive values for pirfenidone and placebo groups were 87.1% and 86.1% respectively, and the difference was not significant.", Vital capacity (after 3 months) , Placebo , Pirfenidone (low-dose)  ,0,
edin,3927,5220753,No significant difference,"he overall rates of major adverse events such as mortality, Stent thrombosis (ST), Myocardial Infarction (MI), target lesion revascularization (TLR), target vessel revascularization (TVR), CVA, and emergency CABG within 24 h after stent implantation were low and comparable between the two groups; P > 0.05 considered significant for all comparisons.", Target lesion revascularization and target vessel revascularization , Control , Eptifibatide ,0,
edin,3875,4683729,Cannot tell based on the abstract,, effectiveness of preventive interventions on Latinos with mental disorders , enhanced psychoeducation , the newly refined HOLA ,0,
edin,3875,4683729,Invalid Prompt,, effectiveness of preventive interventions on Latinos with mental disorders , enhanced psychoeducation , the newly refined HOLA ,1, There is no results section of the article. 
edin,3914,5103331,Cannot tell based on the abstract,, Improvement in visual analogue scale scores after 8 weeks , Sham catgut implantation group , Active catgut implantation group ,0,
edin,3914,5103331,Significantly increased,"For the analysis based on VAS scores, the difference between the treatment group and the sham-controlled group was not significant until 8Â weeks after the 2-week treatment regimen (tâ=ââ2.424, Pâ=â0.017; TableÂ 4).,<td>Treatment group (<italic>n</italic>â=â64)</td><td>7.036âÂ±â1.839</td><td>5.302âÂ±â1.86</td><td>3.75âÂ±â1.93</td><td>83.933âÂ±â10.076</td><td>78.67âÂ±â8.57</td><td>73.73âÂ±â10.48</td>,<td>Sham-controlled group (<italic>n</italic>â=â64)</td><td>6.648âÂ±â1.379</td><td>5.204âÂ±â1.72</td><td>4.535âÂ±â1.724</td><td>88.801âÂ±â8.872</td><td>84.471âÂ±â6.883</td><td>79.807âÂ±â6.221</td>,<td>Statistical analysis</td><td>Uâ=â1739.500</td><td>
<italic>t</italic> =0.324</td><td>
<italic>t</italic>â=ââ2.424</td><td>tâ=ââ1.405</td><td>
<italic>t</italic>â=ââ2.045</td><td>
<italic>t</italic>â=ââ2.246</td>,<td>
<italic>P</italic> value</td><td>0.136</td><td>0.751</td><td>0.017</td><td>0.171</td><td>0.050</td><td>0.033</td>", Improvement in visual analogue scale scores after 8 weeks , Sham catgut implantation group , Active catgut implantation group ,0,
edin,3980,3376478,No significant difference,Similar effects were found in both the intervention and control group models regarding open communication., Open communication , Control group , Parental monitoring ,0,
edin,3906,4231047,Significantly increased,"Minimal mean hepatic threshold dose 6 weeks after radiotherapy (primary endpoint) was significantly higher in the study treatment-group compared with the control (19.1 Gy versus 14.6 Gy, pâ=â0.011).", Minimal mean hepatic threshold dose 6 weeks after radiotherapy , No medication ," Pentoxifylline, ursodeoxycholic acid, and low-dose low molecular weight heparin. ",0,
edin,3868,3637600,Cannot tell based on the abstract,, Chronic diseases prevention and management , Preliminary clinical evaluation , Practical training ,0,
edin,3868,3637600,Invalid Prompt,, Chronic diseases prevention and management , Preliminary clinical evaluation , Practical training ,1, There is no results section
edin,3911,5103331,Cannot tell based on the abstract,, Improvement of Rhinoconjunctivitis Quality of Life Questionnaire score after 8 weeks , Sham catgut implantation group , Active catgut implantation group ,0,
edin,3911,5103331,Significantly decreased,"However, the RQLQ scores between the two groups after 2Â weeks of treatment completion significantly differed (tâ=ââ2.045, Pâ=â0.05), and this difference could be observed until the end of the 8-week follow-up (tâ=ââ2.246, Pâ=â0.033).Table 4", Improvement of Rhinoconjunctivitis Quality of Life Questionnaire score after 8 weeks , Sham catgut implantation group , Active catgut implantation group ,0,
edin,3903,4709811,Cannot tell based on the abstract,, Vaginal pH , Conjugated estrogen (Premarin) , Hyaluronic acid ,0,
edin,3903,4709811,No significant difference,"Also, studies showed that comparing the results of intra-group (before and after treatment), the amount of PH of both groups reduced, moving towards acidity (P<0.001) and no significant difference was obtained when the results of both groups were compared (P>0.05) (table 4).", Vaginal pH , Conjugated estrogen (Premarin) , Hyaluronic acid ,0,
edin,3892,3984270,Cannot tell based on the abstract,, short-term graft function , control group , Î±-melanocyte stimulating hormone (Î±-MSH) ,0,
edin,3892,3984270,No significant difference,"Thus, in a porcine experimental model Î±-MSH did not reduce renal inflammation and did not improve short-term graft function following DBD kidney transplantation.", short-term graft function , control group , Î±-melanocyte stimulating hormone (Î±-MSH) ,0,
edin,3917,3914313,Significantly increased,"Results showed that the average heart rate, the fastest heart rate, and the lowest heart rate in the trial group were all significantly higher than those in the control group at the end of treatment (P < 0.05 or 0.01, resp.).", Lowest heart rate  , Placebo , Shensong Yangxin ,0,
edin,3812,3864139,Cannot tell based on the abstract,, Epistaxis intensity(outside OR) , Endotracheal tube , Laryngeal mask  ,0,
edin,3812,3864139,Significantly increased,"Thus, outside the OR, the incidence of the first episode of epistaxis in the ETT group was lower than that in the LMA group (RD: â26.5%; 95% CI: â42.2% to â10.7%; P < 0.001; Table 3).", Epistaxis intensity(outside OR) , Endotracheal tube , Laryngeal mask  ,0,
edin,3902,4709811,Significantly increased,"Improvement in urinary incontinence, dryness, maturation index (P<0.05) and composite score of vaginal symptoms (P<0.001) in the hyaluronic acid group was better than those in the Premarin group.", Improvement in the composite score of vaginal symptoms , Conjugated estrogen (Premarin) , Hyaluronic acid ,0,
edin,3887,5564101,Cannot tell based on the abstract,, The number of cases requiring additional anesthetic ," 4% lidocaine along with 1:100,000 epinephrine "," 2% lidocaine along with 1:100,000 epinephrine ",0,
edin,3887,5564101,Significantly increased,The proportion of cases requiring additional anesthetic was significantly greater in the 2% lidocaine group than in the 4% group (26/36 vs. 16/31; P = 0.006)., The number of cases requiring additional anesthetic ," 4% lidocaine along with 1:100,000 epinephrine "," 2% lidocaine along with 1:100,000 epinephrine ",0,
edin,3999,5504600,No significant difference,"Vomiting on day 1 occurred in 11%, constipation in 35% of the tapentadol patients and in 16% and 30% of the oxycodone/naloxone patients (pâ=â0.60 and 0.33), respectively.", Incidence of Vomiting on day 1 , extended-release oxycodone/naloxone , perioperative oral extended-release tapentadol ,0,
edin,3794,5550381,Significantly decreased,"BVL was lower for teriflunomide 14 mg vs placebo at year 1 (36.9% relative reduction, p = 0.0001)", Loss of Brain volume , Placebo , Teriflunomide 14 mg (1 year) + presence of on-study disability worsening ,0,
edin,3925,5220753,No significant difference,"The overall rates of major adverse events such as mortality, Stent thrombosis (ST), Myocardial Infarction (MI), target lesion revascularization (TLR), target vessel revascularization (TVR), CVA, and emergency CABG within 24 h after stent implantation were low and comparable between the two groups; P > 0.05 considered significant for all comparisons.", Mortality rate , Control , Eptifibatide ,0,
edin,3969,4412792,Cannot tell based on the abstract,, Amount of PAX2+/p-ERK+-positive cells , Hydralazine , Enalapril ,0,
edin,3969,4412792,Significantly increased,"The number of double-positive PAX2+/p-ERK+ cells per Bowmanâs capsule cross section increased along Bowmanâs capsule in untreated (0.86Â±0.13 vs. 0, p < 0.001, normal) and in hydralazine-treated mice with FSGS (0.75Â±0.13, p < 0.001 vs. normal) at day 7. Enalapril further increased the number of PAX2+/p-ERK+-positive cells approximately two-fold at day 7 (1.40Â±0.16, p < 0.01 vs. hydralazine-treated FSGS mice) (Figure 8(f)).", Amount of PAX2+/p-ERK+-positive cells , Hydralazine , Enalapril ,0,
edin,3807,3734718,Significantly decreased,"The HAART arm was characterized by significant improvements in CD4 cell count (154.4 cells/Î¼l/year, P<0.001) and reduction in plasma viral load within 3 to 6 months (-0.431+ 0.004 log10 IU/month, P<0.001).", Viral load , No treatment , Highly active antiretroviral treatment ,0,
edin,3786,3432828,Cannot tell based on the abstract,, Calcium absorption , Control diet (GC) , Fructooligosaccharides diet (GF) and Isoflavone + Fructooligosaccharides diet (GIF) ,0,
edin,3786,3432828,Significantly increased,"Absorption (%) of Ca appeared to decrease after GX; however, the absorption in rats fed the FOS diet (GF and GIF) was significantly higher than that in rats fed the control diet (GC) (p<0.05),", Calcium absorption , Control diet (GC) , Fructooligosaccharides diet (GF) and Isoflavone + Fructooligosaccharides diet (GIF) ,0,
edin,3937,4960789,No significant difference,"PIVC average dwell was 3.1Â days. PIVC failure rates per 1000Â hours were not significantly different for the volume intervention (4.84 [3Â mL] versus 7.44 [10Â mL], pâ=â0.06, log-rank). PIVC failure rates per 1000Â hours were also not significantly different for the frequency intervention (5.06 [24Â hour] versus 7.34 [6Â hour], pâ=â0.05, log-rank).", Peripheral intravenous catheter failure rates per 1000 hours , Flush volume , Flush frequency ,0,
edin,3984,3738485,No significant difference,Serum albumin level did not increase significantly within groups (P < 0.90 vs. P < 0.82) with no difference between groups (P = 0.39)., Increase in serum albumin levels , Soya Beans , Spirulina Platensis ,0,
edin,3965,4412792,Significantly decreased,Both glomerulosclerosis and urinary albumin-to-creatinine ratio were less in the ACE-inhibition arm at day 14., Glomerulosclerosis at day 14 , Hydralazine , Enalapril ,0,
edin,3867,3637600,Cannot tell based on the abstract,, Chronic diseases prevention and management , Preliminary clinical evaluation , patient-centered care ,0,
edin,3867,3637600,Invalid Prompt,, Chronic diseases prevention and management , Preliminary clinical evaluation , patient-centered care ,1, There is no results section 
edin,3846,4402460,Cannot tell based on the abstract,, IL-8. , No treatment , Bevacizumab (1 dose) ,0,
edin,3846,4402460,No significant difference,"Among those nine genes (FLT1, IL-8, PDGFA, CTGF, ROBO4, ENPEP, THBS1, ANGPT2 and CYR61), only for PDGFA, a relevant difference was found in bevacizumab-induced changes in expression between patients with and without a pCR (P=0.1).,Six circulating markers (PDGF-AA, PDGF-BB, thrombospondin-1, IL-8, angiopoietin-2 and CYR61), selected based on the microarray results and literature, were quantified by ELISA. None of these markers showed significant changes in circulating levels between T0 and T1.", IL-8. , No treatment , Bevacizumab (1 dose) ,0,
edin,3758,3395326,No significant difference,"Gender, BMI, ASA score, total and hidden blood losses, calculated blood loss, preop PLT, PT, PTT, and INR were similar between groups.", hidden blood loss , control , epoetin-Î± ,0,
edin,3930,4793655,Cannot tell based on the abstract,, Sway in the A/P direction , Repulsive cuing , Attractive cuing ,0,
edin,3930,4793655,Significantly increased,Sway in the A/P direction (A/P RMS) was significantly smaller (~1Â°) for repulsive versus attractive cues (pâ<â0.001);, Sway in the A/P direction , Repulsive cuing , Attractive cuing ,0,
edin,3837,5832511,Cannot tell based on the abstract,, Iron levels (at 2 weeks) , Lipid based nutrients , ARV ,0,
edin,3837,5832511,No significant difference,"For iron, no interactions by treatment (ARV and LNS) or with treatment and TP and/or FTP were significant indicating that the effects of ARV and LNS at 2, 6, and 24Â weeks were not different from each other (Table S2).", Iron levels (at 2 weeks) , Lipid based nutrients , ARV ,0,
edin,3972,2748711,Cannot tell based on the abstract,, Matrix metalloproteinases in cerebrospinal fluid in late treatment , Placebo , Dexamethasone ,0,
edin,3972,2748711,No significant difference,MMP-9 concentrations at later time points were not statistically different between the two groups., Matrix metalloproteinases in cerebrospinal fluid in late treatment , Placebo , Dexamethasone ,0,
edin,3816,5153686,Cannot tell based on the abstract,, Opioid usage , Ropivacaine (0.5%) 20ml , Ropivacaine (0.25%) 40ml ,0,
edin,3816,5153686,Significantly decreased,"Total postoperative opioid use in group A was slightly higher. Group B used 26Â mg less morphine than group A (â26.1, â75.9 to 23.8), while group C used 23Â mg less than group A (â22.7, â74.72 to 29.34).", Opioid usage , Ropivacaine (0.5%) 20ml , Ropivacaine (0.25%) 40ml ,0,
edin,3994,3972946,Significantly decreased,Patient's demand and pump's delivery count for bolus dose in Group P were lower than in Group C in all measurement times., Patient's demand and pump's delivery count for bolus dose , Conventional Postoperative Epidural Analgesia (Group C) , Preemptive Thoracic Epidural Analgesia (Group P) ,0,
edin,3916,3914313,Significantly increased,"Compared with pretreatment, the average heart rate, the fastest heart rate, and the lowest heart rate in the trial group all increased significantly after treatment (P < 0.05 or 0.01, resp.).", Fastest heart rate  , Placebo , Shensong Yangxin ,0,
edin,3821,3952602,Cannot tell based on the abstract,, Resuppression  , Abacavir , Nevirapine ,0,
edin,3821,3952602,No significant difference,"Nineteen of 70 (27%) of individuals (12/46 ABC vs 7/24 NVP; P = .82) with viral load >1000 copies/mL at week 48 experienced resuppression by week 96, indicating issues with adherence.", Resuppression  , Abacavir , Nevirapine ,0,
edin,3928,5220753,No significant difference,"The overall rates of major adverse events such as mortality, Stent thrombosis (ST), Myocardial Infarction (MI), target lesion revascularization (TLR), target vessel revascularization (TVR), CVA, and emergency CABG within 24 h after stent implantation were low and comparable between the two groups; P > 0.05 considered significant for all comparisons.", Emergency CABG , Control , Eptifibatide ,0,
edin,3804,3734718,Cannot tell based on the abstract,, CD4 reduction , No treatment , Polyherbal formulation ,0,
edin,3804,3734718,Significantly increased,"The slow kinetics of the CD4 cell reduction in the PHF arm, 14.3 Â± 6.1 cells/Î¼l lost per year (R2 = 0.029, P=0.021), contrasted that of the HAART and the difference between the two arms was statistically significant at all the time points (P<0.001) subsequent to the baseline.", CD4 reduction , No treatment , Polyherbal formulation ,0,
edin,3880,4357072,No significant difference,"On intergroup comparison, there was no statistically significant difference between the groups in the reduction in burning sensation (P = 0.18) and erythematous area (P = 0.07)", reduction in erythematous area , triamcinolone acetonide oral paste 0.1% , topical pimecrolimus cream 1% ,0,
edin,3876,4226329,Significantly increased,"The MPH-treated group reduced their ADHD symptoms during the trial (P = 0.011) and had a significantly higher proportion of drug-negative urines compared with the placebo group (P = 0.047),", decrease on attention deficit hyperactivity disorder symptoms , placebo , methylphenidate ,0,
edin,3863,4280721,Cannot tell based on the abstract,, severity of pain in primary dysmenorrhea , placebo , extracts of fennelin ,0,
edin,3863,4280721,No significant difference,"In this study, pain intensity was evaluated within a cycle (zero cycle) before treatment with oral drops, mefenamic acid, and placebo drops, and the mean pain intensity of the four groups was not significantly different at the end of the cycle", severity of pain in primary dysmenorrhea , placebo , extracts of fennelin ,0,
edin,3968,4412792,Cannot tell based on the abstract,, Decrease in blood pressure  , Hydralazine , Enalapril ,0,
edin,3968,4412792,No significant difference,"The decrease in systolic BP and diastolic BP was similar in FSGS mice treated with hydralazine and enalapril on day 4 (111/66 mmHg, enalapril; 118/75 mmHg, hydralazine, p > 0.05), day 6 (101/63 mmHg, enalapril; 114/77 mmHg, hydralazine, p > 0.05) and day 13 (90/58 mmHg, enalapril; 97/66 mmHg, hydralazine, p > 0.05). These data show a similar BP-lowering effect with hydralazine and enalapril in this FSGS model.", Decrease in blood pressure  , Hydralazine , Enalapril ,0,
edin,4099,5440738,No significant difference,"Patients assigned to the text messaging adjunct also generally attended more sessions (median=6 sessions) during this period than patients assigned to the control condition (median =2.5 sessions), but the effect was not significant (Wilcoxon-Mann-Whitney z=â1.65, P=.10).", attending of sessions , standard group CBT for depression standard group ,  CBT for depression  with the addition of a text messaging adjunct ,0,
edin,4093,5137281,Cannot tell based on the abstract,, global CBF , placebo , pramipexole (PX) ,0,
edin,4093,5137281,No significant difference,"If global CBF was included as confounding variable in the analysis, we found further decreases in CBF in the left fusiform gyrus, right cuneus, and superior temporal gyrus (global CBF was not significantly different between the treatments, all P>.5).", global CBF , placebo , pramipexole (PX) ,0,
edin,4096,5137281,Cannot tell based on the abstract,," CBF  in the bilateral caudate nuclei, left brainstem (including substantia nigra), and the left SMA and middle frontal gyrus ", placebo , pramipexole (PX) ,0,
edin,4096,5137281,Significantly increased,"PX increased CBF relative to placebo in the bilateral caudate nuclei, left brainstem (including substantia nigra, 7% CBF change), and the left SMA and middle frontal gyrus (BA 11) if global CBF was included in the GLM."," CBF  in the bilateral caudate nuclei, left brainstem (including substantia nigra), and the left SMA and middle frontal gyrus ", placebo , pramipexole (PX) ,0,
edin,4011,5153622,Cannot tell based on the abstract,,  International Prostate Symptom Score (IPSS-T (total) ,  placebo  , onabotulinumtoxinA (100âU) ,0,
edin,4011,5153622,Significantly increased,"Interestingly, there was a significantly greater reduction in IPSS-T in the placebo group than in the onabotulinumtoxinA group (pâ=â0.026).",  International Prostate Symptom Score (IPSS-T (total) ,  placebo  , onabotulinumtoxinA (100âU) ,0,
edin,4100,5440738,Significantly increased,"Intent-to-treat analyses on therapy attendance during 16 sessions of weekly therapy found that patients assigned to the text messaging adjunct stayed in therapy significantly longer (median of 13.5 weeks before dropping out) than patients assigned to the control condition (median of 3 weeks before dropping out; Wilcoxon-Mann-Whitney z=â2.21, P=.03).", time staying in therapy , standard group CBT for depression standard group ,  CBT for depression  with the addition of a text messaging adjunct ,0,
edin,4013,5153622,Cannot tell based on the abstract,, maximum flow rate , baseline , onabotulinumtoxinA (100âU)  ,0,
edin,4013,5153622,Significantly increased,"Among the videourdynamic parameters measured, maximum flow rate and voiding efficiency were significantly elevated after treatment in both groups,", maximum flow rate , baseline , onabotulinumtoxinA (100âU)  ,0,
edin,4127,4093188,Significantly increased,"A comparison of half carcasses across the groups has shown no difference between the control group and the one with supplements, while the weight of half carcasses in the grazing group was smaller in comparison with groups C and S (p<0.001).", the weight of half carcasses ," G, outdoor with no supplement "," group C, indoor with no supplement; S, indoor with supplement, ",0,
edin,4083,4301837,Cannot tell based on the abstract,, 24-h urinary cortisol , placebo , LCI699 ,0,
edin,4083,4301837,Significantly decreased,"Significant reductions in 24-h urinary cortisol (34â42%) were observed following single LCI699 doses of 30, 100 or 200Â mg (vs 33% increase with placebo relative to time-matched baseline; Pââ¤â0.001), but with no clear dose-dependence (results not shown).", 24-h urinary cortisol , placebo , LCI699 ,0,
edin,4012,5153622,Cannot tell based on the abstract,, detrusor pressure , baseline , onabotulinumtoxinA (100âU) ,0,
edin,4012,5153622,Significantly decreased,"Nevertheless, significant improvements in videourodynamic parameters including detrusor pressure (from 40.3âÂ±â23.0 to 31.6âÂ±â22.3 cmH2O), maximum flow rate (from 6.4âÂ±â5.4 to 11.1âÂ±â10.1âmL/s) and voided volume (from 119.9âÂ±â82.2 to 191.0âÂ±â140.1âmL) were only found in the onabotulinumtoxinA group.", detrusor pressure , baseline , onabotulinumtoxinA (100âU) ,0,
edin,4129,4093188,Cannot tell based on the abstract,, internal fat depot  -  kidney with pelvic fat , baseline ," G, outdoor with no supplement ",0,
edin,4129,4093188,Significantly decreased,"Grazing had a lesser effect on internal fat depot (kidney with pelvic fat; p<0.05) than on intermuscular (p<0.001) and on subcutaneous (p<0.001) fat, in keeping with the findings of other authors (KuÅºnicka, 2006; Joy et al., 2008; Carrasco et al., 2009b).", internal fat depot  -  kidney with pelvic fat , baseline ," G, outdoor with no supplement ",0,
edin,4102,5440738,No significant difference,"Both patients assigned to the text messaging adjunct (B=â.29, 95% CI â0.38 to â0.19, z=â5.80, P<.001) and patients assigned to the control conditions (B=â.20, 95% CI â0.32 to â0.07, z=â3.12, P=.002) experienced significant decreases in depressive symptom severity over the course of treatment; however, the conditions did not significantly differ in their degree of symptom reduction.", depressive symptom severity , baseline , standard group CBT for depression standard group ,0,
edin,4089,4301837,Cannot tell based on the abstract,, Levels of the cortisol precursor 11-deoxycortisol , placebo , eplerenon ,0,
edin,4089,4301837,Significantly increased,"Levels of the cortisol precursor 11-deoxycortisol increased with LCI699 at dosesââ¥â100Â mg (942% and 584% with 100Â mg and 200Â mg, respectively; Pâ<â0.001 vs placebo), likely due to off-target inhibition of 11-Î² hydroxylase (results not shown).", Levels of the cortisol precursor 11-deoxycortisol , placebo , eplerenon ,0,
edin,4054,5458653,Significantly decreased,"Vildagliptin did not significantly alter the mean plasma glucose level (175.5 Â± 54.4 mg/dL vs. 179.1 Â± 73.4 mg/dL) or HbA1c (8.01% vs. 8.02%) after 12 weeks. With alogliptin, mean plasma glucose increased from 175.4 Â± 50.9 mg/dL to 195.3 Â± 55.0 mg/dL after 12 weeks and HbA1c increased significantly from 8.0% to 8.3% (P < 0.05).,The reduction of HbA1c was significantly greater in the vildagliptin group than the alogliptin group (P = 0.008),", HbA1c , alogliptin (25 mg once daily) , vildagliptin (50 mg twice daily) for 12weeks ,0,
edin,3836,5832511,Cannot tell based on the abstract,, CD4 count , Lipid based nutrient , ARV ,0,
edin,3836,5832511,Significantly increased,Significant differences were only observed for the CD4 counts with higher counts for the groups that received ARV., CD4 count , Lipid based nutrient , ARV ,0,
edin,4111,5399146,Cannot tell based on the abstract,," circadian variation of F1+2, a marker of thrombin generation, and D-dimer, a marker of activated coagulation and fibrinolysis ", placebo for  tetraplegic patients , 2âmg of melatonin given 4 days for tetraplegic patients ,0,
edin,4111,5399146,No significant difference,"The circadian patterns of the F1+2, a marker of thrombin generation, and D-dimer, a marker of activated coagulation and fibrinolysis, were apparently similar (P>0.05) between the tetraplegic groups, that is, irrespective of whether they were given melatonin (Figures 2a and c)."," circadian variation of F1+2, a marker of thrombin generation, and D-dimer, a marker of activated coagulation and fibrinolysis ", placebo for  tetraplegic patients , 2âmg of melatonin given 4 days for tetraplegic patients ,0,
edin,4123,5846302,Significantly decreased,"Median time to hemostasis was 1.5 min with Verisetâ¢ hemostatic patch, compared to 3.0 min with TachoSilÂ® (p<0.0001).", Median time to hemostasis , TachoSilÂ® (control) , Verisetâ¢ hemostatic patch ,0,
edin,4010,5515187,Cannot tell based on the abstract,, systolic and diastolic BP , routine care from health-care center ," 6 weekly sessions including exercises, weight control, medication adherence, and home self-monitoring ",0,
edin,4010,5515187,Significantly decreased,"As shown in table 3, results show that there is a significant difference between systolic BP of intervention and control group overall (P = 0.045).

Trend of these changes is significant in two groups too (P < 0.001) so that systolic BP decrease as 7 mmHg in the intervention group, while this decrease is 3 mmHg in control group after 6 months (P < 0.001).,there is a significant difference in diastolic BP between the groups (P = 0.010) and follow-up time in the intervention group (P = 0.013).,After 6 months, there was a significant reduction in systolic (P < 0.001) and diastolic BP (P = 0.010) in the intervention group.", systolic and diastolic BP , routine care from health-care center ," 6 weekly sessions including exercises, weight control, medication adherence, and home self-monitoring ",0,
edin,4103,5440738,No significant difference,"Both patients assigned to the text messaging adjunct (B=â.29, 95% CI â0.38 to â0.19, z=â5.80, P<.001) and patients assigned to the control conditions (B=â.20, 95% CI â0.32 to â0.07, z=â3.12, P=.002) experienced significant decreases in depressive symptom severity over the course of treatment; however, the conditions did not significantly differ in their degree of symptom reduction.", the degree of symptom reduction , CBT for depression with the addition of a text messaging adjunct , standard group CBT for depression standard group ,0,
edin,4058,4755968,Cannot tell based on the abstract,, fatigue after the training session , virtual-reality (VR) balance training ," Biodex Balance System (BBS)  balance training,  ",0,
edin,4058,4755968,Significantly increased,There was a significant difference between the groups regarding the participantsâ sense of fatigue after the training session (p< 0.05) with higher fatigue reported by of the BBSG. T, fatigue after the training session , virtual-reality (VR) balance training ," Biodex Balance System (BBS)  balance training,  ",0,
edin,4077,3346068,Cannot tell based on the abstract,," mean satisfaction ratings, based on an 11-point NRS (0 = completely unsatisfied; 10 = completely satisfied) ", bupivacaine HCl 150 mg group at day 8 , liposome bupivacaine 532 mg at day 8 ,0,
edin,4077,3346068,Significantly increased,"Statistically significant differences in favor of liposome bupivacaine were also observed in study 3, where mean satisfaction ratings, based on an 11-point NRS (0 = completely unsatisfied; 10 = completely satisfied), were 9.2 in the liposome bupivacaine 532 mg group and 8.3 in the bupivacaine HCl 150 mg group (P = 0.045) at day 8, and in study 4 where mean ratings in the liposome bupivacaine 266 mg and bupivacaine HCl 75 mg groups were 7.4 and 6.0, respectively (P = 0.03) at 96 hours."," mean satisfaction ratings, based on an 11-point NRS (0 = completely unsatisfied; 10 = completely satisfied) ", bupivacaine HCl 150 mg group at day 8 , liposome bupivacaine 532 mg at day 8 ,0,
edin,4047,2741450,Significantly decreased,"However, there was a significant decrease in systolic blood pressure in the pedometer group (112.8 Â± 2.44 mm Hg) compared to the control group (117.3 Â± 2.03 mm Hg) (p = 0.003).", Systolic blood pressure , baseline , record the number of steps on a daily basis for 12 weeks ,0,
edin,4035,5747102,Significantly decreased,"The ADAS-cog scores for AG group showed obvious decreases at T2 and â(T2-T0)when compared with DG group, and significant between-group differences were detected (all pÂ <â0.05).", The Assessment Scale-Cognitive (ADAS-cog) scores at 12-week follow-up period (T2) , donepezil hydrochloride once daily (5&amp;nbsp;mg/day for the first 4&amp;nbsp;weeks and 10&amp;nbsp;mg/day thereafter) , acupuncture three times per week ,0,
edin,4088,4301837,Cannot tell based on the abstract,, ACTH-stimulated aldosterone levels , placebo , eplerenon ,0,
edin,4088,4301837,Significantly decreased,"For ACTH-stimulated aldosterone levels (FigureÂ 7A), LCI699 0.5â3Â mg resulted in peak inhibition of 41â64% from baseline (Day â2) on Day 6 (vs 7% reduction with placebo; Pâ<â0.001).", ACTH-stimulated aldosterone levels , placebo , eplerenon ,0,
edin,4080,4369830,Cannot tell based on the abstract,, overall survival (OS)  in patients with metastatic colorectal cancer (mCRC) , placebo , Regorafenib (RE) ,0,
edin,4080,4369830,Significantly increased,"Treatment cycles consisted of 160Â mg of regorafenib (or matching placebo) once daily for three weeks on/one week off. The study met its primary endpoint, showing statistically significant improvement in overall survival (OS) by 29% (HRâ=â0.77, pâ=â0.0052, median OS: 6.4Â months vs. 5.0Â months for the placebo group) in patients with metastatic colorectal cancer (mCRC) whose disease had progressed after approved standard therapies.", overall survival (OS)  in patients with metastatic colorectal cancer (mCRC) , placebo , Regorafenib (RE) ,0,
edin,4028,2887151,Cannot tell based on the abstract,," prothrombin time (PT),  Activated Partial Thromboplastin Time (APTT), activity, antithrombin (AT), platelet count, fibrinogen, thrombin-antithrombin complexes (TAT) complexes, or D-dimer levels "," 40, 50, 60 mg SC enoxaparin for a period of 24 hours ", 70 mg SC enoxaparin for a period of 24 hours ,0,
edin,4028,2887151,No significant difference,"No significant difference was found in the PT, aPTT, AT, platelet count, fibrinogen, TAT complexes, or D-dimer levels between the four groups."," prothrombin time (PT),  Activated Partial Thromboplastin Time (APTT), activity, antithrombin (AT), platelet count, fibrinogen, thrombin-antithrombin complexes (TAT) complexes, or D-dimer levels "," 40, 50, 60 mg SC enoxaparin for a period of 24 hours ", 70 mg SC enoxaparin for a period of 24 hours ,0,
edin,4106,4161265,Cannot tell based on the abstract,, Mean Pain intensity rating , saline , Acetylsalicylic acid ,0,
edin,4106,4161265,No significant difference,Mean Pain intensity rating (Â±SEM) for the ASA session was 61.7âÂ±â2.73 and for the saline session 62.1âÂ±â2.71. A paired t-test comparing the average pain ratings of both sessions failed to reach significance (pâ>â0.05)., Mean Pain intensity rating , saline , Acetylsalicylic acid ,0,
edin,4059,4755968,Cannot tell based on the abstract,, enjoyment attribute , virtual-reality (VR) balance training ," Biodex Balance System (BBS)  balance training,  ",0,
edin,4059,4755968,Significantly decreased,"There was a significant difference between the groups in the enjoyment attribute (p< 0.05), with higher enjoyment reported by the VRG.", enjoyment attribute , virtual-reality (VR) balance training ," Biodex Balance System (BBS)  balance training,  ",0,
edin,4084,4301837,Cannot tell based on the abstract,, Levels of the cortisol precursor 11-deoxycortisol , placebo , LCI699 ,0,
edin,4084,4301837,Cannot tell based on the abstract,, Levels of the cortisol precursor 11-deoxycortisol , placebo , LCI699 ,0,
edin,4084,4301837,Significantly increased,"Levels of the cortisol precursor 11-deoxycortisol increased with LCI699 at dosesââ¥â100Â mg (942% and 584% with 100Â mg and 200Â mg, respectively; Pâ<â0.001 vs placebo), likely due to off-target inhibition of 11-Î² hydroxylase (results not shown).", Levels of the cortisol precursor 11-deoxycortisol , placebo , LCI699 ,0,
edin,4073,3346068,Cannot tell based on the abstract,, the proportion of patients avoiding rescue medication through 72 hours after surgery ,  placebo , liposome bupivacaine 266 mg ,0,
edin,4073,3346068,Significantly decreased,"In study 9 (hemorrhoidectomy), the proportion of patients avoiding rescue medication through 72 hours after surgery was significantly lower in favor of liposome bupivacaine 266 mg (28% avoided use of rescue opioids) compared with placebo (10% avoided use of rescue opioids; P = 0.0007).", the proportion of patients avoiding rescue medication through 72 hours after surgery ,  placebo , liposome bupivacaine 266 mg ,0,
edin,4094,5137281,Cannot tell based on the abstract,, perfusion of the left middle and right superior prefrontal cortex and left caudate nucleus and at the border of left posterior part of the putamen and insular cortex , placebo , quetiapine (QT) ,0,
edin,4094,5137281,Significantly increased,QT increased perfusion relative to placebo in the left middle and right superior prefrontal cortex and left caudate nucleus and at the border of left posterior part of the putamen and insular cortex (4% CBF change)., perfusion of the left middle and right superior prefrontal cortex and left caudate nucleus and at the border of left posterior part of the putamen and insular cortex , placebo , quetiapine (QT) ,0,
edin,4116,5529983,Significantly decreased,"Compared with standard care alone, CTCA was associated with less marked improvements in physical limitation (difference â1.74 (95% CIs, â3.34 to â0.14), p=0.0329), angina frequency (difference â1.55 (â2.85 to â0.25), p=0.0198) and quality of life (difference â3.48 (â4.95 to â2.01), p<0.0001) at 6âmonths."," improvements in physical limitation , angina frequency  and quality of life ", standard care , standard care plus CT coronary angiography (CTCA) ,0,
edin,4076,3346068,Cannot tell based on the abstract,, Ã¢â¬ÅsatisfiedÃ¢â¬ï¿½ or Ã¢â¬Åextremely satisfiedÃ¢â¬ï¿½ with their postoperative analgesia at 72 hours after surgery ,  placebo , liposome bupivacaine 266 mg   ,0,
edin,4076,3346068,Significantly increased,"At 24 hours after surgery in this study, 95% of patients in the liposome bupivacaine 266 mg group were âsatisfiedâ or âextremely satisfiedâ with their postoperative analgesia compared with 72% in the placebo group (P = 0.0007). At 72 hours after surgery, percentages were 95% and 73%, respectively (P = 0.0007).", Ã¢â¬ÅsatisfiedÃ¢â¬ï¿½ or Ã¢â¬Åextremely satisfiedÃ¢â¬ï¿½ with their postoperative analgesia at 72 hours after surgery ,  placebo , liposome bupivacaine 266 mg   ,0,
edin,4046,2741450,Cannot tell based on the abstract,," waist, BMI, waist/hip ratio, HR or % body fat ", was not able to record their steps daily , record the number of steps on a daily basis for 12 weeks ,0,
edin,4046,2741450,No significant difference,"There was no significant differences within groups or between groups in waist, BMI, waist/hip ratio, HR or % body fat at 12 weeks."," waist, BMI, waist/hip ratio, HR or % body fat ", was not able to record their steps daily , record the number of steps on a daily basis for 12 weeks ,0,
edin,4039,5409664,Significantly decreased,"In plasma phospholipids the n-6/n-3 fatty acids ratio declined from 15.47 Â± 5.51 to 10.62 Â± 5.07 (p = 0.005), and from 18.15 Â± 5.04 to 13.50 Â± 4.81 (p = 0.005) in groups I and II respectively. T", phospholipids the n-6/n-3 fatty acids ratio , baseline ," 12 week supplementation with fish oil (group I), fish oil with primrose evening oil (group II) ",0,
edin,4105,4161265,Cannot tell based on the abstract,, activity of the secondary somatosensory cortex (SII) , saline , Acetylsalicylic acid ,0,
edin,4105,4161265,Significantly decreased,Increased BOLD signal intensity in the anterior cingulate cortex (left) and secondary somatosensory cortex (right) during nociceptive input (ammoniaâ>âair puffs) after saline treatment compared to ASA condition., activity of the secondary somatosensory cortex (SII) , saline , Acetylsalicylic acid ,0,
edin,4075,3346068,Cannot tell based on the abstract,, Ã¢â¬ÅsatisfiedÃ¢â¬ï¿½ or Ã¢â¬Åextremely satisfiedÃ¢â¬ï¿½ with their postoperative analgesia at 24 hours after surgery ,  placebo , liposome bupivacaine 266 mg  ,0,
edin,4075,3346068,Significantly increased,"In the studies that included assessment of patient ratings of postsurgical analgesia (studies 1, 6, 7, 8, 9, and 10), the liposome bupivacaine group in study 9 showed statistically significantly better patient satisfaction scores than the comparator. At 24 hours after surgery in this study, 95% of patients in the liposome bupivacaine 266 mg group were âsatisfiedâ or âextremely satisfiedâ with their postoperative analgesia compared with 72% in the placebo group (P = 0.0007).", Ã¢â¬ÅsatisfiedÃ¢â¬ï¿½ or Ã¢â¬Åextremely satisfiedÃ¢â¬ï¿½ with their postoperative analgesia at 24 hours after surgery ,  placebo , liposome bupivacaine 266 mg  ,0,
edin,4125,5846302,Cannot tell based on the abstract,, difference in any surgical procedure or  target bleeding site (TBS) characteristic , TachoSilÂ® (control) , Verisetâ¢ hemostatic patch ,0,
edin,4125,5846302,No significant difference,There was no significant difference between the two treatment groups in any surgical procedure or TBS characteristic, difference in any surgical procedure or  target bleeding site (TBS) characteristic , TachoSilÂ® (control) , Verisetâ¢ hemostatic patch ,0,
edin,4068,2429977,Cannot tell based on the abstract,, death/periprocedural MI/stroke or transient ischaemic attack/re-intervention within 7 days ," group B (âselectiveââclopidogrel 600 mg in the cath-lab after CAG, only in case of PCI; in  subgroup of patients who underwent PCI ", group A (ânon-selectiveââclopidogrel 600 mg 6 h before CAG; in subgroup of patients who underwent PCI ,0,
edin,4068,2429977,No significant difference,"<th colspan=""1"" rowspan=""1""></th><th align=""left"" colspan=""1"" rowspan=""1"">Group A (non-selective clopidogrel before CAG)</th><th align=""left"" colspan=""1"" rowspan=""1"">Group B (selective clopidogrel before PCI)</th><th align=""left"" colspan=""1"" rowspan=""1""><italic>P</italic>-value</th>,TableÂ 3
Periprocedural ischaemic events in both groups", death/periprocedural MI/stroke or transient ischaemic attack/re-intervention within 7 days ," group B (âselectiveââclopidogrel 600 mg in the cath-lab after CAG, only in case of PCI; in  subgroup of patients who underwent PCI ", group A (ânon-selectiveââclopidogrel 600 mg 6 h before CAG; in subgroup of patients who underwent PCI ,0,
edin,4053,5458653,Significantly decreased,"At 12 weeks after switching from vildagliptin to high-dose sitagliptin (100 mg daily), HbA1c was increased to 8.3%, but it was significantly (P < 0.05) reduced to the baseline level of 8.0% after switching from alogliptin."," mean plasma glucose level, HbA1c ", baseline , switching from vildagliptin to high-dose sitagliptin (100 mg daily) ,0,
edin,4095,5137281,Cannot tell based on the abstract,, CBF , quetiapine (QT) , pramipexole (PX) ,0,
edin,4095,5137281,No significant difference,No CBF increases were detected when comparing QT with PX at P<.001 or P<.005., CBF , quetiapine (QT) , pramipexole (PX) ,0,
edin,4023,4414618,Cannot tell based on the abstract,, force of pressure on the piston , non- low frequency transcutaneous electrical nerve stimulation (TENS) ,  low frequency transcutaneous electrical nerve stimulation (TENS) ,0,
edin,4023,4414618,Significantly decreased,"Post-hoc comparisons showed that the experimental group pressed the piston more frequently weaker in the final (14.98 Â± 7.16%) and in manipulation (25.29 Â± 6.53) compared to the baseline (51.52 Â± 1.47%) session (p < 0.001 and p = 0.004, respectively) (Fig 2C).", force of pressure on the piston , non- low frequency transcutaneous electrical nerve stimulation (TENS) ,  low frequency transcutaneous electrical nerve stimulation (TENS) ,0,
edin,4034,5429471,No significant difference,"The control group showed the highest bond strength with significant differences with other groups (P<0.05). Among the experimental groups, the saline group had no significant difference with CHX (P=0.09)", bond strength , chlorhexidine (CHX) , saline ,0,
edin,4045,2741450,Cannot tell based on the abstract,, steps/day , baseline , was not able to record their steps daily ,0,
edin,4045,2741450,No significant difference,"Baseline characteristics of participants, such as steps/day, height, weight, age did not significantly differ between the groups (Table 1).", steps/day , baseline , was not able to record their steps daily ,0,
edin,4044,2741450,Cannot tell based on the abstract,, steps/day , baseline , record the number of steps on a daily basis for 12 weeks ,0,
edin,4044,2741450,Significantly increased,"At 12 weeks, the pedometer group had a 32% higher number of steps/day than the control group.,The control group remained unchanged in the number of steps during the 12-week intervention. For the pedometer group, the daily average number of steps at weeks six (8321 Â± 884 steps per day) and twelve (9703 Â± 921 steps per day) were significantly higher than the baseline daily average of 6242 Â± 541 steps per day (p = 0.046 and p = 0.035, respectively). At week twelve, the pedometer group was taking an average of 3461 steps per day more (36% increase) than at baseline.", steps/day , baseline , record the number of steps on a daily basis for 12 weeks ,0,
edin,4007,5515187,Cannot tell based on the abstract,, self-efficacy , routine care from health-care center ," 6 weekly sessions including exercises, weight control, medication adherence, and home self-monitoring ",0,
edin,4007,5515187,Significantly increased,"As shown in table 2, a significant difference is in the mean of self-efficacy between the groups (P < 0.001) and follow-up time (P < 0.001). So that the mean of self-efficacy improve immediately after intervention and 6 months later in comparison to control group after adjusting for baseline.", self-efficacy , routine care from health-care center ," 6 weekly sessions including exercises, weight control, medication adherence, and home self-monitoring ",0,
edin,4015,5153622,Cannot tell based on the abstract,, post-void residual volume , onabotulinumtoxinA (100âU) ,   placebo ,0,
edin,4015,5153622,Significantly increased,"Among the videourdynamic parameters measured, maximum flow rate and voiding efficiency were significantly elevated after treatment in both groups, whereas improvements in voided volume and post-void residual volume were only observed in the onabotulinumtoxinA and placebo groups, respectively.,Reduction in post-void residual volume, however, was significantly greater in the placebo group (from 415.0âÂ±â304.0 to 131âÂ±â169.1âmL) than in the onabotulinumtoxinA group (from 350.0âÂ±â174.6 to 293âÂ±â233.1âmL) (pâ=â0.046)", post-void residual volume , onabotulinumtoxinA (100âU) ,   placebo ,0,
edin,4052,5458653,Significantly decreased,"At 12 weeks after switching from vildagliptin to high-dose sitagliptin (100 mg daily), HbA1c was increased to 8.3%, but it was significantly (P < 0.05) reduced to the baseline level of 8.0% after switching from alogliptin"," mean plasma glucose level, HbA1c ", baseline , alogliptin (25 mg once daily) ,0,
edin,4081,4369830,Cannot tell based on the abstract,, progression-free survival (PFS)  in patients with metastatic colorectal cancer (mCRC) , placebo , Regorafenib (RE) ,0,
edin,4081,4369830,Significantly increased,"The study met its primary endpoint, showing statistically significant improvement in overall survival (OS) by 29% (HRâ=â0.77, pâ=â0.0052, median OS: 6.4Â months vs. 5.0Â months for the placebo group) in patients with metastatic colorectal cancer (mCRC) whose disease had progressed after approved standard therapies. Additionally, findings from the secondary endpoints of the CORRECT study showed statistically significant improvement in progression-free survival (PFS) (HRâ=â0.49, pâ<â0.000001, median PFS: 1.9Â months vs. 1.7Â months) and an improvement in disease control rate (44.8% vs. 15.3%) in patients treated with regorafenib compared to those treated with placebo.", progression-free survival (PFS)  in patients with metastatic colorectal cancer (mCRC) , placebo , Regorafenib (RE) ,0,
edin,4078,3346068,Cannot tell based on the abstract,," mean satisfaction ratings, based on an 11-point NRS (0 = completely unsatisfied; 10 = completely satisfied) at 96 hours ", bupivacaine HCl 75 mg ,  liposome bupivacaine 266 mg  ,0,
edin,4078,3346068,Significantly increased,"Statistically significant differences in favor of liposome bupivacaine were also observed in study 3, where mean satisfaction ratings, based on an 11-point NRS (0 = completely unsatisfied; 10 = completely satisfied), were 9.2 in the liposome bupivacaine 532 mg group and 8.3 in the bupivacaine HCl 150 mg group (P = 0.045) at day 8, and in study 4 where mean ratings in the liposome bupivacaine 266 mg and bupivacaine HCl 75 mg groups were 7.4 and 6.0, respectively (P = 0.03) at 96 hours."," mean satisfaction ratings, based on an 11-point NRS (0 = completely unsatisfied; 10 = completely satisfied) at 96 hours ", bupivacaine HCl 75 mg ,  liposome bupivacaine 266 mg  ,0,
edin,4018,3420321,Cannot tell based on the abstract,, Impulse values , placebo , Î²-alanine (nâ=â7; 6.4âgÂ·d-1 over 4âweeks) ,0,
edin,4018,3420321,Significantly increased,"Impulse values pre- and post-supplementation are shown in Table 3. The 3.7âÂ±â1.3 kNÂ·s-1 gain (+13.9%) in the Î²-alanine group was significantly different (tâ=â(11) 3.1, pâ<â0.05) to the change in the placebo group (â1.1âÂ±â1.5 kNÂ·s-1).", Impulse values , placebo , Î²-alanine (nâ=â7; 6.4âgÂ·d-1 over 4âweeks) ,0,
edin,4041,3733287,Cannot tell based on the abstract,, Quality of life (QOL) , did not receive the intervention , psycho-educational intervention ,0,
edin,4041,3733287,Significantly increased,"The total score of QOL in two groups are presented in the Table 2. Low mean scores for quality of life in both physical and mental component revealed an inferior quality of life for depressed patients before intervention. It showed that there was a statistically significant difference within two groups in seven aspects of QOL which are physical function, limitation of role performance due to physical pain, limitation of role performance due to psychological problem, social function, pain, psychological health, vitality, but only in one aspect there was not a statistically significant difference which was role performance limitation due to physical problems (P < 0.117). Also the result showed that there was a statistically significant difference between two groups in all aspects of QOL (P < .0.001) [Table 3].", Quality of life (QOL) , did not receive the intervention , psycho-educational intervention ,0,
edin,4033,5429471,Cannot tell based on the abstract,, bond strength , sodium hypochlorite , saline ,0,
edin,4033,5429471,Significantly increased,"Also, significant differences were noted in bond strength between saline and Smear Clear (P=0.007) and saline and sodium hypochlorite (P=0.001) groups.,In the current study, the push-out bond strength of the MTA group exposed to saline was the highest. Immersion in Smear Clear, CHX and NaOCl irrigants decreased the bond strength of MTA to dentin following the first 10 minutes of its setting.", bond strength , sodium hypochlorite , saline ,0,
edin,4061,4717319,Significantly increased,"In the double-blind phase, lurasidone significantly delayed time to relapse compared with placebo (log-rank test, p=0.039), reflecting a 33.7% reduction in risk of relapse (Cox hazard ratio (95% confidence interval), 0.663 (0.447â0.983); p=0.041).", time to relapse , placebo ," (40â80 mg/d, flexibly dosed) for an additional 28-week treatment period ",0,
edin,4024,4414618,Cannot tell based on the abstract,, CSP duration , baseline ,  low frequency transcutaneous electrical nerve stimulation (TENS) ,0,
edin,4024,4414618,Significantly decreased,"st-hoc comparisons showed that the experimental group presented shorter FDIcsp duration in the final (146.17 Â± 3.94 ms) than in the baseline (156.76 Â± 4.39 ms; p = 0.005) session,", CSP duration , baseline ,  low frequency transcutaneous electrical nerve stimulation (TENS) ,0,
edin,4016,5153622,No significant difference,"There were no significant differences in subjective or objective parameters between patients who received onabotulinumtoxinA and those who received saline injection therapy, and the overall success rate was 43.5% (reduction in Patient perception of Bladder Condition by â¥2: onabotulinumtoxinA 36.8% vs placebo 54.2%, pâ=â0.114).",  Patient perception of Bladder Condition ,   placebo ,  onabotulinumtoxinA (100âU) ,0,
edin,4132,4093188,Significantly increased,The concentrations of Se and Zn in the blood plasma of ram-lambs from the supplemented group were significantly higher than for the control and grazing lambs., The concentrations of Se and Zn in the blood plasma of ram-lambs ," G, outdoor with no supplement, group C, indoor with no supplement;  "," S, indoor with supplement, ",0,
edin,4108,3382640,Significantly decreased,"The results showed that caffeinated coffee significantly reduced SDLP as compared to decaffeinated coffee, both in the first (pâ=â0.024) and second hour (pâ=â0.019) after the break.", standard deviation of lateral position (SDLP) in the first and second hour after the break , decaffeinated coffee , a single cup of coffee (80 mg caffeine) ,0,
edin,4043,4319305,No significant difference,"The WaveOne group presented a larger amount of debris than the Reciproc Group, however, without statistically significant difference (P > 0.05).", amount of debris , no instrumentation was performed ," The WaveOne group,  Reciproc Group ",0,
edin,4131,4093188,Significantly increased,"The pelvic limb of grazing lambs contained less fat compared to the control and supplemented groups (p<0.001).,The lambs from group G were grazed every day", The fat of pelvic limb   ," G, outdoor with no supplement "," group C, indoor with no supplement; S, indoor with supplement, ",0,
edin,4001,4879328,Cannot tell based on the abstract,, weight loss , no continued contact ," Get Healthy, Stay Healthyâ (GHSH) ",0,
edin,4001,4879328,Significantly increased,"Intervention group improvements were significantly greater than controls for weight loss (â1.35 kg, 95% CI: â2.24, â0.46, P=.003), but not for waist circumference ( P=.115; Table 3).", weight loss , no continued contact ," Get Healthy, Stay Healthyâ (GHSH) ",0,
edin,4122,4274545,Cannot tell based on the abstract,, Mortality , not receive any prebiotic , prebiotic mixture (SCGOS/LCFOS; 9:1) ,0,
edin,4122,4274545,No significant difference,Mortality was similar between the two groups; only one neonate died in each group [P - 0.66; Table 1]., Mortality , not receive any prebiotic , prebiotic mixture (SCGOS/LCFOS; 9:1) ,0,
edin,4097,5137281,Cannot tell based on the abstract,, CBF in the left cerebellum and brainstem (including substantia nigra) and right hypothalamus , quetiapine (QT) , pramipexole (PX) ,0,
edin,4097,5137281,Significantly increased,"PX showed elevated CBF compared with QT in the left cerebellum and brainstem (including substantia nigra, 8% CBF change) and right hypothalamus.", CBF in the left cerebellum and brainstem (including substantia nigra) and right hypothalamus , quetiapine (QT) , pramipexole (PX) ,0,
edin,4042,4319305,No significant difference,"The WaveOne group presented a larger amount of debris than the Reciproc Group, however, without statistically significant difference (P > 0.05).", amount of debris , Reciproc Group , The WaveOne group ,0,
edin,4009,5515187,Significantly increased,After 6 months intervention self-efficacy (< 0.001) and physical activity (< 0.001) improvement of in the intervention group was significantly different in comparison with the control group., average of physical activity , routine care from health-care center ," 6 weekly sessions including exercises, weight control, medication adherence, and home self-monitoring ",0,
edin,4029,3813772,Cannot tell based on the abstract,, Mu rhythm desynchronization of hand area of cortex in child ,  no touching , adult reach towards and touch an object using her hand  ,0,
edin,4029,3813772,Significantly increased,"Specifically, the mu rhythm showed greater desynchronization over hand areas for the infants who observed hand actions,", Mu rhythm desynchronization of hand area of cortex in child ,  no touching , adult reach towards and touch an object using her hand  ,0,
edin,4067,2429977,No significant difference,Periprocedural troponin elevation (>3Ã ULN) was detected in 2.6% group A vs. 3.3% group B (P = 0.475; 90% CI â2.5â1.0)., Periprocedural troponin elevation ," group B (âselectiveââclopidogrel 600 mg in the cath-lab after CAG, only in case of PCI; ", group A (ânon-selectiveââclopidogrel 600 mg &amp;amp;amp;amp;gt;6 h before CAG; ,0,
edin,4140,3713866,No significant difference,The difference between saliva secretion rates before and after medications was not significant for bromhexine users at two steps of the study (P=0.35);, Salivary secretion , No treatment , Bromhexine ,0,
edin,4244,5350209,No significant difference,"We found that compared with the control condition, the beverage was consumed at a slower rate in the two health-warning conditions, which surprisingly did not differ from each other.", Speed of alcohol consumption , Visual warning (text) , Visual warning (image) ,0,
edin,4226,3633335,Significantly decreased,"The incidence of nausea was 55% in group I, 42.5% in group II, 30% in group III, 27.5% in group IV, 30% in group V, and 30% in group VI. Groups III and V had a lower incidence of nausea than group I (P < 0.05).,Group I, anesthesia was maintained with sevoflurane;,Group III, anesthesia was maintained with propofol", Nausea , Sevoflurane alone , Propofol alone ,0,
edin,4269,2360030,Cannot tell based on the abstract,, Hand-foot syndrome , Oxaliplatin , Irinotecan ,0,
edin,4269,2360030,Significantly decreased,"Handâfoot syndrome (palmarâplantar erythrodysesthesia-HFS) was classified as 3 grades: grade 1 (numbness, dysesthesia, painless swelling or erythema not disrupting normal activity); grade 2 (painful erythema with swelling affecting daily living activities); grade 3 (desquamation, ulceration, blistering or severe pain or any symptoms leading to an inability to work or perform daily living activities).,No HFS was reported in the TEGAFIRI group whereas grade 1â2 HFS was evident in 10% of the TEGAFOX group.", Hand-foot syndrome , Oxaliplatin , Irinotecan ,0,
edin,4270,2360030,Cannot tell based on the abstract,, Grade 3â4 toxicity , Oxaliplatin , Irinotecan ,0,
edin,4270,2360030,No significant difference,"Sequential grade 3â4 toxicity (as defined in the Materials and methods section) was recorded in four (5.9, 95% CL, from 1.6 to 14.4%) TEGAFIRI patients and three (4.1, 95% CL, from 0.9 to 11.5%) TEGAFOX patients.", Grade 3â4 toxicity , Oxaliplatin , Irinotecan ,0,
edin,4197,5728078,No significant difference,"In both groups triglycerides, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, fasting glucose, haemoglobin A1c, homeostasis model assessment index and diastolic blood pressure did not significantly change.", Low-density lipoprotein cholesterol , No Vitamin D supplementation , Vitamin D supplementation ,0,
edin,4272,4984795,Cannot tell based on the abstract,, Liver metastasis , High  Ang-2  , Low  Ang-2  ,0,
edin,4272,4984795,Significantly decreased,"In non-Asian patients, the frequency of liver metastasis in the high vs low Ang-2 group was 45% and 27%, respectively. In Asian patients, the frequency of liver metastasis at baseline in the high vs low Ang-2 group was 37% and 23%, respectively. Logistic regression analysis confirmed that Ang-2 levels were strongly correlated with the frequency of liver metastasis at any time (Figure 4).", Liver metastasis , High  Ang-2  , Low  Ang-2  ,0,
edin,4143,3713866,Cannot tell based on the abstract,, Difficulties with chewing , No treatment , Policarpine ,0,
edin,4143,3713866,Significantly decreased,"All the (100%) pilocarpine users and 14.3% of bromhexine users demonstrated improvement of chewing difficulties,All the differences mentioned were statistically significant with P-values of 0.0001, 0.04, 0.005, 0.0001 and 0.004 for improvement in chewing, swallowing, speech, tasting problems and burning sensation, respectively", Difficulties with chewing , No treatment , Policarpine ,0,
edin,4309,3937058,Cannot tell based on the abstract,, confidence to use reminder/recall systems , in-person , webinar consultations ,0,
edin,4309,3937058,No significant difference,"<td align=""left"">âReminder/recall training</td><td align=""center"">4.4 (0.7)</td><td align=""center"">4.5 (0.9)</td>,In-person and webinar conditions had comparable satisfaction scores (all comparisons pâ>â0.05).", confidence to use reminder/recall systems , in-person , webinar consultations ,0,
edin,4218,4950066,Cannot tell based on the abstract,, Blood pressure  , Placebo , Vitamin D3 (cholecalciferol) supplementation ,0,
edin,4218,4950066,No significant difference,"Among the secondary outcomes, there were no differences comparing D2 with placebo (Figure 4A) or D3 with placebo (Figure 4B) for anthropometric measures, blood pressure, hsCRP, CVD risk, assessed by UKPDS risk engine, hepatic markers, or fructosamine.", Blood pressure  , Placebo , Vitamin D3 (cholecalciferol) supplementation ,0,
edin,4229,2361515,Cannot tell based on the abstract,, Time to tumor progression , Irinotecan + Raltitrexed , Oxaliplatin + Raltitrexed ,0,
edin,4229,2361515,No significant difference,Median time to progression was 8.2 months for arm A and 8.8 months for arm B., Time to tumor progression , Irinotecan + Raltitrexed , Oxaliplatin + Raltitrexed ,0,
edin,4234,5846971,Significantly decreased,"Between 3 and 9 months, environmental quality of life decreased among RT1 compared to RT2 and RT3 (groupâÃâtime pâ=â.025).", Quality of life 3-9 months , Resistance training (Twice a week) , Resistance training (Once a week) ,0,
edin,4254,3897026,No significant difference,"There were no differences in the recovery time (17.3 Â± 3.4 in the case group vs. 16.3 Â± 3 in the control group, P < 0.05), postoperative pain scores (5 Â± 1 in the case group vs. 5.6 Â± 2 in the control group, P < 0.05),", Post-Surgical Pain , Control , Ketamine ,0,
edin,4171,3314673,Cannot tell based on the abstract,, Perceived stress scale , No program , Second Life program ,0,
edin,4171,3314673,No significant difference,"<td align=""left"" colspan=""1"" rowspan=""1"">PSS</td><td align=""left"" colspan=""1"" rowspan=""1"">15.7Â±5.9</td><td align=""left"" colspan=""1"" rowspan=""1"">15Â±6.7</td><td align=""left"" colspan=""1"" rowspan=""1"">â0.7</td><td align=""left"" colspan=""1"" rowspan=""1"">0.501</td>,PSSâ=âperceived stress scale,", Perceived stress scale , No program , Second Life program ,0,
edin,4308,3937058,Significantly decreased,"Delivery cost per clinic was $152 for in-person consultations versus $100 for webinar consultations.,In-person and webinar delivery modes were both well received, but webinar AFIX consultations cost substantially less.", cost of intervention  , $152.45 for the in-person , $99.95 for the webinar ,0,
edin,4280,3678237,Cannot tell based on the abstract,, Motor arm Score improvement , Control , Erythropoietin ,0,
edin,4280,3678237,Significantly increased,"In this study, erythropoietin group had better outcome in comparison to control group. Total NIHSS was significantly lower in erythropoietin group. This effectwas of value in LOC Commands (P= 0.024), facial palsy (P= 0.003), motor arm (P= 0.0001), motor leg (P= 0.0001), sensory (P= 0.009), and best language (P= 0.023).", Motor arm Score improvement , Control , Erythropoietin ,0,
edin,4267,2360030,Cannot tell based on the abstract,, Response duration , Oxaliplatin , Irinotecan ,0,
edin,4267,2360030,No significant difference,The median duration of response was 6 (range: 3â15) for TEGAFIRI and 6 months (range: 3â23) for TEGAFOX group., Response duration , Oxaliplatin , Irinotecan ,0,
edin,4236,5846971,Significantly increased,Sense of coherence increased in RT2 compared to the control group and RT3 (groupâÃâtime pâ=â.032)., Sense of coherence , Resistance training (Three times a week) , Resistance training (Twice a week) ,0,
edin,4161,4758401,Cannot tell based on the abstract,, Elevation of glucose and glucagon after 1 hour , Insulin alone , Insulin + Pramlintide (all doses) ,0,
edin,4161,4758401,No significant difference,"Compared with placebo/insulin, all three pramlintide/insulin ratios produced marked and statistically equivalent reductions of increments of glucose and glucagon in the first hour, with levels subsequently increasing", Elevation of glucose and glucagon after 1 hour , Insulin alone , Insulin + Pramlintide (all doses) ,0,
edin,4187,2723123,Significantly decreased,"Statistically significant differences for mineral loss and lesion depth were found between the toothpaste and the mouth rinse as well as between the toothpaste and the control group, but not between the mouth rinse and the control group.,Within the limitations of this study, the results suggest that treatment of demineralised dentin with a toothpaste containing 5000 ppm fluoride may considerably reduce mineral loss and lesion depth on exposed dentin.", Depth of the lesion , Control (distilled water) , Fluoride toothpaste (5000 ppm)  ,0,
edin,4255,3897026,No significant difference,"There were no differences in the recovery time (17.3 Â± 3.4 in the case group vs. 16.3 Â± 3 in the control group, P < 0.05), postoperative pain scores (5 Â± 1 in the case group vs. 5.6 Â± 2 in the control group, P < 0.05), the consumption of anesthetic (9376.9 Â± 1245.8 in the case group vs. 9012.9 Â± 1620 in the control group, P < 0.05),", Anesthetic usage , Control , Ketamine ,0,
edin,4302,165418,Significantly increased,A trend towards a superior improvement in glycemic control was found in the paroxetine group (p = 0.08)., glycemic control , placebo , paroxetine ,0,
edin,4170,4632405,Significantly increased,JinqiÂ JiangtangÂ tabletÂ effectivelyÂ reducedÂ theÂ incidenceÂ ofÂ diabetes mellitusÂ and enhanced reversionÂ rate.Â comparedÂ withÂ theÂ controlÂ group (p< 0.05);, Pre-diabetes reversion , Placebo , JQJT tablets ,0,
edin,4273,1913602,Significantly decreased,"After adjusting for age, body mass index, an asset index, smoking, secondhand tobacco smoke, apparent temperature, season, day of week, time of day, and a random subject intercept, the improved stove intervention was associated with 3.7 mm Hg lower SBP [95% confidence interval (CI), â8.1 to 0.6] and 3.0 mm Hg lower DBP (95% CI, â5.7 to â0.4) compared with controls.", Systolic blood pressure  , Control , Improved cookstove ,0,
edin,4139,3713866,Significantly increased,"The difference between saliva secretion rates before and after medications was not significant for bromhexine users at two steps of the study (P=0.35); however, it was significant for pilocarpine users (P=0.0001).,Pilocarpine is probably more effective in improving xerostomia and its associated problems compared with bromhexine, although the use of the latter was also shown to ease some of the consequences of radiotherapy in the head and neck region.", Salivary secretion , No treatment , Pilocarpine ,0,
edin,4185,2723123,Significantly decreased,"Within the limitations of this study, the results suggest that treatment of demineralised dentin with a toothpaste containing 5000 ppm fluoride may considerably reduce mineral loss and lesion depth on exposed dentin.", Dentin mineral loss , Control  , Fluoride mouth rinse (250 ppm)  ,0,
edin,4135,5704449,Cannot tell based on the abstract,, Weight gained , Prenatal care only , Aerobic and resistance exercice + prenatal care ,0,
edin,4135,5704449,No significant difference,"There were no significant differences between the groups regarding maternal weight gain and BMI during the exercise programme period, TableÂ 2.Table 2", Weight gained , Prenatal care only , Aerobic and resistance exercice + prenatal care ,0,
edin,4158,3984795,Cannot tell based on the abstract,, Lipid profile improvement , Placebo , Omega-3 ,0,
edin,4158,3984795,Significantly increased,"In the omega-3 group, total cholesterol, triglycerides, LDL, and VLDL decreased and HDL increased significantly by 6.7% (P < 0.01). HDL increased by 23.2% and LDL decreased by 10.7%; triglycerides decreased by 7.78% and VLDL by 7.78% (P < 0.01) in the probiotic with omega-3 group, compared with baseline levels (Table 1).", Lipid profile improvement , Placebo , Omega-3 ,0,
edin,4177,4292865,Cannot tell based on the abstract,, Hemorrhage  , C-mode Endoscopic sphincterotomy , E-mode Endoscopic sphincterotomy ,0,
edin,4177,4292865,No significant difference,"There was no case of clinically evident hemorrhage in either group at the time of EST, 24 hours after EST, or within 7 days of randomization.", Hemorrhage  , C-mode Endoscopic sphincterotomy , E-mode Endoscopic sphincterotomy ,0,
edin,4174,3314673,Significantly decreased,There was a significant decrease of 2.8 points on the SCL-90-R Global Severity Index (p<0.05)., Anxiety Index of the SCL-90-r , No program , Second Life program ,0,
edin,4258,4648234,No significant difference,"Raw agreement between the expert group and sponsors was 0.74 in the concept and 0.78 in the ad hoc arm. Chance-corrected agreement was higher in the ad hoc (kappa: 0.34 (95% confidence interval = 0.10â0.58)) than in the concept arm (0.27 (0.06â0.50)), but the difference was not significant (p = 0.67).", Agreement between  Experts and Sponsors , Intuitive approach (ad hoc) , New law criteria (Concept) ,0,
edin,4193,5022334,No significant difference,"The differences between the two groups in the estimated intraoperative blood loss, postoperative hospital stay time, numbers of lymph node removed, postoperative thyroglobulin levels, and complications were not statistically significant (all P > 0.05).", Complications , Conventional open thyroidectomy  , Thyroidectomy via BABA ,0,
edin,4282,3678237,Significantly increased,"Evaluations revealed that in days14 and 28 during follow-up, Erythropoietin was effective in NIHSS (P= 0.0001). This effect was of value in level of consciousness Commands (P= 0.024), facial palsy (P= 0.003), motor arm (P= 0.0001), motor leg (P= 0.0001), sensory (P= 0.009), and best language (P= 0.023).", Sensory score improvement , Control , Erythropoietin ,0,
edin,4237,5947263,Cannot tell based on the abstract,, AUC (FEV1)/h , Approved inhaler , Procaterol hydrochloride inhaler ,0,
edin,4237,5947263,No significant difference,"The mean Â± SD AUC (FEV1)/h was 2.41 Â± 0.73 L for the new DPI and 2.37 Â± 0.75 L for the approved DPI. The mean of differences in AUC (FEV1)/h between the 2 DPIs was 0.04 Â± 0.09 L (Table 2).,Results of ANOVA showed no significant group or carryover effects for either AUC (FEV1)/h and maximum FEV1 (P = .50 and P = .59, respectively), and no significant period effects for either AUC (FEV1)/h and maximum FEV1 (P = .19 and P = .42, respectively) (Table 3).", AUC (FEV1)/h , Approved inhaler , Procaterol hydrochloride inhaler ,0,
edin,4179,4292865,Cannot tell based on the abstract,, Perforation , C-mode Endoscopic sphincterotomy , E-mode Endoscopic sphincterotomy ,0,
edin,4179,4292865,No significant difference,No patients experienced perforation., Perforation , C-mode Endoscopic sphincterotomy , E-mode Endoscopic sphincterotomy ,0,
edin,4235,5846971,Significantly increased,"Between baseline and 9 months, environmental quality of life increased in RT2 compared to all other groups (groupâÃâtime pâ=â.011).", Quality of life 0-9 months , Resistance training (Three times a week) , Resistance training (Twice a week) ,0,
edin,4279,3678237,Significantly increased,"Evaluations revealed that in days14 and 28 during follow-up, Erythropoietin was effective in NIHSS (P= 0.0001). This effect was of value in level of consciousness Commands (P= 0.024), facial palsy (P= 0.003), motor arm (P= 0.0001), motor leg (P= 0.0001), sensory (P= 0.009), and best language (P= 0.023).", Facial palsy score improvement , Control , Erythropoietin ,0,
edin,4142,3713866,Significantly decreased,"Users of both drugs showed significant differences in improvement of xerostomia, chewing, swallowing, tasting and mouth burning", Xerostomia  , No treatment , Bromhexine ,0,
edin,4205,4253794,Significantly increased,Intubation time was longer in the GVL group (9.80 Â± 1.27 s) than in the MDL group (8.20 Â± 1.17 s) (P < 0.05)., Time needed to intubate , Macintosh direct laryngoscope , GlideScope video-laryngoscope ,0,
edin,4208,4253794,Significantly decreased,"MAP, pulse rate, and RPP were lower in the GVL than the MDL group after endotracheal intubation (P < 0.05).", Mean arterial blood pressure (after 5 minutes) , Macintosh direct laryngoscope , GlideScope video-laryngoscope ,0,
edin,4213,4610679,Cannot tell based on the abstract,, Glucose measurement frequency , No HRA , Health risk assessment (HRA) ,0,
edin,4213,4610679,Significantly decreased,"<td align=""left"" colspan=""1"" rowspan=""1"">Glucose measurement in past 3 y</td><td align=""left"" colspan=""1"" rowspan=""1"">670 (81.0)</td><td align=""left"" colspan=""1"" rowspan=""1"">1,014 (76.8)</td><td align=""left"" colspan=""1"" rowspan=""1"">1.29 (1.03â1.62)</td><td align=""left"" colspan=""1"" rowspan=""1"">0.03</td>", Glucose measurement frequency , No HRA , Health risk assessment (HRA) ,0,
edin,4233,5846971,Significantly increased,"After 3 months, there was an intervention effect on environmental quality of life (groupâÃâtime pâ=â.048).", Quality of life after 3 months , No training , Resistance training (Twice a week) ,0,
edin,4285,3557008,Cannot tell based on the abstract,, Heart rate , Control (nothing) , Saline ,0,
edin,4285,3557008,No significant difference,No significant change in PR was detected in normal saline group (93.9 Â± 18.3 vs. 93.8 Â± 17.2 beats/min; P = 0.938) or the Ephedrine group (100.1 Â± 20.9 vs. 97.6 Â± 12.9; P = 0.341)., Heart rate , Control (nothing) , Saline ,0,
edin,4188,5022334,Significantly increased,"he mean operative time of the robotic group was longer than that of the conventional open approach group (118.8 Â± 16.5 min vs. 90.7 Â± 10.3 min, P < 0.05).", Surgery time , Conventional open thyroidectomy  , Thyroidectomy via BABA ,0,
edin,4145,4636858,No significant difference,"MRI plaques number reduced in groups significantly (2.29 vs. 2.17) without significant difference between the groups (P = 0.782). Six months after trial completion, plaques number increased in groups without significantly difference (0.72 vs. 0.77, P = 0.611)", Multiple sclerosis plaques  , No treatment , Mitoxantrone + methylprednisolone ,0,
edin,4150,4164149,No significant difference,"In addition, rates of initial positive Î²-hCG (56.4% subcutaneous versus 59.0% vaginal; 95% CI â9.5, 4.3),", Positive Î²-hCG at start , Vaginal progesterone , Subcutaneous progesterone ,0,
edin,4134,5704449,Cannot tell based on the abstract,, Triglycerides  , Prenatal care only , Aerobic and resistance exercice + prenatal care ,0,
edin,4134,5704449,Significantly decreased,"<td>âTriglycerides, mg/dL</td><td>139 (62)</td><td>116 (37)</td><td>195 (45)</td><td>199 (42)</td><td>â28 (1 to 55)</td><td>0.03</td>", Triglycerides  , Prenatal care only , Aerobic and resistance exercice + prenatal care ,0,
edin,4189,5022334,Significantly decreased,"The study showed significant differences between the two groups in terms of the VASs (2.1 Â± 1.0 vs. 3.8 Â± 1.2, P < 0.05)", Visual analogue scale , Conventional open thyroidectomy  , Thyroidectomy via BABA ,0,
edin,4175,4292865,No significant difference,"The complications occurred in 20 (11.2%) patients from the E-mode group: pancreatitis in 6 (3.4%) and endoscopically evident bleeding in 14 (7.8%). In contrast, the complications occurred in 25 (13.8%) patients from the C-mode group: pancreatitis in 7 (3.9%) and endoscopically evident bleeding in 18 (9.9%), although these findings were not statistically significant.", Pancreatitis , C-mode Endoscopic sphincterotomy , E-mode Endoscopic sphincterotomy ,0,
edin,4301,165418,Cannot tell based on the abstract,, improvement in GHbA1c , placebo , paroxetine ,0,
edin,4301,165418,No significant difference,"After ten weeks we found that the mean decrease of the GHbA1c value in the paroxetine group was 0.44%-units (Table 2). There was a trend towards a more beneficial outcome in the paroxetine group, as GHbA1c in the placebo group decreased only 0.07%-units (U = 9.0, p = 0,08).", improvement in GHbA1c , placebo , paroxetine ,0,
edin,4202,5124283,No significant difference,"However, the plasma CXCL4L1, CXCL1, macrophage migration inhibitory factor (MIF) and human plasminogen activator inhibitor 1 (PAI-1) levels did not significantly change following anthocyanin supplementation.", Macrophage migration inhibitory factor  , Placebo , Purified anthocyanins ,0,
edin,4133,5704449,Cannot tell based on the abstract,, Low density lipoprotein , Prenatal care only , Aerobic and resistance exercice + prenatal care ,0,
edin,4133,5704449,Significantly decreased,"At the end of the intervention programme, the multivariable analysis, which we adjusted for baseline levels, showed a difference between groups in LDL-c (-8Â mg/dL, 95%CI -3 to â29; Pâ<â0.001) and TG (â6Â mg/dL, 95%CI 1 to 11; Pâ=â0.03).", Low density lipoprotein , Prenatal care only , Aerobic and resistance exercice + prenatal care ,0,
edin,4263,5471755,Cannot tell based on the abstract,, Abdominal discomfort , Control , MLC601 ,0,
edin,4263,5471755,No significant difference,"Only 5 patients (14.7%) reported AEs in the MLC601 group, including nausea (8.8%), diarrhea (8.8%), constipation (5.8%), abdominal discomfort (2.9%), and anorexia.", Abdominal discomfort , Control , MLC601 ,0,
edin,4228,2361515,Cannot tell based on the abstract,, Duration of response , Irinotecan + Raltitrexed , Oxaliplatin + Raltitrexed ,0,
edin,4228,2361515,No significant difference,"Median duration of response was 7.9 and 9.2 months, respectively (P=0.696, log-rank test).", Duration of response , Irinotecan + Raltitrexed , Oxaliplatin + Raltitrexed ,0,
edin,4275,1913602,Significantly decreased,"After adjusting for age, body mass index, an asset index, smoking, secondhand tobacco smoke, apparent temperature, season, day of week, time of day, and a random subject intercept, the improved stove intervention was associated with 3.7 mm Hg lower SBP [95% confidence interval (CI), â8.1 to 0.6] and 3.0 mm Hg lower DBP (95% CI, â5.7 to â0.4) compared with controls.", Systolic blood pressure  , Improved cookstove + No smoking , Improved cookstove + smoking ,0,
edin,4290,4558453,Cannot tell based on the abstract,, Heart Rate in virtual immersive environment , No exercise , Exercise of moderate intensity ,0,
edin,4290,4558453,Significantly increased,"Heart rates showed significant increases from rest to No-Exercise and Exercise trials (F (3,51) = 39.63, p < 0.05), and these changes were consistent across the three levels of virtual environment exposure (Table 1).", Heart Rate in virtual immersive environment , No exercise , Exercise of moderate intensity ,0,
edin,4172,3314673,Significantly decreased,There was a significant decrease of 2.8 points on the SCL-90-R Global Severity Index (p<0.05)., Global Severity Index of the SCL 90-r , No program , Second Life program ,0,
edin,4192,5022334,No significant difference,"The differences between the two groups in the estimated intraoperative blood loss, postoperative hospital stay time, numbers of lymph node removed, postoperative thyroglobulin levels, and complications were not statistically significant (all P > 0.05).", Amount of lymph nodes removed , Conventional open thyroidectomy  , Thyroidectomy via BABA ,0,
edin,4153,4164149,Cannot tell based on the abstract,, Babies born alive , Vaginal progesterone , Subcutaneous progesterone ,0,
edin,4153,4164149,No significant difference,"No statistically significant differences between Prolutex and Endometrin were seen for any of the secondary efficacy variables, including rates of initial positive serum Î²-hCG, clinical pregnancy at 6â7 weeks of gestation, live birth,", Babies born alive , Vaginal progesterone , Subcutaneous progesterone ,0,
edin,4232,5846971,Significantly increased,"After 3 months, there was an intervention effect on environmental quality of life (groupâÃâtime pâ=â.048).", Quality of life after 3 months , No training , Resistance training (Once a week) ,0,
edin,4184,2723123,Significantly decreased,"Statistically significant differences for mineral loss and lesion depth were found between the toothpaste and the mouth rinse as well as between the toothpaste and the control group, but not between the mouth rinse and the control group.,Within the limitations of this study, the results suggest that treatment of demineralised dentin with a toothpaste containing 5000 ppm fluoride may considerably reduce mineral loss and lesion depth on exposed dentin.", Dentin mineral loss , Control (distilled water) , Fluoride toothpaste (5000 ppm)  ,0,
edin,4293,4704894,Cannot tell based on the abstract,, Intervention engagement for all groups over time , TTM based posts (later) , TTM based posts (beginning) ,0,
edin,4293,4704894,Significantly decreased,"As can be seen in Figure 1, intervention engagement with TTM posts decreased over time in each of the seven Facebook groups (range of correlation coefficients from -.81 to -.55; all P<.001) and the number of comments varied by group (F 6,505=29.7; P<.001).", Intervention engagement for all groups over time , TTM based posts (later) , TTM based posts (beginning) ,0,
edin,4223,3633335,Significantly decreased,"We found that the incidence of vomiting was lower in group II (17.5%), group IV (7.5%), and group VI (10%) compared with group I (55%), group III (27.5%), and group V (30%), respectively (P < 0.05). The incidence of vomiting was also lower in group III (27.5%) and group V (30%) when compared with group I (55%) (P < 0.05).,We conclude that compared with sevoflurane anesthesia alone, anesthesia with either propofol alone or propofol combined with sevoflurane resulted in a reduced incidence of vomiting and nausea during the first 24 h after surgery", Vomiting , Sevoflurane alone , Propofol alone ,0,
edin,4281,3678237,Significantly increased,"Evaluations revealed that in days14 and 28 during follow-up, Erythropoietin was effective in NIHSS (P= 0.0001). This effect was of value in level of consciousness Commands (P= 0.024), facial palsy (P= 0.003), motor arm (P= 0.0001), motor leg (P= 0.0001), sensory (P= 0.009), and best language (P= 0.023).", Best language score improvement , Control , Erythropoietin ,0,
edin,4155,3984795,Cannot tell based on the abstract,, Fasting blood glucose , Placebo , Probiotic (VSL#3) ,0,
edin,4155,3984795,Significantly decreased,"Fasting blood glucose (FBG) rose slightly in the placebo group but reduced significantly (P < 0.05) in the probiotic, omega-3, and probiotic + omega-3 combination groups.", Fasting blood glucose , Placebo , Probiotic (VSL#3) ,0,
edin,4231,2361515,Cannot tell based on the abstract,, Asthenia  , Irinotecan + Raltitrexed , Oxaliplatin + Raltitrexed ,0,
edin,4231,2361515,No significant difference,"Overall, asthenia was detected in 17 patients (35%) in arm A and in 24 patients (52%) in arm B. However, these differences were not significant from a statistical point of view (P=NS).", Asthenia  , Irinotecan + Raltitrexed , Oxaliplatin + Raltitrexed ,0,
edin,4278,3678237,Significantly increased,"Evaluations revealed that in days14 and 28 during follow-up, Erythropoietin was effective in NIHSS (P= 0.0001). This effect was of value in level of consciousness Commands (P= 0.024), facial palsy (P= 0.003), motor arm (P= 0.0001), motor leg (P= 0.0001), sensory (P= 0.009), and best language (P= 0.023)", Consciousness Commands improvement , Control , Erythropoietin ,0,
edin,4215,4950066,No significant difference,"There was no effect of vitamin D supplementation on HbA1c: D2 versus placebo: â0.05% [95% confidence interval (CI) â0.11, 0.02] or â0.51 mmol/mol (95% CI â1.16, 0.14; p = 0.13); D3 versus placebo: 0.02% (95% CI â0.04, 0.08) or 0.19 mmol/mol (95% CI â0.46, 0.83; p = 0.57).", Glycated hemoglobin , Placebo , Vitamin D3 (cholecalciferol) supplementation ,0,
edin,4210,4610679,Significantly increased,"At 2 y, favourable health behaviours and use of preventive care were more frequent in the intervention than in the control group (based on z-statistics from generalised estimating equation models). For example, 70% compared to 62% were physically active (odds ratio 1.43, 95% CI 1.16â1.77, p = 0.001),", Physical activity , No HRA , Health risk assessment (HRA) ,0,
edin,4164,4758401,Cannot tell based on the abstract,, Glucagon AUC 0â3 h , Insulin alone , Insulin + Pramlintide (all doses) ,0,
edin,4164,4758401,Significantly decreased,"Reductions of AUC0â3 h for glucagon for the 6, 9 and 12 mcg/U were 57, 59 and 55% (Table 1; all doses vs placebo: p < 0.05).", Glucagon AUC 0â3 h , Insulin alone , Insulin + Pramlintide (all doses) ,0,
edin,4239,5947263,Cannot tell based on the abstract,, Period effects for AUC (FEV1)/h , Approved inhaler , Procaterol hydrochloride inhaler ,0,
edin,4239,5947263,No significant difference,"Results of ANOVA showed no significant group or carryover effects for either AUC (FEV1)/h and maximum FEV1 (P = .50 and P = .59, respectively), and no significant period effects for either AUC (FEV1)/h and maximum FEV1 (P = .19 and P = .42, respectively) (Table 3).", Period effects for AUC (FEV1)/h , Approved inhaler , Procaterol hydrochloride inhaler ,0,
edin,4224,3633335,No significant difference,"he incidence of nausea was 55% in group I, 42.5% in group II, 30% in group III, 27.5% in group IV, 30% in group V, and 30% in group VI. Groups III and V had a lower incidence of nausea than group I (P < 0.05).,We conclude that compared with sevoflurane anesthesia alone, anesthesia with either propofol alone or propofol combined with sevoflurane resulted in a reduced incidence of vomiting and nausea during the first 24 h after surgery.,Administration of ondansetron effectively reduced the incidence of vomiting but not that of nausea for all three types of general anesthesia.", Nausea , Sevoflurane alone , Sevoflurane + Ondansetron ,0,
edin,4156,3984795,Cannot tell based on the abstract,, Fasting blood glucose , Placebo , Omega-3 ,0,
edin,4156,3984795,Significantly decreased,"Fasting blood glucose (FBG) rose slightly in the placebo group but reduced significantly (P < 0.05) in the probiotic, omega-3, and probiotic + omega-3 combination groups.", Fasting blood glucose , Placebo , Omega-3 ,0,
edin,4253,3897026,No significant difference,"There were no differences in the recovery time (17.3 Â± 3.4 in the case group vs. 16.3 Â± 3 in the control group, P < 0.05),", Recovery time , Control , Ketamine ,0,
edin,4137,5704449,Cannot tell based on the abstract,, Baby's weight at birth , Prenatal care only , Aerobic and resistance exercice + prenatal care ,0,
edin,4137,5704449,No significant difference,"here was no significant difference between the experimental and control groups regarding mean birth weight (3133âÂ±â406Â g versus 3013âÂ±â494Â g, Pâ=â0.34), low birth weight (< 2500Â g; (nâ=â3 versus nâ=â2) or high birth weight (> 4000Â g; nâ=â1 versus nâ=â0).", Baby's weight at birth , Prenatal care only , Aerobic and resistance exercice + prenatal care ,0,
edin,4181,3926947,Significantly decreased,There was less need for reminders in the IVR group (pâ=â0.000)., Need for reminders , Questionnaire sent by post , Interactive Voice Response ,0,
edin,4230,2361515,Significantly decreased,"In all, 14 patients (29%) from arm A and 24 patients (52%) from arm B had some grade of diarrhoea (P<0.03).", Diarrhoea of some grade , Irinotecan + Raltitrexed , Oxaliplatin + Raltitrexed ,0,
edin,4249,5015408,Cannot tell based on the abstract,, HASBLED score of â¥3 , No system , Electronic alert system ,0,
edin,4249,5015408,No significant difference,"On the other hand, 391 (44.0%) patients had a HASBLED score of â¥3. There was no difference in the proportion of patients with HASBLED score of â¥3 between the alert (208; 45.7%) and the control (183; 42.2%) groups (P=0.287).", HASBLED score of â¥3 , No system , Electronic alert system ,0,
edin,4277,1913602,Cannot tell based on the abstract,, Personal PM 2.5 , Control , Improved cookstove ,0,
edin,4277,1913602,Significantly decreased,Personal PM2.5 was about 61% lower on average and had a narrower distribution among the plancha improved stove group compared with the open fire group, Personal PM 2.5 , Control , Improved cookstove ,0,
edin,4138,5704449,Cannot tell based on the abstract,, Need for C-section , Prenatal care only , Aerobic and resistance exercice + prenatal care ,0,
edin,4138,5704449,No significant difference,"The experimental group showed a higher percentage in of Caesarean sections in comparison to the control group without significant differences (27% compared with 13%, Pâ=â0.89).", Need for C-section , Prenatal care only , Aerobic and resistance exercice + prenatal care ,0,
edin,4306,3937058,Significantly increased,"Clinics that received in-person and webinar consultations reported similar levels of participation on key programmatic activities with one exception: more webinar clinics reported improving documentation of previously administered, âhistoricalâ vaccine doses."," documentation for the previously given, âhistoricalâ vaccine doses ", in-person , webinar consultations ,0,
edin,4176,4292865,No significant difference,"The complications occurred in 20 (11.2%) patients from the E-mode group: pancreatitis in 6 (3.4%) and endoscopically evident bleeding in 14 (7.8%). In contrast, the complications occurred in 25 (13.8%) patients from the C-mode group: pancreatitis in 7 (3.9%) and endoscopically evident bleeding in 18 (9.9%), although these findings were not statistically significant.", Evident bleeding , C-mode Endoscopic sphincterotomy , E-mode Endoscopic sphincterotomy ,0,
edin,4074,3346068,Cannot tell based on the abstract,, patient satisfaction scores ,  placebo , liposome bupivacaine 266 mg ,0,
edin,4074,3346068,Significantly increased,"In the studies that included assessment of patient ratings of postsurgical analgesia (studies 1, 6, 7, 8, 9, and 10), the liposome bupivacaine group in study 9 showed statistically significantly better patient satisfaction scores than the comparator.", patient satisfaction scores ,  placebo , liposome bupivacaine 266 mg ,0,
edin,4222,3633335,Significantly decreased,"We conclude that compared with sevoflurane anesthesia alone, anesthesia with either propofol alone or propofol combined with sevoflurane resulted in a reduced incidence of vomiting and nausea during the first 24 h after surgery. Administration of ondansetron effectively reduced the incidence of vomiting but not that of nausea for all three types of general anesthesia.", Vomiting , Propofol alone , Propofol + Ondansetron ,0,
edin,4154,4164149,No significant difference,"In addition, rates of initial positive Î²-hCG (56.4% subcutaneous versus 59.0% vaginal; 95% CI â9.5, 4.3), clinical intrauterine pregnancy with fetal cardiac activity (42.6 versus 46.4%; 95% CI â10.8, 3.2), implantation defined as number of gestational sacs divided by number of embryos transferred (33.2 versus 35.1%; 95% CI â7.6, 4.0), live birth (41.1 versus 43.1%; 95% CI â8.9, 4.9) and take-home baby (41.1 versus 42.6%; 95% CI â8.4, 5.4) were comparable.", Babies taken home , Vaginal progesterone , Subcutaneous progesterone ,0,
edin,4167,4632405,No significant difference,theÂ scoresÂ ofÂ SF-36Â ofÂ twoÂ groupsÂ hadÂ noÂ significantÂ difference P> 0.05);, SF-36 questionnaire , Placebo , JQJT tablets ,0,
edin,4212,4610679,Significantly decreased,"At 8 y, based on an intention-to-treat analysis, the estimated proportion alive was 77.9% in the intervention and 72.8% in the control group, for an absolute mortality difference of 4.9% (95% CI 1.3%â8.5%, p = 0.009; based on z-test for risk difference).", Mortality rate (after 8 years) , No HRA , Health risk assessment (HRA) ,0,
edin,4206,4253794,No significant difference,"MAP, heart rate, and RPP returned to pre-intubation values at 3 and 4 minutes after intubation in the GVL and MDL groups, respectively (P < 0.05).", Increase in Rate pressure product (First 3 minutes) , Macintosh direct laryngoscope , GlideScope video-laryngoscope ,0,
edin,4151,4164149,No significant difference,"In addition, rates of initial positive Î²-hCG (56.4% subcutaneous versus 59.0% vaginal; 95% CI â9.5, 4.3), clinical intrauterine pregnancy with fetal cardiac activity (42.6 versus 46.4%; 95% CI â10.8, 3.2), implantation defined as number of gestational sacs divided by number of embryos transferred (33.2 versus 35.1%; 95% CI â7.6, 4.0), live birth (41.1 versus 43.1%; 95% CI â8.9, 4.9) and take-home baby (41.1 versus 42.6%; 95% CI â8.4, 5.4) were comparable.", Pregnancy with fetal cardiac activity (in uterus) , Vaginal progesterone , Subcutaneous progesterone ,0,
edin,4311,4139980,Cannot tell based on the abstract,, Serum lipids at 8 weeks , Placebo therapy , Omega-3 therapy ,0,
edin,4311,4139980,No significant difference,"After 8 weeks, there were no significant differences in serum HDL-C, LDL-C, total cholesterol and triglycerides.", Serum lipids at 8 weeks , Placebo therapy , Omega-3 therapy ,0,
edin,4340,5122613,No significant difference,No adverse effects related to study products were observed., Adverse events , Placebo , Digestion-resistant maltodextrin ,0,
edin,4333,3511947,Significantly increased,The durations of complete analgesia and effective analgesia were longer for all patients in group III compared with group II (P < 0.05) and group I (P < 0.005) patients., Complete analgesia and effective analgesia duration , Fentanyl and normal saline (group II) , Fentanyl and neostigmine (group III) ,0,
edin,4396,5590362,Cannot tell based on the abstract,The lowest mean pain score recorded in the massage group (0.92) whereas it was 4.84 in the breastfeeding group and 6.16 in the control group. ANOVA test and post-hoc statistics revealed that both interventions resulted in a significant reduction of the pain scores., Mean pain score , Massage (group 2) , Breastfeeding (group 1) ,0,
edin,4396,5590362,Significantly increased,"Mean scores of pain were 0.92, 6.16, and 4.84 in the massage, control, and breastfeeding groups, respectively, which showed a significant difference in pain scores (F = 437.50, P < 0.01).", Mean pain score , Massage (group 2) , Breastfeeding (group 1) ,0,
edin,4327,3557743,Cannot tell based on the abstract,, Days of post-surgical hospitalization  , Roux-en-Y gastric bypass , Laparoscopic sleeve gastrectomy ,0,
edin,4327,3557743,No significant difference,The median length of hospitalization after the operation was 6.0 (4-9) days in the RYGB group and 6.0 (range 4-77) days in the LSG group (p > 0.05)., Days of post-surgical hospitalization  , Roux-en-Y gastric bypass , Laparoscopic sleeve gastrectomy ,0,
edin,4380,3199060,Cannot tell based on the abstract,, Baseline characteristics , Traditional controllers , Motion-based controllers ,0,
edin,4380,3199060,No significant difference,There were no significant differences between groups on any sociodemographic variables., Baseline characteristics , Traditional controllers , Motion-based controllers ,0,
edin,4384,5986454,No significant difference,here was no significant difference in subjective feelings and body temperature between the test drink conditions., Subjective feelings and body temperature , Isoenergetic placebo drink , Acidified milk protein drink ,0,
edin,4351,5103733,Cannot tell based on the abstract,, Serum levels of CK , Control group , Esmolol group ,0,
edin,4351,5103733,Significantly increased,"The serum levels of CK (Fig. 2B) did not show any significant difference between the two groups at four of the five time points (baseline, before aortic cannulation, before aortic cross-clamp and 120 min after the release of aortic cross-clamp); however, the levels were significantly higher in the esmolol group compared with the control group (esmolol group, 125.67Â±30.81 IU/ml; control group, 89.67Â±23.31 IU/ml; P=0.002).", Serum levels of CK , Control group , Esmolol group ,0,
edin,4379,3199060,Significantly increased,"n interaction was found such that in one pair, motion control (mean [SD] 0.96 [0.20]âkcal Â· kgâ1 Â· hrâ1) produced 0.10âkcal Â· kgâ1 Â· hrâ1 (95% confidence interval 0.03 to 0.17) greater energy expenditure than traditional control (0.86 [0.17]âkcal Â· kgâ1 Â· hrâ1, P = .048).", Energy expenditure , Traditional controllers , Motion-based controllers ,0,
edin,4391,5018700,No significant difference,The incidence of complications was comparable among the groups., Rate of complications , Fentanyl (Group F) , Oxycodone (Group O/70 and Group O/100) ,0,
edin,4386,5986454,Cannot tell based on the abstract,, RMSSD and HF , Isoenergetic placebo drink , Acidified milk protein drink ,0,
edin,4386,5986454,Significantly increased,"Among the HRV indices calculated, RMSSD and HF were significantly higher when they ingested the milk protein drink compared with the placebo drink (p = 0.019 and p = 0.029, respectively), as shown in Figure 4.", RMSSD and HF , Isoenergetic placebo drink , Acidified milk protein drink ,0,
edin,4406,4540107,Significantly decreased,Plasma TNF-Î± was significantly decreased in the DM60 group compared to the placebo group., Plasma TNF-Î± , Placebo , Dextromethorphan (DM60) ,0,
edin,4363,5588713,Cannot tell based on the abstract,, Coagulation parameters , Placebo , Nanoparticles ,0,
edin,4363,5588713,No significant difference,Comparison of coagulation parameters after bronchial segmental challenge with saline (placebo) or 100Â Î¼g nanoparticles showed no significant differences between those groups., Coagulation parameters , Placebo , Nanoparticles ,0,
edin,4339,5122613,Significantly decreased,"In the RMD group, the total CTT, left SCTT and rectosigmoidal SCTT decreased significantly compared to baseline (pÂ <Â 0.01 each; â13.3, â4.7, â8.7Â h, respectively).", Left SCTT , Placebo , Digestion-resistant maltodextrin ,0,
edin,4438,4128609,Cannot tell based on the abstract,, Mean âoffâ-time percentage during waking hours , Pramipexole immediate-release , Pramipexole extended-release ,0,
edin,4438,4128609,No significant difference,"The mean (SE) âoffâ-time percentage during waking hours at baseline for advanced PD patients was 27.78 (0.81) for ER and 30.80 (1.21) for IR, and decreased to 21.68 (1.53) at week 18 for ER and 22.46 (1.61) for IR, respectively (no statistical difference for superiority).", Mean âoffâ-time percentage during waking hours , Pramipexole immediate-release , Pramipexole extended-release ,0,
edin,4335,3511947,Cannot tell based on the abstract,"The total number of epidural top ups (rescue analgesia) required was less in group II (P < 0.05) and group III (P < 0.005) patients, compared with the control group.", Need of rescue analgesia , Normal saline (group I) , Fentanyl and neostigmine (group III) ,0,
edin,4335,3511947,Significantly decreased,The total number of epidural top ups (rescue analgesia) required was less in the fentanyl group (P < 0.05) and fentanylâneostigmine group (P < 0.005) compared with the control group., Need of rescue analgesia , Normal saline (group I) , Fentanyl and neostigmine (group III) ,0,
edin,4418,4317856,No significant difference,"In an efficacy analysis of 94 patients (DZ, 48; D, 46), the median progression-free survival was 2.7 months (95% confidence interval [CI], 1.5â3.5 months) for the DZ group and 2.6 months (95% CI, 1.5â3.4 months) for the D group (stratified log-rank test, P = 0.89).", Median progression-free survival , Docetaxel alone (group D) , Docetaxel with zoledronic acid (group DZ) ,0,
edin,4397,5590362,Significantly decreased,The lowest mean pain score recorded in the massage group (0.92) whereas it was 4.84 in the breastfeeding group and 6.16 in the control group. ANOVA test and post-hoc statistics revealed that both interventions resulted in a significant reduction of the pain scores., Mean pain score , Control (group 3) , Breastfeeding (group 1) ,0,
edin,4444,3941910,Significantly increased,"The results showed that MS media containing 1.5 mg/L kinetin along with 0.15 or 0.3 mg/L NAA produced the highest percentage of proliferated shoots. In addition, the percentage of proliferated shoots in MS medium containing 2.0 or 2.5 mg/L benzylaminopurine (BAP) + 0.15 mg/L NAA was significantly higher than the other treatments.", Number of proliferated shoots ," kinetin (1.5 mg/L) + NAA (0.3 mg/L), and/or MS media containing 0.15 mg/L NAA along with kinetin 1.5 or 2.0 mg/L ", MS medium containing 1.5 mg/L kinetin + 0.15 mg/L NAA ,0,
edin,4441,5047020,Significantly increased,"In hydroxyethyl starch (Voluven) and normal saline groups, base excess level after solution therapy increased about 9.65 and 5.46 volumes, respectively, in which augmentation in hydroxyethyl starch (Voluven) group is significantly higher than normal saline group (P â¤ 0.001).", Level of base excess after therapy , Normal saline , Hydroxyethyl starch (Voluven) ,0,
edin,4334,3511947,Significantly increased,The durations of complete analgesia and effective analgesia were longer for all patients in group III compared with group II (P < 0.05) and group I (P < 0.005) patients., Complete analgesia and effective analgesia duration , Normal saline (group I) , Fentanyl and neostigmine (group III) ,0,
edin,4374,5054596,Cannot tell based on the abstract,, IoF-scores improvement , Control , Direct grasping ,0,
edin,4374,5054596,Significantly increased,"A repeated measures ANOVA on the IoF-scores demonstrated a main effect of test, in that the four training groups and control group improved on IoF-scores on the posttest, RT1 and RT2 compared with the pretest and also improved from posttest to RT1 and RT2 (pâsâ<â.001 in pairwise comparison) (TableÂ 1).", IoF-scores improvement , Control , Direct grasping ,0,
edin,4331,3557743,No significant difference,There was no significant difference in the overall prevalence of comorbidities and nutritional deficiencies., Comorbidities , Roux-en-Y gastric bypass , Laparoscopic sleeve gastrectomy ,0,
edin,4326,3043099,Cannot tell based on the abstract,, Glucose area under the curve , NonHispanic whites , Mexican Americans ,0,
edin,4326,3043099,No significant difference,The pre-intervention IVGTT revealed no significant differences in glucose area under the curve between ethnic groups ( Figure 1 )., Glucose area under the curve , NonHispanic whites , Mexican Americans ,0,
edin,4404,4540107,Significantly decreased,"After 12 weeks, the DM60 group had significantly longer treatment retention and lower plasma morphine levels than did the placebo group.", Morphine levels in plasma , Placebo , Dextromethorphan (DM60) ,0,
edin,4328,3557743,No significant difference,"There was no 30-day mortality and no significant difference in major complication rate (0% after RYGB and 8.3% after LSG, p > 0.05) or minor complication rate (16.6% after RYGB and 10.1% after LSG, p > 0.05).", Rate of minor and major complications  , Roux-en-Y gastric bypass , Laparoscopic sleeve gastrectomy ,0,
edin,4354,4030712,Significantly decreased,"Analysis of variance demonstrated an overall treatment effect on distal radius BMD (p = 0.005), with the active treatment groups showing a lower rate of BMD loss when compared to the placebo group.", Rate of bone mineral density loss , Placebo , Calcium and vitamin D3 supplementation ,0,
edin,4350,5103733,Significantly decreased,"However, the serum level of cardiac troponin I was higher in patients of the control group compared with those of the esmolol group during the preoperative period (P<0.05).", Cardiac troponin I during the preoperative period , Control group , Esmolol group ,0,
edin,4394,4892327,Significantly increased,"Also, results indicated a significant increase in Bax/Bcl-2 ratio in ischemia group, compared to sham-operated group (P<0.001).", Bax/Bcl-2 ratio , Sham group , Ischemia group ,0,
edin,4312,4139980,Cannot tell based on the abstract,, Serum hemoglobin and ferritin levels at 8 weeks , Placebo therapy , Omega-3 therapy ,0,
edin,4312,4139980,No significant difference,Serum iron and ferritin level and hemoglobin had no significant differences as did for Erythropoietin need during study [Table 2]., Serum hemoglobin and ferritin levels at 8 weeks , Placebo therapy , Omega-3 therapy ,0,
edin,4313,4139980,No significant difference,Erythropoietin requirements also had no significant differences., Need of erythropoietin , Placebo therapy , Omega-3 therapy ,0,
edin,4419,4317856,No significant difference,"The median overall survival was 10.4 months (95% CI, 7.0â15.8 months) for the DZ group and 9.7 months (95% CI, 6.1â12.5 months) for the D group (stratified log-rank test, P = 0.62).", Median overall survival , Docetaxel alone (group D) , Docetaxel with zoledronic acid (group DZ) ,0,
edin,4411,5564145,Cannot tell based on the abstract,, Onset of local anesthesia , Single cartridges of 4% articaine , Double cartridges of 4% articaine ,0,
edin,4411,5564145,No significant difference,Table 2 shows the onset of local anesthesia and there was no significant difference (P > 0.05) between the groups despite the fact that the DC group had early onset of anesthesia compared to the SC group., Onset of local anesthesia , Single cartridges of 4% articaine , Double cartridges of 4% articaine ,0,
edin,4352,5292014,Significantly increased,"NCOVA showed that after adjusting for effects of pretest scores, the difference between mean scores on the scale of lifestyle related to vaginal health in the intervention group (28.48 Â± 0.38) and control group (23.65 Â± 1.23) was significant (P < 0.001).,According to the findings, educational intervention is beneficial in promoting three aspects of women's lifestyle related to vaginal health.", Improvement in mean scores of lifestyle-related vaginal health scale , Routine treatment , Educational intervention ,0,
edin,4435,4128609,No significant difference,"Non-inferiority was based on the primary endpoint, the change from baseline to end of maintenance (week 18) in the UPDRS (Parts IIâ+âIII) total score.,For the primary endpoint, the adjusted mean changes (standard error) of UPDRS Parts IIâ+âIII at week 18 were -13.81 (0.655) and -13.05 (0.643) for ER and IR formulations, respectively, using ANCOVA adjusted for treatment and centre (fixed effect) and baseline (covariate).", UPDRS total score , Pramipexole immediate-release , Pramipexole extended-release ,0,
edin,4382,5986454,Significantly increased,"Subjects showed a significant improvement in performance in the UchidaâKraepelin test, the primary outcome measured, when they consumed the acidified milk protein drink compared with the placebo control condition.", Improvement in UchidaâKraepelin test score  , Isoenergetic placebo drink , Acidified milk protein drink ,0,
edin,4367,4396730,Cannot tell based on the abstract,, LDL-C and blood pressure , Placebo , Sulodexide composed of 80% fast-moving heparin and 20% dermatan sulfate ,0,
edin,4367,4396730,No significant difference,"Moreover, body weight, fasting plasma glucose, hemoglobin A1C, LDL-cholesterol, systolic blood pressure, and diastolic blood pressure were comparable in both groups and did not change significantly throughout the study (Table 2).", LDL-C and blood pressure , Placebo , Sulodexide composed of 80% fast-moving heparin and 20% dermatan sulfate ,0,
edin,4332,3511947,Significantly decreased,Overall 24-h visual analog score in group III was significantly less than in those who received fentanyl alone (P = 0.00)., 24-h visual analog score , Fentanyl and normal saline (group II) , Fentanyl and neostigmine (group III) ,0,
edin,4376,5054596,Cannot tell based on the abstract,, Force required to pick-up an object , Combination , Indirect grasping ,0,
edin,4376,5054596,Significantly decreased,"A large main effect of group was found for the grasp force when grasping the object, which showed that the IG group required less force than the COM group in order to pick up an object (pâ<â0.05 in pairwise comparisons).", Force required to pick-up an object , Combination , Indirect grasping ,0,
edin,4388,5018700,No significant difference,"The 2 oxycodone groups showed no significant differences in MBP, HR, SpO2, and BIS compared to Group F at the time points assessed. T", Heart rate , Fentanyl (Group F) , Oxycodone (Group O/70 and Group O/100) ,0,
edin,4387,5018700,No significant difference,"The 2 oxycodone groups showed no significant differences in MBP, HR, SpO2, and BIS compared to Group F at the time points assessed.", Mean blood pressure , Fentanyl (Group F) , Oxycodone (Group O/70 and Group O/100) ,0,
edin,4442,5047020,Cannot tell based on the abstract,, Incidence of adverse events , Normal saline , Hydroxyethyl starch (Voluven) ,0,
edin,4442,5047020,Cannot tell based on the abstract,, Incidence of adverse events , Normal saline , Hydroxyethyl starch (Voluven) ,0,
edin,4442,5047020,No significant difference,"Besides, in neither of the two groups, adverse reaction to the received solutions was observed.", Incidence of adverse events , Normal saline , Hydroxyethyl starch (Voluven) ,0,
edin,4399,5590362,Cannot tell based on the abstract,, Weight at randomization , Control (group 3) , Breastfeeding (group 1) or Massage (group 2) ,0,
edin,4399,5590362,No significant difference,"As mentioned before, randomization was successful as there was no significant difference in groups concerning age, sex, and weight.", Weight at randomization , Control (group 3) , Breastfeeding (group 1) or Massage (group 2) ,0,
edin,4410,5564145,Significantly increased,The DC of 4 % articaine had a significantly higher success rate (83.3%) than did the SC (53.3%; P < 0.05)., Success rate , Single cartridges of 4% articaine , Double cartridges of 4% articaine ,0,
edin,4362,5588713,Cannot tell based on the abstract,, Leukocytes in blood , Placebo , Nanoparticles ,0,
edin,4362,5588713,Significantly increased,There was a significant dose-dependent increase in blood neutrophils (Spearman pÂ =Â 0.0468) and a trend towards increased blood leukocytes (pÂ =Â 0.061) after challenge with carbon nanoparticles as compared to placebo., Leukocytes in blood , Placebo , Nanoparticles ,0,
edin,4381,3199060,Cannot tell based on the abstract,, Enjoyment by playing Resident evil , Traditional controllers , Motion-based controllers ,0,
edin,4381,3199060,Significantly increased,The motion-controlled Resident Evil game produced a 1.39 (95% CI 0.84â1.95) point higher enjoyment rating (on a scale of 1â7) than the traditionally controlled Resident Evil game., Enjoyment by playing Resident evil , Traditional controllers , Motion-based controllers ,0,
edin,4361,5588713,Cannot tell based on the abstract,, Adverse events , Placebo , Nanoparticles ,0,
edin,4361,5588713,No significant difference,"Interim analysis, as assessed by the DSMB, after completion of each dose-group showed no significant adverse events, symptoms, or doubling of white blood cell counts.", Adverse events , Placebo , Nanoparticles ,0,
edin,4349,5103733,Significantly increased,"No significant differences in hemodynamic parameters, including the central venous pressure and heart rate, were detected between patients in the two groups during the perioperative period or within the first 12 h post-surgery (P>0.05), except for the mean arterial pressure, which was higher in the esmolol group compared with the control group at 5 and 12 h post-surgery (P<0.05).", Mean arterial pressure after the surgery , Control group , Esmolol group ,0,
edin,4348,5103733,No significant difference,"No significant differences in hemodynamic parameters, including the central venous pressure and heart rate, were detected between patients in the two groups during the perioperative period or within the first 12 h post-surgery (P>0.05),", Heart rate , Control group , Esmolol group ,0,
edin,4323,4283272,Cannot tell based on the abstract,, Hypoglyacemic events , Placebo , Sitagliptin and lansoprazole ,0,
edin,4323,4283272,No significant difference,The frequencies of various adverse events and the frequencies of hypoglyacemic events did not differ significantly between the two groups (table 3)., Hypoglyacemic events , Placebo , Sitagliptin and lansoprazole ,0,
edin,4342,5551190,Cannot tell based on the abstract,, Distance ran , Nature-based images , Self-selected entertainment ,0,
edin,4342,5551190,Significantly increased,"Distance run was influenced by the designs, F (29) = 10.572, p < 0.05, pÆ2 = 0.2 with participants in the self-selected entertainment condition (3066.8 Â± 688.5 m) running longer distances than the static image condition (2767.2 Â± 662.6 m) (p < 0.05).", Distance ran , Nature-based images , Self-selected entertainment ,0,
edin,4341,5122613,Cannot tell based on the abstract,, Baseline characteristics and diet , Placebo , Digestion-resistant maltodextrin ,0,
edin,4341,5122613,No significant difference,"The two study groups were well balanced with respect to demographics and baseline characteristics, and no significant difference was found in any of the variables between groups.", Baseline characteristics and diet , Placebo , Digestion-resistant maltodextrin ,0,
edin,4353,5292014,Cannot tell based on the abstract,, Demographic characteristics and vaginitis relapse , Routine treatment , Educational intervention ,0,
edin,4353,5292014,No significant difference,"<td colspan=""1"" rowspan=""1"" style=""padding-left: 20pt;"">Two times</td><td colspan=""1"" rowspan=""1"" style=""text-align: center;"">72 (41.1)</td><td colspan=""1"" rowspan=""1"" style=""text-align: center;"">56 (32.6)</td><td colspan=""1"" rowspan=""1"" style=""text-align: center;""></td>", Demographic characteristics and vaginitis relapse , Routine treatment , Educational intervention ,0,
edin,4412,5564145,Cannot tell based on the abstract,, Duration of surgery , Single cartridges of 4% articaine , Double cartridges of 4% articaine ,0,
edin,4412,5564145,No significant difference,"However, the difference in surgical time between SC and DC had no statistical significance (P > 0.05).", Duration of surgery , Single cartridges of 4% articaine , Double cartridges of 4% articaine ,0,
edin,4407,4540107,No significant difference,"However, changes in plasma cytokine levels, BDNF levels, and the methadone dose required in the three groups were not significantly different.", Methadone requirement , Placebo , Dextromethorphan (DM60 and DM120) ,0,
edin,4432,5726464,Cannot tell based on the abstract,, Glucose and insulin , Placebo , Vitamin D plus calcium supplementation ,0,
edin,4432,5726464,No significant difference,"Between-arm differences were not significant for glucose, insulin, or HOMA-IR changes at either week 24 or week 48 (P > .05 for all).", Glucose and insulin , Placebo , Vitamin D plus calcium supplementation ,0,
edin,4416,3829814,Cannot tell based on the abstract,,  Lung function and asthma symptoms , Placebo , Lactobacillus casei Shirota ,0,
edin,4416,3829814,No significant difference,"There were no differences between the two groups for TNSS, PNIF, asthma symptoms or lung function at any of the time points following the nasal allergen challenge before or after the intervention period (Fig. 2).",  Lung function and asthma symptoms , Placebo , Lactobacillus casei Shirota ,0,
edin,4390,5018700,No significant difference,"The 2 oxycodone groups showed no significant differences in MBP, HR, SpO2, and BIS compared to Group F at the time points assessed.", Bispectral index , Fentanyl (Group F) , Oxycodone (Group O/70 and Group O/100) ,0,
edin,4415,3829814,Significantly increased,"Delivery of probiotic also suppressed production of sCD23 (pâ=â0.0081), TGF-Î² (pâ=â0.0283) and induced increased production of IFN-Î³ (pâ=â0.0351) in supernatants of cultured peripheral blood.", Production of IFN-Î³ , Placebo , Lactobacillus casei Shirota ,0,
edin,4359,4395675,Cannot tell based on the abstract,, Overall balance ability , Gait training alone , Gait training with constrained induced movement therapy ,0,
edin,4359,4395675,Significantly increased,"The experimental group showed an improvement of 28.6% in dynamic balance as determined by the TIS, and of 34.3% in movement distances of the paretic side as determined by the LOS, and the changes in dynamic balance were significantly larger in the experimental group than in the control group, which showed no significant improvements in balance ability after gait training.", Overall balance ability , Gait training alone , Gait training with constrained induced movement therapy ,0,
edin,4316,5920342,Cannot tell based on the abstract,, Time of hospitalization after the surgery , No monitoring , Soleus muscle H-reflex monitoring ,0,
edin,4316,5920342,Significantly decreased,"The operation time in observation group (65.5Â±2.1 min) was shorter than that in control group (76.5Â±3.2 min) (t=18.176, P<0.05); the intraoperative blood loss amount in observation group (28.9Â±1.7 ml) was less than that in control group (56.8Â±5.6 ml) (t=30.151, P<0.05); the postoperative hospitalization time in observation group (5.9Â±1.1 days) was shorter than that in control group (8.1Â±1.5 days) (t=7.378, P<0.05; Fig. 1).", Time of hospitalization after the surgery , No monitoring , Soleus muscle H-reflex monitoring ,0,
edin,4373,5054596,Cannot tell based on the abstract,"On a kinematic level movement times decreased and hook closing velocities increased over time.,During training movement times decreased and the indirect grasping group showed advantages. It is advisable to start body-powered training with indirect grasping tasks but also to practice hook-object orientations.", Movement times ," Direct grasping, fixation, or combination ", Indirect grasping ,0,
edin,4373,5054596,Significantly decreased,"On a kinematic level movement times decreased and hook closing velocities increased over time. The indirect grasping group showed significantly shorter plateau times than the other training groups,During training movement times decreased and the indirect grasping group showed advantages.", Movement times ," Direct grasping, fixation, or combination ", Indirect grasping ,0,
edin,4319,4283272,Cannot tell based on the abstract,, C-peptide AUC , Placebo , Sitagliptin and lansoprazole ,0,
edin,4319,4283272,No significant difference,"During the course of the study, the C-peptide AUC fell to a similar extent and significantly from baseline in each group (table 2); comparison of these differences was not significant (p=0Â·91; figure 2A)", C-peptide AUC , Placebo , Sitagliptin and lansoprazole ,0,
edin,4385,5986454,Cannot tell based on the abstract,, Net incremental area under the curve , Isoenergetic placebo drink , Acidified milk protein drink ,0,
edin,4385,5986454,Significantly increased,"To assess the postprandial effect of the drinks throughout the testing time, the net incremental area under the curve (niAUC), calculated from the pre- and postprandial time points, were tested.,The niAUC was significantly higher when subjects consumed the acidified milk protein drink compared to the placebo drink (p = 0.044).", Net incremental area under the curve , Isoenergetic placebo drink , Acidified milk protein drink ,0,
edin,4371,4198846,Significantly increased,The total ITAQ score also showed significant improvement in both groups over the three months and the degree of improvement was significantly greater in the CRT group than in the TAU group., Improvement in the Insight and Treatment Attitude Questionnaire , Treatment as usual , Cognitive remediation therapy ,0,
edin,4392,4892327,Significantly increased,"The number of active caspase-3-positive neurons in CA1 area were significantly increased in ischemia group, compared to sham-operated group (P<0.001)", Active caspase-3-positive neurons in CA1 area , Sham group , Ischemia group ,0,
edin,4439,2686715,Significantly increased,Highly significant improvements in motor performance were observed with MPH compared to baseline ratings on all the 17 subtests of the MFNU 1â2 hr after administration of MPH., Motor performance improvement , Placebo , Methylphenidate ,0,
edin,4347,5103733,No significant difference,"No significant differences in hemodynamic parameters, including the central venous pressure and heart rate, were detected between patients in the two groups during the perioperative period or within the first 12 h post-surgery (P>0.05),", Central venous pressure , Control group , Esmolol group ,0,
edin,4557,4855961,Significantly increased,"The postsupplementation levels of 25(OH)D were higher in Group 2K (42.86 Â± 12.83) than in Group 1K (36.96 Â± 10.56) with P value of 0.023.,We concluded that Vitamin D supplementation with 2000 IU/day or 60,000 IU/month is very effective and safe in achieving Vitamin D sufficiency in pregnant women.",  25-hydroxyvitamin D , Control , 60.000 IU monthly ,0,
edin,4654,5457252,Cannot tell based on the abstract,, Shear bond strength , Control , 1.0 M EDC treatment  ,0,
edin,4654,5457252,Significantly decreased,"The SBS was significantly influenced by the 1.0 M EDC concentration (P < 0.0001); specifically, the mean SBS dropped dramatically compared with the other groups.", Shear bond strength , Control , 1.0 M EDC treatment  ,0,
edin,4635,4823346,Cannot tell based on the abstract,, Return to work , Semi-rigid ankle support  , Tape ,0,
edin,4635,4823346,No significant difference,"<td align=""left"">&nbsp;Below level</td><td align=""left"">15&nbsp;% (8/55)</td><td align=""left"">12&nbsp;% (5/41)</td><td align=""left"">11&nbsp;% (5/44)</td><td align=""left""></td>,TableÂ 3", Return to work , Semi-rigid ankle support  , Tape ,0,
edin,4616,2427034,Significantly increased,The A2143G mutation rate among the 23S rRNA-positive subjects in the OAC group [31.7% (13/41)] was significantly higher than that in the OA group [10.2% (16/157)] and the placebo group [13.8% (36/260)]., A2143G mutation , Placebo , Amoxicillin + Omeprazole + Clarithromycin ,0,
edin,4589,4149239,No significant difference,<td>C-peptide</td><td></td><td></td><td></td><td></td><td></td>, Glucagon-like peptide-1 , Voglibose , Sitagliptin ,0,
edin,4650,3095445,Cannot tell based on the abstract,, Postmicturition score improvement , Control , Naftopidil 75 mg ,0,
edin,4650,3095445,Significantly increased,"The 75âmg group showed improvement in all of these in a time-dependent and dose-dependent manner (baseline versus 4 weeks after treatment: P < .001 in all; 4 weeks after treatment versus 8 weeks after treatment: P = .019, P = .057, P = .047, P = .057, and P = .003, resp.), although the difference in the storage and postmicturition scores were of borderline significance between at 4 weeks and 8 weeks (Figures 1(b) and 1(d)).", Postmicturition score improvement , Control , Naftopidil 75 mg ,0,
edin,4491,5880177,Cannot tell based on the abstract,, Risk of death , Being on Class 3 , Being on Class 1 ,0,
edin,4491,5880177,Significantly increased,"As compared with class 3, class 1 (OR: 2.76; 95% CI [1.38â5.82]) was associated with higher risk of death.", Risk of death , Being on Class 3 , Being on Class 1 ,0,
edin,4584,4941128,Cannot tell based on the abstract,, Tremor improvement , Control , Adaptive deep brain stimulation ,0,
edin,4584,4941128,Significantly increased,"Remaining items, including tremor, speech, facial expression and freezing, improved by 55Â±12%.,There was a substantial improvement with aDBS in every participant (43% reduction: t3=3.24, p=0.04; Cohen's d=1.62).", Tremor improvement , Control , Adaptive deep brain stimulation ,0,
edin,4488,5448649,Cannot tell based on the abstract,, IFNÃ¢â¬ï¿½ÃÂ³ spot numbers , Control , Cyclophosphamide ,0,
edin,4488,5448649,No significant difference,"The numbers of wells positive for IFNâÎ³ spots among total wells examined were 16 of 93 (17%) or 16 of 105 (15%) wells in preâvaccination PBMC, 23 of 78 (29%) or 20 of 93 (22%) at the 6th vaccination, and 31 of 58 (58%) or 20 of 44 (45%) at the 12th vaccination in the PPV/CPA or PPV alone, respectively,Although not statistically significant (P = 0.334), the increase of IFNâÎ³ spot numbers per well in the PPV/CPA tended to be greater than that in the PPV alone at the 12th vaccination (Fig. 2a).", IFNÃ¢â¬ï¿½ÃÂ³ spot numbers , Control , Cyclophosphamide ,0,
edin,4562,4359119,Cannot tell based on the abstract,, Mental health score , MOR approach , PASTOR approach ,0,
edin,4562,4359119,No significant difference,"For mental health score (SF 12), and total activity sub score (FFkA), as well as further endurance related responses to pain (AEQ) there were no differences between both groups at the end of rehabilitation, as well as at the 12-month follow-up (Table 6, Table 8).", Mental health score , MOR approach , PASTOR approach ,0,
edin,4524,5010179,Cannot tell based on the abstract,, Recurrence-free survival , Control , Uracil-tegafur and leucovorin ,0,
edin,4524,5010179,Significantly increased,"The recurrence-free survival curves of the UFT/LV group (red line) and surgery alone group (black line) group are shown. The 3-year recurrence-free rate was significantly higher in the UFT/LV group than in the surgery alone group (38.6% vs. 32.3%, P = 0.003).", Recurrence-free survival , Control , Uracil-tegafur and leucovorin ,0,
edin,4494,5874317,Cannot tell based on the abstract,, Knee flexion (1-rep Max) , Unilateral training , Bilateral training ,0,
edin,4494,5874317,Significantly increased,"Results from between-group analyses are illustrated in Figure 2. The beneficial changes in 1RM_KE (8.1% [CL90%: 4.2; 11.8]; QC = 99/0/0%; p = 0.074) and 1RM_KF (6.7% [CL90%: 2.8; 10.4]; QC = 98/1/0%; p = 0.004),", Knee flexion (1-rep Max) , Unilateral training , Bilateral training ,0,
edin,4461,5360998,Cannot tell based on the abstract,, Good TMT-A results , Being in the Stop gruop , Being in the Safe gruop ,0,
edin,4461,5360998,Significantly decreased,"TMT-A, TMT-B, and MOCA-K showed significant differences between the three groups.,Additionally, the caution group showed higher ability in the TMT-B and MOCA-K than the stop group.,<td align=""left"" colspan=""1"" rowspan=""2"" valign=""top"">TMT</td><td align=""left"" colspan=""1"" rowspan=""1"">TMT-A (second)</td><td align=""center"" colspan=""1"" rowspan=""1"">46.88 Â± 13.45<sup>a*</sup></td><td align=""center"" colspan=""1"" rowspan=""1"">62.65 Â± 30.39</td><td align=""center"" colspan=""1"" rowspan=""1"">83.25 Â± 30.00<sup>a*</sup></td><td align=""center"" colspan=""1"" rowspan=""1"">4.362*</td>", Good TMT-A results , Being in the Stop gruop , Being in the Safe gruop ,0,
edin,4588,4149239,No significant difference,<td>C-peptide</td><td></td><td></td><td></td><td></td><td></td>, Gastric inhibitory polypeptide , Voglibose , Sitagliptin ,0,
edin,4609,2630316,Cannot tell based on the abstract,,  Health related quality of life (physical) , Care at clinic , Care at home ,0,
edin,4609,2630316,No significant difference,Health related quality of life scores physical (PCS) and mental component scores (MCS) were not statistically different between the groups,  Health related quality of life (physical) , Care at clinic , Care at home ,0,
edin,4652,3095445,Cannot tell based on the abstract,, Postmicturition score improvement , Control , Naftopidil 50 mg ,0,
edin,4652,3095445,Significantly decreased,"In the 50âmg group, all of these scores reduced 4 weeks after treatment compared with those at baseline (P = .004, P = .015, P = .020, P = .041, and P < .001, resp.); these scores were not different between 4 weeks and 8 weeks after treatment (Figures 1(a)â1(e)), although the difference was of borderline significance regarding the QOL score (P = .053).", Postmicturition score improvement , Control , Naftopidil 50 mg ,0,
edin,4556,4855961,Cannot tell based on the abstract,"Group 2 (n = 21), 30,000 IU",  25-hydroxyvitamin D , Control , 30.000 IU monthly ,0,
edin,4556,4855961,Significantly increased,"ne of the primary objectives of the study was to find the difference in the postsupplementation levels of 25(OH)D between Group 1K and 2K regimen. As shown in Table 3, there was a significant difference (P = 0.023) between these two groups with Group 2K showing higher levels.",  25-hydroxyvitamin D , Control , 30.000 IU monthly ,0,
edin,4651,3095445,Cannot tell based on the abstract,, Storage score improvement , Control , Naftopidil 50 mg ,0,
edin,4651,3095445,Significantly decreased,"n the 50âmg group, all of these scores reduced 4 weeks after treatment compared with those at baseline (P = .004, P = .015, P = .020, P = .041, and P < .001, resp.); these scores were not different between 4 weeks and 8 weeks after treatment (Figures 1(a)â1(e)), although the difference was of borderline significance regarding the QOL score (P = .053).", Storage score improvement , Control , Naftopidil 50 mg ,0,
edin,4532,1831486,Cannot tell based on the abstract,, Nicotine replacement therapy , Control , 1 auricular acupressure bead ,0,
edin,4532,1831486,No significant difference,"Reporting of NRT consumption was poor, with much missing data, but reporting of ratings of withdrawal symptom scores was nearly complete. However, these showed no significant changes or differences between groups for any week.", Nicotine replacement therapy , Control , 1 auricular acupressure bead ,0,
edin,4548,2892494,Significantly decreased,"Compared with patients with PSP â¥ 71 group, the hazard for new hospitalization was 8.351 times greater (P = 0.0001) for patients with the poorest functioning (PSP 1 to 30) and 1.977 times greater (P = 0.0295) for patients with PSP of 31-70 compared to the â¥ 71 group.", Hospitalization , Low PSP Score , High PSP Score ,0,
edin,4483,3289190,Significantly increased,The results showed that the Pilates training group improved flexibility significantly (P<0.001) during time intervals., Flexibility , Control , Pilates 4 weeks ,0,
edin,4560,4359119,Cannot tell based on the abstract,, Fear-avoidance responses improvement , MOR approach , PASTOR approach ,0,
edin,4560,4359119,Significantly increased,"In the ANCOVA there were significant adjusted between-group differences in favour of PASTOR for physical health status (SF 12), all cognitive and behavioural pain coping strategies (FESV) as well as the most fear-avoidance responses (AEQ) with the subscales help-/hopelessness, anxiety/depression, avoidance of social activities and physical activities at the end of rehabilitation, as well as at the 12-month follow-up (Tables 6â8).", Fear-avoidance responses improvement , MOR approach , PASTOR approach ,0,
edin,4622,3576519,Cannot tell based on the abstract,, Nasal congestion , Placebo , Oral vaccine ,0,
edin,4622,3576519,Significantly increased,"The cumulative frequency of abdominal pain, diarrhoea, and nasal congestion after all three vaccinations was significantly higher in vaccinees than placebo recipients (21 [16Â·8%] of 125 vs one [2Â·4%] of 41, p=0Â·017; 24 [19Â·2%] of 125 vs two [4Â·9%] of 41, p=0Â·027; 41 [32Â·8%] of 125 vs six [14Â·6%] of 41, p=0Â·028; respectively; appendix).", Nasal congestion , Placebo , Oral vaccine ,0,
edin,4617,2427034,Significantly increased,The frequency of the AAGGG â CTTCA (2222â2226) and AACC â GAAG (2081â2084) sequence alterations in the OAC group was also significantly higher than those in the OA group and the placebo group., AAGGG â CTTCA sequence alterations , Amoxicillin + Omeprazole , Amoxicillin + Omeprazole + Clarithromycin ,0,
edin,4450,3961596,Cannot tell based on the abstract,, Fasting glucose , Placebo , Luseogliflozin ,0,
edin,4450,3961596,No significant difference,"Although plasma glucose levels decreased slightly at some time points with luseogliflozin administration compared with placebo, luseogliflozin did not produce clinically significant decreases in fasting plasma glucose levels.Fig.Â 5", Fasting glucose , Placebo , Luseogliflozin ,0,
edin,4546,3459547,Cannot tell based on the abstract,, Remission period , Control , Olopatadine 5 mg ,0,
edin,4546,3459547,Significantly increased,"The average remission period was 19.1 days in the 10-mg group, 23.7 days in the 5-mg group, and 11.8 days in the no-medication group. The average remission period was also compared for the three groups. The average period in the 10-mg and 5-mg groups was significantly longer than that in the no-medication group (10 mg, P < 0.01; 5 mg, P < 0.001).", Remission period , Control , Olopatadine 5 mg ,0,
edin,4596,1839864,Cannot tell based on the abstract,, Incorrect identification of cardiac causes of death , Printed instruction material , Interactive workshop ,0,
edin,4596,1839864,Significantly decreased,"Of note, the workshop group showed a dramatic reduction of incorrect identification of cardiac causes of death from 56 to 6% (p<0.001). TableÂ 3", Incorrect identification of cardiac causes of death , Printed instruction material , Interactive workshop ,0,
edin,4517,4030092,No significant difference,"In the lipid trial, the general pattern of results showed no evidence of benefit of intensive regimens (whether single or combined) compared with combined standard lipid and glycemia treatment.", Lipid levels , Standard treatment of glycemia and lipids , Intensive treatment of glycemia and lipids ,0,
edin,4602,4232010,Significantly increased,"The SPTP conferred significant benefit in MOBID-2 scores compared with the control group [average treatment effect (ATE) â1.388; pâ<â0.001] at week 8, and MOBID-2 scores worsened during the washout period (ATEâ=ââ0.701; pâ=â0.022).",  MOBID-2 score improvement after 8 weeks , Control , Pregabalin  ,0,
edin,4496,5874317,Cannot tell based on the abstract,, Squat jump , Unilateral training , Bilateral training ,0,
edin,4496,5874317,No significant difference,"SJ (m)	0.35 Â± 0.05	0.37 Â± 0.04*	6.5 (2.6; 10.6)	0.36 (0.15; 0.58)	90/10/0%	Likely	0.36 Â± 0.05	0.34 Â± 0.04	â6.0 (â12.8; 1.2)	â0.45 (â0.99; 0.09)	3/18/79%	Likely harmful,Although both training groups improved CMJ, CMJd, CMJnd, SJnd, and HC3Jnd, only the TG improved SJ and HCMJ, whereas only the UG improved SJd, H3Jd, H3Jnd, and HC3Jd test results. Moreover, improvements in CMJ, SJ and HCMJ were greater in the TG, whereas CMJd, CMJnd, SJd, H3Jd, H3Jnd, and HC3Jd improvements were greater in the UG.", Squat jump , Unilateral training , Bilateral training ,0,
edin,4466,4411465,Significantly increased,"In SG, a significant advantage is observed for nausea (Î² S â Î² P = â0.398âu, P < 0.001),",  Improvement of nausea  , Placebo , Ginger and artichoke supplementation ,0,
edin,4452,5697645,Significantly increased,"Additionally, the proportion of patients achieving HbA1c <6.5% was significantly higher in the evogliptin group than in the placebo group (33.3% vs 15.2%; P = .008).", Reaching Glycated hemoglobin &amp;lt;6.5% , Placebo , Evogliptin ,0,
edin,4522,2689169,Significantly decreased,"Both the GlidescopeÂ® and the AWSÂ® performed better than the Macintosh, and demonstrate considerable promise in this context. The AWSÂ® had the least number of dental compressions in all three scenarios, and in the cervical spine immobilization scenario it required fewer maneuvers to optimize the view of the glottis.", Severity of dental compression , Macintosh laryngoscope , Glydescope laryngoscope ,0,
edin,4470,3612585,Cannot tell based on the abstract,, Complete response (no emesis + no rescue medication) , Oral Palonosetron 0.25 mg , Oral Palonosetron 0.5 mg ,0,
edin,4470,3612585,No significant difference,"The CR (defined as no emesis and no rescue medication) rates were generally similar in all treatment groups during the acute (0â24Â h) and delayed (24â120Â h) phases, as well as the overall 0â120Â h time interval (Fig.Â 2).", Complete response (no emesis + no rescue medication) , Oral Palonosetron 0.25 mg , Oral Palonosetron 0.5 mg ,0,
edin,4520,2689169,Cannot tell based on the abstract,, Time to intubate , Macintosh laryngoscope , Glydescope laryngoscope ,0,
edin,4520,2689169,No significant difference,"<td align=""left"">Duration (sec, 1<sup>st </sup>attempt)</td><td align=""left"">8 (7, 13)</td><td align=""left"">11 (7, 17)</td><td align=""left"">7 (6, 12)</td><td align=""left"">P = 0.1</td>,There was no significant difference in the duration of tracheal intubation attempts between the GlidescopeÂ® and AWSÂ® devices (Table 2).", Time to intubate , Macintosh laryngoscope , Glydescope laryngoscope ,0,
edin,4558,4855961,Cannot tell based on the abstract,, Pregnancy outcomes , 30.000 IU monthly , 60.000 IU monthly ,0,
edin,4558,4855961,No significant difference,"With respect to the safety of Vitamin D supplementation, overall there were few adverse outcomes in the study population; however the difference in pregnancy outcomes between various study groups did not reach statistical significance.", Pregnancy outcomes , 30.000 IU monthly , 60.000 IU monthly ,0,
edin,4576,4973627,Cannot tell based on the abstract,, General mortality	 , Control , Physical activity alone ,0,
edin,4576,4973627,No significant difference,"Compared with PAâ/HEâ, ageâsexâraceâadjusted hazard ratios (HRs) and 95% confidence intervals (CIs) for allâcause mortality associated with PAâ/HE+, PA+/HEâ, and PA+/HE+ were 0.96 (0.76â1.21), 0.61 (0.52â0.71), and 0.62 (0.52â0.75), respectively (Table 2 and Figure 1).", General mortality	 , Control , Physical activity alone ,0,
edin,4503,4701182,Cannot tell based on the abstract,, Mortality , Tipranavir/Ritonavir (500/100) , Lopinavir/Ritonavir (400/100) ,0,
edin,4503,4701182,No significant difference,"Deathsc	5 (2.7%)	2 (1.1%)	2 (1.1%),Fatalities during the trial were uncommon among these treatment-naive patients; a total of nine (1.6%) deaths were reported, of which eight were during treatment or within 30 days following drug discontinuation.", Mortality , Tipranavir/Ritonavir (500/100) , Lopinavir/Ritonavir (400/100) ,0,
edin,4559,4359119,Significantly increased,"The adjusted between-group difference in the FFbH-R at 12 months was 6.58 (95% CI 3.38 to 9.78) using complete data and 3.56 (95% CI 0.45 to 6.67) using available da-ta, corresponding to significant small-to-medium effect sizes of d=0.42 (p<0.001) and d=0.10 (p=0.025) in favour of PASTOR.,Participants were assessed with self-report measures at baseline, discharge, and 12 months for functional ability (primary outcome) using the Hannover Functional Ability Questionnaire (FFbH-R) and vari-ous secondary outcomes (e.g. pain, health status, physical activity, pain coping, pain-related cognitions).", Functional ability , MOR approach , PASTOR approach ,0,
edin,4663,3056480,Cannot tell based on the abstract,, SEAR Sexual Relationship Satisfaction domain , Sildenafil 50 mg , Sildenafil 100 mg ,0,
edin,4663,3056480,Significantly increased,"The 100-mg fixed dose was significantly more effective than the 50-mg fixed dose in improving the IIEF Overall Satisfaction domain score; the SEAR Sexual Relationship Satisfaction domain, Overall Relationship Satisfaction subscale and Total scores; all SEX-Q domain scores; and the SEX-Q total score (Table 2).", SEAR Sexual Relationship Satisfaction domain , Sildenafil 50 mg , Sildenafil 100 mg ,0,
edin,4624,3576519,Cannot tell based on the abstract,, Interleukin 2 response  , Placebo , Oral vaccine ,0,
edin,4624,3576519,No significant difference,Interleukin-2 responses were much the same (appendix)., Interleukin 2 response  , Placebo , Oral vaccine ,0,
edin,4582,4941128,Cannot tell based on the abstract,, Limb bradykinesia improvement , Control , Adaptive deep brain stimulation ,0,
edin,4582,4941128,No significant difference,"For limb bradykinesia and axial symptoms, the reductions were 37Â±10% and 39Â±5%, respectively.", Limb bradykinesia improvement , Control , Adaptive deep brain stimulation ,0,
edin,4583,4941128,Cannot tell based on the abstract,, Axial symptoms improvement , Control , Adaptive deep brain stimulation ,0,
edin,4583,4941128,No significant difference,"For limb bradykinesia and axial symptoms, the reductions were 37Â±10% and 39Â±5%, respectively.", Axial symptoms improvement , Control , Adaptive deep brain stimulation ,0,
edin,4507,4450858,Significantly decreased,"Most women required oxytocin (77Â %). The outpatient group were 24Â % less likely to require oxytocin (risk difference â23.6Â %, 95Â % CI â43.8 to â3.5).", Need of oxytocin , Conventional inpatient procedures , Balloon catheter ripening (at home) ,0,
edin,4533,1831486,No significant difference,"Reporting of NRT consumption was poor, with much missing data, but reporting of ratings of withdrawal symptom scores was nearly complete. However, these showed no significant changes or differences between groups for any week.", Nicotine replacement therapy , 2 auricular acupressure beads , 1 auricular acupressure bead ,0,
edin,4498,5874317,Cannot tell based on the abstract,, Horizontal triple jump (non-dominant leg)  , Unilateral training , Bilateral training ,0,
edin,4498,5874317,No significant difference,"<td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">H3Jnd (m)</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""top"">6.29 Â± 0.30</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""top"">6.29 Â± 0.31</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""top"">0.0 (â0.4; 0.3)</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""top"">â0.01 (â0.07; 0.05)</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""top"">0/100/0%</td><td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">Most Likely trivial</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""top"">5.97 Â± 0.33</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""top"">6.35 Â± 0.34<sup>*</sup></td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""top"">6.4 (2.7; 10.3)</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""top"">0.99 (0.42; 1.55)</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""top"">98/1/0%</td><td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">Very Likely</td>", Horizontal triple jump (non-dominant leg)  , Unilateral training , Bilateral training ,0,
edin,4565,4639584,Cannot tell based on the abstract,, Weight after 8 weeks , Normal flour , Fiber enriched flour ,0,
edin,4565,4639584,Significantly decreased,"Weight and BMI resulted significantly lower in Group A after the 4-week placebo period (change from baseline â1.35Â kg, p<0.01; â0.57Â kg/m2, p<0.01, respectively). We observed a further decrease in weight and BMI in this group after the period of fiber-enriched diet (change from placebo â1.4Â kg, pÂ =Â 0.01; â0.22Â kg/m2, pÂ =Â 0.02, respectively). In Group B we observed a significant reduction of weight and BMI after the fiber enriched period (change from baseline â1.52Â kg, p<0.01; â0.58Â kg/m2, p<0.01, respectively), and an additional slight decrease of weight after the period of placebo diet (â0.78Â kg, pÂ =Â 0.05).", Weight after 8 weeks , Normal flour , Fiber enriched flour ,0,
edin,4610,2630316,Cannot tell based on the abstract,,  Health related quality of life (mental) , Care at clinic , Care at home ,0,
edin,4610,2630316,No significant difference,Health related quality of life scores physical (PCS) and mental component scores (MCS) were not statistically different between the groups,  Health related quality of life (mental) , Care at clinic , Care at home ,0,
edin,4577,4973627,Cannot tell based on the abstract,"Compared with PAâ/HEâ, ageâsexâraceâadjusted hazard ratios and 95% confidence intervals for allâcause mortality for PAâ/HE+, PA+/HEâ, and PA+/HE+ groups were 0.96 (0.76â1.21), 0.61 (0.52â0.71), and 0.62 (0.52â0.75), respectively.", General mortality	 , Control , Healthy eating alone ,0,
edin,4577,4973627,No significant difference,"Compared with PAâ/HEâ, ageâsexâraceâadjusted hazard ratios (HRs) and 95% confidence intervals (CIs) for allâcause mortality associated with PAâ/HE+, PA+/HEâ, and PA+/HE+ were 0.96 (0.76â1.21), 0.61 (0.52â0.71), and 0.62 (0.52â0.75), respectively (Table 2 and Figure 1).,<td align=""center"" colspan=""1"" rowspan=""1"" valign=""top"">PAâ/HE+ (<italic>n</italic>â=â162)</td><td align=""char"" char=""("" colspan=""1"" rowspan=""1"" valign=""top"">61% (98)</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"" valign=""top"">0.90 (0.71â1.13); <italic>P</italic>â=â0.358</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"" valign=""top"">0.96 (0.76â1.21); <italic>P</italic>â=â0.719</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"" valign=""top"">0.97 (0.76â1.23); <italic>P</italic>â=â0.779</td>", General mortality	 , Control , Healthy eating alone ,0,
edin,4623,3576519,Cannot tell based on the abstract,, Interferon Î³ response  , Placebo , Oral vaccine ,0,
edin,4623,3576519,Significantly increased,"Interferon-Î³ T-cell response to recombinant H5 haemagglutinin protein or peptide pools ranged from 38% (nine of 24 vaccinees) with 107 VP to 70% (16 of 23 vaccines) with 1011 VP, compared with only 5% (two of 41) of placebo recipients (figure 2).", Interferon Î³ response  , Placebo , Oral vaccine ,0,
edin,4513,4030092,Significantly decreased,"In the BP trial, risk of the primary outcome was lower in the groups intensively treated for glycemia (hazard ratio [HR] 0.67; 95% CI 0.50â0.91), BP (HR 0.74; 95% CI 0.55â1.00), or both (HR 0.71; 95% CI 0.52â0.96) compared with combined standard BP and glycemia treatment."," Primary outcomes (CVD deaths, nonfatal MI, nonfatal stroke) ", Standard treatment of glycemia and BP , Intensive treatment of BP ,0,
edin,4545,3459547,Cannot tell based on the abstract,, Remission period , Control , Olopatadine 10 mg ,0,
edin,4545,3459547,Significantly increased,"The average remission period was 19.1 days in the 10-mg group, 23.7 days in the 5-mg group, and 11.8 days in the no-medication group. The average remission period was also compared for the three groups. The average period in the 10-mg and 5-mg groups was significantly longer than that in the no-medication group (10 mg, P < 0.01; 5 mg, P < 0.001).", Remission period , Control , Olopatadine 10 mg ,0,
edin,4473,3612585,No significant difference,"Acute CR rates were 73.5, 76.3, 74.1, and 70.4Â % for all patients receiving the palonosetron 0.25, 0.50, and 0.75Â mg oral doses, and for IV palonosetron 0.25Â mg, respectively; delayed CR (24â120Â h) rates were 59.4, 62.5, 60.1, and 65.4Â %, and overall CR (0â120Â h) rates were 53.5, 58.8, 53.2, and 59.3Â %, respectively.", Complete response (no emesis + no rescue medication) , Oral Palonosetron 0.25 mg , IV Palonosetron 0.5 mg ,0,
edin,4642,4273016,Cannot tell based on the abstract,, Psychological distress , Control , Stress managin training ,0,
edin,4642,4273016,Significantly decreased,"<td align=""left"" colspan=""1"" rowspan=""1"" style=""padding-left:10pt"">Psychological distress</td><td align=""right"" colspan=""1"" rowspan=""1"">2.0</td><td align=""left"" colspan=""1"" rowspan=""1"">(0.56)</td><td align=""right"" colspan=""1"" rowspan=""1"">2.0</td><td align=""left"" colspan=""1"" rowspan=""1"">(0.48)</td><td align=""center"" colspan=""1"" rowspan=""1"">0.157</td><td align=""center"" colspan=""1"" rowspan=""1"">0.032</td>,Non-completers had significantly higher psychological distress scores (t=2.04, p=0.043) and lower scores for seeking social support (t=â2.63, p=0.009) and changing a point of view compared to completers (t=â2.70, p=0.008).", Psychological distress , Control , Stress managin training ,0,
edin,4567,4639584,Cannot tell based on the abstract,, Fasting glucose , Normal flour , Fiber enriched flour ,0,
edin,4567,4639584,No significant difference,Fasting glucose and fasting insulin did not change significantly in both groups during the 8 weeks of the study., Fasting glucose , Normal flour , Fiber enriched flour ,0,
edin,4649,3095445,Cannot tell based on the abstract,, Voiding score improvement , Control , Naftopidil 75 mg ,0,
edin,4649,3095445,Significantly increased,"The alteration of the total IPSS, storage score, voiding score, postmicturition score (domain for feeling of incomplete emptying), and QOL score was presented in Figures 1(a)â1(e). The 75âmg group showed improvement in all of these in a time-dependent and dose-dependent manner (baseline versus 4 weeks after treatment: P < .001 in all; 4 weeks after treatment versus 8 weeks after treatment: P = .019, P = .057, P = .047, P = .057, and P = .003, resp.),", Voiding score improvement , Control , Naftopidil 75 mg ,0,
edin,4569,4639584,Cannot tell based on the abstract,, LDL , Normal flour , Fiber enriched flour ,0,
edin,4569,4639584,Significantly decreased,"A significant decrease in LDL cholesterol concentration was observed in Group A and Group B after the fiber-enriched period (Group A: â13.27Â mg/dl, p<0.01 vs placebo; Group B â12.63Â mg/dl, pÂ =Â 0.002 vs basal).", LDL , Normal flour , Fiber enriched flour ,0,
edin,4614,2427034,Cannot tell based on the abstract,"The presence of 23S rRNA due to H. pylori infection in the OA group remained lower than that in the placebo group 7.3 yrs after OA-therapy [51.1% (157/307) vs. 83.9% (260/310), p = 0.0000].", 23S rRNA , Placebo , Amoxicillin + Omeprazole + Clarithromycin ,0,
edin,4614,2427034,Significantly decreased,"<td></td><td align=""left""><italic>23S rRNA</italic></td><td align=""left"">83.9 (260/310)</td><td align=""left"">51.1<sup>1 </sup>(157/307)</td><td align=""left"">26.8<sup>2 </sup>(41/153)</td><td align=""left"">59.5 (458/770)</td>,OAC group vs. placebo group, OR = 2.89, 95%CI [1.28â6.46];", 23S rRNA , Placebo , Amoxicillin + Omeprazole + Clarithromycin ,0,
edin,4644,4273016,Cannot tell based on the abstract,, Work engagement , Control , Stress managin training ,0,
edin,4644,4273016,Significantly increased,"<td align=""left"" colspan=""1"" rowspan=""1"" style=""padding-left:10pt"">Work engagement</td><td align=""right"" colspan=""1"" rowspan=""1"">2.7</td><td align=""left"" colspan=""1"" rowspan=""1"">(0.92)</td><td align=""right"" colspan=""1"" rowspan=""1"">3.0</td><td align=""left"" colspan=""1"" rowspan=""1"">(0.91)</td><td align=""center"" colspan=""1"" rowspan=""1"">0.028</td><td align=""center"" colspan=""1"" rowspan=""1"">0.033</td>,Although the intervention group had significantly higher scores on work engagement compared to the wait-list control group (t=â2.2, p=0.00), no other significant differences were found between the groups (p>0.05).", Work engagement , Control , Stress managin training ,0,
edin,4611,2630316,Cannot tell based on the abstract,, Waiting time , Care at clinic , Care at home ,0,
edin,4611,2630316,Significantly increased,Individuals receiving clinic care reported less waiting time for nurse with 80% of the home having 30 minutes or less compared to 98% of clinic group (p = 0.03)., Waiting time , Care at clinic , Care at home ,0,
edin,4630,5866927,Cannot tell based on the abstract,, Vineland motor improvement  , Placebo , AUCB ,0,
edin,4630,5866927,Significantly decreased,"There were statistically significant (pâ<â.05) group X treatment interactions for the Vineland ABC, Communication, Motor, and Daily subscales which indicated that changes over time between these scores depended on the order that AUCB was administered.,<td align=""left"" colspan=""1"" rowspan=""1"" style=""padding-left:10%"" valign=""top"">Placebo</td><td align=""char"" char=""Â±"" colspan=""1"" rowspan=""1"" valign=""top"">77.67âÂ±â13.57</td><td align=""char"" char=""Â±"" colspan=""1"" rowspan=""1"" valign=""top"">79.57âÂ±â11.51</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""top"">.029</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""top"">.020</td><td align=""char"" char=""Â±"" colspan=""1"" rowspan=""1"" valign=""top"">76.67âÂ±â7.61</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""top"">.022</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""top"">.010</td>,The results of these ANCOVAs (Table 4) showed that all Vineland subscales had lower mean scores for the AUCB group than the placebo group at both 12 and 24 weeks.", Vineland motor improvement  , Placebo , AUCB ,0,
edin,4581,4941128,Significantly increased,UPDRS scores were 43% (p=0.04; Cohenâs d=1.62) better with aDBS than without stimulation., Overall UPDRS improvement , Control , Adaptive deep brain stimulation ,0,
edin,4640,5656562,Cannot tell based on the abstract,, Sildenafil levels , CYP2C9 Poor metabolizers   , CYP2C9 Intermediate metabolizers  ,0,
edin,4640,5656562,No significant difference,No association was observed between the CYP2C9 inferred phenotype and the sildenafil concentration:dose ratio (Figure 2)., Sildenafil levels , CYP2C9 Poor metabolizers   , CYP2C9 Intermediate metabolizers  ,0,
edin,4490,5880177,Cannot tell based on the abstract,, Risk of death , Being on Class 2 , Being on Class 1 ,0,
edin,4490,5880177,Significantly increased,"As compared with class 3, class 1 (OR: 2.76; 95% CI [1.38â5.82]) was associated with higher risk of death. Class 1 was associated with higher risk of death than class 2 (OR: 1.72; 95% CI [1.09â2.68]).", Risk of death , Being on Class 2 , Being on Class 1 ,0,
edin,4501,4701182,No significant difference,"At week 48, VL<50 copies/mL was 68.4%, 69.9%, and 72.4% in TPV/r100, TPV/r200, and LPV/r groups, respectively, and TPV/r groups showed non-inferiority to LPV/r.", Viral load improvement , Tipranavir/Ritonavir (500/200) , Tipranavir/Ritonavir (500/100) ,0,
edin,4506,4786378,No significant difference,"For the knowledge tests, there was no statistically significant difference between the groups (P = 0.14).", Score on knowledge test , Conventional training , Virtual reality training ,0,
edin,4595,1839864,Cannot tell based on the abstract,, Correct identification of cause of death , Printed instruction material , Interactive workshop ,0,
edin,4595,1839864,Significantly increased,"<td colspan=""4"">Correctly identified cause of death</td>,Group I statistically significant improvement than group II in correct identification of cause of death (91 vs 55%, p<0.001),", Correct identification of cause of death , Printed instruction material , Interactive workshop ,0,
edin,4638,5656562,Cannot tell based on the abstract,, Sildenafil levels , CYP2C9 Extensive metabolizers   , CYP2C9 Intermediate metabolizers  ,0,
edin,4638,5656562,Significantly decreased,We observed that increasing levels of predicted metabolizing capacity appeared to be associated with decreasing levels of dose-adjusted sildenafil concentrations (F test P = 0.0238; Figure 4)., Sildenafil levels , CYP2C9 Extensive metabolizers   , CYP2C9 Intermediate metabolizers  ,0,
edin,4612,2630316,Cannot tell based on the abstract,, Patient satisfaction , Care at clinic , Care at home ,0,
edin,4612,2630316,No significant difference,"oth home and clinic groups reported high satisfaction levels with the information they receive on how to care for their leg ulcers (98% vs. 96% very/quite satisfied, respectively).", Patient satisfaction , Care at clinic , Care at home ,0,
edin,4446,3961596,No significant difference,"There were no serious adverse events, adverse events leading to discontinuation, or episodes of hypoglycemia.", Serious adverse effects  , Placebo , Luseogliflozin ,0,
edin,4539,5107204,Cannot tell based on the abstract,, Psychomotor activities , Placebo , Bilastine 20 mg ,0,
edin,4539,5107204,No significant difference,"Psychomotor activities were evaluated using objective DSST and subjective SSS.,The meanÂ Â±Â SD of DSST and SSS at predose in Part I were 59.0Â Â±Â 8.7 and 2.2Â Â±Â 0.4 in placebo (nÂ =Â 9), 58.6Â Â±Â 9.3 and 2.3Â Â±Â 0.9 in 10Â mg (nÂ =Â 9), 58.6Â Â±Â 9.1 and 2.7Â Â±Â 0.7 in 20Â mg (nÂ =Â 9), and 57.4Â Â±Â 8.9 and 2.9Â Â±Â 0.3 in 50Â mg group (nÂ =Â 9), respectively. Changes in DSST or SSS from predose at 2 and 24Â h after single oral doses of 10â50Â mg were not significant differences from placebo (data not shown).,No significant differences were observed for SSS at any time points between the drug-treated groups and placebo group (Fig.Â 4b).Fig.Â 4", Psychomotor activities , Placebo , Bilastine 20 mg ,0,
edin,4605,3724560,Cannot tell based on the abstract,, Risk of falling , Usual care , Integrative medicine ,0,
edin,4605,3724560,Significantly increased,"There was a higher risk for falls in the IM than in the UC (odds ratio 3.30; 95% confidence interval: 0.43; 25.26), but hospital admissions were in general comparable for both groups (IM: 0.7 Â± 1.1; UC 1.0 Â± 1.8).", Risk of falling , Usual care , Integrative medicine ,0,
edin,4544,3459547,Cannot tell based on the abstract,, Itch control time , Olopatadine 5 mg , Olopatadine 10 mg ,0,
edin,4544,3459547,No significant difference,The suppressive effects of both the 5 mg and 10 mg olopatadine treatments on the VAS itch score were more significant and longer lasting over a period of 4 weeks than the no-medication treatment. Both the 5-mg group and the 10-mg group showed improved urticarial symptoms and maintained their VAS itch score within normal limits compared to the no-medication group. The differences between the 5-mg and 10-mg groups were not significant., Itch control time , Olopatadine 5 mg , Olopatadine 10 mg ,0,
edin,4749,5331968,Cannot tell based on the abstract,," Heart rate, beats/mind - ratio between low frequency power (LF) and HF (LF:HF) of the autonomous nervous system, log m/s2c ", baseline , blue (Castelldefels beach) ,0,
edin,4749,5331968,Significantly decreased,"<td align=""justify"" colspan=""2"" rowspan=""1"">TMD</td><td align=""justify"" colspan=""1"" rowspan=""1""></td><td align=""justify"" colspan=""1"" rowspan=""1""></td><td align=""justify"" colspan=""1"" rowspan=""1""></td><td align=""justify"" colspan=""1"" rowspan=""1""></td><td align=""justify"" colspan=""1"" rowspan=""1""></td><td align=""justify"" colspan=""1"" rowspan=""1""></td><td align=""justify"" colspan=""1"" rowspan=""1""></td><td align=""justify"" colspan=""1"" rowspan=""1""></td>"," Heart rate, beats/mind - ratio between low frequency power (LF) and HF (LF:HF) of the autonomous nervous system, log m/s2c ", baseline , blue (Castelldefels beach) ,0,
edin,4688,5509647,Significantly decreased,"Alcohol consumption resulted in a significant impairment of mean (tâ=â2.456, dfâ=â13, pâ=â0.029) and maximum potentiation (tâ=ââ2.945, dfâ=â13, pâ=â0.011) compared to the placebo beverage in the DLPFC and globally.", mean  and maximum potentiation , placebo , consumption of an alcohol (1.5âg/l of body water) ,0,
edin,4726,5539943,Cannot tell based on the abstract,, Motivational Interviewing (MI) knowledge , baseline ," Language Enhanced Attention and Focus MI training condition (MI-LEAF), MI training (MI-AU) ",0,
edin,4726,5539943,Significantly increased,"The MI Knowledge Test was used as the outcome measure to estimate the impact of training. It was administered at baseline and post-training, and results indicate a significant increase in MI knowledge (b = 0.111, SE = 0.015, t = 7.146, p < 0.001) for all participants with no significant differences between training conditions (b = â0.041, SE = 0.031, t = â1.328, p = 0.186).", Motivational Interviewing (MI) knowledge , baseline ," Language Enhanced Attention and Focus MI training condition (MI-LEAF), MI training (MI-AU) ",0,
edin,4677,1774569,No significant difference,"Risk of non-completion of detoxification was reduced if allocated buprenorphine (68% vs 88%, RR 0.58 CI 0.35â0.96, p = 0.065).", Risk of non-completion of detoxification , oral dihydrocodeine , buprenorphine ,0,
edin,4672,5472412,Significantly decreased,"Additionally, olopatadine HCl 0.77% substantially reduced conjunctival redness and total redness over vehicle and olopatadine 0.2% at onset and 24-hour duration of action.", total redness at onset of action and 24 hours post-dosing , vehicle , Olopatadine HCl 0.77% ,0,
edin,4665,5129854,Significantly decreased,"At week 6, mean diurnal IOP with BBFC+PGA was lower than with vehicle+PGA (17.1Â±0.4âmmâHg vs 20.5Â±0.4âmmâHg; between-group difference, â3.4Â±0.5âmmâHg; P<0.0001; 95% confidence interval, â4.5 to â2.4âmmâHg).", diurnal intraocular pressure (IOP) , vehicle adjunctive treatment and  prostaglandin analog (PGA) , fixed-combination brinzolamide/brimonidine (BBFC) adjunctive to a prostaglandin analog (PGA) ,0,
edin,4709,3982948,Cannot tell based on the abstract,, The occurrence of apnea , routine , CPAP ,0,
edin,4709,3982948,No significant difference,The occurrence of apnea was high in both groups (33.6% in the CPAP group and 42.4% in the routine group)., The occurrence of apnea , routine , CPAP ,0,
edin,4699,5312688,Cannot tell based on the abstract,,  The Community Programs for Clinical Research on AIDS (CPCRA) Adherence Self-Report Questionnaire , standard care , interactive short message service (SMS) ,0,
edin,4699,5312688,Significantly increased,"The participants reported VAS score of 98.72% in the SMS group at the end of the study, significantly higher than that in the control group (93.11%; P=0.006). Similar effect on CPCRA adherence was noticed.",  The Community Programs for Clinical Research on AIDS (CPCRA) Adherence Self-Report Questionnaire , standard care , interactive short message service (SMS) ,0,
edin,4756,3214443,Cannot tell based on the abstract,, The mean difference in the reduction of both SBP and DBP ,"  Yoga (NG IV) for 30 to 45 minutes/day, five days/week ","  Salt Intake Reduction (NG III) to at least half of their previous intake, ",0,
edin,4756,3214443,Significantly increased,"the mean reduction in the SBP and DBP values of the physical exercise group when compared with those of the salt reduction group, was significantly higher (P<0.001).", The mean difference in the reduction of both SBP and DBP ,"  Yoga (NG IV) for 30 to 45 minutes/day, five days/week ","  Salt Intake Reduction (NG III) to at least half of their previous intake, ",0,
edin,4752,4941182,No significant difference,Rates of safety events of special interest were generally similar between tofacitinib doses and subpopulations;, Rates of safety events , tofacitinib 5 or 10âmg twice daily   bDMARD-IR patients  , tofacitinib 5 or 10âmg twice daily  bDMARD-naive ,0,
edin,4733,3293068,Cannot tell based on the abstract,, bloatedness  at 3 hours post dehydrating exercise ," bottled water (BW), carbohydrate-electrolyte sport drink (SD) "," pure coconut water (VitaCocoÂ®: CW), coconut water from concentrate (CWC) ",0,
edin,4733,3293068,Significantly increased,"Over the two hour rehydration period, the bloatedness decreased for all four conditions but remained statistically significant at 3 hours post dehydrating exercise for VitaCocoÂ® (p = 0.012) and coconut water from concentrate (p = 0.034).,<td align=""left"">3 hours Post DHE</td><td align=""center"">2.33 Â± 1.23</td><td align=""center"">1.42 Â± 0.67</td><td align=""center"">2.45 Â± 1.21</td><td align=""center"">1.25 Â± 0.62</td>,Bloatedness: 3 hours Post DHE > Immediately Post DHE for VitaCocoÂ® (p = 0.012) and coconut water from concentrate (p = 0.034)", bloatedness  at 3 hours post dehydrating exercise ," bottled water (BW), carbohydrate-electrolyte sport drink (SD) "," pure coconut water (VitaCocoÂ®: CW), coconut water from concentrate (CWC) ",0,
edin,4680,5721317,Cannot tell based on the abstract,, Preoperative mechanical alignment - varus , measured resection (MR) , gap balancing (GB) technique ,0,
edin,4680,5721317,No significant difference,Preoperative mechanical alignment was 5.2Â° Â± 4.5Â° varus in the GB group and 5.4Â° Â± 4.8Â° in the MR group., Preoperative mechanical alignment - varus , measured resection (MR) , gap balancing (GB) technique ,0,
edin,4670,5472412,Significantly increased,Olopatadine HCl 0.77% was superior to vehicle (P<0.0001) at onset and 24-hour duration of action (difference in means: â1.14 to â1.52) and to olopatadine 0.2% (P=0.0009) at 24-hour duration of action in relieving ocular itch., 24-hour duration of action in relieving ocular itch , olopatadine 0.2% , Olopatadine HCl 0.77% ,0,
edin,4762,4079189,Significantly decreased,"The mean number of bleeding days significantly declined from 10.6âÂ±â2.7Â days to 8.2âÂ±â1.9Â days after 3Â months treatment with the syrup (pâ=â0.01) and consequently the participants in the intervention group used fewer pads after 3Â months (16.4âÂ±â10.7) compared with the number of pads used at the beginning of the treatment (22.7âÂ±â12.0, pâ=â0.01).", The  consequently number of pads , baseline , 15&amp;amp;nbsp;ml oral myrtle syrup daily (5&amp;amp;nbsp;ml three times a day) for 7&amp;amp;nbsp;days ,0,
edin,4702,3154486,Cannot tell based on the abstract,," differences in the changes of the anthropometric measurements, RMR, and physical activity level ","  chocolate, or potato crisps, control "," ~1100âkJ/d of hazelnuts, ",0,
edin,4702,3154486,No significant difference,"Although there was an apparent decrease in physical activity level in the control group, there were no statistically significant differences in the changes of the anthropometric measurements, RMR, and physical activity level from baseline to 12 weeks between the groups (all P â¥ 0.106, Table 3)."," differences in the changes of the anthropometric measurements, RMR, and physical activity level ","  chocolate, or potato crisps, control "," ~1100âkJ/d of hazelnuts, ",0,
edin,4714,3573831,Significantly decreased,"On average, breast exposure dose in lumbar spine imaging in both projections (anteroposterior (AP) and lateral) was found reduced by approximately 80% (p < 0,001) when shielding with 0.5 mm lead equivalent was used (from 0.45Â±0.25 mGy to 0.09Â±0.07 mGy on the right and from 0.26Â±0.14 mGy to 0.06Â±0.04 mGy on the left breast)", left breast exposure dose in lumbar spine imaging in both projections (anteroposterior (AP) and lateral) , baseline , breast shielding ,0,
edin,4686,4329963,Significantly increased,"Analysis of covariance showed that after adjusting for effects of pretest scores, the difference between mean post-test scores of health-promoting lifestyle scale, health-related QoL scale, and all constructs of Pender's health promotion model (self-efficacy, perceived affect, perceived social support, and perceived barriers) in the intervention group 1 and control group were significant (P< 0.0001). In addition, changes in mean scores of lifestyle scale (42.4 Â± 13.6), QoL scale (29.1 Â± 14.2), self-efficacy (16.1 Â± 2.6), perceived affect (16.1 Â± 8), social support (35.4 Â± 12.4), and barriers (17.2 Â± 15.8) before and after intervention were significant in the intervention group 2 (P < 0.0001)."," mean post-test scores of health-promoting lifestyle scale, health-related QoL scale, and all constructs of Pender's health promotion model (self-efficacy, perceived affect, perceived social support, and perceived barriers) ", baseline , a group for training of methamphetamine users who were in recovery phase (intervention group 1) and control ,0,
edin,4707,3982948,No significant difference,"The routine (n=99) and CPAP (n=98) infants studied presented no statistically significant differences regarding birth characteristics, complications during the prenatal period, the need for mechanical ventilation during the first 5 days of life (19.2 vs 23.4%, P=0.50), use of surfactant (18.2 vs 17.3% P=0.92), or respiratory morbidity and mortality until discharge."," birth characteristics, complications during the prenatal period, the need for mechanical ventilation during the first 5 days of life, use of surfactant ", routine , CPAP ,0,
edin,4706,5384532,Cannot tell based on the abstract,, The total number of days on which MRSA-positive admitted patients were not isolated , Conventional laboratory-based culture screens (CS) , rapid point-of-care screening (POCS) ,0,
edin,4706,5384532,Significantly decreased,The total number of days on which MRSA-positive admitted patients were not isolated was 257 (67% of their total stay of 378.3 days) in the control arm and 205 (40.6% of their total stay of 504.8 days) in the intervention arm (PÂ <Â 0.001)., The total number of days on which MRSA-positive admitted patients were not isolated , Conventional laboratory-based culture screens (CS) , rapid point-of-care screening (POCS) ,0,
edin,4731,3798588,Cannot tell based on the abstract,, consumption of at least 800 mg/day of dietary calcium , control , Current health education programs for osteoporosis prevention ,0,
edin,4731,3798588,No significant difference,"<td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">Elderly men (C1) women (B)</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""top"">22 (43.1%)</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""top"">23 (46.9%)</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""top"">ns</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""top"">29 (56.9%)</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""top"">21 (42.9%)</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""top"">ns</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""top"">0.030</td>,Regarding nutrient intakes, consumption of at least 800 mg/day of dietary calcium was more likely (P = 0.074) to be implemented in the intervention group than in the control group.", consumption of at least 800 mg/day of dietary calcium , control , Current health education programs for osteoporosis prevention ,0,
edin,4678,1774569,Significantly increased,"<td align=""center"">2</td><td align=""center"">8</td>", clean urine sample , oral dihydrocodeine , buprenorphine ,0,
edin,4735,3293068,Cannot tell based on the abstract,, Plasma osmolality , bottled water (BW) , coconut water from concentrate (CWC) ,0,
edin,4735,3293068,Significantly increased,"Plasma osmolality displayed similar results as noted for body mass and fluid retention, with greater values for coconut water from concentrate compared only to bottled water (p = 0.049; when expressed as change from pre dehydrating exercise at 3 hours post dehydrating exercise)", Plasma osmolality , bottled water (BW) , coconut water from concentrate (CWC) ,0,
edin,4690,5509647,Significantly decreased,"Additionally, the effect of alcohol on PAS-induced potentiation of theta-gamma coupling (an index associated with learning and memory) was examined prior to and following PAS.,Alcohol also suppressed the potentiation of theta-gamma coupling by PAS.", theta- gamma coupling following PAS , baseline , consumption of an alcohol (1.5âg/l of body water) ,0,
edin,4763,3896966,Significantly decreased,"In confirmation of diet formulation and compound delivery, both the PS and EZ treatments lowered (pâ<â0.05) intestinal cholesterol absorption (24 and 31%, respectively), blood non-HDL cholesterol (61 and 66%, respectively), and hepatic cholesterol (45 and 55%, respectively) compared with the HF-fed animals."," intestinal cholesterol absorption, blood non-HDL cholesterol, and hepatic cholesterol ", high fat (HF) diet ," phytosterols (PS), ezetimibe (EZ) ",0,
edin,4704,3154486,Cannot tell based on the abstract,, Plasma total cholesterol ,  chocolate , ~1100âkJ/d of hazelnuts ,0,
edin,4704,3154486,Significantly decreased,"Plasma total cholesterol in the hazelnut group was lower compared to the chocolate group (P = 0.006), with a tendency for the hazelnut group to be lower than the control (Pâ = 0.057).", Plasma total cholesterol ,  chocolate , ~1100âkJ/d of hazelnuts ,0,
edin,4682,5721317,Cannot tell based on the abstract,, With survival for aseptic reasons , measured resection (MR) , gap balancing (GB) technique ,0,
edin,4682,5721317,No significant difference,"With survival for aseptic reasons as the endpoint of interest, survival rates were 94.6% (95% CI, 87.5% and 97.7%) and 91.6% (84.0% - 95.7%) for the GB group and the MR group, respectively (p = 0.386).", With survival for aseptic reasons , measured resection (MR) , gap balancing (GB) technique ,0,
edin,4713,3573831,Significantly decreased,"On average, breast exposure dose in lumbar spine imaging in both projections (anteroposterior (AP) and lateral) was found reduced by approximately 80% (p < 0,001) when shielding with 0.5 mm lead equivalent was used (from 0.45Â±0.25 mGy to 0.09Â±0.07 mGy on the right and from 0.26Â±0.14 mGy to 0.06Â±0.04 mGy on the left breast). No correlation between the body mass index (BMI) and the breast surface radiation dose was observed.", right breast exposure dose in lumbar spine imaging in both projections (anteroposterior (AP) and lateral) , baseline , breast shielding ,0,
edin,4758,2848004,Significantly increased,Trough FEV1 after one dose was significantly higher with indacaterol than placebo (p < 0.001)., FEV1 after one dose , placebo , indacaterol 150 Î¼g o.d ,0,
edin,4754,3214443,Cannot tell based on the abstract,"All three intervention groups showed significant reduction in BP (SBP/DBP mmHg: 5.3/6.0 in NG II, 2.5/2.0 in NG III, and 2.3/2.4 in NG IV, respectively), while the Control Group showed no significant difference.", The mean difference in the reduction of both SBP and DBP , Salt Intake Reduction (NG III) to at least half of their previous intake; ," Physical Exercise (NG II)-brisk walking for 50 to 60 minutes, three to four days/week; ",0,
edin,4754,3214443,Significantly increased,"In the per protocol population, that is, the 94 subjects who had successfully completed the interventions in the groups assigned to them and in the Intention-to-Intervene population of all 98 subjects, who were initially enrolled and randomized, the mean reduction in the SBP and DBP values of the physical exercise group when compared with those of the salt reduction group, was significantly higher (P<0.001).", The mean difference in the reduction of both SBP and DBP , Salt Intake Reduction (NG III) to at least half of their previous intake; ," Physical Exercise (NG II)-brisk walking for 50 to 60 minutes, three to four days/week; ",0,
edin,4675,2944304,Significantly increased,"Geometric mean time to recovery of the train-of-four ratio to 0.9 was 15-fold faster with sugammadex (4.5 minutes) compared with neostigmine (66.2 minutes; p < 0.0001) (median, 3.3 minutes with sugammadex versus 49.9 minutes with neostigmine).", Geometric mean time to recovery of the train-of-four ratio to 0.9 , neostigmine 70 Î¼g/kg with glycopyrrolate 14 Î¼g/kg at 1-2 post-tetanic counts , sugammadex 4 mg/kg ,0,
edin,4693,5986478,Cannot tell based on the abstract,," The serum level of the circulating BCAAs isoleucine, valine and leucine ", non-seafood diet period , the lean-seafood diet period (postprandial state) ,0,
edin,4693,5986478,Significantly decreased,"The serum level of the circulating BCAAs isoleucine, valine and leucine was decreased during the postprandial state after lean-seafood intake."," The serum level of the circulating BCAAs isoleucine, valine and leucine ", non-seafood diet period , the lean-seafood diet period (postprandial state) ,0,
edin,4701,3154486,Cannot tell based on the abstract,," vitamin E intake , the percentage of energy derived from total fat , monounsaturated fatty acids (MUFAs) , and polyun-saturated fatty acids (PUFAs) ","  chocolate, or potato crisps, control "," ~1100âkJ/d of hazelnuts, ",0,
edin,4701,3154486,Significantly increased,"On the other hand, vitamin E intake (all P â¤ 0.007), the percentage of energy derived from total fat (all P â¤ 0.011), MUFA (all P â¤ 0.001), and PUFA (all P â¤ 0.011) increased at 12 weeks in the hazelnut group compared to all other groups, with the exception of one pairwise comparison (hazelnut versus control; P = 0.057) for PUFA."," vitamin E intake , the percentage of energy derived from total fat , monounsaturated fatty acids (MUFAs) , and polyun-saturated fatty acids (PUFAs) ","  chocolate, or potato crisps, control "," ~1100âkJ/d of hazelnuts, ",0,
edin,4767,3896966,Cannot tell based on the abstract,, desmosterol  , high fat (HF) diet ," phytosterols (PS), ezetimibe (EZ) ",0,
edin,4767,3896966,Invalid Prompt,, desmosterol  , high fat (HF) diet ," phytosterols (PS), ezetimibe (EZ) ",1," PS feeding led to an expected increase (pâ<â0.05) in RBC campesterol and sitosterol concentrations compared with the HF and EZ groups (Figure 2) but also reduced (pâ<â0.05) RBC desmosterol concentrations compared with the other groups. EZ supplementation increased (pâ<â0.05) RBC desmosterol and lathosterol concentrations compared with the HF and PS groups (Figure 2).

In first part, PS  reduces desmosterol and in second part EZ increases it. "
edin,4718,5292678,No significant difference,"There were no differences in cumulative incidence of relapse (74% vs 68% hazard ratio (HR) 0.93 (0.77â1.14), P=0.5); survival from relapse (7% vs 9% HR 0.96 (0.77â1.19), P=0.7); relapse-free (31% vs 32% HR 1.02 (0.83â1.24), P=0.9) or overall survival (23% vs 22% HR 1.08 (0.93â1.26), P=0.3).", overall survival , daunorubicin/ara-C (DA)  ,  daunorubicin/clofarabine (DClo) ,0,
edin,4667,5129854,Significantly decreased,"At week 6, mean diurnal IOP with BBFC+PGA was lower than with vehicle+PGA (17.1Â±0.4âmmâHg vs 20.5Â±0.4âmmâHg; between-group difference, â3.4Â±0.5âmmâHg; P<0.0001; 95% confidence interval, â4.5 to â2.4âmmâHg). BBFC+PGA reduced mean diurnal IOP by 5.7âmmâHg (25%) from the baseline IOP achieved with PGA monotherapy.", The percent diurnal IOP change , vehicle adjunctive treatment and  prostaglandin analog (PGA) , fixed-combination brinzolamide/brimonidine (BBFC) adjunctive to a prostaglandin analog (PGA) ,0,
edin,4685,3929824,Cannot tell based on the abstract,, Rhodes index scores , the acupressure ,  ginger ,0,
edin,4685,3929824,Significantly increased,The mean difference Rhodes index scores calculated by mean Rhodes index scores in pre intervention (three days before intervention) minus mean Rhodes index scores in post intervention (four days after intervention). It was significantly greater in ginger group than acupressure and control groups., Rhodes index scores , the acupressure ,  ginger ,0,
edin,4698,5312688,Significantly increased,"For the adherence measures, compared with the control group, participants in the intervention group had significantly higher VAS mean score (Z=2.735, P=0.006) and lower suboptimal adherence rate (Z=2.208, P=0.027) at the end of the study.", VAS mean score , standard care , interactive short message service (SMS) ,0,
edin,4736,3293068,Cannot tell based on the abstract,, body mass , bottled water (BW) , coconut water from concentrate (CWC) ,0,
edin,4736,3293068,Significantly increased,"However, body mass (p = 0.023) was slightly greater with coconut water from concentrate compared only to bottled water (when expressed as change from pre dehydrating exercise at 3 hours post dehydrating exercise).", body mass , bottled water (BW) , coconut water from concentrate (CWC) ,0,
edin,4697,5312688,Significantly increased,Repeated-measures analysis showed that both HIV-related and ART medication knowledge of the intervention group showed better improvement over time than those of the control group after the intervention (P<0.0001)., HIV-related and ART medication knowledge , standard care , interactive short message service (SMS) ,0,
edin,4700,3154486,Cannot tell based on the abstract,, total energy derived from saturated fatty acids (SAFAs)  and carbohydrate ,"  chocolate, or potato crisps, control "," ~1100âkJ/d of hazelnuts, ",0,
edin,4700,3154486,Significantly decreased,The results from pairwise comparison showed that the percentage of total energy derived from SAFA (all P â¤ 0.045) and carbohydrate (all P â¤ 0.006) in the hazelnut group was significantly lower than all the other groups., total energy derived from saturated fatty acids (SAFAs)  and carbohydrate ,"  chocolate, or potato crisps, control "," ~1100âkJ/d of hazelnuts, ",0,
edin,4668,5472412,Significantly increased,Olopatadine HCl 0.77% was superior to vehicle (P<0.0001) at onset and 24-hour duration of action (difference in means: â1.14 to â1.52) and to olopatadine 0.2% (P=0.0009) at 24-hour duration of action in relieving ocular itch., 24-hour duration of action in relieving ocular itch , vehicle (at onset and 24 hours) , Olopatadine HCl 0.77% ,0,
edin,4734,3293068,No significant difference,No differences were noted between coconut water (CW or CWC) and SD for any measures of fluid retention (p > 0.05)., fluid retention (based on body mass) ," bottled water (BW), carbohydrate-electrolyte sport drink (SD) "," pure coconut water (VitaCocoÂ®: CW), coconut water from concentrate (CWC) ",0,
edin,4739,3293068,Cannot tell based on the abstract,," heart rate, systolic blood pressure, or diastolic blood pressure "," bottled water (BW), carbohydrate-electrolyte sport drink (SD) "," pure coconut water (VitaCocoÂ®: CW), coconut water from concentrate (CWC) ",0,
edin,4739,3293068,No significant difference,"No differences were noted between conditions for heart rate, systolic blood pressure, or diastolic blood pressure (p > 0.05)."," heart rate, systolic blood pressure, or diastolic blood pressure "," bottled water (BW), carbohydrate-electrolyte sport drink (SD) "," pure coconut water (VitaCocoÂ®: CW), coconut water from concentrate (CWC) ",0,
edin,4744,5653840,Significantly increased,Subjects performed a 6â8 week home trial using direct and pattern recognition control with a custom prostheses made from commercially available parts. Subjects showed statistically better performance in the Southampton Hand Assessment Procedure (pâ=â0.04) and the Clothespin relocation task (pâ=â0.02)., improving of Clothespin Relocation Task , direct control , recognition control ,0,
edin,4757,2848004,Significantly increased,"Trough FEV1 (LSM Â± SEM) at Week 12 was 1.48 Â± 0.018 L for indacaterol and 1.35 Â± 0.019 L for placebo, a clinically relevant difference of 130 Â± 24 mL (p < 0.001).", forced expiratory volume in 1 s (FEV1) at Week 12 , placebo , indacaterol 150 Î¼g o.d ,0,
edin,4671,5472412,Significantly decreased,"Additionally, olopatadine HCl 0.77% substantially reduced conjunctival redness and total redness over vehicle and olopatadine 0.2% at onset and 24-hour duration of action.", conjunctival redness at onset and 24 hours , olopatadine 0.2% , Olopatadine HCl 0.77% ,0,
edin,4696,5986478,Cannot tell based on the abstract,," level of ceramide 18:1/14:0, LPC 20:4 and 22:5, LPE 18:0, PA 34:2, 36:1 , 36:2, 36:1 , PE 34:0 , 34:1, 34:2, 36:3 , 40:4 , 40:5 , PE 40:4, PE 40:5, PC 34:3 , PC 36:4 , PC 36:5 , PC 38:5 , PC 40:5  and PC 40:8 . ", the lean-seafood diet period , 120 min postprandial the non-seafood diet ,0,
edin,4696,5986478,Significantly increased,"Furthermore, 120 min postprandial the non-seafood diet significantly increased level of ceramide 18:1/14:0 (p = 0.01, Figure 2A), LPC 20:4 (p = 0.01, Figure 2C) and 22:5 (p = 0.03, Figure 2D), LPE 18:0 (p = 0.009), PA 34:2 (p = 0.01), 36:1 (p = 0.01), 36:2 (p = 0.02), 36:1 (p = 0.01), PE 34:0 (p = 0.01), 34:1 (p = 0.004), 34:2 (p = 0.03), 36:3 (p = 0.01), 40:4 (p = 0.005), 40:5 (p = 0.04), PE 40:4 (p = 0.005), PE 40:5 (p = 0.04), PC 34:3 (p = 0.02), PC 36:4 (p = 0.007), PC 36:5 (p = 0.004), PC 38:5 (p = 0.005), PC 40:5 (p = 0.04) and PC 40:8 (p = 0.04) (Table S3)."," level of ceramide 18:1/14:0, LPC 20:4 and 22:5, LPE 18:0, PA 34:2, 36:1 , 36:2, 36:1 , PE 34:0 , 34:1, 34:2, 36:3 , 40:4 , 40:5 , PE 40:4, PE 40:5, PC 34:3 , PC 36:4 , PC 36:5 , PC 38:5 , PC 40:5  and PC 40:8 . ", the lean-seafood diet period , 120 min postprandial the non-seafood diet ,0,
edin,4679,5721317,Significantly increased,"Mean KS was 82 (95% confidence interval (CI), 80 â 83) and 77 (95% CI, 76 â 79) in the GB and MR group, respectively. The TOST test and linear mixed model both revealed statistical significance (p < 0.001).", Knee Society Knee Score (KS) 10 years postoperatively using the two one-sided test (TOST) , measured resection (MR) , gap balancing (GB) technique ,0,
edin,4748,5331968,Cannot tell based on the abstract,," Heart rate, beats/mind - high frequency power (HF) of the autonomous nervous system, log m/s2c ", baseline , green (Collserola Natural Park) ,0,
edin,4748,5331968,No significant difference,"<td align=""justify"" colspan=""1"" rowspan=""1"">âHF, log m/s<sup>2</sup><xref ref-type=""table-fn"" rid=""t003fn004""><sup>c</sup></xref></td><td align=""justify"" colspan=""1"" rowspan=""1"">25</td><td align=""justify"" colspan=""1"" rowspan=""1"" style=""background-color:#BFBFBF"">-0.32 (-0.58, -0.06)</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"" style=""background-color:#BFBFBF"">0.02</td><td align=""justify"" colspan=""1"" rowspan=""1"">0.01 (-0.24, 0.26)</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">0.93</td>"," Heart rate, beats/mind - high frequency power (HF) of the autonomous nervous system, log m/s2c ", baseline , green (Collserola Natural Park) ,0,
edin,4760,2848004,No significant difference,"The overall rates of AEs were comparable between the groups (indacaterol 49.3%, placebo 46.8%)", The overall rate of adverse events (ASs) , placebo , indacaterol 150 Î¼g o.d ,0,
edin,4732,3293068,No significant difference,No differences were noted between coconut water (CW or CWC) and SD for any measures of fluid retention (p > 0.05)., measures of fluid retention , carbohydrate-electrolyte sport drink (SD) ," pure coconut water (VitaCocoÂ®: CW), coconut water from concentrate (CWC ",0,
edin,4795,2613135,Significantly increased,Detailed analyses showed that Cmax of EudorlinÂ® extra was higher than that of NurofenÂ® forte (36.62 vs. 32.92 Î¼g/ml; p = 0.0014), Cmax , 400 mg NurofenÂ® forte and 400 mg MigrÃ¤ninÂ® , 400 mg EudorlinÂ® extra* (Ibuprofen) ,0,
edin,4889,3546025,Significantly increased,"While EAAMR did not promote a significant preservation of lean tissue, the reduction in adipose tissue was greater in EAAMR compared to CMR. Interestingly, these results corresponded to an increase in the acute skeletal muscle protein FSR.", Skeletal muscle protein FSR , competitive meal replacement (CMR) , essential amino acid meal replacement (EAAMR) ,0,
edin,4884,3546025,No significant difference,"By design, both groups lost ~7% of total body weight.", absolute amount of weight loss , competitive meal replacement (CMR) , essential amino acid meal replacement (EAAMR) ,0,
edin,4842,4138551,Cannot tell based on the abstract,"QP and SP were equally effective in distalizing maxillary molars (3.5 and 4Â mm, respectively) between T1 and T2; however, the maxillary first molar showed less distal tipping (4.6Â° vs. 9.6Â°) and more extrusion (1.1 vs. 0.2Â mm) in the QP group than in the SP group,", molar extrusion , group 2   treated with the Quad Pendulum (QP) and fixed appliances , group 1 treated with the Segmented Pendulum (SP) and fixed appliances; ,0,
edin,4842,4138551,Significantly decreased,"However, QP showed greater molar extrusion (1.8âÂ±â0.7Â mm) than SP (1.0âÂ±â0.4Â mm) at the end of treatment (pâ<â0.001).", molar extrusion , group 2   treated with the Quad Pendulum (QP) and fixed appliances , group 1 treated with the Segmented Pendulum (SP) and fixed appliances; ,0,
edin,5056,4080584,Significantly increased,"Adjustment for age and BMI made no substantive difference to outcomes, and there were no cluster effects. For HRQoL, after adjustment for baseline scores, the intervention group showed significantly higher scores on all three PedsQL scores (physical functioning: MâÂ±âSEâ=â83.9âÂ±â0.7, pâ=â.005; psychosocial: 79.9âÂ±â0.8, pâ=â.001; total score: 81.3âÂ±â0.7, pâ=â.001) than the control group (80.9âÂ±â0.8; 76.1âÂ±â0.9 and 77.8âÂ±â0.8).", total score , control group , intervention group ,0,
edin,4831,2748072,No significant difference,"There were no significant differences in the other direct cost categories (outpatient clinic and admittance related costs), indirect costs, and total costs."," outpatient clinic and admittance related costs, indirect costs, and total costs ", small-incision cholecystectomy , laparoscopic ,0,
edin,5024,4129110,No significant difference,No significant changes in BMI or body composition were found., BMI , moderate-intensity aerobic and resistance training (ART) , high-intensity functional training (HIFT) ,0,
edin,4802,5515881,Significantly increased,"Moreover, the balance group significantly improved in memory and spatial cognition.,These results suggest that balance training is capable of improving particularly memory and spatial cognition.", memory score , relaxation group , demanding balance training program ,0,
edin,4966,5462678,Cannot tell based on the abstract,, effect of balance taping for prevention of menstrual pain in female middle school students after 4 hours , medication , balance taping ,0,
edin,4966,5462678,Significantly increased,"The balance taping group showed a statistically significant difference in pain compared with the medication group from 4 hours after the taping, and it lasted until 24 hours after the taping.,<td align=""left"" colspan=""1"" rowspan=""1"">Taping**</td><td align=""center"" colspan=""1"" rowspan=""1"">6.91 Â± 0.98</td><td align=""center"" colspan=""1"" rowspan=""1"">3.94 Â± 1.84</td><td align=""center"" colspan=""1"" rowspan=""1"">1.67 Â± 1.65</td><td align=""center"" colspan=""1"" rowspan=""1"">0.82 Â± 1.07</td><td align=""center"" colspan=""1"" rowspan=""1"">0.36 Â± 0.70</td>", effect of balance taping for prevention of menstrual pain in female middle school students after 4 hours , medication , balance taping ,0,
edin,4907,3339723,Cannot tell based on the abstract,, adverse effects , conventional therapy plus hydrocortisone IV (100 mg in 2 ml 8 hourly for 48 h) ," recumbent positioning, IV or oral hydration, analgesics with caffeine, stool softeners, and soft diet) plus 2 ml  ",0,
edin,4907,3339723,No significant difference,No adverse effects were noted and no patient was re-referred to hospital for relapse of headache., adverse effects , conventional therapy plus hydrocortisone IV (100 mg in 2 ml 8 hourly for 48 h) ," recumbent positioning, IV or oral hydration, analgesics with caffeine, stool softeners, and soft diet) plus 2 ml  ",0,
edin,4829,2748072,Cannot tell based on the abstract,, Operation theatre costs , small-incision cholecystectomy , laparoscopic ,0,
edin,4829,2748072,Significantly increased,"The difference in operation theatre cost is in favor of the SIC group however. Operation theatre costs are over 23% more expensive in the LC group compared to the SIC group (LC: 1112 euro compared to SIC: 901 euro; difference 211 euro, p < 0.001).", Operation theatre costs , small-incision cholecystectomy , laparoscopic ,0,
edin,4892,1175929,Cannot tell based on the abstract,, C-reactive protein , baseline , endotoxin intravenously (2 ng/kg Escherichia coli O113) ,0,
edin,4892,1175929,No significant difference,"In the control individuals no elevations in temperature (from 36.9 Â± 0.1 to 37.0 Â± 0.1Â°C), clinical symptoms, cytokine levels (TNF-Î± <8 pg/ml, IL-1Î² <8 pg/ml) or C-reative protein (<5 mg/ml) were observed (Fig. 1).", C-reactive protein , baseline , endotoxin intravenously (2 ng/kg Escherichia coli O113) ,0,
edin,4822,3904487,Significantly increased,"The duration of sedation in piperine receiving group was greater that the placebo group (188Â±59 vs. 102Â±43 min, p<0.0001).", The duration of sedation , placebo and midazolam (10 mg) , piperine (15 mg) and midazolam (10 mg) ,0,
edin,5030,4215680,Cannot tell based on the abstract,Long-term treatment with rifaximin and the probiotic VSL#3 is effective in lowering the progression of prostatitis into more complicated forms of male accessory gland infections in infertile patients with bacteriologically cured CBP plus IBS., bacteriological methods , no treatment , rifaximin followed by the probiotic VSL#3 ,0,
edin,5030,4215680,Significantly increased,Long-term treatment with rifaximin and the probiotic VSL#3 is effective in lowering the progression of prostatitis into more complicated forms of male accessory gland infections in infertile patients with bacteriologically cured CBP plus IBS., bacteriological methods , no treatment , rifaximin followed by the probiotic VSL#3 ,0,
edin,5058,4080584,Significantly increased,"For HRQoL, after adjustment for baseline scores, the intervention group showed significantly higher scores on all three PedsQL scores (physical functioning: MâÂ±âSEâ=â83.9âÂ±â0.7, pâ=â.005; psychosocial: 79.9âÂ±â0.8, pâ=â.001; total score: 81.3âÂ±â0.7, pâ=â.001) than the control group (80.9âÂ±â0.8; 76.1âÂ±â0.9 and 77.8âÂ±â0.8).", physical functioning , control group , intervention group ,0,
edin,5025,4129110,Significantly decreased,Workouts were shorter for HIFT than ART (p < .001)., Time spent completing daily workouts , moderate-intensity aerobic and resistance training (ART) , high-intensity functional training (HIFT) ,0,
edin,4847,4535555,Significantly increased,"On acute imaging, mean % encirclements by LGE and T2W signal were 72% and 80% in the robotic group vs. 60% (P = 0.002) and 76%(P = 0.45) for standard ablation.", mean circumferential extent obtained by a combination of LGE&amp;amp;T2 signal overlay , standard navigation , robotic-assisted navigation (Hansen SenseiÂ® X) ,0,
edin,5022,4129110,Cannot tell based on the abstract,"Participants provided mostly intrinsic reasons for exercise initiation. Eighteen participants adhered (ART = 9, 81.8%; HIFT = 9, 75%). HIFT dropouts (p = .012) and ART participants (p = .009) reported lower baseline exercise enjoyment than HIFT participants, although ART participants improved enjoyment at posttest (p = .005).", exercise initiation , moderate-intensity aerobic and resistance training (ART) , high-intensity functional training (HIFT) ,0,
edin,5022,4129110,No significant difference,"Twenty-two participants provided reasons for exercise initiation, with many listing multiple reasons. Overall, 9 participants (39.1%) listed only intrinsic reasons and 13 (56.5%) listed both intrinsic and extrinsic reasons. For the ART participants, extrinsic reasons included wanting to lose weight (nâ=â7) and to work with a trainer (nâ=â2). Intrinsic reasons included to have motivation to exercise (nâ=â4), to develop an exercise habit (nâ=â3), to improve fitness/get into shape (nâ=â3), to learn new exercises/gain knowledge (nâ=â3), to lose stress (nâ=â1), and to learn about nutrition (nâ=â1). HIFT participants were also extrinsically motivated to participate by wanting to lose weight (nâ=â5). Intrinsic reasons included to have the motivation to exercise (nâ=â4), to develop an exercise habit (nâ=â3), to improve health (nâ=â3), to see results (nâ=â3), to improve fitness/get into shape (nâ=â2), and to be exposed to a new type of exercise (nâ=â1).", exercise initiation , moderate-intensity aerobic and resistance training (ART) , high-intensity functional training (HIFT) ,0,
edin,4960,5555437,Cannot tell based on the abstract,, Median progression-free survival , 45 Gy radiotherapy in 30 twice-daily fractions of 1Â·5 Gy over 19 days , 66 Gy in 33 once-daily fractions of 2 Gy over 45 days ,0,
edin,4960,5555437,No significant difference,Median progression-free survival was 15Â·4 months (95% CI 13Â·7â19Â·8) in the twice-daily group and 14Â·3 months (12Â·0â17Â·0) in the once-daily group (hazard ratio 1Â·12 [95% CI 0Â·92â1Â·38]; p=0Â·26)., Median progression-free survival , 45 Gy radiotherapy in 30 twice-daily fractions of 1Â·5 Gy over 19 days , 66 Gy in 33 once-daily fractions of 2 Gy over 45 days ,0,
edin,5020,3925077,Cannot tell based on the abstract,, probability of antibiotic prophylaxis being cost-effective from a societal perspective , placebo , low dose penicillin V ,0,
edin,5020,3925077,Significantly increased,"If a break-even (no-investment) criterion is required then prophylaxis is 62% likely to be cost-effective from an NHS perspective and 73% from a secondary, societal perspective.", probability of antibiotic prophylaxis being cost-effective from a societal perspective , placebo , low dose penicillin V ,0,
edin,4778,3466131,No significant difference,"After a median follow-up of 42âmonths, median PFS was 10.2 and 10.8âmonths (pâ=â0.74), while median OS was 20.0 and 25.3âmonths (pâ=â0.099), for groups A and B, respectively.", overall survival (OS) ," group B (irinotecan, leucovorin, fluorouracil, bevacizumab, every 2âweeks; FOLFIRI-bevacizumab) "," group A (irinotecan, capecitabine, bevacizumab, every 3âweeks; XELIRI-bevacizumab) ",0,
edin,4914,400417,No significant difference,Fewer than 20% of patients in each arm of the study achieved an ACR 20 response at 24 weeks (P = 0.71)., the proportion of patients achieving an American College of Rheumatology (ACR) 20 response at 24 weeks , placebo , 30 Î¼g IFN-Î²-1a by weekly self-injection for 24 weeks ,0,
edin,4888,3546025,Cannot tell based on the abstract,, muscle phenyalanine enrichments , competitive meal replacement (CMR) , essential amino acid meal replacement (EAAMR) ,0,
edin,4888,3546025,Significantly increased,"Upon ingestion of each product, muscle phenyalanine enrichments increased (pâ<â0.05) dramatically in EAAMR compared to no change with CMR (pâ>â0.05).", muscle phenyalanine enrichments , competitive meal replacement (CMR) , essential amino acid meal replacement (EAAMR) ,0,
edin,4978,5694844,Cannot tell based on the abstract,, Microleakage of Two Bulk Fill and One Conventional Composite in Class II Restorations of Primary Posterior Teeth , Z250 conventional composite , SonicFill bulk fill ,0,
edin,4978,5694844,No significant difference,No significant difference was noted among the three groups in terms of microleakage in the gingival (P=0.252) or occlusal (P=0.516) margins (Table 2)., Microleakage of Two Bulk Fill and One Conventional Composite in Class II Restorations of Primary Posterior Teeth , Z250 conventional composite , SonicFill bulk fill ,0,
edin,4970,3608893,Significantly increased,"Significantly more PCD than DSME participants lost â©¾5% of initial weight (54.0% vs 14.0%, P<0.0001) and â©¾10% (26.0% vs 6.0%, P<0.0001).", Loss in initial weight , self-management education (DSME) , portion-controlled diet (PCD) ,0,
edin,5005,3682293,Cannot tell based on the abstract,," mean oxygenation index after adjusting for age, blood products, and ECC time ", propofol , sevoflurane ,0,
edin,5005,3682293,No significant difference,"The mean oxygenation index in the sevoflurane group was 42 points higher on POD1 compared with the propofol group in the unadjusted model (P = 0.04) (Table 4).,After adjusting for age, blood products, and ECC time, the difference decreased to 27 points and was no longer significant."," mean oxygenation index after adjusting for age, blood products, and ECC time ", propofol , sevoflurane ,0,
edin,4850,5425769,No significant difference,We found no overall significant effect of the Sonas programme with regard to communication ability as measured by the HCS., Holden Communication Scale (HCS)  , baseline , Sonas programme ,0,
edin,4921,4260384,No significant difference,"he probing depth changes were significant (P < 0.01) for both groups, but the difference was nonsignificant.", probing depth changes ," Group A, which were treated with the envelope type of CAF ", Group B were treated with envelope type of CAF along with the Type I collagen membrane (NEOMEM) ,0,
edin,4833,4984426,No significant difference,"The mean maximum Clinical Opiate Withdrawal Scale scores were similar, and numerically lower on buccal buprenorphine.", median maximum COWS scores , Full Î¼-opioid agonist* ,  Buccal buprenorphine (BBUP) ,0,
edin,4834,4984426,No significant difference,There were no significant differences in pain ratings between treatments., pain ratings , Full Î¼-opioid agonist* ,  Buccal buprenorphine (BBUP) ,0,
edin,5011,4764962,Significantly decreased,"The results revealed a significant difference between the preoperative and postoperative Wexner scores of incontinence in all the 3 groups. Additionally, the difference between the preoperative and postoperative scores was significant only in Group I and Group III, but not in Group II. The reduction in the Wexner score was significantly less in Group III.", Wexner score ," Group III, only surgical management was performed "," Group II, biofeedback therapy was applied only 6 months after the surgery ",0,
edin,4975,5958473,Significantly increased,"Varenicline in combination with behavioral support resulted in high abstinence rates inpatients hospitalized for exacerbation of COPD, asthma attack, or CAP, and improved QoL.", high abstinence rates of smoking in smokers hospitalized due to community-acquired pneumonia (CAP) , Varenicline , Varenicline in combination with behavioral support ,0,
edin,4997,3407981,Significantly increased,"Blood glucose levels (30 min after beverage ingestion) differed across all treatments (CHO > HCLP > LCHP; p < 0.05),", Glucose levels obtained 30 min post-feeding , LHCP , HCLP ,0,
edin,4845,4535555,Significantly increased,Late gadolinium enhancement remained the predominant signal with 56% encirclement in the robotic group vs. 45% in the standard group (P = 0.04)., Late gadolinium enhancement  , standard navigation , robotic-assisted navigation (Hansen SenseiÂ® X) ,0,
edin,4964,5462678,Significantly increased,"The balance-taping group showed a difference in pain from 1 hour after the taping compared with the control group, and the pain was significantly reduced until 24 hours after the taping.,Balance taping was shown to be effective in relieving menstrual pain.", effect of balance taping for prevention of menstrual pain in female middle school students after 24 hours , control , balance taping ,0,
edin,4843,4138551,Significantly increased,"At T3, the QP group maintained greater increase in lower anterior facial height and molar extrusion and decrease in overbite than the SP group.", The overbite , group 2   treated with the Quad Pendulum (QP) and fixed appliances , group 1 treated with the Segmented Pendulum (SP) and fixed appliances; ,0,
edin,4926,4493951,Significantly increased,"In the PACU, group H2 had a higher sedation score than groups H1 and H0 (Pâ<â0.001).", The sedation score recorded in the postanesthesia care unit (PACU) over the 2-h observation period ," H0 (saline), H1(haloperidol 1 mg), ",  and H2 (haloperidol 2 mg) ,0,
edin,4814,5124485,No significant difference,"At a median follow-up of 48 months (IQR:31â56), median PFS was 39 months (IQR:16â46) in the TMZ arm and 46 months (IQR:19â48) in the RT group (hazard ratio 1.16, 95% CI, 0.9â1.5; p=0.22).", median  progression-free survival (PFS) , standard radiotherapy (RT)  (50.4 Gy/28 fractions) ," temozolomide (TMZ)  (75 mg/m2 daily Ã 21 days, q28 days, max. 12 cycles) ",0,
edin,5059,4080584,Significantly increased,"For HRQoL, after adjustment for baseline scores, the intervention group showed significantly higher scores on all three PedsQL scores (physical functioning: MâÂ±âSEâ=â83.9âÂ±â0.7, pâ=â.005; psychosocial: 79.9âÂ±â0.8, pâ=â.001; total score: 81.3âÂ±â0.7, pâ=â.001) than the control group (80.9âÂ±â0.8; 76.1âÂ±â0.9 and 77.8âÂ±â0.8). T", psychosocial functioning , control group , intervention group ,0,
edin,4989,2885597,Significantly decreased,"Significant reductions in total cholesterol, triglycerides and non-high density lipoprotein cholesterol were observed in the combination treatment group. The serum activities of alkaline phosphatase, gamma-glutamyl transpeptidase and alanine aminotranferase also decreased in this group compared with baseline (-32.6%; p=0.012, -44%; p=0.031 and -16.9%; p=0.029, respectively).", alkaline phosphatase , UDCA monotherapy , fenofibrate plus UDCA ,0,
edin,4941,4907437,No significant difference,"There was no significant difference between groups in pain-related disability at 6 or 12 mo (12 mo: difference â1.0, intervention versus control, 95% CI â4.9 to 3.0), pain intensity, or the census global health question", pain-related disability at 12 mo , usual care and a relaxation CD , COPERS intervention ,0,
edin,4992,2360567,Significantly increased,Tumour-specific survival in the IL-2 group and the control group was 98 vs 81% after 1 year and 86 vs 73% after 5 years (P=0.04)., Tumour-specific survival after 5 years , immunomonitoring without immunomodulation , preoperative administration of interleukin-2 (IL-2) ,0,
edin,5021,4129110,Significantly increased,"HIFT participants spent significantly less time exercising per week, yet were able to maintain exercise enjoyment and were more likely to intend to continue.", intend to continue , moderate-intensity aerobic and resistance training (ART) , high-intensity functional training (HIFT) ,0,
edin,4977,5958473,Cannot tell based on the abstract,"Varenicline in combination with behavioral support resulted in high abstinence rates inpatients hospitalized for exacerbation of COPD, asthma attack, or CAP, and improved QoL.", improved quality of Life (QoL) , Varenicline , Varenicline in combination with behavioral support ,0,
edin,4977,5958473,No significant difference,Smoking cessation improved QoL in both groups. The comparison of mean scores between baseline and week 52 showed statistically significant changes for all SF36 domains (Table 2). These figures must be viewed with caution due to the small number of eight completers in group B., improved quality of Life (QoL) , Varenicline , Varenicline in combination with behavioral support ,0,
edin,4929,4331939,Significantly increased,"A comparison of the experimental and the control groups showed more significant improvements in the VAS, PRS, and ODI for the experimental group than for the control group.", pain rating scale [PRS] ,  normal saline-pharmacopuncture-treated group , Chukyu (spinehealing)- pharmacopuncture-treated group  ,0,
edin,4799,5515881,Cannot tell based on the abstract,, dynamic balance performance on the stability platform , relaxation group , demanding balance training program ,0,
edin,4799,5515881,Cannot tell based on the abstract,, dynamic balance performance on the stability platform , relaxation group , demanding balance training program ,0,
edin,4799,5515881,Significantly increased,"The balance training increased participantsâ dynamic balance performance on the stability platform as indicated by a significant effect of group, F(1, 36)â=â8.72, pâ=â0.005.", dynamic balance performance on the stability platform , relaxation group , demanding balance training program ,0,
edin,5046,2363617,Cannot tell based on the abstract,"According to the criteria of the 5th edition, 39% of the node-positive patients had another N stage compared to the 4th: 21% had a lower and 18% had a higher stage. 5-year survival rates according to the 4th edition N0, N1 and N2 groups were respectively 72%, 34% and 27%. According to the 5th edition these percentages were for the N0, N1, N2, N3 and Nx groups respectively 75%, 38%, 19%, 8% and 65%.", N1 and N2 groups , 4th edition (1987) , 5th edition (1997) of the TNM classification for gastric cancer ,0,
edin,5046,2363617,Significantly increased,"According to the criteria of the 5th edition, 39% of the node-positive patients had another N stage compared to the 4th: 21% had a lower and 18% had a higher stage. 5-year survival rates according to the 4th edition N0, N1 and N2 groups were respectively 72%, 34% and 27%. According to the 5th edition these percentages were for the N0, N1, N2, N3 and Nx groups respectively 75%, 38%, 19%, 8% and 65%. The former 1987 N1 and N2 group were significantly split into three new N 1997 groups (P = 0.006, respectively P< 0.0005).", N1 and N2 groups , 4th edition (1987) , 5th edition (1997) of the TNM classification for gastric cancer ,0,
edin,5034,5106769,Significantly increased,"Additionally, PSR times and DG thresholds improved significantly from baseline compared to placebo at 6- and 12-month visits (pâ<â0.001 for all).", disability glare (DG) performance , placebo , macular carotenoids (MC): 20 mg Lâ+â4 mg total Z (2 mg Zâ+â2 mg MZ; nâ=â25) ,0,
edin,4938,3262135,Cannot tell based on the abstract,NSAID consumption was lower in the Bupivacaine group compared with the NaCl group (PÂ <Â 0.01).," One&amp;nbsp;h postoperative, NSAID consumption ", Control group , Bupivacaine group ,0,
edin,4938,3262135,Significantly decreased,"OneÂ h postoperative, NSAID consumption was reported by 64 (67%) patients in the Control group, 42 (47%) patients in the Bupi group and 38 (42%) patients in the Ropi group. Significantly, more patients in the Control group used NSAIDâs compared with the Bupi group (PÂ <Â 0.01)."," One&amp;nbsp;h postoperative, NSAID consumption ", Control group , Bupivacaine group ,0,
edin,4775,5119624,Significantly increased,"ORR was also higher in the talimogene laherparepvec arm (40.5% versus 2.3%; P<0.0001), and 27 patients in the talimogene laherparepvec arm had a complete response, compared with none in GM-CSF-treated patients.", overall response rate (ORR) , granulocyte-macrophage colony-stimulating factor (GM-CSF) , Talimogene laherparepvec ,0,
edin,5027,4215680,Cannot tell based on the abstract,, positive sperm culture (with CFU &amp;gt; 105 mlâ1) , no treatment , rifaximin followed by the probiotic VSL#3 ,0,
edin,5027,4215680,Significantly decreased,"Overall, the treatment with rifaximin and VSL#3 was beneficial in terms of lowering the frequency of bacteriospermia when it was started immediately after the initial germ eradication rather than 6 months later. Indeed, patients of group â6Tx/6-â had the lowest frequency of positive sperm culture compared with patients of group â6-/6Txâ who received the treatment during the last 6 months of observation. The highest frequency was found in patients who were not prescribed any treatment and conversely, the lowest frequency was found among patients of group â12Txâ who received the treatment for all 12 months (Table 2).", positive sperm culture (with CFU &amp;gt; 105 mlâ1) , no treatment , rifaximin followed by the probiotic VSL#3 ,0,
edin,4792,3693661,No significant difference,"Variations within group had been changed in FBS; sodium, phosphorus and osmolarity levels were not changed significantly."," FBS, sodium, phosphorus and osmolarity levels ", baseline ," fasting + exercise (FE),  fasting + non exercise (FNE) ",0,
edin,4809,3591547,Cannot tell based on the abstract,," stopping the anesthesia drugs up to opening eyes, return to verbal response, and discharge from the recovery "," Remifentanil 0.5 Î¼g/kg, infusion of Remifentanil 0.1 Î¼g/kg/min "," 10 Î¼g/kg of Alfentanil, infusion of Alfentanil 1 Î¼g/kg/min ",0,
edin,4809,3591547,No significant difference,"There was no significant difference in stopping the anesthesia drugs up to opening eyes, return to verbal response, and discharge from the recovery between two groups."," stopping the anesthesia drugs up to opening eyes, return to verbal response, and discharge from the recovery "," Remifentanil 0.5 Î¼g/kg, infusion of Remifentanil 0.1 Î¼g/kg/min "," 10 Î¼g/kg of Alfentanil, infusion of Alfentanil 1 Î¼g/kg/min ",0,
edin,4771,5395991,No significant difference,"The primary macular hole closure and reattachment rates were not significantly different in both groups (P=0.056, respectively).", The primary reattachment rate , ILM peeling , internal limiting membrane (ILM) flap technique ,0,
edin,4800,5515881,Cannot tell based on the abstract,, center of pressure (CoP) sway velocity , relaxation group , demanding balance training program ,0,
edin,4800,5515881,No significant difference,"There was no significant training effect on neither the CoP sway velocity as assessed with the forceplate, F(1, 36)â<â0.001, pâ=â0.962, group differenceâ=ââ0.001, 95% CIâ=â[â0.08, 0.08], dâ=ââ0.01, nor on functional balance, as measured with the BESS, F(1, 36)â=â0.16, pâ=â0.704, group differenceâ=ââ0.52, 95% CIâ=â[â0.3.25, 2.22], dâ=ââ0.09.", center of pressure (CoP) sway velocity , relaxation group , demanding balance training program ,0,
edin,4805,4968829,Cannot tell based on the abstract,, peak HR in younger subjects , cycling   , rowing ,0,
edin,4805,4968829,No significant difference,"While older subjects demonstrated no significant difference in peak HR during cycling and rowing (p>0.05),", peak HR in younger subjects , cycling   , rowing ,0,
edin,4949,4616122,Significantly decreased,"The scores for the Visual Analogue Scale, Pain Disability Assessment Scale, and affective subscale of the Short-Form McGill Pain Questionnaire and number of nonorganic pain drawings in the good outcome group were significantly lower than those in the poor outcome group", Pain Disability Assessment Scale , poor outcome group , good outcome group ,0,
edin,4912,3215945,Cannot tell based on the abstract,," The levels of urine N-telopeptide, serum osteocalcin, and serum bone-specific alkaline phosphatase (BSAP) ", placebo , zoledronic acid (4âmg) IV infusion ,0,
edin,4912,3215945,Significantly decreased,"he levels of urine N-telopeptide, serum osteocalcin, and serum bone-specific alkaline phosphatase (BSAP) were 49 Â± 6.6%, 51.6 Â± 6.1%, and 38.8 Â± 7.5%, lower than baseline in the zoledronic acid group (Table 2). These changes were significantly lower than the percent changes in placebo at significance level 0.05."," The levels of urine N-telopeptide, serum osteocalcin, and serum bone-specific alkaline phosphatase (BSAP) ", placebo , zoledronic acid (4âmg) IV infusion ,0,
edin,4817,5331731,Significantly increased,"Econometric analysis shows that PBF led to increased job satisfaction and decreased attrition on a subset of measures, with little effect on motivation.", job satisfaction ,  and control 2 (C2; pure control) , Performance-based financing (PBF) ,0,
edin,4891,1175929,Cannot tell based on the abstract,," TNF-Î± plasma levels,  IL-1Î² ", baseline , endotoxin intravenously (2 ng/kg Escherichia coli O113) ,0,
edin,4891,1175929,Significantly increased,"The clinical onset of inflammation was accompanied by a sudden rise in TNF-Î± plasma levels at 60 min (373 Â± 71 pg/ml), which reached its zenith at 90 min (856 Â± 158 pg/ml), closely followed by a rise in IL-1Î² that was maximal at 120 min (23.9 Â± 2.2 pg/ml)."," TNF-Î± plasma levels,  IL-1Î² ", baseline , endotoxin intravenously (2 ng/kg Escherichia coli O113) ,0,
edin,4957,5555437,Cannot tell based on the abstract,, overall survival 5 years , 45 Gy radiotherapy in 30 twice-daily fractions of 1Â·5 Gy over 19 days , 66 Gy in 33 once-daily fractions of 2 Gy over 45 days ,0,
edin,4957,5555437,No significant difference,5-year overall survival was 34% (95% CI 27â41) in the twice-daily group and 31% (25â37) in the once-daily group (absolute difference 2Â·8% [95% CI â6Â·4% to 12Â·0%])., overall survival 5 years , 45 Gy radiotherapy in 30 twice-daily fractions of 1Â·5 Gy over 19 days , 66 Gy in 33 once-daily fractions of 2 Gy over 45 days ,0,
edin,4927,4493951,Cannot tell based on the abstract,, The sedation score recorded in the postanesthesia care unit (PACU) over the 2-h observation period ,"  H1(haloperidol 1 mg), ", H0 (saline) ,0,
edin,4927,4493951,No significant difference,"The change in the sedation score in the PACU clearly differed among the groups according to the dose of haloperidol. Group H2 had an overall higher sedation score than groups H1 and H0 over the 2-h observation period (Pâ<â0.001, Fig.Â 2), while there was no significant difference between groups H1 and H0. In addition, three patients in group H2 required treatment with ephedrine in the PACU, due to hypotension (systolic 75â80/diastolic 50â55 mmHg).", The sedation score recorded in the postanesthesia care unit (PACU) over the 2-h observation period ,"  H1(haloperidol 1 mg), ", H0 (saline) ,0,
edin,4954,4269914,Significantly increased,"There was also a positive, although statistically insignificant, increase of 2.6Â L% in serum testosterone levels in the experimental group.", serum testosterone levels , control group with Carborade DrinkÂ® alone ," experimental group was supplemented with 500 mg of SAA per kg of body mass, dissolved in 250 ml of a Carborade DrinkÂ®; ",0,
edin,4860,4141579,Significantly increased,"The mean values of high-density lipoprotein were also significantly higher in the first and 2nd years in the carb counting group (p=0.02 and p=0.043, respectively).", Mean  high-density lipoprotein (HDL) levels , control , carb counting ,0,
edin,4806,4968829,Significantly increased,Rowing VO2max was higher than cycling VO2max in both groups (p<0.05)., VO2max in older and younger subjects , cycling ,   rowing ,0,
edin,5047,2363617,Significantly increased,"In addition, the new TNM stage was also a better prognosticator.", better prognosticator , 4th edition (1987) , 5th edition (1997) of the TNM classification for gastric cancer ,0,
edin,4869,4958948,Cannot tell based on the abstract,, HDL cholesterol , baseline , Active Body Control ,0,
edin,4869,4958948,Significantly increased,"ABC program led to significant reductions of systolic and diastolic blood pressure (â7.69%, pâ<â0.001; and â9.47%, pâ<â0.001), serum triglyceride levels (â34.57%, pâ<â0.001), total cholesterol (â8.70%, pâ<â0.001), LDL cholesterol (â13.69%, pâ<â0.001), HbA1c (â3.70%, relative value, pâ<â0.001), fasting blood glucose (â6.10%, pâ<â0.001), fasting insulin (â40.86%, pâ<â0.001) and HOMA-I (â45.71%, pâ<â0.001), whereas HDL cholesterol increased (14.85%, pâ<â0.001).", HDL cholesterol , baseline , Active Body Control ,0,
edin,4768,5395991,No significant difference,"o significant differences were found in the pre- and postoperative BCVA at 1 and 3 months after surgery in either group (inverted ILM flap technique group, preoperatively 1.04Â±0.55, 1 month 0.95Â±0.30, 3 months 0.83Â±0.22; ILM peeling group, preoperatively 1.00Â±0.44, 1 month 1.05Â±0.38, 3 months 1.06Â±0.49; P>0.05, respectively).", best-corrected visual acuity (BCVA) , ILM peeling , internal limiting membrane (ILM) flap technique ,0,
edin,4786,3457720,Cannot tell based on the abstract,, systolic blood pressure at week seven , control , therapeutic massage (TM) ,0,
edin,4786,3457720,Significantly decreased,"There was no significant group difference in systolic blood pressure at week six, but by week seven the TM group was significantly lower.", systolic blood pressure at week seven , control , therapeutic massage (TM) ,0,
edin,5052,4461930,Significantly decreased,"Assignment to the active treatment arms was associated with reduction in plasma amyloid-Î² (AÎ²) peptides, increase in ventricular volume, decrease in cerebrospinal fluid phosphorylated tau (p-tau) and several other laboratory measures and adverse event categories.", plasma amyloid-Î² (AÎ²) peptides , placebo , semagacestat 140 mg ,0,
edin,4794,1713239,Significantly increased,"At 1 minute after inhalation, statistically significant decreases in Borg score were observed for budesonide/formoterol and salbutamol (p = 0.0233 and p < 0.0001, respectively, versus placebo), with similar rapid increases in FEV1 (both active treatments p < 0.0001 versus placebo)", Forced expiratory volume (FEV1) , placebo , budesonide/formoterol and salbutamol ,0,
edin,5010,4764962,Significantly decreased,"Additionally, the difference between the preoperative and postoperative scores was significant only in Group I and Group III, but not in Group II. The reduction in the Wexner score was significantly less in Group III.", Wexner score ," Group III, only surgical management was performed "," Group I, biofeedback therapy was performed 3 months before and 6 months after the surgery ",0,
edin,5037,5741844,No significant difference,"The results of the study showed the least amount of the smear layer at coronal, middle and apical thirds of the root canals in groups 2, which was not significantly different from the negative control group (P<0.5).", Root canal walls without any smear layer , Positive and Negative control groups ," Group 1, 2, 3, 4 ",0,
edin,5050,4461930,Significantly increased,"Assignment to the active treatment arms was associated with reduction in plasma amyloid-Î² (AÎ²) peptides, increase in ventricular volume, decrease in cerebrospinal fluid phosphorylated tau (p-tau) and several other laboratory measures and adverse event categories.", ventricular volume , placebo , semagacestat 100 mg ,0,
edin,4897,1175929,Cannot tell based on the abstract,, Heart rate , baseline , endotoxin intravenously (2 ng/kg Escherichia coli O113) ,0,
edin,4897,1175929,Significantly increased,Heart rate remained unchanged in the control group (from 66 Â± 4 to 65 Â± 2 beats/min; not significant) and increased from 63 Â± 3 to 91 Â± 3 beats/min at 6 hours in the LPS group (P < 0.0001)., Heart rate , baseline , endotoxin intravenously (2 ng/kg Escherichia coli O113) ,0,
edin,4943,4907437,No significant difference,"There was no significant difference between groups in pain-related disability at 6 or 12 mo (12 mo: difference â1.0, intervention versus control, 95% CI â4.9 to 3.0), pain intensity, or the census global health question.,For secondary outcomes, we found sustained benefits on depression and social integration at 6 and 12 mo, but there was no effect on anxiety, pain-related self-efficacy, pain acceptance, pain intensity, or the census global health question at 12 mo.", census global health question at 6- or 12-mo follow-up , control group , COPERS intervention ,0,
edin,4980,5694844,Cannot tell based on the abstract,, Microleakage of Two Bulk Fill and One Conventional Composite in Class II Restorations of Primary Posterior Teeth , Z250 conventional composite , 3M bulk fill ,0,
edin,4980,5694844,No significant difference,"Table 2.
Dye penetration depth in millimeters (indicative of microleakage) in the three groups

Composite	Margin	Mean (Î¼m)	Minimum (Î¼m)	Maximum (Î¼m)	Std. deviation
Bulk-fill (3M)	Gingival	523.40	0.00	1508.00	543.50
Occlusal	93.80	0.00	808.00	214.17
Bulk-fill (SonicFill)	Gingival	290.25	0.00	860.00	343.07
Occlusal	127.35	0.00	1254.00	302.04
Conventional (Z250)	Gingival	590.20	0.00	1498.00	597.78
Occlusal	145.45	0.00	507.00	199.14,No significant difference was noted among the three groups in terms of microleakage in the gingival (P=0.252) or occlusal (P=0.516) margins (Table 2). Microleakage (dye penetration depth) in the gingival margin of all groups was significantly greater than that in the occlusal margin (P=0.001 for 3M bulk fill, P=0.049 for SonicFill and P=0.001 for Z250 conventional composite).,Bulk fill composites have similar properties to conventional composites in terms of microleakage and may be preferred for class II restoration of primary posterior teeth to decrease working time given that their other properties are also favorable.", Microleakage of Two Bulk Fill and One Conventional Composite in Class II Restorations of Primary Posterior Teeth , Z250 conventional composite , 3M bulk fill ,0,
edin,4924,4493951,Significantly decreased,"The total incidence of PONV over 24 h was significantly lower in groups H1 (29Â %) and H2 (24Â %) than in group H0 (54Â %; Pâ=â0.003),", the incidence of postoperative nausea and vomiting (PONV) , H0 (saline) ," H1(haloperidol 1 mg), and H2 (haloperidol 2 mg) ",0,
edin,4844,4535555,Significantly increased,"On acute imaging, mean % encirclements by LGE and T2W signal were 72% and 80% in the robotic group vs. 60% (P = 0.002) and 76%(P = 0.45) for standard ablation", mean % encirclements by  late gadolinium enhancement (LGE) and T2W signal , standard navigation , robotic-assisted navigation (Hansen SenseiÂ® X) ,0,
edin,4846,4535555,No significant difference,"At 6 months follow-up, arrhythmia-free patients had an almost similar mean LGE encirclement (robotic 64%, standard 60%, P = 0.45) but in recurrences, LGE was higher in the robotic group (43% vs. 30%, P = 0.001).", mean LGE encirclement at 6 months follow-up , standard navigation , robotic-assisted navigation (Hansen SenseiÂ® X) ,0,
edin,4789,3693661,No significant difference,"The mean of weight, BMI, WHR, body fat, protein, mineral and total water showed no difference between groups (P > 0.05)."," weight, BMI, WHR ", baseline ," fasting + exercise (FE), fasting + non exercise (FNE) ",0,
edin,4854,5425769,Cannot tell based on the abstract,, Mini-Mental State Examination (MMSE) scores , control , Sonas programme ,0,
edin,4854,5425769,No significant difference,"When stratifying on MMSE (moderate and severe; cut-off of 10 points), a significant difference was found between the Sonas group and the reading group among those with an MMSE score of 0â10 at T0 (p = 0.011) and at T1 (p = 0.044), while among those with an MMSE score of 11â20, there was a significant difference between the Sonas and the reading group at baseline (p = 0.026). No difference was found between the Sonas and the control group.", Mini-Mental State Examination (MMSE) scores , control , Sonas programme ,0,
edin,4923,4260384,Significantly increased,"The width of keratinized tissue was also significantly (P < 0.001) increased in both groups, but the increase was significantly greater (P < 0.001) in group B (2.30 Â± 1.06 mm) than in group A (1.21 Â± 0.67 mm", keratinized tissue ," Group A, which were treated with the envelope type of CAF ", Group B were treated with envelope type of CAF along with the Type I collagen membrane (NEOMEM) ,0,
edin,4959,5555437,Cannot tell based on the abstract,"The primary endpoint was overall survival, defined as time from randomisation until death from any cause, analysed by modified intention-to-treat. A 12% higher overall survival at 2 years in the once-daily group versus the twice-daily group was considered to be clinically significant to show superiority of the once-daily regimen.", median survival , 45 Gy radiotherapy in 30 twice-daily fractions of 1Â·5 Gy over 19 days , 66 Gy in 33 once-daily fractions of 2 Gy over 45 days ,0,
edin,4959,5555437,No significant difference,"In our survival analysis (which included 273 patients in the twice-daily group and 270 in the once-daily group), median overall survival was 30 months (95% CI 24â34) in the twice-daily group and 25 months (21â31) in the once-daily group (hazard ratio 1Â·18 [95% CI 0Â·95â1Â·45]; p=0Â·14; figure 2A).", median survival , 45 Gy radiotherapy in 30 twice-daily fractions of 1Â·5 Gy over 19 days , 66 Gy in 33 once-daily fractions of 2 Gy over 45 days ,0,
edin,4871,4958948,Cannot tell based on the abstract,," Bile acids (BAs), glycine and taurine conjugated BAs ", baseline , Active Body Control ,0,
edin,4871,4958948,Significantly decreased,"We observed a significant decrease of total BA levels in participants of the ABC arm (â34.59%, pâ=â0.007) that resulted mainly from a decrease of glycine and taurine conjugated BAs (â49.11%, pâ=â0.002 and â54.46%, pâ=â0.001) (Fig. 1b and Supplementary Table S2)."," Bile acids (BAs), glycine and taurine conjugated BAs ", baseline , Active Body Control ,0,
edin,4872,4958948,Cannot tell based on the abstract,," CDCA, CA and UDCA ", baseline , Active Body Control ,0,
edin,4872,4958948,Significantly decreased,"Regarding different BA-fractions, lifestyle-induced weight loss was accompanied by a significant decrease of total CDCA (â52.38%, pâ=â0.001), CA (â31.49%, pâ=â0.018) and UDCA (â49.37%, pâ=â0.002) (Fig. 1c and Supplementary Table S2)."," CDCA, CA and UDCA ", baseline , Active Body Control ,0,
edin,5013,5009836,No significant difference,"There was also no difference between groups with respect to bradycardia, APGAR scores, and nausea and vomiting.", incidence of maternal nausea and vomiting , crystalloid preload - Lactated Ringer's solution (1500 ml) ," colloid preload - hydroxyethyl starch (6% in normal saline, 500 ml) ",0,
edin,4870,4958948,Cannot tell based on the abstract,," systolic and diastolic blood pressure, serum triglyceride levels , total cholesterol , LDL cholesterol , HbA1c , fasting blood glucose, fasting insulin  and HOMA-I ", baseline , Control ,0,
edin,4870,4958948,Significantly decreased,"ABC program led to significant reductions of systolic and diastolic blood pressure (â7.69%, pâ<â0.001; and â9.47%, pâ<â0.001), serum triglyceride levels (â34.57%, pâ<â0.001), total cholesterol (â8.70%, pâ<â0.001), LDL cholesterol (â13.69%, pâ<â0.001), HbA1c (â3.70%, relative value, pâ<â0.001), fasting blood glucose (â6.10%, pâ<â0.001), fasting insulin (â40.86%, pâ<â0.001) and HOMA-I (â45.71%, pâ<â0.001),"," systolic and diastolic blood pressure, serum triglyceride levels , total cholesterol , LDL cholesterol , HbA1c , fasting blood glucose, fasting insulin  and HOMA-I ", baseline , Control ,0,
edin,4937,3262135,Significantly decreased,NSAID consumption was lower in the Bupivacaine group compared with the NaCl group (PÂ <Â 0.01)., used NSAIDâs , Control group , Bupivacaine group ,0,
edin,5036,5741844,No significant difference,"The results of the study showed the least amount of the smear layer at coronal, middle and apical thirds of the root canals in groups 2, which was not significantly different from the negative control group (P<0.5)."," amount of the smear layer at coronal, middle and apical thirds of the root canals ", negative control group , Group 2: XPF with 1 mL of 17% EDTA for one minute ,0,
edin,4812,3635629,No significant difference,"Transfusion requirements, excluding FFP in pump prime, and postoperative bleeding were comparable between the control and treatment groups of infants and children.", FFP transfusion , control , 20% albumin (50-100 mL) or fresh frozen plasma (FFP) (1-2 units) ,0,
edin,4883,3774725,Significantly increased,"For patients resolving in the first three months, the adjusted Hazard Ratio (aHR) was 0.85 (95% Confidence Interval [CI]: 0.64-1.13) suggesting that PN had no effect on resolution time during this period.,Beyond three months, however, navigated patients resolved more quickly to diagnostic resolution compared with the control group (aHR 2.8, 95%CI: 1.30-6.13). Th", effect on resolution time beyond first three months , Control , patient navigation (PN) program ,0,
edin,4951,4616122,Significantly decreased,"The scores for the Visual Analogue Scale, Pain Disability Assessment Scale, and affective subscale of the Short-Form McGill Pain Questionnaire and number of nonorganic pain drawings in the good outcome group were significantly lower than those in the poor outcome group", number of nonorganic pain drawings , poor outcome group , good outcome group ,0,
edin,4798,3108651,Cannot tell based on the abstract,, grade 3â4 neutropenia , 400  mg/day imatinib , 800 mg/day imatinib ,0,
edin,4798,3108651,No significant difference,"On the other hand, no increase in grade 3â4 neutropenia was documented after crossover to the higher dosage (P = 0.002).", grade 3â4 neutropenia , 400  mg/day imatinib , 800 mg/day imatinib ,0,
edin,4876,4958948,Cannot tell based on the abstract,," total GLP-1, FGF-19 levels ", baseline , Control ,0,
edin,4876,4958948,No significant difference,"Lifestyle-induced weight loss had no effect on circulating FGF-19 levels (Fig. 2a), while total GLP-1 decreased significantly (pâ=â0.003; Fig. 2b). Both parameters remained stable in the control arm."," total GLP-1, FGF-19 levels ", baseline , Control ,0,
edin,4838,4138551,Significantly increased,"QP and SP were equally effective in distalizing maxillary molars (3.5 and 4Â mm, respectively) between T1 and T2; however, the maxillary first molar showed less distal tipping (4.6Â° vs. 9.6Â°) and more extrusion (1.1 vs. 0.2Â mm) in the QP group than in the SP group, as well as the vertical facial dimension, which increased more in the QP group (1.2Â°) than in the SP group (0.7Â°).", molar tipping , group 2   treated with the Quad Pendulum (QP) and fixed appliances , group 1 treated with the Segmented Pendulum (SP) and fixed appliances; ,0,
edin,4939,3262135,Cannot tell based on the abstract,," One h postoperative, NSAID consumption ", Control group , Ropivacaine ,0,
edin,4939,3262135,No significant difference,"OneÂ h postoperative, NSAID consumption was reported by 64 (67%) patients in the Control group, 42 (47%) patients in the Bupi group and 38 (42%) patients in the Ropi group. Significantly, more patients in the Control group used NSAIDâs compared with the Bupi group (PÂ <Â 0.01).,No significant differences were found comparing the Control group to the Ropi group or the Ropi group to the Bupi group."," One h postoperative, NSAID consumption ", Control group , Ropivacaine ,0,
edin,4769,5395991,Significantly increased,The primary macular hole closure rates were 100% in the inverted ILM flap technique group and 55.5% in the ILM peeling group., The primary macular hole closure rates , ILM peeling , internal limiting membrane (ILM) flap technique ,0,
edin,5159,2713840,Cannot tell based on the abstract,, Success rate , Shoulder type covered stent , Uncovered nitinol stent ,0,
edin,5159,2713840,No significant difference,"The clinical success rate was 80.0% (24/30): 100% for type A, 68.8% for type B, and 83.3% for type C (Table 3); the differences were statistically insignificant (p=0.191", Success rate , Shoulder type covered stent , Uncovered nitinol stent ,0,
edin,5165,3785902,No significant difference,"We concluded that propofol can reduce SBP, DBP, MAP, HR & cough production at the time of injection but there were no significant changes in these parameters after extubation.", Cough  , Control , Propofol ,0,
edin,5120,3980039,Cannot tell based on the abstract,"In Study 3, beta cell glucose sensitivity was minimally affected, but the insulin secretion rate at 9Â mmol/l glucose increased to similar degrees from baseline with canagliflozin and sitagliptin [LSM (SEM) changes 38 (8) and 28 (9) pmolÂ minâ1Â mâ2, respectively; pâ<â0.05 for both].", Total insulin secretion , Sitagliptin , Canagliflozin 300 mg ,0,
edin,5120,3980039,Significantly decreased,"Consistent with the greater reductions in plasma glucose concentrations in the canagliflozin group, total insulin secretion was reduced with canagliflozin treatment compared with sitagliptin (pâ=â0.005) (TableÂ 5)", Total insulin secretion , Sitagliptin , Canagliflozin 300 mg ,0,
edin,5169,5091022,No significant difference,"The total bleeding measured at the suction drains within 48Â h was higher in Group II, with a statistically significant difference (pÂ =Â 0.005); in the first 24Â h, there was major bleeding in Group II (mean 893Â mL), with a significant difference (pÂ =Â 0.004). Between 24 and 48Â h, there was no statistically significant difference in both groups (pÂ =Â 0.710). The total estimated bleeding was higher in Group I, with mean of 463Â mL, versus 409Â mL in Group II, with no statistical significance (pÂ =Â 0.394).", Total blood suctioned after 48 hrs , 4.8 mm drain , 3.2 mm drain ,0,
edin,5226,4815882,Cannot tell based on the abstract,, Time to progression  , Placebo , Simvastatine ,0,
edin,5226,4815882,No significant difference,"No significant differences were observed between the simvastatin and placebo groups regarding two of the secondary end points, OS and TTP.", Time to progression  , Placebo , Simvastatine ,0,
edin,5151,1852293,Significantly increased,"Using five diagnostic criteria, 18% of CVC patients were cured and 70.8% either cured and/or improved compared to 1.6% and 12% of placebo patients respectively (p < 0.0001).", Cured patients using 5 criteria , Placebo , Clindamycin cream ,0,
edin,5094,3279644,Cannot tell based on the abstract,,  MEP amplitudes , anodal-tDCS&amp;nbsp;+&amp;nbsp;iTBS condition , cathodal-tDCS + iTBS ,0,
edin,5094,3279644,Significantly increased,"Post hoc t tests showed that baseline MEP amplitudes did not differ between conditions (all PÂ >Â 0.05).,However, in the cathodal-tDCSÂ +Â iTBS condition, MEPs after stimulation were larger than in the sham-tDCSÂ +Â iTBS condition (tÂ =Â 2.983, dfÂ =Â 8, PÂ =Â 0.020) and the anodal-tDCSÂ +Â iTBS condition (PÂ =Â 0.080, trend level).",  MEP amplitudes , anodal-tDCS&amp;nbsp;+&amp;nbsp;iTBS condition , cathodal-tDCS + iTBS ,0,
edin,5204,4311411,Cannot tell based on the abstract,, Sensitive Conduction Velocity  , Placebo ," High dose (baclofen, naltrexone, sorbitol) ",0,
edin,5204,4311411,Significantly increased,"DML was significantly decreased in the HD group when compared to Placebo (8%, Pâ=â0.038), and SCV was significantly increased in HD when compared to Placebo (26.6%, Pâ=â3.70Ã10â4) and PLI (20.1%, Pâ=â0.03).", Sensitive Conduction Velocity  , Placebo ," High dose (baclofen, naltrexone, sorbitol) ",0,
edin,5063,5610548,Cannot tell based on the abstract,, Sialylated HMOs , Iron and folic acid , LipÃ­d based nutrient suplement ,0,
edin,5063,5610548,No significant difference,"At 6 mo postpartum, there were no significant differences in mean concentrations of total HMOs, sialylated or fucosylated HMOs, lactoferrin, lactalbumin, lysozymes, antitrypsin, IgA, or osteopontin between the 3 intervention groups in either the unadjusted or adjusted models (each P > 0.10) (Table 2).", Sialylated HMOs , Iron and folic acid , LipÃ­d based nutrient suplement ,0,
edin,5083,5617873,Cannot tell based on the abstract,, Compulsion scale , Placbeo , Aripiprazole ,0,
edin,5083,5617873,No significant difference,"<td align=""left"">CY-BOCS (compulsion scale only)</td><td align=""char"" char=""."">5.4 (0.9)</td><td align=""left"">â1.3 (0.5)</td><td align=""char"" char=""."">6.3 (0.9)</td><td align=""left"">â2.0 (0.5)</td><td align=""left"">â0.69 (â2.03, 0.66)<sup>b</sup>
<break>0.311</break></td>", Compulsion scale , Placbeo , Aripiprazole ,0,
edin,5103,3682900,No significant difference,Ultra-high dose intravenous N-acetylcysteine did not alter creatinine or cystatin C levels., Creatitine after 2 days , Control , N-acetylcysteine ,0,
edin,5194,3781502,Cannot tell based on the abstract,, Weight , Exenatide , Lixisenatide ,0,
edin,5194,3781502,No significant difference,"Body weight decreased from baseline in both the lixisenatide once-daily group and exenatide twice-daily group. Mean (Â±SD) body weight decreased from 94.5 (Â±19.4) to 91.7 (Â±18.9) kg with lixisenatide and from 96.7 (Â±22.8) to 92.9 (Â±22.3) kg with exenatide (Fig. 1C). The LS mean (Â±SE) body weight reduction at week 24 (LOCF) was â2.96 (Â±0.23) kg for lixisenatide compared with â3.98 (Â±0.23) kg for exenatide. The LS mean change difference between the two groups was 1.02 kg (95% CI, 0.456â1.581). Overall, 25.1% of lixisenatide-treated patients and 31.4% of exenatide-treated patients had â¥5% weight loss from baseline to week 24.", Weight , Exenatide , Lixisenatide ,0,
edin,5069,2949642,Significantly increased,"Tamoxifen-treated patients with estrogen receptor-positive tumors expressing none or low levels of HOXB13 had a clear benefit from tamoxifen in terms of longer distant recurrence-free survival (DRFS) (hazard ratio = 0.38, 95% confidence interval = 0.23 to 0.60, P = 0.000048).", Distant recurrence-free survival , Control , Tamoxifen + No HOXB13 ,0,
edin,5125,5865731,Cannot tell based on the abstract,, Anxiety , Contractive posture , Expansive posture ,0,
edin,5125,5865731,No significant difference,"However, there were no main effects of condition for BISS and negative ES (insecurity, anxiety, disgust, shame, sadness, anger, and total score).,<td align=""left"" colspan=""1"" rowspan=""1"">&nbsp;&nbsp;&nbsp;&nbsp;Anxiety</td><td align=""center"" colspan=""1"" rowspan=""1"">2.00 (1.13)</td><td align=""center"" colspan=""1"" rowspan=""1"">2.09 (1.31)</td><td align=""center"" colspan=""1"" rowspan=""1"">2.77 (1.35)</td><td align=""center"" colspan=""1"" rowspan=""1"">2.62 (1.78)</td><td align=""center"" colspan=""1"" rowspan=""1""><italic>F</italic>(1,65) = 0.41</td><td align=""center"" colspan=""1"" rowspan=""1"">.524</td><td align=""center"" colspan=""1"" rowspan=""1""><italic>Î·</italic><sub><italic>p</italic></sub><sup><italic>2</italic></sup> = .01</td>", Anxiety , Contractive posture , Expansive posture ,0,
edin,5223,5856907,Cannot tell based on the abstract,, Not wanting to participate again in the future , Control ," ""Question writing"" method ",0,
edin,5223,5856907,No significant difference,"<td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">5. Felt uncomfortable and I did not participate in the future in these programs</td><td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">3.44Â±1.03</td><td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">3.50Â±1.09</td><td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">-0.166</td><td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">0.87</td>,<td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">5. Felt uncomfortable and I did not participate in the future in these programs</td><td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">1(3%)</td><td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">6(19%)</td><td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">6(19%)</td><td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">15(47%)</td><td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">4(13%)</td><td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">19(60%)</td><td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">3.47</td><td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">1</td>,verall, the students slightly agreed with creating MCQs. They also mentioned they would not like to take part in similar activity in the future (Table 3).", Not wanting to participate again in the future , Control ," ""Question writing"" method ",0,
edin,5106,3682900,Cannot tell based on the abstract,, Cystatin C after 4 days , Control , N-acetylcysteine ,0,
edin,5106,3682900,No significant difference,"The variations in creatinine and cystatin C concentrations on days 2, 4 and 10 in both groups are reported in FigureÂ 2. The evolution from baseline to day 10 in creatinine and cystatin C levels concentration was not different between the two groups.,<td align=""left"" valign=""bottom"">ââCreatinine<hr></td><td align=""left"" valign=""bottom"">â8.25 Â± 65.62<hr></td><td align=""left"" valign=""bottom"">â8.37 Â± 36.52<hr></td><td align=""left"" valign=""bottom"">0.37<hr></td>", Cystatin C after 4 days , Control , N-acetylcysteine ,0,
edin,5238,4609664,No significant difference,There was no significant difference between RCP and control group (P>0.05)., Cracks , Control , Reciproc system ,0,
edin,5216,2882922,Cannot tell based on the abstract,, Negative events , Control , Late tamoxifen ,0,
edin,5216,2882922,No significant difference,"<td align=""left"">âER-</td><td align=""left"">3</td><td align=""left"">0</td><td align=""left"">p = 0.24</td>", Negative events , Control , Late tamoxifen ,0,
edin,5096,5103135,Significantly increased,"After treatment, peak E, E/A and IVEF were increased by 41%, 44% and 16% respectively, but peak A, LVPWT/mm and IVST/mm were significantly reduced.", IVEF , No treatment , Bisoprolol + trimetazidine ,0,
edin,5176,4831776,Cannot tell based on the abstract,, Insulin AUC , Carbohydrates alone  , Carbohydrates + protein ,0,
edin,5176,4831776,No significant difference,"There was a tendency for a higher insulin concentration at 60 minutes (p = 0.053) after ingestion of CHO+PROT as compared to CHO alone,Area under curve also tended to be higher for insulin after CHO+PROT compared to CHO (p<0.06).", Insulin AUC , Carbohydrates alone  , Carbohydrates + protein ,0,
edin,5225,4815882,No significant difference,"No significant difference was observed between the two groups with respect to OS (median, 15.9 months (simvastatin) vs 19.9 months (placebo), P=0.826).", Overall survival , Placebo , Simvastatine ,0,
edin,5178,4831776,Cannot tell based on the abstract,, Carbohydrate oxidation , Carbohydrates alone  , Carbohydrates + protein ,0,
edin,5178,4831776,No significant difference,"Total carbohydrate oxidation during the exhaustive cycling was 261 Â± 28, 233 Â± 22 and 226 Â± 21 g before the CHO, CHO+PROT and PLA, respectively, and did not differ.,<td align=""left"" colspan=""1"" rowspan=""1""><bold>CHO oxidation (gÂ·min</bold><sup><bold>-1</bold></sup><bold>)</bold></td><td align=""left"" colspan=""1"" rowspan=""1""></td><td align=""left"" colspan=""1"" rowspan=""1""></td><td align=""left"" colspan=""1"" rowspan=""1""></td><td align=""left"" colspan=""1"" rowspan=""1""></td><td align=""left"" colspan=""1"" rowspan=""1""></td>,RER and CHO oxidation was significantly higher in CHO compared to PLA (p<0.05), but there was no difference between CHO and CHO+PROT.", Carbohydrate oxidation , Carbohydrates alone  , Carbohydrates + protein ,0,
edin,5090,4423288,Significantly increased,"The gastrotomy creation times for Groups 1, 2, and 3 were 28.0âÂ±â10.1, 4.3âÂ±â1.4, and 20.1âÂ±â10.6 minutes, respectively, with significantly lower time in Group 2 (Pâ<â0.001).", Gastrotomy creation times , Knife + ballon + OTSC , Tunnel + endoclips ,0,
edin,5118,3980039,Cannot tell based on the abstract,, Insulin clearance , Control , Canagliflozin 300 mg ,0,
edin,5118,3980039,Significantly increased,"Insulin clearance was increased by approximately 15% with both doses of canagliflozin compared with placebo (ESM TableÂ 2).Table 5,Insulin clearance was increased with both doses of canagliflozin compared with placebo, although the increase observed with the 100Â mg dose did not reach statistical significance (pâ=â0.07) (ESM TableÂ 2); the increase in insulin clearance observed with the 300Â mg dose compared with placebo was approximately 24% (pâ<â0.0001).", Insulin clearance , Control , Canagliflozin 300 mg ,0,
edin,5071,2949642,Cannot tell based on the abstract,"Tamoxifen-treated patients with estrogen receptor-positive tumors expressing none or low levels of HOXB13 had a clear benefit from tamoxifen in terms of longer distant recurrence-free survival (DRFS) (hazard ratio = 0.38, 95% confidence interval = 0.23 to 0.60, P = 0.000048). However, for patients with a high or intermediate HOXB13 tumor expression, tamoxifen did not prolong the DRFS compared with the untreated patients (hazard ratio = 0.88, 95% confidence interval = 0.47 to 1.65, P = 0.69).", Distant recurrence-free survival , Tamoxifen + low levels of HOXB13 , Tamoxifen + intermediate levels of HOXB13 ,0,
edin,5071,2949642,Significantly decreased,"<td align=""left"" colspan=""7"">ER-positive</td>", Distant recurrence-free survival , Tamoxifen + low levels of HOXB13 , Tamoxifen + intermediate levels of HOXB13 ,0,
edin,5105,3682900,Cannot tell based on the abstract,, Creatitine after 10 days , Control , N-acetylcysteine ,0,
edin,5105,3682900,No significant difference,"The evolution from baseline to day 10 in creatinine and cystatin C levels concentration was not different between the two groups.,<td align=""left"" valign=""bottom""><bold>Day 10</bold><hr></td><td align=""left"" valign=""bottom"">&nbsp;<hr></td><td align=""left"" valign=""bottom"">&nbsp;<hr></td><td align=""left"" valign=""bottom"">&nbsp;<hr></td>", Creatitine after 10 days , Control , N-acetylcysteine ,0,
edin,5168,5091022,No significant difference,"Regarding the hematocrit, there were no differences between groups in measured periods (24, 48, and 72Â h after surgery).", Hematocrit after 72 hrs , 4.8 mm drain , 3.2 mm drain ,0,
edin,5192,3781502,Cannot tell based on the abstract,Responder rate (HbA1c <7.0%) and improvements in fasting plasma glucose were comparable., Goal HbA1c &amp;lt;7.0% , Exenatide , Lixisenatide ,0,
edin,5192,3781502,No significant difference,A similar proportion of patients in each group achieved HbA1c goals of <7.0% at week 24 (48.5% lixisenatide and 49.8% exenatide); t, Goal HbA1c &amp;lt;7.0% , Exenatide , Lixisenatide ,0,
edin,5256,3898240,Significantly increased,"In the â¥6- vs. 1-portion post-intervention comparisons, carotenoids increased in serum, HDL2 and particularly HDL3, (Î±-carotene, pâ=â0.008; Î²-cryptoxanthin, pâ=â0.042; lutein, pâ=â0.012; lycopene, pâ=â0.016), as did the activities of PON-1 and LCAT in HDL3 (pâ=â0.006 and 0.044, respectively).", Serum Lutein , Fruits and vegetables 1 portion , Fruits and vegetables +6 portions ,0,
edin,5074,3219771,No significant difference,"There were no significant differences in pH, PaCO2, the apparent strong ion difference, the strong ion gap, bicarbonate ion, or lactate between two groups throughout the whole investigation period.", Strong ion difference , Room temperature CO2 , Heated CO2 ,0,
edin,5187,3669111,Cannot tell based on the abstract,, Calcium-phosphorus product , Control , Cinacalcet ,0,
edin,5187,3669111,No significant difference,"Median iPTH (A), mean calcium-phosphorus product (Ca X P) (B), calcium (Ca) (C), and phosphorus (P) (D). iPTH decreased by 42.3% in the cinacalcet group, and by 30.7% in the control group (P = 0.483).", Calcium-phosphorus product , Control , Cinacalcet ,0,
edin,5189,3669111,Cannot tell based on the abstract,, Phosphorus , Control , Cinacalcet ,0,
edin,5189,3669111,No significant difference,"Median iPTH (A), mean calcium-phosphorus product (Ca X P) (B), calcium (Ca) (C), and phosphorus (P) (D). iPTH decreased by 42.3% in the cinacalcet group, and by 30.7% in the control group (P = 0.483).", Phosphorus , Control , Cinacalcet ,0,
edin,5127,5301372,No significant difference,"For the FGF pathwayâamplified subgroup (nâ=â31), the median PFS (95% CI) was 10.9 (3.5â16.5) months vs 5.5 (3.5â16.4) months in the dovitinib vs placebo arms, respectively (HR, 0.64; met the predefined superiority criteria).", Median progression-free survival , Placebo , Dovitinib  ,0,
edin,5119,3980039,Cannot tell based on the abstract,, Plasma glucose , Sitagliptin , Canagliflozin 300 mg ,0,
edin,5119,3980039,Cannot tell based on the abstract,, Plasma glucose , Sitagliptin , Canagliflozin 300 mg ,0,
edin,5119,3980039,Significantly decreased,"Within each study, baseline plasma glucose, insulin and C-peptide profiles, and the corresponding ISRâplasma glucose relationships at baseline were generally similar between the different treatment groups, with the exception of the placebo group in Study 1, which had modestly lower mean plasma glucose concentrations and modestly higher plasma C-peptide concentrations than the two canagliflozin groups, leading to a shift in the mean relationship between baseline ISR and plasma glucose concentration in the placebo compared with the canagliflozin groups (FigsÂ 2, 3, 4).Table 2,In Study 1, both doses of canagliflozin led to an upward shift in the relationship between ISR and plasma glucose, as well as an increased slope (Fig.Â 2jâl), whereas a slight downward shift was observed with placebo.,The effects of canagliflozin on beta cell function observed in Study 2 were generally similar to those seen in Study 1, with both doses of canagliflozin leading to an upward shift and steepening of the curve expressing the relationship between ISR and plasma glucose.,In Study 3, treatment with sitagliptin 100Â mg and canagliflozin 300Â mg produced similar upward shifts in the relationship between ISR and plasma glucose (Fig.Â 4g, h).", Plasma glucose , Sitagliptin , Canagliflozin 300 mg ,0,
edin,5141,4148632,Cannot tell based on the abstract,"Membrane exposure was not observed in any cases. Significant probing depth reduction, attachment-level gain and bone fill were observed for both test and control groups compared to baseline at 3 months after surgery (P<0.05).", Probing pocket depth , Control , Nonchemical membrane ,0,
edin,5141,4148632,No significant difference,"The probing depth reduction for the NC+BM, BC+BM, and BM groups was 5.10Â±1.52, 3.60Â±1.27, and 3.60Â±2.12 mm, respectively,Both collagen membranes (NC and BC) were comparable in terms of pocket depth reduction and gain of CAL.", Probing pocket depth , Control , Nonchemical membrane ,0,
edin,5245,4804082,Cannot tell based on the abstract,, Glutathione  , Control , Vitamin B6 ,0,
edin,5245,4804082,Significantly decreased,"Plasma homocysteine and GSH concentrations, GSH/GSSG ratio, and activity of GR in the vitamin B-6 group significantly decreased by week 12, while total antioxidant capacity (i.e., TEAC level) significantly increased at the end of the intervention period.", Glutathione  , Control , Vitamin B6 ,0,
edin,5107,3682900,No significant difference,Ultra-high dose intravenous N-acetylcysteine did not alter creatinine or cystatin C levels., Cystatin C after 10 days , Control , N-acetylcysteine ,0,
edin,5146,4545550,Cannot tell based on the abstract,, HDL , Control , Yoga ,0,
edin,5146,4545550,No significant difference,"<td>HDL (mmol/L)</td><td>1.3 (0.4)</td><td>1.5 (0.4)</td><td>1.4 (0.4)</td>,<td>HDL (mmol/L) change from baseline</td><td>0.0 (â0.1â0.1)</td><td>0.0 (â0.1â0.1)</td><td>0.0 (â0.1â0.1)</td><td>0.0 (â0.0â0.1)</td><td>0.0 (â0.1â0.1)</td><td>0.0 (â0.1â0.1)</td>", HDL , Control , Yoga ,0,
edin,5160,2713840,Cannot tell based on the abstract,, Success rate , Shoulder type covered stent , Flare type covered stent ,0,
edin,5160,2713840,No significant difference,"The clinical success rate was 80.0% (24/30): 100% for type A, 68.8% for type B, and 83.3% for type C (Table 3); the differences were statistically insignificant (p=0.191).", Success rate , Shoulder type covered stent , Flare type covered stent ,0,
edin,5115,3980039,Cannot tell based on the abstract,"In Study 3, beta cell glucose sensitivity was minimally affected, but the insulin secretion rate at 9Â mmol/l glucose increased to similar degrees from baseline with canagliflozin and sitagliptin [LSM (SEM) changes 38 (8) and 28 (9) pmolÂ minâ1Â mâ2, respectively; pâ<â0.05 for both].", Beta cell glucose sensitivity , Control , Canagliflozin 100 mg ,0,
edin,5115,3980039,Significantly increased,The model-assessed parameters for ISR at 9Â mmol/l glucose and beta cell glucose sensitivity were significantly increased with both doses of canagliflozin (TableÂ 5)., Beta cell glucose sensitivity , Control , Canagliflozin 100 mg ,0,
edin,5070,2949642,No significant difference,"Tamoxifen-treated patients with estrogen receptor-positive tumors expressing none or low levels of HOXB13 had a clear benefit from tamoxifen in terms of longer distant recurrence-free survival (DRFS) (hazard ratio = 0.38, 95% confidence interval = 0.23 to 0.60, P = 0.000048). However, for patients with a high or intermediate HOXB13 tumor expression, tamoxifen did not prolong the DRFS compared with the untreated patients (hazard ratio = 0.88, 95% confidence interval = 0.47 to 1.65, P = 0.69).", Distant recurrence-free survival , Control , Tamoxifen + intermediate levels of HOXB13 ,0,
edin,5072,3219771,No significant difference,"There were no significant differences in pH, PaCO2, the apparent strong ion difference, the strong ion gap, bicarbonate ion, or lactate between two groups throughout the whole investigation period. At T2, pH was decreased whereas PaCO2 was increased in both groups compared with T1 but these changes were not significantly different", pH , Room temperature CO2 , Heated CO2 ,0,
edin,5139,4148632,No significant difference,Membrane exposure was not observed in any cases., Membrane exposure , Bilayer membrane , Nonchemical membrane ,0,
edin,5085,3689826,Cannot tell based on the abstract,, Kessler Psychological Distress Scale , Control ,  E-mail based Self-Help for Depression  ,0,
edin,5085,3689826,No significant difference,"The interaction between group and time on the K10 was significant, F (2, 677.2)â=â3.94, pâ=â.020, but differences between groups in change from pre-intervention to post-intervention were not significant, t (663.9)â=â0.84, pâ=â.399.,The interaction between group and time on the K10 was not significant, F (2, 546.1)â=â2.71, pâ=â.068, and differences between groups in change from pre-intervention to post-intervention were also not significant, t (572.0)â=â0.89, pâ=â.375.", Kessler Psychological Distress Scale , Control ,  E-mail based Self-Help for Depression  ,0,
edin,5230,5215525,Significantly decreased,"After 24 weeks, for dapagliflozin/exenatide versus placebo: the difference in body weight change was â4.13 kg (95% confidence interval â6.44, â1.81; P < .001), which was mostly attributable to adipose tissue reduction without lean tissue change; 36.0% versus 4.2% of participants achieved â¥5% body weight loss, respectively; and prediabetes was less frequent with active treatment (34.8% vs 85.0%, respectively; P < .01).", Body weight , Control , Dapagliflozin + exenatide ,0,
edin,5181,4009088,No significant difference,There was no significant difference between groups for MDF or MPF in VMM and RFM., Median frecuency on Rectus femoris , Control , Glutamine  ,0,
edin,5202,4311411,Significantly increased,"The highest dose (HD) showed consistent evidence of improvement beyond stabilization. CMTNS and ONLS, with a significant improvement of respectively of 8% (0.4% - 16.2%) and 12.1% (2% - 23.2%) in the HD group versus the pool of all other groups, appear to be the most sensitive clinical endpoints to treatment despite their quasi-stability over one year under Placebo", Overall Neuropathy Limitations Scale improvement , Placebo ," High dose (baclofen, naltrexone, sorbitol) ",0,
edin,5196,3570228,Cannot tell based on the abstract,, Mean BP ," Remifentanil 3 ng/ml  and sufentanil 0,3 ng/ml (induction and maintenance)  ", Remifentanil 5 ng/ml (induction) and 4 ng/ml (maintenance) ,0,
edin,5196,3570228,Significantly increased,"In each group, HR and MAP decreased at T1 (P<0.01) and increased at T2 compared with the values at T0. At T2, the MAP in group IV was higher than that in group II, and the HR and MAP of group IV were higher than those in group III (P<0.05). At T8 and T9, the HR and MAP in group IV were higher than those in any other group (P<0.05). At T9, the SpO2 levels in all the groups were lower than those at T0 (P<0.01); the level in group II was lower than that in group IV (P<0.05). The results are summarized in Table I.", Mean BP ," Remifentanil 3 ng/ml  and sufentanil 0,3 ng/ml (induction and maintenance)  ", Remifentanil 5 ng/ml (induction) and 4 ng/ml (maintenance) ,0,
edin,5219,5856907,Cannot tell based on the abstract,, Subjective understanding  , Control ," ""Question writing"" method ",0,
edin,5219,5856907,No significant difference,Achieved a better understanding of the issues	2.56Â±1.15	1.75Â±1.0	2.13	0.042, Subjective understanding  , Control ," ""Question writing"" method ",0,
edin,5248,5339463,Cannot tell based on the abstract,, Child-Turcotte-Pugh score , Granulocyte-colony stimulating factor + peripheral blood monocyte cell , Granulocyte-colony stimulating factor ,0,
edin,5248,5339463,No significant difference,"At baseline, biochemical markers including total bilirubin, albumin, prothrombin time, creatinine, aspartate aminotransferase, alanine aminotransferase, the CTP scores, and the MELD scores were comparable in study groups. PBMC transplantation therapy showed a tendency to improve in median CTP scores at weeks 24 compared to baseline (Fig. 1). However, there were no significant reductions in the median CTP and MELD scores among study groups probably due to small sample size (Fig. 2). In addition, there were no statistical differences in the median CTP and MELD scores among different etiologies of chronic liver diseases.", Child-Turcotte-Pugh score , Granulocyte-colony stimulating factor + peripheral blood monocyte cell , Granulocyte-colony stimulating factor ,0,
edin,5163,3785902,Cannot tell based on the abstract,, Systolic blood pressure during injection , Control , Propofol ,0,
edin,5163,3785902,Significantly decreased,"Significant changes were observed in the SBP, DBP, MBP and HR during injection of drugs (T3) between the two groups (Î± = 0.001, Î± = 0.029, Î± = 0.004, Î± = 0.03 respectively).,<td colspan=""1"" rowspan=""1"" style=""padding-left:25pt"">Î±</td><td colspan=""1"" rowspan=""1"">0.361</td><td colspan=""1"" rowspan=""1"">0.684</td><td colspan=""1"" rowspan=""1"">0.001</td><td colspan=""1"" rowspan=""1"">0.377</td><td colspan=""1"" rowspan=""1"">0.534</td><td colspan=""1"" rowspan=""1"">0.357</td>", Systolic blood pressure during injection , Control , Propofol ,0,
edin,5208,3112403,Cannot tell based on the abstract,, Body weight , Wheat , Flaxseed  ,0,
edin,5208,3112403,No significant difference,"Body weight and BMI were not significantly different compared to the baseline, nor between treatment groups. The average body weight was 96.2 Â± 18.9 vs. 92.2 Â± 20.4 (kg), flaxseed group; 94.7 Â± 20.0 vs. 95.2 Â± 20.3 (kg), wheat bran group at the baseline and end of the study, respectively.,No significant relationships between weight change and glucose, insulin, HOMA-IR, or inflammatory biomarkers were found.", Body weight , Wheat , Flaxseed  ,0,
edin,5157,2713840,Cannot tell based on the abstract,, Patency period  , Shoulder type covered stent , Flare type covered stent ,0,
edin,5157,2713840,No significant difference,"The mean period of patency was 96.25 Â± 105.12 days: 146.25 Â± 112.93 for type-A, 78.82 Â± 112.26 for type-B, and 94.25 Â± 84.21 for type-C; the differences were statistically insignificant (p=0.576) (Table 4).", Patency period  , Shoulder type covered stent , Flare type covered stent ,0,
edin,5080,5617873,No significant difference,"All patients randomized to aripiprazole completed the study, and no serious adverse events were reported.", Serious adverse effects , Placbeo , Aripiprazole ,0,
edin,5065,5610548,Cannot tell based on the abstract,, Lactoferrin , Multiple micronutrient  , LipÃ­d based nutrient suplement ,0,
edin,5065,5610548,No significant difference,"At 6 mo postpartum, there were no significant differences in mean concentrations of total HMOs, sialylated or fucosylated HMOs, lactoferrin, lactalbumin, lysozymes, antitrypsin, IgA, or osteopontin between the 3 intervention groups in either the unadjusted or adjusted models (each P > 0.10) (Table 2).,There were no significant differences in the proportion of women with low concentrations of total HMOs, sialylated HMOs, fucosylated HMOs, lactoferrin, lactalbumin, lysozymes, antitrypsin, or IgA between the 3 intervention groups in either adjusted or unadjusted models (each P > 0.10)", Lactoferrin , Multiple micronutrient  , LipÃ­d based nutrient suplement ,0,
edin,5221,5856907,Cannot tell based on the abstract,, Subjective depth perceived when studying subjects , Control ," ""Question writing"" method ",0,
edin,5221,5856907,Invalid Prompt,, Subjective depth perceived when studying subjects , Control ," ""Question writing"" method ",1, I was not able to find Subjective depth perceived when studying subjects in any part of the article 
edin,5109,4524824,Cannot tell based on the abstract,, Excessive adhesion formation , Colorectal anastomosis with leakage , Colorectal anastomosis without leakage ,0,
edin,5109,4524824,No significant difference,"<td align=""left"" colspan=""1"" rowspan=""1"">Adhesions in all</td><td align=""left"" colspan=""1"" rowspan=""1"">9 (90)</td><td align=""left"" colspan=""1"" rowspan=""1"">9 (90)</td>", Excessive adhesion formation , Colorectal anastomosis with leakage , Colorectal anastomosis without leakage ,0,
edin,5177,4831776,Significantly increased,TTE was increased after intake of CHO+PROT compared to CHO (63.5Â±4.4 vs 49.8Â±5.4 min; p<0.05)., Time to exhaustion , Carbohydrates alone  , Carbohydrates + protein ,0,
edin,5117,3980039,Cannot tell based on the abstract,, Insulin clearance , Control , Canagliflozin 100 mg ,0,
edin,5117,3980039,No significant difference,"Insulin clearance was increased by approximately 15% with both doses of canagliflozin compared with placebo (ESM TableÂ 2).Table 5,Insulin clearance was increased with both doses of canagliflozin compared with placebo, although the increase observed with the 100Â mg dose did not reach statistical significance (pâ=â0.07) (ESM TableÂ 2); the increase in insulin clearance observed with the 300Â mg dose compared with placebo was approximately 24% (pâ<â0.0001).", Insulin clearance , Control , Canagliflozin 100 mg ,0,
edin,5220,5856907,Cannot tell based on the abstract,, Subjective learning skills  , Control ," ""Question writing"" method ",0,
edin,5220,5856907,Significantly increased,"<td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">2. Developed approaches study and Learning skills</td><td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">2.75Â±1.0</td><td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">2.06Â±0.85</td><td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">2.09</td><td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">0.045</td>", Subjective learning skills  , Control ," ""Question writing"" method ",0,
edin,5156,2713840,Cannot tell based on the abstract,, Patency period  , Shoulder type covered stent , Uncovered nitinol stent ,0,
edin,5156,2713840,No significant difference,"The mean period of patency was 96.25 Â± 105.12 days: 146.25 Â± 112.93 for type-A, 78.82 Â± 112.26 for type-B, and 94.25 Â± 84.21 for type-C; the differences were statistically insignificant (p=0.576) (Table 4).", Patency period  , Shoulder type covered stent , Uncovered nitinol stent ,0,
edin,5172,5091022,Cannot tell based on the abstract,, Blood products used , 4.8 mm drain , 3.2 mm drain ,0,
edin,5172,5091022,No significant difference,The use of blood products was similar in both groups â two units of red blood cells with 300Â mL each unit., Blood products used , 4.8 mm drain , 3.2 mm drain ,0,
edin,5200,3570228,Significantly decreased,"Although group IV had shorter postoperative eye-opening and extubation times compared with the other groups (P<0.05), it also had higher restlessness and pain scores (P<0.01)", Eye opening time ," Remifentanil 3 ng/ml and sufentanil 0,3 ng/ml (induction and maintenance) ", Remifentanil 5 ng/ml (induction) and 4 ng/ml (maintenance) ,0,
edin,5233,5215525,Significantly decreased,"The difference in SBP change for dapagliflozin/exenatide versus placebo was â6.7 mm Hg.,Compared with placebo, dapagliflozin/exenatide dual therapy reduced body weight, frequency of prediabetes and SBP over 24 weeks and was well tolerated in obese adults without diabetes.", Systolic blood pressure , Control , Dapagliflozin + exenatide ,0,
edin,5082,5617873,Cannot tell based on the abstract,, Social withdrawal  , Placbeo , Aripiprazole ,0,
edin,5082,5617873,No significant difference,"here was no significant difference between aripiprazole group and the placebo group in the mean ABC-J stereotypy, inappropriate speech and lethargy/social withdrawal subscale scores, as well as ABC-J response rate, CY-BOCS (compulsion scale) (TableÂ 2).", Social withdrawal  , Placbeo , Aripiprazole ,0,
edin,5232,5215525,Cannot tell based on the abstract,, Pre-diabetes   , Control , Dapagliflozin + exenatide ,0,
edin,5232,5215525,Significantly decreased,"<td align=""left"" colspan=""1"" id=""dom12779-ent-0241"" rowspan=""1"" style=""padding-left:15%"" valign=""top"">Proportion with any IFG or IGT (prediabetes), n/N (%)</td><td align=""char"" char=""("" colspan=""1"" id=""dom12779-ent-0242"" rowspan=""1"" valign=""top"">8/23 (34.8)</td><td align=""char"" char=""("" colspan=""1"" id=""dom12779-ent-0243"" rowspan=""1"" valign=""top"">17/20 (85.0)</td><td align=""char"" colspan=""1"" id=""dom12779-ent-0244"" rowspan=""1"" valign=""top""></td><td align=""char"" char=""."" colspan=""1"" id=""dom12779-ent-0245"" rowspan=""1"" valign=""top"">.002<xref ref-type=""fn"" rid=""dom12779-note-0018"">d</xref>
</td>,Combined, the proportion of participants with prediabetes (any IFG or IGT) significantly decreased from 68.0% to 34.8% (p = .005).,Reduction in prediabetes (any IFG or IGT) from baseline to 24 weeks was significantly greater with dapagliflozin/exenatide than placebo (p = .002).", Pre-diabetes   , Control , Dapagliflozin + exenatide ,0,
edin,5129,5301372,Cannot tell based on the abstract,, Des-continuation due to adverse effects , Placebo , Dovitinib ,0,
edin,5129,5301372,Significantly increased,"The reasons for discontinuation in the dovitinib vs placebo arms were progressive disease (55.3% vs 80.0%), AEs (21.3% vs 2.0%), patient or guardian decision (10.6% vs 0%), termination by sponsor (8.5% vs 16.0%), death (2.1% vs 2.0%), and nonadherence to study treatment (2.1% vs 0%).,More patients discontinued study treatment owing to AEs in the dovitinib arm than in the placebo arm (38.3% vs 8.0%).", Des-continuation due to adverse effects , Placebo , Dovitinib ,0,
edin,5252,5339463,Cannot tell based on the abstract,, Mortality , Control , Granulocyte-colony stimulating factor + peripheral blood monocyte cell ,0,
edin,5252,5339463,No significant difference,"During the 6 months of follow-up, there was no mortality in study groups.", Mortality , Control , Granulocyte-colony stimulating factor + peripheral blood monocyte cell ,0,
edin,5137,5986443,Cannot tell based on the abstract,, Chest press , Placebo then placebo again , Protein then Placebo ,0,
edin,5137,5986443,Significantly increased,"A significant (p < 0.001) time vs. group interaction was observed for SMM, LLLST, CP, KE, and total strength (TS), with both the WP-PLA and PLA-WP presenting greater increases compared with the PLA-PLA, without differences between the timing of protein intake.", Chest press , Placebo then placebo again , Protein then Placebo ,0,
edin,5144,4148632,Cannot tell based on the abstract,, Bone level change , Bilayer membrane , Nonchemical membrane ,0,
edin,5144,4148632,No significant difference,There was no statistically significant difference in bone level change between the test and control groups., Bone level change , Bilayer membrane , Nonchemical membrane ,0,
edin,5229,4815882,No significant difference,The addition of 40âmg simvastatin to the XELIRI/FOLFIRI regimens did not improve PFS in patients with previously treated metastatic colorectal cancer nor did it increase toxicity., Toxicity  , Placebo , Simvastatine ,0,
edin,5241,4609664,Cannot tell based on the abstract,, Cracks , ProTaper system , Mtwo ,0,
edin,5241,4609664,No significant difference,"Based on fracture pattern, all these cracks were exclusively categorized as defected (type I). Regarding crack formation, there was no significant difference between RCP and control samples (P=0.300). Both Mtwo and PTU showed more cracks than RCP (P=0.042) and control (P=0.022). The difference between Mtwo and PTU was not significant (P=1.000).", Cracks , ProTaper system , Mtwo ,0,
edin,5258,3898240,Significantly increased,"In the â¥6- vs. 1-portion post-intervention comparisons, carotenoids increased in serum, HDL2 and particularly HDL3, (Î±-carotene, pâ=â0.008; Î²-cryptoxanthin, pâ=â0.042; lutein, pâ=â0.012; lycopene, pâ=â0.016), as did the activities of PON-1 and LCAT in HDL3 (pâ=â0.006 and 0.044, respectively).", HDL 3 Lecithinâcholesterol acyltransferase , Fruits and vegetables 1 portion , Fruits and vegetables +6 portions ,0,
edin,5227,4815882,Cannot tell based on the abstract,, Response rate , Placebo , Simvastatine ,0,
edin,5227,4815882,No significant difference,"The ORR (overall response rate) was 11.9% in the simvastatin group and 11.8% in the placebo group; the DCR (disease control rate) was 67.2% and 71.1%, respectively. No significant difference in response rate was observed between the two treatment arms (P=1.00 for ORR, P=0.511 for DCR, Table 2).", Response rate , Placebo , Simvastatine ,0,
edin,5087,4423288,Significantly increased,The mean air-leak pressure was statistically higher in Group 3 than in Groups 1 and 2â95.2âÂ±â19.3âmmHg versus 72.5âÂ±â35.2 and 79.0âÂ±â24.5âmmHg (Pâ<â0.05)., Air-leak pressure , Tunnel + endoclips , Tunnel + OTSC ,0,
edin,5218,5856907,Significantly increased,"The differences between pre- and post-test mean scores of the experimental and control groups were 24.53Â±5.74 and 20.63Â±5.58, respectively. The results of independent t-test showed that these differences in the two groups were significant (p=0.009).", Test scores , Control ," ""Question writing"" method ",0,
edin,5108,4524824,No significant difference,None of the animals showed signs of illness 48 hours after the intraperitoneal gastrostomy tube placement., Illness , Colorectal anastomosis with leakage , Colorectal anastomosis without leakage ,0,
edin,5140,4148632,No significant difference,"Membrane exposure was not observed in any cases. Significant probing depth reduction, attachment-level gain and bone fill were observed for both test and control groups compared to baseline at 3 months after surgery (P<0.05). However, there were no statistically significant differences in clinical improvement and radiographic bone fill between treatment protocols (P>0.05).", Probing pocket depth , Bilayer membrane , Nonchemical membrane ,0,
edin,5210,3112403,Cannot tell based on the abstract,, Waist circumference , Wheat , Flaxseed  ,0,
edin,5210,3112403,No significant difference,"The waist circumference did not change significantly. The average waist circumference was 106.9 Â± 13.5 vs. 105.9 Â± 12.7 (cm), flaxseed group; 108.7 Â± 12.2 vs. 106.7 Â± 13.5 (cm), wheat bran group at the baseline and end of the study, respectively.", Waist circumference , Wheat , Flaxseed  ,0,
edin,5150,4545550,Cannot tell based on the abstract,, hs-CRP , Control , Yoga ,0,
edin,5150,4545550,Significantly decreased,"<td>hs-CRP (mg/L)</td><td>5.0 (3.6)</td><td>2.9 (2.2)</td><td>3.6 (3.6)</td>,<td>hs-CRP (mg/L) change from baseline</td><td>â0.8 (â2.2â0.5)</td><td>â0.6 (â2.3â1.1)</td><td>0.2 (â0.6â1.0)</td><td>0.1 (â1.0â1.2)</td><td>0.4 (â1.2â2.1)</td><td>0.5 (â1.4â2.4)</td>", hs-CRP , Control , Yoga ,0,
edin,5102,3682900,No significant difference,Ultra-high dose intravenous N-acetylcysteine did not alter creatinine or cystatin C levels., Cystatin C , Control , N-acetylcysteine ,0,
edin,5161,3785902,No significant difference,"Heart rate and blood pressure in patients receiving propofol were less than the control group (P < 0.05) at the time of injection of propofol, but there were no differences between the two groups at the time of extubation.", Systolic blood pressure after extubation , Control , Propofol ,0,
edin,5123,5865731,Cannot tell based on the abstract,, Happiness  , Contractive posture , Expansive posture ,0,
edin,5123,5865731,Significantly increased,"Pairwise comparisons showed that participants in the expansive condition showed more self-confidence and happiness than participants in the contractive condition (p = .015 and p = .029, respectively)", Happiness  , Contractive posture , Expansive posture ,0,
edin,5158,2713840,Cannot tell based on the abstract,, Success rate , Flare type covered stent , Uncovered nitinol stent ,0,
edin,5158,2713840,No significant difference,"The clinical success rate was 80.0% (24/30): 100% for type A, 68.8% for type B, and 83.3% for type C (Table 3); the differences were statistically insignificant (p=0.191).", Success rate , Flare type covered stent , Uncovered nitinol stent ,0,
edin,5116,3980039,Significantly increased,"In Studies 1 and 2, both canagliflozin doses increased beta cell glucose sensitivity compared with placebo. Placebo-subtracted least squares mean (LSM) (SEM) changes were 23 (9) and 18 (9) pmolÂ minâ1Â mâ2 (mmol/l)â1 with canagliflozin 100 and 300Â mg, respectively (pâ<â0.002, Study 1), and 16 (8) and 10 (9) pmolÂ minâ1Â mâ2 (mmol/l)â1 (pâ<â0.02, Study 2). In Study 3, beta cell glucose sensitivity was minimally affected, but the insulin secretion rate at 9Â mmol/l glucose increased to similar degrees from baseline with canagliflozin and sitagliptin [LSM (SEM) changes 38 (8) and 28 (9) pmolÂ minâ1Â mâ2, respectively; pâ<â0.05 for both].", Beta cell glucose sensitivity , Control , Canagliflozin 300 mg ,0,
edin,5198,3570228,Cannot tell based on the abstract,, Heart rate ," Remifentanil 2 ng/ml  and sufentanil 0,5 ng/ml (induction) and  Remifentanil 3 ng/ml  and sufentanil 0,2 ng/ml (maintenance)  ", Remifentanil 5 ng/ml (induction) and 4 ng/ml (maintenance) ,0,
edin,5198,3570228,Significantly increased,"At T2, the MAP in group IV was higher than that in group II, and the HR and MAP of group IV were higher than those in group III (P<0.05).", Heart rate ," Remifentanil 2 ng/ml  and sufentanil 0,5 ng/ml (induction) and  Remifentanil 3 ng/ml  and sufentanil 0,2 ng/ml (maintenance)  ", Remifentanil 5 ng/ml (induction) and 4 ng/ml (maintenance) ,0,
edin,5234,5215525,Cannot tell based on the abstract,, Diastolic blood pressure , Control , Dapagliflozin + exenatide ,0,
edin,5234,5215525,No significant difference,No significant differences between dapagliflozin/exenatide and placebo were observed for DBP or heart rate (Table 2)., Diastolic blood pressure , Control , Dapagliflozin + exenatide ,0,
edin,5195,3781502,Significantly decreased,"In the lixisenatide group, fewer participants experienced symptomatic hypoglycemia (2.5 vs. 7.9%; P < 0.05), with fewer gastrointestinal events (especially nausea; 24.5 vs. 35.1%; P < 0.05).", Gastrointestinal events , Exenatide , Lixisenatide ,0,
edin,5128,5301372,Cannot tell based on the abstract,, On-treatment deaths , Placebo , Dovitinib  ,0,
edin,5128,5301372,No significant difference,"The reasons for discontinuation in the dovitinib vs placebo arms were progressive disease (55.3% vs 80.0%), AEs (21.3% vs 2.0%), patient or guardian decision (10.6% vs 0%), termination by sponsor (8.5% vs 16.0%), death (2.1% vs 2.0%), and nonadherence to study treatment (2.1% vs 0%).,A total of four on-treatment deaths were reported (two deaths in each treatment arm); of the two on-treatment deaths that occurred in the dovitinib arm, one patient died as a result of breast cancer progression and one patient died because of a pulmonary embolism suspected to be related to study treatment.", On-treatment deaths , Placebo , Dovitinib  ,0,
edin,5142,4148632,No significant difference,"However, there were no statistically significant differences in clinical improvement and radiographic bone fill between treatment protocols (P>0.05).", Clinical improvement , Control , Bilayer membrane ,0,
edin,5170,5091022,Significantly decreased,"The total bleeding measured at the suction drains within 48Â h was higher in Group II, with a statistically significant difference (pÂ =Â 0.005); in the first 24Â h, there was major bleeding in Group II (mean 893Â mL), with a significant difference (pÂ =Â 0.004).", Total blood suctioned after 24 hrs , 4.8 mm drain , 3.2 mm drain ,0,
edin,5067,2949642,Significantly increased,"Tamoxifen-treated patients with estrogen receptor-positive tumors expressing none or low levels of HOXB13 had a clear benefit from tamoxifen in terms of longer distant recurrence-free survival (DRFS) (hazard ratio = 0.38, 95% confidence interval = 0.23 to 0.60, P = 0.000048).", Distant recurrence-free survival , Control , Tamoxifen + low levels of HOXB13 ,0,
edin,5100,5103135,No significant difference,"The differences in the respiratory symptoms, limitation of motion, disease impacts and SGRQ total scores were statistically significant compared with those before treatment (P<0.05) and those of the control group (P<0.05).", Limitation of motion ,  Oxygen + inotropic agents , Bisoprolol + trimetazidine ,0,
edin,5205,4311411,Cannot tell based on the abstract,, Charcot Marie Tooth Neuropathy Score , Placebo ," Low dose (baclofen, naltrexone, sorbitol) ",0,
edin,5205,4311411,No significant difference,"<td>
<bold>CMTNS</bold>
</td><td>2.6 (17.5)</td><td>0.5 (23.2)</td><td>â3.1 (16.0)</td><td>
<bold>7.7 (18.4)</bold>
</td><td>â2.6 (â11.9;7.6)</td><td>0.67</td><td>â3.1 (â11.0;5.4)</td><td>0.74</td><td>5.5 (â3.4;15.2)</td><td>0.16</td><td>0.54</td><td>0.30</td>", Charcot Marie Tooth Neuropathy Score , Placebo ," Low dose (baclofen, naltrexone, sorbitol) ",0,
edin,5206,4311411,Cannot tell based on the abstract,, Charcot Marie Tooth Neuropathy Score , Placebo ," Intermediate dose (baclofen, naltrexone, sorbitol) ",0,
edin,5206,4311411,No significant difference,"<td>
<bold>CMTNS</bold>
</td><td>2.6 (17.5)</td><td>0.5 (23.2)</td><td>â3.1 (16.0)</td><td>
<bold>7.7 (18.4)</bold>
</td><td>â2.6 (â11.9;7.6)</td><td>0.67</td><td>â3.1 (â11.0;5.4)</td><td>0.74</td><td>5.5 (â3.4;15.2)</td><td>0.16</td><td>0.54</td><td>0.30</td>", Charcot Marie Tooth Neuropathy Score , Placebo ," Intermediate dose (baclofen, naltrexone, sorbitol) ",0,
edin,5101,5103135,Cannot tell based on the abstract,, Disease impacts ,  Oxygen + inotropic agents , Bisoprolol + trimetazidine ,0,
edin,5101,5103135,No significant difference,"There were no statistically significant differences in respiratory symptoms, limitation of motion, disease impacts or SGRQ total scores between the treatment group and the control group before treatment (P>0.05).", Disease impacts ,  Oxygen + inotropic agents , Bisoprolol + trimetazidine ,0,
edin,5061,5610548,No significant difference,HMO and bioactive protein concentrations did not differ between groups (P > 0.10 for all comparisons)., Total  Human milk oligosaccharides , Iron and folic acid , LipÃ­d based nutrient suplement ,0,
edin,5088,4423288,Significantly increased,The mean air-leak pressure was statistically higher in Group 3 than in Groups 1 and 2â95.2âÂ±â19.3âmmHg versus 72.5âÂ±â35.2 and 79.0âÂ±â24.5âmmHg (Pâ<â0.05)., Air-leak pressure , Knife + ballon + OTSC , Tunnel + OTSC ,0,
edin,5247,4804082,Cannot tell based on the abstract,, Superoxide dismutase levels , Control , Vitamin B6 ,0,
edin,5247,4804082,No significant difference,"There were no significant changes in blood urea nitrogen, ALT and aspartate aminotransferase, alkaline phosphatase, MDA, activities of SOD, GPx, and GST during the intervention period for both groups.,Vitamin B-6 supplementation had no effect on the changes (Î week 12 â week 0) of MDA, GSH, GSSG, and TEAC levels and the activities of SOD, GPx, GST, and GR (p > 0.05),", Superoxide dismutase levels , Control , Vitamin B6 ,0,
edin,5173,4831776,Cannot tell based on the abstract,, Lactate concentrations  , Carbohydrates alone  , Carbohydrates + protein ,0,
edin,5173,4831776,No significant difference,"<td align=""left"" colspan=""1"" rowspan=""1""><bold>Blood lactate (mM)</bold></td><td align=""left"" colspan=""1"" rowspan=""1""></td><td align=""left"" colspan=""1"" rowspan=""1""></td><td align=""left"" colspan=""1"" rowspan=""1""></td><td align=""left"" colspan=""1"" rowspan=""1""></td><td align=""left"" colspan=""1"" rowspan=""1""></td><td align=""left"" colspan=""1"" rowspan=""1""></td><td align=""left"" colspan=""1"" rowspan=""1""></td><td align=""left"" colspan=""1"" rowspan=""1""></td>,Blood lactate concentrations decreased rapidly after exhaustive exercise independent of dietary intervention. Lactate levels declined rapidly and were back at baseline after 30 minutes in all three dietary interventions (Fig 2A).,However, there were no significant differences in substrate selection during the performance test andthe concentrations of plasma lactate and amino acids did not differ between CHO and CHO+PROT.", Lactate concentrations  , Carbohydrates alone  , Carbohydrates + protein ,0,
edin,5443,3685524,Significantly increased,"Central arterial stiffness, measured as augmentation index, augmentation pressure and pulse wave velocity, was higher after wood smoke exposure as compared to filtered air (p < 0.01 for all),", Pulse wave velocity , Control , Wood smoke ,0,
edin,5466,4156403,Significantly decreased,"In PLCO, randomization to cancer screening compared with usual care was associated with a significant decrease in thyroid cancer risk for men (HR â=â0.61; 95% CI: 0.49â0.95) but not women (HR â=â0.91; 95% CI: 0.66â1.26).", PLCO thyroid cancer risk in men , Control , Randomized CT scan ,0,
edin,5449,4478821,Cannot tell based on the abstract,, Laryngeal mask airway insertion score improvement , No atricurium , Atracurium 100% dose  ,0,
edin,5449,4478821,Significantly increased,The LMA insertion score was statistically significant in the four groups (P - 0.001) [Table 3]. The score progressively improved with the increasing dose of the atracurium., Laryngeal mask airway insertion score improvement , No atricurium , Atracurium 100% dose  ,0,
edin,5398,2800022,Cannot tell based on the abstract,, Vitamin D concentration , Breast milk alone , Breast milk + Vit. D ,0,
edin,5398,2800022,Significantly increased,"The 25OHD3 levels of infants in group A, B, and S were 48.8Â±9.74, 33.2Â±7.89 and 42.8Â±9.80 ng/mL, respectively, which was the lowest in group B and showed no differences between group A and S (P<0.001, A=S>B).,At both 6 and 12 months of age, total intake of vitamin D (the sum of vitamin D intake from milk, solid food and vitamin supplementation) were the highest in group A, middle in group S, and lowest in group B (P<0.001, A>S>B).", Vitamin D concentration , Breast milk alone , Breast milk + Vit. D ,0,
edin,5280,5718865,Cannot tell based on the abstract,, Pain after 3 days , Control , Perioneal massage ,0,
edin,5280,5718865,Significantly decreased,"Based on the results, the postpartum perineal pain was different in both groups. Comparison of degrees of pain in the two groups showed that the severity of pain 3 days and 3 months after childbirth was significant (p=0.01, p=0.008, respectively), but the severity of pain in the 10th day did not differ significantly (p=0.78) (Table 3).,The results of this study showed that the two groups were significantly different in terms of perineal pain 3 days, 10 days, and 3 months after childbirth, and the severity of pain 3 days and 3 months after childbirth was significant, but the severity of pain in the 10th day did not significantly differ.,The results showed mean and standard deviation of the participants in the case group (receiving perineal massage) as 25.62Â±4.25 years and those in the control group as 25.31Â±3.86 years.", Pain after 3 days , Control , Perioneal massage ,0,
edin,5431,4399299,No significant difference,Insulin sensitivity during the euglycemic clamp was similar in each group at baseline (3.24 Â± 0.30 vs 3.19 Â± 0.38 mg/kg/min) and did not change (adjusted mean change of 0.26 Â± 0.22 vs 0.32 Â± 0.22 mg/kg/min; P = .86)., Insulin sensitivity , Placebo , Vildagliptin ,0,
edin,5477,3263438,No significant difference,"There were no clinically relevant effects on laboratory values, including glucose and potassium, or on vital signs or ECGs/Holters.", Potassium , Control , Fluticasone furoate + vilanterol ,0,
edin,5460,5501521,Significantly decreased,"n the Lignocaine group, the average mean arterial pressure was 80.3Â mmHg (SD: 4.9) compared to 85.1Â mmHg (SD: 5.4) in the Saline group (95% CI 2.4â7.1, pÂ <Â 0.001).", Mean arterial blood pressure , Control , Lignocaine ,0,
edin,5423,3920467,Significantly decreased,"<td colspan=""1"" rowspan=""1"">Dimetinden</td><td colspan=""1"" rowspan=""1""></td><td colspan=""1"" rowspan=""1""></td><td colspan=""1"" rowspan=""1""></td><td colspan=""1"" rowspan=""1""></td>", Pruritus  , Placebo , Dimetinden ,0,
edin,5368,3117815,Cannot tell based on the abstract,, Emotional aspect of Functional Assessment of Cancer Therapy-Breast , 3-weekly docetaxel , Weekly docetaxel  ,0,
edin,5368,3117815,No significant difference,"<td align=""left"">âEmotional</td><td align=""center"">19.21 (0.51)</td><td align=""center"">19.32 (0.51)</td><td align=""center"">0.024</td><td align=""center"">0.88</td>,Table 2
Primary and secondary outcomes at three weeks after completion of chemotherapy", Emotional aspect of Functional Assessment of Cancer Therapy-Breast , 3-weekly docetaxel , Weekly docetaxel  ,0,
edin,5498,5380326,Significantly decreased,"Our important finding revealed that upon correction of vitamin D insufficiency or deficiency, the serum IP-10 and DPP IV levels were decreased significantly as compare to the placebo group (delta changes; 83.27 vs -133.80; 95% CI [-326.910, -40.758], p = 0.0125, and 271.04 vs -518.69; 95% CI [-1179,15, -59.781], p = 0.0305, respectively.", Interferon gamma-induced protein 10  , Control , Vitamin D supplementation  ,0,
edin,5465,4156403,No significant difference,"In NLST, randomization to lung CT scan was associated with a non-significant increase in thyroid cancer risk (HR â=â1.61; 95% CI: 0.96â2.71).", NLST thyroid cancer risk , Control , Randomized CT scan ,0,
edin,5281,5718865,Cannot tell based on the abstract,, Pain after 10 days , Control , Perioneal massage ,0,
edin,5281,5718865,No significant difference,"Based on the results, the postpartum perineal pain was different in both groups. Comparison of degrees of pain in the two groups showed that the severity of pain 3 days and 3 months after childbirth was significant (p=0.01, p=0.008, respectively), but the severity of pain in the 10th day did not differ significantly (p=0.78) (Table 3).", Pain after 10 days , Control , Perioneal massage ,0,
edin,5476,3263438,Cannot tell based on the abstract,, Plasma glucose , Control , Fluticasone furoate + vilanterol ,0,
edin,5476,3263438,Significantly increased,A small statistically significant increase (0.32âmmol/l; 95% CI 0.10 to 0.53) with FF/VI versus placebo was observed on day 28 (but not on days 1 and 14) for change from baseline in weighted mean plasma glucose FF/VI (figure 3A)., Plasma glucose , Control , Fluticasone furoate + vilanterol ,0,
edin,5386,3894078,Cannot tell based on the abstract,, Collony-forming units , Ultraviolet sanitization , Microwave sanitization   ,0,
edin,5386,3894078,Significantly decreased,"Tukey's post hoc comparisons of the three groups after the sanitization procedure indicated that the microwave group (M = 1.49, 95% CI [1.2729, 1.7071]) gave a significantly lower CFU count than the UV radiation group (M = 3.22, 95% CI [2.93, 3.50], P < 0.001) and the control group (M = 5.88, 95% CI [5.49, 6.26], P < 0.001).", Collony-forming units , Ultraviolet sanitization , Microwave sanitization   ,0,
edin,5263,4731528,No significant difference,"Cytotoxicity of the four materials was not significantly different from that of the control group at 24, 48 and 168 h (P>0.05)", Cytotoxicity  , Control , Biodentine ,0,
edin,5394,4472939,No significant difference,"There was no significant difference in the reduction in CVD by atorvastatin, with above median (HR 0.57) or below median (HR 0.52) change in CRP or change in LDL-cholesterol (HR 0.61 vs 0.50).",  LDL-cholesterol , Control , Atorvastatin ,0,
edin,5393,4472939,No significant difference,"After 1Â year, the atorvastatin arm showed a net CRP lowering of 32% (95% CI â40%, â22%) compared with placebo. The CRP response was highly variable, with 45% of those on atorvastatin having no decrease in CRP (median [interquartile range, IQR] per cent change â9.8% [â57%, 115%]).,There was no significant difference in the reduction in CVD by atorvastatin, with above median (HR 0.57) or below median (HR 0.52) change in CRP or change in LDL-cholesterol (HR 0.61 vs 0.50).",  C-reactive protein , Control , Atorvastatin ,0,
edin,5348,4667406,Cannot tell based on the abstract,, Important adverse effects  , Ischemic pressure  , Anesthetic injections  ,0,
edin,5348,4667406,No significant difference,There were no important harmful or unintended effects., Important adverse effects  , Ischemic pressure  , Anesthetic injections  ,0,
edin,5480,5244020,Cannot tell based on the abstract,, Pain , Control , Lavender  ,0,
edin,5480,5244020,Significantly decreased,"Relative to pretreatment levels, pain magnitude pain magnitude scores after the intervention were reduced 8.22 Â± 4.77% (0.37 Â± 0.21 points) in the control group, 14.39 Â± 4.14% (0.56 Â± 0.16 points) in the lavender group, and 19.65 Â± 4.44% (0.86 Â± 0.19 points) in the linalyl acetate group, with the differences between the lavender (P = 0.002) and linalyl acetate (P < 0.001) groups being significantly more reduced than in the control group (Figure 1(a)).", Pain , Control , Lavender  ,0,
edin,5379,4967427,Cannot tell based on the abstract,, Disability pensions , Standard management  , Intensive case management  ,0,
edin,5379,4967427,No significant difference,"<td align=""left"">&nbsp;&nbsp;Treatment costs (in 1000 CHF)</td><td align=""char"" char=""("">39.8 (1.11)</td><td align=""char"" char=""("">43.5 (1.22)</td><td align=""left"">9.4 [2.3â17.6]</td><td align=""char"" char=""."">0.01</td>,We found no statistically significant differences in allocation of disability pensions between SCM and ICM (TableÂ 2).", Disability pensions , Standard management  , Intensive case management  ,0,
edin,5470,5434591,Significantly decreased,"The primary effect variable, MTPM after 12 months, showed that migration in the denosumab group was statistically significantly less than in the controls. Denosumab MTPM 12 months was reduced by one-third (denosumab: median 0.24âmm, 10% and 90% percentiles: 0.15 and 0.41; placebo: median 0.36âmm, 10% and 90% percentiles: 0.20 and 0.62). The secondary MTPM variables (6 and 24 months) also showed a statistically significant reduction in migration. There was no significant difference in MTPM for the period 12â24 months.", Migration by RSA maximal total point motion after 2 years , Control , Denosumab ,0,
edin,5378,4967427,No significant difference,"Average work incapacity over the 6-year follow-up, including contributions from daily allowances and permanent losses from disability, was slightly but insignificantly higher under ICM than under SCM (21.6 vs. 21.3Â % of pre-accident work capacity).", Average work incapacity  , Standard management  , Intensive case management  ,0,
edin,5274,4713813,Significantly increased,"Following treatment, the silver spike point and acupuncture groups showed significant improvement, based on the Constipation Assessment Scale and the Bowel Function Assessment Form, compared with the control group.", Constipation assessment scale improvement  , Control  , Acupuncture  ,0,
edin,5324,4153077,Cannot tell based on the abstract,, Monocytes and granulocytes engaged in phagocytosis , Control , Galacto-oligosaccharides ,0,
edin,5324,4153077,No significant difference,"The supplementations did not change the percentages of monocytes and granulocytes engaged in phagocytosis compared with maltodextrin (Fig. 2(a) and 2(b)); however, there was a higher percentage of phagocytosing monocytes in the probiotic group compared with the prebiotic (PÂ =Â 0Â·005) group (Fig. 2(a))", Monocytes and granulocytes engaged in phagocytosis , Control , Galacto-oligosaccharides ,0,
edin,5340,5509595,Cannot tell based on the abstract,, VO2max , Half bath , Endurance exercise  ,0,
edin,5340,5509595,Significantly increased,"VO2max (ml/kg/min)	Aerobic exercise	25.12 Â± 1.21	33.07 Â± 2.37	group	7.680*
Half bath	26.18 Â± 1.20	27.07 Â± 1.10	time	8.223*
Control	27.13 Â± 1.01	27.05 Â± 1.00	group*time	9.618**,The results of this study showed a significant improvement of body composition in the exercise and half-bath treatment groups.,In this study, the maximum oxygen uptake, HRmax, and maximum ventilation were also significantly increased after 12 weeks of treatment only in exercise group.", VO2max , Half bath , Endurance exercise  ,0,
edin,5359,3432818,Cannot tell based on the abstract,, Delayed recall  improvement , Control , Astaxanthin-rich Haematococcus pluvialis ,0,
edin,5359,3432818,Significantly increased,"âDelayed recallâ, a measure of accuracy, significantly improved in the high-dosage group at 12 weeks (72.9Â Â±Â 7.5 vs 67.3Â Â±Â 11.8; p<0.05).,However, the changes in response time were as follows: in the high-dosage group, improvement trends were observed for âchoice reactionâ (451.1Â Â±Â 56.7 vs 480.1Â Â±Â 77.5), âdelayed recallâ (818.3Â Â±Â 195.9 vs 880.1Â Â±Â 189.4),", Delayed recall  improvement , Control , Astaxanthin-rich Haematococcus pluvialis ,0,
edin,5331,4183888,Cannot tell based on the abstract,, MucusTM improvement  , Control , Prophylactic professional oral health care ,0,
edin,5331,4183888,No significant difference,"<td>Mucus<sup>TM</sup>
</td><td align=""char"" char=""("">21.4 (3)</td><td align=""char"" char=""("">33.3 (4)</td><td align=""char"" char=""."">0.404</td>,The Saxon test, oral moisture checker test (MucusTM), and electrogustometer test each demonstrated no statistically significant differences between the two treatment groups with regard to changes before and after chemotherapy", MucusTM improvement  , Control , Prophylactic professional oral health care ,0,
edin,5293,4281164,Cannot tell based on the abstract,, Infectious complications , Thymoglobulin four infusions of 1.5 mg/kg  , Thymoglobulin single infusion  ,0,
edin,5293,4281164,Significantly decreased,"In a multivariate regression model of infectious complications, SD rATG induction (P=0.046) and higher 12-month absolute lymphocyte counts (P=0.033) associated with significantly fewer occurrences of severe viral infection (CMV infection or disease, BK nephropathy, and PTLD).", Infectious complications , Thymoglobulin four infusions of 1.5 mg/kg  , Thymoglobulin single infusion  ,0,
edin,5308,3195393,Cannot tell based on the abstract,, Continuous restraint  , Before restraint reduction program , After restraint reduction program ,0,
edin,5308,3195393,Significantly decreased,"there was a significant decrease of continuous restraint after RRC conference (from 85.5% to 63.6%, P = 0.009).", Continuous restraint  , Before restraint reduction program , After restraint reduction program ,0,
edin,5494,4733270,Cannot tell based on the abstract,, Probability of having an injury , Control , Hyperactivity ,0,
edin,5494,4733270,Significantly increased,"After controlling for sociodemographic factors, schizoid behavior problem (ORâ=â2.43, 95Â % CIâ=â1.44-4.11), anxiety/depression (ORâ=â2.76, 95Â % CIâ=â1.50-5.06), and hyperactivity (ORâ=â2.42, 95Â % CIâ=â1.26-4.68) were determined to be the predictors for injury in boys. The results indicate that boys who had scores above the cut-off in schizoid, anxiety/ depression, and hyperactivity behavior were 2.42 to 2.76 times more likely to have an injury than boys with normal scores.,<td></td><td>Hyperactivity</td><td align=""char"" char=""."">0.873</td><td align=""char"" char=""."">0.245</td><td align=""char"" char=""."">12.661</td><td align=""char"" char=""."">2.418</td><td align=""char"" char=""."">1.258</td><td align=""char"" char=""."">4.68</td><td align=""char"" char=""."">0.001</td>", Probability of having an injury , Control , Hyperactivity ,0,
edin,5283,5911298,Significantly decreased,The mean percentage of remaining filling material was 12.96% for PR group and 24.26% for MR group (P=0.0056). T, Remaining filling material , Mani NRT-GPR , Pro Taper universal retreatment  ,0,
edin,5434,4399299,Cannot tell based on the abstract,, Glycated hemoglobin , Placebo , Vildagliptin ,0,
edin,5434,4399299,Significantly decreased,"Mean HbA1c changed by â0.5 Â± 0.1% (P < .0001) from a baseline of 6.5 Â± 0.1% in the vildagliptin group, whereas a small numerical increase (0.2 Â± 0.1% from a baseline of 6.4 Â± 0.1%; P = .14) was seen in the placebo group, resulting in a significant between-group difference of â0.7 Â± 0.1% (P < .001).", Glycated hemoglobin , Placebo , Vildagliptin ,0,
edin,5347,4667406,Significantly increased,"Clinical response rates and pain relief were significantly better at 1, 4, and 12Â weeks for those receiving local anaesthetic injections than ischemic compression via physical therapy. The pain relief of women treated with local anaesthetic injections progressively improved at 1, 4, and 12Â weeks after intervention.", Progressive pain relief  , Ischemic pressure  , Anesthetic injections  ,0,
edin,5313,3944580,No significant difference,"A two-way ANOVA revealed a significant (P < 0.05) interaction effect for leptin and acyl ghrelin. However, changes in obestatin and des-acyl ghrelin concentration were statistically insignificant (P > 0.05).", Des-acyl ghrelin , Control , Motor-driven treadmill exercise  ,0,
edin,5435,3222191,No significant difference,"When controlling for baseline differences, no significant main effect of the learning method was found on computer/Web knowledge, skills, or eHealth literacy efficacy.", Computer knowledge , Control , Collaborative eHealth literacy intervention ,0,
edin,5314,5511285,Cannot tell based on the abstract,, Positional differences improvement (mediolateral) , Traditional measurement  , Genioplasty template system ,0,
edin,5314,5511285,Significantly increased,"The largest angular discrepancy occurred in pitch orientation: RMSD was 2.6Â°, and Bland-Altman lower and upper limits were â5.77Â° and 2.75Â° (TablesÂ 1 and 3). It indicated that the chin segments had an unplanned rotation around the mediolateral (xâ) axis.,<td>Without template</td><td>Mediolateral</td><td>1.45</td><td>Pitch</td><td>7.21</td>,<td>With template</td><td>Mediolateral</td><td>0.62</td><td>Pitch</td><td>2.63</td>,<td>Without template</td><td>Mediolateral</td><td>0.04</td><td>1.47</td><td>â2.84</td><td>(â4.57 to â2.07)</td><td>2.91</td><td>(2.14 to 3.68)</td>,<td>With template</td><td>Mediolateral</td><td>â0.01</td><td>0.62</td><td>â1.23</td><td>(â2.96 to â0.90)</td><td>1.21</td><td>(0.88 to 1.54)</td>,The worse outcomes were found in the control group not using the genioplasty templates.,In all 6 measurements of the chin position and orientation, the result of independent t test showed that there was statistically significant difference between the groups with and without the genioplasty templates.", Positional differences improvement (mediolateral) , Traditional measurement  , Genioplasty template system ,0,
edin,5454,5863632,Significantly decreased,Results indicated that Aussie Optimism with teacher training plus coaching was associated with the best outcomes: a significant increase in student-reported pro-social behavior from pre-test to post-test 1 (maintained at post-test 2) and significantly lower incidence rates from suicidal ideation at post-test 2 and follow-up., Suicidal ideas , Control , Training only ,0,
edin,5478,3263438,Cannot tell based on the abstract,, Vital signs  , Control , Fluticasone furoate + vilanterol ,0,
edin,5478,3263438,No significant difference,"There were no clinically relevant effects on laboratory values, including glucose and potassium, or on vital signs or ECGs/Holters.", Vital signs  , Control , Fluticasone furoate + vilanterol ,0,
edin,5319,4674480,Cannot tell based on the abstract,, Systolic blood pressure , Basal bolus , Insulin degludec and liraglutide ,0,
edin,5319,4674480,Significantly decreased,"Compared with BB or up-titrated basal therapy, estimated improvements in body weight, BMI, and SBP were statistically significantly better with IDegLira.", Systolic blood pressure , Basal bolus , Insulin degludec and liraglutide ,0,
edin,5284,5911298,Significantly increased,The percentage of dentin removal was greater in the PR group (5.02%) than MR group (1.36%) (P=0.0028)., Dentin removed , Mani NRT-GPR , Pro Taper universal retreatment  ,0,
edin,5303,2703617,Significantly decreased,The mean WTs of urgent patients (CTAS 2/3) were also significantly reduced after the FTA was opened (P < 0.001)., Waiting time of urgent patients , Control , Fast track area ,0,
edin,5442,3685524,Significantly increased,"Central arterial stiffness, measured as augmentation index, augmentation pressure and pulse wave velocity, was higher after wood smoke exposure as compared to filtered air (p < 0.01 for all),", Augmentation pressure , Control , Wood smoke ,0,
edin,5415,4899895,Cannot tell based on the abstract,, Respiratory exchange ratio during rest , Placebo , Green tea ,0,
edin,5415,4899895,Significantly decreased,"During the resting period, before exercise, RER was significantly decreased, p < 0.05, after GT ingestion (0.82 Â± 0.08) compared with the placebo (0.86 Â± 0.08).", Respiratory exchange ratio during rest , Placebo , Green tea ,0,
edin,5468,3462792,Cannot tell based on the abstract,, Probability of asking partner about HIV condition , Control , HIV Prevention Digital Media Intervention ,0,
edin,5468,3462792,Significantly decreased,"Contrary to expectations, men in both the webpage and control conditions had significant reductions in asking their partnerâs HIV status at follow-up compared to baseline (OR 0.61, OR 0.60).", Probability of asking partner about HIV condition , Control , HIV Prevention Digital Media Intervention ,0,
edin,5399,2800022,Significantly decreased,"PTH was significantly lower in group S than in group B at 6 months (P=0.001), but did not differ at 12 months.", Intact parathyroid hormone , Breast milk alone , Breast milk + Vit. D ,0,
edin,5367,3117815,Cannot tell based on the abstract,, Physical aspect of Functional Assessment of Cancer Therapy-Breast , 3-weekly docetaxel , Weekly docetaxel  ,0,
edin,5367,3117815,No significant difference,"<td align=""left"">âPhysical</td><td align=""center"">21.20 (0.73)</td><td align=""center"">21.63 (0.74)</td><td align=""center"">0.172</td><td align=""center"">0.68</td>,At the primary endpoint, there were no significant differences in RSCL, physical and psychological scores between groups.", Physical aspect of Functional Assessment of Cancer Therapy-Breast , 3-weekly docetaxel , Weekly docetaxel  ,0,
edin,5428,4399299,Significantly decreased,"Mean fasting liver triglyceride content decreased by 27% with vildagliptin, from 7.3 Â± 1.0% (baseline) to 5.3 Â± 0.9% (endpoint). There was no change in the placebo group.,The between-group difference in change from baseline was significant (P = .013).", Fasting liver triglycerides , Placebo , Vildagliptin ,0,
edin,5341,5509595,Cannot tell based on the abstract,, VO2max , Control , Half bath ,0,
edin,5341,5509595,No significant difference,"VO2max (ml/kg/min)	Aerobic exercise	25.12 Â± 1.21	33.07 Â± 2.37	group	7.680*
Half bath	26.18 Â± 1.20	27.07 Â± 1.10	time	8.223*
Control	27.13 Â± 1.01	27.05 Â± 1.00	group*time	9.618**,In this study, the maximum oxygen uptake, HRmax, and maximum ventilation were also significantly increased after 12 weeks of treatment only in exercise group.", VO2max , Control , Half bath ,0,
edin,5388,4415997,Significantly increased,"Exposure was associated with over twice the odds of using STI services (AOR 2.47; 95%CI 1.78â3.42), 89% greater odds of using perinatal services (AOR 1.89; 95%CI 1.37â2.60) and 56% greater odds of using antenatal services (AOR 1.56; 95%CI 1.10â2.20) among participants in intervention versus comparison communities, after adjustment for baseline differences.", Usage of sexually-transmitted infections services , Control , Sexual and Reproductive Health Intervention ,0,
edin,5312,3944580,No significant difference,"However, changes in obestatin and des-acyl ghrelin concentration were statistically insignificant (P > 0.05).,The data indicated that although acute treadmill exercise resulted in a significant change in acyl ghrelin and leptin levels, it had no effect on plasma obestatin and des-acyl ghrelin levels.", Obestatin , Control , Motor-driven treadmill exercise  ,0,
edin,5492,4733270,Significantly increased,"The significant behavior disorder predictors for unintentional injury in boys were schizoid behavior problem (ORâ=â2.43), anxiety/depression (ORâ=â2.76) and hyperactive (ORâ=â2.42). T", Probability of having an injury , Control , Being schizoid  ,0,
edin,5329,4183888,Cannot tell based on the abstract,, Plaque control record improvement  , Control , Prophylactic professional oral health care ,0,
edin,5329,4183888,Significantly increased,"The PCR showed numerical improvement in 11 patients and deterioration in 1 patient in the POHC group after chemotherapy, as compared with pre-chemotherapy PCR. In the self-care group, six patients showed improvement, while eight patients showed deterioration. Thus, the self-care group showed significantly greater oral health deterioration compared with the POHC group.", Plaque control record improvement  , Control , Prophylactic professional oral health care ,0,
edin,5481,5244020,Cannot tell based on the abstract,"Systolic BP, diastolic BP, heart rate, LUTS, and QoL satisfaction with urinary symptoms were similar in the three groups.", Blood pressure , Control , Linalyl acetate ,0,
edin,5481,5244020,No significant difference,"Aroma inhalation reduced systolic BP, diastolic BP, and HR slightly, but similarly, in the three groups, with no statistically significant differences across the three groups (data unshown).", Blood pressure , Control , Linalyl acetate ,0,
edin,5467,4156403,No significant difference,"In PLCO, randomization to cancer screening compared with usual care was associated with a significant decrease in thyroid cancer risk for men (HR â=â0.61; 95% CI: 0.49â0.95) but not women (HR â=â0.91; 95% CI: 0.66â1.26).", PLCO thyroid cancer risk in women , Control , Randomized CT scan ,0,
edin,5404,2689497,Cannot tell based on the abstract,, Oxygen saturation , IV ovine lipopolysaccharide , Inhaled human activated protein C + IV ovine lipopolysaccharide ,0,
edin,5404,2689497,Significantly increased,"Table 1 displays that oxygen saturation (SaO2) and mixed venous oxygen saturation (SvO2) both improved significantly on inhalation of APC, but without significant intergroup differences compared with LPS alone.", Oxygen saturation , IV ovine lipopolysaccharide , Inhaled human activated protein C + IV ovine lipopolysaccharide ,0,
edin,5488,3417877,No significant difference,The cellulose mask increased moisture levels in the skin significantly more than moist towels (P < 0.05) after a single application. No obvious effects on other skin characteristics were found., Skin texture , Control , Cellulose mask ,0,
edin,5381,4967427,Cannot tell based on the abstract,, Integrity indemnity , Standard management  , Intensive case management  ,0,
edin,5381,4967427,Significantly increased,"As shown in TableÂ 2, the percentage of patients who had received an integrity indemnity until the end of the 6-year follow-up was significantly higher under ICM (37.0Â %) than under SCM (32.0Â %, pÂ <Â 0.001).", Integrity indemnity , Standard management  , Intensive case management  ,0,
edin,5290,4281164,Cannot tell based on the abstract,, Mortality , Thymoglobulin four infusions of 1.5 mg/kg  , Thymoglobulin single infusion  ,0,
edin,5290,4281164,Significantly decreased,"There were significantly fewer deaths among kidney recipients who received SD rATG induction; causes of patient death are presented in Table S3 (SDC, http://links.lww.com/TP/B12)", Mortality , Thymoglobulin four infusions of 1.5 mg/kg  , Thymoglobulin single infusion  ,0,
edin,4918,4260384,Significantly increased,"The envelope type of CAF along with Type I collagen membrane (NEOMEM) was more effective than envelope type of CAF alone, in producing root coverage in multiple gingival recession defects, associated with gain in CAL as also in the width of KT.", the extent of root coverage at 6 months , baseline ," Group A, which were treated with the envelope type of CAF ",0,
edin,4918,4260384,Significantly increased,"The envelope type of CAF along with Type I collagen membrane (NEOMEM) was more effective than envelope type of CAF alone, in producing root coverage in multiple gingival recession defects, associated with gain in CAL as also in the width of KT.", the extent of root coverage at 6 months , baseline ," Group A, which were treated with the envelope type of CAF ",0,
edin,5450,4478821,Significantly increased,The laryngeal mask airway (LMA) insertion score was statistically significant in the four groups (P - 0.001)., Laryngeal mask airway insertion score improvement , No atricurium , Atracurium 50% dose  ,0,
edin,5267,5868223,Cannot tell based on the abstract,, Visiting the ophthalmologist  , Control , Eye health promotion program ,0,
edin,5267,5868223,Significantly increased,"There was statistical difference in the mean change positively in the how frequently children should be taken to an ophthalmologist, believed it was necessary to wear sunglasses on sunny days, knew the symptoms of visual problems in children, had bought their children's sunglasses from an optical store, children spend time outdoors to protect their eye health between the experimental (n = 98) and control (n = 93) groupsâ parents (P < 0.05) [Table 4].", Visiting the ophthalmologist  , Control , Eye health promotion program ,0,
edin,5344,4667406,Cannot tell based on the abstract,, Pain VAS (1 week) , Ischemic pressure  , Anesthetic injections  ,0,
edin,5344,4667406,Cannot tell based on the abstract,, Pain VAS (1 week) , Ischemic pressure  , Anesthetic injections  ,0,
edin,5344,4667406,No significant difference,"<td>P</td><td>.50</td><td>.08</td><td>&lt;.01</td><td>&lt;.01</td><td>---</td>,Although the differences between groups in the various time points were not significant, pain threshold and tolerance improved progressively in the women who received the local anaesthetic injection (TableÂ 4).Table 4", Pain VAS (1 week) , Ischemic pressure  , Anesthetic injections  ,0,
edin,5462,5501521,Significantly decreased,"Systolic blood pressure was also lower in the Lignocaine group: 121.7Â mmHg (SD: 6.1) vs. 128.0Â mmHg (SD: 6.4) in the Saline group; 95% CI 3.5â9.2, pÂ <Â 0.001, as was the mean heart rate [Lignocaine group: 74.9 beats/min (SD: 1.8) vs. 81.5 beats/min (SD: 1.7) in the Saline group, 95% CI 4.1â9.1, pÂ <Â 0.001].", Heart rate , Control , Lignocaine ,0,
edin,5409,2689497,Cannot tell based on the abstract,, PaCO2 level , IV ovine lipopolysaccharide , Inhaled human activated protein C + IV ovine lipopolysaccharide ,0,
edin,5409,2689497,Significantly decreased,"Except for a slight increase in pH (P = 0.002) and a decrease in partial pressure of carbon dioxide in arterial blood (PaCO2; P = 0.013) after inhaled APC, we noticed no changes in acid-base balance.", PaCO2 level , IV ovine lipopolysaccharide , Inhaled human activated protein C + IV ovine lipopolysaccharide ,0,
edin,5485,3417877,Significantly increased,The cellulose mask increased moisture levels in the skin significantly more than moist towels (P < 0.05) after a single application., Facial moisture , Control , Cellulose mask ,0,
edin,5392,4415997,Cannot tell based on the abstract,, Patient service satisfaction , Control , Sexual and Reproductive Health Intervention ,0,
edin,5392,4415997,Significantly increased,"Reported satisfaction increased from 18% to 43% among intervention adolescents versus 17% to 28% among comparison adolescents. Thus, intervention adolescents had 92% higher odds of reporting satisfaction with services than comparison adolescents at endline (OR 1.92, adjusted for baseline satisfaction; 95%CI 1.63â2.26). No gender differences were found in reported service satisfaction.,<td align=""left"" colspan=""1"" rowspan=""1"">Intervention</td><td align=""left"" colspan=""1"" rowspan=""1"">1692</td><td align=""left"" colspan=""1"" rowspan=""1"">304 (18.0)</td><td align=""left"" colspan=""1"" rowspan=""1"">141 (46.4)</td><td align=""left"" colspan=""1"" rowspan=""1"">163 (53.6)</td><td align=""left"" colspan=""1"" rowspan=""1"">1288</td><td align=""left"" colspan=""1"" rowspan=""1"">556 (43.2)</td><td align=""left"" colspan=""1"" rowspan=""1"">250 (45.0)</td><td align=""left"" colspan=""1"" rowspan=""1"">306 (55.0)</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">25.2</td>", Patient service satisfaction , Control , Sexual and Reproductive Health Intervention ,0,
edin,5318,4674480,Significantly decreased,"At end of study, differences between IDegLira and BB or up-titrated IGlar, respectively, were as follows: reduction in HbA1c â0.30%, 95% confidence interval (â0.58; â0.01) and â0.65% (â0.83; â0.47); change in body weight â6.89Â kg (â7.92; â5.86) and â4.04Â kg (â4.69; â3.40) all in favor of IDegLira.", Body weight  , Basal bolus , Insulin degludec and liraglutide ,0,
edin,5369,3117815,Cannot tell based on the abstract,, Functional aspect of Functional Assessment of Cancer Therapy-Breast , 3-weekly docetaxel , Weekly docetaxel  ,0,
edin,5369,3117815,No significant difference,"<td align=""left"">âFunctional</td><td align=""center"">19.80 (0.71)</td><td align=""center"">18.48 (0.72)</td><td align=""center"">1.691</td><td align=""center"">0.20</td>,Table 2
Primary and secondary outcomes at three weeks after completion of chemotherapy", Functional aspect of Functional Assessment of Cancer Therapy-Breast , 3-weekly docetaxel , Weekly docetaxel  ,0,
edin,5322,4674480,Significantly decreased,"Confirmed hypoglycemia rate was 122.8 (90.7; 166.1), 1060.8 (680.2; 1654.4), and 286.1 (231.1; 354.1) events/100 patient-years for IDegLira, BB, and up-titrated IGlar, respectively.", Hypoglycemia  , Basal bolus , Insulin degludec and liraglutide  ,0,
edin,5357,3432818,Cannot tell based on the abstract,, Divided attention improvement , Control , Astaxanthin-rich Haematococcus pluvialis ,0,
edin,5357,3432818,Significantly increased,"However, the changes in response time were as follows: in the high-dosage group, improvement trends were observed for âchoice reactionâ (451.1Â Â±Â 56.7 vs 480.1Â Â±Â 77.5), âdelayed recallâ (818.3Â Â±Â 195.9 vs 880.1Â Â±Â 189.4), and âdivided attentionâ (385.3Â Â±Â 72.5 vs 419.4Â Â± 79.6), each p values <0.1 at 12 weeks,", Divided attention improvement , Control , Astaxanthin-rich Haematococcus pluvialis ,0,
edin,5338,5509595,Significantly decreased,The aerobic exercise group showed a significant decrease in body fat than those in the half-bath and control groups., Body fat , Control , Endurance exercise  ,0,
edin,5317,5511285,Cannot tell based on the abstract,, Orientational differences improvement (Pitch) , Traditional measurement  , Genioplasty template system ,0,
edin,5317,5511285,Significantly increased,"Table 3
Bland-Altmanâs Accuracy Estimate of Orientational Differences between the Planned and Postoperative Outcomes (degrees).,<td>Without template</td><td>Pitch</td><td>â4.00</td><td>6.06</td><td>â15.89</td><td>(â17.62 to â12.69)</td><td>7.89</td><td>(4.69 to 11.08)</td>,<td>With template</td><td>Pitch</td><td>â1.51</td><td>2.17</td><td>â5.77</td><td>(â7.50 to â4.63)</td><td>2.75</td><td>(1.61 to 3.90)</td>,The worse outcomes were found in the control group not using the genioplasty templates. In all 6 measurements of the chin position and orientation, the result of independent t test showed that there was statistically significant difference between the groups with and without the genioplasty templates.", Orientational differences improvement (Pitch) , Traditional measurement  , Genioplasty template system ,0,
edin,5389,4415997,Significantly increased,"Exposure was associated with over twice the odds of using STI services (AOR 2.47; 95%CI 1.78â3.42), 89% greater odds of using perinatal services (AOR 1.89; 95%CI 1.37â2.60) and 56% greater odds of using antenatal services (AOR 1.56; 95%CI 1.10â2.20) among participants in intervention versus comparison communities, after adjustment for baseline differences.", Usage of antenatal services  , Control , Sexual and Reproductive Health Intervention ,0,
edin,5426,3920467,Cannot tell based on the abstract,, +25% improvement  , Placebo , Hydroxyzine + chlorpheniramine ,0,
edin,5426,3920467,Significantly increased,"Improvement of more than 25 per cent (50 per cent) of pruritus was seen in 10 (2)/17 dogs with the combination of chlorpheniramine and hydroxyzine, 12 (2)/18 with dimetinden and 2 (1)/19 with placebo. For dogs improving by more than 25 per cent, the difference between placebo and the combination of chlorpheniramine and hydroxyzine and dimetinden, respectively, was significant (P=0.003 and P=0.001, respectively)", +25% improvement  , Placebo , Hydroxyzine + chlorpheniramine ,0,
edin,5295,5530360,Significantly decreased,"At week 24, more baricitinib-treated patients versus placebo-treated patients reported normal physical functioning (HAQ-DI <0.5; pâ¤0.001), reductions in fatigue (FACIT-F â¥3.56; pâ¤0.05), improvements in PtGA (pâ¤0.001) and pain (pâ¤0.001) and reductions in duration of MJS (p<0.01).",   Functional Assessment of Chronic Illness Therapy-Fatigue improvement , Placebo , Baricitinib 2 mg ,0,
edin,5302,2703617,Significantly decreased,"Similarly, mean WTs of CTAS 5 patients decreased by 28 min (95% CI 19 min to 37 min, P < 0.001) post FTA.", Waiting time of CTAS 5 , Control , Fast track area ,0,
edin,5486,3417877,No significant difference,"Skin moisture, sebum, elasticity, texture, dullness, and desquamation levels were assessed using a system used for routine skin counseling before applying the trial product and five minutes after its removal.,The cellulose mask increased moisture levels in the skin significantly more than moist towels (P < 0.05) after a single application. No obvious effects on other skin characteristics were found.", Sebum level , Control , Cellulose mask ,0,
edin,5380,4967427,Cannot tell based on the abstract,, Degree of disability , Standard management  , Intensive case management  ,0,
edin,5380,4967427,No significant difference,"<td align=""left"">&nbsp;&nbsp;Average degree (%) of disability for patients receiving a pension</td><td align=""char"" char=""("">34.7 (0.92)</td><td align=""char"" char=""("">34.9 (0.94)</td><td align=""left"">0.4 [â6.0â7.2]</td><td align=""char"" char=""."">0.90</td>,The average degree of disability across these patients was almost identical for both study groups (34.7Â % under SCM vs. 34.9Â % under ICM, pÂ =Â 0.90).", Degree of disability , Standard management  , Intensive case management  ,0,
edin,5345,4667406,Cannot tell based on the abstract,, Pain VAS (4 weeks) , Ischemic pressure  , Anesthetic injections  ,0,
edin,5345,4667406,Significantly decreased,<td>P</td><td>.50</td><td>.08</td><td>&lt;.01</td><td>&lt;.01</td><td>---</td>, Pain VAS (4 weeks) , Ischemic pressure  , Anesthetic injections  ,0,
edin,5352,4676931,Significantly increased,Post hoc analyses showed the statistical superiority of rasagiline versus placebo in the UPDRS Part I depression item (PÂ =Â 0.04) and PDQ-39 mobility (PÂ =Â 0.007) and cognition domains (PÂ =Â 0.026)., Parkinsonâs disease quality of life questionnaire - mobility score improvement , Control , Rasagiline ,0,
edin,5374,5559992,Significantly decreased,"The results showed a significant reduction in anxiety symptoms within each of the three groups (P = 0.00), but no difference in outcome between the groups (P = 0.605).", Anxiety , No treatment , Buprenophine 96 mg ,0,
edin,5361,3883373,No significant difference,"Incidences of UTI - febrile and afebrile - reduced in both groups without any significant differences after two years of prophylaxis. Also, incidence of afebrile UTIs did not significantly differ (0.51Â±1.30 and 0.81Â±1.41 respectively, P =0.3);", Afebrile urianry tract infections , Antibiotics alone  , Probiotics + antibiotics  ,0,
edin,5323,4674480,Significantly decreased,"Confirmed hypoglycemia rate was 122.8 (90.7; 166.1), 1060.8 (680.2; 1654.4), and 286.1 (231.1; 354.1) events/100 patient-years for IDegLira, BB, and up-titrated IGlar, respectively.", Hypoglycemia  , Glucagon-like peptide-1 receptor agonist + basal insulin , Insulin degludec and liraglutide  ,0,
edin,5332,4183888,Cannot tell based on the abstract,, Gustatory measurement improvement  , Control , Prophylactic professional oral health care ,0,
edin,5332,4183888,No significant difference,"Results of the oral environment assessments, including the OAG score, oral mucositis grade assessment, PCR, Saxon test, and tests with the oral moisture checker (MucusTM) and electrogustometer, are presented in TableÂ 4.Table 4

Deterioration rates of oral environment assessment parameters (Ï 2 test),Electrogustometer	21.4 (3)	25.0 (3)	0.596,The assessment parameters consisted of oral cavity photographs, assessment of the oral mucositis grade using the United States National Cancer Institute Common Terminology Criteria for Adverse Events version 3.0 (NCI-CTCAE) [11], evaluation of the oral environment using Eilersâ Oral Assessment Guide (OAG) [12, 13], evaluation of oral hygiene using plaque control records (PCR) [13, 14], evaluation of dry mouth and oral moisture using the Saxon test [15, 16] and MucusTM [16, 17], and gustatory measurements using an electrogustometer [18â22].", Gustatory measurement improvement  , Control , Prophylactic professional oral health care ,0,
edin,5499,5380326,Significantly decreased,"Our important finding revealed that upon correction of vitamin D insufficiency or deficiency, the serum IP-10 and DPP IV levels were decreased significantly as compare to the placebo group (delta changes; 83.27 vs -133.80; 95% CI [-326.910, -40.758], p = 0.0125, and 271.04 vs -518.69; 95% CI [-1179,15, -59.781], p = 0.0305, respectively.", Dipeptidyl peptidase-4  , Control , Vitamin D supplementation  ,0,
edin,5383,3459660,Cannot tell based on the abstract,, Morning prebronchodilator FEV1 , Control , Tiotropium ,0,
edin,5383,3459660,Significantly increased,"At all time points, tiotropium significantly improved morning prebronchodilator FEV1 compared with control (P < 0.01, Figure 1);", Morning prebronchodilator FEV1 , Control , Tiotropium ,0,
edin,5440,3222191,Cannot tell based on the abstract,, Learning Preferences , Control , Collaborative  eHealth literacy intervention ,0,
edin,5440,3222191,No significant difference,"Multivariate repeated measures analyses found neither an interaction effect among learning preference matching, learning method, and time of measurement (P = .18) nor a significant main effect of the learning preference matching factor (P = .41).", Learning Preferences , Control , Collaborative  eHealth literacy intervention ,0,
edin,5294,4281164,Cannot tell based on the abstract,, Multiple infections , Thymoglobulin four infusions of 1.5 mg/kg  , Thymoglobulin single infusion  ,0,
edin,5294,4281164,Significantly decreased,"Frequencies of multiple infections (two or more infectious origins, e.g., bacterial, viral, fungal) were lower among SD patients (1 vs. 9; P=0.02).", Multiple infections , Thymoglobulin four infusions of 1.5 mg/kg  , Thymoglobulin single infusion  ,0,
edin,5372,5559992,Significantly decreased,"The results showed a significant reduction in anxiety symptoms within each of the three groups (P = 0.00), but no difference in outcome between the groups (P = 0.605).", Anxiety , No treatment , Buprenophine 32 mg ,0,
edin,5337,3996328,Cannot tell based on the abstract,, Body mass index , Traditional exercise  , Eccentric exercise  ,0,
edin,5337,3996328,No significant difference,"Neither the ECC (P = 0.51) nor the TRAD (P = 0.15) group demonstrated a significant change in BMI over time.,Further, the high IMAT group experienced a parallel lowering (P = 0.03) of their elevated pretraining BMI, while the low IMAT group's BMI did not change (P = 0.73).", Body mass index , Traditional exercise  , Eccentric exercise  ,0,
edin,5472,5434591,No significant difference,KOOS sub-variables were similiar between denosumab and placebo after 12 and 24 months., Knee osteoarthritis outcome score after 1 year , Control , Denosumab  ,0,
edin,5279,5718865,Cannot tell based on the abstract,, Second degree lacerations  , Control , Perioneal massage ,0,
edin,5279,5718865,No significant difference,"The results revealed 23.16% of first-degree perineal laceration and 2.11% of second-degree perineal laceration in the case group, and no vestibular laceration or third- and fourth-degree lacerations in the case group. However, there were 5.13% of vestibular laceration, 7.69% of first-degree laceration, 2.56% of second-degree laceration, and 1.05% of third-degree laceration (one woman) in the control group", Second degree lacerations  , Control , Perioneal massage ,0,
edin,5261,4731528,No significant difference,"Cytotoxicity of the four materials was not significantly different from that of the control group at 24, 48 and 168 h (P>0.05).", Cytotoxicity  , Control , Mineral trioxide aggregate  ,0,
edin,5403,2800022,Significantly increased,"Total intake of vitamin D differed among 3 groups (P<0.001, A>S>B), but total intake of Ca and P were higher in group A than in group B and S (P<0.001).", Calcium and phosphorus intake , Breast milk alone , Formula ,0,
edin,5464,5501521,Cannot tell based on the abstract,, Need of ephedrine  , Control , Lignocaine ,0,
edin,5464,5501521,No significant difference,"In the Lignocaine group, twenty-two patients (59%) required either intermittent boluses of either metaraminol or ephedrine compared to fifteen patients (39%) in the Saline group (pÂ =Â 0.1).", Need of ephedrine  , Control , Lignocaine ,0,
edin,5402,2800022,Significantly increased,"Total intake of vitamin D differed among 3 groups (P<0.001, A>S>B), but total intake of Ca and P were higher in group A than in group B and S (P<0.001)", Calcium and phosphorus intake , Breast milk + Vit. D , Formula ,0,
edin,5447,4478821,Significantly decreased,The need of atracurium due to unacceptable surgical conditions based on surgeon satisfaction score was statistically significant when compared among the groups being maximum in Group 0 (P < 0.001), Need of atricurium , No atricurium , Atracurium 25% dose  ,0,
edin,5373,5559992,Significantly decreased,"The results showed a significant reduction in anxiety symptoms within each of the three groups (P = 0.00), but no difference in outcome between the groups (P = 0.605).", Anxiety , No treatment , Buprenophine 64 mg ,0,
edin,5285,5911298,Cannot tell based on the abstract,, Creation of ledges , Mani NRT-GPR , Pro Taper universal retreatment  ,0,
edin,5285,5911298,No significant difference,"No complications, such as creation of ledges, obstructions, perforations or instrument fractures were registered for the PR or MR instruments, after retreatment procedures.", Creation of ledges , Mani NRT-GPR , Pro Taper universal retreatment  ,0,
edin,5424,3920467,Significantly decreased,"<td colspan=""1"" rowspan=""1"">Dimetinden</td><td colspan=""1"" rowspan=""1""></td><td colspan=""1"" rowspan=""1""></td><td colspan=""1"" rowspan=""1""></td><td colspan=""1"" rowspan=""1""></td>", Pruritus  , Placebo , Hydroxyzine + chlorpheniramine ,0,
edin,5343,5509595,Cannot tell based on the abstract,, Pulse wave velocity , Control , Half bath ,0,
edin,5343,5509595,Significantly decreased,"<td align=""left"" colspan=""1"" rowspan=""1"">Control</td><td align=""center"" colspan=""1"" rowspan=""1"">1.64 Â± 0.04</td><td align=""center"" colspan=""1"" rowspan=""1"">1.64 Â± 0.03</td><td align=""center"" colspan=""1"" rowspan=""1"">group*time</td><td align=""center"" colspan=""1"" rowspan=""1"">39.760***</td>,According to those results, body composition, maximal oxygen uptake, heart rate, and arterial pulse wave velocity were significantly different among the groups.", Pulse wave velocity , Control , Half bath ,0,
edin,5420,5316445,Cannot tell based on the abstract,, Rand Short Form 36 score improvement , Control , Wi-Fit exercise program ,0,
edin,5420,5316445,No significant difference,"Adjusting for MMSE and SF-36 Physical and Mental summary scores resulted in between-group differences that were only slightly (<10%) larger, and these covariates were nonsignificant (all p > 0.15, results not shown).", Rand Short Form 36 score improvement , Control , Wi-Fit exercise program ,0,
edin,5339,5509595,Significantly decreased,The aerobic exercise group showed a significant decrease in body fat than those in the half-bath and control groups., Body fat , Half bath , Endurance exercise  ,0,
edin,5371,3117815,Cannot tell based on the abstract,, Depression aspect of the Hospital anxiety and depression scale , 3-weekly docetaxel , Weekly docetaxel  ,0,
edin,5371,3117815,No significant difference,"<td align=""left"">âDepression</td><td align=""center"">4.12 (0.39)</td><td align=""center"">3.14 (0.39)</td><td align=""center"">3.237</td><td align=""center"">0.08</td>,There were also no significant differences between groups in HADS anxiety and depression scores.", Depression aspect of the Hospital anxiety and depression scale , 3-weekly docetaxel , Weekly docetaxel  ,0,
edin,5493,4733270,Significantly increased,"he significant behavior disorder predictors for unintentional injury in boys were schizoid behavior problem (ORâ=â2.43), anxiety/depression (ORâ=â2.76) and hyperactive (ORâ=â2.42).", Probability of having an injury , Control , Anxiety/Depression ,0,
edin,5309,3195393,Cannot tell based on the abstract,, Restraint knowledge , Before restraint reduction program , After restraint reduction program ,0,
edin,5309,3195393,Significantly increased,"When further analysis were conducted, a subsample of nurses (of one unit) were found to have better knowledge after intervention (mean score results: 5.51 versus 6.23, P = 0.04).", Restraint knowledge , Before restraint reduction program , After restraint reduction program ,0,
edin,5354,4676931,Significantly increased,Rasagiline significantly improved UPDRS Parts I (PÂ =Â 0.03) and II (PÂ =Â 0.003) scores versus placebo at week 12., Unified Parkinsonâs Disease Rating Scale Part I score improvement , Control , Rasagiline ,0,
edin,5479,5244020,Significantly decreased,"Significant differences in pain magnitude and urinary residual sense of indwelling catheters were observed among the three groups, with inhalation of linalyl acetate being significantly more effective than inhalation of lavender or vehicle.", Pain , Control , Linalyl acetate ,0,
edin,5501,5380326,Cannot tell based on the abstract,, Tumor necrosis factor alpha , Control , Vitamin D supplementation  ,0,
edin,5501,5380326,Significantly decreased,"<td align=""center"" colspan=""1"" rowspan=""1"">TNF-Î±</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">-14.351</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">-23.407</td><td align=""center"" colspan=""1"" rowspan=""1"">2.515 (38.146)</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">0.9476</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">0.08</td>", Tumor necrosis factor alpha , Control , Vitamin D supplementation  ,0,
edin,5487,3417877,No significant difference,"Skin moisture, sebum, elasticity, texture, dullness, and desquamation levels were assessed using a system used for routine skin counseling before applying the trial product and five minutes after its removal.,The cellulose mask increased moisture levels in the skin significantly more than moist towels (P < 0.05) after a single application. No obvious effects on other skin characteristics were found.", Elasticity , Control , Cellulose mask ,0,
edin,4526,5010179,Cannot tell based on the abstract,, Resection rates , Control , Uracil-tegafur and leucovorin ,0,
edin,4526,5010179,No significant difference,The resection rates for the first recurrence were similar between the UFT/LV and surgery alone groups (55.9% vs. 41.0%)., Resection rates , Control , Uracil-tegafur and leucovorin ,0,
edin,5315,5511285,Cannot tell based on the abstract,, Positional differences improvement (anteroposterior) , Traditional measurement  , Genioplasty template system ,0,
edin,5315,5511285,Significantly increased,"Table 2
Bland-Altmanâs Accuracy Estimate of Positional Differences between the Planned and Postoperative Outcomes (mm).,<th colspan=""2"">Lower Limit</th><th colspan=""2"">Upper Limit</th>,The worse outcomes were found in the control group not using the genioplasty templates. In all 6 measurements of the chin position and orientation, the result of independent t test showed that there was statistically significant difference between the groups with and without the genioplasty templates.", Positional differences improvement (anteroposterior) , Traditional measurement  , Genioplasty template system ,0,
edin,5301,2703617,Significantly decreased,"Mean WTs of Canadian Triage Acuity Scale (CTAS) 4 patients decreased by 22 min (95% CI 21 min to 24 min, P < 0.001).", Waiting time of CTAS 4 , Control , Fast track area ,0,
edin,5473,5434591,No significant difference,KOOS sub-variables were similiar between denosumab and placebo after 12 and 24 months., Knee osteoarthritis outcome score after 2 years , Control , Denosumab  ,0,
edin,5410,5427603,No significant difference,"However, the accuracy of these variables in identifying responders in each group was modest (62 and 53%, respectively).", Responders identification accuracy  , Foot orthoses  , Rocker-sole footwear ,0,
edin,5427,3920467,Cannot tell based on the abstract,, +25% improvement  , Placebo , Dimetinden ,0,
edin,5427,3920467,Significantly increased,"mprovement of more than 25 per cent (50 per cent) of pruritus was seen in 10 (2)/17 dogs with the combination of chlorpheniramine and hydroxyzine, 12 (2)/18 with dimetinden and 2 (1)/19 with placebo. For dogs improving by more than 25 per cent, the difference between placebo and the combination of chlorpheniramine and hydroxyzine and dimetinden, respectively, was significant (P=0.003 and P=0.001, respectively).", +25% improvement  , Placebo , Dimetinden ,0,
edin,5475,3263438,No significant difference,The wm heart rate 0â4âh postdose was similar between groups (difference: 0.6âbeats per minute; 95% CI â3.9 to 5.1)., Heart rate , Control , Fluticasone furoate + vilanterol ,0,
edin,5334,4175229,Significantly decreased,"In the experimental group, it was found that pain in the SCM was relived, as the VAS and PPT score decrease significantly and range of motion of temporomandibular joint increase significantly.", Pressure pain threshold improvement  , Control , Kinesio taping  ,0,
edin,5377,5559992,No significant difference,"he results showed a significant reduction in anxiety symptoms within each of the three groups (P = 0.00), but no difference in outcome between the groups (P = 0.605).", Anxiety , Buprenophine 96 mg , Buprenophine 64 mg ,0,
edin,5446,3685524,Cannot tell based on the abstract,, Successive NN interval differences &amp;gt;50 ms , Control , Wood smoke ,0,
edin,5446,3685524,No significant difference,"Data expressed as mean Â± SEM or median with inter quartile range. SDNN standard deviation of successive NN intervals, RMSSD root-mean square of successive NN interval differences; HFn high frequency components expressed as normalised units, LFn low frequency components expressed as normalised units, HF/LF high frequency/low frequency. There were no significant differences in any parameter pre exposure (p>0.05 for all).", Successive NN interval differences &amp;gt;50 ms , Control , Wood smoke ,0,
edin,5297,5530360,Significantly increased,"At week 24, more baricitinib-treated patients versus placebo-treated patients reported normal physical functioning (HAQ-DI <0.5; pâ¤0.001),",  Health Assessment Questionnaire-Disability Index improvement , Placebo , Baricitinib 2 mg ,0,
edin,5726,5858425,Cannot tell based on the abstract,, descriptive improvements post measurement , control group (CG) received lessons as usual , Intervention group (IG) with standing desks and balance pads for 11 weeks ,0,
edin,5726,5858425,No significant difference,"Based on the pre-measurement, descriptive improvements could be found at post measurement for the IG compared to the CG.,The mean changes and their effect sizes were higher in the IG (IG: 0.46â0.48; CG: 0.26) for the digit span task.", descriptive improvements post measurement , control group (CG) received lessons as usual , Intervention group (IG) with standing desks and balance pads for 11 weeks ,0,
edin,5760,5524701,Cannot tell based on the abstract,, post-test scores acute bacterial meningitis scenario , mannequin-based scenarios , SP-based scenarios  ,0,
edin,5760,5524701,No significant difference,The improvement of the SP group scores compared to the mannequin group reached statistical significance in all scenarios except for the acute bacterial meningitis scenario (Table 1)., post-test scores acute bacterial meningitis scenario , mannequin-based scenarios , SP-based scenarios  ,0,
edin,5727,3956097,Significantly decreased,"Our findings showed that there was a statistically significant increase in the mean score of the patientsâ life quality after rehabilitation. Also, the comparison of the scores of the eight aspects of patientsâ life quality before and after rehabilitation revealed that life quality improved in the following directions: physical functioning, limitation of physical health, limitation of psychological health, energy, social functioning, and physical pain", physical pain after rehabilitation , before rehabilitation program , after rehabilitation program ,0,
edin,5532,2876942,No significant difference,"Drug palatability, vomiting, and onset of action of premedication; showed no significant differences between both groups.", Vomiting , Control , Ketamine ,0,
edin,5739,4119719,Cannot tell based on the abstract,, effectiveness after early ischemic stroke , placebo , 4 Channel Functional Electrical Stimulation (FES) ,0,
edin,5739,4119719,Significantly increased,"Four-channel FES and dual-channel FES can both improve motor function, balance, walking ability, and performance in the activities of daily living in subjects with early ischemic stroke.", effectiveness after early ischemic stroke , placebo , 4 Channel Functional Electrical Stimulation (FES) ,0,
edin,5635,5712123,Cannot tell based on the abstract,, time to first rescue analgesic , Duloxetine (D) , duloxetine 60 and etoricoxib 120mg (group D/E) ,0,
edin,5635,5712123,Significantly increased,"The time to first rescue analgesic was significantly prolonged in (D/E)when compared with group D,", time to first rescue analgesic , Duloxetine (D) , duloxetine 60 and etoricoxib 120mg (group D/E) ,0,
edin,5719,3750766,Cannot tell based on the abstract,, pain perception in dorsal anterior cingulate cortex  , placebo , multi-coil rTMS ,0,
edin,5719,3750766,Significantly decreased,"Multi-coil repetitive transcranial magnetic stimulation was successfully used to reliably and safely affect the dorsal anterior cingulate cortex, a deep brain structures that is critical to pain perception, but which cannot be selectively reached with single-coil approaches. Particular configurations and frequencies of field pulses directed toward the dorsal anterior cingulate cortex reduced acute pain in volunteers and chronic pain in fibromyalgia patients.", pain perception in dorsal anterior cingulate cortex  , placebo , multi-coil rTMS ,0,
edin,5541,3952721,No significant difference,"No effect on QTci (individually corrected) was observed at either strength of FF/VI, with mean time-matched treatment differences <5 ms at all time points [upper 90% CIs <10 ms (0â24âh)].", QTc (Fridericia's correction) time , Control , Fluticasone furoate + vilanterol ,0,
edin,5536,2876942,Significantly decreased,Postoperative agitation score and rescue fentanyl consumption were higher in group M than in group KM on admission to the PACU (P < 0.01)., Fentanyl consumption , Control , Ketamine ,0,
edin,5540,3912320,Cannot tell based on the abstract,," Correct response rate for 4,000 Hz frequency ", Control , Occupational noise ,0,
edin,5540,3912320,Significantly increased,"FigureÂ 4 compares the mean correct responses between the control and test groups according to the stimulus frequency. The control group obtained means that were 24%, 21% and 25% higher than those of the test group for the 500, 2,000 and 4,000 Hz frequencies, respectively."," Correct response rate for 4,000 Hz frequency ", Control , Occupational noise ,0,
edin,5749,2364538,No significant difference,"After 6 months use of panty liners the frequencies (and densities) of the selected microorganisms in these two sites had not changed compared to controls, and fatty acid analyses of vaginal secretions gave no evidence of shifts in the microbial flora.", fatty acid analyses of vaginal secretions , control group C (no panty liner wear) , panty liner B (AlwaysÂ® non-deodorant) ,0,
edin,5600,4355974,Cannot tell based on the abstract,, Days patient had to slow down	 , Control , BostonBreathes system ,0,
edin,5600,4355974,No significant difference,<td>Days had to slow down</td><td>2.5</td><td>â1.4</td><td>0.07</td><td>1.1</td><td>â0.4</td><td>0.48</td><td>0.79</td>, Days patient had to slow down	 , Control , BostonBreathes system ,0,
edin,5682,3721088,Cannot tell based on the abstract,, total time taken to complete the test for Object Cancelation test (OC) , computer-based testing , computer-based prism adaptation (PA) ,0,
edin,5682,3721088,Significantly decreased,"The total time taken to complete the test improved significantly after PA for the OC, LC, as well as the LB.", total time taken to complete the test for Object Cancelation test (OC) , computer-based testing , computer-based prism adaptation (PA) ,0,
edin,5642,4307639,Cannot tell based on the abstract,, younger age , no interest group , committed with interest group ,0,
edin,5642,4307639,Significantly decreased,"The committed without interest group were younger (ORâ=â0.79, Pâ=â0.01), and more physically active (ORâ=â1.06, Pâ=â0.005).", younger age , no interest group , committed with interest group ,0,
edin,5543,3952721,Cannot tell based on the abstract,, Adverse effects  , Moxifloxacin , Fluticasone furoate + vilanterol ,0,
edin,5543,3952721,No significant difference,"<td align=""left"" colspan=""1"" rowspan=""1""><bold>âAdverse events/serious adverse events</bold></td><td align=""center"" colspan=""1"" rowspan=""1"">0</td><td align=""center"" colspan=""1"" rowspan=""1"">0</td>,here were no serious adverse events or subject withdrawals due to AEs", Adverse effects  , Moxifloxacin , Fluticasone furoate + vilanterol ,0,
edin,5708,5887937,Cannot tell based on the abstract,, efficacy , treatment arms with repeated switches (pooled switched) , continued treatment arms (pooled continued) ,0,
edin,5708,5887937,No significant difference,"Also, no relevant differences were identified in any efficacy parameter when considering the four treatment arms (two continued and two switched) separately during TP2.", efficacy , treatment arms with repeated switches (pooled switched) , continued treatment arms (pooled continued) ,0,
edin,5680,3721088,Cannot tell based on the abstract,, efficacy , computer based testing , computer-based prism adaptation (PA) ,0,
edin,5680,3721088,No significant difference,These patients were not included in the analyses on the efficacy of the digitalized neuropsychological tests (see below). One patient whom had also a small after-effect was not secondly adapted due to emotional factors (see above)., efficacy , computer based testing , computer-based prism adaptation (PA) ,0,
edin,5630,2841147,Cannot tell based on the abstract,, Methacholine reactivity at 24 hrs post allergen challenge , placebo , selective phosphodiesterase 4 inhibitor (GSK256066) ,0,
edin,5630,2841147,No significant difference,"Methacholine reactivity at 24 hrs post allergen challenge was not different after treatment with GSK256066 compared to placebo; the PC20 was 0.31 compared to 0.39 mg/mL respectively, geometric mean (95% CI) doubling dose difference -0.31 (-1.18 to 0.57).", Methacholine reactivity at 24 hrs post allergen challenge , placebo , selective phosphodiesterase 4 inhibitor (GSK256066) ,0,
edin,5593,4737269,Cannot tell based on the abstract,, Ascent vertical toe clearance , Distance single vision lenses , Intermediate progressive addition lenses  ,0,
edin,5593,4737269,No significant difference,"Gait safety parameters were similar between intermediate PALs and distance single vision lenses for all gait safety parameters measured: vertical toe clearance on ascent (Wald Ï2Â =Â 0.4, pÂ =Â 0.54) and its variability (Wald Ï2Â =Â 0.1, pÂ =Â 0.93),", Ascent vertical toe clearance , Distance single vision lenses , Intermediate progressive addition lenses  ,0,
edin,5619,4356062,Cannot tell based on the abstract,Ovarian tissue frozen in CV7 solution showed a higher percentage of morphologically normal follicles or viable follicles than other cryoprotectant solutions Pâ<â0.05., Viable follicles , 10% EG in DPBS + 0.5 M sucroseâ+â20% FBS group , EG plus DMSO in ascending concentrations ,0,
edin,5619,4356062,Significantly increased,"Percentages of viable ovarian follicles derived from non-vitrified and vitrifed ovaries after trypan blue staining is presented in TableÂ 1.Table 1,10% EG in DPBS with 0.5Â M sucroseâ+â20% FBS group CV2,,EG plus DMSO in ascending concentrations or equilibrated in solutions of CV 5 then vitrified in CV 6 group CV7.,<td>CV7</td><td>266</td><td>85</td><td>82 (97)</td><td>3 (3)</td><td>-</td><td>90</td><td>87 (97)</td><td>3 (3)</td><td>-</td><td>91</td><td>89 (98)</td><td>2 (2)</td><td>-</td>,<td>CV2</td><td>275</td><td>84</td><td>79 (94)</td><td>5 (6)</td><td>-</td><td>96</td><td>85 (88)</td><td>11 (12)</td><td>a, b</td><td>95</td><td>81 (85)</td><td>14 (15)</td><td>a, b</td>", Viable follicles , 10% EG in DPBS + 0.5 M sucroseâ+â20% FBS group , EG plus DMSO in ascending concentrations ,0,
edin,5661,2759629,Significantly increased,"Individual movement of dorsiflexion, palmar flexion, supination, pronation and radial-ulnar deviation were all significantly better in the dorsiflexed-immobilized group as compared with the palmar flexed immobilized group.", dorsiflexion , conventionally immobilized in palmar flexion and ulnar deviation (PF) , dorsiflexed-immobilized method (DF) ,0,
edin,5506,5707653,Cannot tell based on the abstract,, Formula intakes , Standard formula , Partially Hydrolysed Whey Formula ,0,
edin,5506,5707653,No significant difference,"Secondary outcomes were the frequency of regurgitation episodes, growth rates (weight, length, and head circumference, measured at week 0 and 4), and formula intakes.,Mean formula intakes were also similar in the test (742 mL/day) and the control (738 mL/day) groups", Formula intakes , Standard formula , Partially Hydrolysed Whey Formula ,0,
edin,5523,4144850,Cannot tell based on the abstract,, Open defecation , Control , Total Sanitation Campaign ,0,
edin,5523,4144850,Significantly decreased,"Although on average fewer households in intervention villages were likely to report daily open defecation compared to control villages for adult men (75% intervention versus 84% control; mean difference: 9.5%; p-valueâ=â0.001), adult women (73% intervention versus 83% control; mean difference: 10%; p-value<0.001), and children <5 years (84% intervention versus 89% control; mean difference: 5%; p-valueâ=â0.014), these reductions in reported open defecation behaviors were smaller than the gains in IHL availability.", Open defecation , Control , Total Sanitation Campaign ,0,
edin,5653,3176493,Cannot tell based on the abstract,, maternal immune responses , placebo , praziquantel ,0,
edin,5653,3176493,No significant difference,"Comparing maternal treatment arms, praziquantel during pregnancy had no significant effect on any specific cytokine response in cord blood. That is, the differences between the placebo and praziquantel groups seen among maternal responses were not seen among the cord responses (Figure 2A and 2B).", maternal immune responses , placebo , praziquantel ,0,
edin,5557,5133227,Significantly increased,"In the tube-exchanger group, the success rate of NGT insertion on the first attempt was 92%, which is significantly higher than 68%, the rate in the control group (P = 0.007).", Success rate of NGT insertion , Control , Tube-exchanger ,0,
edin,5607,4030328,Cannot tell based on the abstract,, Saccadic amplitude gain , Ketamine  , Risperidone + saline ,0,
edin,5607,4030328,Significantly decreased,Reduced amplitude gain was observed for risperidone-treated groups compared with the other groups. No other significant main effects or interactions were observed., Saccadic amplitude gain , Ketamine  , Risperidone + saline ,0,
edin,5742,4119719,Cannot tell based on the abstract,, Modified Barthel Index (MBI) after 3 months , placebo , 4 Channel Functional Electrical Stimulation (FES) ,0,
edin,5742,4119719,Significantly increased,"To compare the long-term effects of FES, all of the measurements were reassessed 3 months after the 3-week treatment had ended. A total of 37 came back, with 13 from the four-channel group and 12 each from the placebo and the dual-channel groups. Eight subjects did not come back (3 had moved out of the city, 3 had lost contact, and 2 refused). Almost all of the subjects in all 3 groups demonstrated further improvement since the 3-week treatment had finished, but significant differences were found only between the four-channel and placebo groups in terms of BBS (P = 0.028) and MBI (P = 0.047). At that point 68.8% of those in the four-channel group walked independently compared with 40% of those in the placebo group and 35.7% of the dual-channel group.", Modified Barthel Index (MBI) after 3 months , placebo , 4 Channel Functional Electrical Stimulation (FES) ,0,
edin,5624,4476212,Significantly increased,"Based on the present results, it can be concluded that the 14-day coenzyme Q10 supplementation (5mg.kg-1.day-1) is more effective than the acute supplementation to overcome the exercise-induced adverse responses in some oxidative, inflammatory and biochemical parameters. Therefore, short-term coenzyme Q10 supplementation is recommended to reduce exercise-induced adverse consequences.", overcome the exercise-induced adverse responses , acute supplementation of Q10 , 14-day coenzyme Q10 supplementation (5mg.kg-1.day-1) ,0,
edin,5673,4392433,Significantly decreased,"Vorapaxar also significantly reduced the composite of CV death, MI, stroke, and urgent coronary revascularization (10.1% versus 11.8%, HR, 0.83; 95% CI 0.76 to 0.90; P<0.001),", urgent coronary revascularization , placebo , Vorapaxar ,0,
edin,5694,5019971,Cannot tell based on the abstract,, vWF , unchanged cART regimen , maraviroc intensification ,0,
edin,5694,5019971,No significant difference,"To assess the effect of maraviroc on immune activation and inflammation, we measured T cell activation (defined as either CD38 and HLA-DR double positivity or positivity for CD95) of CD4+ and CD8+ T cells, the inflammation and coagulation markers hsCRP, D-dimer and vWF and the expression of CD40 and CD169 in monocytes (defined by CD14 positivity). No significant differences in change were found between these variables when comparing the intervention to control (data not shown).", vWF , unchanged cART regimen , maraviroc intensification ,0,
edin,5748,2364538,Cannot tell based on the abstract,, better define the labial microflora , control group C (no panty liner wear) , panty liner B (AlwaysÂ® non-deodorant) ,0,
edin,5748,2364538,No significant difference,"After 6 months use of panty liners the frequencies (and densities) of the selected microorganisms in these two sites had not changed compared to controls, and fatty acid analyses of vaginal secretions gave no evidence of shifts in the microbial flora.", better define the labial microflora , control group C (no panty liner wear) , panty liner B (AlwaysÂ® non-deodorant) ,0,
edin,5597,4355974,Cannot tell based on the abstract,, Days limited activity from asthma	 , Control , BostonBreathes system ,0,
edin,5597,4355974,No significant difference,<td>Days limited activity from asthma</td><td>0.6</td><td>â0.2</td><td>0.99</td><td>2.0</td><td>â1.8</td><td>0.13</td><td>0.14</td>, Days limited activity from asthma	 , Control , BostonBreathes system ,0,
edin,5654,3176493,No significant difference,"Despite strong effects on maternal infection intensity and maternal immune responses, praziquantel treatment of infected women during pregnancy had no effect on anti-schistosome immune responses among offspring by age one year.", immune responsiveness of uninfected offspring , placebo , praziquantel ,0,
edin,5528,4608626,Significantly decreased,"In the music therapy group, the time for completion of the Japanese Raven's Colored Progressive Matrices was significantly reduced (p = 0.026), and the results obtained from interviewing the patients' caregivers revealed a significant decrease in the Neuropsychiatric Inventory score (p = 0.042) and a prolongation of the patients' sleep time (p = 0.039).", Neuropsychiatric Inventory score , Control , Singing Training ,0,
edin,5545,4913581,Significantly decreased,"Supplemented cows showed a lower risk for OS, as reflected by a lower OS index (P = .036),", Oxidative stress index , Control , Antioxidant supplementation ,0,
edin,5660,2759629,Cannot tell based on the abstract,, tilt at final check up , conventionally immobilized in palmar flexion and ulnar deviation (PF) , dorsiflexed-immobilized method (DF) ,0,
edin,5660,2759629,Significantly increased,At final follow-up 25 patients (73.52%) of DF group had 13 to 33Â° radial tilt as compared to 14 patients (46.7%) in PF group (P value = 0.002561)., tilt at final check up , conventionally immobilized in palmar flexion and ulnar deviation (PF) , dorsiflexed-immobilized method (DF) ,0,
edin,5534,2876942,No significant difference,Time of eye opening after discontinuation of sevoflurane showed no significant differences between both groups., Eye opening time  , Control , Ketamine ,0,
edin,5616,3487501,No significant difference,There were no significant differences in impeding saliva leakage between the three experimental groups (P>0.05)., Leakage , Guttaflow system  , Lateral compaction ,0,
edin,5744,4060171,No significant difference,"When accounting for missing values with a multiple imputation approach, we found a tendency toward a difference in both the compliance scale and PANSS favoring the system-oriented therapy, although it did not reach statistical significance.", improvement of medical compliance in patients with schizophrenia , reference intervention , system-oriented therapy ,0,
edin,5732,3956097,Significantly increased,"Also, the comparison of the scores of the eight aspects of patientsâ life quality before and after rehabilitation revealed that life quality improved in the following directions: physical functioning, limitation of physical health, limitation of psychological health, energy, social functioning, and physical pain. All differences were statistically significant yet, the difference regarding the aspects of psychological health and general well-being were not significant.", social functioning , before rehabilitation program , after rehabilitation program ,0,
edin,5707,5887937,Cannot tell based on the abstract,, injection site reactions (ISRs) , treatment arms with repeated switches (pooled switched) , continued treatment arms (pooled continued) ,0,
edin,5707,5887937,No significant difference,"The proportion of patients with at least 1 treatmentâemergent AE during TP2 was similar between pooled switched (36.7%) and pooled continued (34.9%) treatment groups. ISRs were treatmentâemergent AEs with the highest incidence in pooled switched and pooled continued treatment groups (4.6% vs 4.3%) followed by pharyngitis (2.6% vs. 3.3%), nasopharyngitis (2.0% vs. 2.7%), headache (2.6% vs. 1.7%) and viral upper respiratory tract infection (2.6% vs. 1.3%, Table 3). The majority of ISRs were mild in severity in both groups (4.1% vs. 4.0%), and none were severe.", injection site reactions (ISRs) , treatment arms with repeated switches (pooled switched) , continued treatment arms (pooled continued) ,0,
edin,5681,3721088,Cannot tell based on the abstract,, feasibility of procedure in sub-acute stroke patients admitted to a rehabilitation center , computer-based testing , computer-based prism adaptation (PA) ,0,
edin,5681,3721088,Significantly increased,"Regarding time for test completion, all tests were performed significantly faster (total time) after PA, see Table 2. Additionally, when addressing the search-times (Table 2) on either the ipsilesional as well as the contralesional side of the stimulus-sheets presented on the tablet, patients performed significantly faster post PA in the OC.", feasibility of procedure in sub-acute stroke patients admitted to a rehabilitation center , computer-based testing , computer-based prism adaptation (PA) ,0,
edin,5514,4994668,Cannot tell based on the abstract,, Colectomy rates , Ciclosporin , Infliximab ,0,
edin,5514,4994668,No significant difference,"urthermore, there was also no significant difference between allocated groups in colectomy rates (in-hospital: 29 [21%] of 135 patients in the infliximab group vs 34 [25%] of 135 patients in the ciclosporin group; at 3 months: 39 [29%] vs 41 [30%]; 12 months: 47 [35%] vs 61 [45%]; overall: 55 [41%] vs 65 [48%]; odds ratio [OR] 1Â·350 [95% CI 0Â·832 to 2Â·188]; p=0Â·223);", Colectomy rates , Ciclosporin , Infliximab ,0,
edin,5596,4355974,No significant difference,Emergency room or acute visits to a physician for asthma did not significantly change in either group., ER visits , Control , BostonBreathes system ,0,
edin,5649,3903148,Cannot tell based on the abstract,, sleep efficiency after 2âweeks , near sea level , high altitude ,0,
edin,5649,3903148,Significantly increased,"<td colspan=""1"" rowspan=""1"">Sleep efficiency (%)</td><td colspan=""1"" rowspan=""1"">86 (5)</td><td colspan=""1"" rowspan=""1"">82 (6)</td><td colspan=""1"" rowspan=""1"">â0.56 â1.21; 0.09</td><td colspan=""1"" rowspan=""1"">1/42/57</td><td colspan=""1"" rowspan=""1"">86 (5)</td><td colspan=""1"" rowspan=""1"">0.03 â0.78; 0.83</td><td colspan=""1"" rowspan=""1"">15/71/13</td><td colspan=""1"" rowspan=""1"">89 (4)</td><td colspan=""1"" rowspan=""1"">0.57 0.04; 1.09</td><td colspan=""1"" rowspan=""1"">59/41/0</td>,hese differences are indicators of poorer sleep at altitude than at near sea level. In contrast, sleep onset latency, stage N1 sleep and wake after sleep onset were possibly lower; and sleep efficiency (figure 2A) was possibly higher after 2âweeks at altitude than on the baseline night (table 2).", sleep efficiency after 2âweeks , near sea level , high altitude ,0,
edin,5511,4994668,Cannot tell based on the abstract,, Crohn's and Ulcerative Colitis Questionnaire scores , Ciclosporin , Infliximab ,0,
edin,5511,4994668,No significant difference,"There was no significant difference in quality-adjusted survival between infliximab and ciclosporin: the observed mean total area under the CUCQ curve was 564Â·0 (SD 241Â·9) in the infliximab group and 587Â·0 (226Â·2) in the ciclosporin group (mean adjusted difference 7Â·9 [95% CI â22Â·0 to 37Â·8]; p=0Â·603).,There was no significant difference between groups in terms of CUCQ scores (mean adjusted difference in AUC/day of survivors 0Â·020 [95% CI â0Â·019 to 0Â·0581]; p=0Â·319", Crohn's and Ulcerative Colitis Questionnaire scores , Ciclosporin , Infliximab ,0,
edin,5508,4731919,Significantly increased,The intervention yielded effects on flossing frequency (pâ<â0.01) and flossing intentions (pâ<â0.01) at follow-up., Dental flossing , Control , Oral health promotion program + free dental treatment ,0,
edin,5567,5440538,Cannot tell based on the abstract,, Calcium levels , Control , Paricalcitol ,0,
edin,5567,5440538,No significant difference,"Overall, of the 29 children for whom data were available, 12 (41.4%) achieved two consecutive reductions of â¥30% from baseline in iPTH levels, and eight (27.6%), 25 (86.2%), and 16 (55.2%) achieved final iPTH, calcium, and phosphorus levels within KDOQI target ranges, respectively.,Changes in laboratory measures, including eGFR, creatinine, calcium, and phosphorus, over the 12-week double-blind period are summarized in Fig.Â 4. There were no statistically significant differences for any of the laboratory assessments between the paricalcitol and placebo groups at any of the time points or overall.Fig 4", Calcium levels , Control , Paricalcitol ,0,
edin,5588,3985324,Cannot tell based on the abstract,, HCV infection , Short-term buprenorphine-naloxone , Long-term buprenorphine-naloxone ,0,
edin,5588,3985324,No significant difference,"Overall, in China, short-term versus long-term B-N treatment was not associated with HCV infection (HR = 0.95; 95% CI, 0.45 to 1.97; P = 0.9) with the Kaplan Meier curve shown in Figure 1 by treatment arm", HCV infection , Short-term buprenorphine-naloxone , Long-term buprenorphine-naloxone ,0,
edin,5658,2759629,Significantly increased,"All fractures united. Individual movement of dorsiflexion, palmar flexion, supination, pronation and radial-ulnar deviation were all significantly better in the dorsiflexed-immobilized group as compared with the palmar flexed immobilized group.", radial-ulnar deviation , conventionally immobilized in palmar flexion and ulnar deviation (PF) , dorsiflexed-immobilized method (DF) ,0,
edin,5520,4895420,Cannot tell based on the abstract,, Resolving lesions &amp;gt;27 mm , clarithromycin + rifampin , Gallium maltolate ,0,
edin,5520,4895420,No significant difference,"<td align=""left"" colspan=""1"" rowspan=""1"">Resolved lesions &gt;27</td><td align=""char"" char="" "" colspan=""1"" rowspan=""1"">17/25 (68%)</td><td align=""char"" char="" "" colspan=""1"" rowspan=""1"">2/6 (33%)</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">.17</td>,mong foals with smaller lesions (<27Â mm), proportions resolving were similar for both groups (TableÂ 2). Although the proportion resolving among the foals with larger lesions (ie, â¥27Â mm) was lower for the GaMâtreated foals than the CLRâtreated foals, this difference was not significant (TableÂ 2).", Resolving lesions &amp;gt;27 mm , clarithromycin + rifampin , Gallium maltolate ,0,
edin,5527,4608626,Significantly decreased,"n the music therapy group, the time for completion of the Japanese Raven's Colored Progressive Matrices was significantly reduced (p = 0.026),", Raven's Colored Progressive Matrice completion time , Control , Singing Training ,0,
edin,5710,3343759,Significantly increased,"Patients with a higher level of education (>12 years) improved more on ANELT by day 21 than those with <12 years of education (3.4 vs. 1.0, respectively).", improvment in ANELT by day 21 , &amp;lt;12 years of education , higher level of education (&amp;gt;12 years) ,0,
edin,5570,3337377,Cannot tell based on the abstract,, Successful epidural space identification , Conventional technique , EpidrumÂ® ,0,
edin,5570,3337377,Significantly increased,"The ED group showed a lower failure rate, fewer cases of more than 2 attempts, a shorter time needed to identify the epidural space, greater ease of the procedure, and better satisfaction scores of the procedure than in the C group, with statistical significance (Table 2).", Successful epidural space identification , Conventional technique , EpidrumÂ® ,0,
edin,5591,4737269,Cannot tell based on the abstract,, Ascent  duration  , Full bifocals  , Intermediate addition multifocals ,0,
edin,5591,4737269,No significant difference,"Gait safety parameters were similar between intermediate PALs and distance single vision lenses for all gait safety parameters measured: vertical toe clearance on ascent (Wald Ï2Â =Â 0.4, pÂ =Â 0.54) and its variability (Wald Ï2Â =Â 0.1, pÂ =Â 0.93), ascent duration (Wald Ï2Â =Â 1.4, pÂ =Â 0.25", Ascent  duration  , Full bifocals  , Intermediate addition multifocals ,0,
edin,5586,4805129,Cannot tell based on the abstract,, Adverse effects , IV iron isomaltoside 1000 (1000 mg) , IV iron isomaltoside 1000 (500 mg) ,0,
edin,5586,4805129,No significant difference,There was no statistical significant difference in the proportion of patients experiencing an adverse event (AE) between Groups A and B [Group A: 95/228 (41.7%); Group B: 53/117 (45.3%)] (Table, Adverse effects , IV iron isomaltoside 1000 (1000 mg) , IV iron isomaltoside 1000 (500 mg) ,0,
edin,5711,3343759,No significant difference,"There was no difference in the degree of aphasia at baseline except for fluency, which was higher in the group responding to treatment.", aphasia types , control , very early speech and language therapy (SLT) ,0,
edin,5577,3003523,Cannot tell based on the abstract,, Short-Form 36-Items improvement , Control , Certolizumab 400 mg ,0,
edin,5577,3003523,Significantly increased,"ignificantly more patients treated with CZP plus MTX than PBO plus MTX also reported improvements in SF-36 MCS equal to or greater than the MCID from weeks 12 to 52 (Table 2; P < 0.05).,Changes from baseline for all SF-36 domains were statistically significant for CZP versus PBO at Weeks 12 and 52; P < 0.05.", Short-Form 36-Items improvement , Control , Certolizumab 400 mg ,0,
edin,5512,4994668,Cannot tell based on the abstract,, Short-Form Six-Dimension scores , Ciclosporin , Infliximab ,0,
edin,5512,4994668,No significant difference,"There was no significant difference between groups in terms of CUCQ scores (mean adjusted difference in AUC/day of survivors 0Â·020 [95% CI â0Â·019 to 0Â·0581]; p=0Â·319; figure 3A), SF-6D scores (mean adjusted difference 0Â·005 [95% CI â0Â·025 to 0Â·035]; p=0Â·737; figure 3B), or EQ-5D scores (QALY mean adjusted difference 0Â·021 [95% CI â0Â·032 to 0Â·096]; p=0Â·350; figure 3C).", Short-Form Six-Dimension scores , Ciclosporin , Infliximab ,0,
edin,5640,4307639,Significantly increased,"Compared with the no interest group, the committed with interest group were more likely to be personal computer users (odds ratio (OR)â=â2.78), physically active (ORâ=â1.03) and had higher levels of loneliness (ORâ=â1.16).", loneliness score , no interest group , committed with interest group ,0,
edin,5628,2147023,Cannot tell based on the abstract,, response rates , study team , directly by the GP ,0,
edin,5628,2147023,Significantly increased,"Two thirds of these (52,948) were sent directly by the GP, and one third (24,872) were sent by the study team, on the GP's behalf. In total, 22,251 questionnaires (28.6%) were returned, with slightly higher response rates achieved by the direct (15,775, or 29.8%) than indirect method (6,470, or 26.0%).", response rates , study team , directly by the GP ,0,
edin,5544,3952721,Cannot tell based on the abstract,, Adverse effects  , Control , Fluticasone furoate + vilanterol ,0,
edin,5544,3952721,No significant difference,"<td align=""left"" colspan=""1"" rowspan=""1""><bold>âAdverse events/serious adverse events</bold></td><td align=""center"" colspan=""1"" rowspan=""1"">0</td><td align=""center"" colspan=""1"" rowspan=""1"">0</td>,There were no serious adverse events or subject withdrawals due to AEs. No AEs were severe and all resolved during the study.", Adverse effects  , Control , Fluticasone furoate + vilanterol ,0,
edin,5611,4030328,Cannot tell based on the abstract,, Clinician Administered Dissociative States Scale scores , Placebo , Ketamine   ,0,
edin,5611,4030328,Significantly increased,"CADSS total scores and the subscales of amnesia, and derealisation were significantly higher in the ketamine-treated groups compared with the placebo groups (all P<0.01).", Clinician Administered Dissociative States Scale scores , Placebo , Ketamine   ,0,
edin,5612,3487501,No significant difference,There were no significant differences in impeding saliva leakage between the three experimental groups (P>0.05)., Leakage , Control , Lateral compaction ,0,
edin,5602,5506697,Significantly increased,"OFC-treated patients demonstrated an improvement over placebo at endpoint with respect to mean change from baseline in the patient-rated KINDL-R Self-esteem subscale score (pÂ =Â 0.028), and in the parent KINDL-R ratings of emotional well-being (pÂ =Â 0.020),", Parent rated emotional well being , Control  , Olanzapine + fluoxetine ,0,
edin,5766,5548257,No significant difference,The vitamin D supplementation did not have any significant effect on the exercise capacity (p-value=0.175) or the saturation of oxygen (p-value = 0.635)., exercise capacity , Before vitamin D supplementation in COPD patients , after vitamin D supplementation in COPD patients ,0,
edin,5773,3281341,Significantly increased,The level of plasma Î²-endorphin after the administration of omeprazole was significantly greater than at the start of the study and following the placebo. Responders to omeprazole had an average lower Î²-endorphin plasma concentration than subjects who failed to respond to this therapy. Subjects with symptoms in class III (according to the Canadian Cardiovascular Society classification) after omeprazole administration had a greater Î²-endorphin plasma level than subjects in class II for anginal symptom severity., plasma level of Î²-endorphin after 2-week omeprazole administration , class II anginal symptoms , class III anginal symptoms ,0,
edin,5662,2759629,Significantly increased,"Individual movement of dorsiflexion, palmar flexion, supination, pronation and radial-ulnar deviation were all significantly better in the dorsiflexed-immobilized group as compared with the palmar flexed immobilized group.", palmar flexion , conventionally immobilized in palmar flexion and ulnar deviation (PF) , dorsiflexed-immobilized method (DF) ,0,
edin,5771,3281341,Cannot tell based on the abstract,, relationships between the Î²-endorphin plasma level and the course of the treadmill stress test , placebo , double omeprazole dose ,0,
edin,5771,3281341,No significant difference,"We did not find any statistically significant relationships between the Î²-endorphin plasma level and the course of the treadmill stress test, either at the start of the study or after therapy with omeprazole or the placebo.", relationships between the Î²-endorphin plasma level and the course of the treadmill stress test , placebo , double omeprazole dose ,0,
edin,5504,5707653,Cannot tell based on the abstract,, Body weight , Standard formula , Partially Hydrolysed Whey Formula ,0,
edin,5504,5707653,No significant difference,No difference in body weight or in the other anthropometric parameters was seen between the two groups at the end of the trial (Table 2), Body weight , Standard formula , Partially Hydrolysed Whey Formula ,0,
edin,5555,2994546,Cannot tell based on the abstract,, Task analyses usage	 , Control , RSI QuickScan intervention ,0,
edin,5555,2994546,Significantly increased,"<td align=""left"">- Mean costs (SD)</td><td align=""left"">0.75 (6.68)</td><td align=""left"">0.00 (0.00)</td><td></td><td align=""left"">0.75 (0.02; 1.49)</td>,There were significant between-group differences in utilization rates for the ""Education on the Prevention of RSI for Employees"", the training ""RSI and Stress"", the eyesight check, and task analysis (Table 3).", Task analyses usage	 , Control , RSI QuickScan intervention ,0,
edin,5775,5415292,Cannot tell based on the abstract,, scores on pre-tests , noncompleters , completers ,0,
edin,5775,5415292,Significantly increased,"We compared completers and dropouts on baseline sociodemographic characteristics and pre-test scores on knowledge. Using Ï2 and 2-sample t tests, significant association for differences by age or gender was determined between completers and noncompleters. However, those who completed had higher scores on pre-tests compared to dropouts at post-test (P = .03)", scores on pre-tests , noncompleters , completers ,0,
edin,5517,4895420,Cannot tell based on the abstract,, Mortality , clarithromycin + rifampin , Gallium maltolate ,0,
edin,5517,4895420,No significant difference,"our foals died. The cause of death was attributed to infection with R.Â equi in all these foals. One foal (a GaMâtreated foal) was euthanized because it developed colic, underwent celiotomy, and was found to have a septic mesenteric lymphadenitis caused by R.Â equi, and a mesenteric rent with small intestinal entrapment; necropsy revealed chronic, focal granulomatous pneumonia and subacute, multifocal hepatitis attributed to R equi on the basis of microbiologic culture; this foal had been treated for 15Â days. One of the CLR/rifampinâtreated foals was anesthetized for an orthopedic surgical procedure; this foal died during anesthesia, and death was attributed to respiratory failure resulting from bilateral necrotizing granulomatous pneumonia caused by R.Â equi infection; this foal had been treated for 2Â days.", Mortality , clarithromycin + rifampin , Gallium maltolate ,0,
edin,5752,2364538,No significant difference,No increased carriage of medically important species was detected for either site after 6 months of daily (average 7.8 h) panty liner use., increased carriage of medically important species after wearing panty liner , vagina , labia ,0,
edin,5664,2759629,Significantly increased,"All fractures united. Individual movement of dorsiflexion, palmar flexion, supination, pronation and radial-ulnar deviation were all significantly better in the dorsiflexed-immobilized group as compared with the palmar flexed immobilized group.", pronation , conventionally immobilized in palmar flexion and ulnar deviation (PF) , dorsiflexed-immobilized method (DF) ,0,
edin,5751,2364538,No significant difference,"After 6 months use of panty liners the frequencies (and densities) of the selected microorganisms in these two sites had not changed compared to controls, and fatty acid analyses of vaginal secretions gave no evidence of shifts in the microbial flora.", fatty acid analyses of vaginal secretions , control group C (no panty liner wear) , panty liner wear groups A (AlwaysÂ® deodorant) ,0,
edin,5715,3750766,Cannot tell based on the abstract,, safety of multi-coil rTMS affect on the dorsal anterior cingulate cortex , single coil rTMS , multi-coil rTMS ,0,
edin,5715,3750766,Significantly increased,"The results provided here indicate that multi-coil shaped field rTMS directed toward the dACC might provide a safe and effective means of alleviating both acute and chronic pain.,Multi-coil repetitive transcranial magnetic stimulation was successfully used to reliably and safely affect the dorsal anterior cingulate cortex, a deep brain structures that is critical to pain perception, but which cannot be selectively reached with single-coil approaches", safety of multi-coil rTMS affect on the dorsal anterior cingulate cortex , single coil rTMS , multi-coil rTMS ,0,
edin,5636,5712123,Significantly decreased,"Neither Duloxetine nor etoricoxib individually had effect on pain with movement, while their combination revealed a significant reduction in pain scores over the entire postoperative period at rest and on movement. Etoricoxib showed a significant decrease in pain at all times at rest when compared with group P, while it showed significant pain decrease only at 0, 2 and 4Â h when compared with group D.", postoperative pain , placebo , duloxetine 60 and etoricoxib 120mg (group D/E) ,0,
edin,5580,3003523,Significantly decreased,"Patients treated with CZP plus MTX reported significant (P < 0.001), clinically meaningful improvements in HRQoL at the first assessment (week 12); reductions in fatigue, disease activity and pain and improvements in physical function were reported at week 1.,<td align=""left"">MCS</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td>", Pain , Control , Certolizumab 400 mg ,0,
edin,5709,5887937,Cannot tell based on the abstract,, safety , two treatment arms with repeated switches (pooled switched) , continued treatment arms (pooled continued) ,0,
edin,5709,5887937,No significant difference,"ISRs were treatmentâemergent AEs with the highest incidence in pooled switched and pooled continued treatment groups (4.6% vs 4.3%) followed by pharyngitis (2.6% vs. 3.3%), nasopharyngitis (2.0% vs. 2.7%), headache (2.6% vs. 1.7%) and viral upper respiratory tract infection (2.6% vs. 1.3%, Table 3),Clinical laboratory parameters, vital signs, physical examination and ECG findings were all comparable for pooled continued and pooled switched groups; no patterns were evident that would suggest a relation to treatment or a potential safety concern.", safety , two treatment arms with repeated switches (pooled switched) , continued treatment arms (pooled continued) ,0,
edin,5631,2841147,Cannot tell based on the abstract,, responses to allergen challenge in mild asthmatics , placebo , selective phosphodiesterase 4 inhibitor (GSK256066) ,0,
edin,5631,2841147,No significant difference,"Methacholine reactivity at 24 hrs post allergen challenge was not different after treatment with GSK256066 compared to placebo; the PC20 was 0.31 compared to 0.39 mg/mL respectively, geometric mean (95% CI) doubling dose difference -0.31 (-1.18 to 0.57).", responses to allergen challenge in mild asthmatics , placebo , selective phosphodiesterase 4 inhibitor (GSK256066) ,0,
edin,5652,3176493,Cannot tell based on the abstract,, IgG4 , placebo , praziquantel ,0,
edin,5652,3176493,Significantly decreased,"For SEA-specific antibodies (Figure 1D), IgE levels were higher in the treated mothers than in the placebo group (p = 0.048) while IgG4 levels were lower in treated mothers compared to the placebo group (p = 0.001).", IgG4 , placebo , praziquantel ,0,
edin,5525,4144850,Cannot tell based on the abstract,, Helminth infections  , Control , Total Sanitation Campaign ,0,
edin,5525,4144850,No significant difference,"In the subsample of 1,150 children with stool collection, 5.7% (66/1150) had helminth infections and the majority (50/66) were Ascaris infections. All remaining infections were tapeworms; no children were infected with T. trichiura or hookworm. We observed no difference in helminth prevalence between intervention and control groups.,<td align=""left"" colspan=""1"" rowspan=""1"">Any helminth present</td><td align=""left"" colspan=""1"" rowspan=""1"">569</td><td align=""left"" colspan=""1"" rowspan=""1"">0.056</td><td align=""left"" colspan=""1"" rowspan=""1"">581</td><td align=""left"" colspan=""1"" rowspan=""1"">0.059</td><td align=""left"" colspan=""1"" rowspan=""1"">0.001 [â0.021 to 0.023]</td><td align=""left"" colspan=""1"" rowspan=""1"">â0.005 [â0.028 to 0.018]</td>", Helminth infections  , Control , Total Sanitation Campaign ,0,
edin,5505,5707653,Cannot tell based on the abstract,, Head circumference , Standard formula , Partially Hydrolysed Whey Formula ,0,
edin,5505,5707653,No significant difference,"Secondary outcomes were the frequency of regurgitation episodes, growth rates (weight, length, and head circumference, measured at week 0 and 4), and formula intakes.,No difference in body weight or in the other anthropometric parameters was seen between the two groups at the end of the trial (Table 2).", Head circumference , Standard formula , Partially Hydrolysed Whey Formula ,0,
edin,5656,3176493,Significantly increased,"Praziquantel treatment during pregnancy showed no effect on cytokine responses or antibodies levels to SWA or SEA either in cord blood or at age one year, except for IgG1 to SWA, which was elevated in infants of treated mothers, reflecting maternal levels.", IgG1 , placebo , praziquantel ,0,
edin,5769,5548257,No significant difference,"The mean FEV1 (p-value = 0.866), FVC (p-value = 0.475) and VC (p-value = 0.425) were not significantly different before and after intervention.", mean forced expiratory volume in one second (FEV1) , Before vitamin D supplementation in COPD patients , after vitamin D supplementation in COPD patients ,0,
edin,5627,4476212,Cannot tell based on the abstract,"Based on the present results, it can be concluded that the 14-day coenzyme Q10 supplementation (5mg.kg-1.day-1) is more effective than the acute supplementation to overcome the exercise-induced adverse responses in some oxidative, inflammatory and biochemical parameters.", inflammatory markers , placebo , coenzyme Q10 supplementation  ,0,
edin,5627,4476212,Significantly decreased,"In other word, compared with the placebo group, inflammatory markers were significantly lower in the group of CoQ10.", inflammatory markers , placebo , coenzyme Q10 supplementation  ,0,
edin,5529,4608626,Significantly increased,"In the music therapy group, the time for completion of the Japanese Raven's Colored Progressive Matrices was significantly reduced (p = 0.026), and the results obtained from interviewing the patients' caregivers revealed a significant decrease in the Neuropsychiatric Inventory score (p = 0.042) and a prolongation of the patients' sleep time (p = 0.039).", Sleep time , Control , Singing Training ,0,
edin,5530,4608626,Cannot tell based on the abstract,, Disability Assessment for Dementia score , Control , Singing Training ,0,
edin,5530,4608626,Significantly decreased,There was also a significant decrease in the DAD score (p = 0.002)., Disability Assessment for Dementia score , Control , Singing Training ,0,
edin,5502,5707653,Significantly decreased,"Compared to controls, the test group showed greater percentage changes in GErate (12.3% vs. 9.1%, p < 0.01).,Compared to a standard formula, a starch-thickened partially hydrolysed whey protein formula supplemented with Lactobacillus reuteri is more effective in decreasing the frequency of regurgitation and improving GErate, and can be of benefit to infants with FR.", Gastric emptying rate , Standard formula , Partially Hydrolysed Whey Formula ,0,
edin,5546,4913581,Cannot tell based on the abstract,, Glucose maximum concentration , Control , Antioxidant supplementation ,0,
edin,5546,4913581,No significant difference,"<td align=""left"" colspan=""1"" rowspan=""1"">Glucose</td><td align=""left"" colspan=""1"" rowspan=""1"">mg/dL</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">76.2</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">23.4</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">76.7</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">14.7</td><td align=""center"" colspan=""1"" rowspan=""1"">NS</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">58.7</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">32.2</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">67.9</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">29.3</td><td align=""center"" colspan=""1"" rowspan=""1"">NS</td>,<td align=""left"" colspan=""1"" rowspan=""1"" style=""padding-left:10%"">Glucose (mg/dL)</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">243.6</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">106.8</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">278.4</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">200.4</td><td align=""center"" colspan=""1"" rowspan=""1"">NS</td>", Glucose maximum concentration , Control , Antioxidant supplementation ,0,
edin,5765,5548257,No significant difference,Pulmonary function and exercise capacity did not improve with vitamin D supplementation in COPD patients., Pulmonary function , Before vitamin D supplementation in COPD patients , after vitamin D supplementation in COPD patients ,0,
edin,5758,5524701,Significantly increased,"When compared with the mannequin group, the SP simulation group showed a significantly higher average realism score (P=0.002).", realism score , mannequin-based scenarios  , SP-based scenarios ,0,
edin,5606,5506697,Cannot tell based on the abstract,, CDRS' depressed feelings improvement , Control  , Olanzapine + fluoxetine ,0,
edin,5606,5506697,Significantly increased,"Changes in CDRS-R Item scores from baseline to week 8 (mixed-model repeated measures),<td align=""left"">Depressed feelings (11)</td><td align=""char"" char=""("">4.6 (1.1)</td><td align=""char"" char=""("">â2.9 (0.1)</td><td align=""char"" char=""("">4.5 (1.1)</td><td align=""char"" char=""("">â2.4 (0.2)</td><td align=""char"" char=""."">0.005</td>", CDRS' depressed feelings improvement , Control  , Olanzapine + fluoxetine ,0,
edin,5615,3487501,No significant difference,There were no significant differences in impeding saliva leakage between the three experimental groups (P>0.05)., Leakage , Warm vertical compaction  , Lateral compaction ,0,
edin,5700,5019971,Significantly increased,"Twenty-one male patients with suppressed plasma HIV-RNA, on cART, had a known HIV infection for 9.2Â years (IQR 6.9â13.5) with abacavir use for 6.5Â years (2.8â9.3). A significantly increased FMD of 0.73% (IQR â0.25 to 1.70) was seen after maraviroc intensification compared to a decrease of â0.42% (IQR â1.89 to 0.25; pÂ =Â 0.049) in the control period. There was a negative relation between ÎFMD with ÎD-dimer (Î² â22.70, 95% CI â39.27; â6.13, pÂ =Â 0.011) and ÎCD95+ CD4+ T cells (Î² â0.16, 95% CI â0.28; â0.04, pÂ =Â 0.013), adjusted for age and duration of HIV.", D-dimer , unchanged cART regimen , maraviroc intensification ,0,
edin,5728,3956097,Significantly increased,"Our findings showed that there was a statistically significant increase in the mean score of the patientsâ life quality after rehabilitation. Also, the comparison of the scores of the eight aspects of patientsâ life quality before and after rehabilitation revealed that life quality improved in the following directions: physical functioning, limitation of physical health, limitation of psychological health, energy, social functioning, and physical pain. All differences were statistically significant yet, the difference regarding the aspects of psychological health and general well-being were not significant.", improvement in the quality life of heart failure patients , before rehabilitation program , after rehabilitation program ,0,
edin,5716,3750766,Cannot tell based on the abstract,, reduction in acute induced pain , placebo , multi-coil rTMS ,0,
edin,5716,3750766,No significant difference,"Correlating the PET activity ratio with the averaged change in NRS pain ratings during the first 2Â minutes (the time period over which H215O PET is most sensitive due to the rapid decay) yielded a significant correlation coefficient of 0.61.,The 1Â Hz pulse frequency that showed analgesic effect in the acute pain/volunteer study was not effective for the treatment of chronic pain in fibromyalgia patients.,Similarly, despite being effective for acute pain in volunteers, the 4 coil 1Â Hz rTMS configuration did not produce a significant analgesic effect in the chronic pain population, but still generated similar sensory cues.", reduction in acute induced pain , placebo , multi-coil rTMS ,0,
edin,5745,4060171,Cannot tell based on the abstract,, completed follow-up , reference intervention , system-oriented therapy ,0,
edin,5745,4060171,Significantly increased,"There was a significantly greater proportion of the individual compared to the system-oriented group that did not complete follow-up (15/40 versus 4/30, P value 0.017).", completed follow-up , reference intervention , system-oriented therapy ,0,
edin,5537,2876942,Significantly decreased,The time of hospital discharge allowance in group M was longer than in group KM (P < 0.05)., Time for discharge , Control , Ketamine ,0,
edin,5513,4994668,Cannot tell based on the abstract,, EuroQol-5D scores , Ciclosporin , Infliximab ,0,
edin,5513,4994668,No significant difference,"There was no significant difference between groups in terms of CUCQ scores (mean adjusted difference in AUC/day of survivors 0Â·020 [95% CI â0Â·019 to 0Â·0581]; p=0Â·319; figure 3A), SF-6D scores (mean adjusted difference 0Â·005 [95% CI â0Â·025 to 0Â·035]; p=0Â·737; figure 3B), or EQ-5D scores (QALY mean adjusted difference 0Â·021 [95% CI â0Â·032 to 0Â·096]; p=0Â·350; figure 3C).", EuroQol-5D scores , Ciclosporin , Infliximab ,0,
edin,5625,4476212,Significantly decreased,"The acute coenzyme Q10 supplementation attenuated only the exercise-induced increase in response of the plasma CRP. The short-term (14-day) coenzyme Q10 supplementation attenuated the exercise-induced increase in response of the lactate, serum interleukin- 6, tumor necrosis factor-alpha, and CRP in male middle-distance runners.", exercise-induced increase in response of the plasma CRP , placebo , acute coenzyme Q10 supplementation  ,0,
edin,5526,4144850,Cannot tell based on the abstract,, Anemia , Control , Total Sanitation Campaign ,0,
edin,5526,4144850,No significant difference,"However, we found no differences between the randomized groups in anemia prevalence or growth outcomes.", Anemia , Control , Total Sanitation Campaign ,0,
edin,5746,4060171,Cannot tell based on the abstract,, Remission , reference intervention , system-oriented therapy ,0,
edin,5746,4060171,Significantly decreased,"LOCF revealed a significantly lower PANSS score on the remission items in the system-oriented group at follow-up, on average a score of 22 compared to 26 in the individual group, P value 0.036.", Remission , reference intervention , system-oriented therapy ,0,
edin,5757,4488565,Cannot tell based on the abstract,, efficacy of treating patients with chronic functional constipation , placebo , Lax-Asab powder ,0,
edin,5757,4488565,Significantly increased,The mean of weekly defecation times increased in both groups (pÂ =Â 0.001); from 1.8Â Â±Â 0.41 to 4.8Â Â±Â 1.12 times in patients receiving Lax-Asab and from 1.7Â Â±Â 0.44 to 2.2Â Â±Â 0.61 times in patients receiving placebo. A timeâtreatment interaction showed that this increase was significantly higher in the intervention group (pÂ <Â 0.0001). All the other measured outcomes concerning defecation difficulty were significantly improved in patients receiving Lax-Asab compared with placebo. The results are presented in TableÂ 1., efficacy of treating patients with chronic functional constipation , placebo , Lax-Asab powder ,0,
edin,5698,5019971,Cannot tell based on the abstract,, CCR5 expression in CD8+ T cells , unchanged cART regimen , maraviroc intensification ,0,
edin,5698,5019971,Significantly increased,"The study did not include a washout period, as maraviroc has a half-life of 13Â h. To minimize bias, we tested for a carry-over effect of maraviroc. Interestingly, in control period 2 (C2), a significant difference was still found when comparing the percentage of CD8+ CCR5+ expression in T cells between week 16 and baseline (16.3 vs. 8.3; pÂ =Â 0.021), suggesting a carry-over effect to the control period of arm A (C2).,A similar pattern was observed for CCR5 expression in CD8+ T cells (Fig.Â 3d) with a significantly increased expression of 12.5% (IQR 7.6â19.8) and 14.1% (IQR 6.1â17.7) in the intervention of arm A (from 8.3% at week 0; pÂ =Â 0.003) and arm B (from 11.6% at week 8; pÂ =Â 0.008), respectively.", CCR5 expression in CD8+ T cells , unchanged cART regimen , maraviroc intensification ,0,
edin,5538,3912320,Cannot tell based on the abstract,, Correct response rate for 500 Hz frequency , Control , Occupational noise ,0,
edin,5538,3912320,Significantly decreased,"FigureÂ 2 presents the firefighters responses in relation to the frequencies used. Very similar values were observed, and the mean percentages of correct answer for the 500, 2,000 and 4,000 Hz frequencies were 31.9%, 30.4% and 28.07%, respectively.,FigureÂ 4 compares the mean correct responses between the control and test groups according to the stimulus frequency. The control group obtained means that were 24%, 21% and 25% higher than those of the test group for the 500, 2,000 and 4,000 Hz frequencies, respectively.,A comparison of the responses between the groups revealed that the number of correct responses was greater in the control group at all frequencies (p-values were less than 0.01 using the Student's t-test).", Correct response rate for 500 Hz frequency , Control , Occupational noise ,0,
edin,5733,4319300,Cannot tell based on the abstract,, periodontal disease (PD)  , scaling and root planning (SRP) alone (control) , scaling and root planning (SRP) in combination with amoxicillin plus metronidazole ,0,
edin,5733,4319300,No significant difference,Both treatment modalities were successful on PD measurements and CAL over 3 and 6 months compared to the baseline (P < 0.05; respectively). No significant differences were observed between the groups (P > 0.05)., periodontal disease (PD)  , scaling and root planning (SRP) alone (control) , scaling and root planning (SRP) in combination with amoxicillin plus metronidazole ,0,
edin,5690,4329409,Significantly increased,"In active RA patients with an incomplete MTX response, CZP 200 mg every 2 weeks and 400 mg every 4 weeks were comparable and better than placebo for maintaining clinical response to week 4 following a 16-week, open-label run-in phase.", maintaining clinical response to week 4 following a 16-week , placebo + methotrexate , certolizumab pegol (CZP) 200 mg every 2 weeks + methotrexate ,0,
edin,5687,4883261,Significantly increased,The 90% CI of Cmax for HCQ is 103.8â142.3%; the AUC0â60 is 100â114.2% and AUC0ââ 100â115.5%. Both met the criteria according to the SFDAâs guidelines for bioequivalence. The relative bioavailability was 109.5% (according to AUC0â60d) and 110.7% (according to AUC0ââ)., AUC0â60d , reference formulation , single dose of 0.2g hydroxychloroquine sulfate tablets (0.1g/piece) with 250ml water in the test formulation ,0,
edin,5515,4994668,Cannot tell based on the abstract,, Adverse reactions  , Ciclosporin , Infliximab ,0,
edin,5515,4994668,No significant difference,"There was no significant difference between the two drugs in serious adverse reactions, or serious adverse events: 16 serious adverse reactions were noted in 14 participants given infliximab and ten in nine given ciclosporin (event ratio 0Â·938 [95% CI 0Â·590â1Â·493]; p=0Â·788; table 3).", Adverse reactions  , Ciclosporin , Infliximab ,0,
edin,5644,4307639,Significantly increased,"Compared with the no interest group, the committed with interest group were more likely to be personal computer users (odds ratio (OR)â=â2.78), physically active (ORâ=â1.03) and had higher levels of loneliness (ORâ=â1.16).", physically active , no interest group , committed with interest group ,0,
edin,5703,3892103,Cannot tell based on the abstract,, fidelity , self-monitoring of urine glucose (SMUG) , self-monitoring of blood glucose (SMBG)  ,0,
edin,5703,3892103,Invalid Prompt,, fidelity , self-monitoring of urine glucose (SMUG) , self-monitoring of blood glucose (SMBG)  ,1, I wasn't able to find significant data regarding fidelity 
edin,5747,4060171,Cannot tell based on the abstract,, average bed day consumption throughout the 12 months , reference intervention , system-oriented therapy ,0,
edin,5747,4060171,No significant difference,There was no significant difference in the duration of the index hospitalization in the two groups or the average bed day consumption throughout the 12 months., average bed day consumption throughout the 12 months , reference intervention , system-oriented therapy ,0,
edin,5563,5104394,Significantly decreased,"SB was associated with a 44% relative reduction in the planned food intake (p<0.001), a longer consecutive binge refractory period compared to regular binges (median: 48 hours versus 4 hours, p = 0.002) and an average relative reduction by 26% of binge number the day after each SB (p = 0.004).", Binge number , Control , Sequential binge intervention ,0,
edin,5522,4144850,Cannot tell based on the abstract,, Independent household latrines number , Control , Total Sanitation Campaign ,0,
edin,5522,4144850,Significantly increased,The intervention increased the coverage of any type of IHL facility by 20 percentage points (95% CI 13%â27%; p-value<0.001) in intervention villages compared to control villages (44.1% intervention versus 24.2% control). These results indicate that available IHLs were predominantly JMP defined improved sanitation facilities and very few rudimentary latrines or latrines defined as unimproved by the JMP were built., Independent household latrines number , Control , Total Sanitation Campaign ,0,
edin,5618,4356062,Cannot tell based on the abstract,, Viable follicles , 5% EG in DPBS + 0.5&amp;nbsp;M sucroseâ+â20% FBS , EG plus DMSO in ascending concentrations ,0,
edin,5618,4356062,Significantly increased,"5% EG in Dulbeccoâs phosphate- buffered saline (DPBS) with 0.5Â M sucroseâ+â20% FBS group CV1,EG plus DMSO in ascending concentrations or equilibrated in solutions of CV 5 then vitrified in CV 6 group CV7.,<td>CV1</td><td>232</td><td>75</td><td>69 (93)</td><td>6 (7)</td><td>-</td><td>84</td><td>73(86)</td><td>11 (14)</td><td>a, b</td><td>73</td><td>62 (83)</td><td>11 (17)</td><td>a, b</td>,<td>CV7</td><td>266</td><td>85</td><td>82 (97)</td><td>3 (3)</td><td>-</td><td>90</td><td>87 (97)</td><td>3 (3)</td><td>-</td><td>91</td><td>89 (98)</td><td>2 (2)</td><td>-</td>,There was no significant effect of the cryoprotectant type on the viability of primordial follicles Pâ>â0.05. Furthermore, when double cryoprotectant EG plus DMSO was used, primary and secondary follicles had higher viability than that achieved from single cryoprotectant Pâ<â0.05.", Viable follicles , 5% EG in DPBS + 0.5&amp;nbsp;M sucroseâ+â20% FBS , EG plus DMSO in ascending concentrations ,0,
edin,5666,3200258,Cannot tell based on the abstract,, therapeutic targets , HCT in the range 45%â50% , HCT &amp;lt; 45% ,0,
edin,5666,3200258,No significant difference,"At 6-month clinical visit in the standard arm (<45%), 130 (82.3%) patients have been treated with phlebotomy and 83 (52.5%) with HU as cytoreductive therapy and therapeutic targets were broadly respected in the two arms for the majority of patients (Table 2), mean HCT values being 44.4 Â± 2.3 versus 46.5 Â± 2.7. Although the levels of HCT determined by randomization are broadly maintained, there is some difficulty in maintaining HCT levels lower than 44%. Though the HCT levels were significantly different in the two arms, more than 25% of the subjects in each arm were not maintained in the therapeutic range allocated by randomization (Figure 4). At variance with HCT values, the levels of WBC and platelet count were not significantly different between the two treatment arms.", therapeutic targets , HCT in the range 45%â50% , HCT &amp;lt; 45% ,0,
edin,5573,3337377,Significantly increased,"The ED group showed a lower failure rate, fewer cases of more than 2 attempts, a lesser time to identify the epidural space, and better ease and satisfaction scores of procedure than the C group, with statistical significance.", Physician satisfaction  , Conventional technique , EpidrumÂ® ,0,
edin,5699,5019971,Cannot tell based on the abstract,, hsCRP , unchanged cART regimen , maraviroc intensification ,0,
edin,5699,5019971,No significant difference,"To assess the effect of maraviroc on immune activation and inflammation, we measured T cell activation (defined as either CD38 and HLA-DR double positivity or positivity for CD95) of CD4+ and CD8+ T cells, the inflammation and coagulation markers hsCRP, D-dimer and vWF and the expression of CD40 and CD169 in monocytes (defined by CD14 positivity). No significant differences in change were found between these variables when comparing the intervention to control (data not shown).", hsCRP , unchanged cART regimen , maraviroc intensification ,0,
edin,5718,3750766,Significantly decreased,"In fibromyalgia patients, the 20 rTMS sessions also produced a significant pain inhibition (43% reduction in NRS pain over last 24Â hours), but only when operated at 10Â Hz. This degree of pain control was maintained for at least 4Â weeks after the final session.", maintenance of reduction in chronic fibromyalgia pain at 4 weeks , placebo , multi-coil rTMS ,0,
edin,5723,5858425,Cannot tell based on the abstract,, intra-class correlation coefficients , control group (CG) received lessons as usual , Intervention group (IG) with standing desks and balance pads for 11 weeks ,0,
edin,5723,5858425,No significant difference,"Participants noted on average 40.7 (Â±6.5) min of standing time per day on their control sheet (self-report). The external observers recorded 40.4 (Â±4.9) min. The comparison of the two subjective assessments yielded similar results of self-report and external report (t(15) = â0.40, p = 0.70). The intra-class correlation coefficients between both subjective measure were excellent (ICC = 0.94). The Bland-Altman analysis is shown in Figure 2: Comparison between the two subjective measures (self vs. external report) of standing time using Bland-Altman plots. The chart presents the mean difference (intermediate line) and Â±1.96* standard deviation of difference (upper and lower line), showing the limits of agreement.", intra-class correlation coefficients , control group (CG) received lessons as usual , Intervention group (IG) with standing desks and balance pads for 11 weeks ,0,
edin,5604,5506697,Significantly increased,"OFC-treated patients demonstrated an improvement over placebo at endpoint with respect to mean change from baseline in the patient-rated KINDL-R Self-esteem subscale score (pÂ =Â 0.028), and in the parent KINDL-R ratings of emotional well-being (pÂ =Â 0.020), Self-esteem (pÂ =Â 0.030), and Family (pÂ =Â 0.006).", Parent rated self-esteem  , Control  , Olanzapine + fluoxetine ,0,
edin,5669,3585302,Cannot tell based on the abstract,, colicky symptoms , non-responders , responders ,0,
edin,5669,3585302,Invalid Prompt,, colicky symptoms , non-responders , responders ,1, I wasn't able to find results for colicky symptoms
edin,5696,5019971,Significantly increased,A significantly increased FMD of 0.73% (IQR â0.25 to 1.70) was seen after maraviroc intensification compared to a decrease of â0.42% (IQR â1.89 to 0.25; pÂ =Â 0.049) in the control period., flow-mediated dilatation (FMD) , unchanged cART regimen , maraviroc intensification ,0,
edin,5535,2876942,Significantly decreased,Postoperative agitation score and rescue fentanyl consumption were higher in group M than in group KM on admission to the PACU (P < 0.01)., Postoperative agitation , Control , Ketamine ,0,
edin,5768,5548257,No significant difference,The vitamin D supplementation did not have any significant effect on the exercise capacity (p-value=0.175) or the saturation of oxygen (p-value = 0.635)., saturation of oxygen during 6MWT , Before vitamin D supplementation in COPD patients , after vitamin D supplementation in COPD patients ,0,
edin,5576,3003523,Significantly increased,"<td align=""left"">MCS</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td>", Short-Form 36-Items improvement , Control , Certolizumab 200 mg ,0,
edin,5706,5887937,Cannot tell based on the abstract,, biosimilarity , ETN , GP2015 ,0,
edin,5706,5887937,No significant difference,"The EGALITY study confirmed biosimilarity of GP2015 and ETN during the first 12 weeks of treatment.10 The results observed during TP2 are of importance considering that EGALITY is the first study (and the only study to our knowledge), which actually demonstrates that multiple switches between a biosimilar (GP2015) and its originator (ETN) have no impact on efficacy, safety and immunogenicity, across the reported period.", biosimilarity , ETN , GP2015 ,0,
edin,5622,4356062,Cannot tell based on the abstract,, Viable follicles , 5% EGâ+â5% DMSO in DPBS with 0.5 M sucroseâ+â20% FBS group , EG plus DMSO in ascending concentrations ,0,
edin,5622,4356062,Significantly decreased,"<td>CV7</td><td>266</td><td>85</td><td>82 (97)</td><td>3 (3)</td><td>-</td><td>90</td><td>87 (97)</td><td>3 (3)</td><td>-</td><td>91</td><td>89 (98)</td><td>2 (2)</td><td>-</td>,EG plus DMSO in ascending concentrations or equilibrated in solutions of CV 5 then vitrified in CV 6 group CV7.,5% EGâ+â5% DMSO in DPBS with 0.5Â M sucroseâ+â20% FBS group CV5,", Viable follicles , 5% EGâ+â5% DMSO in DPBS with 0.5 M sucroseâ+â20% FBS group , EG plus DMSO in ascending concentrations ,0,
edin,5679,3721088,Cannot tell based on the abstract,, total time taken to complete the test for Line bisection test (LB) , computer-based testing , computer-based prism adaptation (PA) ,0,
edin,5679,3721088,Significantly decreased,"The total time taken to complete the test improved significantly after PA for the OC, LC, as well as the LB.", total time taken to complete the test for Line bisection test (LB) , computer-based testing , computer-based prism adaptation (PA) ,0,
edin,5657,3176493,No significant difference,"Praziquantel treatment during pregnancy showed no effect on cytokine responses or antibodies levels to SWA or SEA either in cord blood or at age one year, except for IgG1 to SWA, which was elevated in infants of treated mothers, reflecting maternal levels.", SWA-specific IgE , placebo , praziquantel ,0,
edin,5674,4392433,Significantly increased,"In patients with prior MI or PAD who have not had a previous stroke or TIA, vorapaxar added to standard therapy is effective for longâterm secondary prevention of thrombotic CV events, while increasing moderate or severe bleeding.", longÃ¢â¬ï¿½term secondary prevention of thrombotic CV events , placebo , Vorapaxar ,0,
edin,5583,4805129,Cannot tell based on the abstract,, Iron concentration , Oral iron  , IV iron isomaltoside 1000 (500 mg) ,0,
edin,5583,4805129,Significantly increased,"There was a statistically significant larger increase in serum iron concentration from baseline to Week 1 and Week 2 in Group A compared with Group B (Week 1: P < 0.001; Week 2: P = 0.003) (TableÂ 4).,Similar results were observed when Group A1 was compared with Group B (Supplementary Table S1) and when Group A2 was compared with Group B at Week 2 (Supplementary Table S2).", Iron concentration , Oral iron  , IV iron isomaltoside 1000 (500 mg) ,0,
edin,5610,4030328,Significantly increased,Ketamine increased saccadic frequency and decreased velocity gain of SPEM (all P<0.01) but had no significant effects on PS or AS (all Pâ©¾0.07)., Smooth pursuit saccadic frequency , Placebo , Ketamine   ,0,
edin,5639,5712123,Significantly decreased,"ConcerningMorphine requirement after 24Â h.; it wassignificantly lower in the D/E group in comparison with groups P, E and D. It should be noted also that there was a significant decrease morphine requirement in both groups E and D.", morphine requirements , P group ," E, D and D/E groups ",0,
edin,5590,4737269,Cannot tell based on the abstract,, Ascent  vertical toe clearance variability  , Full bifocals  , Intermediate addition multifocals ,0,
edin,5590,4737269,No significant difference,"Gait safety parameters were similar between intermediate PALs and distance single vision lenses for all gait safety parameters measured: vertical toe clearance on ascent (Wald Ï2Â =Â 0.4, pÂ =Â 0.54) and its variability (Wald Ï2Â =Â 0.1, pÂ =Â 0.93), ascent duration (Wald Ï2Â =Â 1.4, pÂ =Â 0.25), heel clearance on descent (Wald Ï2Â =Â 0.7, pÂ =Â 0.42) and its variability (Wald Ï2Â =Â 2.4, pÂ =Â 0.12) and descent duration (Wald Ï2Â =Â 1.6, pÂ =Â 0.20).,As the participants were all well adapted PAL wearers, the intermediate bifocals not surprisingly provided gait safety parameters that were poorer than the intermediate PALs and/or distance single vision lenses (TableÂ 1).", Ascent  vertical toe clearance variability  , Full bifocals  , Intermediate addition multifocals ,0,
edin,5689,4329409,Cannot tell based on the abstract,," prior anti-TNF exposure at baseline, ESR ", placebo + methotrexate , certolizumab pegol (CZP) 400 mg every 4 weeks + methotrexate ,0,
edin,5689,4329409,Significantly decreased,"However, more patients who were randomized to the CZP treatment arms had prior anti-TNF exposure at baseline compared to placebo patients; patients with prior anti-TNF use at baseline had longer disease duration and lower ESR than those without (Table1)."," prior anti-TNF exposure at baseline, ESR ", placebo + methotrexate , certolizumab pegol (CZP) 400 mg every 4 weeks + methotrexate ,0,
edin,5916,1859980,Cannot tell based on the abstract,, Dihydrotestosterone concentrations , 50 grams of lipids  , 19 grams of lipids  ,0,
edin,5916,1859980,No significant difference,"<td align=""left"" colspan=""5"" rowspan=""1"">DHT</td>", Dihydrotestosterone concentrations , 50 grams of lipids  , 19 grams of lipids  ,0,
edin,5954,5937795,Significantly increased,"Confinement housed calves shed significantly more oocysts (P = 0.05), had higher plasma cortisol (P = 0.001), and required more supportive care (P = 0.0009) than calves in box stalls.", supportive care , box stalls , confinement housing ,0,
edin,5938,3916855,Significantly increased,"he findings showed that the reduction in serum ferritin level and the increments in haemoglobin, serum iron and transferrin saturation were found to be significant among children allocated to the vitamin A group compared to those allocated to the placebo group (p < 0.01).", haemoglobin , placebo group , vitamin A group ,0,
edin,5831,5228186,Significantly increased,SNP rs11185644 near the RXRA was significantly associated with 25(OH)D dose-response (Pâ=â1.01âÃâ10â4)., Vitamin D level , Calcium  , Vitamin D + Calcium ,0,
edin,5884,4065280,Cannot tell based on the abstract,, Non-inflammatory lesions , Control , Pantothenic acid ,0,
edin,5884,4065280,Significantly decreased,"<td align=""left"">&nbsp;Non-inflammatory</td><td align=""left"">41.2 (16.7)</td><td align=""left"">48.9 (33.7)</td><td align=""char"" char=""."">0.374</td>,Analysis of the number of non-inflammatory blemishes demonstrated a significant mean reduction in lesion count from baseline to week 12 in the study agent versus the placebo group (PÂ =Â 0.0162) (Fig.Â 3).", Non-inflammatory lesions , Control , Pantothenic acid ,0,
edin,5847,4608185,No significant difference,Systolic and diastolic blood pressure did not change significantly over the study for either the ChiRunning or control groups., Systolic blood pressure  , Control , Chi running program ,0,
edin,5869,3348575,Significantly decreased,"On ABPM, the week 14 mean changes from baseline in diastolic and systolic BP were also significantly greater with azilsartan over a 24-h period, and during the daytime, night-time and early morning.,These data demonstrate that once-daily azilsartan provides a more potent 24-h sustained antihypertensive effect than that of candesartan but with equivalent safety.", Systolic blood pressure   , Candesartan , Azilsartan  ,0,
edin,5943,3932017,Significantly increased,"Pulse wave velocity (PWV) and stiffness index (Î²) were remarkably greater (8.388âÂ±â3.254Â m/s vs. 7.269âÂ±â1.332Â m/s; 12.51âÂ±â14.16 vs.9.279âÂ±â2.871), while compliance coefficient (CC) decreased significantly in the diabetes group (0.802âÂ±â0.3094Â mm2/Kpa vs. 0.968âÂ±â0.3992Â mm2/Kpa) (Pâ<â0.05).", Pulse wave velocity (PWV) , control group , diabetes group ,0,
edin,5941,3932017,Cannot tell based on the abstract,, time of rotation peak displacement , control group , diabetes group ,0,
edin,5941,3932017,No significant difference,"In addition, the time difference of radial peak displacement (RD-TD) and the time of rotation peak displacement difference (ROT-DT) in the patient group presented earlier than in the healthy controls. No significant differences were found between the two groups as far as other variables were concerned.", time of rotation peak displacement , control group , diabetes group ,0,
edin,5924,5454908,Cannot tell based on the abstract,, galunisertib plus lomustine , placebo+lomustine , galunisertib plus lomustine ,0,
edin,5924,5454908,Invalid Prompt,, galunisertib plus lomustine , placebo+lomustine , galunisertib plus lomustine ,1, I believe that his question is wrong. You are asking for galunisertib plus lomustine in question stem and it repeats again in provided possibilities 
edin,5911,3327628,Cannot tell based on the abstract,, Medical survey response rate on the south , Control , Offering free continuing medical education ,0,
edin,5911,3327628,Significantly decreased,"<td align=""left"">âSouth</td><td align=""left"">14.1</td><td align=""left"">12.0</td><td align=""left"">16.1</td><td align=""left"">.001</td>,Across all specialties, the response rate among the control group (no offer of CME credit) was 16.6%, while among those offered the CME opportunity, the response rate was actually lower at 12.0% (Table 2).", Medical survey response rate on the south , Control , Offering free continuing medical education ,0,
edin,5912,3327628,Significantly decreased,"A total of 1214 out of 8477 potentially eligible physicians responded to our survey, for an overall response rate of 14.3%. The response rate among the control group (no offer of CME credit) was 16.6%, while among those offered the CME opportunity, the response rate was 12.0% (p < 0.0001).", Overall survey response rate  , Control , Offering free continuing medical education ,0,
edin,5932,3539107,Significantly increased,"Mean operating time and postoperative hospital stay were longer in the diverticulitis group (55.3 Â± 28.8 minutes vs. 41.4 Â± 17.8 minutes, 6.8 Â± 3.4 days vs. 4.9 Â± 1.5 days, P < 0.05).", Mean operating time , appendicitis group , diverticulitis group ,0,
edin,5964,5571924,Significantly increased,"The discrimination performance of the present model for high-risk patients with advanced CRN was better than that of the Asia-Pacific Colorectal Screening score (AUC = 0.678, P < .001) and Schroyâs CAN index (AUC = 0.672, P < .001).,The high-risk group had a 3.7-fold increased risk of advanced CRN compared to the low-risk group (1.1% vs. 4.0%, P < .001).", advanced colorectal neoplasia (CRN) , low-risk group , high-risk group ,0,
edin,5843,3376511,Significantly decreased,"The findings demonstrate that having less user control (ie, a tunneled version of the website) had a negative effect on usersâ perception of efficiency (F1,452 = 97.69, P < .001), but a positive effect on number of pages visited (F1,452 = 171.49, P < .001), time on the website (F1,452 = 6.32, P = .01), and knowledge gained from the website (F1,452 = 134.32, P < .001).", Time spent on the site , Low user control , High user control ,0,
edin,5799,4007144,Significantly increased,"Significant differences were found between men in the intervention and control armsâ reported ability to control their hostility and manage conflict (ARR 1.3, 95% CI 1.06-1.58), and participation in gendered household tasks (ARR 2.47, 95% CI 1.24-4.90).", Participation in household tasks , Control , Intimate partner prevention intervention ,0,
edin,5823,4723179,Cannot tell based on the abstract,, Fusional divergence improvement , Control , Sports Vision Training ,0,
edin,5823,4723179,No significant difference,"To the contrary, no significant difference was found in fusional divergence results (Ï2=2.513, p=0.285).", Fusional divergence improvement , Control , Sports Vision Training ,0,
edin,5950,3751685,Cannot tell based on the abstract,, Between-group differences in frailty at 3 months , usual health care and support services , interdisciplinary multifaceted treatment ,0,
edin,5950,3751685,No significant difference,Between-group differences in frailty were statistically significant at 12 months but not at 3 months., Between-group differences in frailty at 3 months , usual health care and support services , interdisciplinary multifaceted treatment ,0,
edin,5934,3539107,No significant difference,"The site of abdominal pain, fever, signs of localized peritonitis, accompanying gastrointestinal symptoms, and white blood cell count showed no differences between the two groups.", fever , appendicitis group , diverticulitis group ,0,
edin,5965,5571924,Cannot tell based on the abstract,, discrimination performance using AUC (Area under the receiver operating curve) for high risk patients , advanced CRN (ACN) index , final model ,0,
edin,5965,5571924,Significantly increased,"In the validation set, the discrimination performance of the final model was compared with that of the advanced CRN (ACN) index [14] and Asia-Pacific Colorectal Screening score (APCS) [12] using the AUC (Fig 7). The AUC of the final model was 0.716 (95% CI, 0.691â0.741), whereas that of the ACN index was 0.672 (95% CI, 0.645â0.699), and that of the APCS was 0.678 (95% CI, 0.651â0.705). The discrimination performance of the developed model for high-risk patients with advanced CRN was better than that of the ACN index (P < .001) or APCS (P < .001).", discrimination performance using AUC (Area under the receiver operating curve) for high risk patients , advanced CRN (ACN) index , final model ,0,
edin,5921,3411720,Cannot tell based on the abstract,, magnitude of the effect of zinc on rates of respiratory illness , zinc with multi-nutrients , zinc ,0,
edin,5921,3411720,No significant difference,"Upon examination of interaction effects ( Table 4 ), we found no evidence that concurrent supplementation with multi-nutrients influenced the magnitude of the effect of zinc on rates of diarrhea, respiratory illness, fever without localizing signs, or other illness.", magnitude of the effect of zinc on rates of respiratory illness , zinc with multi-nutrients , zinc ,0,
edin,5975,4682219,Cannot tell based on the abstract,, additional CIN lesions , HC2 or COBAS at baseline , both HC2 and COBAS at baseline ,0,
edin,5975,4682219,No significant difference,"<th colspan=""2"" rowspan=""3""></th><th colspan=""9"">COBAS</th>", additional CIN lesions , HC2 or COBAS at baseline , both HC2 and COBAS at baseline ,0,
edin,5963,5844554,Significantly increased,"However in the secure priming condition, WM performance was boosted in the n-back task for individuals who rated higher levels of attachment anxiety. In other words, the subliminal priming of the security led to increased WM capacity of individuals who rated higher levels of attachment anxiety.", WM capacity of individuals who rated higher levels of attachment anxiety , neutral priming conditions , secure conditions ,0,
edin,5968,5549592,Cannot tell based on the abstract,, saliva contamination effect on immediate bond strength , control , simplified conventional system Transbond XTâ¢ Light cure adhesive ,0,
edin,5968,5549592,Significantly decreased,The saliva contamination prior to the application of a hydrophobic simplified conventional adhesive system was responsible for decreasing the immediate bond strength values of brackets cemented on the dental enamel., saliva contamination effect on immediate bond strength , control , simplified conventional system Transbond XTâ¢ Light cure adhesive ,0,
edin,5966,5571924,Significantly increased,"The developed model had good discrimination (AUC = 0.726) and was internally validated (AUC = 0.713). The high-risk group had a 3.7-fold increased risk of advanced CRN compared to the low-risk group (1.1% vs. 4.0%, P < .001). The discrimination performance of the present model for high-risk patients with advanced CRN was better than that of the Asia-Pacific Colorectal Screening score (AUC = 0.678, P < .001) and Schroyâs CAN index (AUC = 0.672, P < .001).", discrimination performance using AUC (Area under the receiver operating curve) for high risk patients , Asia-Pacific Colorectal Screening score (APCS) , final model ,0,
edin,5944,3932017,Significantly increased,"Pulse wave velocity (PWV) and stiffness index (Î²) were remarkably greater (8.388âÂ±â3.254Â m/s vs. 7.269âÂ±â1.332Â m/s; 12.51âÂ±â14.16 vs.9.279âÂ±â2.871), while compliance coefficient (CC) decreased significantly in the diabetes group (0.802âÂ±â0.3094Â mm2/Kpa vs. 0.968âÂ±â0.3992Â mm2/Kpa) (Pâ<â0.05).", stiffness index (Î²) , control group , diabetes group ,0,
edin,5925,5454908,Cannot tell based on the abstract,, Reduction of plasma levels of TGF-Î²1 , galunisertib plus lomustine , galunisertib  ,0,
edin,5925,5454908,No significant difference,"No association was found between tissue pSMAD2 expression and TGF-Î²1 levels in plasma, FOXP3 in blood, or CD4+CD25+CD127â/LOFOXP3+ in plasma, collected at the time of study enrollment (Table S4b).,TGF-Î²1 levels were not changed over time (data not shown).", Reduction of plasma levels of TGF-Î²1 , galunisertib plus lomustine , galunisertib  ,0,
edin,5793,4825255,No significant difference,"The Visual Analogue Scale suggested that in the transitional stages (8-10 cm cervical dilation), the level of pain felt by the experimental group was meaningfully lower than that felt by the control group (p=0.03). However, this was not significantly different between the two groups at 3-4 cm cervical dilation and the second stage of childbirth.", VAS pain during second stage of labor , Control  , Prenatal education ,0,
edin,5891,5011602,Significantly increased,"After the intervention, both groups showed significant improvements in the forced vital capacity, forced expiratory volume in one second, 10-meter walking test, and six-minute walking test over the baseline results.", 10-minute walking test improvement  , Control , Intensive aerobic exercise ,0,
edin,5923,3411720,Significantly decreased,"Zinc supplementation reduced the hazard rate of diarrhea by 24% (4%â40%). By contrast, multi-nutrients seemed to increase this rate (HR; 95% CI: 1.19; 0.94â1.50), particularly in children with asymptomatic Giardia infection at baseline (2.03; 1.24â3.32).,We found no evidence that the efficacy of zinc supplements in reducing diarrhea rates is enhanced by concurrent supplementation with other micronutrients.", rate of diarrhea , multi-nutrients , zinc ,0,
edin,5903,3821116,Significantly decreased,Nausea frequency was also higher in the placebo group than the pregabalin group (P = 0.003)., Nausea  , Placebo , Pregabalin ,0,
edin,5877,4916104,Significantly increased,"12-week study: Lower-limb muscle strength, balancing capacity, and whole body reaction time significantly improved in the exercise group.", Whole body reaction time , Control , Exercise gaming ,0,
edin,5894,4339173,Significantly increased,"All the physical fitness tests were significantly improved after a single session of Thai massage, whereas only the sit and reach, and the sit-ups tests were improved in the control group.", Push-ups , Control , Thai massage  ,0,
edin,5796,4007144,No significant difference,"At follow-up, reported levels of physical and/or sexual IPV in the intervention arm had decreased compared to the control arm (ARR 0.52, 95% CI 0.18-1.51, not significant).", Partner physical violence  , Control , Intimate partner prevention intervention ,0,
edin,5880,4916104,Cannot tell based on the abstract,, Adverse events  , Control , Exercise gaming ,0,
edin,5880,4916104,No significant difference,"We confirmed the presence or absence of adverse events during exercise in each participant at every session.,No adverse events were observed during the 12-week training period.", Adverse events  , Control , Exercise gaming ,0,
edin,5952,5937795,No significant difference,"Calves in confinement had no significant differences in mean log oocysts enumerated per gram of fecal dry matter between CFC and IC samples (P = 0.6), nor were there diurnal variations in oocyst shedding (P = 0.1).", oocysts shedding , box stalls , confinement housing ,0,
edin,5845,3376511,Cannot tell based on the abstract,, Enjoyment , Low user control , High user control ,0,
edin,5845,3376511,No significant difference,"<td colspan=""1"" rowspan=""1""> Enjoyment </td><td colspan=""1"" rowspan=""1""> 1â7 </td><td colspan=""1"" rowspan=""1""> 4.9 (1.5) </td><td colspan=""1"" rowspan=""1""> 5.0 (1.4) </td><td colspan=""1"" rowspan=""1""> 0.72 </td><td colspan=""1"" rowspan=""1""> .40 </td>,Efficiency has a positive effect on website use, but effectiveness and enjoyment do not have a direct effect on website use (only partly confirming Hypothesis 1).", Enjoyment , Low user control , High user control ,0,
edin,5904,3821116,Cannot tell based on the abstract,, Vomiting , Placebo , Pregabalin ,0,
edin,5904,3821116,No significant difference,Vomiting frequency of the pregabalin group was 2.5% (one patient) and in the placebo group the figure was 12.5% (five patients) (P = 0.09)., Vomiting , Placebo , Pregabalin ,0,
edin,5783,4237982,Cannot tell based on the abstract,, Total adipose tissue in women , Control , Intensive lifestyle intervention ,0,
edin,5783,4237982,Significantly decreased,"If TAT loss is partitioned into its component parts, for females, 86% of the reduction was from SAT and 17% from VAT, while IMAT increased 3%. For males, the corresponding values were 70% from SAT, 27% from VAT, and 3% from IMAT. Thus, as a proportion of TAT loss, females have a greater reduction in SAT than males and males have a greater reduction in VAT than females (both P < 0.001). The IMAT difference is not statistically reliable.", Total adipose tissue in women , Control , Intensive lifestyle intervention ,0,
edin,5881,4065280,Significantly decreased,There was a significant mean reduction in total lesion count in the pantothenic acid group versus placebo at week 12 (PÂ =Â 0.0197)., Total lesion count , Control , Pantothenic acid ,0,
edin,5882,4065280,Significantly decreased,Mean reduction in inflammatory lesions was also significantly reduced and DLQI scores were significantly lower at week 12 in the pantothenic acid group versus placebo., Inflammatory lesions , Control , Pantothenic acid ,0,
edin,5906,3821116,Cannot tell based on the abstract,, Sedation , Placebo , Pregabalin ,0,
edin,5906,3821116,No significant difference,"None of the patients complained about other side effects such as: dizziness, sedation, headache or visionary disorder in this study.", Sedation , Placebo , Pregabalin ,0,
edin,5899,2650591,Significantly increased,Whole lung deposition was higher with RespimatÂ® SMI than with pMDI for untrained (37% of delivered dose vs 21% of metered dose) and trained patients (53% of delivered vs 21% of metered dose) (pSign-Test].15; pANOVA < = 0.05)., Lung deposition in trained patients  , Pressurized metered-dose inhalers , RespimatÂ® Soft Mistâ¢ ,0,
edin,5928,3539107,No significant difference,"The site of abdominal pain, fever, signs of localized peritonitis, accompanying gastrointestinal symptoms, and white blood cell count showed no differences between the two groups.", WBC counts , appendicitis group , diverticulitis group ,0,
edin,5788,5852865,Significantly increased,"In this study, we compared the changes in macular pigment over a 24-week supplementation period for two groups of 24 subjects each assigned to either of two supplement formulations, 20âmg/day of lutein or 20âmg equivalent free carotenoids of a combination of diacetate esters of the macular carotenoids. The latter group responded with a larger increase (0.0666âÂ±â0.0481) in macular pigment optical density than the former group (0.0398âÂ±â0.0430), driven largely by the older subjects.", Macular pigment optical density , Lutein , Diacetate esters of macular carotenoids ,0,
edin,5973,4429825,Cannot tell based on the abstract,, difference in the proportions of correct and incorrect trial arm allocations after vignettes standardization for intervention group , phase 1 , phase 2 ,0,
edin,5973,4429825,Cannot tell based on the abstract,, difference in the proportions of correct and incorrect trial arm allocations after vignettes standardization for intervention group , phase 1 , phase 2 ,0,
edin,5973,4429825,No significant difference,"Consequently, intervention arm men were incorrectly assigned to the control arm by reviewers because of the absence of a PSA test (21%) or other study-specific criteria which may have implied the absence of screening (9%), or because men were symptomatic at diagnosis (12%). Correct decisions about the control arm were also based on the absence of either a PSA test result (31%), or prostate cancer diagnosis (8%); or because men were symptomatic or had advanced disease at presentation (13%).Table 1,<td></td><td>b. Symptomatic, high PSA test result, locally advanced/metastatic disease, late presentation</td><td>13</td><td>0</td><td>0</td><td>23</td><td>0</td><td>2</td>", difference in the proportions of correct and incorrect trial arm allocations after vignettes standardization for intervention group , phase 1 , phase 2 ,0,
edin,5918,1859980,Cannot tell based on the abstract,, Dihydrotestosterone concentrations , 5 grams of lipids  , 19 grams of lipids  ,0,
edin,5918,1859980,Significantly increased,"<td align=""left"" colspan=""5"" rowspan=""1"">DHT</td>,<td align=""left"" colspan=""1"" rowspan=""1"">â<italic>C</italic><sub>max</sub> (nmol/l)</td><td align=""char"" char=""Â·"" colspan=""1"" rowspan=""1"">1Â·50 (65Â·8)</td><td align=""char"" char=""Â·"" colspan=""1"" rowspan=""1"">1Â·89 (53Â·7)</td><td align=""char"" char=""Â·"" colspan=""1"" rowspan=""1"">6Â·67 (45Â·7)</td><td align=""char"" char=""Â·"" colspan=""1"" rowspan=""1"">6Â·74 (49Â·3)</td>", Dihydrotestosterone concentrations , 5 grams of lipids  , 19 grams of lipids  ,0,
edin,5852,4608185,No significant difference,"Self-reported running-related injury (i.e. discomfort leading to a decrease in running) was similar between groups (ChiRunning, 4 [1.2 to 8.4] vs. control, 3 [0.7 to 7.1] injuries per 100Â h of running, pâ=â0.72)", Injury incidence  , Standard running program , Chi running program ,0,
edin,5897,4339173,Cannot tell based on the abstract,, Sit and reach , Control , Thai massage  ,0,
edin,5897,4339173,No significant difference,"<td align=""left"" colspan=""1"" rowspan=""1"">Sit and reach<sup># </sup>(cm)</td><td align=""center"" colspan=""1"" rowspan=""1"">21.45 Â± 5.50</td><td align=""center"" colspan=""1"" rowspan=""1"">23.06 Â± 5.20<sup>*</sup></td><td align=""center"" colspan=""1"" rowspan=""1"">20.90 Â± 5.41</td><td align=""center"" colspan=""1"" rowspan=""1"">20.57 Â± 6.02</td><td align=""center"" colspan=""1"" rowspan=""1"">18.83 Â± 5.11</td><td align=""center"" colspan=""1"" rowspan=""1"">19.47 Â±4.74<sup>*</sup></td><td align=""center"" colspan=""1"" rowspan=""1"">19.28 Â± 5.04</td><td align=""center"" colspan=""1"" rowspan=""1"">20.80 Â± 5.04<sup>*</sup></td>,Significant improved when compared with the pre-test value (p < 0.05)

), whereas only the sit and reach, and sit-ups tests showed improvements in the control group.,<td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">Sit and reach (cm) (n = 17)</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""top"">1.61 Â± 1.65</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""top""> 1.51 Â± 1.43</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""top"">â0.1 (â1.17 to 0.98)</td>", Sit and reach , Control , Thai massage  ,0,
edin,5805,4562579,Cannot tell based on the abstract,, Leg blood flow , Control , Resistance exercise ,0,
edin,5805,4562579,No significant difference,"There was no effect of SR or SRÂ +Â RT on femoral artery diameter, leg blood flow, or mean arterial pressure. Heart rate was higher in the fed state as compared to the fasted state (PÂ <Â 0.0001) with no difference between the times when leg blood flow measurements were made on each leg.

Table 3", Leg blood flow , Control , Resistance exercise ,0,
edin,5876,4916104,Significantly increased,"Lower-limb muscle strength, balancing capacity, and whole body reaction time significantly improved in the exercise group.", Balancing capacity , Control , Exercise gaming ,0,
edin,5855,5013640,Significantly decreased,"In the univariable analysis, higher insulin (HRâ=â0.81 [0.67, 0.98] pâ=â0.03) and C-peptide (HRâ=â0.62 [0.39, 1.00]; pâ=â0.05) levels were associated with a longer PFS, while higher Hepatocyte Growth Factor (HGF; HRâ=â1.63 [1.06, 2.51] pâ=â0.03) and Osteopontin (OPN; HRâ=â1.56 [1.13, 2.15]; pâ=â0.01) levels were associated with a shorter PFS.", Progression-free survival , Low hepatocyte growth factor levels , High hepatocyte growth factor levels ,0,
edin,5792,4825255,No significant difference,"The Visual Analogue Scale suggested that in the transitional stages (8-10 cm cervical dilation), the level of pain felt by the experimental group was meaningfully lower than that felt by the control group (p=0.03). However, this was not significantly different between the two groups at 3-4 cm cervical dilation and the second stage of childbirth", VAS pain during 3-4 cm dilatation  , Control  , Prenatal education ,0,
edin,5830,3951509,Cannot tell based on the abstract,, Influenza risk , Control , Home Environment Interventions ,0,
edin,5830,3951509,Significantly decreased,"Compared to children from households not using improved stoves and not in the IHIP trial, children in IHIP intervention households had a relative risk (RR) for influenza-associated illness of 0.35 (95% CI 0.19â0.62), while children living in IHIP control households had a RR of 0.61 (95% CI 0.37â0.98).", Influenza risk , Control , Home Environment Interventions ,0,
edin,5863,3040733,Cannot tell based on the abstract,, Hemorrhages within the fovea. , Climbing profile 2 , Climbing profile 1  ,0,
edin,5863,3040733,No significant difference,No hemorrhages were sighted within the fovea., Hemorrhages within the fovea. , Climbing profile 2 , Climbing profile 1  ,0,
edin,5816,3283075,Significantly decreased,"The numbers of mature oocytes, fertilized oocytes and grade I, II embryos were significantly lower in group 2 than in group 1 or 3.", Fertilized oocytes , GnRH antagonist + oral contraceptive pill , GnRH antagonist   ,0,
edin,5800,4007144,Significantly decreased,"Men participating in the intervention reported decreased intentions to use physical IPV (ARR 0.83, 95% CI 0.66-1.06) and improved attitudes toward sexual IPV (ARR 1.21, 95% CI 0.77-1.91). Significant differences were found between men in the intervention and control armsâ reported ability to control their hostility and manage conflict (ARR 1.3, 95% CI 1.06-1.58), and participation in gendered household tasks (ARR 2.47, 95% CI 1.24-4.90).", Men's intentions to use violence  , Control , Intimate partner prevention intervention ,0,
edin,5837,5584005,Significantly increased,"Improvement in attitudes toward patient safety was statistically significant in the intervention group in six domains: staff, training, and skill (pÂ =Â 0.017); patient counseling (pÂ =Â 0.043); communication about mistakes (pÂ <Â 0.001); response to mistakes (pÂ <Â 0.001); organizational learning â continuous improvement (pÂ <Â 0.001); and overall patient safety perceptions (pÂ =Â 0.033).", Communication about mistakes , Control , Continuous quality improvement program ,0,
edin,5885,4065280,Cannot tell based on the abstract,, Investigators Global Assessment-measured overall efficacy , Control , Pantothenic acid ,0,
edin,5885,4065280,Significantly increased,The overall investigator assessment of improvement at week 12 as measured by a 5-point scale demonstrated that 85.7% of subjects had â¥1 rank improvement in the study agent versus the placebo group (35.7%)., Investigators Global Assessment-measured overall efficacy , Control , Pantothenic acid ,0,
edin,5879,4916104,Cannot tell based on the abstract,, Borgâs scale scores , Control , Exercise gaming ,0,
edin,5879,4916104,Significantly decreased,"The mean score on Borgâs scale was 12Â Â±Â 2 on the first day of the step exercise and 9Â Â±Â 2 on the final day, showing a significant decrease (PÂ <Â 0.001). Therefore, an improvement in exercise tolerance was achieved.", Borgâs scale scores , Control , Exercise gaming ,0,
edin,5809,3506492,No significant difference,"EPO treatment did not significantly modify the difference in uNGAl between 48 hours and randomization compared to placebo [2.5 ng/ml (â17.3; 22.5) vs 0.7 ng/ml (â31.77; 25.15), pâ=â0.77] and the incidence of AKI was similar. I", Acute kidney injury , Control , Erythropoietin ,0,
edin,5892,4339173,Significantly increased,"even physical fitness tests consisting of sit and reach, hand grip strength, 40 yards technical agility, 50-meter sprint, sit-ups, push-ups, and VO2, max were measured before and after Thai massage or rest. [Results] All the physical fitness tests were significantly improved after a single session of Thai massage, whereas only the sit and reach, and the sit-ups tests were improved in the control group.", VO2 Max , Control , Thai massage  ,0,
edin,5927,5454908,Cannot tell based on the abstract,, treatment differences , galunisertib plus lomustine , galunisertib  ,0,
edin,5927,5454908,Significantly increased,"While on treatment, there were significant differences in CD4+, CD4+/CD8+ ratio, eosinophils, and total lymphocyte counts. All these immune cells were reduced in patients treated in both lomustine-containing arms compared to the galunisertib monotherapy arm (overall treatment p < 0.05).", treatment differences , galunisertib plus lomustine , galunisertib  ,0,
edin,5865,4175232,No significant difference,The reaction time showed no statistically significant differences in the interaction involving the time of response and group., Reaction time , Control , Galvanic vestibular stimulation ,0,
edin,5870,3348575,Significantly decreased,"On ABPM, the week 14 mean changes from baseline in diastolic and systolic BP were also significantly greater with azilsartan over a 24-h period, and during the daytime, night-time and early morning.,These data demonstrate that once-daily azilsartan provides a more potent 24-h sustained antihypertensive effect than that of candesartan but with equivalent safety.", Diastolic blood pressure   , Candesartan , Azilsartan  ,0,
edin,5827,4398332,Significantly increased,"THC was detrimental to the recognition of ambiguous faces of 40% intensity. The combination of THC+CBD produced no impairment. Relative to placebo, both THC alone and combined THC+CBD equally increased feelings of being âstonedâ.", Stoned feeling , Control , Tetrahydrocannabinol ,0,
edin,5841,3376511,Significantly increased,"The findings demonstrate that having less user control (ie, a tunneled version of the website) had a negative effect on usersâ perception of efficiency (F1,452 = 97.69, P < .001),", Perception of efficiency , Low user control , High user control ,0,
edin,5873,3348575,Cannot tell based on the abstract,, Controlled patients at week 8 , Candesartan , Azilsartan  ,0,
edin,5873,3348575,Significantly increased,"As shown in Table 2, the proportions of responders at week 16 (LOCF) and week 8 (LOCF) were significantly higher in the azilsartan group (51.8% and 44.1%, respectively) than in the candesartan group (34.3% and 29.4%, respectively) (P<0.0001 and P=0.0001, respectively). Similarly, the proportions of well-controlled patients at week 16 (LOCF) and week 8 (LOCF) were also significantly higher in the azilsartan group (19.3% and 18.0%, respectively) than in the candesartan group (13.3% and 10.0%, respectively) (P=0.0409 and P=0.0041, respectively).", Controlled patients at week 8 , Candesartan , Azilsartan  ,0,
edin,5905,3821116,Cannot tell based on the abstract,, Dizziness , Placebo , Pregabalin ,0,
edin,5905,3821116,No significant difference,"None of the patients complained about other side effects such as: dizziness, sedation, headache or visionary disorder in this study.", Dizziness , Placebo , Pregabalin ,0,
edin,5971,4429825,Cannot tell based on the abstract,, level of uncertainty for the intervention arm men , phase 1 , phase 2 ,0,
edin,5971,4429825,No significant difference,"In phase 2 there was a reduction in the proportion of correct guesses and much greater uncertainty: reviewers were unsure of the trial arm in 45% of all intervention and 48% of control arm assessments.,In phase 1, reviewers were unsure of trial arm allocation in 33% of intervention and 30% of control arm assessments.,<td></td><td>
<bold><italic>(Total for each phaseâ=â100%)</italic></bold>
</td><td>
<bold><italic>21%</italic></bold>
</td><td>
<bold><italic>46%</italic></bold>
</td><td>
<bold><italic>33%</italic></bold>
</td><td>
<bold><italic>9%</italic></bold>
</td><td>
<bold><italic>46%</italic></bold>
</td><td>
<bold><italic>45%</italic></bold>
</td>", level of uncertainty for the intervention arm men , phase 1 , phase 2 ,0,
edin,5859,270049,Cannot tell based on the abstract,, Session duration  , Passive range of motion , Resistance exercise program ,0,
edin,5859,270049,Significantly increased,"<td align=""left"">Duration of session, min. (SD)</td><td></td><td align=""center"">10.0 (0.0)</td><td align=""center"">36.2 (4.8)</td><td align=""center"">&lt;0.001<sup>d</sup></td>,The average duration for an exercise session was 10 minutes for the control group and 36.2 minutes for the exercise group (Table 3).", Session duration  , Passive range of motion , Resistance exercise program ,0,
edin,5933,3539107,No significant difference,"The site of abdominal pain, fever, signs of localized peritonitis, accompanying gastrointestinal symptoms, and white blood cell count showed no differences between the two groups.", accompanying gastrointestinal symptoms , appendicitis group , diverticulitis group ,0,
edin,5961,5844554,Significantly increased,"However in the secure priming condition, WM performance was boosted in the n-back task for individuals who rated higher levels of attachment anxiety. In other words, the subliminal priming of the security led to increased WM capacity of individuals who rated higher levels of attachment anxiety.", attachment anxiety positively predicted performance in n-back tasks in attachment related words , neutral priming conditions , secure conditions ,0,
edin,5931,3539107,Significantly increased,Twenty-five patients (65.8%) of the diverticulitis group and 10 patients (10.2%) of the appendicitis group showed perforation of appendix (P < 0.05)., perforation of appendix , appendicitis group , diverticulitis group ,0,
edin,5794,4825255,Significantly decreased,"The McGill scaleâs results for measuring pain levels, proved a meaningful difference between the experimental group and the control group (p=0.018).", McGill scaleâs pain  , Control  , Prenatal education ,0,
edin,5862,3040733,Cannot tell based on the abstract,, Distance from  optic disc to hemorrhage , Climbing profile 2 , Climbing profile 1  ,0,
edin,5862,3040733,No significant difference,The mean distance from the center of the optic disc to the center of the hemorrhage was 1.5Â±0.8 disc diameters in all climbers; no statistically significant differences were detected between groups and altitudes., Distance from  optic disc to hemorrhage , Climbing profile 2 , Climbing profile 1  ,0,
edin,5946,3751685,Significantly increased,"The score on the Short Physical Performance Battery, in which higher scores indicate better physical status, was stable in the intervention group and had declined in the control group; with the mean difference between groups being 1.44 (95% confidence interval, 0.80, 2.07; P <0.001) at 12 months.", Short Physical Performance Battery at 12 months , interdisciplinary multifaceted treatment , usual health care and support services  ,0,
edin,5782,5532580,Cannot tell based on the abstract,, Depression improvement  , Control , Sexual Assault history ,0,
edin,5782,5532580,Significantly decreased,"The depression symptoms increased monotonically with the number of PA types experienced (p < 0.05) as did all alcohol-related measures, and global functioning decreased (p = 0.006).,For depression, at the 12-month follow-up there was evidence of less improvement in the SA and PA group compared with the No SA and No PA group (5.3, 95% CI 0.1 to 10.5, p < 0.05), and in the SA and PA group versus the SA and No PA group (modelled difference = 7.0, 95% CI 0.6 to 13.4, p < 0.05).", Depression improvement  , Control , Sexual Assault history ,0,
edin,5851,4608185,No significant difference,"Changes in BMI over time were significantly different from zero in the ChiRunning group (pâ=â0.04) but not in the control group (slope for ChiRunning â0.05 [â0.1 to â0.002] vs. control â0.01 [â0.06 to 0.04], between slope difference, pâ=â0.22).", Body mass index , Standard running program , Chi running program ,0,
edin,5795,4825255,Cannot tell based on the abstract,, McGill scaleâs anxiety   , Control  , Prenatal education ,0,
edin,5795,4825255,Significantly decreased,"<td align=""left"" colspan=""1"" rowspan=""1"">Anxiety hospital</td><td align=""center"" colspan=""1"" rowspan=""1"">14.47Â±4.69</td><td align=""center"" colspan=""1"" rowspan=""1"">16.79Â±4.86</td><td align=""center"" colspan=""1"" rowspan=""1"">*p=0.002</td>", McGill scaleâs anxiety   , Control  , Prenatal education ,0,
edin,5857,270049,Cannot tell based on the abstract,"Thirty-nine ill patients, recently admitted to an acute care hospital, who were over age 70 [mean age of 82.0 (SD= 7.3)] and ambulatory prior to admission, were randomized to the resistance exercise group (19) or passive range of motion (ROM) group (20). For the resistance exercise group, participation was 71% (p = 0.004) and adherence was 63% (p = 0.020). Participation and adherence for ROM exercises was 96% and 95%, respectively.", Participation  , Passive range of motion , Resistance exercise program ,0,
edin,5857,270049,Significantly decreased,"In the exercise group, participation was 71% and adherence was 63%. For the control group, participation and adherence were 96% and 95%, respectively (Table 3).,<td align=""left"">Participation, total</td><td></td><td align=""center"">96%</td><td align=""center"">71%</td><td align=""center"">0.004</td>", Participation  , Passive range of motion , Resistance exercise program ,0,
edin,5959,3786468,No significant difference,Green tea suppressed waist-hip ratio of women from a significant increase and suppressed mean arterial pressure of men and women from a significant decrease after week 14. It reduced ALT level in women by 13.0% (P < 0.1) while increasing the antioxidant potential of men and women sera by 2.7% (P < 0.1) and 5.1% (P < 0.1)., antioxidant potential , water , Mauritian green tea ,0,
edin,5820,4723179,Significantly increased,"The phoria screening examination showed that exophoria was the most frequent disorder of binocular vision. Low fusional vergence range was also observed. Following the training period, 3 of the 6 oculomotor variables improved. The greatest effect was observed in near dissociated phoria (Ï2 =14.56, p=0.001 for the right eye; Ï2 =14.757, p=0.001 for the left eye) and fusional convergence (Ï2 =8.522, p=0.014).", Near dissociated phoria improvement of left eye , Control , Sports Vision Training ,0,
edin,5960,5844554,Significantly increased,"WM performance declined in terms of capacity in the n-back task for individuals who rated higher levels of attachment anxiety. However in the secure priming condition, WM performance was boosted in the n-back task for individuals who rated higher levels of attachment anxiety.", WM capacity of individuals who rated higher levels of attachment avoidance , neutral priming conditions , secure conditions ,0,
edin,5589,4737269,Cannot tell based on the abstract,, Ascent vertical toe clearance , Full bifocals  , Intermediate addition multifocals ,0,
edin,5589,4737269,No significant difference,"Gait safety parameters were similar between intermediate PALs and distance single vision lenses for all gait safety parameters measured: vertical toe clearance on ascent (Wald Ï2Â =Â 0.4, pÂ =Â 0.54) and its variability (Wald Ï2Â =Â 0.1, pÂ =Â 0.93), ascent duration (Wald Ï2Â =Â 1.4, pÂ =Â 0.25), heel clearance on descent (Wald Ï2Â =Â 0.7, pÂ =Â 0.42) and its variability (Wald Ï2Â =Â 2.4, pÂ =Â 0.12) and descent duration (Wald Ï2Â =Â 1.6, pÂ =Â 0.20).", Ascent vertical toe clearance , Full bifocals  , Intermediate addition multifocals ,0,
edin,5850,4608185,No significant difference,Systolic and diastolic blood pressure did not change significantly over the study for either the ChiRunning or control groups., Diastolic blood pressure  , Standard running program , Chi running program ,0,
edin,5962,5844554,Cannot tell based on the abstract,, attachment anxiety positively predicted performance in n-back tasks in non-attachment related words , neutral priming conditions , secure conditions ,0,
edin,5962,5844554,Significantly increased,"In secure priming condition, this negative association between attachment anxiety and n-back task performance became reversed (see Fig 4). Specifically, after secure priming, attachment anxiety positively predicted performance in n-back tasks including both attachment related (Î² = .28, p < .05) and non-attachment related words (Î² = .37, p < .05).", attachment anxiety positively predicted performance in n-back tasks in non-attachment related words , neutral priming conditions , secure conditions ,0,
edin,5801,4007144,Cannot tell based on the abstract,, Believing a woman can refuse sex in all circumstances , Control , Intimate partner prevention intervention ,0,
edin,5801,4007144,Significantly increased,"We also found a lower prevalence of menâs reported intention to commit physical IPV (ARR 0.83, 95% CI 0.66 - 1.06) and increased levels of men who believe a woman has the right to refuse sex under all circumstances (ARR 1.21, 95% CI 0.77 - 1.91).", Believing a woman can refuse sex in all circumstances , Control , Intimate partner prevention intervention ,0,
edin,5872,3348575,Cannot tell based on the abstract,, Response at week 16 , Candesartan , Azilsartan  ,0,
edin,5872,3348575,Significantly increased,"As shown in Table 2, the proportions of responders at week 16 (LOCF) and week 8 (LOCF) were significantly higher in the azilsartan group (51.8% and 44.1%, respectively) than in the candesartan group (34.3% and 29.4%, respectively) (P<0.0001 and P=0.0001, respectively).", Response at week 16 , Candesartan , Azilsartan  ,0,
edin,5956,3786468,Significantly increased,Green tea suppressed waist-hip ratio of women from a significant increase and suppressed mean arterial pressure of men and women from a significant decrease after week 14., waist-hip ratio of women , water , Mauritian green tea ,0,
edin,5898,2650591,Significantly increased,"Deposition was measured by gamma scintigraphy. All 13 patients entered (9 males, mean age 62 years; FEV1 46% of predicted) inhaled too fast at screening (peak inspiratory flow rate [IF]: 69â161 L/min). Whole lung deposition was higher with RespimatÂ® SMI than with pMDI for untrained (37% of delivered dose vs 21% of metered dose) and trained patients (53% of delivered vs 21% of metered dose) (pSign-Test].15; pANOVA < = 0.05).", Lung deposition in untrained patients  , Pressurized metered-dose inhalers , RespimatÂ® Soft Mistâ¢ ,0,
edin,5861,3040733,Cannot tell based on the abstract,, Hemorrhages area , Climbing profile 2 , Climbing profile 1  ,0,
edin,5861,3040733,No significant difference,"There was no statistically significant difference in total area and number of hemorrhages between groups at the same altitudes.,egression analysis of drug intake did not yield a significant partial correlation to total number (Betaâ=ââ0.009, pâ=â0.14) or total area of hemorrhages (betaâ=ââ0.08, pâ=â0.19) when corrected for age, time at altitude and AMS-c scores.", Hemorrhages area , Climbing profile 2 , Climbing profile 1  ,0,
edin,5922,3411720,No significant difference,"We found no evidence that concurrent supplementation with multi-nutrients influenced the magnitude of the effect of zinc on rates of diarrhea, respiratory illness, fever without localizing signs, or other illness (guardian-reported illness with symptoms involving skin, ears, eyes and abscesses, but excluding trauma or burns)", magnitude of the effect of zinc on rates of fever without localizing signs , zinc with multi-nutrients , zinc ,0,
edin,5917,1859980,Cannot tell based on the abstract,, Dihydrotestosterone concentrations , 0.6 grams of lipids  , 19 grams of lipids  ,0,
edin,5917,1859980,Significantly increased,"<td align=""left"" colspan=""1"" rowspan=""1"">â<italic>C</italic><sub>max</sub> (nmol/l)</td><td align=""char"" char=""Â·"" colspan=""1"" rowspan=""1"">1Â·50 (65Â·8)</td><td align=""char"" char=""Â·"" colspan=""1"" rowspan=""1"">1Â·89 (53Â·7)</td><td align=""char"" char=""Â·"" colspan=""1"" rowspan=""1"">6Â·67 (45Â·7)</td><td align=""char"" char=""Â·"" colspan=""1"" rowspan=""1"">6Â·74 (49Â·3)</td>,<td align=""left"" colspan=""5"" rowspan=""1"">DHT</td>", Dihydrotestosterone concentrations , 0.6 grams of lipids  , 19 grams of lipids  ,0,
edin,5929,3539107,Significantly increased,"The mean age of patients in the diverticulitis group was significantly older than that of the appendicitis group (49.0 Â± 15.2 years vs. 25.4 Â± 14.2 years, P < 0.05).", mean age of patients , appendicitis group , diverticulitis group ,0,
edin,5802,4562579,Cannot tell based on the abstract,Leg fat-free mass decreased with SR (â124Â Â±Â 61Â g) and increased in the SRÂ +Â RT (+126Â Â±Â 68Â g; PÂ =Â 0.003)., Fat-free leg mass , Control , Resistance exercise ,0,
edin,5802,4562579,Significantly increased,"<td align=""left"" colspan=""1"" rowspan=""1"">âSR&nbsp;+&nbsp;RT</td><td align=""left"" colspan=""1"" rowspan=""1"">9206&nbsp;Â±&nbsp;258</td><td align=""left"" colspan=""1"" rowspan=""1"">9332&nbsp;Â±&nbsp;254<xref ref-type=""table-fn"" rid=""tf2-3"">*</xref><sup>,</sup><xref ref-type=""table-fn"" rid=""tf2-4"">â </xref></td>", Fat-free leg mass , Control , Resistance exercise ,0,
edin,5945,3932017,Significantly decreased,"Pulse wave velocity (PWV) and stiffness index (Î²) were remarkably greater (8.388âÂ±â3.254Â m/s vs. 7.269âÂ±â1.332Â m/s; 12.51âÂ±â14.16 vs.9.279âÂ±â2.871), while compliance coefficient (CC) decreased significantly in the diabetes group (0.802âÂ±â0.3094Â mm2/Kpa vs. 0.968âÂ±â0.3992Â mm2/Kpa) (Pâ<â0.05).", compliance coefficient (CC) , control group , diabetes group ,0,
edin,5815,3283075,Significantly decreased,"The numbers of mature oocytes, fertilized oocytes and grade I, II embryos were significantly lower in group 2 than in group 1 or 3.", Mature oocytes amount  , GnRH agonist luteal low-dose , GnRH antagonist   ,0,
edin,5909,3327628,Cannot tell based on the abstract,, Medical survey response rate on cardiologists  , Control , Offering free continuing medical education ,0,
edin,5909,3327628,Significantly increased,"<td align=""left"">âCardiology</td><td align=""left"">12.7</td><td align=""left"">9.9</td><td align=""left"">15.5</td><td align=""left"">&lt; .0001</td>,Table 2
Response Rates (N = 8477)", Medical survey response rate on cardiologists  , Control , Offering free continuing medical education ,0,
edin,5926,5454908,Cannot tell based on the abstract,, treatment differences , placebo+lomustine , galunisertib  ,0,
edin,5926,5454908,Significantly increased,"While on treatment, there were significant differences in CD4+, CD4+/CD8+ ratio, eosinophils, and total lymphocyte counts. All these immune cells were reduced in patients treated in both lomustine-containing arms compared to the galunisertib monotherapy arm (overall treatment p < 0.05).", treatment differences , placebo+lomustine , galunisertib  ,0,
edin,5784,4237982,Significantly decreased,"Mean ILI changes were different from DSE (P < 0.001 for TAT, SAT, and IMAT and P < 0.01 for VAT in females). Within ILI, SAT and VAT decreased in males and females (P < 0.0001), but IMAT was unchanged (0.00 Â± 0.54 kg; P = 0.99).", Subcutaneous adipose tissue in women , Control , Intensive lifestyle intervention ,0,
edin,6362,3232074,Cannot tell based on the abstract,, Adverse events , Placebo , Semelil (ANGIPARSâ¢) ,0,
edin,6362,3232074,No significant difference,In this study significant adverse effect was not observed by the laboratory evaluations., Adverse events , Placebo , Semelil (ANGIPARSâ¢) ,0,
edin,6314,3162205,No significant difference,"The control sides treated with an autograft showed significantly better Lenke scores than the study sides treated with Î²-CPP at 3 and 6 months postoperatively, but there was no difference between the two sides at 12 months", Lenke scores at 12 months , Autograft alone , Porous Î²-calcium pyrophosphate (Î²-CPP) plus autograft ,0,
edin,6417,5610004,Cannot tell based on the abstract,"The C-index was higher for the NSCLC cohort nomogram than for the TNM staging system (0.67 vs. 0.64, P = 0.01) and higher for the SCLC nomogram than for the clinical staging system (limited vs. extensive) (0.60 vs. 0.53, P = 0.12).", C-index in the NSCLC group , Validation cohort , Training cohort ,0,
edin,6417,5610004,Significantly increased,"The C-index of our nomogram for predicting OS was higher in the primary cohort (0.67; 95%CI, 0.65-0.69), compared to the C-index values obtained from the TNM staging system in the NSCLC cohort (0.64; 95%CI, 0.62-0.66; P = 0.01). The C-index of our nomogram (0.60; 95%CI, 0.55-0.65) was superior to clinical stage, limited / extensive stage, and diagnosis (0.53; 95%CI, 0.47-0.59) for the SCLC cohort, although this was not significantly different (P =0.12).", C-index in the NSCLC group , Validation cohort , Training cohort ,0,
edin,6297,3309323,Cannot tell based on the abstract,, Normalized jerk score of the elbow , Home program plus general rehabilitation therapy , Comprehensive Hand Repetitive Intensive Strength Training plus general rehabilitation therapy ,0,
edin,6297,3309323,Significantly increased,"n the comparison of motion analysis before and after conducting training, the experimental group showed a significant difference in the movement time of comfortable speed and fast speed, mean velocity, normalized jerk score, mean angular velocity of wrist, shoulder, elbows and normalized jerk score of wrist on reaching motion (p<0.05) (Table 2).", Normalized jerk score of the elbow , Home program plus general rehabilitation therapy , Comprehensive Hand Repetitive Intensive Strength Training plus general rehabilitation therapy ,0,
edin,6315,3162205,Significantly decreased,"The control sides treated with an autograft showed significantly better Lenke scores than the study sides treated with Î²-CPP at 3 and 6 months postoperatively, but there was no difference between the two sides at 12 months.", Lenke scores at 3 months and 6 months , Autograft alone , Porous Î²-calcium pyrophosphate (Î²-CPP) plus autograft ,0,
edin,6317,3391000,Cannot tell based on the abstract,, Baseline characteristics , Gatorade and polyethylene glycol (PEG) without bisacodyl , Gatorade and polyethylene glycol (PEG) with bisacodyl ,0,
edin,6317,3391000,No significant difference,The baseline characteristics of the 200 subjects in each of the three arms of the study were generally well balanced and are shown in Table 3., Baseline characteristics , Gatorade and polyethylene glycol (PEG) without bisacodyl , Gatorade and polyethylene glycol (PEG) with bisacodyl ,0,
edin,6310,4300351,No significant difference,Surgical intervention was required in 4 individuals (3.7%): 2 patients in the A + BE group and 2 patients treated with A + HC (p > 0.05)., Need of surgery , Injection of adrenaline with mechanical therapy (haemostatic clips) (A + HC) , Injection of adrenaline solution and bipolar electrocoagulation (A + BE) ,0,
edin,6365,2758835,Cannot tell based on the abstract,, Baseline headache characteristics , Manual therapy , Usual care ,0,
edin,6365,2758835,No significant difference,Baseline headache characteristics of both groups are displayed in table 1. No significant differences were found between both groups., Baseline headache characteristics , Manual therapy , Usual care ,0,
edin,6309,4300351,No significant difference,Ten individuals (9.3%) experienced recurrent bleeding during hospitalisation: 4 patients from the A + BE group and 6 patients from the A + HC group (p > 0.05)., Bleeding recurrence , Injection of adrenaline with mechanical therapy (haemostatic clips) (A + HC) , Injection of adrenaline solution and bipolar electrocoagulation (A + BE) ,0,
edin,6307,4300351,No significant difference,"Overall, treatment failed in 20 patients (20/107, 18.7%): in 10 individuals from the A + BE group (10/52; 18.2%) and in 10 individuals from the A + HC group (10/55; 19.2%) (p > 0.05).", Treatment failure , Injection of adrenaline with mechanical therapy (haemostatic clips) (A + HC) , Injection of adrenaline solution and bipolar electrocoagulation (A + BE) ,0,
edin,6329,2074536,No significant difference,"The early mucosal reactions appeared sooner and were more troublesome with CHART, however they quickly settled; so far no difference in long-term morbidity has emerged.", Long-term morbidity , Conventional radiotherapy , Continuous hyperfractionated accelerated radiation therapy  ,0,
edin,6328,2074536,Cannot tell based on the abstract,, Survival rate after 2 years in non-small cell lung cancer patients , Conventional radiotherapy , Continuous hyperfractionated accelerated radiation therapy  ,0,
edin,6328,2074536,Invalid Prompt,, Survival rate after 2 years in non-small cell lung cancer patients , Conventional radiotherapy , Continuous hyperfractionated accelerated radiation therapy  ,1, There is no results section. 
edin,6344,3381083,No significant difference,"Final refractive error within 1D of emmetropia was achieved in 90% versus 92.2% of eyes in the alcohol and mechanical groups, respectively (P = 0.23).", Final refractive error within 1D of emmetropia , Mechanical epithelial removal , Alcohol-assisted epithelial removal ,0,
edin,6423,3654355,Cannot tell based on the abstract,, Baseline eating behavior  , Waiting list control , Intensive lifestyle intervention (ILI) group ,0,
edin,6423,3654355,No significant difference,Group comparisons of scores on the TFEQ-R21 showed no differences in eating behavior at baseline (Table 7)., Baseline eating behavior  , Waiting list control , Intensive lifestyle intervention (ILI) group ,0,
edin,6303,3929816,Significantly increased,Histopathologic evaluations revealed more pathological changes at the kidney of all the dogs in test group in comparison to control group., Pathologic changes in the kidneys , Intraabdominal pressure 12 mm Hg , Intraabdominal pressure 20 mm Hg ,0,
edin,6345,3381083,Significantly decreased,"Alcohol-assisted debridement required less time than mechanical debridement (96Â±18 vs. 118Â±26 seconds, P=0.035).", Time needed for debridement , Mechanical epithelial removal , Alcohol-assisted epithelial removal ,0,
edin,6346,5662620,Significantly increased,"The findings showed significant increases in subjective well-being and positive learning behaviors among the intervention participants, with no significant changes in the control group.", Subjective well-being , Wait-list control  , Positive psychology-based intervention ,0,
edin,6402,3170595,No significant difference,"here was no difference between the AZA- and MTX-groups in respect of prednisone dosing (apart from months 10 and 12), in quantitative MG Score improvement, proportions in sustained remission, frequencies of MG relapses, or adverse reactions and/or withdrawals.", Mean prednisone requirement (except for months 10 and 12) , Azathioprine , Methotrexate ,0,
edin,6411,3103853,Cannot tell based on the abstract,, Changes in serum biochemistry values , Cyclosporine , Tacrolimus ,0,
edin,6411,3103853,No significant difference,Serum biochemistry values were within normal limits for all patients., Changes in serum biochemistry values , Cyclosporine , Tacrolimus ,0,
edin,6379,5404432,Significantly decreased,Recurrence rates were 12% in the COP flap group and 60% in the conventional flap coverage group (P < 0.001)., Recurrence rates , Conventional flap , Cone of pressure flap ,0,
edin,6304,5367746,Cannot tell based on the abstract,, Overexposure , Tac target whole-blood predose concentrations , Tac starting dose based on bodyweight ,0,
edin,6304,5367746,Significantly increased,This study demonstrates that dosing Tac solely on bodyweight results in overexposure in a considerable proportion of patients., Overexposure , Tac target whole-blood predose concentrations , Tac starting dose based on bodyweight ,0,
edin,6349,5662620,Cannot tell based on the abstract,, Positive emotions , Wait-list control  , Positive psychology-based intervention ,0,
edin,6349,5662620,Significantly increased,"Analyses of the self-report outcomes showed significant interaction effects between intervention and time (pre- and post-intervention) on childrenâs positive emotions, F(1,313) = 10.93, p = 0.001, Î·2 = 0.04, life satisfaction, F(1,313) = 9.68, p = 0.002, Î·2 = 0.03, and empathy, F(1,313) = 8.65, p = 0.004, Î·2 = 0.03, but not on negative emotions, F(1,313) = 1.83, p = 0.18, Î·2 = 0.007. Post hoc t-test comparisons revealed that children in the intervention group showed significant pre- to post-intervention increases in positive emotions (M = 0.84, p < 0.001, Cohenâs d = 0.38), life satisfaction (M = 0.46, p < 0.001, Cohenâs d = 0.67) and empathy (M = 2.01, p = 0.003, Cohenâs d = 0.34), with no significant changes in these measures in the control group.", Positive emotions , Wait-list control  , Positive psychology-based intervention ,0,
edin,6288,5703870,Cannot tell based on the abstract,, Overall effectiveness after 4 days , Sterile water , T-EO formulation and Af-EO formulation ,0,
edin,6288,5703870,Significantly increased,"The T-EO and Af-EO formulations after 4 days of use showed similar effectiveness in maintaining the BV at significantly lower levels than the negative control (BV for 4D-T-EO and 4D-Af-EO vs. 4D-WATER = 26.27 Â± 14.61% and 31.08 Â± 16.52% vs. 51.35 Â± 5.38%, respectively; P < 0.001; Table 2).", Overall effectiveness after 4 days , Sterile water , T-EO formulation and Af-EO formulation ,0,
edin,6299,5168495,Significantly increased,There was a statistically significant improvement in adherence in the intervention group compared to control at 3âmonths (mean MAQ score 0.42: 95% CI (0.27 to 0.57) vs 1.58: 95% CI (1.42 to 1.75); p<0.001). The significant improvement in MAQ score in the intervention group compared to control was sustained at 6âmonths (0.48: 95% CI (0.31 to 0.65) vs 1.48: 95% CI (1.27 to 1.69); p<0.001)., Adherence at 6 months , Control group , Tailored intervention ,0,
edin,6374,4048141,Significantly increased,"A significantly greater proportion of vilazodone-treated versus placebo-treated patients shifted from baseline â¥ 4 to end of study â¤ 2 on MADRS items of apparent sadness, reported sadness, inner tension, reduced sleep, and lassitude (OR range, 1.5â2.0, P < .05).", Overall severity category shift from â¥ 4 to â¤ 2  , Placebo , Vilazodone ,0,
edin,6397,4183584,Cannot tell based on the abstract,, Baseline characteristics , Non-social or anti-social priming groups , Pro-social priming group  ,0,
edin,6397,4183584,No significant difference,The results revealed no difference on the basic demographic and clinical information between schizophrenia groups (see Table 1)., Baseline characteristics , Non-social or anti-social priming groups , Pro-social priming group  ,0,
edin,6335,4687242,Cannot tell based on the abstract,, Vital parameters , Placebo , Ashwagandha (Withania somnifera [L.] Dunal) ,0,
edin,6335,4687242,No significant difference,"There were no changes in the vital parameters such as pulse rate, blood pressure (systolic and diastolic), and respiratory at resting state in the subjects of both groups.", Vital parameters , Placebo , Ashwagandha (Withania somnifera [L.] Dunal) ,0,
edin,6298,5168495,Significantly increased,There was a statistically significant improvement in adherence in the intervention group compared to control at 3âmonths (mean MAQ score 0.42: 95% CI (0.27 to 0.57) vs 1.58: 95% CI (1.42 to 1.75); p<0.001)., Adherence at 3 months , Control group , Tailored intervention ,0,
edin,6424,1868022,Cannot tell based on the abstract,," Cervicovaginal lavages levels of IL-8, IL-1Î² and IL-6 ", No intervention at enrollment , Pap smear at enrollment ,0,
edin,6424,1868022,No significant difference,"CVLs from each participant were investigated for the presence of cervical inflammatory cytokines (IL-8, IL-1Î², IL-6, TNF-Î±, IL-12 p70 and IL-10) at baseline and follow-up (Figure 1; see also Additional file 1 and 2). We found that levels of IL-1Î² (Figure 1B), IL-8 (Figure 1C), and IL-6 (Figure 1D) did not differ significantly between baseline and follow-up in either the control group (left panels) or the intervention group (right panels) indicating that a Pap smear was not detectably associated with increases in these proinflammatory cytokines."," Cervicovaginal lavages levels of IL-8, IL-1Î² and IL-6 ", No intervention at enrollment , Pap smear at enrollment ,0,
edin,6359,3304380,No significant difference,"At the end of the study, the indices in all groups showed significant decreases in comparison to the first day (p< 0.05), except for the bleeding index in the group without SRP and drug therapy (p=0.111).", Improvement in Bleeding Index  ," Group 1(only extract), group 2 (only powder), group 3 (no medicament and no SRP), group 4 (extract and SRP), and group 5 (powder and SRP) ", Group 6 (only SRP) ,0,
edin,6149,5343026,Cannot tell based on the abstract,, craving , two type e-cigarettes , classic cigarette ,0,
edin,6149,5343026,Significantly increased,"Within-group repeated measures analyses showed a significant time effect, indicating an increase of participants' current Craving measure in group âC,â âHâ âE.â C group [F(5, 29) = 18.3 and p < 0.001]. H group [F(5, 29) = 3.9 and p < 0.001]. E group [F(5, 29) = 4.19 and p < 0.001] (Table 6).,In N and O group condition, we don't have a Craving effect differences.

In C group, craving measure increase over the course of the experiment from T1 to T6 time ratings; also, in H group, craving measure increase over the course of the experiment from T1 to T6 time ratings.

In E group, craving measure increase over the course of the experiment form T1 to T3 time ratings (see Figure 3).", craving , two type e-cigarettes , classic cigarette ,0,
edin,6388,4763824,Cannot tell based on the abstract,, Patient-Specific Functional Scale score 24 hours after injection , Intracutaneous isotonic saline injections (placebo) , Intracutaneous sterile water injection ,0,
edin,6388,4763824,Significantly increased,The PSFS score 1 day after treatment in the experimental group (6.2Â±1.8) was significantly higher compared with that in the control group (3.8Â±2.0; P<0.001)., Patient-Specific Functional Scale score 24 hours after injection , Intracutaneous isotonic saline injections (placebo) , Intracutaneous sterile water injection ,0,
edin,6409,3103853,Cannot tell based on the abstract,, Clinical scores at week 12 , Cyclosporine , Tacrolimus ,0,
edin,6409,3103853,Significantly increased,"There was a significant difference in the clinical scores between the CsA group and the tacrolimus group at week 12 (P = .040). The CsA group had lower clinical scores than the tacrolimus group at all time points, although this was not significant except at week 12.", Clinical scores at week 12 , Cyclosporine , Tacrolimus ,0,
edin,6414,4544795,Significantly increased,The BITT group improved significantly on the AK and significantly more on the performance and satisfaction scores of the COPM at 12 and 24Â weeks regarding several goals., ABILHAND-Kids logit unitsâ score at 12 and 18 weeks , No-BITT , BITT ,0,
edin,6394,3137438,No significant difference,"In both group 1 and group 2, microleakage increased after three months but this increase was not statistically significant (P>.05).", Microleakage after three months , No medication , Calcium hydroxide ,0,
edin,6395,3137438,Cannot tell based on the abstract,, Microleakage after one week , No medication , Calcium hydroxide ,0,
edin,6395,3137438,No significant difference,"Analysis of the results in both evaluation periods (one week and three months), showed no significant differences between group 1 (with calcium hydroxide medication) and group 2 (without calcium hydroxide medication) (P>.05). In both groups, microleakage increased after three months but this increase was not statistically significant (P>.05).", Microleakage after one week , No medication , Calcium hydroxide ,0,
edin,6382,3786549,Significantly increased,"The Controlled phase results for a change in VMI demonstrated superiority of the 0.03 mg estriolâlactobacilli combination to placebo (p < 0.001). In the test group, the positive change in VMI was 35.2%, compared to 9.9% in the placebo group. In the Open phase after the initial therapy, the VMI was increased to 55.4% and, during maintenance therapy, it stayed at a comparable level (52.8â49.4%).", Improvement in Vaginal Maturation Index , Placebo , Vaginal estriol plus viable Lactobacillus acidophilus KS400  ,0,
edin,6381,5404432,Cannot tell based on the abstract,, Rate of minor complications , Conventional flap , Cone of pressure flap ,0,
edin,6381,5404432,No significant difference,"Minor complications, defined as delayed healing and wound dehiscence that did not require surgical intervention, have been comparable between the 2 groups. There were similar occurrences of minor complications", Rate of minor complications , Conventional flap , Cone of pressure flap ,0,
edin,6351,4069731,Cannot tell based on the abstract,, Duration of diarrhea , No probiotic medication , Lactobacillus GG ,0,
edin,6351,4069731,Significantly decreased,"edian duration of diarrhoea was significantly (P<0.001) lesser by about 18 h in children who received LGG in comparison to control group (Fig. 2A, Table II).", Duration of diarrhea , No probiotic medication , Lactobacillus GG ,0,
edin,6393,5265791,Cannot tell based on the abstract,, Lenght of hospital stay after surgery , Saline group , Dexmedetomidine group ,0,
edin,6393,5265791,Significantly decreased,"The patients in the DEX group had better postoperative sleep quality (3.52âÂ±â0.308 vs 5.78âÂ±â0.415, Pâ<â0.001) and shorter postoperative hospital stay (8.15âÂ±â0.37 days vs 9.70âÂ±â0.63 days, Pâ=â0.045, Table 2) than those in the CON group.", Lenght of hospital stay after surgery , Saline group , Dexmedetomidine group ,0,
edin,6366,3790036,Significantly increased,"The PaO2 levels and alveolar-arterial difference in oxygen tension (AaDO2) were improved in patients with PEEPs compared with patients in whom PEEP was not used. The application of PEEP (10 cmH2O) resulted in higher PaO2 levels compared to those with lower PEEP levels, but excessive peak airway pressure (PAP) was sometimes observed.", Improvement in PaO2 levels  , No use of positive end-expiratory pressure , Use of positive end-expiratory pressure ,0,
edin,6353,4069731,Cannot tell based on the abstract,, Baseline characteristics and duration of symptoms before enrollment , No probiotic medication , Lactobacillus GG ,0,
edin,6353,4069731,No significant difference,"The baseline characteristics in the two groups were comparable in age, sex and anthropometry.", Baseline characteristics and duration of symptoms before enrollment , No probiotic medication , Lactobacillus GG ,0,
edin,6302,3929816,Cannot tell based on the abstract,, Pathologic changes in the liver , Intraabdominal pressure 12 mm Hg , Intraabdominal pressure 20 mm Hg ,0,
edin,6302,3929816,No significant difference,The pathologic changes at the liver were similar in both groups and were mild., Pathologic changes in the liver , Intraabdominal pressure 12 mm Hg , Intraabdominal pressure 20 mm Hg ,0,
edin,6396,4183584,Significantly increased,Results showed that schizophrenia patients with pro-social priming had significantly more nonverbal behaviors than schizophrenia patients with anti-social and non-social priming conditions., Nonverbal behaviors , Non-social or anti-social priming groups , Pro-social priming group  ,0,
edin,6305,3208342,No significant difference,"Directly after therapy there was a significant improvement of the TQ-score in both groups. Comparison of both groups revealed a trend toward more pronounced effects for the combined group (effect size: Cohenâs dâ=â0.176), but this effect did not reach significance.", TQ-score improvement , Only low-frequency left temporal rTMS  , Low-frequency right prefrontal followed by low-frequency left temporal rTMS ,0,
edin,6392,5265791,Cannot tell based on the abstract,, Rates of good postoperative sleep quality , Saline group , Dexmedetomidine group ,0,
edin,6392,5265791,Significantly increased,"The patients in the DEX group had better postoperative sleep quality (3.52âÂ±â0.308 vs 5.78âÂ±â0.415, Pâ<â0.001) and shorter postoperative hospital stay (8.15âÂ±â0.37 days vs 9.70âÂ±â0.63 days, Pâ=â0.045, Table 2) than those in the CON group.", Rates of good postoperative sleep quality , Saline group , Dexmedetomidine group ,0,
edin,6294,5466093,Cannot tell based on the abstract,, Markers of systemic inflammation , Protocolized standard of care , Preoperative oxygen delivery ,0,
edin,6294,5466093,No significant difference,Markers of systemic inflammation were similar between groups (Supplementary Figure S2)., Markers of systemic inflammation , Protocolized standard of care , Preoperative oxygen delivery ,0,
edin,6372,4048141,Significantly increased,"The percentage of patients who completed these studies with severity category shift from baseline â¥ 2 to end of study < 2 was significantly higher for vilazodone versus placebo on all MADRS items (odds ratio [OR] range, 1.4â1.7, P < .05) except reduced appetite (OR = 1.3, P = .232).", Severity category shift from â¥ 2 to &amp;lt; 2 on the reduced appetite MADRS item , Placebo , Vilazodone ,0,
edin,6290,5703870,No significant difference,"After 4 days, the T-EO and Af-EO solutions were significantly more effective than the WATER, reducing the BV, thickness, and CG of the PL-biofilm (P < 0.001). Although, both EO antiseptics presented a similar bactericidal activity, the Af-EO rinses led to more significant reductions in the thickness and CG of the PL-biofilm than the T-EO rinses (thickness = 7.90 vs. 9.92 Î¼m, P = 0.012; CG = 33.36 vs. 46.61%, P = 0.001).", Bacterial viability , Af-EO formulation , T-EO formulation  ,0,
edin,6376,4221328,No significant difference,None of the patients d, Acute kidney injury , Sevoflurane , Propofol ,0,
edin,6311,4300351,No significant difference,No significant intergroup differences were documented with regards to the mean number of transfused blood units and the mean length of hospital stay., Number of blood units transfused , Injection of adrenaline with mechanical therapy (haemostatic clips) (A + HC) , Injection of adrenaline solution and bipolar electrocoagulation (A + BE) ,0,
edin,6337,3726585,No significant difference,"Dairy and nondairy treatments did not produce significantly different mean SBP or DBP in the resting postprandial state or from premeal to 3.5 hours postmeal (SBP, 126.3 mmHg versus 124.9 mmHg; DBP, 76.5 mmHg versus 75.7 mmHg), premeal (2.35 versus 2.20) or 2 hours postmeal (2.33 versus 2.30) RHI, and premeal (22.5 versus 23.8) or 2 hours postmeal (12.4 versus 13.2) augmentation index.", Mean pre-prandial to post-prandial systolic and diastolic blood pressures  , Nondairy treatment , Dairy treatment ,0,
edin,6367,3790036,Cannot tell based on the abstract,, Improvement in PaO2 levels  ," 3, 5, and 7 cmH2O of positive end-expiratory pressure ", 10 cmH2O of positive end-expiratory pressure ,0,
edin,6367,3790036,No significant difference,"In the 10 PEEP group, the PaO2 levels were significantly higher after 1 h of CO2-insufflation compared with preinsufflation levels (P < 0.05), but there were no significant differences among the PEEP groups", Improvement in PaO2 levels  ," 3, 5, and 7 cmH2O of positive end-expiratory pressure ", 10 cmH2O of positive end-expiratory pressure ,0,
edin,6415,4544795,Significantly increased,The BITT group improved significantly on the AK and significantly more on the performance and satisfaction scores of the COPM at 12 and 24Â weeks regarding several goals., ABILHAND-Kids logit unitsâ score at 24 weeks , No-BITT , BITT ,0,
edin,6358,3304380,Cannot tell based on the abstract,," Changes in gingival index, alteration in plaque index, bleeding index, and probing pocket depth. ", Scaling and root planning , Treatment alone ,0,
edin,6358,3304380,No significant difference,"<td align=""left"" colspan=""1"" rowspan=""1"">Significance<xref ref-type=""table-fn"" rid=""TF0003"">â â </xref></td><td align=""left"" colspan=""1"" rowspan=""1"">F(3, 46)=14.68 <italic>p</italic>&lt;0.001</td><td align=""left"" colspan=""1"" rowspan=""1"">F(2, 70)=7.95 <italic>p</italic>&lt;0.001</td><td align=""left"" colspan=""1"" rowspan=""1"">F(3, 44.59)=20.01 <italic>p</italic>&lt;0.001</td><td align=""left"" colspan=""1"" rowspan=""1"">F(2, 58.53)=4.41 <italic>p</italic>=0.007</td><td align=""left"" colspan=""1"" rowspan=""1"">F(3, 51.68) <italic>p</italic>&lt;0.001</td>,Significant inter group differences were observed after analysis of pooled data from combined groups considering all indices [F (3, 51.68) =16.01, p<0.001]. Collectively, group C showed better outcomes when calculating the overall improvement in all 4 indices [3.24(Â±1.18)], followed by group A, D and B (Table 2),Medicaments with or without SRP were effective [Post Hoc Dunnett T3 (group A vs. B, p <0.001), (group C vs. D, p=0.002)], although SRP itself, had no remarkable effect [Post Hoc Dunnett T3 (group B vs. D, p=0.516), (group A vs. C, p=0.096).,Sole treatment with either SRP or medicament had the same impact [Post Hoc Dunnett T3 (group A vs. D), p=0.169],"," Changes in gingival index, alteration in plaque index, bleeding index, and probing pocket depth. ", Scaling and root planning , Treatment alone ,0,
edin,6313,3162205,Significantly increased,"The fusion mass volumes and bone absorption percentage at 12 months postoperatively were 2.49 mL (58.4%) and 1.89 mL (69.5%) for the Î²-CPP and autograft groups, respectively, and mean fusion mass volume was significantly higher in the Î²-CPP group.", Mean fusion mass volume , Autograft alone , Porous Î²-calcium pyrophosphate (Î²-CPP) plus autograft ,0,
edin,6338,3726585,Significantly increased,"Among subjects with endothelial dysfunction (RHI â¤ 1.67; n = 14) during the control treatment, premeal RHI was significantly higher in the dairy versus nondairy condition (2.32 versus 1.50, P = 0.002).", Pre-meal reactive hyperemia index in individuals with endothelial dysfunction , Nondairy treatment , Dairy treatment ,0,
edin,6324,4344344,No significant difference,"At 96 weeks, both RAL and Control maintained efficacy greater than 75% and continued to demonstrate similar safety profiles", Overall safety at 96 weeks , LPV/r with nucleoside/nucleotide reverse transcriptase inhibitors (Control) , Lopinavir/ritonavir (LPV/r) and raltegravir (RAL) ,0,
edin,6348,5662620,Cannot tell based on the abstract,, Negative emotions or total mental health difficulties , Wait-list control  , Positive psychology-based intervention ,0,
edin,6348,5662620,No significant difference,"There were no significant differences between the intervention and the control groups in changes in negative emotions, F(1,171) = 1.78, p = 0.19, Î·2 = 0.05, and in total mental health difficulties, F(1,171) = 1.63, p = 0.18, Î·2 = 0.04.", Negative emotions or total mental health difficulties , Wait-list control  , Positive psychology-based intervention ,0,
edin,6427,1868022,Cannot tell based on the abstract,, Baseline characteristics , No intervention at enrollment , Pap smear at enrollment ,0,
edin,6427,1868022,No significant difference,"Table 1 summarizes the socio-demographic, reproductive and sexual characteristics by randomization group; no significant differences were observed between these groups at baseline or at follow-up (in terms of any vaginal intercourse, number of acts of vaginal intercourse, condom use and use of any vaginal medications during the study follow-up period, data not shown).", Baseline characteristics , No intervention at enrollment , Pap smear at enrollment ,0,
edin,6318,3391000,No significant difference,Adding bisacodyl to G/PEG caused more abdominal bloating/cramps (P<0.01) and did not result in a cleaner colon (P=0.66) compared with G/PEG without bisacodyl., Colon cleanliness , Gatorade and polyethylene glycol (PEG) without bisacodyl , Gatorade and polyethylene glycol (PEG) with bisacodyl ,0,
edin,6422,3654355,Cannot tell based on the abstract,," Baseline characteristics, except age ", Waiting list control , Intensive lifestyle intervention (ILI) group ,0,
edin,6422,3654355,No significant difference,"Baseline characteristics of the participants who completed the study are shown in Table 1. The ILI-group was older than the control group, but no other significant differences between the two study groups were seen at baseline."," Baseline characteristics, except age ", Waiting list control , Intensive lifestyle intervention (ILI) group ,0,
edin,6419,3654355,Significantly decreased,"Compared to controls body weight (â17.0 (95% CI:ââ18.7, â15.3)âkg, P < 0.0001), fat mass (â15.2 (95% CI:ââ17.4, â13.1)âkg, P < 0.0001), fat free mass (â1.2 (95% CI:ââ2.2, â0.2)âkg, P = 0.016) and visceral fat (â86.6(95% CI:ââ97.4, â75.7)âcm2, P < 0.0001) were reduced in the ILI-group after 10â14 weeks.", Body weight , Waiting list control , Intensive lifestyle intervention (ILI) group ,0,
edin,6405,3170595,No significant difference,"There was no difference between the AZA- and MTX-groups in respect of prednisone dosing (apart from months 10 and 12), in quantitative MG Score improvement, proportions in sustained remission, frequencies of MG relapses, or adverse reactions and/or withdrawals", Myasthenia gravis relapses , Azathioprine , Methotrexate ,0,
edin,6287,5703870,Significantly decreased,"After 4 days, the T-EO and Af-EO solutions were significantly more effective than the WATER, reducing the BV, thickness, and CG of the PL-biofilm (P < 0.001). Although, both EO antiseptics presented a similar bactericidal activity, the Af-EO rinses led to more significant reductions in the thickness and CG of the PL-biofilm than the T-EO rinses (thickness = 7.90 vs. 9.92 Î¼m, P = 0.012; CG = 33.36 vs. 46.61%, P = 0.001).", Reduction of thickness and CG of the PL-biofilm , Af-EO formulation , T-EO formulation ,0,
edin,6301,3929816,Cannot tell based on the abstract,, Baseline characteristics and general anesthesia procedure , Intraabdominal pressure 12 mm Hg , Intraabdominal pressure 20 mm Hg ,0,
edin,6301,3929816,No significant difference,"There were no differences between dogs in body weight, age and the procedure of general anesthesia. In heart rate evaluation at equal intervals, no significant differences were observed over time between the two groups. Also in respiratory rate, there were no significant differences (P>0.05)", Baseline characteristics and general anesthesia procedure , Intraabdominal pressure 12 mm Hg , Intraabdominal pressure 20 mm Hg ,0,
edin,6352,4069731,Significantly increased,"Also, there was faster improvement in stool consistency in children receiving Lactobacillus GG than control group [36 (30-36) h vs. 42 (36-48) h; P<0.001].",  Improvement in faeces consistency , No probiotic medication , Lactobacillus GG ,0,
edin,6343,3381083,No significant difference,"Uncorrected visual acuity â¥ 20/20 and â¥ 20/40 was achieved in 90.9% versus 93.4% (P = 0.08), and 98.9% versus 99.5% (P = 0.36) of eyes in the alcohol and mechanical groups, respectively.", Uncorrected visual acuity â¥ 20/20 and â¥ 20/40 , Mechanical epithelial removal , Alcohol-assisted epithelial removal ,0,
edin,6416,4544795,Cannot tell based on the abstract,, Grasp finger score , no-BoNT-A and BITT-only , BoNT-A and BoNT-Aâ+âBITT ,0,
edin,6416,4544795,Significantly increased,"The grasp finger score of the sandwich-making task differed significantly at 6Â weeks comparing BoNT-A to no-BoNT-A (1.18 to 1.88 versus 1.69 to 1.60, p 0.011) and comparing BoNT-Aâ+âBITT to BITT-only (1.78 to 1.84 versus 1.76 to 1.63, p 0.020) favouring BoNT-A.", Grasp finger score , no-BoNT-A and BITT-only , BoNT-A and BoNT-Aâ+âBITT ,0,
edin,6356,3304380,Significantly decreased,More precise analysis of data revealed that SRP in association with Frankincense application (either extract or powder) can lead to remarkable decrease in inflammatory indices in comparison to the groups without SRP and drug therapy (p<0.001)., Inflammatory indices ," Group 1(only extract), group 2 (only powder), group 3 (no medicament and no SRP), and group 6 (only SRP) ", Group 4 (extract and SRP) and group 5 (powder and SRP)  ,0,
edin,6401,5133722,Cannot tell based on the abstract,, Baseline demographic characteristics , Placebo , Intranasal salmon calcitonin ,0,
edin,6401,5133722,No significant difference,"There is no statistical difference between the two groups in demographics (Table 1). Also, there is homogeneity between the two groups regarding demographic characteristics.", Baseline demographic characteristics , Placebo , Intranasal salmon calcitonin ,0,
edin,6556,4099602,Cannot tell based on the abstract,, Clinical complications  , Control , Intrapulmonary percussive ventilation ,0,
edin,6556,4099602,No significant difference,Blood gas analysis (days 1 and 3) and frequency of postoperative clinical complications were not statistically different., Clinical complications  , Control , Intrapulmonary percussive ventilation ,0,
edin,6491,4620004,Significantly decreased,"An overall improvement was achieved in total cholesterol levels (Mean Difference âMD-â=ââ19.60; 95 % CI: â15.33 at â23.87Â mg/dl; pâ<â0.001), LDL-cholesterol levels (MDâ=ââ13.78; 95 % CI: â9.77 at â17.79Â mg/dl; pâ<â0.001) and triglycerides (MDâ=ââ19.14; CI 95 %: â11.29 at â26.99Â mg/dl; pâ<â0.001).", Low density lipoprotein  , Standard practice , Motivational interviewing  ,0,
edin,6462,4371718,No significant difference,"Although serum levels of osteocalcin and alkaline phosphatase biomarkers and total serum calcium were not significantly different within and between study groups, their levels were increased in tail suspension model compared to control group.", Osteocalcin , Hind-limb suspension , Calcitriol + Hind-limb suspension ,0,
edin,6500,4293505,Significantly decreased,"Incidence of nausea and the need for rescue antiemetics, verbal rating scale (VRS) 1 hour pain value, ketorolac consumption, and incidence of shivering were significantly lower in group R and group RD, than in group C (P < 0.05).,Moreover, these parameters were significantly lower in group RD than in group R (P < 0.05).", Ketorolac consumption , Ramosetron , Dexamethasone + ramosetron ,0,
edin,6601,5384512,Significantly increased,"For 1.25/1.75-mg pooled versus placebo, mean changes from baseline to study end were +0.7 versus +0.2 satisfying sexual events/month (p = 0.0180), +3.6 versus +1.9 female sexual function index total score (p = 0.0017), â11.1 versus â6.8 female sexual distress scale-desire/arousal/orgasm total score (p = 0.0014)", Sexual distress improvement  , Placebo , Bremelanotide 1.25 ,0,
edin,6458,5301061,Significantly increased,"However in the posttest step and follow-up stage, the mean scores of spiritual wellbeing, the religious dimension, and the existential aspect of spiritual wellbeing in the experimental group was significantly higher than in the control group (P < 0.001).", Religious dimension improvement right after test  , Control  , Religious programs ,0,
edin,6459,5301061,Cannot tell based on the abstract,, Religious dimension improvement 1 month after test  , Control  , Religious programs ,0,
edin,6459,5301061,Significantly increased,"In other words, the effect of time on the spiritual health score and its religious and spiritual dimensions was not equal in control and test groups, and as the table indicates, in the control group, the spiritual health score and its religious and spiritual dimensions were roughly similar before, during, and after intervention; however, in the test group, the spiritual health score and its religious and spiritual dimensions increased over time.", Religious dimension improvement 1 month after test  , Control  , Religious programs ,0,
edin,6593,4734818,No significant difference,"IOP values with noncontact tonometry at 1, 2, 4, 24, and 48 hours were not statistically significant (P>0.05) for both the groups.", Intraocular pressure after 1 hour , Control , Hydroxypropylmethylcellulose ,0,
edin,6553,4033571,No significant difference,Adverse event types reflected the drug's established profile. Adverse event frequency was consistent with a pharmacokinetic profile in which SPN-804 produces lower peak plasma concentrations vs immediate-release OXC., Adverse effects  , Control , Extended-release oxcarbazepine 1200 mg ,0,
edin,6546,5033379,Significantly increased,"A higher number of facilities in the intervention arm had all appropriate drugs, equipment and supplies to deal with gestational hypertension (19 vs.3, OR (odds ratio) 9.2, 95% C.I 2.5 to33.6), postpartum haemorrhage (29 vs. 12, OR 3.7, 95% C.I 1.6 to8.3); and obstructed labour (25 vs.9, OR 3.4, 95% CI 1.6 to8.3).", Readiness for managing obstructed labour  , Control , Onsite Nurse Mentoring ,0,
edin,6521,4061622,Cannot tell based on the abstract,, Stress  , Control , Religious prayers ,0,
edin,6521,4061622,Significantly decreased,"Paired t-test showed a significant difference in anxiety, stress, and depression in the study group before and after intervention (P < 0.05), but in the control group in which no extra intervention except routine interventions were administered, no significant difference was observed.", Stress  , Control , Religious prayers ,0,
edin,6501,4293505,Cannot tell based on the abstract,, Adverse effects , Ramosetron , Dexamethasone + ramosetron ,0,
edin,6501,4293505,No significant difference,There were no clinically serious adverse events attributed to dexamethasone., Adverse effects , Ramosetron , Dexamethasone + ramosetron ,0,
edin,6478,5471569,Cannot tell based on the abstract,Visuospatial ability however did impact correct answers at F(1) = 5.63 and p = .02., Amount of correct answers  , Control , Digital stereopsis ,0,
edin,6478,5471569,No significant difference,The ANCOVA to assess the influence of digitally implemented stereopsis on virtual learning showed no effect of experimental condition on either reaction times or correct answers, Amount of correct answers  , Control , Digital stereopsis ,0,
edin,6467,5380277,Cannot tell based on the abstract,, Blood loss , Control , Heated infusions  ,0,
edin,6467,5380277,No significant difference,"As shown in Table 2, no significant difference was observed in terms of blood loss, transfusion volume, and blood transfusion volume between control group and warming infusion group (Pâ>â0.05).", Blood loss , Control , Heated infusions  ,0,
edin,6436,4092903,No significant difference,Ruminal temperature and pH were not significantly affected by MUP supplementation while NH3-N concentration was increased (p<0.05) and maintained at a high level (18.5 mg/dl) with supplementation of MUP at 600 g/hd/d., Ruminal pH , Mulberry leaf pellet at 200 g/hd/d , Mulberry leaf pellet at 600 g/hd/d ,0,
edin,6550,4033571,Significantly increased,"When data were analyzed separately for study site clusters, a post hoc analysis demonstrated that both SPN-804 dosages were significantly superior to placebo in median percent seizure reduction (placebo: â13.3%; 1200Â mg: â34.5%, PÂ =Â 0.02; 2400Â mg: â52.7%, PÂ =Â 0.006) in the North American study site cluster.", Overall seizure median percent improvement  , Control , Extended-release oxcarbazepine 2400 mg ,0,
edin,6489,5419060,Cannot tell based on the abstract,, Preanalytical  errors , Control , Phlebotomy training programme ,0,
edin,6489,5419060,No significant difference,"Unaccountable preanalytical errors, because of âage of sample > 3 daysâ also contributed to many of the blood sample rejections, 11 (0.04%) rejected samples pre-training and 7 (0.31%) post-training (Figure 3).,<td align=""left"" colspan=""1"" rowspan=""1"">Unaccountable preanalytical errors</td><td align=""center"" colspan=""1"" rowspan=""1"">46 (0.32)</td><td align=""center"" colspan=""1"" rowspan=""1"">51 (0.30)</td><td align=""center"" colspan=""1"" rowspan=""1"">0.73</td><td align=""center"" colspan=""1"" rowspan=""1"">-11.59 to 9.09</td>", Preanalytical  errors , Control , Phlebotomy training programme ,0,
edin,6540,3892495,Significantly decreased,"Plasma FFA levels were also significantly lower in the CHO compared to the CON at 30, 45 and 60 min.", Free fatty acid , Control , Pre-exercise meal ,0,
edin,6488,5419060,Cannot tell based on the abstract,, Request-form errors , Control , Phlebotomy training programme ,0,
edin,6488,5419060,No significant difference,"Request form errors improved post-training from 11 (0.15%) pre-training to 8 (0.08%) post-training.,<td align=""left"" colspan=""1"" rowspan=""1"">Request form errors</td><td align=""center"" colspan=""1"" rowspan=""1"">25 (0.17)</td><td align=""center"" colspan=""1"" rowspan=""1"">26 (0.15)</td><td align=""center"" colspan=""1"" rowspan=""1"">0.85</td><td align=""center"" colspan=""1"" rowspan=""1"">-4.23 to 3.73</td>", Request-form errors , Control , Phlebotomy training programme ,0,
edin,6564,3551224,Significantly increased,"Combination therapy was statistically superior to methotrexate in obtaining higher ACR20/50/70 responses, more clinical remissions, greater mean reductions in DAS28(CRP), no radiographic progression, and normal functional status at week 26 (p<0.001 for all).", DAS28 improvement  , MTX , Adalimumab +MTX ,0,
edin,6453,4140394,Cannot tell based on the abstract,, OSCE  total score 1 month after procedure , Text/image e-learning , Video e-learning  ,0,
edin,6453,4140394,Significantly increased,"The OSCE showed significant differences between the two groups both in the primary test (P=0.001) and follow-up test (P=0.01).,Based on our findings, we conclude that video-based e-learning is superior to illustrated text-based e-learning when teaching certain practical clinical skills, such as the DixâHallpike test.", OSCE  total score 1 month after procedure , Text/image e-learning , Video e-learning  ,0,
edin,6532,3302141,No significant difference,"No significant intervention effect was found for serum lipid profile, high-sensitive C-reactive protein or for adiponectin.", High-sensitive C-reactive protein , Control , Behavioral lifestyle intervention ,0,
edin,6566,3551224,Significantly increased,"Combination therapy was statistically superior to methotrexate in obtaining higher ACR20/50/70 responses, more clinical remissions, greater mean reductions in DAS28(CRP), no radiographic progression, and normal functional status at week 26 (p<0.001 for all).", Achieving normal functional status  , MTX , Adalimumab +MTX ,0,
edin,6571,2769033,Significantly increased,More falls (P<0.001) and injuries (P=0.03) were recorded in the intervention group., Falls , Control , Primary care based exercise programme  ,0,
edin,6524,3788226,Significantly decreased,The atlantooccipital distance (AOD) traversed while using Truview laryngoscope was significantly less than with Macintosh blade (26%; P = 0.001)., Atlantooccipital distance , Macintosh laryngoscope , Truview laryngoscope ,0,
edin,6506,3333807,Cannot tell based on the abstract,, Brain natriuretic peptide , Control , Aliskiren ,0,
edin,6506,3333807,No significant difference,"Although there were no statistically significant differences in BNP and d-ROM level between the aliskiren group and the aliskiren-withdrawal group at baseline and at month 2, BNP showed a tendency to be higher in the aliskiren-withdrawal group (Table 1).", Brain natriuretic peptide , Control , Aliskiren ,0,
edin,6474,5643995,Cannot tell based on the abstract,, Depth of sealer penetration at coronal third , Ethylenediaminetetraacetic acid  , Chitosan ,0,
edin,6474,5643995,No significant difference,"Despite the results showing nonsignificant difference in depth of sealer penetration at coronal and middle third between Group A (chitosan) and Group B (EDTA), a statistically significant difference was observed at apical third (P < 0.05).", Depth of sealer penetration at coronal third , Ethylenediaminetetraacetic acid  , Chitosan ,0,
edin,6531,3302141,No significant difference,"No significant intervention effect was found for serum lipid profile, high-sensitive C-reactive protein or for adiponectin.", Lipid profile , Control , Behavioral lifestyle intervention ,0,
edin,6508,3637243,Cannot tell based on the abstract,, Infarct size , Control , Lixisenatide ,0,
edin,6508,3637243,Significantly decreased,Treatment with lixisenatide significantly reduced infarct-size when starting 10Â min prior to end of ischemia (FigureÂ 1)., Infarct size , Control , Lixisenatide ,0,
edin,6461,5301061,Significantly increased,". However in the posttest step and follow-up stage, the mean scores of spiritual wellbeing, the religious dimension, and the existential aspect of spiritual wellbeing in the experimental group was significantly higher than in the control group (P < 0.001).", Spiritual existential aspect 1 month after test  , Control  , Religious programs ,0,
edin,6558,4099602,Cannot tell based on the abstract,,  Subjective dyspnoea , Control , Intrapulmonary percussive ventilation ,0,
edin,6558,4099602,Significantly decreased,Subjective dyspnoea sensation is less in the patients of the IPV group.,  Subjective dyspnoea , Control , Intrapulmonary percussive ventilation ,0,
edin,6530,3302141,Significantly decreased,"An intervention effect after 1 year was found for adiposity (P=0.02 for BMI-SDS, P=0.03 for waist circumference (WC)-SDS), physical fitness (absolute measured peak value of oxygen uptake (mlâminâ1), standardized for age and gender (VO2peak-SDS), P<0.01) and insulin resistance (HOMA-SDS, P=0.04).", Insulin resistance , Control , Behavioral lifestyle intervention ,0,
edin,6545,5033379,Significantly increased,"The providers in the intervention arm had better knowledge of active management of the third stage of labour (82.4% vs.35.8%, AOR (adjusted odds ratio) 10, 95% C.I 5.5 to 18.2); management of maternal sepsis (73.5% vs. 10.9%, AOR 36.1, 95% C.I 13.6 to 95.9); neonatal resuscitation (48.5% vs.11.7%, AOR 10.7, 95% C.I 4.6 to 25.0) and low birth weight newborn care (58.1% vs. 40.9%, AOR 2.4, 95% C.I 1.2 to 4.7).", Readiness for managing maternal sepsis , Control , Onsite Nurse Mentoring ,0,
edin,6595,4734818,Cannot tell based on the abstract,, Uncorrected visual acuity after 15 days , Control , Hydroxypropylmethylcellulose ,0,
edin,6595,4734818,No significant difference,"At 15 days postoperatively, IOP (NCT), uncorrected visual acuity, postoperative vault on AS-OCT (Optovue, Fremont, CA, USA), and ECD were comparable between both the groups (P>0.05) (Table 1).", Uncorrected visual acuity after 15 days , Control , Hydroxypropylmethylcellulose ,0,
edin,6529,3302141,Significantly increased,"An intervention effect after 1 year was found for adiposity (P=0.02 for BMI-SDS, P=0.03 for waist circumference (WC)-SDS), physical fitness (absolute measured peak value of oxygen uptake (mlâminâ1), standardized for age and gender (VO2peak-SDS), P<0.01) and insulin resistance (HOMA-SDS, P=0.04)", Physical fitness , Control , Behavioral lifestyle intervention ,0,
edin,6526,3788226,Significantly increased,"Truview blade produced a better laryngoscopic view (P = 0.005) than Macintosh blade, but had a longer time to laryngoscopy (P = 0.04).", Laryngoscopy time , Macintosh laryngoscope , Truview laryngoscope ,0,
edin,6475,5643995,Cannot tell based on the abstract,, Depth of sealer penetration at middle third , Ethylenediaminetetraacetic acid  , Chitosan ,0,
edin,6475,5643995,No significant difference,"Despite the results showing nonsignificant difference in depth of sealer penetration at coronal and middle third between Group A (chitosan) and Group B (EDTA), a statistically significant difference was observed at apical third (P < 0.05).", Depth of sealer penetration at middle third , Ethylenediaminetetraacetic acid  , Chitosan ,0,
edin,6535,5406030,No significant difference,"There was no significant difference in the proportion of patients with unplanned rehospitalisations (mean difference 0.17%, 95% CI -8.85;8.51), and in QALYs (mean difference -0.0085, 95% CI -0.0170;0.0001).", Drug-related rehospitalisation , Control , COACH program ,0,
edin,6517,5493377,No significant difference,"CPM only improved in the AT+EX group but no between-group difference was observed (p = 0.054, partial Î·2 = 0.158).", Conditioned pain modulation , Control , Transcranial direct current stimulation ,0,
edin,6479,4270681,No significant difference,"The overall incidence of awareness in the BIS and routine monitoring groups were 5.5% and 4.1%, which was not significantly different.", Patient awareness  , Control , Bispectral monitoring  ,0,
edin,6539,3892495,Significantly decreased,"The fat oxidation rate in the CHO was significantly lower than the CON while walking for 5~15, 25~35 and 45~55 min.", Fat oxidation rate  , Control , Pre-exercise meal ,0,
edin,6590,5762965,Cannot tell based on the abstract,, Hypercalcemia  , Calcifediol , Paricalcitol ,0,
edin,6590,5762965,No significant difference,"Overall, hypercalcemia, defined as serum calcium >10.3 mg/dl, was reported in 7.1% and 4.7% in the PAR and CAL groups, respectively (PÂ = 0.67). Hypercalcemia that caused dose adjustment of study medications was numerically higher in the PAR group. At month 1, hypercalcemia was observed inÂ 7% and 2.2% in the PAR and CAL groups, respectively (PÂ = 0.35). At month 3, hypercalcemia was observed in 12.2% and 4.4% in the PAR and CAL groups, respectively (PÂ = 0.19).TableÂ 3", Hypercalcemia  , Calcifediol , Paricalcitol ,0,
edin,6472,5380277,Cannot tell based on the abstract,, Extubation time  , Control , Heated infusions  ,0,
edin,6472,5380277,Significantly decreased,"Additionally, the mean time to extubation in the control group was significantly longer than that in the warming infusion group (11.13âÂ±â1.34âminutes vs 10.09âÂ±â1.91âminutes, Pâ=â0.015).", Extubation time  , Control , Heated infusions  ,0,
edin,6455,4140394,Cannot tell based on the abstract,, Student satisfaction  , Text/image e-learning , Video e-learning  ,0,
edin,6455,4140394,Significantly increased,"Secondary outcomes were the difference in self-evaluated skills and satisfaction with the teaching material.,The OSCE showed significant differences between the two groups both in the primary test (P=0.001) and follow-up test (P=0.01).,Further analysis of the OSCE results revealed, that the result was primarily due to the differences in the procedural scores (P<0.001 in primary test; P=0.005 in follow-up test), while there were no significant differences in scores for the theoretical part (P=0.9; P=0.6).", Student satisfaction  , Text/image e-learning , Video e-learning  ,0,
edin,6442,4672844,No significant difference,The results obtain after analysis showed no significant differences in the fracture resistance between the two tested groups of endodontic sealers., Fracture resistance , Control , Gutta-percha ,0,
edin,6514,5493377,No significant difference,"Pain reduced in both groups following treatment (AT+EX: p<0.001, partial Î·2 = 0.55; ST+EX: p = 0.026, partial Î·2 = 0.18) but no between-group differences were observed (p = 0.18, partial Î·2 = 0.08). F", Pain , Control , Transcranial direct current stimulation ,0,
edin,6503,3333807,Significantly decreased,"Plasma renin activity, angiotensin I, and angiotensin II decreased from baseline to month 20 (plasma renin activity (ng/mL/h): 2.3 Â± 2.6 to 0.3 Â± 0.4 (P < 0.05), angiotensin I (pg/mL): 909.1 Â± 902.5 to 41.5 Â± 14.8 (P < 0.05), angiotensin II (pg/mL): 41.5 Â± 45.8 to 11.0 Â± 4.9 (P < 0.05)).", Plasma renin activity , Control , Aliskiren ,0,
edin,6599,5384512,Significantly increased,"For 1.25/1.75-mg pooled versus placebo, mean changes from baseline to study end were +0.7 versus +0.2 satisfying sexual events/month (p = 0.0180), +3.6 versus +1.9 female sexual function index total score (p = 0.0017), â11.1 versus â6.8 female sexual distress scale-desire/arousal/orgasm total score (p = 0.0014).", Sexual function index total score , Placebo , Bremelanotide 1.25 ,0,
edin,6525,3788226,Significantly increased,"Truview blade produced a better laryngoscopic view (P = 0.005) than Macintosh blade, but had a longer time to laryngoscopy (P = 0.04).", Appropriate laryngoscopic view , Macintosh laryngoscope , Truview laryngoscope ,0,
edin,6516,5493377,Significantly increased,AT+EX produced greater improvements in PPTs than ST+EX (p<0.05) (superolateral knee: partial Î·2 = 0.17; superior knee: partial Î·2 = 0.3; superomedial knee: partial Î·2 = 0.26)., Pressure pain thresholds improvement , Control , Transcranial direct current stimulation ,0,
edin,6450,4140394,Cannot tell based on the abstract,, Multiple-choice questionnaire right after procedure , Text/image e-learning , Video e-learning  ,0,
edin,6450,4140394,No significant difference,"For the MCQ, there were no statistically significant differences between the two groups in the primary test, but the video group performed statistically better in procedural questions (P=0.04) for the follow-up test. T", Multiple-choice questionnaire right after procedure , Text/image e-learning , Video e-learning  ,0,
edin,6536,5406030,No significant difference,"Total costs for the COACH program were non-significantly lower than usual care (-â¬1160, 95% CI -3168;847). Cost-effectiveness planes showed that the program was not cost-effective compared with usual care for unplanned rehospitalisations and QALYs gained.", Lost productivity costs , Control , COACH program ,0,
edin,6574,5966460,Cannot tell based on the abstract,, Protein expression , Hydroxyethylcellulose gel , Carbopol  gel ,0,
edin,6574,5966460,Significantly increased,"In both placebo gel formulations, significant intra-macaque differences in protein expression were observed between the averaged baseline and the 2âhours post-gel timepoint, with carbopol inducing more changes (76/382 proteins (19.9%), pâ<â0.017) than HEC (36/382 (9.4%), pâ<â0.0073) (two-tailed, paired t test, Local FDRâ<5%).", Protein expression , Hydroxyethylcellulose gel , Carbopol  gel ,0,
edin,6570,2769033,Cannot tell based on the abstract,, Lipids levels  , Control , Primary care based exercise programme  ,0,
edin,6570,2769033,No significant difference,There was also no significant difference in the proportions on antihypertensive (P=0.90) or lipid lowering (P=0.80) drugs between the groups over the two years. Adjustment for medication did not significantly change the results on blood pressure and lipid outcome in sensitivity analyses., Lipids levels  , Control , Primary care based exercise programme  ,0,
edin,6583,5661713,Significantly increased,there was found a significant moderate positive correlation (r = 0.508; P = 0.007) between headache intensity and serum glutamate levels after amitriptyline 12.5 mg administration., Serum glutamate levels , Control , Amitriptiline 12.5 mg ,0,
edin,6468,5380277,Cannot tell based on the abstract,, Surgery time  , Control , Heated infusions  ,0,
edin,6468,5380277,Significantly decreased,"However, the operation time of patients who received fluid kept at room temperature was significantly longer than that of patients who received warmed infusion (3.094âÂ±â0.254âmin vs 2.925âÂ±â0.216âmin, Pâ<â0.05).", Surgery time  , Control , Heated infusions  ,0,
edin,6454,4140394,Significantly increased,"Regarding theoretical knowledge, no differences were found between the groups on the primary test, though the video group performed better on the follow-up test (P=0.04).", OSCE theoretical part score  , Text/image e-learning , Video e-learning  ,0,
edin,6567,2769033,Cannot tell based on the abstract,"At baseline, 10% of intervention participants and 11% of control participants were achieving 150 minutes of at least moderate intensity physical activity a week.,SF-36 physical functioning (P=0.03) and mental health (P<0.05) scores improved more in intervention compared with control participants, but role physical scores were significantly lower (P<0.01).", Weekly physical activity , Control , Primary care based exercise programme  ,0,
edin,6567,2769033,Significantly increased,"Mean physical activity levels, however, were higher (P=0.01) and a greater proportion reached the target of 150 minutes of at least moderate intensity physical activity in the intervention group compared with the control group at 12 months (233 (43%) v 165 (30%), (P<0.001), with levels declining but still significantly different at two years (214 (39%) v 179 (33%), fig 2 and table 2).", Weekly physical activity , Control , Primary care based exercise programme  ,0,
edin,6484,5419060,No significant difference,"The sample rejection rate was 0.79% (n = 60) at CHC A, 1.13% (n = 45) at CHC B, 1.64% (n = 38) at CDC C and 1.36% (n = 8) at CDC D pre-training. The rejection rate remained approximately the same post-training (p > 0.05).", Sample rejection rate  , Control , Phlebotomy training programme ,0,
edin,6439,4092903,Cannot tell based on the abstract,, Cellulolytic bacteria , Mulberry leaf pellet at 200 g/hd/d , Mulberry leaf pellet at 600 g/hd/d ,0,
edin,6439,4092903,Significantly increased,"As shown in Table 4, total viable, amylolytic bacteria, proteolytic bacteria and cellulolytic bacteria counts were enhanced by MUP levels and significantly higher (p<0.05) at 400 and 600 g/hd/d of MUP supplementation when compared to control treatment.,The results of this study demonstrated that cellulolytic bacteria groups were influenced by diets while the methanogenic bacteria were similar among treatments.", Cellulolytic bacteria , Mulberry leaf pellet at 200 g/hd/d , Mulberry leaf pellet at 600 g/hd/d ,0,
edin,6598,5384512,Significantly increased,"For 1.25/1.75-mg pooled versus placebo, mean changes from baseline to study end were +0.7 versus +0.2 satisfying sexual events/month (p = 0.0180), +3.6 versus +1.9 female sexual function index total score (p = 0.0017), â11.1 versus â6.8 female sexual distress scale-desire/arousal/orgasm total score (p = 0.0014).", Satisfying sexual events/month , Placebo , Bremelanotide 1.75 ,0,
edin,6579,4355443,Cannot tell based on the abstract,, Time-to-locally-non-treatable-progression , Drug-eluting bead transarterial chemoembolization , Selective internal radiotherapy ,0,
edin,6579,4355443,No significant difference,"<td align=""left"">nTTP</td><td align=""char"" char=""("">488 (148/925); 490&nbsp;Â±&nbsp;114</td><td align=""char"" char=""("">647 (182/â); 416&nbsp;Â±&nbsp;83</td><td align=""left"">
<italic>p</italic>&nbsp;=&nbsp;0.9322</td>,There was no significant difference between groups with respect to TTP (371Â days after SIRT versus 336Â days after TACE) and nTTP (488 after SIRT versus 647Â days after TACE) (TableÂ 3).", Time-to-locally-non-treatable-progression , Drug-eluting bead transarterial chemoembolization , Selective internal radiotherapy ,0,
edin,6451,4140394,Cannot tell based on the abstract,, Procedural questions 1 month after procedure  , Text/image e-learning , Video e-learning  ,0,
edin,6451,4140394,Significantly increased,"For the MCQ, there were no statistically significant differences between the two groups in the primary test, but the video group performed statistically better in procedural questions (P=0.04) for the follow-up test.,Further analysis of the OSCE results revealed, that the result was primarily due to the differences in the procedural scores (P<0.001 in primary test; P=0.005 in follow-up test), while there were no significant differences in scores for the theoretical part (P=0.9; P=0.6).", Procedural questions 1 month after procedure  , Text/image e-learning , Video e-learning  ,0,
edin,6496,4293505,Significantly decreased,"Incidence of nausea and the need for rescue antiemetics, verbal rating scale (VRS) 1 hour pain value, ketorolac consumption, and incidence of shivering were significantly lower in group R and group RD, than in group C (P < 0.05). Moreover, these parameters were significantly lower in group RD than in group R (P < 0.05).", Nausea , Control , Dexamethasone + ramosetron ,0,
edin,6433,3697207,Significantly decreased,"Over the study period, plantar fascia thickness significantly reduced in the ESWT group (4.1 Â± 1.3 to 3.6 Â± 1.2 mm, P < 0.001), but slightly increased in the sham group (4.1 Â± 0.8 to 4.5 Â± 0.9 mm, P = 0.03).", Plantar fascia thickness , Control , Extracorporeal shock wave therapy ,0,
edin,6509,3637243,Cannot tell based on the abstract,, Left ventricular total area  , Control , Lixisenatide ,0,
edin,6509,3637243,No significant difference,There were no differences between the different treatment groups regarding left ventricular total area (543âÂ±â16Â mm2 for placebo versus 505âÂ±â7Â mm2 for lixisenatide treatment) left ventricular risk area (306âÂ±â9Â mm2 for placebo versus 288âÂ±â5Â mm2 for lixisenatide treatment)., Left ventricular total area  , Control , Lixisenatide ,0,
edin,6446,2909923,No significant difference,"Plasma glucose, blood lactate, and respiratory exchange ratio during the 2-hour ride, as well as VO2 peak, were not affected by creatine supplementation.", Respiratory exchange ratio  , Control , Creatine supplementation  ,0,
edin,6470,5380277,Cannot tell based on the abstract,, Eye opening time  , Control , Heated infusions  ,0,
edin,6470,5380277,Significantly decreased,"Patients from the control group presented longer time to spontaneous breath, eye opening, and consciousness recovery than patients from the warming infusion group (spontaneous breath, 4.47âÂ±â0.84âminutes vs 4.06âÂ±â0.72âminutes, Pâ=â0.042; eye opening, 8.66âÂ±â2.03âminutes vs 6.72âÂ±â1.73âminutes, Pâ<â0.001; consciousness recovery, 11.19âÂ±â1.49âminutes vs 9.91âÂ±â1.91âminutes, Pâ=â0.004).", Eye opening time  , Control , Heated infusions  ,0,
edin,6465,4371718,No significant difference,"Although serum levels of osteocalcin and alkaline phosphatase biomarkers and total serum calcium were not significantly different within and between study groups, their levels were increased in tail suspension model compared to control group.,The levels of these biomarkers were lower in those who were submitted to tail suspension model and received calcitriol supplementation compared to those who were only submitted to tail suspension (60.14âÂ±â11.73Â ng/mL vs. 58.29âÂ±â2.69Â ng/mL; pâ=â0.696 for osteocalcin and 381.86âÂ±â99.16Â mU/mL vs. 362.57âÂ±â27.41âng/mL; pâ=â0.635 for alkaline phosphatase).", Alkaline phosphatase , Control  , Calcitriol + Hind-limb suspension ,0,
edin,6578,4355443,Cannot tell based on the abstract,, Time to progression , Drug-eluting bead transarterial chemoembolization , Selective internal radiotherapy ,0,
edin,6578,4355443,No significant difference,"Median progression-free survival (PFS) was 180Â days for SIRT versus 216Â days for TACE patients (pÂ =Â 0.6193) with a median TTP of 371Â days versus 336Â days, respectively (pÂ =Â 0.5764).", Time to progression , Drug-eluting bead transarterial chemoembolization , Selective internal radiotherapy ,0,
edin,6432,3813126,Cannot tell based on the abstract,, Peak expiratory flow rate , Control , Atorvastatin ,0,
edin,6432,3813126,No significant difference,"There were no significant difference between the alterations of PEFR, FEV1 and FEV1% in neither placebo nor atorvastatin group.", Peak expiratory flow rate , Control , Atorvastatin ,0,
edin,6582,5661713,Significantly decreased,"<td align=""left"" colspan=""1"" rowspan=""1"">Flunarizine</td><td align=""center"" colspan=""1"" rowspan=""1""></td><td align=""center"" colspan=""1"" rowspan=""1""></td><td align=""center"" colspan=""1"" rowspan=""1""></td><td align=""center"" colspan=""1"" rowspan=""1""></td><td align=""center"" colspan=""1"" rowspan=""1""></td>", Serum glutamate levels , Control , Flunarizine 10 mg ,0,
edin,6429,3813126,No significant difference,"Changes in airway responsiveness categories (moderate to severe, mild, borderline, normal) after the intervention were not significant in atorvastatin group as in placebo group (p-value= 0.131 for atorvastatin group and p-value = 0.305 for placebo group).", Mild to borderline airway responsiveness , Control , Atorvastatin ,0,
edin,6534,5406030,No significant difference,"There was no significant difference in the proportion of patients with unplanned rehospitalisations (mean difference 0.17%, 95% CI -8.85;8.51), and in QALYs (mean difference -0.0085, 95% CI -0.0170;0.0001).", Quality-adjusted life-years  , Control , COACH program ,0,
edin,6569,2769033,Significantly increased,"At 12 months rates increased to 43% and 30% and at 24 months to 39.3% and 32.8% (P<0.001), respectively. SF-36 physical functioning (P=0.03) and mental health (P<0.05) scores improved more in intervention compared with control participants, but role physical scores were significantly lower (P<0.01).", SF-36 mental health improvement  , Control , Primary care based exercise programme  ,0,
edin,6580,4355443,No significant difference,Median OS was 592Â days for SIRT versus 788Â days for TACE patients (pÂ =Â 0.9271), Overall survival , Drug-eluting bead transarterial chemoembolization , Selective internal radiotherapy ,0,
edin,6504,3333807,Significantly decreased,"Plasma renin activity, angiotensin I, and angiotensin II decreased from baseline to month 20 (plasma renin activity (ng/mL/h): 2.3 Â± 2.6 to 0.3 Â± 0.4 (P < 0.05), angiotensin I (pg/mL): 909.1 Â± 902.5 to 41.5 Â± 14.8 (P < 0.05), angiotensin II (pg/mL): 41.5 Â± 45.8 to 11.0 Â± 4.9 (P < 0.05)).", Angiotensin I , Control , Aliskiren ,0,
edin,6586,5762965,Cannot tell based on the abstract,, Serum iPTH â¥30% reduction  , Calcifediol , Paricalcitol ,0,
edin,6586,5762965,No significant difference,"No significant difference was observed between the groups in the proportion of patients with a reduction in serum iPTH levels ofÂ â¥30% (95.1% vs. 88.4% in PAR and CAL groups, respectively; PÂ = 0.26).", Serum iPTH â¥30% reduction  , Calcifediol , Paricalcitol ,0,
edin,6498,4293505,Significantly decreased,"Incidence of nausea and the need for rescue antiemetics, verbal rating scale (VRS) 1 hour pain value, ketorolac consumption, and incidence of shivering were significantly lower in group R and group RD, than in group C (P < 0.05). Moreover, these parameters were significantly lower in group RD than in group R (P < 0.05).", Pain , Control , Dexamethasone + ramosetron ,0,
edin,6527,3302141,Significantly decreased,"An intervention effect after 1 year was found for adiposity (P=0.02 for BMI-SDS, P=0.03 for waist circumference (WC)-SDS), physical fitness (absolute measured peak value of oxygen uptake (mlâminâ1), standardized for age and gender (VO2peak-SDS), P<0.01) and insulin resistance (HOMA-SDS, P=0.04). No significant intervention effect was found for serum lipid profile, high-sensitive C-reactive protein or for adiponectin. At 2-year follow-up, BMI-SDS in the intervention group (n=31) was 3.8Â±1.2 SDS, significantly less than at baseline (P=0.02).", BMI standard deviation score , Control , Behavioral lifestyle intervention ,0,
edin,6490,4620004,Significantly decreased,"An overall improvement was achieved in total cholesterol levels (Mean Difference âMD-â=ââ19.60; 95 % CI: â15.33 at â23.87Â mg/dl; pâ<â0.001),", Total cholesterol , Standard practice , Motivational interviewing  ,0,
edin,6438,4092903,Cannot tell based on the abstract,, Total viable rumen bacteria , Mulberry leaf pellet at 200 g/hd/d , Mulberry leaf pellet at 600 g/hd/d ,0,
edin,6438,4092903,Significantly increased,"As shown in Table 4, total viable, amylolytic bacteria, proteolytic bacteria and cellulolytic bacteria counts were enhanced by MUP levels and significantly higher (p<0.05) at 400 and 600 g/hd/d of MUP supplementation when compared to control treatment.", Total viable rumen bacteria , Mulberry leaf pellet at 200 g/hd/d , Mulberry leaf pellet at 600 g/hd/d ,0,
edin,6469,5380277,Cannot tell based on the abstract,, Spontaneous breath time  , Control , Heated infusions  ,0,
edin,6469,5380277,Significantly decreased,"Patients from the control group presented longer time to spontaneous breath, eye opening, and consciousness recovery than patients from the warming infusion group (spontaneous breath, 4.47âÂ±â0.84âminutes vs 4.06âÂ±â0.72âminutes, Pâ=â0.042; eye opening, 8.66âÂ±â2.03âminutes vs 6.72âÂ±â1.73âminutes, Pâ<â0.001; consciousness recovery, 11.19âÂ±â1.49âminutes vs 9.91âÂ±â1.91âminutes, Pâ=â0.004).", Spontaneous breath time  , Control , Heated infusions  ,0,
edin,6449,2909923,Cannot tell based on the abstract,, Muscle glycogen , Control , Creatine supplementation  ,0,
edin,6449,2909923,Significantly increased,"Muscle glycogen content (Figure 7b) was reduced (P < 0.05) by approximately 600 mmol/kg dry mass both before and after supplementation in creatine and placebo groups. After supplementation, muscle glycogen content at the end of the two-hour ride was higher in the creatine than placebo group (P < 0.05) due to the higher resting muscle glycogen content after supplementation in the creatine than placebo group.", Muscle glycogen , Control , Creatine supplementation  ,0,
edin,6499,4293505,Significantly decreased,"Incidence of nausea and the need for rescue antiemetics, verbal rating scale (VRS) 1 hour pain value, ketorolac consumption, and incidence of shivering were significantly lower in group R and group RD, than in group C (P < 0.05). Moreover, these parameters were significantly lower in group RD than in group R (P < 0.05).", Nausea , Ramosetron , Dexamethasone + ramosetron ,0,
edin,6434,3697207,Significantly decreased,"Both groups showed significant pain improvement over the course of the study (P < 0.001), though pain scores were significantly more reduced in the ESWT than the sham group (-4.2 Â± 2.9 vs. -2.7 Â± 1.8, P = 0.049).", Pain  , Control , Extracorporeal shock wave therapy ,0,
edin,6493,4620004,Cannot tell based on the abstract,, High density lipoprotein  , Standard practice , Motivational interviewing  ,0,
edin,6493,4620004,No significant difference,"<td>âHDL Cholesterol (mg/dl)</td><td>57.03âÂ±â17.63</td><td>55.55âÂ±â14.53</td><td>0.508</td>,Conversely, no significant differences were observed in HDL-cholesterol levels after the intervention when assessed globally (MDâ=â0.28; 95 % CI: â2.26 to 1.69Â mg/dl; Friedman testâ=â3.591; pâ=â0.309). As it occurred with the other lipid parameters, no significant differences were found in HDL-cholesterol levels between the groups (Fâ=â0.048; pâ=â0.826).", High density lipoprotein  , Standard practice , Motivational interviewing  ,0,
edin,6691,3816860,Cannot tell based on the abstract,, Adverse events , Control , Linagliptin  ,0,
edin,6691,3816860,No significant difference,"The overall incidence of clinical AEs was similar between the linagliptin and placebo groups (63.0 vs. 63.6%, respectively) (Supplementary Table 2).", Adverse events , Control , Linagliptin  ,0,
edin,6756,5273788,No significant difference,"Whereas IPM supplementation failed to increased haemoglobin or ferritin concentrations, the IPM group had a significantly higher rate of occurrence of microscopically detectable parasitaemia [hazard ratio 2.2, 95% C.I. 1.2â4.0; PÂ =Â 0.01].", Serum ferritin  , Control , Elemental iron (IPM) ,0,
edin,6694,5815696,Cannot tell based on the abstract,, Chronic fatigue syndrome values , Control , Hydroxypropyl methylcellulose  ,0,
edin,6694,5815696,Significantly increased,"Comparison of measurements for the crowd of preoperatively dry eye patients whose surgery time is longer than median between the 2 groups at different time points. CFS values of the patients in the study group were superior to that of the patients in the control group 1 week after operation, and a significant difference was found between the 2 groups (âPâ=â.032).", Chronic fatigue syndrome values , Control , Hydroxypropyl methylcellulose  ,0,
edin,6668,5655938,Cannot tell based on the abstract,, Overall score provided  , White student  , Asian students ,0,
edin,6668,5655938,No significant difference,The average overall scores when the performances were acted by Asian students was 3.1 (2.9â3.3) vs 3.1 (3.0â3.3) when acted by white students (pâ=â0.88)., Overall score provided  , White student  , Asian students ,0,
edin,6701,4266769,No significant difference,"For pain at movement and at rest, no significant differences were found between the paracetamol/naproxen group and either the paracetamol/CR oxycodone for 24 hours group (Î² = 2.6 [4.9]; P = 0.597) or the paracetamol/CR oxycodone for 48 hours (Î² = â1.7 [5.1]; P = 0.736).", Pain at movement , Paracetamol + oxycodone for 24 hours , Paracetamol + naproxen ,0,
edin,6836,4084282,Cannot tell based on the abstract,, ICU length of stay , Control , Bispectral index monitoring ,0,
edin,6836,4084282,No significant difference,"Neither ICU LOS (median (IQR) 11 (6 to 21) (WC), 12 (7 to 23) (BIS), and 11 (6 to 24) days (control), P = 0.67) nor duration of mechanical ventilation (median 165 (0 to 581) (WC), 158 (3 to 590) (BIS), and 163 (5 to 385) hours control, P = 0.97) were different between groups.", ICU length of stay , Control , Bispectral index monitoring ,0,
edin,6757,5273788,Cannot tell based on the abstract,, Hemoglobin  , Control , Elemental iron (IPM) ,0,
edin,6757,5273788,No significant difference,"<td align=""left"">&nbsp;â Haemoglobin, g/dl, mean&nbsp;Â±&nbsp;SD</td><td align=""left"" char=""Â±"">0.09&nbsp;Â±&nbsp;.91</td><td align=""left"" char=""Â±"">0.08&nbsp;Â±&nbsp;.85</td>,Changes in values of Hb, serum ferritin and MCV were small and similar in both groups", Hemoglobin  , Control , Elemental iron (IPM) ,0,
edin,7065,2995234,Significantly decreased,"However, the Lactobacillus group showed lower change in bowel frequency and consistency (50/103, 48.5%) than the placebo group (35/111, 31.5%) (P=0.01).", change in bowel frequency in patients with respiratory tract infection receiving antibiotics , placebo , Lactobacillus (LacidofilÂ® cap) ,0,
edin,6606,4658539,Cannot tell based on the abstract,, TH-like immunoreactive cells , Placebo analgesic + Naloxone , Placebo analgesic +âHaloperidol ,0,
edin,6606,4658539,Significantly decreased,"The number of TH-like immunoreactive cells in the VTA was 43.8âÂ±â3.4 in the Control group, 72.4âÂ±â5.1 in the Placebo group, 64.0âÂ±â4.2 in the Pâ+âN group, and 28.0âÂ±â1.7 in the Pâ+âH group. The number of TH-like immunoreactive cells significantly differed among the groups (ANOVA followed by Tukeyâs post-hoc tests, F(3, 12)â=â36.152, pâ<â0.001). We observed significantly more TH-like immunoreactive cells in the VTA region of the Placebo (pâ<â0.001) and Pâ+âN groups (pâ<â0.01) than in the Control group. There were significantly fewer TH-like immunoreactive cells in the Pâ+âH group than in the Control (pâ<â0.05) and other Placebo groups (pâ<â0.001), which demonstrated the successful blockage of TH expression in the VTA region (Fig. 4A).", TH-like immunoreactive cells , Placebo analgesic + Naloxone , Placebo analgesic +âHaloperidol ,0,
edin,6650,4114185,Cannot tell based on the abstract,, Mortality , Standard arm therapy , Brain-Computer Interface + Haptic Knob ,0,
edin,6650,4114185,No significant difference,"There were no reported serious adverse events, deaths, or significant increases in shoulder or hand pain for any of the 3 intervention groups at any time during the study duration.", Mortality , Standard arm therapy , Brain-Computer Interface + Haptic Knob ,0,
edin,6699,5154016,No significant difference,he drainage volumes in the second 24Â h were similar in the 3 groups., Second 24 h drainage volume , Gelatin sponge , Stypro hemostatic sponge ,0,
edin,6923,5636096,Cannot tell based on the abstract,, mean portosystemic hepatic encephalopathy score (PHES) , triple placebos , anti-HE intervention (lactulose+branched-chain amino acids+rifaximin) ,0,
edin,6923,5636096,Significantly increased,"he mean PHES improved from -8.0 to -5.0 in the patients on active intervention (p = 0.02). There was no difference in exit PHES between the active and placebo group (-5.0 vs. -5.5, p = 0.40) but the mean PHES change was larger in the active group (3.9Â±0.9 vs. -0.8Â±0.8, p = 0.02).", mean portosystemic hepatic encephalopathy score (PHES) , triple placebos , anti-HE intervention (lactulose+branched-chain amino acids+rifaximin) ,0,
edin,6930,5760819,Cannot tell based on the abstract,, interferences at the retention time , internal standard (IS) - Tizanidine hydrochloride , MDL (a main metabolite of nicergoline) ,0,
edin,6930,5760819,No significant difference,"Under optimized chromatographic conditions, no interferences were found at the retention time of MDL (8.280Â±0.34Â min) and IS (6.883Â±0.49Â min).Figure 1", interferences at the retention time , internal standard (IS) - Tizanidine hydrochloride , MDL (a main metabolite of nicergoline) ,0,
edin,6695,5154016,Significantly decreased,"In our study, drainage volume in the first 24Â h of patients in Group A and B is significantly smaller, as well as total postoperative volumes of drainage (pâ<â0.05) during their hospital stay.", 24 h drainage volume , Gelatin sponge , Stypro hemostatic sponge ,0,
edin,6727,3556767,Significantly decreased,The mean mepridine consumption in remifentanil-treated group was significantly (P=0.001) more than that in fentanyl- or fentanyl plus morphine-treated group in 24 hours after the surgery respectively., Mepridine consumption , Remifentanyl , Fentanyl + morphine ,0,
edin,6655,5719521,Significantly decreased,"Youth who had recently dealt drugs (adjusted hazard ration [AHR], 0.50; 95% CI, 0.29â0.87), engaged in prohibited street-based income generation (AHR, 0.41; 95% CI, 0.24â0.69), and engaged in illegal income generating activities (AHR, 0.19; 95% CI, 0.06â0.61) were significantly less likely to report cessation of injection drug use", Cessation of injected drugs , Not engaging in prohibited street-based income generation , Engaging in prohibited street-based income generation ,0,
edin,6740,3941354,No significant difference,"There were no statistically significant differences in the number of retrieved oocyte (p=0.545), fertilization (p=0.876), implantation (p=0.716) and pregnancy rate (p=0.727) between the two groups.", Total number of embryos , Decapeptyl , Triptorelin ,0,
edin,7077,3649350,Cannot tell based on the abstract,, systolic blood pressures before the procedures ," group B, who were NOT allowed to observe DJ stent insertion "," group A, who were allowed to observe DJ stent insertion ",0,
edin,7077,3649350,No significant difference,The pulse rate and systolic and diastolic blood pressures before the procedures were also found to be comparable for both groups of patients., systolic blood pressures before the procedures ," group B, who were NOT allowed to observe DJ stent insertion "," group A, who were allowed to observe DJ stent insertion ",0,
edin,6665,5655938,Significantly increased,"Examiners responded to Asian-stereotypical words (716Â ms, 95% confidence interval (CI) 702â731Â ms) faster than neutral words (769Â ms, 95% CI 753â786Â ms, pâ<â0.001), suggesting Asian stereotypes were activated (or at least active) in examinersâ minds.",  Asian-stereotypical words response speed , Viewing  stereotype-inconsistent performances , Viewing stereotype-consistent performances ,0,
edin,6948,4258972,Cannot tell based on the abstract,, complain of mild pain , normal saline (Group 3) (control) , clonidine (Group 2) ,0,
edin,6948,4258972,No significant difference,Majority of subjects complained of mild pain in all the three groups showing no statistically significant intergroup difference (P > 0.05)., complain of mild pain , normal saline (Group 3) (control) , clonidine (Group 2) ,0,
edin,6929,2936735,Cannot tell based on the abstract,, number of daysâ stay in the ICU - effect of multimodality chest physiotherapy in ICUs for prevention of VAP (ventilator-associated pneumonia) in intubated and mechanically ventilated patients , Manual hyperinflation (MH) and suctioning , positioning and chest wall vibrations in addition to MH plus suctioning (multimodality chest physiotherapy) ,0,
edin,6929,2936735,No significant difference,"Neither the number of days of ventilation nor the number of daysâ stay in the ICU showed any statistical significance (P = 0.986 and P = 0.102, respectively) between both groups [Table 1]", number of daysâ stay in the ICU - effect of multimodality chest physiotherapy in ICUs for prevention of VAP (ventilator-associated pneumonia) in intubated and mechanically ventilated patients , Manual hyperinflation (MH) and suctioning , positioning and chest wall vibrations in addition to MH plus suctioning (multimodality chest physiotherapy) ,0,
edin,6748,3821103,Significantly decreased,"Meanwhile, VRS scores did not differ significantly between the morphine and tramadol treated groups postoperatively, except for in the one-hour post-operative scores in which the tramadol-treated group experienced less pain (P < 0.007).", VRS 1-hour post-operative scores , Morphine , Tramadol  ,0,
edin,6833,4724125,Cannot tell based on the abstract,, C-Reactive Protein , Control , Exercise training ,0,
edin,6833,4724125,No significant difference,"<td align=""left"">CRP (mg/L)<sup>b</sup>
</td><td align=""left"">2.41 (1.15, 4.99)</td><td align=""left"">2.04 (0.95, 4.40)</td><td align=""left"">1.99 (1.00, 4.21)</td><td align=""left"">2.40 (1.19, 4.98)</td><td align=""left"">1.77 (0.96, 3.86)</td><td align=""char"" char=""."">0.91</td>,We could also not demonstrate any significant differences between the randomized groups in changes of BP, HDL cholesterol or CRP, whereas LDL cholesterol increased in the exercise group compared to controls (TableÂ 2).", C-Reactive Protein , Control , Exercise training ,0,
edin,6707,4511304,Significantly decreased,"In study 03-1, luseogliflozin significantly decreased glycated hemoglobin at the end of the 24-week double-blind period compared with the placebo (â0.88%, PÂ <Â 0.001), and glycated hemoglobin reduction from baseline at weekÂ 52 was â0.63%. In study 03-2, luseogliflozin added to other OADs significantly decreased glycated hemoglobin from baseline at weekÂ 52 (â0.52 to â0.68%, PÂ <Â 0.001 for all OADs).", Glycated hemoglobin , Sulfonylureas alone , Luseogliflozin + sulfonylureas ,0,
edin,6926,2936735,Cannot tell based on the abstract,, decrease in infection - effect of multimodality chest physiotherapy in ICUs for prevention of VAP (ventilator-associated pneumonia) in intubated and mechanically ventilated patients , Manual hyperinflation (MH) and suctioning , positioning and chest wall vibrations in addition to MH plus suctioning (multimodality chest physiotherapy) ,0,
edin,6926,2936735,No significant difference,"There was no statistical difference with respect to VAP â¥ 5 days or VAP â¤ 5 days between both the groups. Neither the number of days of ventilation nor the number of daysâ stay in the ICU showed any statistical significance (P = 0.986 and P = 0.102, respectively) between both groups [Table 1]", decrease in infection - effect of multimodality chest physiotherapy in ICUs for prevention of VAP (ventilator-associated pneumonia) in intubated and mechanically ventilated patients , Manual hyperinflation (MH) and suctioning , positioning and chest wall vibrations in addition to MH plus suctioning (multimodality chest physiotherapy) ,0,
edin,6890,4482193,Cannot tell based on the abstract,, sustained improvement in quality of life , stem cell infusion - one session treatment (G-I) , stem cell infusion - two session treatment (G-II)  ,0,
edin,6890,4482193,Significantly increased,"In addition, patients receiving autologous BMSCs demonstrated considerable improvement in their laboratory data and quality of life, with no procedure-related complications,Our results provide evidence for the first time that two infusions with HSC result in more sustained improvement in liver functions and quality of life during 12-months follow-up than a single infusion.", sustained improvement in quality of life , stem cell infusion - one session treatment (G-I) , stem cell infusion - two session treatment (G-II)  ,0,
edin,6957,3407716,Cannot tell based on the abstract,"There was significantly less mean fluid accumulated in the drain group on both day 1, 16.4 versus 25.1 ml (P-valueâ=â0.005), and day 2, 18.4 versus 25.7 ml (P-valueâ=â0.026), following surgery.", no-drain group fluid accumulation , resected glands below 36.5 cm , resected glands above 36.5 cm ,0,
edin,6957,3407716,Significantly increased,The no-drain group also showed significantly more fluid accumulation in resected glands above 36.5 cm (Pâ=â0.012) [3] (the median size of glands in this study)., no-drain group fluid accumulation , resected glands below 36.5 cm , resected glands above 36.5 cm ,0,
edin,6954,4241940,Significantly increased,"Neointiaml formation in BIC was significantly higher than SO, but it was significantly recovered in BIE compared with BIC.,These data suggest that endurance exercise inhibits neointimal formation and endothelial-dependent relaxation via FOXO expression in balloon-induce atherosclerosis rat model.", effect of endurance exercise on neointimal formation in balloon-injured rat , Sham-operated control (SO) , Balloon-induced control (BIC) ,0,
edin,6847,4663612,Significantly decreased,"Condition effects or trends were noted for subjective feelings, with values for attentive, alert, focused, and energetic higher for TheaTrim than for placebo and caffeine, while values for lethargic and groggy were lower for TheaTrim than for placebo and caffeine.", Lethargic condition , Caffeine , Theacrine ,0,
edin,6908,4867039,Significantly decreased,"A considerable reduction in mean percentage of number, natural morphology of sperm, sperm motility and viability and serum testosterone concentration besides DNA injury increment among mice treating with PHZ in comparison with control group were observed.", Average sperm count , control group - normal saline , phenylhydrazine (PHZ) ,0,
edin,6912,4942591,Cannot tell based on the abstract,, Systolic Blood Pressure (SBP) , before intervention , exercise intervention with Football Fitness ,0,
edin,6912,4942591,Significantly decreased,"SBP and DBP were 124 Â± 1 and 81 Â± 1âmmHg at baseline and decreased (P < 0.05) by â3.5 Â± 1.0 and â2.3 Â± 0.6âmmHg, respectively, during the 18 wk training period (Figure 1).,In participants suffering from arterial hypertension (MAP > 100âmmHg; n = 50), there were marked reductions in MAP (â6 Â± 1âmmHg; Figure 2) and the decrements in SBP, DBP, and MAP were greater (P < 0.05) than in the remaining normotensive participants (MAP < 100âmmHg; n = 101; Figure 2).", Systolic Blood Pressure (SBP) , before intervention , exercise intervention with Football Fitness ,0,
edin,6656,5719521,Significantly decreased,"Youth who had recently dealt drugs (adjusted hazard ration [AHR], 0.50; 95% CI, 0.29â0.87), engaged in prohibited street-based income generation (AHR, 0.41; 95% CI, 0.24â0.69), and engaged in illegal income generating activities (AHR, 0.19; 95% CI, 0.06â0.61) were significantly less likely to report cessation of injection drug use.", Cessation of injected drugs , Not engaging in illegal income generating activities  , Engaging in illegal income generating activities  ,0,
edin,6968,5925011,Cannot tell based on the abstract,, mean RF measured immediately after surgery , standard implant protocol treatment , intervention group with added low-intensity power ultrasound treatment (LIPUS) ,0,
edin,6968,5925011,No significant difference,"The mean RF measured immediately after surgery showed no important or statistically significant differences between the control and intervention groups (55.3% and 53.2%, resp.).", mean RF measured immediately after surgery , standard implant protocol treatment , intervention group with added low-intensity power ultrasound treatment (LIPUS) ,0,
edin,6943,5099199,No significant difference,"The eradication rates of S10 and T14 were 87.2% (567/650, 95% CI 84.4% to 89.6%) and 85.7% (557/650, 95% CI 82.8% to 88.2%) in the ITT analysis, respectively, and were 91.6% (556/607, 95% CI 89.1% to 93.4%) and 91.0% (548/602, 95% CI 88.5% to 93.1%) in the PP analysis, respectively.,S10 was not superior to T14 in areas with low clarithromycin resistance.", eradication rates by intention-to-treat (ITT) ," T14 (lansoprazole, amoxicillin and clarithromycin for 14âdays) "," S10 (lansoprazole and amoxicillin for the first 5âdays, followed by lansoprazole, clarithromycin and metronidazole for another 5âdays) ",0,
edin,6932,5963741,Cannot tell based on the abstract,, testosterone levels , control - vitamin E soft capsules , Mild moxibustion ,0,
edin,6932,5963741,No significant difference,There were no significant differences in testosterone levels., testosterone levels , control - vitamin E soft capsules , Mild moxibustion ,0,
edin,6636,5754420,Significantly decreased,"Muscle CS maximal activity increased (Pâ<â0.05) by 18% in SET only, demonstrating larger (Pâ<â0.05) improvement than SSG, while HAD activity increased (Pâ<â0.05) by 24% in both groups. Na+âK+ ATPase Î±1 subunit protein expression increased (Pâ<â0.05) in SET and SSG (19 and 37%, respectively), while MCT4 protein expression rose (Pâ<â0.05) by 30 and 61% in SET and SSG, respectively. SOD2 protein expression increased (Pâ<â0.05) by 28 and 37% in SET and SSG, respectively, while GLUT-4 protein expression increased (Pâ<â0.05) by 40% in SSG only.", GLUT-4 expression , Small-sided game , Speed endurance training ,0,
edin,7104,3517358,No significant difference,Pre-test scores did not differ significantly., pre-test scores , non-relevant tutorial  = âout of sequenceâ , relevant computer tutorial = âin sequenceâ ,0,
edin,7046,3050701,Cannot tell based on the abstract,, AUC results in severity of throat soreness ," unflavoured, non-medicated lozenge ", AMC/DCBA Cool lozenge ,0,
edin,7046,3050701,Significantly decreased,"The AMC/DCBA Warm lozenge produced significantly different AUC results for the change from baseline to 2 hours in severity of throat soreness compared with the unflavoured, non-medicated lozenge (p = 0.001; Table 2).,The AUC for change from baseline to 2 hours post dose in difficulty in swallowing showed significant differences with both AMC/DCBA throat lozenge variants compared with the unflavoured, non-medicated lozenge (Table 3B). At 1 minute post dose, the AMC/DCBA Cool lozenge induced significantly different changes from baseline in difficulty in swallowing compared with the unflavoured, non-medicated lozenge (p < 0.0001).,A significant improvement in swallowing remained at each of the subsequent assessment timepoints between 5 and 120 minutes (all p < 0.01).", AUC results in severity of throat soreness ," unflavoured, non-medicated lozenge ", AMC/DCBA Cool lozenge ,0,
edin,6865,5683978,Cannot tell based on the abstract,, Infectious emergent adverse effects in Japanese patients  , Placebo , Ustekinumab 130 mg  ,0,
edin,6865,5683978,No significant difference,"The incidence of infection TEAEs was similar across the treatment groups in Japanese patients (ustekinumab 130 mg, 18.5%; ~6 mg/kg, 25.0%; placebo, 22.2%) and none of these were serious infections.", Infectious emergent adverse effects in Japanese patients  , Placebo , Ustekinumab 130 mg  ,0,
edin,6877,2571050,Cannot tell based on the abstract,, Complications  , Insulin 0.07 IU/kg load + 0.07 IU/kg infusion , Insulin 0.07 IU/kg infusion ,0,
edin,6877,2571050,No significant difference,"The length of hospitalization was not significantly different among the groups, there were no complications in any of the groups, and no deaths occurred in this cohort.", Complications  , Insulin 0.07 IU/kg load + 0.07 IU/kg infusion , Insulin 0.07 IU/kg infusion ,0,
edin,6621,4751474,No significant difference,"In intent-to-treat analyses, intervention was not associated with significant improvement in primary adherence, medication persistence, or intermediate outcomes of care.", Intermediate outcomes of care , Control , Telephone Outreach ,0,
edin,7089,3208043,Cannot tell based on the abstract,, cumulative hazard of recurrence during the follow-up - menstrually related migraine , rizatriptan , frovatriptan ,0,
edin,7089,3208043,Significantly decreased,"Also, the cumulative hazard of recurrence during the follow-up was significantly (pÂ <Â 0.01) lower under frovatriptan (Fig.Â 1).Fig.Â 1", cumulative hazard of recurrence during the follow-up - menstrually related migraine , rizatriptan , frovatriptan ,0,
edin,6798,5200867,Significantly increased,Radiographic analysis showed that the hidden X suture had a significant effect in preserving horizontal width and minimizing vertical reduction in comparison to X suture (P<0.05)., Preservation of horizontal width , Crossed mattress suture , Hidden X suture  ,0,
edin,6806,5141553,Significantly decreased,"Time required for insertion was significantly shorter in the visual group compared to the conventional group (22.56 Â± 3.08 versus 37.30 Â± 4.12 seconds, P < 0.001).,Medical students performed better NGT insertions (shorter insertion time and less procedure-related complications) after undergoing the visual guidance training.", Insertion time by students  , Conventional insertion  , Visual nasogastric tube insertion  ,0,
edin,6751,3821103,Cannot tell based on the abstract,"Post-operative VRS scores at 6, 12, and 24 hours were significantly decreased when compared with previous scores in both morphine and tramadol prescribed subjects (P < 0.001), hence, both local analgesics can significantly reduce pain after minor knee surgery.", VRS 12-hours post-operative scores , Morphine , Tramadol  ,0,
edin,6751,3821103,No significant difference,"Results also revealed that VRS scores did not differ significantly between the morphine and tramadol treated groups postoperatively, except for the one hour post-operative scores in which the tramadol-treated group experienced less pain (P < 0.007).,<td colspan=""1"" rowspan=""1"">12</td><td colspan=""1"" rowspan=""1"">2.2 Â± 1.5 <sup><xref ref-type=""table-fn"" rid=""fn85"">a</xref></sup></td><td colspan=""1"" rowspan=""1"">2.8 Â± 2.1 <sup><xref ref-type=""table-fn"" rid=""fn85"">a</xref></sup></td><td colspan=""1"" rowspan=""1"">0.21</td>", VRS 12-hours post-operative scores , Morphine , Tramadol  ,0,
edin,6902,3827502,Significantly increased,"More PNs than GPs would offer testing opportunistically to asymptomatic patients aged â¤25 years; women having a pap smear (84% vs 55%, P<0.01); antenatal checkup (83% vs 44%, P<0.01) and Aboriginal men with a sore throat (79% vs 33%, P<0.01), but also to patients outside of the guideline age group at the time of the survey; 26 year old males presenting for a medical check (78% vs 30%, P = <0.01) and 33 year old females presenting for a pill prescription (83% vs 55%, P<0.01).", Aboriginal or Torres Strait Islander male with a sore throat - testing opportunities to asymptomatic patients aged â¤25 years , general practitioners (GPs) , practice nurses (PNs) ,0,
edin,6639,4510702,Significantly increased,The proportion of time when sensor glucose was in the target range (3.9â8.0 mmol/l) overnight (between 24:00 and 08:00 hours) was 18.5% greater during closedâloop insulin delivery than during sensorâaugmented therapy (p < 0.001)., Time at target range , Control , Closedâloop insulin ,0,
edin,7041,4882797,Cannot tell based on the abstract,, Hypertensive disorders , other sites , Pakistan ,0,
edin,7041,4882797,Significantly increased,"Hypertensive disorders were reported to be much higher in Pakistan than the other sites, as were reported cases of chorioamnionitis or fever (37.6Â %).", Hypertensive disorders , other sites , Pakistan ,0,
edin,6993,4059969,Cannot tell based on the abstract,, flexion at 3 months - conventional total knee arthroplasty (TKA) , Patients operated with no fluoroscopy assistance (C) , Patients operated with fluoroscopy assistance (F) ,0,
edin,6993,4059969,Significantly increased,"Flexion was slightly better in group F at 3Â months (pÂ =Â 0.001), but did not differ at the 1-year follow-up (pÂ =Â n.s.) (TableÂ 3).", flexion at 3 months - conventional total knee arthroplasty (TKA) , Patients operated with no fluoroscopy assistance (C) , Patients operated with fluoroscopy assistance (F) ,0,
edin,6733,4869362,Cannot tell based on the abstract,"The primary outcomes were the change from baseline in callus hydration, elasticity, texture, and size at each of the three time points.", Elasticity  , Trichloroacetic acid , Podiatry ,0,
edin,6733,4869362,No significant difference,"Improvement in skin elasticity (pâ=â0.04 and pâ=â0.91) and skin surface texture (pâ=â0.33 and pâ=â0.04) at D21 compared to baseline, was not significantly different for either group (Fig.Â 2).", Elasticity  , Trichloroacetic acid , Podiatry ,0,
edin,7019,3806618,Significantly decreased,"In the intent to treat analysis of the primary end point, patients treated with teplizumab had a reduced decline in C-peptide at 2 years (mean â0.28 nmol/L [95% CI â0.36 to â0.20]) versus control (mean â0.46 nmol/L [95% CI â0.57 to â0.35]; P = 0.002), a 75% improvement.", decline in C-peptide at 2 years - new-onset type 1 diabetes (T1D) , control , teplizumab ,0,
edin,7001,4377530,Cannot tell based on the abstract,, staphylococcal UTI , Foley catheter , Nelatone catheter ,0,
edin,7001,4377530,No significant difference,"Moreover, three cases of staphylococcal UTI were observed in the Foley group compared to only one case in the Nelatone group (P = 0.605) (Table 2).", staphylococcal UTI , Foley catheter , Nelatone catheter ,0,
edin,6755,5273788,No significant difference,he proportion of plasmodial RT-PCR positive children was similar in both groups at week 16 (IPM group 16.6% vs placebo group 14.3%; PÂ =Â 0.47)., Plasmodial reverse transcription PCR , Control , Elemental iron (IPM) ,0,
edin,6638,5754420,Cannot tell based on the abstract,,  Na+âK+ ATPase expresion , Small-sided game , Speed endurance training ,0,
edin,6638,5754420,No significant difference,"Protein expression for the Î±1 Na+âK+ ATPase subunit increased in SET (ESâ=â0.5, CIâ=â46â34%) (19âÂ±â26%; nâ=â15; Pâ<â0.05) and SSG (ESâ=â0.7, CIâ=â13â63%) (37âÂ±â41%; nâ=â12; Pâ<â0.01), with a tendency (Pâ=â0.07) for a greater change score in SSG (Fig.Â 2a).",  Na+âK+ ATPase expresion , Small-sided game , Speed endurance training ,0,
edin,6723,3556767,No significant difference,"here was no significant difference between the three groups in terms of frequency of nausea, vomiting, and mean nausea and pain scores at any time points.", Frequency of nausea , Fentanyl + morphine , Fentanyl ,0,
edin,6686,5351968,Cannot tell based on the abstract,, Insulin level immediately after exercise  , Protein alone , Protein + carbohydrate ,0,
edin,6686,5351968,No significant difference,There was no difference in plasma insulin levels among groups immediately post exercise (p>0.05)., Insulin level immediately after exercise  , Protein alone , Protein + carbohydrate ,0,
edin,7055,4631431,Cannot tell based on the abstract,, overall incidence of AEs , placebo , IV ibuprofen ,0,
edin,7055,4631431,No significant difference,"Overall, subjects who received preoperative IV ibuprofen therapy experienced a similar frequency of AEs (91%) as those receiving intraoperative IV ibuprofen or placebo (86% and 89%, respectively). P", overall incidence of AEs , placebo , IV ibuprofen ,0,
edin,6625,4751474,Cannot tell based on the abstract,, Clinical improvement , Control , Telephone Outreach ,0,
edin,6625,4751474,No significant difference,"There were sufficient data to adjudicate clinical improvement for 1,157 of 1,501 clinical domains (77.1%) in the intervention group and 1,082 of 1,432 clinical domains (75.6%) in the control group. Clinical improvement occurred in 75.7% of the 1,157 intervention group clinical domains and in 75.4% of the 1,082 control group clinical domains (P = 0.87).", Clinical improvement , Control , Telephone Outreach ,0,
edin,6799,5200867,Cannot tell based on the abstract,, Mucogingival junction pushing to  buccal side , Crossed mattress suture , Hidden X suture  ,0,
edin,6799,5200867,Significantly decreased,"The MGJ line shifted to the lingual side immediately after the application of the X suture by 1.56Â±0.90 mm, while the application of the hidden X suture slightly pushed the MGJ line to the buccal side by 0.25Â±0.66 mm (Table 2). The difference between the groups was statistically significant (P=0.003).", Mucogingival junction pushing to  buccal side , Crossed mattress suture , Hidden X suture  ,0,
edin,6976,4894062,Cannot tell based on the abstract,, PCoA of the weighted UniFrac distances , healthy controls , T2D (type 2 diabetes) patients ,0,
edin,6976,4894062,Cannot tell based on the abstract,, PCoA of the weighted UniFrac distances , healthy controls , T2D (type 2 diabetes) patients ,0,
edin,6976,4894062,Significantly increased,"The PCoA of the weighted UniFrac distances resulted in a significant segregation between the two groups (Fig. 1(a)) (P<0Â·001, permutation test with pseudo F ratios), confirming the presence of compositional differences in the GM structure of T2D patients and healthy controls.,Comparison of the gut microbiota compositional structure of type 2 diabetes (T2D) patients before and after the nutritional interventions. (a) Principal coordinates analysis (PCoA) based on weighted UniFrac distances for T2D subjects following the Ma-Pi 2 diet (n 21) shows separation between T0 () and T1 (). The two components explain 35Â·0 and 24Â·8 % of the variance, respectively. P=0Â·01; permutation test with pseudo F ratios. (b) PCoA based on weighted UniFrac distances for T2D subjects following the control (CTR) diet (n 19). , T0; , T1. The two components explain 32Â·0 and 20Â·2 % of the variance, respectively. P=0Â·04; permutation test with pseudo F ratios. Lines connect T0 and T1 samples from the same patient. , responding bacterial genera and biochemical parameters, respectively; , direction of significant correlations; , , , , centroids for each time point.", PCoA of the weighted UniFrac distances , healthy controls , T2D (type 2 diabetes) patients ,0,
edin,6607,4658539,Cannot tell based on the abstract,, TH-like immunoreactive cells , Placebo analgesic alone , Placebo analgesic +âHaloperidol ,0,
edin,6607,4658539,Significantly decreased,"The number of TH-like immunoreactive cells in the VTA was 43.8âÂ±â3.4 in the Control group, 72.4âÂ±â5.1 in the Placebo group, 64.0âÂ±â4.2 in the Pâ+âN group, and 28.0âÂ±â1.7 in the Pâ+âH group. The number of TH-like immunoreactive cells significantly differed among the groups (ANOVA followed by Tukeyâs post-hoc tests, F(3, 12)â=â36.152, pâ<â0.001). We observed significantly more TH-like immunoreactive cells in the VTA region of the Placebo (pâ<â0.001) and Pâ+âN groups (pâ<â0.01) than in the Control group. There were significantly fewer TH-like immunoreactive cells in the Pâ+âH group than in the Control (pâ<â0.05) and other Placebo groups (pâ<â0.001), which demonstrated the successful blockage of TH expression in the VTA region (Fig. 4A).", TH-like immunoreactive cells , Placebo analgesic alone , Placebo analgesic +âHaloperidol ,0,
edin,7033,5560514,Significantly increased,Greater pain reductions with Cingal up to 3âweeks were only significant in the anteromedial subgroup., pain reduction up to 3âweeks in patients with knee osteoarthritis - anteromedial subgroup , saline , Cingal ,0,
edin,6942,5099199,Cannot tell based on the abstract,, nausea ," T14 (lansoprazole, amoxicillin and clarithromycin for 14âdays) "," S10 (lansoprazole and amoxicillin for the first 5âdays, followed by lansoprazole, clarithromycin and metronidazole for another 5âdays) ",0,
edin,6942,5099199,Significantly increased,"The frequencies of adverse effects were not significantly different between the two groups, except for a slightly higher proportion of nausea in S10 than T14 (5.3% vs 2.8%, p=0.04).", nausea ," T14 (lansoprazole, amoxicillin and clarithromycin for 14âdays) "," S10 (lansoprazole and amoxicillin for the first 5âdays, followed by lansoprazole, clarithromycin and metronidazole for another 5âdays) ",0,
edin,6704,4266769,No significant difference,"For pain at movement and at rest, no significant differences were found between the paracetamol/naproxen group and either the paracetamol/CR oxycodone for 24 hours group (Î² = 2.6 [4.9]; P = 0.597) or the paracetamol/CR oxycodone for 48 hours (Î² = â1.7 [5.1]; P = 0.736).", Pain at rest , Paracetamol + oxycodone for 48 hours , Paracetamol + naproxen ,0,
edin,6671,3882495,Cannot tell based on the abstract,"The mean difference in resistance between Cannula P and I was: 307Â mmHg.L-1.hr-1 (95% CI: 289â325, pâ<â0.001) for 22G; 135Â mmHg.L-1.hr-1 (95% CI: 125â144, pâ<â0.001) for 20G; and 27Â mmHg.L-1.hr-1 (95% CI: 26â28, pâ<â0.001) for 18G.", Resistance through the 22G cannula  , Cannula I , Cannula P ,0,
edin,6671,3882495,Significantly increased,"The resistance in the 22G Cannula P was 73% higher than Cannula I (pâ<â0.001), 89% higher in the 20G (pâ<â0.001) and 61% higher in the 18G (pâ<â0.001).", Resistance through the 22G cannula  , Cannula I , Cannula P ,0,
edin,6760,3424202,Significantly decreased,"he DP combination exerted a significant post-treatment prophylactic effect, and compared with Aâ+âM a significant reduction in the incidence of new infections for DP was observed (respectively 17.1% versus 7.5% of patients experienced new infection within follow up)",  Incidence of new infections , Artesunate + mefloquine , Dihydroartemisinin-piperaquine ,0,
edin,6749,3821103,Cannot tell based on the abstract,, VRS 3-hours post-operative scores , Morphine , Tramadol  ,0,
edin,6749,3821103,No significant difference,"Results also revealed that VRS scores did not differ significantly between the morphine and tramadol treated groups postoperatively, except for the one hour post-operative scores in which the tramadol-treated group experienced less pain (P < 0.007).,<td colspan=""1"" rowspan=""1"">3</td><td colspan=""1"" rowspan=""1"">4.1 Â± 2.4</td><td colspan=""1"" rowspan=""1"">4.7 Â± 3.0</td><td colspan=""1"" rowspan=""1"">0.21</td>", VRS 3-hours post-operative scores , Morphine , Tramadol  ,0,
edin,7027,5349672,Cannot tell based on the abstract,, median nausea ratings at rest , eyes open , blindfolded ,0,
edin,7027,5349672,No significant difference,"At rest, nausea ratings did not differ for all times T0 and T30 of both conditions (all medians zero; Ï2(3) = 4.0, p = 0.26).", median nausea ratings at rest , eyes open , blindfolded ,0,
edin,6775,3931696,Cannot tell based on the abstract,"Urinary kidney injury molecule-1 levels were significantly increased in vehicle+celecoxib (0.65Â±0.02 vs. 0.35Â±0.07 ng/mL, pâ=â0.0002) and misoprostol+celecoxib (0.61Â±0.06 vs. 0.37Â±0.06 ng/mL, pâ=â0.0015) groups when compared to baseline; while plasma levels of cardiac troponin I increased significantly in vehicle+celecoxib (pâ=â0.0040) and misoprostol+misoprostol (pâ=â0.0078) groups when compared to vehicle+vehicle",  Kidney Injury Molecule-1 , Vehicle + celecoxib , Misoprostol + celecoxib ,0,
edin,6775,3931696,No significant difference,No significant difference was noted in KIM-1 levels between vehicle+celecoxib and misoprostol+celecoxib groups (pâ=â0.6624).,  Kidney Injury Molecule-1 , Vehicle + celecoxib , Misoprostol + celecoxib ,0,
edin,6904,3827502,Significantly increased,"More PNs than GPs would offer testing opportunistically to asymptomatic patients aged â¤25 years; women having a pap smear (84% vs 55%, P<0.01); antenatal checkup (83% vs 44%, P<0.01) and Aboriginal men with a sore throat (79% vs 33%, P<0.01), but also to patients outside of the guideline age group at the time of the survey; 26 year old males presenting for a medical check (78% vs 30%, P = <0.01) and 33 year old females presenting for a pill prescription (83% vs 55%, P<0.01).", women having a pap smear - testing opportunities to asymptomatic patients aged â¤25 years , general practitioners (GPs) , practice nurses (PNs) ,0,
edin,6961,3407716,Cannot tell based on the abstract,, no-drain group fluid accumulation , completion thyroidectomy , total thyroidectomy ,0,
edin,6961,3407716,Significantly increased,"However, the no-drain group showed a significantly increased fluid accumulation following total thyroidectomy (Pâ=â0.021) and significantly less following completion thyroidectomy (Pâ=â0.026) compared with the other types of surgery performed.", no-drain group fluid accumulation , completion thyroidectomy , total thyroidectomy ,0,
edin,7035,4385682,No significant difference,"After one week (t = 2), there was no difference between the four products evaluated (P = 0.674), so, all research individuals completed the study with a similar reduction in dental biofilm between themselves but it was different from initial state (Friedman test).", efficacy in the reduction of dental biofilm after first use (t=1) , other mouthwashes , B. dracunculifolia ,0,
edin,6905,4867039,Cannot tell based on the abstract,, testosterone concentration , phenylhydrazine (PHZ) , phenylhydrazine plus Ethyl pyruvate (PHZ+EP) ,0,
edin,6905,4867039,Significantly increased,"The level of testosterone was found to be significantly lower in PHZ group in comparison with other groups (p < 0.05).,In PHZ+EP group there was a significant increase in testosterone concentration compared to PHZ and control groups (p < 0.05).", testosterone concentration , phenylhydrazine (PHZ) , phenylhydrazine plus Ethyl pyruvate (PHZ+EP) ,0,
edin,6900,3827502,Significantly increased,"More PNs than GPs knew that retesting was recommended after chlamydia treatment (93% vs 87%, P=0.027);", retesting was recommended after chlamydia treatment , general practitioners (GPs) , practice nurses (PNs) ,0,
edin,6659,4876157,Significantly decreased,The OOA of 0.2% lidocaine in a one-per-mil tumescent solution is statistically shorter than 2% plain lidocaine (P=0.04); while its DOA is statistically longer than 2% plain lidocaine (P<0.001)., Onset of action speed , 2 % lidocaine , 0.2% lidocaine in a one-per-mil solution ,0,
edin,7009,4845107,Significantly increased,"Switching to ES10/20 reduced LpâPLA2 activity significantly more than did statin doseâdoubling (â28.0 versus â3.8Â nmol/min per mL, P<0.05) and was comparable with R10 (â28.0 versus â18.6Â nmol/min per mL; P>0.05); effects on LpâPLA2 concentration were modest.", LpâPLA2 , doubling the statin dose , combination ezetimibe/simvastatin 10/20mg (ES10/20)  OR rosuvastatin 10&amp;nbsp;mg (R10) ,0,
edin,6648,4114185,No significant difference,"FMMA score improved in all groups, but no intergroup differences were found at any time points.", Upper extremity FMMA score , Standard arm therapy , Brain-Computer Interface + Haptic Knob ,0,
edin,6721,4030121,Significantly increased,"Student t test indicated significantly higher SNDD values (60.46 ms vs. 37.42 ms, P=0.003) and RMSSD (57.90 ms vs. 26.92 ms, P=0.000) in the patient group than in the control group. In the patient group, RMSSD (80.41 ms vs. 45.89 ms, P=0.015) and normalized HF (61.18 ms vs. 43.19 ms, P=0.022) were significantly higher in adolescents, whereas normalized LF (38.81 ms vs. 56.76 ms, P=0.022) and LF/HF ratio (0.76 vs. 1.89, P=0.041) were significantly lower in adolescents. In contrast, the control group did not have significant differences in HRV values between adolescents and preadolescents.", Root mean square of the successive differences , Control , Vasovagal syncope ,0,
edin,6820,5122147,Cannot tell based on the abstract,, Blood glucose  , Metformin 1500 mg , Metformin 1000 mg ,0,
edin,6820,5122147,No significant difference,"As shown in TableÂ 1, there was no significant difference in biochemical parameters including fasting blood glucose, glycated hemoglobin A1c, total cholesterol, or triglyceride between metformin and non-metformin (i.e., gliclazide, acarbose, or repaglinide) treated type 2 diabetic patients.,<td>Blood glucose (mmol/L)</td><td>6.44âÂ±â0.96</td><td>91</td><td>6.27âÂ±â1.04</td><td>21</td><td align=""char"" char=""."">0.4684</td>", Blood glucose  , Metformin 1500 mg , Metformin 1000 mg ,0,
edin,7070,5065057,Cannot tell based on the abstract,," From baseline to week 12 (primary endpoint), mean (SD) NRS (numerical rating scale) pain scores ", placebo group , buprenorphine HCl buccal film - BBUP group ,0,
edin,7070,5065057,Significantly decreased,"From baseline to week 12 (primary endpoint), mean (SD) NRS pain scores increased significantly more in the placebo group (1.92 [1.87]) than in the BBUP group (0.88 [1.79]), with a between-group difference (favoring buprenorphine) of â0.98 (95% CI, â1.32 to â0.64; P < 0.001; Figs. 3 and 4)."," From baseline to week 12 (primary endpoint), mean (SD) NRS (numerical rating scale) pain scores ", placebo group , buprenorphine HCl buccal film - BBUP group ,0,
edin,6945,5099199,No significant difference,There were no differences in compliance or adverse effects., compliance to treatment ," T14 (lansoprazole, amoxicillin and clarithromycin for 14âdays) "," S10 (lansoprazole and amoxicillin for the first 5âdays, followed by lansoprazole, clarithromycin and metronidazole for another 5âdays) ",0,
edin,6843,3830844,Cannot tell based on the abstract,, Hannover Functional Ability Questionnaire score , Standardized acupuncture , Individualized acupuncture ,0,
edin,6843,3830844,No significant difference,"Furthermore, for the secondary outcomes HFAQ, QoL, and sick leave days at week 8 and week 26, no significant group differences were observed (Table 2).", Hannover Functional Ability Questionnaire score , Standardized acupuncture , Individualized acupuncture ,0,
edin,6676,3882495,Cannot tell based on the abstract,, Static resistance for 18G cannula  , Cannula I , Cannula P ,0,
edin,6676,3882495,Significantly increased,"The resistance in the 22G Cannula P was 73% higher than Cannula I (pâ<â0.001), 89% higher in the 20G (pâ<â0.001) and 61% higher in the 18G (pâ<â0.001).,<td align=""left"">18G static resistance; N</td><td align=""center"">2.40 (37.4)</td><td align=""center"">0.44 (13.3)</td><td align=""center"">1.96 [1.40 to 2.52]</td><td align=""center"">7 Ã 10<sup>-5</sup></td>", Static resistance for 18G cannula  , Cannula I , Cannula P ,0,
edin,7100,5593818,Cannot tell based on the abstract,, mean age , placebo ," JinqiJiangtang tablets (JQJT tablets, a traditional Chinese patent medicine) ",0,
edin,7100,5593818,Significantly increased,"The distributions of the demographic and clinical characteristics between the two groups were reasonably well-balanced, except that the mean age in the placebo group was younger than that in the JQJT tablets group (53.49âÂ±â8.85 vs. 55.49âÂ±â8.61, Pâ=â0.036).Table 1,<td>Age<sup>*</sup>, years</td><td>55.49âÂ±â8.61</td><td>53.49âÂ±â8.85</td><td>0.036</td>", mean age , placebo ," JinqiJiangtang tablets (JQJT tablets, a traditional Chinese patent medicine) ",0,
edin,6898,4173360,No significant difference,The success rate of intubation through Intubating Laryngeal Mask is comparable with that of DLS., success rate of intubation ," group DLS, Direct Laryngoscopy "," group ILMA, Intubating Laryngeal Mask Airway ",0,
edin,7092,5776520,Significantly increased,"At day 1, 3 and 5 after operation, the mitochondrial membrane potentials of the two groups were decreased in different degrees, but the decrease range in the dexmedetomidine group was smaller than that in the propofol + remifentanil group, and the differences were statistically significant (P<0.05).", mitochondrial membrane potentials , dexmedetomidine  , propofol + remifentanil ,0,
edin,6895,4173360,No significant difference,The upper airway morbidity and mean oxygen saturation are comparable in both the groups., mean oxygen saturation ," group DLS, Direct Laryngoscopy "," group ILMA, Intubating Laryngeal Mask Airway ",0,
edin,6690,3816860,Cannot tell based on the abstract,, Fasting plasma glucose  , Control , Linagliptin  ,0,
edin,6690,3816860,Significantly decreased,"Furthermore, significant results were seen in adjusted mean changes in FPG from baseline to week 24 (â8.88 mg/dL with linagliptin versus +16.22 mg/dL with placebo; between-group difference â25.1 mg/dL [95% CI â38.55 to â11.65]; P = 0.0003).", Fasting plasma glucose  , Control , Linagliptin  ,0,
edin,6988,3169777,Cannot tell based on the abstract,, adverse event profile , placebo , macitentan dose of 600 mg ,0,
edin,6988,3169777,No significant difference,"Up to and including a dose of 300Â mg, the adverse event profile of macitentan did not significantly differ from that of placebo, whereas more adverse events than in the placebo group were reported at a dose of 600Â mg", adverse event profile , placebo , macitentan dose of 600 mg ,0,
edin,6889,5688834,Cannot tell based on the abstract,, Glycated hemoglobin , Control , Asanadi Ghana Vati ,0,
edin,6889,5688834,Significantly decreased,Statistically significant reduction was found in glycosylated hemoglobin percentage in both groups., Glycated hemoglobin , Control , Asanadi Ghana Vati ,0,
edin,6684,5351968,No significant difference,"The phosphorylation of Akt, GSK3, and eIF2BÎµ were unchanged by treatments.", Glycogen synthase kinase 3 phosphorylation  , Protein alone , Protein + carbohydrate ,0,
edin,6795,5426394,Significantly decreased,The lowest pain score related to endoscopy was obtained for oxymetazoline+lidocaine (P<0.001)., Pain , Saline , Lidocaine ,0,
edin,7000,4235563,Cannot tell based on the abstract,, depression in MI (Myocardial Infarction) patients - at discharge , control group did not receive any intervention , educated through face to face training and an educational booklet ,0,
edin,7000,4235563,Significantly decreased,"There was no significant difference between the control and experimental groups before the intervention, but after the intervention, anxiety and depression in the experimental group was significantly less than that in the control group at the discharge time and 3 months after discharge from hospital (p<0.05).", depression in MI (Myocardial Infarction) patients - at discharge , control group did not receive any intervention , educated through face to face training and an educational booklet ,0,
edin,6802,5200867,Cannot tell based on the abstract,, Change in ridge height at the buccal crest , Crossed mattress suture , Hidden X suture  ,0,
edin,6802,5200867,No significant difference,"VHB, change in ridge height at the buccal crest;,<td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">VHB</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""top"">â0.30Â±0.64 (â0.45)</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""top"">â0.50Â±0.51 (â0.40)</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""top"">0.699</td>", Change in ridge height at the buccal crest , Crossed mattress suture , Hidden X suture  ,0,
edin,6899,4173360,No significant difference,The upper airway morbidity and mean oxygen saturation are comparable in both the groups., upper airway morbidity ," group DLS, Direct Laryngoscopy "," group ILMA, Intubating Laryngeal Mask Airway ",0,
edin,6867,3271295,Significantly decreased,"The slope of AALSRS was 1.17 points/month lower while the patients were treated with UDCA than with placebo (95% CI for difference 0.08-2.26, P = 0.037), whereas the slopes of ALSFRS-R and FVC did not show significant differences between treatments.", Appel ALS rating scale slope speed , Placebo , Ursodeoxycholic acid ,0,
edin,6615,5129050,No significant difference,"Compared with control, intervention students reported greater peer support 0.5 (0.1 to 0.9) p=0.03, well-being 1.8 (0.1 to 3.4) p=0.04 but no difference in shyness/sociability.", Sociability , Control , GoActive intervention ,0,
edin,6913,4942591,Cannot tell based on the abstract,, Diastolic Blood Pressure (DBP) , before intervention , exercise intervention with Football Fitness ,0,
edin,6913,4942591,Significantly decreased,"SBP and DBP were 124 Â± 1 and 81 Â± 1âmmHg at baseline and decreased (P < 0.05) by â3.5 Â± 1.0 and â2.3 Â± 0.6âmmHg, respectively, during the 18 wk training period (Figure 1).", Diastolic Blood Pressure (DBP) , before intervention , exercise intervention with Football Fitness ,0,
edin,6934,5963741,Significantly increased,"Mild moxibustion significantly improved physical condition, living conditions, and emotional status compared to the control group after treatment (P<0.05).", living conditions in perimenopausal women , control - vitamin E soft capsules , Mild moxibustion ,0,
edin,6939,4968528,Cannot tell based on the abstract,, 25(OH) vitamin D concentration , diabetes mellitus patients without neuropathy (GI) , diabetic peripheral neuropathy patients (GII) ,0,
edin,6939,4968528,Significantly decreased,"The 25(OH)D levels of Group I and Group II were lower than those of Group III (p=0.036 and p<0.001, respectively). The 25(OH)D levels of Group II were significantly lower than those of Group I (p=0.005).", 25(OH) vitamin D concentration , diabetes mellitus patients without neuropathy (GI) , diabetic peripheral neuropathy patients (GII) ,0,
edin,7007,2853089,Cannot tell based on the abstract,, knowing whether the trial yielded useful results - Breast cancer patients participating in a trial on the efficacy of Trastuzumab , control group (who did not receive it) , Internet group (who received the letter of invitation) ,0,
edin,7007,2853089,No significant difference,"Expectations about the results were also similar in both groups: knowing whether the trial yielded useful results (82.2% P=0.633), understanding the treatment received (20.6% P=0.468), and understanding clinical trials (9.3% P=0.745).", knowing whether the trial yielded useful results - Breast cancer patients participating in a trial on the efficacy of Trastuzumab , control group (who did not receive it) , Internet group (who received the letter of invitation) ,0,
edin,6664,5599448,Cannot tell based on the abstract,, C Max , Pirfenidone capsules , Pirfenidone tablet ,0,
edin,6664,5599448,No significant difference,"In the fasted state, pirfenidone PK, measured using the geometric mean AUC0ât, AUC0ââ, and C max, was similar between the tablet and capsules (TableÂ 2).,The geometric mean C max for the pirfenidone tablet was approximately 17% higher compared with the capsules [geometric mean (% coefficient of variation)Â =Â 7640 (27.9) vs. 6560 (25.5) ng/mL, respectively),The upper CI value for the natural log-transformed C max for the tablet slightly exceeded the standard bioequivalence criteria (by 0.6%), with a value of 125.60% compared with capsules (TableÂ 3).TableÂ 3,PK parameter	Tablet vs. capsules, % GLSM ratio (90% CI)
Fed state (nÂ =Â 43)	Fasted state (nÂ =Â 42)
C max (ng/mL)	116.61 (108.26, 125.60)	101.26 (94.41, 108.60,The small difference in C max between the tablet and the capsules observed in the fed state is not expected to have a clinically meaningful impact on the benefitârisk profile of pirfenidone, while the simplified dosing regimen with tablets may increase adherence to treatment.", C Max , Pirfenidone capsules , Pirfenidone tablet ,0,
edin,7098,5593818,Significantly decreased,"The risk of converting from pre-diabetes to diabetes was 0.58-fold less in the JQJT tablets group than in the placebo group [HR (95% CI): 0.58 (0.384, 0.876), Pâ=â0.010].", risk of converting from pre-diabetes to diabetes , placebo ," JinqiJiangtang tablets (JQJT tablets, a traditional Chinese patent medicine) ",0,
edin,6903,3827502,Significantly increased,"More PNs than GPs would offer testing opportunistically to asymptomatic patients aged â¤25 years; women having a pap smear (84% vs 55%, P<0.01); antenatal checkup (83% vs 44%, P<0.01) and Aboriginal men with a sore throat (79% vs 33%, P<0.01),", antenatal checkup - testing opportunities to asymptomatic patients aged â¤25 years , general practitioners (GPs) , practice nurses (PNs) ,0,
edin,6634,5754420,Cannot tell based on the abstract,, HAD maximal activity , Small-sided game , Speed endurance training ,0,
edin,6634,5754420,No significant difference,"Muscle HAD maximal activity was also elevated (ESâ=â1.1, CIâ=â5.1â1.3, Pâ<â0.05) post intervention in SET (15.3âÂ±â1.9 to 18.5âÂ±â4.0 ÂµmolÂ·gâ1Â·minâ1; nâ=â15) and in SSG (ESâ=â1.3, CIâ=â6.4â1.4) (15.7âÂ±â2.8 to 19.5âÂ±â3.0 ÂµmolÂ·gâ1Â·minâ1; nâ=â11) with no between-groups difference (Fig.Â 1).", HAD maximal activity , Small-sided game , Speed endurance training ,0,
edin,6921,5636096,Significantly decreased,"The patients with an abnormal CRT index who were randomized to receive the active intervention normalized or improved their CRT index (mean change 0.92 Â± 0.29, p = 0.01).", patients with an abnormal CRT index , triple placebos , anti-HE intervention (lactulose+branched-chain amino acids+rifaximin) ,0,
edin,7038,4882797,Cannot tell based on the abstract,, Antenatal corticosteroids (ACS) , in home deliveries , hospital settings ,0,
edin,7038,4882797,Significantly increased,"Received any antepartum steroids by location of delivery1							
âHospitals (overall), n (%)	61/137 (44.5)	21/94 (22.3)	80/645 (12.4)	14/252 (5.6)	21/342 (6.1)	7/63 (11.1)	2/53 (3.8)
âFacilities with maternal and neonatal care capabilities2	57/131 (43.5)	16/62 (25.8)	40/198 (20.2)	12/163 (7.4)	12/214 (5.6)	0/0 (0.0)	1/25 (4.0)
âClinic, n (%)	0/0 (0.0)	0/3 (0.0)	8/95 (8.4)	1/43 (2.3)	7/162 (4.3)	1/101 (1.0)	1/62 (1.6)
âHome, n (%)	0/1 (0.0)	0/78 (0.0)	1/67 (1.5)	0/23 (0.0)	1/312 (0.3)	0/72 (0.0)	1/84 (1.2),When we restricted the analysis to hospital births, the use of ACS in mothers of <5th percentile babies ranged from 4Â % in Kenya to 45Â % in Argentina. Sites in sub-Saharan African and south Asian countries showed ACS rates not higher than 13Â %. Considering the use in hospitals with all maternal and neonatal care capabilities, the rates were slightly higher in Guatemala (25.9Â %) and Belgaum, India (20.2Â %). Zambia did not have any facilities with all care capabilities available; however, in all hospitals, 11Â % of mothers with <5th percentile babies received ACS. In health centers, ACS were only used in South Asia, with the highest rate of 8.4Â % found in Belgaum, India.", Antenatal corticosteroids (ACS) , in home deliveries , hospital settings ,0,
edin,6870,3271295,No significant difference,"The slope of AALSRS was 1.17 points/month lower while the patients were treated with UDCA than with placebo (95% CI for difference 0.08-2.26, P = 0.037), whereas the slopes of ALSFRS-R and FVC did not show significant differences between treatments", Forced vital capacity , Placebo , Ursodeoxycholic acid ,0,
edin,7050,3135864,Significantly increased,"State anxiety and trait anxiety, pain, quality of life and Pittsburgh sleep quality index were significantly higher in the intervention versus placebo group after the treatment period and at the 6-month follow-up.", Pittsburgh sleep quality index at the 6-month follow-up , placebo group (simulated treatment with disconnected ultrasound) , intervention group (craniosacral therapy) ,0,
edin,7094,5776520,Significantly increased,"At day 3 and 5 after operation, the National Institutes of Health Stroke Scale (NIHSS) scores and AVLT scores in the two groups were decreased in different degrees, but the decrease range in the dexmedetomidine group was smaller than that in the propofol + remifentanil group, and the differences were statistically significant (P<0.05).", AVLT scores , dexmedetomidine  , propofol + remifentanil ,0,
edin,6649,4114185,Cannot tell based on the abstract,, Serious adverse events , Standard arm therapy , Brain-Computer Interface + Haptic Knob ,0,
edin,6649,4114185,No significant difference,"There were no reported serious adverse events, deaths, or significant increases in shoulder or hand pain for any of the 3 intervention groups at any time during the study duration.", Serious adverse events , Standard arm therapy , Brain-Computer Interface + Haptic Knob ,0,
edin,6622,4751474,Cannot tell based on the abstract,, Medication possession ratio , Control , Telephone Outreach ,0,
edin,6622,4751474,No significant difference,"There were no significant differences between the intervention and control arms in primary medication adherence within 60 days of the prescription date (intervention arm 85.9%, control arm 87.6%, P = 0.54), medication persistence at 180 days (intervention arm 66.9%, control arm 62.2%, P = 0.14), MPR (intervention arm 0.80, control arm 0.79, P = 0.90),", Medication possession ratio , Control , Telephone Outreach ,0,
edin,7012,4845107,Cannot tell based on the abstract,, Net changes , rosuvastatin 10mg (R10) , combination ezetimibe/simvastatin 10/20mg (ES10/20) ,0,
edin,7012,4845107,No significant difference,Net changes with ES 10/20 were not statistically different from changes obtained with R10., Net changes , rosuvastatin 10mg (R10) , combination ezetimibe/simvastatin 10/20mg (ES10/20) ,0,
edin,6773,3931696,Significantly increased,Significant elevation in diastolic (pâ=â0.0071) and mean blood pressure (pâ=â0.0153) was noted in misoprostol+celecoxib compared to vehicle+celecoxib, Mean blood pressure , Vehicle + celecoxib , Misoprostol + celecoxib ,0,
edin,6940,4968528,Cannot tell based on the abstract,, 25(OH) vitamin D concentration , control - healthy (GIII) , diabetic peripheral neuropathy patients (GII) ,0,
edin,6940,4968528,Significantly decreased,"The 25(OH)D levels of Group I and Group II were lower than those of Group III (p=0.036 and p<0.001, respectively). The 25(OH)D levels of Group II were significantly lower than those of Group I (p=0.005).", 25(OH) vitamin D concentration , control - healthy (GIII) , diabetic peripheral neuropathy patients (GII) ,0,
edin,6972,3806324,No significant difference,Ventral urethrotomy group had considerably lesser operative time although the difference was not statistically significant., operative time , dorsal onlay BMG urethroplasty (Group A) (Barbagli) , dorsal BMG urethroplasty by ventral urethrotomy (Group B) (Asopa) ,0,
edin,6909,4867039,Cannot tell based on the abstract,, Sperm nucleus immaturity , control group - normal saline , phenylhydrazine (PHZ) ,0,
edin,6909,4867039,Significantly increased,Monitoring the immaturity of sperm nucleus in PHZ group compared to the control group indicated that it was increased significantly (p < 0.05)., Sperm nucleus immaturity , control group - normal saline , phenylhydrazine (PHZ) ,0,
edin,6959,3407716,Cannot tell based on the abstract,, mean fluid accumulation on day 2 , no-drain group , drain group ,0,
edin,6959,3407716,Significantly decreased,"At both measured time points, fluid accumulation in the drain group was significantly less than in the no-drain group (16.4âÂ±â9.3 ml versus 25.1âÂ±â17.7 ml, Pâ=â0.005; and 18.4âÂ±â9.9 ml versus 25.7âÂ±â18.6 ml, Pâ=â0.026, at 24 and 48 hours, respectively).", mean fluid accumulation on day 2 , no-drain group , drain group ,0,
edin,7067,2995234,Cannot tell based on the abstract,, normal bowel movement in patients with respiratory tract infection receiving antibiotics , placebo , Lactobacillus (LacidofilÂ® cap) ,0,
edin,7067,2995234,No significant difference,"However, normal bowel movement was reported by 36 (43.4%) of 83 patients in the Lactobacillus group and 27 (30.3%) of 89 patients in the placebo group (P=0.10) (Table 5).,The Lactobacillus group was less likely to experience changes in bowel frequency and consistency compared with the placebo group (OR 0.43, 95% CI 0.25-0.82), which means that although LacidofilÂ® cap does not reduce the rate of occurrence rate of AAD in adult patients with respiratory tract infection who have taken antibiotics, the Lactobacillus group maintained their bowel habits to a greater extent than the placebo group.", normal bowel movement in patients with respiratory tract infection receiving antibiotics , placebo , Lactobacillus (LacidofilÂ® cap) ,0,
edin,6662,5599448,Cannot tell based on the abstract,,  AUC 0ââ  , Pirfenidone capsules , Pirfenidone tablet ,0,
edin,6662,5599448,No significant difference,"<td align=""left"">AUC<sub>0ââ</sub> (ng&nbsp;h/mL)</td><td align=""left"">39,800 (37.0)</td><td align=""left"">40,900 (35.5)</td><td align=""left"">49,700 (34.9)</td><td align=""left"">49,400 (35.5)</td>,In the fed state, pirfenidone PK, as measured using the geometric mean AUC0ât and AUC0ââ, was similar between the pirfenidone 1Â ÃÂ 801-mg tablet and the pirfenidone 3Â ÃÂ 267-mg capsules (TableÂ 2).,<td align=""left"">AUC<sub>0ââ</sub> (ng&nbsp;h/mL)</td><td align=""left"">103.05 (99.54, 106.69)</td><td align=""left"">99.61 (96.64, 102.68)</td>",  AUC 0ââ  , Pirfenidone capsules , Pirfenidone tablet ,0,
edin,6952,4241940,Cannot tell based on the abstract,, FOXOs expression in the injured carotid arteries of rats , Balloon-induced control (BIC) , Balloon-induced exercise (BIE) ,0,
edin,6952,4241940,Significantly increased,"We investigated FOXOs expression in the injured carotid arteries of rats (Fig. 3). FOXO1 was significantly increased in BIC than SO (p < 0.05, 1.0 Â± 0.2 vs. 1.8 Â± 0.4), but it was more significantly increased in BIE than BIC (p < .05, 1.8 Â± 0.4 vs. 2.52 Â± 0.5).", FOXOs expression in the injured carotid arteries of rats , Balloon-induced control (BIC) , Balloon-induced exercise (BIE) ,0,
edin,7061,4566202,Cannot tell based on the abstract,, Patients with large Modic changes - worse , exercise group , rest group ,0,
edin,7061,4566202,No significant difference,"<td colspan=""4"">Large Modic changes Type 1</td>,<td colspan=""4"">Modic changes Type 1</td>,Patients with large Modic changes were 0.41 (â1.62 to 0.79) points worse with rest, while those without large Modic changes were 1.08 points better with rest (â0.97 to 3.12).", Patients with large Modic changes - worse , exercise group , rest group ,0,
edin,6624,4751474,No significant difference,"This low-intensity intervention did not significantly improve medication adherence or control of glucose, BP, or LDL cholesterol.",  LDL cholesterol improvement , Control , Telephone Outreach ,0,
edin,6801,5200867,Significantly increased,It was demonstrated that the amount of keratinized tissue (KT) preserved on the buccal side was significantly greater in the hidden X suture group 4 months after the procedure (P<0.05)., Keratinized tissue width reduction , Crossed mattress suture , Hidden X suture  ,0,
edin,6984,5412886,No significant difference,"On day 8 (Â±1 day) and day 15 (Â±2 days), all the antiallergic agents were found to be more effective than vehicle (p < 0.05) in terms of all the symptoms and signs.,However, there was no statistical significance (p â¥ 0.05) shown among the treatment groups.", more effective for treating seasonal allergic conjunctivitis (SAC) on day 15 , loteprednol etabonate (LE) 0.5% 4 times a day , olopatadine hydrochloride 0.1% twice a day ,0,
edin,7087,4803206,Cannot tell based on the abstract,, weight loss of overweight persons , non-routine counseling group , routine counseling group ,0,
edin,7087,4803206,Significantly increased,"Body weight was significantly more reduced when supported by RDs in the routine counseling group than when supported by RDs in the non-routine counseling group (-1.8 kg versus -0.4 kg, fully adjusted P = 0.0089). As for duration of work as an RD and JDA membership, participantsâ body weight reduction was significantly greater for long-working RDs and JDA members, but the significance of changes in body weight disappeared after full adjustmen", weight loss of overweight persons , non-routine counseling group , routine counseling group ,0,
edin,6605,4658539,Cannot tell based on the abstract,, TH-like immunoreactive cells , Control , Placebo analgesic +âHaloperidol ,0,
edin,6605,4658539,Significantly decreased,"There were significantly fewer TH-like immunoreactive cells in the Pâ+âH group than in the Control (pâ<â0.05) and other Placebo groups (pâ<â0.001), which demonstrated the successful blockage of TH expression in the VTA region (Fig. 4A).", TH-like immunoreactive cells , Control , Placebo analgesic +âHaloperidol ,0,
edin,7054,4631431,Cannot tell based on the abstract,, Severe AEs , placebo , IV ibuprofen ,0,
edin,7054,4631431,No significant difference,"A greater proportion (85%) of placebo-treated individuals experienced at least one AE, with a similar distribution of severities (mild, 56%; moderate, 38%; severe, 6%).", Severe AEs , placebo , IV ibuprofen ,0,
edin,6741,5325897,Significantly increased,"Mean scores of first and second evaluations were 10.24 Â± 0.77, 17.73 Â± 0.46 in feedback receivers and 9.73 Â± 0.77 and 12.13 Â± 0.47 in others (p < 0.001).", First 2 tests results , Evaluation without feedback , Evaluation with feedback ,0,
edin,7068,2995234,Cannot tell based on the abstract,, change in bowel consistency in patients with respiratory tract infection receiving antibiotics , placebo , Lactobacillus (LacidofilÂ® cap) ,0,
edin,7068,2995234,Significantly decreased,"The Lactobacillus group was less likely to experience changes in bowel frequency and consistency compared with the placebo group (OR 0.43, 95% CI 0.25-0.82), which means that although LacidofilÂ® cap does not reduce the rate of occurrence rate of AAD in adult patients with respiratory tract infection who have taken antibiotics, the Lactobacillus group maintained their bowel habits to a greater extent than the placebo group.", change in bowel consistency in patients with respiratory tract infection receiving antibiotics , placebo , Lactobacillus (LacidofilÂ® cap) ,0,
edin,6892,4482193,Cannot tell based on the abstract,"Statistically significant improvement was reported in the transplanted patients (G-1) as regards the mean serum albumin, bilirubin and INR levels which started to improve after 2Â weeks of treatment and continued to improve till the 6th month in the single infusion group.", bilirubin , control group (G-III) who received regular liver treatment , stem cell infusion - one session treatment (G-I) ,0,
edin,6892,4482193,Significantly increased,"Statistically significant improvement was reported in the transplanted patients (G-1) as regards the mean serum albumin, bilirubin and INR levels which started to improve after 2Â weeks of treatment and continued to improve till the 6th month in the single infusion group.", bilirubin , control group (G-III) who received regular liver treatment , stem cell infusion - one session treatment (G-I) ,0,
edin,6891,4482193,Significantly increased,"Statistically significant improvement was reported in the transplanted patients (G-1) as regards the mean serum albumin, bilirubin and INR levels which started to improve after 2Â weeks of treatment and continued to improve till the 6th month in the single infusion group. T", mean serum albumin , control group (G-III) who received regular liver treatment , stem cell infusion - one session treatment (G-I) ,0,
edin,6646,4114185,No significant difference,"FMMA score improved in all groups, but no intergroup differences were found at any time points.", Fugl-Meyer motor assessment scores , Standard arm therapy , Brain-Computer Interface + Haptic Knob ,0,
edin,6772,3931696,Significantly increased,Significant elevation in diastolic (pâ=â0.0071) and mean blood pressure (pâ=â0.0153) was noted in misoprostol+celecoxib compared to vehicle+celecoxib., Diastolic blood pressure , Vehicle + celecoxib , Misoprostol + celecoxib ,0,
edin,6805,5141553,Significantly decreased,Less mucosal damage was noted in the visual group (3.43 Â± 1.63 versus 9.86 Â± 2.31âcm2)., Mucosal damage by physicians  , Conventional insertion  , Visual nasogastric tube insertion  ,0,
edin,7015,4845107,Cannot tell based on the abstract,, PLAC , doubling the statin dose , combination ezetimibe/simvastatin 10/20mg (ES10/20)  OR rosuvastatin 10&amp;amp;nbsp;mg (R10) ,0,
edin,7015,4845107,Significantly decreased,"Switching to either ES10/20 or R10 resulted in significant reductions from baseline in PLAC (P<0.001), whereas small, nonsignificant reductions were observed with doubling the statin dose (P>0.05) (TableÂ 3).", PLAC , doubling the statin dose , combination ezetimibe/simvastatin 10/20mg (ES10/20)  OR rosuvastatin 10&amp;amp;nbsp;mg (R10) ,0,
edin,6919,4411165,Cannot tell based on the abstract,, diastolic BP ," whole-body except the head (partial-body cryostimulation, PBC) "," whole-body to cold (whole-body cryostimulation, WBC) ",0,
edin,6919,4411165,No significant difference,"No marked changes in systolic and diastolic BP were recorded after the cryostimulation sessions in PBC and WBC modalities. Only a likely small decrease in systolic BP was recorded after the third PBC session and a likely small increase in diastolic BP after the two first WBC sessions, but these increases disappeared for the next sessions (Fig 4).", diastolic BP ," whole-body except the head (partial-body cryostimulation, PBC) "," whole-body to cold (whole-body cryostimulation, WBC) ",0,
edin,6620,4751474,No significant difference,"In intent-to-treat analyses, intervention was not associated with significant improvement in primary adherence, medication persistence, or intermediate outcomes of care.", Medication persistence , Control , Telephone Outreach ,0,
edin,7105,3517358,No significant difference,"Students spent longer on the tutorials when they were done in sequence (12.1âmin (SD 7.3) vs. 10.5 (6.5)) though the difference was not statistically significant (95% CI diff: -1.2âmin, +4.5).", time spent on the tutorials , non-relevant tutorial  = âout of sequenceâ , relevant computer tutorial = âin sequenceâ ,0,
edin,7048,3050701,Cannot tell based on the abstract,"ore throat relief, improvements in throat soreness and difficulty in swallowing, and throat numbness were observed as early as 1-5 minutes, and lasted up to 2 hours post dose. S", changes from baseline in throat soreness between 5 and 120 minutes ," unflavoured, non-medicated lozenge ", AMC/DCBA Warm lozenge ,0,
edin,7048,3050701,Significantly decreased,"The AMC/DCBA Warm lozenge produced significantly different AUC results for the change from baseline to 2 hours in severity of throat soreness compared with the unflavoured, non-medicated lozenge (p = 0.001; Table 2). Similarly, the AMC/DCBA Cool lozenge also significantly reduced the severity of throat soreness versus the unflavoured, non-medicated lozenge, as measured by AUC for the change from baseline to 2 hours (p < 0.0001).", changes from baseline in throat soreness between 5 and 120 minutes ," unflavoured, non-medicated lozenge ", AMC/DCBA Warm lozenge ,0,
edin,7101,5593818,Cannot tell based on the abstract,, increase in the proportion of patients developing diabetes , placebo ," JinqiJiangtang tablets (JQJT tablets, a traditional Chinese patent medicine) ",0,
edin,7101,5593818,Significantly decreased,"The JQJT tablets group exhibited a significantly smaller increase in the proportion of patients developing diabetes compared with the placebo group (16.5%vs. 28.9% at month12, Pâ=â0.005; 20. 3% vs. 32. 8% at month 24, Pâ=â0.007).", increase in the proportion of patients developing diabetes , placebo ," JinqiJiangtang tablets (JQJT tablets, a traditional Chinese patent medicine) ",0,
edin,6875,2571050,Cannot tell based on the abstract,, Time for reaching  pH predetermined value  , Insulin 0.07 IU/kg load + 0.07 IU/kg infusion , Insulin 0.07 IU/kg infusion ,0,
edin,6875,2571050,No significant difference,"Table 3 demonstrates the outcome recovery data for DKA, depicting the time that predetermined values were reached for glucose, HCO3â, and pH. The results suggested no significant differences in these values for the three doses of insulin, but 5 of 12 patients in the no load group required additional insulin for control of their blood glucose.", Time for reaching  pH predetermined value  , Insulin 0.07 IU/kg load + 0.07 IU/kg infusion , Insulin 0.07 IU/kg infusion ,0,
edin,7078,3649350,Cannot tell based on the abstract,, diastolic blood pressures before the procedures ," group B, who were NOT allowed to observe DJ stent insertion "," group A, who were allowed to observe DJ stent insertion ",0,
edin,7078,3649350,No significant difference,The pulse rate and systolic and diastolic blood pressures before the procedures were also found to be comparable for both groups of patients., diastolic blood pressures before the procedures ," group B, who were NOT allowed to observe DJ stent insertion "," group A, who were allowed to observe DJ stent insertion ",0,
edin,6711,4511304,Cannot tell based on the abstract,, Glycated hemoglobin , Glinides alone , Luseogliflozin + glinides  ,0,
edin,6711,4511304,Significantly decreased,"In study 03-1, luseogliflozin significantly decreased glycated hemoglobin at the end of the 24-week double-blind period compared with the placebo (â0.88%, PÂ <Â 0.001), and glycated hemoglobin reduction from baseline at weekÂ 52 was â0.63%.", Glycated hemoglobin , Glinides alone , Luseogliflozin + glinides  ,0,
edin,6761,3424202,Cannot tell based on the abstract,, Fever prevalence at day 1 , Artesunate + mefloquine , Dihydroartemisinin-piperaquine ,0,
edin,6761,3424202,No significant difference,"All patients were febrile at the time of enrollment with the exception of two subjects in the DP arm who were afebrile at admission but had a history of fever prior to admission.,Table 3
Fever prevalence and parasitaemia (ITT population),<td align=""left"" valign=""bottom"">Day 1<hr></td><td align=""left"" valign=""bottom"">45/101 (44.6)<hr></td><td align=""left"" valign=""bottom"">21/49 (42.9)<hr></td><td align=""left"" valign=""bottom"">0.844<hr></td>,Fever prevalence, calculated as the number of days in which temperature was greater or equal to 37.5âÂ°C during the first week divided by the total number of follow-up days in the first week, was similar for DP- and Aâ+âM-treated patients; 260/695 (374.1) versus 125/334 (374.3) (pâ=â0.994) respectively.", Fever prevalence at day 1 , Artesunate + mefloquine , Dihydroartemisinin-piperaquine ,0,
edin,6652,3698473,Significantly increased,"There were significant main effects for time for creatinine (increased from pre to post intervention; P = 0.043) and alkaline phosphatase (decreased from pre to post intervention; P = 0.009), with no condition differences noted (P > 0.05).", Creatinine  , Control , Dimethylamylamine suplement  ,0,
edin,6752,3821103,Cannot tell based on the abstract,"Post-operative VRS scores at 6, 12, and 24 hours were significantly decreased when compared with previous scores in both morphine and tramadol prescribed subjects (P < 0.001), hence, both local analgesics can significantly reduce pain after minor knee surgery.", VRS 24-hours post-operative scores , Morphine , Tramadol  ,0,
edin,6752,3821103,No significant difference,"Meanwhile, as shown in Figure, post-operative VRS scores at 6, 12, and 24 hours were significantly decreased when compared with previous scores in both morphine and tramadol prescribed subjects (P < 0.001), hence, both local analgesics can significantly reduce pain after minor knee surgery through a local opioid receptor-specific site of action, reaching a maximum effect 6 hours post-injection.,<td colspan=""1"" rowspan=""1"">
24
</td><td colspan=""1"" rowspan=""1"">
2.0 Â± 1.4 <sup><xref ref-type=""table-fn"" rid=""fn85"">a</xref></sup>
</td><td colspan=""1"" rowspan=""1"">
2.3 Â± 1.6 <sup><xref ref-type=""table-fn"" rid=""fn85"">a</xref></sup>
</td><td colspan=""1"" rowspan=""1"">
0.24
</td>", VRS 24-hours post-operative scores , Morphine , Tramadol  ,0,
edin,6629,4282314,Significantly increased,"At 12Â weeks [meanÂ (SEM)], percentage weight loss in the meal provision group was 6.6%Â (0.5%) compared to 4.3%Â (0.6%) for those on the self-directed diet. In terms of clinically relevant weight loss, 61% of participants lost 5% or more of their body weight with meal provision compared to 22% on the self-directed diet (PÂ <Â 0.001).", Weight loss at 12 weeks , Self-directed diet , Meal provision ,0,
edin,6693,5815696,Cannot tell based on the abstract,,  Schirmer test values in women , Control , Hydroxypropyl methylcellulose  ,0,
edin,6693,5815696,No significant difference,"Comparison of dry eye measurements (ST-I, BUT, CFS) for the female patients between the 2 groups at different time points. There is no significant difference between the dry eye test values of the 2 groups of female patients on days 1, 7, and 30 after cataract operation.",  Schirmer test values in women , Control , Hydroxypropyl methylcellulose  ,0,
edin,6708,4511304,Significantly decreased,"In study 03-1, luseogliflozin significantly decreased glycated hemoglobin at the end of the 24-week double-blind period compared with the placebo (â0.88%, PÂ <Â 0.001), and glycated hemoglobin reduction from baseline at weekÂ 52 was â0.63%. In study 03-2, luseogliflozin added to other OADs significantly decreased glycated hemoglobin from baseline at weekÂ 52 (â0.52 to â0.68%, PÂ <Â 0.001 for all OADs).", Glycated hemoglobin , Biguanides alone , Luseogliflozin + biguanides ,0,
edin,6983,5412886,No significant difference,"On day 8 (Â±1 day) and day 15 (Â±2 days), all the antiallergic agents were found to be more effective than vehicle (p < 0.05) in terms of all the symptoms and signs. However, there was no statistical significance (p â¥ 0.05) shown among the treatment groups.", more effective for treating seasonal allergic conjunctivitis (SAC) on day 15 , emedastine difumarate 0.05% twice a day , olopatadine hydrochloride 0.1% twice a day ,0,
edin,6817,5122147,Significantly decreased,"We found that metformin reduced the levels of IL-6 in blood and MCP-1 in urine, but increased IL-10 levels in blood of patients with type 2 diabetes.,Furthermore, compared to individual drug treatment, metformin significantly reduced the levels of serum IL-6 and TNF-Î±, as well as urine MCP-1.", Monocyte chemoattractant protein-1 , Control , Metformin ,0,
edin,6647,4114185,No significant difference,"FMMA score improved in all groups, but no intergroup differences were found at any time points.", Fugl-Meyer motor assessment scores , Standard arm therapy , Haptic Knob ,0,
edin,6920,5636096,Cannot tell based on the abstract,, Post hoc analysis of psychometric effects according to entry PSE , triple placebos , anti-HE intervention (lactulose+branched-chain amino acids+rifaximin) ,0,
edin,6920,5636096,Significantly increased,"Post hoc analysis of psychometric effects according to entry PSE: The patients were primarily stratified according to their CRT index, so the analysis according to PSE is an exploratory secondary analysis. It is based on 25 patients with an abnormal entry PSE, 13 of them receiving the active intervention and 12 of them receiving the placebos. Those on the active intervention improved their CRT index from 1.6Â±0.4 to 2.2Â±0.5 (p = 0.02) and PHES from -8.9Â±3.2 to -5.0Â±4.4 (p = 0.0014). No improvement in PHES or CRT index was observed in the placebo group (-9.0Â±3.6 to -7.6Â±4.2, p = 0.22 and 1.7Â±0.5 to 1.8Â±0.5, p = 0.87).", Post hoc analysis of psychometric effects according to entry PSE , triple placebos , anti-HE intervention (lactulose+branched-chain amino acids+rifaximin) ,0,
edin,6850,4663612,Cannot tell based on the abstract,, Attentive  condition , Caffeine , Theacrine ,0,
edin,6850,4663612,No significant difference,"A trend was noted for a condition effect for attentive (p = 0.06), alert (p = 0.06), focused (p = 0.11), and energetic (p = 0.06), with values for TheaTrim higher than for placebo and caffeine.", Attentive  condition , Caffeine , Theacrine ,0,
edin,6854,3421236,Cannot tell based on the abstract,, Beck depression inventory-II , Control , Transcranial direct current stimulation ,0,
edin,6854,3421236,No significant difference,The mean post-BDI-II score in the active tDCS group and sham stimulation group are shown in Table 2. There was no difference in BDI-II change between the two groups (Fâ=â1.1; dfâ=â1; pâ=â0.38)., Beck depression inventory-II , Control , Transcranial direct current stimulation ,0,
edin,7053,3135864,Cannot tell based on the abstract,, trait anxiety at 35 weeks , placebo group (simulated treatment with disconnected ultrasound) , intervention group (craniosacral therapy) ,0,
edin,7053,3135864,Significantly decreased,"At 35 weeks, the intervention group showed significant improvements in state anxiety (P < .029) and trait anxiety (P < .042) versus baseline scores. No changes were observed in the placebo group,The groups differed significantly in trait anxiety (P < .045).", trait anxiety at 35 weeks , placebo group (simulated treatment with disconnected ultrasound) , intervention group (craniosacral therapy) ,0,
edin,6728,3556767,No significant difference,There was no significant difference in hemodynamic parameters of the three groups in all measurements after the surgery., Hemodynamic parameters , Remifentanyl , Fentanyl + morphine ,0,
edin,7029,5349672,No significant difference,"At rest (T0, T30), median nausea ratings were zero whether subjects were blindfolded or not.", nausea ratings at movement at T30 , eyes open , blindfolded ,0,
edin,7095,5776520,Significantly increased,"he activities of mitochondrial respiratory chain complex IâIV in the propofol + remifentanil group at day 1 after operation were significantly decreased compared with those before operation, and the differences were statistically significant (P<0.05). The decrease in activities of mitochondrial respiratory chain complex IâIV in the propofol + remifentanil group at day 1 after operation was more significant than that in the dexmedetomidine group, and the difference was statistically significant (P<0.05).", decrease in activities of mitochondrial respiratory chain complex IâIV , dexmedetomidine  , propofol + remifentanil ,0,
edin,6703,4266769,No significant difference,"For pain at movement and at rest, no significant differences were found between the paracetamol/naproxen group and either the paracetamol/CR oxycodone for 24 hours group (Î² = 2.6 [4.9]; P = 0.597) or the paracetamol/CR oxycodone for 48 hours (Î² = â1.7 [5.1]; P = 0.736).", Pain at rest , Paracetamol + oxycodone for 24 hours , Paracetamol + naproxen ,0,
edin,7043,3050701,Cannot tell based on the abstract,, improvements in swallowing ," unflavoured, non-medicated lozenge ", AMC/DCBA Cool lozenge ,0,
edin,7043,3050701,Significantly increased,"The AUC for change from baseline to 2 hours post dose in difficulty in swallowing showed significant differences with both AMC/DCBA throat lozenge variants compared with the unflavoured, non-medicated lozenge (Table 3B). At 1 minute post dose, the AMC/DCBA Cool lozenge induced significantly different changes from baseline in difficulty in swallowing compared with the unflavoured, non-medicated lozenge (p < 0.0001). A significant improvement in swallowing remained at each of the subsequent assessment timepoints between 5 and 120 minutes (all p < 0.01). The AMC/DCBA Warm lozenge induced significantly different changes from baseline in difficulty in swallowing compared with the unflavoured, non-medicated lozenge at each of the timepoints between 5 and 60 minutes and at 90 minutes post dose (all p < 0.05; Figure 4).", improvements in swallowing ," unflavoured, non-medicated lozenge ", AMC/DCBA Cool lozenge ,0,
edin,6631,4282314,Cannot tell based on the abstract,, Health state (EQ-5D)	 , Self-directed diet , Meal provision ,0,
edin,6631,4282314,No significant difference,"There were no differences between groups between baseline and 12Â weeks; however, weight-related quality of life (IWQoL-lite), mental toughness (MTQ48) and the 100-point health state scale from EQ-5D all improved in participants completing the studies, although these changes did not significantly correlate with weight loss (Table2).", Health state (EQ-5D)	 , Self-directed diet , Meal provision ,0,
edin,6777,3931696,Cannot tell based on the abstract,, Aldosterone , Vehicle alone , Misoprostol + celecoxib ,0,
edin,6777,3931696,No significant difference,"As has been indicated in Figure 4, final day aldosterone plasma concentrations ranged from 197.49Â±80.59 to 277.26Â±143.93 pg/mL. No significant difference was noticed among the treatment groups (pâ=â0.8269).", Aldosterone , Vehicle alone , Misoprostol + celecoxib ,0,
edin,6979,4894062,Cannot tell based on the abstract,, Lactobacillus , healthy controls , T2D (type 2 diabetes) patients ,0,
edin,6979,4894062,Significantly increased,"T2D patients also showed a significantly higher abundance of Lactobacillus, with an increase of about 150 times, and Lachnospiraceae:Ruminococcus, which was 1Â·1 times more than in healthy controls.", Lactobacillus , healthy controls , T2D (type 2 diabetes) patients ,0,
edin,7091,3208043,Significantly decreased,Recurrence at 24Â h was significantly (pÂ <Â 0.01) lower with frovatriptan (10 vs. 32% rizatriptan)., Recurrence at 24h - menstrually related migraine , rizatriptan , frovatriptan ,0,
edin,6626,4282314,Significantly increased,"In terms of clinically relevant weight loss, 61% of participants lost 5% or more of their body weight with meal provision compared to 22% on the self-directed diet (PÂ <Â 0.001).", &amp;gt;5% weight loss , Self-directed diet , Meal provision ,0,
edin,6745,5244277,Significantly increased,"More patients stated a preference for FFNS versus MFNS for the attributes of âless drip down the throatâ (p < 0.001), âless run out of the noseâ (p < 0.05), âmore soothingâ (p < 0.05), and âless irritatingâ (p < 0.001).", Preference for less running out of the nose , mometasone furoate nasal spray , fluticasone furoate nasal spray ,0,
edin,6857,2981076,No significant difference,"Compliance and drug attitude were measured using the Drug Attitude Inventory (DAI-10) and Medication Adherence Form (MAF) scales;,There was no significant change in DAI-10 with either formulation. MAF was above 75% in 94% vs. 93% of patients on ODC and OCT, respectively. Compliance as measured by tablet count was above 98% on both formulations.", Compliance , Olanzapine conventional tablet , Olanzapine orodispersible tablet ,0,
edin,6853,3421236,Cannot tell based on the abstract,, MontgomeryâAsberg Depression Rating Scale , Control , Transcranial direct current stimulation ,0,
edin,6853,3421236,No significant difference,There was no difference in MADRS change between the two groups (Fâ=â0.38; dfâ=â1; pâ=â0.55). One of the subjects in the active tDCS group achieved response (Fisherâs exact pâ=â1.00) and remission criteria (Fisherâs exact pâ=â1.00) while no subjects met response or remission criteria in the sham stimulation group., MontgomeryâAsberg Depression Rating Scale , Control , Transcranial direct current stimulation ,0,
edin,6844,3830844,Cannot tell based on the abstract,, Quality of life , Standardized acupuncture , Individualized acupuncture ,0,
edin,6844,3830844,No significant difference,"Furthermore, for the secondary outcomes HFAQ, QoL, and sick leave days at week 8 and week 26, no significant group differences were observed (Table 2).", Quality of life , Standardized acupuncture , Individualized acupuncture ,0,
edin,6924,5636096,Cannot tell based on the abstract,, mean CRT index change , triple placebos , anti-HE intervention (lactulose+branched-chain amino acids+rifaximin) ,0,
edin,6924,5636096,No significant difference,"There was also a marginal difference in the mean CRT index change between the patients on active and placebo intervention (a mean CRT index change of 0.50Â±0.20 vs. 0.13Â±0.12, p = 0.06).", mean CRT index change , triple placebos , anti-HE intervention (lactulose+branched-chain amino acids+rifaximin) ,0,
edin,6814,3432554,Cannot tell based on the abstract,, Cycle sprint total work , Control , Coenzyme Q10 ,0,
edin,6814,3432554,Significantly increased,"Although not a main focus of the present research, the relationship between the percentage change in total blood CoQ10 and exercise performance (placebo versus CoQ10 supplement) was noted for GXT time (R2 = 0.0744; P = 0.35) and cycle sprint total work (R2 = 0.6009; P = 0.001).", Cycle sprint total work , Control , Coenzyme Q10 ,0,
edin,7018,3806618,Cannot tell based on the abstract,, use of exogenous insulin - new-onset type 1 diabetes (T1D) , control , teplizumab ,0,
edin,7018,3806618,Significantly decreased,"We screened 125 subjects <8 weeks from diagnosis of T1D and enrolled 83 (Fig. 1). Six subjects left the study before the first MMTT and are not included in the ITT analysis (n = 77). Fifty-two of the subjects randomized to drug treatment received all or part of the first drug course and are included in the ITT analysis; 15 discontinued teplizumab treatment after receiving some of cycle 1 or 2 (Supplementary Table 1). Twelve of the 15 subjects developed laboratory abnormalities or experienced AEs, leading to drug discontinuation. There were no significant differences between the study groups at entry (Table 1). The majority of subjects (94%) were <18 years old; 64% were â¤12 years old.,We conclude that teplizumab treatment preserves insulin production and reduces the use of exogenous insulin in some patients with new-onset T1D.", use of exogenous insulin - new-onset type 1 diabetes (T1D) , control , teplizumab ,0,
edin,7056,4631431,Cannot tell based on the abstract,, Mild AEs , placebo , IV ibuprofen ,0,
edin,7056,4631431,No significant difference,"he majority (>90%) of these events were deemed either mild (53%) or moderate (38%) in terms of severity. A greater proportion (85%) of placebo-treated individuals experienced at least one AE, with a similar distribution of severities (mild, 56%; moderate, 38%; severe, 6%).", Mild AEs , placebo , IV ibuprofen ,0,
edin,6719,4427989,Cannot tell based on the abstract,, Perceived stress  , Control , Phone-Based Education and Counseling ,0,
edin,6719,4427989,Significantly decreased,"At baseline, about 78% had higher than average stress scores meaning high stress while only 1% had the least stress score of much less than average with similar distributions throughout the scores. At 3 months follow-up, this proportion was reduced to less than half (46%) for higher than average stress scores; higher proportion of reduction was seen in the intervention group", Perceived stress  , Control , Phone-Based Education and Counseling ,0,
edin,6709,4511304,Significantly decreased,"n study 03-1, luseogliflozin significantly decreased glycated hemoglobin at the end of the 24-week double-blind period compared with the placebo (â0.88%, PÂ <Â 0.001), and glycated hemoglobin reduction from baseline at weekÂ 52 was â0.63%. In study 03-2, luseogliflozin added to other OADs significantly decreased glycated hemoglobin from baseline at weekÂ 52 (â0.52 to â0.68%, PÂ <Â 0.001 for all OADs).", Glycated hemoglobin , DPP-4 inhibitors alone , Luseogliflozin + DPP-4 inhibitors ,0,
edin,7045,3050701,Cannot tell based on the abstract,, AUC results in severity of throat soreness ," unflavoured, non-medicated lozenge ", AMC/DCBA Warm lozenge ,0,
edin,7045,3050701,Significantly decreased,"The AMC/DCBA Warm lozenge produced significantly different AUC results for the change from baseline to 2 hours in severity of throat soreness compared with the unflavoured, non-medicated lozenge (p = 0.001; Table 2). Similarly, the AMC/DCBA Cool lozenge also significantly reduced the severity of throat soreness versus the unflavoured, non-medicated lozenge, as measured by AUC for the change from baseline to 2 hours (p < 0.0001).", AUC results in severity of throat soreness ," unflavoured, non-medicated lozenge ", AMC/DCBA Warm lozenge ,0,
edin,6821,3230393,Cannot tell based on the abstract,, Urinary 1-Hydroxypyrene , Control  , Patsari Biomass Stove ,0,
edin,6821,3230393,Significantly decreased,"<td colspan=""1"" rowspan=""1"">1-Hydroxypyrene (1âPYR)</td><td colspan=""1"" rowspan=""1"">Pre</td><td colspan=""1"" rowspan=""1"">3.18 (2.63â3.85)</td><td colspan=""1"" rowspan=""1""></td><td colspan=""1"" rowspan=""1"">3.51</td><td colspan=""1"" rowspan=""1"">4.94</td><td colspan=""1"" rowspan=""1"">5.93</td><td colspan=""1"" rowspan=""1"">6.83</td><td colspan=""1"" rowspan=""1""></td><td colspan=""1"" rowspan=""1"">36 (0.001)</td>", Urinary 1-Hydroxypyrene , Control  , Patsari Biomass Stove ,0,
edin,7066,2995234,No significant difference,"Although the LacidofilÂ® cap does not reduce the rate of occurrence of AAD in adult patients with respiratory tract infection who have taken antibiotics, the Lactobacillus group maintains their bowel habits to a greater extent than the placebo group.", antibiotic use in patients with respiratory tract , placebo , Lactobacillus (LacidofilÂ® cap) ,0,
edin,6944,5099199,No significant difference,"The eradication rates of S10 and T14 were 87.2% (567/650, 95% CI 84.4% to 89.6%) and 85.7% (557/650, 95% CI 82.8% to 88.2%) in the ITT analysis, respectively, and were 91.6% (556/607, 95% CI 89.1% to 93.4%) and 91.0% (548/602, 95% CI 88.5% to 93.1%) in the PP analysis, respectively.", eradication rates by per-protocol (PP) ," T14 (lansoprazole, amoxicillin and clarithromycin for 14âdays) "," S10 (lansoprazole and amoxicillin for the first 5âdays, followed by lansoprazole, clarithromycin and metronidazole for another 5âdays) ",0,
edin,6849,4663612,Cannot tell based on the abstract,, Depressed condition , Caffeine , Theacrine ,0,
edin,6849,4663612,Significantly decreased,"A condition effect was noted for jittery (p = 0.01) and depressed (p = 0.02), with values higher for caffeine than for TheaTrim and placebo.", Depressed condition , Caffeine , Theacrine ,0,
edin,7023,4862081,Cannot tell based on the abstract,, intestinal villous height of fetus , control , high fat diets (HF diet) ,0,
edin,7023,4862081,No significant difference,"Feeding HF diet tended to increase intestinal villous height (Pâ=â0.055), but decrease crypt depth (Pâ=â0.098) of fetus (Fig.Â 1).", intestinal villous height of fetus , control , high fat diets (HF diet) ,0,
edin,6786,3918522,Cannot tell based on the abstract,, Complete control , Azasetron , Ondansetron ,0,
edin,6786,3918522,Significantly increased,"In the present study, azasetron showed inferiority in the control of delayed chemotherapy-induced nausea and vomiting compared with ondansetron whereas safety profiles were similar between the two groups", Complete control , Azasetron , Ondansetron ,0,
edin,6896,4173360,Cannot tell based on the abstract,, attenuation of hemodynamic responses ," group DLS, Direct Laryngoscopy "," group ILMA, Intubating Laryngeal Mask Airway ",0,
edin,6896,4173360,No significant difference,"Analysis of baseline hemodynamic parameters like SBP â 0, DBP â 0, MBP â 0 and HR â 0 was done. These baseline hemodynamic variables were found to be comparable between the two groups [Table 8].", attenuation of hemodynamic responses ," group DLS, Direct Laryngoscopy "," group ILMA, Intubating Laryngeal Mask Airway ",0,
edin,6642,4510702,Significantly decreased,"Closedâloop therapy significantly reduced mean overnight glucose levels by 0.9 mmol/l (p < 0.001), with no difference in glycaemic variability, as measured by the standard deviation of sensor glucose.", Sensor hypoglycaemia  , Control , Closedâloop insulin ,0,
edin,6623,4751474,Cannot tell based on the abstract,, Systolic blood pressure improvement , Control , Telephone Outreach ,0,
edin,6623,4751474,No significant difference,"There were no significant differences between the intervention and control study arms in primary medication adherence within 60 days of the prescription date (intervention arm 85.8%, control arm 83.0%, P = 0.35), medication persistence at 180 days (intervention arm 64.0%, control arm 60.3%, P = 0.30), MPR (intervention arm 0.90, control arm 0.92, P = 0.13), SBP change from baseline (intervention arm â18.1 mmHg, control arm â16.4 mmHg, P = 0.26), or the proportion of subjects with a â¥4 mmHg drop in SBP (intervention arm 78.5%, control arm 75.8%, P = 0.38). Among the 129 subjects whose new prescription was not filled before the index date, the change in SBP from baseline was â19.6 mmHg in the intervention arm vs. â15.6 mmHg in the control arm (P = 0.25).", Systolic blood pressure improvement , Control , Telephone Outreach ,0,
edin,6713,2447849,No significant difference,There were no significant differences between the groups with respect to total adherence or any of the satisfaction scales., Total adherence , Questionnaires made by independent researchers  , Questionnaires made by the GP  ,0,
edin,6800,5200867,Significantly increased,Radiographic analysis showed that the hidden X suture had a significant effect in preserving horizontal width and minimizing vertical reduction in comparison to X suture (P<0.05)., Vertical reduction , Crossed mattress suture , Hidden X suture  ,0,
edin,6663,5599448,Cannot tell based on the abstract,, t max , Pirfenidone capsules , Pirfenidone tablet ,0,
edin,6663,5599448,No significant difference,Median t max were similar between the tablet and capsules (TableÂ 2).TableÂ 2, t max , Pirfenidone capsules , Pirfenidone tablet ,0,
edin,6679,5126873,Cannot tell based on the abstract,, Fruit and vegetables intake , Control , Diet and physical activity ,0,
edin,6679,5126873,No significant difference,There was no change between the groups in scores for the Fruit and vegetables and African/Caribbean dietary patterns at 28 and 36Â weeks gestation., Fruit and vegetables intake , Control , Diet and physical activity ,0,
edin,6613,5129050,Significantly increased,"Compared with control, intervention students reported greater peer support 0.5 (0.1 to 0.9) p=0.03, well-being 1.8 (0.1 to 3.4) p=0.04 but no difference in shyness/sociability.", Peer support , Control , GoActive intervention ,0,
edin,6906,4867039,Significantly decreased,"A considerable reduction in mean percentage of number, natural morphology of sperm, sperm motility and viability and serum testosterone concentration besides DNA injury increment among mice treating with PHZ in comparison with control group were observed.", Sperm mobility status , control group - normal saline , phenylhydrazine (PHZ) ,0,
edin,7003,4377530,Cannot tell based on the abstract,, frequency of entrococcal infection , Foley catheter , Nelatone catheter ,0,
edin,7003,4377530,Significantly decreased,The frequency of entrococcal infection was less in the Nelatone group (3 cases) compared with the Foley group (nine cases) and this difference was statistically significant (P = 0.038)., frequency of entrococcal infection , Foley catheter , Nelatone catheter ,0,
edin,6706,4266769,No significant difference,Compliance was comparable across the groups., Compliance  , Paracetamol + oxycodone for 48 hours , Paracetamol + naproxen ,0,
edin,6970,5925011,Cannot tell based on the abstract,, effect size after six months compared to immediate postoperative measurements , standard implant protocol treatment , intervention group with added low-intensity power ultrasound treatment (LIPUS) ,0,
edin,6970,5925011,Significantly increased,"Moreover, the effect size after six months compared to immediate postoperative measurements was much stronger for the intervention group (Cohen's dâ=â7.4) compared to the control group (Cohen's dâ=â2.25).", effect size after six months compared to immediate postoperative measurements , standard implant protocol treatment , intervention group with added low-intensity power ultrasound treatment (LIPUS) ,0,
edin,6614,5129050,Significantly increased,"Compared with control, intervention students reported greater peer support 0.5 (0.1 to 0.9) p=0.03, well-being 1.8 (0.1 to 3.4) p=0.04 but no difference in shyness/sociability.", Well-being , Control , GoActive intervention ,0,
edin,6916,4411165,Significantly decreased,"The WBC sessions caused an almost certain decrease in tympanic temperature from Pre to P20 (-0.28 Â±0.11Â°C), while it only decreased at P20 (-0.14Â±0.05Â°C) after PBC sessions.", tympanic temperature from Pre to P20 (-0.28 Â±0.11Â°C) ," whole-body except the head (partial-body cryostimulation, PBC) "," whole-body to cold (whole-body cryostimulation, WBC) ",0,
edin,7016,3806618,Cannot tell based on the abstract,, detectable levels of C-peptide - new-onset type 1 diabetes (T1D) - month 24 visit , control , teplizumab ,0,
edin,7016,3806618,Significantly increased,"At the month 24 visit, more subjects treated with teplizumab had detectable levels of C-peptide compared with control subjects (P = 0.002; Fig. 2C).,There was a significantly greater loss of detectable C-pep secretion in the control group at month 24 (P = 0.002, Ï2 test).", detectable levels of C-peptide - new-onset type 1 diabetes (T1D) - month 24 visit , control , teplizumab ,0,
edin,6700,5154016,No significant difference,The drainage volumes in the second 24Â h were similar in the 3 groups., Second 24 h drainage volume , Gelatin sponge , Collagen hemostatic sponge ,0,
edin,6643,4510702,Significantly increased,Lower mean overnight glucose levels during closedâloop therapy were brought about by increased overnight insulin delivery (p < 0.001) without changes to the total daily delivery (p = 0.84)., Overnight insulin delivered  , Control , Closedâloop insulin ,0,
edin,6658,5719521,Significantly decreased,"Youth who had recently dealt drugs (adjusted hazard ration [AHR], 0.50; 95% CI, 0.29â0.87), engaged in prohibited street-based income generation (AHR, 0.41; 95% CI, 0.24â0.69), and engaged in illegal income generating activities (AHR, 0.19; 95% CI, 0.06â0.61) were significantly less likely to report cessation of injection drug use.", Cessation of injected drugs , No incarceration in the last 6 months  , Incarceration in the last 6 months  ,0,
edin,6829,4724125,Cannot tell based on the abstract,, Systolic blood pressure , Control , Exercise training ,0,
edin,6829,4724125,Significantly decreased,"The non-significant reduction of cIMT in the exercise group (pÂ =Â 0.19), correlated with change in systolic BP (rÂ =Â 0.279, pÂ =Â 0.041) and tended to correlate with change in HbA1c (rÂ =Â 0.254, pÂ =Â 0.064), but not with change in LDL cholesterol (pÂ =Â 0.55)", Systolic blood pressure , Control , Exercise training ,0,
edin,6884,5688834,Cannot tell based on the abstract,, Fasting blood sugar  , Control , Shilajatu ,0,
edin,6884,5688834,Significantly increased,"FBS and PPBS reduced by 24.01% and 20.23%, respectively, in Group A, which was statistically highly significant (P < 0.001). In Group B, reduction in FBS and PPBS was 26.03% and 19.29%, respectively, which was also statistically highly significant (P < 0.001)", Fasting blood sugar  , Control , Shilajatu ,0,
edin,6960,3407716,No significant difference,There were four versus one wound infections in the drain versus no-drain groups. This finding was not statistically significant (Pâ=â0.154)., infections , no-drain group , drain group ,0,
edin,6791,5426394,Cannot tell based on the abstract,, Pain , Lidocaine  , Lidocaine + Oxymetazoline ,0,
edin,6791,5426394,Significantly decreased,The lowest pain score was obtained for oxymetazoline+lidocaine (P<0.05) (Fig. 4). There were no differences in pain between NS+lidocaine and NS+NS (P>0.05)., Pain , Lidocaine  , Lidocaine + Oxymetazoline ,0,
edin,6669,5655938,No significant difference,"Despite this stereotype activation, student ethnicity had no influence on examinersâ scores; on the feedback examiners gave; or on examinersâ memories for one performance.", Feedback provided  , White student  , Asian students ,0,
edin,6894,4482193,Cannot tell based on the abstract,, sustained improvement in liver functions , stem cell infusion - one session treatment (G-I) , stem cell infusion - two session treatment (G-II)  ,0,
edin,6894,4482193,Significantly increased,Repeated HSC infusions give more sustained clinical efficacy and improvement in liver functions and quality of life during 12-month follow-up compared with single HSC infusion., sustained improvement in liver functions , stem cell infusion - one session treatment (G-I) , stem cell infusion - two session treatment (G-II)  ,0,
edin,6860,2981076,Cannot tell based on the abstract,, Serious adverse events , Olanzapine conventional tablet , Olanzapine orodispersible tablet ,0,
edin,6860,2981076,No significant difference,There were two serious adverse events (SAEs) reported in this study: appendicitis and completed suicide. None of those SAEs were considered as related to study drug by the investigators., Serious adverse events , Olanzapine conventional tablet , Olanzapine orodispersible tablet ,0,
edin,7010,4845107,No significant difference,"Switching to ES10/20 reduced lowâdensity lipoproteinâparticle number numerically more than did statin doseâdoubling and was comparable with R10 (â133.3, â94.4, and â56.3Â nmol/L, respectively; P>0.05).", lowâdensity lipoproteinâparticle number , statin doseâdoubling , combination ezetimibe/simvastatin 10/20mg (ES10/20) ,0,
edin,6737,3941354,No significant difference,"There were no statistically significant differences in the number of retrieved oocyte (p=0.545), fertilization (p=0.876), implantation (p=0.716) and pregnancy rate (p=0.727) between the two groups.", Implantation rate , Decapeptyl , Triptorelin ,0,
edin,6848,4663612,Cannot tell based on the abstract,, Jittery  condition , Caffeine , Theacrine ,0,
edin,6848,4663612,Significantly decreased,"A condition effect was noted for jittery (p = 0.01) and depressed (p = 0.02), with values higher for caffeine than for TheaTrim and placebo.", Jittery  condition , Caffeine , Theacrine ,0,
edin,6971,3806324,Cannot tell based on the abstract,, failure managed by optical internal urethrotomy (OIU) , dorsal onlay BMG urethroplasty (Group A) (Barbagli) , dorsal BMG urethroplasty by ventral urethrotomy (Group B) (Asopa) ,0,
edin,6971,3806324,No significant difference,"In Group A, 18 patients were satisfied with surgery and had Q maxâ¡ greater than 25âmL/sec. One patient had persistent narrowing at the stricture site and voided with a poor stream. Patient was managed with optical internal urethrotomy (OIU).,On subsequent follow-up, 2 patients showed evidence of stricture at 1 year in Group B. Both of these patients were managed with OIU. There was no significant difference in the subjective symptom score, residual urine, Q maxâ¡, and restricture rate between the two groups.", failure managed by optical internal urethrotomy (OIU) , dorsal onlay BMG urethroplasty (Group A) (Barbagli) , dorsal BMG urethroplasty by ventral urethrotomy (Group B) (Asopa) ,0,
edin,6823,3230393,Cannot tell based on the abstract,, Urinary 2-Hydroxyfluorene , Control  , Patsari Biomass Stove ,0,
edin,6823,3230393,Significantly decreased,"<td colspan=""1"" rowspan=""1"">2-Hydroxyfluorene (2-FLUO)</td><td colspan=""1"" rowspan=""1"">Pre</td><td colspan=""1"" rowspan=""1"">2.67 (2.37â3.01)</td><td colspan=""1"" rowspan=""1""></td><td colspan=""1"" rowspan=""1"">2.69</td><td colspan=""1"" rowspan=""1"">3.51</td><td colspan=""1"" rowspan=""1"">4.43</td><td colspan=""1"" rowspan=""1"">4.96</td><td colspan=""1"" rowspan=""1""></td><td colspan=""1"" rowspan=""1"">23 (0.029)</td>,Reductions in whole-weight concentrations ranged from 33% for 9-hydroxyfluorene (9-FLUO) to 57% for 1-hydroxynaphthalene (1-NAP), with a 42% total reduction for the sum of 10 metabolites [see Supplemental Material, Table 1 (http://dx.doi.org/10.1289/ehp.1002927)].", Urinary 2-Hydroxyfluorene , Control  , Patsari Biomass Stove ,0,
edin,7024,4862081,Cannot tell based on the abstract,, intestinal villous crypt depth of fetus , control , high fat diets (HF diet) ,0,
edin,7024,4862081,Significantly decreased,"Feeding HF diet tended to increase intestinal villous height (Pâ=â0.055), but decrease crypt depth (Pâ=â0.098) of fetus (Fig.Â 1).", intestinal villous crypt depth of fetus , control , high fat diets (HF diet) ,0,
edin,7093,5776520,Significantly decreased,"At day 3 and 5 after operation, the National Institutes of Health Stroke Scale (NIHSS) scores and AVLT scores in the two groups were decreased in different degrees, but the decrease range in the dexmedetomidine group was smaller than that in the propofol + remifentanil group, and the differences were statistically significant (P<0.05).", National Institutes of Health Stroke Scale (NIHSS) scores , dexmedetomidine  , propofol + remifentanil ,0,
edin,6856,2981076,Significantly increased,A total of 175 patients answered a preference question: 106 (61%) preferred ODT and 48 (27%) preferred OCT (P<0.001 adjusted for treatment sequence); 21 (12%) expressed no preference., Preference , Olanzapine conventional tablet , Olanzapine orodispersible tablet ,0,
edin,6792,5426394,Cannot tell based on the abstract,Nasal decongestion was best achieved with NS+oxymetazoline (P<0.001)., Nasal decongestion , Oxymetazoline , Lidocaine + Oxymetazoline ,0,
edin,6792,5426394,Significantly decreased,"Nasal decongestion scores were significantly different between spray combinations (P<0.001). Nasal decongestion was best achieved with NS+oxymetazoline (P<0.001), whereas NS+lidocaine had the least effect (Fig. 4). Nasal decongestion scores were significantly higher for NS+oxymetazoline than for oxymetazoline+lidocaine (P<0.05) (Fig. 4).", Nasal decongestion , Oxymetazoline , Lidocaine + Oxymetazoline ,0,
edin,7058,4566202,Cannot tell based on the abstract,, Patients without Modic changes Type 1 - better , exercise group , rest group ,0,
edin,7058,4566202,Significantly increased,"<td colspan=""4"">Modic changes Type 1</td>,Patients with large Modic changes were 0.41 (â1.62 to 0.79) points worse with rest, while those without large Modic changes were 1.08 points better with rest (â0.97 to 3.12).,<td>No Modic changes Type 1</td><td>2.91 (1.51;4.31)</td><td align=""char"" char=""."">2.09 (0.69;3.49)</td><td align=""char"" char=""."">0.82 (â1.23;2.86)</td>", Patients without Modic changes Type 1 - better , exercise group , rest group ,0,
edin,7062,4566202,Cannot tell based on the abstract,, Patients without large Modic changes - better , exercise group , rest group ,0,
edin,7062,4566202,Significantly increased,"Patients with large Modic changes were 0.41 (â1.62 to 0.79) points worse with rest, while those without large Modic changes were 1.08 points better with rest (â0.97 to 3.12).,<td>No large Modic changes Type 1</td><td>1.57 (0.49;2.65)</td><td align=""char"" char=""."">0.68 (â0.45;1.82)</td><td align=""char"" char=""."">0.89 (â0.93;2.70)</td>", Patients without large Modic changes - better , exercise group , rest group ,0,
edin,6730,4869362,Cannot tell based on the abstract,, Hydration  , Trichloroacetic acid , Podiatry ,0,
edin,6730,4869362,No significant difference,"Median change in hydration, elasticity, and texture for plantar callus at D7, D14 and D21 for potassium hydroxide (KOH), trichloroacetic acid (TCA) and podiatry treatment groups.,<td>KOH vs TCA</td><td align=""char"" char=""("">0.91: 1.60 (0.28)</td><td align=""char"" char=""("">0.08: â0.01 (0.53)</td><td align=""char"" char=""("">â0.04: â0.25 (0.43)</td><td align=""char"" char=""("">0.81: 0.43 (0.97)</td>,There was no significant difference between the groups at each time point with regards to hydration and elasticity measures; however, at D7 the skin texture had improved significantly in the TCA group compared to the KOH group (pâ=â0.00).", Hydration  , Trichloroacetic acid , Podiatry ,0,
edin,6630,4282314,Cannot tell based on the abstract,, Impact of Weight on Quality of Life , Self-directed diet , Meal provision ,0,
edin,6630,4282314,No significant difference,"There were no differences between groups between baseline and 12Â weeks; however, weight-related quality of life (IWQoL-lite), mental toughness (MTQ48) and the 100-point health state scale from EQ-5D all improved in participants completing the studies, although these changes did not significantly correlate with weight loss (Table2).", Impact of Weight on Quality of Life , Self-directed diet , Meal provision ,0,
edin,6975,4894062,Cannot tell based on the abstract,, Ruminococcus , healthy controls , T2D (type 2 diabetes) patients ,0,
edin,6975,4894062,Significantly increased,"T2D patients also showed a significantly higher abundance of Lactobacillus, with an increase of about 150 times, and Lachnospiraceae:Ruminococcus, which was 1Â·1 times more than in healthy controls.,<td align=""left"" colspan=""1"" rowspan=""1"">Lachnospiraceae:<italic>Ruminococcus</italic>
</td><td align=""char"" char=""Â·"" colspan=""1"" rowspan=""1"">4Â·98</td><td align=""char"" char=""Â·"" colspan=""1"" rowspan=""1"">0Â·05</td><td align=""char"" char=""Â·"" colspan=""1"" rowspan=""1"">2Â·33</td><td align=""char"" char=""Â·"" colspan=""1"" rowspan=""1"">0Â·02</td><td align=""char"" char=""Â·"" colspan=""1"" rowspan=""1"">0Â·01</td>", Ruminococcus , healthy controls , T2D (type 2 diabetes) patients ,0,
edin,6710,4511304,Significantly decreased,"In study 03-1, luseogliflozin significantly decreased glycated hemoglobin at the end of the 24-week double-blind period compared with the placebo (â0.88%, PÂ <Â 0.001), and glycated hemoglobin reduction from baseline at weekÂ 52 was â0.63%. In study 03-2, luseogliflozin added to other OADs significantly decreased glycated hemoglobin from baseline at weekÂ 52 (â0.52 to â0.68%, PÂ <Â 0.001 for all OADs).", Glycated hemoglobin , Thiazolidinediones alone , Luseogliflozin + thiazolidinediones ,0,
edin,6918,4411165,Cannot tell based on the abstract,, systolic BP ," whole-body except the head (partial-body cryostimulation, PBC) "," whole-body to cold (whole-body cryostimulation, WBC) ",0,
edin,6918,4411165,No significant difference,"No marked changes in systolic and diastolic BP were recorded after the cryostimulation sessions in PBC and WBC modalities. Only a likely small decrease in systolic BP was recorded after the third PBC session and a likely small increase in diastolic BP after the two first WBC sessions, but these increases disappeared for the next sessions (Fig 4).", systolic BP ," whole-body except the head (partial-body cryostimulation, PBC) "," whole-body to cold (whole-body cryostimulation, WBC) ",0,
edin,6780,4525010,No significant difference,"Oseltamivir treatment did not reduce illness duration, severity, or duration of virus detection.", Severity of illness , Control , Oseltamivir ,0,
edin,6974,3806324,No significant difference,"Operative time, success rate, satisfaction rate, and complications were compared between the two groups.", complication rate , dorsal onlay BMG urethroplasty (Group A) (Barbagli) , dorsal BMG urethroplasty by ventral urethrotomy (Group B) (Asopa) ,0,
edin,6666,5655938,Cannot tell based on the abstract,, Knowledge score provided  , White student  , Asian students ,0,
edin,6666,5655938,No significant difference,The average knowledge score when performances were acted by Asian students was 3.9 (95% CI 3.8â4.0) vs 3.9 (3.8â4.0) when acted by white students (pâ=â0.77)., Knowledge score provided  , White student  , Asian students ,0,
edin,6969,5925011,Cannot tell based on the abstract,FD on both the mesial and distal sides serve as very good-to-excellent tests with high validity (ROC area exceeding 0.8) in predicting high implant stability (ISQââ¥â70)., FD mesial values after six months of follow-up  , standard implant protocol treatment , intervention group with added low-intensity power ultrasound treatment (LIPUS) ,0,
edin,6969,5925011,Significantly increased,"After six months of follow-up, the FD-mesial values were significantly increased by a mean of 0.132 units in the control group and 0.342 units in the intervention group which reflects a very strong effect size.", FD mesial values after six months of follow-up  , standard implant protocol treatment , intervention group with added low-intensity power ultrasound treatment (LIPUS) ,0,
edin,6764,3424202,Cannot tell based on the abstract,, Asthenia , Artesunate + mefloquine , Dihydroartemisinin-piperaquine ,0,
edin,6764,3424202,No significant difference,"In particular, the highest differences in favour of DP were observed for asthenia (DP:10%; Aâ+âM: 18%; pâ=â0.144) and decreasing number of red blood cells (DP: 11%; Aâ+âM: 20%; pâ=â0.115);,<td align=""left"" valign=""bottom"">Asthenia<hr></td><td align=""left"" valign=""bottom"">10 (9.9%)<hr></td><td align=""left"" valign=""bottom"">9 (18.4%)<hr></td>", Asthenia , Artesunate + mefloquine , Dihydroartemisinin-piperaquine ,0,
edin,6714,2447849,Cannot tell based on the abstract,, Doses alteration  , Questionnaires made by independent researchers  , Questionnaires made by the GP  ,0,
edin,6714,2447849,Significantly decreased,"This figure reveals that a smaller proportion of patients reported altering doses in the medical practice group (3.8% v 12.7%, p = 0.009, difference in proportions 95% CI 2.5% to 15.3%).", Doses alteration  , Questionnaires made by independent researchers  , Questionnaires made by the GP  ,0,
edin,6811,3432554,No significant difference,"Treatment with CoQ10 resulted in a significant increase in total blood CoQ10 (138%; P = 0.02) and reduced blood CoQ10 (168%; P = 0.02), but did not improve exercise performance (with the exception of selected individuals) or impact oxidative stress.", Exercise performance  , Control , Coenzyme Q10 ,0,
edin,6973,3806324,Cannot tell based on the abstract,, suitability in cases where anterior urethra was found to be densely adhered to corpus cavernosum due to extensive spongiofibrosis , dorsal onlay BMG urethroplasty (Group A) (Barbagli) , dorsal BMG urethroplasty by ventral urethrotomy (Group B) (Asopa) ,0,
edin,6973,3806324,Significantly increased,Asopa technique was also found to be more suitable in cases where anterior urethra was found to be densely adhered to corpus cavernosum due to extensive spongiofibrosis., suitability in cases where anterior urethra was found to be densely adhered to corpus cavernosum due to extensive spongiofibrosis , dorsal onlay BMG urethroplasty (Group A) (Barbagli) , dorsal BMG urethroplasty by ventral urethrotomy (Group B) (Asopa) ,0,
edin,7071,5065057,Cannot tell based on the abstract,, Patient-reported impression of treatment benefit , placebo group , buprenorphine HCl buccal film - BBUP group ,0,
edin,7071,5065057,Significantly increased,"Patient-reported impression of treatment benefit was significantly greater with BBUP: the mean (SD) PGIC score at week 12 was 4.5 (1.86) in the BBUP group vs 3.2 (1.98) in the placebo group (treatment difference, 1.3; 95% CI, 0.9-1.6; P < 0.001).", Patient-reported impression of treatment benefit , placebo group , buprenorphine HCl buccal film - BBUP group ,0,
edin,6611,3326921,Cannot tell based on the abstract,, Cure rate , Metronidazole  , Secnidazole  ,0,
edin,6611,3326921,Significantly increased,"At 1 week, the cure rate of tinidazole and ornidazole was 100% and at 4 weeks, it was 97.7% for both medicines. Metronidazole showed a cure rate of 88.4% at 1 week and 77.9% at 4 weeks, which was the lowest among all groups.", Cure rate , Metronidazole  , Secnidazole  ,0,
edin,6766,5003992,Significantly increased,"Compared with the SG, the concentration of insulin significantly increased before puberty in HDG (p<0.05);", Insulin concentration  , Starch , Glucose high dose ,0,
edin,7074,3649350,Cannot tell based on the abstract,, mean pain score ," group B, who were NOT allowed to observe DJ stent insertion "," group A, who were allowed to observe DJ stent insertion ",0,
edin,7074,3649350,Significantly decreased,The mean pain score experienced by the patients from group B (who could not view the procedures) is almost four times higher than the mean pain score of group A (who did view the procedures)., mean pain score ," group B, who were NOT allowed to observe DJ stent insertion "," group A, who were allowed to observe DJ stent insertion ",0,
edin,6667,5655938,Cannot tell based on the abstract,, Communication score provided  , White student  , Asian students ,0,
edin,6667,5655938,No significant difference,The average communication score when the performances were acted by Asian students was 3.9 (3.8â4.1) vs 3.9 (3.7â4.0) when acted by white students (pâ=â0.31)., Communication score provided  , White student  , Asian students ,0,
edin,6851,4663612,Significantly increased,"Condition effects or trends were noted for subjective feelings, with values for attentive, alert, focused, and energetic higher for TheaTrim than for placebo and caffeine, while values for lethargic and groggy were lower for TheaTrim than for placebo and caffeine.", Focused  condition , Caffeine , Theacrine ,0,
edin,6763,3424202,Cannot tell based on the abstract,, Overall fever prevalence  , Artesunate + mefloquine , Dihydroartemisinin-piperaquine ,0,
edin,6763,3424202,No significant difference,"<td align=""left"" valign=""bottom"">Day 7<hr></td><td align=""left"" valign=""bottom"">13/98 (13.3)<hr></td><td align=""left"" valign=""bottom"">7/46 (15.2)<hr></td><td align=""left"" valign=""bottom"">0.752<hr></td>,Fever prevalence, calculated as the number of days in which temperature was greater or equal to 37.5âÂ°C during the first week divided by the total number of follow-up days in the first week, was similar for DP- and Aâ+âM-treated patients; 260/695 (374.1) versus 125/334 (374.3) (pâ=â0.994) respectively.", Overall fever prevalence  , Artesunate + mefloquine , Dihydroartemisinin-piperaquine ,0,
edin,6804,5141553,Significantly decreased,Tube misplacement was observed in 19/100 cases (19%) in the conventional group; no misplacement was observed in the visual group., Tube misplacement by physicians  , Conventional insertion  , Visual nasogastric tube insertion  ,0,
edin,6685,5351968,No significant difference,"The phosphorylation of Akt, GSK3, and eIF2BÎµ were unchanged by treatments.", eIF2BÎµ phosphorylation  , Protein alone , Protein + carbohydrate ,0,
edin,6726,3556767,Significantly decreased,The mean mepridine consumption in remifentanil-treated group was significantly (P=0.001) more than that in fentanyl- or fentanyl plus morphine-treated group in 24 hours after the surgery respectively., Mepridine consumption , Remifentanyl , Fentanyl ,0,
edin,6782,4525010,Cannot tell based on the abstract,, Probability of staying Reverse-trasncriptase-PCR positive , Control , Oseltamivir ,0,
edin,6782,4525010,No significant difference,". The probability that patients were RT-PCR positive through day 3â4 postrandomization was 0.13 (95% CI, 0.06â0.20) and 0.11 (95% CI, 0.01â0.21) for patients who received oseltamivir and placebo, respectively (P = .8) (Supplementary Figure 2).", Probability of staying Reverse-trasncriptase-PCR positive , Control , Oseltamivir ,0,
edin,6689,3816860,Cannot tell based on the abstract,, Glycated hemoglobin , Control , Linagliptin  ,0,
edin,6689,3816860,Significantly decreased,The between-group difference in the change in HbA1c from baseline to week 24 was â0.61% (â6.7 mmol/mol) in favor of linagliptin (95% CI â0.88 to â0.34% [â9.6 to â3.7 mmol/mol]; P < 0.0001)., Glycated hemoglobin , Control , Linagliptin  ,0,
edin,7088,3208043,No significant difference,"At 24Â h, 67 and 81% of frovatriptan-treated, and 61 and 74% of rizatriptan-treated patients were pain free and had pain relief, respectively (pÂ =Â NS).", Pain relief at 24h - menstrually related migraine , rizatriptan , frovatriptan ,0,
edin,6935,5963741,Significantly increased,"Mild moxibustion significantly improved physical condition, living conditions, and emotional status compared to the control group after treatment (P<0.05).,Physical condition (P<0.01) and living conditions (P<0.05) improved significantly in post-menopausal women, while living conditions and emotional status were improved in pre-menopausal women (P<0.05).", emotional status in premenopausal women , control - vitamin E soft capsules , Mild moxibustion ,0,
edin,6768,5003992,No significant difference,"There was no difference in serum progesterone (P) levels amongst the different feed groups,", Serum progesterone , Glucose low dose , Glucose high dose ,0,
edin,6785,3918522,Cannot tell based on the abstract,"Thus, the non-inferiority of azasetron compared with ondansetron in delayed chemotherapy-induced nausea and vomiting was not proven in the present study", Degree of nausea  , Azasetron , Ondansetron ,0,
edin,6785,3918522,No significant difference,"Although the degree of nausea and the CC by treatment day were not significantly different between the two groups, the azasetron group showed trends of higher degree of nausea than ondansetron (Table 4).", Degree of nausea  , Azasetron , Ondansetron ,0,
edin,6640,4510702,Significantly decreased,"Closedâloop therapy significantly reduced mean overnight glucose levels by 0.9 mmol/l (p < 0.001), with no difference in glycaemic variability, as measured by the standard deviation of sensor glucose.", Mean overnight sensor glucose , Control , Closedâloop insulin ,0,
edin,7032,5560514,Significantly increased,Greater pain reductions with Cingal up to 3âweeks were only significant in the anteromedial subgroup., pain reduction up to 3âweeks in patients with knee osteoarthritis - anteromedial subgroup , Monovisc , Cingal ,0,
edin,6735,3941354,No significant difference,"There were no statistically significant differences in the number of retrieved oocyte (p=0.545), fertilization (p=0.876), implantation (p=0.716) and pregnancy rate (p=0.727) between the two groups.", Retrieved oocytes , Decapeptyl , Triptorelin ,0,
edin,7276,4126186,Cannot tell based on the abstract,, Low-density lipoprotein , Rosuvastatin , Atorvastatin ,0,
edin,7276,4126186,Significantly increased,"In both groups, TC, TG and LDL-C were significantly decreased after 12 weeks of treatment (p <0.001, for either group), whereas there was a significant reduction in HDL-C levels only in group A (p=0.007). The reduction in LDL-C was greater with rosuvastatin (49.4 vs. 41.7%, p=0.015) while the reductions in TC and TG levels were similar between the 2 groups (37 vs. 32.9%, respectively; p=0.05 and 27.4 vs. 22.5%, respectively; p=0.168) (Table 2).", Low-density lipoprotein , Rosuvastatin , Atorvastatin ,0,
edin,7176,4893238,No significant difference,"In the rebamipide group, the mean tissue PGE2 concentration was 999âÂ±â109Â pg/mL before treatment, and 168âÂ±â13Â pg/mL after treatment (pâ<â0.001). There was no difference in mean tissue PGE2 between the two groups (differenceâ=â5; 95%CI from â334.870 to 345.650; pâ=â0.975).", Mean tissue PGE2 , Placebo , Rebamipide ,0,
edin,7450,1550608,Cannot tell based on the abstract,, the subjects who were married , mailed paper-and-pencil versions , questionnaires online ,0,
edin,7450,1550608,Significantly increased,The Internet subjects were slightly more likely to be married than the paper questionnaire subjects (P=.043)., the subjects who were married , mailed paper-and-pencil versions , questionnaires online ,0,
edin,7240,2765950,No significant difference,No significant reductions in SAR or LOOH levels were observed in the placebo group., Lipid hydroperoxide levels , Placebo , Noni juice 118 mL ,0,
edin,7552,2910303,Cannot tell based on the abstract,," goal ownership, goal support and âdiabetes self-efficacy ", baseline ,"  active control group, and a passive control group ",0,
edin,7552,2910303,Significantly decreased,"TableÂ 1) indicated that study non-completers were employed for more hours [t (98)â=ââ1.98, pâ=â.050] and scored lower on âgoal ownershipâ [t (94)â=â11.53, pâ<â.000], âgoal supportâ [t (88)â=â5.99, pâ=â.000] and âdiabetes self-efficacyâ [t(90)â=â2.55, pâ=â.013]. Interestingly, study non-completers scored higher on âgoal planningâ [t (89)â=ââ2.99, pâ=â.004]."," goal ownership, goal support and âdiabetes self-efficacy ", baseline ,"  active control group, and a passive control group ",0,
edin,7293,3479017,Cannot tell based on the abstract,, Weight  , Control , Comprehensive lifestyle intervention ,0,
edin,7293,3479017,Significantly decreased,"<th align=""left"">&nbsp;</th><th align=""left""><bold>Intervention, nâ=â71 mean (SD)</bold></th><th align=""left""><bold>Control, nâ=â75 mean (SD)</bold></th><th align=""left""><bold>Intergroup differences</bold><sup><bold>a</bold></sup><bold>B</bold><bold>(95% CI)</bold></th><th align=""left""><bold><italic>p</italic></bold></th><th align=""left""><bold>Intergroup differences</bold><sup><bold>a</bold></sup><bold>B</bold><bold>(95% CI)</bold></th><th align=""left""><bold><italic>p</italic></bold></th>,Weight, BMI and waist circumference showed a significant decrease in the intervention group compared with the control group.", Weight  , Control , Comprehensive lifestyle intervention ,0,
edin,7364,4834398,Cannot tell based on the abstract,, Heart Rate , Sham control , Acupuncture  ,0,
edin,7364,4834398,Significantly decreased,Post hoc analysis revealed significant more decrease at the acupuncture group compared to sham group (p = 0.004) but not control group (p > 0.05)., Heart Rate , Sham control , Acupuncture  ,0,
edin,7596,4386768,Cannot tell based on the abstract,, Qmax , placebo , tadalafil with tamsulosin ,0,
edin,7596,4386768,Significantly increased,"Qmax increased by 1.4, 2.5 (P<0.001), 2.2 (P<0.001), and 3.7 (P<0.001) mL/sec, respectively.,Endpoint I-PSS scores decreased by 10.7, 6.8, and 11.7 points for the tamsulosin group, tadalafil group, and combination group, respectively; further, Qmax increased by 3.1, 2.6, and 3.7 mL/sec.", Qmax , placebo , tadalafil with tamsulosin ,0,
edin,7310,3253463,Cannot tell based on the abstract,, Accuracy of choice reaction time  , Control , Zingiber officinale 800 mg ,0,
edin,7310,3253463,Significantly increased,"It was found that participants who consumed Zingiber officinale at the dose of 800âmg/day for one month showed a significant increase in % accuracy of choice reaction time and numeric working memory (t = 4.1014, P = 0.0001, t = 1.9467, P = 0.0295, resp.)", Accuracy of choice reaction time  , Control , Zingiber officinale 800 mg ,0,
edin,7558,4181789,No significant difference,Colon-cleansing efficiency was not significantly different between the two preparations., cleansing score , polyethylene glycol (PEG) preparation , Sodium phosphates (L-NaP) preparation ,0,
edin,7207,4336131,No significant difference,"The portions of enteral nutrition provided to the target amount and the quantity of gastric discharge were not statistically significantly different between the two groups. The Rikkunshito group reached 50% of the target amount of enteral feeding significantly earlier than the metoclopramide group, although the proportion of patients in whom enteral feeding was successful did not differ significantly between the two groups.", Successful enteral feeding   , Metoclopramide , Rikkunshito  ,0,
edin,7390,5467351,Significantly decreased,A significant increase in fasting glucose (p = 0.001) and a decrease in ISI (p < 0.001) and DIo (p = 0.002) were only found in group A.,  insulin sensitivity index (ISI)  and oral disposition index (DIo) , baseline , receive daily GH treatment (GHT) ,0,
edin,7455,5904467,Significantly increased,The median primary patency period was 9 months for paclitaxel-coated balloons and 2.5 months for the last previous procedure with conventional balloons (p < 0.001)., The median primary patency period , procedure with conventional balloons , double paclitaxel-coated balloons (diameter 6â7 mm) plus a high pressure balloon (diameter 12â14 mm) ,0,
edin,7255,4889193,Significantly increased,"Patients following the rapid protocol reached higher doses of captopril (0.93Â±0.24 versus 0.57Â±0.38Â mg/kg per dose, P<0.0001) and were more likely to have achieved the predefined target (88% versus 43%, P=0.002) and optimal ACEI doses (80% versus 29%, P=0.001) before discharge.", Achieving the predefined target , Prolonged uptitration , Rapid uptitration ,0,
edin,7470,3087256,No significant difference,Sensory and motor blockade were identical in all three groups., sensory blockade , group II lignocaine1% (9ml) with neostigmine 100Î¼g in saline (1ml) and group III received lignocaine 1% (9ml) with neostigmine 200Î¼g in NS (1ml) , Group I received lignocaine 1% (9ml) with normal saline (1ml) ,0,
edin,7205,4744955,Cannot tell based on the abstract,, Adverse events related to oral soft tissue , Control , Lauroyl arginateâcontaining mouthrinse  ,0,
edin,7205,4744955,No significant difference,No adverse events related to oral soft tissue were recorded during the study in either treatment group., Adverse events related to oral soft tissue , Control , Lauroyl arginateâcontaining mouthrinse  ,0,
edin,7444,4744782,Cannot tell based on the abstract,, Caregiving status , baseline ," a 14âweek behavioral intervention using video instructional materials, workbook and telephone coaching in behavioral management, pleasant events scheduling, and relaxation ",0,
edin,7444,4744782,No significant difference,"The two intervention conditions did not differ in caregiving status changes, either immediately postâintervention (X 2(2, Nâ=â74)â=â1.70, pâ=â.43) or 6âmonths postâintervention (X 2(2, Nâ=â73)â=â0.22, pâ=â.90).", Caregiving status , baseline ," a 14âweek behavioral intervention using video instructional materials, workbook and telephone coaching in behavioral management, pleasant events scheduling, and relaxation ",0,
edin,7565,5534217,Cannot tell based on the abstract,, fever-alleviation time , oseltamivir (Tamiflu) , peramivir (Rapiacta) ,0,
edin,7565,5534217,No significant difference,"The respective medians of fever-alleviation time were 40.0 hours (95% confidence interval [CI] = 23.3â64.5) and 37.8 hours (95% CI = 26.3â45.3) in the peramivir and oseltamivir groups, respectively; these values did not exhibit a significant intergroup difference (log-rank test; P = .69; Ï2 = 0.156).", fever-alleviation time , oseltamivir (Tamiflu) , peramivir (Rapiacta) ,0,
edin,7147,5976903,Cannot tell based on the abstract,, Axilary numeric rating scale , Control , Pectoral nerve block type II  ,0,
edin,7147,5976903,Significantly decreased,"Median NRS value of the axilla, however, was significantly lower in the PECS II than in the control group throughout the first 24 hours after surgery (Figure 4)", Axilary numeric rating scale , Control , Pectoral nerve block type II  ,0,
edin,7362,4834398,Significantly decreased,"Furthermore, the results showed that acupuncture significantly decreased the skin conductance in acupuncture group compared to sham group (p = 0.006) and wait-list control group (p < 0.001).", Skin conductance , Sham control , Acupuncture  ,0,
edin,7493,4840766,Cannot tell based on the abstract,, fasting blood glucose (FBG) levels , recombinant human growth hormone (rhGH) 0.05 U/kg  , recombinant human growth hormone (rhGH) 0.1 ,0,
edin,7493,4840766,Significantly decreased,"The differences in FBG, IGF-1 and IGFBP-3 levels between the two groups were statistically significant (F=41. 512, 26. 412, 21. 051; P<0.05; data not shown).,The differences in FBG and IGFBP-3 before, and 3 months after, treatment were also statistically significant (P<0.05). For the FBG levels, the difference between the initial value and that after 6 months of treatment between the two groups was statistically significant (P<0.05).", fasting blood glucose (FBG) levels , recombinant human growth hormone (rhGH) 0.05 U/kg  , recombinant human growth hormone (rhGH) 0.1 ,0,
edin,7456,5904467,Cannot tell based on the abstract,, The median primary patency durations of the right and left central veins , procedure with conventional balloons , double paclitaxel-coated balloons (diameter 6â7 mm) plus a high pressure balloon (diameter 12â14 mm) ,0,
edin,7456,5904467,No significant difference,"The median primary patency durations of the right and left central veins were 7.5 months and 9 months, respectively (p = 0.809).", The median primary patency durations of the right and left central veins , procedure with conventional balloons , double paclitaxel-coated balloons (diameter 6â7 mm) plus a high pressure balloon (diameter 12â14 mm) ,0,
edin,7575,5499864,Cannot tell based on the abstract,, switch to an LAI , control , patient drug adherence information (PDAI) ,0,
edin,7575,5499864,Significantly decreased,"Across the 2 cases, providers with access to credible PDAI were more likely to increase the dose (49.1% vs 39.1% control; P<0.001) and switch medications (24.8% vs 20.9% control; P<<0.001), but were less likely to switch to an LAI (2.8% vs16.4% for control; P=0.061).", switch to an LAI , control , patient drug adherence information (PDAI) ,0,
edin,7230,5881763,Cannot tell based on the abstract,, Inflammatory Bowel Disease Questionnaire improvement (Induction 1) , Placebo , Tofacitinib 10 mg ,0,
edin,7230,5881763,Significantly increased,"In both OCTAVE Induction 1 and 2, treatment with tofacitinib 10 mg BID resulted in statistically significant improvements from baseline in mean IBDQ total score versus placebo at Week 4 and Week 8 [p < 0.0001 for all comparisons;", Inflammatory Bowel Disease Questionnaire improvement (Induction 1) , Placebo , Tofacitinib 10 mg ,0,
edin,7585,3987287,Cannot tell based on the abstract,,  plasma acetate concentrations  , placebo , 40âg of type 2 RS (HAM-RS2) ,0,
edin,7585,3987287,No significant difference,"Fasting plasma propionate and butyrate concentrations were significantly lower (P=0.021 and P<0.001 respectively) following the HAM-RS2 compared with the placebo, but there were no significant differences between treatments for plasma acetate concentrations (Table 1).",  plasma acetate concentrations  , placebo , 40âg of type 2 RS (HAM-RS2) ,0,
edin,7123,4210064,Cannot tell based on the abstract,, Glycated hemoglobin reduction  , Switching from nateglinide to vildagliptin , Combining nateglinide + vildagliptin ,0,
edin,7123,4210064,Significantly increased,"he pattern of decrease in HbA1c was different in the two groups: the mean HbA1c level decreased rapidly in the combination group from the start of the treatment until weekÂ 16, but decreased more gradually thereafter until the end of the treatment period. In contrast, the mean HbA1c level was slightly, but significantly, lower after 24Â weeks of treatment, relative to the baseline in the switching group. The mean change in HbA1c (from baseline to endâpoint, week 24) was â1.2Â Â±Â 0.3% in the combination group and â0.3Â Â±Â 0.5% in switching group, and the difference was significant (PÂ <Â 0.001; FigureÂ 2b).", Glycated hemoglobin reduction  , Switching from nateglinide to vildagliptin , Combining nateglinide + vildagliptin ,0,
edin,7300,2759981,Cannot tell based on the abstract,, Elective Caesarean , Standard antenatal education , Natural childbirth preparation ,0,
edin,7300,2759981,No significant difference,"<td align=""left"" colspan=""1"" rowspan=""1"">Elective Caesarean</td><td align=""center"" colspan=""1"" rowspan=""1"">29 (6)</td><td align=""center"" colspan=""1"" rowspan=""1"">31 (6)</td><td align=""center"" colspan=""1"" rowspan=""1"">0.9 (0.6 to 1.6)</td><td align=""center"" colspan=""1"" rowspan=""1"">0.8</td><td align=""center"" colspan=""1"" rowspan=""1""></td><td align=""center"" colspan=""1"" rowspan=""1""></td><td align=""center"" colspan=""1"" rowspan=""1""></td><td align=""center"" colspan=""1"" rowspan=""1""></td>", Elective Caesarean , Standard antenatal education , Natural childbirth preparation ,0,
edin,7556,2699080,Significantly decreased,The duration of analgesic requirement was also significantly less in LP group., The duration of analgesic requirement , pyeloplasty (OP) , laparoscopic (LP) ,0,
edin,7543,5928132,No significant difference,"In contrast, baclofen did not significantly suppress PAS-induced LTP compared to placebo.", PAS-induced LTP , placebo , baclofen ,0,
edin,7143,5976903,Significantly decreased,"Opioid requirement was lower in the PECS II than in the control group (43.8âÂ±â28.5âÂµg versus 77.0âÂ±â41.9âÂµg, p < 0.001).", Opioid requirement , Control , Pectoral nerve block type II  ,0,
edin,7445,4744782,Significantly decreased,"For those providing inâhome care at postâtreatment, depressive symptoms, upset following disruptive behaviors, and negative mood states were statistically lower in the behavioral coaching condition than in the basic education and support condition."," Upset following behavior problems,  negative mood and anxiety, caregiving selfâefficacy after 6 months ", a basic education guide and telephone support comparison condition ," a 14âweek behavioral intervention using video instructional materials, workbook and telephone coaching in behavioral management, pleasant events scheduling, and relaxation ",0,
edin,7132,4662763,No significant difference,The mean SBS value in group one (pH 3.8) was significantly lower than that in other groups (P<0.05). The differences between other groups were not significant (P>0.05)., Shear bond strength , pH 5.8 saliva , pH 6.8 saliva ,0,
edin,7420,5346199,Cannot tell based on the abstract,," physical health, psychological health, and overall health ",   the control group had the usual care ," Group 1 had the integrated care model including a multidisciplinary team and continuous care coordination, Group 2 had both the integrated care model and provider-level financial incentives, ",0,
edin,7420,5346199,Significantly increased,"Integrated care improved health outcomes measured by SF36 scores: it increased physical health by 11.4 points, psychological health by 9.5 points, and overall health by 10.8 points. However, the intervention of provider-level financial incentives was associated with a worse self-assessed health-related quality of life: overall health is lowered by 8.06 points.Fig. 3"," physical health, psychological health, and overall health ",   the control group had the usual care ," Group 1 had the integrated care model including a multidisciplinary team and continuous care coordination, Group 2 had both the integrated care model and provider-level financial incentives, ",0,
edin,7217,3227609,No significant difference,There was no difference in the incidence of adverse events between the two formula groups., Overall adverse events  , Regular formula , Oligosaccharides Prebiotic Formula ,0,
edin,7506,2837810,Significantly increased,"The overall Constant score in the partial repair group was superior to the outcome in the debridement group (PÂ <Â 0.01, FÂ =Â 8.561), according to better results in abduction (PÂ <Â 0.01, FÂ =Â 13.249), activity (PÂ <Â 0.01, FÂ =Â 21.391) and motion (PÂ <Â 0.01, FÂ =Â 4.967).", abduction , arthroscopic debridement , arthroscopic partial repair ,0,
edin,7569,5499864,Cannot tell based on the abstract,, differences in treatment choices , control , patient drug adherence information (PDAI) ,0,
edin,7569,5499864,No significant difference,"A Wald Ï2 test revealed no statistically significant differences in treatment choices between the 2 groups (P=0.553 in the vignette where the patient was nonadherent, whereas P=0.071 in the vignette where the patient was adherent).", differences in treatment choices , control , patient drug adherence information (PDAI) ,0,
edin,7272,5381869,Cannot tell based on the abstract,, Peak to peak power	 , Sham tsDCS , Active anodal tsDCS ,0,
edin,7272,5381869,Significantly decreased,"<td align=""left"" colspan=""1"" rowspan=""2"">Total work</td><td align=""right"" colspan=""1"" rowspan=""1""><italic>F</italic></td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">12.95</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">0.14</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">0.29</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">2.12</td>,<td align=""left"" colspan=""1"" rowspan=""1"">Peak to peak power</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">1.3%</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">- 2.3%</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">3.6%</td><td align=""right"" colspan=""1"" rowspan=""1"">2.0, 5.2</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">0.000</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">0.76</td><td align=""left"" colspan=""1"" rowspan=""1"">Medium</td>,The effects of tsDCS were manifest post-sham as an overall fatigue in VCJ performance, evidenced by significant reductions from baseline in CM velocity (t (47) = -2.87, P = 0.006), peak to peak power (t (47) = -4.76, P < 0.001), CM power (t (47) = -3.49, P = 0.001),", Peak to peak power	 , Sham tsDCS , Active anodal tsDCS ,0,
edin,7174,4826692,Cannot tell based on the abstract,, Hematoma volume , Control , Nao-Xue-Shu oral liquid ,0,
edin,7174,4826692,Significantly decreased,"The volume of the hematoma had decreased at the end of week 1 and week 2 in the treatment group, while the volume in the control group only indicated a significantly decreased outcome at the end of week 2 compared with its baseline, and the decreased level at the end of week 2 was much smaller than that in the treatment group (Table 2).", Hematoma volume , Control , Nao-Xue-Shu oral liquid ,0,
edin,7238,2765950,Significantly decreased,"After 30 days, mean SAR decreased from 0.26 Â± 0.14 to 0.19 Â± 0.10 Î¼mol/mL in the 29.5 mL dose group (P < 0.01) and from 0.26 Â± 0.22 to 0.18 Â± 0.11 Î¼mol/mL in the 118 mL dose group (P < 0.001).,No significant reductions in SAR or LOOH levels were observed in the placebo group.", Superoxide anion radicals , Placebo , Noni juice 118 mL ,0,
edin,7148,5976903,Cannot tell based on the abstract,, Complications , Control , Pectoral nerve block type II  ,0,
edin,7148,5976903,No significant difference,None of these patients reported complications associated with the PECS II block., Complications , Control , Pectoral nerve block type II  ,0,
edin,7505,2837810,Significantly increased,"The overall Constant score in the partial repair group was superior to the outcome in the debridement group (PÂ <Â 0.01, FÂ =Â 8.561),", Constant score , arthroscopic debridement , arthroscopic partial repair ,0,
edin,7388,5467351,Significantly increased,"As regards the metabolic parameters, in both groups, we found a significant increase in fasting insulin (p < 0.001 and p = 0.026) and Homa-IR (p < 0.001 and p = 0.019).", fasting insulin  and homeostasis model assessment estimate of insulin resistance (Homa-IR) , baseline ," three injections per week (TIW)  (GHT), daily (GHT) ",0,
edin,7358,4265247,Cannot tell based on the abstract,, Skin firmness and elasticity , Placebo , Oral supplement 1 ,0,
edin,7358,4265247,No significant difference,"Firmness & elasticity
Skin elasticity was measured using a Courage & Khazaka Cutometer (probe aperture size 8Â mm) at baseline and week 15 on the inner & outer forearm. However, there was no statistical difference from baseline or between placebo and test treatment at any time point in any of the parameters measured (data not shown).", Skin firmness and elasticity , Placebo , Oral supplement 1 ,0,
edin,7496,4840766,Cannot tell based on the abstract,, level of T3 , baseline , recombinant human growth hormone (rhGH) 0.05 U/kg  ,0,
edin,7496,4840766,Significantly increased,"In the low-dose group, when the level of T3 prior to treatment was compared to T3 3 months following treatment, the difference was clearly statistically significant (P<0.05).,Concerning TSH prior to and after treatment, the difference was not statistically significant (P>0.05), whereas 6 months after treatment, the difference in the levels of T3 and TSH, as compared with the levels prior to treatment, were statistically significant (P<0.05) (Table III).", level of T3 , baseline , recombinant human growth hormone (rhGH) 0.05 U/kg  ,0,
edin,7360,4834398,Significantly decreased,"The results of ANOVA on posttest scores showed that acupuncture had a significant effect on cognitive anxiety (p = 0.001) and somatic anxiety (p < 0.001) but not on self-confidence (p > 0.05).,In conclusion, the results suggested that acupuncture has the capacity to decrease cognitive anxiety and somatic anxiety prior to competition in adolescent athletes, while this was accompanied by significant physiological changes.", Somatic  anxiety , Sham control , Acupuncture  ,0,
edin,7323,4269544,No significant difference,"Heart rate, systolic blood pressure, diastolic blood pressure, mean arterial pressure and rate pressure product were compared to basal values at pre-induction, induction, intubation and post-intubation as well as at time increments of 1, 3, 5, 7 and 10 min.", Systolic blood pressure 7 min after intubation  , Fentanyl  , Fentanyl + nitroglycerin ,0,
edin,7274,5381869,Cannot tell based on the abstract,, Take-off velocity , Sham tsDCS , Active anodal tsDCS ,0,
edin,7274,5381869,Significantly increased,"The smallest significant effect was on change in take-off velocity (Table 3).,<td align=""right"" colspan=""1"" rowspan=""1""><italic>P</italic></td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">0.038</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">0.718</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">0.800</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">0.001</td>,<td align=""left"" colspan=""1"" rowspan=""1"">Take-off velocity</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">0.0%</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">- 1.3%</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">1.4%</td><td align=""right"" colspan=""1"" rowspan=""1"">0.0, 2.8</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">0.038</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">0.39</td><td align=""left"" colspan=""1"" rowspan=""1"">Small</td>,The effects of tsDCS were manifest post-sham as an overall fatigue in VCJ performance, evidenced by significant reductions from baseline in CM velocity (t (47) = -2.87, P = 0.006), peak to peak power (t (47) = -4.76, P < 0.001), CM power (t (47) = -3.49, P = 0.001), total work done (t (47) = -2.99, P = 0.004), CM vertical displacement/work done (t (47) = -2.27, P = 0.028), push-off work done (t (47) = -2.52, P = 0.015), and take-off velocity (t (47) = -3.13, P = 0.003) (Fig 3 and Table 3).", Take-off velocity , Sham tsDCS , Active anodal tsDCS ,0,
edin,7138,2500197,Significantly increased,"Compared with controls at nine months, parents and adolescents in the intervention group reported greater ability to communicate with each other about sex (P<0.001) and more openness in communication about sex (P<0.001).", Openness in communication about sex , Control  , Parent-adolescent communication program  ,0,
edin,7305,4112798,No significant difference,No statistically significant quality of life differences were found., Quality of life , Placebo  , Erlotinib  ,0,
edin,7137,2500197,Significantly increased,"Compared with controls at nine months, parents and adolescents in the intervention group reported greater ability to communicate with each other about sex (P<0.001) and more openness in communication about sex (P<0.001).", Ability to communicate about sex  , Control  , Parent-adolescent communication program  ,0,
edin,7410,5214464,No significant difference,"Forced inspiratory vital capacity demonstrated no significant difference within subjects (F(1, 17)= .073, p > .05), or between the two groups (F(1, 17)= 3.724, p= .073).", forced inspiratory vital capacity (FIVC) , without the mask , Elevation Training MasksÂ© (ETM) ,0,
edin,7499,3730064,Cannot tell based on the abstract,,  uncorrected visual acuity (UCVA) and best-corrected visual acuity (BCVA) , 1 mg of ranibizumab (group 2) , 2.5 mg of bevacizumab (group 1) ,0,
edin,7499,3730064,No significant difference,"There was no difference in UCVA or BCVA between groups 1 and 2 (p = 0.721, p = 0.878; Mann-Whitney U-test)",  uncorrected visual acuity (UCVA) and best-corrected visual acuity (BCVA) , 1 mg of ranibizumab (group 2) , 2.5 mg of bevacizumab (group 1) ,0,
edin,7187,5136709,Significantly decreased,"During the 11-week study period, systolic blood pressure (â3.5 vs 0.9âmmâHg), mean arterial blood pressure (â1.9 vs 0.4âmmâHg), body mass index (â0.02 vs 0.13 kg/m2) and body fat percentage (â0.83% vs â0.04%) decreased more (p<0.05) in IG than in CG.", Body fat percentage , Control , FIFA 11 for Healthâ programme ,0,
edin,7308,3253463,Significantly increased,"We found that the ginger-treated groups had significantly decreased P300 latencies, increased N100 and P300 amplitudes, and exhibited enhanced working memory.", P300 amplitude , Control , Zingiber officinale 400 mg ,0,
edin,7301,2759981,Cannot tell based on the abstract,, Spontaneous vaginal delivery , Standard antenatal education , Natural childbirth preparation ,0,
edin,7301,2759981,No significant difference,"<td align=""left"" colspan=""1"" rowspan=""1"">Spontaneous vaginal</td><td align=""center"" colspan=""1"" rowspan=""1"">321 (66)</td><td align=""center"" colspan=""1"" rowspan=""1"">327 (66)</td><td align=""center"" colspan=""1"" rowspan=""1"">1.0 (0.9 to 1.1)</td><td align=""center"" colspan=""1"" rowspan=""1"">1.0</td><td align=""center"" colspan=""1"" rowspan=""1""></td><td align=""center"" colspan=""1"" rowspan=""1""></td><td align=""center"" colspan=""1"" rowspan=""1""></td><td align=""center"" colspan=""1"" rowspan=""1""></td>", Spontaneous vaginal delivery , Standard antenatal education , Natural childbirth preparation ,0,
edin,7551,5067642,Cannot tell based on the abstract,," BMI, waist circumference and percent body fat, ", baseline ," standard behavioral weight loss, a technologyâbased system combined with a monthly intervention telephone call (TECH) ; an enhanced technologyâbased system combined with a monthly intervention telephone call (ENâTECH) ",0,
edin,7551,5067642,Significantly decreased,"Weight loss occurred in all intervention conditions across 6âmonths (pâ<â0.0001) (TableÂ 2 and FigureÂ 2). Weight loss (least square meansâÂ±âstandard error) at 3âmonths was â3.39âÂ±â1.04, â5.06âÂ±â1.08 and â4.76âÂ±â1.25âkg in SBWL, TECH and ENâTECH, respectively. Weight loss at 6âmonths was â6.57âÂ±â1.65âkg in SBWL, â5.18âÂ±â1.72âkg in TECH and â6.25âÂ±â1.95âkg in ENâTECH. A similar pattern was observed for change in BMI, waist circumference and percent body fat, with these outcomes showing a reduction across the 6âmonth intervention (TableÂ 2).,<td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">TECH</td><td align=""char"" char=""Â±"" colspan=""1"" rowspan=""1"" valign=""top"">122.8âÂ±â2.6</td><td align=""char"" char=""Â±"" colspan=""1"" rowspan=""1"" valign=""top"">116.4âÂ±â2.8</td><td align=""char"" char=""Â±"" colspan=""1"" rowspan=""1"" valign=""top"">118.2âÂ±â3.2</td><td align=""left"" colspan=""1"" rowspan=""1"" valign=""top""></td><td align=""left"" colspan=""1"" rowspan=""1"" valign=""top""></td><td align=""left"" colspan=""1"" rowspan=""1"" valign=""top""></td>,<td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">TECH</td><td align=""char"" char=""Â±"" colspan=""1"" rowspan=""1"" valign=""top"">45.8âÂ±â1.2</td><td align=""char"" char=""Â±"" colspan=""1"" rowspan=""1"" valign=""top"">44.7âÂ±â1.4</td><td align=""char"" char=""Â±"" colspan=""1"" rowspan=""1"" valign=""top"">44.4âÂ±â1.6</td><td align=""left"" colspan=""1"" rowspan=""1"" valign=""top""></td><td align=""left"" colspan=""1"" rowspan=""1"" valign=""top""></td><td align=""left"" colspan=""1"" rowspan=""1"" valign=""top""></td>"," BMI, waist circumference and percent body fat, ", baseline ," standard behavioral weight loss, a technologyâbased system combined with a monthly intervention telephone call (TECH) ; an enhanced technologyâbased system combined with a monthly intervention telephone call (ENâTECH) ",0,
edin,7480,2948428,Cannot tell based on the abstract,, Fasting plasma glucose , placebo ," taspoglutide 20 mg, titration to 30 mg (20/30), 40 mg (20/40) ",0,
edin,7480,2948428,Significantly decreased,"<td align=""left"" colspan=""1"" rowspan=""1"">Fasting glucose (mmol/l)</td><td align=""center"" colspan=""1"" rowspan=""1"">9.4 Â± 0.3</td><td align=""center"" colspan=""1"" rowspan=""1"">9.4 Â± 0.3</td><td align=""center"" colspan=""1"" rowspan=""1"">8.9 Â± 0.3</td><td align=""center"" colspan=""1"" rowspan=""1"">8.9 Â± 0.3</td>,Fasting plasma glucose was reduced (Fig. 5), with LS mean changes from baseline to week 8 of â2.3 Â± 0.3 mmol/l (20/20, P < 0.0001 vs. placebo), â1.6 Â± 0.3 mmol/l (20/30, P = 0.007 vs. placebo) and â2.2 Â± 0.3 mmol/l (20/40, P < 0.0001 vs. placebo) in the active study arms. By comparison over the same time period, in subjects randomized to receive placebo, fasting plasma glucose levels fell by 0.6 Â± 0.3 mmol/l.", Fasting plasma glucose , placebo ," taspoglutide 20 mg, titration to 30 mg (20/30), 40 mg (20/40) ",0,
edin,7338,4914255,Cannot tell based on the abstract,, Visual attention test , Control , D-serine ,0,
edin,7338,4914255,No significant difference,"D-serine administration did not have any statistically significant effect on the key measures of the n-back working memory test (accuracy, p > 0.1), the Set-Shifting cognitive flexibility task (extra-dimensional shift errors, p = 0.47), or the visual attention test (errors, p > 0.7).", Visual attention test , Control , D-serine ,0,
edin,7433,4212559,Significantly decreased,"The cumulative incidence of T2DM was significantly lower in the ILG than in the UCG among participants with HbA1c levels â¥5.7% (log-rank=3.52, p=0.06; Breslow=4.05, p=0.04; Tarone-Ware=3.79, p=0.05), while this was not found among participants with HbA1c levels <5.7%.", cumulative incidence of  type 2 diabetes mellitus (T2DM)  among participants with baseline HbA1c levels â¥5.7% , usual care group (UCG) , intensive lifestyle intervention group (ILG) ,0,
edin,7332,3017961,Significantly increased,The number of persons who showed improvement in Sattva and decrease in Tamas was significant in the Y but not in the PE group (McNemar test), Sattva improvement  , Regular exercise  , Yoga ,0,
edin,7220,3898378,Cannot tell based on the abstract,, Antenatal care visits timing  , Standard care , Mobile phone intervention ,0,
edin,7220,3898378,No significant difference,The timing of antenatal care visits and preventive health services were similar in both the intervention and control groups (TableÂ 4)., Antenatal care visits timing  , Standard care , Mobile phone intervention ,0,
edin,7500,3730064,Significantly decreased,"In group I, the preoperative corneal NV area (8.75 Â± 4.33%) was significantly decreased to 5.62 Â± 3.86% one week after the injection and to 6.35 Â± 3.02% one month after the injection (p = 0.012, 0.012, respectively).", the preoperative corneal  neovascularization (NV) area , baseline , 2.5 mg of bevacizumab (group 1) ,0,
edin,7128,4210064,Cannot tell based on the abstract,, Body weight  changes  , Switching from nateglinide to vildagliptin , Combining nateglinide + vildagliptin ,0,
edin,7128,4210064,No significant difference,"There was no significant difference in changes in bodyweight between the two groups (combination group 1.0Â Â±Â 1.7Â kg, switching group 0.4Â Â±Â 1.6Â kg; PÂ =Â 0.308).", Body weight  changes  , Switching from nateglinide to vildagliptin , Combining nateglinide + vildagliptin ,0,
edin,7533,3425422,Significantly increased,U46619-induced fibrinogen binding was unchanged after meal intake with placebo but was markedly enhanced (by â¼50â60%) after premeal insulin., U46619-induced fibrinogen binding , placebo , insulin aspart 0.1 units/kg or 0.2 units/kg ,0,
edin,7292,3479017,Cannot tell based on the abstract,, Fruit intake/day , Control , Comprehensive lifestyle intervention ,0,
edin,7292,3479017,No significant difference,"<td align=""left"" valign=""bottom"">Number of fruit intake/day<hr></td><td align=""left"" valign=""bottom"">1.5 (1.3)<hr></td><td align=""left"" valign=""bottom"">1.7 (1.2)<hr></td><td align=""left"" valign=""bottom"">0.03 (â0.3/0.3)<hr></td><td align=""left"" valign=""bottom"">0.86<hr></td><td align=""left"" valign=""bottom"">â0.05 (â0.4/0.3)<hr></td><td align=""left"" valign=""bottom"">0.8<hr></td>", Fruit intake/day , Control , Comprehensive lifestyle intervention ,0,
edin,7534,3199893,Significantly increased,"ADAS-cog scores significantly improved in all rivastigmine-treated patients (p < 0.05 vs. placebo), except 9.5 mg/24 h patch-treated patients with VRF, and were significantly affected by VRF status in the study population as a whole.", AD Assessment Scale-cognitive subscale (ADAS-cog) , placebo , rivastigmine ,0,
edin,7347,3822756,No significant difference,"Neither ACE inhibition nor ARB significantly affectedplasminogen activator inhibitor-1 (PAI-1), interleukin (IL)-6, IL-8, or IL-10 concentrations.", Interleukin-10 , Placebo , Candesartan ,0,
edin,7213,3227609,Cannot tell based on the abstract,, Gastrointestinal symptom , Regular formula , Oligosaccharides Prebiotic Formula ,0,
edin,7213,3227609,No significant difference,No difference in the incidence of any gastrointestinal symptom was detected between the two formula groups., Gastrointestinal symptom , Regular formula , Oligosaccharides Prebiotic Formula ,0,
edin,7378,3379583,Cannot tell based on the abstract,, A1C glycated hemoglobin (A1C) , liraglutide to metformin , insulin (detemir) ,0,
edin,7378,3379583,Significantly decreased,"Addition of insulin detemir further reduced A1C compared with continued metformin + liraglutide (â0.51% [n = 162] vs. +0.02% [n = 157], respectively; estimated treatment difference [ETD] â0.52 [95% CI â0.68 to â0.36]; P < 0.0001), resulting in A1C values of 7.1 and 7.5%, respectively, at week 26 (Fig. 2A and Supplementary Tables 5 and 6), and meeting the trialâs primary end point.", A1C glycated hemoglobin (A1C) , liraglutide to metformin , insulin (detemir) ,0,
edin,7375,3307993,Significantly increased,"Altogether, the responder rate was higher in the EcN than in the placebo group.", responder rate , placebo , Escherichia coli Nissle 1917 (EcN) ,0,
edin,7495,4840766,Cannot tell based on the abstract,, area under blood glucose curve (AUCglu) ,  baseline ," recombinant human growth hormone (rhGH) 0.1, recombinant human growth hormone (rhGH) 0.05 U/kg  ",0,
edin,7495,4840766,No significant difference,There was no statistically significant difference between AUCglu levels before and after treatment (P>0.05) (Table II)., area under blood glucose curve (AUCglu) ,  baseline ," recombinant human growth hormone (rhGH) 0.1, recombinant human growth hormone (rhGH) 0.05 U/kg  ",0,
edin,7604,4386768,Cannot tell based on the abstract,, erectile function , placebo , tadalafil ,0,
edin,7604,4386768,Significantly increased,"The authors also noted that tadalafil has the ability to improve erectile function (change in International Index of Erectile Function [IIEF] of 4.0, P<0.001 versus â0.4, P=0.699) when comparing tadalafil with tamsulosin, whereas other BPH therapies have the potential for sexual side effects, including erectile dysfunction and ejaculatory dysfunction.", erectile function , placebo , tadalafil ,0,
edin,7291,3479017,Cannot tell based on the abstract,, Average vegetable intake/day , Control , Comprehensive lifestyle intervention ,0,
edin,7291,3479017,No significant difference,"<td align=""left"" valign=""bottom"">Average vegetable intake/day, <italic>grams</italic><hr></td><td align=""left"" valign=""bottom"">172.4 (91.9)<hr></td><td align=""left"" valign=""bottom"">181.9 (90.1)<hr></td><td align=""left"" valign=""bottom"">â2.0 (â27.3/23.2)<hr></td><td align=""left"" valign=""bottom"">0.98<hr></td><td align=""left"" valign=""bottom"">â0.5 (â25.7/24.7)<hr></td><td align=""left"" valign=""bottom"">0.97<hr></td>", Average vegetable intake/day , Control , Comprehensive lifestyle intervention ,0,
edin,7164,4858101,No significant difference,"None of the dogs showed complete response. In the mitoxantrone group, there were 2 (8%) partial responses (PR) and 18 (69%) dogs with stable disease (SD). In the carboplatin group, there were 3 PR (13%) and 13 (54%) dogs with SD", Complete response  , Carboplatin , Mitoxantrone ,0,
edin,7415,4331314,No significant difference,"There were no significant differences between groups for matched data and prognostic scores: injury severity score, revised trauma score, and trauma injury severity score."," injury severity score, revised trauma score, and trauma injury severity score ", control , specially designed molding titanium clips ,0,
edin,7222,3898378,Cannot tell based on the abstract,, Tetanus vaccination , Standard care , Mobile phone intervention ,0,
edin,7222,3898378,Significantly increased,"Tetanus vaccinations were given later than recommended while preventive treatment for malaria was administered within the recommended timeframe.,In the intervention group 72% of nullipara women received two doses of tetanus vaccination versus 56% in the control group (OR, 1.62; 95% CI, 0.81-3.26) and 65% received two doses of preventive malaria treatment versus 52% in the control group (OR, 1.97; 95% CI, 0.98-3.94).", Tetanus vaccination , Standard care , Mobile phone intervention ,0,
edin,7560,4181789,Cannot tell based on the abstract,, âvery easyâ or âeasyâ to ingest than patients , polyethylene glycol (PEG) preparation , Sodium phosphates (L-NaP) preparation ,0,
edin,7560,4181789,Significantly increased,"Likewise, Figure 3(b) shows that, with regard to ease of ingestion of the bowel preparation, a greater fraction of patients in the L-NaP group rated the reagent as âvery easyâ or âeasyâ to ingest than patients in the PEG group: 73.9% versus 22.7% (P < 0.001).", âvery easyâ or âeasyâ to ingest than patients , polyethylene glycol (PEG) preparation , Sodium phosphates (L-NaP) preparation ,0,
edin,7335,4914255,No significant difference,D-serine administration was not associated with any significant changes in the other cognitive tests or in the mood of older adults (p > 0.05)., Mood , Control , D-serine ,0,
edin,7394,4168417,Cannot tell based on the abstract,, Perceived Usefulness and Perceived Satisfaction of System , conventional therapy (Conv) , telerehabilitation (Tele) ,0,
edin,7394,4168417,No significant difference,"The results showed no significant difference on all the items, including Perceived Usefulness (p = 0.053) and Perceived Satisfaction of System (p = 0.052) (Figure 3a).", Perceived Usefulness and Perceived Satisfaction of System , conventional therapy (Conv) , telerehabilitation (Tele) ,0,
edin,7259,3132856,Cannot tell based on the abstract,, Meteorism in IBS-Diarrhea  , Control , Mesalazine  ,0,
edin,7259,3132856,Significantly decreased,At baseline most patients suffered from meteorism. Standard therapy and therapy including mesalazine reduced the number of patients with meteorism significantly in all IBS categories. The difference between standard therapy and mesalazine therapy was significant only in the IBS-D and the IBS-M group (Figure 8)., Meteorism in IBS-Diarrhea  , Control , Mesalazine  ,0,
edin,7210,4336131,Significantly increased,Patients in the Rikkunshito group showed significantly higher plasma levels of active ghrelin compared to those in the metoclopramide group., Active ghrelin levels  , Metoclopramide , Rikkunshito  ,0,
edin,7514,4701161,Significantly increased,"VARA supplementation increased total retinol in plasma, liver and lung, with a dose-by-dose accumulation in neonatal liver and lung, while transcripts for Lrat in liver, megalin in kidney, Cyp26A1/B1 in liver and lung, respectively, and Stra6 in lung, were all increased, suggesting pathways of VA uptake, storage and RA oxidation were each augmented after VARA. VARA decreased hepatic expression of Rbp4, responsible for VA trafficking from liver to plasma, and, in lung, of Raldh-1 and Raldh-2, which function in RA production.", megalin mRNA in adults , baseline , VARA ,0,
edin,7527,5465806,No significant difference,"The z-scores for endothelial dysfunction (â0Â·02; 95 % CI â0Â·15, 0Â·11) and low-grade inflammation (â0Â·04; 95 % CI â0Â·16, 0Â·07) were also not significantly changed after PS intake compared with placebo.", The z-scores for endothelial dysfunction and low-grade inflammation , placebo , Plant sterols (PS) ,0,
edin,7475,3087256,Cannot tell based on the abstract,, heart rate ," group III received lignocaine 1% (9ml) with neostigmine 200Î¼g in NS (1ml), "," group II lignocaine1% (9ml) with neostigmine 100Î¼g in saline (1ml) and  Group I received lignocaine 1% (9ml) with normal saline (1ml),  ",0,
edin,7475,3087256,No significant difference,"During 30 to 120 mins, heart rate decreased significantly from baseline in all the three groups (p<0.001), but this decrease was found to be more in group III. No significant difference in heart rate changes were seen in any of the groups during 3hr to 24 hr.", heart rate ," group III received lignocaine 1% (9ml) with neostigmine 200Î¼g in NS (1ml), "," group II lignocaine1% (9ml) with neostigmine 100Î¼g in saline (1ml) and  Group I received lignocaine 1% (9ml) with normal saline (1ml),  ",0,
edin,7296,2759981,No significant difference,"There were no statistically significant differences in the experience of childbirth or parental stress between the randomised groups, either in women or men.", Experience of childbirth , Standard antenatal education , Natural childbirth preparation ,0,
edin,7329,3349215,No significant difference,"In both groups, the pain intensity (VAS score) decreased significantly immediately after therapy as compared to therapy. There was a significant difference between the test and control groups immediately after therapy (P < 0.05), while no effect 6 months later.", VAS pain score after 6 months , Control , Linear-polarized near-infrared light irradiation ,0,
edin,7270,5381869,Cannot tell based on the abstract,, Countermovement power , Sham tsDCS , Active anodal tsDCS ,0,
edin,7270,5381869,Significantly increased,"<td align=""left"" colspan=""1"" rowspan=""2"">CM displacement</td><td align=""right"" colspan=""1"" rowspan=""1""><italic>F</italic></td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">12.38</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">0.30</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">0.85</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">3.33</td>,The effects of tsDCS were manifest post-sham as an overall fatigue in VCJ performance, evidenced by significant reductions from baseline in CM velocity (t (47) = -2.87, P = 0.006), peak to peak power (t (47) = -4.76, P < 0.001), CM power (t (47) = -3.49, P = 0.001), total work done (t (47) = -2.99, P = 0.004), CM vertical displacement/work done (t (47) = -2.27, P = 0.028),", Countermovement power , Sham tsDCS , Active anodal tsDCS ,0,
edin,7184,5136709,Significantly decreased,"During the 11-week study period, systolic blood pressure (â3.5 vs 0.9âmmâHg), mean arterial blood pressure (â1.9 vs 0.4âmmâHg), body mass index (â0.02 vs 0.13 kg/m2) and body fat percentage (â0.83% vs â0.04%) decreased more (p<0.05) in IG than in CG", Systolic blood pressure  , Control , FIFA 11 for Healthâ programme ,0,
edin,7372,3785381,Cannot tell based on the abstract,,  StateâTrait Anxiety Inventory Y1 (STAI Y1) scores at T2 , baseline ," (group C), had to receive patient-centered counseling throughout the hospitalization ",0,
edin,7372,3785381,Significantly decreased,"Patients showed moderate-to-severe baseline anxiety levels, but there was no significant difference between groups (the mean STAI-Y1 score was 54.1 Â± 13.1 in group C and 49 Â± 12.9 in group NC; Table 2). In patients undergoing counseling (group C) STAI-Y1 scores at T2 were lower than at admission (P < 0.05), while the reduction of anxiety levels was not reported in group NC.",  StateâTrait Anxiety Inventory Y1 (STAI Y1) scores at T2 , baseline ," (group C), had to receive patient-centered counseling throughout the hospitalization ",0,
edin,7188,5136709,No significant difference,"Within-group improvements (p<0.05) were observed in IG for 20âm sprint (4.09Â±0.29 to 4.06Â±0.28âs) and YYIR1C performance (852Â±464 to 896Â±517âm), but these changes were not significantly different from CG, and balance or jump performance remained unchanged in both groups.", 20âm sprint time , Control , FIFA 11 for Healthâ programme ,0,
edin,7602,4386768,Cannot tell based on the abstract,, I-PSS scores , baseline , tadalafil and finasteride ,0,
edin,7602,4386768,Significantly increased,"I-PSS scores at 4, 12, and 26 weeks decreased by an average of 2.3, 3.8, and 4.5 points for the placebo group and by 4.0 (P<0.001), 5.2 (P=0.001), and 5.5 (P=0.022) points for the combination group (see Figure 1). These differences in I-PSS score improvements proved to be significantly better for the combination therapy group.", I-PSS scores , baseline , tadalafil and finasteride ,0,
edin,7197,4279802,Cannot tell based on the abstract,, Diastolic blood pressure  , Midazolam in hypertensive patients  , Dexmedetomidine in hypertensive patients  ,0,
edin,7197,4279802,No significant difference,DBP values did not differ significantly between the groups at the different time points, Diastolic blood pressure  , Midazolam in hypertensive patients  , Dexmedetomidine in hypertensive patients  ,0,
edin,7529,2898847,Cannot tell based on the abstract,," total symptom score, total number of symptoms reported ,  symptom severity and number of symptoms ", controls , Terrestrial Trunked Radio Telecommunications System (TETRA) ,0,
edin,7529,2898847,No significant difference,"During the open provocation test, we found an overall difference between groups for both the total symptom score (z = â5.985, p < 0.001) and total number of symptoms reported (z = â6.448, p < 0.001), indicating that sensitive participants experienced a greater severity (mean Â± SE = 5.92 Â± 1.23, n = 51) and number of symptoms (4.63 Â± 0.86, n = 51) than did controls (1.04 Â± 0.17 and 0.92 Â± 0.13, respectively; n = 132)."," total symptom score, total number of symptoms reported ,  symptom severity and number of symptoms ", controls , Terrestrial Trunked Radio Telecommunications System (TETRA) ,0,
edin,7129,4662763,Significantly decreased,The mean SBS value in group one (pH 3.8) was significantly lower than that in other groups (P<0.05). The differences between other groups were not significant (P>0.05)., Shear bond strength , pH 6.8 saliva , pH 3.8 saliva  ,0,
edin,7144,5976903,No significant difference,"However, the frequency of rescue analgesics did not differ between these groups.", Rescue analgesics frequency  , Control , Pectoral nerve block type II  ,0,
edin,7204,4744955,Cannot tell based on the abstract,, Wholeâmouth mean Bleeding Index score , Control , Lauroyl arginateâcontaining mouthrinse  ,0,
edin,7204,4744955,Significantly decreased,"<td align=""left"" colspan=""1"" rowspan=""1"" style=""padding-left:10%"">BI</td><td align=""char"" char="" "" colspan=""1"" rowspan=""1"">0.13 (0.06)</td><td align=""char"" char="" "" colspan=""1"" rowspan=""1"">0.14 (0.06)</td>,After 4Â weeks of use, the 0.15% LAEâcontaining mouthrinse was associated with a statistically significantly greater reduction from baseline in the wholeâmouth mean PI score compared with the control mouthrinse, with a betweenâtreatment difference in the least squares means of 1.23 (95% confidence interval [95% CI]: 1.07, 1.39), equating to a 42.6% greater reduction versus control (pÂ <Â 0.001; TableÂ 3).,The reduction in the wholeâmouth mean MGI score was also statistically significantly greater with the LAE mouthrinse (difference: 0.23 [95% CI: 0.19, 0.28]; 10.7% reduction compared with the control; pÂ < 0.001). Statistically significant differences in wholeâmouth mean PI and MGI scores between the 0.15% LAE mouthrinse and control mouthrinse, in favour of the LAE mouthrinse, were also evident after 2Â weeks of treatment (TableÂ 3).", Wholeâmouth mean Bleeding Index score , Control , Lauroyl arginateâcontaining mouthrinse  ,0,
edin,7165,4858101,No significant difference,The PFI was not significantly different between groups (mitoxantroneÂ =Â 106Â days; carboplatinÂ =Â 73.5Â days; PÂ =Â .62; hazard ratio 0.86; 95% confidence interval 0.47â1.56)., Progressionâfree interval , Carboplatin , Mitoxantrone ,0,
edin,7501,3730064,Cannot tell based on the abstract,"In group I, the preoperative corneal NV area (8.75 Â± 4.33%) was significantly decreased to 5.62 Â± 3.86% one week after the injection and to 6.35 Â± 3.02% one month after the injection (p = 0.012, 0.012, respectively).", the preoperative corneal  neovascularization (NV) area , baseline , 1 mg of ranibizumab (group 2) ,0,
edin,7501,3730064,Significantly decreased,The corneal NV area of group 2 patients also exhibited a significant change from 7.37 Â± 4.33% preoperatively to 6.72 Â± 4.16% one week after the injection (p = 0.012; Wilcoxon signed-rank test)., the preoperative corneal  neovascularization (NV) area , baseline , 1 mg of ranibizumab (group 2) ,0,
edin,7439,3515466,No significant difference,"There was a significant difference between the response of the physical component score of the SF-36, favouring the singing group +12.9(19.0) vs -0.25(11.9) (p=0.02), but no difference in response of the mental component score of the SF-36, breathing control measures, exercise capacity or daily physical activity.", mental component score of the Short Form 36 (SF-36) questionnaire ,  film club , singing classes ,0,
edin,7542,5928132,Significantly decreased,"As predicted, L-DOPA and rivastigmine resulted in enhanced PAS-induced LTP in the DLPFC and dextromethorphan inhibited it compared to placebo.", PAS-induced LTP , placebo ,  Dextromethorphan ,0,
edin,7328,3349215,Significantly decreased,"In both groups, the pain intensity (VAS score) decreased significantly immediately after therapy as compared to therapy.", VAS pain score after therapy  , Control , Linear-polarized near-infrared light irradiation ,0,
edin,7377,3307993,Significantly increased,"Altogether, the responder rate was higher in the EcN than in the placebo group. However, only after 10 and 11Â weeks, the differences were significant (Î 20.0% points [95% CI 2.6; 37.4], pâ=â0.01 and Î 18.3% points [95% CI 1.0; 35.7], pâ=â0.02, respectively). The best response was observed in the subgroup of patients with gastroenteritis or antibiotics prior to irritable bowel syndrome onset (Î 45.7% points, pâ=â0.029).", responder rate in the subgroup of patients with gastroenteritis or antibiotics prior to irritable bowel syndrome onset , placebo , Escherichia coli Nissle 1917 (EcN) ,0,
edin,7282,2291568,Significantly increased,"t this final follow up, the albendazole-treated arm exhibited a similar height gain but a 35 (SE 5) % greater weight gain, equivalent to an extra 1 (SE 0.15) kg over 2 years (99% CI 0.6â1.4 kg, pâ=â10â11).,In such urban slums in the 1990s, five 6-monthly rounds of single dose anthelmintic treatment of malnourished, poor children initially aged 1â5 years results in substantial weight gain.", Weight gain in not underweight children  , Control , Albendazole ,0,
edin,7110,5358282,No significant difference,We observed no differences in periprocedural pain perception (31% in the premedicated group versus 29% in the non-premedicated group; P = 0.75) or anxiety (59% in the premedicated group versus 50% in the non-premedicated group; P = 0.2)., Anxiety , Control , Diazepam + chlorpheniramine ,0,
edin,7114,5358282,Cannot tell based on the abstract,, Non-catheter-induced spasms , Control , Diazepam + chlorpheniramine ,0,
edin,7114,5358282,No significant difference,"<td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">Non-catheter-induced spasms</td><td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">1 (1)</td><td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">1 (1)</td><td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">NS</td>", Non-catheter-induced spasms , Control , Diazepam + chlorpheniramine ,0,
edin,7373,3785381,Cannot tell based on the abstract,,  StateâTrait Anxiety Inventory Y1 (STAI Y1) scores at T2 , baseline ," group NC), receiving the analgesic treatment without receiving counseling ",0,
edin,7373,3785381,No significant difference,"In patients undergoing counseling (group C) STAI-Y1 scores at T2 were lower than at admission (P < 0.05), while the reduction of anxiety levels was not reported in group NC.",  StateâTrait Anxiety Inventory Y1 (STAI Y1) scores at T2 , baseline ," group NC), receiving the analgesic treatment without receiving counseling ",0,
edin,7208,4336131,No significant difference,The portions of enteral nutrition provided to the target amount and the quantity of gastric discharge were not statistically significantly different between the two groups., Gastric discharge volume  , Metoclopramide , Rikkunshito  ,0,
edin,7286,2291568,Cannot tell based on the abstract,, Weight gain in non-wasted children  , Control , Albendazole ,0,
edin,7286,2291568,Significantly increased,"In the under-nourished categories, the greatest gain in weight was for wasted children and the least for stunted children.,<td align=""left"" colspan=""1"" rowspan=""1"">f. Not wasted</td><td align=""left"" colspan=""1"" rowspan=""1"">2.65Â±0.08 (1613)</td><td align=""left"" colspan=""1"" rowspan=""1"">3.56Â±0.11 (1452)</td><td align=""left"" colspan=""1"" rowspan=""1"">
<italic>&lt;0.00001</italic>
</td>", Weight gain in non-wasted children  , Control , Albendazole ,0,
edin,7170,4826692,Significantly decreased,"The incidence of SBI at the end of week 2 was 8.97% in the treatment group and 23.75% in the control group, and the difference was significant (P < 0.001).", Secondary brain insults , Control , Nao-Xue-Shu oral liquid ,0,
edin,7367,3533739,No significant difference,"There was no evidence that the number of times salicylic acid was applied was different between the preference groups at one week (p=0.89) or at three weeks (p=0.24). Similarly, for the number of clinic visits for cryotherapy (p=0.71)", number of clinic visits for cryotherapy ," cryotherapy,  no treatment preference ", salicylic acid ,0,
edin,7406,4946773,Cannot tell based on the abstract,, Expanded Disability Status Scale (EDSS) score , no smoking cigarettes , smoking cigarettes ,0,
edin,7406,4946773,No significant difference,"here was no difference in baseline EDSS score between tobacco users (mean of 1.92, SD = 0.85) and nonâtobacco users (mean of 1.85, SD = 0.84) (p = 0.7). During the study period, 26 patients progressed â¥1 EDSS point. A total of 19 (37%) of the tobacco users had EDSS progression compared to 7 (21%) of the nonâtobacco users, but the difference was not significant (p = 0.14).", Expanded Disability Status Scale (EDSS) score , no smoking cigarettes , smoking cigarettes ,0,
edin,7158,2966708,No significant difference,"The peak serum IL-6 (P < 0.05) and CRP concentrations were significantly less increased in the laparoscopic group as compared with that of the abdominal hysterectomy group (P < 0.05), while the serum cortisol concentration showed a similar time course and changes and there were no significant difference between the groups.", Cortisol levels  , Abdominal hysterectom , Laparoscopic hysterectomy ,0,
edin,7578,3987287,No significant difference,HAM-RS2 resulted in significantly lower postprandial glucose concentrations (P=0.045) and a trend for greater glucose uptake across the forearm muscle (P=0.077);, glucose uptake across the forearm muscle , baseline , 40âg of type 2 RS (HAM-RS2) ,0,
edin,7544,4532714,Significantly increased,"Patients randomized to personalized audio-playlists with tempo-pace synchrony achieved higher weekly volumes of physical activity than did their non-music usual-care comparators (475.6Â min vs. 370.2Â min, Pâ<â0.001).", weekly volumes of physical activity , no music usual-care control , tempo-pace synchronized audio-devices with personalized music playlistsâ+âusual-care (rhythmic auditory stimulation (RAS)) ,0,
edin,7421,4119301,Significantly decreased,"There was a 50% difference in preference rates (in favour of silicone) (95%CI 32.7â67.3%, pÂ <Â 0.0001).", preference rates , silicone impressions , alginate impressions ,0,
edin,7426,5395810,Significantly increased,"Regarding to weight loss, the delayed-image group did consistently better in all analyses.,At 24Â weeks there was a significant change in weight overall (pâ<â0.0001), and a difference in rate of change between groups (delayed-image group: â0.60Â kg, early-image group: â0.42Â kg, pâ=â0.01).", weight , self-image at recruitment after 8&amp;nbsp;weeks (delayed image) , self-image at recruitment (early image)  ,0,
edin,7530,3425422,Cannot tell based on the abstract,," 90 min after the meal (PP), plasma insulin ", insulin aspart  0.2 units/kg , insulin aspart 0.1 units/kg ,0,
edin,7530,3425422,Significantly decreased,"Maximal levels of insulin were achieved 30â60 min after the meal (Fig. 1); 90 min after the meal (PP), plasma insulin was higher after 0.2 compared with 0.1 units/kg insulin aspart (P = 0.004)."," 90 min after the meal (PP), plasma insulin ", insulin aspart  0.2 units/kg , insulin aspart 0.1 units/kg ,0,
edin,7582,3987287,Cannot tell based on the abstract,, fasting TNFÎ± concentrations , baseline , 40âg of type 2 RS (HAM-RS2) ,0,
edin,7582,3987287,Significantly decreased,Increased intake of HAM-RS2 for 12 weeks resulted in significantly lower fasting TNFÎ± concentrations (P=0.013; Table 1) but had no effects on fasting IL6 concentrations (Table 1)., fasting TNFÎ± concentrations , baseline , 40âg of type 2 RS (HAM-RS2) ,0,
edin,7262,3132856,Significantly decreased,"Treatment of IBS patients with mesalazine significantly reduced intensity and duration of pain in all subtypes of IBS, except for duration of pain in the subtype âundifferentiatedâ, where the difference was not significant.", Pain duration on IBS-Diarrhea  , Control , Mesalazine  ,0,
edin,7579,3987287,Significantly increased,Fasting triglyceride (TG) concentrations and soleus intramuscular TG concentrations were significantly higher following the consumption of HAM-RS2 (P=0.039 and P=0.027 respectively)., fasting plasma triglyceride (TG) concentrations , placebo , 40âg of type 2 RS (HAM-RS2) ,0,
edin,7225,5358738,No significant difference,"At 4 months post-intervention an increase of 20 percentage points (p.p.) for complete Active Management of Third Stage of Labor (AMTSL) (p = 0.044), and 16 p.p. increase for Skin-to-Skin Contact (p = 0.067); at 12 months a 25 p.p. increase of the 1st step of AMTSL (p = 0.026) and a 42 p.p. increase of Delayed Cord Clamping (p = 0.004); at 4 months a 30 (p = 0.001) and at 8 months a 22 (p = 0.010) p.p. decrease for Uterine Sweeping.", Skin-to-Skin Contact % points  , Control , Simulation and team-training program ,0,
edin,7146,5976903,Cannot tell based on the abstract,, Mean NRS value , Control , Pectoral nerve block type II  ,0,
edin,7146,5976903,Significantly decreased,"Mean NRS value of the breast was significantly lower in the PECS II than in the control group at 0 (3.0âÂ±â1.5 versus 4.9âÂ±â1.6, p < 0.001) and 0.5 (3.6âÂ±â1.5 versus 5.1âÂ±â1.8, p < 0.001) hours after the procedure.", Mean NRS value , Control , Pectoral nerve block type II  ,0,
edin,7261,3132856,No significant difference,"Treatment of IBS patients with mesalazine significantly reduced intensity and duration of pain in all subtypes of IBS, except for duration of pain in the subtype âundifferentiatedâ, where the difference was not significant.", Pain duration on IBS-Undifferentiated  , Control , Mesalazine  ,0,
edin,7152,4296330,Cannot tell based on the abstract,, Gastric reflux , Laryngeal mask airway , iâgelâ¢ ,0,
edin,7152,4296330,Significantly decreased,Frequency of gastric reflux was significantly higher with LMA-Classicâ¢ (P < 0.05)., Gastric reflux , Laryngeal mask airway , iâgelâ¢ ,0,
edin,7466,3438419,Cannot tell based on the abstract,"Comparing the two groups at 2 and 4 weeks of training respectively, 10mWT, TUG, and BBS showed statistically more significant improvements in the experimental group (p<0.05).", 10-meter Walking Test (10mWT) , baseline , conventional therapy ,0,
edin,7466,3438419,Significantly increased,"Over the 4 week total, all parameters had statistically significant improvements in the experimental group, while only 10mWT was seen as improved in the control group (Fig. 4).", 10-meter Walking Test (10mWT) , baseline , conventional therapy ,0,
edin,7154,4296330,Cannot tell based on the abstract,, Side effects , Laryngeal mask airway , iâgelâ¢ ,0,
edin,7154,4296330,No significant difference,"Furthermore, different side effects were compared between mentioned groups. Twenty-six (81.2%) out of LMA-Classicâ¢ patients and 19 (59.4%) out of i-gelâ¢ patients had at least one side effect after surgery (P = 0.055); from which three (9.4%) and two (6.2%) had blood on cuff (P > 0.999); and five (15.6%) and four (12.5%) had postoperative cough (P > 0.999) in LMA-Classicâ¢ and i-gelâ¢ group, respectively [Figure 2].", Side effects , Laryngeal mask airway , iâgelâ¢ ,0,
edin,7340,4914255,Cannot tell based on the abstract,, Groton Maze Learning Test ilegal errors , Control , D-serine ,0,
edin,7340,4914255,Significantly decreased,"D-serine administration was associated with a statistically significant decrease in legal errors on the Groton Maze Learning test for spatial memory, learning and problem solving (F(3, 38) = 4.74, p = 0.03, Figure 1).", Groton Maze Learning Test ilegal errors , Control , D-serine ,0,
edin,7541,5928132,Significantly increased,"As predicted, L-DOPA and rivastigmine resulted in enhanced PAS-induced LTP in the DLPFC and dextromethorphan inhibited it compared to placebo.", PAS-induced LTP , placebo , L-DOPA and rivastigmine ,0,
edin,7139,2984512,Cannot tell based on the abstract,, Diametral tensile strength after 5 minutes , Luxatemp , Protemp 3 Garan ,0,
edin,7139,2984512,Significantly increased,"The values for PT3, TMP and LXT at 1 hour were higher than those at 5 minutes. The strength was improved by 62.3% for PT3, 42.4% for LXT and 26.1% for TMP. Those increases in diametral tensile strength of PT3, TMP and LXT were significant with time (P < .001) (Table V).", Diametral tensile strength after 5 minutes , Luxatemp , Protemp 3 Garan ,0,
edin,7482,2948428,Cannot tell based on the abstract,, nausea and vomiting , baseline ," taspoglutide 20 mg, titration to 30 mg (20/30), 40 mg (20/40) ",0,
edin,7482,2948428,Significantly increased,"Nausea was most prevalent after the first and second weekly administrations, decreasing with subsequent injections (Fig. 2). Of the subjects who reported nausea, most reported it as mild to moderate in severity and in most cases the nausea resolved spontaneously.,<td align=""left"" colspan=""1"" rowspan=""1"">Nausea</td><td align=""center"" colspan=""1"" rowspan=""1"">4 (13)</td><td align=""center"" colspan=""1"" rowspan=""1"">12 (38)</td><td align=""center"" colspan=""1"" rowspan=""1"">17 (52)</td><td align=""center"" colspan=""1"" rowspan=""1"">11 (34)</td>", nausea and vomiting , baseline ," taspoglutide 20 mg, titration to 30 mg (20/30), 40 mg (20/40) ",0,
edin,7517,5985784,No significant difference,No significant difference was found in alarmin levels between the mixed LPS and LPT groups. IL-6 was higher in the LPS group on day 2 (p=0.03) and day 3 (p=0.04)., serum alarmin levels , open surgery group (LPT) , mixed laparoscopy group (LPS) ,0,
edin,7546,4532714,Cannot tell based on the abstract,, The number of audio-plays , no music usual-care control , tempo-pace synchronized audio-devices with personalized music playlistsâ+âusual-care (rhythmic auditory stimulation (RAS) ,0,
edin,7546,4532714,Significantly increased,"The number of audio-plays was significantly higher among patients randomized to music playlists with RAS-enhancements than without (780.7 vs. 174.0 audio-plays, RAS vs. non-RAS groups, respectively, Pâ<â0.001).Table 2", The number of audio-plays , no music usual-care control , tempo-pace synchronized audio-devices with personalized music playlistsâ+âusual-care (rhythmic auditory stimulation (RAS) ,0,
edin,7202,4744955,Cannot tell based on the abstract,, Wholeâmouth mean Modified Gingival Index score , Control , Lauroyl arginateâcontaining mouthrinse  ,0,
edin,7202,4744955,Significantly decreased,"<td align=""left"" colspan=""1"" rowspan=""1"" style=""padding-left:10%"">BI</td><td align=""char"" char="" "" colspan=""1"" rowspan=""1"">0.13 (0.06)</td><td align=""char"" char="" "" colspan=""1"" rowspan=""1"">0.14 (0.06)</td>,After 4Â weeks of use, the 0.15% LAEâcontaining mouthrinse was associated with a statistically significantly greater reduction from baseline in the wholeâmouth mean PI score compared with the control mouthrinse, with a betweenâtreatment difference in the least squares means of 1.23 (95% confidence interval [95% CI]: 1.07, 1.39), equating to a 42.6% greater reduction versus control (pÂ <Â 0.001; TableÂ 3).", Wholeâmouth mean Modified Gingival Index score , Control , Lauroyl arginateâcontaining mouthrinse  ,0,
edin,7474,3087256,Cannot tell based on the abstract,, heart rate , baseline ," group II lignocaine1% (9ml) with neostigmine 100Î¼g in saline (1ml) and group III received lignocaine 1% (9ml) with neostigmine 200Î¼g in NS (1ml), Group I received lignocaine 1% (9ml) with normal saline (1ml),  ",0,
edin,7474,3087256,No significant difference,"At baseline and 15 mins, no significant difference in heart rate was observed in the any of the groups.", heart rate , baseline ," group II lignocaine1% (9ml) with neostigmine 100Î¼g in saline (1ml) and group III received lignocaine 1% (9ml) with neostigmine 200Î¼g in NS (1ml), Group I received lignocaine 1% (9ml) with normal saline (1ml),  ",0,
edin,7330,3349215,Cannot tell based on the abstract,, Thermal injuries  , Control , Linear-polarized near-infrared light irradiation ,0,
edin,7330,3349215,No significant difference,No thermal injury or other complications were observed in the study., Thermal injuries  , Control , Linear-polarized near-infrared light irradiation ,0,
edin,7198,3140921,Cannot tell based on the abstract,, End-extinction gaze velocity , Short-ramp extinction , Mid-ramp extinction  ,0,
edin,7198,3140921,Significantly increased,"Differences between the MRE and the SRE conditions were also found; end-extinction gaze velocity was significantly greater in the MRE condition than in the SRE condition (F(1,Â 15)Â =Â 6.65, PÂ <Â 0.05).Fig.Â 3", End-extinction gaze velocity , Short-ramp extinction , Mid-ramp extinction  ,0,
edin,7448,4335628,Significantly increased,"No significant changes in Hcy levels were observed in the experimental group (p > 0.05), but there was a significant increase in peak oxygen consumption and workload at VT-1 as well as a significant improvement in cholesterol, triglycerides, HDL, glucose, alkaline phosphatase, urea, T3, T4 and prostate-specific antigen compared with the control group (p < 0.05).", peak oxygen consumption and workload at VT-1 , (1) a control group asked not to change their normal everyday activities and not to start any regular physical exercise program , (2) an experimental group trained at a heart rate intensity corresponding to ventilatory threshold 1 (VT-1) for 60 min/day 3 times weekly on alternate days for 6 months using a cycle ergometer ,0,
edin,7524,4621723,No significant difference,"Average OABSS (score 1) was determined as: 9.5 Â± 2.8 for Group 1 and 10.7 Â± 1.8 for Group 2 at week 0; 2.2 Â± 1.2 (Group 1) and 2.4 Â± 1.3 (Group 2) at week 4 (score 2); and 1.3 Â± 0.5 for Group 1 and 1.3 Â± 0.6 for Group 2 at week 12 (score 3). In addition, no statistically significant difference was found between the scores (p=0.062 (score 1), p=0.464 (score 2), and p=0.527 (score 3).", overactive bladder (OAB) symptom scores (OABSS) , Group 2  received 4 mg fesoterodine per day , Group 1  received 5 mg solifenacin per day ,0,
edin,7571,5499864,Cannot tell based on the abstract,, adherent patient who had recently been experiencing paranoid delusions , control , patient drug adherence information (PDAI) ,0,
edin,7571,5499864,No significant difference,"For an adherent patient who had recently been experiencing paranoid delusions, a Wald Ï2 test indicated that overall differences in treatment patterns were not significantly different (P=0.054) between providers who had access to PDAI and those who did not.", adherent patient who had recently been experiencing paranoid delusions , control , patient drug adherence information (PDAI) ,0,
edin,7192,4969326,Significantly increased,"<th align=""left"" rowspan=""2""></th><th align=""left"" colspan=""4"">EQ-5D</th>", EQ-5D Self-Care improvement   , Control , Naloxegol  ,0,
edin,7172,4826692,Cannot tell based on the abstract,, TNF-Î± levels , Control , Nao-Xue-Shu oral liquid ,0,
edin,7172,4826692,Significantly decreased,"Compared with baseline, IL-6 and TNF-Î± had decreased at the end of week 1 and week 2 in the treatment group (P < 0.05 for both laboratory factors of week 1 and P < 0.001 for both laboratory factors at the end of week 2), while the factors in the control group only indicated a significantly decreased outcome at the end of week 2 compared with its baseline (P < 0.05 for IL-6 and P < 0.01 for TNF-Î±), and the decreased level at the end of week 2 was much smaller than that in the treatment group (P < 0.001 for both factors, Table 2).", TNF-Î± levels , Control , Nao-Xue-Shu oral liquid ,0,
edin,7591,4386768,Cannot tell based on the abstract,, symptom scores , placebo , Tamsulosin ,0,
edin,7591,4386768,Significantly decreased,Tamsulosin improved symptom scores by â3.3 points while men on placebo improved by â2.4 points (P=0.002)., symptom scores , placebo , Tamsulosin ,0,
edin,7242,4867750,Cannot tell based on the abstract,, Use of corporal punishment , Control , Parent Training Intervention ,0,
edin,7242,4867750,No significant difference,"There were no significant differences between the intervention and control conditions on parentsâ reports of their follow through on discipline, use of corporal punishment, parenting stress, parenting self-efficacy, or child behavior problems.", Use of corporal punishment , Control , Parent Training Intervention ,0,
edin,7563,4181789,Cannot tell based on the abstract,," âvomiting,â âabdominal pain,â and âabdominal distensionâ ", polyethylene glycol (PEG) preparation , Sodium phosphates (L-NaP) preparation ,0,
edin,7563,4181789,Significantly decreased,"There was no adverse event requiring medical intervention in either group. The most common adverse events were ânausea,â âvomiting,â âabdominal pain,â and âabdominal distensionâ (Figure 3(d)).,Among these, ânauseaâ was more common in the PEG group than in the L-NaP group (P = 0.002). Overall, a smaller fraction of patients in the L-NaP group experienced an adverse event than patients in the PEG group (P = 0.013)."," âvomiting,â âabdominal pain,â and âabdominal distensionâ ", polyethylene glycol (PEG) preparation , Sodium phosphates (L-NaP) preparation ,0,
edin,7504,5820800,Cannot tell based on the abstract,, time to decresenig neutrophil fraction  , withholding PN for one week in PICU (late PN) , parenteral nutrition (PN) (early PN) ,0,
edin,7504,5820800,Significantly increased,"The neutrophil fraction decreased from PICU admission to discharge in both groups, but even more in the early PN than in the late PN group (P = 0.007) (Fig. 3b).", time to decresenig neutrophil fraction  , withholding PN for one week in PICU (late PN) , parenteral nutrition (PN) (early PN) ,0,
edin,7369,3785381,Cannot tell based on the abstract,," vitality (VT), physical functioning (PF), role limitation due to physical problems (RP), role limitation due to emotional problems (RE), and mental health (MH)   ", baseline ," group NC), receiving the analgesic treatment without receiving counseling ",0,
edin,7369,3785381,No significant difference,"With regards to the QoL perception, in group C we found increased scores for VT, PF, RP, RE, and MH (T2 versus T0; P < 0.05); in group NC, all the items remained unmodified, except for PF, which decreased at T2 (P < 0.05)."," vitality (VT), physical functioning (PF), role limitation due to physical problems (RP), role limitation due to emotional problems (RE), and mental health (MH)   ", baseline ," group NC), receiving the analgesic treatment without receiving counseling ",0,
edin,7460,5594766,Significantly decreased,"Mean arterial pressure was well attenuated by pregabalin than others, and mean heart rate following laryngoscopy and intubation was attenuated by clonidine group significantly.", the mean blood pressure ," clonidine 200 Î¼g,  gabapentin 900mg ", pregabalin 150 ,0,
edin,7177,4893238,No significant difference,"No significant change was observed at the histopathological evaluation, despite the evident macroscopic damage induced by naproxen.", Median histopathological scores , Placebo , Rebamipide ,0,
edin,7478,2948428,Cannot tell based on the abstract,, HbA1c , baseline ," taspoglutide 20 mg, titration to 30 mg (20/30), 40 mg (20/40) ",0,
edin,7478,2948428,Significantly decreased,". At week 8, the changes from baseline in HbA1c were â1.2 Â± 0.1, â0.9 Â± 0.1 and â1.2 Â± 0.1% in the 20/20-, 20/30- and 20/40-mg arms, respectively [LS mean Â± standard error (se)], vs. â0.5 Â± 0.1% with placebo (P < 0.0001 in all groups vs. the placebo group). Moreover, the percentage of subjects achieving HbA1c < 7.0% was 72% (20/20-mg group), 53% (20/30 mg) and 70% (20/40 mg) in the taspoglutide arms vs. 19% in the placebo arm.", HbA1c , baseline ," taspoglutide 20 mg, titration to 30 mg (20/30), 40 mg (20/40) ",0,
edin,7311,3253463,Significantly increased,"We found that the ginger-treated groups had significantly decreased P300 latencies, increased N100 and P300 amplitudes, and exhibited enhanced working memory.", Working memory , Control , Zingiber officinale 800 mg ,0,
edin,7479,2948428,Significantly decreased,"The proportion of subjects achieving HbA1c < 7.0% after 8 weeks of treatment was 72, 53 and 70% in the 20/20-, 20/30- and 20/40-mg arms, respectively, vs. 19% for placebo.", HbA1c , placebo ," taspoglutide 20 mg, titration to 30 mg (20/30), 40 mg (20/40) ",0,
edin,7457,3611073,Significantly decreased,Sensory block levels were significantly lower at all time points for the L group., Sensory block levels , emain in the sitting position for 2 minutes before they also assumed the supine position (S group) , supine position immediately after 6.5 mg hyperbaric bupivacaine were injected (L group) ,0,
edin,7508,2837810,No significant difference,"All treatment groups had similar pain relief (PÂ =Â 0.172, FÂ =Â 1.802) and satisfaction, reflected in equal values of disabilities of the arm, shoulder and hand (DASH) score (PÂ =Â 0.948, FÂ =Â 0.004).", pain  , arthroscopic debridement , arthroscopic partial repair ,0,
edin,7289,3635879,Significantly increased,"Compared with formative assessments, summative assessments increased the odds of correctly identifying at least three out of five ECG diagnoses (OR 5.14; 95% CI 3.26 to 8.09), of spending at least 2 h/week extra on ECG self-study (OR 4.02; 95% CI 2.65 to 6.12) and of using additional learning material (OR 2.86; 95% CI 1.92 to 4.24).", Probability of using additional learning material , Formative assessments , Summative assessments ,0,
edin,7290,3479017,Significantly increased,The intervention led to increased physical activity/fitness levels and an improved cardiovascular risk factor profile (reduced BMI and waist circumference), Physical activity levels , Control , Comprehensive lifestyle intervention ,0,
edin,7268,4354356,Significantly increased,"Our results indicate that acute heroin substitution induces a subjective rewarding effect via increased striatal connectivity in heroin-dependent patients, suggesting that positive reinforcement effects in the striatum still occur after protracted maintenance therapy.", Regions showing increased functional resting-state connectivity , Placebo , Heroin ,0,
edin,7227,5358738,Significantly increased,"At 4 months post-intervention an increase of 20 percentage points (p.p.) for complete Active Management of Third Stage of Labor (AMTSL) (p = 0.044), and 16 p.p. increase for Skin-to-Skin Contact (p = 0.067); at 12 months a 25 p.p. increase of the 1st step of AMTSL (p = 0.026) and a 42 p.p. increase of Delayed Cord Clamping (p = 0.004); at 4 months a 30 (p = 0.001) and at 8 months a 22 (p = 0.010) p.p. decrease for Uterine Sweeping.", Delayed Cord Clamping % points  , Control , Simulation and team-training program ,0,
edin,7594,4386768,Cannot tell based on the abstract,, prostate volumes , baseline ,  dutasteride 0.5 mg ,0,
edin,7594,4386768,Significantly decreased,Prostate volumes decreased by 25.7% in the dutasteride group and increased by 1.5% in the placebo group (P<0.001)., prostate volumes , baseline ,  dutasteride 0.5 mg ,0,
edin,7265,4354356,Significantly increased,"Relative to the placebo treatment in patients, heroin significantly increased rsFC of the left putamen within the basal ganglia/limbic network, the extent of which correlated positively with patients' feelings of rush and with the plasma level of morphine.", Subjective feelings of rush  , Placebo , Heroin ,0,
edin,7149,4296330,Cannot tell based on the abstract,, Insertion time , Laryngeal mask airway , iâgelâ¢ ,0,
edin,7149,4296330,Significantly decreased,The difference between both groups regarding insertion time was statistically significant (P < 0.05) (14.93 Â± 4.6 s in i-gelâ¢ vs 27.1 Â± 16.7 s in LMA-Classicâ¢) [Figure 1]., Insertion time , Laryngeal mask airway , iâgelâ¢ ,0,
edin,7547,5940475,Significantly increased,"Both the experimental group and the control group showed significant improvement in the Six-Minute Walk Test, Tinetti gait index, and TIS total score."," six-minute walk test, Tinetti Gait Index, and TIS Total score ", baseline ,  7 in the chest expansion exercise with transcutaneous electrical nerve stimulation (TENS)  group (experimental group); 7 in the chest expansion exercise with placebo transcutaneous electrical nerve stimulation (TENS)  (control group) ,0,
edin,7424,4119301,Cannot tell based on the abstract,, Likert scores , silicone impressions , alginate  impressions ,0,
edin,7424,4119301,Significantly increased,There was significant evidence from the patient reported Likert scores that silicone impressions were more comfortable than alginate impressions (pÂ =Â 0.0021) but no evidence of a difference in taste between the two impression materials (pÂ =Â 0.1128)., Likert scores , silicone impressions , alginate  impressions ,0,
edin,7467,3438419,Cannot tell based on the abstract,," The Functional Ambulation Categories (FAC),  Timed Up and Go test (TUG), the Berg Balance Scale (BBS), knee extensor power ", baseline , conventional therapy ,0,
edin,7467,3438419,Significantly increased,"There were statistically significant improvements in all parameters (FAC, 10mWT, TUG, BBS, and MBI) except knee extensor power at 2 weeks of training in the experimental group, while only two parameters (BBS and MBI) in control group (p<0.05)."," The Functional Ambulation Categories (FAC),  Timed Up and Go test (TUG), the Berg Balance Scale (BBS), knee extensor power ", baseline , conventional therapy ,0,
edin,7485,5241452,Cannot tell based on the abstract,," The positive rate of H. pylori infection with each single biopsy taken from site 2 , and site 3 ", baseline , group A (Rapid urease test (RUT) plus noninvasive tests) ,0,
edin,7485,5241452,Significantly increased,"The detection rates of H. pylori infection by RUT with each single biopsy taken from site 1 (83.8%), site 2 (90.1%), and site 3 (85.6%) were not significantly different (p = 0.284) (Table 4). The detection rates by combined results from 2 biopsy sites: site 1 and site 2 (97.3%), site 1 and site 3 (94.6%), and site 2 and site 3 (95.5%) were also not different from each other but significantly increased when compared with each single biopsy site (Figure 2). The detection rate combined result from 3 biopsy sites was the highest, 98.2%."," The positive rate of H. pylori infection with each single biopsy taken from site 2 , and site 3 ", baseline , group A (Rapid urease test (RUT) plus noninvasive tests) ,0,
edin,7119,3233513,Cannot tell based on the abstract,, Use of salbutamol as reliever  , Placebo , Formoterol 4.5 Î¼g ,0,
edin,7119,3233513,Significantly decreased,"Similarly, while both formoterol 4.5 and 9 Î¼g bid significantly reduced the use of salbutamol as reliever medication compared with placebo (9 Î¼g vs. placebo difference: -0.55, p < 0.001; 4.5 Î¼g vs. placebo difference: -0.27, p = 0.027),", Use of salbutamol as reliever  , Placebo , Formoterol 4.5 Î¼g ,0,
edin,7601,4386768,Cannot tell based on the abstract,, Prostate volumes , baseline , tamsulosin 0.4 mg ,0,
edin,7601,4386768,No significant difference,"However, dutasteride decreased prostate volumes by 28% while tamsulosin resulted in a 4.6% increase in prostate volumes.", Prostate volumes , baseline , tamsulosin 0.4 mg ,0,
edin,7454,1550608,Cannot tell based on the abstract,,  Emergency Room Visits  and health distress , mailed paper-and-pencil versions , questionnaires online ,0,
edin,7454,1550608,No significant difference,"Although there were no other differences approaching significance, there were slight trends (less than .20) for ER Visits (p=.146) and health distress (p=.116).",  Emergency Room Visits  and health distress , mailed paper-and-pencil versions , questionnaires online ,0,
edin,7555,2699080,Cannot tell based on the abstract,, Mean total operative time with stent placement , pyeloplasty (OP) , laparoscopic (LP) ,0,
edin,7555,2699080,Significantly increased,Mean total operative time with stent placement in LP group was 244.2 min (188-300 min) compared to 122 min (100-140 min) in open group. Total operative time did improve with experience for LP patients as average time reduced to 202 min for last five patients., Mean total operative time with stent placement , pyeloplasty (OP) , laparoscopic (LP) ,0,
edin,7350,2752780,Cannot tell based on the abstract,, Hamilton Rating Scales for Depression  , Control , Biofeedback  ,0,
edin,7350,2752780,No significant difference,"Age, BMI, the baseline HAM-D, HAM-A, and STAI-S were not associated with treatment response in terms of headache index (all P values >0.1) in the biofeedback-assisted training group.,However, the multivariate logistic regression revealed that the greater reduction of the HAM-A score was associated with the treatment response controlling for age, BMI, and the baseline HAM-A in the biofeedback-assisted autogenic training group (OR=1.52, CI=1.01-2.33, P=0.048) whereas the reduction of the HAM-D score nor that of the STAI-S were not (P=0.088 and P=0.080, respectively).", Hamilton Rating Scales for Depression  , Control , Biofeedback  ,0,
edin,7461,5594766,Cannot tell based on the abstract,, sedation and anxiety score , baseline ," pregabalin 150, clonidine 200 Î¼g,  gabapentin 900mg ",0,
edin,7461,5594766,No significant difference,"As shown in Table 4, we found that all three drugs significantly reduces anxiety and sedation, maximally by pregabalin.", sedation and anxiety score , baseline ," pregabalin 150, clonidine 200 Î¼g,  gabapentin 900mg ",0,
edin,7190,4969326,Cannot tell based on the abstract,, EQ-5D utility index scores improvement at 4 weeks , Control , Naloxegol  ,0,
edin,7190,4969326,No significant difference,"<td align=""left"">Week 4<sup>a</sup>
</td><td align=""char"" char=""."">40</td><td align=""char"" char=""("">0.55 (0.31)</td><td align=""char"" char=""."">44</td><td align=""char"" char=""("">0.63 (0.24)</td><td align=""char"" char=""."">0.2196</td>", EQ-5D utility index scores improvement at 4 weeks , Control , Naloxegol  ,0,
edin,7344,3822756,Cannot tell based on the abstract,"Both ACE inhibition and ARB decreased plasma transfusion compared to placebo, but only ACE inhibition decreased length of stay.", Need of plasma transfusion , Placebo , Candesartan ,0,
edin,7344,3822756,Significantly decreased,he blood product transfusion exposure was similar among treatment groups except fresh frozen plasma was more frequently transfused in the placebo group., Need of plasma transfusion , Placebo , Candesartan ,0,
edin,7468,3087256,Significantly decreased,The addition of neostigmine resulted in significant longer duration of analgesia (dose independent) and sedation (dose dependent)., duration of analgesia , group II lignocaine1% (9ml) with neostigmine 100Î¼g in saline (1ml) and group III received lignocaine 1% (9ml) with neostigmine 200Î¼g in NS (1ml) , Group I received lignocaine 1% (9ml) with normal saline (1ml) ,0,
edin,7345,3822756,No significant difference,"Neither ACE inhibition nor ARB significantly affectedplasminogen activator inhibitor-1 (PAI-1), interleukin (IL)-6, IL-8, or IL-10 concentrations.", Plasminogen activator inhibitor-1  , Placebo , Ramipril  ,0,
edin,7464,2845036,Cannot tell based on the abstract,, A1C , mofetil (MMF)  , mofetil (MMF)  with daclizumab (DZB) ,0,
edin,7464,2845036,No significant difference,"Figure 1C and D show that these mean ratios and confidence limits within subgroups, defined by baseline characteristics, are not nominally significantly different from 1, with the exception of the effect of MMF alone within the 10 subjects in the highest tertile of baseline A1C (P = 0.042). However, comparison of ratios among the A1C tertiles, and among all other subgroups, failed to reach significance demonstrating that variation among subgroups was within the realm of chance. Similar results applied to subgroups defined from the mean levels of A1C and insulin dose over 24 months.", A1C , mofetil (MMF)  , mofetil (MMF)  with daclizumab (DZB) ,0,
edin,7125,4210064,Cannot tell based on the abstract,, Postprandial glucose , Switching from nateglinide to vildagliptin , Combining nateglinide + vildagliptin ,0,
edin,7125,4210064,Significantly decreased,These results show that vildagliptin strongly improved both fasting and postprandial hyperglycemia when combined with nateglinide., Postprandial glucose , Switching from nateglinide to vildagliptin , Combining nateglinide + vildagliptin ,0,
edin,7510,4701161,Cannot tell based on the abstract,, Lrat expression , baseline , VARA ,0,
edin,7510,4701161,Significantly decreased,"Adult rats that had been treated with VARA as neonates had significantly lower levels of Lrat expression (Fig 2B, red bar) compared both to oil-treated controls and VARA-supplemented adult rats.", Lrat expression , baseline , VARA ,0,
edin,7169,4858101,Cannot tell based on the abstract,, Gastrointestinal toxicosis , Carboplatin , Mitoxantrone ,0,
edin,7169,4858101,No significant difference,"Overall, more dogs treated with carboplatin experienced some form of gastrointestinal toxicosis (9/35; 26%) than did dogs treated with mitoxantrone (3/38; 8%); however, this difference did not reach statistical significance (PÂ =Â .06).", Gastrointestinal toxicosis , Carboplatin , Mitoxantrone ,0,
edin,7427,5395810,Cannot tell based on the abstract,, waist circumference , self-image at recruitment after 8&amp;amp;nbsp;weeks (delayed image) , self-image at recruitment (early image)  ,0,
edin,7427,5395810,No significant difference,"Mean change in waist circumference over 24Â weeks was â2.74Â cm for the delayed-image group and â3.23Â cm for the early-image group, which was not statistically significant (pâ=â0.68).", waist circumference , self-image at recruitment after 8&amp;amp;nbsp;weeks (delayed image) , self-image at recruitment (early image)  ,0,
edin,7411,5214464,No significant difference,"Similar to the VO2max results, forced vital capacity demonstrated a significant increase within subjects (F(1, 17)=6.201, p<.05), but there was no significant difference between the control and experimental groups (F(1,17)=3.562, p= .079)", forced vital capacity (FVC) , without the mask ," Elevation Training MasksÂ© (ETM) ,  ",0,
edin,7201,4744955,Cannot tell based on the abstract,, Wholeâmouth mean Plaque index score , Control , Lauroyl arginateâcontaining mouthrinse  ,0,
edin,7201,4744955,Significantly decreased,"The reduction in the wholeâmouth mean MGI score was also statistically significantly greater with the LAE mouthrinse (difference: 0.23 [95% CI: 0.19, 0.28]; 10.7% reduction compared with the control; pÂ < 0.001).", Wholeâmouth mean Plaque index score , Control , Lauroyl arginateâcontaining mouthrinse  ,0,
edin,7285,2291568,Cannot tell based on the abstract,, Weight gain in wasted children  , Control , Albendazole ,0,
edin,7285,2291568,Significantly increased,"For all nutritional categories, the weight gain was significantly greater for those children who received albendazole in addition to usual care. In the under-nourished categories, the greatest gain in weight was for wasted children and the least for stunted children.,<td align=""left"" colspan=""1"" rowspan=""1"">e. Wasted<xref ref-type=""table-fn"" rid=""nt103"">*</xref>
</td><td align=""left"" colspan=""1"" rowspan=""1"">3.63Â±0.11 (247)</td><td align=""left"" colspan=""1"" rowspan=""1"">4.56Â±0.12 (400)</td><td align=""left"" colspan=""1"" rowspan=""1"">
<italic>&lt;0.00001</italic>
</td>", Weight gain in wasted children  , Control , Albendazole ,0,
edin,7561,4181789,Cannot tell based on the abstract,, easiness of bowel preparation experience , polyethylene glycol (PEG) preparation , Sodium phosphates (L-NaP) preparation ,0,
edin,7561,4181789,Significantly increased,"As seen in Figure 3(a), 80% of patients in the L-NaP group reported that they had an easier bowel preparation experience than in the past in comparison with 38.9% of the patients in the PEG group (P < 0.001).", easiness of bowel preparation experience , polyethylene glycol (PEG) preparation , Sodium phosphates (L-NaP) preparation ,0,
edin,7249,4877819,No significant difference,"No statistically significant differences were observed for relapse rate, EDSS or inflammatory parameters, with a trend in reducing new lesions among the A. paniculata group.", Expanded Disability Status Scale , Placebo , Andrographis paniculata ,0,
edin,7334,3017961,Cannot tell based on the abstract,, Global self esteem  , Regular exercise  , Yoga ,0,
edin,7334,3017961,Significantly increased,Global self esteem (GSE): The Y group (scores of 46.68â49.47) (P = 0.036) showed a significant increase in global self esteem., Global self esteem  , Regular exercise  , Yoga ,0,
edin,7365,4834398,Cannot tell based on the abstract,, Heart Rate , Acupuncture  wait-list control , Acupuncture  ,0,
edin,7365,4834398,Significantly decreased,Post hoc analysis revealed significant more decrease at the acupuncture group compared to sham group (p = 0.004) but not control group (p > 0.05)., Heart Rate , Acupuncture  wait-list control , Acupuncture  ,0,
edin,7553,2910303,Cannot tell based on the abstract,,  hours  employing , baseline ," active control group, and a passive control group ",0,
edin,7553,2910303,No significant difference,"<td><italic>N</italic>â=â61</td><td><italic>N</italic>â=â39</td><td><italic>N</italic>â=â31</td><td><italic>N</italic>â=â10</td><td><italic>N</italic>â=â30</td><td><italic>N</italic>â=â29</td>,ANCOVAs (HbA1c, demographic variables, diabetes self-efficacy, and diabetes distress) and MANCOVAs (BMI and waist, S-R cognitions, and lifestyle variables; TableÂ 1) indicated that study non-completers were employed for more hours [t (98)â=ââ1.98, pâ=â.050] and scored lower on âgoal ownershipâ [t (94)â=â11.53, pâ<â.000], âgoal supportâ [t (88)â=â5.99, pâ=â.000] and âdiabetes self-efficacyâ [t(90)â=â2.55, pâ=â.013]. Interestingly, study non-completers scored higher on âgoal planningâ [t (89)â=ââ2.99, pâ=â.004].",  hours  employing , baseline ," active control group, and a passive control group ",0,
edin,7539,3620516,Significantly decreased,"Preventive treatment with anodal tDCS turned out to be beneficial in MoA: migraine attack frequency, migraine days, attack duration and acute medication intake significantly decreased during the treatment period compared to pre-treatment baseline (all p < 0.05), and this benefit persisted on average 4.8 weeks after the end of tDCS.", acute medication intake , baseline , Transcranial direct current stimulation (tDCS) ,0,
edin,7112,5358282,Cannot tell based on the abstract,, Comfort during the procedure , Control , Diazepam + chlorpheniramine ,0,
edin,7112,5358282,No significant difference,"<td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">Comfortable during the procedure</td><td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">81 (81)</td><td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">81 (81)</td><td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">NS</td>", Comfort during the procedure , Control , Diazepam + chlorpheniramine ,0,
edin,7498,4840766,Cannot tell based on the abstract,, TSH , baseline ," recombinant human growth hormone (rhGH) 0.1, recombinant human growth hormone (rhGH) 0.05 U/kg  ",0,
edin,7498,4840766,No significant difference,"Concerning TSH prior to and after treatment, the difference was not statistically significant (P>0.05),", TSH , baseline ," recombinant human growth hormone (rhGH) 0.1, recombinant human growth hormone (rhGH) 0.05 U/kg  ",0,
edin,7389,5467351,Significantly increased,A significant increase in fasting glucose (p = 0.001) and a decrease in ISI (p < 0.001) and DIo (p = 0.002) were only found in group A., fasting glucose , baseline  , receive daily  GH  treatment (GHT) ,0,
edin,7326,2785868,Significantly decreased,"After 3 years, hip fracture had occurred in 3.8% of risedronate-treated patients and 7.4% of placebo-treated patients (relative risk 0.54; 95% confidence interval 0.32â0.91; P = 0.019).", Hip fracture frequency , Placebo , Risedronate  2.5 mg ,0,
edin,7518,5985784,Significantly increased,IL-6 was higher in the LPS group on day 2 (p=0.03) and day 3 (p=0.04)., IL-6 on day 2 and day 3 , baseline , mixed laparoscopy group (LPS) ,0,
edin,7403,5968838,Significantly decreased,"For the study group, compared with the standard or control group, had a significantly reduced operation time (60.15Â±9.97 min vs. 71.85Â±9.74 min) and suturing time (18.05Â±4.71 min vs. 28.35Â±3.13 min) (both p<0.05), significantly less intraoperative blood loss (93.25Â±19.62 ml vs. 121.50Â±24.87 ml) (p<0.05) and significantly less reduction in postoperative hemoglobin levels (8.9Â±1.97 g/L vs. 11.15Â±2.23 g/L) (p<0.05)."," intraoperative blood loss, drop in hemoglobin ", standard suture method , âbaseballâ suture technique ,0,
edin,7371,3785381,Cannot tell based on the abstract,, Hamilton Rating Scale for Depression (HAM-D) scores at T2 , baseline ," (group C), had to receive patient-centered counseling throughout the hospitalization ",0,
edin,7371,3785381,Significantly decreased,"Patients undergoing counseling showed decreasing HAM-D scores at T2 when compared to the baseline evaluation (P < 0.01), and they could be defined as being nondepressed (HAM-D â¤ 10).", Hamilton Rating Scale for Depression (HAM-D) scores at T2 , baseline ," (group C), had to receive patient-centered counseling throughout the hospitalization ",0,
edin,7142,2984512,Cannot tell based on the abstract,, Diametral tensile strength after 1 hour , Luxatemp , Protemp 3 Garan ,0,
edin,7142,2984512,Significantly increased,"The strength was improved by 62.3% for PT3, 42.4% for LXT and 26.1% for TMP. Those increases in diametral tensile strength of PT3, TMP and LXT were significant with time (P < .001) (Table V).", Diametral tensile strength after 1 hour , Luxatemp , Protemp 3 Garan ,0,
edin,7271,5381869,Cannot tell based on the abstract,, Countermovement displacement , Sham tsDCS , Active anodal tsDCS ,0,
edin,7271,5381869,Significantly increased,"<td align=""right"" colspan=""1"" rowspan=""1""><italic>P</italic></td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">0.001</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">0.826</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">0.469</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">0.001</td>,<td align=""left"" colspan=""1"" rowspan=""1"">CM displacement</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">2.9%</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">- 3.1%</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">6.0%</td><td align=""right"" colspan=""1"" rowspan=""1"">2.6, 9.4</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">0.001</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">0.63</td><td align=""left"" colspan=""1"" rowspan=""1"">Medium</td>,or these 7 ÎVCJ performance parameters, the substantive effect of tsDCS, determined by effect size [25], was largest for the differences in changes in CM velocity, followed by changes in peak to peak power, CM power, total work, CM displacement and push-off work, all with moderate effects.,Interestingly, there was also a post-anodal tsDCS increase in CM power (t (47) = 2.26, P = 0.028), CM displacement/work done (t (47) = 2.18, P = 0.034) and total work done (t (47) = 2.01, P = 0.050) above baseline (Fig 3 and Table 3).", Countermovement displacement , Sham tsDCS , Active anodal tsDCS ,0,
edin,7299,2759981,Cannot tell based on the abstract,, Emergency Caesarean , Standard antenatal education , Natural childbirth preparation ,0,
edin,7299,2759981,No significant difference,"<td align=""left"" colspan=""1"" rowspan=""1"">Emergency Caesarean</td><td align=""center"" colspan=""1"" rowspan=""1"">67 (14)</td><td align=""center"" colspan=""1"" rowspan=""1"">75 (15)</td><td align=""center"" colspan=""1"" rowspan=""1"">0.9 (0.7 to 1.2)</td><td align=""center"" colspan=""1"" rowspan=""1"">0.5</td><td align=""center"" colspan=""1"" rowspan=""1""></td><td align=""center"" colspan=""1"" rowspan=""1""></td><td align=""center"" colspan=""1"" rowspan=""1""></td><td align=""center"" colspan=""1"" rowspan=""1""></td>", Emergency Caesarean , Standard antenatal education , Natural childbirth preparation ,0,
edin,7131,4662763,Significantly decreased,The mean SBS value in group one (pH 3.8) was significantly lower than that in other groups (P<0.05)., Shear bond strength , pH 4.8 saliva , pH 3.8 saliva  ,0,
edin,7384,4166083,Cannot tell based on the abstract,, Agitation score ," propofol-saline [PS],  thiopental sodium-lidocaine [TL] propofol-lidocaine [PL] ",  thiopental sodium-saline [TS] ,0,
edin,7384,4166083,Significantly increased,"Agitation score in PL group was the lowest and then PS and TL groups followed, and the highest score was in TS group (P < 0.001),Agitation incidence in the four groups was recorded at different times after anesthesia, and as in Table 3, agitation in the TS group was significantly higher than other groups at all times (P < 0.001).", Agitation score ," propofol-saline [PS],  thiopental sodium-lidocaine [TL] propofol-lidocaine [PL] ",  thiopental sodium-saline [TS] ,0,
edin,7162,5762262,Cannot tell based on the abstract,, Hemoglobin after 18 months , Placebo , Zinc ,0,
edin,7162,5762262,No significant difference,"Infants treated with MV alone had higher mean Hb than those given Zn alone at 12 mo (9.9 vs. 9.6 g/dL, p â¤ .05) and 18 mo (9.9 vs. 9.6 g/dL, p â¤ .05 (Table 4)).,In linear regression models including both MV and Zn treatment, MV treatment was associated with an increase in Hb of 0.2 g/dL (p â¤ .01) at 12 months and 0.3 g/dL (p â¤ .001) at 18 months. No differences in Hb values between infants treated with Zn and those with placebo or Zn + MV therapy were observed at any age.", Hemoglobin after 18 months , Placebo , Zinc ,0,
edin,7481,2948428,Cannot tell based on the abstract,, Body weight , placebo ," taspoglutide 20 mg, titration to 30 mg (20/30), 40 mg (20/40) ",0,
edin,7481,2948428,No significant difference,"Body weight decreased progressively in all groups throughout the 8-week treatment period. Changes from baseline (LS mean Â± se) were â2.1 Â± 0.4 kg in the 20/20 group (P = 0.77 vs. placebo), â3.0 Â± 0.3 kg in the 20/30 group (P = 0.03 vs. placebo) and â2.7 Â± 0.4 kg in the 20/40 group (P = 0.17 vs. placebo) compared with â2.0 Â± 0.3 kg in the placebo group.", Body weight , placebo ," taspoglutide 20 mg, titration to 30 mg (20/30), 40 mg (20/40) ",0,
edin,7566,5534217,Cannot tell based on the abstract,, The numbers of days required for the disappearance of influenza symptoms , oseltamivir (Tamiflu) , peramivir (Rapiacta) ,0,
edin,7566,5534217,No significant difference,"The numbers of days (mean Â± SE) required for the disappearance of influenza symptoms were 5.26 Â± 0.15 and 5.38 Â± 0.16 days for the peramivir and the oseltamivir groups, respectively (log-rank test; P = .65; Ï2 value = 0.204).", The numbers of days required for the disappearance of influenza symptoms , oseltamivir (Tamiflu) , peramivir (Rapiacta) ,0,
edin,7526,5465806,No significant difference,The intake of PS did not significantly change the individual biomarkers of endothelial dysfunction and low-grade inflammation., individual biomarkers of endothelial dysfunction and low-grade inflammation , placebo , Plant sterols (PS) ,0,
edin,7526,5465806,No significant difference,The intake of PS did not significantly change the individual biomarkers of endothelial dysfunction and low-grade inflammation., individual biomarkers of endothelial dysfunction and low-grade inflammation , placebo , Plant sterols (PS) ,0,
edin,7441,4744782,Significantly decreased,"For those providing inâhome care at postâtreatment, depressive symptoms, upset following disruptive behaviors, and negative mood states were statistically lower in the behavioral coaching condition than in the basic education and support condition.", Upset following behavior problems , baseline ," a 14âweek behavioral intervention using video instructional materials, workbook and telephone coaching in behavioral management, pleasant events scheduling, and relaxation ",0,
edin,7166,4858101,Cannot tell based on the abstract,, Improvement in signs , Carboplatin , Mitoxantrone ,0,
edin,7166,4858101,No significant difference,"In the mitoxantrone group, 18/20 (90%) dogs had improvement in signs, and 2/20 (10%) had no change in signs. In the carboplatin group, 13/20 (65%) had improvement in clinical signs, and 7/20 (35%) had stable clinical signs. These differences were not statistically significant (PÂ =Â .13).", Improvement in signs , Carboplatin , Mitoxantrone ,0,
edin,7196,4279802,Cannot tell based on the abstract,, Systolic blood pressure  , Midazolam in hypertensive patients  , Dexmedetomidine in hypertensive patients  ,0,
edin,7196,4279802,Significantly increased,"SBP was significantly different between the normotensive and hypertensive groups at the following time points: premedication 5th min (Tpreop 5 min,Pâ<â0.001), premedication 10th min (Tpreop 10 min, Pâ=â0.002), induction (Tinduction, Pâ<â0.001), intubation 1st min (Tintubation, Pâ<â0.001), intubation 5th min (Tintubation5 min, Pâ<â0.001) and initial surgery (Tinitial surgery, Pâ<â0.001). The mean values of SBP at Tpreop 5 min, Tpreop 10 min and Tinduction were significantly reduced in the hypertensive groups. In particular, a marked reduction was noted in Group HM after induction.,Group HM, hypertensive patients who received midazolam before anesthesia.", Systolic blood pressure  , Midazolam in hypertensive patients  , Dexmedetomidine in hypertensive patients  ,0,
edin,7181,3880665,No significant difference,"For waist to hip ratio (WHR), body fat percentage and maximal oxygen consumption there were no significant differences between the exercise group and the control group.", Maximal oxygen consumption , Control , Moderate intensity aerobic exercise ,0,
edin,7108,2474851,Cannot tell based on the abstract,, AUC for predicting prostate cancer at biopsy , Clinical base model + free PSA , Clinical full model ,0,
edin,7108,2474851,Significantly increased,"The AUC of the laboratory base model (age+total PSA) was 0.68. Addition of all markers enhanced the AUC of the laboratory base model to 0.83. Predictive accuracy of the full model was higher than that of the base model (p < 0.0005); because free PSA is widely used in clinical practice, we also compared the AUC of the full model to that of the base model plus free PSA (p = 0.005).", AUC for predicting prostate cancer at biopsy , Clinical base model + free PSA , Clinical full model ,0,
edin,7414,4710971,No significant difference,Between groups no difference in the global GMA (primary outcome) could be observed., General Movement Assessment (GMA) , standard care (CG) , craniosacral therapy (IG) ,0,
edin,7280,4126186,Cannot tell based on the abstract,, High Sensitivity C-Reactive Protein , Rosuvastatin , Atorvastatin ,0,
edin,7280,4126186,Significantly decreased,"Regarding systemic inflammation, only atorvastatin significantly reduced hsCRP levels (-13.5%, p=0.025).", High Sensitivity C-Reactive Protein , Rosuvastatin , Atorvastatin ,0,
edin,7351,2752780,Cannot tell based on the abstract,, Spielberger State Anxiety Inventory  , Control , Biofeedback  ,0,
edin,7351,2752780,No significant difference,"Age, BMI, the baseline HAM-D, HAM-A, and STAI-S were not associated with treatment response in terms of headache index (all P values >0.1) in the biofeedback-assisted training group.,However, the multivariate logistic regression revealed that the greater reduction of the HAM-A score was associated with the treatment response controlling for age, BMI, and the baseline HAM-A in the biofeedback-assisted autogenic training group (OR=1.52, CI=1.01-2.33, P=0.048) whereas the reduction of the HAM-D score nor that of the STAI-S were not (P=0.088 and P=0.080, respectively).", Spielberger State Anxiety Inventory  , Control , Biofeedback  ,0,
edin,7134,4662763,No significant difference,The mean SBS value in group one (pH 3.8) was significantly lower than that in other groups (P<0.05). The differences between other groups were not significant (P>0.05)., Shear bond strength , pH 4.8 saliva , pH 5.8 saliva ,0,
edin,7228,5358738,Significantly decreased,"At 4 months post-intervention an increase of 20 percentage points (p.p.) for complete Active Management of Third Stage of Labor (AMTSL) (p = 0.044), and 16 p.p. increase for Skin-to-Skin Contact (p = 0.067); at 12 months a 25 p.p. increase of the 1st step of AMTSL (p = 0.026) and a 42 p.p. increase of Delayed Cord Clamping (p = 0.004); at 4 months a 30 (p = 0.001) and at 8 months a 22 (p = 0.010) p.p. decrease for Uterine Sweeping.", Uterine Sweeping % points  , Control , Simulation and team-training program ,0,
edin,7357,4265247,Cannot tell based on the abstract,,  R3z value , Placebo , Oral supplement 2 ,0,
edin,7357,4265247,Significantly decreased,"In particular, the change in R3z value over 14Â weeks in both test groups was significantly reduced compared with placebo (Fig.3).",  R3z value , Placebo , Oral supplement 2 ,0,
edin,7554,2910303,Cannot tell based on the abstract,, goal planning , baseline ," active control group, and a passive control group ",0,
edin,7554,2910303,Significantly increased,"<td><italic>N</italic>â=â57</td><td><italic>N</italic>â=â34</td><td><italic>N</italic>â=â31</td><td><italic>N</italic>â=â9</td><td><italic>N</italic>â=â29</td><td><italic>N</italic>â=â25</td>,ANCOVAs (HbA1c, demographic variables, diabetes self-efficacy, and diabetes distress) and MANCOVAs (BMI and waist, S-R cognitions, and lifestyle variables; TableÂ 1) indicated that study non-completers were employed for more hours [t (98)â=ââ1.98, pâ=â.050] and scored lower on âgoal ownershipâ [t (94)â=â11.53, pâ<â.000], âgoal supportâ [t (88)â=â5.99, pâ=â.000] and âdiabetes self-efficacyâ [t(90)â=â2.55, pâ=â.013]. Interestingly, study non-completers scored higher on âgoal planningâ [t (89)â=ââ2.99, pâ=â.004].,<td>&nbsp;Goal planning</td><td>â.430</td><td>.629</td><td>.494</td>", goal planning , baseline ," active control group, and a passive control group ",0,
edin,7322,4269544,Cannot tell based on the abstract,"Heart rate, systolic blood pressure, diastolic blood pressure, mean arterial pressure and rate pressure product were compared to basal values at pre-induction, induction, intubation and post-intubation as well as at time increments of 1, 3, 5, 7 and 10 min.", Heart 7 min after intubation  , Fentanyl  , Fentanyl + nitroglycerin ,0,
edin,7322,4269544,No significant difference,". Likewise, at 7 min after intubation the heart rate for the NTG-fentanyl group only increased by 5.06% when compared to that of the control group which was also not significant (T-12) (t=1.39, P=0.085).", Heart 7 min after intubation  , Fentanyl  , Fentanyl + nitroglycerin ,0,
edin,7356,4265247,Cannot tell based on the abstract,,  R3z value , Placebo , Oral supplement 1 ,0,
edin,7356,4265247,Significantly decreased,"In particular, the change in R3z value over 14Â weeks in both test groups was significantly reduced compared with placebo (Fig.3).",  R3z value , Placebo , Oral supplement 1 ,0,
edin,7194,4969326,Cannot tell based on the abstract,, EQ-5D Pain improvement   , Control , Naloxegol  ,0,
edin,7194,4969326,No significant difference,"<th align=""left"" rowspan=""2""></th><th align=""left"" colspan=""4"">EQ-5D</th>", EQ-5D Pain improvement   , Control , Naloxegol  ,0,
edin,7203,4744955,Cannot tell based on the abstract,, Proportion of bleeding sites , Control , Lauroyl arginateâcontaining mouthrinse  ,0,
edin,7203,4744955,No significant difference,"At Week 2, a 36.3% reduction in the proportion of bleeding sites was observed compared with the control group (0.077 versus 0.121; difference 0.04 [95% CI: 0.03, 0.06]). At Week 4, a 50.9% reduction in the proportion of bleeding sites was observed compared with the control group (0.058 versus 0.119; difference 0.06 [95% CI: 0.04, 0.08]). All bleeding scores were either 0 or 1 in both treatment groups across all study visits. Therefore, in this study, the mean scores were equivalent to proportions of bleeding sites", Proportion of bleeding sites , Control , Lauroyl arginateâcontaining mouthrinse  ,0,
edin,7215,3227609,Cannot tell based on the abstract,, Vomiting , Breastfeeding , Oligosaccharides Prebiotic Formula ,0,
edin,7215,3227609,No significant difference,"The number of spitting episodes within the first 24 weeks of age in the formula groups partly differs from the one of breastfeeding group infants, whereas the frequency of vomiting in the two formula groups was similar to that in the breastfeeding group.", Vomiting , Breastfeeding , Oligosaccharides Prebiotic Formula ,0,
edin,7549,5940475,Significantly increased,"In comparison between the two groups, the experimental group showed a more significant improvement in Tinetti gait index and TIS total score than the control group.", Tinetti Gait Index and the TIS Total Score , 7 in the chest expansion exercise with placebo TENS (control group) , 7 in the chest expansion exercise with transcutaneous electrical nerve stimulation (TENS) group (experimental group) ,0,
edin,7422,4119301,Cannot tell based on the abstract,," comfort, stability, chewing efficiency ", silicone impressions , alginate impressions ,0,
edin,7422,4119301,No significant difference,"After the âConfirmationâ period, the patient reported assessment of the âComfortâ, âStabilityâ and âChewing Efficiencyâ of the dentures showed there was again no evidence of a difference in comfort rating between silicone and alginate impression materials (pÂ =Â 0.5417)."," comfort, stability, chewing efficiency ", silicone impressions , alginate impressions ,0,
edin,7382,5494175,No significant difference,"No statistical association was found for visual abilities-âConceptual Thinkingâ, âFace recognitionâ, âStory completionâ, and reasoning tests-âRoverâ, âBlock countingâ, and âPattern Reasoningâ."," âConceptual Thinkingâ, âFace recognitionâ, âStory completionâ, and reasoning tests-âRoverâ, âBlock countingâ, and âPattern Reasoningâ ", children whose mothers did not consume alcohol during pregnancy , children whose mothers reported alcohol consumption during pregnancy ,0,
edin,7278,4126186,Cannot tell based on the abstract,, Triglycerides   , Rosuvastatin , Atorvastatin ,0,
edin,7278,4126186,No significant difference,"The reduction in LDL-C was greater with rosuvastatin (49.4 vs. 41.7%, p=0.015) while the reductions in TC and TG levels were similar between the 2 groups (37 vs. 32.9%, respectively; p=0.05 and 27.4 vs. 22.5%, respectively; p=0.168) (Table 2).", Triglycerides   , Rosuvastatin , Atorvastatin ,0,
edin,7521,5985784,Cannot tell based on the abstract,," Number of complications, in-hospital mortality, and 30-day mortality ", open surgery group (LPT) , mixed laparoscopy group (LPS) ,0,
edin,7521,5985784,No significant difference,"The clinical outcomes that were followed, such as complications after surgery, ICU-LOS, H-LOS, in-hospital mortality, and 30-day mortality, did not differ between the two groups. T"," Number of complications, in-hospital mortality, and 30-day mortality ", open surgery group (LPT) , mixed laparoscopy group (LPS) ,0,
edin,7312,3134103,Significantly decreased,"Mean blood loss in the first 24 hours was 962 Â± 595âmL in the treatment group (n = 79) and 1,178 Â± 788âmL in the control group (n = 106), P = .040.", Blood loss during day 1 , Control , N-acetylcysteine ,0,
edin,7512,4701161,Cannot tell based on the abstract,, Raldh-1 &amp;amp;gt; Raldh-3 &amp;amp;gt; Raldh-2. Raldh-1 expression , baseline , VARA ,0,
edin,7512,4701161,Significantly increased,"Based on cycle threshold numbers, the relative expression levels among these three genes were Raldh-1 > Raldh-3 > Raldh-2. Raldh-1 expression displayed an age-related increase (P < 0.001) in the control group, driven by higher expression in adults (Fig 4A; black bars).,VARA supplementation altered expression only in adults, in which expression was reduced (Fig 4A; blue bars).", Raldh-1 &amp;amp;gt; Raldh-3 &amp;amp;gt; Raldh-2. Raldh-1 expression , baseline , VARA ,0,
edin,7336,4914255,Cannot tell based on the abstract,, N-back working memory test , Control , D-serine ,0,
edin,7336,4914255,No significant difference,"D-serine administration did not have any statistically significant effect on the key measures of the n-back working memory test (accuracy, p > 0.1), the Set-Shifting cognitive flexibility task (extra-dimensional shift errors, p = 0.47), or the visual attention test (errors, p > 0.7).", N-back working memory test , Control , D-serine ,0,
edin,7339,4914255,Cannot tell based on the abstract,, Groton Maze Learning Test legal errors , Control , D-serine ,0,
edin,7339,4914255,Significantly decreased,"D-serine administration was associated with a statistically significant decrease in legal errors on the Groton Maze Learning test for spatial memory, learning and problem solving (F(3, 38) = 4.74, p = 0.03, Figure 1).", Groton Maze Learning Test legal errors , Control , D-serine ,0,
edin,7434,4212559,Significantly decreased,"The cumulative incidence of T2DM was significantly lower in the ILG than in the UCG among participants with HbA1c levels â¥5.7% (log-rank=3.52, p=0.06; Breslow=4.05, p=0.04; Tarone-Ware=3.79, p=0.05), while this was not found among participants with HbA1c levels <5.7%.", cumulative incidence of  type 2 diabetes mellitus (T2DM)  among participants with baseline HbA1c levels &amp;lt;5.7% , usual care group (UCG) , intensive lifestyle intervention group (ILG) ,0,
edin,7193,4969326,Cannot tell based on the abstract,, EQ-5D Usual activities improvement   , Control , Naloxegol  ,0,
edin,7193,4969326,Significantly increased,"<td align=""left"">Some problems</td><td align=""left"">131 (67.5)</td><td align=""char"" char=""("">124 (66.7)</td>,<th align=""left"" rowspan=""2""></th><th align=""left"" colspan=""4"">EQ-5D</th>", EQ-5D Usual activities improvement   , Control , Naloxegol  ,0,
edin,7348,2752780,Significantly increased,We found greater treatment response rate (defined as â¥50% reduction in headache index) in patients with biofeedback-assisted autogenic training than in monitoring group., Treatment response rate , Control , Biofeedback  ,0,
edin,7550,5067642,Cannot tell based on the abstract,," standard behavioral weight loss, ", baseline ,  standard behavioral weight loss; a technologyâbased system combined with a monthly intervention telephone call (TECH) ; an enhanced technologyâbased system combined with a monthly intervention telephone call (ENâTECH) ,0,
edin,7550,5067642,Significantly increased,"Standard behavioral weight loss returned 12.4âÂ±â8.9 weekly selfâmonitoring diaries and selfâmonitored their diet for 84.6âÂ±â62.3âd. TECH and ENâTECH selfâmonitored their diet 80.0âÂ±â56.4 and 70.1âÂ±â66.9âd, respectively (pâ=â0.828).,Weight loss occurred in all intervention conditions across 6âmonths (pâ<â0.0001) (TableÂ 2 and FigureÂ 2). Weight loss (least square meansâÂ±âstandard error) at 3âmonths was â3.39âÂ±â1.04, â5.06âÂ±â1.08 and â4.76âÂ±â1.25âkg in SBWL, TECH and ENâTECH, respectively. Weight loss at 6âmonths was â6.57âÂ±â1.65âkg in SBWL, â5.18âÂ±â1.72âkg in TECH and â6.25âÂ±â1.95âkg in ENâTECH."," standard behavioral weight loss, ", baseline ,  standard behavioral weight loss; a technologyâbased system combined with a monthly intervention telephone call (TECH) ; an enhanced technologyâbased system combined with a monthly intervention telephone call (ENâTECH) ,0,
edin,7221,3898378,No significant difference,There was a trend towards improved timing and quality of antenatal care services across all secondary outcome measures although not statistically significant., Antenatal care visits quality , Standard care , Mobile phone intervention ,0,
edin,7264,3132856,Cannot tell based on the abstract,, Adverse events  , Control , Mesalazine  ,0,
edin,7264,3132856,No significant difference,There was no significant difference in frequency of these AEs in the two groups., Adverse events  , Control , Mesalazine  ,0,
edin,7609,4273020,Cannot tell based on the abstract,,  time of sleep and a sleep quality , residential based settings ," Fly-in, Fly-out (FIFO) settings ",0,
edin,7609,4273020,Significantly increased,"<td align=""left"" colspan=""1"" rowspan=""1"">Subjective sleep quality (ratings)</td><td align=""center"" colspan=""1"" rowspan=""1"">2.8 Â± 0.9</td><td align=""center"" colspan=""1"" rowspan=""1"">2.5 Â± 0.9</td><td align=""center"" colspan=""1"" rowspan=""1"">1,432</td><td align=""center"" colspan=""1"" rowspan=""1"">6.4</td><td align=""center"" colspan=""1"" rowspan=""1"">0.01</td>,Finally, there was a main effect of break onset time on subjective sleep quality (F7,209=3.21, p=0.003).",  time of sleep and a sleep quality , residential based settings ," Fly-in, Fly-out (FIFO) settings ",0,
edin,7597,4386768,Cannot tell based on the abstract,, I-PSS score , tamsulosin , tadalafil  ,0,
edin,7597,4386768,Significantly decreased,"They reported an improvement in I-PSS score of â2.1 (P=0.001) for tadalafil compared with â1.5 (P=0.23) for tamsulosin, with results seen as early as 1 week.", I-PSS score , tamsulosin , tadalafil  ,0,
edin,7316,3134103,Cannot tell based on the abstract,, Lowest hemoglobin  , Control , N-acetylcysteine ,0,
edin,7316,3134103,Significantly decreased,"In addition, patients treated with NAC had significantly lower hemoglobin and hematocrit levels before surgery, but this did not translate into lower hemoglobin and hematocrit levels postoperatively or an increased number of transfusions.", Lowest hemoglobin  , Control , N-acetylcysteine ,0,
edin,7614,5245138,Cannot tell based on the abstract,," including tidal volume (VT), ratio of time to peak [t-PTEF/t-E (%)], ratio of momentary flow rate in case of exhalation of 75% of tidal volume to peak tidal expiratory flow [TEF75/PTEF (%)] and ratio of medium term inspiration flow to medium term expiration flow (MTIF/MTEF) ", budesonide atomization inhalation ," intravenous infusion of salbutamol aerosol combined with magnesium sulfate,  ",0,
edin,7614,5245138,Significantly increased,"Before treatment, the levels of VT, t-PTEF/t-E, MTIF/MTEF and TEF75/PTEF of the groups were compared and the differences were not statistically significant (P>0.05). After treatment, the levels of the above indexes of both groups increased when compared to before and the observation group had more significant improvement. The differences were statistically significant (P<0.05)"," including tidal volume (VT), ratio of time to peak [t-PTEF/t-E (%)], ratio of momentary flow rate in case of exhalation of 75% of tidal volume to peak tidal expiratory flow [TEF75/PTEF (%)] and ratio of medium term inspiration flow to medium term expiration flow (MTIF/MTEF) ", budesonide atomization inhalation ," intravenous infusion of salbutamol aerosol combined with magnesium sulfate,  ",0,
edin,7297,2759981,No significant difference,"There were no statistically significant differences in the experience of childbirth or parental stress between the randomised groups, either in women or men.", Parental stress , Standard antenatal education , Natural childbirth preparation ,0,
edin,7359,4834398,Significantly decreased,"The results of ANOVA on posttest scores showed that acupuncture had a significant effect on cognitive anxiety (p = 0.001) and somatic anxiety (p < 0.001) but not on self-confidence (p > 0.05).,In conclusion, the results suggested that acupuncture has the capacity to decrease cognitive anxiety and somatic anxiety prior to competition in adolescent athletes, while this was accompanied by significant physiological changes.", Cognitive anxiety , Sham control , Acupuncture  ,0,
edin,7306,3253463,Significantly increased,"We found that the ginger-treated groups had significantly decreased P300 latencies, increased N100 and P300 amplitudes, and exhibited enhanced working memory.", N100 amplitude , Control , Zingiber officinale 800 mg ,0,
edin,7302,4112798,Cannot tell based on the abstract,, Neurological progression-free survival , Placebo  , Erlotinib  ,0,
edin,7302,4112798,No significant difference,"The unadjusted HR for neurological PFS was 0.99 (95% CI = 0.62 to1.58; P = .97), which became 0.95 (95% CI = 0.59 to 1.54; P = .84) after allowing for the randomization stratification factors.", Neurological progression-free survival , Placebo  , Erlotinib  ,0,
edin,7381,5494175,Significantly decreased,Children whose mothers reported alcohol consumption during pregnancy performed significantly poorly for memory and spatial abilities tests from small effect size difference for âAtlantisâ (0.27) and âTriangleâ (0.29) to moderate effect size difference for âNumber recallâ (0.72) compared to children whose mothers did not consume alcohol during pregnancy; the exposed children scored significantly higher errors with a small effect size (0.37) at problem solving (CCT-1) test compared to unexposed children.," âAtlantisâ  and âNumber recallâ, and spatial ability tests-âTriangleâ, problem solving CCT-1 test ", children whose mothers did not consume alcohol during pregnancy , children whose mothers reported alcohol consumption during pregnancy ,0,
edin,7525,4621723,Significantly decreased,"The discontinuation rate of medication due to its side effects was 0 (0%) for Group 1, and 6 (10.2%) for Group 2.,However, discontinuation of drugs due to side effects was more frequent in fesoterodine.", discontinuation of drugs due to side effects , Group 2  received 4 mg fesoterodine per day , Group 1 received 5 mg solifenacin per day ,0,
edin,7469,3087256,Cannot tell based on the abstract,, The number of intramuscular diclofenac injections , group II lignocaine1% (9ml) with neostigmine 100Î¼g in saline (1ml) and group III received lignocaine 1% (9ml) with neostigmine 200Î¼g in NS (1ml) , Group I received lignocaine 1% (9ml) with normal saline (1ml) ,0,
edin,7469,3087256,Significantly increased,"The number of intramuscular diclofenac injections ([median, 25th-75th percentile]) during the first 24 h postoperatively was less for the group II (1 or 2) and group III (1 or 2) as compared to the control group (3 or 4). (P < 0.05)", The number of intramuscular diclofenac injections , group II lignocaine1% (9ml) with neostigmine 100Î¼g in saline (1ml) and group III received lignocaine 1% (9ml) with neostigmine 200Î¼g in NS (1ml) , Group I received lignocaine 1% (9ml) with normal saline (1ml) ,0,
edin,7607,4705007,No significant difference,"From baseline to 18 months, participants showed statistically significantly lower mean weight (-4.2 kg [95% CI -6.0 to -2.4]; P<.001) and higher physical activity (mean 10.4 mins/day [95% CI 3.6-17.2]; P=.003), but no significant differences in energy intake (P=.200).", Energy intake , usual care , telephone-delivered weight loss intervention ,0,
edin,7179,3880665,No significant difference,"For waist to hip ratio (WHR), body fat percentage and maximal oxygen consumption there were no significant differences between the exercise group and the control group.", Waist to hip ratio , Control , Moderate intensity aerobic exercise ,0,
edin,7446,4335628,Significantly increased,A significant improvement in cognitive function was observed in the experimental group compared with the control group (p < 0.05)., cognitive function , (1) a control group asked not to change their normal everyday activities and not to start any regular physical exercise program , (2) an experimental group trained at a heart rate intensity corresponding to ventilatory threshold 1 (VT-1) for 60 min/day 3 times weekly on alternate days for 6 months using a cycle ergometer ,0,
edin,7477,4804276,Significantly decreased,"Also, hsCRP and EMPs were significantly reduced by the NC (â41% and â16%, respectively).", high sensitivity C-reactive protein (hsCRP) and endothelial microparticle (EMPs) levels , no active treatment (noNC) , nutraceutical combination (NC) ,0,
edin,7121,3233513,Cannot tell based on the abstract,, Use of salbutamol as reliever  , Formoterol 4.5 Î¼g , Formoterol 9 Î¼g ,0,
edin,7121,3233513,Significantly increased,"Similarly, while both formoterol 4.5 and 9 Î¼g bid significantly reduced the use of salbutamol as reliever medication compared with placebo (9 Î¼g vs. placebo difference: -0.55, p < 0.001; 4.5 Î¼g vs. placebo difference: -0.27, p = 0.027), the reduction observed in patients receiving formoterol 9 Î¼g bid was significantly greater than that seen in those receiving 4.5 Î¼g bid (9 Î¼g vs. 4.5 Î¼g difference: -0.27, p = 0.029) (Table 3; Figure 4).", Use of salbutamol as reliever  , Formoterol 4.5 Î¼g , Formoterol 9 Î¼g ,0,
edin,7509,4701161,Significantly increased,"ARA supplementation increased total retinol in plasma, liver and lung, with a dose-by-dose accumulation in neonatal liver and lung, while transcripts for Lrat in liver, megalin in kidney, Cyp26A1/B1 in liver and lung, respectively, and Stra6 in lung, were all increased, suggesting pathways of VA uptake, storage and RA oxidation were each augmented after VARA.", Stra6 expression , baseline , VARA ,0,
edin,7401,5968838,Significantly decreased,"For the study group, compared with the standard or control group, had a significantly reduced operation time (60.15Â±9.97 min vs. 71.85Â±9.74 min)", operation time , standard suture method , âbaseballâ suture technique ,0,
edin,7731,5946268,Cannot tell based on the abstract,, 10-year overall survival rate and 10-year disease free survival rate , Control patients , Supplemental Se ,0,
edin,7731,5946268,No significant difference,"he calculated 10-year overall survival rate of patients in the SeG was 55.3% compared to 42.7% in the CG (p = 0.09). The 10-year disease free survival rate was not different, i.e., a calculated 80.1% in Se-supplemented as compared to 83.2% in the control patients (p = 0.65).", 10-year overall survival rate and 10-year disease free survival rate , Control patients , Supplemental Se ,0,
edin,7714,4085197,Cannot tell based on the abstract,," Baseline characteristics, except for scaphoid bone ", Placebo therapy , Kaltenborn mobilization therapy ,0,
edin,7714,4085197,No significant difference,"No significant statistical differences were found in any outcome at baseline between groups, except for the scaphoid bone."," Baseline characteristics, except for scaphoid bone ", Placebo therapy , Kaltenborn mobilization therapy ,0,
edin,7718,4261896,Cannot tell based on the abstract,, Eye examination rates , No intervention , Printed educational materials ,0,
edin,7718,4261896,No significant difference,"While the probability of having an eye examination depended on patient age and rises sharply at age 65, there was no indication that intervention effectiveness varied with patient age.,Neither the unadjusted nor the adjusted results show any evidence that the interventions (alone or in combination), were effective in increasing rates of eye examination among eligible trial patients.", Eye examination rates , No intervention , Printed educational materials ,0,
edin,7654,4686557,Cannot tell based on the abstract,, Pain at 4 mins ,  Filtered Technetium Sulfur Colloid , Technetium-99m Tilmanocept ,0,
edin,7654,4686557,No significant difference,"The final model with pain score predictions over the first 5Â min postinjection is depicted in Fig.Â 3. Furthermore, the model found fTcSC resulted in significantly more pain of 15.2Â mm (pÂ <Â 0.001), 11.3Â mm (pÂ =Â 0.001), and 7.5Â mm (pÂ =Â 0.013) at 1, 2, and 3Â min postinjection, respectively (TableÂ 2). Differences at 4 and 5Â min postinjection were not statistically significant.Fig.Â 3", Pain at 4 mins ,  Filtered Technetium Sulfur Colloid , Technetium-99m Tilmanocept ,0,
edin,7641,3916852,Cannot tell based on the abstract,, IL-6 levels , Medium/long chain triglyceride emulsion , Olive oil-based lipid emulsion ,0,
edin,7641,3916852,No significant difference,"IL-6 level in the olive oil-based LE group and TNF-Î± in the MCT/LCT group both increased on postoperative day 1. Both IL-6 and TNF-Î± remained stable at day 8 when compared with day 1.,<td align=""center"" colspan=""1"" rowspan=""1"" valign=""middle"">MCT/LCT</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""middle"">59.53 Â± 57.58</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""middle"">63.87 Â± 30.02</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""middle"">68.94 Â± 53.04</td>", IL-6 levels , Medium/long chain triglyceride emulsion , Olive oil-based lipid emulsion ,0,
edin,7767,4552663,Cannot tell based on the abstract,, Baseline  characteristics , Control group , Oral carbohydrate group or oral rehydration solution group ,0,
edin,7767,4552663,No significant difference,"We could not find any statistically significant differences among the groups in the patientsâ baseline characteristics, preexisting medical conditions, and surgical factors (Table 2).", Baseline  characteristics , Control group , Oral carbohydrate group or oral rehydration solution group ,0,
edin,7724,4332717,Significantly decreased,"Four-year cumulative incidences of relapse/progression were 22% and 50% in Flu-TBI and TLI-ATG patients, respectively (Pâ=â0.017).", Incidence of relapse/progression at four years , 8 Gy TLIâ+âanti-thymocyte globulin (TLI-ATG arm) , Fludarabine plus 2 Gy total body irradiation (Flu-TBI arm) ,0,
edin,7761,3292461,Cannot tell based on the abstract,"Significant differences between-group in weight (P = 0.001), Body Mass Index (P = 0.001), waist circumference (P = 0.001), hip circumference (P = 0.032) and waist-hip ratio (P = 0.02) were presented after the intervention.", Improvement in waist circumference and hip circumference , Routine postpartum care , 12 week physical activity tailored program ,0,
edin,7761,3292461,Significantly decreased,"The intervention group significantly decreased in weight (66.8 kg pre- and 64.7 kg post-intervention, p = 0.001), BMI (26.28 kg/m2 pre- and 25.47 kg/m2 post-intervention, p = 0.001), waist circumference (80.41 cm pre- and 76.76 cm post-intervention, p = 0.001), hip circumference (104.6 cm pre- and 101.5 cm post-intervention, p = 0.001) and WHR (0.76 pre- and 0.74 post-intervention, p = 0.001) over the study period.", Improvement in waist circumference and hip circumference , Routine postpartum care , 12 week physical activity tailored program ,0,
edin,7646,4673714,Cannot tell based on the abstract,, Triglyceride , Control , Pitavastatin ,0,
edin,7646,4673714,Significantly decreased,"Furthermore, although HDL-C and triglyceride were similar in the two groups after the treatment period (diet vs diet-plus-statin: HDL-C, 56âÂ±â4 vs 57âÂ±â5Â mg/dL, Pâ=â0.775; triglyceride, 149âÂ±â21 vs 122âÂ±â18Â mg/dL, Pâ=â0.252; TableÂ 3), TC and LDL-C in the diet-plus-statin therapy group were significantly lower than those in the diet therapy group after the 12-months treatment period (diet vs diet-plus-statin: TC, 201âÂ±â6 vs 157âÂ±â5Â mg/dL, Pâ<â0.001; LDL-C, 126âÂ±â5 vs 83âÂ±â4Â mg/dL, Pâ<â0.001; TableÂ 3).", Triglyceride , Control , Pitavastatin ,0,
edin,7695,3775167,Significantly decreased,"Clopidogrel group has shown a significant decrease in hsCRP (P < 0.01), UKPDS risk scoring (P < 0.01) and better anti-aggregatory effect.", High sensitivity C-reactive protein  , Low-dose aspirin , Clopidogrel  ,0,
edin,7620,4284010,No significant difference,"There was no evidence of a difference in snapshot response between abacavir/lamivudine (ABC/3TC) and tenofovir/emtricitabine (TDF/FTC) overall [ABC/3TC 86%, TDF/FTC 85%, difference 1.1%, confidence interval (CI) â1.8, 4.0 percentage points, Pâ=â0.61] or at high viral loads (difference â2.5, 95% CI â8.9, 3.8 percentage points, Pâ=â0.42).", Snapshot response , Tenofovir/emtricitabine , Abacavir/lamivudine ,0,
edin,7789,4101294,Significantly increased,"Compared with patients in the chemotherapy group, patients in the combination group had significantly longer PFS (5.4 months vs 3.0 months, P < .01) and median survival (9.5 months vs 5.3 months, P < .01).", Progression-free survival , Second-line chemotherapy alone (chemotherapy group) , CT-PFNECII plus second-line chemotherapy (combination group) ,0,
edin,7651,4686557,Significantly decreased,"The model found fTcSC resulted in significantly more pain of 15.2Â mm (pÂ <Â 0.001), 11.3Â mm (pÂ =Â 0.001), and 7.5Â mm (pÂ =Â 0.013) at 1, 2, and 3Â min postinjection, respectively.", Pain at 1 min ,  Filtered Technetium Sulfur Colloid , Technetium-99m Tilmanocept ,0,
edin,7666,5125721,No significant difference,"The primary outcomes were that TB significantly decreased the rela tive changes in UACR (2.43â2.35, logarithmic transformed mg/g creatinine) and UN (5.12â4.91 mmol/L) in the TB intervention group vs the diet control group at 4 weeks (P<0.05), without obvious effect on blood glucose during the 4-week study", Blood glucose  , Control , Tartary buckwheat ,0,
edin,7703,5413468,Cannot tell based on the abstract,, Proportion of prevented signals on second series  , Control , Unsolvable task ,0,
edin,7703,5413468,No significant difference,"The distributions of the proportions of prevented signals were not substantially skewed,Î³1 = 0.3 for the first meeting and Î³1 = â0.22 for the second meeting.,Also, there was a difference in the proportion of prevented or stopped signals in the second series between the control and the experimental group, MC = .95, ME = .82, t(87.9) = 4.23, p < .001, p = 0.78. The difference in the proportion of prevented signals was not significant, MC = .55, ME = .63, t(110.56) = â1.02, p = .31, p = â.19,", Proportion of prevented signals on second series  , Control , Unsolvable task ,0,
edin,7805,3368260,Cannot tell based on the abstract,, Tryptophan levels , Placebo , ATD ,0,
edin,7805,3368260,Significantly decreased,ATD significantly reduced both plasma tryptophan levels and the ratio between tryptophan and other large neutral amino acids (TRP:Î£LNAA)., Tryptophan levels , Placebo , ATD ,0,
edin,7790,4101294,Significantly increased,"Compared with patients in the chemotherapy group, patients in the combination group had significantly longer PFS (5.4 months vs 3.0 months, P < .01) and median survival (9.5 months vs 5.3 months, P < .01).", Median survival , Second-line chemotherapy alone (chemotherapy group) , CT-PFNECII plus second-line chemotherapy (combination group) ,0,
edin,7746,2818614,No significant difference,"After one year, no significant differences were found between the three groups regarding change in BMD, serum OPG or RANKL.", Changes in receptor activator of nuclear factor-kappaB ligand (RANKL) after 1 year , Placebo (PP group) , Vitamin D3 40.000 IU (DD group) or Vitamin D3 20.000 IU (DP group) ,0,
edin,7787,4101294,Significantly increased,"The ORR and DCR in the combination group were significantly higher than in the chemotherapy group (23.53% vs 11.76% for ORR, P < .01; and 58.82% vs 35.29% for DCR, P < .01).", Overall response rate , Second-line chemotherapy alone (chemotherapy group) , CT-PFNECII plus second-line chemotherapy (combination group) ,0,
edin,7769,4552663,No significant difference,No significant differences existed between the groups regarding intraoperative vasopressor use during the surgery (p = 0.475)., Vasopressor use during the surgery , Control group , Oral carbohydrate group or oral rehydration solution group ,0,
edin,7648,4976892,Significantly increased,"We found that the DNA prime-rAd5 boost vaccine induced a significant cross-clade HIV-specific antibody response, which correlated with antibody neutralization efficiency.", HIV-specific antibody response , Control , DNA prime-rAd5 boost vaccine ,0,
edin,7783,4018592,No significant difference,"Although no significant difference was seen in newbornsâ height and Apgar score between the two groups, mean birth weight (3.3 Â± 0.4 vs. 3.1 Â± 0.4 kg, P = 0.04) and head circumference (35 Â± 1.4 vs. 34 Â± 1.3 cm, P < 0.0001) of the infants whose mothers receiving multivitamin-mineral supplements were higher than those whose mothers received multivitamins.", Newbornsâ height and Apgar score , Multivitamin supplement , Multivitamin-mineral supplement ,0,
edin,7747,2818614,Cannot tell based on the abstract,, Rate of adverse events , Placebo (PP group) , Vitamin D3 40.000 IU (DD group) or Vitamin D3 20.000 IU (DP group) ,0,
edin,7747,2818614,No significant difference,"As previously described in detail [16], no serious adverse events were seen and there were no significant differences between the treatment groups regarding adverse events.", Rate of adverse events , Placebo (PP group) , Vitamin D3 40.000 IU (DD group) or Vitamin D3 20.000 IU (DP group) ,0,
edin,7638,3916852,Cannot tell based on the abstract,, IgA levels , Medium/long chain triglyceride emulsion , Olive oil-based lipid emulsion ,0,
edin,7638,3916852,No significant difference,"Although there was no significant difference in the changes in IgA, IgM, C3 and C4 between the two groups after 7 days PN, there was a more significant increase in IgG level from day 1 to day 8 in the olive oil-based LE group compared with the MCT/LCT group (Table 4).,<td align=""center"" colspan=""1"" rowspan=""1"" valign=""middle"">MCT/LCT</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""middle"">2.29 Â± 1.01</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""middle"">1.84 Â± 0.88 *<sup>,â </sup></td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""middle"">2.69 Â± 1.72</td>", IgA levels , Medium/long chain triglyceride emulsion , Olive oil-based lipid emulsion ,0,
edin,7689,4198969,Significantly increased,"Significant increases in total antioxidant performance were also observed in both the healthy and the metabolic syndrome groups compared to baseline (P < 0.05).,Findings of this study clearly demonstrate the bioavailability of phytonutrients of Angelica keiskei and their ability to increase antioxidant status in humans.", Total antioxidant performance in adults with metabolic syndrome  , Control , Angelica keiskei  ,0,
edin,7794,3508963,Cannot tell based on the abstract,, Pain relief , Intravenous morphine , Intravenous lidocaine ,0,
edin,7794,3508963,Significantly increased,"Pain relief in lidocaine group was statistically significant compared to the morphine group (pâ=â0.0001) (Table 2).,108 patients (90â%) in group I responded to lidocaine successfully whereas in group II, 84 patients (70â%) responded properly to morphine, at the end of the study it was demonstrated that there were more considerable respond and pain relief in lidocaine group which was statistically significant (pâ=â0.0001).", Pain relief , Intravenous morphine , Intravenous lidocaine ,0,
edin,7781,4018592,Significantly decreased,"Mean body mass index at week 28 (25.8 Â± 4.0 vs. 28.4 Â± 3.7 kg/m2, P = 0.001) as well as at delivery (28.0 Â± 3.9 vs. 30.1 Â± 3.8 kg/m2, P = 0.006) was lower among women taking multivitamin-mineral supplements than those taking multivitamin supplements.", BMI at week 28 of pregnancy , Multivitamin supplement , Multivitamin-mineral supplement ,0,
edin,7734,5380284,Cannot tell based on the abstract,, Pain scores 48 hours after the surgery , No gum group , Gum-chewing group ,0,
edin,7734,5380284,Significantly increased,We found that the 48-hour postoperative pain scores in the Gum group were significantly higher (Pâ=â0.032)., Pain scores 48 hours after the surgery , No gum group , Gum-chewing group ,0,
edin,7647,4673714,Significantly decreased,"After the 12-months treatment period, LDL-C was significantly lower in the diet-plus-statin therapy group compared with the diet therapy group (diet vs diet-plus-statin: LDL-C, 126âÂ±â5 vs 83âÂ±â4Â mg/dL, Pâ<â0.001).", LDL-C  , Control , Pitavastatin ,0,
edin,7753,4990278,Cannot tell based on the abstract,, Changes in AXL during the 2-hour recovery period , Control group , Myopic defocus group and Hyperopic defocus group  ,0,
edin,7753,4990278,No significant difference,"While the change in AXL during the first 2 hours was small and not statistically significant in the control group, AXL decreased in the afternoon, i.e., from 12:00 p.m. to 2:00 p.m. (mean change at 2:00 p.m. in CG Â± SEM: -11.25 Â± 3.64 Î¼m, repeated measurement, p < 0.05, Table 2).", Changes in AXL during the 2-hour recovery period , Control group , Myopic defocus group and Hyperopic defocus group  ,0,
edin,7758,3292461,Significantly increased,"After 12 weeks, women in the intervention group had significantly increased their physical activity and energy expenditure per week (4394 vs. 1651 calorie, p < 0.001).", Improvement in physical activity and energy expenditure , Routine postpartum care , 12 week physical activity tailored program ,0,
edin,7657,5893461,Cannot tell based on the abstract,, Mental health improvements , Metformin  , Intensive lifestyle intervention ,0,
edin,7657,5893461,Significantly increased,"There was greater mean weight loss and larger mental health improvements among ILI participants than those who received metformin and standard care. (TableÂ 2),<td align=""left"" colspan=""1"" rowspan=""1"" style=""padding-left:10%"" valign=""top"">Perceived stress score<xref ref-type=""fn"" rid=""osp4157-note-0008"">d</xref>
</td><td align=""char"" colspan=""1"" rowspan=""1"" valign=""top"">â0.9&nbsp;Â±&nbsp;7.1</td><td align=""char"" colspan=""1"" rowspan=""1"" valign=""top"">â0.6&nbsp;Â±&nbsp;5.8</td><td align=""char"" colspan=""1"" rowspan=""1"" valign=""top"">â5.3&nbsp;Â±&nbsp;4.3</td><td align=""char"" colspan=""1"" rowspan=""1"" valign=""top"">2.0&nbsp;Â±&nbsp;5.7</td>", Mental health improvements , Metformin  , Intensive lifestyle intervention ,0,
edin,7774,3599938,Cannot tell based on the abstract,, Age of the participants , Follow-up invitation by mail , Follow-up invitation by telephone ,0,
edin,7774,3599938,No significant difference,"Participants in each group were similar in age (telephone group: mean age 55.7 years, standard deviation 6.1; mail group: mean age 55.6 years, standard deviation 6.3).", Age of the participants , Follow-up invitation by mail , Follow-up invitation by telephone ,0,
edin,7712,5056957,Significantly decreased,"At 12 months, there were group-by-time effects for weight (mean difference=â0.90âkg (95% confidence interval (CI)=â1.50, â0.30), P<0.01) and BMI (â0.28âkgâmâ2 (â0.50, â0.06), P=0.01) in favour of the intervention group, but not for BMI z-score (â0.05 (â0.11; 0.01), P=0.13). These findings were consistent for weight (â0.62âkg (â1.21, 0.03), P=0.01) and BMI (â0.28âkgâmâ2 (â0.49, â0.06), P=0.01) at 24 months, with group-by-time effects also found for BMI z-score (â0.08 (â0.14; â0.02), P=0.02) favouring the intervention group.", Weight and BMI reduction at 24 months , Usual PE and sport programmes , Multi-component physical activity  ,0,
edin,7677,5432698,Cannot tell based on the abstract,, Hospital stay , Control ,  Glucose-insulin-potassium ,0,
edin,7677,5432698,No significant difference,"<td align=""left"" colspan=""1"" rowspan=""1"">Hospital Stay (Days)</td><td align=""center"" colspan=""1"" rowspan=""1"">7.00Â±1.84</td><td align=""center"" colspan=""1"" rowspan=""1"">7.63Â±3.19</td><td align=""center"" colspan=""1"" rowspan=""1"">0.14</td>", Hospital stay , Control ,  Glucose-insulin-potassium ,0,
edin,7644,4673714,Cannot tell based on the abstract,, Total cholesterol  , Control , Pitavastatin ,0,
edin,7644,4673714,Significantly decreased,"After 12Â months of treatment, TC was significantly reduced in the diet-plus-statin therapy group (baseline vs 12Â months: TC, 207âÂ±â7 vs 157âÂ±â5Â mg/dL, Pâ<â0.001), but not in the diet therapy group (baseline vs 12Â months: TC, 211âÂ±â6 vs 201âÂ±â6Â mg/dL, Pâ=â0.187; TableÂ 3).", Total cholesterol  , Control , Pitavastatin ,0,
edin,7679,4056784,Cannot tell based on the abstract,,  Mean arterial pressure  , Supine position  ,  30Â° head of bed elevation ,0,
edin,7679,4056784,Significantly decreased,"<td align=""left""><bold>MAP (mmHg)</bold></td><td align=""left"">83.8 (14.5)</td><td align=""left"">75.1 (13.1)</td><td align=""left"">71.1 (15.2)</td><td align=""left"">&lt;0.001 (&lt;0.001; &lt;0.001; &lt;0.001)</td>",  Mean arterial pressure  , Supine position  ,  30Â° head of bed elevation ,0,
edin,7710,5056957,Significantly increased,"At 12 months, there were group-by-time effects for weight (mean difference=â0.90âkg (95% confidence interval (CI)=â1.50, â0.30), P<0.01) and BMI (â0.28âkgâmâ2 (â0.50, â0.06), P=0.01) in favour of the intervention group, but not for BMI z-score (â0.05 (â0.11; 0.01), P=0.13).", Weight and BMI reduction at 12 months , Usual PE and sport programmes , Multi-component physical activity  ,0,
edin,7780,4018592,No significant difference,"Women taking multivitamin-mineral supplements gained marginally less weight until week 28 than those taking multivitamin supplements (weight at week 28 of gestation: 67.5 Â± 11.4 vs. 71.6 Â± 10.3 kg, P = 0.06).", Weight until week 28 of pregnancy , Multivitamin supplement , Multivitamin-mineral supplement ,0,
edin,7722,4332717,No significant difference,"The 180-day cumulative incidences of grade II-IV acute GVHD (primary endpoint) were 12.2% versus 8.9% in Flu-TBI and TLI-ATG patients, respectively (Pâ=â0.5).", Incidence of grade II-IV acute GVHD at 180 days , 8&amp;nbsp;Gy TLIâ+âanti-thymocyte globulin (TLI-ATG arm) , Fludarabine plus 2&amp;nbsp;Gy total body irradiation (Flu-TBI arm) ,0,
edin,7708,3335250,Cannot tell based on the abstract,, Readiness to quit after 10 weeks  , Control , Online Smoking Cessation Program ,0,
edin,7708,3335250,Significantly increased,"In terms of psychosocial factors, being quit for the past 30 days at EOT and FU was associated with confidence in quitting (EOT: 10.0 Â± 0.00 versus 8.48 Â± 1.50, P < .001; FU: 10.00 Â± 0.00 versus 8.31 Â± 1.49, P < .001).", Readiness to quit after 10 weeks  , Control , Online Smoking Cessation Program ,0,
edin,7766,2900076,No significant difference,None of the patients in any of the groups developed deep vein thrombosis., Deep vein thrombosis , Placebo , Tranexamic acid ,0,
edin,7633,3066231,Cannot tell based on the abstract,, Health Related Quality of Life - Physical Component , Control , Physical activity promotion programme ,0,
edin,7633,3066231,No significant difference,"<td align=""left"" colspan=""1"" rowspan=""1"">12 months</td><td align=""left"" colspan=""1"" rowspan=""1"">1.20 (0.40â2.01)</td><td align=""left"" colspan=""1"" rowspan=""1"">1.30 (0.49â2.11)</td><td align=""left"" colspan=""1"" rowspan=""1"">â0.10 (â0.58â0.38 )</td><td align=""left"" colspan=""1"" rowspan=""1""></td>", Health Related Quality of Life - Physical Component , Control , Physical activity promotion programme ,0,
edin,7788,4101294,Significantly increased,"The ORR and DCR in the combination group were significantly higher than in the chemotherapy group (23.53% vs 11.76% for ORR, P < .01; and 58.82% vs 35.29% for DCR, P < .01)", Disease control rate , Second-line chemotherapy alone (chemotherapy group) , CT-PFNECII plus second-line chemotherapy (combination group) ,0,
edin,7730,5946268,Cannot tell based on the abstract,, Reduction in radiation-induced diarrhea , Control patients , Supplemental Se ,0,
edin,7730,5946268,Significantly decreased,"Importantly, side effects were less frequent and severe in the SeG and the actuarial incidence of at least CTC 2 diarrhea was significantly reduced in the SeG as compared to the CG", Reduction in radiation-induced diarrhea , Control patients , Supplemental Se ,0,
edin,7804,5960495,Cannot tell based on the abstract,, Baseline characteristics , Lightweight mesh , Heavyweight mesh ,0,
edin,7804,5960495,No significant difference,"<td align=""left"" colspan=""3"">ASA class</td>", Baseline characteristics , Lightweight mesh , Heavyweight mesh ,0,
edin,7699,5518918,Cannot tell based on the abstract,, PeakVO2  , Centre-based training , Home-based training with telemonitoring ,0,
edin,7699,5518918,No significant difference,"Patients in both groups improved their peakVO2 from baseline to discharge from CR (centre-based +11% pâ<â0.01, home-basedâ+â15% pâ<â0.01) without significant between-group differences (pâ=â0.25).", PeakVO2  , Centre-based training , Home-based training with telemonitoring ,0,
edin,7752,4990278,Significantly increased,"SFChT thinned when exposed to hyperopic defocus for 2 hours but less thinning was observed in response to myopic defocus compared to the control group (p < 0.05, two-way ANOVA).", Thickening of subfoveal choroid during the recovery period , Myopic defocus group  , Hyperopic defocus group  ,0,
edin,7711,5056957,No significant difference,"At 12 months, there were group-by-time effects for weight (mean difference=â0.90âkg (95% confidence interval (CI)=â1.50, â0.30), P<0.01) and BMI (â0.28âkgâmâ2 (â0.50, â0.06), P=0.01) in favour of the intervention group, but not for BMI z-score (â0.05 (â0.11; 0.01), P=0.13).", BMI z-score at 12months , Usual PE and sport programmes , Multi-component physical activity  ,0,
edin,7742,5897859,Cannot tell based on the abstract,, Baseline characteristics , Lansoprazole 15 mg , Vonoprazan 10 and 20 mg ,0,
edin,7742,5897859,No significant difference,"The three maintenance groups were well matched in terms of demographic and other baseline characteristics (Table 1), and had similar baseline EE severities and medical histories.", Baseline characteristics , Lansoprazole 15 mg , Vonoprazan 10 and 20 mg ,0,
edin,7687,4198969,Cannot tell based on the abstract,, Lutein concentrations in adults with metabolic syndrome  , Control , Angelica keiskei  ,0,
edin,7687,4198969,Significantly increased,The plasma lutein concentrations were significantly increased (P < 0.05) at 8 h in both healthy and metabolic syndrome groups as compared to those of the baseline after ingesting 5g of Angelica keiskei dry powder., Lutein concentrations in adults with metabolic syndrome  , Control , Angelica keiskei  ,0,
edin,7716,4085197,Significantly increased,"Significant increases in PPT in the experimental group at all follow-up periods as compared with baseline data were found. The post-intervention between-group mean differences for PPT were 1.1 (95%CI 0.4â1.8) for the CMC joint, 1.1 (95%CI 0.2â2.1) for the scaphoid, and 1.5 (95%CI 0.5â2.8) for the hamate."," Pressure pain thresholds at the thumb CMC joint, scaphoid bone and hamate bone ", Placebo therapy , Kaltenborn mobilization therapy ,0,
edin,7693,3775167,Significantly decreased,"Significant decrease in blood pressure (P < 0.01), total cholesterol (P = 0.02), LDL (P < 0.01), triglyceride (P < 0.01) and a better glycemic control (P < 0.01) was found in clopidogrel group.", LDL cholesterol , Low-dose aspirin , Clopidogrel  ,0,
edin,7625,5689110,Cannot tell based on the abstract,, Yale Global Tics Severity Scale- total motor tic score  , Placebo , Aripiprazole low-dose ,0,
edin,7625,5689110,Significantly increased,A statistically significant improvement was demonstrated for the change from baseline to week 8 in YGTSS-TTS in the low-dose (pâ=â0.002) and high-dose (pâ<â0.0001) groups versus placebo (ITT population; Table 2) and remained significant after adjustment for multiple testing., Yale Global Tics Severity Scale- total motor tic score  , Placebo , Aripiprazole low-dose ,0,
edin,7652,4686557,Significantly decreased,"The model found fTcSC resulted in significantly more pain of 15.2Â mm (pÂ <Â 0.001), 11.3Â mm (pÂ =Â 0.001), and 7.5Â mm (pÂ =Â 0.013) at 1, 2, and 3Â min postinjection, respectively.", Pain at 2 mins ,  Filtered Technetium Sulfur Colloid , Technetium-99m Tilmanocept ,0,
edin,7694,3775167,Cannot tell based on the abstract,, Serum urea , Low-dose aspirin , Clopidogrel  ,0,
edin,7694,3775167,Significantly decreased,"There was a decrease in serum urea level by 6.8% (P = 0.01) in clopidogrel group, whereas for aspirin group it was 1%.", Serum urea , Low-dose aspirin , Clopidogrel  ,0,
edin,7773,3599938,Significantly increased,"Enrollment into the RCT was also greater among patients followed-up by telephone (59/480, 12.3%) compared to those followed-up by mail (35/472, 7.4%) (RR 1.66, 95% CI 1.11 to 2.47, P=0.01).", Enrollment into the randomized controlled trial , Follow-up invitation by mail , Follow-up invitation by telephone ,0,
edin,7763,2900076,Cannot tell based on the abstract,, Baseline characteristics , Placebo , Tranexamic acid ,0,
edin,7763,2900076,No significant difference,"<td align=""left"" colspan=""1"" rowspan=""1"">Final</td><td align=""left"" colspan=""1"" rowspan=""1"">36.3(0.8)</td><td align=""left"" colspan=""1"" rowspan=""1"">34.7(1.1)</td><td align=""left"" colspan=""1"" rowspan=""1"">36.6(1.3)</td><td align=""left"" colspan=""1"" rowspan=""1"">34.8(1.4)</td>", Baseline characteristics , Placebo , Tranexamic acid ,0,
edin,7698,5518918,No significant difference,"Healthcare costs were statistically non-significantly lower in the home-based group (â¬437 per patient, 95% confidence interval â562 to 1436, pâ=â0.39).", Healthcare costs , Centre-based training , Home-based training with telemonitoring ,0,
edin,7618,5627854,Cannot tell based on the abstract,, Real video clips Test 1 scores  , Real video clip group , Simulated group ,0,
edin,7618,5627854,Significantly increased,"However, R-1 and R-2 (correct answer score of real video clips) in SG is greater than S-1 and S-2 (correct answer score of simulated video clips) in SG (Table 1)", Real video clips Test 1 scores  , Real video clip group , Simulated group ,0,
edin,7688,4198969,Significantly increased,"Significant increases in total antioxidant performance were also observed in both the healthy and the metabolic syndrome groups compared to baseline (P < 0.05).,Findings of this study clearly demonstrate the bioavailability of phytonutrients of Angelica keiskei and their ability to increase antioxidant status in humans.", Total antioxidant performance in healthy adults , Control , Angelica keiskei  ,0,
edin,7616,5627854,Cannot tell based on the abstract,, Simulated video clips Test 1 scores   , Real video clip group , Simulated group ,0,
edin,7616,5627854,Significantly increased,"However, R-1 and R-2 (correct answer score of real video clips) in SG is greater than S-1 and S-2 (correct answer score of simulated video clips) in SG (Table 1).", Simulated video clips Test 1 scores   , Real video clip group , Simulated group ,0,
edin,7635,3916852,No significant difference,"There were no differences in perioperative fever (>38 Â°C), infectious complications, length of hospital stay (>14 days), length of critical care stay (>2 days), time for oral food intake, and in-hospital mortality between the two groups.", Perioperative fever , Medium/long chain triglyceride emulsion , Olive oil-based lipid emulsion ,0,
edin,7867,5513842,Cannot tell based on the abstract,"Twenty four hours after surgery, NRS at rest was 4 (3â6) vs 5 (5â7) and at movement 4 (4â7) vs 6 (5â7.5) for the PVB and control groups, respectively. The difference between the groups over the whole observation period was statistically significant (P<0.05).", Numerical Rating Scale (NRS) pain scores , control , paravertebral block (PVB) ,0,
edin,7867,5513842,Significantly decreased,The pain intensity at rest and while coughing (movement) reported with the NRS score was significantly lower in the paravertebral group as compared with the control group for each time point (P<0.05) (Tables 2 and 3)., Numerical Rating Scale (NRS) pain scores , control , paravertebral block (PVB) ,0,
edin,8049,5453890,No significant difference,"Changes in the anxiety and sedation scores on the day of surgery were not significantly different among groups, whereas the increases in systolic blood pressure and heart rate were significantly less in both triazolam groups.", sedation scores , no premedication , triazolam 0.25 mg or 0.375 mg ,0,
edin,7896,3438438,Cannot tell based on the abstract,, instructions for jogging , control , program and jogging based on health belief model (HBM) on sugar control in type 2 diabetic patients ,0,
edin,7896,3438438,Significantly increased,"Three months after the end of training program, experimental group showed better instructions for jogging in comparison to the control group.,In addition, before training intervention, most of internal instructions of patients for jogging in the group of intervention and control respectively included feeling exhilaration during jogging (50% and 47%), fear of blood sugar increase (38% and 34%) and fear of catching side effects of diabetes (36% and 40%). But after training intervention, Chi Square test indicated a significant difference in all the internal instructions of diabetic patients for jogging (Table 3).", instructions for jogging , control , program and jogging based on health belief model (HBM) on sugar control in type 2 diabetic patients ,0,
edin,8089,3339727,Cannot tell based on the abstract,, bradycardia , F2 (fentanyl 2 mcg/kg) , F1 (fentanyl 1 mcg/kg) ,0,
edin,8089,3339727,No significant difference,The heart rate did not show any significant changes in either group though the incidence of bradycardia (heart rate < 60 beats per minute) was higher (16%) in group F2 compared to group F1., bradycardia , F2 (fentanyl 2 mcg/kg) , F1 (fentanyl 1 mcg/kg) ,0,
edin,7876,5234109,Cannot tell based on the abstract,, plasma creatine levels after 1h and 2h , maltodextrin placebo (PLA) ,  pre-workout dietary supplement (PWS) with  p-synephrine (S);  pre-workout dietary supplement (PWS) without  p-synephrine (S); ,0,
edin,7876,5234109,Significantly increased,Results revealed that PWS and PWSâ+âS ingestion significantly increased plasma creatine levels after 1Â h and 2Â h in comparison to the PLA treatment., plasma creatine levels after 1h and 2h , maltodextrin placebo (PLA) ,  pre-workout dietary supplement (PWS) with  p-synephrine (S);  pre-workout dietary supplement (PWS) without  p-synephrine (S); ,0,
edin,7966,2784472,Significantly increased,"Measured against the placebo, subjects in the probiotic group achieved significant improvements in GSRS abdominal pain subscore (p = 0.046) and the GSRS total score (p = 0.048), with a strong trend for improvement on the GSRS abdominal distension subscore (p = 0.061).", Improvement in GSRS (Gastrointestinal Symptom Rating Scale) VAS-Gas score - in adults with post prandial intestinal gas-related symptoms and no GI diagnoses , Placebo group , Digestive Advantageâ¢ Gas Defense Formula (GD) group ,0,
edin,7917,4258079,Cannot tell based on the abstract,,   time sedation score curve (AUCsed) , 30kgâ1 to ten control calves IV (V. jugularis) , Detomidine at 80kgâ1 was administered to ten calves sublingually (GEL) ,0,
edin,7917,4258079,No significant difference,"<td align=""left"" colspan=""1"" rowspan=""1"">AUC<sub>sed</sub></td><td align=""center"" colspan=""1"" rowspan=""1"">1026&nbsp;Â±&nbsp;477</td><td align=""center"" colspan=""1"" rowspan=""1"">784&nbsp;Â±&nbsp;209</td><td align=""center"" colspan=""1"" rowspan=""1"">0.16</td>,The maximum sedation scores for each animal and the overall levels of sedation (AUCsed) did not differ between the treatments (Table1).",   time sedation score curve (AUCsed) , 30kgâ1 to ten control calves IV (V. jugularis) , Detomidine at 80kgâ1 was administered to ten calves sublingually (GEL) ,0,
edin,8029,5771357,Significantly increased,"owever, wall mrotion score was significantly better in clopidogrel â aspirin patients in late (3 months) post operation (p<0.001).,Since warfarin has serious hemorrhagic complications and requires closed monitoring of serum drug activity by serial INR checking, it is recommended that clopidogrel â aspirin can be the preferred alternative anticoagulation therapy in CABG / CE patients.", wall motion score - patients undergoing CABG / CE ," In group 2, the patients were given 75 mg plavix (clopidogrel) daily together with 80 mg aspirin daily for 3 months "," group 1, the patients were given warfarin (INR) between 2-3) together with 80 mg aspirin daily for 3 months ",0,
edin,7921,4856346,Significantly decreased,"As expected, negative tweets drew longer viewing times and elicited more attention to themselves than positive tweets.", viewing times ,  negative Twitter messages ,  positive Twitter messages ,0,
edin,7879,3691930,Significantly increased,"Fugl-Meyer Assessment Scale (FMA) score, National Institutes of Health Stroke Scale (NIHSS) score, and TSTratio were statistically more significant in electroacupuncture group than those in WCM group (P < 0.01)."," National Institutes of Health Stroke Scale (NIHSS) score, Fugl-Meyer Assessment Scale (FMA) score, and triple-stimulation technique (TST) ratio ", single western conventional medication (WCM) , electroacupuncture plus western conventional medication (WCM) ,0,
edin,7907,4389469,Cannot tell based on the abstract,, evaluation of coronary flow , (B group) graft of left internal mammary artery to the same branch , (A group) graft of right internal mammary artery to the anterior interventricular branch ,0,
edin,7907,4389469,Significantly increased,The central point of this study is the evaluation of coronary flow. The evaluation of the measured flow through the transit time showed an average flow of 42.2 Â± 23.4 ml/min in Group A and 34.2 Â± 19.1 ml/min in group B. featuring a statistically significant difference in favor of group A., evaluation of coronary flow , (B group) graft of left internal mammary artery to the same branch , (A group) graft of right internal mammary artery to the anterior interventricular branch ,0,
edin,7827,5754508,Cannot tell based on the abstract,, macrophage activation , Saline axposure , LPS exposure ,0,
edin,7827,5754508,Significantly increased,"The mean concentration of sCD163 was comparable at baseline (placebo and LPS at timeâ=â0âmin, Pâ=â0.78) but increased rapidly 2â3-fold and remained elevated throughout the study period during LPS conditions compared with placebo (Fig. 1, two-way repeated measure ANOVA interaction Pâ<â0.001).,Macrophage activation determined by levels of soluble sCD163", macrophage activation , Saline axposure , LPS exposure ,0,
edin,8019,5772830,Cannot tell based on the abstract,, effect of homonymous hemianopia (HH) duration , p-prisms after 2 weeks but before training , p-prisms after training  ,0,
edin,8019,5772830,No significant difference,"There was no effect of side of HH (P = 0.992) or duration of HH (P = 0.790).,There was no effect of side of HH (P = 0.758) or duration of HH (P = 0.974).", effect of homonymous hemianopia (HH) duration , p-prisms after 2 weeks but before training , p-prisms after training  ,0,
edin,8012,5118645,Cannot tell based on the abstract,, mean Emax scores ," eluxadoline 100, 300, and 1000 mg ", oxycodone (OXY) 60mg oral ,0,
edin,8012,5118645,Significantly increased,"Mean (Â±S.D.) Emax scores were close to neutral (50.0) following oral eluxadoline administration (100 mg: 56.8 Â± 13.7; 300 mg: 58.7 Â± 13.4; 1000 mg: 60.0 Â± 14.8), with minimal mean increases (<5 points) with increasing eluxadoline dose (Table 2). Median differences compared with placebo were significant only for eluxadoline 300 and 1000 mg (P < 0.05 versus placebo for both doses). Mean Emax scores were between 25 and 35 points lower with eluxadoline compared with oxycodone, with median Emax scores being significantly higher for both doses of oxycodone compared with all eluxadoline doses (P < 0.0001 for all pairwise comparisons).", mean Emax scores ," eluxadoline 100, 300, and 1000 mg ", oxycodone (OXY) 60mg oral ,0,
edin,8108,5835896,Cannot tell based on the abstract,, overall survival (OS) in metastatic colorectal cancer (CRC) - stage IIIb , patients without HLA-A*2402  , patients with HLA-A*2402  ,0,
edin,8108,5835896,No significant difference,There was no significant difference in OS between HLA-A*2402 matched and unmatched stage IIIb CRC groups., overall survival (OS) in metastatic colorectal cancer (CRC) - stage IIIb , patients without HLA-A*2402  , patients with HLA-A*2402  ,0,
edin,7984,3651817,Cannot tell based on the abstract,, mean values of Cmax , placebo , inhalative epinephrine ,0,
edin,7984,3651817,Significantly increased,The mean values of Cmax and AUC0-t(last) were considerably higher following inhalative epinephrine administrations compared to placebo., mean values of Cmax , placebo , inhalative epinephrine ,0,
edin,7898,3556012,Significantly decreased,"The severity of pain during defecation and consistency of stool improved significantly better in CFE group than MO group (p < 0.05), but there were not any significant differences between the two groups in fecal incontinence and retentive posturing.", The severity of pain during defecation and consistency of stool , mineral oil (MO) , cassia fistula emulsion (CFE)  ,0,
edin,7871,5234109,Cannot tell based on the abstract,," HR, systolic blood pressure (SBP), and diastolic blood pressure (DBP) ", maltodextrin placebo (PLA) , pre-workout dietary supplement (PWS) with  p-synephrine (S); pre-workout dietary supplement (PWS) without  p-synephrine ,0,
edin,7871,5234109,No significant difference,"No significant treatment x time interactions were observed in HR, SBP, or DBP responses obtained prior to and during the REE test.,<th>0</th><th>2</th>"," HR, systolic blood pressure (SBP), and diastolic blood pressure (DBP) ", maltodextrin placebo (PLA) , pre-workout dietary supplement (PWS) with  p-synephrine (S); pre-workout dietary supplement (PWS) without  p-synephrine ,0,
edin,8099,4890862,No significant difference,"No effects were observed for girls or for the continuous measures of Total, Internalizing, and Externalizing problems.", Externalizing problems , control group ," intervention group, involving home visits ",0,
edin,8090,3339727,Cannot tell based on the abstract,, stable hemodynamic profile , F2 (fentanyl 2 mcg/kg) , F1 (fentanyl 1 mcg/kg) ,0,
edin,8090,3339727,Significantly increased,The patients who received fentanyl 1 mcg/kg remained more hemodynamically stable compared to those receiving fentanyl 2 mcg/kg in our cancer patient population., stable hemodynamic profile , F2 (fentanyl 2 mcg/kg) , F1 (fentanyl 1 mcg/kg) ,0,
edin,8081,4141807,No significant difference,The reduction of HbA1c levels and the proportion of patients with HbA1c of 6.5% or less were similar in the three groups after acarbose and metformin treatment., reduction of HbA1c levels , metformin , acarbose ,0,
edin,7957,5153384,Significantly increased,"The harmful treatment effect of the IMHP versus HP enteral nutrition on 6-month mortality was only demonstrated in the medical subgroup (HR 2.52, 95% CI 1.36â4.78, PÂ =Â 0.004).,IMHP feeding resulted in statistically significant increase in plasma levels of glutamine, vitamin e, vitamin c and (epaÂ +Â dha)/lcf ratio from baseline to day 4, while only the change from baseline to day 4 of (epaÂ +Â dha)/lcf ratio was statistically significant associated with 6-month mortality (HR 1.18, 95% CI 1.02â1.35, PÂ =Â 0.021) and identified as mediator for the harmful treatment effect of IMHP enteral nutrition among medical ICU patients.", The  treatment effect , isocaloric high-protein (HP) enteral nutrition ," immune-modulating (glutamine, fish oil and antioxidant enriched) high-protein (IMHP) ",0,
edin,7938,4486927,Significantly increased,"Compared to patients treated for 24 weeks, the SVR rate in those treated for 48 weeks increased by 10.9% [95% CI: â5.9% to 27.7%] and 65.6% [95% CI: 44.5% to 86.7%] if they had IL-28B rs8099917 TT genotype, and GT/GG genotype, respectively (interaction Pâ=â0.002)."," The SVR rates if the patients had IL-28B rs8099917 TT genotype, and GT/GG genotype ", peginterferon (Peg-IFN) plus ribavirin (RBV) for 24 weeks , peginterferon (Peg-IFN) plus ribavirin (RBV) for 48 weeks ,0,
edin,7998,4898395,Significantly decreased,"Heart rate (beats/min) (Ketâ=â119âÂ±â18; FMMâ=â89âÂ±â17; pâ=â0.0066), systolic blood pressure (mmHg) (Ketâ=â109âÂ±â10; FMMâ=â97âÂ±â10; pâ=â0.0313), and respiratory rate (breaths/min) (Ketâ=â39âÂ±â9; FMMâ=â29âÂ±â10; pâ=â0.0416) were significantly lower in the FMM group.", respiratory rate , ketamine (KET) , fentanyl-midazolam-medetomidine (FMM) ,0,
edin,7895,3438438,Cannot tell based on the abstract,, HbA1c  and blood sugar , control , program and jogging based on health belief model (HBM) on sugar control in type 2 diabetic patients ,0,
edin,7895,3438438,Significantly decreased,While the amount of HbA1c (from 8.95 to 7.90 Unit? in three months after the training intervention) and blood sugar (from 180 before the intervention to147.5 mg/dl in three months after the training intervention) had a remarkable decrease and it was statistically significant (p<0.001)., HbA1c  and blood sugar , control , program and jogging based on health belief model (HBM) on sugar control in type 2 diabetic patients ,0,
edin,8122,2822946,Cannot tell based on the abstract,, increased risk for PC in first round , men without BPH medication , men with BPH medication ,0,
edin,8122,2822946,Significantly increased,"Of the men with a screen-positive result in the first round, 67.3% turned out to be FP and 27.5% were diagnosed with PC (5.2% of screen-positive men were not biopsied according to the protocol).,There were 128 men who had FP in the first round and were diagnosed with PC in the second round â 78.1% of the cancers were localised and of low grade (T1-2NxM0 and Gleason score <7), 13.3% were localised with Gleason score 7, and 8.6% were advanced (T3-4NxM0 or TxNxM1 or Gleason score â©¾8).,In the men with a negative screening result in the first round and a screen-detected PC in the second round, the corresponding numbers were 77.5, 13.2 and 9.3%.", increased risk for PC in first round , men without BPH medication , men with BPH medication ,0,
edin,7969,2784472,Significantly increased,"Measured against the placebo, subjects in the probiotic group achieved significant improvements in GSRS abdominal pain subscore (p = 0.046) and the GSRS total score (p = 0.048), with a strong trend for improvement on the GSRS abdominal distension subscore (p = 0.061).", Improvement in GSRS (Gastrointestinal Symptom Rating Scale) total score - in adults with post prandial intestinal gas-related symptoms and no GI diagnoses , Placebo group , Digestive Advantageâ¢ Gas Defense Formula (GD) group ,0,
edin,7999,4898395,Significantly increased,"Onset of a sufficient degree of sedation for safe handling was more rapid with ketamine (KETâ=â2.9âÂ±â1.4Â min; FMMâ=â7.9âÂ±â1.2Â min; pâ=â0.0009), but FMM recovery was faster (KETâ=â21.4âÂ±â13.4Â min; FMMâ=â9.1âÂ±â3.6Â min; pâ=â0.0379) and of better quality (KETâ=â1.3âÂ±â0.9; FMMâ=â7.4âÂ±â1.9; pâ=â0.0009) most probably because of the effectiveness of the reversal agents used.", Recovery rate , ketamine (KET) , fentanyl-midazolam-medetomidine (FMM) ,0,
edin,8054,5534041,Cannot tell based on the abstract,, composite z-scores in autism spectrum disorder (ASD)  , sham stimulation , right dorsolateral prefrontal cortex (DLPFC) anodal transcranial direct current stimulation (tDCS) ,0,
edin,8054,5534041,Significantly increased,"As shown in the final row of Table 1, the composite z-scores (full battery) were â0.25 (SD 0.71) for sham stimulation, 0.13 (SD 0.82) for left anodal stimulation, and 0.11 (SD 0.81) for right anodal stimulation, which repeated measures ANOVA showed to be significantly different (F 2,22Â =Â 12.85, pÂ =Â 0.0002).", composite z-scores in autism spectrum disorder (ASD)  , sham stimulation , right dorsolateral prefrontal cortex (DLPFC) anodal transcranial direct current stimulation (tDCS) ,0,
edin,8039,5008205,Significantly increased,"Weight loss was greater with dulaglutide 1.5âmg (pâ<â0.001) and similar with 0.75âmg versus sitagliptin (2.88âÂ±â0.25, 2.39âÂ±â0.26 and 1.75âÂ±â0.25âkg, respectively).", Weight loss , sitagliptin 100âmg , dulaglutide (1.5 or 0.75âmg) ,0,
edin,7860,5324269,Significantly increased,"25(OH)D3 AUC140 was lower in daily than 2-weekly (11%, pâ=â0.002) and 4-weekly D3-treated groups (10%, pâ=â0.008).", 25(OH)D3 AUC140 , baseline , 2-weekly and 4-weekly D3-treated groups ,0,
edin,8073,2694359,Cannot tell based on the abstract,, IL-6 , nonfatal CVD , fatal other CV events ,0,
edin,8073,2694359,Significantly increased,"These curves clearly show that while thirds of IL-6 showed little discriminative ability in separating risk for nonfatal CVD in unadjusted models (pâ=â0.13), associations with risk for fatal CVD events, fatal other CV events, or non-CVD mortality were all highly significant (pâ¤0.0002 for all).,As can be seen clearly, the HR for association of elevation in IL-6 with risk for nonfatal CVD of 1.06 (95% CI 0.94â1.20) was weaker than each of the mortality endpoints, as the upper confidence limits were less than the lower confidence limits of each of the mortality endpoints: HR 1.58 (1.28â1.94) for fatal CVD, 2.02 (1.28â3.18) for fatal other CV events, and 1.47 (1.24â1.74) for non-CVD death.", IL-6 , nonfatal CVD , fatal other CV events ,0,
edin,7858,5324269,Cannot tell based on the abstract,,  25(OH)D level , placebo ," D2, D3, D2/D3 ",0,
edin,7858,5324269,Significantly decreased,"Adjusted mean 25(OH)D level was not significantly different from the placebo group until day 2 in the D2 daily (pâ=â0.005) and until day 3 in the D3 daily (pâ=â0.02) and the D2/D3 daily (pâ=â0.001) groups.,At day 4, adjusted mean 25(OH)D level was significantly lower in the D2 and D3 daily groups compared to the corresponding 2-weekly groups (pâ=â0.02 and 0.006, respectively) and in the D2 and D3 2-weekly groups compared to the corresponding 4-weekly groups (pâ=â0.03 and pâ=â0.004, respectively). At day 28, adjusted mean 25(OH)D level was higher in D3 4-weekly group compared to D2 4-weekly group (mean difference 6.4Â nmol/L (CI, 1.5 to 11.3, pâ=â0.01)) and in D3 2-weekly group compared to D2 2-weekly group (mean difference 4.5Â nmol/L (CI, â0.4 to 9.5, pâ=â0.07)). On the other hand, 25(OH)D level was significantly higher in D2 daily group compared to D3 daily group (mean difference 6.2Â nmol/L (CI, 1.4 to 11.0, pâ=â0.01)).Fig. 3",  25(OH)D level , placebo ," D2, D3, D2/D3 ",0,
edin,8075,4483416,Cannot tell based on the abstract,, Mean VO2max , control group after intervention , control group before intervention ,0,
edin,8075,4483416,No significant difference,Mean VO2max in the control group increased from 44.86âmLÂ·kgâ1Â·minâ1 before the intervention to 45.57âmLÂ·kgâ1Â·minâ1 after the intervention; this change was not statistically significant., Mean VO2max , control group after intervention , control group before intervention ,0,
edin,8109,5835896,Cannot tell based on the abstract,, relapse-free survival (RFS) in metastatic colorectal cancer (CRC) , patients without HLA-A*2402 , patients with HLA-A*2402 ,0,
edin,8109,5835896,Significantly increased,"In our earlier trial of the same treatment strategy, no remarkable clinical responses were observed in patients with metastatic CRC refractory to standard chemotherapy,The 3-year RFS was significantly better in patients with positive CTL responses than in those without in the HLA-A*2402 matched group (85.7 vs. 33.3%, respectively, HR=0.159, 95% CI: 0.023â0.697, P=0.011) (Fig. 5).,The 3-year RFS in HLA-A*2402 matched and unmatched stage IIIb CRC groups was 46.1 and 0%, respectively (HR=0.293, 95% CI: 0.070â1.45, P=0.0789), with the HLA-A*2402 matched stage IIIb group showing a nonsignificant trend toward better survival (Fig. 4).", relapse-free survival (RFS) in metastatic colorectal cancer (CRC) , patients without HLA-A*2402 , patients with HLA-A*2402 ,0,
edin,8055,5534041,Significantly increased,"Compared to sham stimulation, both left DLPFC anodal stimulation (t 11Â =Â 5.4, pÂ =Â 0.0002) and right DLPFC anodal stimulation (t 11Â =Â 3.57, pÂ =Â 0.004) improved overall WM performance", overall working memory (WM) performance in autism spectrum disorder (ASD)  , sham stimulation , right dorsolateral prefrontal cortex (DLPFC) anodal transcranial direct current stimulation (tDCS) ,0,
edin,8008,5125808,Significantly increased,"At Week 8, the CKD-828 2.5/40 mg (sitDBP/SBP: P=0.0002/P<0.0001) and CKD-828 2.5/80 mg (sitDBP/SBP: P=0.0001/P<0.0001) showed superior BP-lowering effects to S-amlodipine 2.5 mg (P<0.001).", BP-lowering effects at Week 8 , S-amlodipine 2.5 mg (who failed to respond after 4-week S-amlodipine 2.5 mg monotherapy) , CKD-828 2.5/80 mg (who failed to respond after 4-week S-amlodipine 2.5 mg monotherapy) ,0,
edin,7899,3556012,No significant difference,"The severity of pain during defecation and consistency of stool improved significantly better in CFE group than MO group (p < 0.05), but there were not any significant differences between the two groups in fecal incontinence and retentive posturing.", fecal incontinence and retentive posturing , mineral oil (MO) , cassia fistula emulsion (CFE)  ,0,
edin,7897,3556012,Significantly increased,The frequency of defecation in CFE group improved from 1.7 per week (before the study) to 10.6 per week (at the third week) while this parameter differed in MO group from 2 to 6.1 (p < 0.001)., The frequency of defecation , mineral oil (MO) , cassia fistula emulsion (CFE)  ,0,
edin,8021,5772830,Cannot tell based on the abstract,, decreased blind-side detection with increasing age , p-prisms after 2 weeks but before training , p-prisms after training  ,0,
edin,8021,5772830,Significantly increased,"Blind side detection rate without p-prisms (NP) was 42%, improved significantly with p-prisms to 56% even before training (PBT) (P < 0.001), and further improved after training (PAT) to 72% (P < 0.001; Fig. 3 top left). At the 3 month follow-up (P3M), the effect of p-prisms and training was maintained 65% (169/260); detection was not significantly worse than PAT (P = 0.12) and was still significantly better than PBT (P = 0.02). As expected, increasing age was associated with lower detection rates (P < 0.001).", decreased blind-side detection with increasing age , p-prisms after 2 weeks but before training , p-prisms after training  ,0,
edin,7855,4517417,No significant difference,"Analysis of implantation rate (19.5âÂ±â27.7 vs. 21.7âÂ±â32.6; pâ=â0.6), chemical pregnancy rate (51Â % vs. 50.5Â %; pâ=â0.94), clinical pregnancy rate (35.7Â % vs. 38.1Â %; pâ=â0.73), ongoing pregnancy rate (31.6Â % vs. 30.9Â %; pâ=â0.92), ectopic pregnancy rate (8.6Â % vs. 2.7Â %; pâ=â0.35), and miscarriage rate (11.4Â % vs. 16.2Â %; 0.74) revealed comparable results for both groups."," implantation rate, chemical pregnancy rate, clinical pregnancy rate, ongoing pregnancy rate, ectopic pregnancy rate, and miscarriage rate ", midpoint of ECL , DFE 2 cm ,0,
edin,7926,3526879,Significantly increased,"The values (mean Â± standard deviation [SD]) of relative changes to BW (â8.0% Â± 0.8%), BF (â21.4% Â± 2.1%), LM (3.0% Â± 0.3%), and FM (â31.2% Â± 3.0%) to the OT group were higher (P < 0.05) than in the AWT (BW: â2.0% Â± 1.1%; BF: â4.6% Â± 1.8%; FM: â7.0% Â± 2.8%; LM: 0.2% Â± 1.1%) and OWT (BW: â4.5% Â± 1.0%; BF: â11.0% Â± 2.2%; FM: â16.1% Â± 3.2%; LM: â0.2% Â± 1.0%) groups; additionally, no differences were found for C groups.",  lean mass (LM) , baseline , obesity (O) trained (OT) group ,0,
edin,7845,4483323,Cannot tell based on the abstract,, swelling , serratiopeptidase , methylprednisolone ,0,
edin,7845,4483323,No significant difference,"The mean size of the swelling in group I was 36.4 Â± 27.6, 26.8 Â± 38.4 and 10.2 Â± 28.3 on day 1, 3 and 5 respectively whereas in group II the mean size was 37.7 Â± 24.9, 16.8 Â± 18.5 and 1.4 Â± 8.2 on day 1, 3 and 5 respectively. When compared, the results were statistically insignificant between group I and group II on the day 1 and 3 (p=0.80 and 0.10 respectively).", swelling , serratiopeptidase , methylprednisolone ,0,
edin,7868,5513842,Cannot tell based on the abstract,, nurse-administered morphine , control , paravertebral block (PVB) ,0,
edin,7868,5513842,Significantly decreased,"The median (25thâ75th percentiles) cumulative morphine consumption, including nurse-administered morphine, in the paravertebral group was 0 mg (0â2) and 2.5 mg (2â4) in the control group, with P-value of 0.001.", nurse-administered morphine , control , paravertebral block (PVB) ,0,
edin,7817,4499971,Cannot tell based on the abstract,, Effect of training on the non-dominant hand , dominant hand , non-dominant hand ,0,
edin,7817,4499971,Significantly increased,"Meanwhile, the non-dominant hand group showed significant differences after training in turning cards, simulated feeding, stacking checkers, and lifting large heavy objects with the untrained hand (p < 0.05; Table 2Table 2.", Effect of training on the non-dominant hand , dominant hand , non-dominant hand ,0,
edin,8080,4141807,Significantly decreased,"In overweight group, fasting blood glucose (FBG) after metformin treatment showed greater decline compared to acarbose group at 48 weeks [â1.73 (â1.99 to â1.46) vs. â1.37 (â1.61 to â1.12), P<0.05), however the decrease of 2 h post-challenge blood glucose (PBG) after acarbose treatment at 48 weeks was bigger compared to metformin group [â3.34 (â3.83 toâ2.84) vs. â2.35 (â2.85 to â1.85), P<0.01 ]"," In overweight group, decrease of 2 h post-challenge blood glucose (PBG) ", metformin , acarbose ,0,
edin,7986,3651817,Cannot tell based on the abstract,, Cmax , i.m. epinephrine , inhalative epinephrine ,0,
edin,7986,3651817,Significantly increased,"Mean exposure to epinephrine as derived from Cmax, partial AUCs and AUC0-t(last) was highest for the 8Â mg inhalative dose and decreased from the 4Â mg inhalative dose to the 0.3Â mg i.m. dose, with all active treatments being significantly higher than placebo (TableÂ 1, Fig.Â 1).", Cmax , i.m. epinephrine , inhalative epinephrine ,0,
edin,8007,5125808,Significantly increased,"At Week 4, all groups showed significant antihypertensive effects but both CKD-828 combinations (CKD-828 2.5/40 mg and CKD-828 2.5/80 mg) exhibited superior BP-lowering effects to that of S-amlodipine 2.5 mg (sitDBP/SBP: P=0.0028/P=0.0001 and P<0.0001/P=0.0012, respectively)", BP-lowering effects at Week 4 , S-amlodipine 2.5 mg (who failed to respond after 4-week S-amlodipine 2.5 mg monotherapy) , CKD-828 2.5/40 mg (who failed to respond after 4-week S-amlodipine 2.5 mg monotherapy) ,0,
edin,7964,3940644,Cannot tell based on the abstract,, The relative risk of having had any fall at 24 months , control , multifactorial intervention to reduce falls among the oldest-old people ,0,
edin,7964,3940644,No significant difference,"The relative risk of having had any fall at 24 months of follow-up was increased (but not significantly so, relative risk 1.28, 95% confidence interval [CI] 0.94â1.75).", The relative risk of having had any fall at 24 months , control , multifactorial intervention to reduce falls among the oldest-old people ,0,
edin,7884,5471294,No significant difference,"The LB rate was 36% in the treatment group and 31% in the control group [OR: 1.3 (95% CI 0.8â2.0), Pâ<â0.27].",  live birth (LB) rate , control , GnRH agonist ,0,
edin,7954,3603112,Significantly increased,here was a significant reduction in HbA1c within the study group (8.76% to 7.43%) (P = 0.08) vs rise in the control group (8.34% to 9.34%) (P = 0.07)., HbA1c , baseline , control ,0,
edin,7939,4491277,Cannot tell based on the abstract,," pregnancy rates (PR), clinical pregnancy rates (cPR), miscarriage rates (MR), and live birth rates (LBR) "," cohort B, the administration of hCG occurred just prior to embryo transfer on day 5 "," cohort A, hCG application was performed two days before blastocyst transfer,   ",0,
edin,7939,4491277,No significant difference,"No statistically significant differences in PR (31.7Â % vs. 29.5Â %, respectively), cPR (19.5Â % vs. 20.5Â %, respectively), LBR (17.1Â % vs. 18.2Â %, respectively), and MR (2.4Â % vs. 2.3Â %, respectively) were found after intrauterine hCG vs. medium injection."," pregnancy rates (PR), clinical pregnancy rates (cPR), miscarriage rates (MR), and live birth rates (LBR) "," cohort B, the administration of hCG occurred just prior to embryo transfer on day 5 "," cohort A, hCG application was performed two days before blastocyst transfer,   ",0,
edin,7979,3996149,Cannot tell based on the abstract,, LDL-C - type 2 diabetes patients , 10 grams milk powder , 10 grams cocoa powder and 10 grams milk powder ,0,
edin,7979,3996149,Significantly decreased,"Data analysis for comparison between the groups before and after a 6-week intervention (Figureâ1) detects that total cholesterol, triglyceride, HDL-C, LDL-C and MDA are changed significantly only in TG: 16.57% total cholesterol reduction in TG, Pâ<â0.0001 vs. 5.08% reduction in CG, Pâ=â0.0006; 13.3% triglyceride reduction in TG, Pâ<â0.0001 vs. 3.99% in CG, Pâ=â0.0009; 7.58% reduction of HDL-C in TG, Pâ=â0.0003 vs. 4.57% in CG, Pâ=â0.0258; 17.54% reduction of LDL-C in TG, Pâ<â0.0001 vs. 2.57% in CG, Pâ=â0.1308; malondialdehyde levels, however, were not reduced significantly in TG (0.45%, Pâ=â0.787) but increased significantly in CG (17.75%, Pâ<â0.0001).", LDL-C - type 2 diabetes patients , 10 grams milk powder , 10 grams cocoa powder and 10 grams milk powder ,0,
edin,8104,5405916,Cannot tell based on the abstract,, voter turnout , control group , banner plus news feed (Facebook) ,0,
edin,8104,5405916,Significantly increased,"These results suggest the banner and feed condition combined to yield a 0.24% increase in voter turnout, and that it likely depended on both mechanisms to generate this increase. Asterisks indicate p<0.05.", voter turnout , control group , banner plus news feed (Facebook) ,0,
edin,8116,4932043,Cannot tell based on the abstract,, gain in the range of motion , Control , Infrared and Neural Mob. ,0,
edin,8116,4932043,Significantly increased,"<td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">Infrared and Neural Mob.</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""top"">8.5</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""top"">25.20*</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""top"">â1â50</td>", gain in the range of motion , Control , Infrared and Neural Mob. ,0,
edin,7985,3651817,Cannot tell based on the abstract,, blood pressure , i.m. epinephrine , inhalative epinephrine ,0,
edin,7985,3651817,No significant difference,"In response to the administration of the study medication, heart rate increased, while blood pressure values were essentially unchanged (TableÂ 1, see also supplementary material).", blood pressure , i.m. epinephrine , inhalative epinephrine ,0,
edin,8110,5835896,Cannot tell based on the abstract,, Number of patients - stage IIIb in metastatic colorectal cancer (CRC) , patients without HLA-A*2402 , patients with HLA-A*2402 ,0,
edin,8110,5835896,No significant difference,"Fewer patients with stage IIIb were in the HLA-A*2402 unmatched group than the HLA-A*2402 matched group, but this difference was not significant (P=0.059).", Number of patients - stage IIIb in metastatic colorectal cancer (CRC) , patients without HLA-A*2402 , patients with HLA-A*2402 ,0,
edin,7872,5234109,Cannot tell based on the abstract,, oxygen uptake (VO2) , maltodextrin placebo (PLA) , pre-workout dietary supplement (PWS) with  p-synephrine (S);  ,0,
edin,7872,5234109,Significantly increased,"Analysis of AUC changes from baseline revealed significant differences among treatments in VO2 (PLA 684âÂ±â376; PWS 802âÂ±â434; PWSâ+âS 1,034âÂ±â584Â ml/min, pâ=â0.015),,Post-hoc analysis revealed that VO2 AUC in the PWSâ+âS treatment was significantly greater than the PLA treatment (pâ=â0.013, CI [64, 636]) but not the PWS treatment.", oxygen uptake (VO2) , maltodextrin placebo (PLA) , pre-workout dietary supplement (PWS) with  p-synephrine (S);  ,0,
edin,8048,5453890,Cannot tell based on the abstract,, amnesia , no premedication , triazolam 0.25 mg or 0.375 mg ,0,
edin,8048,5453890,Significantly increased,"The incidence of amnesia was also dose-dependent (linear-by-linear association, P = 0.001), and significantly higher in the T0.25 and T0.375 groups (Table 2). No patient showed amnesia in the control group.", amnesia , no premedication , triazolam 0.25 mg or 0.375 mg ,0,
edin,7933,1868720,Significantly increased,Sickness absence was higher in the 'at risk' (N = 212) group (42%) compared to the 'not at risk' (N = 2503) group (25%) (OR 2.17 CI 1.63â2.89; p = 0.000)., Sickness absence , 'not at risk'  group , at risk'  group ,0,
edin,7930,3526879,Significantly decreased,"While reduction (P < 0.03) in BMI according to absolute values was observed for all trained groups (AWT: 22 Â± 1 versus 21 Â± 1; OWT: 27 Â± 1 versus 25 Â± 1, OT: 34 Â± 1 versus 30 Â± 1) after training, no differences were found for C groups.",  BMI ,  obesity (O) control (OC) group ," appropriate weight (AW) control (AWC) groups,  overweight (OW) control (OWC) group ",0,
edin,7977,3996149,Significantly decreased,"Cocoa consumption lowered blood cholesterol,triglyceride, LDL-cholesterol, and TNF-Î±, hs-CRP, IL-6 significantly (Pâ<â0.01). The results showed that the levels of HDL-cholesterol decreased significantly (Pâ<â0.05) but Cocoa inhibited lipid peroxidation in treatment group than control group (Pâ<â0.0001).", blood cholesterol - type 2 diabetes patients , 10 grams milk powder , 10 grams cocoa powder and 10 grams milk powder ,0,
edin,7836,4738984,Cannot tell based on the abstract,, effect of condition on psyhological changes , negative input , positive input ,0,
edin,7836,4738984,No significant difference,Analyses indicated that condition had no effect on the physiological changes with and without controlling for performance. T, effect of condition on psyhological changes , negative input , positive input ,0,
edin,7908,4389469,Cannot tell based on the abstract,, assessment of functional class -  NYHA class , (B group) graft of left internal mammary artery to the same branch , (A group) graft of right internal mammary artery to the anterior interventricular branch ,0,
edin,7908,4389469,No significant difference,In the assessment of functional class. no patient in group A (0%) were in NYHA class I. 15 (60%) in class II. seven (28%) in class III. and three (12%) in class IV . In group B. three (12%) were in class I. 14 (56%) in class II. seven (28%) in class III and one (4%) in class IV. There was no statistical difference (P=0.258) between the two groups., assessment of functional class -  NYHA class , (B group) graft of left internal mammary artery to the same branch , (A group) graft of right internal mammary artery to the anterior interventricular branch ,0,
edin,8026,3881751,No significant difference,"<td colspan=""1"" rowspan=""1"">RHAL</td><td align=""center"" colspan=""1"" rowspan=""1""></td><td align=""center"" colspan=""1"" rowspan=""1""></td>", probing pocket depth (PPD) reduction , identical treatment using distilled water as the cooling liquid (control group). , subgingival instrumentation with an ultrasonic device using PVP-I (10%) as the cooling liquid (test group) ,0,
edin,7924,1475428,Cannot tell based on the abstract,"The change in hSGLT3 transcript levels in the vastus lateralis muscle was positively correlated with glucose uptake, as measured by the change in muscle glycogen stores (r=0.53, P=0.02); and with exercise intensity, as measured by the change in muscle strength (r=0.73, P=0.001).", whole-body muscle strength , standard of care (controls) , resistance training (3x/wk) ,0,
edin,7924,1475428,Significantly increased,"Exercisers gained on average 43 Â± 29% of whole-body muscle strength, as compared to a 19 Â± 31% loss in control subjects (P = 0.01).", whole-body muscle strength , standard of care (controls) , resistance training (3x/wk) ,0,
edin,8085,5761719,Cannot tell based on the abstract,, pre-test probability of obstructive CAD , remainder of the cohort , patients with minimal-risk ,0,
edin,8085,5761719,Significantly decreased,"In comparison with the remainder of the cohort, patients with minimal-risk were less likely to have symptoms of typical angina (24.1% vs 42.6%, pÂ <Â 0.001) and had lower pre-test probability of obstructive CAD as determined from the CADC risk score (30.0% vs 47.0%, pÂ <Â 0.001).", pre-test probability of obstructive CAD , remainder of the cohort , patients with minimal-risk ,0,
edin,7839,4546316,Cannot tell based on the abstract,, vision impairment , no steroid , topical steroid ,0,
edin,7839,4546316,Significantly decreased,"Importantly, patients who were not treated with steroids were more likely to have worse than 20/2,000 vision (41 % versus 21 %) and this was statistically significant (P <0.00001)", vision impairment , no steroid , topical steroid ,0,
edin,7944,4274965,No significant difference,Subjective and physiological stress levels showed no age difference and no detrimental association with PM., stress levels , older adults , younger adults ,0,
edin,7883,5471294,No significant difference,"Similarly, the OP rate was 37% in the treatment group and 31% in the control group [OR 1.3 (95% CI 0.8â2.0), Pâ<â0.23].", Ongoing pregnancy (OP) rate , control , GnRH agonist ,0,
edin,7947,4061773,Significantly increased,Post-ingestion bicarbonate and base excess were higher (Pâ<â0.05) in both the ACU and CHR trials compared to placebo showing adequate pre-exercise alkalosis., Post-ingestion bicarbonate and base excess ," acute placebo (PLC-A),), and chronic placebo (PLC-C) ", (ACU) sodium citrate dihydrate (Na-CIT) supplementation (0.5kg-1;  chronic sodium citrate dihydrate (Na-CIT) (CHR) supplementation (0.1kg-1 for three days and 0.3kg-1 on the forth day 120;min pre-trial ,0,
edin,7834,4541185,Cannot tell based on the abstract,, drop in heart rate , ropivacaine + saline , ropivacaine + diluted clonidine with saline ,0,
edin,7834,4541185,Significantly increased,"Significantly lower pulse rate was observed from 60 min to 180 min in the clonidine group, but was not clinically significant and did not need any intervention [Figure 1].", drop in heart rate , ropivacaine + saline , ropivacaine + diluted clonidine with saline ,0,
edin,8096,4625433,Cannot tell based on the abstract,, levels of pyruvate , non-tourniquet group , tourniquet group ,0,
edin,8096,4625433,No significant difference,"Pyruvate concentration was initially reduced to 60Â % (25.9âÂ±â5.6Â Î¼mol/L; pâ<â0.001), while it was dramatically elevated during first period of 30â60Â min of reperfusion to 123Â % (145.6+/10.9Â Î¼mol/L; pâ<â0.001). At 180Â min it was restored back to baseline and no difference was detected (pâ=â0.118).", levels of pyruvate , non-tourniquet group , tourniquet group ,0,
edin,8066,4206772,Cannot tell based on the abstract,, walking distance improvement at week 12 - patients with Morquio A syndrome (mucopolysaccharidosis IVA) , placebo , elosulfase alfa 2.0mg/kg/week (weekly) ,0,
edin,8066,4206772,Significantly increased,"Elosulfase alfa 2.0Â mg/kg/week improved walking distance, relative to placebo, by 11 m at week 12 and by 23 m at week 24 (Supportive online material 4,In this clinical trial in Morquio A patients, an improvement in 6MWT distance on elosulfase alfa 2.0Â mg/kg/week over placebo began to emerge at 12Â weeks and became more apparent at week 24, where the placebo adjusted mean increase in 6MWT distance was 22.5 m.", walking distance improvement at week 12 - patients with Morquio A syndrome (mucopolysaccharidosis IVA) , placebo , elosulfase alfa 2.0mg/kg/week (weekly) ,0,
edin,7837,4738984,Cannot tell based on the abstract,, performance prediction , negative input , positive input ,0,
edin,7837,4738984,Significantly increased,"An analysis of group differences in performance showed that participants in the favorable somatic information condition (M = 75.18, SD = 42.36) scored higher than the unfavorable information condition (M = 64.32, SD = 32.76); t = 2.00, df = 184, p = .047. This indicates that condition is a significant predictor of performance.", performance prediction , negative input , positive input ,0,
edin,7808,5623327,Cannot tell based on the abstract,," Percentage of patients achieving comprehensive disease control based on DAS28(CRP)â¤3.2, DAS28(CRP)&amp;lt;2.6 or SDAIâ¤3.3 at week 52 ", therapy with placebo in addition to MTX , therapy with adalimumab in addition to MTX ,0,
edin,7808,5623327,Significantly increased,"Percentage of patients achieving comprehensive disease control based on DAS28(CRP)â¤3.2, DAS28(CRP)<2.6 or SDAIâ¤3.3 at week 52 in (A) DE019, (B) PREMIER and (C) the Rescue ADA arm of OPTIMA. ADA, adalimumab; DAS28(CRP), 28-joint Disease Activity Score based on C-reactive protein; HAQ-DI, Health Assessment Questionnaire Disability Index; IR, inadequate response; ÎmTSS, change in modified total Sharp score; MTX, methotrexate; PBO, placebo; SDAI, Simplified Disease Activity Index. *p<0.05 from Fisherâs exact test, ADA+MTXâversus PBO+MTX. ***p<0.001 from generalised estimating equation or logistic regression, ADA+MTXâversus PBO+MTX.,Consistent with the comparative treatment data for CDC in DE019 and PREMIER, a greater percentage of patients in the adalimumab+MTX arms achieved each of the individual components for CDC (onlineÂ supplementary figures 1 and 2)."," Percentage of patients achieving comprehensive disease control based on DAS28(CRP)â¤3.2, DAS28(CRP)&amp;lt;2.6 or SDAIâ¤3.3 at week 52 ", therapy with placebo in addition to MTX , therapy with adalimumab in addition to MTX ,0,
edin,7815,2602945,Significantly increased,"Exam room utilization was lower for late patients (28.9% versus 44.7%, P = .03) with physician utilization lower in clinics with 3 or more late patients when compared to clinics with 2 or fewer (59.7% versus 68.7%, P = .004). Conclusions. Late patients had significantly less time with the physician than on-time patients. Late patients also decreased the overall efficiency of the clinic; therefore, measures to reduce late patients are vital to improve clinic efficiency.", exam room utilization time , return patient , new patient ,0,
edin,7948,4061773,Significantly increased,"Further analysis revealed that five swimmers, identified as responders, improved their performance time by 1.03% (Pâ<â0.05) and attained higher post-trial lactate concentrations in the ACU versus PLC-A trial (Pâ<â0.05).", improving performance time  , acute placebo (PLC-A) , (ACU) sodium citrate dihydrate (Na-CIT) supplementation (0.5kg-1;   ,0,
edin,8091,3339727,Cannot tell based on the abstract,, Incidence of sore throat , F2 (fentanyl 2 mcg/kg) , F1 (fentanyl 1 mcg/kg) ,0,
edin,8091,3339727,No significant difference,"Incidence of sore throat was comparable immediately after recovery and 24 h after recovery in both groups.,The overall conditions for LMA insertion, mean time taken, total number of attempts taken for insertion, fiberoptic view, and incidence of sore throat were comparable in both study groups.", Incidence of sore throat , F2 (fentanyl 2 mcg/kg) , F1 (fentanyl 1 mcg/kg) ,0,
edin,8001,4207147,Significantly decreased,"Five minutes after nasotracheal suction, the BG showed a decrease in LF and HF oscillations; however, after 40 minutes, the values were similar to those observed after application of CPT.", HRV high frequency (HF) oscillations - Five minutes after nasotracheal suction , control group (CG); conventional physical therapy (CPT) for airway clearance , acute bronchiolitis group (BG); conventional physical therapy (CPT) for airway clearance and nasotracheal suction ,0,
edin,7820,5341634,Cannot tell based on the abstract,, time before rescue analgesic , normal saline in addition to levobupivacaine , nalbuphine hydrochloride in addition to levobupivacaine ,0,
edin,7820,5341634,Significantly increased,"The mean time from block placement to the first request for pain medication, i.e., the duration of analgesia was 531.45 min in the nalbuphine group but 501.02 min in the control normal saline group. This difference (about 30.43 min) was statistically as well as clinically significant (P < 0.05) [Table 5 and Figure 2].", time before rescue analgesic , normal saline in addition to levobupivacaine , nalbuphine hydrochloride in addition to levobupivacaine ,0,
edin,8078,4483416,Cannot tell based on the abstract,, cortisol levels - prior to exercise , control group , exercise group ,0,
edin,8078,4483416,Significantly decreased,"The control group had higher cortisol levels at all stages (i.e., prior to exercise, immediately after exercise, and after a 30-min rest), while the exercise group had lower cortisol levels at all stages (Table 3Table 3.,<td align=""left"" colspan=""1"" rowspan=""1"">Control (n = 12)</td><td align=""center"" colspan=""1"" rowspan=""1"">8.38 Â± 1.02</td><td align=""center"" colspan=""1"" rowspan=""1"">9.17 Â± 1.15*</td>", cortisol levels - prior to exercise , control group , exercise group ,0,
edin,7830,4230312,Cannot tell based on the abstract,, improvement of disorder , placebo , quetiapine 600 mg/day ,0,
edin,7830,4230312,Significantly increased,"Patients with bipolar II disorder stratified by a rapid- (â¥4 mood episodes per year) or nonrapid-cycling course also demonstrated significant improvements in MADRS total score at week 8. Among patients without a rapid-cycling course, MADRS total score improved significantly by a mean (SE) of 15.18 (0.67) and 14.25 (0.66) with quetiapine 300 and 600Â mg/day compared with 11.58 (0.75) points for placebo (pâ<â0.001 and pâ=â0.005 for quetiapine 300 and 600Â mg/day, respectively) at week 8.", improvement of disorder , placebo , quetiapine 600 mg/day ,0,
edin,8011,5118645,Cannot tell based on the abstract,, median Emax scores , placebo (PBO) , oxycodone (OXY) 60mg  oral ,0,
edin,8011,5118645,Significantly increased,"In the oral study, the primary endpoint, Drug Liking VAS Emax score, indicating maximum âliking,â showed mean (Â±S.D.) scores of 85.8 Â± 14.3 for oxycodone 30 mg, and 90.9 Â± 11.5 for oxycodone 60 mg, which were 30â35 points higher than placebo, and median Emax scores were significantly higher with both doses of oxycodone compared with placebo (P < 0.0001 for both pairwise comparisons), demonstrating study validity (Table 2).", median Emax scores , placebo (PBO) , oxycodone (OXY) 60mg  oral ,0,
edin,8028,5771357,Cannot tell based on the abstract,, gender - patients undergoing CABG / CE ," In group 2, the patients were given 75 mg plavix (clopidogrel) daily together with 80 mg aspirin daily for 3 months "," group 1, the patients were given warfarin (INR) between 2-3) together with 80 mg aspirin daily for 3 months ",0,
edin,8028,5771357,Invalid Prompt,, gender - patients undergoing CABG / CE ," In group 2, the patients were given 75 mg plavix (clopidogrel) daily together with 80 mg aspirin daily for 3 months "," group 1, the patients were given warfarin (INR) between 2-3) together with 80 mg aspirin daily for 3 months ",1, I wasn't able to find anything related to gender - patients undergoing CABG / CE
edin,8095,4625433,Significantly decreased,"ourniquet induced ischemia resulted in decreased levels of glucose and pyruvate to 54 and 60Â % respectively, compared to baseline.", levels of glucose , non-tourniquet group , tourniquet group ,0,
edin,7843,1896161,Cannot tell based on the abstract,, respiratory rate and heart rate , epinephrine , albuterol ,0,
edin,7843,1896161,Significantly increased,"imilar to the lung sounds, the total clinical score also did not differ significantly within or between the groups prior to, 10 minutes post and 30 minutes post treatment. In individual parameter analysis, a significant difference in favor of epinephrine was seen at 10 minutes in respiratory rate (p < 0.04), and at 30 minutes in heart rate (p < 0.02). There was no difference in oxygen saturation or respiratory distress score.", respiratory rate and heart rate , epinephrine , albuterol ,0,
edin,8093,3339727,Cannot tell based on the abstract,, heart rate , F2 (fentanyl 2 mcg/kg) , F1 (fentanyl 1 mcg/kg) ,0,
edin,8093,3339727,No significant difference,The heart rate did not show any significant changes in either group though the incidence of bradycardia (heart rate < 60 beats per minute) was higher (16%) in group F2 compared to group F1., heart rate , F2 (fentanyl 2 mcg/kg) , F1 (fentanyl 1 mcg/kg) ,0,
edin,7877,5234109,Cannot tell based on the abstract,," HDL-C, LDL-C or triglyceride levels ", maltodextrin placebo (PLA) ,  pre-workout dietary supplement (PWS) with  p-synephrine (S);  pre-workout dietary supplement (PWS) without  p-synephrine (S); ,0,
edin,7877,5234109,No significant difference,"No significant interactions were observed among treatments in HDL-C, LDL-C or triglyceride levels."," HDL-C, LDL-C or triglyceride levels ", maltodextrin placebo (PLA) ,  pre-workout dietary supplement (PWS) with  p-synephrine (S);  pre-workout dietary supplement (PWS) without  p-synephrine (S); ,0,
edin,8113,4932043,Cannot tell based on the abstract,, elbow extension , G3: infrared , G4: infrared plus neural mobilization ,0,
edin,8113,4932043,Significantly increased,"Analysis of the gain in the range of motion there were very significant showed differences among the intervention groups M (3)=11.3837, pâ¤0.01 (Tables 2Table 2.
Groups	Median	Mean rank	MinâMax
Control	1	10.60*	â9â5
Neural Mob.	7	19.85*	â2â23
Infrared	10.5	26.35*	1â20
Infrared and Neural Mob.	8.5	25.20*	â1â50
*p<0.05, Kruskal-Wallis test,In the present study, unlike other studies, NM was not superior to the other techniques compared with it10, 35). Its use resulted in a significant increase in elbow range of motion, showing it is an effective remedy for the treatment of ANT.,This research provides new experimental evidence that NM in combination with superficial heat elicits an immediate effect on elbow range of motion compared to NM alone.", elbow extension , G3: infrared , G4: infrared plus neural mobilization ,0,
edin,7946,4668670,Significantly decreased,"High sensitivity CRP (hs-CRP) was measured at emergency department presentation, and 6 and 12Â h into infusion. Logarithmically transformed hs-CRP values at 12-hours were lower with GIK vs. placebo (mean =0.65 mg/L in GIK, 0.84 mg/L in placebo), with a marginal trend toward significance (Pâ=â0.053). Furthermore, using mixed models of hs-CRP, time, and study group, there was a significant increase in hs-CRP levels over time, but the rate of change did not differ between treatment arms (Pâ=â0.3). Multivariable analysis showed that an elevation in hs-CRP, measured at 12Â h, was an independent predictor of 30-day infarct size (Î² coefficient, 6.80; Pâ=â0.04) using sestamibi SPECT imaging.", high sensitivity C-reactive protein (hs-CRP) , C-reactive protein (CRP) levels , glucose-insulin-potassium (GIK) ,0,
edin,8107,5405916,Cannot tell based on the abstract,, âmultiplierâ effect , news feed , banner ,0,
edin,8107,5405916,Significantly increased,"Only the banner treatment generated a âmultiplierâ effect as it spread from one person to another. We can estimate this multiplier effect by calculating the ratio of the expected friends motivated (this is the average number of friends times the per friend treatment effect) to the direct treatment effect. The results suggest that for every one person directly motivated to vote, an additional 5 x 0.10% / 0.24% â 2 friends were indirectly motivated to vote.", âmultiplierâ effect , news feed , banner ,0,
edin,7811,2602945,Cannot tell based on the abstract,"Exam room utilization was lower for late patients (28.9% versus 44.7%, P = .03) with physician utilization lower in clinics with 3 or more late patients when compared to clinics with 2 or fewer (59.7% versus 68.7%, P = .004).", Utilization of Physician time , patients who came late , patients who came on time ,0,
edin,7811,2602945,Significantly increased,"The overall exam room utilization ratio was 32.5% and did not significantly differ between on-time and late patients (P = .067) or new and return patients (P = .35) (Table 4). When new patients were stratified as late or on-time, exam room utilization was significantly lower for late patients (28.9% versus 44.7%, P = .03). Furthermore, physician utilization was significantly lower in clinics with greater than 2 late patients when compared to clinics with 2 or fewer late patients (59.7% versus 68.7%, P = 0.004) (Table 5).", Utilization of Physician time , patients who came late , patients who came on time ,0,
edin,7831,4541185,Significantly increased,he duration of both sensory and motor block were significantly prolonged by clonidine (P < 0.001)., duration of sensory and motor block , ropivacaine + saline , ropivacaine + diluted clonidine with saline ,0,
edin,7995,4898395,Significantly decreased,"Onset of a sufficient degree of sedation for safe handling was more rapid with ketamine (KETâ=â2.9âÂ±â1.4Â min; FMMâ=â7.9âÂ±â1.2Â min; pâ=â0.0009), but FMM recovery was faster (KETâ=â21.4âÂ±â13.4Â min; FMMâ=â9.1âÂ±â3.6Â min; pâ=â0.0379) and of better quality (KETâ=â1.3âÂ±â0.9; FMMâ=â7.4âÂ±â1.9; pâ=â0.0009) most probably because of the effectiveness of the reversal agents used.", onset of a sufficient degree of sedation for safe handling , ketamine (KET) , fentanyl-midazolam-medetomidine (FMM) ,0,
edin,8068,4179329,Cannot tell based on the abstract,, alertness , single sham session combined with neglect therapy , single real session biparietal tDCS ,0,
edin,8068,4179329,Significantly increased,"Intrinsic and phasic alertness were impaired at admission (intrinsic: T = 40; phasic: T = 38) with phasic alertness improving significantly after 1 week of standard therapy (T = 45, p = 0.002). After the single sham session combined with neglect therapy alertness worsened significantly (intrinsic: T = 39, p < 0.001; phasic: T = 38, p < 0.001), whereas after the single real session, alertness improved significantly (intrinsic: T = 45, p = 0.008; phasic: T = 49, p < 0.001).", alertness , single sham session combined with neglect therapy , single real session biparietal tDCS ,0,
edin,7980,3996149,Significantly decreased,"Cocoa consumption lowered blood cholesterol,triglyceride, LDL-cholesterol, and TNF-Î±, hs-CRP, IL-6 significantly (Pâ<â0.01).", IL-6 - type 2 diabetes patients , 10 grams milk powder , 10 grams cocoa powder and 10 grams milk powder ,0,
edin,7987,4314171,Cannot tell based on the abstract,, average systolic BP level in patients who had stage I hypertension , after 10 days therapy- Sulphate-sulphide mineral water âMljeÄanicaâ plus kinesitherapy and electrotherapy , Before therapy- Sulphate-sulphide mineral water âMljeÄanicaâ plus kinesitherapy and electrotherapy ,0,
edin,7987,4314171,Significantly decreased,"Student t-test showed statistically significant difference (0.05 significance) between average systolic BP before and after 10 days bath therapy in experimental group, which differs in control group.,Sulphate-sulphite mineral water âMljeÄanicaâ brought significant decrease of arterial blood pressure values in patients having stage I hypertension, only 10 days after treatment.", average systolic BP level in patients who had stage I hypertension , after 10 days therapy- Sulphate-sulphide mineral water âMljeÄanicaâ plus kinesitherapy and electrotherapy , Before therapy- Sulphate-sulphide mineral water âMljeÄanicaâ plus kinesitherapy and electrotherapy ,0,
edin,8038,5008205,Cannot tell based on the abstract,, decrease from baseline in mean fasting plasma glucose concentration , sitagliptin 100âmg , dulaglutide (1.5 or 0.75âmg) ,0,
edin,8038,5008205,Significantly increased,"The decrease from baseline in mean fasting plasma glucose concentration was significantly greater in both dulaglutide arms throughout the 104âweek treatment period and at final endpoint (104âweek LS meanâÂ±âs.e.: â2.0âÂ±â0.2, â1.4âÂ±â0.2, and â0.5âÂ±â0.2âmmol/l, respectively; pâ<â0.001) (Figure 2D).", decrease from baseline in mean fasting plasma glucose concentration , sitagliptin 100âmg , dulaglutide (1.5 or 0.75âmg) ,0,
edin,7863,4368876,Cannot tell based on the abstract,, Montgomery-Ãsberg Depression Rating Scale (MADRS; Montgomery and Asberg) , brief (at 5 times seizure threshold) pulse RUL ECT , ultrabrief (at 8 times seizure threshold) RUL ECT ,0,
edin,7863,4368876,No significant difference,"The mean adjusted MADRS scores at follow-up are shown in Figure 2B. The groups did not differ significantly in MADRS scores at either the one-week follow-up (F = 0.03 p = 0.87) or the one-month follow-up (F = 0.59 p = 0.45). At the six-month follow-up, there was a trend for the ultrabrief-pulse group to show lower depression scores relative to the brief-pulse group (F = 3.71, p = 0.07); however, data was only available for a subset of participants (n = 35).", Montgomery-Ãsberg Depression Rating Scale (MADRS; Montgomery and Asberg) , brief (at 5 times seizure threshold) pulse RUL ECT , ultrabrief (at 8 times seizure threshold) RUL ECT ,0,
edin,7878,3691930,Significantly increased,The total clinical effective rate was statistically significantly superior in electroacupuncture group to that in WCM group (P < 0.01), The total effective rate , single western conventional medication (WCM) , electroacupuncture plus western conventional medication (WCM) ,0,
edin,7905,60007,Cannot tell based on the abstract,,  systolic blood pressure (SBP) and diastolic blood pressure (DBP) , mivacurium 200  Î¼g/kg , mivacurium  250 Î¼g/kg ,0,
edin,7905,60007,Significantly decreased,"In relation to the cardiovascular response, the AUC-HR was similar in the two groups (p > 0.05) while both AUC-SBP and AUC-DBP were significantly lower (p < 0.05) in patients receiving 250 Î¼g/kg.",  systolic blood pressure (SBP) and diastolic blood pressure (DBP) , mivacurium 200  Î¼g/kg , mivacurium  250 Î¼g/kg ,0,
edin,8033,4251615,Significantly increased,Significant improvements in quality of life (overall St. Georgeâs Hospital Respiratory Questionnaire and Clinical COPD Questionnaire) were observed with arformoterol vs placebo (P < .05)., improvements in quality of life (overall St. Georgeâs Hospital Respiratory Questionnaire and Clinical COPD Questionnaire) , placebo , arformoterol ,0,
edin,8034,4251615,Significantly decreased,Risk for first respiratory serious adverse event was 50% lower with arformoterol than placebo (P = .003)., first respiratory serious adverse event risk , placebo , arformoterol ,0,
edin,8044,5694526,Cannot tell based on the abstract,, crude incidence of treatment-emergent nausea , placebo for each indication , lubiprostone (24 mcg BID for CIC and OIC; 8 mcg BID for IBS-C) ,0,
edin,8044,5694526,Significantly increased,"<td align=""left"">&nbsp;Crude incidence</td><td align=""left"">15 (6.3)</td><td align=""left"">70 (29.3)*</td><td align=""left"">42 (6.4)</td><td align=""left"">89 (13.4)*</td><td align=""left"">28 (6.4)</td><td align=""left"">91 (10.9)<sup>â </sup>
</td>,<td align=""left"">&nbsp;Crude incidence</td><td align=""char"" char=""("">346 (31.1)</td><td align=""char"" char=""("">124 (13.9)</td><td align=""char"" char=""("">115 (11.4)</td>,The crude incidence of treatment-emergent nausea in the RCT populations was significantly higher in patients who received lubiprostone (24 mcg BID for CIC and OIC; 8 mcg BID for IBS-C) compared with placebo for each indication (CIC, 29.3 vs 6.3%, respectively; OIC, 13.4 vs 6.4%; IBS-C, 10.9 vs 6.4%; TableÂ 2). T", crude incidence of treatment-emergent nausea , placebo for each indication , lubiprostone (24 mcg BID for CIC and OIC; 8 mcg BID for IBS-C) ,0,
edin,7849,3224655,No significant difference,"PaCO2 dropped significantly only in the NIV group (NIV: 55.4 [7.7] â 44.5 [4.70], P = 0.0076; control: 52.4 [6.0] â 47.6 [8.2], NS).", paco2 , routine + NIV , routine ,0,
edin,7932,3526879,Cannot tell based on the abstract,,  change in BMI ," appropriate weight (AWT) groups,  overweight (OWT) group  ",  obesity  (OT) group ,0,
edin,7932,3526879,No significant difference,"For all analyzed parameters in the AWT group, there was no significant difference in the values before versus after training and AWC; however, in the OWT and OT groups, the values of BW, BF, FM, and BMI were lower than the baseline values and respective controls.,Although a significant (P < 0.03) reduction in BMI (Figure 2) was found in all trained groups (AWT: 22 Â± 1 versus 21 Â± 1, kg/m2; OWT: 27 Â± 1 versus 25 Â± 1, kg/m2; OT: 34 Â± 1 versus 30 Â± 1, kg/m2) after training (Figure 2), no differences were found in control groups (AWC: 23 Â± 5 versus 23 Â± 4, kg/m2; OWC: 26 Â± 1 versus 27 Â± 1, kg/m2; OC: 33 Â± 1 versus 33 Â± 1, kg/m2). Additionally, the relative change in BMI (Figure 1) in trained groups (AWT: â5% Â± 2%; OWT: â1% Â± 3%; OT: â22% Â± 2%) was higher than in control groups (AWC: 1% Â± 1%; OWC: 2% Â± 1%; OC: 2% Â± 1%). Furthermore, the decrease in values of the OT group was statistically (P < 0.05) stronger than other groups.",  change in BMI ," appropriate weight (AWT) groups,  overweight (OWT) group  ",  obesity  (OT) group ,0,
edin,7833,4541185,Significantly increased,The onset of sensorimotor block was earlier in Group II (4.36 Â± 0.81 min for sensory block and 9.83 Â± 1.12 min for motor block) than in Group I (4.84 Â± 0.65 min for sensory block and 10.85 Â± 0.79 min for motor block)., onset of block , ropivacaine + saline , ropivacaine + diluted clonidine with saline ,0,
edin,8119,2822946,Cannot tell based on the abstract,, increased risk for PC in third round , men without BPH medication , men with BPH medication ,0,
edin,8119,2822946,No significant difference,"There was no increased risk for PC, as the risk in men with BPH medication vs men without BPH medication was 2.4 vs 2.6% in the first round (age-adjusted RR 0.8, CI 0.5â1.2, P-value=0.20), 3.8 vs 3.2% in the second round (age-adjusted RR 1.0, CI 0.8â1.3, P-value=0.99) and 7.2 vs 4.7% in the third round (age-adjusted RR 1.4, CI 1.0â2.0, P-value=0.08).", increased risk for PC in third round , men without BPH medication , men with BPH medication ,0,
edin,7816,4499971,Cannot tell based on the abstract,, Effect of training on the dominant hand , non-dominant hand , dominant hand ,0,
edin,7816,4499971,Invalid Prompt,, Effect of training on the dominant hand , non-dominant hand , dominant hand ,1, The question was Effect of training on the dominant hand and provided answer was dominant hand so ti doesn't have any sense to me. 
edin,8082,4141807,Significantly increased,"In overweight group, fasting blood glucose (FBG) after metformin treatment showed greater decline compared to acarbose group at 48 weeks [â1.73 (â1.99 to â1.46) vs. â1.37 (â1.61 to â1.12), P<0.05), h"," In overweight group, fasting blood glucose (FBG) ", metformin , acarbose ,0,
edin,7840,4546316,Cannot tell based on the abstract,, survival , no steroid , topical steroid ,0,
edin,7840,4546316,No significant difference,"The major evidence against treating TEN with steroids is a clinical study (N = 30) in which patients who were managed without corticosteroids had improved survival, a finding that trended towards but did not reach significance", survival , no steroid , topical steroid ,0,
edin,7828,5754508,Significantly increased,"We observed a significant two-fold increase in plasma sCD163 levels following LPS exposure (Pâ<â0.001), and sCD163 concentrations correlated positively with the plasma concentration of free fatty acids, Rapalmitate, lipid oxidation rates and phosphorylation of the hormone-sensitive lipase at serine 660 in adipose tissue (Pâ<â0.05, all).", concentration of sCD163 , placebo exposure , LPS exposure ,0,
edin,7886,3814649,Significantly decreased,"However, both cleavage and blastocyst rates were lower (Pâ<â0.001) in the Vitrified group than in the Control, VS1 and VS1â+âVS2 groups (40.9 and 1.6% vs 92.2 and 34.4%, 79.4 and 25.2%, and 80.2 and 20.8%, respectively in Experiment 1, and 25.0 and 1.7% vs 75.3 and 27.2%, 67.9 and 19.5%, and 62.7 and 22.5%, respectively in Experiment 2).", cleavage and blastocyst rates , Control group: no treatment; VS1 group: COCs were exposed to vitrification solution 1 (VS1) containing 7.5% ethylene glycol [EG]â+â7.5% dimethyl sulfoxide [DMSO]â+â20% calf serum [CS] in TCM-199 at 37 C for 5âmin; VS1â+âVS2 group: COCs were exposed to VS1 for 5âmin followed by VS2 (15% EGâ+â15% DMSOâ+â17.1% sucroseâ+â20% CS) at 37 C for 45â60âsec; ," Vitrified group: COCs were exposed to VS1 and VS2, loaded on cryotops, vitrified in liquid nitrogen and then warmed in TCM-199â+â17.1% sucroseâ+â20% CS at 37 C for 1âmin. ",0,
edin,7972,4494428,Significantly increased,"Hogs transported 6 h had increased cortisol concentrations (103.0 vs. 95.5 ng/mL; P < 0.001) and decreased L* (52.49 vs. 52.69; P = 0.09), b* (6.28 vs. 6.36; P = 0.03), and hue angle (20.70 vs. 20.95; P = 0.03) compared to hogs transported 3 h.", Transport duration - effect on serum cortisol concentration , hogs transported for only 3 h , hogs being transported for 6 h ,0,
edin,7925,3526879,Significantly decreased,"The values (mean Â± standard deviation [SD]) of relative changes to BW (â8.0% Â± 0.8%), BF (â21.4% Â± 2.1%), LM (3.0% Â± 0.3%), and FM (â31.2% Â± 3.0%) to the OT group were higher (P < 0.05) than in the AWT (BW: â2.0% Â± 1.1%; BF: â4.6% Â± 1.8%; FM: â7.0% Â± 2.8%; LM: 0.2% Â± 1.1%) and OWT (BW: â4.5% Â± 1.0%; BF: â11.0% Â± 2.2%; FM: â16.1% Â± 3.2%; LM: â0.2% Â± 1.0%) groups; additionally, no differences were found for C groups."," body weight (BW), body fat (BF), fat mass (FM), lean mass (LM), and BMI ", baseline , appropriate weight (AW) trained (AWT) group ,0,
edin,8103,5405916,Cannot tell based on the abstract,, likelihood a person voted , control , banner ,0,
edin,8103,5405916,Significantly increased,"A simple regression of turnout on an indicator variable for receiving both treatments increased the likelihood of voting by +0.17% (the 95% confidence interval [CI] for the coefficient in the regression is â0.05% to +0.4%) but this estimate is too noisy to yield confidence that it is different from chance.,The results suggest that the banner treatment was effective in spreading behavior to friends (a 0.1% increase in voting likelihood for each close friend treated), but the feed treatment was not. Stratified statistical analyses also replicate these results.,Fig 3 shows that each additional close friend who received the banner treatment increased the likelihood a person voted by about +0.10%.", likelihood a person voted , control , banner ,0,
edin,7965,3940644,Cannot tell based on the abstract,, time to first  and second fall , control , multifactorial intervention to reduce falls among the oldest-old people ,0,
edin,7965,3940644,No significant difference,"Similarly, during 2 years of follow-up in this study, the KaplanâMeier method revealed no significant differences between intervention and control participants in time to first (P=0.138) and second fall (P=0.062), as shown in Figure 2. I", time to first  and second fall , control , multifactorial intervention to reduce falls among the oldest-old people ,0,
edin,7812,2602945,Significantly increased,"Exam room utilization was lower for late patients (28.9% versus 44.7%, P = .03) with physician utilization lower in clinics with 3 or more late patients when compared to clinics with 2 or fewer (59.7% versus 68.7%, P = .004).", exam room utilization time , late patients , on-time patients ,0,
edin,7861,4368876,Cannot tell based on the abstract,, treatment condition , brief (at 5 times seizure threshold) pulse RUL ECT , ultrabrief (at 8 times seizure threshold) RUL ECT ,0,
edin,7861,4368876,No significant difference,"There was no significant effect of treatment condition (pulsewidth; t = -0.68, p = 0.50), or interaction between treatment condition and time (t = 0.74, p = 0.46), or treatment condition and time squared (t = -0.72, p = 0.48).", treatment condition , brief (at 5 times seizure threshold) pulse RUL ECT , ultrabrief (at 8 times seizure threshold) RUL ECT ,0,
edin,7934,1868720,Cannot tell based on the abstract,, For duration of sick leave (days) and frequency of sickness absence (spells) , 'not at risk'  group , at risk'  group ,0,
edin,7934,1868720,No significant difference,"As regards duration of sick leave (days) and frequency of sickness absence (spells), no difference was found between the medians of the respondents and non-respondents (p = 0.468 and p = 0.708 respectively) (Table 1).", For duration of sick leave (days) and frequency of sickness absence (spells) , 'not at risk'  group , at risk'  group ,0,
edin,7857,4955417,Cannot tell based on the abstract,"The mean paracetamol dose/patient was 3.96 Â± 1.43, 2.94 Â± 0.81, 2.18 Â± 0.69, 1.87 Â± 0.78 in group RO, ST, DL and SL, respectively, P < 0.0001.", The mean ParacetamolÂ® dose/patient , baseline ," RO (had external ring opened, hernial sac twisted and doubly ligated), ST (had hernial sac twisted and doubly ligated without opening the ring), DL (had double ligation of hernial sac without ring opening nor twisted) while SL (had single ligation of hernial sac with neither ring opening nor sac twisting) ",0,
edin,7857,4955417,Significantly increased,"The mean ParacetamolÂ® dose/patient was 3.96 Â± 1.43, 2.94 Â± 0.81, 2.18 Â± 0.69 and 1.87 Â± 0.78 in groups RO, ST, DL and SL, respectively, (P < 0.001) [Figure 1].", The mean ParacetamolÂ® dose/patient , baseline ," RO (had external ring opened, hernial sac twisted and doubly ligated), ST (had hernial sac twisted and doubly ligated without opening the ring), DL (had double ligation of hernial sac without ring opening nor twisted) while SL (had single ligation of hernial sac with neither ring opening nor sac twisting) ",0,
edin,8115,4932043,Cannot tell based on the abstract,, gain in the range of motion , Control , Infrared ,0,
edin,8115,4932043,Significantly increased,"<td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">Infrared and Neural Mob.</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""top"">8.5</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""top"">25.20*</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""top"">â1â50</td>", gain in the range of motion , Control , Infrared ,0,
edin,8016,3441280,Cannot tell based on the abstract,, increase in plasma lithium , administration via distal-release pellets , administration via proximal-release pellets ,0,
edin,8016,3441280,Significantly increased,Comparison of the AUC of the two types of ATP-containing pellets revealed that the proximal-release pellets caused a significantly higher increase in plasma lithium than the distal-release pellets (Pâ=â0.001) (Figureâ3)., increase in plasma lithium , administration via distal-release pellets , administration via proximal-release pellets ,0,
edin,7913,2796659,Significantly decreased,"Patients experienced highly significant reductions in both HAM-D and HAM-A scores following treatment, with the greatest reductions occurring at 2 weeks.", Hamilton Anxiety Rating Scale (HAM-A) , baseline , NIR to left forehead at F3 to right forehead at F4 ,0,
edin,8047,5694526,Cannot tell based on the abstract,," irritable bowel syndrome with constipation (IBS-C) - incidence of treatment-emergent nausea, moderate ", placebo for each indication , lubiprostone (8 mcg BID for IBS-C) ,0,
edin,8047,5694526,Significantly increased,"The crude incidence of treatment-emergent nausea in the RCT populations was significantly higher in patients who received lubiprostone (24 mcg BID for CIC and OIC; 8 mcg BID for IBS-C) compared with placebo for each indication (CIC, 29.3 vs 6.3%, respectively; OIC, 13.4 vs 6.4%; IBS-C, 10.9 vs 6.4%; TableÂ 2)."," irritable bowel syndrome with constipation (IBS-C) - incidence of treatment-emergent nausea, moderate ", placebo for each indication , lubiprostone (8 mcg BID for IBS-C) ,0,
edin,7991,5154305,Cannot tell based on the abstract,, treatment of RA (Rheumatoid arthritis) patients with a high disease activity at baseline , adalimumab , abatacept ,0,
edin,7991,5154305,No significant difference,"In patients with a high disease activity at baseline, the clinical efficacy of abatacept was similar to adalimumab and tocilizumab.", treatment of RA (Rheumatoid arthritis) patients with a high disease activity at baseline , adalimumab , abatacept ,0,
edin,8031,5771357,Cannot tell based on the abstract,, mean hospital stay - patients undergoing CABG / CE ," In group 2, the patients were given 75 mg plavix (clopidogrel) daily together with 80 mg aspirin daily for 3 months "," group 1, the patients were given warfarin (INR) between 2-3) together with 80 mg aspirin daily for 3 months ",0,
edin,8031,5771357,No significant difference,The mean hospital stay was 9.07Â±3.29 days in clopidogrel group and 9.26Â±1.93 days in warfarin group (p=0.820)., mean hospital stay - patients undergoing CABG / CE ," In group 2, the patients were given 75 mg plavix (clopidogrel) daily together with 80 mg aspirin daily for 3 months "," group 1, the patients were given warfarin (INR) between 2-3) together with 80 mg aspirin daily for 3 months ",0,
edin,8025,3881751,No significant difference,"<td colspan=""1"" rowspan=""1"">RHAL</td><td align=""center"" colspan=""1"" rowspan=""1""></td><td align=""center"" colspan=""1"" rowspan=""1""></td>", relative horizontal attachment level (RHAL) gain , identical treatment using distilled water as the cooling liquid (control group). , subgingival instrumentation with an ultrasonic device using PVP-I (10%) as the cooling liquid (test group) ,0,
edin,8060,5908397,Cannot tell based on the abstract,, Percentage of treatment failure on day 10 - severe pneumonia in children , placebo , zinc as an adjunct treatment ,0,
edin,8060,5908397,No significant difference,There was no significant difference in the proportion of treatment failure on day-5 (14.0% vs 14.1%) or on day-10 (5.2% vs 5.9%) in placebo and zinc arm respectively (Table 2)., Percentage of treatment failure on day 10 - severe pneumonia in children , placebo , zinc as an adjunct treatment ,0,
edin,7832,4541185,Significantly increased,The duration of analgesia was also prolonged in patients receiving clonidine (613.10 Â± 51.797 min vs. 878.33 Â± 89.955 min)., duration of analgesia , ropivacaine + saline , ropivacaine + diluted clonidine with saline ,0,
edin,7842,1896161,No significant difference,There was no significant change in objective quantification of wheezes and crackles or in the total clinical scores either within the groups or between the groups., computerized quantification of wheezing and crackles in infants , epinephrine , albuterol ,0,
edin,7949,4061773,Cannot tell based on the abstract,"However, performance time, rate of perceived exertion as well as post-trial pH and lactate concentration were not significantly different between trials. Further analysis revealed that five swimmers, identified as responders, improved their performance time by 1.03% (Pâ<â0.05) and attained higher post-trial lactate concentrations in the ACU versus PLC-A trial (Pâ<â0.05). They also had significantly higher post-trial lactate concentrations compared to the non-responders in the ACU and CHR trials.", blood lactate concentrations , baseline ," (ACU) sodium citrate dihydrate (Na-CIT) supplementation (0.5kg-1;  acute placebo (PLC-A),), and chronic placebo (PLC-C);   chronic sodium citrate dihydrate (Na-CIT) (CHR) supplementation (0.1kg-1 for three days and 0.3kg-1 on the forth day 120;min pre-trial ",0,
edin,7949,4061773,Significantly increased,"As expected, blood lactate concentrations were significantly increased from post-ingestion to post-trial (Pâ<â0.05), across all trials. The responders had significantly higher blood lactate concentrations in the ACU compared to the PLC-A trial (Pâ<â0.05), but this was not the case when comparing the CHR versus the PLC-C trial. Furthermore, responders had significantly higher post-trial blood lactate concentrations than non-responders in both the ACU (Pâ<â0.05) and the CHR trials (Pâ<â0.05) (FigureÂ  2).", blood lactate concentrations , baseline ," (ACU) sodium citrate dihydrate (Na-CIT) supplementation (0.5kg-1;  acute placebo (PLC-A),), and chronic placebo (PLC-C);   chronic sodium citrate dihydrate (Na-CIT) (CHR) supplementation (0.1kg-1 for three days and 0.3kg-1 on the forth day 120;min pre-trial ",0,
edin,7821,5341634,Significantly decreased,"Postoperative VAS value at 24 h was significantly lower in Group LN (P < 0.05). Intraoperative hemodynamics was comparable between two groups, and no any appreciable side effect was noted throughout the study period.", Postoperative lower VAS scale , levobupivacaine + normal saline , nalbuphine hydrochloride ,0,
edin,7988,4314171,Cannot tell based on the abstract,, after 10 days therapy - arterial BP level in patients who had stage I hypertension , kinesitherapy and electrotherapy , Sulphate-sulphide mineral water âMljeÄanicaâ plus kinesitherapy and electrotherapy ,0,
edin,7988,4314171,Significantly decreased,"In experimental group, after 10 days BP values lowered 10 mmHg in average and the decrease in values is evident already in first 5 days of therapy.", after 10 days therapy - arterial BP level in patients who had stage I hypertension , kinesitherapy and electrotherapy , Sulphate-sulphide mineral water âMljeÄanicaâ plus kinesitherapy and electrotherapy ,0,
edin,7958,3816862,Cannot tell based on the abstract,, body weight and BMI regain at follow-up , baseline , 6-month hypocaloric diet ,0,
edin,7958,3816862,Significantly increased,"We calculated weight regain as the difference between body weight at follow-up and body weight after the active dietary intervention period at 6 months. After successful reduction of body weight and BMI with dietary intervention, we observed a significant weight regain at follow-up (Table 1 and Fig. 1).", body weight and BMI regain at follow-up , baseline , 6-month hypocaloric diet ,0,
edin,7993,5154305,Cannot tell based on the abstract,, Juvenile Idiopathic Arthritis (JIA) - onset of action , TNF-alpha treatment , abatacept ,0,
edin,7993,5154305,No significant difference,"The ACR20 response rate was comparable with the 2 biologic therapies at 2 years (59.7% abatacept plus MTX and 60.1% MTX plus adalimumab), with the onset of action of the two agents generally comparable.", Juvenile Idiopathic Arthritis (JIA) - onset of action , TNF-alpha treatment , abatacept ,0,
edin,7854,5379244,Cannot tell based on the abstract,, glucose control , usual pump therapy , day-and-night closed-loop insulin ,0,
edin,7854,5379244,Significantly increased,"The user feedback questionnaire was fully completed by 26 participants, and four of the six questions were answered by all participants (appendix). 27 (93%) of 29 participants were happy to have their glucose levels automatically controlled by the closed-loop system. 20 (69%) participants stated that they spent less time managing their diabetes while using the closed-loop system, but seven (24%) disagreed with this statement. 18 (62%) expressed fewer concerns about their glycaemic control while using the closed-loop system.", glucose control , usual pump therapy , day-and-night closed-loop insulin ,0,
edin,7809,5623327,Cannot tell based on the abstract,," patients with early RA (PREMIER), CDC based on DAS28(CRP)&amp;lt;2.6 ", therapy with placebo in addition to MTX , therapy with adalimumab in addition to MTX ,0,
edin,7809,5623327,Significantly increased,"In patients with early RA (PREMIER), CDC based on DAS28(CRP)<2.6 was achieved in 25% (n/N=67/268) of patients in the adalimumab+MTXâarm compared with 9% (n/N=22/257) in the placebo+MTXâarm (p<0.001; figure 1B)."," patients with early RA (PREMIER), CDC based on DAS28(CRP)&amp;lt;2.6 ", therapy with placebo in addition to MTX , therapy with adalimumab in addition to MTX ,0,
edin,8087,5761719,Cannot tell based on the abstract,, Goodness-of-fit , CADC model , PROMISE minimal-risk tool ,0,
edin,8087,5761719,Significantly increased,"Goodness-of-fit was not demonstrated for either established CADC model (Ï2 1010.1, HL pÂ <Â 0.001) or the PROMISE minimal-risk risk tool (Ï2 197.6, HL pÂ <Â 0.001). Goodness-of-fit for the PROMISE minimal-risk risk tool remained suboptimal following recalibration of the model intercept (Ï2 32.2, HL pÂ <Â 0.001) and calibration slope (Ï2 23.7, HL pÂ =Â 0.026) but was improved by the further addition of re-estimated model coefficients (Ï2 5.6, HL pÂ =Â 0.692; Supplementary Table 2) resulting in good calibration (Fig. 1).Fig. 1", Goodness-of-fit , CADC model , PROMISE minimal-risk tool ,0,
edin,8002,4207147,Cannot tell based on the abstract,, HRV low frequency (LF) oscillations - Five minutes after nasotracheal suction , control group (CG); conventional physical therapy (CPT) for airway clearance , acute bronchiolitis group (BG); conventional physical therapy (CPT) for airway clearance and nasotracheal suction ,0,
edin,8002,4207147,Significantly decreased,"n turn, 5 minutes after nasotracheal suction, there were reductions in overall variance and in LF and HF oscillations (compared to those values after CPT) in absolute and normalized units resulting in a significant increase in the LF/HF ratio.", HRV low frequency (LF) oscillations - Five minutes after nasotracheal suction , control group (CG); conventional physical therapy (CPT) for airway clearance , acute bronchiolitis group (BG); conventional physical therapy (CPT) for airway clearance and nasotracheal suction ,0,
edin,8114,4932043,Cannot tell based on the abstract,, gain in the range of motion , Control , Neural Mob ,0,
edin,8114,4932043,Significantly increased,"<td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">Infrared and Neural Mob.</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""top"">8.5</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""top"">25.20*</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""top"">â1â50</td>", gain in the range of motion , Control , Neural Mob ,0,
edin,7847,3224655,Cannot tell based on the abstract,, lung function , routine treatment and NIV , routine pharmacological treatment ,0,
edin,7847,3224655,Cannot tell based on the abstract,, lung function , routine treatment and NIV , routine pharmacological treatment ,0,
edin,7847,3224655,Invalid Prompt,, lung function , routine treatment and NIV , routine pharmacological treatment ,1, I was not able to find anything regarding lung function
edin,7892,4124476,No significant difference,"There were no significant differences in the incidence of PONV or need for rescue antiemetics 0â2Â h postoperatively,", the incidence of PONV or need for rescue antiemetics 0â2&amp;nbsp;h postoperatively ," ondansetron (4mg; group A), ondansetron (8 mg; group B)  ", ramosetron (0.3mg; group C) ,0,
edin,8102,4890862,No significant difference,"No effects were observed for girls or for the continuous measures of Total, Internalizing, and Externalizing problems.", Internalizing problems , control group ," intervention group, involving home visits ",0,
edin,8106,5405916,Cannot tell based on the abstract,, effective in spreading behavior to friends , news feed , banner ,0,
edin,8106,5405916,Significantly increased,"The results suggest that the banner treatment was effective in spreading behavior to friends (a 0.1% increase in voting likelihood for each close friend treated), but the feed treatment was not. Stratified statistical analyses also replicate these results.", effective in spreading behavior to friends , news feed , banner ,0,
edin,7922,1475428,Cannot tell based on the abstract,, hSGLT3 transcript levels in skeletal muscle , standard of care (controls) , resistance training (3x/wk) ,0,
edin,7922,1475428,Significantly increased,"As shown in Figure 1, the median relative expression ratio (2-ÎÎCt) of hSGLT3 transcript levels in skeletal muscle increased by a factor of 10.02 after 16 weeks of progressive resistance exercise training compared to control subjects (0.10, P = 0.03).", hSGLT3 transcript levels in skeletal muscle , standard of care (controls) , resistance training (3x/wk) ,0,
edin,8092,3339727,Significantly decreased,There was no statistically significant difference in any parameter in the two groups except for a significant fall in systolic and mean arterial pressure in F2 group., decrease in systolic blood pressure , F2 (fentanyl 2 mcg/kg) , F1 (fentanyl 1 mcg/kg) ,0,
edin,7967,2784472,Significantly increased,"Measured against the placebo, subjects in the probiotic group achieved significant improvements in GSRS abdominal pain subscore (p = 0.046) and the GSRS total score (p = 0.048), with a strong trend for improvement on the GSRS abdominal distension subscore (p = 0.061).", Improvement in GSRS (Gastrointestinal Symptom Rating Scale) abdominal pain subscore - in adults with post prandial intestinal gas-related symptoms and no GI diagnoses , Placebo group , Digestive Advantageâ¢ Gas Defense Formula (GD) group ,0,
edin,7911,2877680,Cannot tell based on the abstract,," Similarly, lipid ratios, including total-cholesterol:HDL-cholesterol, LDL-cholesterol:HDL-cholesterol, TAG:HDL-cholesterol, non-HDL-cholesterol:HDL-cholesterol and apolipoprotein B:apolipoprotein AI ", white bread , whole grain wheat sourdough bread ,0,
edin,7911,2877680,No significant difference,"Similarly, lipid ratios, including total-cholesterol:HDL-cholesterol, LDL-cholesterol:HDL-cholesterol, TAG:HDL-cholesterol, non-HDL-cholesterol:HDL-cholesterol and apolipoprotein B:apolipoprotein AI, did not significantly differ between the whole grain wheat sourdough and white bread treatments, within either the NGI or HGI group (data not shown)."," Similarly, lipid ratios, including total-cholesterol:HDL-cholesterol, LDL-cholesterol:HDL-cholesterol, TAG:HDL-cholesterol, non-HDL-cholesterol:HDL-cholesterol and apolipoprotein B:apolipoprotein AI ", white bread , whole grain wheat sourdough bread ,0,
edin,7888,4039994,Significantly decreased,"<td colspan=""13"">Balance Test</td>", Psychomotor Vigilance Test (PVT) , placebo ," three different doses of alcohol leading to blood alcohol concentrations (BACs) of  0.5, and 0.8g/L. ",0,
edin,8121,2822946,Cannot tell based on the abstract,, proportion of false positive (FP) results , first round , repeat screening ,0,
edin,8121,2822946,Significantly decreased,"When men of similar age at screening were compared, the proportion of FP results was lower at repeat screening compared with the first round.", proportion of false positive (FP) results , first round , repeat screening ,0,
edin,7865,2778511,Cannot tell based on the abstract,, Patients preferense ,  the standard hospital procedure (control group) ," âone-time general consent' (asked written informed consent), âopt-out plus' (had the opportunity to opt out by a form) ",0,
edin,7865,2778511,Significantly increased,"Based on all groups combined, 43% of respondents preferred âopt-out plus', 16% âopt-out', 34% âone-time consent', and 8% âno information at all' (Table 3). The majority of respondents preferred information to be given before or during hospitalisation (Table 3).,In the follow-up questionnaire, patients preferred âopt-out plus' above âone-time consent' or âopt-out' without actively being informed.", Patients preferense ,  the standard hospital procedure (control group) ," âone-time general consent' (asked written informed consent), âopt-out plus' (had the opportunity to opt out by a form) ",0,
edin,7952,2715417,Cannot tell based on the abstract,, Distribution of T and N status by IHC scores ," CRT, chemoradiation "," RT, radiation ",0,
edin,7952,2715417,No significant difference,"Instead we examined for correlation between COX-2 expression and the following prognostic factors: treatment received (RT versus CRT) (Table 2), T status, N status and TMN stage. The only correlation which reached statistical significance was between T status and COX-2 IHC scores (p = 0.029); it was observed that within the T1 tumors, there was none which showed moderate or strong COX-2 expression (Table 3).", Distribution of T and N status by IHC scores ," CRT, chemoradiation "," RT, radiation ",0,
edin,8020,5772830,Significantly increased,"P-prisms improved blind-side detection from 42% to 56%, which further improved after training to 72% (all P < 0.001).", blind-side detection , p-prisms after 2 weeks but before training , p-prisms after training  ,0,
edin,7953,3603112,Significantly decreased,There was a significant reduction in HbA1c within the study group (8.76% to 7.43%) (P = 0.08) vs rise in the control group (8.34% to 9.34%) (P = 0.07)., HbA1c , baseline , walk for 5 minutes per hour for most waking hours for 24 weeks ,0,
edin,8006,5125808,Significantly increased,"At Week 8, the CKD-828 2.5/40 mg (sitDBP/SBP: P=0.0002/P<0.0001) and CKD-828 2.5/80 mg (sitDBP/SBP: P=0.0001/P<0.0001) showed superior BP-lowering effects to S-amlodipine 2.5 mg (P<0.001).", BP-lowering effects at Week 8 , S-amlodipine 2.5 mg (who failed to respond after 4-week S-amlodipine 2.5 mg monotherapy) , CKD-828 2.5/40 mg (who failed to respond after 4-week S-amlodipine 2.5 mg monotherapy) ,0,
edin,8117,4932043,Cannot tell based on the abstract,, elbow extension , G2: neural mobilization , G4: infrared plus neural mobilization ,0,
edin,8117,4932043,Significantly increased,"<td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">Infrared and Neural Mob.</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""top"">8.5</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""top"">25.20*</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""top"">â1â50</td>", elbow extension , G2: neural mobilization , G4: infrared plus neural mobilization ,0,
edin,7994,5154305,Cannot tell based on the abstract,, Juvenile Idiopathic Arthritis (JIA) - time to relapse , TNF-alpha treatment , abatacept ,0,
edin,7994,5154305,Significantly increased,"Compared with TNF-alpha treatment, the onset of action abatacept was delayed; it took a longer time to relapse and a smaller proportion of patients relapsed after stopping the treatment", Juvenile Idiopathic Arthritis (JIA) - time to relapse , TNF-alpha treatment , abatacept ,0,
edin,8191,4963027,Cannot tell based on the abstract,, Body mass index z-scores in obese kids  , Control , Information sessions plus digital resources ,0,
edin,8191,4963027,Significantly decreased,"<td colspan=""1"" rowspan=""1""><break><break><break></break></break></break></td><td colspan=""3"" rowspan=""1""><break></break></td><td colspan=""2"" rowspan=""1""><break></break></td><td colspan=""3"" rowspan=""1""><break></break></td>,In obese children, the effect on BMIZ between groups was -0.12 (95% CI -0.23 to -0.02) at 6 months and -0.16 (95% CI -0.32 to -0.01) at 12 months.,Concerning obese children, those of CG maintained their BMIZ throughout the follow-up, whereas BMIZ of IG children decreased at 6 months (P<.001) and continued decreasing to 12 months (P=.001).", Body mass index z-scores in obese kids  , Control , Information sessions plus digital resources ,0,
edin,8299,3984416,Cannot tell based on the abstract,, Energy intake , Placebo , Î²-alanine  ,0,
edin,8299,3984416,No significant difference,"The energy, carbohydrate, protein, fat and Î²-alanine intake are presented in TableÂ 3. No significant differences were observed within or between groups (all pÂ >Â 0.05).", Energy intake , Placebo , Î²-alanine  ,0,
edin,8220,5530334,Cannot tell based on the abstract,, Trunk injury , Control , Pre-activity movement control exercise programme ,0,
edin,8220,5530334,No significant difference,"<td align=""left"" colspan=""1"" rowspan=""1"">âTrunk</td><td align=""left"" colspan=""1"" rowspan=""1"">Incidence</td><td align=""left"" colspan=""1"" rowspan=""1"">2 (1â3)</td><td align=""left"" colspan=""1"" rowspan=""1"">2 (1â3)</td><td align=""char"" char=""("" colspan=""1"" rowspan=""1"">0.90 (0.47â1.71)</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">0.78</td>,Of 441 reported match injuries, 168 were sustained to the head/neck (intervention, 82; control, 86), 125 to the upper limb (intervention, 65; control, 60), 113 to the lower limb (intervention, 67; control, 46) and 35 to the trunk (intervention, 19; control, 16).", Trunk injury , Control , Pre-activity movement control exercise programme ,0,
edin,8311,3793422,No significant difference,"The surface treatment methods did not have any significant effect (P > 0.05) on any group but EDTA group had the highest bond strength.,Surface treatment with (ethanol, EDTA, and EDTA + ethanol) does not significantly appear to be effective in improving the bond strength of fiber posts into root dentine.", Bond strength , Ethanol , Ethylene di-amine tetra-acetic acid ,0,
edin,8254,3511173,Cannot tell based on the abstract,The PEG-only preparation was better tolerated as shown by the lower frequency of nausea than in the PEG-EL group., Nausea , PEG-based laxatives + electrolytes , PEG-based laxatives ,0,
edin,8254,3511173,Significantly increased,"The PEG-only group was better in terms of tolerability. The comparison is significant for the symptom of nausea (p=0.003), but not for abdominal discomfort (Table 3).,Nausea
Â 
Â 
No episodes
48
(98%)
33
(79%)
1 or 2 episodes
1
(2%)
9
(21%)
Â 
Â 
p=0.003", Nausea , PEG-based laxatives + electrolytes , PEG-based laxatives ,0,
edin,8142,3635645,Cannot tell based on the abstract,"The SBP, DBP, MAP and HR within group R4 were not significantly different as compared with baseline values.", Systolic blood pressure  , Remifentanil 2 ng/mL , Remifentanil 6 ng/mL ,0,
edin,8142,3635645,Significantly decreased,"Comparing the SBP among these groups, the SBP of group R2 was significantly higher than that of group R4 or R6 1 minute after inhalation.,The SBP of group R6 was significantly lower 3 minutes after inhalation compared to group R2 or R4 (p<0.05) (Fig. 3).", Systolic blood pressure  , Remifentanil 2 ng/mL , Remifentanil 6 ng/mL ,0,
edin,8171,3628802,Significantly increased,"Following alternate nostril breathing (ANYB) there was a significant decrease in systolic and diastolic blood pressure (p<0.001 and p<0.05), and an improvement in Purdue pegboard task scores for both hands (p<0.05), and for the right hand (p<.001).", Purdue pegboard task score improvement (right hand) , Control , Breath awareness control session ,0,
edin,8176,2762857,No significant difference,"First, the cues did not affect how long the women spent on the site or how long they spent reading the text.,Second, there were no effects of the cues on any of the measures of cognition, affect, vulnerability, or intentions.", Affect ,  Positive Cues , Negative Cues ,0,
edin,8265,4228518,Cannot tell based on the abstract,, Rhodes Index scores reduction for retching , Placebo , Ginger ,0,
edin,8265,4228518,Significantly increased,"An ANOVA test showed that there were significant differences in the mean reduction of Rhodes Index scores in vomiting, nausea, retching and total scores between the three groups (P < 0.001) (Table 2).,<td colspan=""1"" rowspan=""1"">
<bold>Retching</bold>
</td><td colspan=""1"" rowspan=""1"">2.15 Â± 1.62</td><td colspan=""1"" rowspan=""1"">0.45 Â± 1.60</td><td colspan=""1"" rowspan=""1"">-0.34 Â± 1.26</td><td colspan=""1"" rowspan=""1"">0.001</td>", Rhodes Index scores reduction for retching , Placebo , Ginger ,0,
edin,8318,2887201,Significantly decreased,"When the subgroup of patients prescribed to receive full volume feeds in the after group were evaluated (n = 18), they received 83.2% and 89.4% of their energy and protein requirements by EN respectively (P = 0.02 for energy and 0.002 for protein compared to the before group).,In the before group, on average, patients received 58.8% of their energy and 61.2% of their protein requirements by EN compared to 67.9% and 73.6% in the after group (P = 0.33 and 0.13).", Protein requirements intake , Placebo , Enhanced protein-energy provision ,0,
edin,8175,2762857,No significant difference,"Second, there were no effects of the cues on any of the measures of cognition, affect, vulnerability, or intentions.", Cognition ,  Positive Cues , Negative Cues ,0,
edin,8228,5409660,Cannot tell based on the abstract,, Monocyte Chemoattractant Protein-1 , Cooked ham , Dry-cured ham ,0,
edin,8228,5409660,Significantly increased,"The mean differences between dry-cured ham and cooked ham followed by a time period adjustment for plasmatic P-selectin and interleukin 6 proteins slightly failed (p = 0.062 and p = 0.049, respectively), notably increased for MCP-1 levels (p = 0.023) while VCAM-1 was not affected.", Monocyte Chemoattractant Protein-1 , Cooked ham , Dry-cured ham ,0,
edin,8258,3301259,Cannot tell based on the abstract,, PaO2/FioO2 improvement  , Placebo , Pentoxifylline  ,0,
edin,8258,3301259,Significantly increased,"PaO2/FioO2-ratio was significantly improved in POF treated patients from day 10 (266 Â± 132) to day 21 (346 Â± 142) compared to the placebo group (201 Â± 161 vs 221 Â± 112, P < 0.05 and P < 0.01 on day 14 and 17).", PaO2/FioO2 improvement  , Placebo , Pentoxifylline  ,0,
edin,8301,3984416,Cannot tell based on the abstract,, Protein intake , Placebo , Î²-alanine  ,0,
edin,8301,3984416,No significant difference,"The energy, carbohydrate, protein, fat and Î²-alanine intake are presented in TableÂ 3. No significant differences were observed within or between groups (all pÂ >Â 0.05).", Protein intake , Placebo , Î²-alanine  ,0,
edin,8264,4228518,Cannot tell based on the abstract,, Rhodes Index scores reduction for nausea , No intervention , Ginger ,0,
edin,8264,4228518,Significantly increased,"An ANOVA test showed that there were significant differences in the mean reduction of Rhodes Index scores in vomiting, nausea, retching and total scores between the three groups (P < 0.001) (Table 2).,<td colspan=""1"" rowspan=""1"">
<bold>Nausea</bold>
</td><td colspan=""1"" rowspan=""1"">3.86 Â± 2.35</td><td colspan=""1"" rowspan=""1"">1.26 Â± 1.57</td><td colspan=""1"" rowspan=""1"">-0.33 Â± 1.74</td><td colspan=""1"" rowspan=""1"">0.001</td>,A Tukeyâs post hoc test was performed and the results showed a significant difference between the three groups in the mean reduction of vomiting, nausea, retching and total Rhodes Index scores (P < 0.001).", Rhodes Index scores reduction for nausea , No intervention , Ginger ,0,
edin,8217,5739798,Cannot tell based on the abstract,, Fever (&amp;gt;38Â°C) , Radical surgery alone  , Radical surgery + surgical wound surface injection  ,0,
edin,8217,5739798,Significantly increased,"The adverse events and surgical complications were summarized in Table 5. Among them, only fever was classed as the rAd-p53 related adverse event.,<td align=""left"" colspan=""1"" rowspan=""1"" valign=""middle"">Fever (&gt;38Â°C)</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""middle"">49 (59.8)</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""middle"">6 (7.4)</td>", Fever (&amp;gt;38Â°C) , Radical surgery alone  , Radical surgery + surgical wound surface injection  ,0,
edin,8151,3580622,Significantly increased,"The mean (Â± SD) change in pleural opacity was greater in the t-PA-DNase group than in the placebo group (-29.5 Â± 23.3% vs. -17.2 Â± 19.6%; difference, -7.9%; 95% confidence interval [CI], -13.4 to -2.4; P = 0.005).", Pleural opacity , Placebo , Tissue plasminogen activator + deoxyribonuclease  ,0,
edin,8242,3139306,Significantly increased,"Compared with placebo group, patients in the dexmedetomidine group required 52.7% less PCA morphine during the first 24 hours postoperatively, with significantly better visual analogue scale scores, less incidence of respiratory obstruction (5 vs. 12 patients, respectively; P = .037) and longer time to first analgesic request (21 (11) vs. 9 (4) minutes; P = .002).", Time to first analgesic request  , Placebo , Dexmedetomidine  ,0,
edin,8288,4682450,Cannot tell based on the abstract,, Wake time after sleep onset improvement  , Naproxen sodium + diphenhydramine (220mg/50mg) , Naproxen sodium + diphenhydramine (440mg/50mg) ,0,
edin,8288,4682450,Significantly increased,"Only the NS 440Â mg/DPH 50Â mg combination showed significant improvement in both WASO and SL when compared with the individual components alone. The NS 440Â mg/DPH 50Â mg combination had a significantly shorter WASO than NS alone (â70.3Â min, pÂ =Â 0.0002).,<th align=""left"" colspan=""1"" rowspan=""1""><italic>N</italic>&nbsp;=&nbsp;203</th><th align=""left"" colspan=""1"" rowspan=""1""><italic>N</italic>&nbsp;=&nbsp;204</th><th align=""left"" colspan=""1"" rowspan=""1""><italic>N</italic>&nbsp;=&nbsp;203</th><th align=""left"" colspan=""1"" rowspan=""1""><italic>N</italic>&nbsp;=&nbsp;102</th><th align=""left"" colspan=""1"" rowspan=""1""><italic>N</italic>&nbsp;=&nbsp;107</th><th align=""left"" colspan=""1"" rowspan=""1""><italic>N</italic>&nbsp;=&nbsp;106</th><th align=""left"" colspan=""1"" rowspan=""1""><italic>N</italic>&nbsp;=&nbsp;54</th>,When comparing the two combination formulations, NS 440Â mg/DPH 50Â mg was significantly better than NS 220Â mg/DPH 50Â mg for both WASO (â87.1Â min, pÂ <Â 0.0001) and SL (25.50 for the 440Â mg combination and 30.25 for the 220Â mg combination, pÂ =Â 0.0096; Table2).", Wake time after sleep onset improvement  , Naproxen sodium + diphenhydramine (220mg/50mg) , Naproxen sodium + diphenhydramine (440mg/50mg) ,0,
edin,8320,2887201,No significant difference,"The rates of vomiting, regurgitation, aspiration, and pneumonia were similar between the two groups.", Regurgitation , Placebo , Enhanced protein-energy provision ,0,
edin,8308,2129145,Significantly decreased,"Subjects in the CF group tended to report less fatigue (p = 0.07), hunger (p = 0.02), and fullness (p = 0.04).", Fatigue  , Placebo , ForsLeanâ¢ ,0,
edin,8266,4228518,Cannot tell based on the abstract,, Rhodes Index scores reduction for retching , No intervention  , Ginger ,0,
edin,8266,4228518,Significantly increased,"An ANOVA test showed that there were significant differences in the mean reduction of Rhodes Index scores in vomiting, nausea, retching and total scores between the three groups (P < 0.001) (Table 2). A Tukeyâs post hoc test was performed and the results showed a significant difference between the three groups in the mean reduction of vomiting, nausea, retching and total Rhodes Index scores (P < 0.001).,<td colspan=""1"" rowspan=""1"">
<bold>Retching</bold>
</td><td colspan=""1"" rowspan=""1"">2.15 Â± 1.62</td><td colspan=""1"" rowspan=""1"">0.45 Â± 1.60</td><td colspan=""1"" rowspan=""1"">-0.34 Â± 1.26</td><td colspan=""1"" rowspan=""1"">0.001</td>", Rhodes Index scores reduction for retching , No intervention  , Ginger ,0,
edin,8127,4711101,No significant difference,"There was no significant difference of component alignment between the two surgical groups with respect to flexion/extension (pâ=â0.269), varus/valgus (pâ=â0.653) or rotational alignment (pâ=â0.485) of the femur component and varus valgus alignment (pâ=â0.778) or posterior slope (pâ=â0.164) of the tibial component.", Flexion/extension of the femur , Standard approach , Mini-midvastus ,0,
edin,8215,5739798,Significantly increased,"The hazard ratios after adjusting of age and disease stage (S vs. SP) of PFS and OS are 1.772 (95% CI, 1.102 to 2.848) and 2.047 (95% CI, 1.109 to 3.377), respectively. The 3 years PFS and OS for SP vs. S were 71.9% vs. 46.9%, and 88.4% vs. 67.0%, respectively. Differences in PFS and OS between two treatment groups were significant with the p values of 0.0165 and 0.0191, respectively, using Log-Rank test.", Progression free survival  , Radical surgery alone  , Radical surgery + surgical wound surface injection  ,0,
edin,8218,5530334,Cannot tell based on the abstract,, Head/neck injury , Control , Pre-activity movement control exercise programme ,0,
edin,8218,5530334,No significant difference,"However, clear effects favouring the intervention programme were noted for head/neck injuries (incidence RR=0.72, 0.51Â toÂ 1.01), upper limb injuries (burden RR=0.66, 0.40Â toÂ 1.10) and concussion (incidence RR=0.71, 0.48Â toÂ 1.05).,Head/neck	Incidence	9 (7â11)	13 (10â15)	0.72 (0.51â1.01)	0.11
Burden	260 (252â269)	285 (274â296)	0.91 (0.55â1.51)	0.77", Head/neck injury , Control , Pre-activity movement control exercise programme ,0,
edin,8167,3628802,Cannot tell based on the abstract,, Systolic blood pressure  , Control , Nostril yoga breathing ,0,
edin,8167,3628802,Significantly decreased,"There was a significant difference in the systolic blood pressure when (i) Pre and Post data were compared (F=24.38, df=1, 29.0, p<0.001) and (ii) between the three groups (i.e., ANYB, breath awareness, and a group reading a magazine, F=6.01, df=1, 29.0, p<0.05).,The systolic blood pressure significantly decreased immediately after the practice of ANYB (p<0.001, two-tailed) and breath awareness (the control session) (p<0.05, two-tailed) compared to pre.", Systolic blood pressure  , Control , Nostril yoga breathing ,0,
edin,8281,4431324,Significantly increased,"The infliximab group accumulated higher drug and healthcare costs (â¬27â487 vs â¬10â364; adjusted mean difference â¬16â956 (95% CI 14â647 to 19â162)), while productivity losses did not differ (â¬33â804 vs â¬29â220; â¬3961 (95% CI â3986 to 11â850)), resulting in higher societal cost compared to the conventional group (â¬61â291 vs â¬39â584; â¬20â916 (95% CI 12â800 to 28â660)).", Societal cost  , Conventional treatment , Infliximab  ,0,
edin,8251,3511173,Significantly decreased,"In the PEG-only group, 96% of patients did not demonstrate any difficulties associated with treatment, as compared with 52% of patients in the PEG-EL group (p < 0.001).", Difficulties associated with treatment , PEG-based laxatives + electrolytes , PEG-based laxatives ,0,
edin,8133,4804512,Cannot tell based on the abstract,, Ability to mobilise , Placebo , Ropivacaine ,0,
edin,8133,4804512,No significant difference,"Of the remaining 60 subjects there were no differences in mobilisation ability (CASâ=â5 in both groups, pâ=â0.26) or time to first mobilisation (368 vs. 420Â min, pâ=â0.69).", Ability to mobilise , Placebo , Ropivacaine ,0,
edin,8289,4682450,Significantly increased,"In the first study, only the NS 440Â mg/DPH 50Â mg combination showed significant improvements in both WASO vs. NS alone (â70.3Â min pÂ =Â 0.0002) and SL vs. DPH alone (25.50 and 41.50Â min respectively, pÂ <Â 0.0001).", Sleep latency improvement  , Naproxen sodium + diphenhydramine (220mg/50mg) , Naproxen sodium + diphenhydramine (440mg/50mg) ,0,
edin,8221,5530334,Cannot tell based on the abstract,, Contact injuries , Control , Pre-activity movement control exercise programme ,0,
edin,8221,5530334,Significantly decreased,"Per-protocol analyses conducted in the intervention arm indicated that teams typically completing at least three sessions per week with the intervention programme (four schools, seven teams) suffered 39% fewer match injuries (incidence RR=0.61, 0.42Â toÂ 0.88), 48% fewer days lost to match injuries (burden RR=0.52, 0.29Â toÂ 0.93), 42% fewer match contact injuries (incidence RR=0.58, 0.41Â toÂ 0.82) and 55% fewer days lost to match contact injuries (burden RR=0.45, 0.25Â toÂ 0.82) than teams that completed the intervention programme fewer than threeÂ times per week (10 schools, 25 teams).", Contact injuries , Control , Pre-activity movement control exercise programme ,0,
edin,8126,4711101,Significantly increased,Surgery time was significantly longer (pâ<â0.001) and there were significantly higher blood loss (pâ=â0.002) in the MIS group as compared to the conventional group., Blood loss  , Standard approach , Mini-midvastus ,0,
edin,8207,1414018,Significantly decreased,The median duration of hospital stay in the GDT group was significantly reduced (11 days (IQR 7 to 15) versus 14 days (IQR 11 to 27); p = 0.001).,  Hospital stay duration  , Control , Goal-directed therapy ,0,
edin,8300,3984416,Cannot tell based on the abstract,, Carbohydrate intake , Placebo , Î²-alanine  ,0,
edin,8300,3984416,No significant difference,"The energy, carbohydrate, protein, fat and Î²-alanine intake are presented in TableÂ 3. No significant differences were observed within or between groups (all pÂ >Â 0.05).", Carbohydrate intake , Placebo , Î²-alanine  ,0,
edin,8169,3628802,Significantly decreased,Breath awareness (the control session) also showed a significant decrease in systolic blood pressure (p<0.05)., Systolic blood pressure , Control , Breath awareness control session ,0,
edin,8200,4756047,No significant difference,Changes in hypoglycemia rates from baseline were not significantly different between the age groups and there was no weight increase in either age group., Body weight , â¥65 years , &amp;lt;65 years ,0,
edin,8146,3635645,Cannot tell based on the abstract,, Heart rate , Remifentanil 2 ng/mL , Remifentanil 4 ng/mL ,0,
edin,8146,3635645,Significantly decreased,"Among the three groups, the HR of group R2 at 1, 2 and 3 minutes after inhalation was significantly higher than that of group R4 or R6 (p<0.05) (Fig. 6).", Heart rate , Remifentanil 2 ng/mL , Remifentanil 4 ng/mL ,0,
edin,8317,2887201,Cannot tell based on the abstract,, Energy requirements intake , Placebo , Enhanced protein-energy provision ,0,
edin,8317,2887201,No significant difference,"<td align=""left"" colspan=""3""><bold>Prescribed energy intake by weight (kcals|kg)</bold></td><td align=""center"">0.18</td>,In the before group, on average, patients received 58.8% (range 0 to 116%) of their energy and 61.2% (range 0 to 104%) of their protein requirements from EN. In the after group, patients received 67.9% (range 0 to 139%) and 73.6% (range 0 to 119%) of their energy and protein requirements respectively (P = 0.33 and 0.13) (See Figure 1a, b) from EN. When only the subgroup of patients prescribed to receive full volume feeds were evaluated (n = 18), they received 83.2% (range 47.9% to 139%) and 89.4% (range 43.2% to 119%) of their energy and protein requirements respectively (See Figure 2a, b)", Energy requirements intake , Placebo , Enhanced protein-energy provision ,0,
edin,8196,5103151,Cannot tell based on the abstract,, Surgeon Satisfaction	 , Control , Intravenous line placement ,0,
edin,8196,5103151,Significantly increased,"When surgeon satisfaction was evaluated, 95.5% of surgeons favored for IV anesthesia and 18% of patients favored for IA. Surgeon satisfaction was significantly higher in Group 1 compared to Group 2 (Table-III).,<td align=""left"" colspan=""1"" rowspan=""1"">Medium</td><td align=""left"" colspan=""1"" rowspan=""1"">-</td><td align=""left"" colspan=""1"" rowspan=""1"">-</td><td align=""left"" colspan=""1"" rowspan=""1""></td>", Surgeon Satisfaction	 , Control , Intravenous line placement ,0,
edin,8290,4577526,Cannot tell based on the abstract,There was no significant difference of BP reduction at week 6 between Original-xLosartan and Generic Losartan group. After crossover the BP reduction was maintained in both groups. The percentage of patient whose Office BP <140/90 or HBPM <135/85 were not different among the two Losartan groups., Office blood pressure , Generic Losartan , Original-xLosartan ,0,
edin,8290,4577526,No significant difference,There was no significant difference of BP reduction at week 6 between Original-xLosartan and Generic Losartan group. After crossover the BP reduction was maintained in both groups. The percentage of patient whose Office BP <140/90 or HBPM <135/85 were not different among the two Losartan groups. T, Office blood pressure , Generic Losartan , Original-xLosartan ,0,
edin,8183,4069047,Significantly increased,"Patients treated with PRM (24 weeks) had significantly better cognitive performance than those treated with placebo, as measured by the IADL (P=0.004) and MMSE (P=0.044).", IADL cognitive performance    , Placebo , Prolonged-release melatonin ,0,
edin,8130,4804512,Cannot tell based on the abstract,, Pain at rest , Placebo , Ropivacaine ,0,
edin,8130,4804512,No significant difference,"Pain at rest. For T0, T1, T2, T4, and T24 there are 0, 9, 5, 4, and 16Â % missing data respectively, equally distributed between groups. No differences were statistical significant. VAS, Visual Analogue Scale", Pain at rest , Placebo , Ropivacaine ,0,
edin,8298,3984416,Cannot tell based on the abstract,"Total work done was significantly increased following supplementation in both NTBA (pÂ =Â 0.03) and TBA (pÂ =Â 0.002), and it was significantly reduced in NTPL (pÂ =Â 0.03) with no difference for TPL (pÂ =Â 0.73).", Total work of non-trained athletes  , Placebo , Î²-alanine  ,0,
edin,8298,3984416,Significantly decreased,"TWD was significantly increased following supplementation in both the NTBA (+1,349Â Â±Â 1,411Â J; pÂ =Â 0.03) and TBA groups (+1,978Â Â±Â 1,508Â J; pÂ =Â 0.002), and it was significantly reduced in the NTPL (â1,385Â Â±Â 2,815Â J; pÂ =Â 0.03) with no significant difference being shown in the TPL group (â219Â Â±Â 1,507Â J; pÂ =Â 0.73).", Total work of non-trained athletes  , Placebo , Î²-alanine  ,0,
edin,8210,5301992,Significantly decreased,"There was a statistically significant difference (P < 0.05) between the mean of systolic blood pressure (SBP), diastolic blood pressures (DBP), and pulse rate (PR) in the massage group prior to intervention (97.05 Â± 20.7, 60.35 Â± 16.69 and 95.45 Â± 13.02 respectively) and on the fifth day (88.32 Â± 16.58, 55.95 Â± 12.7 and 90.45 Â± 15.1 respectively).", Diastolic blood pressure  , Control  , Slow-stroke back massage ,0,
edin,8189,4963027,Cannot tell based on the abstract,, Body mass index z-scores in normo-weight kids , Control , Information sessions plus digital resources ,0,
edin,8189,4963027,Significantly decreased,"When stratified by nutritional status according to baseline BMIZ, the BMIZ of CG children with normal weight increased at 6 months (P=.002) and was maintained at 12 months (P=.04), whereas the BMIZ of the IG was maintained throughout the follow-up.,<td colspan=""9"" rowspan=""1""><bold>BMIZ<sup>c,d</sup></bold></td>", Body mass index z-scores in normo-weight kids , Control , Information sessions plus digital resources ,0,
edin,8284,4682450,Significantly increased,"In the first study, only the NS 440Â mg/DPH 50Â mg combination showed significant improvements in both WASO vs. NS alone (â70.3Â min pÂ =Â 0.0002) and SL vs. DPH alone (25.50 and 41.50Â min respectively, pÂ <Â 0.0001).", Wake time after sleep onset improvement  , Naproxen sodium , Naproxen sodium + diphenhydramine (440&amp;nbsp;mg/50&amp;nbsp;mg) ,0,
edin,8149,5573922,Cannot tell based on the abstract,, Discontinuation due to adverse events , Glecaprevir 300mg + pibrentasvir 120 mg , Glecaprevir 200mg + pibrentasvir 80 mg  ,0,
edin,8149,5573922,No significant difference,"<td align=""left"" colspan=""1"" rowspan=""1"" style=""padding-left:10%"" valign=""top"">Serious</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""top"">1 (16.7)<xref ref-type=""fn"" rid=""hep29081-note-0010"">a</xref>
</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""top"">1 (4.5)<xref ref-type=""fn"" rid=""hep29081-note-0011"">b</xref>
</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""top"">0</td>", Discontinuation due to adverse events , Glecaprevir 300mg + pibrentasvir 120 mg , Glecaprevir 200mg + pibrentasvir 80 mg  ,0,
edin,8124,4711101,Cannot tell based on the abstract,, Range of motion , Standard approach , Mini-midvastus ,0,
edin,8124,4711101,No significant difference,"No differences in range of motion between groups were found at the different time points (two-way ANOVA, F(1)â=â0.73; pâ=â0.12) (TableÂ 3).Table 3", Range of motion , Standard approach , Mini-midvastus ,0,
edin,8212,5301992,No significant difference,"However, no difference was observed in mean respiratory rate (RR) in the massage group from the second day (17.55 Â± 3.6) to fifth day (17.62 Â± 3.27) (P = 0.096).",  Respiratory  Rate , Control  , Slow-stroke back massage ,0,
edin,8267,4947329,Significantly decreased,"Daily doses of prednisone up to 60Â mg resulted in dose- and time-dependent decreases in plasma osteocalcin, plasma P1NP, serum cortisol, and absolute blood eosinophil counts.", Osteocalcin , Placebo , Daily prednisone  ,0,
edin,8194,3575357,Cannot tell based on the abstract,, FEV1/FVC , Health education , Physical Activity Promotion Programme ,0,
edin,8194,3575357,No significant difference,"FEV1/FVC (%)
66.59(57â76)
68(59â78)
65.61(57â74)
71(63â79),FEV1/FVC (%)
17.47(â28.01-(â6.95)
â1.22(â11.30-8.85)
â10.45(â18.6-(â2.23)**
5.17(â11.45-1.11),he changes between both the experimental and control group in the cardiopulmonary function outcome for the FEV1/FVC value did not show statistically significant changes in the experimental group, which the mean FEV1/FVC value for both men and women was (â10.45 vs. 5.17%) respectively (Tableâ 2).", FEV1/FVC , Health education , Physical Activity Promotion Programme ,0,
edin,8314,3793422,No significant difference,The surface treatment methods did not have any significant effect (P > 0.05) on any group but EDTA group had the highest bond strength., Bond strength , Ethanol , Ethylene di-amine tetra-acetic acid + Ethanol ,0,
edin,8274,4558893,Significantly decreased,"Over 36Â months, twice-daily exenatide was associated with improved body weight (â3.9Â kg), waist circumference (â3.6Â cm), systolic/diastolic BP (â2.5/â2.6Â mmHg), high-density lipoprotein (HDL)-cholesterol (0.05Â mmol/L), triglycerides (â0.2Â mmol/L), and hsCRP (â1.7Â mg/L). Heart rate did not increase (â0.3 beats/minute), and low-density lipoprotein-cholesterol (0.2Â mmol/L) and total cholesterol (0.1Â mmol/L) increased slightly. Between-group differences were significantly in favor of exenatide for body weight (PÂ <Â 0.0001), waist circumference (PÂ <Â 0.001), systolic BP (PÂ <Â 0.001), diastolic BP (PÂ =Â 0.023), HDL-cholesterol (PÂ =Â 0.001), and hsCRP (PÂ =Â 0.004).", Waist circumference , Glimepiride , Exenatide  ,0,
edin,8257,3301259,Cannot tell based on the abstract,, Multiple organ failure scores , Placebo , Pentoxifylline  ,0,
edin,8257,3301259,Significantly decreased,"MOF-score was lower in POF treated patients after day 4 compared to placebo treated patients which reached significant differences on day 14 and 21 (P < 0.05, unpaired t-test).", Multiple organ failure scores , Placebo , Pentoxifylline  ,0,
edin,8170,3628802,Significantly increased,"Following alternate nostril breathing (ANYB) there was a significant decrease in systolic and diastolic blood pressure (p<0.001 and p<0.05), and an improvement in Purdue pegboard task scores for both hands (p<0.05), and for the right hand (p<.001).", Purdue pegboard task score improvement (right hand) , Control , Nostril yoga breathing ,0,
edin,8263,4228518,Cannot tell based on the abstract,, Rhodes Index scores reduction for nausea , Placebo , Ginger ,0,
edin,8263,4228518,Significantly increased,"An ANOVA test showed that there were significant differences in the mean reduction of Rhodes Index scores in vomiting, nausea, retching and total scores between the three groups (P < 0.001) (Table 2).,A Tukeyâs post hoc test was performed and the results showed a significant difference between the three groups in the mean reduction of vomiting, nausea, retching and total Rhodes Index scores (P < 0.001).,Nausea	3.86 Â± 2.35	1.26 Â± 1.57	-0.33 Â± 1.74	0.001,Nausea	46	19	-0.5", Rhodes Index scores reduction for nausea , Placebo , Ginger ,0,
edin,8224,5956569,Cannot tell based on the abstract,, Cumulative uptake at 3 months , Control , Pre-invitation leaflet ,0,
edin,8224,5956569,No significant difference,"Figure 2(a) shows a Kaplan Meier plot of the cumulative uptake over time for PIL and control groups. There was an early increase in uptake for the PIL group immediately post invitation, but any small difference had dissipated by three months.", Cumulative uptake at 3 months , Control , Pre-invitation leaflet ,0,
edin,8184,4069047,Significantly increased,"Patients treated with PRM (24 weeks) had significantly better cognitive performance than those treated with placebo, as measured by the IADL (P=0.004) and MMSE (P=0.044).", MMSE cognitive performance    , Placebo , Prolonged-release melatonin ,0,
edin,8321,2887201,No significant difference,"The rates of vomiting, regurgitation, aspiration, and pneumonia were similar between the two groups.", Aspiration , Placebo , Enhanced protein-energy provision ,0,
edin,8193,3575357,Cannot tell based on the abstract,,  EQ-5D quality of life in women , Health education , Physical Activity Promotion Programme ,0,
edin,8193,3575357,No significant difference,"In our study, the changes between both the experimental and the control group in the self-reported questionnaires found the range of EQ-5D of the male population with a difference between groups in the effect size value of 0.05 (pâ=â0.05), whereas women did not improve their quality of life.",  EQ-5D quality of life in women , Health education , Physical Activity Promotion Programme ,0,
edin,8195,5103151,Significantly decreased,Emergence of postoperative recovery agitation (WBSâ¥3) was observed more frequent in Group 2 (p<0.05) than Group 1., Postoperative recovery agitation , Control , Intravenous line placement ,0,
edin,8214,5739798,Significantly decreased,Recurrence or metastasis (Rec/Met) after surgery were 24/82 (29.27%) in SP group and 37/81 (45.68%) in S group. The difference in the Rec/Met rate was statistically significant (p = 0.0304) by chi-square test., Metastasis , Radical surgery alone  , Radical surgery + surgical wound surface injection  ,0,
edin,8225,5956569,Cannot tell based on the abstract,, Cumulative uptake at 6 months , Control , Pre-invitation leaflet ,0,
edin,8225,5956569,No significant difference,"<td colspan=""1"" rowspan=""1"">Six months</td><td colspan=""1"" rowspan=""1"">30.63% (3191/10,418)</td><td colspan=""1"" rowspan=""1"">31.13% (3256/10,461)</td><td colspan=""1"" rowspan=""1"">30.88% (6447/20,879)</td><td colspan=""1"" rowspan=""1"">1.014</td><td colspan=""1"" rowspan=""1"">(0.928, 1.109)</td><td colspan=""1"" rowspan=""1"">0.747</td><td colspan=""1"" rowspan=""1"">0.0157</td>,able 1 and Figure 2(b) suggest a slight increase in uptake for online booking by six months, but this was not statistically significant (Adj. ORâ=â1.10; 95% CI 0.94â1.28, pâ=â0.24). At six months, the marginal increase in uptake was 1.83% (95% CI â1.23â4.89).", Cumulative uptake at 6 months , Control , Pre-invitation leaflet ,0,
edin,8131,4804512,Cannot tell based on the abstract,, Oxycodone consumption , Placebo , Ropivacaine ,0,
edin,8131,4804512,No significant difference,"he median intravenous-oxycodone consumption was 7Â mg (2â13) and 6Â mg (2â9), pâ=â0.12 in the ropivacaine group and the placebo group, respectively.", Oxycodone consumption , Placebo , Ropivacaine ,0,
edin,8185,4069047,Significantly increased,Median ADAS-Cog values (â3.5 versus +3 points) (P=0.045) were significantly better with PRM., AD Assessment ScaleâCognition , Placebo , Prolonged-release melatonin ,0,
edin,8285,4682450,Significantly increased,"In the first study, only the NS 440Â mg/DPH 50Â mg combination showed significant improvements in both WASO vs. NS alone (â70.3Â min pÂ =Â 0.0002) and SL vs. DPH alone (25.50 and 41.50Â min respectively, pÂ <Â 0.0001).", Sleep latency improvement  , Diphenhydramine , Naproxen sodium + diphenhydramine (440mg/50mg) ,0,
edin,8277,4558893,Significantly increased,"Between-group differences were significantly in favor of exenatide for body weight (PÂ <Â 0.0001), waist circumference (PÂ <Â 0.001), systolic BP (PÂ <Â 0.001), diastolic BP (PÂ =Â 0.023), HDL-cholesterol (PÂ =Â 0.001), and hsCRP (PÂ =Â 0.004).", HDL-cholesterol , Glimepiride , Exenatide  ,0,
edin,8187,4069047,Cannot tell based on the abstract,, Neuropsychiatric Inventory score at week 24 , Placebo , Prolonged-release melatonin ,0,
edin,8187,4069047,Significantly increased,A statistically significant difference in NPI distress score was observed between the groups at week 24 (P=0.026). NPI distress scores increased significantly in the PRM group between baseline and week 24 (3.1Â±7.59) (P=0.033) and decreased nonsignificantly in the placebo group (â0.24Â±4.17) (P=0.758)., Neuropsychiatric Inventory score at week 24 , Placebo , Prolonged-release melatonin ,0,
edin,8312,3793422,No significant difference,The surface treatment methods did not have any significant effect (P > 0.05) on any group but EDTA group had the highest bond strength., Bond strength , Control , Ethylene di-amine tetra-acetic acid ,0,
edin,8247,3139306,Cannot tell based on the abstract,, Patient satisfaction , Placebo , Dexmedetomidine  ,0,
edin,8247,3139306,Significantly increased,"Patient satisfaction scores were significantly higher in group D [median, 4 (range, 2-4)] compared to group P [median, 3 (range, 1-4)] (P < .05).", Patient satisfaction , Placebo , Dexmedetomidine  ,0,
edin,8323,5662512,Cannot tell based on the abstract,, Microhardness  , Control , Proanthocyanidin ,0,
edin,8323,5662512,No significant difference,"One-way ANOVA showed significant differences among the groups (P<0.001). Pairwise comparisons of the groups revealed no significant differences between groups C and PA (P=0.972), PA and CP (P= 0.189), F and PAF (P=1.000), F and FCP (P=1.000), PAF and FCP (P=1.000), and PACP and PAFCP (P= 0.826); but significant differences were found between other groups (P<0.05; Table 1).", Microhardness  , Control , Proanthocyanidin ,0,
edin,8197,4756047,Cannot tell based on the abstract,, Glycated hemoglobin  , â¥65 years , &amp;lt;65 years ,0,
edin,8197,4756047,No significant difference,"<td align=""left"">A1C (%)</td><td align=""char"" char=""."">1219</td><td align=""char"" char=""."">â0.56</td><td align=""char"" char=""."">1.5 (0.04)</td><td align=""char"" char=""."">584</td><td align=""char"" char=""."">â0.47</td><td align=""char"" char=""."">1.3 (0.05)</td><td align=""left"">0.094, <italic>p</italic>&nbsp;=&nbsp;0.17</td>,Mean baseline values of A1C and FPG were numerically lower in the group aged â¥65Â years than in the group aged <65Â years (TableÂ 1). Mean differences between groups in changes from baseline for A1C, FPG, and body weight were not significantly different (Figs.Â 1, 2; TableÂ 2). Starting and ending A1C for patients <65Â years were 8.65 and 8.0Â %, respectively, compared with 8.2 and 7.7Â % for patients â¥65Â years. Mean estimated A1C difference in change from baseline between age groups (â¥65Â âÂ <65) was 0.09Â % (pÂ =Â 0.17).", Glycated hemoglobin  , â¥65 years , &amp;lt;65 years ,0,
edin,8166,5800236,Significantly decreased,"The results show that both the NNBT and the STreSS lead to a significant decrease in number of contacts with a general practitioner in the period from twelve months prior to treatment to twelve months after treatment; and, a significant decrease in long-term sick leave from the month prior to treatment to twelve months after treatment.", Months of sick leave  , Cognitive behavioral therapy ,  NacadiaÂ® nature-based therapy ,0,
edin,8307,2129145,No significant difference,"No significant differences were observed in caloric or macronutrient intake. CF tended to mitigate gains in body mass (-0.7 Â± 1.8, 1.0 Â± 2.5 kg, p = 0.10) and scanned mass (-0.2 Â± 1.3, 1.7 Â± 2.9 kg, p = 0.08) with no significant differences in fat mass (-0.2 Â± 0.7, 1.1 Â± 2.3 kg, p = 0.16), fat free mass (-0.1 Â± 1.3, 0.6 Â± 1.2 kg, p = 0.21), or body fat (-0.2 Â± 1.0, 0.4 Â± 1.4%, p = 0.40).", Body fat , Placebo , ForsLeanâ¢ ,0,
edin,8297,3984416,Significantly increased,"Total work done was significantly increased following supplementation in both NTBA (pÂ =Â 0.03) and TBA (pÂ =Â 0.002), and it was significantly reduced in NTPL (pÂ =Â 0.03) with no difference for TPL (pÂ =Â 0.73).", Total work of trained athletes  , Placebo , Î²-alanine  ,0,
edin,8245,3139306,Significantly decreased,"Compared with placebo group, patients in the dexmedetomidine group required 52.7% less PCA morphine during the first 24 hours postoperatively, with significantly better visual analogue scale scores, less incidence of respiratory obstruction (5 vs. 12 patients, respectively; P = .037) and longer time to first analgesic request (21 (11) vs. 9 (4) minutes; P = .002).", Morphine usage at 24 hours , Placebo , Dexmedetomidine  ,0,
edin,8153,3580622,Significantly decreased,"The mean (Â± SD) change in pleural opacity was greater in the t-PA-DNase group than in the placebo group (-29.5 Â± 23.3% vs. -17.2 Â± 19.6%; difference, -7.9%; 95% confidence interval [CI], -13.4 to -2.4; P = 0.005).", Pleural opacity , Placebo , Deoxyribonuclease  ,0,
edin,8155,3580622,Significantly increased,"The frequency of surgical referral at 3 months was lower in the t-PA-DNase group than in the placebo group (2 of 48 patients [4%] vs. 8 of 51 patients [16%]; odds ratio for surgical referral, 0.17; 95% CI, 0.03 to 0.87; P = 0.03) but was greater in the DNase group (18 of 46 patients [39%]) than in the placebo group (odds ratio, 3.56; 95% CI, 1.30 to 9.75; P = 0.01).", Surgical referral at 3 months , Placebo , Deoxyribonuclease  ,0,
edin,8230,5409660,Cannot tell based on the abstract,, Toll-like receptor 4 , Cooked ham , Dry-cured ham ,0,
edin,8230,5409660,Significantly increased,"Expression levels of TLR4 in the three monocytes subsets were also strongly affected after the intervention (all p < 0.05) (Figure 3).,The expression of adhesion and scavenging markers (ICAM1R, CXCR4 and TLR4) in the three subsets of monocytes was significantly higher (all p < 0.05).", Toll-like receptor 4 , Cooked ham , Dry-cured ham ,0,
edin,8138,5133075,Significantly increased,The area under the curve (p < 0.001) and incremental area under the curve (p = 0.001) for insulin was significantly higher after the red meat/refined grain diet than after the dairy/chicken/nuts/whole grain diet., Insulin incremental AUC , Dairy/chicken/nuts/whole grain diet , Red meat/refined grain diet  ,0,
edin,8192,3575357,Cannot tell based on the abstract,,  EQ-5D quality of life in men , Health education , Physical Activity Promotion Programme ,0,
edin,8192,3575357,Significantly increased,"In our study, the changes between both the experimental and the control group in the self-reported questionnaires found the range of EQ-5D of the male population with a difference between groups in the effect size value of 0.05 (pâ=â0.05), whereas women did not improve their quality of life.",  EQ-5D quality of life in men , Health education , Physical Activity Promotion Programme ,0,
edin,8134,4804512,Cannot tell based on the abstract,, Length of stay , Placebo , Ropivacaine ,0,
edin,8134,4804512,No significant difference,"<td>Length of hospital stay, hours</td><td>49 (10)</td><td>50 (20)</td><td>
<italic>P</italic>â=â0.53</td>", Length of stay , Placebo , Ropivacaine ,0,
edin,8125,4711101,Significantly increased,Surgery time was significantly longer (pâ<â0.001) and there were significantly higher blood loss (pâ=â0.002) in the MIS group as compared to the conventional group., Surgery time , Standard approach , Mini-midvastus ,0,
edin,8279,4431324,Significantly increased,"The infliximab group accumulated higher drug and healthcare costs (â¬27â487 vs â¬10â364; adjusted mean difference â¬16â956 (95% CI 14â647 to 19â162)), while productivity losses did not differ (â¬33â804 vs â¬29â220; â¬3961 (95% CI â3986 to 11â850)), resulting in higher societal cost compared to the conventional group (â¬61â291 vs â¬39â584; â¬20â916 (95% CI 12â800 to 28â660)).", Drug cost , Conventional treatment , Infliximab  ,0,
edin,8188,4069047,No significant difference,"Differences were more significant at longer treatment duration. PRM was well tolerated, with an adverse event profile similar to that of placebo.", Adverse events  , Placebo , Prolonged-release melatonin ,0,
edin,8283,4431324,Significantly increased,"The infliximab group accumulated higher drug and healthcare costs (â¬27â487 vs â¬10â364; adjusted mean difference â¬16â956 (95% CI 14â647 to 19â162)), while productivity losses did not differ (â¬33â804 vs â¬29â220; â¬3961 (95% CI â3986 to 11â850)), resulting in higher societal cost compared to the conventional group (â¬61â291 vs â¬39â584; â¬20â916 (95% CI 12â800 to 28â660))", Healthcare costs , Conventional treatment , Infliximab  ,0,
edin,8156,3580622,Significantly decreased,"Combined t-PA-DNase therapy was associated with a reduction in the hospital stay, as compared with placebo (difference, -6.7 days; 95% CI, -12.0 to -1.9; P = 0.006).", Hospital stay , Placebo , Tissue plasminogen activator + deoxyribonuclease  ,0,
edin,8159,4808857,Significantly decreased,"Statistical tests performed revealed that compared to CG, participants in IG increased fruit intake and decreased intake of snacks high in sugar and fat significantly (p < 0.05).", Snacks intake , Control ,  Dietitian-Based Nutrition Education Strategy ,0,
edin,8235,3617313,No significant difference,"No significant differences in the number of adverse reactions, prevalence and degree of severity of the solicited and unsolicited adverse reactions were observed among the three groups.", Number of averse reactions , Control  , GC1107-T5.0 diphtheria vaccine ,0,
edin,8163,4808857,Significantly increased,NK and attitudinal scores also increased significantly in the IG (p < 0.05)., Nutrition knowledge  , Control ,  Dietitian-Based Nutrition Education Strategy ,0,
edin,8186,4069047,Significantly increased,"Sleep efficiency, as measured by the PSQI, component 4, was also better with PRM (P=0.017).", Pittsburgh Sleep Quality Index  sleep efficiency , Placebo , Prolonged-release melatonin ,0,
edin,8276,4558893,Significantly decreased,"Between-group differences were significantly in favor of exenatide for body weight (PÂ <Â 0.0001), waist circumference (PÂ <Â 0.001), systolic BP (PÂ <Â 0.001), diastolic BP (PÂ =Â 0.023), HDL-cholesterol (PÂ =Â 0.001), and hsCRP (PÂ =Â 0.004).", Diastolic blood pressure , Glimepiride , Exenatide  ,0,
edin,8129,4804512,Cannot tell based on the abstract,, Pain during 30Â° flexion  , Placebo , Ropivacaine ,0,
edin,8129,4804512,No significant difference,"The VAS-scores at T4 during 30Â Â° flexion of the hip were 31 and 26.5Â mm in the Group Placebo and the Group Ropivacaine, respectively, and the difference was â5Â mm (95Â % CI: â15 - +5Â mm), pâ=â0.41.", Pain during 30Â° flexion  , Placebo , Ropivacaine ,0,
edin,8226,5409660,No significant difference,"The mean differences between dry-cured ham and cooked ham followed by a time period adjustment for plasmatic P-selectin and interleukin 6 proteins slightly failed (p = 0.062 and p = 0.049, respectively), notably increased for MCP-1 levels (p = 0.023) while VCAM-1 was not affected.", P-selectin  , Cooked ham , Dry-cured ham ,0,
edin,8255,3301259,Cannot tell based on the abstract,, Tumor necrosis factor levels  , Placebo , Pentoxifylline  ,0,
edin,8255,3301259,No significant difference,Serum concentrations of TNF and IL-6 were not significantly different throughout the evaluation., Tumor necrosis factor levels  , Placebo , Pentoxifylline  ,0,
edin,8145,3635645,Cannot tell based on the abstract,, Heart rate , Remifentanil 2 ng/mL , Remifentanil 6 ng/mL ,0,
edin,8145,3635645,Significantly decreased,"The HR in group R2 increased significantly 2 and 3 minutes after inhalation compared to baseline values (p<0.05). Among the three groups, the HR of group R2 at 1, 2 and 3 minutes after inhalation was significantly higher than that of group R4 or R6 (p<0.05) (Fig. 6).", Heart rate , Remifentanil 2 ng/mL , Remifentanil 6 ng/mL ,0,
edin,8309,2129145,Significantly decreased,"Subjects in the CF group tended to report less fatigue (p = 0.07), hunger (p = 0.02), and fullness (p = 0.04).", Hunger  , Placebo , ForsLeanâ¢ ,0,
edin,8252,3511173,Cannot tell based on the abstract,, Good taste  , PEG-based laxatives + electrolytes , PEG-based laxatives ,0,
edin,8252,3511173,Significantly increased,"Taste/palatability
Â 
Â 
good / very good
21
(43%)
1
(2%),Also the taste of the PEG-only product was evaluated as better than PEG-EL (p < 0.001) (Table 4).", Good taste  , PEG-based laxatives + electrolytes , PEG-based laxatives ,0,
edin,8293,5852701,No significant difference,"Appetite AUC did not differ between interventions (standardised effect of RAB compared to SIT: Day 1: 0.11; 95% CI: â0.28, 0.06; p = 0.212; Day 2: 0.04; 95% CI: â0.15, 0.24; p = 0.648).", Appetite area under the curve at day 1 , Prolonged sitting , Regular activity breaks ,0,
edin,8213,5301992,Significantly decreased,"The mean of state of anxiety, which was 36.4 Â± 5.1 before intervention, was reduced by the fifth day to 31.2 Â± 5.1 in the massage group (P < 0.0001, t = 5.2).", Anxiety , Control  , Slow-stroke back massage ,0,
edin,8239,2681019,Cannot tell based on the abstract,, Adiponectin in men , Control , Beer ,0,
edin,8239,2681019,Significantly increased,"Among females, adiponectin significantly increased after intervention with red wine (29.8%, P < 0.05) and increased among men after ethanol solution (17.4%, P < 0.05) and beer consumption (16.1%, P < 0.04).", Adiponectin in men , Control , Beer ,0,
edin,8147,5573922,Cannot tell based on the abstract,"By intentâtoâtreat analysis, sustained virologic response at posttreatment week 12 was achieved in 100% (6/6, 95% confidence interval 61â100), 95% (21/22, 95% confidence interval 78â99), and 86% (19/22, 95% confidence interval 67â95) of patients in arms A, B, and C, respectively.", Sustained viral response 12 weeks , Glecaprevir 300mg + pibrentasvir 120 mg , Glecaprevir 300mg + pibrentasvir 120 mg + ribavirin  ,0,
edin,8147,5573922,Significantly increased,"By intentâtoâtreat analysis, sustained virologic response at posttreatment week 12 was achieved in 100% (6/6, 95% confidence interval 61â100), 95% (21/22, 95% confidence interval 78â99), and 86% (19/22, 95% confidence interval 67â95) of patients in arms A, B, and C, respectively.", Sustained viral response 12 weeks , Glecaprevir 300mg + pibrentasvir 120 mg , Glecaprevir 300mg + pibrentasvir 120 mg + ribavirin  ,0,
edin,8649,3944283,Cannot tell based on the abstract,, initial training of lower limb muscle activities - inpatients receiving physical therapy for chronic stroke , patients wore only their shoes , ankle-foot orthosis (AFO) group ,0,
edin,8649,3944283,No significant difference,"However, an ankle-foot orthosis used postural adjustment by 42 stroke patients whose onset of a stroke was 6 months prior or earlier, and 61 stroke patients whose onset of a stroke was 12 months ago or longer, was effective at providing stability for the ankle of early phase stroke patients but not chronic phase stroke patients, as structural changes has occurred, including changes in alignment and muscle shortening", initial training of lower limb muscle activities - inpatients receiving physical therapy for chronic stroke , patients wore only their shoes , ankle-foot orthosis (AFO) group ,0,
edin,8674,4644305,Cannot tell based on the abstract,, baseline detected temperature - Painful diabetic peripheral neuropathy (DPN) , transcutaneous electrical nerve stimulation (TENS) , pulsed radiofrequency (PRF) lumbar sympathectomy  ,0,
edin,8674,4644305,Significantly increased,An increase over baseline detected temperature was observed in all PRF subjects., baseline detected temperature - Painful diabetic peripheral neuropathy (DPN) , transcutaneous electrical nerve stimulation (TENS) , pulsed radiofrequency (PRF) lumbar sympathectomy  ,0,
edin,8413,3191350,Cannot tell based on the abstract,, Error rate , Low-maintenance demand , High-maintenance demand training ,0,
edin,8413,3191350,Significantly decreased,"Although both groups (high and low demand) increased performance in posttest in contrast to the pretest, the high-maintenance demand trainings lead to significant less error rates in posttest compared to the low-maintenance demand trainings (Fâ=â10.96, Î·2â=â0.06, pâ=â0.001).", Error rate , Low-maintenance demand , High-maintenance demand training ,0,
edin,8341,5524909,Cannot tell based on the abstract,"Cerebral ischaemia was associated with reduced numbers of calbindin-28k, calretinin, parvalbumin and GAD positive striatal neurons (Pâ<â0.05 ischaemiaâ+âvehicle, nâ=â6 vs. sham ischaemia, nâ=â6) but not ChAT or nNOS positive neurons.,Long infusion of peptide (nâ=â6) was associated with increased survival of calbindin-28k, calretinin, parvalbumin and GAD positive neurons (Pâ<â0.05 vs. ischaemiaâ+âvehicle).", Glutamic acid decarboxylase positive neurons , Sham ischaemia , Ischaemiaâ+âvehicle ,0,
edin,8341,5524909,Significantly decreased,"Ischaemiaâ+âvehicle was associated with loss of calbindin-28k, calretinin, parvalbumin and GAD positive neurons compared to sham ischaemia (Pâ<â0.05; FigsÂ 2â4).", Glutamic acid decarboxylase positive neurons , Sham ischaemia , Ischaemiaâ+âvehicle ,0,
edin,8451,5260131,No significant difference,"There were no significant differences in the ETCO2, PaCO2, minute ventilation, or inotropic support.", Ventilation time , Control , High flow CO2 warming system ,0,
edin,8641,4636656,Cannot tell based on the abstract,, Psychosocial work characteristics at baseline , control , intervention - e-learning programme on work-related stress ,0,
edin,8641,4636656,No significant difference,"Psychosocial work characteristics at baseline, including supervisor relationships and information, job insecurity, work social support and job strain were similar between the intervention and control clusters and there were few differences between psychosocial characteristics in the intervention and control clusters at follow-up.", Psychosocial work characteristics at baseline , control , intervention - e-learning programme on work-related stress ,0,
edin,8617,4599047,Significantly increased,"At 3 years, the proportion of subjects achieving the primary composite endpoint was greater for SuperionÂ® (63/120, 52.5%) than for X-STOPÂ® (49/129, 38.0%) (P=0.023) and the corresponding success rates exceeded 80% for each of the individual components of the primary endpoint in the SuperionÂ® group (range: 81%â91%).", subjects achieving the primary composite endpoint - moderate degenerative lumbar spinal stenosis. ," X-STOPÂ® (49/129, 38.0%) "," SuperionÂ® (63/120, 52.5%) ",0,
edin,8445,5320771,Cannot tell based on the abstract,, Pain , Placebo , Human adipose-derived stromal/stem cells ,0,
edin,8445,5320771,No significant difference,"There were no cases of hemorrhage, need for blood transplants, pain, diarrhea, colon inflammation, infection, allergic reactions, recurrence of disease, readmission, and mortality.", Pain , Placebo , Human adipose-derived stromal/stem cells ,0,
edin,8529,4061186,Significantly increased,"The intestinal function recovery time, incidence rate of multiple organ failure (MOF), length of hospitalization and fatality rates were observed. IIT + LMWH noticeably increased the white blood cell count, hemodiastase level, serum albumin level and the arterial partial pressure of oxygen in the patients with SAP (P<0.05).", Hemodiastase levels , Insulin , Low molecular weight heparin  ,0,
edin,8568,5506593,Cannot tell based on the abstract,, temphos protectionn against dengue , experimental conditions , routine field conditions ,0,
edin,8568,5506593,No significant difference,"Table 3 shows the association between the presence of at least one larvae or pupae positive container in the household and observed temephos presence, in six surveys in the Managua control clusters between 2005 and 2013; none of the six GLMM models showed a significant negative association between temephos presence and household positivity for larvae or pupae.", temphos protectionn against dengue , experimental conditions , routine field conditions ,0,
edin,8507,4595235,Cannot tell based on the abstract,, Systolic blood pressure  , Placebo , Bio-active peptide supplement ,0,
edin,8507,4595235,No significant difference,"The analyses of resting hemodynamic measurements revealed significant time effects for HR (p < 0.05) with no significant effects of group or significant group Ã time interactions for HR, SBP, or DBP (p values < 0.05) again indicating that the supplementation had no specific effects on these variables.", Systolic blood pressure  , Placebo , Bio-active peptide supplement ,0,
edin,8500,5435062,Cannot tell based on the abstract,, Intragastric pH â¥4 mean percent time , IV esomeprazole  , PO esomeprazole  ,0,
edin,8500,5435062,No significant difference,"Among all 3 treatment groups, the differences in MPT with intragastric pH â¥4 were not significant (P > .05);", Intragastric pH â¥4 mean percent time , IV esomeprazole  , PO esomeprazole  ,0,
edin,8428,5655345,Cannot tell based on the abstract,, Lumefantrine peak concentration  , Artemether-lumefantrine , Nevirapine + Artemether-lumefantrine  ,0,
edin,8428,5655345,Significantly increased,"Similarly, peak concentration was decreased by 50% (p = 0.07) for artemether and 36% (p = 0.01) for dihydroartemisinin. In contrast, exposure to lumefantrine increased significantly in the context of nevirapine [AUC0-120hr:123% (p<0.001); Cday7:116% (p<0.001), Cmax: 95% (p<0.001)].", Lumefantrine peak concentration  , Artemether-lumefantrine , Nevirapine + Artemether-lumefantrine  ,0,
edin,8332,3009979,Cannot tell based on the abstract,, Duration of hospitalization , Cefuroxime , Ampicillin/sulbactam ,0,
edin,8332,3009979,No significant difference,"<td align=""left"">Duration of hospitalization in days, median (IQR)</td><td align=""center"">4 (4-4)</td><td align=""center"">4 (4-5)</td><td align=""center"">4 (4-4)</td><td align=""center"">0.09</td>", Duration of hospitalization , Cefuroxime , Ampicillin/sulbactam ,0,
edin,8576,4526789,Cannot tell based on the abstract,, intrinsic motivation , before Computer-based auditory training (CBAT) intervention , after Computer-based auditory training (CBAT) intervention ,0,
edin,8576,4526789,Significantly increased,"The majority of participants agreed that the CBAT intervention was both interesting and enjoyable, suggesting there was intrinsic motivation to undertake training. Most agreed or strongly agreed with the statements âThe training program held my interestâ (n = 35, 79.5%) and âI enjoyed training with the programâ (n = 38, 86.4%), which is indicative of participants acting of their own free will (autonomy). There was little agreement shown for âI found my attention on the training program wandered during the sessionâ (n = 7, 15.9%), suggesting that those participants were actively engaged with the CBAT. Finally, low agreement with the item âI found the training program difficult to useâ (n = 1, 2.3%) and high agreement with âI understood what to do when using the training programâ (n = 42, 95.5%) demonstrates competence in participants' ability to undertake CBAT. Only, three participants (6.8%) agreed with the statement âI would never use this training program again.â", intrinsic motivation , before Computer-based auditory training (CBAT) intervention , after Computer-based auditory training (CBAT) intervention ,0,
edin,8418,5629940,No significant difference,"Changes from baseline in DAS28-CRP, ACR50 and ACR70 were similar.", ACR50 results , Adalimumab , ABP 501 ,0,
edin,8362,5634356,No significant difference,No significant difference was noted between the two groups in pain score and number of analgesics taken (p> 0.05)., Number of analgesics taken , Control group , Coe-PakTM dressing ,0,
edin,8491,5807031,Significantly increased,"In START-pilot, adverse effect rates were higher after 13 fractions of 3.3â¯Gy, consistent with effects reported in the breast/chest wall (significant for shoulder stiffness, HR 3.07, 95%CI 1.62â5.83, pâ¯=â¯0.001).", Shoulder stiffness , 2.0â¯Gy fractions , 2.67â3.3â¯Gy fractions ,0,
edin,8712,5971365,Significantly increased,"At week 96, significantly greater mean improvement from baseline in SDMT was observed with daclizumab beta versus IM IFN beta-1a (pâ=â0.0274). Significantly more patients treated with daclizumab beta showed clinically meaningful improvement in SDMT (increase from baseline of â©¾3 points (pâ=â0.0153) or â©¾4 points (pâ=â0.0366)), and significantly fewer patients showed clinically meaningful worsening (decrease from baseline of â©¾3 points (pâ=â0.0103)). Odds representing risk of worsening versus stability or improvement on SDMT were significantly smaller for daclizumab beta (pâ=â0.0088 (3-point threshold); pâ=â0.0267 (4-point threshold)). In patients completing 144âweeks of treatment, the effects of daclizumab beta were generally sustained.", Symbol Digit Modalities Test (SDMT) score at week 144 in limited patients , intramuscular (IM) interferon (IFN) beta-1a , daclizumab beta ,0,
edin,8351,2639329,Cannot tell based on the abstract,, Having at least 1 treatment-related adverse event , Usual medical practices , Discharged 24 h after PM implant/4â6 h after replacement ,0,
edin,8351,2639329,No significant difference,"By the end of the trial, the proportion of patients with at least one treatment-related AE was 19.5% (n = 74) in the overall population (95% CI 15.5â23.5), 20.1% (n = 37) in the active group, and 19.0% (n = 37) in the control group (absolute RR 1.1%; 95% CI â6.9 to 9.1; P=0.78)", Having at least 1 treatment-related adverse event , Usual medical practices , Discharged 24 h after PM implant/4â6 h after replacement ,0,
edin,8721,4374075,Significantly increased,"The proportion of patients achieving target HbA1cÂ <7.0% was significantly higher with vildagliptin/metformin SPC compared with vildagliptin/placebo SPC (45.8% vs. 13.5%, PÂ <0.001).", patients who achieved an HbA1c of &amp;lt;7.0% at week 14 , vildagliptin monotherapy , vildagliptin/metformin SPC (single-pill combination) ,0,
edin,8399,4694650,Significantly decreased,"In the last year of study the risk of neonatal death was reduced by 69% among poor mothers in the intervention area as compared to poor mothers in the control area (OR 0.31, 95% CI 0.15â0.66).", Risk of neonatal death with poor mothers , Control , Facilitation of Local Stakeholder Groups on Equity in Neonatal Survival ,0,
edin,8518,5722122,Cannot tell based on the abstract,, Microcrack formation in the coronal section , SafeSider , Neolix  ,0,
edin,8518,5722122,No significant difference,"Micro cracks mainly occurred in the coronal section (9 mm), although was no statistically significant difference (P=0.486).", Microcrack formation in the coronal section , SafeSider , Neolix  ,0,
edin,8753,5119439,No significant difference,No other significant differences in translations or rotations were found between the 2 surgical techniques at 2 years (p > 0.4) and 5 years (p > 0.7) postoperatively., other significant differences in translations at 5 years , femoral bone preparation with broaching on the other side , femoral bone preparation with compaction on 1 side ,0,
edin,8549,3215881,Cannot tell based on the abstract,, Subcapital location , Placebo , Zoledronic acid ,0,
edin,8549,3215881,No significant difference,"<td align=""left"">Subcapital</td><td align=""char"" char=""("">220 (20.7)</td><td align=""char"" char=""("">213 (20.1)</td>", Subcapital location , Placebo , Zoledronic acid ,0,
edin,8467,5611398,Cannot tell based on the abstract,, Snack food consumption in men , Control , TV while eating ,0,
edin,8467,5611398,No significant difference,". For men, there was a non-significant tendency for proportion of processed snack food consumption to be moderated by TV grouping, with greater proportional consumption in those who habitually consume processed food and who watched TV, and in those who do not habitually consume processed food and did not watch TV (p = 0.065).", Snack food consumption in men , Control , TV while eating ,0,
edin,8581,2808793,Significantly increased,"The remission rate (7 and below in HRSD) of the forest group was 61% (14/23), significantly higher than both the hospital group (21%, 4/19) and the controls (5%, 1/21).", patients reaching remission , control group - pharmacotherapy in outpatient , forest group - cognitive behavior therapy (CBT)-based psychotherapy plus pharmacotherapy ,0,
edin,8676,4774750,Cannot tell based on the abstract,, mean values of EPG , T2 feed containing 16% digestible crude protein , T3 concentrate feed containing  20% digestible crude protein ,0,
edin,8676,4774750,Significantly decreased,"The mean values of EPG (Table-1) significantly differ (p<0.05) among the treatments. The highest values were obtained in T1 and lowest in T3 and T4, even from the first 15 days of protein dietary supplementation. The values were increased throughout the experiment possibly due to flock grazing. Especially, T3 have significantly (p<0.01) lower values than T1 and T2 groups suggesting that the supplementation influenced the rate of larval development in the kids.", mean values of EPG , T2 feed containing 16% digestible crude protein , T3 concentrate feed containing  20% digestible crude protein ,0,
edin,8454,4893099,Significantly increased,"Peficitinib 50, 100 and 150âmg each showed statistically significantly higher ACR20 response rates compared with placebo, and response rates increased up to 150âmg with a statistically significant dose response.", ACR20 response rate , Placebo , Peficitinib 50 mg ,0,
edin,8616,4599047,Cannot tell based on the abstract,, leg pain - moderate degenerative lumbar spinal stenosis. ," X-STOPÂ® (49/129, 38.0%) "," SuperionÂ® (63/120, 52.5%) ",0,
edin,8616,4599047,Significantly decreased,"Table 2 provides the 36-month success rates for pain severity as well as back- and disease-specific outcomes based on the minimal clinically important difference criteria for each variable. Five of six comparisons qualitatively favored treatment with the SuperionÂ® device; however, only the leg pain results achieved statistical significance. Inspection of the line graphs for each outcome captures both the durability of the SuperionÂ® results and the modest degradation in X-STOPÂ® results between 24 and 36 months for the ZCQ (Figure 1) as well as for back and leg pain severity (Figure 2) and back function (Figure 3).", leg pain - moderate degenerative lumbar spinal stenosis. ," X-STOPÂ® (49/129, 38.0%) "," SuperionÂ® (63/120, 52.5%) ",0,
edin,8571,4076897,Significantly decreased,"Comparing with baseline measures, both groups had significantly improved post-treatment pain (P < 0.0001 for both groups) and mandibular opening (P value: 0.001 for glucosamine sulfate and 0.03 for ibuprofen). Post treatment pain and mandibular opening showed significantly more improvement in the glucosamine treated patients (P < 0.0001 and 0.01 respectively).", Post treatment pain in temporomandibular joint (TMJ) disorders , ibuprofen 400 mg twice a day , glucosamine sulfate 1500 mg daily  ,0,
edin,8710,5971365,Significantly increased,"At week 96, significantly greater mean improvement from baseline in SDMT was observed with daclizumab beta versus IM IFN beta-1a (pâ=â0.0274). Significantly more patients treated with daclizumab beta showed clinically meaningful improvement in SDMT (increase from baseline of â©¾3 points (pâ=â0.0153) or â©¾4 points (pâ=â0.0366)), and significantly fewer patients showed clinically meaningful worsening (decrease from baseline of â©¾3 points (pâ=â0.0103)). Odds representing risk of worsening versus stability or improvement on SDMT were significantly smaller for daclizumab beta (pâ=â0.0088 (3-point threshold); pâ=â0.0267 (4-point threshold)). In patients completing 144âweeks of treatment, the effects of daclizumab beta were generally sustained.", clinically meaningful improvement at week 144 (â©¾3-point increase on the SDMT) , intramuscular (IM) interferon (IFN) beta-1a , daclizumab beta ,0,
edin,8609,5077078,Cannot tell based on the abstract,, correlation between target energy and visual analogue scale (VAS) values , (HC) age-matched healthy control subjects , (PD) early-stage Parkinsonâs disease patients without cognitive or sensory impairment were investigated OFF medication ,0,
edin,8609,5077078,No significant difference,The correlation between target energy and VAS values was not significantly different between PD and HC (p = 0.795)., correlation between target energy and visual analogue scale (VAS) values , (HC) age-matched healthy control subjects , (PD) early-stage Parkinsonâs disease patients without cognitive or sensory impairment were investigated OFF medication ,0,
edin,8587,4433997,No significant difference,"There was not remarkable difference between the two treatments in dynamic balance functions, balance confidence, and activities of daily living", balance confidence (ABC) scale at week 4 , progressive balance training (PBT) , Wii Fit balance training (WBT) ,0,
edin,8624,4508540,Cannot tell based on the abstract,, EI (Effectiveness Index) for Quality of life 6 months later , CIMT 1.5 hours of supervised CIMT+1.5 hours home exercises supervised by a caregiver , CIMT 3 hours of CIMT supervised by a therapist ,0,
edin,8624,4508540,No significant difference,Figure 1C shows EI results. There were no significant differences between the two groups immediately after treatment (P=0.90) and at six months post-treatment (P=0.04)., EI (Effectiveness Index) for Quality of life 6 months later , CIMT 1.5 hours of supervised CIMT+1.5 hours home exercises supervised by a caregiver , CIMT 3 hours of CIMT supervised by a therapist ,0,
edin,8503,4595235,Cannot tell based on the abstract,, Blood chemistry count , Placebo , Bio-active peptide supplement ,0,
edin,8503,4595235,No significant difference,There were no statistically significant interaction effects (group Ã time) for any blood chemistry count measures indicating no specific effects of supplementation on these variables (p values > 0.05), Blood chemistry count , Placebo , Bio-active peptide supplement ,0,
edin,8565,2952311,Cannot tell based on the abstract,, Verbal rating scale pain intensity  , Control , Acupressure at distal points ,0,
edin,8565,2952311,Significantly decreased,"There were no significant differences in all parameters in the control group. VRS (Figure 3), STAI-I (Figure 4), and MH (Figure 5) values significantly decreased immediately after treatment, and NDI (Figure 6) was lower at 1 day following treatment compared with pre-treatment in the LP and the DP groups.", Verbal rating scale pain intensity  , Control , Acupressure at distal points ,0,
edin,8366,5431359,Significantly decreased,"The intervention had a positive effect on somatic anxiety (pâ<â0.05), reflecting a beneficial development over time compared with the controls.", Somatic anxiety , Control , Cognitive behavioral therapy ,0,
edin,8446,5320771,Cannot tell based on the abstract,, Diarrhea , Placebo , Human adipose-derived stromal/stem cells ,0,
edin,8446,5320771,No significant difference,"There were no cases of hemorrhage, need for blood transplants, pain, diarrhea, colon inflammation, infection, allergic reactions, recurrence of disease, readmission, and mortality.", Diarrhea , Placebo , Human adipose-derived stromal/stem cells ,0,
edin,8726,2770415,Cannot tell based on the abstract,, Helping Alliance Questionnaire (HAQ) , usual treatment for substance-dependent patients , shared decision-making intervention (SDMI) for substance-dependent patients ,0,
edin,8726,2770415,Significantly increased,"A significant difference between SDMI and control condition was measured on the HAQ completed by clinicians. Helpfulness (t = 2.44, p < 0.05 and t = 2.82, p < 0.01 respectively at interim and exit measurement) and total score (t = 2.01, p < 0.05 and t = 3.01, p < 0.01 respectively at interim and exit measurement) were significantly higher when clinicians carried out SDMI. T", Helping Alliance Questionnaire (HAQ) , usual treatment for substance-dependent patients , shared decision-making intervention (SDMI) for substance-dependent patients ,0,
edin,8420,4570722,Cannot tell based on the abstract,, Erythropoietin at week 24 , BAT (Control) , Ruxolitinib ,0,
edin,8420,4570722,Significantly increased,"Ruxolitinib-treated patients had higher median levels of erythropoietin than BAT-treated patients at week 24 (ruxolitinib, 36.0Â pg/mL, 95Â % CI 19â77Â pg/mL; BAT, 8.7Â pg/mL, 95Â % CI 7â29Â pg/mL) and even higher levels at week 48 [54.0Â pg/mL, 95Â % CI 31â98Â pg/mL (216.3Â % change) vs 26.0Â pg/mL, 95Â % CI 16â72Â pg/mL (77.0Â % change), respectively]", Erythropoietin at week 24 , BAT (Control) , Ruxolitinib ,0,
edin,8347,4064756,Cannot tell based on the abstract,, Dose needed for expulsion  , Vaginal misoprostol and sublingual placebo , Sublingual misoprostol and vaginal placebo  ,0,
edin,8347,4064756,Significantly decreased,The mean dose applied was 1311.34 Âµg in the sublingual group and 1593.62 Âµg in the vaginal group that shows the sublingual group needed lower dose of misoprostol for fetus expulsion in comparison with the vaginal group (p= 0.010), Dose needed for expulsion  , Vaginal misoprostol and sublingual placebo , Sublingual misoprostol and vaginal placebo  ,0,
edin,8372,5648980,Significantly decreased,"The mechanical ventilation time, time for recovering from chest X-ray scan and hospitalization time of patients in the observation group were shorter than that of the control group, and the difference had statistical significance (P<0.05).", Mechanical ventilation time , Control , Budesonide  ,0,
edin,8352,2639329,No significant difference,"At least one treatment-related MAE was observed in 9.2% of patients (n = 17) assigned to the active group vs. 13.3% of patients (n = 26) in the control group (P = 0.21), a 4.1% absolute risk reduction (95% CI â2.2 to 10.4; P = 0.98).", Treatment-related MAE , Usual medical practices , Discharged 24 h after PM implant/4â6 h after replacement ,0,
edin,8403,2717426,Significantly increased,The insulin/glucose ratio at 270 minutes was increased with GLP-1 infusion (GLP-1 (9.1 Â± 2.7) vs. placebo (5.8 Â± 1.8); P = 0.02) but there was no difference in absolute insulin concentrations., Insulin/glucose ratio , Control , Exogenous glucagon-like peptide-1 infusion ,0,
edin,8613,4162719,No significant difference,"There was no significant difference in time to complete the simple model (HN vs. HS, 18 seconds vs. 18 seconds, p=0.93), time to complete the difficult model (HN vs. HS, 56 seconds vs. 50 seconds, p=0.63), needle visualization, or needle tip targeting accuracy.", time to complete the difficult model , two-operator hand-on-needle (HN) technique , single operator hand-on-syringe (HS) needle technique ,0,
edin,8599,3248601,Cannot tell based on the abstract,, RPP (rate pressure product) values , conventional laryngoscopy (CL) , intubating laryngeal mask airway (ILMA)  ,0,
edin,8599,3248601,Significantly increased,The RPP values in the ILMA group were greater than those for the CL group at 1 and 2 min following intubation (p<0.05)., RPP (rate pressure product) values , conventional laryngoscopy (CL) , intubating laryngeal mask airway (ILMA)  ,0,
edin,8735,4304200,Significantly increased,"The intervention resulted in significant improvements in fiber intake (M between-group differenceâ=â5.7Â g/day, pâ<â.001) but not fat consumption (â2.3Â g/day, pâ=â0.13), that were predictive of weight loss at both four months (M between-group differenceâ=ââ1.98Â kg, pâ<â.01; R2â=â0.2, pâ<â0.005), and 12Â months (M differenceâ=ââ1.85Â kg, pâ=â0.1; R2â=â0.1, pâ<â0.01).", fiber intake at 12r months , usual care , weight management intervention targeting diet and physical activity plus usual care ,0,
edin,8471,5426232,Cannot tell based on the abstract,, Diameter stenosis , Zotarolimus-eluting stent , Drug-eluting balloon + bare metal stent ,0,
edin,8471,5426232,Significantly increased,"<td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">ââIn-stent</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""top"">24.5 Â± 17.1</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""top"">30.6 Â± 17.8</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""top"">18.2 Â± 13.9</td><td align=""right"" colspan=""1"" rowspan=""1"" valign=""top"">&lt; 0.001</td>", Diameter stenosis , Zotarolimus-eluting stent , Drug-eluting balloon + bare metal stent ,0,
edin,8690,3148260,Cannot tell based on the abstract,, hypoglycemia , without cerebral swelling on CT scan , cerebral swelling on CT scan ,0,
edin,8690,3148260,No significant difference,"Severe jaundice (total plasma bilirubin level, >3 mg/dL) was present in 33 (72%) of 46 patients without swelling and in 53 (68%) of 78 patients with swelling (P = .69), whereas severe anemia (hemoglobin level, <5g/dL) was present in 5 (11%) of 46 patients without swelling versus 6 (8%) of 76 patients with swelling (P = .58), and hypoglycemia (plasma glucose level, <40 mg/dL) in 4 (9%) of patients without swelling and 2 (3%) of patients with swelling (P = .19).", hypoglycemia , without cerebral swelling on CT scan , cerebral swelling on CT scan ,0,
edin,8459,4893099,No significant difference,"The total incidence of treatment-emergent adverse events (TEAEs) was similar between the placebo (64.3%) and peficitinib 25, 50, 100 and 150âmg groups (70.9%, 64.9%, 52.7% and 67.2%, respectively).", Treatment-emergent adverse events , Placebo , Peficitinib 150 mg ,0,
edin,8539,4065461,No significant difference,Patients who had received dexamethasone + epinephrine exhibited similar admission rates compared to placebo + epinephrine or salbutamol (P = 0.64)., Admission rates , Placebo + epinephrine , Dexamethasone + epinephrine ,0,
edin,8594,5045523,No significant difference,"The response rate for those receiving letters or postcards was similar (odds ratio 1.14, 95% CI 0.91-1.44, P=.26).", response rate by degree , doctor of osteopathy (DO) degree , doctor of medicine (MD) degree ,0,
edin,8551,2503659,Cannot tell based on the abstract,, Methicillin-resistant Staphylococcus aureus eradication rate , Vancomycin , Telavancin  ,0,
edin,8551,2503659,No significant difference,"In addition, telavancin showed a higher eradication rate of MRSA than vancomycin (89.9% versus 85.4%), which again was not statistically significant", Methicillin-resistant Staphylococcus aureus eradication rate , Vancomycin , Telavancin  ,0,
edin,8714,5971365,Significantly increased,"At week 96, significantly greater mean improvement from baseline in SDMT was observed with daclizumab beta versus IM IFN beta-1a (pâ=â0.0274).", clinically meaningful improvement at week 96 (â©¾3-point increase on the SDMT) , intramuscular (IM) interferon (IFN) beta-1a , daclizumab beta ,0,
edin,8588,4433997,No significant difference,"There was not remarkable difference between the two treatments in dynamic balance functions, balance confidence, and activities of daily living.", balance confidence (ABC) scale at week 8 , progressive balance training (PBT) , Wii Fit balance training (WBT) ,0,
edin,8432,3295238,No significant difference,"Blood pressure was lower on nifedipine than on placebo by 5.8/2.1 mmHg (P < 0.001) as was total and LDL cholesterol (4.8 mg/dL; P = 0.495), while HDL was higher (3.6 mg/dL; P = 0.026).", LDL cholesterol  , Placebo , Nifedipine ,0,
edin,8339,5524909,Significantly decreased,"Cerebral ischaemia was associated with reduced numbers of calbindin-28k, calretinin, parvalbumin and GAD positive striatal neurons (Pâ<â0.05 ischaemiaâ+âvehicle, nâ=â6 vs. sham ischaemia, nâ=â6) but not ChAT or nNOS positive neurons.", Calretinin , Sham ischaemia , Ischaemiaâ+âvehicle ,0,
edin,8435,3295238,No significant difference,"The percentage change in plaque volume with nifedipine and placebo, respectively, was 1.0 and 1.9%, ns.", Change in plaque volume , Placebo , Nifedipine ,0,
edin,8379,4754570,Significantly increased,All groups showed greater microleakage at the gingival in comparison to the incisal margin and the differences were significant among groups with transillumination (P<0.001)., Microleakage at gingival vs incisal margin , Control , Transbond XT self-etching primer + transillumination. ,0,
edin,8646,3944283,Cannot tell based on the abstract,, Muscle activity of the medial gastrocnemius muscle - inpatients receiving physical therapy for chronic stroke , patients wore only their shoes , ankle-foot orthosis (AFO) group ,0,
edin,8646,3944283,Significantly increased,"<td align=""left"" colspan=""1"" rowspan=""1"">Change</td><td align=""center"" colspan=""1"" rowspan=""1"">3.00 Â± 0.81<sup>*</sup></td><td align=""center"" colspan=""1"" rowspan=""1"">0.63 Â± 0.59</td>", Muscle activity of the medial gastrocnemius muscle - inpatients receiving physical therapy for chronic stroke , patients wore only their shoes , ankle-foot orthosis (AFO) group ,0,
edin,8583,2808793,Significantly decreased,Montgomery-Asberg Depression Rating Scales (MADRS) scores of the forest group were significantly decreased compared with both the hospital group and the controls., Montgomery-Asberg Depression Rating Scale (MADRS) scores , control group - pharmacotherapy in outpatient , forest group - cognitive behavior therapy (CBT)-based psychotherapy plus pharmacotherapy ,0,
edin,8728,5812048,Cannot tell based on the abstract,, Heart rate (HR) at 30 min , placebo  (CON) , caffeine (CAF) ,0,
edin,8728,5812048,Significantly decreased,"However, HR values for CON were higher than CAF at 30-min (pâ=â0.013).", Heart rate (HR) at 30 min , placebo  (CON) , caffeine (CAF) ,0,
edin,8754,5119439,No significant difference,"Femoral stems in the compaction group had a higher degree of medio-lateral migration (0.21âmm, 95% CI: 0.03â0.40) than femoral stems in the broaching group at 5 years (p = 0.02). No other significant differences in translations or rotations were found between the 2 surgical techniques at 2 years (p > 0.4) and 5 years (p > 0.7) postoperatively.", other significant differences in rotations at 5 years , femoral bone preparation with broaching on the other side , femoral bone preparation with compaction on 1 side ,0,
edin,8693,5079608,Cannot tell based on the abstract,, Adherence to medication - 10â17 years old with recent-onset type 2 diabetes and â¥80% adherence to metformin therapy for â¥8 weeks , Low adherence; taking &amp;lt;80% of medication , High adherence; taking â¥80% of medication ,0,
edin,8693,5079608,Cannot tell based on the abstract,, Adherence to medication - 10â17 years old with recent-onset type 2 diabetes and â¥80% adherence to metformin therapy for â¥8 weeks , Low adherence; taking &amp;lt;80% of medication , High adherence; taking â¥80% of medication ,0,
edin,8693,5079608,Significantly increased,"Data are from prior to treatment failure when participants were placed on a uniform diabetes management regimen. A: For insulin inverse, there was a significant difference between the adherence groups (i.e., the higher-adherence group had higher values of insulin inverse) (P = 0.0012), but the lines were parallel (no interaction) and flat (no visit or time trend). B: For the insulinogenic index, there was a significant difference over time (P = 0.0076), and a rise at month 36 was detected, which was the same in both adherence groups.", Adherence to medication - 10â17 years old with recent-onset type 2 diabetes and â¥80% adherence to metformin therapy for â¥8 weeks , Low adherence; taking &amp;lt;80% of medication , High adherence; taking â¥80% of medication ,0,
edin,8627,4696773,Significantly decreased,"Vasorelaxation to ADP was reduced in LADs from Occl-Sed and Occl-Ex pigs (P<0.001) as compared to Non-Occl-Con pigs; however, Occl-Ex pigs exhibited partial recovery (P<0.001) intermediate to the other two groups.", Vasorelaxation to adenosine diphosphate (ADP) in LAD ," non-occluded, non-exercised control (Non-Occl-Con) ", occluded exercise trained (Occl-Ex) ,0,
edin,8741,3840008,Significantly increased,"The mean serum concentrations of TFF3 in patients with CKD, metastatic and secondary carcinoma (MC) and acute gastroenteritis (AG) (200.9 ng/ml, 95.7 ng/ml and 71.7 ng/ml, respectively) were significantly higher than those in patients with other common clinical diseases", Trefoil factor 3 (TFF3) in each common clinical disease group , other clinical diseases groups , metastatic and secondary carcinoma (MC) group ,0,
edin,8623,4508540,Cannot tell based on the abstract,, EI (Effectiveness Index) for Fugl-Meyer Assessment of Sensorimotor Recovery after Stroke (FMA) 6 months later , CIMT 1.5 hours of supervised CIMT+1.5 hours home exercises supervised by a caregiver , CIMT 3 hours of CIMT supervised by a therapist ,0,
edin,8623,4508540,No significant difference,"There were no significant differences in EI results regarding FMA scores between CIMT1.5h_direct group and the CIMT3h_direct group immediately after treatment (P=0.60). Similarly, no significant differences between

CIMT1.5h_direct and the CIMT3h_directÂ·group after 6 months (P=0.84) indicating similar effects of therapies on motor impairment (Figure 2B).", EI (Effectiveness Index) for Fugl-Meyer Assessment of Sensorimotor Recovery after Stroke (FMA) 6 months later , CIMT 1.5 hours of supervised CIMT+1.5 hours home exercises supervised by a caregiver , CIMT 3 hours of CIMT supervised by a therapist ,0,
edin,8651,5294576,Cannot tell based on the abstract,, efficiency in cognitive control , Control group , Tai Chi Chuan group ,0,
edin,8651,5294576,Significantly increased,"After 12-week interventions, the mental control subscores were 34.52âÂ±â3.17, 36.00âÂ±â3.78, 28.46âÂ±â5.76 (meanâÂ±âSD) for Tai Chi Chuan, Baduanjin and Control respectively. Mixed-model regression analysis showed significant mental control score increases in the Tai Chi Chuan and Baduanjin groups compared with the control group (Baduanjin: pâ<â0.001, Tai Chi Chuan: pâ=â0.017)", efficiency in cognitive control , Control group , Tai Chi Chuan group ,0,
edin,8354,3848942,Significantly increased,"Children in the intervention areas were more likely to receive prompt and appropriate antibiotics for pneumonia symptoms compared to children in the control areas (RRâ=â3.51, 95%CIâ=â1.75-7.03)", Likeliness to receive prompt and appropriate antibiotics for pneumonia , Control , Integrated community case management of malaria and pneumonia ,0,
edin,8462,3263860,Cannot tell based on the abstract,, Diabetic ketoacidosis , Control , Real-Time Continuous Glucose Monitoring ,0,
edin,8462,3263860,No significant difference,"There were no cases of diabetic ketoacidosis and no serious adverse events attributable to the study interventions, including no serious skin reactions.", Diabetic ketoacidosis , Control , Real-Time Continuous Glucose Monitoring ,0,
edin,8475,5139733,Significantly increased,"<th align=""left"" colspan=""1"" rowspan=""2"" valign=""top""></th><th align=""center"" colspan=""4"" rowspan=""1"" valign=""top"">TJ-100</th>", Abdominal pain improvement  , Control , Daikenchuto  (TJ-100) ,0,
edin,8555,5541727,No significant difference,No cell-related serious adverse effects were observed., Treatment-related serious adverse events  , Control , Allogeneic mesenchymal precursor cells ,0,
edin,8591,5045523,No significant difference,"The response rate for those receiving letters or postcards was similar (odds ratio 1.14, 95% CI 0.91-1.44, P=.26).", response rate , postcards , letters ,0,
edin,8345,4064756,No significant difference,There was no significant difference in the success rate at 24 and 48 hours and in side effects., Success rate at 48 hours , Vaginal misoprostol and sublingual placebo , Sublingual misoprostol and vaginal placebo  ,0,
edin,8748,4555162,Cannot tell based on the abstract,, dietary intakes after intervention , national average , participants in the current study ,0,
edin,8748,4555162,Significantly increased,"Although almost a third of participants acknowledged little change to the healthiness of their diet post-study due to persistence of major barriers (e.g., partner reluctance, personal preference and taste), the majority reported having made permanent changes to their dietary intake and food habits.,Comparison of the dietary intakes of participants in the current study to data from the 2011â2012 Australian Health Survey (AHS) [26] indicates that this group were consuming higher energy intakes compared to the national average of 8672 kJ (value also obtained from 24-h recall), both before and after the intervention, while the proportion of energy from discretionary food choices was similar at 34.6% of total energy for adults.", dietary intakes after intervention , national average , participants in the current study ,0,
edin,8344,4064756,No significant difference,here was no significant difference in the success rate at 24 and 48 hours and in side effects., Success rate at 24 hours , Vaginal misoprostol and sublingual placebo , Sublingual misoprostol and vaginal placebo  ,0,
edin,8495,2876855,Cannot tell based on the abstract,, T-wave amplitude , Lidocaine 1.0% 3 ml + epinephrine 10 Âµg , Lidocaine 1.0% 3 ml + epinephrine 5 Âµg ,0,
edin,8495,2876855,No significant difference,The T-wave amplitude was decreased at 20-80 seconds intervals in groups E5 and E10. The maximum decreases were 0.29 Â± 0.20 mV and 0.32 Â± 0.24 mV respectively. The rate of the decrease was 66 Â± 24% and 64 Â± 34% respectively. There was no significant difference between groups E5 and E10 (Fig. 3)., T-wave amplitude , Lidocaine 1.0% 3 ml + epinephrine 10 Âµg , Lidocaine 1.0% 3 ml + epinephrine 5 Âµg ,0,
edin,8407,3215316,Cannot tell based on the abstract,, Fatigue , Control , Dhatri Avaleha ,0,
edin,8407,3215316,Significantly decreased,"After the completion of treatment with follow up result obtained in 08 patients of Group A (Dhatri Avaleha) i.e highly significant (p<0.001) in fatigue, significant (p<0.01) in abdominal pain and pallor, while insignificant (p>0.10) in joint pain, depression spleenomegaly, and irritable bowel syndrome.", Fatigue , Control , Dhatri Avaleha ,0,
edin,8559,5541727,Significantly increased,"<td colspan=""4"">KOOS</td>", SF-36 bodily pain score improvement  , Control , Allogeneic mesenchymal precursor cells ,0,
edin,8381,4754570,No significant difference,All groups showed greater microleakage at the gingival in comparison to the incisal margin and the differences were significant among groups with transillumination (P<0.001). No significant differences were observed in the microleakage scores at the gingival and incisal margins in any of the interfaces (P>0.05)., Microleakage at gingival vs incisal margin , Control , Transbond XT self-etching primer + direct illumination ,0,
edin,8672,4644305,Cannot tell based on the abstract,, superior efficacy , transcutaneous electrical nerve stimulation (TENS) , pulsed radiofrequency (PRF) lumbar sympathectomy  ,0,
edin,8672,4644305,Significantly increased,"In conclusion, both PRF sympathectomy and TENS can reduce lower extremity pain in patients with PDPN. However, PRF sympathectomy seems to be more effective than TENS.", superior efficacy , transcutaneous electrical nerve stimulation (TENS) , pulsed radiofrequency (PRF) lumbar sympathectomy  ,0,
edin,8514,5722122,Cannot tell based on the abstract,, Percentage of cracks , SafeSider , ProTaper Universal system ,0,
edin,8514,5722122,No significant difference,"Both rotary and reciprocating systems increased the number and percentage of cracks in roots (13.3% in ProTaper group, 26.7% in SafeSider group and 40% in Neolix group) (Table 1). But, there was no significant difference among the three groups (P>0.05).", Percentage of cracks , SafeSider , ProTaper Universal system ,0,
edin,8401,2717426,Significantly decreased,"In all patients, exogenous GLP-1 infusion reduced the overall glycaemic response during enteral nutrient stimulation (AUC30â270 min GLP-1 (2077 Â± 144 mmol/l min) vs placebo (2568 Â± 208 mmol/l min); P = 0.02) and the peak blood glucose (GLP-1 (10.1 Â± 0.7 mmol/l) vs placebo (12.7 Â± 1.0 mmol/l); P < 0.01).", Glycaemic response , Control , Exogenous glucagon-like peptide-1 infusion ,0,
edin,8557,5541727,Significantly increased,"<td colspan=""4"">KOOS</td>", Activities of daily living , Control , Allogeneic mesenchymal precursor cells ,0,
edin,8730,5812048,Cannot tell based on the abstract,, Bioelectrical impedance analysis (BIA) derived BF(Body Fat)% at 30-90 min , placebo  (CON) , caffeine (CAF) ,0,
edin,8730,5812048,No significant difference,"There was a statistical significant condition Ã time interaction for BF% (F12, 228â=â2.605; pâ=â0.003). Post hoc analysis revealed BF% for CAF was lower than CON and PLA at PRE (pâ=â0.001 and 0.009, ESâ=â0.10 and 0.08, respectively) and 15-min (pâ=â0.56 and 0.004, ESâ=â0.05 and 0.08, respectively), but not statistically significant for the remaining time points.", Bioelectrical impedance analysis (BIA) derived BF(Body Fat)% at 30-90 min , placebo  (CON) , caffeine (CAF) ,0,
edin,8630,4696773,No significant difference,"BK induced relaxation was reduced in LADs from Occl-Ex and Occl-Sed pigs (P<0.001), compared to Non-Occl-Con, and exercise modestly increased responses to BK (P<0.05). In addition, SNP, PE, Ang II, and ET-1 responses were not significantly different among the groups.", Vasorelaxation to sodium nitro-prusside (SNP) in LAD ," non-occluded, non-exercised control (Non-Occl-Con) ", occluded-sedentary (Occl-Sed) ,0,
edin,8342,5524909,Significantly increased,"Long infusion of peptide (nâ=â6) was associated with increased survival of calbindin-28k, calretinin, parvalbumin and GAD positive neurons (Pâ<â0.05 vs. ischaemiaâ+âvehicle).", Calbindin-28k , Ischaemiaâ+âvehicle , Long infusion of peptide  ,0,
edin,8442,5320771,No significant difference,Comparing Wexner scores in the cell group and the control group showed no significant difference., Wexner scores , Placebo , Human adipose-derived stromal/stem cells ,0,
edin,8650,5294576,Significantly increased,"We found that compared to the controls, 1) both Tai Chi Chuan and Baduanjin groups demonstrated significant improvements in mental control function; 2) the Tai Chi Chuan group showed a significant decrease in rsFC between the DLPFC and the left superior frontal gyrus (SFG) and anterior cingulate cortex; and 3) the Baduanjin group showed a significant decrease in rsFC between the DLPFC and the left putamen and insula."," After 12-week interventions, the mental control subscores ", Control group , Baduanjin groups ,0,
edin,8677,4774750,Cannot tell based on the abstract,"In this study, protein supplementation had a significant (p<0.05) effect on fecal egg counts even after 15 days; hemoglobin (Hb) (g/dl) after 45 days; total leukocyte count (103/mm3) and total erythrocyte count (106/mm3) after 30 days; packed cell volume (%), lymphocyte (%), and eosinophil (%) after 15 days of supplementation, whereas monocyte (%) and neutrophil (%) values were not significantly influenced by protein supplementation effect during the entire experiment.", fecal egg counts ," T1, served as a negative control "," T2, T3, and T4 that received concentrate feed containing 16, 20, and 24% digestible crude protein ",0,
edin,8677,4774750,Significantly decreased,"<th align=""center"" colspan=""1"" rowspan=""1"">T1</th><th align=""center"" colspan=""1"" rowspan=""1"">T2</th><th align=""center"" colspan=""1"" rowspan=""1"">T3</th><th align=""center"" colspan=""1"" rowspan=""1"">T4</th>", fecal egg counts ," T1, served as a negative control "," T2, T3, and T4 that received concentrate feed containing 16, 20, and 24% digestible crude protein ",0,
edin,8371,5431359,Cannot tell based on the abstract,, Social support , Control , Cognitive behavioral therapy ,0,
edin,8371,5431359,No significant difference,"Exploratory analyses showed that the estimated interactions of intervention and time on social support and physical activity were â0.07 (95% confidence interval (CI) â0.23 to 0.09) and 0.07 (95% CI â0.53 to 0.69), respectively, suggesting no effect of the treatment on these outcomes.", Social support , Control , Cognitive behavioral therapy ,0,
edin,8439,5568719,Cannot tell based on the abstract,, Improvement in Patient Health Questionnaire , Control , Computerized cognitive behavioral therapy for insomnia ,0,
edin,8439,5568719,Significantly increased,"A significant improvement in ISI (pÂ =Â 0.002), ESS (pÂ =Â 0.042), PIRS20 (pÂ =Â 0.005) and PHQ-9 (pÂ <Â 0.001) scores were observed in the treatment group.", Improvement in Patient Health Questionnaire , Control , Computerized cognitive behavioral therapy for insomnia ,0,
edin,8408,3215316,Cannot tell based on the abstract,, Abdominal pain , Control , Dhatri Avaleha ,0,
edin,8408,3215316,Significantly increased,"After the completion of treatment with follow up result obtained in 08 patients of Group A (Dhatri Avaleha) i.e highly significant (p<0.001) in fatigue, significant (p<0.01) in abdominal pain and pallor, while insignificant (p>0.10) in joint pain, depression spleenomegaly, and irritable bowel syndrome.", Abdominal pain , Control , Dhatri Avaleha ,0,
edin,8534,3979125,Cannot tell based on the abstract,, IL-6 mRNA response , Control , Brodalumab  ,0,
edin,8534,3979125,No significant difference,"While predose samples from several patients displayed the attenuated IL-6 mRNA response, no significant increase in the magnitude of the IL-6 mRNA response was observed following treatment with brodalumab compared to placebo (data not shown).", IL-6 mRNA response , Control , Brodalumab  ,0,
edin,8405,2717426,Significantly decreased,"There was a transient, non-sustained, reduction in plasma glucagon concentrations during GLP-1 infusion (t = 30 minutes GLP-1 (90 Â± 12 pmol/ml) vs. placebo (104 Â± 10 pmol/ml); P < 0.01).", Glucagon concentrations during infusion , Control , Exogenous glucagon-like peptide-1 infusion ,0,
edin,8409,3215316,Cannot tell based on the abstract,, Joint pain , Control , Dhatri Avaleha ,0,
edin,8409,3215316,No significant difference,"After the completion of treatment with follow up result obtained in 08 patients of Group A (Dhatri Avaleha) i.e highly significant (p<0.001) in fatigue, significant (p<0.01) in abdominal pain and pallor, while insignificant (p>0.10) in joint pain, depression spleenomegaly, and irritable bowel syndrome.", Joint pain , Control , Dhatri Avaleha ,0,
edin,8691,5079608,Cannot tell based on the abstract,, loss of glycemic control - 10â17 years old with recent-onset type 2 diabetes and â¥80% adherence to metformin therapy for â¥8 weeks , Low adherence; taking &amp;lt;80% of medication , High adherence; taking â¥80% of medication ,0,
edin,8691,5079608,No significant difference,"Failure was not associated with lower adherence to taking medication. Among those subjects who failed therapy, 62.5% had at least an 80% adherence to study medication on average compared with 50.3% in those who did not fail therapy by the end of the study (P = 0.0018).,With regard to the TODAY study primary outcome, we did not find an adherence threshold that predicted loss of glycemic control.", loss of glycemic control - 10â17 years old with recent-onset type 2 diabetes and â¥80% adherence to metformin therapy for â¥8 weeks , Low adherence; taking &amp;lt;80% of medication , High adherence; taking â¥80% of medication ,0,
edin,8699,4081799,Cannot tell based on the abstract,, higher weight at end of intervention , control group , relapse prevention (RP) intervention group (full completers) ,0,
edin,8699,4081799,Significantly increased,Pairwise comparison of groups showed full completers reached a significantly (pâ<â.05) higher weight compared to the partial users and the control group at T2 (end of intervention) and at T3 (follow-up)., higher weight at end of intervention , control group , relapse prevention (RP) intervention group (full completers) ,0,
edin,8750,5119439,No significant difference,No other significant differences in translations or rotations were found between the 2 surgical techniques at 2 years (p > 0.4) and 5 years (p > 0.7) postoperatively. T, other significant differences in rotations at 2 years , femoral bone preparation with broaching on the other side , femoral bone preparation with compaction on 1 side ,0,
edin,8376,5648980,No significant difference,"The head circumference, height and weight of the patients in the observation group in the 3rd and 6th month were compared to those of the control group, suggesting no significant differences (P>0.05).", Head circumference , Control , Budesonide  ,0,
edin,8687,3148260,Cannot tell based on the abstract,, mortality , without cerebral swelling on CT scan , cerebral swelling on CT scan ,0,
edin,8687,3148260,No significant difference,"<td colspan=""1"" rowspan=""1"">Mortality,<xref ref-type=""table-fn"" rid=""tblfn2"">b</xref> proportion (%)</td><td align=""char"" char=""("" colspan=""1"" rowspan=""1"">16/44 (36)</td><td align=""char"" char=""("" colspan=""1"" rowspan=""1"">19/78 (24)</td><td align=""char"" char=""."" colspan=""1"" rowspan=""1"">.21</td>,Excluding the 4 patients with intracerebral hemorrhage or infarction identified on CT scan, mortality was 16 (36%) of 44 patients without cerebral swelling and 19 (24%) of 78 patients with cerebral swelling (P = .21).,Mortality was 15 (35%) of 43 in patients with a pressure of â¥200 mmH2O and 17 (22%) of 77 in patients with lower pressures (P = .14).", mortality , without cerebral swelling on CT scan , cerebral swelling on CT scan ,0,
edin,8697,4081799,Cannot tell based on the abstract,, long-term predictors for favorable course , control group , relapse prevention (RP) intervention group (full and partial completers) ,0,
edin,8697,4081799,No significant difference,"Comparing profiles of RP and controls, no specific pattern of change could be identified, but generally, data for RP participants showed slightly more favorable course (lower scores) of recovery.", long-term predictors for favorable course , control group , relapse prevention (RP) intervention group (full and partial completers) ,0,
edin,8482,4960805,Cannot tell based on the abstract,, Increases in hemoglobin when GFR &amp;lt;15 mL/min , Iron sucrose , Ferumoxytol  ,0,
edin,8482,4960805,Significantly increased,"<td>âStage 5 (eGFR &lt;15&nbsp;mL/min)</td><td>38 (7.8)</td><td>42 (14.9)</td><td>80 (10.4)</td>,<td>Stage 5 (eGFR &lt;15&nbsp;mL/min)</td><td>10.2 (1.09) (<italic>n</italic>â=â38)</td><td>10.2 (1.10) (<italic>n</italic>â=â42)</td><td>22.3 (12.91) (<italic>n</italic>â=â38)</td><td>21.7 (14.76) (<italic>n</italic>â=â42)</td><td>411.3 (348.97) (<italic>n</italic>â=â38)</td><td>359.7 (287.65) (<italic>n</italic>â=â42)</td>,Ferumoxytol-treated patients with eGFRs of 60 to <90Â mL/min and <15Â mL/min at Week 2 also had a significantly greater increase in Hgb levels compared with iron sucrose-treated patients (pâ=â0.009 and pâ=â0.012, respectively, vs. iron sucrose); there were no significant treatment differences in Hgb levels between treatment groups in the other categories of renal function (Fig.Â 3b).Fig. 3", Increases in hemoglobin when GFR &amp;lt;15 mL/min , Iron sucrose , Ferumoxytol  ,0,
edin,8388,3477095,Cannot tell based on the abstract,, Pain intensity , Control , Hyaluronic acid + chondroitin sulfate  ,0,
edin,8388,3477095,Significantly decreased,"Pain intensity decreased during the study: as compared to baseline, the change (mean Â± SD) was -23.3âÂ±â22.51 at Visit 3 (one week) and -36.1 Â±28.54 at Visit 6 (12âweeks),<td align=""left"" valign=""top"">Change, mm, mean Â± SD</td><td align=""left"" valign=""top"">-23.3âÂ±â22.51</td><td align=""left"" valign=""top"">-34.0âÂ±â26.98</td><td align=""left"" valign=""top"">-39.5âÂ±â29.23</td><td align=""left"" valign=""top"">-36.1âÂ±â28.54</td>", Pain intensity , Control , Hyaluronic acid + chondroitin sulfate  ,0,
edin,8564,2952311,Cannot tell based on the abstract,, Muscle hardness , Control , Acupressure at local points ,0,
edin,8564,2952311,Significantly decreased,"VRS (Figure 3), STAI-I (Figure 4), and MH (Figure 5) values significantly decreased immediately after treatment, and NDI (Figure 6) was lower at 1 day following treatment compared with pre-treatment in the LP and the DP groups.", Muscle hardness , Control , Acupressure at local points ,0,
edin,8447,5320771,Cannot tell based on the abstract,, Area occupied by muscles , Placebo , Human adipose-derived stromal/stem cells ,0,
edin,8447,5320771,Significantly increased,"Measuring the amount of muscle in the repair site using ImageJ/Fiji 1.46 software showed that the mean ratio of the area occupied by muscles was 18.85âÂ±â5.06% in the cell group and 11.65âÂ±â7.75% in the control group, which indicates a significant difference (pâ=â0.02) (TableÂ 3).Fig. 3", Area occupied by muscles , Placebo , Human adipose-derived stromal/stem cells ,0,
edin,8370,5431359,Cannot tell based on the abstract,, Physical activity , Control , Cognitive behavioral therapy ,0,
edin,8370,5431359,No significant difference,"Exploratory analyses showed that the estimated interactions of intervention and time on social support and physical activity were â0.07 (95% confidence interval (CI) â0.23 to 0.09) and 0.07 (95% CI â0.53 to 0.69), respectively, suggesting no effect of the treatment on these outcomes.", Physical activity , Control , Cognitive behavioral therapy ,0,
edin,8353,2639329,Cannot tell based on the abstract,, Proportions of NMAE relative to all AE , Usual medical practices , Discharged 24 h after PM implant/4â6 h after replacement ,0,
edin,8353,2639329,Significantly increased,"Conversely, the proportions of NMAE relative to all AE were 55% (22/40) in the active group, vs. 32% (12/38) in the control group (P = 0.04).", Proportions of NMAE relative to all AE , Usual medical practices , Discharged 24 h after PM implant/4â6 h after replacement ,0,
edin,8592,5045523,Cannot tell based on the abstract,, response rate , not offered a book; by email , offered a book; by email ,0,
edin,8592,5045523,No significant difference,"Of 2973 physicians who were offered a book in the email invitation, 345 (11.6%) responded to at least one survey question compared with 106 of 993 (10.7%) physicians who were not offered a book (odds ratio 1.10, 95% CI 0.87-1.38, P=.42); see Figure 2. Converting this odds ratio to absolute rates relative to the baseline rate for those not offered a book, the 95% CI for response among those offered a book ranged from 9.5% to 14.2%.", response rate , not offered a book; by email , offered a book; by email ,0,
edin,8703,3576910,Significantly decreased,"Compared with maintaining existing stimulant monotherapy, adding GXR to existing stimulant monotherapy was associated with an incremental drug cost of $US1016 but a lower medical cost of $US124, resulting in a total incremental cost of $US892 at 1 year.", medical cost , Stimulant ," Stimulant plus non-stimulant, guanfacine extended release (GXR)  ",0,
edin,8685,3513028,Significantly increased,"This showed that antihistamine therapy was effective for the sneezing/rhinorrhea type and anti-leukotriene therapy was effective for the nasal blockage type, with no difference between the 2 drugs the combined type. For the nasal blockage type, symptoms and QOL improved faster with anti-leukotriene than antihistamine therapy from the peak to the end of the pollen season.,Stratified analysis showed that the antihistamine was more effective for the sneezing/rhinorrhea type and the anti-leukotriene was more effective for the nasal blockage type, with no difference in effectiveness for the combined type.", effectiveness - nasal blockage type , antihistamine , anti-leukotriene agent (pranlukast) ,0,
edin,8464,3263860,Cannot tell based on the abstract,, PAID questionnaire fear  of fypoglycemia  , Control , Real-Time Continuous Glucose Monitoring ,0,
edin,8464,3263860,No significant difference,"At 26 weeks, there were no significant differences between treatment groups on the Hypoglycemia Fear or the PAID questionnaire survey scores (Table 2 and Supplementary Tables A3 and A6).", PAID questionnaire fear  of fypoglycemia  , Control , Real-Time Continuous Glucose Monitoring ,0,
edin,8603,3439673,Significantly increased,"In multiple linear regression, a low demanding/high responsive feeding style was found to be positively associated (Ã = 0.56) with a higher child weight as compared to high demanding/high responsive, controlling for known covariates (p = 0.01).", child weight , high demanding/high responsive feeding style , low demanding/high responsive feeding style ,0,
edin,8389,3477095,Cannot tell based on the abstract,, Functional impairment , Control , Hyaluronic acid + chondroitin sulfate  ,0,
edin,8389,3477095,Significantly decreased,"Likewise, functional impairment as assessed by Lequesneâs index decreased during the study: as compared to baseline, the change (mean Â± SD) was -1.34âÂ±â3.472 at Visit 3 and -3.40âÂ±â4.193 at Visit 6 (12âweeks). Linear regressions of the absolute changes were performed on the baseline values: the most significant changes from baseline were measured at Visit 5 (6âweeks) (pâ=â0.0031) and at Visit 6 (12âweeks) (pâ=â0.0012). The evolution of Lequesneâs algo-functional knee index is summarized in Table 4.", Functional impairment , Control , Hyaluronic acid + chondroitin sulfate  ,0,
edin,8492,5807031,Cannot tell based on the abstract,, Physician-assessed moderate/marked arm oedema , 2.0â¯Gy fractions , 2.67â3.3â¯Gy fractions ,0,
edin,8492,5807031,No significant difference,There were no statistically significant differences in physician-assessed moderate/marked arm oedema between the schedules for any of the trials., Physician-assessed moderate/marked arm oedema , 2.0â¯Gy fractions , 2.67â3.3â¯Gy fractions ,0,
edin,8572,4076897,Significantly increased,"Comparing with baseline measures, both groups had significantly improved post-treatment pain (P < 0.0001 for both groups) and mandibular opening (P value: 0.001 for glucosamine sulfate and 0.03 for ibuprofen). Post treatment pain and mandibular opening showed significantly more improvement in the glucosamine treated patients (P < 0.0001 and 0.01 respectively).", mandibular opening in temporomandibular joint (TMJ) disorders 90 days after starting treatment , ibuprofen 400 mg twice a day , glucosamine sulfate 1500 mg daily  ,0,
edin,8584,4433997,Cannot tell based on the abstract,," activities of daily living measured with the FAI, week 8 ", progressive balance training (PBT) , Wii Fit balance training (WBT) ,0,
edin,8584,4433997,No significant difference,"The activities of daily living measured with the FAI were found to be increased in both groups after treatment (week 4). When comparing the groups, no significant differences were found between them after treatment (weeks 4 and 8)."," activities of daily living measured with the FAI, week 8 ", progressive balance training (PBT) , Wii Fit balance training (WBT) ,0,
edin,8593,5045523,Cannot tell based on the abstract,, response rate by age , younger and older , age group 45-65 years  ,0,
edin,8593,5045523,Significantly increased,"Response rate varied significantly by age (P<.001), with both younger (response rate 8.8% for age < 45 years) and older (9.0% for age â¥65 years) physicians responding less frequently than others (12.8% for age group 45-54 years, 14.9% for age group 55-64 years).", response rate by age , younger and older , age group 45-65 years  ,0,
edin,8744,3840008,Cannot tell based on the abstract,, aberrant expression of TF localization , peritubular capillaries , renal tubular epithelial cells ,0,
edin,8744,3840008,Significantly increased,"Furthermore, the IHC analysis of 23 tissue specimens that were collected by renal biopsy (11 cases of stage 1 CKD, 8 cases of stage 2 CKD and 4 cases of stage 3 CKD) indicated that the aberrant expression of TFF3 was localized to renal tubular epithelial cells. No clearly positive reactions for TFF3 were observed in the renal glomeruli, the peritubular capillaries or the renal interstitium in the biopsy specimens. The representative IHC results are showed in Figure 2", aberrant expression of TF localization , peritubular capillaries , renal tubular epithelial cells ,0,
edin,8666,4418140,Significantly decreased,"Systolic, diastolic and mean arterial pressures were statistically significant less at 1, 3, and 5 minutes after intubation in comparison with other times of following-up in the three groups received MgSO4 than the control group."," (DBP) diastolic blood pressures at 1, 3, and 5 minutes after intubation ", normal saline as a control group (S) ," MgSO4 - Group I, II, III: 30. 40/ 50 mg/kg ",0,
edin,8465,5611398,Cannot tell based on the abstract,, Food intake (lunch) in women , Control , TV while eating ,0,
edin,8465,5611398,No significant difference,Although women appeared to consume more of the snack food in the TV group relative to the no-TV group â see Figure 1 â this difference was not significant (p = 0.25)., Food intake (lunch) in women , Control , TV while eating ,0,
edin,8577,4526789,Cannot tell based on the abstract,, actively engaged , before Computer-based auditory training (CBAT) intervention , after Computer-based auditory training (CBAT) intervention ,0,
edin,8577,4526789,Significantly increased,"There was little agreement shown for âI found my attention on the training program wandered during the sessionâ (n = 7, 15.9%), suggesting that those participants were actively engaged with the CBAT.", actively engaged , before Computer-based auditory training (CBAT) intervention , after Computer-based auditory training (CBAT) intervention ,0,
edin,8164,2954378,Significantly increased,"he variability of the median day-to-day forced expiratory volume in 1 s (FEV1) was 72.5 mL (25th percentile of 40 mL and 75th percentile of 130 mL). The daily FEV1 variation was 70 mL (25th percentile of 50 mL and 75th percentile of 100 mL). The overall laboratory FEV1 variability was larger after the steroid course (P < 0.001), but not clinically significant.", Laboratory FEV1 , Placebo , Prednisone ,0,
edin,8416,5629940,No significant difference,There were no clinically meaningful differences in AEs and laboratory abnormalities., Laboratory tests , Adalimumab , ABP 501 ,0,
edin,8547,3215881,Cannot tell based on the abstract,, Adverse effects on the healing of fractures , Placebo , Zoledronic acid ,0,
edin,8547,3215881,No significant difference,"Further, in the safety analysis of the overall study population, no adverse effects on the healing of fractures were noted.", Adverse effects on the healing of fractures , Placebo , Zoledronic acid ,0,
edin,8328,3572221,Cannot tell based on the abstract,, Cadmium concentration after 3 weeks , Control , Cadium + 20 mg/L taurine ,0,
edin,8328,3572221,Significantly increased,"In gill, cadmium concentrations were 24.69 Â± 6.15 mg/kg in the 14-day treatment group and 43.01 Â± 3.16 mg/kg in the 28-day treatment group, which were particularly remarkable compared to other organs. The cadmium concentration in bone was not significant until after week 1, whereas a rapid increase was observed from 3 weeks (P < 0.05).", Cadmium concentration after 3 weeks , Control , Cadium + 20 mg/L taurine ,0,
edin,8720,4374075,Cannot tell based on the abstract,, change in HbA1c at week 14 , vildagliptin monotherapy , vildagliptin/metformin SPC (single-pill combination) ,0,
edin,8720,4374075,Significantly decreased,"At week 14, a statistically significant between-treatment difference in (meanÂ Â±Â SE) HbA1c of â1.0Â Â±Â 0.1% (PÂ <0.001), in favor of the vilda/met group was observed (both doses combined) (TableÂ 2).,The proportion of patients who achieved either an HbA1c of <7.0% or an HbA1c drop of â¥0.5% at week 14 was significantly higher (PÂ <0.001) for the vilda/met group compared with the vilda/placebo group (TableÂ 3).", change in HbA1c at week 14 , vildagliptin monotherapy , vildagliptin/metformin SPC (single-pill combination) ,0,
edin,8536,5094122,Cannot tell based on the abstract,, Need for borrowing  , Control , Insurance ,0,
edin,8536,5094122,Significantly decreased,"In 2013, after the intervention, a substantially lower-percentage of insured HHs than uninsured HHs reported borrowing: 31.8, 27.7 and 42.5 per cent of insured HHs, compared to 46.1, 51.6 and 52.7 per cent of uninsured HHs, respectively in Pratapgarh, Kanpur-Dehat and Vaishali. Incidence of borrowing was seven percentage points lower among the insured than among the uninsured HHs in Kanpur Dehat, and the difference was significant (P<0.05).", Need for borrowing  , Control , Insurance ,0,
edin,8395,3767244,Significantly increased,The EX had a significant increase in lean tissue mass (LTM) (P < 0.001) following the intervention., Lean tissue mass , Control , Moderate-intensity exercise training ,0,
edin,8558,5541727,Significantly increased,"<td colspan=""4"">KOOS</td>", Symptom improvement  , Control , Allogeneic mesenchymal precursor cells ,0,
edin,8696,4081799,Cannot tell based on the abstract,, higher weight at follow-up , relapse prevention (RP) intervention group (partial completers) , relapse prevention (RP) intervention group (full completers) ,0,
edin,8696,4081799,Significantly increased,Pairwise comparison of groups showed full completers reached a significantly (pâ<â.05) higher weight compared to the partial users and the control group at T2 (end of intervention) and at T3 (follow-up)., higher weight at follow-up , relapse prevention (RP) intervention group (partial completers) , relapse prevention (RP) intervention group (full completers) ,0,
edin,8481,4960805,Cannot tell based on the abstract,, Increases in hemoglobin when GFR 60 to &amp;lt;90 mL/min , Iron sucrose , Ferumoxytol  ,0,
edin,8481,4960805,Significantly increased,"Ferumoxytol-treated patients with eGFRs of 60 to <90Â mL/min and <15Â mL/min at Week 2 also had a significantly greater increase in Hgb levels compared with iron sucrose-treated patients (pâ=â0.009 and pâ=â0.012, respectively, vs. iron sucrose); there were no significant treatment differences in Hgb levels between treatment groups in the other categories of renal function (Fig.Â 3b).Fig. 3", Increases in hemoglobin when GFR 60 to &amp;lt;90 mL/min , Iron sucrose , Ferumoxytol  ,0,
edin,8742,3840008,Cannot tell based on the abstract,, aberrant expression of TF localization , renal interstitium , renal tubular epithelial cells ,0,
edin,8742,3840008,Significantly increased,"Furthermore, the IHC analysis of 23 tissue specimens that were collected by renal biopsy (11 cases of stage 1 CKD, 8 cases of stage 2 CKD and 4 cases of stage 3 CKD) indicated that the aberrant expression of TFF3 was localized to renal tubular epithelial cells. No clearly positive reactions for TFF3 were observed in the renal glomeruli, the peritubular capillaries or the renal interstitium in the biopsy specimens. The representative IHC results are showed in Figure 2", aberrant expression of TF localization , renal interstitium , renal tubular epithelial cells ,0,
edin,8496,5435062,Cannot tell based on the abstract,, Esomeprazole Max concentration , IV esomeprazole , PO esomeprazole ,0,
edin,8496,5435062,Significantly decreased,"Differences in the AUC0ââ and halfâlife values were not significant (P = .25 and P = .13, respectively); however, significant differences were observed for C max among the administration routes (P = .009).,<td align=""left"" colspan=""1"" rowspan=""1"">
<italic>C</italic>
<sub>max</sub> (Î¼g/mL)</td><td align=""left"" colspan=""1"" rowspan=""1""></td><td align=""char"" char="" "" colspan=""1"" rowspan=""1"">2.62 (2.53) Â± 0.79</td><td align=""char"" char="" "" colspan=""1"" rowspan=""1"">1.34 (0.96) Â± 0.91</td><td align=""char"" char="" "" colspan=""1"" rowspan=""1"">1.75 (1.69) Â± 0.49</td>,he C max of the PO esomeprazole treatment was significantly lower than that of the IV (P = .004) treatment, and the bioavailability was 71.43%.", Esomeprazole Max concentration , IV esomeprazole , PO esomeprazole ,0,
edin,8656,4630885,No significant difference,Both groups showed significant improvement in the written exam score as well as in the Megacode assessment score at post-test and 3Â months (retention) period. However there was no significant difference in the âimprovementâ between both the groups with respect to written exam (pÂ =Â 0.38) or Megacode assessment (pÂ =Â 0.92). F, post-test - written exam , low fidelity mannequins , high fidelity mannequins ,0,
edin,8484,5910333,Cannot tell based on the abstract,"In ITT analyses at 6Â months, subjects in both arms performed the 5XSTS test faster (â4.9Â s, PÂ =â0.001) and improved scores on Borg Effort (â1, PÂ =â0.02), PSFS (1.6, PÂ <â0.001), and SDMT (5.9, Pâ<â0.001).", SymbolâDigit Modalities Test improvement  , Clinic for Low-Income Patients , Chronic Pain Self-Management Program in the Community ,0,
edin,8484,5910333,Significantly decreased,"<td>â6&nbsp;Months</td><td>36</td><td>4.61 (8.67)</td><td>0.003</td><td>0.53</td><td>30</td><td>7.37 (8.94)</td><td>&lt;0.001</td><td>0.82</td><td>66</td><td>5.86 (8.84)</td><td>&lt;0.001</td><td>0.66</td><td>0.10</td>,For the clinic arm at 6Â months, the effect size was moderate for the SF-12 PCS (Cohenâs dâ=â0.68) but large for the SDMT (Cohenâs dâ=â0.82) and PSFS (Cohenâs dâ=â0.93). For the SDMT, the effect size was moderate only for the community arm (Cohenâs dâ=â0.53).", SymbolâDigit Modalities Test improvement  , Clinic for Low-Income Patients , Chronic Pain Self-Management Program in the Community ,0,
edin,8525,4061186,Significantly increased,"IIT + LMWH noticeably increased the white blood cell count, hemodiastase level, serum albumin level and the arterial partial pressure of oxygen in the patients with SAP (P<0.05). It", White blood cell count , Control , Low molecular weight heparin ,0,
edin,8357,3848942,Cannot tell based on the abstract,, Hospitalization , Control , Integrated community case management of malaria and pneumonia ,0,
edin,8357,3848942,No significant difference,"Hospitalization
10 (1.6%)
9 (1.4%)
1.47 (0.64-3.38),Hospitalization
9 (1.5%)
9 (1.4%)
1.36 (0.59-3.16),Hospitalization
4 (1.6%)
3 (1.1%)
2.42 (0.60-9.84)", Hospitalization , Control , Integrated community case management of malaria and pneumonia ,0,
edin,8739,3840008,Significantly increased,"The mean serum concentrations of TFF3 in patients with CKD, metastatic and secondary carcinoma (MC) and acute gastroenteritis (AG) (200.9 ng/ml, 95.7 ng/ml and 71.7 ng/ml, respectively) were significantly higher than those in patients with other common clinical diseases.", Trefoil factor 3 (TFF3) in each common clinical disease group , other clinical diseases groups , acute gastroenteritis (AG) group ,0,
edin,8511,4704299,Cannot tell based on the abstract,, Number of sessions involving splinting techniques , Conventional physical therapy , SWIFT Cast ,0,
edin,8511,4704299,Significantly increased,"As expected, there were significantly (P < .001) more sessions involving splinting techniques for the SWIFT Cast (n = 313; 64.9%) than for the CPT group (n = 125; 31.4%) as a result of use of a SWIFT Cast.", Number of sessions involving splinting techniques , Conventional physical therapy , SWIFT Cast ,0,
edin,8642,4636656,Cannot tell based on the abstract,"WEMWBS scores fell from 50.4â49.0 in the control (n=59) and 51.0â49.9 in the intervention (n=225), giving an intervention effect of 0.5 (95% CI â3.2 to 4.2)", Warwick Edinburgh Mental Wellbeing Scale (WEMWBS) scores intervention effect , control , intervention - e-learning programme on work-related stress ,0,
edin,8642,4636656,Significantly increased,"Wellbeing score on the WEMWBS declined from 50.4 to 49.0 in the control and from 51.0 to 49.9 in the intervention clusters. The overall intervention effect after adjusting for clustering and baseline value was small with a difference of 0.5 points between the intervention and control cluster (95% CI â3.2 to 4.2; table 3).,During the study period, a fall in the WEMWBS scores was seen for employees in both arms but it was a significantly smaller reduction among managers who engaged with the intervention (â0.7 vs â1.6 with an adjusted difference of 1.6, 95% CI 0.1 to 3.2).", Warwick Edinburgh Mental Wellbeing Scale (WEMWBS) scores intervention effect , control , intervention - e-learning programme on work-related stress ,0,
edin,8515,5722122,Cannot tell based on the abstract,, Percentage of cracks , Neolix  , ProTaper Universal system ,0,
edin,8515,5722122,No significant difference,"Both rotary and reciprocating systems increased the number and percentage of cracks in roots (13.3% in ProTaper group, 26.7% in SafeSider group and 40% in Neolix group) (Table 1). But, there was no significant difference among the three groups (P>0.05).", Percentage of cracks , Neolix  , ProTaper Universal system ,0,
edin,8466,5611398,Cannot tell based on the abstract,, Food intake (lunch) in men , Control , TV while eating ,0,
edin,8466,5611398,Significantly increased,"For women, there was no difference in food intake between the TV and no-TV group (p = 0.56), while for men there was significantly greater intake in the TV group relative to the no-TV group (p = 0.029).", Food intake (lunch) in men , Control , TV while eating ,0,
edin,8406,3215316,Significantly increased,Statistically significant (P<0.01) result was obtained in Blood transfusion interval in group âAâ in comparison to group âBâ. Dhatri Avaleha may have a potential to increase blood transfusion interval and decrease secondary infection and thus it can be used as supportive therapy with modern medical management.,  Blood transfusion interval , Control , Dhatri Avaleha ,0,
edin,8334,5525241,Cannot tell based on the abstract,, Sagittal plane lordosis  , Control , Computer-Aided Design/Computer-Aided Manufacturing + numerical simulation ,0,
edin,8334,5525241,No significant difference,"<td>L1âS1 lordosis</td><td>66Â°</td><td>9Â°</td><td>25</td><td>
<italic>p</italic>â=â0.91</td><td>66Â°</td><td>11Â°</td><td>23</td>,<td>L1âS1 lordosis reduction (degrees)</td><td>12</td><td>25</td><td>
<italic>p</italic>â=â0.44</td><td>11</td><td>24</td>,In the sagittal plane, the kyphosis was significantly less reduced in the test vs. control group (pâ<â0.05) (2 vs. 16%), but there was no significant difference for the change of lordosis (21 vs. 16%) (TableÂ 2).", Sagittal plane lordosis  , Control , Computer-Aided Design/Computer-Aided Manufacturing + numerical simulation ,0,
edin,8718,4374075,Cannot tell based on the abstract,, incidences of AEs , vildagliptin/metformin SPC (single-pill combination) 50/500 mg bid , vildagliptin/metformin SPC (single-pill combination) 50/250 mg bid ,0,
edin,8718,4374075,No significant difference,"he incidences of AEs were similar between the two vilda/met subgroups (44.6% and 42.4% for vilda/met 50/250 and 50/500, respectively).", incidences of AEs , vildagliptin/metformin SPC (single-pill combination) 50/500 mg bid , vildagliptin/metformin SPC (single-pill combination) 50/250 mg bid ,0,
edin,8586,4433997,Cannot tell based on the abstract,, functional balance performance scores of the patients at week 4 , progressive balance training (PBT) , Wii Fit balance training (WBT) ,0,
edin,8586,4433997,No significant difference,"The results of the four different functional balance tests (BBS, TUG, DGI, and FRT) showed that both groups improved significantly after treatment (week 4). However, there was no significant difference between the groups after treatment (week 4).", functional balance performance scores of the patients at week 4 , progressive balance training (PBT) , Wii Fit balance training (WBT) ,0,
edin,8625,4696773,Significantly decreased,"BK induced relaxation was reduced in LADs from Occl-Ex and Occl-Sed pigs (P<0.001), compared to Non-Occl-Con, and exercise modestly increased responses to BK (P<0.05).", bradykinin (BK) induced relaxation ," non-occluded, non-exercised control (Non-Occl-Con) ", occluded-sedentary (Occl-Sed) ,0,
edin,8519,5395856,No significant difference,"No difference between the two groups could be observed regarding the proliferative hepatocyte number, proliferative K7-positive cells, or total K7-positive cells at the 4-week follow-up liver biopsy.", Proliferative hepatocyte number , Control , Autologous stem cell therapy ,0,
edin,8582,2808793,Significantly decreased,Hamilton Rating Scales for Depression (HRSD) scores of the forest group were significantly decreased after 4 sessions compared with controls. Montgomery-Asberg Depression Rating Scales (MADRS) scores of the forest group were significantly decreased compared with both the hospital group and the controls., Montgomery-Asberg Depression Rating Scale (MADRS) scores , hospital group - cognitive behavior therapy (CBT)-based psychotherapy plus pharmacotherapy , forest group - cognitive behavior therapy (CBT)-based psychotherapy plus pharmacotherapy ,0,
edin,8716,3747414,No significant difference,"As a result, needle penetration, VAS ratings for either needle and Deqi sensation were not significantly different between two kinds of needles.", needle penetration , placebo needles , real needles ,0,
edin,8566,2952311,Cannot tell based on the abstract,"VRS, NDI, STAI and MH values decreased after acupressure in the LP and the DP group.", State-Trait Anxiety Inventory-I , Control , Acupressure at distal points ,0,
edin,8566,2952311,Significantly decreased,"STAI-I (Figure 4), and MH (Figure 5) values significantly decreased immediately after treatment, and NDI (Figure 6) was lower at 1 day following treatment compared with pre-treatment in the LP and the DP groups.", State-Trait Anxiety Inventory-I , Control , Acupressure at distal points ,0,
edin,8506,4595235,Cannot tell based on the abstract,, Heart rate , Placebo , Bio-active peptide supplement ,0,
edin,8506,4595235,No significant difference,"The analyses of resting hemodynamic measurements revealed significant time effects for HR (p < 0.05) with no significant effects of group or significant group Ã time interactions for HR, SBP, or DBP (p values < 0.05) again indicating that the supplementation had no specific effects on these variables.", Heart rate , Placebo , Bio-active peptide supplement ,0,
edin,8561,5541727,No significant difference,"The MPC + HA group had reduced medial and lateral tibiofemoral joint space narrowing (p < 0.05), less tibial bone expansion (0.5% vs 4.0% over 26 weeks, p = 0.02), and a trend towards reduced tibial cartilage volume loss (0.7% vs â4.0% over 26 weeks, p = 0.10) than the HA controls.", Tibial cartilage volume loss , Control , Allogeneic mesenchymal precursor cells ,0,
edin,8751,5119439,Significantly increased,"Femoral stems in the compaction group had a higher degree of medio-lateral migration (0.21âmm, 95% CI: 0.03â0.40) than femoral stems in the broaching group at 5 years (p = 0.02).", Femoral stems degree of medio-lateral migration at 5 years , femoral bone preparation with broaching on the other side , femoral bone preparation with compaction on 1 side ,0,
edin,8589,4433997,No significant difference,"There was not remarkable difference between the two treatments in dynamic balance functions, balance confidence, and activities of daily living."," activities of daily living measured with the FAI, week 4 ", progressive balance training (PBT) , Wii Fit balance training (WBT) ,0,
edin,8734,4304200,Cannot tell based on the abstract,"The intervention resulted in significant improvements in fiber intake (M between-group differenceâ=â5.7Â g/day, pâ<â.001) but not fat consumption (â2.3Â g/day, pâ=â0.13), that were predictive of weight loss at both four months (M between-group differenceâ=ââ1.98Â kg, pâ<â.01; R2â=â0.2, pâ<â0.005), and 12Â months (M differenceâ=ââ1.85Â kg, pâ=â0.1; R2â=â0.1, pâ<â0.01)."," weight loss - when adjusted for co-interventions (i.e., medical treatment) and incident morbidities that might affect weight ", usual care , weight management intervention targeting diet and physical activity plus usual care ,0,
edin,8734,4304200,Significantly increased,"significant effect on weight loss was only observed in the intervention group (predicted by reduced uncontrolled eating, and increased self-efficacy). No additional explanatory power in predicting dietary or weight loss outcomes was found for the effects of cognitive restraint.,The difference in weight loss fell short of significance (intervention group â3.7Â kg, SDâ=â5.2 vs control group â1.9Â kg, SDâ=â6.7; F(1,108)â=â2.3, pâ=â0.13), although when adjusted for co-interventions (i.e., medical treatment) and incident morbidities that might affect weight, the difference was significant (M Difference 2.9Â kg, 95% CI: â5.1 to â0.6, pâ=â0.014)."," weight loss - when adjusted for co-interventions (i.e., medical treatment) and incident morbidities that might affect weight ", usual care , weight management intervention targeting diet and physical activity plus usual care ,0,
edin,8707,5187654,Cannot tell based on the abstract,, wave V latency , click ABR , CE-chirp ABR ,0,
edin,8707,5187654,Significantly increased,"<td align=""left"" colspan=""1"" rowspan=""1"">Wave V</td><td align=""center"" colspan=""1"" rowspan=""1"">1.149</td><td align=""center"" colspan=""1"" rowspan=""1"">2.825*</td><td align=""center"" colspan=""1"" rowspan=""1"">3.656*</td><td align=""center"" colspan=""1"" rowspan=""1"">3.673*</td>,A significant difference in wave V was obtained for latency [F(2,29)=5.636, P < 0.05] and amplitude [F(2,29)=4.847, P < 0.05] of click-evoked ABR and CE-chirp ABR respectively.", wave V latency , click ABR , CE-chirp ABR ,0,
edin,8456,4893099,Significantly increased,"Peficitinib 50, 100 and 150âmg each showed statistically significantly higher ACR20 response rates compared with placebo, and response rates increased up to 150âmg with a statistically significant dose response.", ACR20 response rate , Placebo , Peficitinib 150 mg ,0,
edin,8473,5426232,Cannot tell based on the abstract,, Binary restenosis , Zotarolimus-eluting stent , Drug-eluting balloon + bare metal stent ,0,
edin,8473,5426232,No significant difference,The binary restenosis rate was also higher in the DEB + BMS group although the result was not statistically significant., Binary restenosis , Zotarolimus-eluting stent , Drug-eluting balloon + bare metal stent ,0,
edin,8392,3477095,Cannot tell based on the abstract,, Vital signs , Control , Hyaluronic acid + chondroitin sulfate  ,0,
edin,8392,3477095,No significant difference,No abnormality of clinical relevance was reported in vital or physical signs monitored during the study., Vital signs , Control , Hyaluronic acid + chondroitin sulfate  ,0,
edin,8477,5139733,No significant difference,There was no significant change in frequency of bowel movements or the dose of sennoside used., Sennoside needed , Control , Daikenchuto  (TJ-100) ,0,
edin,8528,4061186,Significantly increased,"IIT + LMWH noticeably increased the white blood cell count, hemodiastase level, serum albumin level and the arterial partial pressure of oxygen in the patients with SAP (P<0.05).", Hemodiastase levels , Control , Low molecular weight heparin ,0,
edin,8412,3191350,Cannot tell based on the abstract,, Performance , Low-maintenance demand , High-maintenance demand training ,0,
edin,8412,3191350,Significantly increased,"High demand training in the switching component resulted in better performance improvement in posttest than training with low demand in this component (Fâ=â10.39, Î·2â=â0.06, pâ=â0.002).", Performance , Low-maintenance demand , High-maintenance demand training ,0,
edin,8574,4076897,Cannot tell based on the abstract,, pre-treatment pain intensity , ibuprofen 400 mg twice a day , glucosamine sulfate 1500 mg daily  ,0,
edin,8574,4076897,No significant difference,"Although there was no statistically significant difference between groups regarding pre-treatment pain intensity (4.66 Â± 2.43 in the ibuprofen group vs. 4.71 Â± 2.11in the glucosamine sulfate group, P value: 0.83), pain severity was significantly lower in the glucosamine sulfate treated group on all follow-up visits [Table 1 and Figure 1].", pre-treatment pain intensity , ibuprofen 400 mg twice a day , glucosamine sulfate 1500 mg daily  ,0,
edin,8541,4065461,No significant difference,Patients who had received dexamethasone + epinephrine exhibited similar admission rates compared to placebo + epinephrine or salbutamol (P = 0.64)., Admission rates , Placebo + epinephrine , Dexamethasone + salbutamol ,0,
edin,8618,4599047,Cannot tell based on the abstract,, degradation in clinical success - moderate degenerative lumbar spinal stenosis. ," X-STOPÂ® (49/129, 38.0%) "," SuperionÂ® (63/120, 52.5%) ",0,
edin,8618,4599047,No significant difference,"The subjects implanted with the SuperionÂ® showed no degradation in clinical success compared to the 24-month endpoint analysis (53%), whereas X-STOPÂ® subjects showed a modest degradation over the same timeframe (50%).", degradation in clinical success - moderate degenerative lumbar spinal stenosis. ," X-STOPÂ® (49/129, 38.0%) "," SuperionÂ® (63/120, 52.5%) ",0,
edin,8368,5431359,No significant difference,"Stress, vital exhaustion and depression did not differ between the groups over time.", Vital exhaustion  , Control , Cognitive behavioral therapy ,0,
edin,8391,3477095,Cannot tell based on the abstract,, Severe adverse event  , Control , Hyaluronic acid + chondroitin sulfate  ,0,
edin,8391,3477095,No significant difference,No severe adverse event was reported throughout the study., Severe adverse event  , Control , Hyaluronic acid + chondroitin sulfate  ,0,
edin,8433,3295238,Significantly increased,"Blood pressure was lower on nifedipine than on placebo by 5.8/2.1 mmHg (P < 0.001) as was total and LDL cholesterol (4.8 mg/dL; P = 0.495), while HDL was higher (3.6 mg/dL; P = 0.026).", HDL cholesterol  , Placebo , Nifedipine ,0,
edin,8614,4162719,Cannot tell based on the abstract,, superior control , two-operator hand-on-needle (HN) technique , single operator hand-on-syringe (HS) needle technique ,0,
edin,8614,4162719,No significant difference,The HN technique did not demonstrate superior control compared to the HS technique., superior control , two-operator hand-on-needle (HN) technique , single operator hand-on-syringe (HS) needle technique ,0,
edin,8396,3767244,Significantly decreased,"Those in the EX below median body fat (20%) increased LTM (P = 0.014) only, while those above 20% decreased fat mass (P = 0.02), total fat (N = 0.009), and trunk fat (P = 0.001), while also increasing LTM (P = 0.027).", Fat mass if +20% body fat , Control , Moderate-intensity exercise training ,0,
edin,8604,3439673,Cannot tell based on the abstract,, perceived stress score , low demanding/high responsive feeding style , high demanding/low responsive feeding style ,0,
edin,8604,3439673,Significantly increased,"Post hoc analysis also showed that women with a high demanding/low responsive feeding style had a higher perceived stress score as compared to the low demanding/high responsive feeding style (17.7 vs. 15.6, p = 0.02).", perceived stress score , low demanding/high responsive feeding style , high demanding/low responsive feeding style ,0,
edin,8453,5260131,Cannot tell based on the abstract,, Hospital stay , Control , High flow CO2 warming system ,0,
edin,8453,5260131,No significant difference,"There were no differences observed in time on the ventilator, vasoactive support in the ICU, duration of stay in ICU, or length of hospital stay (TableÂ 3).,<td>Hospital length of stay (days)</td><td>13 (10,15)</td><td>13 (10,16)</td><td>-</td><td>-</td><td align=""char"" char=""."">0.96</td>", Hospital stay , Control , High flow CO2 warming system ,0,
edin,8504,4595235,Cannot tell based on the abstract,, Complete blood count measures , Placebo , Bio-active peptide supplement ,0,
edin,8504,4595235,No significant difference,There were no statistically significant interaction effects (group Ã time) for any blood chemistry count measures indicating no specific effects of supplementation on these variables (p values > 0.05)., Complete blood count measures , Placebo , Bio-active peptide supplement ,0,
edin,8708,5187654,Cannot tell based on the abstract,, wave V amplitude , click ABR , CE-chirp ABR ,0,
edin,8708,5187654,Significantly increased,"In click ABR, while both the parameters for wave III were significantly poorer for the experimental group, wave V showed a significant decline in terms of amplitude only.,here was no significant difference obtained for any of the parameters for wave I. In CE-chirp ABR, the latencies for all three waves were significantly prolonged in the experimental group. However, there was a significant decrease in terms of amplitude in only wave V for the same group.,<td align=""left"" colspan=""1"" rowspan=""1"">Wave V</td><td align=""center"" colspan=""1"" rowspan=""1"">1.149</td><td align=""center"" colspan=""1"" rowspan=""1"">2.825*</td><td align=""center"" colspan=""1"" rowspan=""1"">3.656*</td><td align=""center"" colspan=""1"" rowspan=""1"">3.673*</td>", wave V amplitude , click ABR , CE-chirp ABR ,0,
edin,8580,2808793,Significantly decreased,Hamilton Rating Scales for Depression (HRSD) scores of the forest group were significantly decreased after 4 sessions compared with controls., Hamilton Rating Scales for Depression (HRSD) scores , control group - pharmacotherapy in outpatient , forest group - cognitive behavior therapy (CBT)-based psychotherapy plus pharmacotherapy ,0,
edin,8485,5910333,Cannot tell based on the abstract,, 6-Minute Walk improvement  , Control , Chronic Pain Self-Management Program in the Community ,0,
edin,8485,5910333,No significant difference,"Conversely, only the clinic arm subjects improved significantly at 6Â months on the 6Â MW, Borg Effort test, and SF-12 PCS.,<td colspan=""14"">6&nbsp;MW (ft)<sup>Â§Ç</sup>
</td>,Only subjects in the clinic walked farther on the 6Â MW in all models (PÂ â¤â0.04; Fig.Â 3.1). The mean score on the Borg Effort test decreased after the 6Â MW for both groups at 6Â months, but was significant only before imputation (pÂ =â0.02; Fig. 3.2).", 6-Minute Walk improvement  , Control , Chronic Pain Self-Management Program in the Community ,0,
edin,8569,5506593,Cannot tell based on the abstract,, protective temephos effect , no temephos , temephos ,0,
edin,8569,5506593,No significant difference,"In six of 18 multivariate models at the six time points, temephos exposure was associated with higher entomological indices; in these models, we could exclude any protective effect of temephos with 95% confidence.


Conclusion", protective temephos effect , no temephos , temephos ,0,
edin,8397,3767244,Significantly decreased,"Those in the EX below median body fat (20%) increased LTM (P = 0.014) only, while those above 20% decreased fat mass (P = 0.02), total fat (N = 0.009), and trunk fat (P = 0.001), while also increasing LTM (P = 0.027).", Trunk fat if +20% body fat , Control , Moderate-intensity exercise training ,0,
edin,8458,4893099,No significant difference,"The total incidence of treatment-emergent adverse events (TEAEs) was similar between the placebo (64.3%) and peficitinib 25, 50, 100 and 150âmg groups (70.9%, 64.9%, 52.7% and 67.2%, respectively).", Treatment-emergent adverse events , Placebo , Peficitinib 100 mg ,0,
edin,8375,5648980,Significantly increased,"The oxygen index of the patients in the observation group was significantly improved compared to that of the control group, and the difference had statistical significance (P<0.05).",  Oxygen index , Control , Budesonide  ,0,
edin,8449,5260131,No significant difference,"There were no significant differences in the ETCO2, PaCO2, minute ventilation, or inotropic support.", End-tidal CO2 , Control , High flow CO2 warming system ,0,
edin,8635,2865639,Cannot tell based on the abstract,," vaginal practices: insertion of dry or absorbent materials, at baseline ", Durban and Johannesburg   , Harare  ,0,
edin,8635,2865639,No significant difference,"At baseline, there were no differences by randomization group in the three vaginal practices examined: washing, wiping, and insertion (TableÂ 2)."," vaginal practices: insertion of dry or absorbent materials, at baseline ", Durban and Johannesburg   , Harare  ,0,
edin,8450,5260131,No significant difference,"There were no significant differences in the ETCO2, PaCO2, minute ventilation, or inotropic support.", Partial pressure of CO2 , Control , High flow CO2 warming system ,0,
edin,8526,4061186,Significantly increased,"IIT + LMWH noticeably increased the white blood cell count, hemodiastase level, serum albumin level and the arterial partial pressure of oxygen in the patients with SAP (P<0.05).", White blood cell count , Control , Low molecular weight heparin + Insulin ,0,
edin,8393,3767244,Significantly decreased,There was a decrease in salivary cortisol at wake (P = 0.025) in the EX and a trend (P = 0.07) for a decrease 1 hour after waking., Salivary cortisol at wake , Control , Moderate-intensity exercise training ,0,
edin,8552,2503659,No significant difference,"In two identical phase III trials comparing telavancin versus vancomycin at the doses of the FAST 2 study for cSSSI, the clinical cure rates were 88.3% and 87.1%, respectively.", Cure rate , Vancomycin + cloxacillin , Telavancin  ,0,
edin,8675,4644305,Cannot tell based on the abstract,, promising pain relief treatments for painful DNP , transcutaneous electrical nerve stimulation (TENS) , pulsed radiofrequency (PRF) lumbar sympathectomy  ,0,
edin,8675,4644305,Significantly increased,"Both TENS and PRF lumbar sympathectomy are promising pain relief treatments for painful DNP. However, PRF lumbar sympathectomy seems to have a superior efficacy.", promising pain relief treatments for painful DNP , transcutaneous electrical nerve stimulation (TENS) , pulsed radiofrequency (PRF) lumbar sympathectomy  ,0,
edin,8631,5404516,Cannot tell based on the abstract,, QT effect (mean ÎÎQTcF) , full population ," subjects who did not experienced vomiting after the 1,800-mg gepotidacin dose ",0,
edin,8631,5404516,No significant difference,"A sensitivity analysis excluding subjects who experienced vomiting after the 1,800-mg gepotidacin dose did not materially change the results: the largest QT effect (mean ÎÎQTcF) excluding these subjects was 21.4 ms, observed at 2 h, compared to 22.2 ms in the full population.", QT effect (mean ÎÎQTcF) , full population ," subjects who did not experienced vomiting after the 1,800-mg gepotidacin dose ",0,
edin,8619,4508540,Cannot tell based on the abstract,, EI (Effectiveness Index) for Quality of life immediately after treatment , CIMT 1.5 hours of supervised CIMT+1.5 hours home exercises supervised by a caregiver , CIMT 3 hours of CIMT supervised by a therapist ,0,
edin,8619,4508540,No significant difference,"Immediately after treatment, there were no significant differences in EI results between the two groups (P=0.24). Likewise, no significant differences were observed between the groups, 6 months later (P=0.97), indicating comparable benefits from the two programs on real-life motor improvements.", EI (Effectiveness Index) for Quality of life immediately after treatment , CIMT 1.5 hours of supervised CIMT+1.5 hours home exercises supervised by a caregiver , CIMT 3 hours of CIMT supervised by a therapist ,0,
edin,8545,3215881,Cannot tell based on the abstract,, New hip fractures , Placebo , Zoledronic acid ,0,
edin,8545,3215881,No significant difference,"In the overall study population, the rate of new hip fractures was 2.0% (23/1,065) in the zoledronic acid group and 3.5% (33/1,062) in the placebo group (PÂ =Â 0.18).", New hip fractures , Placebo , Zoledronic acid ,0,
edin,8655,4630885,No significant difference,"The baseline written exam score (pÂ =Â 0.07), Megacode assessment score (pÂ =Â 0.19) and sex distribution (pÂ =Â 0.17) were similar in both groups.", baseline sex distribution , low fidelity mannequins , high fidelity mannequins ,0,
edin,8489,5807031,No significant difference,There were no significant differences between the hypofractionated and control groups for patient- and physician-assessed symptoms in START-A or START-B., Patient assessed symptoms , 2.0â¯Gy fractions , 2.67â3.3â¯Gy fractions ,0,
edin,8499,5435062,Cannot tell based on the abstract,, Esomeprazole halfâlife , PO esomeprazole for 5 day , PO esomeprazole for 1 day ,0,
edin,8499,5435062,No significant difference,"Differences in the AUC0ââ and halfâlife values were not significant (P = .25 and P = .13, respectively); however, significant differences were observed for C max among the administration routes (P = .009).,However, no significant differences were observed in the C max (P = .082), AUClast (P = .71), and halfâlife (P = .50) values between day 1 and day 5.", Esomeprazole halfâlife , PO esomeprazole for 5 day , PO esomeprazole for 1 day ,0,
edin,8615,4162719,No significant difference,"There was no significant difference in time to complete the simple model (HN vs. HS, 18 seconds vs. 18 seconds, p=0.93),", time to complete the simple model , two-operator hand-on-needle (HN) technique , single operator hand-on-syringe (HS) needle technique ,0,
edin,8356,3848942,Significantly decreased,"The decrease in fast breathing between day one and four was greater in the intervention (9.2%) compared to the control areas (4.2%, p-valueâ=â0.01).", Fast breathing , Control , Integrated community case management of malaria and pneumonia ,0,
edin,8472,5426232,Significantly increased,"When comparing the DEB + BMS results with the ZES ones, LL was 0.50 Â± 0.46 mm in DEB + BMS patients vs. 0.21 Â± 0.44 mm in ZES patients (P < 0.001).", Late luminal loss , Zotarolimus-eluting stent , Drug-eluting balloon + bare metal stent ,0,
edin,8692,5079608,Significantly decreased,"A greater percentage of participants with low adherence had clinically significant depressive symptoms at baseline (18% vs. 12%, P = 0.0415).", significant depressive symptoms at baseline - 10â17 years old with recent-onset type 2 diabetes and â¥80% adherence to metformin therapy for â¥8 weeks , Low adherence; taking &amp;lt;80% of medication , High adherence; taking â¥80% of medication ,0,
edin,8575,4526789,Cannot tell based on the abstract,, additional benefit in hearing rehabilitation , no involvement of significant others , involvement of significant others ,0,
edin,8575,4526789,Significantly increased,Within hearing rehabilitation there is growing evidence to suggest that the involvement of significant others offers additional benefit to individuals with hearing loss, additional benefit in hearing rehabilitation , no involvement of significant others , involvement of significant others ,0,
edin,8658,4630885,No significant difference,"The baseline written exam score (pÂ =Â 0.07), Megacode assessment score (pÂ =Â 0.19) and sex distribution (pÂ =Â 0.17) were similar in both groups.", baseline written exam score , low fidelity mannequins , high fidelity mannequins ,0,
edin,8377,5648980,No significant difference,"The head circumference, height and weight of the patients in the observation group in the 3rd and 6th month were compared to those of the control group, suggesting no significant differences (P>0.05).", Height  , Control , Budesonide  ,0,
edin,8333,5525241,Cannot tell based on the abstract,, Sagittal plane kyphosis , Control , Computer-Aided Design/Computer-Aided Manufacturing + numerical simulation ,0,
edin,8333,5525241,Significantly decreased,"<td rowspan=""2"">Sagittal plane</td><td>T4âT12 kyphosis reduction (degrees)</td><td>â2</td><td>6</td><td>
<italic>p</italic>â=â0.02</td><td>â16</td><td>28</td>,In the sagittal plane, the kyphosis was significantly less reduced in the test vs. control group (pâ<â0.05) (2 vs. 16%),", Sagittal plane kyphosis , Control , Computer-Aided Design/Computer-Aided Manufacturing + numerical simulation ,0,
edin,8505,4595235,Cannot tell based on the abstract,, Metabolic panel , Placebo , Bio-active peptide supplement ,0,
edin,8505,4595235,No significant difference,Analyses also showed no statistically significant interaction effects (group Ã time) for any comprehensive metabolic panel measures which indicated that Bio-Groâ¢ had not specific effects on the measures of the metabolic panels (p values > 0.05)., Metabolic panel , Placebo , Bio-active peptide supplement ,0,
edin,8689,3148260,Cannot tell based on the abstract,, severe anemia , without cerebral swelling on CT scan , cerebral swelling on CT scan ,0,
edin,8689,3148260,No significant difference,"Severe jaundice (total plasma bilirubin level, >3 mg/dL) was present in 33 (72%) of 46 patients without swelling and in 53 (68%) of 78 patients with swelling (P = .69), whereas severe anemia (hemoglobin level, <5g/dL) was present in 5 (11%) of 46 patients without swelling versus 6 (8%) of 76 patients with swelling (P = .58), and hypoglycemia (plasma glucose level, <40 mg/dL) in 4 (9%) of patients without swelling and 2 (3%) of patients with swelling (P = .19).", severe anemia , without cerebral swelling on CT scan , cerebral swelling on CT scan ,0,
edin,8669,4418140,Cannot tell based on the abstract,, extubation time , normal saline as a control group (S) ," MgSO4 - Group I, II, III: 30. 40/ 50 mg/kg ",0,
edin,8669,4418140,No significant difference,There was no significant difference in extubation time between four groups [Table 1]., extubation time , normal saline as a control group (S) ," MgSO4 - Group I, II, III: 30. 40/ 50 mg/kg ",0,
edin,8695,5079608,Significantly increased,". Longitudinally, participants with high adherence had significantly greater insulin sensitivity and oDI than those with low adherence.", oral disposition index (oDI) - 10â17 years old with recent-onset type 2 diabetes and â¥80% adherence to metformin therapy for â¥8 weeks , Low adherence; taking &amp;lt;80% of medication , High adherence; taking â¥80% of medication ,0,
edin,8688,3148260,Cannot tell based on the abstract,, Severe jaundice , without cerebral swelling on CT scan , cerebral swelling on CT scan ,0,
edin,8688,3148260,No significant difference,"Severe jaundice (total plasma bilirubin level, >3 mg/dL) was present in 33 (72%) of 46 patients without swelling and in 53 (68%) of 78 patients with swelling (P = .69),", Severe jaundice , without cerebral swelling on CT scan , cerebral swelling on CT scan ,0,
edin,8419,5629940,No significant difference,"Changes from baseline in DAS28-CRP, ACR50 and ACR70 were similar.", ACR70 results , Adalimumab , ABP 501 ,0,
edin,8336,5525241,Cannot tell based on the abstract,, Transverse plane maximum curvature reduction , Control , Computer-Aided Design/Computer-Aided Manufacturing + numerical simulation ,0,
edin,8336,5525241,Significantly increased,"<td>T plane of maximum curvature reduction (degrees)</td><td>0</td><td>18</td><td>
<italic>p</italic>â=â0.28</td><td>3</td><td>30</td>,In the transverse plane, the correction also was statistically significantly greater in the test group vs. the control group (pâ<â0.05):", Transverse plane maximum curvature reduction , Control , Computer-Aided Design/Computer-Aided Manufacturing + numerical simulation ,0,
edin,8337,5525241,Cannot tell based on the abstract,, Coronal plane apical axial rotation correction , Control , Computer-Aided Design/Computer-Aided Manufacturing + numerical simulation ,0,
edin,8337,5525241,Significantly increased,"The coronal plane correction was statistically significantly greater in the test group vs. the control group (pâ<â0.05):,T curve apical axial rotation correction (%)	46	24	pâ=â0.004	30	17
L curve apical axial rotation correction (%)	46	22	pâ=â0.003	30	23", Coronal plane apical axial rotation correction , Control , Computer-Aided Design/Computer-Aided Manufacturing + numerical simulation ,0,
edin,8678,4774750,Significantly decreased,The dietary supplementation with different levels of protein significantly improved the hematological profiles and inhibited the nematodosis infection in the experimental goat kids., nematodosis infection ," T1, served as a negative control "," T2, T3, and T4 that received concentrate feed containing 16, 20, and 24% digestible crude protein ",0,
edin,8540,4065461,No significant difference,Patients who had received dexamethasone + epinephrine exhibited similar admission rates compared to placebo + epinephrine or salbutamol (P = 0.64)., Admission rates , Placebo + salbutamol , Dexamethasone + epinephrine ,0,
edin,8837,5620095,Significantly decreased,"Endoscopic findings showed a significant reduction of bile reflux in the remnant stomach in the R-Y group (P<0.001),", reflux of bile in the remnant stomach , Billroth-I (B-I) reconstruction after distal gastrectomy , Roux-en-Y (R-Y) reconstruction after distal gastrectomy ,0,
edin,8860,5763662,No significant difference,There was no significant difference between the two groups in the success rate and the time of cyst treatment (P>0.05)., operative success rate , control group: under ultrasound guidance , observation group: combined MPR-CTU (multi-planar reconstruction (MPR) image post-processing technique-computed tomography (CT) urography (CTU)) ,0,
edin,8819,3856598,Significantly increased,"BMDMC therapy led to improved survival in the CLP group, reduced lung elastance, alveolar collapse, tissue and bronchoalveolar lavage fluid cellularity, collagen fiber content, and interleukin-1Î² and increased chemokine (keratinocyte-derived chemokine and monocyte chemotactic protein-1) expression in lung tissue regardless of the experimental ARDS model.", survival , Control mice , cecal ligation and puncture (CLP) - bone marrow-derived mononuclear cells (BMDMC) ,0,
edin,8878,4546110,Cannot tell based on the abstract,," periodic leg movement index, PLMI ", patients with nightmares , sleepwalkers ,0,
edin,8878,4546110,No significant difference,PLMI did not differ between patient groups (PLMI mean Â± SD: nightmares = 5.3 Â± 7.5; sleepwalkers = 3.2 Â± 5.3; p = .44) nor did the number of apnea-hypopnea episodes (AHI mean Â± SD: nightmares = 5.4 Â± 4.1; sleepwalkers = 3.0 Â± 2.4; p = .09).," periodic leg movement index, PLMI ", patients with nightmares , sleepwalkers ,0,
edin,8839,5730627,No significant difference,"The LS meanÂ Â±Â SEM treatment differences for change from baseline on the ADHD-RS-IV hyperactivity/impulsivity and inattentiveness subscales nominally favored LDX in the forced-dose study (hyperactivity/impulsivity subscale â1.3Â Â±Â 0.49, nominal pÂ =Â 0.0081, ES â0.27; inattentiveness subscale â2.0Â Â±Â 0.63, nominal pÂ =Â 0.0013, ES â0.33), but there were no significant differences between active treatments in the flexible-dose study. I", change from baseline on the ADHD-RS-IV hyperactivity/impulsivity and inattentiveness subscales , osmotic-release oral system methylphenidate (OROS-MPH) - forced-dose study , lisdexamfetamine dimesylate (LDX) - forced-dose study ,0,
edin,8916,4727651,Cannot tell based on the abstract,, mean motor score improvement - cases with incomplete TSCI (traumatic spinal cord injury) , late surgery 24-72 hours , early surgery &amp;lt;24 hours ,0,
edin,8916,4727651,No significant difference,"For incomplete TSCI, both groups showed improvement on follow-up visits (Figure 3). In the early surgery group, the mean motor score improved from 77(Â±22) on preoperative examination, to 92(Â±12) on 12-month follow-up visit. In the late surgery group, a change from 68(Â±22) to 82(Â±16) was observed.", mean motor score improvement - cases with incomplete TSCI (traumatic spinal cord injury) , late surgery 24-72 hours , early surgery &amp;lt;24 hours ,0,
edin,8915,4727651,Cannot tell based on the abstract,, improvement of mean ASIA motor score over 12 months - cases with complete TSCI (traumatic spinal cord injury) , late surgery 24-72 hours , early surgery &amp;lt;24 hours ,0,
edin,8915,4727651,No significant difference,"For cases with complete TSCI, no improvement of mean ASIA motor score was observed in either group over 12 months.", improvement of mean ASIA motor score over 12 months - cases with complete TSCI (traumatic spinal cord injury) , late surgery 24-72 hours , early surgery &amp;lt;24 hours ,0,
edin,8881,4461648,Significantly increased,"However, the percentage of time spent with Pcuff >30 cmH2O was significantly higher during continuous control compared with routine care of tracheal cuff (26Â % (14â39) versus 7Â % (1â18), pâ=â0.002).", percentage of time spent with Pcuff &amp;gt;30 cmH2O , routine care , continuous control of Pcuff ,0,
edin,8910,4402481,Cannot tell based on the abstract,, increased thiobarbituric acid reactive substances (TBARS) concentration - immediately after exercise , adults (trained and untrained) , adolescents (trained and untrained) ,0,
edin,8910,4402481,No significant difference,TBARS responses to exercise were comparable among adolescent and adult groups., increased thiobarbituric acid reactive substances (TBARS) concentration - immediately after exercise , adults (trained and untrained) , adolescents (trained and untrained) ,0,
edin,8757,2994863,Cannot tell based on the abstract,, Demographic similarity , ACRIN study , National Lung Screening Trial (NLST) ,0,
edin,8757,2994863,No significant difference,"Demographically, the baseline age and sex distributions in the two arms were virtually identical because of stratified randomization on these factors. In addition, the race, ethnicity, education, and marital status profiles were similar in the two arms.", Demographic similarity , ACRIN study , National Lung Screening Trial (NLST) ,0,
edin,8927,5508614,No significant difference,D-cycloserine did not improve positive or negative symptoms or cognitive dysfunction in schizophrenia., improvement in cognitive dysfunction (schizophrenia patients) , PCB placebo first , DCS D-cycloserine first ,0,
edin,8848,4262215,No significant difference,"There were no statistical differences in the scores of despair factor, optimistic factor, sleep factor, and cover factor between the two groups before the treatment (P>0.05). After different styles of nursing, the former four factors of patients in the study group were significantly lower than those in the control group (P<0.01), while there were no significant differences in the score of cover factor between the two groups (P>0.05).", scores of sleep factor before reatment (individuals diagnosed with malignant tumor) , usual nursing care , mental clinical nursing pathway care ,0,
edin,8902,5588958,Cannot tell based on the abstract,, body weight in people with type 2 diabetes mellitus (T2DM) , placebo , 28 days of oral SRT2104 (2.0âg/day) ,0,
edin,8902,5588958,Significantly decreased,"During SRT2104 administration, body weight decreased by 0.93âkg (95% CI â1.72 to â0.15, p=0.0236) with a treatment-by-period effect (p=0.080).", body weight in people with type 2 diabetes mellitus (T2DM) , placebo , 28 days of oral SRT2104 (2.0âg/day) ,0,
edin,8877,4546110,Cannot tell based on the abstract,, levels of anxiety , patients with nightmares , sleepwalkers ,0,
edin,8877,4546110,Significantly increased,"Patient groups did not differ for depression, which was within the normal range, but levels of anxiety were significantly higher in sleepwalkers compared to patients with nightmares (STAI-T mean Â± SD: nightmares = 36.4 Â± 6.5; sleepwalkers = 46.2 Â± 5.6; p = .001).", levels of anxiety , patients with nightmares , sleepwalkers ,0,
edin,8778,3316967,Significantly increased,"The scores of VAS for dyspnea, cough and quality of life and also respiratory rate, heart rate, and night time awaking due to dyspnea and night time awaking due to cough improved significantly after morphine nebulization without any major adverse events.", Score: cough improvement - COPD patients due to exposure to sulfur mustard (SM) and refractory to conventional therapies , normal saline as placebo , 1âmg morphine sulfate diluted by 4âcc normal saline 0.5% using nebulizer once daily for 5 days ,0,
edin,8771,4280732,Significantly increased,"Analysis of delivery method showed that in mothers, couples, and control groups, normal vaginal delivery was the most preferred method in that order, w hich was significant (P = 0.017).", Most preferred method; normal vaginal delivery , control: no educational workshop , mothers: educational workshop ,0,
edin,8924,4676914,Cannot tell based on the abstract,, mean decrease in HbA1c level , glargine 100 U/ml (Gla-100) , glargine 300 U/ml (Gla-300) ,0,
edin,8924,4676914,Cannot tell based on the abstract,, mean decrease in HbA1c level , glargine 100 U/ml (Gla-100) , glargine 300 U/ml (Gla-300) ,0,
edin,8924,4676914,No significant difference,"n the pooled dataset of all three studies, the mean decrease in HbA1c level was similar in the two treatment groups (Figure 1A).", mean decrease in HbA1c level , glargine 100 U/ml (Gla-100) , glargine 300 U/ml (Gla-300) ,0,
edin,8853,5702366,Cannot tell based on the abstract,, use of rescue medication (patients with COPD) , tiotropium/olodaterol (TIO/OLO) , umeclidinium/vilanterol (UMEC/VI) ,0,
edin,8853,5702366,Significantly decreased,Patients receiving UMEC/VI used statistically significantly less rescue medication during the study compared with those receiving TIO/OLO [TableÂ 2; âÂ 0.25 (95% CI âÂ 0.37 to âÂ 0.14) puffs per day; pÂ <Â 0.001]., use of rescue medication (patients with COPD) , tiotropium/olodaterol (TIO/OLO) , umeclidinium/vilanterol (UMEC/VI) ,0,
edin,8810,4330076,Cannot tell based on the abstract,, moderate hypertension , losartan/ amlodipine/ hydrochlorothiazide , bisoprolol ,0,
edin,8810,4330076,Invalid Prompt,, moderate hypertension , losartan/ amlodipine/ hydrochlorothiazide , bisoprolol ,1, I wasn't able to find anything regarding moderate hypertension in results section 
edin,8923,4676914,Significantly decreased,"Weight gain was low (<1 kg) in both groups, with less gain with Gla-300 [LS mean difference â0.28 kg (95% CI â0.55 to â0.01); p = 0.039].", Weight gain , glargine 100 U/ml (Gla-100) , glargine 300 U/ml (Gla-300) ,0,
edin,8785,5609346,Cannot tell based on the abstract,, exploitative tendency with each additional task , fourth group: control ," Three groups: thinking protocol, the GPP, or both ",0,
edin,8785,5609346,Significantly increased,"With each additional task, all groups increased exploitative tendency(p<0.0001). The two groups with the thinking protocol leaped from exploitation to exploration (p<0.0001); the other two groups remained in exploitation (p=0.1173, p=0.0758). For the groups that employed exploration learning, the group that received the GPP switched back to exploitation (p<0.0001), but the other group remained in exploration (p=0.2363).", exploitative tendency with each additional task , fourth group: control ," Three groups: thinking protocol, the GPP, or both ",0,
edin,8845,4262215,Cannot tell based on the abstract,, quality of life of patients - (individuals diagnosed with a malignant tumor) , usual nursing care , mental clinical nursing pathway care ,0,
edin,8845,4262215,Significantly increased,"For individuals diagnosed with a malignant tumor, using a mental health clinical nursing pathway can effectively decrease the degree of suicidal ideation and positively impact the quality of life.", quality of life of patients - (individuals diagnosed with a malignant tumor) , usual nursing care , mental clinical nursing pathway care ,0,
edin,8767,4545275,Significantly decreased,"Intervention's mean anxiety score and depression score changes were significantly different compared to the control's (b = â29.4, p < 0.001; b = â29.4, p < 0.001, resp.)", mean anxiety score , control group , intervention group ,0,
edin,8880,4461648,No significant difference,"The percentage of time spent with Pcuff 20â30 cmH2O (median (IQR) 34Â % (17â57) versus 50Â % (35â64), pâ=â0.184) and the percentage of time spent with Pcuff <20 cmH2O (23Â % (5â63) versus 43Â % (16â60), pâ=â0.5) were similar during continuous control of Pcuff and routine care, respectively.", percentage of time with Pcuff 20â30 cmH2O versus Pcuff &amp;lt;20 cmH2O , routine care , continuous control of Pcuff ,0,
edin,8804,4467620,Cannot tell based on the abstract,, weight reduction , Hot conditions , Hot + Cooling conditions ,0,
edin,8804,4467620,No significant difference,"Indeed, we observed no difference in weight reduction between conditions (0.41Â Â±Â 0.07% in the Hot condition and 0.37Â Â±Â 0.22% in the HotÂ +Â Cooling condition).", weight reduction , Hot conditions , Hot + Cooling conditions ,0,
edin,8796,2581757,Cannot tell based on the abstract,, NO/MDA ratios , placebo (group P) , preeclamptics without vitamin supplements (group A) and with vitamin supplements (group B) ,0,
edin,8796,2581757,No significant difference,"The NO/MDA ratios, however, were not significantly different in all the three cases (Fig.Â 3).", NO/MDA ratios , placebo (group P) , preeclamptics without vitamin supplements (group A) and with vitamin supplements (group B) ,0,
edin,8776,3316967,Significantly increased,"The scores of VAS for dyspnea, cough and quality of life and also respiratory rate, heart rate, and night time awaking due to dyspnea and night time awaking due to cough improved significantly after morphine nebulization without any major adverse events.", Score: improvement in visual analogue scale (VAS) for dyspnea - COPD patients due to exposure to sulfur mustard (SM) and refractory to conventional therapies , normal saline as placebo , 1âmg morphine sulfate diluted by 4âcc normal saline 0.5% using nebulizer once daily for 5 days ,0,
edin,8832,5668004,Cannot tell based on the abstract,, risk of death , Low Basal HB levels , High Basal HB levels ,0,
edin,8832,5668004,Significantly increased,The reduced elastic net model for OS showed that Hb basal level was associated with a higher risk of death in 98 of 108 (â91%) leave-one-out iterations. HIF-1 Î± expression intensity was also correlated with the risk of death in 84 out of 108 (â78%) iterations (Supplementary Figure 2)., risk of death , Low Basal HB levels , High Basal HB levels ,0,
edin,8946,2755037,Cannot tell based on the abstract,, minor strokes that lasted fewer than 7 days within 30 days of treatment - patients with carotid artery stenosis , endarterectomy , endovascular treatment ,0,
edin,8946,2755037,Significantly increased,"There were more minor strokes that lasted fewer than 7 days within 30 days of treatment in the endovascular group than in the endarterectomy group (8 vs 1), but there were more cranial nerve palsies in the endarterectomy group than in the endovascular group (0 vs 22).", minor strokes that lasted fewer than 7 days within 30 days of treatment - patients with carotid artery stenosis , endarterectomy , endovascular treatment ,0,
edin,8944,2755037,Cannot tell based on the abstract,, rates of any stroke that lasted for more than 7 days - patients with carotid artery stenosis , endarterectomy , endovascular treatment ,0,
edin,8944,2755037,No significant difference,The rates of any stroke that lasted for more than 7 days or death within 30 days of treatment were well matched between the treatment groups (10% in each arm)., rates of any stroke that lasted for more than 7 days - patients with carotid artery stenosis , endarterectomy , endovascular treatment ,0,
edin,8809,4330076,Cannot tell based on the abstract,, slightly elevated body mass index , losartan/ amlodipine/ hydrochlorothiazide , bisoprolol ,0,
edin,8809,4330076,No significant difference,"The patients were all males, had a slightly elevated body mass index (none had body mass index >32 kg/m2) and a moderate hypertension (mean OBP 152/100 mm Hg).", slightly elevated body mass index , losartan/ amlodipine/ hydrochlorothiazide , bisoprolol ,0,
edin,8803,4467620,Cannot tell based on the abstract,, decrease in exercise intensity as time elapsed , Hot conditions , Hot + Cooling conditions ,0,
edin,8803,4467620,No significant difference,These results indicate that exercise intensity decreased as time elapsed and the degree of decrease was not different between conditions., decrease in exercise intensity as time elapsed , Hot conditions , Hot + Cooling conditions ,0,
edin,8814,4445854,Cannot tell based on the abstract,The results of the t-test indicated that storage time only had significant effect on bond strength of Clearfil SE Bond with no EGCG (p= 0.017)., significant effect on bond strength , Filtek Silorane System , Clearfil SE Bond (0) ,0,
edin,8814,4445854,Significantly increased,"The results of t-test in Clearfil SE Bond groups in-dicated that only Clearfil (0) experimental and control groups had significant effect on bond strength (p= 0.021); whereas in Silorane groups, there were no significant differences between non-stored and stored groups (p> 0.05).", significant effect on bond strength , Filtek Silorane System , Clearfil SE Bond (0) ,0,
edin,8770,4280732,Cannot tell based on the abstract,"Also, the attitude mean was statically significant in mothers (P < 0.0001), couples (P < 0.0001), and control groups (P < 0.0001) before and after intervention.", mean scores of attitudes - before educational intervention , men in the three groups , women in the three groups ,0,
edin,8770,4280732,No significant difference,ANOVA showed no significant difference in mean scores of women's (P = 0.120) and men's (P = 0.112) attitude between the three groups before educational intervention., mean scores of attitudes - before educational intervention , men in the three groups , women in the three groups ,0,
edin,8793,3800406,Significantly decreased,"Group II showed significantly less stain intensity in comparison with group I after 14 and 21 days (P values 0.025 and 0.005, respectively).", stain intensity after 21 days , group I rinsed with chlorhexidine (CHX) 0.2% alone , group II used chlorhexidine (CHX) followed by hydrogen peroxide (H2O2) 1.5% ,0,
edin,8896,4059551,Significantly increased,"In multivariate analysis, the Bloemfontein site [odds ratio (OR): 2.43; 95% confidence interval (CI): 1.32 to 4.48] and liking the pill color (OR: 2.93; 95% CI: 1.18 to 7.27) were positively associated with good adherence, whereas using oral contraceptive pills at enrollment was negatively associated with good adherence (OR: 0.37; 95% CI: 0.18 to 0.74).", negatively associated with good adherence , not using oral contraceptive pills at enrollment , using oral contraceptive pills at enrollment ,0,
edin,8945,2755037,Cannot tell based on the abstract,, death within 30 days of treatment - patients with carotid artery stenosis , endarterectomy , endovascular treatment ,0,
edin,8945,2755037,No significant difference,The rates of any stroke that lasted for more than 7 days or death within 30 days of treatment were well matched between the treatment groups (10% in each arm). T, death within 30 days of treatment - patients with carotid artery stenosis , endarterectomy , endovascular treatment ,0,
edin,8922,4676914,Significantly decreased,"Annualized rates of confirmed (â¤3.9 mmol/l) or severe hypoglycaemia were lower with Gla-300 than with Gla-100 during the night (31% difference in rate ratio over 6 months) and at any time (24 h, 14% difference).", annualized rate (events per participant-year) of confirmed [â¤3.9 mmol/l (â¤70 mg/dl)] or severe hypoglycaemia at any time of day (24 h) over the 6-month , glargine 100 U/ml (Gla-100) , glargine 300 U/ml (Gla-300) ,0,
edin,8929,5508614,Cannot tell based on the abstract,, overall effect of onset age on PANSS (Positive and Negative Syndrome Scale) subscales (schizophrenia patients) , PCB placebo first , DCS D-cycloserine first ,0,
edin,8929,5508614,No significant difference,"No significant difference was noted between the DCS-first and PCB-first groups on age, age at onset, age at starting therapy, duration of illness, education, or CPZ equivalents", overall effect of onset age on PANSS (Positive and Negative Syndrome Scale) subscales (schizophrenia patients) , PCB placebo first , DCS D-cycloserine first ,0,
edin,8888,5636088,Significantly increased,"Continuous rPTH1-34 significantly increased 2D healing and callus volumes at 4-weeks versus Placebo, and sustained the significant increase in cortical union at 8-week (p<0.05).", 2D healing at 8 weeks , Placebo (group 1) , Continuous rPTH1-34 (group 2) ,0,
edin,8826,4696975,Cannot tell based on the abstract,, prevalence of previous stroke/transient ischemic attack , those who did not , immediate recurrence of atrial premature beats (IRAPB) - after Catheter Ablation for Atrial Fibrillation ,0,
edin,8826,4696975,Significantly increased,"The patients who tested positive for IRAPB had a higher CHADS2 score (p=0.003), higher prevalence of previous stroke/transient ischemic attack (p=0.002),", prevalence of previous stroke/transient ischemic attack , those who did not , immediate recurrence of atrial premature beats (IRAPB) - after Catheter Ablation for Atrial Fibrillation ,0,
edin,8920,5447816,Significantly decreased,"All participants then took a personality test, and their microsuture test scores and the time to complete the task were compared. The time to complete the task was significantly shorter in the simulator group than in the video-learning group.", suturing test completion time , video-learning groups , simulator-learning ,0,
edin,8891,5636088,Significantly increased,"Continuous rPTH1-34 significantly increased 2D healing and callus volumes at 4-weeks versus Placebo, and sustained the significant increase in cortical union at 8-week (p<0.05).", callus volumes at 4 weeks , Placebo (group 1) , Continuous rPTH1-34 (group 2) ,0,
edin,8938,4624894,Cannot tell based on the abstract,, dose reduction - patients with chronic hepatitis C with HCV genotype 6 , PEG-IFN Î±-2a - 48 weeks , PEG-IFN Î±-2a - 24 weeks ,0,
edin,8938,4624894,No significant difference,"In the 24- and 48-week groups, 2 (2.6%) and 3 (3.9%) patients, respectively, had platelet counts <50/Î¼L and thus required IFN dose reduction and megakaryocyte colony-stimulating factor administration (P = 0.31). Overall, 18 (23.7%) and 22 (28.9%) patients in the 24- and 48-week groups (P = 0.46), respectively, required dose reduction.", dose reduction - patients with chronic hepatitis C with HCV genotype 6 , PEG-IFN Î±-2a - 48 weeks , PEG-IFN Î±-2a - 24 weeks ,0,
edin,8795,3800406,Cannot tell based on the abstract,, amount of plaque formed at end of week 3 , group I rinsed with chlorhexidine (CHX) 0.2% alone , group III used hydrogen peroxide (H2O2) 1.5% followed by chlorhexidine (CHX) ,0,
edin,8795,3800406,No significant difference,"In comparison to group I, there was significantly less amount of plaque formed in group III after the end of first (P value, 0.000) and second week (0.017). After the end of 3 weeks also, the plaque scores were less in group III than group I but it was not significant (P value, 0.104).", amount of plaque formed at end of week 3 , group I rinsed with chlorhexidine (CHX) 0.2% alone , group III used hydrogen peroxide (H2O2) 1.5% followed by chlorhexidine (CHX) ,0,
edin,8858,4533227,Cannot tell based on the abstract,, maximal voluntary contraction (MVC) , OFF medication , ON medication ,0,
edin,8858,4533227,No significant difference,"Notably, there was no significant difference in MVCs between patients ON medication and controls [Patients 360Â Â±Â 23N vs Controls 350Â Â±Â 24N, t(50)Â =Â .31].,MVCs between patients OFF medication and controls were not significantly different [Patients 354Â Â±Â 23N vs Controls 350Â Â±Â 24N, t(50)Â =Â .129].,To determine if maximal force output was modulated by dopamine, we compared MVCs ON and OFF medication. Importantly, they were not significantly different [OFF 354Â Â±Â 24N vs ON 360Â Â±Â 23N, t(25)Â =Â â1.34].", maximal voluntary contraction (MVC) , OFF medication , ON medication ,0,
edin,8932,4143738,Cannot tell based on the abstract,, colonoscopic findings , previous-evening (PM) PEG solutio , morning (AM) PEG (polyethylene glycol) solution ,0,
edin,8932,4143738,No significant difference,The colonoscopic findings were similar in AM and PM groups (P=0.65) (table2)., colonoscopic findings , previous-evening (PM) PEG solutio , morning (AM) PEG (polyethylene glycol) solution ,0,
edin,8841,5730627,Significantly increased,"The percentage of improved participants on the dichotomized CGI-I at end of treatment was significantly greater with LDX than with OROS-MPH in the forced-dose study (81.4 vs. 71.3%, pÂ =Â 0.0188) but not the flexible-dose study (LDX 83.1%, OROS-MPH 81.0%, pÂ =Â 0.6165).", Improvement on the dichotomized CGI-I at EOS , osmotic-release oral system methylphenidate (OROS-MPH) - forced-dose study , lisdexamfetamine dimesylate (LDX) - forced-dose study ,0,
edin,8933,4143738,No significant difference,The colon prep was adequate in 94.4% in AM group and in 90.2% cases in PM group (P=0.2)., colon preperation , previous-evening (PM) PEG solutio , morning (AM) PEG (polyethylene glycol) solution ,0,
edin,8903,2687939,Cannot tell based on the abstract,, acute grade 3 or 4 toxicity (early breast cancer) , control FEC (fluorouracil) or E-CMF (epirubicin plus cyclophosphamide) , experimental FEC-D (fluorouracil-docetaxel) ,0,
edin,8903,2687939,Significantly increased,"The proportion of patients reporting any acute grade 3 or 4 toxicity, occurring during treatment and within 30 days of treatment end, was significantly greater in the experimental group than in the control group (table 4).", acute grade 3 or 4 toxicity (early breast cancer) , control FEC (fluorouracil) or E-CMF (epirubicin plus cyclophosphamide) , experimental FEC-D (fluorouracil-docetaxel) ,0,
edin,8894,4059551,Cannot tell based on the abstract,, good adherence , Pretoria and Bondo sites , Bloemfontein site ,0,
edin,8894,4059551,Significantly increased,"In multivariate analysis, being from the Bloemfontein site (OR: 2.43; 95% CI: 1.32 to 4.48) and liking the color of the pill (OR: 2.93; 95% CI: 1.18 to 7.27) remained positively associated with good adherence and using OCPs at enrollment remained negatively associated with good adherence (OR: 0.37; 95% CI: 0.18 to 0.74) (Table 4).", good adherence , Pretoria and Bondo sites , Bloemfontein site ,0,
edin,8935,4143738,Significantly decreased,Sleep quality and the need for flush was lower in the AM group (P=0.004 and P=0.03)., flush need , previous-evening (PM) PEG solutio , morning (AM) PEG (polyethylene glycol) solution ,0,
edin,8897,4059551,Cannot tell based on the abstract,, negatively associated with good adherence , having had no sex without using a condom in the 4-week interval before drug measurement , having had sex without using a condom in the 4-week interval before drug measurement ,0,
edin,8897,4059551,Significantly increased,We also found that using OCPs at enrollment (OR: 0.37; 95% CI: 0.20 to 0.70) and reporting having had sex without using a condom in the 4-week interval before drug measurement (OR: 0.60; 95% CI: 0.37 to 0.98) were negatively associated with good adherence., negatively associated with good adherence , having had no sex without using a condom in the 4-week interval before drug measurement , having had sex without using a condom in the 4-week interval before drug measurement ,0,
edin,8759,2994863,Cannot tell based on the abstract,, Median age , chest radiograph , computerized tomography ,0,
edin,8759,2994863,No significant difference,"Mean age of the entire cohort was 61.4 years (standard deviation = 5.0 years). Median age was 60 years (interquartile range = 57â65 years). Because randomization was stratified by sex and 5-year age group, the participant numbers are virtually identical within these categories across study arms.", Median age , chest radiograph , computerized tomography ,0,
edin,8862,5763662,Significantly decreased,The incidence of intraoperative and postoperative complications of the observation group was significantly lower than that of the control group., postoperative complications , control group: under ultrasound guidance , observation group: combined MPR-CTU (multi-planar reconstruction (MPR) image post-processing technique-computed tomography (CT) urography (CTU)) ,0,
edin,8912,4402481,No significant difference,"Catalase activity, uric acid, and bilirubin responses were comparable among groups.", increased uric acid concentration - immediately after exercise , adults (trained and untrained) , adolescents (trained and untrained) ,0,
edin,8898,5588958,Significantly decreased,"Bradykinin-induced vasodilatation was less during treatment with SRT2104 versus placebo (7.753vs9.044, respectively, mean difference=â1.291,(95% CI â2.296 to â0.285, p=0.012)).", bradykinin-induced vasodilatation in people with type 2 diabetes mellitus (T2DM) , placebo , 28 days of oral SRT2104 (2.0âg/day) ,0,
edin,8805,4467620,Significantly decreased,The accuracy of the cognitive tasks was lower during exercise than that at rest in the Hot and HotÂ +Â Cooling condition (pÂ <Â 0.05)., accuracy of the cognitive tasks , At rest - Hot + Cooling conditions , Exercise - Hot + Cooling conditions ,0,
edin,8763,5217809,Significantly increased,The weight of infants in the intervention group was significantly higher than that of those in the control group (p<0.001)., weight of infants , control - received only the routine care , intervention - 8 sessions of consultation for delivery preparation ,0,
edin,8855,4533227,Cannot tell based on the abstract,, maximal voluntary contraction (MVC) , control , ON medication ,0,
edin,8855,4533227,No significant difference,"Notably, there was no significant difference in MVCs between patients ON medication and controls [Patients 360Â Â±Â 23N vs Controls 350Â Â±Â 24N, t(50)Â =Â .31].", maximal voluntary contraction (MVC) , control , ON medication ,0,
edin,8798,2581757,Cannot tell based on the abstract,, Elevated Plasma lipid peroxides (MDA) levels , placebo (group P) , preeclamptics with vitamin supplements (group B) ,0,
edin,8798,2581757,Significantly increased,"Plasma lipid peroxides (MDA) levels were found to be elevated in preeclamptics with and without vitamin supplements. Moreover, the increase was significantly higher in Group A (pÂ =Â 0.0013) than in Group B (pÂ =Â 0.0184) as compared to placebo-P (Fig.Â 1).", Elevated Plasma lipid peroxides (MDA) levels , placebo (group P) , preeclamptics with vitamin supplements (group B) ,0,
edin,8806,4330076,Cannot tell based on the abstract,, reduced kidney glomerular filtration rate , losartan/ amlodipine/ hydrochlorothiazide , bisoprolol ,0,
edin,8806,4330076,No significant difference,No patient had drugâtreated diabetes or reduced kidney glomerular filtration rate., reduced kidney glomerular filtration rate , losartan/ amlodipine/ hydrochlorothiazide , bisoprolol ,0,
edin,8870,5633234,Cannot tell based on the abstract,, trend of temptation to smoke scores , control group , intervention group ,0,
edin,8870,5633234,Significantly decreased,"Also, according to repetitive tests, the trend of temptation to smoke scores among interventions was significantly declining (F=30.215, p=0.001, SE=0.38).", trend of temptation to smoke scores , control group , intervention group ,0,
edin,8943,2755037,Cannot tell based on the abstract,, combined outcome of non-perioperative stroke or TIA - patients with carotid artery stenosis , endarterectomy , endovascular treatment ,0,
edin,8943,2755037,No significant difference,"The combined outcome of non-perioperative stroke or TIA was more common in the endovascular group than it was in the endarterectomy group, but the difference was not significant (HR 1Â·37, 95% CI 0Â·95â1Â·97).", combined outcome of non-perioperative stroke or TIA - patients with carotid artery stenosis , endarterectomy , endovascular treatment ,0,
edin,9188,5667629,Significantly increased,"The improvements in FEV1, VAS, and ODI were significantly greater in the experimental group than in the control group (P<0.01).", Pain VAS improvement  , Control , Abdominal muscle strengthening training ,0,
edin,9426,2992187,Significantly increased,"Controlled for factors associated with diabetes risk, continuous antidepressant use compared with no use was associated with diabetes risk in the placebo (adjusted hazard ratio 2.34 [95% CI 1.32â4.15]) and lifestyle (2.48 [1.45â4.22]) arms, but not in the metformin arm (0.55 [0.25â1.19]).", diabetes risk - lifestyle arm , non users , antidepressant users (ADM) ,0,
edin,9324,3053227,Significantly decreased,"A significant decrease over time in the hemodynamic values, respiratory rate, and shivering was seen in the active core-rewarming group when compared with the controls.", Shivering  , Passive external rewarming , Core rewarming  ,0,
edin,9258,3217852,Cannot tell based on the abstract,, Urinary cortisol excretion  , Placebo , Fluticasone furoate 200 mcg ,0,
edin,9258,3217852,No significant difference,"However, safety data from our study suggest that FF 200 or 400 mcg administered once daily in the evening has a minimal effect on UC levels; 24-hour urinary excretion ratios were similar to placebo for all FF treatment groups and between morning and evening dosing and once-daily and twice-daily dosing. T", Urinary cortisol excretion  , Placebo , Fluticasone furoate 200 mcg ,0,
edin,9413,3650238,Cannot tell based on the abstract,"Multivariate analysis of covariance showed that the experimental group achieved improvement in somatic symptoms, depression, and total score in general mental health; and in anticipation of positive outcome, desire to use opioid, and relief from withdrawal of craving in comparison with the control group.", Improvement in mental health scores  , Maintenance treatment , Maintenance treatment plus neurofeedback sessions ,0,
edin,9413,3650238,Significantly increased,"MANCOVA results are provided in TableÂ 3, where it is seen that the intervention produced significant improvement for physical symptoms, depression, and the total score of mental health.", Improvement in mental health scores  , Maintenance treatment , Maintenance treatment plus neurofeedback sessions ,0,
edin,9127,5536158,No significant difference,"The reduction in systolic blood pressure was similar in both groups (Fixed:7.64Â±2.49%; Free: 7.81Â±4.00%, n.s.), while the reduction of diastolic blood pressure was greater in the Fixed group (Fixed: 14.22Â±2.03%; Free: 4.92Â±5.00%, p<0.05).", Systolic blood pressure reduction ,  ACE-I + Calcium Antagonist free dose ,  ACE-I + Calcium Antagonist fixed dose ,0,
edin,9360,4145491,Cannot tell based on the abstract,, Psychosocial quality of life , Control , Family empowerment ,0,
edin,9360,4145491,Significantly increased,"Results showed that the mean scores (standard deviation) of QOL in physical, psychosocial dimensions, and the total score of QOL were 81.1 (14), 80.2 (13.8), and 80.5 (12.3), respectively, before intervention and 87.3 (9.4), 86.5 (7.6) and 86.8 (7.4), respectively, after intervention. Paired t-test showed a significant difference before and after intervention. This difference was not significant in the control group.,There was also a significant difference in the mean scores of QOL in physical (P = 0.02) and psychosocial (P = 0.03) dimensions and the total QOL score (P = 0.02) after intervention, but this difference was not significant in the control group in physical (P = 0.81) and psychosocial (P = 0.81) dimensions and the total score of QOL (P = 0.79) [Table 2].", Psychosocial quality of life , Control , Family empowerment ,0,
edin,9130,1924504,Significantly decreased,The percentage of symptom-free days was significantly greater (58.8% vs 52.1%; p = 0.034) and the annual exacerbation rate was significantly lower (47%; p = 0.008) with stable-dose SAL/FP compared with FOR/BUD AMD., Annual exacerbation rate , Formoterol/budesonide , Salmeterol/fluticasone propionate  ,0,
edin,9114,5746709,Cannot tell based on the abstract,, disability , other treatment , isolated lumbar extension ,0,
edin,9114,5746709,Significantly decreased,Mean change in ODI was â14.4 pts and ranged from 18 pts to â45 pts. Change in ODI did not meet assumptions of normality of distribution when examined using the Shapiro-Wilk test (p = 0.049)., disability , other treatment , isolated lumbar extension ,0,
edin,9446,5073301,Significantly increased,"HP-Legume induced lower composite appetite score, hunger, prospective food consumption, and higher fullness compared to HP-Meat and LP-Legume (p<0.05).,Furthermore, HP-Legume induced higher fullness than LP-Legume (p<0.05).", fullness , LP (low protein) - Legume meal , HP (high protein) -Legume meal ,0,
edin,9240,3204557,Cannot tell based on the abstract,, 5-year disease-free survival  , Hepatic resection , Radiofrequency ablation ,0,
edin,9240,3204557,Significantly decreased,"However, DFS in the RFA group was significantly lower than the other groups (P = 0.037). The 5-year DFS rate was 6.4% in the RFA group, 16.2% in the resection group, and 18.4% in the combination therapy group.", 5-year disease-free survival  , Hepatic resection , Radiofrequency ablation ,0,
edin,9311,3917884,Significantly decreased,"There was a significant main effect of the D treatment, decreasing waist circumference (Pâ=â0.001), total cholesterol (Pâ=â0.007), LDL-cholesterol (Pâ=â0.003) and fasting insulin (Pâ=â0.042), at the end of the 12-wk treatment. The decreased waist circumference (P<0.001) and insulin (Pâ=â0.024) was sustained and HDL-cholesterol increased (Pâ=â0.005) at the 1-y follow-up.", Waist circumference , Control , Diet intervention ,0,
edin,9356,4190894,Cannot tell based on the abstract,, Heart rate during injection , Control , Dexmedetomidine  ,0,
edin,9356,4190894,Significantly decreased,"In general, heart rates were lower in group B than in group A at the time point of injection of DEX, anesthesia induction, and intubation (Table II). The lowest heart rate in group B was 49 bpm after anesthesia induction, and it returned to 70 bpm after intra-tracheal intubation. There was no serious hypotension recorded.

Table II.
Changes in patients' heart rates.

Group A	Group B
Baseline	78 Â± 6.6	78 Â± 7.0
Study drug injection	78 Â± 6.8	63 Â± 4.2a", Heart rate during injection , Control , Dexmedetomidine  ,0,
edin,9352,4676364,Significantly increased,"In the intervention kindergarten, the willingness to eat the samples increased significantly (pâ¤0.001, Wilcoxon and Friedman), while in the control kindergarten, no significant change was observed when all of the test samples were taken into account.", Willingness to eat lingonberry , Control ,  Sensory-based food education ,0,
edin,9292,4305224,Significantly decreased,"SPAZ reduced maternal parasitaemia (RR: 0.57, 95% CI: 0.35â0.95, Pâ=â0.029) and active placental malaria (0.68, 95% CI: 0.47â0.98, Pâ=â0.037), and reduced carriage of gonorrhoea (0.66, 95% CI: 0.44â0.99, Pâ=â0.041) at second visit.", Risk of active placental malaria  , Control , Sulphadoxine-pyrimethamine + azithromycin ,0,
edin,9293,4305224,Cannot tell based on the abstract,, Risk of adverse events , Control , Sulphadoxine-pyrimethamine + azithromycin ,0,
edin,9293,4305224,No significant difference,"<td>
<bold>All adverse events</bold>
</td><td>414</td><td>(30.1)</td><td>397</td><td>(28.8)</td><td>0.96 (0.85â1.07)</td><td>0.447</td>", Risk of adverse events , Control , Sulphadoxine-pyrimethamine + azithromycin ,0,
edin,9328,3053227,Cannot tell based on the abstract,, Arterial-oxygen saturation , Passive external rewarming , Core rewarming  ,0,
edin,9328,3053227,No significant difference,"No significant difference between groups was found in the measurements of pH, oxygen or carbon dioxide tension, arterial-oxygen tension to the fractional inspired-oxygen ratio, arterial-oxygen saturation (P > 0.05), and in the biochemical variables (Table 1).", Arterial-oxygen saturation , Passive external rewarming , Core rewarming  ,0,
edin,9365,4684352,Significantly decreased,Dogs fed MH had significantly lower post-prandial RQ (p = 0.02) and ratio of fat to lean body mass (p = 0.02)., Post-prandial respiratory quotient , Control , Mannoheptulose ,0,
edin,9248,4045244,Cannot tell based on the abstract,, Proprioceptive drift effect during asynchronous stroking , Sham stimulation , Repetitive transcranial magnetic stimulation ,0,
edin,9248,4045244,No significant difference,"Based on our assumption that rTMS stimulation would produce an effect compared to sham stimulation during synchronous stroking but not asynchronous stroking, we compared proprioceptive drift in the post-stimulation session using post hoc paired t-tests, which revealed a significantly (p < 0.025) stronger effect of rTMS versus sham stimulation on proprioceptive drift during synchronous stroking [t(15) = 2.578, p = 0.021], but not during asynchronous stroking [t(15) = 0.161, p = 0.876].", Proprioceptive drift effect during asynchronous stroking , Sham stimulation , Repetitive transcranial magnetic stimulation ,0,
edin,9242,4969982,Significantly increased,Exogenous lactate clearance was significantly higher in the dexmedetomidine and esmolol groups.,  Exogenous lactate clearance  , Control , Dexmedetomidine ,0,
edin,9220,1185549,Cannot tell based on the abstract,, Drinks per drinking day , Zero sessions , One therapy session ,0,
edin,9220,1185549,Significantly increased,"The one treatment group was significantly worse that the zero treatment group over all time points for both percent days abstinent (F = 4.73 (1, 130) p = .031) and drinks per drinking day (F = 4.51 (1, 130) p = .036).", Drinks per drinking day , Zero sessions , One therapy session ,0,
edin,9279,5029174,Cannot tell based on the abstract,, Proactive problem-solving , Control , Job coaching sessions ,0,
edin,9279,5029174,Significantly increased,"<td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">AVEM â proactive problem-solving</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""top"">0.381</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""top"">0.516</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""top"">0.067</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""top"">0.738</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""top"">0.463</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""top"">0.336</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""top"">0.004</td>", Proactive problem-solving , Control , Job coaching sessions ,0,
edin,9269,4868921,Significantly increased,"<td colspan=""1"" rowspan=""1""></td><td align=""left"" colspan=""1"" rowspan=""1"">Symbol Search</td>", Performance in Stroop , Control , Learning therapy ,0,
edin,9126,5536158,No significant difference,After 3 months BP control was improved in both groups and BP targets were similarly reached in both groups (SBP; Fixed: 61.54%; Free 69.23%; n.s. DPB; Fixed: 80.77%; Free 84.62%; n.s.)., Reaching blood pressure target ,  ACE-I + Calcium Antagonist free dose ,  ACE-I + Calcium Antagonist fixed dose ,0,
edin,9337,5442667,Cannot tell based on the abstract,, âPhysical functioning	 , Control ,  Medication therapy management ,0,
edin,9337,5442667,No significant difference,<td>âPhysical functioning</td><td>3.6âÂ±â16.0</td><td>â5.2âÂ±â15.6</td><td>0.06</td>, âPhysical functioning	 , Control ,  Medication therapy management ,0,
edin,9422,4183968,Cannot tell based on the abstract,, Hyperactivation of the reward system for low-calorie food cues , Control group , Weight-loss intervention ,0,
edin,9422,4183968,Significantly increased,"However, in contrast to that study, which showed only a decrease in activation for HC foods, our intervention participants also had an absolute increase in activation for LC foods.", Hyperactivation of the reward system for low-calorie food cues , Control group , Weight-loss intervention ,0,
edin,9163,2500257,Significantly decreased,"Notification was associated with reduced mortality (8% vs.17%, p = 0.05), further antibiotic use (median â2.5 days, p = 0.01), and trended toward reduced hospital stay and charges.", Further antibiotic use , Control , PNA FISH-generated laboratory data notification  ,0,
edin,9257,3217852,Significantly increased,"FF 400 mcg once daily in the evening and FF 200 mcg twice daily produced similar placebo-adjusted improvements in evening pre-dose FEV1 at week 8 (240 ml vs. 235 ml). FF 400 mcg once daily in the morning, although effective, resulted in a smaller improvement in morning pre-dose FEV1 than FF 200 mcg twice daily at week 8 (315 ml vs. 202 ml). The incidence of oral candidiasis was low (0-4%) and UC excretion was comparable with placebo for all FF groups.,FF at total daily doses of 200 mcg or 400 mcg was significantly more effective than placebo.",  FEV1 improvement   , Placebo , Fluticasone furoate 200 mcg twice a day  ,0,
edin,9198,3221066,Cannot tell based on the abstract,, Tenderness on maxillary sinus , Trayodashanga Kwatha + Madhu , Pradhamana Nasya + Trikatu + Triphala Churna ,0,
edin,9198,3221066,No significant difference,"Though percentage wise Group A and Group C showed better result in comparison to Group B in tenderness on Frontal, maxillary and ethmoid sinuses, the results are insignificant, whereas result of Group B in Frontal sinuses are highly significant and in maxillary sinuses are significant", Tenderness on maxillary sinus , Trayodashanga Kwatha + Madhu , Pradhamana Nasya + Trikatu + Triphala Churna ,0,
edin,9343,4829247,Significantly increased,P-wave duration and Pd significantly increased during MM and ITH compared to BL in all subjects (+13.1ms and +13.8ms during MM; +11.7ms and +12.9ms during ITH; p<0.001 for all comparisons)., P-wave dispersion  , Normal breathing , Simulated Obstructive Sleep Apnea ,0,
edin,9159,4608292,Cannot tell based on the abstract,, Length of the procedure , Control , Goal-directed fluid therapy ,0,
edin,9159,4608292,No significant difference,<th>(<italic>N</italic>â=â40)</th><th>(<italic>N</italic>â=â40)</th><th>(<italic>N</italic>â=â40)</th>, Length of the procedure , Control , Goal-directed fluid therapy ,0,
edin,9171,4895399,Significantly increased,"MeanÂ Â±Â SD percentage of time intragastric pH was â¥3 and â¥4 was 67.0Â Â±Â 24.0% and 54.6Â Â±Â 26.4% for twiceâdaily omeprazole, 24.4Â Â±Â 22.8% and 16.8Â Â±Â 19.3% for onceâdaily omeprazole, 16.5Â Â±Â 9.0% and 9.6Â Â±Â 5.9% for ranitidine, and 9.4Â Â±Â 8.0% and 7.0Â Â±Â 6.6% for placebo administration. Twiceâdaily omeprazole treatment significantly increased intragastric pH, whereas pH after onceâdaily omeprazole and ranitidine treatments did not differ from that of placeboâtreated cats.", Time for â¥3 and â¥4 intragastric pH   , Placebo , Omeprazole twiceâdaily  ,0,
edin,9319,5784025,Significantly decreased,The pulsatility index on transcranial Doppler was significantly reduced in valsartan (pâ=â0.002) and fimasartan group (pâ=â0.008)., Transcranial Doppler pulsatility index  , Atenolol , Fimasartan ,0,
edin,9278,5029174,Cannot tell based on the abstract,, Striving for perfection , Control , Job coaching sessions ,0,
edin,9278,5029174,Significantly decreased,There were no significant differences between the control and intervention group except for one of the AVEM-44 subscales (striving for perfection) for which the control group scored slightly higher., Striving for perfection , Control , Job coaching sessions ,0,
edin,9209,4761605,No significant difference,"The two groups did not differ significantly in terms of prothrombin time, activated partial thromboplastin time, platelet number, blood loss, or operation duration.",  Blood loss , Small drain , Large drain ,0,
edin,9266,3657667,Cannot tell based on the abstract,, Home consultations costs , Control , Hypertension telemonitoring-based service ,0,
edin,9266,3657667,No significant difference,"<td colspan=""1"" rowspan=""1"">âHome consultations</td><td colspan=""1"" rowspan=""1"">0.06 (0.03)</td><td colspan=""1"" rowspan=""1"">7.74 (3.24)</td><td colspan=""1"" rowspan=""1"">0.09 (0.04)</td><td colspan=""1"" rowspan=""1"">10.39 (4.52)</td><td colspan=""1"" rowspan=""1"">â2.65 (â11.91 to 5.27)</td><td colspan=""1"" rowspan=""1"">0.553</td>", Home consultations costs , Control , Hypertension telemonitoring-based service ,0,
edin,9276,5029174,Cannot tell based on the abstract,, Subjective importance of work , Control , Job coaching sessions ,0,
edin,9276,5029174,Significantly increased,"<td align=""left"" colspan=""1"" rowspan=""1"" valign=""top"">AVEM â subjective importance of work</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""top"">â0.922</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""top"">0.532</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""top"">â0.156</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""top"">â1.734</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""top"">0.087</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""top"">0.354</td><td align=""center"" colspan=""1"" rowspan=""1"" valign=""top"">0.024</td>", Subjective importance of work , Control , Job coaching sessions ,0,
edin,9175,2645358,Significantly increased,"At 12 months, the intervention group had greater weight loss (-5.6 Â± 6.8% vs. -1.2 Â± 4.6%, p < .001) and larger decreases in body size dissatisfaction (effect size of 1.08 vs. .41, p < .001) than the comparison group.", Weight loss , Control , Behavioral obesity treatment ,0,
edin,9233,4015738,Cannot tell based on the abstract,, IL-10 , Unbalanced solutions , Balanced solutions ,0,
edin,9233,4015738,Significantly increased,"<td align=""center"">&nbsp;</td><td align=""center""><bold>T3</bold></td><td align=""center"">138 [98â178]</td><td align=""center"">12.6 [8.9 â 17.6]</td><td align=""center"">14.2* [7.0 â 18.2]</td>,IL-6 and IL-8 increased similarly in both groups (TableÂ 3), whilst IL-10 was higher in the BS group (TableÂ 3).", IL-10 , Unbalanced solutions , Balanced solutions ,0,
edin,9125,5721363,Cannot tell based on the abstract,There were no associations between change in strength and change in physical function in participants with mild or moderate physical dysfunction at baseline., function accounting baseline for moderate dysfunction , traditional quadriceps strengthening exercises , neuromuscular exercise ,0,
edin,9125,5721363,No significant difference,"Notably, the association between change in knee extensor strength and change in physical function was not significant for participants with mild and moderate baseline physical dysfunction (TableÂ 3).", function accounting baseline for moderate dysfunction , traditional quadriceps strengthening exercises , neuromuscular exercise ,0,
edin,9222,1185549,Cannot tell based on the abstract,, Drinks per drinking day , Zero sessions , All therapy session ,0,
edin,9222,1185549,No significant difference,"There were no significant differences between the zero treatment dropout group and the full treatment group from week 1 to follow up in percent days abstinent (t = .25, 395 df, p = .800) or in drinks per drinking day (t = 1.22, 395 df, p = .222).", Drinks per drinking day , Zero sessions , All therapy session ,0,
edin,9274,4868921,Significantly increased,"<td colspan=""1"" rowspan=""1""></td><td align=""left"" colspan=""1"" rowspan=""1"">Symbol Search</td>", Symbol Search speed , Control , Learning therapy ,0,
edin,9322,5784025,Significantly decreased,"Plasma NT-proBNP level was also significantly decreased in ARB groups, especially for the fimasartan group (37.8âÂ±â50.6 vs. 29.2âÂ±â36.9 vs.19.2âÂ±â27.8âpg/mL; pâ=â0.006).", N-terminal pro b-type natriuretic peptide  , Atenolol , Valsartan ,0,
edin,9182,4278388,Cannot tell based on the abstract,, Pursuing exercising at least 3 times a week , Control , Guided group exercise intervention ,0,
edin,9182,4278388,No significant difference,"In the exercise intervention group, 26% (95% CI 11â40) of men pursued exercising at least three times a week, in the health check group 16% (95% CI 5â27) and in the control group 17% (95% CI 5â29); however the differences between the groups were not statistically significant (Figure 2).", Pursuing exercising at least 3 times a week , Control , Guided group exercise intervention ,0,
edin,9295,4288428,Cannot tell based on the abstract,, Feeling inadequate  , Inclusion group , Exclusion group ,0,
edin,9295,4288428,No significant difference,Excluded participants also endorsed at marginally greater rates the statement âI felt somewhat inadequate during the Cyberball gameâ ( p = 0.055)., Feeling inadequate  , Inclusion group , Exclusion group ,0,
edin,9390,4397550,Cannot tell based on the abstract,, Dynamic VAS for sedation score , Bupivacaine plus buprenorphine (Group II) , Bupivacaine (Group I) ,0,
edin,9390,4397550,No significant difference,Sedation score was not statistically or clinically significant in the present study., Dynamic VAS for sedation score , Bupivacaine plus buprenorphine (Group II) , Bupivacaine (Group I) ,0,
edin,9314,3917884,Significantly decreased,"There was a significant main effect of the D treatment, decreasing waist circumference (Pâ=â0.001), total cholesterol (Pâ=â0.007), LDL-cholesterol (Pâ=â0.003) and fasting insulin (Pâ=â0.042), at the end of the 12-wk treatment.", Fasting insulin , Control , Diet intervention ,0,
edin,9346,4829247,Cannot tell based on the abstract,, P-wave dispersion  , Normal breathing , Central apnea ,0,
edin,9346,4829247,No significant difference,The AP manoeuvre was not associated with significant changes compared to BL in P-wave duration (-0.1 ms vs BL; p = 0.90) or Pd (+0.4 ms vs BL; p = 0.79)., P-wave dispersion  , Normal breathing , Central apnea ,0,
edin,9121,4058264,Cannot tell based on the abstract,, intensity of pain , control , huxin group ,0,
edin,9121,4058264,No significant difference,"There were no significant differences (P > 0.05) between control group and treatment group on secondary outcomes at all time points after PCI, including angina scale (frequency of attack, duration time, intensity of pain, and dose of nitroglycerin), SAQ (dimension of body activities limitation, angina pectoris stable state, heart attacks, disease knowledge, and treatment satisfaction), and the quality of life scale of integrative medicine.", intensity of pain , control , huxin group ,0,
edin,9129,1924504,Significantly increased,The percentage of symptom-free days was significantly greater (58.8% vs 52.1%; p = 0.034) and the annual exacerbation rate was significantly lower (47%; p = 0.008) with stable-dose SAL/FP compared with FOR/BUD AMD., Symptom-free days , Formoterol/budesonide , Salmeterol/fluticasone propionate  ,0,
edin,9380,4784207,Significantly increased,"The separate written consent had a positive impact on the patientsâ understanding of the nature and purpose of the intended anesthesia procedures (P = 0.04), satisfaction with the adequacy of information provided about common side effects (P < 0.001) and rare but serious complications (P = 0.008).", Patientsâ understanding anesthesia procedure , Control , Additional consent for anesthesia  ,0,
edin,9431,3653044,Cannot tell based on the abstract,, increase in force compensation - cursor color (red or blue) , final trial , initial trial ,0,
edin,9431,3653044,No significant difference,"Although over the course of the exposure period MPE decreased (Fig. 2E, final exposure; F1,5 = 58.220; P = 0.001), no significant increase in force compensation was seen (F1,5 = 0.223; P = 0.657) from the initial to the final trials of the exposure period.", increase in force compensation - cursor color (red or blue) , final trial , initial trial ,0,
edin,9382,4784207,Significantly increased,"The separate written consent had a positive impact on the patientsâ understanding of the nature and purpose of the intended anesthesia procedures (P = 0.04), satisfaction with the adequacy of information provided about common side effects (P < 0.001) and rare but serious complications (P = 0.008).", Satisfaction with information rare complications , Control , Additional consent for anesthesia  ,0,
edin,9357,4190894,Cannot tell based on the abstract,, Bispectral index during intubation  , Control , Dexmedetomidine  ,0,
edin,9357,4190894,Significantly increased,"Compared with group A, the BIS values in group B were lower at the procedures of intubation and skin cut.,<td align=""left"" colspan=""1"" rowspan=""1"">Intubation</td><td align=""center"" colspan=""1"" rowspan=""1"">64.5 Â± 4.3</td><td align=""center"" colspan=""1"" rowspan=""1"">51.4 Â± 2.8<xref ref-type=""fn"" rid=""T3-F1""><sup>a</sup></xref>
</td>", Bispectral index during intubation  , Control , Dexmedetomidine  ,0,
edin,9361,4145491,Significantly increased,The findings showed that family empowerment model was effective in increasing the quality of life of children with chronic kidney diseases., Quality of life total score , Control , Family empowerment ,0,
edin,9144,4868208,Significantly increased,"Experiment group 1 showed a statistically significant improvement in balance and walking speed compared to experiment group 2, and the control group in week 4 and week 8.", Walking speed after 8 weeks , Control , Kinesio taping group ,0,
edin,9254,3698010,Cannot tell based on the abstract,, Activity , Control , Paracetamol 250  mg ,0,
edin,9254,3698010,Significantly decreased,"Systemic reactions were generally less frequent in the prophylaxis group with significant differences noted for fever, rash, irritability, drowsiness, decreased appetite, persistent inconsolable crying, and decreased activity after at least one dose in the infant series (all pâ<â0.05). After the toddler dose, where systemic reactions occurred more often, only âactivityâ was significantly decreased in the prophylaxis group (pâ=â0.005) (TableÂ 4).", Activity , Control , Paracetamol 250  mg ,0,
edin,9288,4305224,Significantly decreased,"SPAZ reduced LBW (risk ratio [RR]: 0.74, 95% CI: 0.60â0.91, Pâ=â0.005; absolute risk reduction (ARR): 4.5%, 95% CI: 1.4â7.6; number needed to treat: 22), and preterm delivery (0.62, 95% CI: 0.43â0.89, Pâ=â0.010), and increased mean birthweight (41.9Â g, 95% CI: 0.2â83.6, Pâ=â0.049).", Risk of low birthweight , Control , Sulphadoxine-pyrimethamine + azithromycin ,0,
edin,9428,2992187,Significantly increased,"Controlled for factors associated with diabetes risk, continuous antidepressant use compared with no use was associated with diabetes risk in the placebo (adjusted hazard ratio 2.34 [95% CI 1.32â4.15]) and lifestyle (2.48 [1.45â4.22]) arms, but not in the metformin arm (0.55 [0.25â1.19]).", diabetes risk - placebo arm , non users , antidepressant users (ADM) ,0,
edin,9320,5784025,Significantly decreased,The pulsatility index on transcranial Doppler was significantly reduced in valsartan (pâ=â0.002) and fimasartan group (pâ=â0.008)., Transcranial Doppler pulsatility index  , Atenolol , Valsartan ,0,
edin,9335,5442667,Significantly increased,"The targeted MTM intervention resulted in statistically significant CDR adjusted differences between groups with regard to improved MAI (change score of 3.6 (1.1) for the MTM group as compared with 1.0 (0.9) for the control group, pâ=â0.04) and ADS (change score of 1.0 (0.3) for the MTM group as compared with 0.2 (0.3) for the control group, pâ=â0.03).", Medication appropriateness index improvement   , Control ,  Medication therapy management ,0,
edin,9305,4910973,No significant difference,Cox multivariate analysis showed no statistically significant difference in TUDD for most of the QLQ-C30 scales between treatments., Time until definitive deterioration of insomnia , Oxaliplatin  , Dose-dense oxaliplatin + Irinotecan   ,0,
edin,9323,3053227,Significantly decreased,"A significant decrease over time in the hemodynamic values, respiratory rate, and shivering was seen in the active core-rewarming group when compared with the controls.", Respiratory rate , Passive external rewarming , Core rewarming  ,0,
edin,9370,4153084,Cannot tell based on the abstract,, ADAS-Cog total score , Control , MSDC-0160 ,0,
edin,9370,4153084,No significant difference,"able 3 shows that changes in performance on the ADAS-Cog total score, the 19-item cognitive test battery global cognitive summary z-score, and the 7-item Executive Function battery summary z-score at 12 weeks of treatment as compared to baseline. There was no significant difference between the groups over this short time frame.", ADAS-Cog total score , Control , MSDC-0160 ,0,
edin,9447,5073301,Significantly increased,"A 12% and 13% lower energy intake, respectively, was seen after HP-Legume compared to HP-Meat or LP-Legume (p<0.01).", lower energy intake , HP (high protein) - Meat meal and the LP (low protein) - Legume meal , HP (high protein) -Legume meal ,0,
edin,9104,5793008,Significantly increased,"Mindfulness, aggression, and negative emotional regulation changed significantly for the YP group, while mindfulness alone improved significantly for the VM group.", mindfulness , control group , yoga ,0,
edin,9433,3653044,Cannot tell based on the abstract,, over the course of the exposure period maximum perpendicular error (MPE) decrease - same cursor color , final trial , initial trial ,0,
edin,9433,3653044,No significant difference,"Although over the course of the exposure period MPE decreased (Fig. 2E, final exposure; F1,5 = 58.220; P = 0.001), no significant increase in force compensation was seen (F1,5 = 0.223; P = 0.657) from the initial to the final trials of the exposure period.", over the course of the exposure period maximum perpendicular error (MPE) decrease - same cursor color , final trial , initial trial ,0,
edin,9186,4278388,Cannot tell based on the abstract,, Cardiovascular outcomes , Control , Health check ,0,
edin,9186,4278388,No significant difference,The cardiovascular outcomes are presented in Table II. The interventions had no statistically significant effects on these outcomes at three months or at 12 months., Cardiovascular outcomes , Control , Health check ,0,
edin,9150,4435702,Cannot tell based on the abstract,"Patients receiving 8Â mg VM202 per leg improved the most in all efficacy measures including a significant (PÂ =Â 0.03) reduction at 3Â months in the mean pain score and continued but not statistically significant reductions in pain at 6 and 9Â months. Of these patients, 48.4% experienced a â¥50% reduction in pain compared to 17.6% of placebo patients.", â¥50% reduction in mean pain , Placebo , VM202 plasmid (16mg) ,0,
edin,9150,4435702,Significantly increased,"A responder was defined as a subject that experienced â¥50% reduction in mean pain from baseline. At 90Â days, patients in the LD group had nearly threefold more responders than Placebo (PÂ =Â 0.06; P: 17.6% responders, LD: 48.4% responders).", â¥50% reduction in mean pain , Placebo , VM202 plasmid (16mg) ,0,
edin,9448,5073301,Cannot tell based on the abstract,"When adjusting for palatability, HP-Legume still resulted in lower composite appetite scores, hunger, prospective consumption, and higher fullness compared to HP-Meat (p<0.05).", palatability , HP (high protein) - Meat meal and the LP (low protein) - Legume meal , HP (high protein) -Legume meal ,0,
edin,9448,5073301,Significantly decreased,The palatability of the HP-Legume meal was rated significantly poorer than that of the other two meals (p<0.0001)., palatability , HP (high protein) - Meat meal and the LP (low protein) - Legume meal , HP (high protein) -Legume meal ,0,
edin,9414,3650238,Cannot tell based on the abstract,, Social functions or anxiety level , Maintenance treatment , Maintenance treatment plus neurofeedback sessions ,0,
edin,9414,3650238,No significant difference,No differences were found for anxiety or social functions.TableÂ 2, Social functions or anxiety level , Maintenance treatment , Maintenance treatment plus neurofeedback sessions ,0,
edin,9227,4094569,No significant difference,Primary analysis revealed no significant difference in transition dyspnea index focal score for any active treatment versus placebo., Transition dyspnea index focal score , Placebo , Olodaterol 10 Î¼g via RespimatÂ® ,0,
edin,9436,4213554,Significantly decreased,"Birth weight of infants in the SC group was lower than that in the UC group (3469 vs. 3371 grams, P = 0.021).", birth weight , usual care (UC) , 3-tierâs shared care (SC) ,0,
edin,9203,5338176,Cannot tell based on the abstract,, Shear bond strength , Full-preparation + finishing with diamond bur , Grinding with diamond bur  ,0,
edin,9203,5338176,Significantly increased,"The highest shear bond strength was observed in group C, followed by A and B. Statistically significant difference was detected between group C and B (p< 0.05).", Shear bond strength , Full-preparation + finishing with diamond bur , Grinding with diamond bur  ,0,
edin,9172,4895399,Cannot tell based on the abstract,, Time for â¥3 and â¥4 intragastric pH   , Ranitidine  , Omeprazole onceâdaily  ,0,
edin,9172,4895399,No significant difference,"With respect to percentage of time intragastric pH was â¥3 and â¥4, twiceâdaily omeprazole had a significantly greater effect than onceâdaily omeprazole, ranitidine, and placebo administration. There were no significant differences among the latter 3 treatment arms.", Time for â¥3 and â¥4 intragastric pH   , Ranitidine  , Omeprazole onceâdaily  ,0,
edin,9228,4094569,Cannot tell based on the abstract,, Need for rescue medication  , Placebo , Olodaterol 10 Î¼g via RespimatÂ® ,0,
edin,9228,4094569,Significantly decreased,"Olodaterol 5 and 10 Î¼g and formoterol 12 Î¼g all provided statistically significant reductions in weekly mean daytime and nighttime rescue medication compared to placebo throughout the 48-week treatment period, as demonstrated by analysis of the combined data set.", Need for rescue medication  , Placebo , Olodaterol 10 Î¼g via RespimatÂ® ,0,
edin,9261,4789479,No significant difference,No statistically significant difference could be detected in SP expression between the two groups., Substance P expression  , Control , Ketoprofen ,0,
edin,9141,4868208,Significantly increased,"Experiment group 1 showed a statistically significant improvement in balance and walking speed compared to experiment group 2, and the control group in week 4 and week 8.", Balance ability after 8 weeks , McConnell taping group , Kinesio taping group ,0,
edin,9139,4868208,Significantly increased,"Experiment group 1 showed a statistically significant improvement in balance and walking speed compared to experiment group 2, and the control group in week 4 and week 8.", Balance ability after 4 weeks , McConnell taping group , Kinesio taping group ,0,
edin,9281,4341337,Significantly increased,Ciclesonide spray was more effective than levocetirizine in reducing nasal symptoms in both SAR and PAR patients., Physician-assessed overall nasal signs and symptoms improvement  , Levocetirizine , Ciclesonide + Levocetirizine ,0,
edin,9332,5525580,Significantly increased,"In addition, group B had a higher ratio of T helper to inducer lymphocytes as well as a higher ratio of CD4 to CD8 lymphocytes (P<0.01 for both) than group A.", T helper to inducer lymphocytes ratio , Sepsis Survival Campaign guidelines , Total parenteral nutrition + Sepsis Survival Campaign guidelines  ,0,
edin,9152,4435702,Cannot tell based on the abstract,, Urinalysis abnormalities  , Placebo , VM202 plasmid (8mg) ,0,
edin,9152,4435702,No significant difference,"There were no significant abnormalities in the urinalysis, hematology, and clinical chemistry results across all treatment groups (data not shown).", Urinalysis abnormalities  , Placebo , VM202 plasmid (8mg) ,0,
edin,9407,5045904,No significant difference,"Although the length of stay and mortality did not differ between the groups in the intensive care unit, Glasgow outcome scale score was significantly lower in the MST group at discharge (3.30Â±1.35 vs 3.90Â±1.10, P=0.004) and 3 months after discharge (2.95Â±1.48 vs 3.66Â±1.44, P=0.009).", Mortality rate , Standard treatment , Magnesium sulfate ,0,
edin,9120,4058264,Cannot tell based on the abstract,, rehospitalization , control , huxin group ,0,
edin,9120,4058264,No significant difference,"There were no significant differences (P > 0.05) between control group and treatment group in major end points at 360-day follow-up (Table 3), including mortality, number of patients with nonfatal myocardial infarction, proportion of further revascularization, and rehospitalization caused by cardiovascular events.", rehospitalization , control , huxin group ,0,
edin,9199,3221066,Cannot tell based on the abstract,, Tenderness on ethmoid sinus , Trayodashanga Kwatha + Madhu , Pradhamana Nasya + Trikatu + Triphala Churna ,0,
edin,9199,3221066,No significant difference,"Though percentage wise Group A and Group C showed better result in comparison to Group B in tenderness on Frontal, maxillary and ethmoid sinuses, the results are insignificant, whereas result of Group B in Frontal sinuses are highly significant and in maxillary sinuses are significant [Table 3].", Tenderness on ethmoid sinus , Trayodashanga Kwatha + Madhu , Pradhamana Nasya + Trikatu + Triphala Churna ,0,
edin,9119,4058264,Cannot tell based on the abstract,, further revascularization , control , huxin group ,0,
edin,9119,4058264,No significant difference,"There were no significant differences (P > 0.05) between control group and treatment group in major end points at 360-day follow-up (Table 3), including mortality, number of patients with nonfatal myocardial infarction, proportion of further revascularization, and rehospitalization caused by cardiovascular events.", further revascularization , control , huxin group ,0,
edin,9251,3698010,Significantly decreased,"Fever >39Â°C was rare during the infant series, such that there were too few cases for assessment. After the toddler dose, paracetamol effectively reduced fever >39Â°C, reaching statistical significance in the PP population only (efficacy 79%; 95% CI: 3.9, 97.7).", Fever â¥39Â°C , Control , Paracetamol 250 mg ,0,
edin,9149,4435702,Significantly increased,"Patients receiving 8Â mg VM202 per leg improved the most in all efficacy measures including a significant (PÂ =Â 0.03) reduction at 3Â months in the mean pain score and continued but not statistically significant reductions in pain at 6 and 9Â months. Of these patients, 48.4% experienced a â¥50% reduction in pain compared to 17.6% of placebo patients.", â¥50% reduction in mean pain , Placebo , VM202 plasmid (8mg) ,0,
edin,9344,4829247,Significantly increased,P-wave duration and Pd significantly increased during MM and ITH compared to BL in all subjects (+13.1ms and +13.8ms during MM; +11.7ms and +12.9ms during ITH; p<0.001 for all comparisons)., P-wave dispersion  , Normal breathing  , Obstructive hypopnea ,0,
edin,9297,4288428,Cannot tell based on the abstract,, Feeling angry , Inclusion group , Exclusion group ,0,
edin,9297,4288428,No significant difference,"There were no significant differences between the exclusion and inclusion groups on statements regarding feeling frustrated, angry, good about oneself, enjoyment of the game, or âfelt as though my existence was meaninglessâ (even though excluded participants did rate âI felt non-existent during the gameâ significantly higher than included participants).", Feeling angry , Inclusion group , Exclusion group ,0,
edin,9151,4435702,No significant difference,There were no significant adverse events attributable to VM202., Significant adverse events , Placebo , VM202 plasmid (8mg) ,0,
edin,9202,5450344,No significant difference,There were no adverse events., Adverse events , Control , Transcranial Random Noise Stimulation ,0,
edin,9183,4278388,Cannot tell based on the abstract,, Pursuing exercising at least 3 times a week , Control , Health check ,0,
edin,9183,4278388,No significant difference,"In the exercise intervention group, 26% (95% CI 11â40) of men pursued exercising at least three times a week, in the health check group 16% (95% CI 5â27) and in the control group 17% (95% CI 5â29); however the differences between the groups were not statistically significant (Figure 2).", Pursuing exercising at least 3 times a week , Control , Health check ,0,
edin,9241,3204557,No significant difference,"In the 226 patients with solitary CRLM < 3 cm, OS and DFS rates did not differ between the RFA group and the resection group (P = 0.962 and P = 0.980).", 5-year overall survival  , Hepatic resection , Radiofrequency ablation ,0,
edin,9349,4676364,Cannot tell based on the abstract,, Willingness to eat swede , Control ,  Sensory-based food education ,0,
edin,9349,4676364,Significantly increased,"When the samples were inspected separately (Table 3), it was found that the willingness to eat carrots (p<0.001), swede (p=0.004), and bilberries (p<0.001) increased statistically (Friedman's) in the intervention group.", Willingness to eat swede , Control ,  Sensory-based food education ,0,
edin,9204,5338176,No significant difference,"However, the difference between group A and C was insignificant, as was the difference between group A and B (p> 0.05).", Shear bond strength , Full-preparation , Grinding with diamond bur  ,0,
edin,9408,5045904,Significantly decreased,"Although the length of stay and mortality did not differ between the groups in the intensive care unit, Glasgow outcome scale score was significantly lower in the MST group at discharge (3.30Â±1.35 vs 3.90Â±1.10, P=0.004) and 3 months after discharge (2.95Â±1.48 vs 3.66Â±1.44, P=0.009).", Glasgow outcome scale score at discharge and 3 months after discharge , Standard treatment , Magnesium sulfate ,0,
edin,9444,3868679,Cannot tell based on the abstract,, Average blood loss , Single incision laparoscopic surgery (SILS) cholecystectomy (group 2) , Single incision laparoscopic surgery (SILS) cholecystectomy (group 1) ,0,
edin,9444,3868679,No significant difference,Average blood loss was similar between the groups., Average blood loss , Single incision laparoscopic surgery (SILS) cholecystectomy (group 2) , Single incision laparoscopic surgery (SILS) cholecystectomy (group 1) ,0,
edin,9173,4895399,No significant difference,"MeanÂ Â±Â SD percentage of time intragastric pH was â¥3 and â¥4 was 67.0Â Â±Â 24.0% and 54.6Â Â±Â 26.4% for twiceâdaily omeprazole, 24.4Â Â±Â 22.8% and 16.8Â Â±Â 19.3% for onceâdaily omeprazole, 16.5Â Â±Â 9.0% and 9.6Â Â±Â 5.9% for ranitidine, and 9.4Â Â±Â 8.0% and 7.0Â Â±Â 6.6% for placebo administration. Twiceâdaily omeprazole treatment significantly increased intragastric pH, whereas pH after onceâdaily omeprazole and ranitidine treatments did not differ from that of placeboâtreated cats.", Time for â¥3 and â¥4 intragastric pH   , Placebo , Omeprazole onceâdaily  ,0,
edin,9224,4094569,Significantly increased,"Olodaterol significantly improved FEV1 area under the curve from 0â3 hours versus placebo in both studies (with olodaterol 5 Î¼g, 0.151 L and 0.129 L; with olodaterol 10 Î¼g, 0.165 L and 0.154 L; for all comparisons P<0.0001) and FEV1 trough responses versus placebo (0.053â0.085 L; P<0.01), as did formoterol.", FEV1 AUC from 0â3 hours , Placebo , Olodaterol 10 Î¼g via RespimatÂ® ,0,
edin,9211,4761605,Cannot tell based on the abstract,, Platelet function , Small drain , Large drain ,0,
edin,9211,4761605,Significantly decreased,"However, platelet function analysis differed significantly between the two groups (LD, 164.7 seconds < SD, 222.3 seconds; p = 0.002).", Platelet function , Small drain , Large drain ,0,
edin,9166,2500257,Significantly decreased,"Notification was associated with reduced mortality (8% vs.17%, p = 0.05), further antibiotic use (median â2.5 days, p = 0.01), and trended toward reduced hospital stay and charges.", Overall mortality , Control , PNA FISH-generated laboratory data notification  ,0,
edin,9405,5045904,Cannot tell based on the abstract,, Glasgow coma scale scores after 7 days , Standard treatment , Magnesium sulfate ,0,
edin,9405,5045904,Significantly increased,"We found significant improvement in the GCS score on days 3 and 7 after admission in the MST group (7.39Â±2.07 with MST and 6.23Â±2.29 without MST, P=0.004) and (8.23Â±2.72 with MST and 7.05Â±2.64 without MST, P=0.016), respectively.", Glasgow coma scale scores after 7 days , Standard treatment , Magnesium sulfate ,0,
edin,9147,3364603,Significantly decreased,"In forty-nine (27, group A; 22, group B) patients completing all tests, the mean value of the natural logarithmic-scaled reactive hyperemia index (L_RHI) increased and those of serum nonesterified fatty acid (NEFA), malondialdehyde, and soluble vascular cell adhesion molecule 1 decreased significantly during the KBG-treatment period,", Malondialdehyde , Control , Keishibukuryogan  ,0,
edin,9388,4397550,Significantly decreased,Median duration of analgesia was 16 h in group I and 20 h in group II (P = 0.002)., Analgesia duration , Bupivacaine plus buprenorphine (Group II) , Bupivacaine (Group I) ,0,
edin,9219,1185549,Cannot tell based on the abstract,, Percent days of abstinence  , Zero sessions , One therapy session ,0,
edin,9219,1185549,No significant difference,"Percent days abstinent at pre-treatment and during the 12 weeks of treatment for patients who received 0, 1 or 12 treatment sessions. The effective improvement in drinking was instantaneous, evident at week 1. The improvement was maintained at the same approximate level for the 12 weeks of scheduled treatment. The effect occurred for all groups, whether they attended all 12 treatment sessions, only one treatment session, or did not attend any treatment sessions. See also Figure 4.", Percent days of abstinence  , Zero sessions , One therapy session ,0,
edin,9393,5491162,Cannot tell based on the abstract,, Disappearance of hematuria , Standard treatment , Standard treatment plus Mizoribine ,0,
edin,9393,5491162,No significant difference,"However, the intention-to-treat analysis demonstrated no significant difference in the hematuria disappearance rate between groups (Fig. 4).", Disappearance of hematuria , Standard treatment , Standard treatment plus Mizoribine ,0,
edin,9160,4608292,Cannot tell based on the abstract,, Mean arterial blood pressure after procedure , Control , Goal-directed fluid therapy ,0,
edin,9160,4608292,Significantly decreased,<td>MAP end of procedure (mmHg)</td><td>118 (14)</td><td>105 (12)<sup>b</sup><sup>c</sup></td><td>103 (18)<sup>b</sup><sup>c</sup></td><td>&lt;0.001</td>, Mean arterial blood pressure after procedure , Control , Goal-directed fluid therapy ,0,
edin,9435,4213554,No significant difference,Women in the SC (n = 339) and UC (n = 361) groups delivered their infants at similar gestational weeks., gestational weeks at delivery , usual care (UC) , 3-tierâs shared care (SC) ,0,
edin,9283,4341337,Cannot tell based on the abstract,, Reflective total ocular symptom scores , Levocetirizine , Ciclesonide + Levocetirizine ,0,
edin,9283,4341337,No significant difference,"Values of rTOSS scores improved from the baseline in the ciclesonide group, but no superiority over the levocetirizine group was observed.", Reflective total ocular symptom scores , Levocetirizine , Ciclesonide + Levocetirizine ,0,
edin,9259,3217852,Cannot tell based on the abstract,, Urinary cortisol excretion  , Placebo , Fluticasone furoate 400 mcg ,0,
edin,9259,3217852,No significant difference,"However, safety data from our study suggest that FF 200 or 400 mcg administered once daily in the evening has a minimal effect on UC levels; 24-hour urinary excretion ratios were similar to placebo for all FF treatment groups and between morning and evening dosing and once-daily and twice-daily dosing.", Urinary cortisol excretion  , Placebo , Fluticasone furoate 400 mcg ,0,
edin,9230,3806550,Cannot tell based on the abstract,, Satisfaction with care , Control , Web-Based Tool to Support Shared Decision Making ,0,
edin,9230,3806550,No significant difference,"Patients also did not differ in self-reported satisfaction with care (CSQ) (F 1,70=0.014, P=.91).", Satisfaction with care , Control , Web-Based Tool to Support Shared Decision Making ,0,
edin,9445,5073301,Significantly increased,"Furthermore, satiety was higher after HP-Legume than HP-Meat (p<0.05).", satiety , HP (high protein) - Meat meal  , HP (high protein) -Legume meal ,0,
edin,9391,4397550,No significant difference,Demographic data were comparable between the groups., Demographic characteristics , Bupivacaine plus buprenorphine (Group II) , Bupivacaine (Group I) ,0,
edin,9110,5125190,Significantly decreased,The intensity of pain was significantly less in patients receiving methylprednisolone and lignocaine than those receiving saline (P < 0.012)., pain , saline group , lignocaine group ,0,
edin,9310,2277487,Cannot tell based on the abstract,, Progression-free survival , Surgery alone , Perioperative chemotherapy + surgery ,0,
edin,9310,2277487,No significant difference,"We have shown that perioperative chemotherapy with FOLFOX4 reduced the risk of progression-free survival events at 3 years by a quarter in patients with resectable liver metastases.,We conclude that perioperative FOLFOX4 chemotherapy reduced the risk of events of progression-free survival by a quarter and was compatible with major surgery.", Progression-free survival , Surgery alone , Perioperative chemotherapy + surgery ,0,
edin,9367,4684352,Significantly decreased,"Physical activity during light time periods (but not dark) was lower in dogs fed MH (p < 0.05) during weekends, but not on weekdays.", Physical activity during light time periods , Control , Mannoheptulose ,0,
edin,9443,3868679,Significantly increased,There was higher cosmetic satisfaction in group 1 (P < 0.05)., cosmetic satisfaction , Single incision laparoscopic surgery (SILS) cholecystectomy (group 2) , Single incision laparoscopic surgery (SILS) cholecystectomy (group 1) ,0,
edin,9430,3653044,Cannot tell based on the abstract,, over the course of the exposure period maximum perpendicular error (MPE) decrease - movement in different workspace locations , final trial , initial trial ,0,
edin,9430,3653044,Significantly increased,"In experiment 3, movements were made in different workspace locations, with location determining the field direction. Over the course of the exposure period, trajectory deviations produced by the introduction of the curl force field diminished substantially (Fig. 3E, final exposure). Using an ANOVA, we found a significant reduction in MPE from the initial to the final trials of the exposure period (F1,5 = 82.295; P < 0.001).", over the course of the exposure period maximum perpendicular error (MPE) decrease - movement in different workspace locations , final trial , initial trial ,0,
edin,9200,3221066,Cannot tell based on the abstract,, Tenderness on frontal sinus , Pradhamana Nasya +l Trayodashanga Kwatha + Madhu , Pradhamana Nasya + Trikatu + Triphala Churna ,0,
edin,9200,3221066,No significant difference,"Though percentage wise Group A and Group C showed better result in comparison to Group B in tenderness on Frontal, maxillary and ethmoid sinuses, the results are insignificant, whereas result of Group B in Frontal sinuses are highly significant and in maxillary sinuses are significant", Tenderness on frontal sinus , Pradhamana Nasya +l Trayodashanga Kwatha + Madhu , Pradhamana Nasya + Trikatu + Triphala Churna ,0,
edin,9392,5491162,No significant difference,"Secondary outcomes were the rate of patients with proteinuria disappearance, clinical remission rate, absolute changes in estimated glomerular filtration rate from baseline, and the change in daily dose of prednisolone. Forty-two patients were randomly assigned to MZR (n = 21) and control groups (n = 21). Nine patients in MZR group and 15 patients in the control group completed the study. No significant differences were observed between the two groups with respect to primary and secondary outcomes.", Reduction in proteinuria , Standard treatment , Standard treatment plus Mizoribine ,0,
edin,9161,4608292,Cannot tell based on the abstract,, Blood loss , Control , Goal-directed fluid therapy ,0,
edin,9161,4608292,No significant difference,"The overall fluid status (amount of fluids administered, blood loss etc.) was comparable in both protocol groups", Blood loss , Control , Goal-directed fluid therapy ,0,
edin,9300,4910973,No significant difference,Cox multivariate analysis showed no statistically significant difference in TUDD for most of the QLQ-C30 scales between treatments., Time until definitive deterioration of pain , Oxaliplatin  , Dose-dense oxaliplatin + Irinotecan   ,0,
edin,9308,2249589,Cannot tell based on the abstract,, Sick leave days , Control , Arthroscopy + exercise ,0,
edin,9308,2249589,Significantly increased,The mean number of sick leave days was 8.7 in the arthroscopy group and 1.4 in the control group (p < 0.001)., Sick leave days , Control , Arthroscopy + exercise ,0,
edin,9389,4397550,Cannot tell based on the abstract,, Visual Analog Score for post-operative pain , Bupivacaine plus buprenorphine (Group II) , Bupivacaine (Group I) ,0,
